data_2lkd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lkd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.818 0.342 . . . . 1.27 110.512 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -92.56 129.93 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 108.763 -0.828 . . . . 1.83 108.763 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.461 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 44.9 mtm -143.82 -171.58 3.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.783 -0.644 . . . . 1.28 109.716 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.456 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 129.96 -158.57 22.36 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.617 -0.993 . . . . 0.34 110.617 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.832 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 50.2 t60 -91.04 157.12 17.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.851 0.834 . . . . 0.28 111.189 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 6.4 p -73.5 154.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.366 -1.288 . . . . 1.09 109.9 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.5 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 20.3 t70 74.84 -18.94 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.295 0.569 . . . . 0.69 110.559 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.537 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 15.1 m170 -83.01 -4.86 58.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.515 -0.921 . . . . 0.63 108.515 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.682 ' HA3' HD12 ' A' ' 24' ' ' LEU . . . 111.01 47.34 0.77 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.391 -0.909 . . . . 0.79 114.062 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -50.61 -66.58 0.36 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.366 0.583 . . . . 3.69 111.691 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -94.15 -30.71 14.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.202 -0.454 . . . . 1.76 111.233 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.519 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.0 -27.46 63.52 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.724 0.639 . . . . 1.71 112.724 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.682 HD12 ' HA3' ' A' ' 20' ' ' GLY . 5.5 mp -78.61 -25.31 45.15 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.95 -0.3 . . . . 2.09 110.956 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.9 -17.1 60.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.936 -0.764 . . . . 2.23 108.936 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.08 -45.71 8.53 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.052 0.929 . . . . 1.23 108.805 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 24' ' ' LEU . . . -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.719 -1.582 . . . . 1.23 110.475 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 tt . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 114.91 -1.041 . . . . 1.59 110.974 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.2 mt . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.592 -0.522 . . . . 1.38 109.592 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 p -116.87 136.47 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 119.957 -0.697 . . . . 1.79 110.618 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 13.0 mt -96.64 128.8 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.501 -0.772 . . . . 1.14 109.98 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 84' ' ' LEU . 2.2 tm? -114.54 109.77 18.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.956 -1.127 . . . . 1.65 107.956 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.07 118.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.333 -0.394 . . . . 1.14 111.051 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.7 m -128.24 120.62 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.698 -0.683 . . . . 1.31 110.3 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.68 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -64.73 131.81 47.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.719 -0.673 . . . . 1.01 110.262 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.741 ' HB1' ' CG2' ' A' ' 114' ' ' ILE . . . -67.65 -18.09 64.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.084 0.469 . . . . 1.07 110.751 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.472 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -90.13 -14.65 33.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.392 -0.822 . . . . 0.58 111.316 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.474 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.5 t0 -123.63 -47.48 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.56 110.75 -170.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.625 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.82 -151.14 27.3 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.37 113.098 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.614 HG12 ' HE2' ' A' ' 134' ' ' TYR . 21.5 t -77.96 129.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.828 0.823 . . . . 1.78 111.025 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.935 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.2 mmm -130.94 179.89 1.23 Allowed Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 114.265 -1.334 . . . . 1.07 108.615 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.935 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.11 -66.01 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.284 2.656 . . . . 0.89 114.564 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.454 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.5 pt20 -73.23 -15.27 61.44 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.287 0.565 . . . . 0.78 110.94 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.832 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.0 -43.83 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 1.07 109.007 176.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 100' ' ' ILE . 30.1 t -66.15 -42.59 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.255 -0.884 . . . . 2.02 111.302 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.28 -29.01 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.239 -0.437 . . . . 2.35 110.098 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 14' ' ' MET . . . -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 1.12 110.538 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.671 HG21 HD11 ' A' ' 136' ' ' LEU . 96.5 mt -75.4 -44.89 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.796 0.808 . . . . 1.14 109.147 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -57.1 -37.42 71.92 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.041 -1.436 . . . . 0.75 110.944 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -71.5 -37.91 71.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.274 0.559 . . . . 3.23 109.795 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -44.31 68.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.785 -0.643 . . . . 1.17 111.824 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.72 ' HD3' HD22 ' A' ' 136' ' ' LEU . 1.8 mmmp? -76.42 -28.9 56.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.051 0.453 . . . . 2.27 110.482 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.12 -44.56 61.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.174 -0.921 . . . . 1.28 110.268 173.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.14 -34.99 22.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.992 -0.549 . . . . 1.31 110.436 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.3 t30 83.87 40.82 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.843 1.257 . . . . 1.6 109.36 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 109' ' ' PRO . 24.5 t -83.8 145.29 46.77 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 113.279 -1.782 . . . . 1.93 110.99 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.43 ' O ' HG11 ' A' ' 108' ' ' VAL . 21.8 Cg_exo -61.93 138.68 75.14 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.257 1.972 . . . . 0.66 111.436 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.0 OUTLIER -107.68 159.07 7.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 122.011 0.91 . . . . 1.34 112.226 -172.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.709 HD11 ' HB ' ' A' ' 146' ' ' ILE . 5.9 mm -126.02 87.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.538 -1.664 . . . . 1.12 106.858 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.544 HG22 HG23 ' A' ' 145' ' ' THR . 61.5 t -78.1 148.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.603 -0.726 . . . . 1.06 109.971 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 148' ' ' CYS . . . -140.12 110.19 6.51 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.569 -1.196 . . . . 1.07 110.679 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.8 HG22 ' HA ' ' A' ' 124' ' ' PRO . 3.2 mp -84.86 108.31 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.148 -1.387 . . . . 1.29 109.636 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.68 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.4 p-10 -99.45 178.02 5.0 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.626 -1.25 . . . . 1.85 107.626 -171.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 74.9 mttt 70.75 28.44 3.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.034 0.834 . . . . 1.18 110.123 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.69 ' HE3' ' HG3' ' A' ' 124' ' ' PRO . 85.5 mmm -81.54 -7.27 59.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.351 -0.981 . . . . 1.64 108.351 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -68.41 -30.44 69.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.521 -1.672 . . . . 0.76 109.634 168.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -71.79 131.73 85.66 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.78 -0.645 . . . . 1.74 110.089 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.27 -15.09 47.67 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.391 2.061 . . . . 0.68 111.388 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -90.24 5.71 45.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.377 -0.829 . . . . 1.45 110.592 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.44 ' HB2' ' SD ' ' A' ' 117' ' ' MET . . . -54.77 124.41 16.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.731 -0.668 . . . . 1.1 111.271 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.31 76.07 68.45 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.337 -0.986 . . . . 0.95 108.337 173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.8 ' HA ' HG22 ' A' ' 114' ' ' ILE . 39.4 Cg_endo -64.17 -62.03 0.1 Allowed 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.025 2.483 . . . . 0.54 113.305 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.49 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 6.9 m-20 -61.63 -16.15 45.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.257 -0.883 . . . . 1.44 111.019 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -75.42 -58.39 3.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.598 0.713 . . . . 4.56 109.307 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.625 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 12.7 m -66.03 -29.48 46.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 1.26 110.194 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.905 ' HE3' ' HG3' ' A' ' 138' ' ' PRO . 15.4 ttt -59.99 -39.59 86.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 1.64 110.793 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.575 ' O ' ' HG2' ' A' ' 132' ' ' MET . 45.0 mt-30 -69.14 -29.67 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 2.0 111.933 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.596 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 9.0 mt-10 -67.05 -29.07 68.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.587 . . . . 1.64 109.533 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.555 HD12 ' CD1' ' A' ' 136' ' ' LEU . 4.0 mm? -64.73 -44.5 89.99 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.641 -0.708 . . . . 1.96 110.071 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.575 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 14.7 ptm -70.57 -10.2 58.7 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.813 -0.755 . . . . 2.05 110.83 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -78.73 -28.3 44.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.05 -0.722 . . . . 1.67 109.05 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.614 ' HE2' HG12 ' A' ' 92' ' ' VAL . 71.3 m-85 -92.73 22.79 4.5 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.836 0.826 . . . . 1.58 109.659 167.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.0 t30 61.33 46.23 7.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 113.855 -1.52 . . . . 1.42 111.749 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.72 HD22 ' HD3' ' A' ' 104' ' ' LYS . 72.9 mt -113.67 93.6 4.46 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.93 109.732 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 1.012 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 44.5 t -102.74 122.87 44.43 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.199 -0.909 . . . . 1.18 110.635 -172.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.905 ' HG3' ' HE3' ' A' ' 128' ' ' MET . 10.6 Cg_endo -60.0 157.52 33.67 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.211 2.608 . . . . 0.88 112.902 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.8 mm-40 -79.72 -12.1 59.81 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.127 -1.397 . . . . 3.08 110.574 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.753 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -69.89 -19.63 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.899 -0.591 . . . . 1.57 109.888 167.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.499 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 45.1 m0 -110.6 -20.43 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.338 -0.392 . . . . 0.66 111.306 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.72 28.75 5.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.839 -0.696 . . . . 0.57 113.417 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 1.012 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.2 -106.8 1.95 Allowed Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.58 -0.819 . . . . 0.6 112.689 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -166.0 61.21 0.1 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 122.284 1.04 . . . . 1.91 110.419 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 98.8 m -164.06 133.93 4.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 1.1 110.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.709 ' HB ' HD11 ' A' ' 111' ' ' ILE . 28.0 mm -97.16 110.1 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 109.495 -0.557 . . . . 1.27 109.495 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.685 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 12.1 m-85 -90.05 150.51 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.53 110.295 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 91.1 m -131.25 127.0 36.92 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.663 -1.153 . . . . 1.0 109.747 171.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.587 ' HB3' ' HE2' ' A' ' 117' ' ' MET . 0.0 OUTLIER -95.1 88.13 5.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.056 -0.72 . . . . 1.96 109.056 176.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 1.058 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -115.98 170.12 8.73 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.685 1.231 . . . . 1.49 112.768 -170.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.1 p -129.94 104.78 7.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.961 -1.126 . . . . 2.07 107.961 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.41 -9.9 59.05 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.377 -0.529 . . . . 1.11 109.762 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -82.54 -46.39 13.44 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.128 -0.629 . . . . 2.78 112.119 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 p -86.39 -3.39 58.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 119.188 -1.005 . . . . 1.35 111.363 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp 64.89 45.59 3.18 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.287 -0.87 . . . . 1.9 110.705 172.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.576 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.51 -58.34 1.97 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.65 -1.159 . . . . 2.48 110.062 -175.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 1.058 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -79.76 -10.65 85.5 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.296 -0.865 . . . . 0.36 113.847 -173.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 27' ' ' ALA . 56.1 mt -66.6 -36.8 83.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.857 0.829 . . . . 1.42 109.043 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 1.6 m-20 -69.84 -42.12 74.01 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.695 -1.139 . . . . 2.2 110.182 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.83 -21.26 64.31 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.499 -0.319 . . . . 0.68 111.154 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -74.13 -51.15 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.659 -0.496 . . . . 1.77 109.659 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.2 pp -60.79 -27.51 68.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.795 -0.639 . . . . 2.1 110.711 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.601 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 42.0 mt-10 -64.63 -48.04 76.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.4 -0.364 . . . . 2.57 110.812 174.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.573 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 0.0 OUTLIER -63.8 -35.63 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.32 -0.4 . . . . 1.21 110.27 176.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 73.4 mt -62.01 -48.57 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.922 -0.581 . . . . 1.2 110.829 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 163' ' ' GLU . 4.5 pp -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 121.007 -0.277 . . . . 2.3 110.965 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.472 ' N ' HD13 ' A' ' 166' ' ' LEU . 4.8 tt -54.38 -50.53 67.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.927 -0.768 . . . . 2.11 108.927 172.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 164' ' ' MET . 65.1 t . . . . . 0 N--CA 1.444 -0.757 0 CA-C-N 115.883 -0.599 . . . . 1.41 110.777 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.69 ' HB ' HG21 ' A' ' 82' ' ' VAL . 7.5 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 110.488 -0.19 . . . . 1.27 110.488 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.442 HD13 ' HB ' ' A' ' 83' ' ' ILE . 46.0 mm -105.06 113.61 42.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 1.83 109.978 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.583 ' SD ' ' HB2' ' A' ' 99' ' ' ALA . 67.3 mtt -127.18 172.81 10.23 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.944 -0.571 . . . . 1.28 109.877 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.433 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 148.57 -172.95 28.68 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.666 -0.778 . . . . 0.34 112.136 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.757 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 49.1 t60 -88.88 159.66 17.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.856 0.836 . . . . 0.28 111.106 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.7 p -69.85 143.98 14.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.656 -1.157 . . . . 1.09 110.258 174.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 30.6 t70 75.93 -18.24 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.384 0.612 . . . . 0.69 110.36 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.0 m170 -85.05 -10.73 56.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.278 -1.008 . . . . 0.63 108.278 170.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.87 48.46 1.08 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.191 -0.913 . . . . 0.79 113.369 174.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -60.83 -53.33 58.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.108 0.454 . . . . 3.69 110.909 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.5 m -98.85 -34.72 10.37 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.374 0.607 . . . . 1.76 110.442 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.579 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.66 -21.01 24.44 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.114 0.783 . . . . 1.71 113.114 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.639 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -75.64 -34.37 60.53 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.294 -1.002 . . . . 2.09 108.294 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' O ' HG21 ' A' ' 28' ' ' ILE . 7.0 tp -67.26 -23.79 65.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.322 -0.854 . . . . 2.23 109.785 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -92.54 -39.4 11.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.776 0.798 . . . . 1.23 109.681 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.29 80.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.56 -1.2 . . . . 1.23 109.738 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.3 tt . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 114.849 -1.069 . . . . 1.59 110.394 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.672 HG23 HG12 ' A' ' 111' ' ' ILE . 55.4 mt . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.916 0.389 . . . . 1.38 111.899 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.69 HG21 ' HB ' ' A' ' 12' ' ' THR . 9.2 p -117.06 140.36 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.457 0.646 . . . . 1.79 110.392 173.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.592 HD13 HD11 ' A' ' 165' ' ' ILE . 18.8 mt -95.25 131.11 42.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.201 -0.909 . . . . 1.14 109.904 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.597 HD13 HG13 ' A' ' 86' ' ' VAL . 1.9 tm? -117.53 107.88 14.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.204 -1.036 . . . . 1.65 108.204 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 57.4 t -89.81 116.48 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.993 -0.549 . . . . 1.14 111.23 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 3.7 m -122.38 137.26 56.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 1.31 110.793 175.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.722 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -75.43 133.95 41.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.939 -0.573 . . . . 1.01 110.011 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.818 ' HA ' HG23 ' A' ' 127' ' ' VAL . . . -76.81 -14.88 59.87 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 120.303 -0.559 . . . . 1.07 110.129 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -10.61 53.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.561 -0.745 . . . . 0.58 110.894 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -128.03 -69.33 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.56 110.284 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.597 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 121.19 -139.8 13.54 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.14 -0.553 . . . . 0.37 113.183 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.5 p -95.67 139.72 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.432 0.634 . . . . 1.78 109.43 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.597 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 72.2 mmm -140.14 178.05 1.76 Allowed Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.419 -0.81 . . . . 1.07 108.815 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 82.9 Cg_exo -46.32 -64.69 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.885 2.39 . . . . 0.89 114.521 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.526 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 2.9 pt20 -70.56 -16.56 62.88 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.555 -0.715 . . . . 0.78 110.787 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.757 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.65 -49.7 51.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.747 -0.661 . . . . 1.07 109.603 178.152 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.594 ' HA ' HD13 ' A' ' 100' ' ' ILE . 3.7 p -74.74 -29.06 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.934 -0.575 . . . . 2.02 112.457 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -57.47 -30.18 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 2.35 109.946 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.583 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -71.14 -40.95 71.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.458 -0.792 . . . . 1.12 110.491 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' A' ' 97' ' ' VAL . 76.9 mt -66.74 -44.31 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.821 0.819 . . . . 1.14 109.641 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -56.63 -42.21 78.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.75 110.842 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -71.23 -35.02 71.33 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.77 -0.455 . . . . 3.23 109.77 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.45 -52.56 38.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 1.17 111.533 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 29.7 mtpt -75.62 -22.78 56.55 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.675 -0.41 . . . . 2.27 110.908 -176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.21 72.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.551 -0.749 . . . . 1.28 110.539 171.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.57 -21.37 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 1.31 111.101 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.0 t30 82.32 61.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.282 0.989 . . . . 1.6 109.195 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 109' ' ' PRO . 7.7 t -117.7 139.69 26.66 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 114.348 -1.296 . . . . 1.93 111.579 -170.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.404 ' O ' HG13 ' A' ' 108' ' ' VAL . 18.3 Cg_exo -69.26 143.05 51.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.993 2.462 . . . . 0.66 111.362 169.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.494 ' C ' HG22 ' A' ' 145' ' ' THR . 1.3 mt -113.89 160.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 122.04 0.924 . . . . 1.34 112.375 -171.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.757 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 26.4 mm -129.94 86.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.816 -1.538 . . . . 1.12 106.89 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.792 HG22 HG21 ' A' ' 145' ' ' THR . 48.4 t -72.5 147.73 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.595 0.712 . . . . 1.06 109.159 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.759 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.94 105.48 4.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.646 -1.161 . . . . 1.07 110.48 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.796 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -73.99 134.08 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 114.163 -1.38 . . . . 1.29 108.97 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.695 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.7 p-10 -113.42 177.24 4.7 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.358 -1.349 . . . . 1.85 107.358 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.8 ' HD3' ' HE2' ' A' ' 119' ' ' LYS . 89.8 mttt 70.77 32.66 2.43 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 123.701 0.626 . . . . 1.18 111.907 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.514 ' CE ' ' HB3' ' A' ' 124' ' ' PRO . 10.8 mmt -79.89 -10.89 59.83 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.896 -1.15 . . . . 1.64 107.896 166.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.546 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 0.7 OUTLIER -70.47 -20.17 62.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.181 -1.827 . . . . 0.76 109.711 169.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.8 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 23.6 mtmt -100.15 134.57 20.75 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-N 115.606 -0.725 . . . . 1.74 110.407 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -64.03 -14.63 44.59 Favored 'Trans proline' 0 N--CA 1.47 0.122 0 C-N-CA 123.074 2.516 . . . . 0.68 111.907 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -81.67 6.52 14.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.417 -0.81 . . . . 1.45 110.42 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.08 115.4 2.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.17 -0.923 . . . . 1.1 111.231 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.4 76.72 44.41 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.04 -1.096 . . . . 0.95 108.04 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.514 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 43.6 Cg_endo -66.13 -60.25 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.949 2.432 . . . . 0.54 113.176 -170.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.482 ' HA ' ' HG2' ' A' ' 128' ' ' MET . 1.5 m-20 -55.87 -21.34 19.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.315 -0.857 . . . . 1.44 110.91 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -78.07 -56.83 4.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.475 0.655 . . . . 4.56 109.663 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.818 HG23 ' HA ' ' A' ' 88' ' ' ALA . 22.6 m -66.66 -24.88 33.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.874 -1.057 . . . . 1.26 111.675 -176.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.743 ' HA ' ' HB2' ' A' ' 131' ' ' LEU . 18.8 ptm -87.86 -13.88 40.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.914 -0.315 . . . . 1.64 110.549 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.628 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.0 mt-30 -75.87 -47.9 23.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.685 0.279 . . . . 2.0 110.423 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.18 -18.3 64.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.445 0.641 . . . . 1.64 109.572 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.869 HD22 ' HE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -65.62 -43.36 89.78 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.084 -0.962 . . . . 1.96 109.012 172.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.861 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.8 ppp? -80.52 -7.5 59.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.965 -0.561 . . . . 2.05 110.55 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -78.59 -24.15 45.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.764 -0.828 . . . . 1.67 108.764 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.409 ' N ' ' HD1' ' A' ' 134' ' ' TYR . 1.8 m-85 -91.58 18.82 6.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.645 -1.161 . . . . 1.58 108.478 169.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 56.69 56.94 5.1 Favored 'General case' 0 CA--C 1.526 0.048 0 CA-C-N 113.716 -1.583 . . . . 1.42 111.463 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.722 ' H ' ' HA ' ' A' ' 132' ' ' MET . 70.8 mt -123.02 105.58 10.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.825 -1.08 . . . . 1.93 109.365 170.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.786 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.4 t -108.17 114.11 59.95 Favored Pre-proline 0 C--N 1.31 -1.132 0 C-N-CA 119.89 -0.724 . . . . 1.18 111.125 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.967 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 1.2 Cg_endo -54.45 160.59 6.68 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.587 2.858 . . . . 0.88 112.97 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.531 ' HB2' HD13 ' A' ' 146' ' ' ILE . 20.6 mm-40 -78.16 -17.29 57.03 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.02 -1.445 . . . . 3.08 109.697 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.967 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 2.0 pm0 -69.35 -24.48 63.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.118 -0.946 . . . . 1.57 110.256 169.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.861 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 30.7 m0 -105.99 -10.1 16.74 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.916 0.388 . . . . 0.66 110.274 -177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.16 33.83 10.34 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.896 -0.593 . . . . 0.57 113.455 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.786 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -91.31 -108.8 1.53 Allowed Glycine 0 CA--C 1.509 -0.317 0 C-N-CA 120.086 -1.054 . . . . 0.6 111.418 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -163.82 61.4 0.16 Allowed 'General case' 0 C--O 1.248 1.015 0 CA-C-O 123.497 1.618 . . . . 1.91 110.457 170.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.792 HG21 HG22 ' A' ' 112' ' ' VAL . 58.1 m -162.67 114.97 1.62 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.745 -1.571 . . . . 1.1 110.224 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.757 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 12.7 mm -68.12 106.16 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.032 -0.729 . . . . 1.27 109.032 172.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.869 ' HE2' HD22 ' A' ' 131' ' ' LEU . 7.9 m-85 -87.99 107.6 18.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.717 -0.674 . . . . 0.53 110.08 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.671 ' HG ' HG21 ' A' ' 146' ' ' ILE . 92.4 m -97.29 112.13 24.08 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.526 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.796 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 81.9 mttt -83.96 96.34 8.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.699 -0.852 . . . . 1.96 108.699 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.801 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.8 pp -122.33 -173.38 2.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.614 1.197 . . . . 1.49 111.974 -173.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 0.7 OUTLIER -154.0 93.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.498 -1.683 . . . . 2.07 107.626 -176.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.14 60.76 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.645 -0.422 . . . . 1.11 110.429 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.546 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 40.9 mttm -78.48 -48.17 15.89 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.311 -0.556 . . . . 2.78 111.541 172.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 p -84.75 -7.11 59.33 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.669 -0.812 . . . . 1.35 111.516 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.424 ' CD ' HD13 ' A' ' 158' ' ' LEU . 39.0 mmtm 66.79 42.54 2.58 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.396 -0.82 . . . . 1.9 111.548 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -102.31 -67.42 0.87 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.346 1.07 . . . . 2.48 109.911 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.801 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -70.06 -8.31 61.27 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.015 -1.448 . . . . 0.36 113.757 -174.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.424 HD13 ' CD ' ' A' ' 155' ' ' LYS . 26.6 mt -69.17 -37.96 78.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.98 0.89 . . . . 1.42 109.578 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 25.0 t70 -72.65 -39.31 67.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.657 -0.701 . . . . 2.2 109.596 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 86.6 t60 -69.28 -20.34 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.24 -0.436 . . . . 0.68 110.884 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.449 HD23 HD11 ' A' ' 83' ' ' ILE . 53.2 tp -67.18 -53.71 27.9 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.322 -0.621 . . . . 1.77 109.322 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.73 -26.97 67.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.043 -0.98 . . . . 2.1 110.72 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 49.8 mt-10 -58.74 -47.51 84.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.259 0.552 . . . . 2.57 110.202 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.731 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 19.5 mmt -71.9 -34.43 69.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.846 -0.616 . . . . 1.21 110.32 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 83' ' ' ILE . 84.5 mt -65.24 -46.13 91.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 1.2 110.995 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.452 HD11 ' N ' ' A' ' 167' ' ' LEU . 4.3 pp -67.47 -33.01 74.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.811 -0.356 . . . . 2.3 111.011 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.452 ' N ' HD11 ' A' ' 166' ' ' LEU . 2.3 tm? -52.99 -48.24 67.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.954 -0.758 . . . . 2.11 108.954 170.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.622 HG11 HD11 ' A' ' 81' ' ' ILE . 67.7 t . . . . . 0 N--CA 1.444 -0.731 0 CA-C-N 115.581 -0.736 . . . . 1.41 111.256 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.806 ' HB ' HG23 ' A' ' 82' ' ' VAL . 3.0 m . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.499 -0.185 . . . . 1.27 110.499 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -112.89 138.14 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.177 0.513 . . . . 1.83 110.592 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.482 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 63.0 mtt -147.05 173.04 12.83 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.561 -0.745 . . . . 1.28 109.28 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' HA2' HD21 ' A' ' 84' ' ' LEU . . . 150.1 -175.99 28.94 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.711 -0.757 . . . . 0.34 112.108 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.738 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 49.5 t60 -86.6 162.15 18.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.997 0.903 . . . . 0.28 111.563 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.503 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.52 150.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.275 -1.329 . . . . 1.09 110.172 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.3 t70 74.44 -14.98 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.476 0.655 . . . . 0.69 109.902 -175.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.542 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 13.6 m170 -87.57 9.0 22.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.95 -1.13 . . . . 0.63 107.95 168.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 76.05 54.4 5.28 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 114.801 -1.09 . . . . 0.79 113.899 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 7.82 7.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.035 0.917 . . . . 3.69 111.453 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.485 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.5 m -129.64 -50.64 1.16 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.974 -0.557 . . . . 1.76 110.011 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -57.52 -24.75 57.8 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.077 -0.51 . . . . 1.71 111.315 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.3 mp -70.43 -35.34 73.32 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 111.98 0.363 . . . . 2.09 111.98 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 22' ' ' THR . 2.5 pp -74.61 -17.74 60.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.61 -0.836 . . . . 2.23 109.909 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' N ' HD11 ' A' ' 25' ' ' LEU . 29.5 t70 -85.55 -42.93 13.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.144 0.973 . . . . 1.23 109.217 174.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -64.52 -38.29 90.5 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.7 -1.591 . . . . 1.23 110.588 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 6.9 tt . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 115.151 -0.931 . . . . 1.59 111.139 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.432 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 110.3 -0.259 . . . . 1.38 110.3 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.806 HG23 ' HB ' ' A' ' 12' ' ' THR . 39.1 t -118.02 126.95 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.368 0.604 . . . . 1.79 112.11 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.652 HG12 ' HB ' ' A' ' 111' ' ' ILE . 6.1 mt -85.04 133.97 28.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.009 -0.996 . . . . 1.14 110.562 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.6 HD13 HG12 ' A' ' 86' ' ' VAL . 2.0 tm? -121.28 110.35 16.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.454 -0.943 . . . . 1.65 108.454 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 93.2 t -89.04 117.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 1.14 111.397 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.646 HG13 HG23 ' A' ' 96' ' ' THR . 1.9 m -126.33 123.35 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.803 -0.635 . . . . 1.31 111.218 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.542 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -62.53 131.81 50.36 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.928 -0.578 . . . . 1.01 110.014 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.724 ' HB1' ' CG2' ' A' ' 114' ' ' ILE . . . -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.22 0.533 . . . . 1.07 111.115 -176.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -90.54 -13.87 33.71 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.479 -0.782 . . . . 0.58 111.069 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.449 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.1 t70 -118.55 -50.43 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 0.56 110.537 -174.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 91.43 -162.77 28.36 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.37 113.449 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.07 136.37 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.754 0.788 . . . . 1.78 109.75 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.746 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 76.8 mmm -139.39 176.93 2.27 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.932 -1.031 . . . . 1.07 109.14 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.746 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 74.7 Cg_exo -40.13 -65.52 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.369 2.712 . . . . 0.89 114.466 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.457 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.4 pt20 -76.13 -16.64 59.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.881 -0.327 . . . . 0.78 111.243 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.738 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -68.23 -43.01 78.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.486 0.66 . . . . 1.07 109.258 176.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 93' ' ' MET . 24.9 t -66.27 -41.35 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 115.049 -0.978 . . . . 2.02 111.289 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -55.07 -29.6 57.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.981 0.419 . . . . 2.35 110.456 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -73.04 -38.14 66.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.017 -0.538 . . . . 1.12 110.565 175.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.9 mt -73.49 -44.43 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.84 0.829 . . . . 1.14 109.056 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -59.36 -30.71 68.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.36 -1.291 . . . . 0.75 111.055 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -80.91 -34.62 33.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.168 0.509 . . . . 3.23 110.038 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 110' ' ' ILE . . . -71.81 -46.21 58.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.885 -0.598 . . . . 1.17 111.482 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.625 ' HD3' HD22 ' A' ' 136' ' ' LEU . 13.6 mmmm -71.59 -29.23 64.46 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.242 0.544 . . . . 2.27 109.58 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.46 72.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.906 -1.043 . . . . 1.28 111.33 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.33 28.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.066 0.46 . . . . 1.31 110.629 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 85.6 53.06 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 114.581 -1.19 . . . . 1.6 109.295 171.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 109' ' ' PRO . 1.3 p -110.34 141.96 25.02 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 113.841 -1.527 . . . . 1.93 110.62 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 108' ' ' VAL . 23.7 Cg_exo -64.27 143.43 83.33 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.554 2.17 . . . . 0.66 112.025 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.46 HD13 ' HB1' ' A' ' 103' ' ' ALA . 31.4 mm -106.34 158.59 6.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.488 0.661 . . . . 1.34 110.976 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.815 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 41.1 mm -124.94 84.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.396 -1.335 . . . . 1.12 107.396 171.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.952 HG23 HD23 ' A' ' 131' ' ' LEU . 63.0 t -70.12 147.84 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.654 0.74 . . . . 1.06 109.753 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.748 ' HB3' HD23 ' A' ' 150' ' ' LEU . . . -145.13 100.37 3.46 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.34 -1.3 . . . . 1.07 109.701 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.806 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.7 mp -70.43 139.21 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.173 -1.376 . . . . 1.29 109.082 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -120.13 171.99 8.08 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.835 -1.542 . . . . 1.85 106.835 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.542 ' HD2' ' HB3' ' A' ' 87' ' ' ALA . 90.2 mttt 66.81 30.58 7.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 O-C-N 123.704 0.627 . . . . 1.18 111.902 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.7 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 83.1 mmm -83.79 -6.39 59.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.651 0.739 . . . . 1.64 109.299 172.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 8.1 p-10 -67.11 -28.1 67.88 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.704 -1.135 . . . . 0.76 108.865 169.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.464 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 29.5 mtpp -74.97 133.19 76.05 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.205 -1.362 . . . . 1.74 110.414 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -64.97 -16.05 53.53 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.449 2.1 . . . . 0.68 110.937 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -80.84 -1.64 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.745 -1.116 . . . . 1.45 110.63 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.481 ' HB3' ' SD ' ' A' ' 117' ' ' MET . . . -54.97 124.29 16.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.189 -0.914 . . . . 1.1 111.731 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.674 HD21 ' HB2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -129.13 75.67 79.99 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.75 -0.833 . . . . 0.95 108.75 173.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.7 ' HG3' ' HE1' ' A' ' 117' ' ' MET . 37.0 Cg_endo -63.24 -60.33 0.18 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 123.085 2.523 . . . . 0.54 112.73 -173.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.449 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 2.5 m-20 -55.92 -18.22 8.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.555 -0.748 . . . . 1.44 111.616 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.674 ' HB2' HD21 ' A' ' 123' ' ' ASN . 5.4 tpm_? -78.7 -56.75 4.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.206 -0.665 . . . . 4.56 109.206 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.608 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 5.0 m -66.47 -22.98 30.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 122.303 1.049 . . . . 1.26 110.165 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.652 ' HE2' ' CG ' ' A' ' 138' ' ' PRO . 8.4 ttt -68.27 -43.94 76.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.767 -1.56 . . . . 1.64 110.522 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.539 ' HA ' ' HG3' ' A' ' 132' ' ' MET . 27.6 mt-30 -68.85 -31.74 70.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.765 -0.652 . . . . 2.0 111.752 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.725 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 12.7 mt-10 -61.52 -37.61 84.36 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.932 0.872 . . . . 1.64 109.162 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.952 HD23 HG23 ' A' ' 112' ' ' VAL . 4.9 mp -62.4 -35.75 80.18 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.502 -0.772 . . . . 1.96 109.846 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.747 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -70.14 -18.05 63.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.051 -0.659 . . . . 2.05 111.864 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.725 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 4.7 pt-20 -78.83 -17.5 55.57 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.204 -1.036 . . . . 1.67 108.204 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -97.9 23.02 8.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.777 -1.101 . . . . 1.58 109.051 167.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.43 52.86 11.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.658 -1.61 . . . . 1.42 111.763 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.625 HD22 ' HD3' ' A' ' 104' ' ' LYS . 76.7 mt -121.67 96.79 5.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.604 -0.726 . . . . 1.93 110.026 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.952 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 61.5 t -103.54 121.71 47.42 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.572 -0.74 . . . . 1.18 111.302 -174.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.747 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 86.5 Cg_exo -41.58 144.16 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.642 3.561 . . . . 0.88 113.854 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HB2' HD11 ' A' ' 146' ' ' ILE . 9.0 mm-40 -74.09 -21.92 59.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.056 -1.429 . . . . 3.08 109.354 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.504 ' HG2' ' HB3' ' A' ' 138' ' ' PRO . 2.3 pm0 -70.53 -21.44 62.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.671 -1.149 . . . . 1.57 110.634 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.542 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 37.6 m0 -102.66 -34.12 9.18 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 120.846 0.355 . . . . 0.66 110.641 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 122.27 29.63 1.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.724 -0.751 . . . . 0.57 112.623 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.952 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.91 -112.46 2.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.442 -0.885 . . . . 0.6 112.48 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -162.89 60.37 0.2 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.65 1.215 . . . . 1.91 111.246 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.848 HG23 HG21 ' A' ' 112' ' ' VAL . 52.3 m -165.12 116.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.686 -1.143 . . . . 1.1 110.347 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.815 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.5 mm -70.74 105.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.062 -0.718 . . . . 1.27 109.062 173.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.697 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.1 m-85 -89.05 114.56 25.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.205 -0.907 . . . . 0.53 110.601 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 95.4 m -102.94 116.63 32.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.754 0.311 . . . . 1.0 110.769 173.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.636 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 88.1 mttt -89.72 103.7 16.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.923 -0.769 . . . . 1.96 108.923 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.904 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.3 pp -135.25 -174.14 3.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.054 1.407 . . . . 1.49 112.953 -172.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.413 ' HB2' ' H ' ' A' ' 118' ' ' ASP . 13.8 t -152.44 118.55 5.51 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.453 -1.703 . . . . 2.07 106.693 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.56 -7.77 58.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.156 -0.618 . . . . 1.11 109.369 175.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -74.47 -55.15 6.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.47 -0.786 . . . . 2.78 110.197 172.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.4 p -82.5 -9.14 59.54 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.148 -0.621 . . . . 1.35 111.619 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.401 ' HE3' ' HB1' ' A' ' 27' ' ' ALA . 38.6 mmtm 65.39 40.14 4.89 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.506 -0.77 . . . . 1.9 111.516 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.13 -67.3 0.85 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.708 1.242 . . . . 2.48 110.281 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.904 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -68.68 -12.62 64.64 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 113.536 -1.665 . . . . 0.36 113.844 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 34.4 mt -67.42 -37.56 83.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 118.287 1.043 . . . . 1.42 109.804 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.988 -1.005 . . . . 2.2 109.401 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.5 -20.56 65.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.396 -0.82 . . . . 0.68 110.861 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.12 -57.31 7.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.23 -0.441 . . . . 1.77 110.327 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.36 -41.27 75.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.405 -0.816 . . . . 2.1 110.178 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -55.23 -45.86 76.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.284 -0.871 . . . . 2.57 111.586 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.867 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 14.4 mmt -70.23 -44.38 68.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 1.21 110.382 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.56 HD11 HD13 ' A' ' 83' ' ' ILE . 72.0 mt -59.18 -49.53 83.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.725 -0.67 . . . . 1.2 111.523 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -22.94 60.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.673 -0.24 . . . . 2.3 110.849 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.13 -50.94 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.905 -0.776 . . . . 2.11 108.905 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 164' ' ' MET . 42.3 t . . . . . 0 N--CA 1.444 -0.743 0 CA-C-N 115.224 -0.898 . . . . 1.41 110.794 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 110.239 -0.282 . . . . 1.27 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -107.4 136.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.385 0.612 . . . . 1.83 110.953 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 99' ' ' ALA . 63.5 mtt -144.12 176.59 9.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.433 -0.803 . . . . 1.28 108.892 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.07 176.69 15.21 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.247 -0.977 . . . . 0.34 112.322 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.707 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 57.7 t60 -80.81 158.94 25.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.82 0.819 . . . . 0.28 111.538 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 6.5 p -71.82 151.34 8.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.5 -1.227 . . . . 1.09 109.933 175.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 20.8 t70 75.03 -25.13 0.21 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.1 0.476 . . . . 0.69 110.703 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.553 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 20.4 m170 -76.71 -17.32 59.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.487 -0.931 . . . . 0.63 108.487 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.793 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . 119.78 65.3 0.28 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.401 -0.818 . . . . 0.79 113.87 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -65.28 -71.43 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.142 -0.623 . . . . 3.69 110.656 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -86.71 -32.48 20.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.517 -0.31 . . . . 1.76 110.924 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.492 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -57.76 -27.86 63.42 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.569 0.581 . . . . 1.71 112.569 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.793 HD22 ' HA3' ' A' ' 20' ' ' GLY . 1.2 mm? -75.86 -36.93 59.42 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.908 -0.404 . . . . 2.09 109.908 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 tp -73.71 -9.67 58.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.631 -0.713 . . . . 2.23 109.941 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -98.92 -44.06 6.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.884 -0.784 . . . . 1.23 108.884 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.48 87.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.279 -1.328 . . . . 1.23 109.761 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 10.9 tt . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.791 -1.095 . . . . 1.59 111.101 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.6 mt . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 108.509 -0.923 . . . . 1.38 108.509 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.408 HG22 ' SD ' ' A' ' 14' ' ' MET . 11.9 p -114.49 135.69 53.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.528 0.68 . . . . 1.79 110.896 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.9 mt -90.83 128.92 42.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.914 -1.039 . . . . 1.14 109.884 173.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.605 HD13 HG13 ' A' ' 86' ' ' VAL . 2.4 tm? -114.8 106.89 14.73 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.369 -0.974 . . . . 1.65 108.369 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -86.29 109.03 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.799 -0.637 . . . . 1.14 110.996 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.5 m -119.99 122.29 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.768 -0.651 . . . . 1.31 110.656 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.684 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -69.85 130.09 41.33 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.406 -0.59 . . . . 1.01 109.406 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.778 ' HA ' HG23 ' A' ' 127' ' ' VAL . . . -69.01 -15.32 63.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 120.897 0.379 . . . . 1.07 111.505 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.52 -5.52 58.16 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.037 -0.529 . . . . 0.58 111.523 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.414 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -133.23 -49.39 0.86 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.556 0.217 . . . . 0.56 111.479 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.553 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 94.75 -148.43 18.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 121.084 -0.579 . . . . 0.37 113.477 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.414 HG12 ' CE2' ' A' ' 134' ' ' TYR . 30.2 t -83.23 131.28 34.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.542 0.687 . . . . 1.78 110.355 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.769 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 83.9 mmm -131.22 176.85 2.56 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 114.645 -1.162 . . . . 1.07 109.477 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 56.5 Cg_exo -38.53 -66.43 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.566 2.844 . . . . 0.89 114.578 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 3.8 pt20 -74.82 -15.5 60.74 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.135 0.493 . . . . 0.78 111.323 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.707 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -71.01 -41.68 70.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.475 0.655 . . . . 1.07 109.482 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.675 HG11 HD21 ' A' ' 101' ' ' ASN . 25.7 t -63.41 -41.16 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.193 -0.912 . . . . 2.02 111.861 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.29 -34.29 68.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 2.35 110.276 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.442 ' HB3' ' SD ' ' A' ' 14' ' ' MET . . . -68.65 -34.26 75.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 1.12 110.609 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.626 HG21 HD13 ' A' ' 136' ' ' LEU . 95.5 mt -74.14 -42.67 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.778 0.799 . . . . 1.14 109.256 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.675 HD21 HG11 ' A' ' 97' ' ' VAL . 6.4 m-80 -65.41 -25.59 67.61 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.446 -1.252 . . . . 0.75 111.349 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -82.63 -39.21 22.45 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.256 0.55 . . . . 3.23 109.846 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.02 44.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.779 -0.646 . . . . 1.17 111.982 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.879 ' HD3' HD21 ' A' ' 136' ' ' LEU . 29.9 mmmt -75.76 -27.15 57.96 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.305 0.574 . . . . 2.27 110.438 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.82 -44.29 81.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.055 -0.975 . . . . 1.28 110.302 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.67 44.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.084 -0.507 . . . . 1.31 110.926 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.2 t30 82.64 37.19 0.05 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.657 1.218 . . . . 1.6 108.583 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 109' ' ' PRO . 31.1 t -77.38 137.35 64.09 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 113.39 -1.732 . . . . 1.93 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.408 ' O ' HG12 ' A' ' 108' ' ' VAL . 16.7 Cg_exo -67.69 138.97 46.82 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.381 2.054 . . . . 0.66 111.321 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.444 ' C ' HG23 ' A' ' 145' ' ' THR . 0.8 OUTLIER -110.59 155.75 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 122.056 0.932 . . . . 1.34 112.196 -173.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.841 HD12 ' HB ' ' A' ' 146' ' ' ILE . 28.4 mm -122.44 82.19 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 113.753 -1.567 . . . . 1.12 107.278 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.912 HG23 HG22 ' A' ' 145' ' ' THR . 64.0 t -69.01 146.04 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 109.044 -0.724 . . . . 1.06 109.044 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.744 ' HB1' HD22 ' A' ' 150' ' ' LEU . . . -140.6 103.01 4.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.545 -1.207 . . . . 1.07 110.111 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.816 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.5 mp -69.02 136.11 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.066 -1.425 . . . . 1.29 108.444 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 62.9 t30 -123.62 167.07 14.44 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.486 -1.302 . . . . 1.85 107.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.684 ' HD2' ' HB3' ' A' ' 87' ' ' ALA . 85.7 mttt 69.55 31.99 3.52 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 124.036 0.835 . . . . 1.18 111.047 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.822 ' HE3' ' HG3' ' A' ' 124' ' ' PRO . 75.6 mmm -85.11 -3.81 58.93 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.84 0.829 . . . . 1.64 108.914 173.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 4.1 p-10 -68.16 -33.1 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.269 -1.332 . . . . 0.76 109.061 168.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.59 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 25.4 mtpp -72.25 129.94 86.9 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 114.814 -1.085 . . . . 1.74 110.202 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.52 -13.99 42.2 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 122.406 2.071 . . . . 0.68 110.788 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -82.47 -1.99 52.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 1.45 110.298 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.417 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -61.36 130.19 44.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.985 -1.007 . . . . 1.1 111.333 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.95 76.64 66.68 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.627 -0.879 . . . . 0.95 108.627 174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.822 ' HG3' ' HE3' ' A' ' 117' ' ' MET . 56.8 Cg_endo -66.71 -53.93 0.5 Allowed 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.77 2.314 . . . . 0.54 113.311 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.55 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.0 m-20 -53.93 -29.21 41.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.22 -0.9 . . . . 1.44 110.115 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -75.95 -56.92 4.21 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.798 -0.761 . . . . 4.56 109.485 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.778 HG23 ' HA ' ' A' ' 88' ' ' ALA . 24.9 m -62.77 -29.03 46.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.424 -0.807 . . . . 1.26 112.033 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.55 ' SD ' ' HA ' ' A' ' 125' ' ' ASP . 18.2 ptm -73.05 -23.77 60.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.518 -0.473 . . . . 1.64 110.219 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -70.73 -32.24 69.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.615 -0.266 . . . . 2.0 110.694 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 3.1 mm-40 -64.23 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.844 0.83 . . . . 1.64 109.719 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.594 HD13 HD11 ' A' ' 136' ' ' LEU . 4.2 mm? -64.03 -41.52 97.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.309 -0.86 . . . . 1.96 109.658 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.735 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 1.6 mtm -72.83 -13.91 61.39 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 119.652 -0.819 . . . . 2.05 110.692 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 5.1 mm-40 -68.49 -26.73 65.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.396 -1.335 . . . . 1.67 107.396 173.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.606 ' HB3' HG23 ' A' ' 100' ' ' ILE . 78.9 m-85 -108.74 33.72 4.06 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.407 -1.269 . . . . 1.58 111.039 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 54.9 t30 61.71 43.01 10.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.631 -1.168 . . . . 1.42 112.013 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.879 HD21 ' HD3' ' A' ' 104' ' ' LYS . 36.1 mt -123.02 97.22 5.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.814 -0.63 . . . . 1.93 111.384 174.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 1.043 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 57.3 t -99.1 121.26 56.14 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 115.561 -0.745 . . . . 1.18 111.185 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.735 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 93.1 Cg_exo -41.86 142.72 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.373 3.382 . . . . 0.88 113.573 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.459 ' HB2' HD12 ' A' ' 146' ' ' ILE . 4.9 mm-40 -73.5 -16.12 61.29 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.514 -1.221 . . . . 3.08 109.81 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.563 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.2 pm0 -69.27 -21.87 63.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.834 . . . . 1.57 110.26 170.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.5 m0 -109.97 -18.21 13.43 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.082 0.468 . . . . 0.66 111.078 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.54 4.97 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.827 . . . . 0.57 113.506 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 1.043 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.23 -110.66 1.43 Allowed Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.39 -0.91 . . . . 0.6 111.909 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.407 ' C ' ' HG1' ' A' ' 145' ' ' THR . 8.7 p-10 -161.22 60.07 0.29 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 122.808 1.29 . . . . 1.91 111.485 173.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.912 HG22 HG23 ' A' ' 112' ' ' VAL . 58.5 m -164.1 119.8 1.58 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.87 -1.059 . . . . 1.1 111.201 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.841 ' HB ' HD12 ' A' ' 111' ' ' ILE . 22.5 mm -72.77 106.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.854 -0.795 . . . . 1.27 108.854 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.73 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.3 m-85 -88.78 116.63 27.18 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.203 -0.908 . . . . 0.53 110.863 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 85.3 m -102.01 115.71 31.14 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.816 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 37.9 mtpt -94.8 85.19 4.36 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.984 -0.746 . . . . 1.96 108.984 -176.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.966 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -121.99 -176.92 3.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.712 1.244 . . . . 1.49 113.192 -164.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.416 ' N ' HD13 ' A' ' 150' ' ' LEU . 1.2 p -149.35 108.39 3.9 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.579 -1.646 . . . . 2.07 108.358 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.409 ' HB1' HD11 ' A' ' 158' ' ' LEU . . . -76.44 -15.43 59.92 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.193 0.52 . . . . 1.11 109.906 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -76.31 -51.39 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.766 -0.652 . . . . 2.78 111.432 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -79.14 -9.63 59.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.03 -0.668 . . . . 1.35 111.318 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp 66.77 43.69 2.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.919 0.866 . . . . 1.9 110.465 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 2.4 tt0 -105.16 -63.07 1.27 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.217 . . . . 2.48 109.912 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.966 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -78.16 -10.7 86.02 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 114.933 -1.03 . . . . 0.36 113.432 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.409 HD11 ' HB1' ' A' ' 152' ' ' ALA . 22.6 mt -67.15 -40.04 86.63 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 117.702 0.751 . . . . 1.42 110.11 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -73.14 -37.84 66.47 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.384 -0.826 . . . . 2.2 109.348 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 163' ' ' GLU . 83.2 t60 -70.41 -20.75 62.9 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.561 -0.745 . . . . 0.68 111.142 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.79 -54.2 30.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.184 0.516 . . . . 1.77 109.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.9 mt -55.98 -38.56 70.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.076 -0.965 . . . . 2.1 110.196 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 49.4 mt-10 -51.97 -52.72 48.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 2.57 110.972 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.824 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 15.0 mmt -69.79 -34.55 73.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.959 -0.564 . . . . 1.21 110.535 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.7 mt -61.17 -51.97 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 1.2 111.192 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 167' ' ' LEU . 4.1 pp -66.19 -33.22 75.28 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 121.032 -0.267 . . . . 2.3 111.176 -177.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.8 tp -54.06 -51.34 64.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.895 -0.593 . . . . 2.11 109.634 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 164' ' ' MET . 61.1 t . . . . . 0 N--CA 1.447 -0.624 0 CA-C-N 115.757 -0.656 . . . . 1.41 110.793 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.557 0.218 . . . . 1.27 111.293 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -93.18 108.49 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.922 0.391 . . . . 1.83 110.256 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.471 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 45.1 mtm -130.22 172.8 11.41 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.887 -0.412 . . . . 1.28 109.887 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.81 -157.14 27.1 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.013 -0.835 . . . . 0.34 111.013 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.809 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 46.9 t60 -94.6 160.4 14.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.116 0.96 . . . . 0.28 111.839 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.52 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.87 152.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.31 -1.314 . . . . 1.09 110.489 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t70 73.44 -20.75 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.205 0.602 . . . . 0.69 110.162 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 17' ' ' VAL . 22.3 m170 -71.6 -20.75 61.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.079 -1.082 . . . . 0.63 108.079 167.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 112.83 58.41 0.42 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.34 -0.846 . . . . 0.79 113.778 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 14' ' ' MET . 2.9 tppp? -58.11 -62.78 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.628 0.714 . . . . 3.69 111.088 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 p -72.08 -40.75 68.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 1.76 111.845 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -27.66 69.05 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.937 -0.574 . . . . 1.71 112.087 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -70.28 -57.31 5.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.441 0.639 . . . . 2.09 109.574 -175.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -12.39 55.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.747 -1.115 . . . . 2.23 111.136 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.77 -37.46 9.46 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.807 0.813 . . . . 1.23 109.678 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.23 70.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.781 -1.1 . . . . 1.23 109.494 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.6 tt . . . . . 0 N--CA 1.446 -0.646 0 CA-C-N 114.713 -1.131 . . . . 1.59 110.057 179.629 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.1 mt . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.654 0.264 . . . . 1.38 110.923 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.58 138.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-O 121.771 0.796 . . . . 1.79 111.147 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 6.3 mt -98.17 132.48 43.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.961 -1.018 . . . . 1.14 110.372 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.616 HD13 HG12 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -107.77 107.26 17.95 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.463 -0.79 . . . . 1.65 110.108 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.59 94.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.152 0.501 . . . . 1.14 110.472 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.616 HG12 HD13 ' A' ' 84' ' ' LEU . 11.4 m -111.29 123.35 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.008 -0.542 . . . . 1.31 111.032 175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.525 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -71.68 130.31 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.161 -0.472 . . . . 1.01 109.752 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.746 ' HB3' ' CG2' ' A' ' 114' ' ' ILE . . . -68.4 -19.37 64.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.055 0.455 . . . . 1.07 111.59 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.39 -14.45 46.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.754 -0.657 . . . . 0.58 110.649 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.442 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 6.6 t70 -118.21 -55.04 2.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.56 110.362 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.38 -128.47 9.58 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.965 -0.562 . . . . 0.37 113.319 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.423 HG23 ' HE2' ' A' ' 134' ' ' TYR . 8.7 p -103.86 136.94 34.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.675 0.75 . . . . 1.78 109.845 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.676 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.9 mmm -140.08 176.73 2.35 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.772 -1.104 . . . . 1.07 108.74 -171.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.676 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.9 Cg_exo -41.35 -66.96 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.15 2.567 . . . . 0.89 114.552 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.46 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.6 pt20 -74.11 -15.4 61.05 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.22 0.533 . . . . 0.78 111.114 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.809 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.7 -43.71 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.119 -0.697 . . . . 1.07 109.119 176.458 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 93' ' ' MET . 22.7 t -66.78 -41.83 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.237 -0.892 . . . . 2.02 111.164 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -56.45 -32.06 64.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.484 . . . . 2.35 110.424 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.53 -31.93 69.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.676 -0.693 . . . . 1.12 110.638 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.604 HG23 HD11 ' A' ' 136' ' ' LEU . 96.7 mt -77.94 -44.65 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.564 0.697 . . . . 1.14 109.371 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -57.41 -38.25 74.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.523 -1.217 . . . . 0.75 110.808 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -68.79 -34.54 75.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.058 0.456 . . . . 3.23 109.872 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.96 -48.91 16.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.015 -0.538 . . . . 1.17 111.932 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.634 ' HD3' HD23 ' A' ' 136' ' ' LEU . 14.0 mmmm -66.46 -38.37 87.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.03 0.443 . . . . 2.27 110.018 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.91 -35.81 71.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 1.28 111.04 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.99 -32.71 39.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.508 -0.314 . . . . 1.31 111.301 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 83.35 42.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.36 1.076 . . . . 1.6 108.902 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 109' ' ' PRO . 1.7 p -103.76 142.86 25.47 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 114.077 -1.419 . . . . 1.93 111.208 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.438 ' O ' HG23 ' A' ' 108' ' ' VAL . 22.1 Cg_exo -65.17 142.27 73.06 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.361 2.041 . . . . 0.66 111.722 171.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 111' ' ' ILE . 1.3 mt -110.82 163.79 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.443 0.64 . . . . 1.34 111.782 -171.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.837 HD12 ' HB ' ' A' ' 146' ' ' ILE . 15.9 mm -142.09 84.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 N-CA-C 106.747 -1.575 . . . . 1.12 106.747 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.846 HG22 HG21 ' A' ' 145' ' ' THR . 63.1 t -76.02 152.27 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 CA-C-N 114.316 -1.311 . . . . 1.06 109.815 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.882 ' HB2' HD23 ' A' ' 150' ' ' LEU . . . -143.51 101.5 3.79 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.554 -1.203 . . . . 1.07 109.739 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.819 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.6 mp -68.65 133.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 114.106 -1.406 . . . . 1.29 108.722 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 64.6 t30 -120.37 166.84 12.99 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.125 -1.435 . . . . 1.85 107.125 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.541 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 81.5 mttt 68.42 31.66 4.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 O-C-N 124.242 0.964 . . . . 1.18 111.672 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.74 ' HE2' ' HG3' ' A' ' 124' ' ' PRO . 82.6 mmm -80.99 -6.94 59.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.466 -0.788 . . . . 1.64 109.378 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -65.5 -32.49 74.12 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.068 -0.969 . . . . 0.76 108.595 169.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.485 ' HB3' ' OE1' ' A' ' 121' ' ' GLU . 26.8 mtpp -77.56 131.37 71.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.856 -1.52 . . . . 1.74 110.724 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.78 -18.17 59.12 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.538 2.159 . . . . 0.68 111.402 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.485 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 15.3 mp0 -68.7 -22.26 64.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.257 -0.883 . . . . 1.45 110.394 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.474 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -40.93 123.62 1.98 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.556 -1.202 . . . . 1.1 112.631 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.2 75.94 79.61 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.959 -1.126 . . . . 0.95 107.959 173.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.799 ' O ' ' HG3' ' A' ' 128' ' ' MET . 33.1 Cg_endo -61.15 -60.37 0.24 Allowed 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 122.806 2.337 . . . . 0.54 113.193 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.408 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 5.1 m-20 -49.15 -27.59 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.859 0.724 . . . . 1.44 110.753 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 129' ' ' GLN . 41.8 ttp180 -77.49 -53.3 7.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.756 -0.656 . . . . 4.56 110.031 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 88' ' ' ALA . 19.5 m -64.36 -20.62 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.659 -0.701 . . . . 1.26 112.219 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.799 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 37.3 mtp -71.45 -35.68 70.97 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.647 0.737 . . . . 1.64 109.131 171.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.561 ' O ' ' HG2' ' A' ' 132' ' ' MET . 46.2 mt-30 -66.65 -35.11 79.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.718 -1.128 . . . . 2.0 110.956 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 127' ' ' VAL . 18.8 mm-40 -57.53 -50.07 74.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.924 0.868 . . . . 1.64 109.835 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.69 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 10.7 mp -65.01 -34.27 78.05 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.998 -1.001 . . . . 1.96 110.917 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.572 ' SD ' ' HZ3' ' A' ' 141' ' ' TRP . 14.6 ptm -73.25 -11.27 60.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.974 -0.691 . . . . 2.05 110.65 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.72 -28.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.515 -0.92 . . . . 1.67 108.515 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.423 ' HE2' HG23 ' A' ' 92' ' ' VAL . 45.4 m-85 -90.12 23.24 2.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.187 -0.915 . . . . 1.58 109.408 167.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.3 t30 52.38 54.44 10.69 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 114.014 -1.448 . . . . 1.42 111.737 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 131' ' ' LEU . 78.9 mt -117.98 98.09 6.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.844 -1.071 . . . . 1.93 109.131 169.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 1.004 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 40.3 t -100.19 118.95 60.45 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.031 -0.532 . . . . 1.18 111.156 -171.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.646 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.4 Cg_exo -42.82 144.04 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 124.306 3.337 . . . . 0.88 112.798 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 146' ' ' ILE . 2.3 mm-40 -72.77 -20.66 61.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.426 -1.261 . . . . 3.08 110.056 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 2.4 pm0 -68.76 -22.59 64.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.341 -0.845 . . . . 1.57 110.232 171.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.572 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 31.2 m0 -103.89 -15.76 15.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.66 110.333 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.39 23.44 9.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.57 113.736 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 1.004 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.86 -107.42 0.73 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.107 -1.044 . . . . 0.6 112.469 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -164.56 61.03 0.14 Allowed 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.664 1.221 . . . . 1.91 111.316 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.846 HG21 HG22 ' A' ' 112' ' ' VAL . 60.7 m -163.94 111.68 1.15 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.447 -1.252 . . . . 1.1 110.225 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.837 ' HB ' HD12 ' A' ' 111' ' ' ILE . 12.9 mm -68.21 105.12 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 109.026 -0.731 . . . . 1.27 109.026 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.646 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 7.7 m-85 -86.37 114.19 22.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.346 -0.843 . . . . 0.53 110.454 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 73.2 m -100.36 113.69 26.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 1.0 110.74 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.735 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.0 mttt -85.72 101.07 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.581 -0.526 . . . . 1.96 109.581 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.92 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.6 pp -133.03 -172.44 2.93 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 123.236 1.493 . . . . 1.49 113.404 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.502 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 13.5 t -159.71 117.05 2.63 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 112.811 -1.995 . . . . 2.07 106.389 172.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.03 -16.95 62.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.059 -0.719 . . . . 1.11 109.059 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -69.82 -54.12 15.06 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.732 -1.122 . . . . 2.78 110.635 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 2.3 p -80.61 -12.35 59.51 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.51 -0.476 . . . . 1.35 111.69 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.525 ' HD3' HD13 ' A' ' 158' ' ' LEU . 19.5 mmtp 67.44 41.63 2.36 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.589 -0.732 . . . . 1.9 110.617 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.649 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -97.37 -63.88 1.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.339 1.066 . . . . 2.48 110.442 -173.025 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.92 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -86.45 1.88 87.37 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.167 -1.016 . . . . 0.36 113.199 -172.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.525 HD13 ' HD3' ' A' ' 155' ' ' LYS . 27.5 mt -70.57 -42.19 71.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.0 0.9 . . . . 1.42 109.019 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -77.73 -34.81 52.43 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.44 -0.8 . . . . 2.2 109.618 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.491 ' HA ' ' OE2' ' A' ' 163' ' ' GLU . 81.6 t60 -69.4 -25.85 64.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.565 -0.454 . . . . 0.68 111.121 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.94 -53.08 60.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.36 0.6 . . . . 1.77 109.484 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 12.4 mt -54.89 -44.23 73.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.688 -1.142 . . . . 2.1 109.742 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.491 ' OE2' ' HA ' ' A' ' 160' ' ' HIS . 40.8 mt-10 -46.76 -53.81 11.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.197 0.936 . . . . 2.57 111.189 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.732 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 20.2 mmt -72.26 -39.72 68.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 1.21 111.051 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 83' ' ' ILE . 69.1 mt -60.13 -49.94 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 1.2 111.294 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.1 pp -70.89 -31.83 68.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.844 -0.342 . . . . 2.3 111.153 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.441 ' N ' HD11 ' A' ' 166' ' ' LEU . 2.6 tm? -54.2 -50.53 66.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 2.11 108.856 172.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.447 -0.601 0 CA-C-N 115.819 -0.628 . . . . 1.41 110.559 175.501 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.647 0.26 . . . . 1.27 110.827 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.31 113.95 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 1.83 109.95 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.84 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 53.3 mtt -126.5 163.94 22.25 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.072 -0.513 . . . . 1.28 109.637 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.48 -168.65 25.42 Favored Glycine 0 N--CA 1.431 -1.633 0 C-N-CA 120.828 -0.701 . . . . 0.34 111.437 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.833 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 52.1 t60 -88.51 157.89 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.893 0.854 . . . . 0.28 111.385 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.501 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.4 p -71.75 153.94 7.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.587 -1.188 . . . . 1.09 109.981 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 20.2 t70 74.85 -21.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.361 0.601 . . . . 0.69 110.514 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.545 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.2 m170 -80.3 -7.38 59.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.342 -0.984 . . . . 0.63 108.342 170.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 113.07 60.88 0.42 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.537 -0.839 . . . . 0.79 114.048 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -59.29 -76.32 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.355 0.577 . . . . 3.69 110.913 171.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 m -84.79 -32.46 23.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.864 0.364 . . . . 1.76 110.873 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.479 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.57 -31.17 63.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.382 0.512 . . . . 1.71 112.382 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.467 HD22 HG23 ' A' ' 85' ' ' VAL . 12.5 tp -73.67 -40.15 63.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.508 -0.553 . . . . 2.09 109.508 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' HA ' HG22 ' A' ' 28' ' ' ILE . 2.9 tp -72.17 -9.52 58.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.654 -0.703 . . . . 2.23 110.562 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -94.99 -43.31 8.21 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.458 -0.941 . . . . 1.23 108.458 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.52 78.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.046 -1.434 . . . . 1.23 110.065 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 7.6 tt . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 114.975 -1.011 . . . . 1.59 110.354 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.472 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 120.49 0.186 . . . . 1.38 110.654 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.41 125.51 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 120.375 -0.53 . . . . 1.79 111.436 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.611 HG12 ' HB ' ' A' ' 111' ' ' ILE . 7.8 mt -87.49 130.19 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-N 115.62 -0.718 . . . . 1.14 109.923 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 HD11 HG12 ' A' ' 86' ' ' VAL . 2.0 tm? -114.08 107.36 15.54 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.289 -1.004 . . . . 1.65 108.289 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 HD22 ' A' ' 24' ' ' LEU . 39.5 t -90.72 110.14 21.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.369 -0.832 . . . . 1.14 110.746 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.703 HG22 HD11 ' A' ' 131' ' ' LEU . 1.7 m -120.49 124.92 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.792 -0.64 . . . . 1.31 110.58 174.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.706 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -65.51 131.38 46.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 1.01 109.87 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.77 ' HA ' HG23 ' A' ' 127' ' ' VAL . . . -73.77 -12.54 60.73 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.182 0.515 . . . . 1.07 110.395 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 1.3 p-10 -95.94 -8.73 33.08 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.576 -0.738 . . . . 0.58 110.847 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.13 -48.9 1.45 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.407 -0.36 . . . . 0.56 110.818 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.571 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.89 -146.08 19.01 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.37 113.538 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.488 HG22 ' CE2' ' A' ' 134' ' ' TYR . 9.9 p -82.13 140.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.571 0.701 . . . . 1.78 110.229 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.661 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.6 mmm -142.21 175.12 3.15 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.836 -1.075 . . . . 1.07 108.916 -173.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 75.0 Cg_exo -42.9 -59.07 1.08 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.197 2.598 . . . . 0.89 114.971 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.51 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.8 pt20 -79.42 -17.51 54.15 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 120.419 -0.513 . . . . 0.78 110.969 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.833 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.33 -43.23 91.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 1.07 109.334 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.469 HG11 ' CE1' ' A' ' 134' ' ' TYR . 32.3 t -60.47 -45.71 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.766 -1.107 . . . . 2.02 111.913 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.66 -31.79 66.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 2.35 110.638 -175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.84 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.01 -30.29 63.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 1.12 110.736 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.0 mt -77.11 -44.73 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.882 0.849 . . . . 1.14 108.775 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -63.63 -32.21 73.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.245 -1.343 . . . . 0.75 111.002 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -63.04 -45.79 90.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.441 0.639 . . . . 3.23 109.626 173.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.546 ' CB ' HD13 ' A' ' 110' ' ' ILE . . . -78.42 -51.53 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 1.17 112.752 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 29.4 mmmt -68.34 -34.08 75.45 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.931 0.396 . . . . 2.27 110.753 -173.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.74 92.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.655 -0.702 . . . . 1.28 110.837 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.71 53.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.471 -0.332 . . . . 1.31 111.158 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 t30 86.09 47.33 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.232 1.013 . . . . 1.6 109.467 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -111.37 138.4 21.36 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.362 -1.29 . . . . 1.93 110.417 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 34.6 Cg_exo -62.5 144.83 95.26 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.863 2.376 . . . . 0.66 113.436 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.546 HD13 ' CB ' ' A' ' 103' ' ' ALA . 27.1 mm -106.12 160.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.076 -0.965 . . . . 1.34 110.696 -175.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.788 HD13 ' HB ' ' A' ' 146' ' ' ILE . 29.9 mm -124.46 83.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.101 -1.444 . . . . 1.12 107.101 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 1.084 HG23 HG21 ' A' ' 145' ' ' THR . 62.0 t -69.03 146.98 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.636 0.731 . . . . 1.06 109.049 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.571 ' HB2' HD23 ' A' ' 150' ' ' LEU . . . -148.01 102.93 3.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.45 -1.25 . . . . 1.07 110.073 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.743 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 2.8 mp -70.57 139.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-N 113.767 -1.56 . . . . 1.29 109.068 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.661 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.1 p-10 -121.19 175.8 5.93 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.081 -1.451 . . . . 1.85 107.081 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.706 ' HD2' ' HB3' ' A' ' 87' ' ' ALA . 83.6 mttt 69.87 30.97 3.57 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.742 0.651 . . . . 1.18 111.098 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.638 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 11.3 mmt -73.18 -14.95 61.45 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.328 1.061 . . . . 1.64 108.624 167.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.551 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 2.0 p-10 -72.63 -19.64 61.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.404 -1.725 . . . . 0.76 110.602 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.441 ' HB3' ' HE2' ' A' ' 119' ' ' LYS . 36.6 mtpt -89.32 144.42 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.775 -0.648 . . . . 1.74 110.684 176.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.25 -17.22 40.01 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.789 2.326 . . . . 0.68 111.694 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -85.45 8.59 18.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.455 -0.793 . . . . 1.45 111.032 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.14 112.36 1.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 1.1 110.743 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.802 HD21 ' HB2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -127.89 76.2 77.64 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.95 108.969 175.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.553 ' HG3' ' HE2' ' A' ' 117' ' ' MET . 37.8 Cg_endo -63.71 -58.03 0.31 Allowed 'Trans proline' 0 CA--C 1.507 -0.845 0 C-N-CA 123.177 2.584 . . . . 0.54 113.022 -174.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.448 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 16.5 t70 -45.6 -29.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.285 0.991 . . . . 1.44 110.93 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.802 ' HB2' HD21 ' A' ' 123' ' ' ASN . 10.5 ttp180 -82.26 -56.45 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 4.56 110.173 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.77 HG23 ' HA ' ' A' ' 88' ' ' ALA . 16.6 m -65.64 -29.92 48.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.719 -0.673 . . . . 1.26 111.387 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 1.059 ' HA ' HD13 ' A' ' 131' ' ' LEU . 4.4 ttt -71.12 -31.16 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.425 1.09 . . . . 1.64 110.56 176.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -73.06 -36.33 66.86 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.653 -0.419 . . . . 2.0 111.375 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.608 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.2 mt-10 -63.06 -28.88 70.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.61 1.195 . . . . 1.64 108.976 175.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 1.059 HD13 ' HA ' ' A' ' 128' ' ' MET . 90.9 mt -62.03 -39.23 91.58 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.4 -1.727 . . . . 1.96 109.585 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.68 ' SD ' ' HZ3' ' A' ' 141' ' ' TRP . 34.5 mtp -77.95 -15.92 58.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.308 0.484 . . . . 2.05 112.308 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.499 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 9.1 mm-40 -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.083 -1.08 . . . . 1.67 108.083 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.488 ' CE2' HG22 ' A' ' 92' ' ' VAL . 85.2 m-85 -104.64 22.87 14.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.888 -1.051 . . . . 1.58 110.635 172.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.9 t30 66.78 28.85 8.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.081 -1.418 . . . . 1.42 112.623 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -116.1 116.79 28.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.627 -0.879 . . . . 1.93 108.627 170.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.902 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 91.5 t -112.21 136.84 21.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 1.18 112.51 -167.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.781 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -45.79 127.92 10.53 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 124.205 3.27 . . . . 0.88 111.681 169.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.656 ' HG2' HD11 ' A' ' 146' ' ' ILE . 1.8 pp20? -73.27 -20.9 60.73 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.661 -0.866 . . . . 3.08 108.661 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.4 ' OE1' ' HB2' ' A' ' 147' ' ' PHE . 1.5 pm0 -59.01 -27.37 65.38 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.659 -0.7 . . . . 1.57 110.608 169.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.68 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 41.0 m0 -103.47 -11.79 17.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.919 0.39 . . . . 0.66 111.049 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.24 24.75 5.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.713 -0.756 . . . . 0.57 113.362 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.902 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.6 -120.22 2.21 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.6 111.952 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.422 ' C ' ' HG1' ' A' ' 145' ' ' THR . 12.3 p-10 -156.27 58.88 0.57 Allowed 'General case' 0 C--O 1.243 0.713 0 CA-C-O 122.293 1.044 . . . . 1.91 112.192 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 1.084 HG21 HG23 ' A' ' 112' ' ' VAL . 81.1 m -165.7 129.27 2.19 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.385 -0.825 . . . . 1.1 110.739 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.788 ' HB ' HD13 ' A' ' 111' ' ' ILE . 24.0 mm -72.78 105.03 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.081 -1.081 . . . . 1.27 108.081 168.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.781 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 9.0 m-85 -89.67 112.3 23.52 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.771 -0.65 . . . . 0.53 110.804 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.94 142.44 29.67 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.347 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.55 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 5.1 mmtp -117.64 96.83 5.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.286 -1.005 . . . . 1.96 108.286 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.746 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 4.0 pp -127.78 -175.71 3.55 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.903 1.335 . . . . 1.49 113.036 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.638 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 1.4 p -157.37 89.98 1.08 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 112.914 -1.948 . . . . 2.07 108.028 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.23 -15.26 63.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.256 0.551 . . . . 1.11 110.4 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -77.8 -42.93 32.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.565 -0.743 . . . . 2.78 112.037 175.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 151' ' ' SER . 0.9 OUTLIER -87.34 -9.27 55.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.526 -0.869 . . . . 1.35 111.804 175.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 66.73 50.19 1.18 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.089 -0.959 . . . . 1.9 110.995 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -109.51 -65.82 1.11 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.702 1.239 . . . . 2.48 110.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.746 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -74.26 -4.05 67.42 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.054 -1.43 . . . . 0.36 113.897 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.8 mt -71.33 -37.62 71.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.044 0.922 . . . . 1.42 109.238 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.84 -40.47 79.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.219 -0.9 . . . . 2.2 109.431 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.605 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 83.7 t60 -74.93 -10.62 59.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.079 -0.51 . . . . 0.68 111.303 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.55 -55.21 5.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.384 0.611 . . . . 1.77 109.837 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 163' ' ' GLU . 4.2 pp -62.89 -28.5 70.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.021 -0.99 . . . . 2.1 111.643 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.605 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 12.5 pt-20 -77.99 -27.3 49.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.847 -0.341 . . . . 2.57 111.23 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.879 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 14.8 mmt -74.53 -44.1 52.74 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.282 -0.636 . . . . 1.21 109.282 173.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.458 HD11 HD12 ' A' ' 83' ' ' ILE . 84.2 mt -58.19 -39.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.227 -0.897 . . . . 1.2 110.203 173.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -59.7 -44.19 93.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.463 -0.79 . . . . 2.3 111.693 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 166' ' ' LEU . 27.2 tp -54.42 -43.02 71.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.555 0.693 . . . . 2.11 109.923 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 N--CA 1.444 -0.756 0 CA-C-N 114.991 -1.004 . . . . 1.41 110.859 175.515 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.78 ' HB ' HG21 ' A' ' 82' ' ' VAL . 90.5 m . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.518 0.199 . . . . 1.27 110.704 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.7 mt -83.42 122.61 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 1.83 110.125 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.593 ' SD ' ' HB2' ' A' ' 99' ' ' ALA . 56.2 mtt -132.75 170.37 15.36 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.148 -0.686 . . . . 1.28 109.148 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.29 179.41 16.64 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.597 -0.811 . . . . 0.34 111.762 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.712 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 50.5 t60 -85.41 158.96 20.09 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.867 0.842 . . . . 0.28 111.631 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 19' ' ' HIS . 5.7 p -73.58 155.27 6.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.495 -1.23 . . . . 1.09 109.643 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 25.9 t70 72.92 -17.56 0.4 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.211 0.529 . . . . 0.69 110.661 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 17' ' ' VAL . 19.7 m170 -85.83 -6.57 59.07 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.001 -0.74 . . . . 0.63 109.001 171.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.781 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . 131.29 39.25 0.26 Allowed Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 118.972 -1.585 . . . . 0.79 115.066 170.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -52.36 -65.97 0.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.559 1.18 . . . . 3.69 111.51 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.9 m -89.51 -29.68 18.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 1.76 110.696 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.605 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.08 -33.92 69.59 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.777 0.658 . . . . 1.71 112.777 -176.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.781 HD22 ' HA3' ' A' ' 20' ' ' GLY . 3.8 mm? -76.14 -33.33 59.4 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 122.142 -0.349 . . . . 2.09 110.447 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.73 -7.43 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.431 -0.508 . . . . 2.23 109.831 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.83 -47.96 4.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.939 0.876 . . . . 1.23 109.65 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB3' ' HB1' ' A' ' 152' ' ' ALA . . . -64.89 -42.58 94.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.213 -1.358 . . . . 1.23 110.434 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 84.9 mt . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.231 -0.895 . . . . 1.59 109.943 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.0 mt . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 109.909 -0.404 . . . . 1.38 109.909 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.78 HG21 ' HB ' ' A' ' 12' ' ' THR . 18.7 t -115.63 118.73 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.255 0.55 . . . . 1.79 111.185 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 51.9 mt -82.41 131.38 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.32 -0.855 . . . . 1.14 109.73 172.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.547 HD11 HG12 ' A' ' 86' ' ' VAL . 2.3 tm? -119.58 107.93 13.87 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.665 -0.865 . . . . 1.65 108.665 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.5 t -89.11 114.57 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.725 -0.67 . . . . 1.14 111.134 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 2.4 m -127.58 123.73 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.807 -0.633 . . . . 1.31 110.593 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.665 ' HB2' ' HD2' ' A' ' 116' ' ' LYS . . . -69.35 135.37 50.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.107 -0.497 . . . . 1.01 109.779 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.851 ' HA ' HG23 ' A' ' 127' ' ' VAL . . . -72.71 -15.59 61.68 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.05 0.452 . . . . 1.07 111.37 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.4 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 5.3 p-10 -90.35 -24.15 20.91 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.753 -0.658 . . . . 0.58 111.244 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.481 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 16.7 t0 -113.53 -41.63 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.56 111.245 -173.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.612 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.11 -131.54 10.7 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 114.419 0.528 . . . . 0.37 114.419 171.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.17 130.82 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.653 . . . . 1.78 110.568 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.674 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.7 mmm -131.32 177.78 2.07 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.461 -1.245 . . . . 1.07 109.377 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 61.2 Cg_exo -41.73 -63.16 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.093 2.529 . . . . 0.89 114.72 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.52 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.1 pt20 -72.97 -19.62 61.19 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.608 -0.437 . . . . 0.78 111.173 -174.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.712 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.82 -45.55 81.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.021 -0.733 . . . . 1.07 109.021 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 93' ' ' MET . 17.8 t -65.51 -43.6 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.889 -1.05 . . . . 2.02 112.065 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -57.02 -24.57 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.488 . . . . 2.35 110.71 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.593 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -76.97 -39.94 48.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 1.12 110.633 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.461 HG23 HD13 ' A' ' 136' ' ' LEU . 91.0 mt -71.53 -41.56 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.829 0.824 . . . . 1.14 109.41 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -61.05 -28.79 69.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.324 -1.307 . . . . 0.75 110.89 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -83.77 -34.4 24.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.811 -0.44 . . . . 3.23 109.811 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 110' ' ' ILE . . . -65.52 -42.09 92.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.198 -0.455 . . . . 1.17 111.046 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 135' ' ' ASN . 18.9 mmtp -73.18 -35.74 66.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.383 0.611 . . . . 2.27 109.796 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.33 -40.72 59.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.306 -1.316 . . . . 1.28 111.413 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.27 -35.19 15.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.338 -0.392 . . . . 1.31 110.96 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.4 t30 87.97 51.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.403 1.081 . . . . 1.6 109.609 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.11 141.73 23.09 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.969 -1.469 . . . . 1.93 110.58 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.01 140.65 66.84 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.549 2.166 . . . . 0.66 111.975 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.564 ' C ' HG22 ' A' ' 145' ' ' THR . 24.2 mm -104.2 158.71 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.46 0.648 . . . . 1.34 110.758 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.759 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 17.0 mm -129.32 88.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.553 -1.277 . . . . 1.12 107.553 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.94 HG21 HG21 ' A' ' 145' ' ' THR . 43.3 t -78.34 146.99 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.941 0.877 . . . . 1.06 110.338 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.892 ' HB1' HD13 ' A' ' 150' ' ' LEU . . . -139.79 111.06 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.925 -1.489 . . . . 1.07 110.144 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.788 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 2.8 mp -83.15 126.24 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.603 -1.18 . . . . 1.29 109.798 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.535 ' ND2' ' HG3' ' A' ' 116' ' ' LYS . 7.1 p-10 -114.35 168.79 9.54 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.42 -1.326 . . . . 1.85 107.42 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.665 ' HD2' ' HB2' ' A' ' 87' ' ' ALA . 89.4 mttt 70.44 31.57 2.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.927 0.767 . . . . 1.18 111.92 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.638 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 77.3 mmm -80.48 -9.7 59.76 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.505 0.669 . . . . 1.64 109.451 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -67.97 -32.54 73.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.968 -1.015 . . . . 0.76 109.415 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.417 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 28.6 mtmt -75.58 139.14 70.67 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.956 -1.02 . . . . 1.74 110.688 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.66 -15.8 51.96 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.885 2.39 . . . . 0.68 111.469 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -78.76 -7.81 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.11 -0.95 . . . . 1.45 110.27 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 117' ' ' MET . . . -58.03 115.39 2.85 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.711 -0.677 . . . . 1.1 111.113 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.886 HD21 ' HB2' ' A' ' 126' ' ' ARG . 1.2 t30 -128.71 77.58 77.32 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.432 -0.951 . . . . 0.95 108.432 173.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.638 ' HG3' ' HE1' ' A' ' 117' ' ' MET . 49.5 Cg_endo -65.13 -50.8 1.86 Allowed 'Trans proline' 0 CA--C 1.5 -1.185 0 C-N-CA 123.267 2.644 . . . . 0.54 112.906 -171.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.6 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 8.1 m-20 -54.43 -26.93 33.63 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.958 -1.019 . . . . 1.44 110.042 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.886 ' HB2' HD21 ' A' ' 123' ' ' ASN . 37.4 ttp180 -79.09 -54.24 6.2 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.411 0.624 . . . . 4.56 109.339 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.851 HG23 ' HA ' ' A' ' 88' ' ' ALA . 21.9 m -65.22 -29.29 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.272 -0.876 . . . . 1.26 111.928 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.921 ' HA ' HD22 ' A' ' 131' ' ' LEU . 16.4 ptm -79.41 -14.87 58.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.827 0.346 . . . . 1.64 110.392 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.585 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 80.3 mt-30 -79.91 -24.85 40.83 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 121.025 -0.27 . . . . 2.0 110.487 171.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 6.5 mm-40 -67.95 -31.13 70.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.431 -0.952 . . . . 1.64 108.431 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.921 HD22 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -61.29 -46.0 92.13 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.581 -1.191 . . . . 1.96 109.335 175.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.51 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -74.82 -7.98 55.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 119.963 -0.695 . . . . 2.05 110.969 -178.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 28.3 mm-40 -72.26 -28.13 62.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.542 -0.91 . . . . 1.67 108.542 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -102.96 31.8 4.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.037 -0.983 . . . . 1.58 110.255 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 104' ' ' LYS . 63.3 t30 55.68 43.49 27.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.699 -1.137 . . . . 1.42 111.761 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.51 ' H ' ' HA ' ' A' ' 132' ' ' MET . 52.5 mt -112.66 104.68 12.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.968 -0.56 . . . . 1.93 109.734 172.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 1.108 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 24.5 t -104.28 117.08 60.21 Favored Pre-proline 0 C--N 1.314 -0.954 0 C-N-CA 120.121 -0.632 . . . . 1.18 111.322 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.754 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.2 Cg_exo -43.73 139.72 5.04 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 124.196 3.264 . . . . 0.88 112.409 171.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -71.6 -18.69 62.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.411 -1.268 . . . . 3.08 110.114 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.52 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.0 pm0 -62.25 -27.11 68.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.759 -0.655 . . . . 1.57 110.089 168.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.585 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 39.4 m0 -102.53 -27.83 12.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.387 -0.369 . . . . 0.66 110.69 -175.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.48 2.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.769 -0.729 . . . . 0.57 112.977 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 1.108 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.25 -119.26 2.54 Favored Glycine 0 CA--C 1.507 -0.46 0 C-N-CA 119.846 -1.169 . . . . 0.6 112.245 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.408 ' C ' ' HG1' ' A' ' 145' ' ' THR . 12.5 m-20 -151.81 59.47 0.86 Allowed 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.773 0.797 . . . . 1.91 111.438 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.94 HG21 HG21 ' A' ' 112' ' ' VAL . 97.6 m -165.27 123.94 1.68 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.351 -0.841 . . . . 1.1 110.488 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.759 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 27.3 mm -75.59 104.25 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.096 -0.705 . . . . 1.27 109.096 171.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.754 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 12.6 m-85 -88.28 117.73 27.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.396 -0.82 . . . . 0.53 110.196 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.2 m -101.42 136.74 40.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.057 -0.349 . . . . 1.0 110.057 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.579 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 91.7 mttt -108.0 91.92 3.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.377 . . . . 1.96 109.981 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 1.044 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -120.85 -167.72 1.53 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 123.077 1.418 . . . . 1.49 113.334 -174.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.81 106.48 0.83 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.315 -1.766 . . . . 2.07 106.411 174.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.581 ' HB1' ' HB3' ' A' ' 27' ' ' ALA . . . -65.83 -14.16 60.9 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.62 -0.718 . . . . 1.11 109.434 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -52.98 30.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.15 -0.932 . . . . 2.78 110.62 173.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -84.99 -7.67 59.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.398 0.518 . . . . 1.35 112.398 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.517 ' HD3' HD13 ' A' ' 158' ' ' LEU . 21.8 mmtp 63.17 46.5 4.57 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.668 -0.696 . . . . 1.9 111.398 176.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.61 -70.79 0.78 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 123.039 1.4 . . . . 2.48 110.602 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 1.044 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -67.45 -8.51 51.65 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 113.664 -1.607 . . . . 0.36 113.269 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.517 HD13 ' HD3' ' A' ' 155' ' ' LYS . 28.6 mt -69.4 -40.48 77.34 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 117.785 0.793 . . . . 1.42 109.423 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.24 -44.2 88.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.345 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -70.87 -17.75 62.71 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.06 -0.518 . . . . 0.68 111.452 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 113' ' ' ALA . 5.9 mt -72.06 -57.49 4.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.011 0.434 . . . . 1.77 110.226 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 163' ' ' GLU . 4.3 pp -60.66 -29.35 69.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.498 -0.774 . . . . 2.1 110.804 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.409 ' N ' HD13 ' A' ' 162' ' ' LEU . 29.7 mm-40 -63.17 -51.67 65.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.993 0.425 . . . . 2.57 110.589 174.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.844 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 17.1 mmt -67.72 -46.25 72.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.153 -0.476 . . . . 1.21 110.533 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 98.7 mt -58.13 -44.12 86.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.682 -0.69 . . . . 1.2 110.971 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -41.37 86.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.423 -0.353 . . . . 2.3 111.19 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.42 -43.47 67.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.284 0.564 . . . . 2.11 109.567 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.421 HG22 HD13 ' A' ' 111' ' ' ILE . 92.6 t . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 114.812 -1.086 . . . . 1.41 111.02 176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.74 ' HB ' HG22 ' A' ' 82' ' ' VAL . 91.4 m . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 120.755 0.312 . . . . 1.27 110.816 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.914 HG13 HD21 ' A' ' 25' ' ' LEU . 45.9 mm -96.97 118.86 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 1.83 110.667 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.645 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 61.5 mtt -131.28 176.05 8.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.175 -0.676 . . . . 1.28 109.175 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 84' ' ' LEU . . . 139.42 -159.58 25.78 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.654 -0.784 . . . . 0.34 111.653 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.514 ' CE1' HG11 ' A' ' 17' ' ' VAL . 42.1 t60 -101.97 162.05 13.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.036 0.922 . . . . 0.28 112.167 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG11 ' CE1' ' A' ' 16' ' ' HIS . 7.4 p -81.86 150.61 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.255 -1.339 . . . . 1.09 110.726 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.9 t70 71.6 -23.43 0.19 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.423 0.689 . . . . 0.69 111.362 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 17' ' ' VAL . 23.5 m170 -62.79 -38.19 89.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.997 -1.482 . . . . 0.63 106.997 163.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 140.76 55.95 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.828 . . . . 0.79 113.751 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -61.4 2.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.49 0.645 . . . . 3.69 111.483 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -87.68 -40.12 14.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.919 0.39 . . . . 1.76 111.452 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -27.44 62.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 1.71 112.179 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -62.12 -51.21 68.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 2.09 109.843 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.914 HD21 HG13 ' A' ' 13' ' ' ILE . 76.8 mt -71.38 -14.61 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.857 -0.611 . . . . 2.23 111.025 -174.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -90.47 -38.63 13.12 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.469 -0.938 . . . . 1.23 108.469 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -70.6 -35.14 72.83 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.29 -1.323 . . . . 1.23 110.186 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 25' ' ' LEU . 13.1 tt . . . . . 0 C--N 1.317 -0.82 0 CA-C-N 114.969 -1.014 . . . . 1.59 111.102 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.0 mt . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.442 -0.577 . . . . 1.38 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.74 HG22 ' HB ' ' A' ' 12' ' ' THR . 15.2 t -107.64 124.36 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.17 0.509 . . . . 1.79 111.635 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 8.2 mt -84.41 132.27 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.524 -0.762 . . . . 1.14 110.555 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.936 HD13 HG12 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -102.3 106.39 17.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.523 -0.762 . . . . 1.65 110.412 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.2 t -84.12 94.08 3.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.933 -0.576 . . . . 1.14 109.738 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.936 HG12 HD13 ' A' ' 84' ' ' LEU . 2.4 m -119.93 123.62 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.927 -0.578 . . . . 1.31 110.523 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -72.32 131.65 42.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.929 -0.578 . . . . 1.01 110.191 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.776 ' HB1' ' CG2' ' A' ' 114' ' ' ILE . . . -65.5 -14.25 60.61 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.077 0.465 . . . . 1.07 111.063 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.23 8.34 44.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.523 -0.762 . . . . 0.58 111.011 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.417 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 12.9 t0 -149.08 -45.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 0.56 110.973 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.458 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 89.18 -141.49 16.29 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.335 -0.46 . . . . 0.37 113.477 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.33 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.347 0.594 . . . . 1.78 110.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.667 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 79.2 mmm -141.42 176.89 2.16 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 1.07 108.962 -173.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.667 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.3 Cg_exo -41.49 -66.62 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.165 2.577 . . . . 0.89 114.843 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.514 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 6.0 pt20 -71.71 -20.28 61.94 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.259 0.552 . . . . 0.78 110.872 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.514 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.54 -44.03 88.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.513 -0.767 . . . . 1.07 109.375 178.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 93' ' ' MET . 19.8 t -67.56 -41.74 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.38 -0.827 . . . . 2.02 111.33 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -55.33 -30.68 60.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.104 0.478 . . . . 2.35 110.319 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.645 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.15 -39.09 75.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 1.12 110.798 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.454 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 72.3 mt -72.35 -43.02 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.852 0.834 . . . . 1.14 109.172 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -59.91 -33.05 71.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.191 -1.368 . . . . 0.75 110.941 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -79.76 -34.49 39.79 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.735 -0.469 . . . . 3.23 109.735 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.475 ' HB1' HD13 ' A' ' 110' ' ' ILE . . . -74.42 -42.61 58.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.179 0.437 . . . . 1.17 112.179 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 12.7 mmmm -76.76 -37.92 55.07 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.058 0.456 . . . . 2.27 110.787 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.07 -30.09 70.75 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.252 -0.885 . . . . 1.28 110.709 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.96 -17.19 41.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 1.31 110.524 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 70.34 60.92 0.23 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.927 -1.033 . . . . 1.6 110.093 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 1.1 t -123.78 145.42 47.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 1.93 111.303 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 20.2 Cg_exo -69.8 144.89 55.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 123.352 2.701 . . . . 0.66 112.45 172.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.481 ' C ' HG22 ' A' ' 145' ' ' THR . 30.6 mm -111.2 158.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.422 0.63 . . . . 1.34 110.654 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.81 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 21.7 mm -129.21 84.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.599 -1.26 . . . . 1.12 107.599 171.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.91 HG12 ' HB3' ' A' ' 84' ' ' LEU . 17.7 t -74.55 152.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.636 0.732 . . . . 1.06 110.525 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 112' ' ' VAL . . . -139.35 107.24 5.67 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.613 -1.176 . . . . 1.07 110.031 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.776 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 3.5 mp -79.99 105.66 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.554 -1.203 . . . . 1.29 108.843 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.709 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 1.2 p-10 -106.34 173.66 6.22 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 106.807 -1.553 . . . . 1.85 106.807 -169.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.561 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 83.3 mttt 65.51 36.24 6.76 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.768 0.667 . . . . 1.18 110.491 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.656 ' HE3' ' HG3' ' A' ' 124' ' ' PRO . 84.3 mmm -82.34 -13.15 57.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.351 -0.841 . . . . 1.64 109.162 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.7 -30.92 71.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.688 -1.142 . . . . 0.76 109.062 171.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 119' ' ' LYS . 18.6 mmmt -64.91 132.04 95.36 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 114.442 -1.254 . . . . 1.74 110.024 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.84 -16.5 54.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.548 2.165 . . . . 0.68 111.065 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -90.77 10.98 23.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.101 -0.954 . . . . 1.45 110.37 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.6 118.09 4.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.448 -0.796 . . . . 1.1 110.665 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.6 OUTLIER -127.64 76.02 77.33 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.736 -0.838 . . . . 0.95 108.736 174.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.788 ' O ' ' HG3' ' A' ' 128' ' ' MET . 37.2 Cg_endo -63.55 -63.34 0.08 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 123.135 2.557 . . . . 0.54 113.395 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.498 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 6.6 m-20 -55.47 -21.34 15.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 1.44 110.998 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.2 tpt180 -72.36 -56.54 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.695 0.759 . . . . 4.56 109.528 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.614 ' HA ' ' HG3' ' A' ' 130' ' ' GLU . 17.4 m -64.79 -29.74 48.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.808 -1.087 . . . . 1.26 111.596 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.788 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 42.5 mtp -61.44 -39.72 91.87 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.398 0.618 . . . . 1.64 109.527 174.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.572 ' O ' ' HG2' ' A' ' 132' ' ' MET . 38.1 mt-30 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.987 -1.006 . . . . 2.0 111.627 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.614 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 6.3 mt-10 -72.37 -32.56 66.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.29 0.567 . . . . 1.64 109.997 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.936 HD12 HD21 ' A' ' 136' ' ' LEU . 4.3 mm? -65.44 -37.44 86.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 1.96 110.176 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 12.5 ptm -76.49 -14.07 60.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.162 -0.615 . . . . 2.05 110.239 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 7.3 mm-40 -71.15 -28.38 64.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.966 -0.753 . . . . 1.67 108.966 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.53 20.41 10.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.007 0.908 . . . . 1.58 110.157 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 60.65 49.97 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.578 -1.646 . . . . 1.42 112.2 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.936 HD21 HD12 ' A' ' 131' ' ' LEU . 1.9 pp -131.25 120.76 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.524 -1.288 . . . . 1.93 107.524 166.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.801 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.9 t -109.29 129.19 24.19 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 1.18 112.367 -165.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.633 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 98.0 Cg_exo -43.21 146.62 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.608 3.539 . . . . 0.88 113.435 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.48 ' HB2' HD11 ' A' ' 146' ' ' ILE . 5.9 mm-40 -75.53 -22.1 57.38 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.347 -1.297 . . . . 3.08 110.412 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 140' ' ' GLU . 2.2 pm0 -67.39 -21.4 65.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.258 -0.883 . . . . 1.57 110.036 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.477 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 38.4 m0 -105.77 -17.41 14.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.394 -0.366 . . . . 0.66 110.55 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.46 21.75 9.63 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.795 -0.716 . . . . 0.57 113.642 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.801 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -82.92 -105.28 0.48 Allowed Glycine 0 CA--C 1.51 -0.271 0 C-N-CA 120.138 -1.029 . . . . 0.6 111.943 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -166.1 62.2 0.1 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.316 1.055 . . . . 1.91 110.665 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.736 HG21 HG23 ' A' ' 112' ' ' VAL . 56.5 m -164.26 111.91 1.11 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.759 -1.109 . . . . 1.1 111.207 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.81 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.3 mm -69.49 107.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.426 -0.583 . . . . 1.27 109.426 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.674 ' HD2' HD12 ' A' ' 114' ' ' ILE . 10.7 m-85 -88.78 110.19 20.81 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.24 -0.891 . . . . 0.53 110.311 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.455 ' HG ' HG22 ' A' ' 146' ' ' ILE . 80.6 m -98.75 116.37 30.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.371 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.546 ' HB3' ' HE2' ' A' ' 117' ' ' MET . 95.2 mttt -87.31 91.19 8.64 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.036 -0.357 . . . . 1.96 110.036 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.962 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.9 OUTLIER -122.48 173.62 7.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.331 1.062 . . . . 1.49 112.089 -173.312 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.2 OUTLIER -138.9 104.91 5.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.38 -0.97 . . . . 2.07 108.38 165.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.55 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . . . -61.68 -18.99 61.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.309 -0.86 . . . . 1.11 109.708 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -63.25 -57.78 9.33 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.993 -1.003 . . . . 2.78 110.736 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 p -78.71 -7.85 58.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.215 0.45 . . . . 1.35 112.215 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.533 ' HD3' HD11 ' A' ' 158' ' ' LEU . 15.6 mmtp 66.78 42.8 2.51 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 123.684 0.615 . . . . 1.9 111.776 174.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -115.75 -63.5 1.44 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.183 0.992 . . . . 2.48 110.006 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.962 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -68.79 -11.83 63.58 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 114.495 -1.229 . . . . 0.36 113.605 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 17.4 mt -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 117.856 0.828 . . . . 1.42 110.373 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 6.5 m-20 -81.49 -33.08 32.15 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.69 -0.687 . . . . 2.2 110.422 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -61.42 -32.45 72.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.05 -0.352 . . . . 0.68 110.05 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.544 HD22 HD13 ' A' ' 83' ' ' ILE . 60.2 tp -59.72 -55.96 27.8 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.857 -0.61 . . . . 1.77 109.541 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.3 mt -56.67 -45.09 81.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.823 -1.08 . . . . 2.1 110.033 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 53.2 mt-10 -53.22 -43.9 67.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.639 -0.71 . . . . 2.57 111.338 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.434 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -76.19 -32.71 59.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.817 -0.353 . . . . 1.21 110.41 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 83' ' ' ILE . 80.8 mt -65.66 -51.26 64.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 1.2 111.108 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.448 HD11 ' N ' ' A' ' 167' ' ' LEU . 4.0 pp -65.39 -34.25 77.87 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 121.056 -0.258 . . . . 2.3 110.552 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.448 ' N ' HD11 ' A' ' 166' ' ' LEU . 1.3 tm? -50.7 -48.11 58.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.397 -0.594 . . . . 2.11 109.397 173.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.2 t . . . . . 0 N--CA 1.443 -0.786 0 CA-C-N 115.646 -0.706 . . . . 1.41 110.629 176.042 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.785 ' HB ' HG21 ' A' ' 82' ' ' VAL . 36.9 m . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 110.431 -0.211 . . . . 1.27 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.1 mt -99.51 127.78 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.993 -0.373 . . . . 1.83 109.993 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.63 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . 63.2 mtt -134.43 165.31 25.46 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.454 -0.573 . . . . 1.28 109.454 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.04 -175.34 36.01 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.566 -0.826 . . . . 0.34 111.788 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.792 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 44.0 t60 -88.06 158.42 18.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.875 0.845 . . . . 0.28 111.648 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 7.3 p -69.8 153.41 8.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.414 -1.267 . . . . 1.09 109.356 172.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.9 t70 73.96 -22.0 0.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.236 0.541 . . . . 0.69 110.713 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.505 ' H ' ' C ' ' A' ' 17' ' ' VAL . 12.8 m170 -84.98 3.55 37.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.132 -1.062 . . . . 0.63 108.132 171.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.435 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 86.81 58.36 1.93 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.775 -1.102 . . . . 0.79 113.596 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.5 2.98 34.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.674 0.75 . . . . 3.69 110.183 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -136.69 -44.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.268 -0.878 . . . . 1.76 109.634 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.435 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.76 -29.26 59.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.737 -0.665 . . . . 1.71 112.022 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 85' ' ' VAL . 15.8 tp -67.64 -42.34 82.4 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.436 -0.579 . . . . 2.09 109.436 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -68.15 -11.54 59.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.189 -0.914 . . . . 2.23 110.534 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.45 -38.99 8.98 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.923 0.868 . . . . 1.23 109.593 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.77 67.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.364 -1.289 . . . . 1.23 110.6 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 9.8 tt . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 114.854 -1.066 . . . . 1.59 110.399 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.4 mt . . . . . 0 C--O 1.236 0.375 0 CA-C-O 120.695 0.283 . . . . 1.38 110.688 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.785 HG21 ' HB ' ' A' ' 12' ' ' THR . 24.7 t -120.98 125.96 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.425 0.631 . . . . 1.79 111.491 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 21.3 mt -84.46 132.27 31.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.987 -1.006 . . . . 1.14 109.636 172.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.667 HD13 HG13 ' A' ' 86' ' ' VAL . 1.7 tm? -120.48 109.87 15.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.703 -0.851 . . . . 1.65 108.703 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 59.8 t -92.69 111.28 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.626 -0.715 . . . . 1.14 110.731 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.667 HG13 HD13 ' A' ' 84' ' ' LEU . 2.2 m -121.0 129.36 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 116.01 -0.541 . . . . 1.31 111.031 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.665 ' HB2' ' HE3' ' A' ' 116' ' ' LYS . . . -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.726 -0.67 . . . . 1.01 110.074 174.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.795 ' HA ' HG22 ' A' ' 127' ' ' VAL . . . -78.49 -7.98 58.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 1.07 110.164 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.804 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 3.1 p-10 -106.27 7.15 31.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.454 -0.794 . . . . 0.58 111.096 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.478 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 22.3 t70 -144.48 -41.43 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 0.56 110.068 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.76 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 90.0 -125.93 8.09 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.37 113.912 170.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.585 HG13 ' HE2' ' A' ' 134' ' ' TYR . 6.8 p -111.82 137.19 45.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.541 0.686 . . . . 1.78 109.697 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.723 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.1 mmm -140.15 177.67 1.91 Allowed Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 114.965 -1.016 . . . . 1.07 108.564 -170.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.723 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 57.4 Cg_exo -38.98 -65.78 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.218 2.612 . . . . 0.89 114.835 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.749 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 6.3 pt20 -74.36 -17.09 60.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.961 0.41 . . . . 0.78 111.527 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.792 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -68.88 -45.49 70.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.749 0.785 . . . . 1.07 109.31 176.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 93' ' ' MET . 20.8 t -69.81 -42.92 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.896 -1.047 . . . . 2.02 111.573 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.749 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -60.94 -25.17 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.449 -0.501 . . . . 2.35 110.003 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 14' ' ' MET . . . -71.28 -40.99 70.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.841 . . . . 1.12 110.919 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -73.95 -39.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.719 0.771 . . . . 1.14 109.311 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -61.3 -30.69 70.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.464 -1.243 . . . . 0.75 110.711 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -79.84 -34.61 39.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.957 -0.386 . . . . 3.23 109.957 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HB3' HD13 ' A' ' 110' ' ' ILE . . . -66.33 -46.11 77.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.384 -0.371 . . . . 1.17 111.336 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -72.21 -34.05 68.06 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.405 0.622 . . . . 2.27 110.106 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.87 -31.97 67.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.568 -1.196 . . . . 1.28 111.582 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.79 -19.47 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.487 -0.324 . . . . 1.31 111.011 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.2 t30 77.46 72.23 0.06 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.167 0.984 . . . . 1.6 108.719 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.55 138.45 31.2 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 114.326 -1.306 . . . . 1.93 111.633 -168.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.33 143.06 56.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.443 2.762 . . . . 0.66 111.705 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 103' ' ' ALA . 38.5 mm -109.96 154.88 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.738 0.78 . . . . 1.34 111.382 -173.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.961 HD13 ' HB ' ' A' ' 146' ' ' ILE . 12.9 mm -125.17 85.21 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 107.352 -1.351 . . . . 1.12 107.352 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.664 HG21 HG23 ' A' ' 145' ' ' THR . 57.5 t -73.43 147.23 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.545 0.688 . . . . 1.06 110.312 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.66 ' HB2' HD22 ' A' ' 150' ' ' LEU . . . -146.75 103.79 3.67 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.291 -1.322 . . . . 1.07 109.997 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.813 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -71.91 144.4 13.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.139 -1.392 . . . . 1.29 110.486 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -122.68 169.69 10.8 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.498 -1.297 . . . . 1.85 107.498 177.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.665 ' HE3' ' HB2' ' A' ' 87' ' ' ALA . 31.2 mtmt 67.74 37.49 3.22 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.163 -0.926 . . . . 1.18 112.38 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.834 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 14.3 mmt -75.95 -11.82 60.03 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.198 -0.91 . . . . 1.64 109.516 166.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 6.6 p-10 -72.86 -29.69 63.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.077 -0.965 . . . . 0.76 108.822 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.81 136.26 82.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.958 -1.019 . . . . 1.74 110.735 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.48 -15.39 48.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 123.058 2.505 . . . . 0.68 112.143 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.804 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 5.0 mm-40 -84.01 -9.0 58.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.49 -0.777 . . . . 1.45 110.704 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -42.47 109.97 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.968 0.792 . . . . 1.1 111.956 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.71 76.59 77.04 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.301 -1.0 . . . . 0.95 108.301 176.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.834 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 22.3 Cg_endo -58.81 -60.1 0.39 Allowed 'Trans proline' 0 CA--C 1.505 -0.933 0 C-N-CA 122.898 2.399 . . . . 0.54 113.286 -174.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.7 -28.88 1.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 124.066 0.854 . . . . 1.44 111.504 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.532 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 37.0 ttm-85 -78.59 -62.36 1.71 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.439 -0.578 . . . . 4.56 109.439 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.795 HG22 ' HA ' ' A' ' 88' ' ' ALA . 4.9 m -64.69 -22.59 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.977 -1.011 . . . . 1.26 111.941 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.614 ' HG3' ' CE2' ' A' ' 147' ' ' PHE . 4.9 ttt -77.12 -31.8 56.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.179 -0.918 . . . . 1.64 110.874 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.574 ' O ' ' HG3' ' A' ' 132' ' ' MET . 20.9 mt-30 -78.1 -32.39 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 2.0 111.372 176.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.9 mm-40 -57.28 -39.6 76.04 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.558 1.17 . . . . 1.64 108.381 173.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 147' ' ' PHE . 0.7 OUTLIER -61.39 -41.22 96.77 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.312 -1.767 . . . . 1.96 110.776 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.618 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.3 ppp? -82.5 -9.09 59.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.035 -0.666 . . . . 2.05 111.536 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.71 -27.91 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.976 -0.75 . . . . 1.67 108.976 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.585 ' HE2' HG13 ' A' ' 92' ' ' VAL . 34.6 m-85 -85.8 13.81 6.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.448 -0.796 . . . . 1.58 110.097 170.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.7 t30 62.84 48.29 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.222 -1.354 . . . . 1.42 111.658 172.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.84 110.49 13.74 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.408 -1.33 . . . . 1.93 107.408 165.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 1.021 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.9 t -104.78 129.16 25.4 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.697 -0.683 . . . . 1.18 111.543 -167.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.674 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 81.2 Cg_exo -44.61 143.6 3.91 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.421 3.414 . . . . 0.88 112.927 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.458 ' HG2' ' C ' ' A' ' 145' ' ' THR . 12.3 mm-40 -67.47 -32.36 73.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.18 -1.373 . . . . 3.08 109.532 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.4 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.7 pm0 -61.25 -24.99 66.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.921 -1.036 . . . . 1.57 110.967 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.618 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 35.7 m0 -102.63 -8.71 20.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.001 0.429 . . . . 0.66 110.912 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.08 32.69 8.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.006 -0.616 . . . . 0.57 113.21 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 1.021 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.9 -109.12 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.252 -0.975 . . . . 0.6 112.053 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.444 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 7.3 t70 -167.43 63.45 0.08 Allowed 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.369 1.08 . . . . 1.91 110.504 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.664 HG23 HG21 ' A' ' 112' ' ' VAL . 78.4 m -164.82 115.63 1.17 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.509 -1.223 . . . . 1.1 110.478 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.961 ' HB ' HD13 ' A' ' 111' ' ' ILE . 19.0 mm -70.93 104.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.175 -0.676 . . . . 1.27 109.175 173.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.674 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 7.9 m-85 -86.98 113.11 22.47 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.237 -0.892 . . . . 0.53 111.305 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.56 136.57 41.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.827 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.656 ' HB3' ' HE1' ' A' ' 117' ' ' MET . 8.3 mptt -111.57 101.27 9.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.24 -0.652 . . . . 1.96 109.24 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.907 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -127.25 -170.07 2.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.743 1.259 . . . . 1.49 111.827 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 117' ' ' MET . 0.3 OUTLIER -164.21 106.68 0.91 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.769 -1.937 . . . . 2.07 105.769 174.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.64 -15.77 63.71 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.669 0.747 . . . . 1.11 109.117 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -62.67 -56.07 21.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.216 -1.356 . . . . 2.78 110.462 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 1.2 p -84.45 -10.36 57.57 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.37 0.508 . . . . 1.35 112.37 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 62.13 51.88 3.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.42 -0.809 . . . . 1.9 110.595 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -109.33 -65.82 1.11 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.156 0.979 . . . . 2.48 110.608 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.907 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.13 -9.09 71.29 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.318 -1.31 . . . . 0.36 114.174 -173.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.36 -39.47 68.05 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.052 0.926 . . . . 1.42 109.362 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 13.8 m-20 -63.71 -44.7 92.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.511 172.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.411 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 80.6 t60 -71.66 -15.82 62.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.057 -0.52 . . . . 0.68 111.371 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -71.21 -53.34 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 1.77 109.651 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.68 -27.58 69.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.256 -0.884 . . . . 2.1 110.56 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 66.1 mt-10 -62.47 -48.88 77.65 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.099 0.476 . . . . 2.57 110.142 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.786 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 19.3 mmt -68.03 -42.85 80.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 1.21 110.549 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.5 mt -59.36 -41.95 85.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.927 -0.579 . . . . 1.2 110.593 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -39.73 89.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 2.3 111.19 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.1 tp -53.7 -43.98 69.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.413 0.625 . . . . 2.11 109.55 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 1.41 110.774 175.748 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 m . . . . . 0 C--O 1.223 -0.311 0 N-CA-C 110.678 -0.119 . . . . 1.27 110.678 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.507 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 14.9 tt -92.22 136.1 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.641 0.734 . . . . 1.83 111.467 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.503 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 58.5 mtt -148.82 174.29 12.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.591 0.756 . . . . 1.28 109.28 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.14 -167.12 32.25 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.711 -0.757 . . . . 0.34 112.761 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.841 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 43.2 t60 -93.93 164.49 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.066 0.936 . . . . 0.28 112.003 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 19' ' ' HIS . 5.9 p -78.34 151.29 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.454 -1.248 . . . . 1.09 110.374 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t70 72.72 -19.85 0.29 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.4 0.619 . . . . 0.69 110.524 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.533 ' H ' ' C ' ' A' ' 17' ' ' VAL . 18.0 m170 -78.94 -7.93 58.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.356 -0.979 . . . . 0.63 108.356 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.414 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 100.13 44.14 2.27 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.192 -0.913 . . . . 0.79 113.413 174.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HZ2' ' HA ' ' A' ' 14' ' ' MET . 0.8 OUTLIER -56.86 -33.26 66.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.591 0.695 . . . . 3.69 112.403 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -107.59 -34.59 6.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.914 0.388 . . . . 1.76 110.614 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -63.9 -28.87 70.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.321 -0.399 . . . . 1.71 111.772 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.414 HD23 ' HA3' ' A' ' 20' ' ' GLY . 2.7 mm? -65.62 -42.37 91.62 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.71 -0.478 . . . . 2.09 109.71 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD12 HD12 ' A' ' 13' ' ' ILE . 2.1 tp -71.85 -12.15 61.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.139 -0.937 . . . . 2.23 110.53 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -98.94 -41.26 7.67 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.992 0.901 . . . . 1.23 109.409 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB2' ' HE2' ' A' ' 155' ' ' LYS . . . -66.22 -30.28 70.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.898 -1.501 . . . . 1.23 109.845 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 1.59 110.894 -176.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.637 HG21 HG12 ' A' ' 111' ' ' ILE . 44.3 mt . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 110.428 -0.212 . . . . 1.38 110.428 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.4 ' O ' HG22 ' A' ' 110' ' ' ILE . 27.2 t -90.96 117.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.733 -0.787 . . . . 1.79 111.167 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 44.3 mt -81.33 131.41 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.798 -1.092 . . . . 1.14 109.384 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.689 HD12 HG11 ' A' ' 86' ' ' VAL . 2.4 tm? -121.11 107.17 12.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.82 -0.807 . . . . 1.65 108.82 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 85.5 t -89.38 109.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.593 -0.731 . . . . 1.14 110.779 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.699 HG22 HD13 ' A' ' 131' ' ' LEU . 2.1 m -121.39 126.26 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.785 -0.643 . . . . 1.31 110.95 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -72.15 127.46 32.64 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.094 -0.503 . . . . 1.01 109.645 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.666 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -68.06 -10.54 54.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.893 0.377 . . . . 1.07 111.383 -175.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.56 -8.06 55.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.837 -0.62 . . . . 0.58 110.778 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.495 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 15.9 t0 -131.69 -45.7 0.97 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.324 -0.398 . . . . 0.56 111.573 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.62 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 95.2 -144.79 17.41 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.312 -0.471 . . . . 0.37 113.062 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.6 p -92.49 143.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.337 -0.616 . . . . 1.78 109.337 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.691 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 77.2 mmm -143.61 177.73 1.71 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.401 -0.818 . . . . 1.07 109.241 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.691 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.6 Cg_exo -43.83 -63.02 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.199 2.599 . . . . 0.89 114.618 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.52 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.7 pt20 -76.69 -12.38 59.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.78 111.191 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.841 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -72.22 -48.23 44.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.675 -0.693 . . . . 1.07 109.662 176.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 93' ' ' MET . 3.5 p -73.69 -27.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.548 -0.751 . . . . 2.02 112.943 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -61.72 -30.34 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.606 -0.838 . . . . 2.35 109.088 176.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.21 -35.07 66.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.495 -0.775 . . . . 1.12 110.476 174.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.3 mt -70.18 -51.16 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 109.08 -0.711 . . . . 1.14 109.08 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -51.26 -41.74 60.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.537 -1.21 . . . . 0.75 110.442 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -55.62 -50.24 70.68 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.102 -0.954 . . . . 3.23 110.208 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.528 ' CB ' HD12 ' A' ' 110' ' ' ILE . . . -74.25 -46.57 40.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 1.17 112.164 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.763 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 10.8 mmpt? -63.69 -35.9 82.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.986 0.422 . . . . 2.27 110.943 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.7 -43.32 72.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.093 -0.958 . . . . 1.28 111.065 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.38 -21.41 39.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.573 -0.285 . . . . 1.31 111.26 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 83.1 41.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.817 1.294 . . . . 1.6 108.842 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 109' ' ' PRO . 29.2 t -89.95 138.16 27.84 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 113.384 -1.734 . . . . 1.93 111.616 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.479 ' O ' HG11 ' A' ' 108' ' ' VAL . 22.3 Cg_exo -66.82 144.18 70.1 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.829 2.353 . . . . 0.66 111.56 170.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.528 HD12 ' CB ' ' A' ' 103' ' ' ALA . 49.6 mm -109.35 157.12 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 121.387 0.613 . . . . 1.34 111.157 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.757 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 22.8 mm -124.02 83.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.195 -1.409 . . . . 1.12 107.195 169.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.774 HG21 HG23 ' A' ' 145' ' ' THR . 58.2 t -70.01 145.35 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-O 121.643 0.735 . . . . 1.06 109.208 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.759 ' HB1' HD23 ' A' ' 150' ' ' LEU . . . -143.55 100.39 3.59 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.374 -1.284 . . . . 1.07 109.67 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.801 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 80.6 mt -73.99 141.92 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.301 -1.318 . . . . 1.29 110.122 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 50.9 t30 -120.9 171.52 8.57 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.325 -1.361 . . . . 1.85 107.325 -177.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' ' 87' ' ' ALA . 81.7 mttt 72.47 33.58 1.41 Allowed 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 123.901 0.751 . . . . 1.18 111.749 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.692 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 13.4 mmt -79.02 -14.9 58.91 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 1.64 108.879 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 3.9 p-10 -65.09 -26.8 68.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.107 -1.406 . . . . 0.76 109.515 171.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.664 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 28.5 mtpp -86.62 132.23 43.17 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.291 -0.868 . . . . 1.74 110.02 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.39 -12.2 31.96 Favored 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 122.584 2.189 . . . . 0.68 111.128 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.27 1.15 38.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.404 -1.271 . . . . 1.45 110.732 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.63 122.96 11.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.119 -0.946 . . . . 1.1 111.348 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.6 OUTLIER -130.47 76.32 77.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.595 -0.891 . . . . 0.95 108.595 175.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.692 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 25.8 Cg_endo -61.16 -65.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.745 2.964 . . . . 0.54 114.153 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.655 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 1.2 m-20 -60.24 -23.07 63.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 1.44 110.102 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.753 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.4 tpt180 -67.8 -60.35 2.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 4.56 109.944 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.666 HG21 ' HA ' ' A' ' 88' ' ' ALA . 33.0 m -66.08 -32.98 60.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.756 -1.111 . . . . 1.26 111.757 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 1.081 ' HA ' HD12 ' A' ' 131' ' ' LEU . 18.7 ptm -74.49 -20.51 59.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.794 0.33 . . . . 1.64 110.961 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 125' ' ' ASP . 20.3 mt-30 -74.86 -43.55 53.87 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.997 -0.44 . . . . 2.0 111.086 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.611 ' HA ' ' HG3' ' A' ' 133' ' ' GLU . 8.8 mt-10 -70.19 -24.23 63.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.895 0.855 . . . . 1.64 109.167 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 1.081 HD12 ' HA ' ' A' ' 128' ' ' MET . 66.8 mt -59.79 -36.71 77.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.464 -1.244 . . . . 1.96 109.27 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.856 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 3.6 mtm -77.14 -17.69 58.42 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.402 -0.519 . . . . 2.05 111.859 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.611 ' HG3' ' HA ' ' A' ' 130' ' ' GLU . 5.4 mt-10 -71.53 -17.47 62.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.437 -0.949 . . . . 1.67 108.437 174.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.404 ' N ' ' HD1' ' A' ' 134' ' ' TYR . 1.7 m-85 -94.9 12.27 28.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.802 -1.09 . . . . 1.58 109.44 171.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 53.1 t30 62.86 53.56 2.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.878 -1.51 . . . . 1.42 111.942 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -139.21 121.82 16.3 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.049 -1.093 . . . . 1.93 108.049 166.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.918 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 98.0 t -113.45 128.62 25.47 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.934 0.397 . . . . 1.18 111.914 -167.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.856 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 85.5 Cg_exo -45.72 145.77 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.707 3.605 . . . . 0.88 113.76 172.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.61 ' HB2' HD12 ' A' ' 146' ' ' ILE . 3.7 mm-40 -81.71 -11.39 59.07 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.321 -1.309 . . . . 3.08 110.746 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -67.65 -26.62 66.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 1.57 109.672 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.471 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.8 m0 -109.21 -2.94 17.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.66 110.735 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.04 33.72 17.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.985 -0.626 . . . . 0.57 113.721 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.918 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -86.45 -105.81 0.78 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.252 -0.975 . . . . 0.6 111.857 174.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.412 ' C ' ' HG1' ' A' ' 145' ' ' THR . 12.8 p-10 -162.97 58.8 0.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.979 0.895 . . . . 1.91 110.907 172.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.774 HG23 HG21 ' A' ' 112' ' ' VAL . 51.5 m -166.9 116.49 0.88 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.463 -0.79 . . . . 1.1 111.0 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.757 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 18.1 mm -71.43 108.02 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.041 -0.726 . . . . 1.27 109.041 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.677 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 9.2 m-85 -89.51 120.0 30.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.53 111.039 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.684 ' HG ' HD21 ' A' ' 150' ' ' LEU . 50.6 t -99.98 153.9 18.82 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.196 0.522 . . . . 1.0 109.73 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.658 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.8 mttt -128.49 91.82 3.31 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.983 -1.008 . . . . 1.96 108.499 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.831 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -122.65 -174.1 2.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.613 1.197 . . . . 1.49 112.242 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 p -155.47 100.76 2.14 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.604 -1.635 . . . . 2.07 107.566 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.56 58.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.736 -0.786 . . . . 1.11 109.653 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -73.08 -52.49 14.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.168 -0.924 . . . . 2.78 110.48 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 p -87.82 -6.61 58.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.971 -0.691 . . . . 1.35 112.399 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.503 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 28.9 mmtp 67.45 45.87 1.5 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.583 -0.735 . . . . 1.9 111.661 171.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -105.72 -65.87 1.03 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.956 1.36 . . . . 2.48 110.617 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.831 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -72.36 -5.14 62.28 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.746 -1.57 . . . . 0.36 113.804 -173.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 26.9 mt -66.05 -41.39 90.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.376 1.088 . . . . 1.42 109.07 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -47.83 71.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.254 -0.885 . . . . 2.2 109.886 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -64.12 -27.07 68.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.68 111.68 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.8 tp -63.89 -58.89 5.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 1.77 110.451 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 11.9 mt -57.51 -39.56 76.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.032 -0.985 . . . . 2.1 110.115 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -54.18 -40.19 67.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.263 -0.88 . . . . 2.57 111.37 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.842 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 16.4 mmt -78.5 -39.18 38.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 1.21 110.621 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 161' ' ' LEU . 89.5 mt -58.98 -46.94 91.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 1.2 111.383 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.86 -34.65 78.27 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.726 -0.389 . . . . 2.3 110.895 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -53.68 -47.17 70.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.012 -0.736 . . . . 2.11 109.012 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.574 HG23 HD11 ' A' ' 111' ' ' ILE . 48.2 t . . . . . 0 N--CA 1.446 -0.643 0 CA-C-N 115.431 -0.804 . . . . 1.41 111.356 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 120.366 0.127 . . . . 1.27 110.841 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.652 HD13 HD23 ' A' ' 25' ' ' LEU . 50.8 mt -86.15 114.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.212 0.53 . . . . 1.83 110.601 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.691 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 21.4 mmt -112.59 -178.48 3.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.439 -0.801 . . . . 1.28 109.432 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.438 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 138.76 -174.13 22.23 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.565 -0.826 . . . . 0.34 112.206 174.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.658 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 50.5 t60 -84.42 162.45 19.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.7 0.762 . . . . 0.28 110.691 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -76.38 152.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.081 -0.963 . . . . 1.09 110.163 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 73.62 -20.36 0.3 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.031 0.532 . . . . 0.69 110.385 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.515 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.8 m170 -79.87 -8.68 59.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.696 -0.853 . . . . 0.63 108.696 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.552 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 122.6 62.09 0.21 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.386 -0.912 . . . . 0.79 114.643 169.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -62.02 -74.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.316 0.558 . . . . 3.69 111.208 168.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 m -80.13 -34.66 37.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.768 0.318 . . . . 1.76 110.955 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.552 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.83 -30.21 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.949 0.722 . . . . 1.71 112.949 -175.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -71.72 -52.55 17.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.953 -0.388 . . . . 2.09 109.953 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.652 HD23 HD13 ' A' ' 13' ' ' ILE . 15.4 mt -70.43 -8.67 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 2.23 110.965 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -89.17 -44.18 10.49 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.244 -1.021 . . . . 1.23 108.244 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.607 ' HB2' ' HE3' ' A' ' 155' ' ' LYS . . . -71.49 -25.33 62.22 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.71 -1.586 . . . . 1.23 110.676 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.438 HG23 ' HA ' ' A' ' 25' ' ' LEU . 9.7 tt . . . . . 0 C--N 1.318 -0.8 0 CA-C-N 115.21 -0.904 . . . . 1.59 111.076 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.462 HG22 HG12 ' A' ' 111' ' ' ILE . 59.9 mt . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 120.615 0.245 . . . . 1.38 111.075 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.863 HG21 ' HE1' ' A' ' 102' ' ' HIS . 6.0 p -111.77 136.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.432 0.634 . . . . 1.79 110.766 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.568 HG12 ' HB ' ' A' ' 111' ' ' ILE . 11.9 mt -90.53 142.58 12.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.287 -0.87 . . . . 1.14 109.555 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.61 HD12 HG11 ' A' ' 86' ' ' VAL . 2.1 tm? -127.44 108.4 10.79 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.3 -1.0 . . . . 1.65 108.3 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 90.4 t -89.89 116.03 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.079 0.466 . . . . 1.14 111.206 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.812 HG22 HD23 ' A' ' 131' ' ' LEU . 1.7 m -123.43 125.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.643 -0.708 . . . . 1.31 111.003 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -65.95 132.04 47.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.059 -0.519 . . . . 1.01 109.88 174.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.791 ' HA ' HG22 ' A' ' 127' ' ' VAL . . . -73.24 -12.3 60.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.016 0.436 . . . . 1.07 111.158 -175.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.36 9.99 37.63 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.816 -0.629 . . . . 0.58 111.634 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -143.25 -40.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.561 0.219 . . . . 0.56 111.068 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.575 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.1 -143.27 21.95 Favored Glycine 0 C--O 1.227 -0.284 0 C-N-CA 121.367 -0.444 . . . . 0.37 114.014 171.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.49 128.74 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.763 0.792 . . . . 1.78 111.02 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.538 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -125.69 177.68 1.81 Allowed Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 114.248 -1.342 . . . . 1.07 108.955 -174.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 76.0 Cg_exo -48.93 -57.91 2.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.497 2.131 . . . . 0.89 114.085 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.422 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.1 pt20 -76.13 -12.46 60.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.246 -0.582 . . . . 0.78 110.783 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.658 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.56 -50.16 40.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.727 -0.669 . . . . 1.07 109.758 178.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.57 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p -74.88 -21.86 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 112.749 0.648 . . . . 2.02 112.749 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.5 mt-10 -64.58 -29.9 70.92 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.452 -0.78 . . . . 2.35 109.171 172.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.691 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -76.39 -19.4 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.555 -0.748 . . . . 1.12 110.396 173.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 136' ' ' LEU . 96.9 mt -79.42 -46.9 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.267 0.556 . . . . 1.14 109.619 171.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -51.76 -45.34 63.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.681 -1.145 . . . . 0.75 110.156 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.863 ' HE1' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -49.12 -46.62 45.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.733 -0.667 . . . . 3.23 111.061 172.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.78 41.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 1.17 111.634 -169.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -73.96 -29.67 62.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.619 0.723 . . . . 2.27 110.161 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.78 -39.55 68.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.251 -1.34 . . . . 1.28 110.755 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.95 -32.61 15.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.463 -0.335 . . . . 1.31 111.591 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 62.3 t30 82.09 52.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.55 1.14 . . . . 1.6 109.123 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.36 143.93 28.74 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.847 -1.524 . . . . 1.93 111.155 -174.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.436 ' O ' HG22 ' A' ' 108' ' ' VAL . 24.5 Cg_exo -63.23 145.07 93.05 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.756 2.304 . . . . 0.66 112.381 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.484 ' C ' HG21 ' A' ' 145' ' ' THR . 1.0 OUTLIER -112.61 161.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.885 0.85 . . . . 1.34 111.881 -173.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.965 HD12 ' HB ' ' A' ' 146' ' ' ILE . 19.7 mm -124.39 82.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.943 -1.502 . . . . 1.12 106.943 171.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.844 HG22 HG23 ' A' ' 145' ' ' THR . 62.0 t -69.77 147.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 109.056 -0.72 . . . . 1.06 109.056 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.783 ' HB1' HD22 ' A' ' 150' ' ' LEU . . . -144.78 104.36 4.01 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.638 -1.164 . . . . 1.07 110.156 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.769 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.3 mp -73.18 136.62 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.165 -1.38 . . . . 1.29 109.198 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -121.99 173.11 7.74 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 106.723 -1.584 . . . . 1.85 106.723 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.718 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 91.0 mttt 66.53 33.88 6.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 O-C-N 123.759 0.662 . . . . 1.18 111.512 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.681 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 78.5 mmm -84.12 -14.64 49.81 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.024 -0.732 . . . . 1.64 109.024 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -66.05 -31.89 73.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.754 -1.112 . . . . 0.76 108.875 171.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.46 133.71 80.17 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.667 -1.151 . . . . 1.74 110.24 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.06 -13.94 34.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.941 2.428 . . . . 0.68 111.937 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.17 -3.41 57.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.956 -1.02 . . . . 1.45 110.712 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 117' ' ' MET . . . -56.45 120.94 8.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.149 -0.932 . . . . 1.1 111.848 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -131.74 76.91 73.65 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.197 -1.038 . . . . 0.95 108.197 170.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.681 ' HG3' ' HE1' ' A' ' 117' ' ' MET . 33.4 Cg_endo -61.67 -56.91 0.65 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.21 2.606 . . . . 0.54 113.916 -173.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.676 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 7.2 m-20 -55.53 -26.7 44.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.493 0.663 . . . . 1.44 110.319 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 123' ' ' ASN . 14.6 tpp180 -74.11 -56.57 4.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 4.56 109.395 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 88' ' ' ALA . 24.1 m -66.92 -29.35 46.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.122 -0.945 . . . . 1.26 111.871 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 1.03 ' HA ' HD21 ' A' ' 131' ' ' LEU . 19.6 ptm -76.16 -17.03 59.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.745 0.307 . . . . 1.64 110.272 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.642 ' O ' ' HG2' ' A' ' 132' ' ' MET . 10.1 mt-30 -76.2 -30.84 58.17 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.483 -0.487 . . . . 2.0 110.424 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -64.35 -31.13 72.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.844 -0.799 . . . . 1.64 108.844 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 1.03 HD21 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -60.57 -47.83 84.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.677 -1.147 . . . . 1.96 109.507 176.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.642 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 18.2 ptm -71.64 -11.84 61.04 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.403 -0.519 . . . . 2.05 111.353 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 29.4 mt-10 -74.59 -28.85 61.09 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.6 -0.889 . . . . 1.67 108.6 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.613 ' HB3' HG23 ' A' ' 100' ' ' ILE . 31.1 m-85 -98.67 31.31 2.95 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.093 -0.958 . . . . 1.58 109.815 168.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.74 40.99 22.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 113.796 -1.547 . . . . 1.42 112.77 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.622 HD13 HG12 ' A' ' 100' ' ' ILE . 70.1 mt -110.04 95.9 5.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.013 -0.54 . . . . 1.93 110.001 172.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 1.007 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 21.9 t -100.64 117.26 63.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.868 -0.606 . . . . 1.18 111.045 -173.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.745 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.4 Cg_exo -44.11 143.94 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 124.446 3.431 . . . . 0.88 113.049 174.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.544 ' HG2' ' C ' ' A' ' 145' ' ' THR . 7.2 mm-40 -71.6 -21.25 61.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.329 -1.305 . . . . 3.08 109.341 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.529 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.5 pm0 -66.88 -19.83 65.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.26 -0.882 . . . . 1.57 110.506 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.511 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 37.8 m0 -110.22 -9.97 14.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.871 0.367 . . . . 0.66 111.081 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.65 29.45 9.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.866 -0.683 . . . . 0.57 113.473 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 1.007 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -89.95 -108.73 1.29 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 119.954 -1.117 . . . . 0.6 112.358 176.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.14 60.91 0.12 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.649 1.214 . . . . 1.91 110.858 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.844 HG23 HG22 ' A' ' 112' ' ' VAL . 72.8 m -165.2 119.2 1.25 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.643 -1.162 . . . . 1.1 110.712 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.965 ' HB ' HD12 ' A' ' 111' ' ' ILE . 19.1 mm -72.92 104.2 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 109.264 -0.643 . . . . 1.27 109.264 174.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m-85 -87.45 117.17 26.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.339 -0.846 . . . . 0.53 110.495 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 82.8 m -103.15 132.87 49.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.391 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.569 ' HE2' ' HB2' ' A' ' 124' ' ' PRO . 95.4 mttt -102.4 107.78 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.226 -0.657 . . . . 1.96 109.226 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.88 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -138.01 -172.52 3.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.703 1.24 . . . . 1.49 112.401 -173.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.3 OUTLIER -160.23 105.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 113.605 -1.634 . . . . 2.07 106.996 176.377 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.2 -14.38 62.94 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.343 -0.614 . . . . 1.11 109.343 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -62.86 -57.51 10.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.841 -1.072 . . . . 2.78 110.449 171.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.07 -8.86 59.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.622 0.601 . . . . 1.35 112.622 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.607 ' HE3' ' HB2' ' A' ' 27' ' ' ALA . 37.2 mmtm 64.38 44.99 3.96 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.9 111.204 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -105.21 -67.85 0.89 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.428 1.109 . . . . 2.48 109.63 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.88 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.78 -8.37 67.86 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 113.861 -1.518 . . . . 0.36 113.816 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.1 mt -66.44 -38.97 88.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.15 0.975 . . . . 1.42 109.41 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.581 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 40.8 m-20 -70.38 -44.16 68.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.326 -0.852 . . . . 2.2 109.291 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -62.8 -22.43 66.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.949 -0.569 . . . . 0.68 111.138 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.92 -52.95 30.27 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.361 0.6 . . . . 1.77 109.497 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -66.97 -26.63 66.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.31 -0.859 . . . . 2.1 110.444 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 94.1 mt-10 -61.99 -35.39 78.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.979 0.419 . . . . 2.57 110.832 175.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.83 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 11.3 mmt -82.3 -37.1 26.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.237 0.541 . . . . 1.21 110.398 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.471 HD13 HD13 ' A' ' 83' ' ' ILE . 79.3 mt -69.59 -44.02 79.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 1.2 111.203 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -69.81 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.746 0.308 . . . . 2.3 110.248 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -57.9 -43.42 86.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.522 -0.918 . . . . 2.11 108.522 171.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 1.41 110.615 174.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.232 -0.655 . . . . 1.27 109.232 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.33 134.76 26.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.712 0.768 . . . . 1.83 110.691 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.509 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 66.3 mtt -138.38 -179.75 5.98 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.052 -0.977 . . . . 1.28 108.883 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' HA2' HD12 ' A' ' 84' ' ' LEU . . . 143.93 -171.44 25.49 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.511 -0.852 . . . . 0.34 112.362 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.634 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 38.9 t60 -98.05 160.96 13.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.91 0.862 . . . . 0.28 111.914 -177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.521 HG12 ' CE1' ' A' ' 16' ' ' HIS . 7.4 p -73.56 150.89 7.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.318 -1.31 . . . . 1.09 110.11 174.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.6 t70 74.01 -32.62 0.24 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.225 0.61 . . . . 0.69 110.749 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.526 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 18.9 m170 -66.32 -20.51 66.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.733 -0.84 . . . . 0.63 108.733 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 126.46 55.83 0.15 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.79 113.331 174.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' HD3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -64.99 -61.19 2.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 117.46 0.63 . . . . 3.69 110.539 176.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.5 m -87.16 -41.76 13.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.972 0.415 . . . . 1.76 110.954 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.439 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -57.64 -33.83 68.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.087 0.773 . . . . 1.71 113.087 -175.198 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -72.41 -43.66 63.58 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.064 -0.717 . . . . 2.09 109.064 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.426 HD21 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.68 -17.56 64.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 2.23 110.494 -178.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -94.21 -43.21 8.56 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.842 0.829 . . . . 1.23 108.958 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.24 97.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.24 -1.346 . . . . 1.23 109.587 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.2 tt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 114.452 -1.249 . . . . 1.59 111.224 -177.164 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.527 0.204 . . . . 1.38 110.604 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 110' ' ' ILE . 25.9 t -112.06 129.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 120.707 -0.397 . . . . 1.79 111.358 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 10.8 mt -97.92 132.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 1.14 110.975 174.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.939 ' HB3' HG13 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -109.44 112.02 23.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.512 -0.767 . . . . 1.65 111.364 -178.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.7 t -87.55 94.12 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.098 0.475 . . . . 1.14 110.067 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 84' ' ' LEU . 7.3 m -117.24 128.22 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.723 -0.671 . . . . 1.31 110.698 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.538 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -79.21 134.07 36.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.464 -0.569 . . . . 1.01 109.464 175.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.755 ' HA ' HG23 ' A' ' 127' ' ' VAL . . . -71.72 -8.02 51.64 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.079 0.466 . . . . 1.07 110.812 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.454 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -85.38 -17.38 36.87 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.355 -0.839 . . . . 0.58 110.972 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.526 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 24.8 t0 -132.0 -49.36 0.94 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.453 -0.34 . . . . 0.56 111.243 -170.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.635 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.24 -137.56 13.39 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 121.007 -0.616 . . . . 0.37 113.629 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 130' ' ' GLU . 6.9 p -88.47 138.51 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.35 -0.611 . . . . 1.78 109.35 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.825 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.4 mmm -142.78 178.2 1.57 Allowed Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.232 -0.655 . . . . 1.07 109.232 -171.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.825 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 49.3 Cg_exo -36.77 -69.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.544 2.829 . . . . 0.89 114.847 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.512 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 8.5 pt20 -73.69 -20.84 60.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.031 0.443 . . . . 0.78 111.346 -175.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.634 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.92 -43.78 82.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.677 -0.692 . . . . 1.07 109.373 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 93' ' ' MET . 47.6 t -66.92 -44.78 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.07 -0.968 . . . . 2.02 110.841 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.2 mm-40 -65.86 -14.84 62.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.153 0.502 . . . . 2.35 110.227 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 14' ' ' MET . . . -81.92 -38.4 25.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.556 -0.747 . . . . 1.12 110.086 170.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 95.6 mt -73.98 -42.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.642 0.734 . . . . 1.14 109.425 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -57.99 -30.31 65.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.577 -1.192 . . . . 0.75 110.503 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -80.66 -37.73 30.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.32 0.581 . . . . 3.23 109.889 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.49 70.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.882 -0.599 . . . . 1.17 111.546 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.5 mmmm -72.79 -32.06 65.3 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.145 0.497 . . . . 2.27 110.133 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -44.51 54.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.731 -1.122 . . . . 1.28 110.798 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.57 -26.92 34.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 1.31 110.591 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 64.51 88.47 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.434 0.694 . . . . 1.6 110.908 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.573 HG23 ' HD2' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -143.56 154.26 59.58 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.488 -0.778 . . . . 1.93 109.83 -176.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.573 ' HD2' HG23 ' A' ' 108' ' ' VAL . 21.6 Cg_exo -61.21 140.51 89.27 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.482 2.121 . . . . 0.66 111.923 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.4 mt -119.68 156.52 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.152 0.977 . . . . 1.34 111.917 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 1.014 HD12 ' HB ' ' A' ' 146' ' ' ILE . 19.0 mm -125.36 83.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.444 -1.707 . . . . 1.12 107.49 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.939 HG13 ' HB3' ' A' ' 84' ' ' LEU . 17.9 t -76.61 148.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.775 -0.77 . . . . 1.06 108.93 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.846 ' HB3' HD22 ' A' ' 150' ' ' LEU . . . -137.74 109.42 7.05 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.819 -1.082 . . . . 1.07 110.25 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.778 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -75.98 132.78 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.128 -1.396 . . . . 1.29 109.43 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.528 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 54.4 t30 -114.06 168.68 9.6 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 107.454 -1.313 . . . . 1.85 107.454 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.589 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 73.6 mttt 72.42 31.86 1.72 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.117 0.885 . . . . 1.18 112.001 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.773 ' HE3' ' HB3' ' A' ' 149' ' ' LYS . 11.4 mmt -72.8 -14.96 61.63 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.699 -0.682 . . . . 1.64 109.767 166.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.1 p-10 -69.7 -22.05 63.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.851 -1.068 . . . . 0.76 108.915 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.84 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 11.0 mmpt? -88.68 133.14 36.62 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.345 -1.298 . . . . 1.74 110.609 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.11 -11.69 28.76 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.878 2.385 . . . . 0.68 111.481 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -85.38 2.23 45.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.773 -1.103 . . . . 1.45 110.314 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -55.68 107.62 0.36 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.382 -0.826 . . . . 1.1 111.062 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.684 HD21 ' HB2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -121.75 76.52 37.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.723 -0.843 . . . . 0.95 108.723 174.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.556 ' HG3' ' HE2' ' A' ' 117' ' ' MET . 45.2 Cg_endo -66.18 -55.01 0.42 Allowed 'Trans proline' 0 CA--C 1.503 -1.034 0 C-N-CA 123.079 2.52 . . . . 0.54 113.223 -171.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.438 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 11.9 m-20 -50.88 -27.64 7.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.189 -0.914 . . . . 1.44 110.386 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.684 ' HB2' HD21 ' A' ' 123' ' ' ASN . 32.2 tpt180 -79.63 -55.9 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 4.56 109.649 -178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.755 HG23 ' HA ' ' A' ' 88' ' ' ALA . 16.3 m -65.35 -28.94 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.476 -0.784 . . . . 1.26 112.078 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.6 ptm -79.4 -19.33 50.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.157 -0.34 . . . . 1.64 110.486 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.641 ' O ' ' HG3' ' A' ' 132' ' ' MET . 13.0 mt-30 -74.4 -32.89 62.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.562 -0.29 . . . . 2.0 110.704 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.461 ' HB3' HG13 ' A' ' 92' ' ' VAL . 2.7 mm-40 -57.83 -46.29 84.94 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.569 0.699 . . . . 1.64 109.97 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 11.2 mp -66.38 -34.85 78.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.522 -0.763 . . . . 1.96 111.295 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.899 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -75.79 -7.89 55.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.724 -0.79 . . . . 2.05 110.738 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -82.45 -26.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.439 -0.948 . . . . 1.67 108.439 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.13 26.69 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.819 0.819 . . . . 1.58 109.854 165.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 53.78 57.0 6.46 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.983 -1.462 . . . . 1.42 111.673 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.777 ' H ' ' HA ' ' A' ' 132' ' ' MET . 62.8 mt -121.62 96.31 5.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.323 -0.853 . . . . 1.93 109.395 170.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.584 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.7 t -94.93 114.58 63.96 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.493 0.663 . . . . 1.18 112.162 -170.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.579 ' HA ' ' HD1' ' A' ' 147' ' ' PHE . 86.1 Cg_exo -45.29 152.63 0.7 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.651 3.567 . . . . 0.88 112.981 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.421 ' HB3' HD11 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -78.43 -19.36 53.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.253 -1.339 . . . . 3.08 109.663 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -70.21 -17.49 63.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.246 -0.888 . . . . 1.57 110.771 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.899 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 44.0 m0 -106.61 -24.96 12.0 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.803 0.335 . . . . 0.66 111.117 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.62 15.56 5.34 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.128 -1.034 . . . . 0.57 113.998 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.584 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.05 -121.11 2.17 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.523 -1.322 . . . . 0.6 111.383 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -164.95 63.01 0.13 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 124.179 1.942 . . . . 1.91 110.496 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.585 ' CG2' HG21 ' A' ' 112' ' ' VAL . 85.9 m -141.7 104.92 4.62 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.689 -2.05 . . . . 1.1 107.361 173.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 1.014 ' HB ' HD12 ' A' ' 111' ' ' ILE . 42.2 mm -74.02 92.3 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-O 121.855 0.836 . . . . 1.27 110.054 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.579 ' HD1' ' HA ' ' A' ' 138' ' ' PRO . 30.6 m-85 -75.81 107.83 8.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.038 -1.437 . . . . 0.53 110.447 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.9 m -98.96 108.22 20.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.004 -0.998 . . . . 1.0 110.211 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.778 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 76.9 mttt -83.36 99.4 10.01 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.902 -0.59 . . . . 1.96 109.867 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.4 pp -128.42 -167.09 1.72 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 1.49 112.463 -174.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.55 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 12.0 t -166.75 119.87 1.01 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.994 -1.912 . . . . 2.07 106.001 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.71 -5.84 51.9 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.124 -0.631 . . . . 1.11 109.372 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 19.5 mmtt -87.23 -37.37 17.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.391 -0.822 . . . . 2.78 111.498 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.55 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 11.6 p -87.69 -13.88 41.35 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.62 -0.832 . . . . 1.35 110.63 171.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 19.4 mmtp 59.64 45.39 13.17 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.95 -1.023 . . . . 1.9 109.703 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 4.4 tp10 -99.03 -68.5 0.8 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.487 -1.233 . . . . 2.48 110.557 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -80.55 2.75 77.02 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.531 -0.842 . . . . 0.36 113.454 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.424 HD11 ' CD ' ' A' ' 155' ' ' LYS . 30.5 mt -74.32 -39.62 62.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.069 0.934 . . . . 1.42 108.879 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 19.4 t70 -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.358 -0.837 . . . . 2.2 108.936 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.471 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 81.9 t60 -67.43 -17.61 64.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.525 -0.761 . . . . 0.68 111.333 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 165' ' ' ILE . 51.6 tp -68.94 -56.9 6.41 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.03 0.443 . . . . 1.77 110.028 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.17 -38.56 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.21 -0.904 . . . . 2.1 109.731 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 31.7 mm-40 -56.39 -41.93 77.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.325 -0.852 . . . . 2.57 111.445 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.838 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 13.7 mmt -77.52 -32.25 53.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 1.21 110.576 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 161' ' ' LEU . 75.7 mt -65.14 -47.18 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.619 . . . . 1.2 111.093 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.404 HD13 ' N ' ' A' ' 167' ' ' LEU . 3.9 pp -65.6 -29.29 69.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.862 0.363 . . . . 2.3 111.261 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.404 ' N ' HD13 ' A' ' 166' ' ' LEU . 35.2 tp -56.25 -49.26 74.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.67 . . . . 2.11 109.708 170.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 N--CA 1.446 -0.638 0 CA-C-N 115.521 -0.763 . . . . 1.41 110.26 174.99 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.775 0.321 . . . . 1.27 110.31 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 25' ' ' LEU . 59.5 mt -96.37 127.93 48.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.915 0.388 . . . . 1.83 110.653 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.53 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . 60.1 mtt -136.34 175.55 9.5 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.037 -0.529 . . . . 1.28 109.823 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.48 -168.97 27.16 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.89 -0.671 . . . . 0.34 111.7 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.683 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 47.1 t60 -89.66 158.49 17.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.86 0.838 . . . . 0.28 111.48 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.523 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.1 p -72.18 148.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.562 -1.199 . . . . 1.09 109.697 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 23.6 t70 73.81 -19.36 0.35 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.457 0.646 . . . . 0.69 110.502 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 17' ' ' VAL . 15.6 m170 -84.67 -0.68 54.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.974 -1.121 . . . . 0.63 107.974 168.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 87.76 49.48 3.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.163 -0.926 . . . . 0.79 113.86 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -63.67 -36.57 84.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.31 -0.556 . . . . 3.69 111.508 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 m -101.8 -42.41 6.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 1.76 110.454 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -54.11 -19.47 5.02 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.125 0.787 . . . . 1.71 113.125 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -74.83 -45.24 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.259 -0.645 . . . . 2.09 109.259 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.443 ' HB2' HD13 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -66.39 -16.12 63.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.731 -1.122 . . . . 2.23 109.199 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -97.78 -41.5 8.03 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.701 0.762 . . . . 1.23 110.194 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -29.1 69.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.817 -1.083 . . . . 1.23 110.132 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.9 tt . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 114.662 -1.154 . . . . 1.59 110.128 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.6 mt . . . . . 0 CA--C 1.522 -0.124 0 N-CA-C 109.026 -0.731 . . . . 1.38 109.026 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.3 t -100.9 116.64 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 C-N-CA 119.408 -0.917 . . . . 1.79 112.183 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 9.2 mt -81.3 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.899 -1.046 . . . . 1.14 109.448 171.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.64 HD11 HG13 ' A' ' 86' ' ' VAL . 2.3 tm? -117.91 105.97 12.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.084 -1.08 . . . . 1.65 108.084 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 53.8 t -90.05 112.11 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.364 -0.834 . . . . 1.14 110.864 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.64 HG13 HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -121.32 129.67 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.733 -0.667 . . . . 1.31 110.874 175.765 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.631 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -70.63 130.69 42.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.896 -0.593 . . . . 1.01 109.935 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.657 ' HB1' ' CG2' ' A' ' 114' ' ' ILE . . . -71.54 -13.58 61.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 1.07 110.632 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.446 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -94.46 -2.42 51.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.686 -0.688 . . . . 0.58 111.521 -178.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.448 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 26.4 t0 -138.03 -49.26 0.56 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.652 -0.249 . . . . 0.56 110.891 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.601 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.36 -146.89 18.46 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.343 -0.456 . . . . 0.37 113.689 171.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.5 136.12 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 1.78 109.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.703 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.2 mmm -138.14 176.5 2.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 114.87 -1.059 . . . . 1.07 108.658 -171.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 55.8 Cg_exo -38.54 -69.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.607 2.872 . . . . 0.89 114.764 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.523 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 7.6 pt20 -72.4 -16.99 61.85 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.01 0.433 . . . . 0.78 111.47 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.683 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.71 -44.01 78.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.097 -0.705 . . . . 1.07 109.097 176.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 93' ' ' MET . 20.8 t -65.86 -41.36 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.22 -0.9 . . . . 2.02 111.096 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.81 -26.73 62.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 2.35 110.777 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 14' ' ' MET . . . -73.7 -34.95 65.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.184 -0.462 . . . . 1.12 110.382 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.493 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.8 mt -74.3 -46.69 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.472 0.653 . . . . 1.14 109.28 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -56.31 -40.56 74.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.608 -1.178 . . . . 0.75 110.491 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -70.65 -35.43 72.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.907 -0.588 . . . . 3.23 110.199 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.428 ' HB1' HD13 ' A' ' 110' ' ' ILE . . . -69.43 -46.92 65.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 1.17 111.109 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.5 mmtp -64.8 -38.68 91.79 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.19 0.519 . . . . 2.27 109.986 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -48.24 -43.31 32.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.301 -1.318 . . . . 1.28 111.239 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.73 -38.27 15.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 1.31 111.022 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 88.08 72.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.631 1.172 . . . . 1.6 109.113 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 109' ' ' PRO . 3.0 p -126.2 144.71 49.95 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.203 -1.362 . . . . 1.93 110.862 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.411 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.9 Cg_exo -66.45 139.32 53.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.716 1.611 . . . . 0.66 111.327 170.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.428 HD13 ' HB1' ' A' ' 103' ' ' ALA . 27.0 mm -104.83 157.4 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.571 0.7 . . . . 1.34 110.68 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 1.011 HD11 ' HB ' ' A' ' 146' ' ' ILE . 16.3 mm -122.91 83.72 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.346 -1.353 . . . . 1.12 107.346 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.891 HG22 HD21 ' A' ' 131' ' ' LEU . 63.5 t -71.14 143.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.907 0.861 . . . . 1.06 109.518 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.755 ' HB3' HD23 ' A' ' 150' ' ' LEU . . . -146.64 100.41 3.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.857 -1.52 . . . . 1.07 109.857 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.775 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 85.0 mt -72.25 140.13 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 113.749 -1.569 . . . . 1.29 109.91 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.631 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.2 p-10 -120.29 176.13 5.62 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.068 -1.456 . . . . 1.85 107.068 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.626 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 75.5 mttt 66.34 27.92 9.92 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.86 0.725 . . . . 1.18 112.165 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.763 ' HE3' ' HG3' ' A' ' 124' ' ' PRO . 85.8 mmm -80.86 -1.64 44.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.697 0.761 . . . . 1.64 109.074 171.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.626 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.4 p-10 -71.01 -31.7 68.27 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.84 -1.073 . . . . 0.76 108.664 168.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 119' ' ' LYS . 39.6 mtpt -77.41 136.75 64.25 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.128 -1.396 . . . . 1.74 110.833 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.78 -17.39 59.7 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.818 2.346 . . . . 0.68 111.683 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.05 1.62 27.04 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.695 -0.684 . . . . 1.45 110.687 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.487 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -56.03 114.9 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.594 -0.73 . . . . 1.1 110.638 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.69 75.46 55.49 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 107.885 -1.154 . . . . 0.95 107.885 173.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.763 ' HG3' ' HE3' ' A' ' 117' ' ' MET . 42.4 Cg_endo -64.86 -57.17 0.31 Allowed 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 122.492 2.128 . . . . 0.54 112.46 -172.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.478 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 4.3 m-20 -50.91 -26.57 6.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 124.2 0.938 . . . . 1.44 111.037 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -77.71 -59.23 2.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.892 -0.594 . . . . 4.56 110.071 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.601 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 4.7 m -64.67 -27.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.105 -0.952 . . . . 1.26 110.398 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.773 ' HE2' ' HG3' ' A' ' 138' ' ' PRO . 23.2 ttt -60.95 -51.79 67.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.726 -1.125 . . . . 1.64 109.815 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.426 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 35.2 mt-30 -59.15 -31.25 68.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.022 0.749 . . . . 2.0 113.022 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.506 ' HA ' ' CG ' ' A' ' 133' ' ' GLU . 4.3 pt-20 -80.91 -16.44 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.081 -0.647 . . . . 1.64 112.081 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.891 HD21 HG22 ' A' ' 112' ' ' VAL . 6.7 mp -68.17 -35.87 78.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.582 -0.847 . . . . 1.96 109.044 167.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.665 ' HE3' ' HG2' ' A' ' 128' ' ' MET . 0.5 OUTLIER -71.19 -18.75 62.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.437 -0.801 . . . . 2.05 109.618 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.506 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 7.9 mm-40 -70.45 -30.51 67.37 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.661 -0.866 . . . . 1.67 108.661 173.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.423 ' HH ' HG22 ' A' ' 97' ' ' VAL . 58.4 m-85 -91.97 17.3 9.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.059 -0.973 . . . . 1.58 109.959 173.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 61.11 47.84 6.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.233 -1.349 . . . . 1.42 111.27 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.473 HD12 HD21 ' A' ' 131' ' ' LEU . 1.5 pp -131.28 121.41 24.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.096 -1.076 . . . . 1.93 108.096 167.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.75 HG13 ' HD2' ' A' ' 138' ' ' PRO . 5.0 t -122.06 142.92 37.62 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.114 0.483 . . . . 1.18 111.382 -168.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.783 ' HB3' ' CD1' ' A' ' 147' ' ' PHE . 18.5 Cg_endo -69.86 -175.21 1.1 Allowed 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 123.621 2.88 . . . . 0.88 113.631 -176.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.817 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -84.61 -32.66 23.6 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.53 -1.668 . . . . 3.08 109.93 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.756 ' HG3' ' CD1' ' A' ' 141' ' ' TRP . 6.7 pt-20 -67.85 -17.66 64.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.092 -0.504 . . . . 1.57 111.205 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.756 ' CD1' ' HG3' ' A' ' 140' ' ' GLU . 21.2 m0 -109.04 -2.82 17.89 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.892 0.377 . . . . 0.66 111.183 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.81 32.13 13.68 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.058 -0.591 . . . . 0.57 113.784 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.19 -127.86 5.84 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.627 -0.796 . . . . 0.6 111.407 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -149.84 62.93 0.99 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.018 0.913 . . . . 1.91 111.894 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.818 HG21 HG23 ' A' ' 112' ' ' VAL . 52.7 m -161.27 128.14 4.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.165 -0.925 . . . . 1.1 109.99 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 1.011 ' HB ' HD11 ' A' ' 111' ' ' ILE . 46.8 mm -79.78 104.89 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 108.863 -0.792 . . . . 1.27 108.863 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.783 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 5.9 m-85 -88.56 116.74 27.02 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.584 -0.734 . . . . 0.53 111.706 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.1 m -106.76 143.31 35.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.814 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.567 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.5 mttt -118.15 97.91 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.885 -0.783 . . . . 1.96 108.885 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.899 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -130.63 -171.47 2.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.749 1.261 . . . . 1.49 112.569 -169.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.521 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 28.9 t -157.88 115.99 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.679 -1.601 . . . . 2.07 106.873 174.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.45 -9.92 58.99 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.084 -0.71 . . . . 1.11 109.084 175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.18 -50.96 17.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.878 -1.055 . . . . 2.78 110.56 174.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 118' ' ' ASP . 2.1 p -81.39 -16.06 53.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.228 -0.589 . . . . 1.35 111.217 175.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.424 ' CD ' HD11 ' A' ' 158' ' ' LEU . 29.1 mmtp 67.21 40.66 2.75 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.307 -0.861 . . . . 1.9 110.539 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.572 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.4 OUTLIER -98.71 -64.66 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.022 -0.99 . . . . 2.48 109.663 -171.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.899 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -76.19 -3.01 74.89 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.111 -0.95 . . . . 0.36 113.433 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.424 HD11 ' CD ' ' A' ' 155' ' ' LYS . 18.1 mt -70.89 -36.16 72.63 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 117.974 0.887 . . . . 1.42 109.416 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.401 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 27.7 t70 -73.04 -39.95 65.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 2.2 109.257 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -68.52 -18.11 64.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.212 -0.449 . . . . 0.68 111.346 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.8 tp -74.81 -54.27 7.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.24 0.543 . . . . 1.77 110.08 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.52 -27.64 69.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.267 -0.879 . . . . 2.1 111.529 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.431 -0.507 . . . . 2.57 110.22 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.797 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 21.7 mmt -71.72 -39.39 70.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.17 0.509 . . . . 1.21 109.649 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.25 -38.7 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.519 -0.764 . . . . 1.2 110.443 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -40.38 95.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.504 . . . . 2.3 111.146 177.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.98 -43.46 63.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.466 0.65 . . . . 2.11 109.561 173.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 68.0 t . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 114.756 -1.111 . . . . 1.41 110.769 176.267 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.499 ' HB ' HG22 ' A' ' 82' ' ' VAL . 89.1 m . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.251 -0.277 . . . . 1.27 110.251 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mt -112.62 122.34 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.051 -0.406 . . . . 1.83 110.402 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.791 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 59.2 mtt -139.65 173.56 11.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.048 -0.524 . . . . 1.28 109.953 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.478 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 145.32 -163.54 28.12 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.641 -0.79 . . . . 0.34 112.335 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.737 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 42.7 t60 -97.1 161.28 13.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.822 0.82 . . . . 0.28 112.031 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.585 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.8 p -73.72 151.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.339 -1.301 . . . . 1.09 109.739 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 10.7 t70 73.39 -27.09 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.304 0.574 . . . . 0.69 110.605 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.0 m170 -77.38 -10.47 59.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.407 -0.96 . . . . 0.63 108.407 171.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.673 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 113.72 51.95 0.48 Allowed Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.605 -0.807 . . . . 0.79 114.22 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 4.2 tptm -53.31 -62.77 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.447 0.623 . . . . 3.69 111.283 174.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -96.07 -32.11 12.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.579 -0.282 . . . . 1.76 111.079 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.547 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -59.34 -20.84 57.87 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.018 0.747 . . . . 1.71 113.018 -179.006 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.673 HD23 ' HA3' ' A' ' 20' ' ' GLY . 1.5 mm? -74.52 -35.73 63.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.919 0.39 . . . . 2.09 110.001 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.02 -15.11 61.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.79 -0.641 . . . . 2.23 109.466 176.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -96.5 -32.03 12.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.706 -0.679 . . . . 1.23 109.29 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -47.32 49.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.198 -0.91 . . . . 1.23 109.051 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 tt . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 114.68 -1.145 . . . . 1.59 110.244 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.2 mt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.597 -0.52 . . . . 1.38 109.597 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.507 ' HB ' HD13 ' A' ' 110' ' ' ILE . 40.1 t -93.84 114.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.424 0.63 . . . . 1.79 111.205 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.5 mt -82.84 126.03 40.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.899 -1.046 . . . . 1.14 109.596 172.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.67 HD12 HG12 ' A' ' 86' ' ' VAL . 2.3 tm? -114.73 106.09 13.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.447 -0.945 . . . . 1.65 108.447 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 57.7 t -88.24 109.76 20.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.395 -0.82 . . . . 1.14 110.921 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.781 HG21 HD22 ' A' ' 131' ' ' LEU . 1.7 m -121.14 135.76 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.855 -0.611 . . . . 1.31 111.338 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.706 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -74.26 134.18 42.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.935 -0.575 . . . . 1.01 109.706 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.759 ' HB3' ' CG2' ' A' ' 114' ' ' ILE . . . -78.61 -9.42 59.36 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.355 0.597 . . . . 1.07 109.846 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -89.25 -10.24 47.68 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.941 -1.027 . . . . 0.58 110.359 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.1 t0 -133.33 -59.51 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.07 -0.514 . . . . 0.56 111.152 -173.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 109.14 -135.11 12.65 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.37 113.637 173.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.27 131.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.786 0.803 . . . . 1.78 110.671 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.609 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 68.6 mmm -134.02 178.93 1.53 Allowed Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 114.333 -1.303 . . . . 1.07 109.402 -171.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.4 Cg_exo -45.64 -64.34 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.27 2.647 . . . . 0.89 114.735 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.585 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 7.0 pt20 -75.17 -10.93 59.92 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.636 -0.665 . . . . 0.78 111.3 -175.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.737 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.85 -49.28 54.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.738 -0.664 . . . . 1.07 109.279 175.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.538 ' HA ' HD13 ' A' ' 100' ' ' ILE . 2.5 p -72.63 -28.61 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.834 -0.621 . . . . 2.02 112.591 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 49.2 mt-10 -57.95 -29.66 65.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.544 0.611 . . . . 2.35 109.448 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -72.36 -42.85 64.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.396 -0.82 . . . . 1.12 110.743 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.538 HD13 ' HA ' ' A' ' 97' ' ' VAL . 65.7 mt -66.05 -41.57 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.62 0.724 . . . . 1.14 109.307 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -57.9 -40.0 79.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.196 -1.366 . . . . 0.75 110.857 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -66.83 -40.45 88.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.643 -0.503 . . . . 3.23 109.643 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HB3' HD12 ' A' ' 110' ' ' ILE . . . -70.41 -46.08 64.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.877 -0.602 . . . . 1.17 111.788 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.78 -29.06 61.98 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.052 0.453 . . . . 2.27 110.659 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.61 -43.23 62.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.689 -1.141 . . . . 1.28 110.69 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.44 -19.18 23.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 1.31 111.3 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 70.04 67.79 0.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.17 -0.923 . . . . 1.6 110.472 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -117.28 152.39 49.1 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 1.93 111.12 -176.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 108' ' ' VAL . 23.2 Cg_exo -65.34 141.58 68.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.041 2.494 . . . . 0.66 112.537 172.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 103' ' ' ALA . 29.2 mm -111.27 155.47 12.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.601 0.715 . . . . 1.34 111.121 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 7.9 mm -125.38 87.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.429 -1.323 . . . . 1.12 107.429 170.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.696 HG22 HG22 ' A' ' 145' ' ' THR . 46.6 t -74.16 148.33 8.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.463 -0.789 . . . . 1.06 109.8 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.545 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -143.73 106.18 4.42 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.473 -1.24 . . . . 1.07 110.427 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.81 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -79.22 135.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.508 -1.224 . . . . 1.29 109.787 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.706 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.5 p-10 -113.47 177.41 4.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.28 -1.378 . . . . 1.85 107.28 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.707 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 84.2 mttt 70.5 33.1 2.52 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.61 0.569 . . . . 1.18 111.754 176.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.645 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 29.8 mmt -73.95 -19.0 60.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.245 -1.391 . . . . 1.64 107.245 166.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.628 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -62.29 -36.44 82.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.37 -1.741 . . . . 0.76 110.503 172.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.707 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 41.1 mtpt -79.34 141.77 57.73 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.94 -0.573 . . . . 1.74 110.3 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.24 -15.95 52.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.792 2.328 . . . . 0.68 111.88 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 34.4 mt-10 -84.75 11.26 9.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.574 -0.739 . . . . 1.45 110.655 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.46 ' HB3' ' HE1' ' A' ' 117' ' ' MET . . . -61.29 100.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.536 -0.756 . . . . 1.1 111.155 176.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.582 HD21 ' HB2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -120.41 77.07 26.27 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.664 -0.865 . . . . 0.95 108.664 176.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.549 ' HD3' ' HE2' ' A' ' 117' ' ' MET . 55.7 Cg_endo -68.15 -56.01 0.22 Allowed 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 123.334 2.689 . . . . 0.54 113.512 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.536 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 2.2 m-20 -55.72 -24.5 35.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.44 110.7 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.582 ' HB2' HD21 ' A' ' 123' ' ' ASN . 15.4 tpp180 -74.15 -57.49 3.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.386 -0.598 . . . . 4.56 109.386 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.706 HG23 ' HA ' ' A' ' 88' ' ' ALA . 26.5 m -64.44 -32.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.999 -1.0 . . . . 1.26 111.681 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.956 ' HA ' HD23 ' A' ' 131' ' ' LEU . 17.1 ptm -76.22 -15.79 59.96 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.889 0.376 . . . . 1.64 110.41 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 132' ' ' MET . 30.1 mt-30 -78.38 -33.95 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 2.0 110.014 171.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.04 -27.26 65.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.905 -0.776 . . . . 1.64 108.905 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.956 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.2 OUTLIER -59.44 -46.41 88.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.484 -1.235 . . . . 1.96 109.263 174.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.604 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 16.6 ptm -75.11 -13.76 60.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.409 -0.516 . . . . 2.05 111.125 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 58.9 mm-40 -70.49 -29.08 65.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.0 -1.111 . . . . 1.67 108.0 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.468 ' N ' ' HD1' ' A' ' 134' ' ' TYR . 1.6 m-85 -98.92 23.17 9.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.473 -1.239 . . . . 1.58 108.986 175.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.4 t30 60.49 49.22 6.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 113.619 -1.628 . . . . 1.42 112.259 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.591 HD12 HD12 ' A' ' 131' ' ' LEU . 52.4 mt -117.93 98.65 6.45 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.329 -0.85 . . . . 1.93 109.522 171.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.998 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 26.2 t -104.68 113.67 64.72 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.089 -0.644 . . . . 1.18 111.497 -172.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.588 ' CB ' ' HG2' ' A' ' 140' ' ' GLU . 82.2 Cg_exo -45.48 141.81 7.31 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.405 3.403 . . . . 0.88 112.8 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.578 ' HB2' HD13 ' A' ' 146' ' ' ILE . 6.3 mm-40 -71.56 -14.75 62.19 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.636 -1.165 . . . . 3.08 110.56 174.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.588 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.8 pm0 -68.39 -19.99 64.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.981 -0.554 . . . . 1.57 109.759 167.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.578 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 42.7 m0 -107.68 -30.3 8.65 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.994 0.426 . . . . 0.66 110.722 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.83 25.63 3.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.752 -0.737 . . . . 0.57 113.255 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.998 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -88.67 -107.28 1.06 Allowed Glycine 0 C--N 1.324 -0.134 0 C-N-CA 120.126 -1.035 . . . . 0.6 112.699 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -165.07 60.83 0.12 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 122.565 1.174 . . . . 1.91 110.694 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.696 HG22 HG22 ' A' ' 112' ' ' VAL . 87.4 m -164.39 122.4 1.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.687 -1.142 . . . . 1.1 110.554 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.673 ' HB ' HD13 ' A' ' 111' ' ' ILE . 16.5 mm -84.42 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.211 -0.663 . . . . 1.27 109.211 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.456 ' HE2' HD23 ' A' ' 131' ' ' LEU . 2.8 m-85 -87.62 145.5 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.884 0.849 . . . . 0.53 110.153 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 65.1 m -118.15 136.32 53.69 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.29 -1.323 . . . . 1.0 109.103 172.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.541 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 94.7 mttt -109.76 89.84 3.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.997 -0.742 . . . . 1.96 108.997 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.858 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -115.45 179.46 3.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.877 1.322 . . . . 1.49 112.054 -170.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 3.9 p -145.28 95.47 2.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.156 -1.838 . . . . 2.07 106.978 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.97 -18.38 65.36 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.463 -0.495 . . . . 1.11 109.732 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.491 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 70.6 mmtt -80.95 -43.49 19.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.701 -0.682 . . . . 2.78 111.563 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.628 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 1.9 m -76.07 -15.49 60.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.387 0.613 . . . . 1.35 110.82 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm 66.49 46.0 1.98 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.845 -1.071 . . . . 1.9 110.373 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.542 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.35 -57.46 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.039 -0.982 . . . . 2.48 110.702 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.858 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.61 1.91 84.21 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.285 -0.959 . . . . 0.36 113.543 -172.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.1 -41.52 61.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.192 -0.67 . . . . 1.42 109.192 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 15.4 m-20 -67.65 -43.93 79.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.503 -0.771 . . . . 2.2 109.318 171.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.581 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 78.1 t60 -63.31 -23.12 67.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.932 -0.576 . . . . 0.68 111.516 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 165' ' ' ILE . 55.0 tp -68.49 -55.81 10.5 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.358 0.599 . . . . 1.77 109.784 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.149 -0.932 . . . . 2.1 110.775 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 65.1 mm-40 -66.48 -45.03 81.05 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.052 0.454 . . . . 2.57 110.398 172.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.857 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 12.7 mmt -67.61 -36.88 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.181 0.515 . . . . 1.21 110.203 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 83' ' ' ILE . 77.9 mt -66.8 -32.21 57.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 1.2 110.128 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -35.07 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 2.3 110.821 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.7 tp -57.03 -42.58 80.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.766 0.793 . . . . 2.11 109.26 171.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.227 -0.897 . . . . 1.41 110.331 175.642 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.971 -0.381 . . . . 1.27 109.971 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.834 HD12 HD21 ' A' ' 25' ' ' LEU . 17.1 pt -96.64 133.51 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.638 0.733 . . . . 1.83 111.446 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.664 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 62.9 mtt -134.96 -179.62 5.73 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.856 -1.065 . . . . 1.28 109.41 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.478 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 140.63 -164.86 26.27 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.517 -0.849 . . . . 0.34 111.776 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.864 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 46.9 t60 -92.18 158.04 16.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.64 0.733 . . . . 0.28 111.204 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.6 p -70.98 147.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.915 -1.039 . . . . 1.09 109.872 174.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.2 t70 75.0 -26.86 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.456 0.646 . . . . 0.69 110.613 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.494 ' H ' ' C ' ' A' ' 17' ' ' VAL . 18.4 m170 -79.44 -13.71 59.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.3 -1.0 . . . . 0.63 108.3 170.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.452 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 116.97 76.35 0.59 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.357 -0.925 . . . . 0.79 114.97 171.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 15' ' ' GLY . 20.6 mmtp -77.32 -86.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.924 -0.71 . . . . 3.69 111.097 165.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 m -75.24 -16.14 60.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.829 0.347 . . . . 1.76 111.109 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -56.21 -35.03 66.85 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 111.863 0.32 . . . . 1.71 111.863 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.433 HD21 ' O ' ' A' ' 20' ' ' GLY . 4.5 mm? -74.06 -40.57 62.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.665 -0.494 . . . . 2.09 109.665 176.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.834 HD21 HD12 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -62.44 -13.11 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.821 -0.627 . . . . 2.23 110.022 176.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -102.18 -47.5 4.51 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.706 0.765 . . . . 1.23 109.706 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.08 73.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.28 -1.327 . . . . 1.23 111.398 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 99.2 mt . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.716 -0.675 . . . . 1.59 111.083 -177.105 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.4 mt . . . . . 0 C--O 1.234 0.28 0 N-CA-C 110.363 -0.236 . . . . 1.38 110.363 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.4 136.33 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.631 -0.828 . . . . 1.79 111.337 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.72 HG12 ' HB ' ' A' ' 111' ' ' ILE . 9.5 mt -96.71 135.88 29.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.068 -0.969 . . . . 1.14 109.612 170.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.644 HD11 HG12 ' A' ' 86' ' ' VAL . 1.8 tm? -119.8 107.8 13.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.975 -1.121 . . . . 1.65 107.975 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -93.17 113.53 28.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.795 -0.639 . . . . 1.14 110.681 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.875 HG23 HD11 ' A' ' 131' ' ' LEU . 2.8 m -121.3 136.88 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.524 -0.762 . . . . 1.31 110.713 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.748 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -75.87 134.64 40.26 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.903 -0.589 . . . . 1.01 110.105 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB3' ' CG2' ' A' ' 114' ' ' ILE . . . -74.87 -10.03 59.11 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.303 0.573 . . . . 1.07 110.035 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.68 -14.48 39.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.181 -0.918 . . . . 0.58 110.624 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.473 ' HB3' ' CE1' ' A' ' 19' ' ' HIS . 2.4 t0 -131.95 -63.0 0.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.56 110.298 -176.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.524 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 115.72 -129.71 8.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.256 -0.497 . . . . 0.37 112.793 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.82 140.58 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.569 0.7 . . . . 1.78 109.621 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.527 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.6 mmm -139.94 176.33 2.62 Favored Pre-proline 0 C--N 1.311 -1.073 0 CA-C-N 114.743 -1.117 . . . . 1.07 108.549 -171.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 86.6 Cg_exo -48.72 -57.21 2.5 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.662 2.241 . . . . 0.89 114.205 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.664 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 1.9 pt20 -78.88 -11.48 60.0 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.11 -0.636 . . . . 0.78 111.002 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.864 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.87 -49.6 44.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.483 -0.781 . . . . 1.07 109.4 176.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' HA ' HD11 ' A' ' 100' ' ' ILE . 3.0 p -76.72 -27.74 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 115.454 -0.793 . . . . 2.02 113.128 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.664 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -66.97 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.31 -0.956 . . . . 2.35 109.549 177.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 14' ' ' MET . . . -77.18 -36.46 55.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.144 -0.935 . . . . 1.12 110.032 170.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.546 HD11 ' HA ' ' A' ' 97' ' ' VAL . 97.9 mt -68.27 -42.81 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.518 0.675 . . . . 1.14 109.434 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.94 -42.01 68.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.685 -1.143 . . . . 0.75 110.523 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -66.36 -35.0 79.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.078 -0.51 . . . . 3.23 110.093 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 -46.73 22.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.127 -0.488 . . . . 1.17 111.775 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.8 mmmt -68.77 -39.58 80.16 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.96 0.409 . . . . 2.27 110.413 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.98 69.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.53 -0.759 . . . . 1.28 110.772 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.97 63.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 1.31 110.495 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.8 t30 76.64 73.53 0.08 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.264 1.03 . . . . 1.6 109.301 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -137.71 147.5 57.33 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 113.545 -1.661 . . . . 1.93 110.016 -170.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -52.59 135.24 55.38 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.554 2.169 . . . . 0.66 113.156 171.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.533 ' C ' HG21 ' A' ' 145' ' ' THR . 1.2 mt -110.72 162.61 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.697 -1.138 . . . . 1.34 110.385 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.72 ' HB ' HG12 ' A' ' 83' ' ' ILE . 27.3 mm -129.58 84.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 107.394 -1.336 . . . . 1.12 107.394 172.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.905 HG22 HG23 ' A' ' 145' ' ' THR . 48.7 t -74.16 146.34 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.725 0.774 . . . . 1.06 109.237 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.855 ' HB2' HD23 ' A' ' 150' ' ' LEU . . . -141.72 105.79 4.77 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.25 -1.341 . . . . 1.07 110.512 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.745 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 3.0 mp -80.06 124.84 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.464 -1.244 . . . . 1.29 109.081 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.748 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.9 p-10 -107.34 177.51 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.772 -1.196 . . . . 1.85 107.772 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.536 ' HD2' ' HB3' ' A' ' 87' ' ' ALA . 80.5 mttt 71.11 37.02 1.29 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 123.981 0.8 . . . . 1.18 111.427 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.484 ' CE ' ' HB2' ' A' ' 122' ' ' ALA . 29.2 mmt -78.14 -15.07 59.19 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.803 -1.184 . . . . 1.64 107.803 168.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.2 -19.79 60.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.635 -1.62 . . . . 0.76 109.942 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 24.0 mmmt -87.68 131.02 44.84 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-N 115.305 -0.861 . . . . 1.74 110.124 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.5 -11.58 26.67 Favored 'Trans proline' 0 N--CA 1.472 0.254 0 C-N-CA 122.71 2.273 . . . . 0.68 111.709 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.91 8.57 31.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.879 -1.055 . . . . 1.45 110.567 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.484 ' HB2' ' CE ' ' A' ' 117' ' ' MET . . . -54.96 106.83 0.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.967 -1.015 . . . . 1.1 111.438 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.95 75.72 14.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.95 108.419 172.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.451 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 57.6 Cg_endo -68.92 -54.38 0.26 Allowed 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 123.002 2.468 . . . . 0.54 113.438 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.451 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 25.3 m-20 -58.11 -28.06 64.29 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.13 -0.941 . . . . 1.44 109.629 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.88 -58.92 3.04 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 119.889 -0.725 . . . . 4.56 109.115 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 88' ' ' ALA . 21.6 m -61.8 -31.32 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.732 -1.122 . . . . 1.26 111.988 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 1.082 ' HA ' HD13 ' A' ' 131' ' ' LEU . 19.9 ptm -79.25 -16.42 56.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.101 -0.24 . . . . 1.64 110.805 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.677 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 13.8 mt-30 -80.14 -39.26 29.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.732 0.301 . . . . 2.0 110.831 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.46 -27.11 65.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.737 -0.838 . . . . 1.64 108.737 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 1.082 HD13 ' HA ' ' A' ' 128' ' ' MET . 77.5 mt -61.79 -45.19 94.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.506 -1.225 . . . . 1.96 110.022 174.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.829 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -76.19 -10.59 59.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.473 -0.491 . . . . 2.05 111.268 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -85.28 -15.6 42.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.366 -0.605 . . . . 1.67 109.366 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.45 17.37 14.74 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.925 -1.139 . . . . 1.58 107.925 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.6 t30 59.37 56.14 3.91 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 113.315 -1.766 . . . . 1.42 112.027 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.666 ' H ' ' HA ' ' A' ' 132' ' ' MET . 77.1 mt -121.53 96.1 4.94 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.787 -1.097 . . . . 1.93 109.03 169.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.895 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 32.9 t -105.02 113.97 64.2 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 120.032 -0.667 . . . . 1.18 111.049 -171.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.924 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 6.8 Cg_endo -56.45 157.8 17.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 123.326 2.684 . . . . 0.88 112.673 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' A' ' 146' ' ' ILE . 16.4 mm-40 -78.6 -13.52 59.79 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.256 -1.338 . . . . 3.08 109.974 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.924 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -68.04 -23.32 64.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 1.57 109.906 168.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.829 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 40.5 m0 -108.33 -14.9 14.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.858 0.361 . . . . 0.66 110.83 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.87 27.74 10.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.705 -0.759 . . . . 0.57 113.52 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.895 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.69 -108.36 0.72 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.238 -0.982 . . . . 0.6 111.621 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -163.28 61.1 0.18 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.575 1.179 . . . . 1.91 111.66 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.905 HG23 HG22 ' A' ' 112' ' ' VAL . 88.8 m -163.49 124.11 2.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.637 -1.165 . . . . 1.1 110.906 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.715 HG22 ' HB3' ' A' ' 164' ' ' MET . 23.3 mm -74.36 104.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 109.146 -0.687 . . . . 1.27 109.146 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 7.4 m-85 -87.67 117.82 26.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.321 -0.854 . . . . 0.53 110.401 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.3 m -101.37 144.17 30.51 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.46 -0.336 . . . . 1.0 110.501 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.485 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.8 mttt -116.77 89.47 3.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.167 -0.679 . . . . 1.96 109.167 175.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.855 HD23 ' HB2' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -117.99 176.22 5.31 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.671 1.224 . . . . 1.49 112.265 -171.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -129.72 102.46 6.35 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.916 -1.493 . . . . 2.07 107.283 164.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.73 64.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.923 -0.769 . . . . 1.11 108.923 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -64.38 -59.83 3.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.41 -1.268 . . . . 2.78 110.936 174.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.7 p -88.94 5.02 46.03 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 119.99 -0.684 . . . . 1.35 112.163 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.482 ' CD ' HD12 ' A' ' 158' ' ' LEU . 29.7 mmtp 64.37 46.85 3.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.555 -0.748 . . . . 1.9 111.834 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.602 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -104.93 -53.71 2.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.925 0.869 . . . . 2.48 110.983 -177.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.832 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.84 2.24 84.11 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.332 -0.937 . . . . 0.36 112.763 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.482 HD12 ' CD ' ' A' ' 155' ' ' LYS . 19.7 mt -76.32 -36.98 58.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.213 -0.662 . . . . 1.42 109.213 174.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.65 -40.84 80.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.621 -0.718 . . . . 2.2 109.371 171.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.506 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 74.2 t60 -72.81 -15.13 61.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.1 -0.5 . . . . 0.68 110.981 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER -77.2 -50.79 12.16 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.889 -0.411 . . . . 1.77 109.889 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 163' ' ' GLU . 4.5 pp -64.46 -29.76 70.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.789 -0.641 . . . . 2.1 111.281 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 11.2 pt-20 -71.8 -36.91 70.43 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.507 -0.477 . . . . 2.57 110.131 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.778 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 23.2 mmt -71.55 -38.27 71.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.201 0.524 . . . . 1.21 109.899 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.48 HD11 HD12 ' A' ' 83' ' ' ILE . 78.9 mt -65.34 -46.76 89.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.782 -0.644 . . . . 1.2 111.007 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.496 ' CD2' ' HA ' ' A' ' 163' ' ' GLU . 1.6 pp -67.92 -29.79 68.96 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.832 -0.433 . . . . 2.3 109.832 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.76 -52.05 63.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.38 -0.827 . . . . 2.11 108.974 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.447 -0.606 0 CA-C-N 115.85 -0.613 . . . . 1.41 110.92 176.893 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 120.481 0.181 . . . . 1.27 111.11 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 43.3 mt -84.02 124.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.265 0.555 . . . . 1.83 110.535 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.497 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 66.6 mtt -127.93 174.0 9.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.393 -0.965 . . . . 1.28 108.393 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.18 -179.47 23.17 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.259 -0.972 . . . . 0.34 111.858 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.661 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 51.5 t60 -85.09 160.63 19.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.766 0.794 . . . . 0.28 111.372 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.517 ' C ' ' H ' ' A' ' 19' ' ' HIS . 7.5 p -74.61 152.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.604 -1.18 . . . . 1.09 109.892 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.1 t70 74.05 -21.14 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.243 0.544 . . . . 0.69 110.556 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.616 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.7 m170 -79.33 -16.31 56.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.634 -0.876 . . . . 0.63 108.634 171.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.476 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 118.19 60.38 0.28 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.363 -0.835 . . . . 0.79 114.136 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -63.78 -66.01 0.6 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.951 -0.7 . . . . 3.69 111.166 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -85.62 -33.91 21.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 1.76 111.029 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -60.94 -24.88 66.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.75 0.648 . . . . 1.71 112.75 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.53 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -71.72 -39.3 70.22 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.018 -0.273 . . . . 2.09 110.592 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.7 mt -71.33 -14.54 62.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.795 -0.446 . . . . 2.23 109.795 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.94 -42.2 11.33 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.081 0.944 . . . . 1.23 108.705 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.062 -1.426 . . . . 1.23 110.026 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 tt . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 115.087 -0.961 . . . . 1.59 110.984 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--O 1.233 0.226 0 N-CA-C 110.104 -0.332 . . . . 1.38 110.104 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -120.8 121.68 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 1.79 111.971 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 10.4 mt -82.97 137.79 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.878 -1.055 . . . . 1.14 109.321 170.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.684 HD11 HD22 ' A' ' 131' ' ' LEU . 2.5 tm? -123.67 105.24 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.355 -0.98 . . . . 1.65 108.355 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 89.3 t -87.73 109.77 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.637 -0.711 . . . . 1.14 110.967 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -120.73 120.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.717 -0.674 . . . . 1.31 110.776 174.262 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -68.75 127.76 34.22 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.926 -0.768 . . . . 1.01 108.926 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.667 ' HB1' ' CG2' ' A' ' 114' ' ' ILE . . . -70.76 -11.59 61.04 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.924 0.392 . . . . 1.07 111.446 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -94.79 2.02 55.46 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.346 -0.542 . . . . 0.58 110.876 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.402 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.0 t0 -134.33 -52.21 0.82 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.352 -0.385 . . . . 0.56 110.977 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.622 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.31 -158.23 21.05 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 121.087 -0.577 . . . . 0.37 113.509 173.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.27 136.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.6 0.714 . . . . 1.78 109.646 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.719 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 73.6 mmm -136.96 177.92 1.96 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.097 -0.956 . . . . 1.07 108.808 -171.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.719 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.3 Cg_exo -40.74 -65.42 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.302 2.668 . . . . 0.89 114.814 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.466 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 7.2 pt20 -74.15 -16.88 60.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.38 0.61 . . . . 0.78 111.062 -174.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.661 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.74 -43.88 71.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 1.07 109.366 177.261 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 93' ' ' MET . 21.0 t -68.24 -39.32 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.401 -0.818 . . . . 2.02 111.276 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.46 -28.92 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 2.35 110.221 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -72.8 -42.19 64.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.819 -0.628 . . . . 1.12 111.032 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 136' ' ' LEU . 85.5 mt -71.44 -42.29 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.842 0.83 . . . . 1.14 109.596 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -63.67 -28.2 69.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.273 -1.331 . . . . 0.75 110.851 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -82.17 -32.31 30.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.047 0.451 . . . . 3.23 109.879 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.475 ' HB1' HD13 ' A' ' 110' ' ' ILE . . . -67.38 -46.6 72.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 1.17 110.901 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.92 -33.71 72.52 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.664 0.745 . . . . 2.27 110.018 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.15 44.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.096 -1.411 . . . . 1.28 111.475 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -100.33 -39.15 8.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.649 -0.25 . . . . 1.31 111.362 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 88.5 75.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.726 1.21 . . . . 1.6 109.182 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.59 142.33 42.22 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.407 -1.27 . . . . 1.93 110.4 -173.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.57 142.48 77.88 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.628 2.219 . . . . 0.66 111.943 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.624 ' HB ' HG21 ' A' ' 145' ' ' THR . 27.0 mm -108.48 155.38 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.64 0.733 . . . . 1.34 111.107 -172.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 1.067 HD12 ' HB ' ' A' ' 146' ' ' ILE . 15.7 mm -122.64 83.34 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.508 -1.293 . . . . 1.12 107.508 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.864 HG22 HD23 ' A' ' 131' ' ' LEU . 58.6 t -73.19 144.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.677 0.751 . . . . 1.06 109.307 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.793 ' HB3' HD22 ' A' ' 150' ' ' LEU . . . -141.16 101.57 4.05 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.099 -1.41 . . . . 1.07 110.013 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.949 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.4 mp -68.61 138.13 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.803 -1.544 . . . . 1.29 108.883 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 59.0 t30 -122.09 166.78 14.01 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 107.147 -1.427 . . . . 1.85 107.147 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.643 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 83.5 mttt 71.68 33.35 1.8 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 124.239 0.962 . . . . 1.18 111.515 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.6 ' CE ' ' HB3' ' A' ' 124' ' ' PRO . 9.0 mmt -74.49 -11.97 60.36 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.171 -0.922 . . . . 1.64 109.586 166.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.643 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 10.5 p-10 -70.52 -19.63 62.89 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.852 -1.067 . . . . 0.76 108.862 172.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.468 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 47.4 mtpt -95.21 131.73 29.37 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 114.769 -1.105 . . . . 1.74 110.47 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -63.68 -15.41 48.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.946 2.431 . . . . 0.68 111.748 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -82.72 7.85 13.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 1.45 110.332 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.44 115.78 2.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.276 -0.875 . . . . 1.1 110.669 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.47 75.45 24.96 Favored Pre-proline 0 CA--C 1.509 -0.621 0 N-CA-C 107.1 -1.444 . . . . 0.95 107.1 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.6 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 27.0 Cg_endo -61.73 -63.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 123.077 2.518 . . . . 0.54 113.298 -169.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 5.9 m-20 -64.01 -15.35 59.16 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.55 -0.75 . . . . 1.44 110.713 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 1.3 tmt_? -74.04 -55.72 5.78 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.475 -0.935 . . . . 4.56 108.475 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 88' ' ' ALA . 5.0 m -70.72 -25.46 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.05 -0.977 . . . . 1.26 110.36 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.581 ' HB3' ' HA ' ' A' ' 125' ' ' ASP . 9.2 ttt -66.4 -42.73 87.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.995 -1.457 . . . . 1.64 110.646 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.594 ' O ' ' HG2' ' A' ' 132' ' ' MET . 15.0 mt-30 -71.94 -24.93 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 2.0 112.282 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.554 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 13.3 mt-10 -65.88 -33.45 75.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.737 0.78 . . . . 1.64 109.067 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.864 HD23 HG22 ' A' ' 112' ' ' VAL . 5.2 mp -65.68 -37.54 86.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.016 -0.993 . . . . 1.96 110.043 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 10.0 ptm -74.88 -11.81 60.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.951 -0.7 . . . . 2.05 110.786 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 35.6 mm-40 -69.25 -35.06 75.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.068 -1.086 . . . . 1.67 108.068 170.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -91.11 23.29 3.32 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.452 -1.249 . . . . 1.58 109.769 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 54.92 49.91 16.71 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.316 -1.311 . . . . 1.42 111.927 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.549 ' H ' ' HA ' ' A' ' 132' ' ' MET . 46.5 mt -110.15 110.54 21.44 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.502 -0.772 . . . . 1.93 109.398 170.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 138' ' ' PRO . 71.0 t -109.12 114.25 58.2 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.662 0.744 . . . . 1.18 112.064 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.586 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -44.18 153.04 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 125.057 3.838 . . . . 0.88 113.314 174.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.866 ' HG2' HD11 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -76.11 -19.86 58.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.947 -1.478 . . . . 3.08 109.726 178.038 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -72.19 -22.19 61.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.588 -0.733 . . . . 1.57 110.665 171.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.455 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 34.1 m0 -102.62 -12.13 17.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.071 0.462 . . . . 0.66 110.571 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.38 21.89 9.56 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.555 -0.831 . . . . 0.57 114.232 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.96 -123.04 4.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.631 -1.271 . . . . 0.6 111.28 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -157.82 64.01 0.47 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-O 124.097 1.903 . . . . 1.91 111.326 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.624 HG21 ' HB ' ' A' ' 110' ' ' ILE . 97.0 m -148.36 112.23 5.12 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.044 -1.889 . . . . 1.1 108.609 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 1.067 ' HB ' HD12 ' A' ' 111' ' ' ILE . 51.9 mm -73.56 97.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.539 0.685 . . . . 1.27 109.412 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 14.8 m-85 -81.46 119.67 24.02 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.612 -1.176 . . . . 0.53 110.588 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 78.2 m -113.83 112.07 22.78 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.459 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.949 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 9.3 ptpt -89.51 91.43 8.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.227 0.537 . . . . 1.96 109.9 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.896 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 2.8 pp -122.37 -169.99 2.0 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.556 1.169 . . . . 1.49 112.412 -169.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.447 ' HB2' ' N ' ' A' ' 117' ' ' MET . 26.1 t -154.69 122.81 5.93 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.553 -1.658 . . . . 2.07 107.061 172.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.64 -8.12 59.0 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.512 0.672 . . . . 1.11 109.641 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -83.25 -46.49 12.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.125 -0.943 . . . . 2.78 111.165 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.8 OUTLIER -85.24 -8.01 58.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.164 -0.615 . . . . 1.35 111.285 175.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HD3' HD11 ' A' ' 158' ' ' LEU . 21.7 mmtp 62.85 43.31 7.07 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.2 -0.909 . . . . 1.9 111.49 174.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -102.9 -71.84 0.71 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.649 1.214 . . . . 2.48 110.554 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.896 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -65.49 -11.03 51.81 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.932 -1.485 . . . . 0.36 113.209 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 19.4 mt -69.21 -39.05 78.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.41 0.605 . . . . 1.42 109.584 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -63.0 -46.32 88.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.96 -0.756 . . . . 2.2 108.96 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -66.25 -27.89 68.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.49 -0.777 . . . . 0.68 111.151 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.7 tp -65.7 -55.73 15.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 1.77 110.279 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.2 mt -57.71 -44.16 85.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 2.1 109.909 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -59.66 -44.44 93.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.574 -0.739 . . . . 2.57 111.398 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.472 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -73.62 -39.74 64.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.011 0.434 . . . . 1.21 110.494 -177.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.492 HD11 HD13 ' A' ' 83' ' ' ILE . 51.9 mt -62.99 -44.69 99.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.807 -0.633 . . . . 1.2 110.596 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -37.64 88.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.942 -0.572 . . . . 2.3 111.076 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.4 tp -51.48 -49.06 62.56 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.376 0.608 . . . . 2.11 109.468 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.078 -0.965 . . . . 1.41 110.883 177.397 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.638 HG23 ' HE1' ' A' ' 14' ' ' MET . 21.0 m . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 110.335 -0.246 . . . . 1.27 110.335 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.777 HG13 HD21 ' A' ' 25' ' ' LEU . 37.2 mm -93.85 120.07 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.899 0.38 . . . . 1.83 110.503 177.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.638 ' HE1' HG23 ' A' ' 12' ' ' THR . 64.0 mtt -139.12 176.23 8.88 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.629 -0.508 . . . . 1.28 109.629 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.499 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 141.06 -163.38 26.67 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.948 -0.861 . . . . 0.34 110.948 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.707 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 48.7 t60 -94.19 157.66 15.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.047 0.927 . . . . 0.28 111.444 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 19' ' ' HIS . 4.6 p -74.9 149.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.348 -1.296 . . . . 1.09 110.528 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 73.18 -21.2 0.26 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.69 110.187 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.534 ' H ' ' C ' ' A' ' 17' ' ' VAL . 19.5 m170 -74.0 -20.15 60.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.434 -0.951 . . . . 0.63 108.434 168.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.445 ' O ' HD13 ' A' ' 24' ' ' LEU . . . 109.97 63.34 0.52 Allowed Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.388 -0.823 . . . . 0.79 114.044 172.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.92 -57.45 4.57 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.971 -0.692 . . . . 3.69 111.378 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -86.4 -28.73 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.275 0.472 . . . . 1.76 112.275 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -29.49 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.668 0.618 . . . . 1.71 112.668 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 20' ' ' GLY . 9.7 mp -69.2 -40.09 78.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.395 -0.19 . . . . 2.09 110.706 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.777 HD21 HG13 ' A' ' 13' ' ' ILE . 19.8 mt -69.61 -11.5 60.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.379 0.609 . . . . 2.23 109.919 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.07 -43.1 7.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.064 0.935 . . . . 1.23 109.001 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -50.55 15.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.01 -1.45 . . . . 1.23 111.311 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 1.59 111.699 -174.163 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.667 HG22 HG12 ' A' ' 111' ' ' ILE . 5.9 mt . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.538 0.208 . . . . 1.38 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.486 HG23 ' HE1' ' A' ' 102' ' ' HIS . 4.2 p -123.51 133.81 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.532 0.682 . . . . 1.79 109.952 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.738 HD13 HD12 ' A' ' 165' ' ' ILE . 15.5 mt -90.61 134.55 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.014 -0.994 . . . . 1.14 109.775 175.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.579 ' O ' HD11 ' A' ' 84' ' ' LEU . 2.1 tm? -116.49 104.92 11.92 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.151 -1.055 . . . . 1.65 108.151 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.6 t -85.83 112.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.744 -0.662 . . . . 1.14 111.192 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.8 m -123.37 118.29 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 115.741 -0.663 . . . . 1.31 110.751 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.99 130.85 43.3 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.224 -0.658 . . . . 1.01 109.224 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.893 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -74.18 -6.95 50.79 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.045 0.45 . . . . 1.07 111.497 -170.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.46 -10.01 45.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.879 -0.6 . . . . 0.58 110.87 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.43 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -128.83 -51.95 1.23 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.56 111.571 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.751 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 100.61 -133.86 11.47 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.523 -0.846 . . . . 0.37 113.749 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.44 134.25 37.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.541 0.686 . . . . 1.78 110.48 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.973 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 78.0 mmm -138.88 -178.77 0.9 Allowed Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 114.695 -1.139 . . . . 1.07 109.133 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.973 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 3.5 Cg_endo -46.93 -68.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.246 2.631 . . . . 0.89 114.652 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.5 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 8.4 pt20 -70.29 -16.5 63.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.23 0.538 . . . . 0.78 111.005 -175.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.707 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.45 -49.13 67.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.643 -0.708 . . . . 1.07 109.495 177.14 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.562 ' HA ' HD11 ' A' ' 100' ' ' ILE . 3.1 p -77.39 -24.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.845 -0.616 . . . . 2.02 112.438 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.44 -35.8 76.7 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.666 -0.646 . . . . 2.35 109.492 172.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -25.82 62.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 1.12 110.612 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.562 HD11 ' HA ' ' A' ' 97' ' ' VAL . 92.2 mt -75.25 -45.12 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.192 -0.67 . . . . 1.14 109.192 174.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.23 -49.53 60.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.119 -0.946 . . . . 0.75 110.458 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.486 ' HE1' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -45.19 -57.01 4.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 3.23 110.732 171.306 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.607 ' CB ' HD13 ' A' ' 110' ' ' ILE . . . -68.96 -47.89 64.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.302 -1.317 . . . . 1.17 113.047 -170.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 13.7 mmmm -72.14 -35.65 69.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.951 0.405 . . . . 2.27 110.641 -173.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.54 75.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.396 -0.82 . . . . 1.28 110.992 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -91.91 -25.33 18.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.208 -0.451 . . . . 1.31 112.097 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 44.4 m-20 80.56 42.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.92 0.867 . . . . 1.6 109.777 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.3 t -96.91 141.99 23.87 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.106 -1.406 . . . . 1.93 111.47 -176.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 21.7 Cg_exo -66.14 142.5 67.79 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.909 2.406 . . . . 0.66 112.905 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.607 HD13 ' CB ' ' A' ' 103' ' ' ALA . 11.5 mm -108.93 158.95 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.804 0.811 . . . . 1.34 111.276 -175.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.784 HD11 ' HB ' ' A' ' 146' ' ' ILE . 23.8 mm -125.76 85.02 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.983 -1.488 . . . . 1.12 106.983 166.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 1.034 HG23 HG23 ' A' ' 145' ' ' THR . 57.4 t -71.48 143.34 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 121.711 0.767 . . . . 1.06 109.175 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.758 ' HB3' HD21 ' A' ' 150' ' ' LEU . . . -140.76 103.64 4.55 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.47 -1.241 . . . . 1.07 110.538 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.966 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.3 mp -70.45 132.81 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-N 113.588 -1.642 . . . . 1.29 108.631 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 61.1 t30 -120.87 169.63 10.26 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.384 -1.339 . . . . 1.85 107.384 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.742 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 88.2 mttt 71.96 34.06 1.55 Allowed 'General case' 0 N--CA 1.424 -1.74 0 O-C-N 124.086 0.866 . . . . 1.18 110.91 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.639 ' CE ' ' HB3' ' A' ' 124' ' ' PRO . 10.6 mmt -74.53 -10.09 59.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 115.14 -0.936 . . . . 1.64 109.2 167.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.584 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 5.1 p-10 -72.96 -21.1 60.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.548 -1.206 . . . . 0.76 110.104 172.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.548 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 27.9 mtpp -91.26 135.02 28.74 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 1.74 110.273 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.34 -15.43 49.88 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.713 2.275 . . . . 0.68 111.058 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -78.5 2.07 20.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.643 -1.162 . . . . 1.45 110.486 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.469 ' HB2' ' HE1' ' A' ' 117' ' ' MET . . . -56.19 108.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.223 -0.899 . . . . 1.1 110.774 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.7 76.14 7.45 Favored Pre-proline 0 CA--C 1.51 -0.591 0 N-CA-C 107.03 -1.471 . . . . 0.95 107.03 171.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.639 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 37.7 Cg_endo -63.92 -66.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.303 0 C-N-CA 122.981 2.454 . . . . 0.54 113.234 -167.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.645 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 1.6 m-20 -64.45 -8.96 15.41 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.723 -0.671 . . . . 1.44 111.216 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -81.83 -53.94 5.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.845 -0.742 . . . . 4.56 109.434 174.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.893 HG21 ' HA ' ' A' ' 88' ' ' ALA . 18.5 m -68.88 -25.71 30.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.337 -0.847 . . . . 1.26 109.795 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 1.069 ' HA ' HD11 ' A' ' 131' ' ' LEU . 8.6 ttt -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.246 -1.343 . . . . 1.64 110.242 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 132' ' ' MET . 15.3 mt-30 -72.38 -37.74 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.674 -0.694 . . . . 2.0 111.205 173.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.7 mm-40 -60.32 -30.75 69.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.253 1.025 . . . . 1.64 109.149 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 1.069 HD11 ' HA ' ' A' ' 128' ' ' MET . 62.7 mt -63.74 -43.47 96.37 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.781 -1.554 . . . . 1.96 109.884 177.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.548 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 7.5 ptm -75.36 -14.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.229 -0.589 . . . . 2.05 110.9 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 17.4 mm-40 -71.61 -27.4 63.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.563 -0.902 . . . . 1.67 108.563 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -99.1 22.21 10.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.56 -1.2 . . . . 1.58 108.686 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 54.93 57.46 5.61 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 113.73 -1.577 . . . . 1.42 111.807 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.548 ' H ' ' HA ' ' A' ' 132' ' ' MET . 47.9 mt -119.38 111.73 18.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.847 -1.069 . . . . 1.93 109.0 167.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.45 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.7 t -118.66 117.44 34.18 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-O 121.369 0.604 . . . . 1.18 111.26 -170.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.59 ' CG ' ' HE3' ' A' ' 128' ' ' MET . 36.9 Cg_exo -56.09 175.47 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 124.11 3.207 . . . . 0.88 113.757 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 1.045 ' HG2' HD11 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -78.96 -31.81 45.14 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.011 -1.904 . . . . 3.08 109.477 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.857 ' HB2' ' HD1' ' A' ' 141' ' ' TRP . 6.7 mm-40 -58.28 -34.74 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.496 -0.775 . . . . 1.57 109.621 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.857 ' HD1' ' HB2' ' A' ' 140' ' ' GLU . 13.2 m0 -97.44 -7.69 31.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.749 -1.114 . . . . 0.66 110.926 -166.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.93 33.07 11.4 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.926 -0.654 . . . . 0.57 113.264 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.45 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.5 -125.05 5.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.174 -1.012 . . . . 0.6 111.685 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.62 62.18 0.53 Allowed 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.769 1.271 . . . . 1.91 111.448 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 1.034 HG23 HG23 ' A' ' 112' ' ' VAL . 73.8 m -160.5 128.96 4.69 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.194 -1.367 . . . . 1.1 110.238 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 1.045 HD11 ' HG2' ' A' ' 139' ' ' GLU . 38.0 mm -76.98 106.34 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.765 -0.828 . . . . 1.27 108.765 172.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 131' ' ' LEU . 8.3 m-85 -90.78 110.01 21.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.568 -0.742 . . . . 0.53 110.947 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.516 ' HG ' HG23 ' A' ' 146' ' ' ILE . 97.4 m -105.01 111.8 24.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.08 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.966 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 ptpt -88.4 91.28 8.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.339 0.59 . . . . 1.96 109.624 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.862 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -119.47 -173.31 2.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.6 1.191 . . . . 1.49 111.913 -170.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.638 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 4.8 p -153.1 101.0 2.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.692 -1.595 . . . . 2.07 107.25 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.86 62.42 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.752 -0.779 . . . . 1.11 109.358 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.79 -44.75 39.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.148 -0.933 . . . . 2.78 111.679 175.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.739 ' HB ' ' HG3' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -78.59 -17.37 56.19 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.166 -0.613 . . . . 1.35 111.657 176.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.544 ' HD3' HD11 ' A' ' 158' ' ' LEU . 21.2 mmtp 68.7 46.6 0.92 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.393 -0.822 . . . . 1.9 110.832 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.739 ' HG3' ' HB ' ' A' ' 154' ' ' THR . 18.1 mt-10 -108.51 -68.78 0.89 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.566 1.174 . . . . 2.48 110.547 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.862 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.17 -10.53 52.56 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.813 -1.539 . . . . 0.36 113.454 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.544 HD11 ' HD3' ' A' ' 155' ' ' LYS . 37.3 mt -69.45 -42.52 74.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 117.308 0.554 . . . . 1.42 109.827 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.37 -42.81 92.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 2.2 109.564 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -67.66 -22.19 65.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.892 -0.595 . . . . 0.68 111.272 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -71.83 -52.55 16.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.133 0.492 . . . . 1.77 109.86 -176.229 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.48 -24.61 66.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.664 . . . . 2.1 111.004 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -72.2 -40.14 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.886 0.374 . . . . 2.57 110.457 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.775 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 23.3 mmt -66.49 -41.37 89.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 1.21 110.085 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.738 HD12 HD13 ' A' ' 83' ' ' ILE . 60.6 mt -61.29 -45.35 98.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 1.2 110.422 175.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -41.01 95.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.067 -0.515 . . . . 2.3 111.079 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.4 ' O ' HD11 ' A' ' 167' ' ' LEU . 1.6 tm? -51.21 -38.7 53.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.62 0.724 . . . . 2.11 109.234 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 1.41 110.802 177.757 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.51 ' HB ' HG22 ' A' ' 82' ' ' VAL . 22.2 m . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 110.401 -0.222 . . . . 1.27 110.401 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -97.72 138.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.215 0.531 . . . . 1.83 110.238 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.608 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . 59.1 mtt -145.99 173.28 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 1.28 109.869 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.68 -174.97 22.77 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.756 -0.735 . . . . 0.34 112.362 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.928 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 53.2 t60 -86.85 161.67 18.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.715 0.769 . . . . 0.28 111.717 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.0 p -73.08 148.88 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.764 -1.107 . . . . 1.09 109.447 173.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 33.4 t70 73.6 -25.35 0.19 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.547 0.689 . . . . 0.69 109.951 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 16.5 m170 -86.99 -4.64 59.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.386 -0.824 . . . . 0.63 109.372 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.826 ' O ' ' HG2' ' A' ' 21' ' ' LYS . . . -143.23 -53.29 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 118.466 -1.186 . . . . 0.79 113.014 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.845 ' HG3' ' HB ' ' A' ' 23' ' ' THR . 15.4 pttt 60.44 138.47 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.073 0.94 . . . . 3.69 112.048 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -62.2 -15.41 46.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.148 0.975 . . . . 1.76 108.433 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.845 ' HB ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 m -67.42 -21.36 65.57 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 1.71 111.511 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.663 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.8 tt -68.95 -32.06 71.39 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.111 -0.993 . . . . 2.09 108.447 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.558 ' O ' HG21 ' A' ' 28' ' ' ILE . 2.6 tp -68.22 -29.08 67.83 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 2.23 110.087 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.45 -38.48 26.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.267 1.032 . . . . 1.23 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.45 77.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.536 -1.665 . . . . 1.23 110.038 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 25' ' ' LEU . 4.5 tt . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 114.99 -1.005 . . . . 1.59 110.343 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 C--O 1.236 0.388 0 N-CA-C 110.419 -0.215 . . . . 1.38 110.419 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.51 HG22 ' HB ' ' A' ' 12' ' ' THR . 23.1 t -122.79 127.19 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.172 0.511 . . . . 1.79 110.998 173.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 24.3 mt -86.57 132.08 33.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.331 -0.849 . . . . 1.14 110.087 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.675 HD11 HG12 ' A' ' 86' ' ' VAL . 2.0 tm? -121.48 110.56 16.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.254 -1.017 . . . . 1.65 108.254 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 33.5 t -96.42 114.52 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.159 -0.473 . . . . 1.14 110.801 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.684 HG21 HG13 ' A' ' 114' ' ' ILE . 3.4 m -119.66 142.16 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.682 -0.69 . . . . 1.31 111.063 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.713 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -80.73 131.02 35.4 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.793 -0.447 . . . . 1.01 109.793 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.715 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -74.97 -12.96 60.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.116 -0.633 . . . . 1.07 109.906 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -91.1 -10.36 42.26 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.17 -0.923 . . . . 0.58 111.519 -177.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 7.0 t70 -134.9 -38.22 0.8 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.755 0.312 . . . . 0.56 111.348 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.437 ' HA2' ' CG1' ' A' ' 127' ' ' VAL . . . 91.03 -133.16 11.65 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 114.157 0.423 . . . . 0.37 114.157 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.527 HG11 ' HE2' ' A' ' 134' ' ' TYR . 12.8 t -100.34 131.46 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.911 0.862 . . . . 1.78 110.551 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.484 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -131.03 173.62 5.66 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 114.017 -1.447 . . . . 1.07 108.086 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 73.1 Cg_exo -49.71 -57.07 2.55 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.325 2.017 . . . . 0.89 113.282 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.577 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -72.34 -13.97 61.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.917 0.389 . . . . 0.78 111.415 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.928 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -69.76 -52.86 21.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.609 0.719 . . . . 1.07 109.647 177.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.543 ' HA ' HD13 ' A' ' 100' ' ' ILE . 2.0 p -83.13 -23.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 113.761 1.023 . . . . 2.02 113.761 -173.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.577 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -63.96 -25.17 68.02 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.111 -0.993 . . . . 2.35 109.428 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 14' ' ' MET . . . -74.57 -39.86 62.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.439 -0.8 . . . . 1.12 110.228 171.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.653 HG22 HD12 ' A' ' 136' ' ' LEU . 93.8 mt -62.98 -49.06 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.582 0.706 . . . . 1.14 109.754 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -55.43 -33.33 63.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.496 -1.229 . . . . 0.75 110.817 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -67.48 -43.68 80.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.696 -0.684 . . . . 3.23 110.375 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.403 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -73.97 -44.58 54.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 1.17 111.578 -177.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.757 ' HD3' HD23 ' A' ' 136' ' ' LEU . 13.5 mmmm -66.18 -32.78 74.43 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.123 0.487 . . . . 2.27 110.064 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.56 -41.75 70.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.926 -1.033 . . . . 1.28 110.83 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.39 44.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 1.31 111.305 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 84.39 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.412 1.07 . . . . 1.6 109.064 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.21 140.79 21.62 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 113.906 -1.497 . . . . 1.93 110.251 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.15 142.81 93.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.643 2.229 . . . . 0.66 111.96 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.49 ' C ' HG23 ' A' ' 145' ' ' THR . 23.0 mm -105.51 156.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.764 0.793 . . . . 1.34 110.735 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.944 HD12 ' HB ' ' A' ' 146' ' ' ILE . 14.2 mm -124.89 86.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 107.102 -1.444 . . . . 1.12 107.102 171.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.953 HG21 HG22 ' A' ' 145' ' ' THR . 59.9 t -75.16 145.83 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 121.779 0.799 . . . . 1.06 109.953 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.637 ' HB1' ' CD2' ' A' ' 150' ' ' LEU . . . -144.07 102.27 3.85 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.067 -1.424 . . . . 1.07 109.932 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.774 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.4 mp -72.18 140.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.148 -1.387 . . . . 1.29 109.636 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.713 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 4.4 p-10 -117.57 176.64 5.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.693 -1.225 . . . . 1.85 107.693 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.672 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 83.9 mttt 69.58 34.28 2.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.892 0.745 . . . . 1.18 111.633 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.438 ' CE ' ' HB3' ' A' ' 122' ' ' ALA . 17.5 mmt -77.78 -13.56 59.85 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.486 -0.931 . . . . 1.64 108.486 169.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.524 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -70.66 -25.94 63.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.861 -1.518 . . . . 0.76 109.519 173.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.493 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 43.5 mtpt -89.07 137.85 29.35 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.36 -0.836 . . . . 1.74 110.247 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.41 -13.94 42.39 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.839 2.36 . . . . 0.68 111.659 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 33.0 mt-10 -81.75 6.66 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.161 -0.927 . . . . 1.45 110.539 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.438 ' HB3' ' CE ' ' A' ' 117' ' ' MET . . . -58.0 107.68 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.565 -0.743 . . . . 1.1 110.975 175.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.84 76.66 29.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.48 -0.934 . . . . 0.95 108.48 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 47.4 Cg_endo -66.6 -54.77 0.41 Allowed 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.74 2.293 . . . . 0.54 113.125 -172.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.422 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.1 m-20 -52.26 -26.45 11.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 1.44 110.78 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.597 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 53.7 ttt180 -79.7 -57.15 3.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.07 -0.652 . . . . 4.56 109.403 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.715 HG11 ' HA ' ' A' ' 88' ' ' ALA . 15.7 m -63.76 -24.52 36.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.406 -0.816 . . . . 1.26 112.128 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.475 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 17.2 ptm -84.74 -17.37 38.56 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.037 0.446 . . . . 1.64 109.929 174.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.622 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.8 mt-30 -76.31 -40.74 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 2.0 110.511 170.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 1.9 mm-40 -58.6 -35.49 72.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.124 0.964 . . . . 1.64 108.978 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.824 HD23 HG23 ' A' ' 112' ' ' VAL . 2.0 mp -64.52 -42.89 95.5 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.542 -1.208 . . . . 1.96 110.352 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.732 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.7 ppp? -75.58 -8.75 57.57 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.506 -0.478 . . . . 2.05 110.685 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 8.0 mm-40 -71.97 -36.68 69.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.872 -1.158 . . . . 1.67 107.872 172.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.527 ' HE2' HG11 ' A' ' 92' ' ' VAL . 23.4 m-85 -91.42 28.56 1.66 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.655 -1.157 . . . . 1.58 110.012 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.74 53.14 13.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.742 -1.572 . . . . 1.42 112.342 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.757 HD23 ' HD3' ' A' ' 104' ' ' LYS . 66.2 mt -113.94 99.03 7.36 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.338 -0.847 . . . . 1.93 108.84 168.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.938 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 35.5 t -100.76 115.42 65.36 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-O 121.565 0.698 . . . . 1.18 111.788 -168.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.736 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 87.4 Cg_exo -43.97 138.69 6.24 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 124.168 3.245 . . . . 0.88 112.072 171.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.921 ' HG2' HD12 ' A' ' 146' ' ' ILE . 0.4 OUTLIER -73.65 -14.93 61.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.199 -0.91 . . . . 3.08 109.963 178.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.461 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.1 pm0 -66.07 -26.14 67.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.488 -0.778 . . . . 1.57 110.135 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.732 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 34.5 m0 -101.63 -14.91 17.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.97 0.414 . . . . 0.66 110.465 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.07 24.55 7.56 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.804 -0.712 . . . . 0.57 113.584 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.938 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.07 -120.27 2.07 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.9 -1.143 . . . . 0.6 112.094 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -157.63 63.38 0.47 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.824 1.297 . . . . 1.91 112.268 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.953 HG22 HG21 ' A' ' 112' ' ' VAL . 56.6 m -160.19 126.13 4.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.195 -1.366 . . . . 1.1 109.992 173.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.944 ' HB ' HD12 ' A' ' 111' ' ' ILE . 30.7 mm -74.47 104.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.539 -0.911 . . . . 1.27 108.539 172.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.736 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.8 m-85 -90.75 105.08 17.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.119 -0.946 . . . . 0.53 111.381 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.85 139.75 30.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.306 -0.861 . . . . 1.0 109.786 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.534 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 mptt -114.93 102.67 10.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.18 -0.674 . . . . 1.96 109.18 176.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.774 ' HG ' ' O ' ' A' ' 114' ' ' ILE . 3.6 pp -125.61 -174.02 2.97 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.389 1.09 . . . . 1.49 111.805 -172.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.407 ' N ' HD12 ' A' ' 150' ' ' LEU . 1.5 p -152.16 92.31 1.7 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.1 -1.409 . . . . 2.07 108.465 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -16.06 63.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.13 0.49 . . . . 1.11 109.867 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -55.99 13.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.32 -0.855 . . . . 2.78 110.847 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -84.79 -9.03 58.57 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.95 -0.7 . . . . 1.35 112.387 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.546 ' HD3' HD12 ' A' ' 158' ' ' LEU . 19.2 mmtp 71.53 42.79 0.64 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.669 0.606 . . . . 1.9 110.966 175.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 -70.72 0.76 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 122.344 1.068 . . . . 2.48 110.318 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.763 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.38 -4.82 46.41 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.269 -1.332 . . . . 0.36 113.967 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.546 HD12 ' HD3' ' A' ' 155' ' ' LYS . 22.5 mt -70.26 -36.74 74.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.155 -0.683 . . . . 1.42 109.155 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -38.89 79.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.144 -0.935 . . . . 2.2 109.035 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.584 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.2 t60 -71.48 -14.74 62.23 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.534 -0.757 . . . . 0.68 111.437 177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.89 -55.75 5.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.335 -0.617 . . . . 1.77 109.335 -177.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.92 -26.71 68.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.508 -0.769 . . . . 2.1 111.383 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.584 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 15.7 pt-20 -76.41 -30.73 57.56 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.403 -0.519 . . . . 2.57 110.79 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.619 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 29.6 mmt -73.23 -39.13 65.74 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.315 0.578 . . . . 1.21 109.507 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.436 HD12 HD11 ' A' ' 83' ' ' ILE . 83.3 mt -61.83 -42.41 94.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 1.2 109.531 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -37.64 86.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.567 -0.742 . . . . 2.3 111.185 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.3 tp -53.37 -45.08 69.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.533 0.682 . . . . 2.11 109.353 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.8 t . . . . . 0 N--CA 1.445 -0.697 0 CA-C-N 114.939 -1.028 . . . . 1.41 110.646 175.667 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 112.029 -0.428 . . . . 11.83 112.029 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m -81.65 64.19 6.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.295 0.569 . . . . 10.75 111.092 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -126.77 27.84 5.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.973 0.892 . . . . 10.82 109.001 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.8 ptp -154.42 136.7 14.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.503 -1.226 . . . . 9.01 109.513 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.55 -23.17 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.93 0.395 . . . . 6.14 110.784 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -92.29 119.42 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.429 -0.582 . . . . 5.7 109.429 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -118.13 91.94 41.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 111.865 0.32 . . . . 7.55 111.865 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.37 108.96 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.806 2.338 . . . . 3.21 110.735 172.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.93 128.31 25.06 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.491 2.128 . . . . 3.14 111.82 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.7 m -86.98 79.92 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.699 0.762 . . . . 2.53 110.718 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 47.9 t -72.99 84.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.295 -0.866 . . . . 1.95 109.713 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 68' ' ' PHE . 22.9 m -62.2 127.09 29.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.6 -0.727 . . . . 1.27 110.512 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -92.56 129.93 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 108.763 -0.828 . . . . 1.83 108.763 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.698 ' HE2' ' HB3' ' A' ' 68' ' ' PHE . 44.9 mtm -143.82 -171.58 3.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.783 -0.644 . . . . 1.28 109.716 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.456 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 129.96 -158.57 22.36 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.617 -0.993 . . . . 0.34 110.617 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.832 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 50.2 t60 -91.04 157.12 17.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.851 0.834 . . . . 0.28 111.189 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 6.4 p -73.5 154.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.366 -1.288 . . . . 1.09 109.9 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.6 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 20.3 t70 74.84 -18.94 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.295 0.569 . . . . 0.69 110.559 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.537 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 15.1 m170 -83.01 -4.86 58.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.515 -0.921 . . . . 0.63 108.515 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.682 ' HA3' HD12 ' A' ' 24' ' ' LEU . . . 111.01 47.34 0.77 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.391 -0.909 . . . . 0.79 114.062 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -50.61 -66.58 0.36 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.366 0.583 . . . . 3.69 111.691 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -94.15 -30.71 14.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.202 -0.454 . . . . 1.76 111.233 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.519 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.0 -27.46 63.52 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.724 0.639 . . . . 1.71 112.724 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.682 HD12 ' HA3' ' A' ' 20' ' ' GLY . 5.5 mp -78.61 -25.31 45.15 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.95 -0.3 . . . . 2.09 110.956 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.617 ' HB3' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -74.9 -17.1 60.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.936 -0.764 . . . . 2.23 108.936 175.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.08 -45.71 8.53 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.052 0.929 . . . . 1.23 108.805 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 24' ' ' LEU . . . -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.719 -1.582 . . . . 1.23 110.475 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 tt -72.09 -30.96 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.91 -1.041 . . . . 1.59 110.974 -177.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 31' ' ' SER . 45.8 mtp180 -77.98 -38.85 44.15 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.655 0.741 . . . . 3.51 109.396 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.02 26.81 1.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.137 0.97 . . . . 3.14 110.826 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 29' ' ' ARG . 29.6 t -114.32 -35.7 4.89 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.563 -1.653 . . . . 1.96 109.031 171.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? 176.05 -158.76 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 115.777 -0.647 . . . . 4.37 110.225 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.66 HG13 ' H ' ' A' ' 34' ' ' THR . 7.7 p 49.9 -80.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.401 1.481 . . . . 3.59 114.078 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.66 ' H ' HG13 ' A' ' 33' ' ' VAL . 22.7 p -105.35 129.2 53.73 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.552 0.575 . . . . 2.99 112.552 -171.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.546 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 1.4 pt-20 -123.2 -49.86 1.93 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.633 -0.712 . . . . 6.34 110.405 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.546 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 11.0 pt20 -109.9 -7.67 14.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.714 -0.675 . . . . 7.38 110.088 -177.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -66.08 131.06 45.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.462 -0.79 . . . . 6.24 110.475 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.21 72.85 9.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.57 -0.741 . . . . 5.33 110.784 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.04 159.37 29.94 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.133 -0.939 . . . . 4.68 111.097 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.36 -72.37 2.76 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.502 -0.856 . . . . 5.06 112.298 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 25' ' ' LEU . 47.1 mm -126.11 100.54 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.776 0.322 . . . . 5.91 110.311 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.6 m -156.96 -83.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.11 -0.495 . . . . 6.29 110.065 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 178.49 -58.94 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.595 -0.52 . . . . 6.97 109.595 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -68.89 109.85 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.55 . . . . 7.26 109.626 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.7 mm 68.88 154.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.167 -0.924 . . . . 5.68 110.532 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.13 150.18 17.56 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.385 -0.686 . . . . 2.62 111.385 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.599 ' HA ' HD13 ' A' ' 25' ' ' LEU . . . 64.88 -172.56 0.18 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.274 0.229 . . . . 1.8 110.987 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.445 ' CZ ' HG23 ' A' ' 50' ' ' VAL . 1.9 p90 -174.2 174.74 2.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.164 0.507 . . . . 1.92 110.904 -174.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.6 ' HG2' ' HG1' ' A' ' 58' ' ' THR . 78.0 mt-30 -95.57 111.74 23.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.287 -0.869 . . . . 2.22 109.715 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 33' ' ' VAL . 3.8 t -82.17 140.9 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.311 0.577 . . . . 2.09 111.145 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.448 ' HA ' ' H ' ' A' ' 55' ' ' LYS . 23.2 m -93.39 84.26 4.71 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.772 -0.649 . . . . 1.99 110.744 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.61 HG23 HD11 ' A' ' 162' ' ' LEU . 14.5 p -99.76 -28.43 3.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 122.531 1.158 . . . . 2.62 107.991 171.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 56' ' ' LYS . 1.9 p30 -125.72 -59.94 1.33 Allowed 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 113.124 -1.853 . . . . 4.06 109.082 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 11.3 p-10 -171.27 43.04 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.459 -1.246 . . . . 2.99 110.139 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 54.6 mtmt 74.01 17.27 3.46 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.171 -0.922 . . . . 7.77 111.695 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . 88.2 tttt -86.56 76.36 9.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.469 0.652 . . . . 4.8 109.72 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.525 HG22 HG22 ' A' ' 165' ' ' ILE . 0.9 OUTLIER 175.61 93.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 C-N-CA 125.474 1.51 . . . . 1.6 108.95 171.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.6 ' HG1' ' HG2' ' A' ' 49' ' ' GLN . 8.0 m -90.85 95.93 10.38 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.158 -0.682 . . . . 1.48 109.158 177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' HE1' HD12 ' A' ' 57' ' ' ILE . 10.4 m-85 -59.23 150.49 25.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.698 -0.683 . . . . 1.63 111.297 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.422 ' CA ' ' HA ' ' A' ' 12' ' ' THR . 28.6 tp 72.11 -91.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.136 -0.938 . . . . 3.67 111.006 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.412 ' OD2' ' HG ' ' A' ' 60' ' ' LEU . 3.8 p30 -170.45 165.82 8.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.21 0.529 . . . . 5.61 111.058 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.2 t -129.52 136.0 28.43 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.251 -0.886 . . . . 5.77 108.63 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.34 106.41 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.035 2.49 . . . . 6.26 112.617 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.57 -22.76 7.28 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.755 -0.736 . . . . 6.42 112.118 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.5 63.23 1.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.049 0.452 . . . . 9.55 110.559 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -88.8 125.57 34.96 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.169 -0.678 . . . . 7.05 109.169 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.43 -65.0 1.08 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.24 0.543 . . . . 5.07 111.647 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.698 ' HB3' ' HE2' ' A' ' 14' ' ' MET . 93.3 m-85 -99.53 -12.42 20.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.216 -0.447 . . . . 2.66 111.932 -175.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.7 m -74.52 -52.14 12.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.312 0.577 . . . . 5.25 110.076 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.1 m -156.01 140.11 16.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.999 -0.741 . . . . 6.21 108.999 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.5 ' HE2' ' HB2' ' A' ' 106' ' ' ALA . 61.3 mtt -105.77 97.49 7.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.899 0.381 . . . . 5.21 110.693 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -62.86 -56.99 12.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.814 -0.63 . . . . 8.75 110.602 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.38 13.25 11.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.445 -0.343 . . . . 6.65 110.797 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 74' ' ' ARG . 28.4 ttm180 70.17 -56.09 0.59 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.631 -0.713 . . . . 10.34 111.749 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.86 55.34 4.23 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.51 -0.376 . . . . 5.22 113.6 -174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.78 -1.31 43.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.627 0.727 . . . . 5.89 109.425 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -87.38 128.5 35.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.557 -1.202 . . . . 6.97 110.766 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.37 -48.95 5.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.132 0.491 . . . . 4.68 109.992 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.04 39.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.494 -0.928 . . . . 3.84 108.494 175.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.23 166.04 20.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.694 -1.139 . . . . 2.66 111.087 -171.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 50.2 mt -129.82 149.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.756 -0.656 . . . . 1.38 109.592 -173.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.597 ' HB ' ' CE2' ' A' ' 68' ' ' PHE . 9.5 p -116.87 136.47 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 119.957 -0.697 . . . . 1.79 110.618 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 13.0 mt -96.64 128.8 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.501 -0.772 . . . . 1.14 109.98 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 84' ' ' LEU . 2.2 tm? -114.54 109.77 18.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.956 -1.127 . . . . 1.65 107.956 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.07 118.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.333 -0.394 . . . . 1.14 111.051 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.7 m -128.24 120.62 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.698 -0.683 . . . . 1.31 110.3 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.68 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -64.73 131.81 47.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.719 -0.673 . . . . 1.01 110.262 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.741 ' HB1' ' CG2' ' A' ' 114' ' ' ILE . . . -67.65 -18.09 64.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.084 0.469 . . . . 1.07 110.751 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.472 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -90.13 -14.65 33.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.392 -0.822 . . . . 0.58 111.316 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.474 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.5 t0 -123.63 -47.48 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.56 110.75 -170.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.625 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.82 -151.14 27.3 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.37 113.098 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.614 HG12 ' HE2' ' A' ' 134' ' ' TYR . 21.5 t -77.96 129.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.828 0.823 . . . . 1.78 111.025 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.935 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.2 mmm -130.94 179.89 1.23 Allowed Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 114.265 -1.334 . . . . 1.07 108.615 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.935 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.11 -66.01 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.284 2.656 . . . . 0.89 114.564 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.454 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.5 pt20 -73.23 -15.27 61.44 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.287 0.565 . . . . 0.78 110.94 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.832 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.0 -43.83 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 1.07 109.007 176.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 100' ' ' ILE . 30.1 t -66.15 -42.59 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.255 -0.884 . . . . 2.02 111.302 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.28 -29.01 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.239 -0.437 . . . . 2.35 110.098 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 14' ' ' MET . . . -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 1.12 110.538 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.671 HG21 HD11 ' A' ' 136' ' ' LEU . 96.5 mt -75.4 -44.89 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.796 0.808 . . . . 1.14 109.147 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -57.1 -37.42 71.92 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.041 -1.436 . . . . 0.75 110.944 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -71.5 -37.91 71.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.274 0.559 . . . . 3.23 109.795 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -44.31 68.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.785 -0.643 . . . . 1.17 111.824 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.72 ' HD3' HD22 ' A' ' 136' ' ' LEU . 1.8 mmmp? -76.42 -28.9 56.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.051 0.453 . . . . 2.27 110.482 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.12 -44.56 61.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.174 -0.921 . . . . 1.28 110.268 173.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.5 ' HB2' ' HE2' ' A' ' 71' ' ' MET . . . -85.14 -34.99 22.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.992 -0.549 . . . . 1.31 110.436 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.3 t30 83.87 40.82 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.843 1.257 . . . . 1.6 109.36 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.501 HG12 ' HZ ' ' A' ' 68' ' ' PHE . 24.5 t -83.8 145.29 46.77 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 113.279 -1.782 . . . . 1.93 110.99 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.43 ' O ' HG11 ' A' ' 108' ' ' VAL . 21.8 Cg_exo -61.93 138.68 75.14 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.257 1.972 . . . . 0.66 111.436 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.0 OUTLIER -107.68 159.07 7.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 122.011 0.91 . . . . 1.34 112.226 -172.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.709 HD11 ' HB ' ' A' ' 146' ' ' ILE . 5.9 mm -126.02 87.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.538 -1.664 . . . . 1.12 106.858 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.544 HG22 HG23 ' A' ' 145' ' ' THR . 61.5 t -78.1 148.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.603 -0.726 . . . . 1.06 109.971 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 148' ' ' CYS . . . -140.12 110.19 6.51 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.569 -1.196 . . . . 1.07 110.679 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.8 HG22 ' HA ' ' A' ' 124' ' ' PRO . 3.2 mp -84.86 108.31 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.148 -1.387 . . . . 1.29 109.636 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.68 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.4 p-10 -99.45 178.02 5.0 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.626 -1.25 . . . . 1.85 107.626 -171.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.829 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 74.9 mttt 70.75 28.44 3.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.034 0.834 . . . . 1.18 110.123 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.69 ' HE3' ' HG3' ' A' ' 124' ' ' PRO . 85.5 mmm -81.54 -7.27 59.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.351 -0.981 . . . . 1.64 108.351 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -68.41 -30.44 69.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.521 -1.672 . . . . 0.76 109.634 168.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -71.79 131.73 85.66 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.78 -0.645 . . . . 1.74 110.089 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.27 -15.09 47.67 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.391 2.061 . . . . 0.68 111.388 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -90.24 5.71 45.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.377 -0.829 . . . . 1.45 110.592 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.44 ' HB2' ' SD ' ' A' ' 117' ' ' MET . . . -54.77 124.41 16.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.731 -0.668 . . . . 1.1 111.271 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.31 76.07 68.45 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.337 -0.986 . . . . 0.95 108.337 173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.8 ' HA ' HG22 ' A' ' 114' ' ' ILE . 39.4 Cg_endo -64.17 -62.03 0.1 Allowed 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.025 2.483 . . . . 0.54 113.305 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.49 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 6.9 m-20 -61.63 -16.15 45.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.257 -0.883 . . . . 1.44 111.019 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -75.42 -58.39 3.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.598 0.713 . . . . 4.56 109.307 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.625 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 12.7 m -66.03 -29.48 46.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 1.26 110.194 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.905 ' HE3' ' HG3' ' A' ' 138' ' ' PRO . 15.4 ttt -59.99 -39.59 86.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 1.64 110.793 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.575 ' O ' ' HG2' ' A' ' 132' ' ' MET . 45.0 mt-30 -69.14 -29.67 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 2.0 111.933 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.596 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 9.0 mt-10 -67.05 -29.07 68.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.587 . . . . 1.64 109.533 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.555 HD12 ' CD1' ' A' ' 136' ' ' LEU . 4.0 mm? -64.73 -44.5 89.99 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.641 -0.708 . . . . 1.96 110.071 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.575 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 14.7 ptm -70.57 -10.2 58.7 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.813 -0.755 . . . . 2.05 110.83 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -78.73 -28.3 44.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.05 -0.722 . . . . 1.67 109.05 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.614 ' HE2' HG12 ' A' ' 92' ' ' VAL . 71.3 m-85 -92.73 22.79 4.5 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.836 0.826 . . . . 1.58 109.659 167.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.0 t30 61.33 46.23 7.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 113.855 -1.52 . . . . 1.42 111.749 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.72 HD22 ' HD3' ' A' ' 104' ' ' LYS . 72.9 mt -113.67 93.6 4.46 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.93 109.732 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 1.012 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 44.5 t -102.74 122.87 44.43 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.199 -0.909 . . . . 1.18 110.635 -172.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.905 ' HG3' ' HE3' ' A' ' 128' ' ' MET . 10.6 Cg_endo -60.0 157.52 33.67 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.211 2.608 . . . . 0.88 112.902 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.8 mm-40 -79.72 -12.1 59.81 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.127 -1.397 . . . . 3.08 110.574 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.753 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -69.89 -19.63 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.899 -0.591 . . . . 1.57 109.888 167.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.499 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 45.1 m0 -110.6 -20.43 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.338 -0.392 . . . . 0.66 111.306 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.72 28.75 5.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.839 -0.696 . . . . 0.57 113.417 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 1.012 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.2 -106.8 1.95 Allowed Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.58 -0.819 . . . . 0.6 112.689 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -166.0 61.21 0.1 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 122.284 1.04 . . . . 1.91 110.419 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 98.8 m -164.06 133.93 4.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 1.1 110.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.709 ' HB ' HD11 ' A' ' 111' ' ' ILE . 28.0 mm -97.16 110.1 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 109.495 -0.557 . . . . 1.27 109.495 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.685 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 12.1 m-85 -90.05 150.51 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.53 110.295 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 91.1 m -131.25 127.0 36.92 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.663 -1.153 . . . . 1.0 109.747 171.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.587 ' HB3' ' HE2' ' A' ' 117' ' ' MET . 0.0 OUTLIER -95.1 88.13 5.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.056 -0.72 . . . . 1.96 109.056 176.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 1.058 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -115.98 170.12 8.73 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.685 1.231 . . . . 1.49 112.768 -170.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.1 p -129.94 104.78 7.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.961 -1.126 . . . . 2.07 107.961 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.41 -9.9 59.05 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.377 -0.529 . . . . 1.11 109.762 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.808 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 3.2 mtmt -82.54 -46.39 13.44 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.128 -0.629 . . . . 2.78 112.119 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 p -86.39 -3.39 58.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 119.188 -1.005 . . . . 1.35 111.363 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp 64.89 45.59 3.18 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.287 -0.87 . . . . 1.9 110.705 172.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.576 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.51 -58.34 1.97 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.65 -1.159 . . . . 2.48 110.062 -175.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 1.058 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -79.76 -10.65 85.5 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.296 -0.865 . . . . 0.36 113.847 -173.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 27' ' ' ALA . 56.1 mt -66.6 -36.8 83.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.857 0.829 . . . . 1.42 109.043 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 1.6 m-20 -69.84 -42.12 74.01 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.695 -1.139 . . . . 2.2 110.182 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.83 -21.26 64.31 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.499 -0.319 . . . . 0.68 111.154 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -74.13 -51.15 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.659 -0.496 . . . . 1.77 109.659 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.61 HD11 HG23 ' A' ' 52' ' ' VAL . 4.2 pp -60.79 -27.51 68.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.795 -0.639 . . . . 2.1 110.711 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.601 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 42.0 mt-10 -64.63 -48.04 76.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.4 -0.364 . . . . 2.57 110.812 174.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.573 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 0.0 OUTLIER -63.8 -35.63 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.32 -0.4 . . . . 1.21 110.27 176.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.525 HG22 HG22 ' A' ' 57' ' ' ILE . 73.4 mt -62.01 -48.57 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.922 -0.581 . . . . 1.2 110.829 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 163' ' ' GLU . 4.5 pp -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 121.007 -0.277 . . . . 2.3 110.965 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.472 ' N ' HD13 ' A' ' 166' ' ' LEU . 4.8 tt -54.38 -50.53 67.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.927 -0.768 . . . . 2.11 108.927 172.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.604 ' HA ' ' HG2' ' A' ' 171' ' ' MET . 65.1 t -65.38 -40.17 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.883 -0.599 . . . . 1.41 110.777 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m -60.64 -32.21 71.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.831 0.348 . . . . 1.82 111.445 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -80.16 -37.98 32.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.966 0.413 . . . . 2.73 110.871 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.938 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 21.0 ptt? -84.35 -7.93 59.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 2.12 111.004 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -35.63 -39.84 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.943 1.297 . . . . 4.27 114.127 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.89 -72.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.258 0.466 . . . . 3.91 112.258 -173.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.35 -19.58 3.09 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.714 -0.394 . . . . 6.06 111.928 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.938 ' HB2' ' HB2' ' A' ' 171' ' ' MET . 25.7 mmtp -70.17 126.45 29.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.657 0.741 . . . . 5.86 112.352 -171.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -161.01 -49.12 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.489 -1.232 . . . . 5.79 107.917 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.445 ' H ' ' HD2' ' A' ' 178' ' ' PRO . 5.7 m-20 -93.02 -55.33 0.24 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.041 -0.982 . . . . 8.44 110.43 171.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 177' ' ' ASN . 40.5 Cg_endo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.03 1.82 . . . . 9.2 111.845 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.829 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.761 -0.536 . . . . 11.83 111.761 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -70.97 121.08 17.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.991 0.424 . . . . 10.75 111.687 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -132.59 145.43 51.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.49 . . . . 10.82 110.151 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 97.5 mmm -88.26 117.85 27.46 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.469 -0.567 . . . . 9.01 109.469 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.7 t 70.48 91.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.229 0 O-C-N 123.784 0.677 . . . . 6.14 111.301 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 50.9 mt-10 -70.75 117.13 11.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.134 -0.691 . . . . 5.7 109.134 170.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -89.25 111.3 44.45 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.937 -0.394 . . . . 7.55 109.937 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 56.4 Cg_endo -99.79 90.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.527 2.818 . . . . 3.21 112.289 177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.55 123.35 10.08 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.079 1.853 . . . . 3.14 111.839 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 m -77.67 70.61 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.546 0.689 . . . . 2.53 110.725 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 83.7 t -62.8 95.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.218 -0.901 . . . . 1.95 110.826 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.69 ' HB ' HG21 ' A' ' 82' ' ' VAL . 7.5 m -76.01 145.76 40.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.701 -0.681 . . . . 1.27 110.488 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.442 HD13 ' HB ' ' A' ' 83' ' ' ILE . 46.0 mm -105.06 113.61 42.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 1.83 109.978 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.583 ' SD ' ' HB2' ' A' ' 99' ' ' ALA . 67.3 mtt -127.18 172.81 10.23 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.944 -0.571 . . . . 1.28 109.877 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.433 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 148.57 -172.95 28.68 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.666 -0.778 . . . . 0.34 112.136 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.757 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 49.1 t60 -88.88 159.66 17.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.856 0.836 . . . . 0.28 111.106 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.55 ' HA ' ' O2B' ' A' ' 179' ' ' GDP . 7.7 p -69.85 143.98 14.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.656 -1.157 . . . . 1.09 110.258 174.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.59 ' HA ' " C4'" ' A' ' 179' ' ' GDP . 30.6 t70 75.93 -18.24 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.384 0.612 . . . . 0.69 110.36 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.0 m170 -85.05 -10.73 56.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.278 -1.008 . . . . 0.63 108.278 170.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.87 48.46 1.08 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.191 -0.913 . . . . 0.79 113.369 174.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -60.83 -53.33 58.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.108 0.454 . . . . 3.69 110.909 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.5 m -98.85 -34.72 10.37 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.374 0.607 . . . . 1.76 110.442 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.579 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.66 -21.01 24.44 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.114 0.783 . . . . 1.71 113.114 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.639 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -75.64 -34.37 60.53 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.294 -1.002 . . . . 2.09 108.294 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.611 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 7.0 tp -67.26 -23.79 65.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.322 -0.854 . . . . 2.23 109.785 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -92.54 -39.4 11.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.776 0.798 . . . . 1.23 109.681 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.29 80.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.56 -1.2 . . . . 1.23 109.738 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.78 HG23 ' HH ' ' A' ' 48' ' ' TYR . 3.3 tt -71.58 -22.27 21.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.849 -1.069 . . . . 1.59 110.394 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 73.5 mtt180 -73.0 -19.75 61.15 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 121.492 0.663 . . . . 3.51 109.862 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -107.01 23.95 13.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.671 -0.695 . . . . 3.14 111.231 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.501 ' OG ' ' HD2' ' A' ' 32' ' ' LYS . 99.2 p -104.67 -35.89 7.65 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.653 -1.158 . . . . 1.96 109.332 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HD2' ' OG ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -175.39 -168.15 0.3 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.573 -0.74 . . . . 4.37 109.96 176.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG13 HG22 ' A' ' 34' ' ' THR . 10.4 p 55.84 -66.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.517 1.527 . . . . 3.59 113.549 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.469 HG22 HG13 ' A' ' 33' ' ' VAL . 3.1 t -107.21 169.0 8.83 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.874 0.369 . . . . 2.99 110.549 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.12 -44.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.887 -0.597 . . . . 6.34 109.959 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -123.03 -46.98 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.61 -0.723 . . . . 7.38 110.277 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -81.6 135.01 35.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.66 -0.7 . . . . 6.24 110.772 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.88 89.88 5.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.142 0.496 . . . . 5.33 110.635 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.59 53.68 4.88 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.735 -0.666 . . . . 4.68 112.384 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.95 47.97 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.974 -0.631 . . . . 5.06 111.803 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 tp -127.63 108.2 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.858 0.837 . . . . 5.91 110.551 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.631 HG21 ' H ' ' A' ' 43' ' ' GLN . 1.1 m -154.36 -154.6 0.52 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.298 -1.001 . . . . 6.29 108.298 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.631 ' H ' HG21 ' A' ' 42' ' ' THR . 50.8 tp60 -76.29 66.8 2.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.781 0.801 . . . . 6.97 110.316 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.412 ' CD2' ' HB ' ' A' ' 42' ' ' THR . 32.4 p80 -170.84 162.68 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.217 -0.901 . . . . 7.26 109.894 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.1 tt -61.95 159.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 5.68 110.297 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.02 24.35 0.84 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 115.813 -0.631 . . . . 2.62 114.462 -171.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.631 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -83.05 153.16 25.05 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.442 -0.577 . . . . 1.8 109.442 174.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.78 ' HH ' HG23 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -163.24 178.88 7.83 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 119.686 -0.806 . . . . 1.92 112.373 -163.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.489 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 54.3 mt-30 -106.9 113.61 27.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.262 -0.881 . . . . 2.22 110.014 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.65 150.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.32 0.581 . . . . 2.09 111.433 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 m -97.43 81.63 3.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.56 0.695 . . . . 1.99 109.456 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -86.32 -32.63 6.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.972 -1.013 . . . . 2.62 108.383 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -140.8 -46.43 0.4 Allowed 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 113.601 -1.636 . . . . 4.06 108.762 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -178.04 77.49 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.124 -0.944 . . . . 2.99 110.536 177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' HB3' ' HE3' ' A' ' 55' ' ' LYS . 22.9 mtpp 57.65 35.81 26.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.135 -0.484 . . . . 7.77 111.526 175.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -102.93 153.9 19.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.593 -0.521 . . . . 4.8 109.593 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mt 72.48 89.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.629 0.728 . . . . 1.6 110.725 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 20.2 m -90.73 101.87 14.62 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.177 -0.919 . . . . 1.48 109.694 176.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.631 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 82.0 m-85 -72.21 106.45 4.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 1.63 110.22 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.3 tp 71.27 124.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 O-C-N 124.321 1.013 . . . . 3.67 110.76 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -95.02 159.47 15.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.272 0.558 . . . . 5.61 110.548 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.507 ' HB ' ' HD3' ' A' ' 63' ' ' PRO . 87.8 m -75.8 -46.71 4.0 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.392 -0.822 . . . . 5.77 112.728 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 62' ' ' THR . 50.4 Cg_exo -55.38 -20.0 24.27 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.267 1.978 . . . . 6.26 112.711 176.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 69' ' ' THR . . . -72.2 76.16 0.76 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 116.515 -0.311 . . . . 6.42 113.106 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -83.29 53.86 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.024 -0.732 . . . . 9.55 109.024 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 67' ' ' ALA . 11.0 tp10 -173.93 -170.98 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.196 -1.409 . . . . 7.05 107.196 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.573 ' H ' ' HG3' ' A' ' 66' ' ' GLU . . . -57.29 -57.43 12.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.325 0.512 . . . . 5.07 110.318 174.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.473 ' HB2' ' CD2' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -97.02 -172.89 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.093 -0.503 . . . . 2.66 109.736 172.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.573 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 6.4 m -55.57 149.12 14.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.544 -0.539 . . . . 5.25 109.544 170.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.52 -50.13 17.59 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 111.598 0.222 . . . . 6.21 111.598 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.7 ttm 56.48 67.09 1.04 Allowed 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.541 0.526 . . . . 5.21 110.865 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -68.54 -46.97 68.1 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.984 -0.553 . . . . 8.75 110.382 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.45 -47.45 0.76 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.889 0.376 . . . . 6.65 111.399 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -147.55 130.34 16.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.844 -0.616 . . . . 10.34 109.83 -175.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.45 -72.48 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.962 -1.113 . . . . 5.22 113.834 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.471 ' HB1' ' CG ' ' A' ' 80' ' ' ASP . . . -144.22 153.55 42.19 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.702 0.26 . . . . 5.89 111.702 -170.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -178.98 -53.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.438 0.461 . . . . 6.97 111.999 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG11 ' H ' ' A' ' 79' ' ' THR . 3.3 p -56.83 -72.07 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 113.375 0.88 . . . . 4.68 113.375 -166.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.73 ' H ' HG11 ' A' ' 78' ' ' VAL . 66.5 p -114.77 19.19 16.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.784 0.802 . . . . 3.84 109.983 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' CG ' ' HB1' ' A' ' 76' ' ' ALA . 6.8 m-20 -83.35 95.41 8.2 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.886 -1.052 . . . . 2.66 108.92 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.707 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 55.4 mt -90.43 148.54 4.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.257 -0.883 . . . . 1.38 111.899 -168.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.69 HG21 ' HB ' ' A' ' 12' ' ' THR . 9.2 p -117.06 140.36 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.457 0.646 . . . . 1.79 110.392 173.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.592 HD13 HD11 ' A' ' 165' ' ' ILE . 18.8 mt -95.25 131.11 42.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.201 -0.909 . . . . 1.14 109.904 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.597 HD13 HG13 ' A' ' 86' ' ' VAL . 1.9 tm? -117.53 107.88 14.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.204 -1.036 . . . . 1.65 108.204 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 57.4 t -89.81 116.48 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.993 -0.549 . . . . 1.14 111.23 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 3.7 m -122.38 137.26 56.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 1.31 110.793 175.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.722 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -75.43 133.95 41.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.939 -0.573 . . . . 1.01 110.011 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.818 ' HA ' HG23 ' A' ' 127' ' ' VAL . . . -76.81 -14.88 59.87 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 120.303 -0.559 . . . . 1.07 110.129 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -10.61 53.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.561 -0.745 . . . . 0.58 110.894 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -128.03 -69.33 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.56 110.284 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.597 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 121.19 -139.8 13.54 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.14 -0.553 . . . . 0.37 113.183 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.5 p -95.67 139.72 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.432 0.634 . . . . 1.78 109.43 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.597 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 72.2 mmm -140.14 178.05 1.76 Allowed Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.419 -0.81 . . . . 1.07 108.815 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 82.9 Cg_exo -46.32 -64.69 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.885 2.39 . . . . 0.89 114.521 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.526 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 2.9 pt20 -70.56 -16.56 62.88 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.555 -0.715 . . . . 0.78 110.787 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.757 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.65 -49.7 51.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.747 -0.661 . . . . 1.07 109.603 178.152 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.594 ' HA ' HD13 ' A' ' 100' ' ' ILE . 3.7 p -74.74 -29.06 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.934 -0.575 . . . . 2.02 112.457 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -57.47 -30.18 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 2.35 109.946 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.583 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -71.14 -40.95 71.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.458 -0.792 . . . . 1.12 110.491 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' A' ' 97' ' ' VAL . 76.9 mt -66.74 -44.31 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.821 0.819 . . . . 1.14 109.641 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -56.63 -42.21 78.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.75 110.842 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 68' ' ' PHE . 5.0 t60 -71.23 -35.02 71.33 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.77 -0.455 . . . . 3.23 109.77 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.45 -52.56 38.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 1.17 111.533 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 29.7 mtpt -75.62 -22.78 56.55 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.675 -0.41 . . . . 2.27 110.908 -176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.21 72.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.551 -0.749 . . . . 1.28 110.539 171.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.57 -21.37 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 1.31 111.101 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.0 t30 82.32 61.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.282 0.989 . . . . 1.6 109.195 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 109' ' ' PRO . 7.7 t -117.7 139.69 26.66 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 114.348 -1.296 . . . . 1.93 111.579 -170.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.404 ' O ' HG13 ' A' ' 108' ' ' VAL . 18.3 Cg_exo -69.26 143.05 51.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.993 2.462 . . . . 0.66 111.362 169.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.494 ' C ' HG22 ' A' ' 145' ' ' THR . 1.3 mt -113.89 160.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 122.04 0.924 . . . . 1.34 112.375 -171.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.757 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 26.4 mm -129.94 86.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.816 -1.538 . . . . 1.12 106.89 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.792 HG22 HG21 ' A' ' 145' ' ' THR . 48.4 t -72.5 147.73 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.595 0.712 . . . . 1.06 109.159 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.759 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.94 105.48 4.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.646 -1.161 . . . . 1.07 110.48 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.796 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -73.99 134.08 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 114.163 -1.38 . . . . 1.29 108.97 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.695 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.7 p-10 -113.42 177.24 4.7 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.358 -1.349 . . . . 1.85 107.358 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.8 ' HD3' ' HE2' ' A' ' 119' ' ' LYS . 89.8 mttt 70.77 32.66 2.43 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 123.701 0.626 . . . . 1.18 111.907 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.514 ' CE ' ' HB3' ' A' ' 124' ' ' PRO . 10.8 mmt -79.89 -10.89 59.83 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.896 -1.15 . . . . 1.64 107.896 166.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.546 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 0.7 OUTLIER -70.47 -20.17 62.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.181 -1.827 . . . . 0.76 109.711 169.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.8 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 23.6 mtmt -100.15 134.57 20.75 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-N 115.606 -0.725 . . . . 1.74 110.407 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -64.03 -14.63 44.59 Favored 'Trans proline' 0 N--CA 1.47 0.122 0 C-N-CA 123.074 2.516 . . . . 0.68 111.907 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -81.67 6.52 14.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.417 -0.81 . . . . 1.45 110.42 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.08 115.4 2.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.17 -0.923 . . . . 1.1 111.231 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.4 76.72 44.41 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.04 -1.096 . . . . 0.95 108.04 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.514 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 43.6 Cg_endo -66.13 -60.25 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.949 2.432 . . . . 0.54 113.176 -170.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.482 ' HA ' ' HG2' ' A' ' 128' ' ' MET . 1.5 m-20 -55.87 -21.34 19.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.315 -0.857 . . . . 1.44 110.91 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -78.07 -56.83 4.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.475 0.655 . . . . 4.56 109.663 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.818 HG23 ' HA ' ' A' ' 88' ' ' ALA . 22.6 m -66.66 -24.88 33.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.874 -1.057 . . . . 1.26 111.675 -176.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.743 ' HA ' ' HB2' ' A' ' 131' ' ' LEU . 18.8 ptm -87.86 -13.88 40.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.914 -0.315 . . . . 1.64 110.549 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.628 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.0 mt-30 -75.87 -47.9 23.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.685 0.279 . . . . 2.0 110.423 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.18 -18.3 64.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.445 0.641 . . . . 1.64 109.572 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.869 HD22 ' HE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -65.62 -43.36 89.78 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.084 -0.962 . . . . 1.96 109.012 172.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.861 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.8 ppp? -80.52 -7.5 59.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.965 -0.561 . . . . 2.05 110.55 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -78.59 -24.15 45.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.764 -0.828 . . . . 1.67 108.764 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.409 ' N ' ' HD1' ' A' ' 134' ' ' TYR . 1.8 m-85 -91.58 18.82 6.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.645 -1.161 . . . . 1.58 108.478 169.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 56.69 56.94 5.1 Favored 'General case' 0 CA--C 1.526 0.048 0 CA-C-N 113.716 -1.583 . . . . 1.42 111.463 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.722 ' H ' ' HA ' ' A' ' 132' ' ' MET . 70.8 mt -123.02 105.58 10.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.825 -1.08 . . . . 1.93 109.365 170.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.786 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.4 t -108.17 114.11 59.95 Favored Pre-proline 0 C--N 1.31 -1.132 0 C-N-CA 119.89 -0.724 . . . . 1.18 111.125 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.967 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 1.2 Cg_endo -54.45 160.59 6.68 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.587 2.858 . . . . 0.88 112.97 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.531 ' HB2' HD13 ' A' ' 146' ' ' ILE . 20.6 mm-40 -78.16 -17.29 57.03 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.02 -1.445 . . . . 3.08 109.697 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.967 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 2.0 pm0 -69.35 -24.48 63.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.118 -0.946 . . . . 1.57 110.256 169.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.861 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 30.7 m0 -105.99 -10.1 16.74 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.916 0.388 . . . . 0.66 110.274 -177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.16 33.83 10.34 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.896 -0.593 . . . . 0.57 113.455 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.786 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -91.31 -108.8 1.53 Allowed Glycine 0 CA--C 1.509 -0.317 0 C-N-CA 120.086 -1.054 . . . . 0.6 111.418 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -163.82 61.4 0.16 Allowed 'General case' 0 C--O 1.248 1.015 0 CA-C-O 123.497 1.618 . . . . 1.91 110.457 170.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.792 HG21 HG22 ' A' ' 112' ' ' VAL . 58.1 m -162.67 114.97 1.62 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.745 -1.571 . . . . 1.1 110.224 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.757 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 12.7 mm -68.12 106.16 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.032 -0.729 . . . . 1.27 109.032 172.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.869 ' HE2' HD22 ' A' ' 131' ' ' LEU . 7.9 m-85 -87.99 107.6 18.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.717 -0.674 . . . . 0.53 110.08 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.671 ' HG ' HG21 ' A' ' 146' ' ' ILE . 92.4 m -97.29 112.13 24.08 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.526 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.796 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 81.9 mttt -83.96 96.34 8.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.699 -0.852 . . . . 1.96 108.699 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.801 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.8 pp -122.33 -173.38 2.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.614 1.197 . . . . 1.49 111.974 -173.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 0.7 OUTLIER -154.0 93.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.498 -1.683 . . . . 2.07 107.626 -176.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.14 60.76 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.645 -0.422 . . . . 1.11 110.429 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.546 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 40.9 mttm -78.48 -48.17 15.89 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.311 -0.556 . . . . 2.78 111.541 172.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 p -84.75 -7.11 59.33 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.669 -0.812 . . . . 1.35 111.516 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.424 ' CD ' HD13 ' A' ' 158' ' ' LEU . 39.0 mmtm 66.79 42.54 2.58 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.396 -0.82 . . . . 1.9 111.548 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -102.31 -67.42 0.87 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.346 1.07 . . . . 2.48 109.911 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.801 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -70.06 -8.31 61.27 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.015 -1.448 . . . . 0.36 113.757 -174.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.424 HD13 ' CD ' ' A' ' 155' ' ' LYS . 26.6 mt -69.17 -37.96 78.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.98 0.89 . . . . 1.42 109.578 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 25.0 t70 -72.65 -39.31 67.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.657 -0.701 . . . . 2.2 109.596 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 86.6 t60 -69.28 -20.34 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.24 -0.436 . . . . 0.68 110.884 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.449 HD23 HD11 ' A' ' 83' ' ' ILE . 53.2 tp -67.18 -53.71 27.9 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.322 -0.621 . . . . 1.77 109.322 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.73 -26.97 67.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.043 -0.98 . . . . 2.1 110.72 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 49.8 mt-10 -58.74 -47.51 84.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.259 0.552 . . . . 2.57 110.202 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.731 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 19.5 mmt -71.9 -34.43 69.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.846 -0.616 . . . . 1.21 110.32 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 83' ' ' ILE . 84.5 mt -65.24 -46.13 91.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 1.2 110.995 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.629 ' HA ' ' OG ' ' A' ' 169' ' ' SER . 4.3 pp -67.47 -33.01 74.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.811 -0.356 . . . . 2.3 111.011 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.452 ' N ' HD11 ' A' ' 166' ' ' LEU . 2.3 tm? -52.99 -48.24 67.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.954 -0.758 . . . . 2.11 108.954 170.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.622 HG11 HD11 ' A' ' 81' ' ' ILE . 67.7 t -65.7 -45.6 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.581 -0.736 . . . . 1.41 111.256 177.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.629 ' OG ' ' HA ' ' A' ' 166' ' ' LEU . 64.8 p -63.39 -26.59 68.82 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.676 -0.41 . . . . 1.82 111.202 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -83.68 -25.26 30.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.517 0.675 . . . . 2.73 109.664 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.615 ' HG3' ' HB2' ' A' ' 175' ' ' LYS . 56.8 ttp -69.69 -34.94 74.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.461 -0.791 . . . . 2.12 110.043 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.67 -26.82 35.72 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.355 -0.384 . . . . 4.27 111.749 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.48 ' HG2' ' HG ' ' A' ' 174' ' ' LEU . 3.4 tt0 -59.83 -77.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 3.91 111.758 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.48 ' HG ' ' HG2' ' A' ' 173' ' ' GLU . 92.4 mt -130.95 -10.07 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.571 -0.286 . . . . 6.06 111.361 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.615 ' HB2' ' HG3' ' A' ' 171' ' ' MET . 27.2 mmtm -85.48 -26.06 26.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 5.86 111.497 -170.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.48 141.5 41.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.097 0.475 . . . . 5.79 112.006 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -116.63 104.19 51.68 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.5 -0.773 . . . . 8.44 109.057 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.962 2.441 . . . . 9.2 112.135 -177.128 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.698 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.406 -0.277 . . . . 11.83 112.406 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m 59.79 62.48 1.69 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.501 0.32 . . . . 10.75 110.876 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -77.42 51.76 0.9 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.526 0.679 . . . . 10.82 111.451 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.2 tpp -129.98 -56.26 1.12 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.283 -0.871 . . . . 9.01 109.147 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.91 97.69 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.692 -0.685 . . . . 6.14 110.009 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.01 133.31 51.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.146 -0.479 . . . . 5.7 110.935 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 58.38 80.73 0.27 Allowed Pre-proline 0 C--O 1.235 0.33 0 O-C-N 123.922 0.764 . . . . 7.55 111.124 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HB2' HG13 ' A' ' 10' ' ' VAL . 14.3 Cg_exo -69.0 117.86 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.615 2.21 . . . . 3.21 111.803 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.75 60.23 6.61 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.713 2.275 . . . . 3.14 111.665 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.621 HG11 ' CE1' ' A' ' 65' ' ' HIS . 6.7 p -128.19 137.12 58.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.586 . . . . 2.53 110.702 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 74.4 t -137.97 104.09 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.969 -0.56 . . . . 1.95 110.327 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.806 ' HB ' HG23 ' A' ' 82' ' ' VAL . 3.0 m -61.93 140.66 58.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.336 . . . . 1.27 110.499 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -112.89 138.14 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.177 0.513 . . . . 1.83 110.592 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.491 ' CE ' ' HB3' ' A' ' 68' ' ' PHE . 63.0 mtt -147.05 173.04 12.83 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.561 -0.745 . . . . 1.28 109.28 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' HA2' HD21 ' A' ' 84' ' ' LEU . . . 150.1 -175.99 28.94 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.711 -0.757 . . . . 0.34 112.108 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.738 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 49.5 t60 -86.6 162.15 18.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.997 0.903 . . . . 0.28 111.563 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.503 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.52 150.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.275 -1.329 . . . . 1.09 110.172 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.719 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 21.3 t70 74.44 -14.98 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.476 0.655 . . . . 0.69 109.902 -175.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.542 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 13.6 m170 -87.57 9.0 22.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.95 -1.13 . . . . 0.63 107.95 168.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA2' ' O2A' ' A' ' 179' ' ' GDP . . . 76.05 54.4 5.28 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 114.801 -1.09 . . . . 0.79 113.899 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 7.82 7.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.035 0.917 . . . . 3.69 111.453 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.485 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.5 m -129.64 -50.64 1.16 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.974 -0.557 . . . . 1.76 110.011 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -57.52 -24.75 57.8 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.077 -0.51 . . . . 1.71 111.315 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.3 mp -70.43 -35.34 73.32 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 111.98 0.363 . . . . 2.09 111.98 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.884 ' HB2' ' CE2' ' A' ' 48' ' ' TYR . 2.5 pp -74.61 -17.74 60.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.61 -0.836 . . . . 2.23 109.909 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.566 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 29.5 t70 -85.55 -42.93 13.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.144 0.973 . . . . 1.23 109.217 174.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -64.52 -38.29 90.5 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.7 -1.591 . . . . 1.23 110.588 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 6.9 tt -73.33 -31.4 33.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.151 -0.931 . . . . 1.59 111.139 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 19.6 ptt180 -81.72 -31.04 32.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.8 0.81 . . . . 3.51 109.986 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -96.0 20.49 10.0 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.853 -1.067 . . . . 3.14 111.405 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.514 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 37.3 t -105.2 -18.34 14.17 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.782 -1.099 . . . . 1.96 110.9 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.815 ' HB3' ' HZ3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -167.58 -166.5 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.896 0.379 . . . . 4.37 111.385 -177.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.2 t -75.04 131.16 35.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.466 0.651 . . . . 3.59 111.858 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.84 142.52 17.67 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.281 -0.872 . . . . 2.99 110.353 169.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -105.92 -35.79 7.19 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.984 -1.007 . . . . 6.34 109.965 -176.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 22.2 tp60 -94.44 63.43 2.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.63 0.729 . . . . 7.38 109.567 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' CG ' ' HD2' ' A' ' 29' ' ' ARG . 29.2 tt0 -88.6 131.39 34.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.134 -0.939 . . . . 6.24 110.829 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.6 179.78 6.21 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.532 -0.544 . . . . 5.33 109.532 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 45' ' ' ILE . . . 174.65 -130.13 1.72 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.56 -0.829 . . . . 4.68 112.011 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.5 71.97 0.69 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.831 -0.699 . . . . 5.06 112.421 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.2 mt -94.94 128.0 46.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.743 0.306 . . . . 5.91 110.855 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.5 m 70.58 -63.99 0.39 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.354 -0.839 . . . . 6.29 111.454 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -167.36 -57.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.166 -0.679 . . . . 6.97 109.166 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -69.4 126.98 31.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.288 -0.869 . . . . 7.26 110.66 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 2.7 pp -81.9 157.41 4.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.935 -0.575 . . . . 5.68 111.143 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.36 155.75 24.8 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.438 -0.665 . . . . 2.62 111.438 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 59' ' ' PHE . . . -90.57 175.49 7.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.8 0.333 . . . . 1.8 111.232 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.884 ' CE2' ' HB2' ' A' ' 25' ' ' LEU . 18.3 p90 -138.99 169.53 17.63 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.401 -0.363 . . . . 1.92 111.257 -167.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 36' ' ' GLN . 72.7 mt-30 -119.7 115.85 24.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.57 -0.53 . . . . 2.22 109.57 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 16.6 t -87.91 150.97 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.341 . . . . 2.09 111.075 -177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.908 HG23 ' HA ' ' A' ' 54' ' ' ASP . 96.1 m -137.69 91.02 2.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.86 -0.609 . . . . 1.99 110.468 -173.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.884 HG12 ' H ' ' A' ' 53' ' ' ASN . 1.9 p -64.25 -72.43 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.259 0.552 . . . . 2.62 109.647 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.884 ' H ' HG12 ' A' ' 52' ' ' VAL . 2.9 p30 -98.19 -57.53 2.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.073 -1.084 . . . . 4.06 108.073 169.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.908 ' HA ' HG23 ' A' ' 51' ' ' THR . 15.4 t70 -175.45 79.11 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.879 -1.51 . . . . 2.99 108.507 167.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.0 tppt? -142.07 79.64 1.68 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.561 -1.274 . . . . 7.77 107.561 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 30.4 mtmm -64.04 81.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 124.389 1.056 . . . . 4.8 112.487 -169.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.527 HD13 HG23 ' A' ' 165' ' ' ILE . 55.0 mt -75.64 105.9 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.254 -0.885 . . . . 1.6 109.722 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 5.1 m -83.75 94.83 8.24 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.737 -0.665 . . . . 1.48 109.658 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 85.9 m-85 -69.17 106.51 2.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.27 -0.423 . . . . 1.63 109.87 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 62.3 tp 76.47 123.43 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.391 1.057 . . . . 3.67 110.808 -173.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.494 ' HB2' HG23 ' A' ' 10' ' ' VAL . 22.1 t70 -89.14 105.75 17.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.305 0.574 . . . . 5.61 110.669 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.514 ' HB ' ' HD3' ' A' ' 63' ' ' PRO . 17.8 m -56.92 -49.53 93.36 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 115.372 -0.831 . . . . 5.77 111.979 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.514 ' HD3' ' HB ' ' A' ' 62' ' ' THR . 69.2 Cg_exo -43.67 -59.42 1.06 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.634 2.223 . . . . 6.26 112.678 174.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.69 58.45 0.37 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.293 -0.956 . . . . 6.42 113.696 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.621 ' CE1' HG11 ' A' ' 10' ' ' VAL . 25.6 p-80 -88.23 -10.8 48.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.044 0.45 . . . . 9.55 110.057 174.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.748 ' HB2' ' HE1' ' A' ' 71' ' ' MET . 41.1 mt-10 -83.82 -168.44 2.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.451 -0.795 . . . . 7.05 111.068 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.782 ' HB1' ' HB3' ' A' ' 76' ' ' ALA . . . -154.38 39.42 0.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.157 -0.929 . . . . 5.07 110.066 176.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.491 ' HB3' ' CE ' ' A' ' 14' ' ' MET . 77.2 m-85 -106.72 -20.66 13.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.486 0.921 . . . . 2.66 113.486 -173.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.532 ' O ' ' HG2' ' A' ' 71' ' ' MET . 12.0 t -159.61 129.37 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.645 -0.422 . . . . 5.25 110.786 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.7 m 70.05 -62.92 0.41 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.771 -0.65 . . . . 6.21 110.9 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.748 ' HE1' ' HB2' ' A' ' 66' ' ' GLU . 9.7 ptt? -69.07 92.62 0.54 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.692 -0.685 . . . . 5.21 109.748 173.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -127.01 8.88 6.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.363 -0.38 . . . . 8.75 111.022 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.59 -15.88 29.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.204 0.526 . . . . 6.65 110.419 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -94.46 141.9 28.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.624 . . . . 10.34 110.146 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.27 116.1 4.2 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.618 -0.801 . . . . 5.22 111.221 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.782 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . . . -76.62 81.77 3.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 5.89 111.138 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -110.22 35.9 3.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.859 0.838 . . . . 6.97 109.184 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.1 143.34 37.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.135 -0.939 . . . . 4.68 109.381 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 p -81.36 69.99 8.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.273 0.471 . . . . 3.84 112.273 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -86.02 -179.58 6.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.873 -0.788 . . . . 2.66 108.873 171.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.432 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt -135.35 139.34 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.3 -0.259 . . . . 1.38 110.3 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.806 HG23 ' HB ' ' A' ' 12' ' ' THR . 39.1 t -118.02 126.95 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.368 0.604 . . . . 1.79 112.11 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.652 HG12 ' HB ' ' A' ' 111' ' ' ILE . 6.1 mt -85.04 133.97 28.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.009 -0.996 . . . . 1.14 110.562 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.6 HD13 HG12 ' A' ' 86' ' ' VAL . 2.0 tm? -121.28 110.35 16.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.454 -0.943 . . . . 1.65 108.454 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 93.2 t -89.04 117.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 1.14 111.397 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.646 HG13 HG23 ' A' ' 96' ' ' THR . 1.9 m -126.33 123.35 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.803 -0.635 . . . . 1.31 111.218 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.542 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -62.53 131.81 50.36 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.928 -0.578 . . . . 1.01 110.014 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.724 ' HB1' ' CG2' ' A' ' 114' ' ' ILE . . . -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.22 0.533 . . . . 1.07 111.115 -176.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -90.54 -13.87 33.71 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.479 -0.782 . . . . 0.58 111.069 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.449 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.1 t70 -118.55 -50.43 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 0.56 110.537 -174.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 91.43 -162.77 28.36 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.37 113.449 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.07 136.37 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.754 0.788 . . . . 1.78 109.75 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.746 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 76.8 mmm -139.39 176.93 2.27 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.932 -1.031 . . . . 1.07 109.14 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.746 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 74.7 Cg_exo -40.13 -65.52 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.369 2.712 . . . . 0.89 114.466 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.457 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.4 pt20 -76.13 -16.64 59.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.881 -0.327 . . . . 0.78 111.243 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.738 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -68.23 -43.01 78.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.486 0.66 . . . . 1.07 109.258 176.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 93' ' ' MET . 24.9 t -66.27 -41.35 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 115.049 -0.978 . . . . 2.02 111.289 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -55.07 -29.6 57.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.981 0.419 . . . . 2.35 110.456 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -73.04 -38.14 66.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.017 -0.538 . . . . 1.12 110.565 175.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.9 mt -73.49 -44.43 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.84 0.829 . . . . 1.14 109.056 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -59.36 -30.71 68.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.36 -1.291 . . . . 0.75 111.055 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.463 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 4.6 t60 -80.91 -34.62 33.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.168 0.509 . . . . 3.23 110.038 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.46 ' HB1' HD13 ' A' ' 110' ' ' ILE . . . -71.81 -46.21 58.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.885 -0.598 . . . . 1.17 111.482 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.625 ' HD3' HD22 ' A' ' 136' ' ' LEU . 13.6 mmmm -71.59 -29.23 64.46 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.242 0.544 . . . . 2.27 109.58 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.46 72.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.906 -1.043 . . . . 1.28 111.33 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.33 28.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.066 0.46 . . . . 1.31 110.629 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 85.6 53.06 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 114.581 -1.19 . . . . 1.6 109.295 171.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 109' ' ' PRO . 1.3 p -110.34 141.96 25.02 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 113.841 -1.527 . . . . 1.93 110.62 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 108' ' ' VAL . 23.7 Cg_exo -64.27 143.43 83.33 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.554 2.17 . . . . 0.66 112.025 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.46 HD13 ' HB1' ' A' ' 103' ' ' ALA . 31.4 mm -106.34 158.59 6.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.488 0.661 . . . . 1.34 110.976 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.815 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 41.1 mm -124.94 84.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.396 -1.335 . . . . 1.12 107.396 171.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.952 HG23 HD23 ' A' ' 131' ' ' LEU . 63.0 t -70.12 147.84 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.654 0.74 . . . . 1.06 109.753 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.748 ' HB3' HD23 ' A' ' 150' ' ' LEU . . . -145.13 100.37 3.46 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.34 -1.3 . . . . 1.07 109.701 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.806 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.7 mp -70.43 139.21 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.173 -1.376 . . . . 1.29 109.082 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -120.13 171.99 8.08 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.835 -1.542 . . . . 1.85 106.835 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.542 ' HD2' ' HB3' ' A' ' 87' ' ' ALA . 90.2 mttt 66.81 30.58 7.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 O-C-N 123.704 0.627 . . . . 1.18 111.902 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.7 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 83.1 mmm -83.79 -6.39 59.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.651 0.739 . . . . 1.64 109.299 172.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 8.1 p-10 -67.11 -28.1 67.88 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.704 -1.135 . . . . 0.76 108.865 169.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.464 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 29.5 mtpp -74.97 133.19 76.05 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.205 -1.362 . . . . 1.74 110.414 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -64.97 -16.05 53.53 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.449 2.1 . . . . 0.68 110.937 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -80.84 -1.64 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.745 -1.116 . . . . 1.45 110.63 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.481 ' HB3' ' SD ' ' A' ' 117' ' ' MET . . . -54.97 124.29 16.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.189 -0.914 . . . . 1.1 111.731 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.674 HD21 ' HB2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -129.13 75.67 79.99 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.75 -0.833 . . . . 0.95 108.75 173.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.7 ' HG3' ' HE1' ' A' ' 117' ' ' MET . 37.0 Cg_endo -63.24 -60.33 0.18 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 123.085 2.523 . . . . 0.54 112.73 -173.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.449 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 2.5 m-20 -55.92 -18.22 8.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.555 -0.748 . . . . 1.44 111.616 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.674 ' HB2' HD21 ' A' ' 123' ' ' ASN . 5.4 tpm_? -78.7 -56.75 4.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.206 -0.665 . . . . 4.56 109.206 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.608 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 5.0 m -66.47 -22.98 30.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 122.303 1.049 . . . . 1.26 110.165 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.652 ' HE2' ' CG ' ' A' ' 138' ' ' PRO . 8.4 ttt -68.27 -43.94 76.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.767 -1.56 . . . . 1.64 110.522 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.539 ' HA ' ' HG3' ' A' ' 132' ' ' MET . 27.6 mt-30 -68.85 -31.74 70.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.765 -0.652 . . . . 2.0 111.752 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.725 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 12.7 mt-10 -61.52 -37.61 84.36 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.932 0.872 . . . . 1.64 109.162 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.952 HD23 HG23 ' A' ' 112' ' ' VAL . 4.9 mp -62.4 -35.75 80.18 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.502 -0.772 . . . . 1.96 109.846 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.747 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -70.14 -18.05 63.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.051 -0.659 . . . . 2.05 111.864 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.725 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 4.7 pt-20 -78.83 -17.5 55.57 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.204 -1.036 . . . . 1.67 108.204 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -97.9 23.02 8.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.777 -1.101 . . . . 1.58 109.051 167.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.43 52.86 11.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.658 -1.61 . . . . 1.42 111.763 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.625 HD22 ' HD3' ' A' ' 104' ' ' LYS . 76.7 mt -121.67 96.79 5.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.604 -0.726 . . . . 1.93 110.026 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.952 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 61.5 t -103.54 121.71 47.42 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.572 -0.74 . . . . 1.18 111.302 -174.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.747 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 86.5 Cg_exo -41.58 144.16 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.642 3.561 . . . . 0.88 113.854 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HB2' HD11 ' A' ' 146' ' ' ILE . 9.0 mm-40 -74.09 -21.92 59.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.056 -1.429 . . . . 3.08 109.354 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.504 ' HG2' ' HB3' ' A' ' 138' ' ' PRO . 2.3 pm0 -70.53 -21.44 62.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.671 -1.149 . . . . 1.57 110.634 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.542 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 37.6 m0 -102.66 -34.12 9.18 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 120.846 0.355 . . . . 0.66 110.641 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 122.27 29.63 1.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.724 -0.751 . . . . 0.57 112.623 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.952 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.91 -112.46 2.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.442 -0.885 . . . . 0.6 112.48 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -162.89 60.37 0.2 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.65 1.215 . . . . 1.91 111.246 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.848 HG23 HG21 ' A' ' 112' ' ' VAL . 52.3 m -165.12 116.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.686 -1.143 . . . . 1.1 110.347 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.815 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.5 mm -70.74 105.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.062 -0.718 . . . . 1.27 109.062 173.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.697 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.1 m-85 -89.05 114.56 25.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.205 -0.907 . . . . 0.53 110.601 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 95.4 m -102.94 116.63 32.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.754 0.311 . . . . 1.0 110.769 173.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.636 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 88.1 mttt -89.72 103.7 16.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.923 -0.769 . . . . 1.96 108.923 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.904 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.3 pp -135.25 -174.14 3.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.054 1.407 . . . . 1.49 112.953 -172.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.413 ' HB2' ' H ' ' A' ' 118' ' ' ASP . 13.8 t -152.44 118.55 5.51 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.453 -1.703 . . . . 2.07 106.693 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.56 -7.77 58.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.156 -0.618 . . . . 1.11 109.369 175.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.582 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 5.1 tmtt? -74.47 -55.15 6.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.47 -0.786 . . . . 2.78 110.197 172.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.4 p -82.5 -9.14 59.54 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.148 -0.621 . . . . 1.35 111.619 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.401 ' HE3' ' HB1' ' A' ' 27' ' ' ALA . 38.6 mmtm 65.39 40.14 4.89 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.506 -0.77 . . . . 1.9 111.516 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.13 -67.3 0.85 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.708 1.242 . . . . 2.48 110.281 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.904 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -68.68 -12.62 64.64 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 113.536 -1.665 . . . . 0.36 113.844 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 34.4 mt -67.42 -37.56 83.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 118.287 1.043 . . . . 1.42 109.804 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.988 -1.005 . . . . 2.2 109.401 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.5 -20.56 65.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.396 -0.82 . . . . 0.68 110.861 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.12 -57.31 7.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.23 -0.441 . . . . 1.77 110.327 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.36 -41.27 75.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.405 -0.816 . . . . 2.1 110.178 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -55.23 -45.86 76.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.284 -0.871 . . . . 2.57 111.586 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.867 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 14.4 mmt -70.23 -44.38 68.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 1.21 110.382 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.56 HD11 HD13 ' A' ' 83' ' ' ILE . 72.0 mt -59.18 -49.53 83.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.725 -0.67 . . . . 1.2 111.523 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 0.0 OUTLIER -73.25 -22.94 60.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.673 -0.24 . . . . 2.3 110.849 -177.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.13 -50.94 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.905 -0.776 . . . . 2.11 108.905 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.748 ' HA ' ' HG2' ' A' ' 171' ' ' MET . 42.3 t -64.53 -37.57 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.224 -0.898 . . . . 1.41 110.794 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 166' ' ' LEU . 22.9 m -60.8 -21.08 62.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.893 0.378 . . . . 1.82 110.568 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 170' ' ' GLU . 41.9 tt0 -104.24 3.4 32.69 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.103 -0.499 . . . . 2.73 111.291 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.787 ' HA ' ' HE2' ' A' ' 171' ' ' MET . 22.9 mmt -40.48 -31.68 0.16 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.335 0.865 . . . . 2.12 113.335 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -55.9 -37.27 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 4.27 111.138 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -99.2 4.51 46.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.887 -0.597 . . . . 3.91 111.214 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.453 HD22 ' SD ' ' A' ' 171' ' ' MET . 58.0 tp -56.37 -41.83 76.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.313 0.578 . . . . 6.06 110.281 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.2 OUTLIER -95.37 34.31 1.46 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.611 -0.722 . . . . 5.86 111.44 -177.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -91.62 -25.66 19.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.468 0.651 . . . . 5.79 109.309 171.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -114.31 93.61 32.09 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.003 -0.999 . . . . 8.44 109.052 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.247 0.935 0 C-N-CA 123.266 2.644 . . . . 9.2 112.037 -177.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.719 " H5'" ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.765 -0.134 . . . . 11.83 112.765 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -74.56 -43.49 55.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.662 0.231 . . . . 10.75 111.517 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.7 m80 55.97 67.1 1.05 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.498 0.666 . . . . 10.82 109.472 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 42.6 ttm -133.37 -44.32 0.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.03 -0.986 . . . . 9.01 111.398 -170.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.5 m -101.81 -22.41 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.309 . . . . 6.14 111.211 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -87.52 141.12 28.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.5 -0.318 . . . . 5.7 110.448 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -106.55 107.89 60.9 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.449 . . . . 7.55 110.64 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -93.36 117.97 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.334 2.689 . . . . 3.21 112.449 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.488 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 16.5 Cg_exo -68.15 91.23 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.86 2.373 . . . . 3.14 111.447 177.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.702 HG21 ' H ' ' A' ' 11' ' ' VAL . 3.8 m -79.69 -67.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 2.53 111.32 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.702 ' H ' HG21 ' A' ' 10' ' ' VAL . 87.9 t 66.28 94.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.526 0.679 . . . . 1.95 110.932 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -80.22 146.57 31.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.773 -0.649 . . . . 1.27 110.239 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -107.4 136.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.385 0.612 . . . . 1.83 110.953 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 99' ' ' ALA . 63.5 mtt -144.12 176.59 9.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.433 -0.803 . . . . 1.28 108.892 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.07 176.69 15.21 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.247 -0.977 . . . . 0.34 112.322 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.707 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 57.7 t60 -80.81 158.94 25.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.82 0.819 . . . . 0.28 111.538 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG22 ' O1B' ' A' ' 179' ' ' GDP . 6.5 p -71.82 151.34 8.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.5 -1.227 . . . . 1.09 109.933 175.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.662 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 20.8 t70 75.03 -25.13 0.21 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.1 0.476 . . . . 0.69 110.703 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.553 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 20.4 m170 -76.71 -17.32 59.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.487 -0.931 . . . . 0.63 108.487 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.793 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . 119.78 65.3 0.28 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.401 -0.818 . . . . 0.79 113.87 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.586 ' HB3' ' O2B' ' A' ' 179' ' ' GDP . 16.0 tppt? -65.28 -71.43 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.142 -0.623 . . . . 3.69 110.656 172.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -86.71 -32.48 20.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.517 -0.31 . . . . 1.76 110.924 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.492 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -57.76 -27.86 63.42 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.569 0.581 . . . . 1.71 112.569 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.793 HD22 ' HA3' ' A' ' 20' ' ' GLY . 1.2 mm? -75.86 -36.93 59.42 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.908 -0.404 . . . . 2.09 109.908 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 47' ' ' ALA . 3.3 tp -73.71 -9.67 58.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.631 -0.713 . . . . 2.23 109.941 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 20.1 t70 -98.92 -44.06 6.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.884 -0.784 . . . . 1.23 108.884 176.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.48 87.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.279 -1.328 . . . . 1.23 109.761 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 10.9 tt -67.0 -36.14 76.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.791 -1.095 . . . . 1.59 111.101 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 79.6 mtm180 -71.31 -42.79 68.2 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.694 0.759 . . . . 3.51 109.587 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -79.0 17.97 0.68 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.113 -0.949 . . . . 3.14 111.941 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 29' ' ' ARG . 74.8 m -105.99 -46.66 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.531 -1.213 . . . . 1.96 109.546 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HD3' ' CD1' ' A' ' 162' ' ' LEU . 14.5 ptmt -174.1 -163.86 0.18 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.932 -0.576 . . . . 4.37 110.077 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.742 HG13 ' H ' ' A' ' 34' ' ' THR . 5.4 p 47.36 -88.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.536 1.135 . . . . 3.59 113.235 -175.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.742 ' H ' HG13 ' A' ' 33' ' ' VAL . 23.3 p -98.43 112.39 24.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.32 0.581 . . . . 2.99 112.169 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.49 -36.89 20.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.391 -0.822 . . . . 6.34 109.48 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -172.18 -39.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.869 -1.059 . . . . 7.38 108.676 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.51 175.01 6.04 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 114.71 -1.132 . . . . 6.24 110.081 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.29 -176.21 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.826 0.704 . . . . 5.33 112.502 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.84 -63.77 4.42 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.956 -0.565 . . . . 4.68 112.435 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.52 68.66 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.596 -0.601 . . . . 5.06 111.596 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.0 tp -151.87 131.75 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.472 0.653 . . . . 5.91 111.391 -176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 44' ' ' HIS . 1.1 m -111.27 143.77 41.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.634 -0.876 . . . . 6.29 108.634 171.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -77.42 28.01 0.15 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.044 0.387 . . . . 6.97 112.044 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.419 ' H ' ' C ' ' A' ' 42' ' ' THR . 84.6 m-70 -140.4 27.76 2.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.369 0.605 . . . . 7.26 109.571 175.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.406 HG21 ' N ' ' A' ' 46' ' ' GLY . 45.8 mm -130.43 158.38 42.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.134 -0.939 . . . . 5.68 109.702 -175.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' N ' HG21 ' A' ' 45' ' ' ILE . . . -101.81 132.1 10.84 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.823 -0.911 . . . . 2.62 110.823 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.565 ' HA ' HD23 ' A' ' 25' ' ' LEU . . . 67.23 -166.99 0.21 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.763 0.331 . . . . 1.8 110.313 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -165.51 176.77 7.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.971 -0.381 . . . . 1.92 109.971 -172.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 45.3 mt-30 -97.07 115.02 26.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.843 -0.617 . . . . 2.22 109.896 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 24.9 t -76.58 160.64 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.732 -0.47 . . . . 2.09 109.732 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.866 HG22 ' HA ' ' A' ' 54' ' ' ASP . 96.1 m -155.19 83.38 1.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.259 -1.015 . . . . 1.99 108.259 -176.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.854 HG13 ' H ' ' A' ' 53' ' ' ASN . 2.2 p -56.98 -67.77 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.85 -0.613 . . . . 2.62 110.251 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.854 ' H ' HG13 ' A' ' 52' ' ' VAL . 19.3 m-20 -100.84 -60.97 1.43 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.822 -1.547 . . . . 4.06 106.822 169.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.866 ' HA ' HG22 ' A' ' 51' ' ' THR . 7.0 p-10 -161.22 39.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.327 -1.306 . . . . 2.99 109.717 171.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -107.5 110.29 22.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 7.77 109.528 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -67.76 118.79 11.48 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.93 0.769 . . . . 4.8 111.413 -174.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.698 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 17.8 mt -128.29 93.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.606 -0.725 . . . . 1.6 109.488 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 6.1 m -89.2 93.59 9.62 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.651 -0.42 . . . . 1.48 110.469 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 4.6 m-30 -49.55 -19.92 0.66 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.841 -1.072 . . . . 1.63 113.855 -177.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 41.4 tp -146.13 96.32 2.77 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.98 -0.45 . . . . 3.67 110.535 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -143.33 -72.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 5.61 111.151 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 92.9 m -120.65 122.57 28.48 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.827 0.346 . . . . 5.77 111.51 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.793 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 72.2 Cg_endo -82.7 135.01 7.67 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.867 2.378 . . . . 6.26 111.619 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.74 -80.17 1.2 Allowed Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.634 -0.793 . . . . 6.42 111.86 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -68.52 80.79 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.506 0.558 . . . . 9.55 112.506 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 73.93 -63.29 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.95 -1.023 . . . . 7.05 112.874 170.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.87 126.89 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.052 0.541 . . . . 5.07 109.93 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.461 ' HZ ' HG23 ' A' ' 108' ' ' VAL . 40.2 m-85 -87.74 -174.47 4.77 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.223 -0.444 . . . . 2.66 109.946 166.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.2 p -58.39 -62.71 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.82 0.674 . . . . 5.25 112.82 -173.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.7 p -87.91 40.82 0.96 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.869 0.322 . . . . 6.21 111.869 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.793 ' SD ' ' HB3' ' A' ' 63' ' ' PRO . 50.9 mtt -136.35 121.22 18.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.085 0.469 . . . . 5.21 111.787 -176.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -125.81 29.08 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.766 -0.652 . . . . 8.75 109.784 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.44 -75.93 0.45 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.222 -0.445 . . . . 6.65 112.066 -170.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 63' ' ' PRO . 25.3 mtm180 -143.02 -179.75 6.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.615 0.245 . . . . 10.34 111.332 -172.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.43 111.94 0.59 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.681 -0.567 . . . . 5.22 111.681 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.18 -153.93 0.59 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.812 0.339 . . . . 5.89 110.444 -175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -131.44 48.12 2.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.431 0.634 . . . . 6.97 110.161 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 t -82.88 158.2 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.293 -0.867 . . . . 4.68 109.929 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 m -76.39 84.37 3.13 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.015 -0.365 . . . . 3.84 110.015 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.443 ' HB2' HG22 ' A' ' 108' ' ' VAL . 9.9 m-20 -63.75 143.6 57.71 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.847 -0.615 . . . . 2.66 111.263 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 47.6 mt -134.77 118.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.113 -0.949 . . . . 1.38 108.509 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.408 HG22 ' SD ' ' A' ' 14' ' ' MET . 11.9 p -114.49 135.69 53.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.528 0.68 . . . . 1.79 110.896 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.9 mt -90.83 128.92 42.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.914 -1.039 . . . . 1.14 109.884 173.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.605 HD13 HG13 ' A' ' 86' ' ' VAL . 2.4 tm? -114.8 106.89 14.73 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.369 -0.974 . . . . 1.65 108.369 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -86.29 109.03 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.799 -0.637 . . . . 1.14 110.996 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.5 m -119.99 122.29 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.768 -0.651 . . . . 1.31 110.656 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.684 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -69.85 130.09 41.33 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.406 -0.59 . . . . 1.01 109.406 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.778 ' HA ' HG23 ' A' ' 127' ' ' VAL . . . -69.01 -15.32 63.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 120.897 0.379 . . . . 1.07 111.505 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.52 -5.52 58.16 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.037 -0.529 . . . . 0.58 111.523 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.414 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -133.23 -49.39 0.86 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.556 0.217 . . . . 0.56 111.479 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.553 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 94.75 -148.43 18.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 121.084 -0.579 . . . . 0.37 113.477 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.414 HG12 ' CE2' ' A' ' 134' ' ' TYR . 30.2 t -83.23 131.28 34.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.542 0.687 . . . . 1.78 110.355 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.769 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 83.9 mmm -131.22 176.85 2.56 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 114.645 -1.162 . . . . 1.07 109.477 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 56.5 Cg_exo -38.53 -66.43 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.566 2.844 . . . . 0.89 114.578 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 3.8 pt20 -74.82 -15.5 60.74 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.135 0.493 . . . . 0.78 111.323 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.707 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -71.01 -41.68 70.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.475 0.655 . . . . 1.07 109.482 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.675 HG11 HD21 ' A' ' 101' ' ' ASN . 25.7 t -63.41 -41.16 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.193 -0.912 . . . . 2.02 111.861 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.29 -34.29 68.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 2.35 110.276 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.442 ' HB3' ' SD ' ' A' ' 14' ' ' MET . . . -68.65 -34.26 75.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 1.12 110.609 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.626 HG21 HD13 ' A' ' 136' ' ' LEU . 95.5 mt -74.14 -42.67 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.778 0.799 . . . . 1.14 109.256 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.675 HD21 HG11 ' A' ' 97' ' ' VAL . 6.4 m-80 -65.41 -25.59 67.61 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.446 -1.252 . . . . 0.75 111.349 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.41 ' NE2' ' HA ' ' A' ' 68' ' ' PHE . 4.3 t60 -82.63 -39.21 22.45 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.256 0.55 . . . . 3.23 109.846 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.02 44.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.779 -0.646 . . . . 1.17 111.982 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.879 ' HD3' HD21 ' A' ' 136' ' ' LEU . 29.9 mmmt -75.76 -27.15 57.96 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.305 0.574 . . . . 2.27 110.438 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.82 -44.29 81.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.055 -0.975 . . . . 1.28 110.302 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.67 44.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.084 -0.507 . . . . 1.31 110.926 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.2 t30 82.64 37.19 0.05 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.657 1.218 . . . . 1.6 108.583 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.461 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 31.1 t -77.38 137.35 64.09 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 113.39 -1.732 . . . . 1.93 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.408 ' O ' HG12 ' A' ' 108' ' ' VAL . 16.7 Cg_exo -67.69 138.97 46.82 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.381 2.054 . . . . 0.66 111.321 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.444 ' C ' HG23 ' A' ' 145' ' ' THR . 0.8 OUTLIER -110.59 155.75 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 122.056 0.932 . . . . 1.34 112.196 -173.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.841 HD12 ' HB ' ' A' ' 146' ' ' ILE . 28.4 mm -122.44 82.19 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 113.753 -1.567 . . . . 1.12 107.278 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.912 HG23 HG22 ' A' ' 145' ' ' THR . 64.0 t -69.01 146.04 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 109.044 -0.724 . . . . 1.06 109.044 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.744 ' HB1' HD22 ' A' ' 150' ' ' LEU . . . -140.6 103.01 4.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.545 -1.207 . . . . 1.07 110.111 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.816 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.5 mp -69.02 136.11 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.066 -1.425 . . . . 1.29 108.444 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 62.9 t30 -123.62 167.07 14.44 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.486 -1.302 . . . . 1.85 107.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.734 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 85.7 mttt 69.55 31.99 3.52 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 124.036 0.835 . . . . 1.18 111.047 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.822 ' HE3' ' HG3' ' A' ' 124' ' ' PRO . 75.6 mmm -85.11 -3.81 58.93 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.84 0.829 . . . . 1.64 108.914 173.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 4.1 p-10 -68.16 -33.1 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.269 -1.332 . . . . 0.76 109.061 168.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.59 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 25.4 mtpp -72.25 129.94 86.9 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 114.814 -1.085 . . . . 1.74 110.202 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.52 -13.99 42.2 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 122.406 2.071 . . . . 0.68 110.788 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -82.47 -1.99 52.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 1.45 110.298 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.417 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -61.36 130.19 44.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.985 -1.007 . . . . 1.1 111.333 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.95 76.64 66.68 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.627 -0.879 . . . . 0.95 108.627 174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.822 ' HG3' ' HE3' ' A' ' 117' ' ' MET . 56.8 Cg_endo -66.71 -53.93 0.5 Allowed 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.77 2.314 . . . . 0.54 113.311 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.55 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.0 m-20 -53.93 -29.21 41.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.22 -0.9 . . . . 1.44 110.115 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -75.95 -56.92 4.21 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.798 -0.761 . . . . 4.56 109.485 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.778 HG23 ' HA ' ' A' ' 88' ' ' ALA . 24.9 m -62.77 -29.03 46.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.424 -0.807 . . . . 1.26 112.033 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.55 ' SD ' ' HA ' ' A' ' 125' ' ' ASP . 18.2 ptm -73.05 -23.77 60.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.518 -0.473 . . . . 1.64 110.219 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -70.73 -32.24 69.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.615 -0.266 . . . . 2.0 110.694 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 3.1 mm-40 -64.23 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.844 0.83 . . . . 1.64 109.719 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.594 HD13 HD11 ' A' ' 136' ' ' LEU . 4.2 mm? -64.03 -41.52 97.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.309 -0.86 . . . . 1.96 109.658 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.735 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 1.6 mtm -72.83 -13.91 61.39 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 119.652 -0.819 . . . . 2.05 110.692 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 5.1 mm-40 -68.49 -26.73 65.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.396 -1.335 . . . . 1.67 107.396 173.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.606 ' HB3' HG23 ' A' ' 100' ' ' ILE . 78.9 m-85 -108.74 33.72 4.06 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.407 -1.269 . . . . 1.58 111.039 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 54.9 t30 61.71 43.01 10.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.631 -1.168 . . . . 1.42 112.013 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.879 HD21 ' HD3' ' A' ' 104' ' ' LYS . 36.1 mt -123.02 97.22 5.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.814 -0.63 . . . . 1.93 111.384 174.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 1.043 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 57.3 t -99.1 121.26 56.14 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 115.561 -0.745 . . . . 1.18 111.185 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.735 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 93.1 Cg_exo -41.86 142.72 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.373 3.382 . . . . 0.88 113.573 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.459 ' HB2' HD12 ' A' ' 146' ' ' ILE . 4.9 mm-40 -73.5 -16.12 61.29 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.514 -1.221 . . . . 3.08 109.81 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.563 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.2 pm0 -69.27 -21.87 63.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.834 . . . . 1.57 110.26 170.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.5 m0 -109.97 -18.21 13.43 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.082 0.468 . . . . 0.66 111.078 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.54 4.97 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.827 . . . . 0.57 113.506 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 1.043 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.23 -110.66 1.43 Allowed Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.39 -0.91 . . . . 0.6 111.909 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.407 ' C ' ' HG1' ' A' ' 145' ' ' THR . 8.7 p-10 -161.22 60.07 0.29 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 122.808 1.29 . . . . 1.91 111.485 173.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.912 HG22 HG23 ' A' ' 112' ' ' VAL . 58.5 m -164.1 119.8 1.58 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.87 -1.059 . . . . 1.1 111.201 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.841 ' HB ' HD12 ' A' ' 111' ' ' ILE . 22.5 mm -72.77 106.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.854 -0.795 . . . . 1.27 108.854 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.73 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.3 m-85 -88.78 116.63 27.18 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.203 -0.908 . . . . 0.53 110.863 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 85.3 m -102.01 115.71 31.14 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.816 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 37.9 mtpt -94.8 85.19 4.36 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.984 -0.746 . . . . 1.96 108.984 -176.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.966 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -121.99 -176.92 3.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.712 1.244 . . . . 1.49 113.192 -164.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.416 ' N ' HD13 ' A' ' 150' ' ' LEU . 1.2 p -149.35 108.39 3.9 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.579 -1.646 . . . . 2.07 108.358 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.493 ' HB2' ' O6 ' ' A' ' 179' ' ' GDP . . . -76.44 -15.43 59.92 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.193 0.52 . . . . 1.11 109.906 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -76.31 -51.39 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.766 -0.652 . . . . 2.78 111.432 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -79.14 -9.63 59.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.03 -0.668 . . . . 1.35 111.318 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp 66.77 43.69 2.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.919 0.866 . . . . 1.9 110.465 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 2.4 tt0 -105.16 -63.07 1.27 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.217 . . . . 2.48 109.912 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.966 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -78.16 -10.7 86.02 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 114.933 -1.03 . . . . 0.36 113.432 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.409 HD11 ' HB1' ' A' ' 152' ' ' ALA . 22.6 mt -67.15 -40.04 86.63 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 117.702 0.751 . . . . 1.42 110.11 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -73.14 -37.84 66.47 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.384 -0.826 . . . . 2.2 109.348 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 163' ' ' GLU . 83.2 t60 -70.41 -20.75 62.9 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.561 -0.745 . . . . 0.68 111.142 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.79 -54.2 30.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.184 0.516 . . . . 1.77 109.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.413 ' CD1' ' HD3' ' A' ' 32' ' ' LYS . 9.9 mt -55.98 -38.56 70.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.076 -0.965 . . . . 2.1 110.196 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 49.4 mt-10 -51.97 -52.72 48.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 2.57 110.972 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.824 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 15.0 mmt -69.79 -34.55 73.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.959 -0.564 . . . . 1.21 110.535 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.659 HG22 HD12 ' A' ' 57' ' ' ILE . 80.7 mt -61.17 -51.97 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 1.2 111.192 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 169' ' ' SER . 4.1 pp -66.19 -33.22 75.28 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 121.032 -0.267 . . . . 2.3 111.176 -177.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.8 tp -54.06 -51.34 64.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.895 -0.593 . . . . 2.11 109.634 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 164' ' ' MET . 61.1 t -65.38 -39.85 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.757 -0.656 . . . . 1.41 110.793 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 166' ' ' LEU . 34.9 t -62.09 -21.33 64.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.829 0.307 . . . . 1.82 111.829 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -104.96 -20.18 13.62 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.118 -0.364 . . . . 2.73 111.268 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 49.3 ttp -74.07 -13.5 60.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.921 0.391 . . . . 2.12 110.531 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.5 -20.78 66.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.938 0.399 . . . . 4.27 110.417 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.46 -15.9 17.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.282 0.563 . . . . 3.91 109.725 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.9 mt -134.33 48.57 2.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.7 -0.682 . . . . 6.06 111.233 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.555 ' H ' ' HD2' ' A' ' 175' ' ' LYS . 9.2 mptt -41.55 130.36 3.12 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.002 0.521 . . . . 5.86 112.361 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -87.19 34.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 5.79 111.486 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 25.6 t-20 -92.49 120.39 67.49 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.096 -0.502 . . . . 8.44 110.444 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 8.2 Cg_exo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 123.154 2.569 . . . . 9.2 111.587 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.734 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.818 -0.513 . . . . 11.83 111.818 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -79.96 60.7 3.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.06 0.457 . . . . 10.75 111.641 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -83.48 -59.8 2.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.114 -0.494 . . . . 10.82 110.779 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.9 ptp -74.32 -7.12 51.75 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.918 -0.583 . . . . 9.01 111.889 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.4 t -66.92 -65.79 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.025 0.441 . . . . 6.14 110.671 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.1 129.1 17.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.928 -0.578 . . . . 5.7 110.476 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -118.32 96.59 49.99 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.566 -0.743 . . . . 7.55 110.007 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.76 128.67 17.33 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.667 2.245 . . . . 3.21 112.114 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.481 ' HB3' ' O ' ' A' ' 79' ' ' THR . 19.2 Cg_endo -59.6 136.44 71.06 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.046 2.498 . . . . 3.14 111.785 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.86 144.32 11.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.551 -0.537 . . . . 2.53 109.551 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.7 t -112.86 93.24 2.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.451 -0.574 . . . . 1.95 109.451 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 61.8 m -78.48 123.11 26.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.909 -0.587 . . . . 1.27 111.293 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -93.18 108.49 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.922 0.391 . . . . 1.83 110.256 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.643 ' HE3' ' HB2' ' A' ' 68' ' ' PHE . 45.1 mtm -130.22 172.8 11.41 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.887 -0.412 . . . . 1.28 109.887 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.81 -157.14 27.1 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.013 -0.835 . . . . 0.34 111.013 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.809 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 46.9 t60 -94.6 160.4 14.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.116 0.96 . . . . 0.28 111.839 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.87 152.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.31 -1.314 . . . . 1.09 110.489 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.712 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 18.3 t70 73.44 -20.75 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.205 0.602 . . . . 0.69 110.162 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 17' ' ' VAL . 22.3 m170 -71.6 -20.75 61.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.079 -1.082 . . . . 0.63 108.079 167.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 112.83 58.41 0.42 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.34 -0.846 . . . . 0.79 113.778 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 14' ' ' MET . 2.9 tppp? -58.11 -62.78 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.628 0.714 . . . . 3.69 111.088 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 p -72.08 -40.75 68.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 1.76 111.845 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -27.66 69.05 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.937 -0.574 . . . . 1.71 112.087 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -70.28 -57.31 5.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.441 0.639 . . . . 2.09 109.574 -175.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.911 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -66.18 -12.39 55.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.747 -1.115 . . . . 2.23 111.136 -178.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.77 -37.46 9.46 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.807 0.813 . . . . 1.23 109.678 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.23 70.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.781 -1.1 . . . . 1.23 109.494 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.849 HG22 ' HH ' ' A' ' 48' ' ' TYR . 7.6 tt -72.11 -23.29 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.713 -1.131 . . . . 1.59 110.057 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.577 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 99.9 mtt180 -65.2 -48.25 74.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.816 0.817 . . . . 3.51 109.18 170.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -85.84 28.33 0.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.623 -1.171 . . . . 3.14 110.955 -172.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 9.9 t -102.38 -42.59 5.94 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.514 -1.221 . . . . 1.96 108.579 176.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 31' ' ' SER . 46.7 pttt 179.89 -167.33 0.09 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.421 -0.809 . . . . 4.37 109.152 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.616 HG11 ' H ' ' A' ' 34' ' ' THR . 4.3 p 50.65 -73.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.004 1.322 . . . . 3.59 112.492 -171.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.782 HG22 ' HB1' ' A' ' 38' ' ' ALA . 18.8 p -82.46 145.3 29.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.947 0.403 . . . . 2.99 110.377 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -96.39 -48.39 5.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.392 0.615 . . . . 6.34 109.887 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -136.93 -78.3 0.4 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.244 -0.889 . . . . 7.38 109.204 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -120.7 126.31 49.88 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.388 -0.824 . . . . 6.24 109.541 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.782 ' HB1' HG22 ' A' ' 34' ' ' THR . . . -171.35 172.51 5.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.387 -0.37 . . . . 5.33 110.389 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.08 -16.25 3.0 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.823 -0.703 . . . . 4.68 111.885 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.79 155.48 9.34 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.191 -0.528 . . . . 5.06 111.85 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.99 101.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.776 -0.824 . . . . 5.91 108.776 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 44' ' ' HIS . 15.1 t -143.27 -176.83 5.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.736 -0.665 . . . . 6.29 110.314 -174.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -102.67 21.37 15.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.087 -0.506 . . . . 6.97 111.927 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.453 ' H ' HG22 ' A' ' 42' ' ' THR . 30.1 p80 -135.68 115.95 13.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.015 0.436 . . . . 7.26 110.43 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.7 pt -93.59 -175.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.014 -0.539 . . . . 5.68 109.92 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.24 -80.08 0.62 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.79 -0.719 . . . . 2.62 112.37 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.911 ' HA ' HD13 ' A' ' 25' ' ' LEU . . . -82.2 156.82 24.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.402 0.144 . . . . 1.8 111.206 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.849 ' HH ' HG22 ' A' ' 28' ' ' ILE . 1.3 p90 -165.57 -178.91 5.13 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.625 -0.43 . . . . 1.92 111.334 -166.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 89.8 mt-30 -114.47 120.67 41.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 2.22 110.39 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 57' ' ' ILE . 32.7 m -89.25 153.56 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.279 0.561 . . . . 2.09 111.536 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.736 HG22 ' HA ' ' A' ' 54' ' ' ASP . 99.2 m -103.64 91.55 4.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.815 -0.63 . . . . 1.99 111.306 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.477 HG22 ' N ' ' A' ' 53' ' ' ASN . 26.8 m -87.62 -36.85 10.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.047 -1.094 . . . . 2.62 108.047 167.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.477 ' N ' HG22 ' A' ' 52' ' ' VAL . 2.7 p30 -119.61 -63.77 1.34 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.659 -1.61 . . . . 4.06 108.899 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.736 ' HA ' HG22 ' A' ' 51' ' ' THR . 23.8 t0 -169.05 81.67 0.13 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.896 -1.047 . . . . 2.99 109.867 167.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' H ' ' HA ' ' A' ' 51' ' ' THR . 47.6 mttp 60.21 31.8 20.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.274 -0.875 . . . . 7.77 112.945 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.847 ' O ' HG13 ' A' ' 57' ' ' ILE . 47.0 mttp -108.0 76.05 1.03 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.29 -0.564 . . . . 4.8 110.964 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.847 HG13 ' O ' ' A' ' 56' ' ' LYS . 66.4 mt 177.36 106.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.485 1.914 . . . . 1.6 106.838 169.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.429 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 14.0 m -102.9 96.11 6.61 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.451 -0.5 . . . . 1.48 110.584 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.675 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 79.1 m-85 -74.16 108.39 6.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.919 -0.771 . . . . 1.63 108.919 174.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.661 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 58.7 tp -122.65 143.11 49.98 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.414 0.446 . . . . 3.67 110.723 -173.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -140.3 114.51 9.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.515 0.198 . . . . 5.61 111.052 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.93 ' HA ' ' HA ' ' A' ' 67' ' ' ALA . 6.8 m 56.87 68.23 2.22 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 124.024 0.827 . . . . 5.77 112.175 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 66' ' ' GLU . 76.1 Cg_endo -77.87 63.71 8.13 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.609 2.206 . . . . 6.26 112.754 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.04 -86.93 0.54 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.55 -0.833 . . . . 6.42 112.696 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -97.03 -72.46 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 9.55 111.171 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 63' ' ' PRO . 14.3 mm-40 -89.91 128.35 36.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.889 -0.596 . . . . 7.05 110.207 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.93 ' HA ' ' HA ' ' A' ' 62' ' ' THR . . . -58.33 -43.12 88.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.718 -1.128 . . . . 5.07 111.909 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.643 ' HB2' ' HE3' ' A' ' 14' ' ' MET . 9.1 t80 -112.63 127.58 56.14 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.761 -0.459 . . . . 2.66 109.761 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.404 ' O ' ' HB ' ' A' ' 70' ' ' THR . 18.1 m -87.72 156.3 19.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.193 -0.458 . . . . 5.25 110.769 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 74' ' ' ARG . 76.4 m 76.93 78.28 0.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.464 0.649 . . . . 6.21 111.591 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.516 ' HG3' ' HA ' ' A' ' 106' ' ' ALA . 49.4 ttm -117.2 -63.54 1.43 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.842 -0.617 . . . . 5.21 109.563 171.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -109.1 2.03 20.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.854 -0.612 . . . . 8.75 109.735 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.55 -10.39 59.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.381 -0.827 . . . . 6.65 110.598 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.435 ' HB2' HG23 ' A' ' 70' ' ' THR . 8.8 tpp180 -123.73 125.45 44.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.027 -0.533 . . . . 10.34 109.707 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.88 117.81 4.49 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.794 -0.717 . . . . 5.22 113.122 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.59 -74.76 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.453 0.701 . . . . 5.89 112.749 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -95.19 107.91 20.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.765 0.317 . . . . 6.97 110.837 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.516 HG13 ' H ' ' A' ' 80' ' ' ASP . 57.2 t -66.51 135.79 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 4.68 110.571 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 9' ' ' PRO . 12.5 p -104.78 -2.48 24.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.092 -0.503 . . . . 3.84 112.263 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.516 ' H ' HG13 ' A' ' 78' ' ' VAL . 7.1 m-20 -119.75 173.97 6.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.768 -0.196 . . . . 2.66 110.591 -173.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.1 mt -135.46 146.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.166 0.291 . . . . 1.38 110.923 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.58 138.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-O 121.771 0.796 . . . . 1.79 111.147 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 6.3 mt -98.17 132.48 43.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.961 -1.018 . . . . 1.14 110.372 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.616 HD13 HG12 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -107.77 107.26 17.95 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.463 -0.79 . . . . 1.65 110.108 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.59 94.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.152 0.501 . . . . 1.14 110.472 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.616 HG12 HD13 ' A' ' 84' ' ' LEU . 11.4 m -111.29 123.35 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.008 -0.542 . . . . 1.31 111.032 175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.525 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -71.68 130.31 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.161 -0.472 . . . . 1.01 109.752 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.746 ' HB3' ' CG2' ' A' ' 114' ' ' ILE . . . -68.4 -19.37 64.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.055 0.455 . . . . 1.07 111.59 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.39 -14.45 46.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.754 -0.657 . . . . 0.58 110.649 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.442 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 6.6 t70 -118.21 -55.04 2.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.56 110.362 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.38 -128.47 9.58 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.965 -0.562 . . . . 0.37 113.319 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.423 HG23 ' HE2' ' A' ' 134' ' ' TYR . 8.7 p -103.86 136.94 34.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.675 0.75 . . . . 1.78 109.845 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.676 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.9 mmm -140.08 176.73 2.35 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.772 -1.104 . . . . 1.07 108.74 -171.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.676 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.9 Cg_exo -41.35 -66.96 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.15 2.567 . . . . 0.89 114.552 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.46 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.6 pt20 -74.11 -15.4 61.05 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.22 0.533 . . . . 0.78 111.114 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.809 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.7 -43.71 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.119 -0.697 . . . . 1.07 109.119 176.458 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 93' ' ' MET . 22.7 t -66.78 -41.83 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.237 -0.892 . . . . 2.02 111.164 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -56.45 -32.06 64.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.484 . . . . 2.35 110.424 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.53 -31.93 69.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.676 -0.693 . . . . 1.12 110.638 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.604 HG23 HD11 ' A' ' 136' ' ' LEU . 96.7 mt -77.94 -44.65 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.564 0.697 . . . . 1.14 109.371 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -57.41 -38.25 74.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.523 -1.217 . . . . 0.75 110.808 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.455 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 5.1 t60 -68.79 -34.54 75.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.058 0.456 . . . . 3.23 109.872 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.96 -48.91 16.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.015 -0.538 . . . . 1.17 111.932 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.634 ' HD3' HD23 ' A' ' 136' ' ' LEU . 14.0 mmmm -66.46 -38.37 87.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.03 0.443 . . . . 2.27 110.018 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.91 -35.81 71.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 1.28 111.04 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.516 ' HA ' ' HG3' ' A' ' 71' ' ' MET . . . -79.99 -32.71 39.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.508 -0.314 . . . . 1.31 111.301 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 83.35 42.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.36 1.076 . . . . 1.6 108.902 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 109' ' ' PRO . 1.7 p -103.76 142.86 25.47 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 114.077 -1.419 . . . . 1.93 111.208 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.438 ' O ' HG23 ' A' ' 108' ' ' VAL . 22.1 Cg_exo -65.17 142.27 73.06 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.361 2.041 . . . . 0.66 111.722 171.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 111' ' ' ILE . 1.3 mt -110.82 163.79 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.443 0.64 . . . . 1.34 111.782 -171.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.837 HD12 ' HB ' ' A' ' 146' ' ' ILE . 15.9 mm -142.09 84.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 N-CA-C 106.747 -1.575 . . . . 1.12 106.747 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.846 HG22 HG21 ' A' ' 145' ' ' THR . 63.1 t -76.02 152.27 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 CA-C-N 114.316 -1.311 . . . . 1.06 109.815 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.882 ' HB2' HD23 ' A' ' 150' ' ' LEU . . . -143.51 101.5 3.79 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.554 -1.203 . . . . 1.07 109.739 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.819 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.6 mp -68.65 133.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 114.106 -1.406 . . . . 1.29 108.722 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 64.6 t30 -120.37 166.84 12.99 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.125 -1.435 . . . . 1.85 107.125 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.673 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 81.5 mttt 68.42 31.66 4.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 O-C-N 124.242 0.964 . . . . 1.18 111.672 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.74 ' HE2' ' HG3' ' A' ' 124' ' ' PRO . 82.6 mmm -80.99 -6.94 59.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.466 -0.788 . . . . 1.64 109.378 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -65.5 -32.49 74.12 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.068 -0.969 . . . . 0.76 108.595 169.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.485 ' HB3' ' OE1' ' A' ' 121' ' ' GLU . 26.8 mtpp -77.56 131.37 71.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.856 -1.52 . . . . 1.74 110.724 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.78 -18.17 59.12 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.538 2.159 . . . . 0.68 111.402 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.485 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 15.3 mp0 -68.7 -22.26 64.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.257 -0.883 . . . . 1.45 110.394 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.474 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -40.93 123.62 1.98 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.556 -1.202 . . . . 1.1 112.631 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.2 75.94 79.61 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.959 -1.126 . . . . 0.95 107.959 173.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.799 ' O ' ' HG3' ' A' ' 128' ' ' MET . 33.1 Cg_endo -61.15 -60.37 0.24 Allowed 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 122.806 2.337 . . . . 0.54 113.193 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.408 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 5.1 m-20 -49.15 -27.59 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.859 0.724 . . . . 1.44 110.753 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 129' ' ' GLN . 41.8 ttp180 -77.49 -53.3 7.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.756 -0.656 . . . . 4.56 110.031 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 88' ' ' ALA . 19.5 m -64.36 -20.62 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.659 -0.701 . . . . 1.26 112.219 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.799 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 37.3 mtp -71.45 -35.68 70.97 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.647 0.737 . . . . 1.64 109.131 171.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.561 ' O ' ' HG2' ' A' ' 132' ' ' MET . 46.2 mt-30 -66.65 -35.11 79.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.718 -1.128 . . . . 2.0 110.956 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 127' ' ' VAL . 18.8 mm-40 -57.53 -50.07 74.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.924 0.868 . . . . 1.64 109.835 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.69 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 10.7 mp -65.01 -34.27 78.05 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.998 -1.001 . . . . 1.96 110.917 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.572 ' SD ' ' HZ3' ' A' ' 141' ' ' TRP . 14.6 ptm -73.25 -11.27 60.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.974 -0.691 . . . . 2.05 110.65 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.72 -28.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.515 -0.92 . . . . 1.67 108.515 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.423 ' HE2' HG23 ' A' ' 92' ' ' VAL . 45.4 m-85 -90.12 23.24 2.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.187 -0.915 . . . . 1.58 109.408 167.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.3 t30 52.38 54.44 10.69 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 114.014 -1.448 . . . . 1.42 111.737 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 131' ' ' LEU . 78.9 mt -117.98 98.09 6.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.844 -1.071 . . . . 1.93 109.131 169.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 1.004 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 40.3 t -100.19 118.95 60.45 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.031 -0.532 . . . . 1.18 111.156 -171.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.646 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.4 Cg_exo -42.82 144.04 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 124.306 3.337 . . . . 0.88 112.798 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 146' ' ' ILE . 2.3 mm-40 -72.77 -20.66 61.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.426 -1.261 . . . . 3.08 110.056 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 2.4 pm0 -68.76 -22.59 64.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.341 -0.845 . . . . 1.57 110.232 171.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.572 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 31.2 m0 -103.89 -15.76 15.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.66 110.333 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.39 23.44 9.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.57 113.736 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 1.004 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.86 -107.42 0.73 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.107 -1.044 . . . . 0.6 112.469 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -164.56 61.03 0.14 Allowed 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.664 1.221 . . . . 1.91 111.316 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.846 HG21 HG22 ' A' ' 112' ' ' VAL . 60.7 m -163.94 111.68 1.15 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.447 -1.252 . . . . 1.1 110.225 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.837 ' HB ' HD12 ' A' ' 111' ' ' ILE . 12.9 mm -68.21 105.12 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 109.026 -0.731 . . . . 1.27 109.026 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.646 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 7.7 m-85 -86.37 114.19 22.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.346 -0.843 . . . . 0.53 110.454 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 73.2 m -100.36 113.69 26.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 1.0 110.74 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.735 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.0 mttt -85.72 101.07 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.581 -0.526 . . . . 1.96 109.581 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.92 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.6 pp -133.03 -172.44 2.93 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 123.236 1.493 . . . . 1.49 113.404 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.502 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 13.5 t -159.71 117.05 2.63 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 112.811 -1.995 . . . . 2.07 106.389 172.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.03 -16.95 62.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.059 -0.719 . . . . 1.11 109.059 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.587 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 6.2 tmtt? -69.82 -54.12 15.06 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.732 -1.122 . . . . 2.78 110.635 176.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 2.3 p -80.61 -12.35 59.51 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.51 -0.476 . . . . 1.35 111.69 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.525 ' HD3' HD13 ' A' ' 158' ' ' LEU . 19.5 mmtp 67.44 41.63 2.36 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.589 -0.732 . . . . 1.9 110.617 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.649 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -97.37 -63.88 1.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.339 1.066 . . . . 2.48 110.442 -173.025 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.92 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -86.45 1.88 87.37 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.167 -1.016 . . . . 0.36 113.199 -172.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.525 HD13 ' HD3' ' A' ' 155' ' ' LYS . 27.5 mt -70.57 -42.19 71.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.0 0.9 . . . . 1.42 109.019 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -77.73 -34.81 52.43 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.44 -0.8 . . . . 2.2 109.618 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.491 ' HA ' ' OE2' ' A' ' 163' ' ' GLU . 81.6 t60 -69.4 -25.85 64.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.565 -0.454 . . . . 0.68 111.121 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.94 -53.08 60.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.36 0.6 . . . . 1.77 109.484 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 12.4 mt -54.89 -44.23 73.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.688 -1.142 . . . . 2.1 109.742 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.491 ' OE2' ' HA ' ' A' ' 160' ' ' HIS . 40.8 mt-10 -46.76 -53.81 11.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.197 0.936 . . . . 2.57 111.189 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.732 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 20.2 mmt -72.26 -39.72 68.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 1.21 111.051 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 83' ' ' ILE . 69.1 mt -60.13 -49.94 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 1.2 111.294 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.1 pp -70.89 -31.83 68.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.844 -0.342 . . . . 2.3 111.153 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 171' ' ' MET . 2.6 tm? -54.2 -50.53 66.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 2.11 108.856 172.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.528 ' O ' ' HG2' ' A' ' 171' ' ' MET . 97.3 t -62.17 -45.11 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 115.819 -0.628 . . . . 1.41 110.559 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.712 ' HA ' ' HB1' ' A' ' 176' ' ' ALA . 38.4 m -58.88 -43.58 90.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.683 0.623 . . . . 1.82 112.683 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.418 ' HG2' HD13 ' A' ' 174' ' ' LEU . 47.0 mt-10 -102.75 0.48 32.94 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.597 0.591 . . . . 2.73 112.597 -171.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 27.2 ptt? -63.89 -37.42 87.32 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.955 -0.298 . . . . 2.12 111.478 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -96.12 -79.69 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.606 -0.438 . . . . 4.27 110.498 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -114.84 -90.63 0.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.888 -0.725 . . . . 3.91 111.031 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.418 HD13 ' HG2' ' A' ' 170' ' ' GLU . 26.8 tp -144.03 6.43 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.401 0.619 . . . . 6.06 110.112 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -130.23 8.09 5.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.674 -0.693 . . . . 5.86 112.02 -166.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.712 ' HB1' ' HA ' ' A' ' 169' ' ' SER . . . 58.82 -87.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.569 0.543 . . . . 5.79 111.619 -175.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 63.5 t30 63.9 99.36 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 123.615 0.766 . . . . 8.44 111.102 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo . . . . . 0 C--O 1.247 0.943 0 C-N-CA 122.884 2.389 . . . . 9.2 112.001 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.712 " H5'" ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.108 -0.397 . . . . 11.83 112.108 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m -131.57 165.47 23.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.323 -0.251 . . . . 10.75 110.323 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 66.49 82.01 0.19 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.662 0.601 . . . . 10.82 110.723 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.9 ttp 60.09 88.39 0.08 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.673 -0.694 . . . . 9.01 110.479 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.54 134.18 62.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.774 -0.648 . . . . 6.14 110.073 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.29 106.86 4.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.043 -0.526 . . . . 5.7 110.587 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.707 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 20.3 mmm180 -106.24 -49.09 0.11 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.007 -0.542 . . . . 7.55 110.577 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HD2' ' H ' ' A' ' 7' ' ' ARG . 24.8 Cg_endo -63.63 124.17 13.24 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.677 1.585 . . . . 3.21 111.495 173.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.503 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 36.3 Cg_endo -64.83 153.64 76.88 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.086 2.524 . . . . 3.14 112.829 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 60' ' ' LEU . 6.8 p -85.84 85.44 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.045 0.926 . . . . 2.53 109.967 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 94.1 t -54.51 109.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.774 -1.103 . . . . 1.95 111.485 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 33.4 m -85.19 136.3 33.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.783 -0.644 . . . . 1.27 110.827 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.31 113.95 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 1.83 109.95 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.84 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 53.3 mtt -126.5 163.94 22.25 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.072 -0.513 . . . . 1.28 109.637 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.48 -168.65 25.42 Favored Glycine 0 N--CA 1.431 -1.633 0 C-N-CA 120.828 -0.701 . . . . 0.34 111.437 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.833 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 52.1 t60 -88.51 157.89 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.893 0.854 . . . . 0.28 111.385 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.501 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.4 p -71.75 153.94 7.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.587 -1.188 . . . . 1.09 109.981 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.513 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 20.2 t70 74.85 -21.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.361 0.601 . . . . 0.69 110.514 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.545 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.2 m170 -80.3 -7.38 59.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.342 -0.984 . . . . 0.63 108.342 170.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.479 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 113.07 60.88 0.42 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.537 -0.839 . . . . 0.79 114.048 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -59.29 -76.32 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.355 0.577 . . . . 3.69 110.913 171.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 m -84.79 -32.46 23.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.864 0.364 . . . . 1.76 110.873 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.479 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.57 -31.17 63.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.382 0.512 . . . . 1.71 112.382 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.467 HD22 HG23 ' A' ' 85' ' ' VAL . 12.5 tp -73.67 -40.15 63.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.508 -0.553 . . . . 2.09 109.508 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' HA ' HG22 ' A' ' 28' ' ' ILE . 2.9 tp -72.17 -9.52 58.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.654 -0.703 . . . . 2.23 110.562 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -94.99 -43.31 8.21 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.458 -0.941 . . . . 1.23 108.458 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.52 78.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.046 -1.434 . . . . 1.23 110.065 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 7.6 tt -72.73 -32.99 42.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.975 -1.011 . . . . 1.59 110.354 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -65.86 -45.42 82.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.483 0.659 . . . . 3.51 109.926 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -84.36 24.75 0.94 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.845 -1.071 . . . . 3.14 111.373 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.7 t -113.24 -34.42 5.66 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.94 -1.027 . . . . 1.96 110.786 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.474 ' HZ1' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -172.98 -179.58 2.06 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.865 -0.42 . . . . 4.37 109.865 -176.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.541 HG13 ' HA ' ' A' ' 50' ' ' VAL . 7.7 p 49.93 -69.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.444 1.497 . . . . 3.59 113.278 -175.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.507 ' H ' HG11 ' A' ' 33' ' ' VAL . 16.9 p -86.67 136.5 33.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.805 0.336 . . . . 2.99 110.927 -177.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.664 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 7.6 pt-20 -114.66 -151.37 0.48 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.234 -0.439 . . . . 6.34 110.474 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.432 ' H ' ' HB2' ' A' ' 35' ' ' GLU . 81.9 mm-40 -76.88 -53.7 7.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 7.38 110.814 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -86.89 120.66 28.4 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.33 -0.619 . . . . 6.24 109.33 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 66.57 27.5 9.58 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.454 0.645 . . . . 5.33 110.785 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 35' ' ' GLU . . . -89.01 79.78 1.6 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.734 -0.666 . . . . 4.68 112.976 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.19 6.95 66.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.772 -0.728 . . . . 5.06 112.946 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.6 tp -86.52 110.81 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.474 0.655 . . . . 5.91 110.389 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 43' ' ' GLN . 17.5 m -145.77 166.94 24.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.015 -0.735 . . . . 6.29 109.015 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.426 ' N ' HG22 ' A' ' 42' ' ' THR . 69.8 mt-30 -49.17 -49.55 42.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.076 0.465 . . . . 6.97 110.83 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -95.13 97.05 9.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.234 0.54 . . . . 7.26 109.797 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 45' ' ' ILE . 2.1 pp -80.47 179.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.875 -0.602 . . . . 5.68 111.71 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.19 -81.36 0.5 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.489 -0.644 . . . . 2.62 111.489 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 59' ' ' PHE . . . -90.77 177.66 6.26 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.216 -0.29 . . . . 1.8 110.216 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.434 ' CZ ' HG21 ' A' ' 50' ' ' VAL . 2.3 p90 -169.07 171.48 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.425 -0.51 . . . . 1.92 110.813 -170.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -100.51 136.23 40.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.877 -0.601 . . . . 2.22 109.652 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.541 ' HA ' HG13 ' A' ' 33' ' ' VAL . 14.6 t -101.63 155.73 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.459 0.647 . . . . 2.09 111.698 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.756 HG22 ' HA ' ' A' ' 54' ' ' ASP . 60.2 m -159.26 83.9 0.78 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.063 -0.972 . . . . 1.99 108.963 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 53' ' ' ASN . 2.8 p -63.67 -54.03 37.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.695 0.759 . . . . 2.62 109.123 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.622 ' H ' HG12 ' A' ' 52' ' ' VAL . 84.6 m-20 -123.63 -57.75 1.63 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 114.214 -1.357 . . . . 4.06 107.447 174.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.756 ' HA ' HG22 ' A' ' 51' ' ' THR . 18.1 t70 -170.64 77.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.566 -1.197 . . . . 2.99 109.686 164.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.644 ' HE3' HD11 ' A' ' 166' ' ' LEU . 75.3 mmtt -128.86 90.44 3.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.034 -1.098 . . . . 7.77 108.034 172.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -71.08 81.2 0.68 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.758 0.661 . . . . 4.8 111.13 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.48 HD11 HG21 ' A' ' 165' ' ' ILE . 16.4 mt -102.0 117.6 47.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.496 -0.774 . . . . 1.6 109.857 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -93.8 95.78 9.34 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.553 -0.536 . . . . 1.48 109.553 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.565 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 33.6 m-85 -66.56 151.2 47.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.819 -0.628 . . . . 1.63 110.544 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.659 ' HB2' HG23 ' A' ' 10' ' ' VAL . 35.6 tp -111.29 153.61 25.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.792 -0.447 . . . . 3.67 109.792 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 62' ' ' THR . 6.8 p-10 -70.96 -93.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.07 0.396 . . . . 5.61 112.07 -175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.524 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 2.4 t -171.77 82.58 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.5 0.667 . . . . 5.77 110.101 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.1 -56.06 2.15 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.249 2.633 . . . . 6.26 113.492 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.0 -122.78 2.93 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.39 -0.909 . . . . 6.42 112.758 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -74.52 -40.84 61.51 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.9 0.381 . . . . 9.55 111.364 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -113.39 149.06 34.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.285 -0.416 . . . . 7.05 111.528 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 63.87 104.92 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.29 0 O-C-N 124.425 1.078 . . . . 5.07 113.299 170.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.426 ' HD2' ' CD2' ' A' ' 102' ' ' HIS . 1.7 p90 -97.78 24.01 7.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.655 0.74 . . . . 2.66 109.037 168.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t 170.65 174.3 0.06 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.463 -1.244 . . . . 5.25 108.257 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.9 m -80.66 74.71 7.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.774 -0.824 . . . . 6.21 108.774 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.1 tpp -76.06 60.79 1.47 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.542 -0.754 . . . . 5.21 111.274 -173.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.17 -11.65 14.21 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.569 -0.9 . . . . 8.75 108.569 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.91 -57.84 5.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.931 -1.031 . . . . 6.65 111.196 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 54.22 55.48 8.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.031 0.443 . . . . 10.34 110.272 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.06 -155.55 28.91 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.813 -0.708 . . . . 5.22 112.834 -174.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.67 98.1 10.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.62 0.247 . . . . 5.89 110.819 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 55.27 43.53 28.97 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.521 -0.763 . . . . 6.97 111.306 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.9 t -80.42 85.94 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.224 -1.028 . . . . 4.68 108.224 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -92.1 108.09 19.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.729 -0.668 . . . . 3.84 112.396 -170.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.503 ' HA ' ' CB ' ' A' ' 9' ' ' PRO . 21.8 m-20 -81.45 127.82 33.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.478 -0.934 . . . . 2.66 108.478 169.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.472 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt -89.9 138.57 19.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.275 -0.42 . . . . 1.38 110.654 -172.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.41 125.51 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 120.375 -0.53 . . . . 1.79 111.436 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.611 HG12 ' HB ' ' A' ' 111' ' ' ILE . 7.8 mt -87.49 130.19 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-N 115.62 -0.718 . . . . 1.14 109.923 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 HD11 HG12 ' A' ' 86' ' ' VAL . 2.0 tm? -114.08 107.36 15.54 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.289 -1.004 . . . . 1.65 108.289 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 HD22 ' A' ' 24' ' ' LEU . 39.5 t -90.72 110.14 21.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.369 -0.832 . . . . 1.14 110.746 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.703 HG22 HD11 ' A' ' 131' ' ' LEU . 1.7 m -120.49 124.92 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.792 -0.64 . . . . 1.31 110.58 174.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.706 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -65.51 131.38 46.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 1.01 109.87 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.77 ' HA ' HG23 ' A' ' 127' ' ' VAL . . . -73.77 -12.54 60.73 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.182 0.515 . . . . 1.07 110.395 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 1.3 p-10 -95.94 -8.73 33.08 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.576 -0.738 . . . . 0.58 110.847 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.13 -48.9 1.45 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.407 -0.36 . . . . 0.56 110.818 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.571 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.89 -146.08 19.01 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.37 113.538 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.488 HG22 ' CE2' ' A' ' 134' ' ' TYR . 9.9 p -82.13 140.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.571 0.701 . . . . 1.78 110.229 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.661 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.6 mmm -142.21 175.12 3.15 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.836 -1.075 . . . . 1.07 108.916 -173.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 75.0 Cg_exo -42.9 -59.07 1.08 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.197 2.598 . . . . 0.89 114.971 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.51 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.8 pt20 -79.42 -17.51 54.15 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 120.419 -0.513 . . . . 0.78 110.969 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.833 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.33 -43.23 91.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 1.07 109.334 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.469 HG11 ' CE1' ' A' ' 134' ' ' TYR . 32.3 t -60.47 -45.71 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.766 -1.107 . . . . 2.02 111.913 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.66 -31.79 66.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 2.35 110.638 -175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.84 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.01 -30.29 63.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 1.12 110.736 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.472 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.0 mt -77.11 -44.73 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.882 0.849 . . . . 1.14 108.775 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -63.63 -32.21 73.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.245 -1.343 . . . . 0.75 111.002 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.426 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 3.5 t-160 -63.04 -45.79 90.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.441 0.639 . . . . 3.23 109.626 173.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.546 ' CB ' HD13 ' A' ' 110' ' ' ILE . . . -78.42 -51.53 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 1.17 112.752 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 29.4 mmmt -68.34 -34.08 75.45 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.931 0.396 . . . . 2.27 110.753 -173.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.74 92.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.655 -0.702 . . . . 1.28 110.837 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.71 53.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.471 -0.332 . . . . 1.31 111.158 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 t30 86.09 47.33 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.232 1.013 . . . . 1.6 109.467 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -111.37 138.4 21.36 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.362 -1.29 . . . . 1.93 110.417 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 34.6 Cg_exo -62.5 144.83 95.26 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.863 2.376 . . . . 0.66 113.436 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.546 HD13 ' CB ' ' A' ' 103' ' ' ALA . 27.1 mm -106.12 160.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.076 -0.965 . . . . 1.34 110.696 -175.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.788 HD13 ' HB ' ' A' ' 146' ' ' ILE . 29.9 mm -124.46 83.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.101 -1.444 . . . . 1.12 107.101 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 1.084 HG23 HG21 ' A' ' 145' ' ' THR . 62.0 t -69.03 146.98 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.636 0.731 . . . . 1.06 109.049 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.571 ' HB2' HD23 ' A' ' 150' ' ' LEU . . . -148.01 102.93 3.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.45 -1.25 . . . . 1.07 110.073 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.743 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 2.8 mp -70.57 139.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-N 113.767 -1.56 . . . . 1.29 109.068 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.661 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.1 p-10 -121.19 175.8 5.93 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.081 -1.451 . . . . 1.85 107.081 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.711 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 83.6 mttt 69.87 30.97 3.57 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.742 0.651 . . . . 1.18 111.098 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.638 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 11.3 mmt -73.18 -14.95 61.45 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.328 1.061 . . . . 1.64 108.624 167.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.551 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 2.0 p-10 -72.63 -19.64 61.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.404 -1.725 . . . . 0.76 110.602 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.441 ' HB3' ' HE2' ' A' ' 119' ' ' LYS . 36.6 mtpt -89.32 144.42 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.775 -0.648 . . . . 1.74 110.684 176.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.25 -17.22 40.01 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.789 2.326 . . . . 0.68 111.694 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -85.45 8.59 18.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.455 -0.793 . . . . 1.45 111.032 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.14 112.36 1.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 1.1 110.743 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.802 HD21 ' HB2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -127.89 76.2 77.64 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.95 108.969 175.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.553 ' HG3' ' HE2' ' A' ' 117' ' ' MET . 37.8 Cg_endo -63.71 -58.03 0.31 Allowed 'Trans proline' 0 CA--C 1.507 -0.845 0 C-N-CA 123.177 2.584 . . . . 0.54 113.022 -174.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.448 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 16.5 t70 -45.6 -29.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.285 0.991 . . . . 1.44 110.93 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.802 ' HB2' HD21 ' A' ' 123' ' ' ASN . 10.5 ttp180 -82.26 -56.45 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 4.56 110.173 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.77 HG23 ' HA ' ' A' ' 88' ' ' ALA . 16.6 m -65.64 -29.92 48.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.719 -0.673 . . . . 1.26 111.387 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 1.059 ' HA ' HD13 ' A' ' 131' ' ' LEU . 4.4 ttt -71.12 -31.16 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.425 1.09 . . . . 1.64 110.56 176.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -73.06 -36.33 66.86 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.653 -0.419 . . . . 2.0 111.375 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.608 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.2 mt-10 -63.06 -28.88 70.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.61 1.195 . . . . 1.64 108.976 175.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 1.059 HD13 ' HA ' ' A' ' 128' ' ' MET . 90.9 mt -62.03 -39.23 91.58 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.4 -1.727 . . . . 1.96 109.585 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.68 ' SD ' ' HZ3' ' A' ' 141' ' ' TRP . 34.5 mtp -77.95 -15.92 58.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.308 0.484 . . . . 2.05 112.308 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.499 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 9.1 mm-40 -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.083 -1.08 . . . . 1.67 108.083 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.488 ' CE2' HG22 ' A' ' 92' ' ' VAL . 85.2 m-85 -104.64 22.87 14.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.888 -1.051 . . . . 1.58 110.635 172.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.9 t30 66.78 28.85 8.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.081 -1.418 . . . . 1.42 112.623 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -116.1 116.79 28.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.627 -0.879 . . . . 1.93 108.627 170.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.902 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 91.5 t -112.21 136.84 21.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 1.18 112.51 -167.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.781 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -45.79 127.92 10.53 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 124.205 3.27 . . . . 0.88 111.681 169.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.656 ' HG2' HD11 ' A' ' 146' ' ' ILE . 1.8 pp20? -73.27 -20.9 60.73 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.661 -0.866 . . . . 3.08 108.661 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.4 ' OE1' ' HB2' ' A' ' 147' ' ' PHE . 1.5 pm0 -59.01 -27.37 65.38 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.659 -0.7 . . . . 1.57 110.608 169.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.68 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 41.0 m0 -103.47 -11.79 17.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.919 0.39 . . . . 0.66 111.049 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.24 24.75 5.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.713 -0.756 . . . . 0.57 113.362 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.902 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.6 -120.22 2.21 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.6 111.952 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.422 ' C ' ' HG1' ' A' ' 145' ' ' THR . 12.3 p-10 -156.27 58.88 0.57 Allowed 'General case' 0 C--O 1.243 0.713 0 CA-C-O 122.293 1.044 . . . . 1.91 112.192 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 1.084 HG21 HG23 ' A' ' 112' ' ' VAL . 81.1 m -165.7 129.27 2.19 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.385 -0.825 . . . . 1.1 110.739 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.788 ' HB ' HD13 ' A' ' 111' ' ' ILE . 24.0 mm -72.78 105.03 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.081 -1.081 . . . . 1.27 108.081 168.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.781 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 9.0 m-85 -89.67 112.3 23.52 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.771 -0.65 . . . . 0.53 110.804 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.94 142.44 29.67 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.347 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.55 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 5.1 mmtp -117.64 96.83 5.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.286 -1.005 . . . . 1.96 108.286 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.746 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 4.0 pp -127.78 -175.71 3.55 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.903 1.335 . . . . 1.49 113.036 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.638 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 1.4 p -157.37 89.98 1.08 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 112.914 -1.948 . . . . 2.07 108.028 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.23 -15.26 63.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.256 0.551 . . . . 1.11 110.4 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.733 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 0.1 OUTLIER -77.8 -42.93 32.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.565 -0.743 . . . . 2.78 112.037 175.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 151' ' ' SER . 0.9 OUTLIER -87.34 -9.27 55.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.526 -0.869 . . . . 1.35 111.804 175.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 66.73 50.19 1.18 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.089 -0.959 . . . . 1.9 110.995 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -109.51 -65.82 1.11 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.702 1.239 . . . . 2.48 110.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.746 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -74.26 -4.05 67.42 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.054 -1.43 . . . . 0.36 113.897 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.8 mt -71.33 -37.62 71.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.044 0.922 . . . . 1.42 109.238 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.84 -40.47 79.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.219 -0.9 . . . . 2.2 109.431 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.605 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 83.7 t60 -74.93 -10.62 59.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.079 -0.51 . . . . 0.68 111.303 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.55 -55.21 5.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.384 0.611 . . . . 1.77 109.837 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.597 HD11 HG11 ' A' ' 52' ' ' VAL . 4.2 pp -62.89 -28.5 70.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.021 -0.99 . . . . 2.1 111.643 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.605 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 12.5 pt-20 -77.99 -27.3 49.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.847 -0.341 . . . . 2.57 111.23 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.879 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 14.8 mmt -74.53 -44.1 52.74 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.282 -0.636 . . . . 1.21 109.282 173.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.48 HG21 HD11 ' A' ' 57' ' ' ILE . 84.2 mt -58.19 -39.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.227 -0.897 . . . . 1.2 110.203 173.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.644 HD11 ' HE3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -59.7 -44.19 93.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.463 -0.79 . . . . 2.3 111.693 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 166' ' ' LEU . 27.2 tp -54.42 -43.02 71.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.555 0.693 . . . . 2.11 109.923 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.82 -41.1 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.991 -1.004 . . . . 1.41 110.859 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.7 m -65.13 -44.67 87.9 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.43 0.53 . . . . 1.82 112.43 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 10.5 pt-20 -103.18 3.73 36.04 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.452 0.538 . . . . 2.73 112.452 -171.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.6 ttm -44.83 -64.54 0.68 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.392 0.432 . . . . 2.12 112.14 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -97.4 -80.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 4.27 110.721 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.63 -80.22 0.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.637 0.732 . . . . 3.91 109.463 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 29.0 tp -134.09 34.52 3.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.798 -1.556 . . . . 6.06 106.798 171.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -162.82 151.6 14.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.554 -1.657 . . . . 5.86 109.039 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.72 -57.42 2.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.189 -0.46 . . . . 5.79 110.919 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 43.1 t30 69.82 101.59 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 123.569 0.543 . . . . 8.44 111.104 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.998 2.465 . . . . 9.2 112.149 -178.711 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.733 ' C2 ' ' HG3' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 111.751 -0.54 . . . . 11.83 111.751 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -64.02 -79.71 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.688 0.28 . . . . 10.75 111.208 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -100.88 -26.25 13.82 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.346 -0.613 . . . . 10.82 109.346 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -72.92 121.8 20.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 9.01 109.412 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.99 160.87 42.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.433 0.635 . . . . 6.14 112.431 -172.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -141.37 77.04 1.57 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.065 -0.97 . . . . 5.7 108.512 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 51.43 72.66 1.15 Allowed Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 115.666 -0.697 . . . . 7.55 110.95 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' N ' ' HD2' ' A' ' 9' ' ' PRO . 87.9 Cg_exo -47.94 -40.59 32.91 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.131 3.221 . . . . 3.21 115.672 -174.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 8' ' ' PRO . 30.2 Cg_endo -64.48 64.22 0.26 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.233 1.955 . . . . 3.14 113.365 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.2 t -95.18 83.04 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.075 -1.083 . . . . 2.53 108.075 171.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.54 HG11 ' HB ' ' A' ' 81' ' ' ILE . 2.9 m -90.32 146.64 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.081 0.467 . . . . 1.95 111.063 -169.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.78 ' HB ' HG21 ' A' ' 82' ' ' VAL . 90.5 m -94.68 125.96 39.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.861 -0.608 . . . . 1.27 110.704 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.696 HD12 ' HB3' ' A' ' 59' ' ' PHE . 66.7 mt -83.42 122.61 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 1.83 110.125 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.593 ' SD ' ' HB2' ' A' ' 99' ' ' ALA . 56.2 mtt -132.75 170.37 15.36 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.148 -0.686 . . . . 1.28 109.148 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.29 179.41 16.64 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.597 -0.811 . . . . 0.34 111.762 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.712 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 50.5 t60 -85.41 158.96 20.09 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.867 0.842 . . . . 0.28 111.631 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 19' ' ' HIS . 5.7 p -73.58 155.27 6.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.495 -1.23 . . . . 1.09 109.643 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.672 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 25.9 t70 72.92 -17.56 0.4 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.211 0.529 . . . . 0.69 110.661 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 17' ' ' VAL . 19.7 m170 -85.83 -6.57 59.07 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.001 -0.74 . . . . 0.63 109.001 171.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.781 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . 131.29 39.25 0.26 Allowed Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 118.972 -1.585 . . . . 0.79 115.066 170.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -52.36 -65.97 0.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.559 1.18 . . . . 3.69 111.51 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.68 HG23 HG21 ' A' ' 45' ' ' ILE . 85.9 m -89.51 -29.68 18.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 1.76 110.696 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.605 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.08 -33.92 69.59 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.777 0.658 . . . . 1.71 112.777 -176.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.781 HD22 ' HA3' ' A' ' 20' ' ' GLY . 3.8 mm? -76.14 -33.33 59.4 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 122.142 -0.349 . . . . 2.09 110.447 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.639 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 1.6 tp -72.73 -7.43 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.431 -0.508 . . . . 2.23 109.831 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.83 -47.96 4.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.939 0.876 . . . . 1.23 109.65 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.581 ' HB3' ' HB1' ' A' ' 152' ' ' ALA . . . -64.89 -42.58 94.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.213 -1.358 . . . . 1.23 110.434 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.657 HG22 ' HH ' ' A' ' 48' ' ' TYR . 84.9 mt -74.07 -31.71 30.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.231 -0.895 . . . . 1.59 109.943 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.639 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 17.4 tpp180 -62.1 -36.15 80.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.409 0.623 . . . . 3.51 109.8 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -103.15 24.18 11.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.073 -0.967 . . . . 3.14 111.431 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 83.5 p -87.37 -45.98 10.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.586 -1.265 . . . . 1.96 107.586 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HE3' ' O ' ' A' ' 51' ' ' THR . 57.5 pttt 178.84 -164.72 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.494 -1.23 . . . . 4.37 108.655 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 9.5 p 52.7 -62.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.36 1.464 . . . . 3.59 114.106 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.527 HG23 ' HB3' ' A' ' 38' ' ' ALA . 49.5 p -107.96 176.04 5.27 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.746 0.419 . . . . 2.99 111.128 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -140.52 -38.35 0.44 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.577 0.227 . . . . 6.34 110.591 171.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -149.17 -85.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 7.38 110.742 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.679 ' HG3' HD13 ' A' ' 41' ' ' ILE . 40.5 tt0 -91.39 83.11 5.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.098 0.475 . . . . 6.24 110.857 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.527 ' HB3' HG23 ' A' ' 34' ' ' THR . . . -155.43 132.79 10.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.641 -0.708 . . . . 5.33 109.662 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.44 -58.83 3.42 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.807 -0.711 . . . . 4.68 112.019 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.02 115.05 0.37 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.456 -0.878 . . . . 5.06 112.958 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.679 HD13 ' HG3' ' A' ' 37' ' ' GLU . 2.5 pp -145.33 149.21 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.475 -0.565 . . . . 5.91 109.475 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.3 m -155.44 -73.25 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.051 0.453 . . . . 6.29 110.373 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -162.37 -59.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.755 -0.831 . . . . 6.97 108.755 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -77.34 138.55 39.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.045 -1.094 . . . . 7.26 108.045 167.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.68 HG21 HG23 ' A' ' 22' ' ' THR . 2.5 pp -80.73 162.62 3.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.336 0.589 . . . . 5.68 111.389 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.24 -90.63 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.44 -1.064 . . . . 2.62 110.44 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.414 ' HB1' ' CA ' ' A' ' 60' ' ' LEU . . . -178.26 -167.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.513 0.197 . . . . 1.8 110.66 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.657 ' HH ' HG22 ' A' ' 28' ' ' ILE . 4.5 p90 -172.54 166.56 5.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.03 -0.532 . . . . 1.92 109.756 -175.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.24 107.06 15.53 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.755 -0.461 . . . . 2.22 109.755 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.59 153.74 3.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.267 0.556 . . . . 2.09 110.304 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.839 HG22 ' HA ' ' A' ' 54' ' ' ASP . 16.6 m -100.5 90.92 4.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.704 0.764 . . . . 1.99 111.01 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 53' ' ' ASN . 3.8 p -77.05 -48.8 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.02 -1.104 . . . . 2.62 108.02 168.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.573 ' H ' HG12 ' A' ' 52' ' ' VAL . 1.8 p30 -112.97 -56.26 2.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.713 -1.585 . . . . 4.06 107.495 168.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.839 ' HA ' HG22 ' A' ' 51' ' ' THR . 30.6 t70 -179.67 106.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.283 -1.326 . . . . 2.99 111.045 163.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' H ' ' HA ' ' A' ' 51' ' ' THR . 45.1 mmtm 66.28 55.76 0.84 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.531 -0.758 . . . . 7.77 111.148 174.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.627 ' HG3' HG13 ' A' ' 57' ' ' ILE . 3.2 tppp? -130.3 140.46 50.66 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.704 -0.85 . . . . 4.8 108.704 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.627 HG13 ' HG3' ' A' ' 56' ' ' LYS . 21.8 mt 70.64 83.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 123.89 0.744 . . . . 1.6 110.275 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.405 HG21 ' H ' ' A' ' 60' ' ' LEU . 7.4 m -76.97 107.16 9.12 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.612 -0.884 . . . . 1.48 108.612 173.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.696 ' HB3' HD12 ' A' ' 13' ' ' ILE . 8.3 m-85 -60.76 -5.6 1.37 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.355 -0.839 . . . . 1.63 112.08 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.414 ' CA ' ' HB1' ' A' ' 47' ' ' ALA . 57.7 tp -80.06 130.61 35.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 3.67 110.149 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 62' ' ' THR . 2.6 p30 -81.28 -163.57 0.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.861 -0.608 . . . . 5.61 111.143 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.679 ' HA ' ' SD ' ' A' ' 71' ' ' MET . 40.8 m 83.39 87.88 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.109 -0.951 . . . . 5.77 111.707 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -91.35 9.6 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.178 2.586 . . . . 6.26 111.799 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.54 -69.28 2.28 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.781 -0.645 . . . . 6.42 113.008 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -70.36 -65.17 0.76 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.823 0.305 . . . . 9.55 111.823 -174.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -75.28 143.1 43.17 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.76 -0.459 . . . . 7.05 109.76 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.54 ' HA ' ' SD ' ' A' ' 71' ' ' MET . . . -119.34 68.73 0.81 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.925 0.393 . . . . 5.07 110.977 -173.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' HB3' ' CE ' ' A' ' 14' ' ' MET . 80.1 m-85 -55.74 -68.22 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.34 -0.845 . . . . 2.66 112.335 -176.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.605 ' H ' ' HE2' ' A' ' 71' ' ' MET . 2.5 p -92.18 50.74 1.68 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 111.75 0.278 . . . . 5.25 111.75 -176.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 m 57.25 77.87 0.25 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.405 0.621 . . . . 6.21 110.743 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.679 ' SD ' ' HA ' ' A' ' 62' ' ' THR . 44.4 mtt -102.78 -66.42 0.93 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 5.21 110.158 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.623 ' HG3' ' H ' ' A' ' 73' ' ' ALA . 26.8 ptt180 -127.73 -78.01 0.57 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.273 -0.571 . . . . 8.75 111.236 170.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.623 ' H ' ' HG3' ' A' ' 72' ' ' ARG . . . -135.1 -75.84 0.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.09 0.405 . . . . 6.65 111.207 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HG2' ' N ' ' A' ' 75' ' ' GLY . 29.9 ttm180 -166.84 158.92 13.15 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.437 -0.949 . . . . 10.34 108.437 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.462 ' N ' ' HG2' ' A' ' 74' ' ' ARG . . . -164.29 -118.07 0.43 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.778 -1.201 . . . . 5.22 112.661 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.64 152.99 10.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.09 -0.337 . . . . 5.89 110.09 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.432 ' HG2' ' HZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -125.36 175.63 7.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.903 -0.589 . . . . 6.97 110.359 176.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.52 -68.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 4.68 110.412 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.4 m -148.92 81.43 1.44 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.222 0.534 . . . . 3.84 109.694 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -107.35 -177.9 3.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.46 -0.791 . . . . 2.66 109.559 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.54 ' HB ' HG11 ' A' ' 11' ' ' VAL . 23.0 mt -135.86 134.38 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.909 -0.404 . . . . 1.38 109.909 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.78 HG21 ' HB ' ' A' ' 12' ' ' THR . 18.7 t -115.63 118.73 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.255 0.55 . . . . 1.79 111.185 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 51.9 mt -82.41 131.38 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.32 -0.855 . . . . 1.14 109.73 172.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.547 HD11 HG12 ' A' ' 86' ' ' VAL . 2.3 tm? -119.58 107.93 13.87 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.665 -0.865 . . . . 1.65 108.665 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.5 t -89.11 114.57 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.725 -0.67 . . . . 1.14 111.134 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 2.4 m -127.58 123.73 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.807 -0.633 . . . . 1.31 110.593 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.665 ' HB2' ' HD2' ' A' ' 116' ' ' LYS . . . -69.35 135.37 50.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.107 -0.497 . . . . 1.01 109.779 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.851 ' HA ' HG23 ' A' ' 127' ' ' VAL . . . -72.71 -15.59 61.68 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.05 0.452 . . . . 1.07 111.37 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.4 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 5.3 p-10 -90.35 -24.15 20.91 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.753 -0.658 . . . . 0.58 111.244 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.481 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 16.7 t0 -113.53 -41.63 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.56 111.245 -173.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.612 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.11 -131.54 10.7 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 114.419 0.528 . . . . 0.37 114.419 171.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.17 130.82 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.653 . . . . 1.78 110.568 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.674 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.7 mmm -131.32 177.78 2.07 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.461 -1.245 . . . . 1.07 109.377 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 61.2 Cg_exo -41.73 -63.16 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.093 2.529 . . . . 0.89 114.72 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.52 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.1 pt20 -72.97 -19.62 61.19 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.608 -0.437 . . . . 0.78 111.173 -174.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.712 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.82 -45.55 81.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.021 -0.733 . . . . 1.07 109.021 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 93' ' ' MET . 17.8 t -65.51 -43.6 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.889 -1.05 . . . . 2.02 112.065 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -57.02 -24.57 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.488 . . . . 2.35 110.71 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.593 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -76.97 -39.94 48.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 1.12 110.633 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.461 HG23 HD13 ' A' ' 136' ' ' LEU . 91.0 mt -71.53 -41.56 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.829 0.824 . . . . 1.14 109.41 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -61.05 -28.79 69.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.324 -1.307 . . . . 0.75 110.89 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.468 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 5.0 t60 -83.77 -34.4 24.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.811 -0.44 . . . . 3.23 109.811 174.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HB2' HD13 ' A' ' 110' ' ' ILE . . . -65.52 -42.09 92.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.198 -0.455 . . . . 1.17 111.046 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 135' ' ' ASN . 18.9 mmtp -73.18 -35.74 66.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.383 0.611 . . . . 2.27 109.796 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.33 -40.72 59.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.306 -1.316 . . . . 1.28 111.413 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.27 -35.19 15.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.338 -0.392 . . . . 1.31 110.96 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.4 t30 87.97 51.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.403 1.081 . . . . 1.6 109.609 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.11 141.73 23.09 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.969 -1.469 . . . . 1.93 110.58 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.01 140.65 66.84 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.549 2.166 . . . . 0.66 111.975 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.564 ' C ' HG22 ' A' ' 145' ' ' THR . 24.2 mm -104.2 158.71 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.46 0.648 . . . . 1.34 110.758 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.759 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 17.0 mm -129.32 88.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.553 -1.277 . . . . 1.12 107.553 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.94 HG21 HG21 ' A' ' 145' ' ' THR . 43.3 t -78.34 146.99 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.941 0.877 . . . . 1.06 110.338 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.892 ' HB1' HD13 ' A' ' 150' ' ' LEU . . . -139.79 111.06 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.925 -1.489 . . . . 1.07 110.144 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.788 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 2.8 mp -83.15 126.24 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.603 -1.18 . . . . 1.29 109.798 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.535 ' ND2' ' HG3' ' A' ' 116' ' ' LYS . 7.1 p-10 -114.35 168.79 9.54 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.42 -1.326 . . . . 1.85 107.42 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.719 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 89.4 mttt 70.44 31.57 2.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.927 0.767 . . . . 1.18 111.92 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.638 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 77.3 mmm -80.48 -9.7 59.76 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.505 0.669 . . . . 1.64 109.451 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -67.97 -32.54 73.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.968 -1.015 . . . . 0.76 109.415 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.417 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 28.6 mtmt -75.58 139.14 70.67 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.956 -1.02 . . . . 1.74 110.688 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.66 -15.8 51.96 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.885 2.39 . . . . 0.68 111.469 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -78.76 -7.81 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.11 -0.95 . . . . 1.45 110.27 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 117' ' ' MET . . . -58.03 115.39 2.85 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.711 -0.677 . . . . 1.1 111.113 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.886 HD21 ' HB2' ' A' ' 126' ' ' ARG . 1.2 t30 -128.71 77.58 77.32 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.432 -0.951 . . . . 0.95 108.432 173.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.638 ' HG3' ' HE1' ' A' ' 117' ' ' MET . 49.5 Cg_endo -65.13 -50.8 1.86 Allowed 'Trans proline' 0 CA--C 1.5 -1.185 0 C-N-CA 123.267 2.644 . . . . 0.54 112.906 -171.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.6 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 8.1 m-20 -54.43 -26.93 33.63 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.958 -1.019 . . . . 1.44 110.042 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.886 ' HB2' HD21 ' A' ' 123' ' ' ASN . 37.4 ttp180 -79.09 -54.24 6.2 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.411 0.624 . . . . 4.56 109.339 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.851 HG23 ' HA ' ' A' ' 88' ' ' ALA . 21.9 m -65.22 -29.29 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.272 -0.876 . . . . 1.26 111.928 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.921 ' HA ' HD22 ' A' ' 131' ' ' LEU . 16.4 ptm -79.41 -14.87 58.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.827 0.346 . . . . 1.64 110.392 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.585 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 80.3 mt-30 -79.91 -24.85 40.83 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 121.025 -0.27 . . . . 2.0 110.487 171.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 6.5 mm-40 -67.95 -31.13 70.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.431 -0.952 . . . . 1.64 108.431 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.921 HD22 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -61.29 -46.0 92.13 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.581 -1.191 . . . . 1.96 109.335 175.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.51 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -74.82 -7.98 55.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 119.963 -0.695 . . . . 2.05 110.969 -178.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 28.3 mm-40 -72.26 -28.13 62.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.542 -0.91 . . . . 1.67 108.542 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -102.96 31.8 4.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.037 -0.983 . . . . 1.58 110.255 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 104' ' ' LYS . 63.3 t30 55.68 43.49 27.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.699 -1.137 . . . . 1.42 111.761 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.51 ' H ' ' HA ' ' A' ' 132' ' ' MET . 52.5 mt -112.66 104.68 12.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.968 -0.56 . . . . 1.93 109.734 172.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 1.108 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 24.5 t -104.28 117.08 60.21 Favored Pre-proline 0 C--N 1.314 -0.954 0 C-N-CA 120.121 -0.632 . . . . 1.18 111.322 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.754 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.2 Cg_exo -43.73 139.72 5.04 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 124.196 3.264 . . . . 0.88 112.409 171.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -71.6 -18.69 62.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.411 -1.268 . . . . 3.08 110.114 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.52 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.0 pm0 -62.25 -27.11 68.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.759 -0.655 . . . . 1.57 110.089 168.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.585 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 39.4 m0 -102.53 -27.83 12.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.387 -0.369 . . . . 0.66 110.69 -175.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.48 2.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.769 -0.729 . . . . 0.57 112.977 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 1.108 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.25 -119.26 2.54 Favored Glycine 0 CA--C 1.507 -0.46 0 C-N-CA 119.846 -1.169 . . . . 0.6 112.245 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.408 ' C ' ' HG1' ' A' ' 145' ' ' THR . 12.5 m-20 -151.81 59.47 0.86 Allowed 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.773 0.797 . . . . 1.91 111.438 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.94 HG21 HG21 ' A' ' 112' ' ' VAL . 97.6 m -165.27 123.94 1.68 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.351 -0.841 . . . . 1.1 110.488 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.759 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 27.3 mm -75.59 104.25 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.096 -0.705 . . . . 1.27 109.096 171.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.754 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 12.6 m-85 -88.28 117.73 27.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.396 -0.82 . . . . 0.53 110.196 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.2 m -101.42 136.74 40.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.057 -0.349 . . . . 1.0 110.057 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.579 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 91.7 mttt -108.0 91.92 3.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.377 . . . . 1.96 109.981 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 1.044 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -120.85 -167.72 1.53 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 123.077 1.418 . . . . 1.49 113.334 -174.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.81 106.48 0.83 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.315 -1.766 . . . . 2.07 106.411 174.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.581 ' HB1' ' HB3' ' A' ' 27' ' ' ALA . . . -65.83 -14.16 60.9 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.62 -0.718 . . . . 1.11 109.434 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -52.98 30.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.15 -0.932 . . . . 2.78 110.62 173.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -84.99 -7.67 59.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.398 0.518 . . . . 1.35 112.398 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.517 ' HD3' HD13 ' A' ' 158' ' ' LEU . 21.8 mmtp 63.17 46.5 4.57 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.668 -0.696 . . . . 1.9 111.398 176.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.61 -70.79 0.78 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 123.039 1.4 . . . . 2.48 110.602 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 1.044 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -67.45 -8.51 51.65 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 113.664 -1.607 . . . . 0.36 113.269 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.517 HD13 ' HD3' ' A' ' 155' ' ' LYS . 28.6 mt -69.4 -40.48 77.34 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 117.785 0.793 . . . . 1.42 109.423 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.24 -44.2 88.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.345 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -70.87 -17.75 62.71 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.06 -0.518 . . . . 0.68 111.452 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 113' ' ' ALA . 5.9 mt -72.06 -57.49 4.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.011 0.434 . . . . 1.77 110.226 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.505 HD12 HG22 ' A' ' 52' ' ' VAL . 4.3 pp -60.66 -29.35 69.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.498 -0.774 . . . . 2.1 110.804 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.409 ' N ' HD13 ' A' ' 162' ' ' LEU . 29.7 mm-40 -63.17 -51.67 65.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.993 0.425 . . . . 2.57 110.589 174.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.844 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 17.1 mmt -67.72 -46.25 72.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.153 -0.476 . . . . 1.21 110.533 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.526 HG21 HG22 ' A' ' 57' ' ' ILE . 98.7 mt -58.13 -44.12 86.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.682 -0.69 . . . . 1.2 110.971 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -41.37 86.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.423 -0.353 . . . . 2.3 111.19 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.42 -43.47 67.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.284 0.564 . . . . 2.11 109.567 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.421 HG22 HD13 ' A' ' 111' ' ' ILE . 92.6 t -69.21 -43.38 81.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.812 -1.086 . . . . 1.41 111.02 176.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.6 m -60.23 -39.87 88.2 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.671 0.272 . . . . 1.82 111.607 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -80.9 -14.7 57.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.121 0.486 . . . . 2.73 110.387 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.555 ' HG2' ' HA ' ' A' ' 175' ' ' LYS . 46.1 ttp -75.26 -10.36 59.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.767 -0.651 . . . . 2.12 110.536 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.509 ' O ' ' HE2' ' A' ' 175' ' ' LYS . 36.8 tt0 -46.47 -50.96 16.18 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.161 -0.472 . . . . 4.27 110.828 175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -100.13 -21.23 15.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.502 0.668 . . . . 3.91 110.242 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.59 48.28 0.85 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.475 -0.784 . . . . 6.06 110.54 -173.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.658 ' H ' ' HD2' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -48.32 118.8 2.61 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.898 0.38 . . . . 5.86 111.324 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.12 133.86 39.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.254 -0.43 . . . . 5.79 110.1 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 4.5 p-10 -110.51 124.06 34.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 121.271 0.557 . . . . 8.44 110.635 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 10.7 Cg_endo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 123.428 2.752 . . . . 9.2 111.765 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.719 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.813 -0.115 . . . . 11.83 112.813 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -81.01 118.49 22.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.273 0.471 . . . . 10.75 112.273 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 m80 58.49 67.61 0.92 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.608 -0.724 . . . . 10.82 112.655 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.7 mmt -109.55 -57.86 2.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.178 0.513 . . . . 9.01 109.927 173.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.79 -21.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.508 0.67 . . . . 6.14 109.332 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.43 93.01 9.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.474 -0.785 . . . . 5.7 110.093 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -140.18 76.62 26.54 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.582 -0.735 . . . . 7.55 110.217 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD2' ' HD3' ' A' ' 9' ' ' PRO . 38.8 Cg_exo -57.61 -51.59 7.93 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.646 2.897 . . . . 3.21 115.486 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.495 ' HB2' ' H ' ' A' ' 57' ' ' ILE . 12.6 Cg_exo -69.15 91.53 0.45 Allowed 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 121.873 1.715 . . . . 3.14 113.529 -171.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.1 139.32 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.859 -0.61 . . . . 2.53 110.045 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 97.9 t -135.24 109.14 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.117 -0.492 . . . . 1.95 111.076 -175.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.74 ' HB ' HG22 ' A' ' 82' ' ' VAL . 91.4 m -77.87 134.69 37.89 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.755 0.312 . . . . 1.27 110.816 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.914 HG13 HD21 ' A' ' 25' ' ' LEU . 45.9 mm -96.97 118.86 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 1.83 110.667 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.645 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 61.5 mtt -131.28 176.05 8.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.175 -0.676 . . . . 1.28 109.175 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 84' ' ' LEU . . . 139.42 -159.58 25.78 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.654 -0.784 . . . . 0.34 111.653 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.514 ' CE1' HG11 ' A' ' 17' ' ' VAL . 42.1 t60 -101.97 162.05 13.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.036 0.922 . . . . 0.28 112.167 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG11 ' CE1' ' A' ' 16' ' ' HIS . 7.4 p -81.86 150.61 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.255 -1.339 . . . . 1.09 110.726 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.562 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 30.9 t70 71.6 -23.43 0.19 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.423 0.689 . . . . 0.69 111.362 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 17' ' ' VAL . 23.5 m170 -62.79 -38.19 89.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.997 -1.482 . . . . 0.63 106.997 163.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 140.76 55.95 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.828 . . . . 0.79 113.751 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -61.4 2.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.49 0.645 . . . . 3.69 111.483 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -87.68 -40.12 14.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.919 0.39 . . . . 1.76 111.452 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -27.44 62.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 1.71 112.179 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -62.12 -51.21 68.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 2.09 109.843 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.914 HD21 HG13 ' A' ' 13' ' ' ILE . 76.8 mt -71.38 -14.61 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.857 -0.611 . . . . 2.23 111.025 -174.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 19.2 t70 -90.47 -38.63 13.12 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.469 -0.938 . . . . 1.23 108.469 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -70.6 -35.14 72.83 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.29 -1.323 . . . . 1.23 110.186 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 25' ' ' LEU . 13.1 tt -76.7 -33.01 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.969 -1.014 . . . . 1.59 111.102 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 24.1 ptt85 -76.44 -35.35 58.55 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.85 0.833 . . . . 3.51 109.4 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -84.96 21.91 1.5 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.364 -1.289 . . . . 3.14 110.495 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 29' ' ' ARG . 1.8 t -121.07 16.16 11.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.55 -1.205 . . . . 1.96 110.191 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 1.3 ptpp? 176.05 -153.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.342 0.592 . . . . 4.37 111.149 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.445 ' H ' ' HB2' ' A' ' 32' ' ' LYS . 21.6 t -114.31 138.7 43.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.837 -1.074 . . . . 3.59 111.222 -175.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.448 HG23 ' HA2' ' A' ' 40' ' ' GLY . 4.0 t -156.55 175.5 13.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.446 -0.946 . . . . 2.99 108.446 172.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.61 ' HG3' ' HB ' ' A' ' 41' ' ' ILE . 1.9 tm-20 58.79 -156.97 0.33 Allowed 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.323 0.39 . . . . 6.34 110.738 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.98 -2.31 57.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.748 -0.381 . . . . 7.38 110.964 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -140.69 139.72 34.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 6.24 111.353 -176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.11 105.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.566 -0.743 . . . . 5.33 111.499 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.49 -28.54 2.44 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.832 -0.907 . . . . 4.68 110.832 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 34' ' ' THR . . . 95.35 -157.29 21.9 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.894 -0.67 . . . . 5.06 112.782 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.61 ' HB ' ' HG3' ' A' ' 35' ' ' GLU . 12.7 tt -136.5 144.06 33.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.656 -0.498 . . . . 5.91 109.656 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 45' ' ' ILE . 6.2 m -100.31 -83.39 0.44 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.21 -0.293 . . . . 6.29 110.21 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 58.74 9.49 1.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.788 0.435 . . . . 6.97 111.995 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 52.85 42.84 32.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.259 -0.428 . . . . 7.26 111.094 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 HG12 ' N ' ' A' ' 46' ' ' GLY . 14.5 tt -91.06 160.89 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.223 0.535 . . . . 5.68 110.104 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 45' ' ' ILE . . . -96.67 98.43 2.17 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.382 -0.826 . . . . 2.62 112.141 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.739 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . 73.08 177.9 0.24 Allowed 'General case' 0 CA--C 1.534 0.34 0 O-C-N 124.195 0.585 . . . . 1.8 111.182 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.481 ' CZ ' HG21 ' A' ' 50' ' ' VAL . 2.2 p90 -171.49 170.92 5.63 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 119.846 -0.742 . . . . 1.92 112.086 -169.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.426 ' HG2' ' CG2' ' A' ' 58' ' ' THR . 82.7 mt-30 -98.04 124.08 42.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.376 -0.829 . . . . 2.22 109.889 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.481 HG21 ' CZ ' ' A' ' 48' ' ' TYR . 3.5 t -94.72 150.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.158 0.504 . . . . 2.09 111.042 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.9 m -107.03 84.13 1.93 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.418 0.628 . . . . 1.99 110.792 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 53' ' ' ASN . 7.5 p -76.83 -43.07 33.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.905 -1.146 . . . . 2.62 107.905 171.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.432 ' N ' HG12 ' A' ' 52' ' ' VAL . 89.0 m-20 -133.47 -52.71 0.88 Allowed 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 113.615 -1.63 . . . . 4.06 107.656 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -173.7 92.2 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.532 -1.213 . . . . 2.99 110.57 172.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.5 mttp 62.54 36.27 13.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.632 -0.713 . . . . 7.77 112.787 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.849 ' HG2' HG13 ' A' ' 57' ' ' ILE . 12.7 ttmt -100.21 142.12 32.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.003 -0.74 . . . . 4.8 109.003 171.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.849 HG13 ' HG2' ' A' ' 56' ' ' LYS . 19.6 mt 69.12 72.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.741 0.781 . . . . 1.6 110.181 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.426 ' CG2' ' HG2' ' A' ' 49' ' ' GLN . 97.1 m -84.78 104.51 14.81 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.259 -0.882 . . . . 1.48 109.695 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.739 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 78.1 m-85 -72.09 123.25 22.44 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.216 -1.401 . . . . 1.63 107.216 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.585 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 33.0 tp -149.45 99.96 2.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.837 0.351 . . . . 3.67 111.521 -172.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.623 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 7.0 p-10 -114.18 120.62 41.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.111 -0.7 . . . . 5.61 109.111 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.474 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 40.3 m -105.82 131.56 21.64 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.83 -0.623 . . . . 5.77 110.966 -174.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 62' ' ' THR . 13.3 Cg_exo -70.7 49.57 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.201 2.6 . . . . 6.26 112.77 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.64 -56.62 0.96 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.994 -0.842 . . . . 6.42 110.994 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -132.85 90.72 2.8 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.536 -0.542 . . . . 9.55 109.536 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 67.07 -67.27 0.17 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.126 0.891 . . . . 7.05 110.835 -174.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB2' ' HB2' ' A' ' 61' ' ' ASP . . . -159.66 -23.95 0.07 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.084 -0.507 . . . . 5.07 110.769 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.448 ' HD2' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -71.22 134.27 46.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.23 0.538 . . . . 2.66 111.523 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.499 ' HB ' ' HG3' ' A' ' 71' ' ' MET . 3.4 m -85.39 157.59 20.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.306 -0.861 . . . . 5.25 110.294 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 p -78.9 62.8 3.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.014 0.435 . . . . 6.21 111.156 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.499 ' HG3' ' HB ' ' A' ' 69' ' ' THR . 69.0 mtm -95.91 36.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.054 -0.521 . . . . 5.21 111.707 -174.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -84.89 -3.05 58.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 8.75 110.41 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.63 12.58 24.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.747 -0.66 . . . . 6.65 110.063 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -107.97 -14.95 14.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.116 -0.947 . . . . 10.34 110.905 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.41 -157.03 27.07 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.704 -0.76 . . . . 5.22 112.191 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.73 -41.32 1.18 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.767 0.318 . . . . 5.89 111.183 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -90.55 11.55 21.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.434 0.635 . . . . 6.97 110.133 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.42 79.31 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.274 -0.876 . . . . 4.68 110.396 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -72.38 134.99 45.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.649 -0.705 . . . . 3.84 111.165 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -89.52 173.38 8.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.729 -0.668 . . . . 2.66 110.818 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.0 mt -127.76 119.68 52.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.182 -0.917 . . . . 1.38 109.442 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.74 HG22 ' HB ' ' A' ' 12' ' ' THR . 15.2 t -107.64 124.36 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.17 0.509 . . . . 1.79 111.635 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 8.2 mt -84.41 132.27 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.524 -0.762 . . . . 1.14 110.555 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.936 HD13 HG12 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -102.3 106.39 17.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.523 -0.762 . . . . 1.65 110.412 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.2 t -84.12 94.08 3.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.933 -0.576 . . . . 1.14 109.738 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.936 HG12 HD13 ' A' ' 84' ' ' LEU . 2.4 m -119.93 123.62 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.927 -0.578 . . . . 1.31 110.523 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -72.32 131.65 42.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.929 -0.578 . . . . 1.01 110.191 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.776 ' HB1' ' CG2' ' A' ' 114' ' ' ILE . . . -65.5 -14.25 60.61 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.077 0.465 . . . . 1.07 111.063 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.23 8.34 44.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.523 -0.762 . . . . 0.58 111.011 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.417 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 12.9 t0 -149.08 -45.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 0.56 110.973 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.458 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 89.18 -141.49 16.29 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.335 -0.46 . . . . 0.37 113.477 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.33 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.347 0.594 . . . . 1.78 110.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.667 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 79.2 mmm -141.42 176.89 2.16 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 1.07 108.962 -173.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.667 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.3 Cg_exo -41.49 -66.62 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.165 2.577 . . . . 0.89 114.843 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.514 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 6.0 pt20 -71.71 -20.28 61.94 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.259 0.552 . . . . 0.78 110.872 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.514 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.54 -44.03 88.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.513 -0.767 . . . . 1.07 109.375 178.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 93' ' ' MET . 19.8 t -67.56 -41.74 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.38 -0.827 . . . . 2.02 111.33 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -55.33 -30.68 60.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.104 0.478 . . . . 2.35 110.319 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.645 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.15 -39.09 75.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 1.12 110.798 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.454 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 72.3 mt -72.35 -43.02 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.852 0.834 . . . . 1.14 109.172 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -59.91 -33.05 71.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.191 -1.368 . . . . 0.75 110.941 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.448 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 4.2 t60 -79.76 -34.49 39.79 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.735 -0.469 . . . . 3.23 109.735 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.475 ' HB1' HD13 ' A' ' 110' ' ' ILE . . . -74.42 -42.61 58.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.179 0.437 . . . . 1.17 112.179 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 12.7 mmmm -76.76 -37.92 55.07 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.058 0.456 . . . . 2.27 110.787 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.07 -30.09 70.75 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.252 -0.885 . . . . 1.28 110.709 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.96 -17.19 41.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 1.31 110.524 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 70.34 60.92 0.23 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.927 -1.033 . . . . 1.6 110.093 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 1.1 t -123.78 145.42 47.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 1.93 111.303 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 20.2 Cg_exo -69.8 144.89 55.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 123.352 2.701 . . . . 0.66 112.45 172.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.481 ' C ' HG22 ' A' ' 145' ' ' THR . 30.6 mm -111.2 158.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.422 0.63 . . . . 1.34 110.654 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.81 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 21.7 mm -129.21 84.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.599 -1.26 . . . . 1.12 107.599 171.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.91 HG12 ' HB3' ' A' ' 84' ' ' LEU . 17.7 t -74.55 152.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.636 0.732 . . . . 1.06 110.525 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 112' ' ' VAL . . . -139.35 107.24 5.67 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.613 -1.176 . . . . 1.07 110.031 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.776 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 3.5 mp -79.99 105.66 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.554 -1.203 . . . . 1.29 108.843 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.709 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 1.2 p-10 -106.34 173.66 6.22 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 106.807 -1.553 . . . . 1.85 106.807 -169.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.712 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 83.3 mttt 65.51 36.24 6.76 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.768 0.667 . . . . 1.18 110.491 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.656 ' HE3' ' HG3' ' A' ' 124' ' ' PRO . 84.3 mmm -82.34 -13.15 57.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.351 -0.841 . . . . 1.64 109.162 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.7 -30.92 71.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.688 -1.142 . . . . 0.76 109.062 171.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 119' ' ' LYS . 18.6 mmmt -64.91 132.04 95.36 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 114.442 -1.254 . . . . 1.74 110.024 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.84 -16.5 54.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.548 2.165 . . . . 0.68 111.065 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -90.77 10.98 23.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.101 -0.954 . . . . 1.45 110.37 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.6 118.09 4.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.448 -0.796 . . . . 1.1 110.665 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.6 OUTLIER -127.64 76.02 77.33 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.736 -0.838 . . . . 0.95 108.736 174.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.788 ' O ' ' HG3' ' A' ' 128' ' ' MET . 37.2 Cg_endo -63.55 -63.34 0.08 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 123.135 2.557 . . . . 0.54 113.395 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.498 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 6.6 m-20 -55.47 -21.34 15.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 1.44 110.998 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.2 tpt180 -72.36 -56.54 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.695 0.759 . . . . 4.56 109.528 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.614 ' HA ' ' HG3' ' A' ' 130' ' ' GLU . 17.4 m -64.79 -29.74 48.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.808 -1.087 . . . . 1.26 111.596 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.788 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 42.5 mtp -61.44 -39.72 91.87 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.398 0.618 . . . . 1.64 109.527 174.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.572 ' O ' ' HG2' ' A' ' 132' ' ' MET . 38.1 mt-30 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.987 -1.006 . . . . 2.0 111.627 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.614 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 6.3 mt-10 -72.37 -32.56 66.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.29 0.567 . . . . 1.64 109.997 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.936 HD12 HD21 ' A' ' 136' ' ' LEU . 4.3 mm? -65.44 -37.44 86.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 1.96 110.176 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 12.5 ptm -76.49 -14.07 60.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.162 -0.615 . . . . 2.05 110.239 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 7.3 mm-40 -71.15 -28.38 64.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.966 -0.753 . . . . 1.67 108.966 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.53 20.41 10.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.007 0.908 . . . . 1.58 110.157 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 60.65 49.97 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.578 -1.646 . . . . 1.42 112.2 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.936 HD21 HD12 ' A' ' 131' ' ' LEU . 1.9 pp -131.25 120.76 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.524 -1.288 . . . . 1.93 107.524 166.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.801 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.9 t -109.29 129.19 24.19 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 1.18 112.367 -165.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.633 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 98.0 Cg_exo -43.21 146.62 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.608 3.539 . . . . 0.88 113.435 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.48 ' HB2' HD11 ' A' ' 146' ' ' ILE . 5.9 mm-40 -75.53 -22.1 57.38 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.347 -1.297 . . . . 3.08 110.412 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 140' ' ' GLU . 2.2 pm0 -67.39 -21.4 65.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.258 -0.883 . . . . 1.57 110.036 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.477 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 38.4 m0 -105.77 -17.41 14.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.394 -0.366 . . . . 0.66 110.55 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.46 21.75 9.63 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.795 -0.716 . . . . 0.57 113.642 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.801 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -82.92 -105.28 0.48 Allowed Glycine 0 CA--C 1.51 -0.271 0 C-N-CA 120.138 -1.029 . . . . 0.6 111.943 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -166.1 62.2 0.1 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.316 1.055 . . . . 1.91 110.665 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.736 HG21 HG23 ' A' ' 112' ' ' VAL . 56.5 m -164.26 111.91 1.11 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.759 -1.109 . . . . 1.1 111.207 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.81 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.3 mm -69.49 107.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.426 -0.583 . . . . 1.27 109.426 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.674 ' HD2' HD12 ' A' ' 114' ' ' ILE . 10.7 m-85 -88.78 110.19 20.81 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.24 -0.891 . . . . 0.53 110.311 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.455 ' HG ' HG22 ' A' ' 146' ' ' ILE . 80.6 m -98.75 116.37 30.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.371 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.546 ' HB3' ' HE2' ' A' ' 117' ' ' MET . 95.2 mttt -87.31 91.19 8.64 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.036 -0.357 . . . . 1.96 110.036 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.962 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.9 OUTLIER -122.48 173.62 7.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.331 1.062 . . . . 1.49 112.089 -173.312 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.2 OUTLIER -138.9 104.91 5.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.38 -0.97 . . . . 2.07 108.38 165.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.55 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . . . -61.68 -18.99 61.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.309 -0.86 . . . . 1.11 109.708 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.8 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 13.5 tmtt? -63.25 -57.78 9.33 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.993 -1.003 . . . . 2.78 110.736 173.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 p -78.71 -7.85 58.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.215 0.45 . . . . 1.35 112.215 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.533 ' HD3' HD11 ' A' ' 158' ' ' LEU . 15.6 mmtp 66.78 42.8 2.51 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 123.684 0.615 . . . . 1.9 111.776 174.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -115.75 -63.5 1.44 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.183 0.992 . . . . 2.48 110.006 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.962 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -68.79 -11.83 63.58 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 114.495 -1.229 . . . . 0.36 113.605 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 17.4 mt -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 117.856 0.828 . . . . 1.42 110.373 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 6.5 m-20 -81.49 -33.08 32.15 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.69 -0.687 . . . . 2.2 110.422 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -61.42 -32.45 72.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.05 -0.352 . . . . 0.68 110.05 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.544 HD22 HD13 ' A' ' 83' ' ' ILE . 60.2 tp -59.72 -55.96 27.8 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.857 -0.61 . . . . 1.77 109.541 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.3 mt -56.67 -45.09 81.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.823 -1.08 . . . . 2.1 110.033 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 53.2 mt-10 -53.22 -43.9 67.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.639 -0.71 . . . . 2.57 111.338 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.434 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -76.19 -32.71 59.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.817 -0.353 . . . . 1.21 110.41 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 83' ' ' ILE . 80.8 mt -65.66 -51.26 64.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 1.2 111.108 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.557 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 4.0 pp -65.39 -34.25 77.87 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 121.056 -0.258 . . . . 2.3 110.552 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.448 ' N ' HD11 ' A' ' 166' ' ' LEU . 1.3 tm? -50.7 -48.11 58.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.397 -0.594 . . . . 2.11 109.397 173.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.56 -46.64 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.646 -0.706 . . . . 1.41 110.629 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.497 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 34.0 t -63.26 -23.0 67.23 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.487 0.551 . . . . 1.82 112.487 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 33.3 mm-40 -84.73 -24.09 29.01 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.789 -0.569 . . . . 2.73 111.204 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.448 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 26.0 ptt? -103.55 -7.69 20.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.381 -0.372 . . . . 2.12 111.276 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 169' ' ' SER . 11.0 pt-20 -54.32 -12.29 0.64 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.504 0.927 . . . . 4.27 113.504 -173.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.09 -58.02 9.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.224 -0.19 . . . . 3.91 110.589 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.62 -44.74 2.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.369 0.604 . . . . 6.06 109.708 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 171' ' ' MET . 19.2 mttt -78.64 64.84 3.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.453 -0.794 . . . . 5.86 111.631 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -106.71 39.43 1.84 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.458 0.647 . . . . 5.79 109.49 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -150.42 132.12 7.72 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.21 -0.905 . . . . 8.44 109.986 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 123.16 2.574 . . . . 9.2 112.62 178.783 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.8 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.957 -0.457 . . . . 11.83 111.957 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 m -79.73 57.63 2.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.214 0.53 . . . . 10.75 110.758 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -123.81 109.25 13.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.611 . . . . 10.82 110.149 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -90.57 -29.04 18.08 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.312 -0.625 . . . . 9.01 109.312 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t 70.39 -77.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.074 -0.966 . . . . 6.14 110.912 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -133.7 134.87 43.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.908 0.385 . . . . 5.7 110.035 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.54 ' HD3' ' N ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -147.83 114.62 4.03 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.572 -0.74 . . . . 7.55 109.76 -178.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.2 124.09 10.57 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.487 2.124 . . . . 3.21 112.201 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.37 69.82 1.95 Allowed 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.068 2.512 . . . . 3.14 112.083 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 58' ' ' THR . 4.8 p -90.66 114.94 28.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.61 0.719 . . . . 2.53 110.3 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 59' ' ' PHE . 76.6 t -119.26 133.06 67.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.701 -0.681 . . . . 1.95 110.453 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.785 ' HB ' HG21 ' A' ' 82' ' ' VAL . 36.9 m -93.62 126.1 38.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.866 -0.334 . . . . 1.27 110.431 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.592 ' H ' HD13 ' A' ' 60' ' ' LEU . 64.1 mt -99.51 127.78 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.993 -0.373 . . . . 1.83 109.993 177.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.63 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . 63.2 mtt -134.43 165.31 25.46 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.454 -0.573 . . . . 1.28 109.454 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.04 -175.34 36.01 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.566 -0.826 . . . . 0.34 111.788 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.792 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 44.0 t60 -88.06 158.42 18.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.875 0.845 . . . . 0.28 111.648 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 7.3 p -69.8 153.41 8.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.414 -1.267 . . . . 1.09 109.356 172.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.9 t70 73.96 -22.0 0.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.236 0.541 . . . . 0.69 110.713 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.505 ' H ' ' C ' ' A' ' 17' ' ' VAL . 12.8 m170 -84.98 3.55 37.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.132 -1.062 . . . . 0.63 108.132 171.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 86.81 58.36 1.93 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.775 -1.102 . . . . 0.79 113.596 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.5 2.98 34.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.674 0.75 . . . . 3.69 110.183 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -136.69 -44.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.268 -0.878 . . . . 1.76 109.634 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.435 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.76 -29.26 59.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.737 -0.665 . . . . 1.71 112.022 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 85' ' ' VAL . 15.8 tp -67.64 -42.34 82.4 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.436 -0.579 . . . . 2.09 109.436 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -68.15 -11.54 59.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.189 -0.914 . . . . 2.23 110.534 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.45 -38.99 8.98 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.923 0.868 . . . . 1.23 109.593 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.77 67.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.364 -1.289 . . . . 1.23 110.6 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.618 HG22 ' HH ' ' A' ' 48' ' ' TYR . 9.8 tt -69.71 -18.57 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.854 -1.066 . . . . 1.59 110.399 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -60.62 -56.63 19.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.869 -0.605 . . . . 3.51 110.952 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -90.41 27.55 1.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.277 -0.874 . . . . 3.14 110.96 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 t -103.01 -2.19 28.01 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.606 -1.179 . . . . 1.96 111.42 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.719 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -167.75 -175.46 2.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.761 0.315 . . . . 4.37 111.171 -177.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 t -82.06 73.84 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.222 0.534 . . . . 3.59 112.074 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.713 ' HG1' ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -158.79 129.23 5.99 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.543 -0.54 . . . . 2.99 109.543 173.095 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -54.61 1.27 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.969 0.359 . . . . 6.34 111.969 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.497 ' HA ' HD11 ' A' ' 41' ' ' ILE . 14.2 pt20 -140.52 -36.53 0.47 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.591 0.234 . . . . 7.38 111.11 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.501 ' HG2' ' H ' ' A' ' 38' ' ' ALA . 29.0 tt0 -100.99 179.58 4.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.218 -0.66 . . . . 6.24 109.218 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.501 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . 71.9 -13.68 0.57 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.43 0.692 . . . . 5.33 111.519 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 1.014 ' HA3' ' HB2' ' A' ' 49' ' ' GLN . . . 145.45 -8.83 1.64 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.703 -0.76 . . . . 4.68 112.899 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -52.87 -64.94 3.7 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.468 -0.396 . . . . 5.06 112.513 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 36' ' ' GLN . 2.2 mp -107.03 107.42 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.334 -0.987 . . . . 5.91 108.334 171.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.6 t -129.76 164.09 24.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.138 -0.483 . . . . 6.29 110.899 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 13.1 mm-40 -84.98 43.72 1.02 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.555 -0.748 . . . . 6.97 110.617 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -135.89 57.46 1.78 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.314 -0.995 . . . . 7.26 108.314 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 62' ' ' THR . 16.8 tt -53.43 153.44 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.82 0.819 . . . . 5.68 112.35 -171.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.89 -43.05 1.79 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 114.395 -1.275 . . . . 2.62 110.488 -170.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 59' ' ' PHE . . . -152.48 -158.45 0.9 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.013 -0.736 . . . . 1.8 109.013 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.618 ' HH ' HG22 ' A' ' 28' ' ' ILE . 3.6 p90 -165.93 177.13 7.3 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.529 -0.468 . . . . 1.92 110.974 -173.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.014 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 47.8 mt-30 -95.85 121.66 37.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.45 -0.795 . . . . 2.22 110.246 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.633 HG22 ' HE2' ' A' ' 59' ' ' PHE . 61.3 t -83.19 157.66 3.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.001 -0.545 . . . . 2.09 110.661 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.896 HG22 ' HA ' ' A' ' 54' ' ' ASP . 40.6 m -152.26 83.63 1.26 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.542 -0.753 . . . . 1.99 109.354 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.788 HG13 ' H ' ' A' ' 53' ' ' ASN . 2.5 p -58.02 -62.14 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.404 0.621 . . . . 2.62 109.394 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.788 ' H ' HG13 ' A' ' 52' ' ' VAL . 98.3 m-20 -113.94 -55.15 2.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.516 -1.29 . . . . 4.06 107.516 170.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.896 ' HA ' HG22 ' A' ' 51' ' ' THR . 29.9 t70 -172.09 64.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.169 -1.378 . . . . 2.99 108.918 167.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.83 97.08 5.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.935 -1.03 . . . . 7.77 108.308 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -69.21 89.17 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.437 -0.801 . . . . 4.8 111.872 -171.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 165' ' ' ILE . 40.2 mt -98.81 102.54 13.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.162 -0.681 . . . . 1.6 109.162 172.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.509 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 7.3 m -94.6 98.0 10.51 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.354 -0.538 . . . . 1.48 110.315 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.633 ' HE2' HG22 ' A' ' 50' ' ' VAL . 73.6 m-85 -66.15 150.23 49.07 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.633 -0.712 . . . . 1.63 110.242 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.592 HD13 ' H ' ' A' ' 13' ' ' ILE . 5.3 mp 38.52 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.226 1.01 . . . . 3.67 113.616 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -73.84 78.69 1.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.094 0.473 . . . . 5.61 110.629 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 5.1 m 60.25 80.31 0.27 Allowed Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.426 -0.807 . . . . 5.77 111.6 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.5 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 37.7 Cg_endo -65.93 88.81 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.987 2.458 . . . . 6.26 112.111 177.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.63 -85.07 0.74 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.919 -0.657 . . . . 6.42 112.393 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -79.98 -6.06 56.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.545 0.212 . . . . 9.55 111.558 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 68' ' ' PHE . 9.9 tp10 -171.51 157.32 4.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.235 -0.654 . . . . 7.05 109.235 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.5 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . . . -67.79 -42.21 82.0 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.553 -0.536 . . . . 5.07 109.553 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.801 ' HZ ' HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -63.21 118.36 7.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.168 -0.924 . . . . 2.66 110.491 173.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.6 p -70.11 130.89 43.33 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.943 -0.392 . . . . 5.25 109.943 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 p -92.16 90.56 7.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.014 0.435 . . . . 6.21 111.258 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -66.41 95.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.753 -0.658 . . . . 5.21 110.34 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -62.03 -21.72 65.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.02 -0.991 . . . . 8.75 111.401 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.09 66.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 6.65 111.382 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 51.77 75.51 0.21 Allowed 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.52 0.512 . . . . 10.34 111.102 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.27 -108.9 0.6 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.329 -0.938 . . . . 5.22 112.113 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.42 86.51 3.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.98 0.419 . . . . 5.89 110.735 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.535 ' HA ' ' OD1' ' A' ' 80' ' ' ASP . 3.1 pt20 -75.58 55.42 0.83 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.511 0.672 . . . . 6.97 111.41 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.3 p -106.01 -19.99 6.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.59 -0.732 . . . . 4.68 109.787 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -92.59 -9.71 40.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.746 -0.661 . . . . 3.84 109.976 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 77' ' ' GLN . 1.4 m-20 -71.88 91.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.325 -0.852 . . . . 2.66 109.501 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.4 mt -124.08 133.21 69.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.423 -0.353 . . . . 1.38 110.688 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.785 HG21 ' HB ' ' A' ' 12' ' ' THR . 24.7 t -120.98 125.96 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.425 0.631 . . . . 1.79 111.491 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 21.3 mt -84.46 132.27 31.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.987 -1.006 . . . . 1.14 109.636 172.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.667 HD13 HG13 ' A' ' 86' ' ' VAL . 1.7 tm? -120.48 109.87 15.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.703 -0.851 . . . . 1.65 108.703 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 59.8 t -92.69 111.28 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.626 -0.715 . . . . 1.14 110.731 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.667 HG13 HD13 ' A' ' 84' ' ' LEU . 2.2 m -121.0 129.36 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 116.01 -0.541 . . . . 1.31 111.031 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.665 ' HB2' ' HE3' ' A' ' 116' ' ' LYS . . . -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.726 -0.67 . . . . 1.01 110.074 174.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.795 ' HA ' HG22 ' A' ' 127' ' ' VAL . . . -78.49 -7.98 58.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 1.07 110.164 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.804 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 3.1 p-10 -106.27 7.15 31.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.454 -0.794 . . . . 0.58 111.096 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.478 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 22.3 t70 -144.48 -41.43 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 0.56 110.068 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.76 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 90.0 -125.93 8.09 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.37 113.912 170.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.585 HG13 ' HE2' ' A' ' 134' ' ' TYR . 6.8 p -111.82 137.19 45.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.541 0.686 . . . . 1.78 109.697 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.723 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.1 mmm -140.15 177.67 1.91 Allowed Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 114.965 -1.016 . . . . 1.07 108.564 -170.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.723 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 57.4 Cg_exo -38.98 -65.78 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.218 2.612 . . . . 0.89 114.835 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.749 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 6.3 pt20 -74.36 -17.09 60.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.961 0.41 . . . . 0.78 111.527 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.792 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -68.88 -45.49 70.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.749 0.785 . . . . 1.07 109.31 176.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 93' ' ' MET . 20.8 t -69.81 -42.92 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.896 -1.047 . . . . 2.02 111.573 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.749 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -60.94 -25.17 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.449 -0.501 . . . . 2.35 110.003 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 14' ' ' MET . . . -71.28 -40.99 70.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.841 . . . . 1.12 110.919 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -73.95 -39.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.719 0.771 . . . . 1.14 109.311 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -61.3 -30.69 70.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.464 -1.243 . . . . 0.75 110.711 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.475 ' CE1' ' HG2' ' A' ' 66' ' ' GLU . 5.4 t60 -79.84 -34.61 39.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.957 -0.386 . . . . 3.23 109.957 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HA ' ' HE2' ' A' ' 68' ' ' PHE . . . -66.33 -46.11 77.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.384 -0.371 . . . . 1.17 111.336 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -72.21 -34.05 68.06 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.405 0.622 . . . . 2.27 110.106 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.87 -31.97 67.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.568 -1.196 . . . . 1.28 111.582 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.79 -19.47 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.487 -0.324 . . . . 1.31 111.011 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.2 t30 77.46 72.23 0.06 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.167 0.984 . . . . 1.6 108.719 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.801 HG21 ' HZ ' ' A' ' 68' ' ' PHE . 3.0 t -133.55 138.45 31.2 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 114.326 -1.306 . . . . 1.93 111.633 -168.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.33 143.06 56.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.443 2.762 . . . . 0.66 111.705 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 103' ' ' ALA . 38.5 mm -109.96 154.88 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.738 0.78 . . . . 1.34 111.382 -173.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.961 HD13 ' HB ' ' A' ' 146' ' ' ILE . 12.9 mm -125.17 85.21 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 107.352 -1.351 . . . . 1.12 107.352 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.664 HG21 HG23 ' A' ' 145' ' ' THR . 57.5 t -73.43 147.23 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.545 0.688 . . . . 1.06 110.312 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.66 ' HB2' HD22 ' A' ' 150' ' ' LEU . . . -146.75 103.79 3.67 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.291 -1.322 . . . . 1.07 109.997 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.813 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -71.91 144.4 13.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.139 -1.392 . . . . 1.29 110.486 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -122.68 169.69 10.8 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.498 -1.297 . . . . 1.85 107.498 177.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.665 ' HE3' ' HB2' ' A' ' 87' ' ' ALA . 31.2 mtmt 67.74 37.49 3.22 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.163 -0.926 . . . . 1.18 112.38 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.834 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 14.3 mmt -75.95 -11.82 60.03 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.198 -0.91 . . . . 1.64 109.516 166.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 6.6 p-10 -72.86 -29.69 63.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.077 -0.965 . . . . 0.76 108.822 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.81 136.26 82.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.958 -1.019 . . . . 1.74 110.735 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.48 -15.39 48.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 123.058 2.505 . . . . 0.68 112.143 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.804 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 5.0 mm-40 -84.01 -9.0 58.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.49 -0.777 . . . . 1.45 110.704 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -42.47 109.97 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.968 0.792 . . . . 1.1 111.956 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.71 76.59 77.04 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.301 -1.0 . . . . 0.95 108.301 176.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.834 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 22.3 Cg_endo -58.81 -60.1 0.39 Allowed 'Trans proline' 0 CA--C 1.505 -0.933 0 C-N-CA 122.898 2.399 . . . . 0.54 113.286 -174.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.7 -28.88 1.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 124.066 0.854 . . . . 1.44 111.504 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.532 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 37.0 ttm-85 -78.59 -62.36 1.71 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.439 -0.578 . . . . 4.56 109.439 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.795 HG22 ' HA ' ' A' ' 88' ' ' ALA . 4.9 m -64.69 -22.59 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.977 -1.011 . . . . 1.26 111.941 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.614 ' HG3' ' CE2' ' A' ' 147' ' ' PHE . 4.9 ttt -77.12 -31.8 56.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.179 -0.918 . . . . 1.64 110.874 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.574 ' O ' ' HG3' ' A' ' 132' ' ' MET . 20.9 mt-30 -78.1 -32.39 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 2.0 111.372 176.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.9 mm-40 -57.28 -39.6 76.04 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.558 1.17 . . . . 1.64 108.381 173.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 147' ' ' PHE . 0.7 OUTLIER -61.39 -41.22 96.77 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.312 -1.767 . . . . 1.96 110.776 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.618 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.3 ppp? -82.5 -9.09 59.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.035 -0.666 . . . . 2.05 111.536 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.71 -27.91 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.976 -0.75 . . . . 1.67 108.976 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.585 ' HE2' HG13 ' A' ' 92' ' ' VAL . 34.6 m-85 -85.8 13.81 6.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.448 -0.796 . . . . 1.58 110.097 170.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.7 t30 62.84 48.29 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.222 -1.354 . . . . 1.42 111.658 172.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.84 110.49 13.74 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.408 -1.33 . . . . 1.93 107.408 165.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 1.021 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.9 t -104.78 129.16 25.4 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.697 -0.683 . . . . 1.18 111.543 -167.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.674 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 81.2 Cg_exo -44.61 143.6 3.91 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.421 3.414 . . . . 0.88 112.927 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.458 ' HG2' ' C ' ' A' ' 145' ' ' THR . 12.3 mm-40 -67.47 -32.36 73.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.18 -1.373 . . . . 3.08 109.532 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.4 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.7 pm0 -61.25 -24.99 66.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.921 -1.036 . . . . 1.57 110.967 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.618 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 35.7 m0 -102.63 -8.71 20.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.001 0.429 . . . . 0.66 110.912 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.08 32.69 8.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.006 -0.616 . . . . 0.57 113.21 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 1.021 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.9 -109.12 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.252 -0.975 . . . . 0.6 112.053 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.444 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 7.3 t70 -167.43 63.45 0.08 Allowed 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.369 1.08 . . . . 1.91 110.504 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.664 HG23 HG21 ' A' ' 112' ' ' VAL . 78.4 m -164.82 115.63 1.17 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.509 -1.223 . . . . 1.1 110.478 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.961 ' HB ' HD13 ' A' ' 111' ' ' ILE . 19.0 mm -70.93 104.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.175 -0.676 . . . . 1.27 109.175 173.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.674 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 7.9 m-85 -86.98 113.11 22.47 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.237 -0.892 . . . . 0.53 111.305 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.56 136.57 41.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.827 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.656 ' HB3' ' HE1' ' A' ' 117' ' ' MET . 8.3 mptt -111.57 101.27 9.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.24 -0.652 . . . . 1.96 109.24 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.907 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -127.25 -170.07 2.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.743 1.259 . . . . 1.49 111.827 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 117' ' ' MET . 0.3 OUTLIER -164.21 106.68 0.91 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.769 -1.937 . . . . 2.07 105.769 174.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.64 -15.77 63.71 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.669 0.747 . . . . 1.11 109.117 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.598 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 1.2 tmtp? -62.67 -56.07 21.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.216 -1.356 . . . . 2.78 110.462 170.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 1.2 p -84.45 -10.36 57.57 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.37 0.508 . . . . 1.35 112.37 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 62.13 51.88 3.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.42 -0.809 . . . . 1.9 110.595 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -109.33 -65.82 1.11 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.156 0.979 . . . . 2.48 110.608 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.907 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.13 -9.09 71.29 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.318 -1.31 . . . . 0.36 114.174 -173.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.36 -39.47 68.05 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.052 0.926 . . . . 1.42 109.362 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 13.8 m-20 -63.71 -44.7 92.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.511 172.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.411 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 80.6 t60 -71.66 -15.82 62.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.057 -0.52 . . . . 0.68 111.371 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -71.21 -53.34 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 1.77 109.651 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.68 -27.58 69.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.256 -0.884 . . . . 2.1 110.56 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 66.1 mt-10 -62.47 -48.88 77.65 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.099 0.476 . . . . 2.57 110.142 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.786 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 19.3 mmt -68.03 -42.85 80.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 1.21 110.549 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 57' ' ' ILE . 81.5 mt -59.36 -41.95 85.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.927 -0.579 . . . . 1.2 110.593 177.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -39.73 89.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 2.3 111.19 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.1 tp -53.7 -43.98 69.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.413 0.625 . . . . 2.11 109.55 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 90.1 t -67.18 -43.14 88.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 1.41 110.774 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.2 m -59.13 -38.85 80.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.691 0.281 . . . . 1.82 111.574 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -86.5 -8.25 57.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.142 0.496 . . . . 2.73 110.865 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.5 ttm -68.27 -11.58 59.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.291 -0.413 . . . . 2.12 111.57 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -56.12 -36.63 68.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.033 0.444 . . . . 4.27 110.507 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -113.47 -14.06 12.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.744 -0.662 . . . . 3.91 110.281 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.9 tp -112.13 46.26 1.18 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.74 -0.663 . . . . 6.06 110.124 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.729 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -56.29 116.65 3.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.008 -0.542 . . . . 5.86 111.754 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 61.06 80.94 0.2 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 123.841 0.713 . . . . 5.79 112.075 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 8.1 t30 -77.87 124.97 86.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.964 -0.562 . . . . 8.44 110.165 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 6.5 Cg_exo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 122.858 2.372 . . . . 9.2 112.046 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.598 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 111.991 -0.444 . . . . 11.83 111.991 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.8 m -81.5 72.17 8.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.332 0.587 . . . . 10.75 111.31 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -162.19 64.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.432 -0.804 . . . . 10.82 109.105 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 69.7 mtm -80.95 64.97 5.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.688 -0.687 . . . . 9.01 111.23 -173.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.66 -26.72 5.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 6.14 109.925 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -86.13 115.51 23.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.405 -0.816 . . . . 5.7 110.218 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.646 ' HD2' HG22 ' A' ' 79' ' ' THR . 25.4 ttm180 -114.41 103.58 54.93 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.326 . . . . 7.55 110.273 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.68 137.93 40.08 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.858 2.372 . . . . 3.21 111.995 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 54.1 Cg_endo -71.27 109.03 2.49 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.59 2.194 . . . . 3.14 112.327 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.573 ' O ' HG22 ' A' ' 11' ' ' VAL . 4.3 m -92.93 -59.22 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.118 -0.492 . . . . 2.53 111.061 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.705 ' HB ' ' O ' ' A' ' 81' ' ' ILE . 1.1 m 60.13 179.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.8 0.84 . . . . 1.95 111.403 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.694 HG22 HD12 ' A' ' 60' ' ' LEU . 71.8 m -142.8 126.41 16.9 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.303 -0.248 . . . . 1.27 110.678 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.507 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 14.9 tt -92.22 136.1 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.641 0.734 . . . . 1.83 111.467 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.503 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 58.5 mtt -148.82 174.29 12.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.591 0.756 . . . . 1.28 109.28 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.14 -167.12 32.25 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.711 -0.757 . . . . 0.34 112.761 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.841 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 43.2 t60 -93.93 164.49 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.066 0.936 . . . . 0.28 112.003 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.718 ' HA ' ' O1B' ' A' ' 179' ' ' GDP . 5.9 p -78.34 151.29 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.454 -1.248 . . . . 1.09 110.374 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' HA ' " C4'" ' A' ' 179' ' ' GDP . 28.2 t70 72.72 -19.85 0.29 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.4 0.619 . . . . 0.69 110.524 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.533 ' H ' ' C ' ' A' ' 17' ' ' VAL . 18.0 m170 -78.94 -7.93 58.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.356 -0.979 . . . . 0.63 108.356 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 100.13 44.14 2.27 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.192 -0.913 . . . . 0.79 113.413 174.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HZ2' ' HA ' ' A' ' 14' ' ' MET . 0.8 OUTLIER -56.86 -33.26 66.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.591 0.695 . . . . 3.69 112.403 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -107.59 -34.59 6.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.914 0.388 . . . . 1.76 110.614 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -63.9 -28.87 70.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.321 -0.399 . . . . 1.71 111.772 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.414 HD23 ' HA3' ' A' ' 20' ' ' GLY . 2.7 mm? -65.62 -42.37 91.62 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.71 -0.478 . . . . 2.09 109.71 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.925 HD22 ' HA ' ' A' ' 47' ' ' ALA . 2.1 tp -71.85 -12.15 61.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.139 -0.937 . . . . 2.23 110.53 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -98.94 -41.26 7.67 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.992 0.901 . . . . 1.23 109.409 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB2' ' HE2' ' A' ' 155' ' ' LYS . . . -66.22 -30.28 70.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.898 -1.501 . . . . 1.23 109.845 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 tt -77.83 -32.48 17.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 1.59 110.894 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -69.9 -18.45 63.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.588 0.709 . . . . 3.51 109.997 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -119.61 28.74 7.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.843 -1.071 . . . . 3.14 110.172 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.532 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 28.7 t -122.53 -21.65 5.66 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.769 -1.105 . . . . 1.96 111.812 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.745 ' HB3' ' HZ2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -161.66 -170.21 2.51 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.893 -0.323 . . . . 4.37 111.464 -177.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' A' ' 51' ' ' THR . 45.1 t -68.81 97.5 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.635 -0.711 . . . . 3.59 112.241 -171.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.41 HG22 ' HE2' ' A' ' 48' ' ' TYR . 9.7 t -156.86 162.02 39.69 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.979 -0.555 . . . . 2.99 109.597 171.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -96.81 128.06 43.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.583 -0.735 . . . . 6.34 110.286 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.01 -18.62 65.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.757 -0.656 . . . . 7.38 110.363 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -145.55 111.04 5.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.895 -0.593 . . . . 6.24 110.575 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 176.03 -44.01 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.811 -1.181 . . . . 5.33 107.811 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.78 43.32 0.35 Allowed Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 114.036 -1.438 . . . . 4.68 109.802 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.862 ' HA2' ' HB2' ' A' ' 48' ' ' TYR . . . -128.55 -8.61 3.88 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.947 -0.644 . . . . 5.06 113.372 -174.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.51 125.91 74.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.862 0.363 . . . . 5.91 110.6 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.2 m -117.85 -12.5 10.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.545 . . . . 6.29 110.476 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 66.87 15.89 10.24 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.66 -0.7 . . . . 6.97 110.372 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -148.96 -162.56 1.59 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.352 -1.351 . . . . 7.26 107.352 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.0 pt -70.86 -177.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.626 -0.509 . . . . 5.68 109.626 167.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.924 ' HA2' HD22 ' A' ' 60' ' ' LEU . . . 131.79 -127.42 4.99 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.002 -1.094 . . . . 2.62 112.607 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.925 ' HA ' HD22 ' A' ' 25' ' ' LEU . . . -175.6 -165.27 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.751 0.324 . . . . 1.8 110.68 -175.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.862 ' HB2' ' HA2' ' A' ' 40' ' ' GLY . 1.2 p90 -153.89 176.12 12.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.86 -0.609 . . . . 1.92 109.643 -175.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -89.99 115.76 27.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.511 -0.313 . . . . 2.22 111.057 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.426 HG23 ' CE1' ' A' ' 48' ' ' TYR . 11.3 t -88.35 158.79 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.544 -0.298 . . . . 2.09 110.537 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.888 HG23 ' HA ' ' A' ' 54' ' ' ASP . 85.1 m -161.41 87.56 0.7 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.822 0.849 . . . . 1.99 109.17 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.874 HG11 ' H ' ' A' ' 53' ' ' ASN . 1.9 p -64.8 -69.11 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.337 0.589 . . . . 2.62 110.005 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.874 ' H ' HG11 ' A' ' 52' ' ' VAL . 86.2 m-20 -100.45 -56.02 2.46 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.674 -1.232 . . . . 4.06 107.674 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.888 ' HA ' HG23 ' A' ' 51' ' ' THR . 34.6 t70 -177.15 67.3 0.02 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.229 -1.35 . . . . 2.99 109.772 167.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' O ' HG13 ' A' ' 57' ' ' ILE . 18.2 tppt? -122.43 97.69 5.58 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.901 -1.148 . . . . 7.77 107.901 177.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -73.29 81.58 1.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.927 -0.579 . . . . 4.8 111.309 -171.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.711 HD12 HG23 ' A' ' 165' ' ' ILE . 7.2 mt -96.6 102.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.538 -0.755 . . . . 1.6 109.51 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 61' ' ' ASP . 4.1 m -88.25 97.74 11.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.904 -0.776 . . . . 1.48 108.904 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 9.0 m-30 -56.8 13.73 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.981 1.845 . . . . 1.63 115.981 -169.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.924 HD22 ' HA2' ' A' ' 46' ' ' GLY . 32.4 tp 175.36 -68.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.377 0.535 . . . . 3.67 110.814 173.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.562 ' HB2' ' CG2' ' A' ' 58' ' ' THR . 30.8 t70 52.87 50.09 18.79 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.605 0.717 . . . . 5.61 110.711 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.1 m -149.85 108.85 3.28 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.9 -0.591 . . . . 5.77 110.848 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.15 -26.25 30.61 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.853 2.369 . . . . 6.26 111.806 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.86 136.98 2.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.006 -0.616 . . . . 6.42 112.221 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -149.26 -61.68 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.913 0.357 . . . . 9.55 110.133 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -156.75 -80.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.293 -0.412 . . . . 7.05 110.861 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.22 -89.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 5.07 111.583 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.582 ' HE1' ' HB2' ' A' ' 80' ' ' ASP . 1.1 p90 -123.48 -55.59 1.73 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.795 -0.184 . . . . 2.66 110.792 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 p -93.95 -171.67 2.63 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.784 0.326 . . . . 5.25 111.644 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.3 m -75.06 -46.22 36.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.401 -0.363 . . . . 6.21 111.185 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 61.3 mtt 57.44 74.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.899 0.381 . . . . 5.21 110.349 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -118.07 -3.4 11.11 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.869 -0.332 . . . . 8.75 111.66 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.9 -66.27 0.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.969 0.414 . . . . 6.65 110.816 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -178.11 -69.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.337 -0.986 . . . . 10.34 108.337 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.38 -97.22 1.84 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.055 -1.218 . . . . 5.22 110.055 169.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.79 63.63 2.16 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.173 0.511 . . . . 5.89 111.6 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -120.33 2.78 10.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.794 -0.639 . . . . 6.97 110.282 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.82 -1.3 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 4.68 111.717 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.646 HG22 ' HD2' ' A' ' 7' ' ' ARG . 28.5 m -93.46 -20.69 20.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.937 0.875 . . . . 3.84 109.333 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.582 ' HB2' ' HE1' ' A' ' 68' ' ' PHE . 1.8 m-20 -80.5 96.46 6.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.761 -1.108 . . . . 2.66 108.879 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.705 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 44.3 mt -88.52 130.02 38.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.451 -0.795 . . . . 1.38 110.428 -172.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.4 ' O ' HG22 ' A' ' 110' ' ' ILE . 27.2 t -90.96 117.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.733 -0.787 . . . . 1.79 111.167 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 44.3 mt -81.33 131.41 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.798 -1.092 . . . . 1.14 109.384 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.689 HD12 HG11 ' A' ' 86' ' ' VAL . 2.4 tm? -121.11 107.17 12.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.82 -0.807 . . . . 1.65 108.82 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 85.5 t -89.38 109.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.593 -0.731 . . . . 1.14 110.779 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.699 HG22 HD13 ' A' ' 131' ' ' LEU . 2.1 m -121.39 126.26 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.785 -0.643 . . . . 1.31 110.95 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -72.15 127.46 32.64 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.094 -0.503 . . . . 1.01 109.645 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.666 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -68.06 -10.54 54.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.893 0.377 . . . . 1.07 111.383 -175.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.56 -8.06 55.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.837 -0.62 . . . . 0.58 110.778 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.495 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 15.9 t0 -131.69 -45.7 0.97 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.324 -0.398 . . . . 0.56 111.573 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.62 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 95.2 -144.79 17.41 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.312 -0.471 . . . . 0.37 113.062 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.6 p -92.49 143.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.337 -0.616 . . . . 1.78 109.337 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.691 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 77.2 mmm -143.61 177.73 1.71 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.401 -0.818 . . . . 1.07 109.241 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.691 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.6 Cg_exo -43.83 -63.02 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.199 2.599 . . . . 0.89 114.618 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.52 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.7 pt20 -76.69 -12.38 59.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.78 111.191 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.841 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -72.22 -48.23 44.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.675 -0.693 . . . . 1.07 109.662 176.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 93' ' ' MET . 3.5 p -73.69 -27.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.548 -0.751 . . . . 2.02 112.943 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -61.72 -30.34 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.606 -0.838 . . . . 2.35 109.088 176.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.21 -35.07 66.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.495 -0.775 . . . . 1.12 110.476 174.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.3 mt -70.18 -51.16 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 109.08 -0.711 . . . . 1.14 109.08 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -51.26 -41.74 60.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.537 -1.21 . . . . 0.75 110.442 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.478 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 2.8 t60 -55.62 -50.24 70.68 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.102 -0.954 . . . . 3.23 110.208 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' CB ' HD12 ' A' ' 110' ' ' ILE . . . -74.25 -46.57 40.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 1.17 112.164 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.763 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 10.8 mmpt? -63.69 -35.9 82.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.986 0.422 . . . . 2.27 110.943 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.7 -43.32 72.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.093 -0.958 . . . . 1.28 111.065 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.38 -21.41 39.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.573 -0.285 . . . . 1.31 111.26 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 83.1 41.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.817 1.294 . . . . 1.6 108.842 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 109' ' ' PRO . 29.2 t -89.95 138.16 27.84 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 113.384 -1.734 . . . . 1.93 111.616 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.479 ' O ' HG11 ' A' ' 108' ' ' VAL . 22.3 Cg_exo -66.82 144.18 70.1 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.829 2.353 . . . . 0.66 111.56 170.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.528 HD12 ' CB ' ' A' ' 103' ' ' ALA . 49.6 mm -109.35 157.12 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 121.387 0.613 . . . . 1.34 111.157 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.757 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 22.8 mm -124.02 83.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.195 -1.409 . . . . 1.12 107.195 169.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.774 HG21 HG23 ' A' ' 145' ' ' THR . 58.2 t -70.01 145.35 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-O 121.643 0.735 . . . . 1.06 109.208 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.759 ' HB1' HD23 ' A' ' 150' ' ' LEU . . . -143.55 100.39 3.59 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.374 -1.284 . . . . 1.07 109.67 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.801 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 80.6 mt -73.99 141.92 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.301 -1.318 . . . . 1.29 110.122 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 50.9 t30 -120.9 171.52 8.57 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.325 -1.361 . . . . 1.85 107.325 -177.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' ' 87' ' ' ALA . 81.7 mttt 72.47 33.58 1.41 Allowed 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 123.901 0.751 . . . . 1.18 111.749 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.692 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 13.4 mmt -79.02 -14.9 58.91 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 1.64 108.879 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 3.9 p-10 -65.09 -26.8 68.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.107 -1.406 . . . . 0.76 109.515 171.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.664 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 28.5 mtpp -86.62 132.23 43.17 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.291 -0.868 . . . . 1.74 110.02 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.39 -12.2 31.96 Favored 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 122.584 2.189 . . . . 0.68 111.128 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.27 1.15 38.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.404 -1.271 . . . . 1.45 110.732 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.63 122.96 11.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.119 -0.946 . . . . 1.1 111.348 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.6 OUTLIER -130.47 76.32 77.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.595 -0.891 . . . . 0.95 108.595 175.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.692 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 25.8 Cg_endo -61.16 -65.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.745 2.964 . . . . 0.54 114.153 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.655 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 1.2 m-20 -60.24 -23.07 63.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 1.44 110.102 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.753 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.4 tpt180 -67.8 -60.35 2.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 4.56 109.944 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.666 HG21 ' HA ' ' A' ' 88' ' ' ALA . 33.0 m -66.08 -32.98 60.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.756 -1.111 . . . . 1.26 111.757 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 1.081 ' HA ' HD12 ' A' ' 131' ' ' LEU . 18.7 ptm -74.49 -20.51 59.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.794 0.33 . . . . 1.64 110.961 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 125' ' ' ASP . 20.3 mt-30 -74.86 -43.55 53.87 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.997 -0.44 . . . . 2.0 111.086 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.611 ' HA ' ' HG3' ' A' ' 133' ' ' GLU . 8.8 mt-10 -70.19 -24.23 63.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.895 0.855 . . . . 1.64 109.167 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 1.081 HD12 ' HA ' ' A' ' 128' ' ' MET . 66.8 mt -59.79 -36.71 77.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.464 -1.244 . . . . 1.96 109.27 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.856 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 3.6 mtm -77.14 -17.69 58.42 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.402 -0.519 . . . . 2.05 111.859 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.611 ' HG3' ' HA ' ' A' ' 130' ' ' GLU . 5.4 mt-10 -71.53 -17.47 62.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.437 -0.949 . . . . 1.67 108.437 174.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.404 ' N ' ' HD1' ' A' ' 134' ' ' TYR . 1.7 m-85 -94.9 12.27 28.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.802 -1.09 . . . . 1.58 109.44 171.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 53.1 t30 62.86 53.56 2.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.878 -1.51 . . . . 1.42 111.942 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -139.21 121.82 16.3 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.049 -1.093 . . . . 1.93 108.049 166.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.918 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 98.0 t -113.45 128.62 25.47 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.934 0.397 . . . . 1.18 111.914 -167.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.856 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 85.5 Cg_exo -45.72 145.77 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.707 3.605 . . . . 0.88 113.76 172.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.61 ' HB2' HD12 ' A' ' 146' ' ' ILE . 3.7 mm-40 -81.71 -11.39 59.07 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.321 -1.309 . . . . 3.08 110.746 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -67.65 -26.62 66.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 1.57 109.672 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.471 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.8 m0 -109.21 -2.94 17.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.66 110.735 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.04 33.72 17.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.985 -0.626 . . . . 0.57 113.721 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.918 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -86.45 -105.81 0.78 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.252 -0.975 . . . . 0.6 111.857 174.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.412 ' C ' ' HG1' ' A' ' 145' ' ' THR . 12.8 p-10 -162.97 58.8 0.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.979 0.895 . . . . 1.91 110.907 172.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.774 HG23 HG21 ' A' ' 112' ' ' VAL . 51.5 m -166.9 116.49 0.88 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.463 -0.79 . . . . 1.1 111.0 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.757 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 18.1 mm -71.43 108.02 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.041 -0.726 . . . . 1.27 109.041 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.677 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 9.2 m-85 -89.51 120.0 30.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.53 111.039 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.684 ' HG ' HD21 ' A' ' 150' ' ' LEU . 50.6 t -99.98 153.9 18.82 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.196 0.522 . . . . 1.0 109.73 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.658 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.8 mttt -128.49 91.82 3.31 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.983 -1.008 . . . . 1.96 108.499 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.831 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -122.65 -174.1 2.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.613 1.197 . . . . 1.49 112.242 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 p -155.47 100.76 2.14 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.604 -1.635 . . . . 2.07 107.566 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.56 58.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.736 -0.786 . . . . 1.11 109.653 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -73.08 -52.49 14.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.168 -0.924 . . . . 2.78 110.48 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 p -87.82 -6.61 58.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.971 -0.691 . . . . 1.35 112.399 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.503 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 28.9 mmtp 67.45 45.87 1.5 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.583 -0.735 . . . . 1.9 111.661 171.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -105.72 -65.87 1.03 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.956 1.36 . . . . 2.48 110.617 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.831 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -72.36 -5.14 62.28 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.746 -1.57 . . . . 0.36 113.804 -173.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 26.9 mt -66.05 -41.39 90.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.376 1.088 . . . . 1.42 109.07 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -47.83 71.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.254 -0.885 . . . . 2.2 109.886 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -64.12 -27.07 68.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.68 111.68 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.8 tp -63.89 -58.89 5.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 1.77 110.451 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.596 HD12 ' HB ' ' A' ' 52' ' ' VAL . 11.9 mt -57.51 -39.56 76.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.032 -0.985 . . . . 2.1 110.115 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -54.18 -40.19 67.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.263 -0.88 . . . . 2.57 111.37 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.842 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 16.4 mmt -78.5 -39.18 38.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 1.21 110.621 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.711 HG23 HD12 ' A' ' 57' ' ' ILE . 89.5 mt -58.98 -46.94 91.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 1.2 111.383 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 3.7 pp -66.86 -34.65 78.27 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.726 -0.389 . . . . 2.3 110.895 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -53.68 -47.17 70.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.012 -0.736 . . . . 2.11 109.012 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.574 HG23 HD11 ' A' ' 111' ' ' ILE . 48.2 t -64.94 -42.48 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.431 -0.804 . . . . 1.41 111.356 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 166' ' ' LEU . 89.2 p -64.19 -26.94 68.74 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.575 -0.45 . . . . 1.82 111.265 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 67.4 mm-40 -80.23 -27.6 38.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.427 0.632 . . . . 2.73 110.011 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 48.9 ttp -80.84 -10.17 59.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.653 -0.703 . . . . 2.12 110.227 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.466 ' O ' ' HD2' ' A' ' 175' ' ' LYS . 5.0 tm-20 -47.69 -49.83 26.71 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.015 -0.539 . . . . 4.27 110.968 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -99.7 -21.32 15.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.82 0.343 . . . . 3.91 111.052 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.54 47.41 0.89 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.184 -0.462 . . . . 6.06 110.524 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.872 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 3.1 mppt? -46.98 -45.76 21.17 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.394 -0.821 . . . . 5.86 111.798 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -141.77 148.94 39.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.015 -0.539 . . . . 5.79 110.722 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -115.5 95.77 44.11 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.443 -0.577 . . . . 8.44 109.443 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 C--O 1.248 0.985 0 C-N-CA 122.97 2.447 . . . . 9.2 112.278 -177.64 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.781 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.288 -0.325 . . . . 11.83 112.288 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m -123.17 87.02 2.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.029 0.442 . . . . 10.75 110.827 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -122.05 -29.98 4.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.235 -0.439 . . . . 10.82 109.937 173.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.8 ttm -70.2 -61.2 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.135 -0.691 . . . . 9.01 109.135 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.7 140.12 47.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.572 -0.74 . . . . 6.14 109.954 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -115.23 147.12 40.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.263 -0.426 . . . . 5.7 110.326 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 7' ' ' ARG . 31.4 ttm180 -114.25 99.39 50.82 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.932 -0.576 . . . . 7.55 109.673 172.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.85 116.7 4.78 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.622 2.215 . . . . 3.21 110.694 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.46 121.11 9.16 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.506 2.138 . . . . 3.14 111.558 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.77 74.0 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.475 0.655 . . . . 2.53 109.818 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 99.7 t -66.26 90.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.12 -0.945 . . . . 1.95 110.104 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.655 HG21 HD12 ' A' ' 60' ' ' LEU . 19.5 m -77.86 122.86 26.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.078 -0.964 . . . . 1.27 110.841 -175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.652 HD13 HD23 ' A' ' 25' ' ' LEU . 50.8 mt -86.15 114.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.212 0.53 . . . . 1.83 110.601 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.8 ' HE3' ' HB2' ' A' ' 67' ' ' ALA . 21.4 mmt -112.59 -178.48 3.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.439 -0.801 . . . . 1.28 109.432 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.438 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 138.76 -174.13 22.23 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.565 -0.826 . . . . 0.34 112.206 174.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.658 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 50.5 t60 -84.42 162.45 19.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.7 0.762 . . . . 0.28 110.691 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -76.38 152.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.081 -0.963 . . . . 1.09 110.163 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.657 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 16.1 t70 73.62 -20.36 0.3 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.031 0.532 . . . . 0.69 110.385 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.515 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.8 m170 -79.87 -8.68 59.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.696 -0.853 . . . . 0.63 108.696 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.552 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 122.6 62.09 0.21 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.386 -0.912 . . . . 0.79 114.643 169.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' HB2' ' O3B' ' A' ' 179' ' ' GDP . 70.0 mmtt -62.02 -74.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.316 0.558 . . . . 3.69 111.208 168.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 m -80.13 -34.66 37.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.768 0.318 . . . . 1.76 110.955 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.552 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.83 -30.21 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.949 0.722 . . . . 1.71 112.949 -175.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -71.72 -52.55 17.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.953 -0.388 . . . . 2.09 109.953 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.652 HD23 HD13 ' A' ' 13' ' ' ILE . 15.4 mt -70.43 -8.67 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 2.23 110.965 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -89.17 -44.18 10.49 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.244 -1.021 . . . . 1.23 108.244 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.607 ' HB2' ' HE3' ' A' ' 155' ' ' LYS . . . -71.49 -25.33 62.22 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.71 -1.586 . . . . 1.23 110.676 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.438 HG23 ' HA ' ' A' ' 25' ' ' LEU . 9.7 tt -81.77 -27.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.21 -0.904 . . . . 1.59 111.076 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 29.7 mtp180 -75.97 -40.98 52.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.531 -0.304 . . . . 3.51 111.404 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -92.89 28.27 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.319 1.057 . . . . 3.14 110.758 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.419 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 13.8 t -105.44 -43.63 4.92 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.233 -1.348 . . . . 1.96 108.207 178.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HE3' ' CD2' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -174.06 -173.02 0.77 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.299 -0.864 . . . . 4.37 110.526 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 50' ' ' VAL . 14.2 p 53.22 -61.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.55 1.54 . . . . 3.59 113.232 -171.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 p -93.75 140.8 29.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.71 0.29 . . . . 2.99 110.367 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -117.58 -80.96 0.62 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.231 0.539 . . . . 6.34 110.71 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -123.93 0.33 8.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.932 -0.576 . . . . 7.38 110.688 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.67 178.7 4.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.084 -0.507 . . . . 6.24 110.407 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 41' ' ' ILE . . . -92.5 -8.56 44.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.064 0.765 . . . . 5.33 113.064 -166.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.6 20.42 73.87 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.99 -0.624 . . . . 4.68 112.643 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.71 -3.24 87.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.845 -0.693 . . . . 5.06 112.594 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 47' ' ' ALA . 48.2 mm -109.22 139.67 31.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.818 0.342 . . . . 5.91 110.689 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.66 HG23 ' H ' ' A' ' 44' ' ' HIS . 8.9 t -100.29 -160.49 0.8 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 6.29 110.062 177.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.431 HE21 ' HB2' ' A' ' 43' ' ' GLN . 1.2 mp0 -71.7 -21.9 61.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.181 0.515 . . . . 6.97 110.192 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.66 ' H ' HG23 ' A' ' 42' ' ' THR . 74.2 m-70 -74.17 113.62 11.57 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.711 -0.848 . . . . 7.26 108.711 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.49 HG21 ' H ' ' A' ' 47' ' ' ALA . 41.0 mm 75.65 150.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 O-C-N 124.223 0.952 . . . . 5.68 109.52 -172.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.34 -5.43 10.39 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.984 -0.627 . . . . 2.62 112.202 -175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HA ' HD13 ' A' ' 25' ' ' LEU . . . -84.84 -176.63 6.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.64 -0.28 . . . . 1.8 110.861 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -177.25 173.5 1.75 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.994 -0.373 . . . . 1.92 109.994 -175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 45.6 mt-30 -100.88 122.51 43.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.226 -0.443 . . . . 2.22 110.305 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 21.7 t -86.0 169.37 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.922 -0.581 . . . . 2.09 110.755 -177.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.814 HG21 ' HA ' ' A' ' 54' ' ' ASP . 86.1 m -159.48 83.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.353 -0.98 . . . . 1.99 108.353 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.668 HG12 ' H ' ' A' ' 53' ' ' ASN . 2.2 p -64.83 -58.43 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.668 0.747 . . . . 2.62 109.647 177.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.668 ' H ' HG12 ' A' ' 52' ' ' VAL . 2.1 p30 -110.33 -56.6 2.32 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.659 -1.155 . . . . 4.06 108.568 173.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.814 ' HA ' HG21 ' A' ' 51' ' ' THR . 5.8 p-10 -167.98 37.5 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.34 -1.3 . . . . 2.99 110.243 170.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.87 100.38 10.0 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.964 -0.562 . . . . 7.77 110.017 -177.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -72.44 86.05 1.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.34 -0.845 . . . . 4.8 111.375 -177.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.48 HD13 HG21 ' A' ' 165' ' ' ILE . 31.8 mt -96.08 109.66 23.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.415 -0.812 . . . . 1.6 110.177 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.452 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 3.1 m -86.34 94.04 9.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.26 -0.427 . . . . 1.48 110.296 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.536 ' O ' ' HB3' ' A' ' 60' ' ' LEU . 77.5 m-85 -72.6 88.66 1.27 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.909 -0.587 . . . . 1.63 110.68 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.655 HD12 HG21 ' A' ' 12' ' ' THR . 54.1 tp 76.46 156.99 0.18 Allowed 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.915 0.759 . . . . 3.67 110.714 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.513 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 27.0 t70 -149.44 -76.53 0.15 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.681 -0.236 . . . . 5.61 111.309 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.5 m -105.68 102.91 40.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.654 0.264 . . . . 5.77 111.674 -176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 44.0 Cg_endo -97.9 36.08 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.445 2.763 . . . . 6.26 111.708 173.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 65' ' ' HIS . . . -92.14 46.41 2.64 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.045 -0.525 . . . . 6.42 112.878 -175.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 21.5 t60 166.09 -46.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.177 -1.416 . . . . 9.55 107.177 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -156.6 160.58 39.55 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 104.816 -2.291 . . . . 7.05 104.816 173.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.8 ' HB2' ' HE3' ' A' ' 14' ' ' MET . . . -73.44 -23.58 60.13 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 118.602 0.637 . . . . 5.07 109.793 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.55 147.18 51.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.706 -0.679 . . . . 2.66 110.491 172.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.8 p -61.09 146.11 48.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.064 -0.516 . . . . 5.25 111.154 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 p -77.03 75.65 3.6 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.369 0.604 . . . . 6.21 110.937 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 68.9 mtm -89.22 30.04 1.01 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.616 -0.72 . . . . 5.21 110.69 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -90.82 -53.77 4.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.055 -0.52 . . . . 8.75 110.084 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.6 -47.02 85.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 6.65 110.311 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 71' ' ' MET . 17.0 ptt180 -167.41 -179.04 4.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.785 -0.643 . . . . 10.34 109.587 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.46 -77.51 0.2 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.782 -0.723 . . . . 5.22 111.71 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.21 56.17 8.12 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.17 0.51 . . . . 5.89 111.647 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -107.43 174.18 6.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.879 -0.6 . . . . 6.97 110.402 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.729 HG22 ' H ' ' A' ' 79' ' ' THR . 3.3 m -66.49 -77.72 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 113.588 0.959 . . . . 4.68 113.588 -168.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.729 ' H ' HG22 ' A' ' 78' ' ' VAL . 4.5 t -171.17 72.62 0.05 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.626 0.727 . . . . 3.84 110.603 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.3 132.36 52.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.501 -0.772 . . . . 2.66 110.142 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.9 mt -89.85 142.55 12.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.579 -0.737 . . . . 1.38 111.075 -170.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.863 HG21 ' HE1' ' A' ' 102' ' ' HIS . 6.0 p -111.77 136.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.432 0.634 . . . . 1.79 110.766 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.568 HG12 ' HB ' ' A' ' 111' ' ' ILE . 11.9 mt -90.53 142.58 12.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.287 -0.87 . . . . 1.14 109.555 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.61 HD12 HG11 ' A' ' 86' ' ' VAL . 2.1 tm? -127.44 108.4 10.79 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.3 -1.0 . . . . 1.65 108.3 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 90.4 t -89.89 116.03 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.079 0.466 . . . . 1.14 111.206 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.812 HG22 HD23 ' A' ' 131' ' ' LEU . 1.7 m -123.43 125.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.643 -0.708 . . . . 1.31 111.003 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -65.95 132.04 47.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.059 -0.519 . . . . 1.01 109.88 174.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.791 ' HA ' HG22 ' A' ' 127' ' ' VAL . . . -73.24 -12.3 60.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.016 0.436 . . . . 1.07 111.158 -175.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.36 9.99 37.63 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.816 -0.629 . . . . 0.58 111.634 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -143.25 -40.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.561 0.219 . . . . 0.56 111.068 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.575 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.1 -143.27 21.95 Favored Glycine 0 C--O 1.227 -0.284 0 C-N-CA 121.367 -0.444 . . . . 0.37 114.014 171.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.49 128.74 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.763 0.792 . . . . 1.78 111.02 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.538 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -125.69 177.68 1.81 Allowed Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 114.248 -1.342 . . . . 1.07 108.955 -174.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 76.0 Cg_exo -48.93 -57.91 2.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.497 2.131 . . . . 0.89 114.085 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.422 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.1 pt20 -76.13 -12.46 60.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.246 -0.582 . . . . 0.78 110.783 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.658 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.56 -50.16 40.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.727 -0.669 . . . . 1.07 109.758 178.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.57 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p -74.88 -21.86 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 112.749 0.648 . . . . 2.02 112.749 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.5 mt-10 -64.58 -29.9 70.92 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.452 -0.78 . . . . 2.35 109.171 172.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.691 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -76.39 -19.4 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.555 -0.748 . . . . 1.12 110.396 173.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 136' ' ' LEU . 96.9 mt -79.42 -46.9 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.267 0.556 . . . . 1.14 109.619 171.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -51.76 -45.34 63.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.681 -1.145 . . . . 0.75 110.156 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.863 ' HE1' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -49.12 -46.62 45.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.733 -0.667 . . . . 3.23 111.061 172.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.78 41.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 1.17 111.634 -169.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -73.96 -29.67 62.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.619 0.723 . . . . 2.27 110.161 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.78 -39.55 68.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.251 -1.34 . . . . 1.28 110.755 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.95 -32.61 15.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.463 -0.335 . . . . 1.31 111.591 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 62.3 t30 82.09 52.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.55 1.14 . . . . 1.6 109.123 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.36 143.93 28.74 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.847 -1.524 . . . . 1.93 111.155 -174.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.436 ' O ' HG22 ' A' ' 108' ' ' VAL . 24.5 Cg_exo -63.23 145.07 93.05 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.756 2.304 . . . . 0.66 112.381 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.484 ' C ' HG21 ' A' ' 145' ' ' THR . 1.0 OUTLIER -112.61 161.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.885 0.85 . . . . 1.34 111.881 -173.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.965 HD12 ' HB ' ' A' ' 146' ' ' ILE . 19.7 mm -124.39 82.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.943 -1.502 . . . . 1.12 106.943 171.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.844 HG22 HG23 ' A' ' 145' ' ' THR . 62.0 t -69.77 147.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 109.056 -0.72 . . . . 1.06 109.056 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.783 ' HB1' HD22 ' A' ' 150' ' ' LEU . . . -144.78 104.36 4.01 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.638 -1.164 . . . . 1.07 110.156 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.769 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.3 mp -73.18 136.62 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.165 -1.38 . . . . 1.29 109.198 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -121.99 173.11 7.74 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 106.723 -1.584 . . . . 1.85 106.723 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.718 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 91.0 mttt 66.53 33.88 6.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 O-C-N 123.759 0.662 . . . . 1.18 111.512 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.681 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 78.5 mmm -84.12 -14.64 49.81 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.024 -0.732 . . . . 1.64 109.024 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -66.05 -31.89 73.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.754 -1.112 . . . . 0.76 108.875 171.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.46 133.71 80.17 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.667 -1.151 . . . . 1.74 110.24 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.06 -13.94 34.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.941 2.428 . . . . 0.68 111.937 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.17 -3.41 57.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.956 -1.02 . . . . 1.45 110.712 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 117' ' ' MET . . . -56.45 120.94 8.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.149 -0.932 . . . . 1.1 111.848 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -131.74 76.91 73.65 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.197 -1.038 . . . . 0.95 108.197 170.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.681 ' HG3' ' HE1' ' A' ' 117' ' ' MET . 33.4 Cg_endo -61.67 -56.91 0.65 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.21 2.606 . . . . 0.54 113.916 -173.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.676 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 7.2 m-20 -55.53 -26.7 44.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.493 0.663 . . . . 1.44 110.319 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 123' ' ' ASN . 14.6 tpp180 -74.11 -56.57 4.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 4.56 109.395 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 88' ' ' ALA . 24.1 m -66.92 -29.35 46.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.122 -0.945 . . . . 1.26 111.871 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 1.03 ' HA ' HD21 ' A' ' 131' ' ' LEU . 19.6 ptm -76.16 -17.03 59.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.745 0.307 . . . . 1.64 110.272 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.642 ' O ' ' HG2' ' A' ' 132' ' ' MET . 10.1 mt-30 -76.2 -30.84 58.17 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.483 -0.487 . . . . 2.0 110.424 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -64.35 -31.13 72.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.844 -0.799 . . . . 1.64 108.844 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 1.03 HD21 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -60.57 -47.83 84.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.677 -1.147 . . . . 1.96 109.507 176.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.642 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 18.2 ptm -71.64 -11.84 61.04 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.403 -0.519 . . . . 2.05 111.353 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 29.4 mt-10 -74.59 -28.85 61.09 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.6 -0.889 . . . . 1.67 108.6 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.613 ' HB3' HG23 ' A' ' 100' ' ' ILE . 31.1 m-85 -98.67 31.31 2.95 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.093 -0.958 . . . . 1.58 109.815 168.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.74 40.99 22.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 113.796 -1.547 . . . . 1.42 112.77 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.622 HD13 HG12 ' A' ' 100' ' ' ILE . 70.1 mt -110.04 95.9 5.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.013 -0.54 . . . . 1.93 110.001 172.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 1.007 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 21.9 t -100.64 117.26 63.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.868 -0.606 . . . . 1.18 111.045 -173.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.745 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.4 Cg_exo -44.11 143.94 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 124.446 3.431 . . . . 0.88 113.049 174.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.544 ' HG2' ' C ' ' A' ' 145' ' ' THR . 7.2 mm-40 -71.6 -21.25 61.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.329 -1.305 . . . . 3.08 109.341 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.529 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.5 pm0 -66.88 -19.83 65.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.26 -0.882 . . . . 1.57 110.506 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.511 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 37.8 m0 -110.22 -9.97 14.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.871 0.367 . . . . 0.66 111.081 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.65 29.45 9.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.866 -0.683 . . . . 0.57 113.473 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 1.007 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -89.95 -108.73 1.29 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 119.954 -1.117 . . . . 0.6 112.358 176.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.14 60.91 0.12 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.649 1.214 . . . . 1.91 110.858 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.844 HG23 HG22 ' A' ' 112' ' ' VAL . 72.8 m -165.2 119.2 1.25 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.643 -1.162 . . . . 1.1 110.712 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.965 ' HB ' HD12 ' A' ' 111' ' ' ILE . 19.1 mm -72.92 104.2 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 109.264 -0.643 . . . . 1.27 109.264 174.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m-85 -87.45 117.17 26.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.339 -0.846 . . . . 0.53 110.495 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 82.8 m -103.15 132.87 49.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.391 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.569 ' HE2' ' HB2' ' A' ' 124' ' ' PRO . 95.4 mttt -102.4 107.78 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.226 -0.657 . . . . 1.96 109.226 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.88 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -138.01 -172.52 3.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.703 1.24 . . . . 1.49 112.401 -173.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.3 OUTLIER -160.23 105.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 113.605 -1.634 . . . . 2.07 106.996 176.377 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.2 -14.38 62.94 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.343 -0.614 . . . . 1.11 109.343 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.726 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 3.9 tmtm? -62.86 -57.51 10.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.841 -1.072 . . . . 2.78 110.449 171.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.07 -8.86 59.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.622 0.601 . . . . 1.35 112.622 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.607 ' HE3' ' HB2' ' A' ' 27' ' ' ALA . 37.2 mmtm 64.38 44.99 3.96 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.9 111.204 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -105.21 -67.85 0.89 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.428 1.109 . . . . 2.48 109.63 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.88 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.78 -8.37 67.86 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 113.861 -1.518 . . . . 0.36 113.816 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.1 mt -66.44 -38.97 88.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.15 0.975 . . . . 1.42 109.41 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.581 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 40.8 m-20 -70.38 -44.16 68.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.326 -0.852 . . . . 2.2 109.291 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -62.8 -22.43 66.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.949 -0.569 . . . . 0.68 111.138 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.92 -52.95 30.27 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.361 0.6 . . . . 1.77 109.497 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -66.97 -26.63 66.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.31 -0.859 . . . . 2.1 110.444 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 94.1 mt-10 -61.99 -35.39 78.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.979 0.419 . . . . 2.57 110.832 175.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.83 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 11.3 mmt -82.3 -37.1 26.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.237 0.541 . . . . 1.21 110.398 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.48 HG21 HD13 ' A' ' 57' ' ' ILE . 79.3 mt -69.59 -44.02 79.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 1.2 111.203 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -69.81 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.746 0.308 . . . . 2.3 110.248 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -57.9 -43.42 86.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.522 -0.918 . . . . 2.11 108.522 171.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.96 -38.72 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 1.41 110.615 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.4 t -53.39 -46.3 69.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.472 -0.331 . . . . 1.82 111.303 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -74.95 -30.78 61.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.828 0.346 . . . . 2.73 111.07 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.555 ' HG2' ' HE2' ' A' ' 175' ' ' LYS . 13.8 tmm? -62.07 -40.72 96.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.176 -0.465 . . . . 2.12 110.329 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.32 1.53 2.89 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.489 -0.778 . . . . 4.27 112.141 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -61.71 -49.72 75.32 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.616 -0.678 . . . . 3.91 111.557 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.9 tp -120.96 -54.98 2.01 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.637 -0.425 . . . . 6.06 111.196 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.555 ' HE2' ' HG2' ' A' ' 171' ' ' MET . 0.3 OUTLIER -103.76 169.04 8.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.29 -0.414 . . . . 5.86 110.344 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.83 28.63 0.84 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.157 0.503 . . . . 5.79 110.37 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.795 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 47.1 t30 -162.89 -61.22 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 8.44 111.774 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 73.5 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.65 2.233 . . . . 9.2 112.999 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.726 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 111.814 -0.515 . . . . 11.83 111.814 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -70.7 96.75 1.26 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.015 0.436 . . . . 10.75 110.246 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.77 123.12 18.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 10.82 110.595 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 97.2 mmm -102.07 -26.72 13.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.302 -0.408 . . . . 9.01 110.777 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.29 125.97 53.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.304 0.573 . . . . 6.14 110.276 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.19 163.24 17.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.997 -0.547 . . . . 5.7 109.74 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.678 ' HG2' HG13 ' A' ' 78' ' ' VAL . 23.9 tpp180 -142.99 103.71 5.22 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.909 -0.404 . . . . 7.55 109.909 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 134.12 58.24 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.26 1.973 . . . . 3.21 111.48 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.12 94.21 0.23 Allowed 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.886 2.391 . . . . 3.14 111.995 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.8 m -72.29 143.68 13.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 2.53 110.29 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.678 ' HB ' ' HA ' ' A' ' 59' ' ' PHE . 22.8 t -113.34 162.65 11.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.844 -0.616 . . . . 1.95 109.672 -175.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 58.2 m -136.78 116.49 13.01 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.232 -0.655 . . . . 1.27 109.232 170.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.33 134.76 26.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.712 0.768 . . . . 1.83 110.691 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.509 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 66.3 mtt -138.38 -179.75 5.98 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.052 -0.977 . . . . 1.28 108.883 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' HA2' HD12 ' A' ' 84' ' ' LEU . . . 143.93 -171.44 25.49 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.511 -0.852 . . . . 0.34 112.362 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.634 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 38.9 t60 -98.05 160.96 13.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.91 0.862 . . . . 0.28 111.914 -177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.521 HG12 ' CE1' ' A' ' 16' ' ' HIS . 7.4 p -73.56 150.89 7.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.318 -1.31 . . . . 1.09 110.11 174.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.598 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 17.6 t70 74.01 -32.62 0.24 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.225 0.61 . . . . 0.69 110.749 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.526 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 18.9 m170 -66.32 -20.51 66.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.733 -0.84 . . . . 0.63 108.733 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 126.46 55.83 0.15 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.79 113.331 174.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' HD3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -64.99 -61.19 2.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 117.46 0.63 . . . . 3.69 110.539 176.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.591 HG21 HG23 ' A' ' 45' ' ' ILE . 25.5 m -87.16 -41.76 13.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.972 0.415 . . . . 1.76 110.954 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.439 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -57.64 -33.83 68.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.087 0.773 . . . . 1.71 113.087 -175.198 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -72.41 -43.66 63.58 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.064 -0.717 . . . . 2.09 109.064 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.765 HD11 ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -66.68 -17.56 64.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 2.23 110.494 -178.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -94.21 -43.21 8.56 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.842 0.829 . . . . 1.23 108.958 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.24 97.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.24 -1.346 . . . . 1.23 109.587 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.487 HG12 ' HE3' ' A' ' 32' ' ' LYS . 10.2 tt -65.22 -25.93 38.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.452 -1.249 . . . . 1.59 111.224 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 19.0 mmm180 -65.23 -37.28 86.79 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.363 0.601 . . . . 3.51 109.892 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -103.6 22.87 13.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.061 -0.972 . . . . 3.14 111.114 -172.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.4 m -111.45 -20.68 12.13 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.414 -0.812 . . . . 1.96 112.21 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.773 ' HE2' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -168.39 -176.72 2.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.737 0.303 . . . . 4.37 110.889 -178.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 t -66.4 151.17 10.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.722 -0.672 . . . . 3.59 111.824 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 t -158.57 167.87 28.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.433 -0.803 . . . . 2.99 109.388 171.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -108.92 -173.21 2.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.803 0.335 . . . . 6.34 110.497 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -79.07 68.1 4.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.439 0.638 . . . . 7.38 112.445 -171.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -116.32 118.49 32.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.525 -0.761 . . . . 6.24 109.09 172.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.52 95.92 3.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.353 -0.385 . . . . 5.33 111.248 -178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.29 -4.21 55.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.893 -0.67 . . . . 4.68 112.115 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.95 85.82 0.14 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.377 -0.689 . . . . 5.06 111.377 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.65 128.41 74.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.715 0.293 . . . . 5.91 110.669 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.2 m 67.28 -77.72 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.715 -0.675 . . . . 6.29 110.609 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -155.18 10.98 0.33 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.581 -0.896 . . . . 6.97 108.581 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -90.56 101.75 14.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.338 -0.846 . . . . 7.26 110.231 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.591 HG23 HG21 ' A' ' 22' ' ' THR . 45.3 pt -96.05 -172.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.54 -0.755 . . . . 5.68 110.945 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.03 -86.32 0.14 Allowed Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.728 -0.669 . . . . 2.62 111.607 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.765 ' HA ' HD11 ' A' ' 25' ' ' LEU . . . -177.06 -170.33 0.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.62 -0.511 . . . . 1.8 109.62 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HH ' HG21 ' A' ' 28' ' ' ILE . 18.1 p90 -171.68 -176.88 1.87 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.689 -0.486 . . . . 1.92 109.689 -170.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 65.4 mt-30 -87.75 112.59 22.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.393 -0.367 . . . . 2.22 110.437 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.902 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 58.6 t -77.2 167.99 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.546 -0.538 . . . . 2.09 109.546 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.845 HG23 ' HA ' ' A' ' 54' ' ' ASP . 44.2 m -154.11 82.69 1.14 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.662 -0.866 . . . . 1.99 108.662 -174.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.753 HG13 ' H ' ' A' ' 53' ' ' ASN . 2.3 p -64.62 -60.18 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.635 0.731 . . . . 2.62 109.43 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.753 ' H ' HG13 ' A' ' 52' ' ' VAL . 1.9 p30 -104.12 -63.23 1.22 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.648 -1.16 . . . . 4.06 108.294 172.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.845 ' HA ' HG23 ' A' ' 51' ' ' THR . 8.5 p-10 -168.96 43.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.48 -1.236 . . . . 2.99 109.491 169.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.742 ' HE3' ' HB3' ' A' ' 169' ' ' SER . 19.9 ttmm -111.55 124.11 51.61 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.776 -0.824 . . . . 7.77 108.776 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -72.99 80.23 1.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.796 0.685 . . . . 4.8 111.205 -174.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.902 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 9.7 mt -79.07 80.11 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.776 -0.824 . . . . 1.6 108.776 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 5.1 m -77.57 102.15 6.85 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.71 -0.677 . . . . 1.48 110.285 -177.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.678 ' HA ' ' HB ' ' A' ' 11' ' ' VAL . 7.9 m-30 -66.04 0.51 1.88 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.755 -1.111 . . . . 1.63 113.462 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.753 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 35.5 tp -175.03 126.5 0.27 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.577 0.227 . . . . 3.67 110.525 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 69' ' ' THR . 2.7 t0 -77.7 115.52 17.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.087 -0.506 . . . . 5.61 110.798 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 m 67.87 104.18 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.035 -0.53 . . . . 5.77 110.88 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -40.69 98.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.846 3.031 . . . . 6.26 113.58 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.19 171.84 12.58 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.344 -1.103 . . . . 6.42 110.344 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.474 ' CB ' ' HA ' ' A' ' 69' ' ' THR . 64.8 m-70 62.34 56.59 2.11 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.776 -0.453 . . . . 9.55 109.776 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.55 -38.39 84.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.927 -0.579 . . . . 7.05 111.859 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.7 60.62 6.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.778 0.323 . . . . 5.07 110.246 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' HD2' ' HD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER 70.1 143.64 0.05 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.839 -1.073 . . . . 2.66 110.994 -174.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.474 ' HA ' ' CB ' ' A' ' 65' ' ' HIS . 8.7 p -79.76 61.71 3.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.713 -0.676 . . . . 5.25 111.668 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.5 m 67.82 -75.11 0.07 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.378 -0.828 . . . . 6.21 111.076 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 63.2 mtt 53.2 71.32 0.5 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.967 0.413 . . . . 5.21 111.248 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -84.97 -9.63 57.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.295 -0.412 . . . . 8.75 110.837 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.02 -64.23 0.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.385 -0.37 . . . . 6.65 110.864 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 18.4 tpt180 54.17 67.09 1.06 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.72 -0.673 . . . . 10.34 110.191 -175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -54.48 36.06 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.61 -0.723 . . . . 5.22 112.19 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.21 106.15 12.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.814 -0.439 . . . . 5.89 109.814 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -67.62 -28.0 67.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 6.97 110.125 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.678 HG13 ' HG2' ' A' ' 7' ' ' ARG . 5.2 m 33.43 -102.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.618 -1.174 . . . . 4.68 113.252 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.677 ' H ' HG21 ' A' ' 78' ' ' VAL . 28.6 m -160.26 76.31 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.749 -0.463 . . . . 3.84 109.749 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' A' ' 108' ' ' VAL . 56.6 m-20 -79.8 146.71 32.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.731 -0.47 . . . . 2.66 109.731 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.2 mt -134.12 133.76 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.665 -0.243 . . . . 1.38 110.604 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 110' ' ' ILE . 25.9 t -112.06 129.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 120.707 -0.397 . . . . 1.79 111.358 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 10.8 mt -97.92 132.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 1.14 110.975 174.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.939 ' HB3' HG13 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -109.44 112.02 23.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.512 -0.767 . . . . 1.65 111.364 -178.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.7 t -87.55 94.12 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.098 0.475 . . . . 1.14 110.067 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 84' ' ' LEU . 7.3 m -117.24 128.22 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.723 -0.671 . . . . 1.31 110.698 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.538 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -79.21 134.07 36.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.464 -0.569 . . . . 1.01 109.464 175.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.755 ' HA ' HG23 ' A' ' 127' ' ' VAL . . . -71.72 -8.02 51.64 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.079 0.466 . . . . 1.07 110.812 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.454 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -85.38 -17.38 36.87 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.355 -0.839 . . . . 0.58 110.972 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.526 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 24.8 t0 -132.0 -49.36 0.94 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.453 -0.34 . . . . 0.56 111.243 -170.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.635 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.24 -137.56 13.39 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 121.007 -0.616 . . . . 0.37 113.629 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 130' ' ' GLU . 6.9 p -88.47 138.51 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.35 -0.611 . . . . 1.78 109.35 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.825 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.4 mmm -142.78 178.2 1.57 Allowed Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.232 -0.655 . . . . 1.07 109.232 -171.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.825 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 49.3 Cg_exo -36.77 -69.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.544 2.829 . . . . 0.89 114.847 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.512 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 8.5 pt20 -73.69 -20.84 60.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.031 0.443 . . . . 0.78 111.346 -175.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.634 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.92 -43.78 82.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.677 -0.692 . . . . 1.07 109.373 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 93' ' ' MET . 47.6 t -66.92 -44.78 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.07 -0.968 . . . . 2.02 110.841 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.2 mm-40 -65.86 -14.84 62.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.153 0.502 . . . . 2.35 110.227 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 14' ' ' MET . . . -81.92 -38.4 25.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.556 -0.747 . . . . 1.12 110.086 170.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 95.6 mt -73.98 -42.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.642 0.734 . . . . 1.14 109.425 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -57.99 -30.31 65.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.577 -1.192 . . . . 0.75 110.503 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.507 ' HD2' ' HD2' ' A' ' 68' ' ' PHE . 3.9 t60 -80.66 -37.73 30.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.32 0.581 . . . . 3.23 109.889 177.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.49 70.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.882 -0.599 . . . . 1.17 111.546 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.5 mmmm -72.79 -32.06 65.3 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.145 0.497 . . . . 2.27 110.133 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -44.51 54.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.731 -1.122 . . . . 1.28 110.798 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.57 -26.92 34.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 1.31 110.591 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 64.51 88.47 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.434 0.694 . . . . 1.6 110.908 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.573 HG23 ' HD2' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -143.56 154.26 59.58 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.488 -0.778 . . . . 1.93 109.83 -176.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.573 ' HD2' HG23 ' A' ' 108' ' ' VAL . 21.6 Cg_exo -61.21 140.51 89.27 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.482 2.121 . . . . 0.66 111.923 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.4 mt -119.68 156.52 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.152 0.977 . . . . 1.34 111.917 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 1.014 HD12 ' HB ' ' A' ' 146' ' ' ILE . 19.0 mm -125.36 83.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.444 -1.707 . . . . 1.12 107.49 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.939 HG13 ' HB3' ' A' ' 84' ' ' LEU . 17.9 t -76.61 148.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.775 -0.77 . . . . 1.06 108.93 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.846 ' HB3' HD22 ' A' ' 150' ' ' LEU . . . -137.74 109.42 7.05 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.819 -1.082 . . . . 1.07 110.25 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.778 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -75.98 132.78 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.128 -1.396 . . . . 1.29 109.43 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.528 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 54.4 t30 -114.06 168.68 9.6 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 107.454 -1.313 . . . . 1.85 107.454 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.723 ' HG2' ' N2 ' ' A' ' 179' ' ' GDP . 73.6 mttt 72.42 31.86 1.72 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.117 0.885 . . . . 1.18 112.001 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.773 ' HE3' ' HB3' ' A' ' 149' ' ' LYS . 11.4 mmt -72.8 -14.96 61.63 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.699 -0.682 . . . . 1.64 109.767 166.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.1 p-10 -69.7 -22.05 63.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.851 -1.068 . . . . 0.76 108.915 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.84 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 11.0 mmpt? -88.68 133.14 36.62 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.345 -1.298 . . . . 1.74 110.609 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.11 -11.69 28.76 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.878 2.385 . . . . 0.68 111.481 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -85.38 2.23 45.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.773 -1.103 . . . . 1.45 110.314 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -55.68 107.62 0.36 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.382 -0.826 . . . . 1.1 111.062 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.684 HD21 ' HB2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -121.75 76.52 37.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.723 -0.843 . . . . 0.95 108.723 174.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.556 ' HG3' ' HE2' ' A' ' 117' ' ' MET . 45.2 Cg_endo -66.18 -55.01 0.42 Allowed 'Trans proline' 0 CA--C 1.503 -1.034 0 C-N-CA 123.079 2.52 . . . . 0.54 113.223 -171.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.438 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 11.9 m-20 -50.88 -27.64 7.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.189 -0.914 . . . . 1.44 110.386 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.684 ' HB2' HD21 ' A' ' 123' ' ' ASN . 32.2 tpt180 -79.63 -55.9 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 4.56 109.649 -178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.755 HG23 ' HA ' ' A' ' 88' ' ' ALA . 16.3 m -65.35 -28.94 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.476 -0.784 . . . . 1.26 112.078 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.6 ptm -79.4 -19.33 50.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.157 -0.34 . . . . 1.64 110.486 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.641 ' O ' ' HG3' ' A' ' 132' ' ' MET . 13.0 mt-30 -74.4 -32.89 62.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.562 -0.29 . . . . 2.0 110.704 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.461 ' HB3' HG13 ' A' ' 92' ' ' VAL . 2.7 mm-40 -57.83 -46.29 84.94 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.569 0.699 . . . . 1.64 109.97 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 11.2 mp -66.38 -34.85 78.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.522 -0.763 . . . . 1.96 111.295 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.899 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -75.79 -7.89 55.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.724 -0.79 . . . . 2.05 110.738 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -82.45 -26.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.439 -0.948 . . . . 1.67 108.439 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.13 26.69 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.819 0.819 . . . . 1.58 109.854 165.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 53.78 57.0 6.46 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.983 -1.462 . . . . 1.42 111.673 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.777 ' H ' ' HA ' ' A' ' 132' ' ' MET . 62.8 mt -121.62 96.31 5.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.323 -0.853 . . . . 1.93 109.395 170.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.584 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.7 t -94.93 114.58 63.96 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.493 0.663 . . . . 1.18 112.162 -170.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.579 ' HA ' ' HD1' ' A' ' 147' ' ' PHE . 86.1 Cg_exo -45.29 152.63 0.7 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.651 3.567 . . . . 0.88 112.981 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.421 ' HB3' HD11 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -78.43 -19.36 53.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.253 -1.339 . . . . 3.08 109.663 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -70.21 -17.49 63.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.246 -0.888 . . . . 1.57 110.771 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.899 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 44.0 m0 -106.61 -24.96 12.0 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.803 0.335 . . . . 0.66 111.117 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.62 15.56 5.34 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.128 -1.034 . . . . 0.57 113.998 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.584 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.05 -121.11 2.17 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.523 -1.322 . . . . 0.6 111.383 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -164.95 63.01 0.13 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 124.179 1.942 . . . . 1.91 110.496 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.585 ' CG2' HG21 ' A' ' 112' ' ' VAL . 85.9 m -141.7 104.92 4.62 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.689 -2.05 . . . . 1.1 107.361 173.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 1.014 ' HB ' HD12 ' A' ' 111' ' ' ILE . 42.2 mm -74.02 92.3 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-O 121.855 0.836 . . . . 1.27 110.054 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.579 ' HD1' ' HA ' ' A' ' 138' ' ' PRO . 30.6 m-85 -75.81 107.83 8.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.038 -1.437 . . . . 0.53 110.447 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.9 m -98.96 108.22 20.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.004 -0.998 . . . . 1.0 110.211 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.778 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 76.9 mttt -83.36 99.4 10.01 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.902 -0.59 . . . . 1.96 109.867 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.4 pp -128.42 -167.09 1.72 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 1.49 112.463 -174.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.55 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 12.0 t -166.75 119.87 1.01 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.994 -1.912 . . . . 2.07 106.001 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.71 -5.84 51.9 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.124 -0.631 . . . . 1.11 109.372 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 19.5 mmtt -87.23 -37.37 17.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.391 -0.822 . . . . 2.78 111.498 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.55 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 11.6 p -87.69 -13.88 41.35 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.62 -0.832 . . . . 1.35 110.63 171.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 19.4 mmtp 59.64 45.39 13.17 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.95 -1.023 . . . . 1.9 109.703 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 4.4 tp10 -99.03 -68.5 0.8 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.487 -1.233 . . . . 2.48 110.557 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -80.55 2.75 77.02 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.531 -0.842 . . . . 0.36 113.454 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.424 HD11 ' CD ' ' A' ' 155' ' ' LYS . 30.5 mt -74.32 -39.62 62.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.069 0.934 . . . . 1.42 108.879 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 19.4 t70 -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.358 -0.837 . . . . 2.2 108.936 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.471 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 81.9 t60 -67.43 -17.61 64.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.525 -0.761 . . . . 0.68 111.333 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 165' ' ' ILE . 51.6 tp -68.94 -56.9 6.41 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.03 0.443 . . . . 1.77 110.028 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.17 -38.56 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.21 -0.904 . . . . 2.1 109.731 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 31.7 mm-40 -56.39 -41.93 77.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.325 -0.852 . . . . 2.57 111.445 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.838 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 13.7 mmt -77.52 -32.25 53.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 1.21 110.576 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.746 HG23 HD13 ' A' ' 57' ' ' ILE . 75.7 mt -65.14 -47.18 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.619 . . . . 1.2 111.093 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 3.9 pp -65.6 -29.29 69.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.862 0.363 . . . . 2.3 111.261 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.404 ' N ' HD13 ' A' ' 166' ' ' LEU . 35.2 tp -56.25 -49.26 74.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.67 . . . . 2.11 109.708 170.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.51 ' HA ' ' HG2' ' A' ' 171' ' ' MET . 57.5 t -65.92 -37.51 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.521 -0.763 . . . . 1.41 110.26 174.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.742 ' HB3' ' HE3' ' A' ' 55' ' ' LYS . 19.6 m -66.46 -7.54 20.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.922 -0.581 . . . . 1.82 111.476 175.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -96.51 -32.41 12.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.016 0.436 . . . . 2.73 110.306 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 17.3 ptp -79.36 -11.52 59.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 2.12 110.656 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 169' ' ' SER . 11.7 pt-20 -67.51 -21.28 65.49 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.732 -0.47 . . . . 4.27 109.732 176.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.419 ' HB2' ' H ' ' A' ' 174' ' ' LEU . 28.2 mt-10 -86.49 -85.72 0.16 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.932 -0.576 . . . . 3.91 110.391 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.419 ' H ' ' HB2' ' A' ' 173' ' ' GLU . 60.1 mt -139.32 -21.4 0.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.135 -0.938 . . . . 6.06 111.041 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -74.96 75.54 2.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.664 -0.698 . . . . 5.86 112.074 -170.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.09 -41.48 50.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.897 0.38 . . . . 5.79 110.119 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -133.53 111.26 12.59 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.036 0.446 . . . . 8.44 110.53 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.072 2.515 . . . . 9.2 111.401 177.805 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.723 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.861 -0.495 . . . . 11.83 111.861 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 p -80.88 102.49 10.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.964 0.412 . . . . 10.75 110.009 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -87.42 -45.7 10.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.387 -0.37 . . . . 10.82 110.889 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.6 mtp -82.45 73.65 9.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.122 0.486 . . . . 9.01 110.814 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -83.6 101.47 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.349 -0.611 . . . . 6.14 109.349 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.45 104.03 8.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 5.7 109.953 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -110.11 100.6 44.49 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.274 -0.421 . . . . 7.55 110.438 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.56 130.91 26.23 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.51 2.14 . . . . 3.21 111.221 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -48.22 114.47 1.16 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.203 2.602 . . . . 3.14 112.569 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.465 HG11 HD13 ' A' ' 60' ' ' LEU . 39.4 t -82.2 128.8 38.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.468 -0.568 . . . . 2.53 109.468 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.53 95.22 2.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.017 0.437 . . . . 1.95 110.798 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.524 HG23 ' HB2' ' A' ' 68' ' ' PHE . 88.5 m -72.2 124.95 26.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.197 -0.456 . . . . 1.27 110.31 175.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 25' ' ' LEU . 59.5 mt -96.37 127.93 48.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.915 0.388 . . . . 1.83 110.653 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.53 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . 60.1 mtt -136.34 175.55 9.5 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.037 -0.529 . . . . 1.28 109.823 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.48 -168.97 27.16 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.89 -0.671 . . . . 0.34 111.7 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.683 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 47.1 t60 -89.66 158.49 17.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.86 0.838 . . . . 0.28 111.48 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.523 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.1 p -72.18 148.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.562 -1.199 . . . . 1.09 109.697 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 23.6 t70 73.81 -19.36 0.35 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.457 0.646 . . . . 0.69 110.502 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 17' ' ' VAL . 15.6 m170 -84.67 -0.68 54.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.974 -1.121 . . . . 0.63 107.974 168.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 87.76 49.48 3.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.163 -0.926 . . . . 0.79 113.86 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HG2' ' PB ' ' A' ' 179' ' ' GDP . 50.6 pttt -63.67 -36.57 84.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.31 -0.556 . . . . 3.69 111.508 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 m -101.8 -42.41 6.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 1.76 110.454 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -54.11 -19.47 5.02 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.125 0.787 . . . . 1.71 113.125 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -74.83 -45.24 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.259 -0.645 . . . . 2.09 109.259 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.443 ' HB2' HD13 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -66.39 -16.12 63.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.731 -1.122 . . . . 2.23 109.199 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 18.9 t70 -97.78 -41.5 8.03 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.701 0.762 . . . . 1.23 110.194 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -29.1 69.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.817 -1.083 . . . . 1.23 110.132 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.9 tt -71.0 -23.28 23.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.662 -1.154 . . . . 1.59 110.128 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 31' ' ' SER . 96.6 mtt180 -68.5 -56.05 9.68 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.706 -0.679 . . . . 3.51 110.045 174.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -79.49 27.57 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.835 0.826 . . . . 3.14 111.12 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 29' ' ' ARG . 23.6 t -117.99 -21.65 8.21 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.729 -1.123 . . . . 1.96 110.633 176.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.804 ' HZ1' ' HB3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER 178.95 -167.05 0.07 Allowed 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.795 -0.446 . . . . 4.37 109.795 -178.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.79 HG12 ' H ' ' A' ' 34' ' ' THR . 4.0 p 40.21 -86.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.497 1.119 . . . . 3.59 113.64 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.867 HG22 ' HA2' ' A' ' 39' ' ' GLY . 23.3 p -99.93 104.31 15.94 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.484 0.659 . . . . 2.99 110.952 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -82.39 -38.38 24.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.816 -1.084 . . . . 6.34 112.152 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -158.52 -50.46 0.06 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.935 0.398 . . . . 7.38 110.593 -174.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -86.26 133.53 33.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.899 -0.591 . . . . 6.24 110.817 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 62.87 -165.56 0.24 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.715 0.634 . . . . 5.33 112.403 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.867 ' HA2' HG22 ' A' ' 34' ' ' THR . . . 134.55 -69.07 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.764 -0.653 . . . . 4.68 111.794 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.26 79.01 0.13 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.659 -0.977 . . . . 5.06 110.659 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.419 ' C ' ' HG1' ' A' ' 42' ' ' THR . 45.6 mt -77.77 115.52 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.889 0.852 . . . . 5.91 112.0 -173.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.419 ' HG1' ' C ' ' A' ' 41' ' ' ILE . 13.0 m -150.44 147.23 27.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.647 -1.161 . . . . 6.29 107.971 174.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -91.54 47.21 1.35 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.392 0.615 . . . . 6.97 111.656 -169.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.426 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 5.5 p-80 -175.94 42.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.057 -0.974 . . . . 7.26 108.699 175.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 44' ' ' HIS . 50.7 mm 73.14 156.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.015 -0.993 . . . . 5.68 109.214 -168.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -155.69 103.1 0.23 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.635 -0.793 . . . . 2.62 112.695 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' A' ' 59' ' ' PHE . . . -66.16 169.87 6.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.692 -0.484 . . . . 1.8 109.692 172.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.476 ' HH ' ' HA ' ' A' ' 29' ' ' ARG . 1.6 p90 -161.18 164.01 30.79 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 118.614 -1.234 . . . . 1.92 113.039 -163.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.463 ' HG2' HG21 ' A' ' 58' ' ' THR . 17.3 mt-30 -92.02 122.51 34.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.8 -1.091 . . . . 2.22 109.383 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.2 m -87.1 162.39 2.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.112 0.482 . . . . 2.09 110.694 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 54' ' ' ASP . 22.8 m -99.11 82.16 2.68 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.302 0.572 . . . . 1.99 109.91 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 p -78.84 -28.22 13.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.256 -1.016 . . . . 2.62 108.256 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -149.03 -52.19 0.16 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.53 -1.668 . . . . 4.06 107.848 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' HA ' HG23 ' A' ' 51' ' ' THR . 29.6 t70 -173.88 87.42 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.026 -0.988 . . . . 2.99 110.438 169.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 73.12 3.33 4.63 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.48 0.919 . . . . 7.77 113.48 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -76.84 153.32 34.93 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.614 -0.435 . . . . 4.8 110.75 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.6 mt 72.95 98.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.668 0.747 . . . . 1.6 110.722 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.463 HG21 ' HG2' ' A' ' 49' ' ' GLN . 8.5 m -102.54 100.59 10.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.237 -0.892 . . . . 1.48 109.731 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.771 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 90.5 m-85 -74.26 119.07 17.95 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.269 -1.011 . . . . 1.63 108.269 176.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.723 ' HB3' ' HG3' ' A' ' 63' ' ' PRO . 87.8 mt -125.74 130.96 52.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.959 0.409 . . . . 3.67 111.659 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -110.3 -41.08 4.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.745 -0.661 . . . . 5.61 109.707 174.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.8 t -134.13 77.85 60.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 121.884 0.849 . . . . 5.77 110.672 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.845 ' HG2' ' HB3' ' A' ' 67' ' ' ALA . 26.1 Cg_exo -63.82 -65.6 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.166 2.578 . . . . 6.26 112.928 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.33 -71.55 0.4 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.316 -0.945 . . . . 6.42 113.556 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -75.55 -77.96 0.12 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.896 0.379 . . . . 9.55 111.757 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.54 99.42 3.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.405 0.622 . . . . 7.05 111.08 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.845 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . . . -165.59 86.06 0.37 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.862 -1.063 . . . . 5.07 110.172 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.737 ' H ' ' HE2' ' A' ' 71' ' ' MET . 82.6 m-85 45.02 -88.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.756 -1.111 . . . . 2.66 113.973 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 m -52.24 -42.68 63.83 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.266 0.555 . . . . 5.25 110.459 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.9 p -111.0 77.98 1.08 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.798 -0.637 . . . . 6.21 109.914 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.737 ' HE2' ' H ' ' A' ' 68' ' ' PHE . 56.6 ttm -138.58 87.59 2.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.02 0.438 . . . . 5.21 110.305 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -67.42 -31.84 72.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.634 -0.712 . . . . 8.75 110.708 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.08 86.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.881 -0.599 . . . . 6.65 111.592 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' H ' ' HG2' ' A' ' 71' ' ' MET . 27.4 ttm180 52.05 87.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.448 0.642 . . . . 10.34 111.22 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.44 23.56 1.1 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.57 -0.741 . . . . 5.22 111.739 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.48 111.36 22.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.753 0.311 . . . . 5.89 110.975 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.88 87.63 3.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.272 0.558 . . . . 6.97 110.099 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.71 152.44 10.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.43 -0.804 . . . . 4.68 109.104 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.2 m -72.08 81.37 0.96 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.458 -0.571 . . . . 3.84 109.458 175.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.597 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . 3.4 t0 -131.24 152.98 49.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.312 -0.858 . . . . 2.66 109.341 -173.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.6 mt -132.75 129.39 58.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.026 -0.731 . . . . 1.38 109.026 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.3 t -100.9 116.64 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 C-N-CA 119.408 -0.917 . . . . 1.79 112.183 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 9.2 mt -81.3 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.899 -1.046 . . . . 1.14 109.448 171.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.64 HD11 HG13 ' A' ' 86' ' ' VAL . 2.3 tm? -117.91 105.97 12.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.084 -1.08 . . . . 1.65 108.084 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 53.8 t -90.05 112.11 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.364 -0.834 . . . . 1.14 110.864 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.64 HG13 HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -121.32 129.67 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.733 -0.667 . . . . 1.31 110.874 175.765 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.631 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -70.63 130.69 42.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.896 -0.593 . . . . 1.01 109.935 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.657 ' HB1' ' CG2' ' A' ' 114' ' ' ILE . . . -71.54 -13.58 61.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 1.07 110.632 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.446 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -94.46 -2.42 51.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.686 -0.688 . . . . 0.58 111.521 -178.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.448 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 26.4 t0 -138.03 -49.26 0.56 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.652 -0.249 . . . . 0.56 110.891 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.601 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.36 -146.89 18.46 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.343 -0.456 . . . . 0.37 113.689 171.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.5 136.12 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 1.78 109.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.703 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.2 mmm -138.14 176.5 2.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 114.87 -1.059 . . . . 1.07 108.658 -171.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 55.8 Cg_exo -38.54 -69.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.607 2.872 . . . . 0.89 114.764 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.523 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 7.6 pt20 -72.4 -16.99 61.85 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.01 0.433 . . . . 0.78 111.47 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.683 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.71 -44.01 78.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.097 -0.705 . . . . 1.07 109.097 176.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 93' ' ' MET . 20.8 t -65.86 -41.36 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.22 -0.9 . . . . 2.02 111.096 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.81 -26.73 62.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 2.35 110.777 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 14' ' ' MET . . . -73.7 -34.95 65.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.184 -0.462 . . . . 1.12 110.382 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.493 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.8 mt -74.3 -46.69 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.472 0.653 . . . . 1.14 109.28 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -56.31 -40.56 74.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.608 -1.178 . . . . 0.75 110.491 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -70.65 -35.43 72.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.907 -0.588 . . . . 3.23 110.199 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.428 ' HB1' HD13 ' A' ' 110' ' ' ILE . . . -69.43 -46.92 65.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 1.17 111.109 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.5 mmtp -64.8 -38.68 91.79 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.19 0.519 . . . . 2.27 109.986 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -48.24 -43.31 32.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.301 -1.318 . . . . 1.28 111.239 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.73 -38.27 15.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 1.31 111.022 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 88.08 72.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.631 1.172 . . . . 1.6 109.113 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 109' ' ' PRO . 3.0 p -126.2 144.71 49.95 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.203 -1.362 . . . . 1.93 110.862 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.411 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.9 Cg_exo -66.45 139.32 53.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.716 1.611 . . . . 0.66 111.327 170.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.428 HD13 ' HB1' ' A' ' 103' ' ' ALA . 27.0 mm -104.83 157.4 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.571 0.7 . . . . 1.34 110.68 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 1.011 HD11 ' HB ' ' A' ' 146' ' ' ILE . 16.3 mm -122.91 83.72 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.346 -1.353 . . . . 1.12 107.346 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.891 HG22 HD21 ' A' ' 131' ' ' LEU . 63.5 t -71.14 143.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.907 0.861 . . . . 1.06 109.518 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.755 ' HB3' HD23 ' A' ' 150' ' ' LEU . . . -146.64 100.41 3.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.857 -1.52 . . . . 1.07 109.857 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.775 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 85.0 mt -72.25 140.13 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 113.749 -1.569 . . . . 1.29 109.91 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.631 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.2 p-10 -120.29 176.13 5.62 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.068 -1.456 . . . . 1.85 107.068 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.626 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 75.5 mttt 66.34 27.92 9.92 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.86 0.725 . . . . 1.18 112.165 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.763 ' HE3' ' HG3' ' A' ' 124' ' ' PRO . 85.8 mmm -80.86 -1.64 44.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.697 0.761 . . . . 1.64 109.074 171.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.626 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.4 p-10 -71.01 -31.7 68.27 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.84 -1.073 . . . . 0.76 108.664 168.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 119' ' ' LYS . 39.6 mtpt -77.41 136.75 64.25 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.128 -1.396 . . . . 1.74 110.833 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.78 -17.39 59.7 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.818 2.346 . . . . 0.68 111.683 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.05 1.62 27.04 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.695 -0.684 . . . . 1.45 110.687 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.487 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -56.03 114.9 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.594 -0.73 . . . . 1.1 110.638 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.69 75.46 55.49 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 107.885 -1.154 . . . . 0.95 107.885 173.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.763 ' HG3' ' HE3' ' A' ' 117' ' ' MET . 42.4 Cg_endo -64.86 -57.17 0.31 Allowed 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 122.492 2.128 . . . . 0.54 112.46 -172.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.478 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 4.3 m-20 -50.91 -26.57 6.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 124.2 0.938 . . . . 1.44 111.037 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -77.71 -59.23 2.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.892 -0.594 . . . . 4.56 110.071 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.601 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 4.7 m -64.67 -27.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.105 -0.952 . . . . 1.26 110.398 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.773 ' HE2' ' HG3' ' A' ' 138' ' ' PRO . 23.2 ttt -60.95 -51.79 67.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.726 -1.125 . . . . 1.64 109.815 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.426 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 35.2 mt-30 -59.15 -31.25 68.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.022 0.749 . . . . 2.0 113.022 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.506 ' HA ' ' CG ' ' A' ' 133' ' ' GLU . 4.3 pt-20 -80.91 -16.44 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.081 -0.647 . . . . 1.64 112.081 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.891 HD21 HG22 ' A' ' 112' ' ' VAL . 6.7 mp -68.17 -35.87 78.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.582 -0.847 . . . . 1.96 109.044 167.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.665 ' HE3' ' HG2' ' A' ' 128' ' ' MET . 0.5 OUTLIER -71.19 -18.75 62.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.437 -0.801 . . . . 2.05 109.618 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.506 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 7.9 mm-40 -70.45 -30.51 67.37 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.661 -0.866 . . . . 1.67 108.661 173.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.423 ' HH ' HG22 ' A' ' 97' ' ' VAL . 58.4 m-85 -91.97 17.3 9.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.059 -0.973 . . . . 1.58 109.959 173.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 61.11 47.84 6.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.233 -1.349 . . . . 1.42 111.27 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.473 HD12 HD21 ' A' ' 131' ' ' LEU . 1.5 pp -131.28 121.41 24.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.096 -1.076 . . . . 1.93 108.096 167.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.75 HG13 ' HD2' ' A' ' 138' ' ' PRO . 5.0 t -122.06 142.92 37.62 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.114 0.483 . . . . 1.18 111.382 -168.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.783 ' HB3' ' CD1' ' A' ' 147' ' ' PHE . 18.5 Cg_endo -69.86 -175.21 1.1 Allowed 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 123.621 2.88 . . . . 0.88 113.631 -176.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.817 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -84.61 -32.66 23.6 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.53 -1.668 . . . . 3.08 109.93 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.756 ' HG3' ' CD1' ' A' ' 141' ' ' TRP . 6.7 pt-20 -67.85 -17.66 64.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.092 -0.504 . . . . 1.57 111.205 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.756 ' CD1' ' HG3' ' A' ' 140' ' ' GLU . 21.2 m0 -109.04 -2.82 17.89 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.892 0.377 . . . . 0.66 111.183 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.81 32.13 13.68 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.058 -0.591 . . . . 0.57 113.784 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.19 -127.86 5.84 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.627 -0.796 . . . . 0.6 111.407 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -149.84 62.93 0.99 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.018 0.913 . . . . 1.91 111.894 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.818 HG21 HG23 ' A' ' 112' ' ' VAL . 52.7 m -161.27 128.14 4.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.165 -0.925 . . . . 1.1 109.99 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 1.011 ' HB ' HD11 ' A' ' 111' ' ' ILE . 46.8 mm -79.78 104.89 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 108.863 -0.792 . . . . 1.27 108.863 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.783 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 5.9 m-85 -88.56 116.74 27.02 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.584 -0.734 . . . . 0.53 111.706 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.1 m -106.76 143.31 35.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.814 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.567 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.5 mttt -118.15 97.91 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.885 -0.783 . . . . 1.96 108.885 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.899 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -130.63 -171.47 2.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.749 1.261 . . . . 1.49 112.569 -169.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.521 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 28.9 t -157.88 115.99 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.679 -1.601 . . . . 2.07 106.873 174.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.45 -9.92 58.99 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.084 -0.71 . . . . 1.11 109.084 175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.692 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 0.5 OUTLIER -74.18 -50.96 17.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.878 -1.055 . . . . 2.78 110.56 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 118' ' ' ASP . 2.1 p -81.39 -16.06 53.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.228 -0.589 . . . . 1.35 111.217 175.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.424 ' CD ' HD11 ' A' ' 158' ' ' LEU . 29.1 mmtp 67.21 40.66 2.75 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.307 -0.861 . . . . 1.9 110.539 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.572 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.4 OUTLIER -98.71 -64.66 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.022 -0.99 . . . . 2.48 109.663 -171.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.899 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -76.19 -3.01 74.89 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.111 -0.95 . . . . 0.36 113.433 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.424 HD11 ' CD ' ' A' ' 155' ' ' LYS . 18.1 mt -70.89 -36.16 72.63 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 117.974 0.887 . . . . 1.42 109.416 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.401 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 27.7 t70 -73.04 -39.95 65.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 2.2 109.257 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -68.52 -18.11 64.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.212 -0.449 . . . . 0.68 111.346 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.8 tp -74.81 -54.27 7.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.24 0.543 . . . . 1.77 110.08 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.52 -27.64 69.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.267 -0.879 . . . . 2.1 111.529 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.431 -0.507 . . . . 2.57 110.22 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.797 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 21.7 mmt -71.72 -39.39 70.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.17 0.509 . . . . 1.21 109.649 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.25 -38.7 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.519 -0.764 . . . . 1.2 110.443 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -40.38 95.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.504 . . . . 2.3 111.146 177.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.98 -43.46 63.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.466 0.65 . . . . 2.11 109.561 173.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.37 -40.48 80.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.756 -1.111 . . . . 1.41 110.769 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.7 m -60.77 -35.22 75.87 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.977 0.418 . . . . 1.82 111.225 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.81 -13.93 57.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.894 -0.504 . . . . 2.73 110.499 177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.696 ' HG2' ' HA ' ' A' ' 175' ' ' LYS . 44.5 ttp -91.45 -9.03 46.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 2.12 110.878 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -37.78 -41.87 0.54 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.065 1.135 . . . . 4.27 114.065 -176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -99.39 -41.65 7.32 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.463 -0.495 . . . . 3.91 111.497 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 171' ' ' MET . 0.9 OUTLIER -99.56 47.31 0.96 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.003 0.371 . . . . 6.06 112.003 -174.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.872 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 1.5 mppt? -49.22 141.26 8.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.004 -0.543 . . . . 5.86 111.605 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -124.3 79.02 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.338 -0.392 . . . . 5.79 110.416 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -81.3 143.97 53.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.844 -0.428 . . . . 8.44 109.844 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.945 2.43 . . . . 9.2 112.185 -179.565 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.692 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.479 -0.648 . . . . 11.83 111.479 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.0 t -106.72 2.35 25.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.873 0.368 . . . . 10.75 110.33 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -101.96 106.12 17.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.357 -0.383 . . . . 10.82 110.224 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 ttp -106.8 -20.69 13.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.787 -0.82 . . . . 9.01 108.787 170.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 m -93.01 132.89 35.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.121 -0.945 . . . . 6.14 110.148 175.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -102.52 147.31 26.92 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.468 -0.567 . . . . 5.7 109.468 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -125.37 100.56 32.13 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.996 0.426 . . . . 7.55 111.285 -173.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 23.4 Cg_exo -64.53 124.81 13.85 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.643 2.229 . . . . 3.21 110.952 175.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 36.2 Cg_exo -58.26 103.31 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.777 2.318 . . . . 3.14 113.024 -176.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -84.63 115.7 27.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.267 -1.012 . . . . 2.53 108.267 171.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 74.2 t -109.1 135.1 49.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.176 -0.465 . . . . 1.95 111.405 -171.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.499 ' HB ' HG22 ' A' ' 82' ' ' VAL . 89.1 m -88.66 133.79 34.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.686 -0.688 . . . . 1.27 110.251 178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mt -112.62 122.34 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.051 -0.406 . . . . 1.83 110.402 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.791 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 59.2 mtt -139.65 173.56 11.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.048 -0.524 . . . . 1.28 109.953 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.478 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 145.32 -163.54 28.12 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.641 -0.79 . . . . 0.34 112.335 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.737 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 42.7 t60 -97.1 161.28 13.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.822 0.82 . . . . 0.28 112.031 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.585 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.8 p -73.72 151.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.339 -1.301 . . . . 1.09 109.739 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 10.7 t70 73.39 -27.09 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.304 0.574 . . . . 0.69 110.605 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.0 m170 -77.38 -10.47 59.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.407 -0.96 . . . . 0.63 108.407 171.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.673 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 113.72 51.95 0.48 Allowed Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.605 -0.807 . . . . 0.79 114.22 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 4.2 tptm -53.31 -62.77 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.447 0.623 . . . . 3.69 111.283 174.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -96.07 -32.11 12.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.579 -0.282 . . . . 1.76 111.079 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.547 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -59.34 -20.84 57.87 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.018 0.747 . . . . 1.71 113.018 -179.006 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.673 HD23 ' HA3' ' A' ' 20' ' ' GLY . 1.5 mm? -74.52 -35.73 63.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.919 0.39 . . . . 2.09 110.001 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -74.02 -15.11 61.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.79 -0.641 . . . . 2.23 109.466 176.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -96.5 -32.03 12.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.706 -0.679 . . . . 1.23 109.29 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -47.32 49.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.198 -0.91 . . . . 1.23 109.051 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 tt -59.34 -25.99 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.68 -1.145 . . . . 1.59 110.244 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' HD2' ' HA3' ' A' ' 39' ' ' GLY . 13.9 tpp85 -64.47 -50.17 68.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.666 -1.152 . . . . 3.51 110.684 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -96.66 22.5 8.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.866 0.841 . . . . 3.14 111.238 -172.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.1 m -98.77 -43.95 6.58 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.784 -1.098 . . . . 1.96 109.616 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -174.42 -169.17 0.43 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.51 -0.768 . . . . 4.37 109.238 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.575 HG11 ' H ' ' A' ' 34' ' ' THR . 3.4 p 48.28 -75.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.626 1.171 . . . . 3.59 113.754 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.575 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.1 p -79.05 123.17 27.07 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.701 0.63 . . . . 2.99 112.701 -172.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.659 ' HG3' ' HG2' ' A' ' 37' ' ' GLU . 8.9 pt-20 -94.96 -146.56 0.27 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.522 -0.763 . . . . 6.34 109.365 173.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -78.86 35.24 0.24 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.38 0.61 . . . . 7.38 111.395 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.659 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 66.4 mm-40 -100.39 -179.56 4.15 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.674 -0.694 . . . . 6.24 109.572 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.71 94.28 1.01 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.901 0.381 . . . . 5.33 110.263 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.426 ' HA3' ' HD2' ' A' ' 29' ' ' ARG . . . -78.07 61.21 3.8 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.118 -0.492 . . . . 4.68 112.745 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 48' ' ' TYR . . . 167.86 126.07 0.82 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.899 -0.88 . . . . 5.06 110.899 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.419 ' C ' ' HG1' ' A' ' 42' ' ' THR . 34.6 mm -91.19 67.56 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.392 0.615 . . . . 5.91 110.424 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 44' ' ' HIS . 2.2 m -167.27 161.36 14.29 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.507 -0.924 . . . . 6.29 108.507 177.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -86.93 8.55 22.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.084 0.945 . . . . 6.97 109.168 172.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.52 ' O ' ' HB ' ' A' ' 42' ' ' THR . 85.7 m-70 -130.02 135.12 47.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.729 -1.123 . . . . 7.26 108.188 173.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 46' ' ' GLY . 9.4 tp -74.86 153.96 6.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.468 0.652 . . . . 5.68 110.654 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' O ' ' HG ' ' A' ' 25' ' ' LEU . . . 171.98 -59.06 0.16 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.182 -0.917 . . . . 2.62 112.342 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . . . -161.71 -171.99 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.735 0.303 . . . . 1.8 111.138 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HB3' ' HA2' ' A' ' 40' ' ' GLY . 0.4 OUTLIER -170.25 177.9 4.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.92 109.951 -173.208 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -93.05 121.96 34.92 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.718 -0.845 . . . . 2.22 108.718 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.691 HG23 ' H ' ' A' ' 51' ' ' THR . 6.6 p -93.04 176.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.357 0.598 . . . . 2.09 110.714 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.691 ' H ' HG23 ' A' ' 50' ' ' VAL . 87.5 m -118.04 94.92 4.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.626 -0.715 . . . . 1.99 110.221 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 56' ' ' LYS . 11.7 p -83.59 -31.31 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 107.536 -1.283 . . . . 2.62 107.536 170.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -141.86 -52.53 0.43 Allowed 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 113.093 -1.867 . . . . 4.06 107.712 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.63 ' HA ' HG22 ' A' ' 51' ' ' THR . 8.9 p-10 179.55 101.44 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.426 -1.261 . . . . 2.99 110.173 168.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 75.6 mmtt 82.28 -9.41 1.18 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.343 -0.844 . . . . 7.77 112.592 169.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.726 ' HE2' ' HB3' ' A' ' 169' ' ' SER . 43.4 tttp -73.39 141.5 46.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.947 -0.39 . . . . 4.8 109.947 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.521 ' HB ' HG12 ' A' ' 50' ' ' VAL . 43.7 mt 82.18 103.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.679 0.791 . . . . 1.6 111.555 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.6 m -114.23 108.17 16.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.431 -0.804 . . . . 1.48 109.487 171.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 55.8 m-85 -72.41 36.58 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.425 -0.807 . . . . 1.63 112.691 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.888 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 10.1 tt -149.97 128.29 12.12 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.798 -0.564 . . . . 3.67 111.967 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -118.98 -74.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.797 -0.638 . . . . 5.61 110.143 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 m -131.08 124.23 20.37 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 5.77 110.519 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -78.94 136.41 13.16 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.764 2.31 . . . . 6.26 113.015 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.42 -136.46 4.53 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.688 -0.965 . . . . 6.42 110.688 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -88.83 -14.74 36.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.496 0.665 . . . . 9.55 109.599 171.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.95 165.46 13.55 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.337 -0.847 . . . . 7.05 110.302 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.62 -35.86 0.1 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.514 -0.921 . . . . 5.07 108.514 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.704 ' HE2' ' HA ' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -48.78 132.78 17.93 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.543 -1.208 . . . . 2.66 109.572 169.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.1 p -54.83 129.73 38.39 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.021 0.439 . . . . 5.25 111.462 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.0 m -67.9 85.46 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.512 0.672 . . . . 6.21 109.975 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.439 ' SD ' HG11 ' A' ' 78' ' ' VAL . 20.8 ptp -92.51 122.59 35.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.131 -0.94 . . . . 5.21 111.426 -175.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -118.1 -34.4 4.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.651 -0.704 . . . . 8.75 109.176 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.19 -62.7 1.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.331 -0.85 . . . . 6.65 110.463 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 59.98 -165.75 0.2 Allowed 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.451 0.469 . . . . 10.34 110.984 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.79 -137.7 7.89 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.74 -0.743 . . . . 5.22 112.243 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.0 87.45 2.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.567 0.222 . . . . 5.89 111.25 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 64.46 101.99 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.756 -0.657 . . . . 6.97 112.111 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.439 HG11 ' SD ' ' A' ' 71' ' ' MET . 13.8 m -67.11 130.43 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 4.68 110.732 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -92.38 54.89 2.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.11 -0.496 . . . . 3.84 111.45 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.726 ' HB3' HG23 ' A' ' 108' ' ' VAL . 10.2 t70 -87.03 133.71 33.56 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.418 -0.956 . . . . 2.66 108.418 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.2 mt -116.18 105.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.597 -0.52 . . . . 1.38 109.597 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.507 ' HB ' HD13 ' A' ' 110' ' ' ILE . 40.1 t -93.84 114.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.424 0.63 . . . . 1.79 111.205 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.5 mt -82.84 126.03 40.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.899 -1.046 . . . . 1.14 109.596 172.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.67 HD12 HG12 ' A' ' 86' ' ' VAL . 2.3 tm? -114.73 106.09 13.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.447 -0.945 . . . . 1.65 108.447 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 57.7 t -88.24 109.76 20.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.395 -0.82 . . . . 1.14 110.921 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.781 HG21 HD22 ' A' ' 131' ' ' LEU . 1.7 m -121.14 135.76 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.855 -0.611 . . . . 1.31 111.338 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.706 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -74.26 134.18 42.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.935 -0.575 . . . . 1.01 109.706 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.759 ' HB3' ' CG2' ' A' ' 114' ' ' ILE . . . -78.61 -9.42 59.36 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.355 0.597 . . . . 1.07 109.846 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -89.25 -10.24 47.68 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.941 -1.027 . . . . 0.58 110.359 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.1 t0 -133.33 -59.51 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.07 -0.514 . . . . 0.56 111.152 -173.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 109.14 -135.11 12.65 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.37 113.637 173.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.27 131.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.786 0.803 . . . . 1.78 110.671 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.609 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 68.6 mmm -134.02 178.93 1.53 Allowed Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 114.333 -1.303 . . . . 1.07 109.402 -171.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.4 Cg_exo -45.64 -64.34 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.27 2.647 . . . . 0.89 114.735 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.585 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 7.0 pt20 -75.17 -10.93 59.92 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.636 -0.665 . . . . 0.78 111.3 -175.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.737 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.85 -49.28 54.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.738 -0.664 . . . . 1.07 109.279 175.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.538 ' HA ' HD13 ' A' ' 100' ' ' ILE . 2.5 p -72.63 -28.61 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.834 -0.621 . . . . 2.02 112.591 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 49.2 mt-10 -57.95 -29.66 65.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.544 0.611 . . . . 2.35 109.448 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -72.36 -42.85 64.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.396 -0.82 . . . . 1.12 110.743 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.538 HD13 ' HA ' ' A' ' 97' ' ' VAL . 65.7 mt -66.05 -41.57 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.62 0.724 . . . . 1.14 109.307 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -57.9 -40.0 79.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.196 -1.366 . . . . 0.75 110.857 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -66.83 -40.45 88.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.643 -0.503 . . . . 3.23 109.643 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.704 ' HA ' ' HE2' ' A' ' 68' ' ' PHE . . . -70.41 -46.08 64.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.877 -0.602 . . . . 1.17 111.788 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.78 -29.06 61.98 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.052 0.453 . . . . 2.27 110.659 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.61 -43.23 62.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.689 -1.141 . . . . 1.28 110.69 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.44 -19.18 23.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 1.31 111.3 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 70.04 67.79 0.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.17 -0.923 . . . . 1.6 110.472 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -117.28 152.39 49.1 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 1.93 111.12 -176.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 108' ' ' VAL . 23.2 Cg_exo -65.34 141.58 68.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.041 2.494 . . . . 0.66 112.537 172.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 103' ' ' ALA . 29.2 mm -111.27 155.47 12.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.601 0.715 . . . . 1.34 111.121 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 7.9 mm -125.38 87.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.429 -1.323 . . . . 1.12 107.429 170.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.696 HG22 HG22 ' A' ' 145' ' ' THR . 46.6 t -74.16 148.33 8.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.463 -0.789 . . . . 1.06 109.8 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.545 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -143.73 106.18 4.42 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.473 -1.24 . . . . 1.07 110.427 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.81 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -79.22 135.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.508 -1.224 . . . . 1.29 109.787 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.706 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.5 p-10 -113.47 177.41 4.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.28 -1.378 . . . . 1.85 107.28 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.707 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 84.2 mttt 70.5 33.1 2.52 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.61 0.569 . . . . 1.18 111.754 176.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.645 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 29.8 mmt -73.95 -19.0 60.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.245 -1.391 . . . . 1.64 107.245 166.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.628 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -62.29 -36.44 82.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.37 -1.741 . . . . 0.76 110.503 172.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.707 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 41.1 mtpt -79.34 141.77 57.73 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.94 -0.573 . . . . 1.74 110.3 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.24 -15.95 52.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.792 2.328 . . . . 0.68 111.88 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 34.4 mt-10 -84.75 11.26 9.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.574 -0.739 . . . . 1.45 110.655 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.46 ' HB3' ' HE1' ' A' ' 117' ' ' MET . . . -61.29 100.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.536 -0.756 . . . . 1.1 111.155 176.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.582 HD21 ' HB2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -120.41 77.07 26.27 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.664 -0.865 . . . . 0.95 108.664 176.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.549 ' HD3' ' HE2' ' A' ' 117' ' ' MET . 55.7 Cg_endo -68.15 -56.01 0.22 Allowed 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 123.334 2.689 . . . . 0.54 113.512 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.536 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 2.2 m-20 -55.72 -24.5 35.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.44 110.7 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.582 ' HB2' HD21 ' A' ' 123' ' ' ASN . 15.4 tpp180 -74.15 -57.49 3.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.386 -0.598 . . . . 4.56 109.386 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.706 HG23 ' HA ' ' A' ' 88' ' ' ALA . 26.5 m -64.44 -32.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.999 -1.0 . . . . 1.26 111.681 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.956 ' HA ' HD23 ' A' ' 131' ' ' LEU . 17.1 ptm -76.22 -15.79 59.96 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.889 0.376 . . . . 1.64 110.41 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 132' ' ' MET . 30.1 mt-30 -78.38 -33.95 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 2.0 110.014 171.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.04 -27.26 65.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.905 -0.776 . . . . 1.64 108.905 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.956 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.2 OUTLIER -59.44 -46.41 88.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.484 -1.235 . . . . 1.96 109.263 174.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.604 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 16.6 ptm -75.11 -13.76 60.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.409 -0.516 . . . . 2.05 111.125 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 58.9 mm-40 -70.49 -29.08 65.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.0 -1.111 . . . . 1.67 108.0 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.468 ' N ' ' HD1' ' A' ' 134' ' ' TYR . 1.6 m-85 -98.92 23.17 9.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.473 -1.239 . . . . 1.58 108.986 175.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.4 t30 60.49 49.22 6.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 113.619 -1.628 . . . . 1.42 112.259 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.591 HD12 HD12 ' A' ' 131' ' ' LEU . 52.4 mt -117.93 98.65 6.45 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.329 -0.85 . . . . 1.93 109.522 171.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.998 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 26.2 t -104.68 113.67 64.72 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.089 -0.644 . . . . 1.18 111.497 -172.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.588 ' CB ' ' HG2' ' A' ' 140' ' ' GLU . 82.2 Cg_exo -45.48 141.81 7.31 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.405 3.403 . . . . 0.88 112.8 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.578 ' HB2' HD13 ' A' ' 146' ' ' ILE . 6.3 mm-40 -71.56 -14.75 62.19 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.636 -1.165 . . . . 3.08 110.56 174.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.588 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.8 pm0 -68.39 -19.99 64.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.981 -0.554 . . . . 1.57 109.759 167.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.578 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 42.7 m0 -107.68 -30.3 8.65 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.994 0.426 . . . . 0.66 110.722 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.83 25.63 3.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.752 -0.737 . . . . 0.57 113.255 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.998 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -88.67 -107.28 1.06 Allowed Glycine 0 C--N 1.324 -0.134 0 C-N-CA 120.126 -1.035 . . . . 0.6 112.699 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -165.07 60.83 0.12 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 122.565 1.174 . . . . 1.91 110.694 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.696 HG22 HG22 ' A' ' 112' ' ' VAL . 87.4 m -164.39 122.4 1.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.687 -1.142 . . . . 1.1 110.554 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.673 ' HB ' HD13 ' A' ' 111' ' ' ILE . 16.5 mm -84.42 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.211 -0.663 . . . . 1.27 109.211 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.456 ' HE2' HD23 ' A' ' 131' ' ' LEU . 2.8 m-85 -87.62 145.5 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.884 0.849 . . . . 0.53 110.153 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 65.1 m -118.15 136.32 53.69 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.29 -1.323 . . . . 1.0 109.103 172.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.541 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 94.7 mttt -109.76 89.84 3.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.997 -0.742 . . . . 1.96 108.997 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.858 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -115.45 179.46 3.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.877 1.322 . . . . 1.49 112.054 -170.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 3.9 p -145.28 95.47 2.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.156 -1.838 . . . . 2.07 106.978 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.97 -18.38 65.36 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.463 -0.495 . . . . 1.11 109.732 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.491 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 70.6 mmtt -80.95 -43.49 19.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.701 -0.682 . . . . 2.78 111.563 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.628 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 1.9 m -76.07 -15.49 60.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.387 0.613 . . . . 1.35 110.82 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm 66.49 46.0 1.98 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.845 -1.071 . . . . 1.9 110.373 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.542 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.35 -57.46 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.039 -0.982 . . . . 2.48 110.702 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.858 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.61 1.91 84.21 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.285 -0.959 . . . . 0.36 113.543 -172.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.1 -41.52 61.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.192 -0.67 . . . . 1.42 109.192 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 15.4 m-20 -67.65 -43.93 79.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.503 -0.771 . . . . 2.2 109.318 171.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.581 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 78.1 t60 -63.31 -23.12 67.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.932 -0.576 . . . . 0.68 111.516 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 165' ' ' ILE . 55.0 tp -68.49 -55.81 10.5 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.358 0.599 . . . . 1.77 109.784 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.149 -0.932 . . . . 2.1 110.775 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 65.1 mm-40 -66.48 -45.03 81.05 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.052 0.454 . . . . 2.57 110.398 172.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.857 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 12.7 mmt -67.61 -36.88 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.181 0.515 . . . . 1.21 110.203 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 83' ' ' ILE . 77.9 mt -66.8 -32.21 57.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 1.2 110.128 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -35.07 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 2.3 110.821 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.7 tp -57.03 -42.58 80.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.766 0.793 . . . . 2.11 109.26 171.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.08 -40.17 80.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.227 -0.897 . . . . 1.41 110.331 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.726 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 28.8 m -67.53 -8.45 33.96 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.23 0.538 . . . . 1.82 111.185 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -83.65 -41.28 17.95 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.806 -0.813 . . . . 2.73 108.806 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 28.2 mtm -83.91 -9.22 58.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.986 -1.007 . . . . 2.12 112.233 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 169' ' ' SER . 11.4 pt-20 -52.6 -35.45 54.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.066 0.46 . . . . 4.27 110.299 175.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -106.33 -33.36 7.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 3.91 110.764 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 176' ' ' ALA . 3.3 mm? -105.17 46.8 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.396 . . . . 6.06 111.699 -174.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.652 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -79.39 30.48 0.23 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.234 0.54 . . . . 5.86 111.362 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 174' ' ' LEU . . . -159.84 91.31 0.96 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.686 -0.688 . . . . 5.79 109.417 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.486 ' N ' ' HD2' ' A' ' 178' ' ' PRO . 14.1 m120 -74.28 -52.05 4.26 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.156 -0.475 . . . . 8.44 111.753 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 177' ' ' ASN . 28.7 Cg_endo . . . . . 0 C--O 1.248 0.994 0 C-N-CA 122.18 1.92 . . . . 9.2 112.288 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.556 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.555 -0.218 . . . . 11.83 112.555 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -121.14 -9.9 9.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.611 -0.347 . . . . 10.75 111.766 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -67.06 -24.53 65.98 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.528 0.566 . . . . 10.82 112.528 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.7 tpp -79.41 -28.56 41.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 9.01 110.75 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.64 -51.34 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.231 -0.441 . . . . 6.14 111.323 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.35 79.16 7.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.138 -0.483 . . . . 5.7 111.204 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -136.31 87.68 22.17 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.907 -0.588 . . . . 7.55 110.018 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.91 151.99 57.2 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.507 2.138 . . . . 3.21 111.485 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.8 83.21 0.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.456 2.104 . . . . 3.14 111.778 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.82 139.33 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.665 -0.698 . . . . 2.53 110.116 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.43 93.2 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.273 0.559 . . . . 1.95 110.067 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -79.33 128.36 33.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.587 -0.733 . . . . 1.27 109.971 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.834 HD12 HD21 ' A' ' 25' ' ' LEU . 17.1 pt -96.64 133.51 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.638 0.733 . . . . 1.83 111.446 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.664 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 62.9 mtt -134.96 -179.62 5.73 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.856 -1.065 . . . . 1.28 109.41 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.478 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 140.63 -164.86 26.27 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.517 -0.849 . . . . 0.34 111.776 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.864 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 46.9 t60 -92.18 158.04 16.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.64 0.733 . . . . 0.28 111.204 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.6 p -70.98 147.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.915 -1.039 . . . . 1.09 109.872 174.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.2 t70 75.0 -26.86 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.456 0.646 . . . . 0.69 110.613 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.494 ' H ' ' C ' ' A' ' 17' ' ' VAL . 18.4 m170 -79.44 -13.71 59.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.3 -1.0 . . . . 0.63 108.3 170.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.452 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 116.97 76.35 0.59 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.357 -0.925 . . . . 0.79 114.97 171.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 15' ' ' GLY . 20.6 mmtp -77.32 -86.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.924 -0.71 . . . . 3.69 111.097 165.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 m -75.24 -16.14 60.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.829 0.347 . . . . 1.76 111.109 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -56.21 -35.03 66.85 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 111.863 0.32 . . . . 1.71 111.863 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.433 HD21 ' O ' ' A' ' 20' ' ' GLY . 4.5 mm? -74.06 -40.57 62.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.665 -0.494 . . . . 2.09 109.665 176.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.834 HD21 HD12 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -62.44 -13.11 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.821 -0.627 . . . . 2.23 110.022 176.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.64 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 20.2 t70 -102.18 -47.5 4.51 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.706 0.765 . . . . 1.23 109.706 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.08 73.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.28 -1.327 . . . . 1.23 111.398 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 99.2 mt -70.34 -25.56 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.716 -0.675 . . . . 1.59 111.083 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.64 ' HE ' ' HA ' ' A' ' 26' ' ' ASP . 54.5 mtm180 -56.23 -52.54 64.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 3.51 110.501 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -81.21 13.02 3.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.131 0.967 . . . . 3.14 110.871 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 29' ' ' ARG . 55.7 m -123.42 20.88 9.57 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.108 -1.406 . . . . 1.96 110.642 177.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.687 ' HD2' ' HA ' ' A' ' 50' ' ' VAL . 43.4 pttt -140.69 -156.24 0.66 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.9 -0.591 . . . . 4.37 109.883 175.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.802 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 10.8 p -58.41 -29.65 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 116.212 -0.449 . . . . 3.59 112.008 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.682 ' H ' ' HG3' ' A' ' 32' ' ' LYS . 10.4 t -95.73 -175.31 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.321 0.581 . . . . 2.99 111.093 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.35 -36.97 0.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.178 -0.919 . . . . 6.34 109.531 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -159.41 -51.34 0.06 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.714 -0.676 . . . . 7.38 110.336 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -74.49 123.64 25.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 6.24 110.216 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.06 39.91 25.8 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.417 0.627 . . . . 5.33 110.618 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.64 ' HA2' HG21 ' A' ' 34' ' ' THR . . . -63.97 -40.51 98.33 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.279 -0.873 . . . . 4.68 112.593 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.56 -51.53 0.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.028 -0.606 . . . . 5.06 112.009 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.2 mp -67.75 101.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.865 0.364 . . . . 5.91 110.237 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.8 m -101.38 -82.94 0.46 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.217 -0.447 . . . . 6.29 110.076 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -167.09 -62.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 6.97 110.421 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -80.6 26.47 0.39 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.15 0.5 . . . . 7.26 111.69 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.551 HG13 ' N ' ' A' ' 46' ' ' GLY . 10.8 tp -178.15 164.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.37 0.605 . . . . 5.68 110.946 -174.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.551 ' N ' HG13 ' A' ' 45' ' ' ILE . . . -139.01 53.12 0.7 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.75 -1.114 . . . . 2.62 110.42 176.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.689 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -142.46 166.6 24.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.856 0.36 . . . . 1.8 110.864 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.528 ' HB2' ' HZ3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -162.59 150.67 14.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.73 -0.668 . . . . 1.92 110.356 -178.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -98.35 123.98 42.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.98 -0.554 . . . . 2.22 109.669 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.687 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 41.0 t -76.51 159.51 5.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.062 0.458 . . . . 2.09 110.268 -178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.802 ' HB ' ' HB ' ' A' ' 33' ' ' VAL . 19.3 m -158.83 82.44 0.8 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.593 -0.891 . . . . 1.99 108.593 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.6 p -77.42 -28.85 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.05 -1.092 . . . . 2.62 108.05 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -145.71 -58.63 0.32 Allowed 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 113.548 -1.66 . . . . 4.06 108.217 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' HG23 ' A' ' 51' ' ' THR . 5.4 p-10 -168.51 27.86 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.636 -0.711 . . . . 2.99 110.79 173.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -98.27 97.16 8.58 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.103 -0.499 . . . . 7.77 109.835 -171.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -73.87 80.09 1.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.506 -0.77 . . . . 4.8 111.246 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.2 mt -92.95 112.87 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.233 -0.894 . . . . 1.6 109.187 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 m -89.11 89.11 7.81 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.07 0.462 . . . . 1.48 111.044 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -71.83 145.17 48.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.649 -0.705 . . . . 1.63 110.132 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.689 HD12 ' HB2' ' A' ' 47' ' ' ALA . 57.1 tp -143.92 129.42 19.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 3.67 110.834 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.75 -171.23 1.93 Allowed 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.081 -0.711 . . . . 5.61 109.081 174.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.71 HG22 ' HB3' ' A' ' 67' ' ' ALA . 14.3 t -167.21 130.64 1.45 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.288 0.566 . . . . 5.77 111.517 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -89.03 50.99 1.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.027 2.484 . . . . 6.26 110.894 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.66 66.71 2.05 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.845 -0.693 . . . . 6.42 111.735 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -141.83 -58.06 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.659 -0.318 . . . . 9.55 111.285 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.43 -71.99 0.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.056 -0.258 . . . . 7.05 110.528 -173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HB3' HG22 ' A' ' 62' ' ' THR . . . 65.83 95.44 0.06 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.855 0.722 . . . . 5.07 112.702 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.647 ' CE1' ' HB ' ' A' ' 82' ' ' VAL . 1.7 t80 65.72 -168.78 0.21 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.964 -0.562 . . . . 2.66 110.697 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 t -64.78 144.51 57.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.03 0.443 . . . . 5.25 109.805 171.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.8 t -81.63 2.77 27.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.108 -0.497 . . . . 6.21 111.266 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.412 ' HE2' ' CD2' ' A' ' 102' ' ' HIS . 64.4 mtt 64.07 20.78 12.34 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.154 0.502 . . . . 5.21 111.227 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -95.26 12.62 28.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.54 0.686 . . . . 8.75 109.443 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.23 -61.1 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.332 -0.849 . . . . 6.65 110.865 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 58.72 87.21 0.08 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.575 0.702 . . . . 10.34 109.936 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.43 137.72 6.11 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.925 -1.27 . . . . 5.22 109.925 -170.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.65 63.07 2.17 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.352 0.596 . . . . 5.89 109.86 -171.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -69.22 -32.38 71.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.16 -0.927 . . . . 6.97 110.945 -172.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.6 t -86.56 72.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.274 0.559 . . . . 4.68 109.83 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.449 HG23 ' OD1' ' A' ' 80' ' ' ASP . 9.5 t -99.66 -18.78 17.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.017 -0.538 . . . . 3.84 110.571 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.449 ' OD1' HG23 ' A' ' 79' ' ' THR . 8.4 p-10 -160.02 165.74 31.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.138 -0.69 . . . . 2.66 109.138 173.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.4 mt -110.73 145.88 16.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 123.255 0.347 . . . . 1.38 110.363 -170.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.647 ' HB ' ' CE1' ' A' ' 68' ' ' PHE . 12.7 p -114.4 136.33 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.631 -0.828 . . . . 1.79 111.337 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.72 HG12 ' HB ' ' A' ' 111' ' ' ILE . 9.5 mt -96.71 135.88 29.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.068 -0.969 . . . . 1.14 109.612 170.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.644 HD11 HG12 ' A' ' 86' ' ' VAL . 1.8 tm? -119.8 107.8 13.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.975 -1.121 . . . . 1.65 107.975 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -93.17 113.53 28.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.795 -0.639 . . . . 1.14 110.681 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.875 HG23 HD11 ' A' ' 131' ' ' LEU . 2.8 m -121.3 136.88 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.524 -0.762 . . . . 1.31 110.713 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.748 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -75.87 134.64 40.26 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.903 -0.589 . . . . 1.01 110.105 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB3' ' CG2' ' A' ' 114' ' ' ILE . . . -74.87 -10.03 59.11 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.303 0.573 . . . . 1.07 110.035 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.68 -14.48 39.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.181 -0.918 . . . . 0.58 110.624 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.473 ' HB3' ' CE1' ' A' ' 19' ' ' HIS . 2.4 t0 -131.95 -63.0 0.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.56 110.298 -176.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.524 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 115.72 -129.71 8.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.256 -0.497 . . . . 0.37 112.793 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.82 140.58 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.569 0.7 . . . . 1.78 109.621 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.527 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.6 mmm -139.94 176.33 2.62 Favored Pre-proline 0 C--N 1.311 -1.073 0 CA-C-N 114.743 -1.117 . . . . 1.07 108.549 -171.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 86.6 Cg_exo -48.72 -57.21 2.5 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.662 2.241 . . . . 0.89 114.205 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.664 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 1.9 pt20 -78.88 -11.48 60.0 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.11 -0.636 . . . . 0.78 111.002 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.864 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.87 -49.6 44.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.483 -0.781 . . . . 1.07 109.4 176.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' HA ' HD11 ' A' ' 100' ' ' ILE . 3.0 p -76.72 -27.74 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 115.454 -0.793 . . . . 2.02 113.128 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.664 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -66.97 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.31 -0.956 . . . . 2.35 109.549 177.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 14' ' ' MET . . . -77.18 -36.46 55.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.144 -0.935 . . . . 1.12 110.032 170.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.546 HD11 ' HA ' ' A' ' 97' ' ' VAL . 97.9 mt -68.27 -42.81 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.518 0.675 . . . . 1.14 109.434 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.94 -42.01 68.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.685 -1.143 . . . . 0.75 110.523 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.412 ' CD2' ' HE2' ' A' ' 71' ' ' MET . 4.8 t60 -66.36 -35.0 79.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.078 -0.51 . . . . 3.23 110.093 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 -46.73 22.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.127 -0.488 . . . . 1.17 111.775 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.8 mmmt -68.77 -39.58 80.16 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.96 0.409 . . . . 2.27 110.413 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.98 69.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.53 -0.759 . . . . 1.28 110.772 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.97 63.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 1.31 110.495 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.8 t30 76.64 73.53 0.08 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.264 1.03 . . . . 1.6 109.301 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.536 HG13 ' CZ ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -137.71 147.5 57.33 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 113.545 -1.661 . . . . 1.93 110.016 -170.225 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -52.59 135.24 55.38 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.554 2.169 . . . . 0.66 113.156 171.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.533 ' C ' HG21 ' A' ' 145' ' ' THR . 1.2 mt -110.72 162.61 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.697 -1.138 . . . . 1.34 110.385 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.72 ' HB ' HG12 ' A' ' 83' ' ' ILE . 27.3 mm -129.58 84.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 107.394 -1.336 . . . . 1.12 107.394 172.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.905 HG22 HG23 ' A' ' 145' ' ' THR . 48.7 t -74.16 146.34 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.725 0.774 . . . . 1.06 109.237 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.855 ' HB2' HD23 ' A' ' 150' ' ' LEU . . . -141.72 105.79 4.77 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.25 -1.341 . . . . 1.07 110.512 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.745 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 3.0 mp -80.06 124.84 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.464 -1.244 . . . . 1.29 109.081 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.748 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.9 p-10 -107.34 177.51 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.772 -1.196 . . . . 1.85 107.772 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.536 ' HD2' ' HB3' ' A' ' 87' ' ' ALA . 80.5 mttt 71.11 37.02 1.29 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 123.981 0.8 . . . . 1.18 111.427 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.484 ' CE ' ' HB2' ' A' ' 122' ' ' ALA . 29.2 mmt -78.14 -15.07 59.19 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.803 -1.184 . . . . 1.64 107.803 168.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.2 -19.79 60.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.635 -1.62 . . . . 0.76 109.942 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 24.0 mmmt -87.68 131.02 44.84 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-N 115.305 -0.861 . . . . 1.74 110.124 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.5 -11.58 26.67 Favored 'Trans proline' 0 N--CA 1.472 0.254 0 C-N-CA 122.71 2.273 . . . . 0.68 111.709 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.91 8.57 31.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.879 -1.055 . . . . 1.45 110.567 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.484 ' HB2' ' CE ' ' A' ' 117' ' ' MET . . . -54.96 106.83 0.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.967 -1.015 . . . . 1.1 111.438 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.95 75.72 14.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.95 108.419 172.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.451 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 57.6 Cg_endo -68.92 -54.38 0.26 Allowed 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 123.002 2.468 . . . . 0.54 113.438 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.451 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 25.3 m-20 -58.11 -28.06 64.29 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.13 -0.941 . . . . 1.44 109.629 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.88 -58.92 3.04 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 119.889 -0.725 . . . . 4.56 109.115 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 88' ' ' ALA . 21.6 m -61.8 -31.32 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.732 -1.122 . . . . 1.26 111.988 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 1.082 ' HA ' HD13 ' A' ' 131' ' ' LEU . 19.9 ptm -79.25 -16.42 56.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.101 -0.24 . . . . 1.64 110.805 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.677 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 13.8 mt-30 -80.14 -39.26 29.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.732 0.301 . . . . 2.0 110.831 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.46 -27.11 65.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.737 -0.838 . . . . 1.64 108.737 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 1.082 HD13 ' HA ' ' A' ' 128' ' ' MET . 77.5 mt -61.79 -45.19 94.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.506 -1.225 . . . . 1.96 110.022 174.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.829 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -76.19 -10.59 59.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.473 -0.491 . . . . 2.05 111.268 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -85.28 -15.6 42.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.366 -0.605 . . . . 1.67 109.366 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.45 17.37 14.74 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.925 -1.139 . . . . 1.58 107.925 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.6 t30 59.37 56.14 3.91 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 113.315 -1.766 . . . . 1.42 112.027 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.666 ' H ' ' HA ' ' A' ' 132' ' ' MET . 77.1 mt -121.53 96.1 4.94 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.787 -1.097 . . . . 1.93 109.03 169.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.895 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 32.9 t -105.02 113.97 64.2 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 120.032 -0.667 . . . . 1.18 111.049 -171.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.924 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 6.8 Cg_endo -56.45 157.8 17.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 123.326 2.684 . . . . 0.88 112.673 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' A' ' 146' ' ' ILE . 16.4 mm-40 -78.6 -13.52 59.79 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.256 -1.338 . . . . 3.08 109.974 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.924 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -68.04 -23.32 64.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 1.57 109.906 168.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.829 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 40.5 m0 -108.33 -14.9 14.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.858 0.361 . . . . 0.66 110.83 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.87 27.74 10.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.705 -0.759 . . . . 0.57 113.52 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.895 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.69 -108.36 0.72 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.238 -0.982 . . . . 0.6 111.621 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -163.28 61.1 0.18 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.575 1.179 . . . . 1.91 111.66 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.905 HG23 HG22 ' A' ' 112' ' ' VAL . 88.8 m -163.49 124.11 2.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.637 -1.165 . . . . 1.1 110.906 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.715 HG22 ' HB3' ' A' ' 164' ' ' MET . 23.3 mm -74.36 104.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 109.146 -0.687 . . . . 1.27 109.146 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 7.4 m-85 -87.67 117.82 26.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.321 -0.854 . . . . 0.53 110.401 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.3 m -101.37 144.17 30.51 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.46 -0.336 . . . . 1.0 110.501 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.485 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.8 mttt -116.77 89.47 3.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.167 -0.679 . . . . 1.96 109.167 175.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.855 HD23 ' HB2' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -117.99 176.22 5.31 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.671 1.224 . . . . 1.49 112.265 -171.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -129.72 102.46 6.35 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.916 -1.493 . . . . 2.07 107.283 164.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.73 64.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.923 -0.769 . . . . 1.11 108.923 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.647 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 9.4 tmtt? -64.38 -59.83 3.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.41 -1.268 . . . . 2.78 110.936 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.7 p -88.94 5.02 46.03 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 119.99 -0.684 . . . . 1.35 112.163 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.482 ' CD ' HD12 ' A' ' 158' ' ' LEU . 29.7 mmtp 64.37 46.85 3.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.555 -0.748 . . . . 1.9 111.834 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.602 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -104.93 -53.71 2.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.925 0.869 . . . . 2.48 110.983 -177.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.832 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.84 2.24 84.11 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.332 -0.937 . . . . 0.36 112.763 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.482 HD12 ' CD ' ' A' ' 155' ' ' LYS . 19.7 mt -76.32 -36.98 58.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.213 -0.662 . . . . 1.42 109.213 174.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.65 -40.84 80.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.621 -0.718 . . . . 2.2 109.371 171.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.506 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 74.2 t60 -72.81 -15.13 61.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.1 -0.5 . . . . 0.68 110.981 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER -77.2 -50.79 12.16 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.889 -0.411 . . . . 1.77 109.889 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 163' ' ' GLU . 4.5 pp -64.46 -29.76 70.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.789 -0.641 . . . . 2.1 111.281 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 11.2 pt-20 -71.8 -36.91 70.43 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.507 -0.477 . . . . 2.57 110.131 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.778 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 23.2 mmt -71.55 -38.27 71.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.201 0.524 . . . . 1.21 109.899 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.48 HD11 HD12 ' A' ' 83' ' ' ILE . 78.9 mt -65.34 -46.76 89.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.782 -0.644 . . . . 1.2 111.007 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.496 ' CD2' ' HA ' ' A' ' 163' ' ' GLU . 1.6 pp -67.92 -29.79 68.96 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.832 -0.433 . . . . 2.3 109.832 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.76 -52.05 63.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.38 -0.827 . . . . 2.11 108.974 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.95 -40.38 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.85 -0.613 . . . . 1.41 110.92 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.6 t -64.58 -23.42 67.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.56 0.219 . . . . 1.82 111.206 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -88.37 -26.57 22.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.536 0.684 . . . . 2.73 109.789 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.492 ' HE1' ' HB3' ' A' ' 174' ' ' LEU . 27.6 ttp -91.8 -4.09 55.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.006 -0.997 . . . . 2.12 111.471 -173.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -46.51 -14.0 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.488 1.292 . . . . 4.27 114.488 -173.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.406 ' HG2' ' OE2' ' A' ' 172' ' ' GLU . 6.4 mm-40 -70.0 14.84 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.521 0.677 . . . . 3.91 110.931 168.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 172' ' ' GLU . 3.0 pp -61.24 -19.55 61.8 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.55 -0.75 . . . . 6.06 110.871 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.409 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -95.79 24.74 5.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.609 -0.723 . . . . 5.86 111.324 177.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.32 101.78 2.0 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.246 -0.434 . . . . 5.79 110.182 175.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -165.05 92.86 0.92 Allowed Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.845 -0.616 . . . . 8.44 110.612 -175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 C--O 1.246 0.883 0 C-N-CA 122.981 2.454 . . . . 9.2 111.548 173.95 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.647 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 112.095 -0.402 . . . . 11.83 112.095 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 t -82.65 122.17 27.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.813 0.34 . . . . 10.75 110.148 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -77.62 70.87 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.041 -0.527 . . . . 10.82 109.912 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 41.8 ttp -163.92 -68.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.494 -0.775 . . . . 9.01 110.319 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.4 -34.8 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 6.14 111.179 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.57 92.04 7.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.29 0.567 . . . . 5.7 109.9 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -92.46 118.81 68.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.712 -0.677 . . . . 7.55 111.217 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.28 113.31 2.34 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.249 2.633 . . . . 3.21 110.992 173.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.09 118.42 5.33 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.432 2.088 . . . . 3.14 112.63 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.1 t -88.84 89.43 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.209 -0.663 . . . . 2.53 109.209 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 46.2 t -95.31 89.31 2.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.574 0.702 . . . . 1.95 110.391 -176.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.484 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 36.2 m -75.14 119.44 19.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.784 -0.644 . . . . 1.27 111.11 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 43.3 mt -84.02 124.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.265 0.555 . . . . 1.83 110.535 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.678 ' HE3' ' HB2' ' A' ' 67' ' ' ALA . 66.6 mtt -127.93 174.0 9.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.393 -0.965 . . . . 1.28 108.393 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.18 -179.47 23.17 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.259 -0.972 . . . . 0.34 111.858 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.661 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 51.5 t60 -85.09 160.63 19.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.766 0.794 . . . . 0.28 111.372 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.517 ' C ' ' H ' ' A' ' 19' ' ' HIS . 7.5 p -74.61 152.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.604 -1.18 . . . . 1.09 109.892 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.653 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 21.1 t70 74.05 -21.14 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.243 0.544 . . . . 0.69 110.556 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.616 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.7 m170 -79.33 -16.31 56.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.634 -0.876 . . . . 0.63 108.634 171.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.476 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 118.19 60.38 0.28 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.363 -0.835 . . . . 0.79 114.136 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -63.78 -66.01 0.6 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.951 -0.7 . . . . 3.69 111.166 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -85.62 -33.91 21.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 1.76 111.029 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -60.94 -24.88 66.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.75 0.648 . . . . 1.71 112.75 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.53 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -71.72 -39.3 70.22 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.018 -0.273 . . . . 2.09 110.592 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.595 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 54.7 mt -71.33 -14.54 62.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.795 -0.446 . . . . 2.23 109.795 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.94 -42.2 11.33 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.081 0.944 . . . . 1.23 108.705 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.062 -1.426 . . . . 1.23 110.026 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.765 HG23 ' HH ' ' A' ' 48' ' ' TYR . 3.8 tt -67.29 -20.39 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.087 -0.961 . . . . 1.59 110.984 -176.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 25.6 mmm180 -57.92 -52.7 64.43 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.11 0.481 . . . . 3.51 110.087 175.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -102.19 25.58 8.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.204 -0.907 . . . . 3.14 111.617 -170.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.8 m -92.63 -5.49 51.39 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.116 -0.947 . . . . 1.96 109.435 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' NZ ' ' HB ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -176.29 -174.76 0.63 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.216 -1.401 . . . . 4.37 107.216 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' HB ' ' A' ' 51' ' ' THR . 20.2 t -74.5 151.37 7.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.888 -0.325 . . . . 3.59 110.244 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.544 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 13.8 t -157.42 -174.11 4.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.034 -0.358 . . . . 2.99 110.034 169.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -68.63 151.64 46.44 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.442 -0.577 . . . . 6.34 109.442 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.17 20.85 0.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.42 . . . . 7.38 112.03 -176.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -137.19 120.22 16.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.656 -0.498 . . . . 6.24 109.656 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.87 141.49 56.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.119 -0.492 . . . . 5.33 111.073 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 48' ' ' TYR . . . -75.9 99.03 1.23 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.028 -0.606 . . . . 4.68 111.678 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -128.01 106.41 0.79 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.595 -0.812 . . . . 5.06 112.982 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.699 HG12 ' HA3' ' A' ' 46' ' ' GLY . 46.9 mm -76.08 128.31 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.507 -0.553 . . . . 5.91 109.507 174.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.541 HG23 ' HG2' ' A' ' 43' ' ' GLN . 77.1 m 65.85 -74.1 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.932 0.77 . . . . 6.29 111.02 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.541 ' HG2' HG23 ' A' ' 42' ' ' THR . 8.1 pt20 -167.61 -33.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.528 -0.305 . . . . 6.97 111.321 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -87.12 40.48 0.92 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 121.181 -0.208 . . . . 7.26 111.462 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.606 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 48.3 mm 65.11 157.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.436 0.636 . . . . 5.68 111.055 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.699 ' HA3' HG12 ' A' ' 41' ' ' ILE . . . -158.13 25.66 0.41 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.789 -0.719 . . . . 2.62 112.324 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.47 ' HA ' HD11 ' A' ' 25' ' ' LEU . . . 64.23 -172.63 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.998 0.47 . . . . 1.8 111.625 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.765 ' HH ' HG23 ' A' ' 28' ' ' ILE . 3.8 p90 -179.96 165.22 1.22 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.071 0.462 . . . . 1.92 110.8 -173.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.447 ' HG3' ' OG1' ' A' ' 58' ' ' THR . 0.8 OUTLIER -79.68 116.14 19.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.43 -0.952 . . . . 2.22 108.43 172.381 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.458 HG13 ' CZ ' ' A' ' 48' ' ' TYR . 22.1 m -76.59 139.29 19.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.53 0.681 . . . . 2.09 111.488 -175.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 34' ' ' THR . 2.4 m -80.9 82.48 6.87 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.347 0.594 . . . . 1.99 110.368 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.4 p -84.04 -27.94 7.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 107.815 -1.18 . . . . 2.62 107.815 173.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -144.0 -51.43 0.31 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.432 -1.713 . . . . 4.06 108.607 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.475 ' HA ' HG21 ' A' ' 51' ' ' THR . 36.4 t70 -173.69 85.1 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.855 -1.066 . . . . 2.99 110.542 170.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' H ' ' HA ' ' A' ' 51' ' ' THR . 25.4 mtmm 57.82 78.55 0.23 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.932 -0.576 . . . . 7.77 112.473 173.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -150.29 168.51 23.84 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.932 -0.766 . . . . 4.8 108.932 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.7 mt 66.07 74.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.809 0.814 . . . . 1.6 109.585 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.447 ' OG1' ' HG3' ' A' ' 49' ' ' GLN . 2.7 m -76.46 98.81 4.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.307 -0.86 . . . . 1.48 110.109 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.76 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 81.6 m-85 -70.55 139.81 51.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.203 -0.453 . . . . 1.63 110.172 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.484 ' H ' ' HA ' ' A' ' 12' ' ' THR . 58.7 tp 49.58 83.19 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.065 0.853 . . . . 3.67 112.53 171.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -66.76 -46.27 75.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.551 -0.295 . . . . 5.61 111.637 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.0 m -111.01 100.84 48.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.016 0.436 . . . . 5.77 111.427 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.5 96.95 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.666 2.244 . . . . 6.26 111.961 175.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.95 -137.79 2.35 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.052 -0.594 . . . . 6.42 112.13 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -81.73 -44.17 17.43 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.545 -0.539 . . . . 9.55 109.545 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -101.11 103.18 14.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.581 -0.736 . . . . 7.05 109.125 173.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.678 ' HB2' ' HE3' ' A' ' 14' ' ' MET . . . -64.58 -34.54 78.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.62 -0.718 . . . . 5.07 110.177 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.36 124.61 23.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.668 -0.696 . . . . 2.66 109.914 172.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -56.81 123.8 16.29 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.064 -0.516 . . . . 5.25 110.687 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -62.42 124.08 19.97 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.382 -0.599 . . . . 6.21 109.382 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.4 mmt -64.46 101.08 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.423 0.63 . . . . 5.21 110.648 -173.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -96.34 -35.22 11.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.412 -0.813 . . . . 8.75 110.386 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.95 13.36 3.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.148 -0.478 . . . . 6.65 111.756 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -128.24 139.35 52.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 10.34 111.016 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.15 -33.09 1.55 Allowed Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.187 -0.765 . . . . 5.22 111.187 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.37 142.54 27.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.105 -0.331 . . . . 5.89 110.105 176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -85.35 129.23 34.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.018 -0.364 . . . . 6.97 110.018 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.667 HG12 ' H ' ' A' ' 79' ' ' THR . 2.6 t -101.63 -144.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.646 -0.872 . . . . 4.68 108.646 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.667 ' H ' HG12 ' A' ' 78' ' ' VAL . 10.6 m -86.4 63.73 8.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.791 0.805 . . . . 3.84 110.645 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' O ' HG21 ' A' ' 108' ' ' VAL . 3.8 m-20 -84.04 131.18 34.83 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.326 -0.99 . . . . 2.66 108.326 172.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.7 mt -126.37 142.44 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.104 -0.332 . . . . 1.38 110.104 -175.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -120.8 121.68 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 1.79 111.971 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 10.4 mt -82.97 137.79 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.878 -1.055 . . . . 1.14 109.321 170.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.684 HD11 HD22 ' A' ' 131' ' ' LEU . 2.5 tm? -123.67 105.24 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.355 -0.98 . . . . 1.65 108.355 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 89.3 t -87.73 109.77 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.637 -0.711 . . . . 1.14 110.967 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -120.73 120.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.717 -0.674 . . . . 1.31 110.776 174.262 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB3' ' HD2' ' A' ' 116' ' ' LYS . . . -68.75 127.76 34.22 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.926 -0.768 . . . . 1.01 108.926 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.667 ' HB1' ' CG2' ' A' ' 114' ' ' ILE . . . -70.76 -11.59 61.04 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.924 0.392 . . . . 1.07 111.446 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -94.79 2.02 55.46 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.346 -0.542 . . . . 0.58 110.876 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.402 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.0 t0 -134.33 -52.21 0.82 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.352 -0.385 . . . . 0.56 110.977 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.622 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.31 -158.23 21.05 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 121.087 -0.577 . . . . 0.37 113.509 173.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.27 136.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.6 0.714 . . . . 1.78 109.646 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.719 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 73.6 mmm -136.96 177.92 1.96 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.097 -0.956 . . . . 1.07 108.808 -171.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.719 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.3 Cg_exo -40.74 -65.42 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.302 2.668 . . . . 0.89 114.814 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.466 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 7.2 pt20 -74.15 -16.88 60.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.38 0.61 . . . . 0.78 111.062 -174.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.661 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.74 -43.88 71.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 1.07 109.366 177.261 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 93' ' ' MET . 21.0 t -68.24 -39.32 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.401 -0.818 . . . . 2.02 111.276 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.46 -28.92 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 2.35 110.221 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -72.8 -42.19 64.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.819 -0.628 . . . . 1.12 111.032 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 136' ' ' LEU . 85.5 mt -71.44 -42.29 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.842 0.83 . . . . 1.14 109.596 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -63.67 -28.2 69.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.273 -1.331 . . . . 0.75 110.851 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -82.17 -32.31 30.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.047 0.451 . . . . 3.23 109.879 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.475 ' HB1' HD13 ' A' ' 110' ' ' ILE . . . -67.38 -46.6 72.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 1.17 110.901 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.92 -33.71 72.52 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.664 0.745 . . . . 2.27 110.018 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.15 44.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.096 -1.411 . . . . 1.28 111.475 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -100.33 -39.15 8.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.649 -0.25 . . . . 1.31 111.362 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 88.5 75.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.726 1.21 . . . . 1.6 109.182 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 80' ' ' ASP . 0.3 OUTLIER -134.59 142.33 42.22 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.407 -1.27 . . . . 1.93 110.4 -173.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.57 142.48 77.88 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.628 2.219 . . . . 0.66 111.943 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.624 ' HB ' HG21 ' A' ' 145' ' ' THR . 27.0 mm -108.48 155.38 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.64 0.733 . . . . 1.34 111.107 -172.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 1.067 HD12 ' HB ' ' A' ' 146' ' ' ILE . 15.7 mm -122.64 83.34 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.508 -1.293 . . . . 1.12 107.508 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.864 HG22 HD23 ' A' ' 131' ' ' LEU . 58.6 t -73.19 144.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.677 0.751 . . . . 1.06 109.307 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.793 ' HB3' HD22 ' A' ' 150' ' ' LEU . . . -141.16 101.57 4.05 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.099 -1.41 . . . . 1.07 110.013 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.949 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.4 mp -68.61 138.13 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.803 -1.544 . . . . 1.29 108.883 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 59.0 t30 -122.09 166.78 14.01 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 107.147 -1.427 . . . . 1.85 107.147 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.742 ' HG2' ' N2 ' ' A' ' 179' ' ' GDP . 83.5 mttt 71.68 33.35 1.8 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 124.239 0.962 . . . . 1.18 111.515 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.6 ' CE ' ' HB3' ' A' ' 124' ' ' PRO . 9.0 mmt -74.49 -11.97 60.36 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.171 -0.922 . . . . 1.64 109.586 166.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.643 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 10.5 p-10 -70.52 -19.63 62.89 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.852 -1.067 . . . . 0.76 108.862 172.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.468 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 47.4 mtpt -95.21 131.73 29.37 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 114.769 -1.105 . . . . 1.74 110.47 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -63.68 -15.41 48.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.946 2.431 . . . . 0.68 111.748 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -82.72 7.85 13.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 1.45 110.332 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.44 115.78 2.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.276 -0.875 . . . . 1.1 110.669 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.47 75.45 24.96 Favored Pre-proline 0 CA--C 1.509 -0.621 0 N-CA-C 107.1 -1.444 . . . . 0.95 107.1 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.6 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 27.0 Cg_endo -61.73 -63.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 123.077 2.518 . . . . 0.54 113.298 -169.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 5.9 m-20 -64.01 -15.35 59.16 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.55 -0.75 . . . . 1.44 110.713 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 1.3 tmt_? -74.04 -55.72 5.78 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.475 -0.935 . . . . 4.56 108.475 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 88' ' ' ALA . 5.0 m -70.72 -25.46 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.05 -0.977 . . . . 1.26 110.36 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.581 ' HB3' ' HA ' ' A' ' 125' ' ' ASP . 9.2 ttt -66.4 -42.73 87.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.995 -1.457 . . . . 1.64 110.646 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.594 ' O ' ' HG2' ' A' ' 132' ' ' MET . 15.0 mt-30 -71.94 -24.93 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 2.0 112.282 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.554 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 13.3 mt-10 -65.88 -33.45 75.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.737 0.78 . . . . 1.64 109.067 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.864 HD23 HG22 ' A' ' 112' ' ' VAL . 5.2 mp -65.68 -37.54 86.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.016 -0.993 . . . . 1.96 110.043 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 10.0 ptm -74.88 -11.81 60.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.951 -0.7 . . . . 2.05 110.786 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 35.6 mm-40 -69.25 -35.06 75.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.068 -1.086 . . . . 1.67 108.068 170.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -91.11 23.29 3.32 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.452 -1.249 . . . . 1.58 109.769 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 54.92 49.91 16.71 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.316 -1.311 . . . . 1.42 111.927 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.549 ' H ' ' HA ' ' A' ' 132' ' ' MET . 46.5 mt -110.15 110.54 21.44 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.502 -0.772 . . . . 1.93 109.398 170.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 138' ' ' PRO . 71.0 t -109.12 114.25 58.2 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.662 0.744 . . . . 1.18 112.064 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.586 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -44.18 153.04 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 125.057 3.838 . . . . 0.88 113.314 174.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.866 ' HG2' HD11 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -76.11 -19.86 58.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.947 -1.478 . . . . 3.08 109.726 178.038 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -72.19 -22.19 61.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.588 -0.733 . . . . 1.57 110.665 171.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.455 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 34.1 m0 -102.62 -12.13 17.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.071 0.462 . . . . 0.66 110.571 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.38 21.89 9.56 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.555 -0.831 . . . . 0.57 114.232 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.96 -123.04 4.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.631 -1.271 . . . . 0.6 111.28 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -157.82 64.01 0.47 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-O 124.097 1.903 . . . . 1.91 111.326 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.624 HG21 ' HB ' ' A' ' 110' ' ' ILE . 97.0 m -148.36 112.23 5.12 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.044 -1.889 . . . . 1.1 108.609 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 1.067 ' HB ' HD12 ' A' ' 111' ' ' ILE . 51.9 mm -73.56 97.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.539 0.685 . . . . 1.27 109.412 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 14.8 m-85 -81.46 119.67 24.02 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.612 -1.176 . . . . 0.53 110.588 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 78.2 m -113.83 112.07 22.78 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.459 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.949 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 9.3 ptpt -89.51 91.43 8.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.227 0.537 . . . . 1.96 109.9 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.896 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 2.8 pp -122.37 -169.99 2.0 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.556 1.169 . . . . 1.49 112.412 -169.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.447 ' HB2' ' N ' ' A' ' 117' ' ' MET . 26.1 t -154.69 122.81 5.93 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.553 -1.658 . . . . 2.07 107.061 172.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.64 -8.12 59.0 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.512 0.672 . . . . 1.11 109.641 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.449 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 1.5 mmmp? -83.25 -46.49 12.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.125 -0.943 . . . . 2.78 111.165 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.8 OUTLIER -85.24 -8.01 58.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.164 -0.615 . . . . 1.35 111.285 175.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HD3' HD11 ' A' ' 158' ' ' LEU . 21.7 mmtp 62.85 43.31 7.07 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.2 -0.909 . . . . 1.9 111.49 174.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -102.9 -71.84 0.71 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.649 1.214 . . . . 2.48 110.554 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.896 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -65.49 -11.03 51.81 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.932 -1.485 . . . . 0.36 113.209 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 19.4 mt -69.21 -39.05 78.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.41 0.605 . . . . 1.42 109.584 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -63.0 -46.32 88.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.96 -0.756 . . . . 2.2 108.96 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -66.25 -27.89 68.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.49 -0.777 . . . . 0.68 111.151 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.7 tp -65.7 -55.73 15.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 1.77 110.279 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.2 mt -57.71 -44.16 85.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 2.1 109.909 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -59.66 -44.44 93.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.574 -0.739 . . . . 2.57 111.398 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.472 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -73.62 -39.74 64.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.011 0.434 . . . . 1.21 110.494 -177.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.492 HD11 HD13 ' A' ' 83' ' ' ILE . 51.9 mt -62.99 -44.69 99.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.807 -0.633 . . . . 1.2 110.596 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -37.64 88.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.942 -0.572 . . . . 2.3 111.076 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.4 tp -51.48 -49.06 62.56 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.376 0.608 . . . . 2.11 109.468 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.561 ' HA ' ' SD ' ' A' ' 171' ' ' MET . 93.9 t -66.35 -38.73 82.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.078 -0.965 . . . . 1.41 110.883 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.1 m -64.52 -28.1 69.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.82 0.343 . . . . 1.82 111.189 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.79 -45.96 14.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.024 0.44 . . . . 2.73 110.68 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.561 ' SD ' ' HA ' ' A' ' 168' ' ' VAL . 20.0 ptm -65.87 -12.0 51.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.934 -0.575 . . . . 2.12 112.019 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.437 ' CD ' ' HG1' ' A' ' 79' ' ' THR . 28.0 tp10 -58.13 -25.52 61.51 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.714 0.406 . . . . 4.27 111.667 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -82.97 -1.9 53.71 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.977 -0.452 . . . . 3.91 111.316 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.658 ' HG ' ' H ' ' A' ' 175' ' ' LYS . 0.3 OUTLIER -132.75 -72.29 0.52 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 122.323 -0.235 . . . . 6.06 111.255 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.658 ' H ' ' HG ' ' A' ' 174' ' ' LEU . 42.9 mtpt 61.26 88.37 0.09 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.629 0.603 . . . . 5.86 112.629 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -144.11 25.26 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.672 0.748 . . . . 5.79 109.136 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 18.2 p-10 -161.95 151.83 13.91 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 114.687 -1.142 . . . . 8.44 109.83 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 19.8 Cg_endo . . . . . 0 C--O 1.254 1.292 0 C-N-CA 123.203 2.602 . . . . 9.2 111.755 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.742 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.802 -0.519 . . . . 11.83 111.802 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 p -99.37 2.44 45.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.992 0.425 . . . . 10.75 111.047 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -87.18 91.4 8.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 10.82 110.1 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.5 tpp -99.99 51.79 0.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.802 -0.636 . . . . 9.01 109.67 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.67 -45.37 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.037 -0.529 . . . . 6.14 109.763 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -81.73 149.78 28.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.457 -0.792 . . . . 5.7 109.754 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.713 ' HD2' HE22 ' A' ' 77' ' ' GLN . 57.0 ttp180 -97.77 119.4 62.52 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.665 -0.243 . . . . 7.55 111.079 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 1.7 Cg_endo -84.01 103.73 1.02 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.323 2.682 . . . . 3.21 111.437 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 46.2 Cg_exo -56.15 133.24 56.83 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 123.053 2.502 . . . . 3.14 113.072 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.5 t -82.75 78.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 2.53 109.889 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.62 105.24 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.548 0.69 . . . . 1.95 110.562 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.638 HG23 ' HE1' ' A' ' 14' ' ' MET . 21.0 m -78.41 128.83 34.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.237 -0.892 . . . . 1.27 110.335 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.777 HG13 HD21 ' A' ' 25' ' ' LEU . 37.2 mm -93.85 120.07 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.899 0.38 . . . . 1.83 110.503 177.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.638 ' HE1' HG23 ' A' ' 12' ' ' THR . 64.0 mtt -139.12 176.23 8.88 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.629 -0.508 . . . . 1.28 109.629 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.499 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 141.06 -163.38 26.67 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.948 -0.861 . . . . 0.34 110.948 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.707 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 48.7 t60 -94.19 157.66 15.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.047 0.927 . . . . 0.28 111.444 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 19' ' ' HIS . 4.6 p -74.9 149.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.348 -1.296 . . . . 1.09 110.528 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 73.18 -21.2 0.26 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.69 110.187 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.534 ' H ' ' C ' ' A' ' 17' ' ' VAL . 19.5 m170 -74.0 -20.15 60.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.434 -0.951 . . . . 0.63 108.434 168.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.445 ' O ' HD13 ' A' ' 24' ' ' LEU . . . 109.97 63.34 0.52 Allowed Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.388 -0.823 . . . . 0.79 114.044 172.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.92 -57.45 4.57 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.971 -0.692 . . . . 3.69 111.378 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -86.4 -28.73 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.275 0.472 . . . . 1.76 112.275 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.612 ' HG1' ' H8 ' ' A' ' 179' ' ' GDP . 0.6 OUTLIER -59.19 -29.49 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.668 0.618 . . . . 1.71 112.668 -175.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 20' ' ' GLY . 9.7 mp -69.2 -40.09 78.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.395 -0.19 . . . . 2.09 110.706 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.777 HD21 HG13 ' A' ' 13' ' ' ILE . 19.8 mt -69.61 -11.5 60.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.379 0.609 . . . . 2.23 109.919 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.07 -43.1 7.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.064 0.935 . . . . 1.23 109.001 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -50.55 15.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.01 -1.45 . . . . 1.23 111.311 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.01 -31.86 52.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 1.59 111.699 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 27.8 mtm180 -54.47 -53.13 58.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.981 0.42 . . . . 3.51 110.642 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -84.23 20.01 1.72 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.942 0.877 . . . . 3.14 111.397 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.7 m -107.82 12.42 27.3 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.065 -0.97 . . . . 1.96 111.239 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -159.27 -173.32 4.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.477 -0.329 . . . . 4.37 110.284 174.201 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.55 -60.02 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.065 0.459 . . . . 3.59 111.462 -176.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.698 ' OG1' ' HB ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -68.47 121.06 15.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.797 -0.638 . . . . 2.99 109.907 175.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -142.78 -43.29 0.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.739 0.304 . . . . 6.34 111.254 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.96 -37.24 16.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.202 -0.454 . . . . 7.38 110.715 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -77.54 141.85 39.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.949 -0.569 . . . . 6.24 110.172 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 48' ' ' TYR . . . 67.61 174.91 0.26 Allowed 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.882 0.739 . . . . 5.33 110.88 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.75 26.45 60.68 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.462 -0.875 . . . . 4.68 111.418 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.83 82.97 0.3 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.426 -0.669 . . . . 5.06 111.426 -177.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.5 tp -102.77 124.63 56.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.809 0.338 . . . . 5.91 110.714 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.0 m 64.76 -83.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.406 -0.815 . . . . 6.29 110.937 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -143.82 16.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.971 0.415 . . . . 6.97 110.046 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -121.26 116.37 24.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 7.26 111.117 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 46' ' ' GLY . 5.9 tp -93.1 157.5 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.588 -0.893 . . . . 5.68 108.588 170.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 45' ' ' ILE . . . 175.9 -62.81 0.1 Allowed Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.319 -0.944 . . . . 2.62 113.155 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.804 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -166.69 -178.89 4.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.334 0.587 . . . . 1.8 112.183 -177.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.768 ' HE1' HD23 ' A' ' 25' ' ' LEU . 11.7 p90 -156.93 158.18 36.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.801 -1.09 . . . . 1.92 108.986 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -104.24 142.37 34.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.192 0.52 . . . . 2.22 110.907 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.609 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 22.8 t -89.17 142.35 13.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.663 -0.698 . . . . 2.09 110.139 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.698 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 57.5 m -161.44 86.4 0.67 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.393 -0.821 . . . . 1.99 109.481 -171.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 53' ' ' ASN . 4.2 p -80.93 -50.07 17.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.962 0.887 . . . . 2.62 109.042 173.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 52' ' ' VAL . 2.2 p30 -108.16 -64.25 1.24 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.406 -1.27 . . . . 4.06 108.92 175.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.609 ' HA ' HG21 ' A' ' 51' ' ' THR . 32.8 t70 -175.59 61.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.866 -1.061 . . . . 2.99 109.635 172.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.708 ' HE2' HD12 ' A' ' 166' ' ' LEU . 96.7 mttt -97.27 165.97 11.78 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.063 -0.972 . . . . 7.77 108.894 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 59.6 mttm -131.75 80.13 1.91 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.393 0.616 . . . . 4.8 110.245 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.5 mt -117.85 112.17 37.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.352 -0.84 . . . . 1.6 109.327 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -99.55 96.33 7.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.031 -0.531 . . . . 1.48 111.069 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.58 ' CD2' HD11 ' A' ' 13' ' ' ILE . 5.9 m-85 -71.01 120.7 16.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.522 -0.763 . . . . 1.63 110.551 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.804 HD12 ' HB1' ' A' ' 47' ' ' ALA . 3.5 mm? -93.65 142.76 26.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.485 0.55 . . . . 3.67 112.485 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.647 ' HA ' HD12 ' A' ' 25' ' ' LEU . 11.9 t70 -60.88 -62.96 1.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.654 -0.703 . . . . 5.61 111.342 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 m 64.06 85.42 0.16 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.959 -0.564 . . . . 5.77 111.466 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.715 ' HD2' HG23 ' A' ' 69' ' ' THR . 1.9 Cg_endo -83.52 -14.07 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.822 2.348 . . . . 6.26 112.22 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.83 143.11 11.84 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.124 -0.56 . . . . 6.42 111.948 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -164.18 -64.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.793 0.33 . . . . 9.55 110.257 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -136.46 -59.18 0.73 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.383 -0.371 . . . . 7.05 111.399 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' H ' ' CD ' ' A' ' 66' ' ' GLU . . . -140.56 -73.26 0.35 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.677 -0.238 . . . . 5.07 111.166 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' HZ ' HG22 ' A' ' 108' ' ' VAL . 16.4 m-85 -96.95 -20.91 17.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.537 0.208 . . . . 2.66 110.772 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.715 HG23 ' HD2' ' A' ' 63' ' ' PRO . 30.7 m 75.12 -52.34 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.238 0.615 . . . . 5.25 112.211 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.6 m -89.68 10.75 22.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.244 0.545 . . . . 6.21 111.434 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.754 ' HG3' ' HA3' ' A' ' 75' ' ' GLY . 54.6 ttm -79.86 75.42 6.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.32 0.581 . . . . 5.21 110.374 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 73' ' ' ALA . 1.2 tpp180 -91.08 -82.82 0.28 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.517 -0.549 . . . . 8.75 109.517 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' H ' ' HB3' ' A' ' 72' ' ' ARG . . . -110.61 -37.25 5.51 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.177 -0.675 . . . . 6.65 109.177 173.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 74' ' ' ARG . 25.0 mtm-85 -79.02 58.35 2.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.197 -0.91 . . . . 10.34 109.731 175.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.754 ' HA3' ' HG3' ' A' ' 71' ' ' MET . . . -153.04 11.65 0.58 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.534 -0.757 . . . . 5.22 111.671 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.11 -30.38 39.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.326 0.584 . . . . 5.89 110.077 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.713 HE22 ' HD2' ' A' ' 7' ' ' ARG . 11.8 pt20 -88.07 138.8 31.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.343 -0.844 . . . . 6.97 109.815 177.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.2 m -105.41 35.41 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.565 0.698 . . . . 4.68 110.44 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.3 m -98.97 -11.55 21.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.225 -0.898 . . . . 3.84 110.071 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -77.89 161.42 27.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.752 -0.658 . . . . 2.66 109.892 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.667 HG22 HG12 ' A' ' 111' ' ' ILE . 5.9 mt -119.53 156.09 22.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.177 -0.465 . . . . 1.38 110.974 -169.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.486 HG23 ' HE1' ' A' ' 102' ' ' HIS . 4.2 p -123.51 133.81 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.532 0.682 . . . . 1.79 109.952 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.738 HD13 HD12 ' A' ' 165' ' ' ILE . 15.5 mt -90.61 134.55 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.014 -0.994 . . . . 1.14 109.775 175.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.579 ' O ' HD11 ' A' ' 84' ' ' LEU . 2.1 tm? -116.49 104.92 11.92 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.151 -1.055 . . . . 1.65 108.151 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.6 t -85.83 112.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.744 -0.662 . . . . 1.14 111.192 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.8 m -123.37 118.29 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 115.741 -0.663 . . . . 1.31 110.751 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.99 130.85 43.3 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.224 -0.658 . . . . 1.01 109.224 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.893 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -74.18 -6.95 50.79 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.045 0.45 . . . . 1.07 111.497 -170.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.46 -10.01 45.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.879 -0.6 . . . . 0.58 110.87 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.43 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -128.83 -51.95 1.23 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.56 111.571 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.751 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 100.61 -133.86 11.47 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.523 -0.846 . . . . 0.37 113.749 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.44 134.25 37.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.541 0.686 . . . . 1.78 110.48 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.973 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 78.0 mmm -138.88 -178.77 0.9 Allowed Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 114.695 -1.139 . . . . 1.07 109.133 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.973 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 3.5 Cg_endo -46.93 -68.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.246 2.631 . . . . 0.89 114.652 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.5 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 8.4 pt20 -70.29 -16.5 63.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.23 0.538 . . . . 0.78 111.005 -175.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.707 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.45 -49.13 67.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.643 -0.708 . . . . 1.07 109.495 177.14 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.562 ' HA ' HD11 ' A' ' 100' ' ' ILE . 3.1 p -77.39 -24.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.845 -0.616 . . . . 2.02 112.438 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.44 -35.8 76.7 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.666 -0.646 . . . . 2.35 109.492 172.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -25.82 62.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 1.12 110.612 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.562 HD11 ' HA ' ' A' ' 97' ' ' VAL . 92.2 mt -75.25 -45.12 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.192 -0.67 . . . . 1.14 109.192 174.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.23 -49.53 60.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.119 -0.946 . . . . 0.75 110.458 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.486 ' HE1' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -45.19 -57.01 4.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 3.23 110.732 171.306 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.607 ' CB ' HD13 ' A' ' 110' ' ' ILE . . . -68.96 -47.89 64.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.302 -1.317 . . . . 1.17 113.047 -170.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 13.7 mmmm -72.14 -35.65 69.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.951 0.405 . . . . 2.27 110.641 -173.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.54 75.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.396 -0.82 . . . . 1.28 110.992 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -91.91 -25.33 18.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.208 -0.451 . . . . 1.31 112.097 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 44.4 m-20 80.56 42.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.92 0.867 . . . . 1.6 109.777 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG22 ' HZ ' ' A' ' 68' ' ' PHE . 3.3 t -96.91 141.99 23.87 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.106 -1.406 . . . . 1.93 111.47 -176.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 21.7 Cg_exo -66.14 142.5 67.79 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.909 2.406 . . . . 0.66 112.905 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.607 HD13 ' CB ' ' A' ' 103' ' ' ALA . 11.5 mm -108.93 158.95 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.804 0.811 . . . . 1.34 111.276 -175.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.784 HD11 ' HB ' ' A' ' 146' ' ' ILE . 23.8 mm -125.76 85.02 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.983 -1.488 . . . . 1.12 106.983 166.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 1.034 HG23 HG23 ' A' ' 145' ' ' THR . 57.4 t -71.48 143.34 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 121.711 0.767 . . . . 1.06 109.175 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.758 ' HB3' HD21 ' A' ' 150' ' ' LEU . . . -140.76 103.64 4.55 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.47 -1.241 . . . . 1.07 110.538 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.966 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.3 mp -70.45 132.81 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-N 113.588 -1.642 . . . . 1.29 108.631 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 61.1 t30 -120.87 169.63 10.26 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.384 -1.339 . . . . 1.85 107.384 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.817 ' HG2' ' N2 ' ' A' ' 179' ' ' GDP . 88.2 mttt 71.96 34.06 1.55 Allowed 'General case' 0 N--CA 1.424 -1.74 0 O-C-N 124.086 0.866 . . . . 1.18 110.91 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.639 ' CE ' ' HB3' ' A' ' 124' ' ' PRO . 10.6 mmt -74.53 -10.09 59.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 115.14 -0.936 . . . . 1.64 109.2 167.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.584 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 5.1 p-10 -72.96 -21.1 60.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.548 -1.206 . . . . 0.76 110.104 172.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.548 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 27.9 mtpp -91.26 135.02 28.74 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 1.74 110.273 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.34 -15.43 49.88 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.713 2.275 . . . . 0.68 111.058 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -78.5 2.07 20.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.643 -1.162 . . . . 1.45 110.486 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.469 ' HB2' ' HE1' ' A' ' 117' ' ' MET . . . -56.19 108.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.223 -0.899 . . . . 1.1 110.774 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.7 76.14 7.45 Favored Pre-proline 0 CA--C 1.51 -0.591 0 N-CA-C 107.03 -1.471 . . . . 0.95 107.03 171.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.639 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 37.7 Cg_endo -63.92 -66.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.303 0 C-N-CA 122.981 2.454 . . . . 0.54 113.234 -167.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.645 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 1.6 m-20 -64.45 -8.96 15.41 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.723 -0.671 . . . . 1.44 111.216 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -81.83 -53.94 5.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.845 -0.742 . . . . 4.56 109.434 174.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.893 HG21 ' HA ' ' A' ' 88' ' ' ALA . 18.5 m -68.88 -25.71 30.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.337 -0.847 . . . . 1.26 109.795 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 1.069 ' HA ' HD11 ' A' ' 131' ' ' LEU . 8.6 ttt -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.246 -1.343 . . . . 1.64 110.242 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 132' ' ' MET . 15.3 mt-30 -72.38 -37.74 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.674 -0.694 . . . . 2.0 111.205 173.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.7 mm-40 -60.32 -30.75 69.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.253 1.025 . . . . 1.64 109.149 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 1.069 HD11 ' HA ' ' A' ' 128' ' ' MET . 62.7 mt -63.74 -43.47 96.37 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.781 -1.554 . . . . 1.96 109.884 177.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.548 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 7.5 ptm -75.36 -14.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.229 -0.589 . . . . 2.05 110.9 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 17.4 mm-40 -71.61 -27.4 63.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.563 -0.902 . . . . 1.67 108.563 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -99.1 22.21 10.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.56 -1.2 . . . . 1.58 108.686 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 54.93 57.46 5.61 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 113.73 -1.577 . . . . 1.42 111.807 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.548 ' H ' ' HA ' ' A' ' 132' ' ' MET . 47.9 mt -119.38 111.73 18.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.847 -1.069 . . . . 1.93 109.0 167.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.45 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.7 t -118.66 117.44 34.18 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-O 121.369 0.604 . . . . 1.18 111.26 -170.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.59 ' CG ' ' HE3' ' A' ' 128' ' ' MET . 36.9 Cg_exo -56.09 175.47 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 124.11 3.207 . . . . 0.88 113.757 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 1.045 ' HG2' HD11 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -78.96 -31.81 45.14 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.011 -1.904 . . . . 3.08 109.477 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.857 ' HB2' ' HD1' ' A' ' 141' ' ' TRP . 6.7 mm-40 -58.28 -34.74 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.496 -0.775 . . . . 1.57 109.621 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.857 ' HD1' ' HB2' ' A' ' 140' ' ' GLU . 13.2 m0 -97.44 -7.69 31.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.749 -1.114 . . . . 0.66 110.926 -166.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.93 33.07 11.4 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.926 -0.654 . . . . 0.57 113.264 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.45 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.5 -125.05 5.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.174 -1.012 . . . . 0.6 111.685 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.62 62.18 0.53 Allowed 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.769 1.271 . . . . 1.91 111.448 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 1.034 HG23 HG23 ' A' ' 112' ' ' VAL . 73.8 m -160.5 128.96 4.69 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.194 -1.367 . . . . 1.1 110.238 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 1.045 HD11 ' HG2' ' A' ' 139' ' ' GLU . 38.0 mm -76.98 106.34 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.765 -0.828 . . . . 1.27 108.765 172.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 131' ' ' LEU . 8.3 m-85 -90.78 110.01 21.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.568 -0.742 . . . . 0.53 110.947 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.516 ' HG ' HG23 ' A' ' 146' ' ' ILE . 97.4 m -105.01 111.8 24.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.08 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.966 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 ptpt -88.4 91.28 8.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.339 0.59 . . . . 1.96 109.624 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.862 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -119.47 -173.31 2.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.6 1.191 . . . . 1.49 111.913 -170.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.638 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 4.8 p -153.1 101.0 2.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.692 -1.595 . . . . 2.07 107.25 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.86 62.42 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.752 -0.779 . . . . 1.11 109.358 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.595 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 0.9 OUTLIER -75.79 -44.75 39.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.148 -0.933 . . . . 2.78 111.679 175.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.739 ' HB ' ' HG3' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -78.59 -17.37 56.19 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.166 -0.613 . . . . 1.35 111.657 176.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.544 ' HD3' HD11 ' A' ' 158' ' ' LEU . 21.2 mmtp 68.7 46.6 0.92 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.393 -0.822 . . . . 1.9 110.832 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.739 ' HG3' ' HB ' ' A' ' 154' ' ' THR . 18.1 mt-10 -108.51 -68.78 0.89 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.566 1.174 . . . . 2.48 110.547 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.862 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.17 -10.53 52.56 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.813 -1.539 . . . . 0.36 113.454 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.544 HD11 ' HD3' ' A' ' 155' ' ' LYS . 37.3 mt -69.45 -42.52 74.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 117.308 0.554 . . . . 1.42 109.827 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.37 -42.81 92.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 2.2 109.564 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -67.66 -22.19 65.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.892 -0.595 . . . . 0.68 111.272 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -71.83 -52.55 16.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.133 0.492 . . . . 1.77 109.86 -176.229 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.48 -24.61 66.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.664 . . . . 2.1 111.004 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -72.2 -40.14 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.886 0.374 . . . . 2.57 110.457 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.775 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 23.3 mmt -66.49 -41.37 89.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 1.21 110.085 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.738 HD12 HD13 ' A' ' 83' ' ' ILE . 60.6 mt -61.29 -45.35 98.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 1.2 110.422 175.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.708 HD12 ' HE2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -60.97 -41.01 95.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.067 -0.515 . . . . 2.3 111.079 178.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.4 ' O ' HD11 ' A' ' 167' ' ' LEU . 1.6 tm? -51.21 -38.7 53.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.62 0.724 . . . . 2.11 109.234 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.59 -39.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 1.41 110.802 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.7 t -62.57 -33.75 75.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.06 0.457 . . . . 1.82 110.865 175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 4.7 mm-40 -75.9 -25.67 56.29 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.132 -0.692 . . . . 2.73 109.132 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 45.4 ttp -74.21 -9.45 58.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.249 -0.887 . . . . 2.12 110.802 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -56.79 -24.01 47.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.788 0.328 . . . . 4.27 111.492 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -101.73 -3.88 27.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.367 0.603 . . . . 3.91 110.18 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.3 mt -115.08 1.73 13.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.051 -0.522 . . . . 6.06 111.062 -173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.524 ' HB2' ' OD1' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -64.58 130.06 42.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.007 0.432 . . . . 5.86 111.123 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -101.95 17.63 22.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.2 -0.455 . . . . 5.79 111.146 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.524 ' OD1' ' HB2' ' A' ' 175' ' ' LYS . 27.4 p-10 -82.79 135.58 45.55 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.251 -0.431 . . . . 8.44 110.654 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 11.1 Cg_exo . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.087 2.525 . . . . 9.2 111.741 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.817 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 112.053 -0.419 . . . . 11.83 112.053 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -82.39 1.61 36.44 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.833 0.349 . . . . 10.75 111.89 -174.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -82.96 110.75 18.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.009 -0.367 . . . . 10.82 110.009 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.4 mmt -76.94 106.32 8.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.253 -0.647 . . . . 9.01 109.253 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.44 146.08 34.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.964 0.412 . . . . 6.14 111.366 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 8.7 tp10 -93.84 94.63 8.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.565 -0.902 . . . . 5.7 108.565 171.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.549 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.9 ttm180 -106.63 103.48 46.78 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.944 -0.571 . . . . 7.55 109.767 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 18.0 Cg_endo -94.68 102.12 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.551 2.834 . . . . 3.21 112.479 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.564 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 20.2 Cg_exo -65.98 112.54 2.29 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.304 2.003 . . . . 3.14 110.51 175.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.582 HG12 ' HB2' ' A' ' 61' ' ' ASP . 72.0 t -73.76 -71.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.216 -0.447 . . . . 2.53 110.389 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 93.4 t 69.69 119.47 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.798 0.808 . . . . 1.95 111.263 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.583 HG22 ' HA ' ' A' ' 60' ' ' LEU . 22.2 m -104.36 136.07 44.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.196 -0.456 . . . . 1.27 110.401 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -97.72 138.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.215 0.531 . . . . 1.83 110.238 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.608 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . 59.1 mtt -145.99 173.28 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 1.28 109.869 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.68 -174.97 22.77 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.756 -0.735 . . . . 0.34 112.362 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.928 ' HB2' ' HG1' ' A' ' 96' ' ' THR . 53.2 t60 -86.85 161.67 18.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.715 0.769 . . . . 0.28 111.717 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.0 p -73.08 148.88 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.764 -1.107 . . . . 1.09 109.447 173.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.476 ' HA ' " O4'" ' A' ' 179' ' ' GDP . 33.4 t70 73.6 -25.35 0.19 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.547 0.689 . . . . 0.69 109.951 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 16.5 m170 -86.99 -4.64 59.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.386 -0.824 . . . . 0.63 109.372 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.826 ' O ' ' HG2' ' A' ' 21' ' ' LYS . . . -143.23 -53.29 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 118.466 -1.186 . . . . 0.79 113.014 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.845 ' HG3' ' HB ' ' A' ' 23' ' ' THR . 15.4 pttt 60.44 138.47 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.073 0.94 . . . . 3.69 112.048 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -62.2 -15.41 46.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.148 0.975 . . . . 1.76 108.433 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.845 ' HB ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 m -67.42 -21.36 65.57 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 1.71 111.511 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.663 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.8 tt -68.95 -32.06 71.39 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.111 -0.993 . . . . 2.09 108.447 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.64 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 2.6 tp -68.22 -29.08 67.83 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 2.23 110.087 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.45 -38.48 26.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.267 1.032 . . . . 1.23 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.45 77.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.536 -1.665 . . . . 1.23 110.038 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.635 HG23 ' HH ' ' A' ' 48' ' ' TYR . 4.5 tt -78.2 -18.88 13.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.99 -1.005 . . . . 1.59 110.343 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 40.3 mtm180 -71.8 -63.27 1.16 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.9 0.381 . . . . 3.51 110.231 175.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -80.88 16.8 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.99 0.9 . . . . 3.14 111.656 -170.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 t -84.15 -17.62 39.42 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.608 -1.178 . . . . 1.96 109.267 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.6 174.66 5.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.517 -0.765 . . . . 4.37 109.293 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.588 ' O ' ' HB ' ' A' ' 51' ' ' THR . 94.2 t -54.61 130.01 16.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.401 0.62 . . . . 3.59 112.372 -177.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.9 t -154.62 -178.2 7.02 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.428 -0.952 . . . . 2.99 108.428 169.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -120.65 143.51 48.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.896 0.379 . . . . 6.34 111.33 -175.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.77 6.03 47.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.552 -0.907 . . . . 7.38 108.552 170.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -84.87 -179.89 7.18 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.872 -1.058 . . . . 6.24 110.193 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.11 -17.52 64.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.972 0.415 . . . . 5.33 110.708 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.39 -16.3 75.46 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.999 -0.619 . . . . 4.68 111.95 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.75 -51.51 0.53 Allowed Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.34 -0.704 . . . . 5.06 111.34 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.35 121.29 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.246 0.546 . . . . 5.91 110.034 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 m -99.88 155.36 17.71 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.072 -0.714 . . . . 6.29 109.072 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -74.13 56.21 0.61 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.137 0.494 . . . . 6.97 112.219 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -172.76 128.94 0.51 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.388 -0.967 . . . . 7.26 108.388 171.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.7 mm -88.64 155.77 3.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.737 -0.468 . . . . 5.68 109.737 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.83 -19.94 12.02 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.935 -0.65 . . . . 2.62 111.832 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . . . -175.43 -173.0 0.61 Allowed 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.575 0.35 . . . . 1.8 110.142 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.635 ' HH ' HG23 ' A' ' 28' ' ' ILE . 5.3 p90 -175.53 -178.62 1.14 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.831 0.348 . . . . 1.92 110.194 -171.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.522 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 36.0 mt-30 -91.9 112.98 25.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.882 -0.599 . . . . 2.22 109.899 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.545 HG13 ' CZ ' ' A' ' 48' ' ' TYR . 24.1 m -87.39 139.91 16.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.212 0.529 . . . . 2.09 111.209 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 33' ' ' VAL . 25.9 m -84.94 82.42 8.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.319 0.581 . . . . 1.99 109.612 172.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.0 p -81.39 -19.86 11.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 122.202 1.001 . . . . 2.62 108.38 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -159.48 -52.76 0.06 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.466 -1.697 . . . . 4.06 107.574 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -167.03 80.9 0.22 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.518 -1.219 . . . . 2.99 110.646 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 58.82 25.85 14.05 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.966 0.728 . . . . 7.77 112.966 172.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -102.64 154.29 19.29 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.713 -0.477 . . . . 4.8 109.713 176.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' PRO . 21.8 mt 73.7 82.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 124.04 0.837 . . . . 1.6 109.783 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.522 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 39.2 m -98.45 97.62 8.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.976 -0.556 . . . . 1.48 109.774 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.615 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 77.2 m-85 -61.43 133.74 56.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.778 -0.646 . . . . 1.63 109.678 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 63.0 tp 64.58 101.21 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.474 0.654 . . . . 3.67 110.82 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB2' HG12 ' A' ' 10' ' ' VAL . 14.6 t0 -75.41 -83.85 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.676 -0.693 . . . . 5.61 111.067 -176.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 m -136.75 117.4 10.99 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.541 -0.3 . . . . 5.77 110.731 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.05 151.02 30.24 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.434 2.09 . . . . 6.26 112.195 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.99 -102.44 0.76 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.824 -0.703 . . . . 6.42 112.349 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -60.7 -59.8 4.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.051 0.453 . . . . 9.55 110.943 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 42.0 mt-10 -127.32 98.97 5.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.058 -0.719 . . . . 7.05 109.058 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB2' ' CE1' ' A' ' 102' ' ' HIS . . . -76.36 55.38 0.98 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.531 0.682 . . . . 5.07 112.228 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -161.01 -165.16 1.3 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.047 -0.979 . . . . 2.66 109.541 173.153 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.471 HG23 ' HA ' ' A' ' 80' ' ' ASP . 8.3 t -59.54 132.57 54.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 5.25 111.748 -176.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.5 p -82.89 82.74 8.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.708 0.766 . . . . 6.21 110.697 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.7 mtm -56.21 -29.44 60.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.059 -0.973 . . . . 5.21 111.365 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.4 mtt-85 -55.43 -63.56 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 8.75 111.803 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.87 3.88 39.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 6.65 111.534 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.679 ' HA ' ' HE ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -109.36 7.71 25.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.991 0.424 . . . . 10.34 110.279 -178.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.29 -109.65 1.73 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.274 -0.731 . . . . 5.22 111.274 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.49 -93.64 0.1 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.344 -0.243 . . . . 5.89 110.344 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -111.05 68.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.267 0.556 . . . . 6.97 109.961 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.44 ' HB ' ' HD3' ' A' ' 7' ' ' ARG . 28.3 m -134.87 16.48 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.481 -0.781 . . . . 4.68 110.529 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -162.7 10.85 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.047 0.451 . . . . 3.84 111.401 -176.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HA ' HG23 ' A' ' 69' ' ' THR . 5.5 p-10 -80.4 88.04 5.61 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.495 0.664 . . . . 2.66 110.634 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.505 ' HB ' HG23 ' A' ' 11' ' ' VAL . 70.6 mt -145.05 132.56 16.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.535 -0.757 . . . . 1.38 110.419 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.51 HG22 ' HB ' ' A' ' 12' ' ' THR . 23.1 t -122.79 127.19 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.172 0.511 . . . . 1.79 110.998 173.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 24.3 mt -86.57 132.08 33.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.331 -0.849 . . . . 1.14 110.087 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.675 HD11 HG12 ' A' ' 86' ' ' VAL . 2.0 tm? -121.48 110.56 16.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.254 -1.017 . . . . 1.65 108.254 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 33.5 t -96.42 114.52 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.159 -0.473 . . . . 1.14 110.801 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.684 HG21 HG13 ' A' ' 114' ' ' ILE . 3.4 m -119.66 142.16 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.682 -0.69 . . . . 1.31 111.063 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.713 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -80.73 131.02 35.4 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.793 -0.447 . . . . 1.01 109.793 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.715 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -74.97 -12.96 60.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.116 -0.633 . . . . 1.07 109.906 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -91.1 -10.36 42.26 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.17 -0.923 . . . . 0.58 111.519 -177.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 7.0 t70 -134.9 -38.22 0.8 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.755 0.312 . . . . 0.56 111.348 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.437 ' HA2' ' CG1' ' A' ' 127' ' ' VAL . . . 91.03 -133.16 11.65 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 114.157 0.423 . . . . 0.37 114.157 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.527 HG11 ' HE2' ' A' ' 134' ' ' TYR . 12.8 t -100.34 131.46 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.911 0.862 . . . . 1.78 110.551 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.484 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -131.03 173.62 5.66 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 114.017 -1.447 . . . . 1.07 108.086 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 73.1 Cg_exo -49.71 -57.07 2.55 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.325 2.017 . . . . 0.89 113.282 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.577 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -72.34 -13.97 61.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.917 0.389 . . . . 0.78 111.415 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.928 ' HG1' ' HB2' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -69.76 -52.86 21.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.609 0.719 . . . . 1.07 109.647 177.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.543 ' HA ' HD13 ' A' ' 100' ' ' ILE . 2.0 p -83.13 -23.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 113.761 1.023 . . . . 2.02 113.761 -173.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.577 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -63.96 -25.17 68.02 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.111 -0.993 . . . . 2.35 109.428 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 14' ' ' MET . . . -74.57 -39.86 62.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.439 -0.8 . . . . 1.12 110.228 171.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.653 HG22 HD12 ' A' ' 136' ' ' LEU . 93.8 mt -62.98 -49.06 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.582 0.706 . . . . 1.14 109.754 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -55.43 -33.33 63.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.496 -1.229 . . . . 0.75 110.817 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 67' ' ' ALA . 3.0 t-160 -67.48 -43.68 80.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.696 -0.684 . . . . 3.23 110.375 176.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.403 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -73.97 -44.58 54.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 1.17 111.578 -177.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.757 ' HD3' HD23 ' A' ' 136' ' ' LEU . 13.5 mmmm -66.18 -32.78 74.43 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.123 0.487 . . . . 2.27 110.064 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.56 -41.75 70.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.926 -1.033 . . . . 1.28 110.83 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.39 44.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 1.31 111.305 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 84.39 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.412 1.07 . . . . 1.6 109.064 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.21 140.79 21.62 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 113.906 -1.497 . . . . 1.93 110.251 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.15 142.81 93.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.643 2.229 . . . . 0.66 111.96 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.49 ' C ' HG23 ' A' ' 145' ' ' THR . 23.0 mm -105.51 156.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.764 0.793 . . . . 1.34 110.735 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.944 HD12 ' HB ' ' A' ' 146' ' ' ILE . 14.2 mm -124.89 86.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 107.102 -1.444 . . . . 1.12 107.102 171.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.953 HG21 HG22 ' A' ' 145' ' ' THR . 59.9 t -75.16 145.83 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 121.779 0.799 . . . . 1.06 109.953 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.637 ' HB1' ' CD2' ' A' ' 150' ' ' LEU . . . -144.07 102.27 3.85 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.067 -1.424 . . . . 1.07 109.932 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.774 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.4 mp -72.18 140.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.148 -1.387 . . . . 1.29 109.636 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.713 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 4.4 p-10 -117.57 176.64 5.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.693 -1.225 . . . . 1.85 107.693 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.672 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 83.9 mttt 69.58 34.28 2.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.892 0.745 . . . . 1.18 111.633 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.438 ' CE ' ' HB3' ' A' ' 122' ' ' ALA . 17.5 mmt -77.78 -13.56 59.85 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.486 -0.931 . . . . 1.64 108.486 169.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.524 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -70.66 -25.94 63.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.861 -1.518 . . . . 0.76 109.519 173.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.493 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 43.5 mtpt -89.07 137.85 29.35 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.36 -0.836 . . . . 1.74 110.247 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.41 -13.94 42.39 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.839 2.36 . . . . 0.68 111.659 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 33.0 mt-10 -81.75 6.66 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.161 -0.927 . . . . 1.45 110.539 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.438 ' HB3' ' CE ' ' A' ' 117' ' ' MET . . . -58.0 107.68 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.565 -0.743 . . . . 1.1 110.975 175.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.84 76.66 29.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.48 -0.934 . . . . 0.95 108.48 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 47.4 Cg_endo -66.6 -54.77 0.41 Allowed 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.74 2.293 . . . . 0.54 113.125 -172.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.422 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.1 m-20 -52.26 -26.45 11.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 1.44 110.78 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.597 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 53.7 ttt180 -79.7 -57.15 3.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.07 -0.652 . . . . 4.56 109.403 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.715 HG11 ' HA ' ' A' ' 88' ' ' ALA . 15.7 m -63.76 -24.52 36.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.406 -0.816 . . . . 1.26 112.128 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.475 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 17.2 ptm -84.74 -17.37 38.56 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.037 0.446 . . . . 1.64 109.929 174.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.622 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.8 mt-30 -76.31 -40.74 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 2.0 110.511 170.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 1.9 mm-40 -58.6 -35.49 72.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.124 0.964 . . . . 1.64 108.978 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.824 HD23 HG23 ' A' ' 112' ' ' VAL . 2.0 mp -64.52 -42.89 95.5 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.542 -1.208 . . . . 1.96 110.352 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.732 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.7 ppp? -75.58 -8.75 57.57 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.506 -0.478 . . . . 2.05 110.685 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 8.0 mm-40 -71.97 -36.68 69.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.872 -1.158 . . . . 1.67 107.872 172.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.527 ' HE2' HG11 ' A' ' 92' ' ' VAL . 23.4 m-85 -91.42 28.56 1.66 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.655 -1.157 . . . . 1.58 110.012 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.74 53.14 13.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.742 -1.572 . . . . 1.42 112.342 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.757 HD23 ' HD3' ' A' ' 104' ' ' LYS . 66.2 mt -113.94 99.03 7.36 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.338 -0.847 . . . . 1.93 108.84 168.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.938 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 35.5 t -100.76 115.42 65.36 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-O 121.565 0.698 . . . . 1.18 111.788 -168.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.736 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 87.4 Cg_exo -43.97 138.69 6.24 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 124.168 3.245 . . . . 0.88 112.072 171.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.921 ' HG2' HD12 ' A' ' 146' ' ' ILE . 0.4 OUTLIER -73.65 -14.93 61.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.199 -0.91 . . . . 3.08 109.963 178.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.461 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.1 pm0 -66.07 -26.14 67.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.488 -0.778 . . . . 1.57 110.135 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.732 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 34.5 m0 -101.63 -14.91 17.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.97 0.414 . . . . 0.66 110.465 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.07 24.55 7.56 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.804 -0.712 . . . . 0.57 113.584 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.938 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.07 -120.27 2.07 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.9 -1.143 . . . . 0.6 112.094 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -157.63 63.38 0.47 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.824 1.297 . . . . 1.91 112.268 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.953 HG22 HG21 ' A' ' 112' ' ' VAL . 56.6 m -160.19 126.13 4.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.195 -1.366 . . . . 1.1 109.992 173.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.944 ' HB ' HD12 ' A' ' 111' ' ' ILE . 30.7 mm -74.47 104.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.539 -0.911 . . . . 1.27 108.539 172.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.736 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.8 m-85 -90.75 105.08 17.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.119 -0.946 . . . . 0.53 111.381 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.85 139.75 30.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.306 -0.861 . . . . 1.0 109.786 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.534 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 mptt -114.93 102.67 10.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.18 -0.674 . . . . 1.96 109.18 176.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.774 ' HG ' ' O ' ' A' ' 114' ' ' ILE . 3.6 pp -125.61 -174.02 2.97 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.389 1.09 . . . . 1.49 111.805 -172.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.407 ' N ' HD12 ' A' ' 150' ' ' LEU . 1.5 p -152.16 92.31 1.7 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.1 -1.409 . . . . 2.07 108.465 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -16.06 63.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.13 0.49 . . . . 1.11 109.867 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.549 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 0.0 OUTLIER -66.2 -55.99 13.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.32 -0.855 . . . . 2.78 110.847 172.203 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -84.79 -9.03 58.57 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.95 -0.7 . . . . 1.35 112.387 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.546 ' HD3' HD12 ' A' ' 158' ' ' LEU . 19.2 mmtp 71.53 42.79 0.64 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.669 0.606 . . . . 1.9 110.966 175.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 -70.72 0.76 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 122.344 1.068 . . . . 2.48 110.318 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.763 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.38 -4.82 46.41 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.269 -1.332 . . . . 0.36 113.967 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.546 HD12 ' HD3' ' A' ' 155' ' ' LYS . 22.5 mt -70.26 -36.74 74.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.155 -0.683 . . . . 1.42 109.155 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -38.89 79.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.144 -0.935 . . . . 2.2 109.035 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.584 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.2 t60 -71.48 -14.74 62.23 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.534 -0.757 . . . . 0.68 111.437 177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.89 -55.75 5.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.335 -0.617 . . . . 1.77 109.335 -177.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.92 -26.71 68.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.508 -0.769 . . . . 2.1 111.383 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.584 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 15.7 pt-20 -76.41 -30.73 57.56 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.403 -0.519 . . . . 2.57 110.79 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.619 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 29.6 mmt -73.23 -39.13 65.74 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.315 0.578 . . . . 1.21 109.507 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.497 HG21 HD12 ' A' ' 57' ' ' ILE . 83.3 mt -61.83 -42.41 94.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 1.2 109.531 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -37.64 86.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.567 -0.742 . . . . 2.3 111.185 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.3 tp -53.37 -45.08 69.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.533 0.682 . . . . 2.11 109.353 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.39 -46.35 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.939 -1.028 . . . . 1.41 110.646 175.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.4 m -58.81 -36.88 75.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.894 0.378 . . . . 1.82 111.301 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -72.35 -42.97 64.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.472 . . . . 2.73 110.143 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.0 ttp -73.67 -11.45 60.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 2.12 111.032 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.13 -28.38 64.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 4.27 111.228 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.429 ' C ' HD13 ' A' ' 174' ' ' LEU . 50.5 mm-40 -109.2 -4.92 16.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.544 -0.298 . . . . 3.91 111.212 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 173' ' ' GLU . 7.7 mp -128.57 41.41 3.49 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.429 . . . . 6.06 110.935 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -96.25 136.09 37.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.463 -0.335 . . . . 5.86 110.428 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -112.07 139.83 47.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.097 -0.502 . . . . 5.79 110.341 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 59.55 77.5 0.38 Allowed Pre-proline 0 N--CA 1.466 0.36 0 O-C-N 123.618 0.574 . . . . 8.44 110.808 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo . . . . . 0 C--O 1.254 1.303 0 C-N-CA 122.757 2.305 . . . . 9.2 111.746 179.063 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GDP . . . . . 0.764 ' O1B' ' HA ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.818 0.342 . . . . 0.64 110.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -92.56 129.93 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 108.763 -0.828 . . . . 1.3 108.763 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.457 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 44.9 mtm -143.82 -171.58 3.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.783 -0.644 . . . . 0.79 109.716 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.469 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 129.96 -158.57 22.36 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.617 -0.993 . . . . 0.31 110.617 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.72 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 13.4 t-80 -91.04 157.12 17.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.851 0.834 . . . . 0.22 111.189 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 6.4 p -73.5 154.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.366 -1.288 . . . . 0.36 109.9 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.505 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 20.3 t70 74.84 -18.94 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.295 0.569 . . . . 0.69 110.559 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.535 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 15.1 m170 -83.01 -4.86 58.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.515 -0.921 . . . . 0.63 108.515 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.7 ' HA3' HD13 ' A' ' 24' ' ' LEU . . . 111.01 47.34 0.77 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.391 -0.909 . . . . 0.79 114.062 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -50.61 -66.58 0.36 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.366 0.583 . . . . 3.31 111.691 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -94.15 -30.71 14.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.202 -0.454 . . . . 1.21 111.233 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.0 -27.46 63.52 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.724 0.639 . . . . 1.25 112.724 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.7 HD13 ' HA3' ' A' ' 20' ' ' GLY . 5.5 mp -78.61 -25.31 45.15 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.95 -0.3 . . . . 1.49 110.956 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.9 -17.1 60.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.936 -0.764 . . . . 1.69 108.936 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.08 -45.71 8.53 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.052 0.929 . . . . 1.23 108.805 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 24' ' ' LEU . . . -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.719 -1.582 . . . . 0.63 110.475 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 tt . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 114.91 -1.041 . . . . 1.02 110.974 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.2 mt . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.592 -0.522 . . . . 0.71 109.592 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 p -116.87 136.47 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 119.957 -0.697 . . . . 1.17 110.618 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 13.0 mt -96.64 128.8 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.501 -0.772 . . . . 0.37 109.98 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 84' ' ' LEU . 2.2 tm? -114.54 109.77 18.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.956 -1.127 . . . . 1.01 107.956 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.07 118.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.333 -0.394 . . . . 0.43 111.051 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.7 m -128.24 120.62 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.698 -0.683 . . . . 0.64 110.3 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -64.73 131.81 47.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.719 -0.673 . . . . 0.28 110.262 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -67.65 -18.09 64.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.084 0.469 . . . . 0.22 110.751 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -90.13 -14.65 33.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.392 -0.822 . . . . 0.58 111.316 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.481 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.5 t0 -123.63 -47.48 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.56 110.75 -170.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.616 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.82 -151.14 27.3 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.37 113.098 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.653 HG11 ' HE2' ' A' ' 134' ' ' TYR . 21.5 t -77.96 129.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.828 0.823 . . . . 1.03 111.025 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.936 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.2 mmm -130.94 179.89 1.23 Allowed Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 114.265 -1.334 . . . . 0.28 108.615 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.936 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.11 -66.01 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.284 2.656 . . . . 0.58 114.564 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.72 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 4.5 pt20 -73.23 -15.27 61.44 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.287 0.565 . . . . 0.75 110.94 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.0 -43.83 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 0.31 109.007 176.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.57 HG12 ' ND2' ' A' ' 101' ' ' ASN . 30.1 t -66.15 -42.59 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.255 -0.884 . . . . 1.38 111.302 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.28 -29.01 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.239 -0.437 . . . . 2.35 110.098 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.538 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.609 HG23 HD11 ' A' ' 136' ' ' LEU . 96.5 mt -75.4 -44.89 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.796 0.808 . . . . 0.41 109.147 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.57 ' ND2' HG12 ' A' ' 97' ' ' VAL . 53.0 m-20 -57.1 -37.42 71.92 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.041 -1.436 . . . . 0.67 110.944 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -71.5 -37.91 71.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.274 0.559 . . . . 2.5 109.795 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -44.31 68.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.785 -0.643 . . . . 0.47 111.824 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.64 ' HD3' HD21 ' A' ' 136' ' ' LEU . 1.8 mmmp? -76.42 -28.9 56.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.051 0.453 . . . . 1.66 110.482 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.12 -44.56 61.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.174 -0.921 . . . . 0.77 110.268 173.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.14 -34.99 22.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.992 -0.549 . . . . 0.74 110.436 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.3 t30 83.87 40.82 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.843 1.257 . . . . 1.41 109.36 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.481 HG13 ' HD2' ' A' ' 109' ' ' PRO . 24.5 t -83.8 145.29 46.77 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 113.279 -1.782 . . . . 1.35 110.99 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 108' ' ' VAL . 21.8 Cg_exo -61.93 138.68 75.14 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.257 1.972 . . . . 0.47 111.436 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.0 OUTLIER -107.68 159.07 7.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 122.011 0.91 . . . . 0.6 112.226 -172.073 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.856 HD13 ' HB ' ' A' ' 146' ' ' ILE . 5.9 mm -126.02 87.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.538 -1.664 . . . . 0.37 106.858 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.473 HG23 HG21 ' A' ' 145' ' ' THR . 61.5 t -78.1 148.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.603 -0.726 . . . . 0.26 109.971 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 148' ' ' CYS . . . -140.12 110.19 6.51 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.569 -1.196 . . . . 0.29 110.679 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.762 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.2 mp -84.86 108.31 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.148 -1.387 . . . . 0.59 109.636 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.4 p-10 -99.45 178.02 5.0 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.626 -1.25 . . . . 1.85 107.626 -171.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 74.9 mttt 70.75 28.44 3.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.034 0.834 . . . . 0.59 110.123 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 85.5 mmm -81.54 -7.27 59.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.351 -0.981 . . . . 0.92 108.351 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.411 ' N ' ' HB3' ' A' ' 151' ' ' SER . 1.2 p-10 -68.41 -30.44 69.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.521 -1.672 . . . . 0.76 109.634 168.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -71.79 131.73 85.66 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.78 -0.645 . . . . 1.17 110.089 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.27 -15.09 47.67 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.391 2.061 . . . . 0.58 111.388 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -90.24 5.71 45.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.377 -0.829 . . . . 1.45 110.592 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.452 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -54.77 124.41 16.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.731 -0.668 . . . . 0.27 111.271 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -125.31 76.07 68.45 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.337 -0.986 . . . . 0.95 108.337 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.75 ' HA ' HG21 ' A' ' 114' ' ' ILE . 39.4 Cg_endo -64.17 -62.03 0.1 Allowed 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.025 2.483 . . . . 0.4 113.305 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 6.9 m-20 -61.63 -16.15 45.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.257 -0.883 . . . . 1.44 111.019 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -75.42 -58.39 3.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.598 0.713 . . . . 3.79 109.307 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.616 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 12.7 m -66.03 -29.48 46.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 0.59 110.194 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.537 ' HG3' ' CD2' ' A' ' 147' ' ' PHE . 15.4 ttt -59.99 -39.59 86.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 0.81 110.793 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.597 ' O ' ' HG2' ' A' ' 132' ' ' MET . 45.0 mt-30 -69.14 -29.67 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 1.31 111.933 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.609 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 9.0 mt-10 -67.05 -29.07 68.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.587 . . . . 1.64 109.533 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.561 HD12 ' CD1' ' A' ' 136' ' ' LEU . 4.0 mm? -64.73 -44.5 89.99 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.641 -0.708 . . . . 1.36 110.071 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.597 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 14.7 ptm -70.57 -10.2 58.7 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.813 -0.755 . . . . 1.61 110.83 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 35.4 mt-10 -78.73 -28.3 44.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.05 -0.722 . . . . 1.67 109.05 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.653 ' HE2' HG11 ' A' ' 92' ' ' VAL . 71.3 m-85 -92.73 22.79 4.5 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.836 0.826 . . . . 1.08 109.659 167.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.0 t30 61.33 46.23 7.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 113.855 -1.52 . . . . 1.1 111.749 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.64 HD21 ' HD3' ' A' ' 104' ' ' LYS . 72.9 mt -113.67 93.6 4.46 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.36 109.732 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.036 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 44.5 t -102.74 122.87 44.43 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.199 -0.909 . . . . 0.43 110.635 -172.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.761 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 10.6 Cg_endo -60.0 157.52 33.67 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.211 2.608 . . . . 0.54 112.902 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.466 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.8 mm-40 -79.72 -12.1 59.81 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.127 -1.397 . . . . 3.08 110.574 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.761 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -69.89 -19.63 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.899 -0.591 . . . . 1.57 109.888 167.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.521 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 45.1 m0 -110.6 -20.43 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.338 -0.392 . . . . 0.66 111.306 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.72 28.75 5.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.839 -0.696 . . . . 0.53 113.417 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 1.036 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.2 -106.8 1.95 Allowed Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.58 -0.819 . . . . 0.6 112.689 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -166.0 61.21 0.1 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 122.284 1.04 . . . . 1.91 110.419 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 98.8 m -164.06 133.93 4.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 0.37 110.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.856 ' HB ' HD13 ' A' ' 111' ' ' ILE . 28.0 mm -97.16 110.1 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 109.495 -0.557 . . . . 0.63 109.495 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.672 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 12.1 m-85 -90.05 150.51 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.5 110.295 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 91.1 m -131.25 127.0 36.92 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.663 -1.153 . . . . 0.68 109.747 171.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.1 88.13 5.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.056 -0.72 . . . . 1.44 109.056 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.077 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -115.98 170.12 8.73 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.685 1.231 . . . . 0.84 112.768 -170.534 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.411 ' HB3' ' N ' ' A' ' 118' ' ' ASP . 3.1 p -129.94 104.78 7.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.961 -1.126 . . . . 1.77 107.961 172.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.41 -9.9 59.05 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.377 -0.529 . . . . 0.41 109.762 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -82.54 -46.39 13.44 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.128 -0.629 . . . . 2.3 112.119 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 p -86.39 -3.39 58.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 119.188 -1.005 . . . . 0.7 111.363 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 25.8 mmtp 64.89 45.59 3.18 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.287 -0.87 . . . . 1.36 110.705 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.51 -58.34 1.97 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.65 -1.159 . . . . 2.48 110.062 -175.039 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 1.077 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -79.76 -10.65 85.5 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.296 -0.865 . . . . 0.29 113.847 -173.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.6 -36.8 83.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.857 0.829 . . . . 0.8 109.043 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 1.6 m-20 -69.84 -42.12 74.01 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.695 -1.139 . . . . 2.2 110.182 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.83 -21.26 64.31 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.499 -0.319 . . . . 0.58 111.154 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -74.13 -51.15 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.659 -0.496 . . . . 1.16 109.659 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.2 pp -60.79 -27.51 68.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.795 -0.639 . . . . 1.51 110.711 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.608 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 42.0 mt-10 -64.63 -48.04 76.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.4 -0.364 . . . . 2.57 110.812 174.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -63.8 -35.63 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.32 -0.4 . . . . 0.64 110.27 176.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 73.4 mt -62.01 -48.57 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.52 110.829 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 163' ' ' GLU . 4.5 pp -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 121.007 -0.277 . . . . 1.73 110.965 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 166' ' ' LEU . 4.8 tt -54.38 -50.53 67.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.927 -0.768 . . . . 1.51 108.927 172.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 164' ' ' MET . 65.1 t . . . . . 0 N--CA 1.444 -0.757 0 CA-C-N 115.883 -0.599 . . . . 0.89 110.777 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.743 ' HB ' HG23 ' A' ' 82' ' ' VAL . 7.5 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 110.488 -0.19 . . . . 0.64 110.488 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.467 HD13 ' HB ' ' A' ' 83' ' ' ILE . 46.0 mm -105.06 113.61 42.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 1.3 109.978 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.587 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 67.3 mtt -127.18 172.81 10.23 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.944 -0.571 . . . . 0.79 109.877 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 148.57 -172.95 28.68 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.666 -0.778 . . . . 0.31 112.136 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.792 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 12.8 t-80 -88.88 159.66 17.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.856 0.836 . . . . 0.22 111.106 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.445 ' C ' ' H ' ' A' ' 19' ' ' HIS . 7.7 p -69.85 143.98 14.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.656 -1.157 . . . . 0.36 110.258 174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 30.6 t70 75.93 -18.24 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.384 0.612 . . . . 0.69 110.36 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.468 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 17.0 m170 -85.05 -10.73 56.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.278 -1.008 . . . . 0.63 108.278 170.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.87 48.46 1.08 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.191 -0.913 . . . . 0.79 113.369 174.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -60.83 -53.33 58.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.108 0.454 . . . . 3.31 110.909 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.5 m -98.85 -34.72 10.37 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.374 0.607 . . . . 1.21 110.442 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.589 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.66 -21.01 24.44 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.114 0.783 . . . . 1.25 113.114 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -75.64 -34.37 60.53 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.294 -1.002 . . . . 1.49 108.294 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 28' ' ' ILE . 7.0 tp -67.26 -23.79 65.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.322 -0.854 . . . . 1.69 109.785 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -92.54 -39.4 11.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.776 0.798 . . . . 1.23 109.681 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.29 80.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.56 -1.2 . . . . 0.63 109.738 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.3 tt . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 114.849 -1.069 . . . . 1.02 110.394 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.702 HG21 HG12 ' A' ' 111' ' ' ILE . 55.4 mt . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.916 0.389 . . . . 0.71 111.899 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.743 HG23 ' HB ' ' A' ' 12' ' ' THR . 9.2 p -117.06 140.36 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.457 0.646 . . . . 1.17 110.392 173.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 165' ' ' ILE . 18.8 mt -95.25 131.11 42.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.201 -0.909 . . . . 0.37 109.904 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.444 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 1.9 tm? -117.53 107.88 14.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.204 -1.036 . . . . 1.01 108.204 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.454 HG21 ' HG ' ' A' ' 24' ' ' LEU . 57.4 t -89.81 116.48 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.993 -0.549 . . . . 0.43 111.23 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 3.7 m -122.38 137.26 56.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 0.64 110.793 175.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.687 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -75.43 133.95 41.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.939 -0.573 . . . . 0.28 110.011 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -76.81 -14.88 59.87 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 120.303 -0.559 . . . . 0.22 110.129 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -10.61 53.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.561 -0.745 . . . . 0.58 110.894 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.405 ' HB3' ' CE1' ' A' ' 19' ' ' HIS . 24.3 t0 -128.03 -69.33 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.56 110.284 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.6 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 121.19 -139.8 13.54 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.14 -0.553 . . . . 0.37 113.183 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.5 p -95.67 139.72 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.432 0.634 . . . . 1.03 109.43 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.635 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 72.2 mmm -140.14 178.05 1.76 Allowed Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.419 -0.81 . . . . 0.28 108.815 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.635 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 82.9 Cg_exo -46.32 -64.69 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.885 2.39 . . . . 0.58 114.521 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.792 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 4.5 pt20 -70.56 -16.56 62.88 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.555 -0.715 . . . . 0.75 110.787 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.637 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.65 -49.7 51.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.747 -0.661 . . . . 0.31 109.603 178.152 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.612 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.7 p -74.74 -29.06 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.934 -0.575 . . . . 1.38 112.457 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -57.47 -30.18 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 2.35 109.946 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.587 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -71.14 -40.95 71.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.458 -0.792 . . . . 0.44 110.491 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 97' ' ' VAL . 76.9 mt -66.74 -44.31 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.821 0.819 . . . . 0.41 109.641 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -56.63 -42.21 78.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.67 110.842 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -71.23 -35.02 71.33 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.77 -0.455 . . . . 2.5 109.77 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.45 -52.56 38.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 0.47 111.533 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 29.7 mtpt -75.62 -22.78 56.55 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.675 -0.41 . . . . 1.66 110.908 -176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.21 72.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.551 -0.749 . . . . 0.77 110.539 171.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.57 -21.37 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.74 111.101 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.0 t30 82.32 61.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.282 0.989 . . . . 1.41 109.195 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 t -117.7 139.69 26.66 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 114.348 -1.296 . . . . 1.35 111.579 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -69.26 143.05 51.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.993 2.462 . . . . 0.47 111.362 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.505 ' C ' HG23 ' A' ' 145' ' ' THR . 1.3 mt -113.89 160.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 122.04 0.924 . . . . 0.6 112.375 -171.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.771 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 26.4 mm -129.94 86.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.816 -1.538 . . . . 0.37 106.89 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.789 HG23 HG21 ' A' ' 145' ' ' THR . 48.4 t -72.5 147.73 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.595 0.712 . . . . 0.26 109.159 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.94 105.48 4.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.646 -1.161 . . . . 0.29 110.48 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.811 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -73.99 134.08 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 114.163 -1.38 . . . . 0.59 108.97 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.687 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.7 p-10 -113.42 177.24 4.7 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.358 -1.349 . . . . 1.85 107.358 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.819 ' HD3' ' HE2' ' A' ' 119' ' ' LYS . 89.8 mttt 70.77 32.66 2.43 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 123.701 0.626 . . . . 0.59 111.907 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.544 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 10.8 mmt -79.89 -10.89 59.83 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.896 -1.15 . . . . 0.92 107.896 166.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 0.7 OUTLIER -70.47 -20.17 62.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.181 -1.827 . . . . 0.76 109.711 169.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.819 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 23.6 mtmt -100.15 134.57 20.75 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-N 115.606 -0.725 . . . . 1.17 110.407 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -64.03 -14.63 44.59 Favored 'Trans proline' 0 N--CA 1.47 0.122 0 C-N-CA 123.074 2.516 . . . . 0.58 111.907 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -81.67 6.52 14.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.417 -0.81 . . . . 1.45 110.42 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.406 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -58.08 115.4 2.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.17 -0.923 . . . . 0.27 111.231 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -122.4 76.72 44.41 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.04 -1.096 . . . . 0.95 108.04 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.544 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 43.6 Cg_endo -66.13 -60.25 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.949 2.432 . . . . 0.4 113.176 -170.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.497 ' HA ' ' HG2' ' A' ' 128' ' ' MET . 1.5 m-20 -55.87 -21.34 19.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.315 -0.857 . . . . 1.44 110.91 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -78.07 -56.83 4.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.475 0.655 . . . . 3.79 109.663 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 88' ' ' ALA . 22.6 m -66.66 -24.88 33.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.874 -1.057 . . . . 0.59 111.675 -176.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.75 ' HA ' ' HB2' ' A' ' 131' ' ' LEU . 18.8 ptm -87.86 -13.88 40.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.914 -0.315 . . . . 0.81 110.549 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.0 mt-30 -75.87 -47.9 23.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.685 0.279 . . . . 1.31 110.423 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.18 -18.3 64.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.445 0.641 . . . . 1.64 109.572 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.904 HD23 ' HE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -65.62 -43.36 89.78 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.084 -0.962 . . . . 1.36 109.012 172.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.857 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.8 ppp? -80.52 -7.5 59.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.965 -0.561 . . . . 1.61 110.55 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 45.8 mt-10 -78.59 -24.15 45.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.764 -0.828 . . . . 1.67 108.764 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.407 ' HD1' ' N ' ' A' ' 134' ' ' TYR . 1.8 m-85 -91.58 18.82 6.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.645 -1.161 . . . . 1.08 108.478 169.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 56.69 56.94 5.1 Favored 'General case' 0 CA--C 1.526 0.048 0 CA-C-N 113.716 -1.583 . . . . 1.1 111.463 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.777 ' H ' ' HA ' ' A' ' 132' ' ' MET . 70.8 mt -123.02 105.58 10.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.825 -1.08 . . . . 1.36 109.365 170.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.805 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.4 t -108.17 114.11 59.95 Favored Pre-proline 0 C--N 1.31 -1.132 0 C-N-CA 119.89 -0.724 . . . . 0.43 111.125 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.996 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 1.2 Cg_endo -54.45 160.59 6.68 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.587 2.858 . . . . 0.54 112.97 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.566 ' HB2' HD13 ' A' ' 146' ' ' ILE . 20.6 mm-40 -78.16 -17.29 57.03 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.02 -1.445 . . . . 3.08 109.697 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.996 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 2.0 pm0 -69.35 -24.48 63.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.118 -0.946 . . . . 1.57 110.256 169.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.857 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 30.7 m0 -105.99 -10.1 16.74 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.916 0.388 . . . . 0.66 110.274 -177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.16 33.83 10.34 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.896 -0.593 . . . . 0.53 113.455 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.805 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -91.31 -108.8 1.53 Allowed Glycine 0 CA--C 1.509 -0.317 0 C-N-CA 120.086 -1.054 . . . . 0.6 111.418 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -163.82 61.4 0.16 Allowed 'General case' 0 C--O 1.248 1.015 0 CA-C-O 123.497 1.618 . . . . 1.91 110.457 170.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.789 HG21 HG23 ' A' ' 112' ' ' VAL . 58.1 m -162.67 114.97 1.62 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.745 -1.571 . . . . 0.37 110.224 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.771 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 12.7 mm -68.12 106.16 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.032 -0.729 . . . . 0.63 109.032 172.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.904 ' HE2' HD23 ' A' ' 131' ' ' LEU . 7.9 m-85 -87.99 107.6 18.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.717 -0.674 . . . . 0.5 110.08 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.29 112.13 24.08 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.246 -0.434 . . . . 0.68 110.526 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.811 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 81.9 mttt -83.96 96.34 8.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.699 -0.852 . . . . 1.44 108.699 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.797 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.8 pp -122.33 -173.38 2.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.614 1.197 . . . . 0.84 111.974 -173.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 0.7 OUTLIER -154.0 93.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.498 -1.683 . . . . 1.77 107.626 -176.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.14 60.76 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.645 -0.422 . . . . 0.41 110.429 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 40.9 mttm -78.48 -48.17 15.89 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.311 -0.556 . . . . 2.3 111.541 172.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 p -84.75 -7.11 59.33 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.669 -0.812 . . . . 0.7 111.516 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.426 ' CD ' HD12 ' A' ' 158' ' ' LEU . 39.0 mmtm 66.79 42.54 2.58 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.396 -0.82 . . . . 1.36 111.548 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -102.31 -67.42 0.87 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.346 1.07 . . . . 2.48 109.911 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.797 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -70.06 -8.31 61.27 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.015 -1.448 . . . . 0.29 113.757 -174.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.426 HD12 ' CD ' ' A' ' 155' ' ' LYS . 26.6 mt -69.17 -37.96 78.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.98 0.89 . . . . 0.8 109.578 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.613 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 25.0 t70 -72.65 -39.31 67.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.657 -0.701 . . . . 2.2 109.596 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.47 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 86.6 t60 -69.28 -20.34 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.24 -0.436 . . . . 0.58 110.884 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.463 HD21 HD13 ' A' ' 83' ' ' ILE . 53.2 tp -67.18 -53.71 27.9 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.322 -0.621 . . . . 1.16 109.322 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.73 -26.97 67.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.043 -0.98 . . . . 1.51 110.72 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 49.8 mt-10 -58.74 -47.51 84.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.259 0.552 . . . . 2.57 110.202 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.651 ' HB3' HG21 ' A' ' 146' ' ' ILE . 19.5 mmt -71.9 -34.43 69.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.846 -0.616 . . . . 0.64 110.32 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 83' ' ' ILE . 84.5 mt -65.24 -46.13 91.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 0.52 110.995 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 167' ' ' LEU . 4.3 pp -67.47 -33.01 74.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.811 -0.356 . . . . 1.73 111.011 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 166' ' ' LEU . 2.3 tm? -52.99 -48.24 67.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.954 -0.758 . . . . 1.51 108.954 170.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.63 HG11 HD11 ' A' ' 81' ' ' ILE . 67.7 t . . . . . 0 N--CA 1.444 -0.731 0 CA-C-N 115.581 -0.736 . . . . 0.89 111.256 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.815 ' HB ' HG22 ' A' ' 82' ' ' VAL . 3.0 m . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.499 -0.185 . . . . 0.64 110.499 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -112.89 138.14 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.177 0.513 . . . . 1.3 110.592 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.455 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 63.0 mtt -147.05 173.04 12.83 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.561 -0.745 . . . . 0.79 109.28 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 84' ' ' LEU . . . 150.1 -175.99 28.94 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.711 -0.757 . . . . 0.31 112.108 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.586 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 49.5 t60 -86.6 162.15 18.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.997 0.903 . . . . 0.22 111.563 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.52 150.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.275 -1.329 . . . . 0.36 110.172 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.3 t70 74.44 -14.98 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.476 0.655 . . . . 0.69 109.902 -175.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.542 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 13.6 m170 -87.57 9.0 22.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.95 -1.13 . . . . 0.63 107.95 168.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 76.05 54.4 5.28 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 114.801 -1.09 . . . . 0.79 113.899 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 7.82 7.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.035 0.917 . . . . 3.31 111.453 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.5 m -129.64 -50.64 1.16 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.974 -0.557 . . . . 1.21 110.011 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -57.52 -24.75 57.8 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.077 -0.51 . . . . 1.25 111.315 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.3 mp -70.43 -35.34 73.32 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 111.98 0.363 . . . . 1.49 111.98 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 22' ' ' THR . 2.5 pp -74.61 -17.74 60.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.61 -0.836 . . . . 1.69 109.909 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' N ' HD12 ' A' ' 25' ' ' LEU . 29.5 t70 -85.55 -42.93 13.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.144 0.973 . . . . 1.23 109.217 174.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -64.52 -38.29 90.5 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.7 -1.591 . . . . 0.63 110.588 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 6.9 tt . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 115.151 -0.931 . . . . 1.02 111.139 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.453 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 110.3 -0.259 . . . . 0.71 110.3 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.815 HG22 ' HB ' ' A' ' 12' ' ' THR . 39.1 t -118.02 126.95 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.368 0.604 . . . . 1.17 112.11 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.67 HG12 ' HB ' ' A' ' 111' ' ' ILE . 6.1 mt -85.04 133.97 28.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.009 -0.996 . . . . 0.37 110.562 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 96' ' ' THR . 2.0 tm? -121.28 110.35 16.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.454 -0.943 . . . . 1.01 108.454 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 93.2 t -89.04 117.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 0.43 111.397 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.9 m -126.33 123.35 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.803 -0.635 . . . . 0.64 111.218 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -62.53 131.81 50.36 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.928 -0.578 . . . . 0.28 110.014 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.732 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.22 0.533 . . . . 0.22 111.115 -176.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -90.54 -13.87 33.71 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.479 -0.782 . . . . 0.58 111.069 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.451 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.1 t70 -118.55 -50.43 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 0.56 110.537 -174.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.585 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 91.43 -162.77 28.36 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.37 113.449 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.07 136.37 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.754 0.788 . . . . 1.03 109.75 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.769 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 76.8 mmm -139.39 176.93 2.27 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.932 -1.031 . . . . 0.28 109.14 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 74.7 Cg_exo -40.13 -65.52 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.369 2.712 . . . . 0.58 114.466 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.472 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.5 pt20 -76.13 -16.64 59.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.881 -0.327 . . . . 0.75 111.243 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.633 HG21 HG12 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -68.23 -43.01 78.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.486 0.66 . . . . 0.31 109.258 176.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.542 HG12 ' ND2' ' A' ' 101' ' ' ASN . 24.9 t -66.27 -41.35 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 115.049 -0.978 . . . . 1.38 111.289 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 41.1 mm-40 -55.07 -29.6 57.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.981 0.419 . . . . 2.35 110.456 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.04 -38.14 66.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.44 110.565 175.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.596 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.9 mt -73.49 -44.43 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.84 0.829 . . . . 0.41 109.056 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.542 ' ND2' HG12 ' A' ' 97' ' ' VAL . 35.1 m-20 -59.36 -30.71 68.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.36 -1.291 . . . . 0.67 111.055 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -80.91 -34.62 33.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.168 0.509 . . . . 2.5 110.038 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.501 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -71.81 -46.21 58.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.885 -0.598 . . . . 0.47 111.482 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 13.6 mmmm -71.59 -29.23 64.46 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.242 0.544 . . . . 1.66 109.58 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.46 72.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.906 -1.043 . . . . 0.77 111.33 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.33 28.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.74 110.629 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 85.6 53.06 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 114.581 -1.19 . . . . 1.41 109.295 171.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.34 141.96 25.02 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 113.841 -1.527 . . . . 1.35 110.62 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.27 143.43 83.33 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.554 2.17 . . . . 0.47 112.025 173.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.501 HD11 ' HB1' ' A' ' 103' ' ' ALA . 31.4 mm -106.34 158.59 6.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.488 0.661 . . . . 0.6 110.976 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.828 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 41.1 mm -124.94 84.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.396 -1.335 . . . . 0.37 107.396 171.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 131' ' ' LEU . 63.0 t -70.12 147.84 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.654 0.74 . . . . 0.26 109.753 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.779 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -145.13 100.37 3.46 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.34 -1.3 . . . . 0.29 109.701 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.823 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.7 mp -70.43 139.21 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.173 -1.376 . . . . 0.59 109.082 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -120.13 171.99 8.08 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.835 -1.542 . . . . 1.85 106.835 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.522 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 90.2 mttt 66.81 30.58 7.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 O-C-N 123.704 0.627 . . . . 0.59 111.902 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.494 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 83.1 mmm -83.79 -6.39 59.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.651 0.739 . . . . 0.92 109.299 172.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 8.1 p-10 -67.11 -28.1 67.88 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.704 -1.135 . . . . 0.76 108.865 169.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.502 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 29.5 mtpp -74.97 133.19 76.05 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.205 -1.362 . . . . 1.17 110.414 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -64.97 -16.05 53.53 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.449 2.1 . . . . 0.58 110.937 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -80.84 -1.64 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.745 -1.116 . . . . 1.45 110.63 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -54.97 124.29 16.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.189 -0.914 . . . . 0.27 111.731 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -129.13 75.67 79.99 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.75 -0.833 . . . . 0.95 108.75 173.107 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.406 ' HB3' ' SD ' ' A' ' 117' ' ' MET . 37.0 Cg_endo -63.24 -60.33 0.18 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 123.085 2.523 . . . . 0.4 112.73 -173.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 2.5 m-20 -55.92 -18.22 8.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.555 -0.748 . . . . 1.44 111.616 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 5.4 tpm_? -78.7 -56.75 4.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.206 -0.665 . . . . 3.79 109.206 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.585 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 5.0 m -66.47 -22.98 30.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 122.303 1.049 . . . . 0.59 110.165 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.62 ' HG3' ' CD2' ' A' ' 147' ' ' PHE . 8.4 ttt -68.27 -43.94 76.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.767 -1.56 . . . . 0.81 110.522 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.561 ' HA ' ' HG3' ' A' ' 132' ' ' MET . 73.5 mt-30 -68.85 -31.74 70.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.765 -0.652 . . . . 1.31 111.752 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.741 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 12.7 mt-10 -61.52 -37.61 84.36 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.932 0.872 . . . . 1.64 109.162 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.848 HD23 HG21 ' A' ' 112' ' ' VAL . 4.9 mp -62.4 -35.75 80.18 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.502 -0.772 . . . . 1.36 109.846 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.765 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -70.14 -18.05 63.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.051 -0.659 . . . . 1.61 111.864 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 4.7 pt-20 -78.83 -17.5 55.57 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.204 -1.036 . . . . 1.67 108.204 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -97.9 23.02 8.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.777 -1.101 . . . . 1.08 109.051 167.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.43 52.86 11.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.658 -1.61 . . . . 1.1 111.763 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 132' ' ' MET . 76.7 mt -121.67 96.79 5.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.604 -0.726 . . . . 1.36 110.026 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.968 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 61.5 t -103.54 121.71 47.42 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.572 -0.74 . . . . 0.43 111.302 -174.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 86.5 Cg_exo -41.58 144.16 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.642 3.561 . . . . 0.54 113.854 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HB2' HD13 ' A' ' 146' ' ' ILE . 9.0 mm-40 -74.09 -21.92 59.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.056 -1.429 . . . . 3.08 109.354 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 138' ' ' PRO . 2.3 pm0 -70.53 -21.44 62.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.671 -1.149 . . . . 1.57 110.634 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.537 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 37.6 m0 -102.66 -34.12 9.18 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 120.846 0.355 . . . . 0.66 110.641 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 122.27 29.63 1.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.724 -0.751 . . . . 0.53 112.623 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.968 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.91 -112.46 2.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.442 -0.885 . . . . 0.6 112.48 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -162.89 60.37 0.2 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.65 1.215 . . . . 1.91 111.246 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.749 HG21 HG23 ' A' ' 112' ' ' VAL . 52.3 m -165.12 116.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.686 -1.143 . . . . 0.37 110.347 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.828 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.5 mm -70.74 105.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.062 -0.718 . . . . 0.63 109.062 173.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.1 m-85 -89.05 114.56 25.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.205 -0.907 . . . . 0.5 110.601 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 95.4 m -102.94 116.63 32.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.754 0.311 . . . . 0.68 110.769 173.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.662 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 88.1 mttt -89.72 103.7 16.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.923 -0.769 . . . . 1.44 108.923 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.899 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.3 pp -135.25 -174.14 3.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.054 1.407 . . . . 0.84 112.953 -172.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.425 ' HB2' ' H ' ' A' ' 118' ' ' ASP . 13.8 t -152.44 118.55 5.51 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.453 -1.703 . . . . 1.77 106.693 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.56 -7.77 58.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.156 -0.618 . . . . 0.41 109.369 175.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -74.47 -55.15 6.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.47 -0.786 . . . . 2.3 110.197 172.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.4 p -82.5 -9.14 59.54 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.148 -0.621 . . . . 0.7 111.619 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.449 ' HE3' ' HB1' ' A' ' 27' ' ' ALA . 38.6 mmtm 65.39 40.14 4.89 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.506 -0.77 . . . . 1.36 111.516 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.13 -67.3 0.85 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.708 1.242 . . . . 2.48 110.281 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.899 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -68.68 -12.62 64.64 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 113.536 -1.665 . . . . 0.29 113.844 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 158' ' ' LEU . 34.4 mt -67.42 -37.56 83.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 118.287 1.043 . . . . 0.8 109.804 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.988 -1.005 . . . . 2.2 109.401 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.5 -20.56 65.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.396 -0.82 . . . . 0.58 110.861 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.12 -57.31 7.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.23 -0.441 . . . . 1.16 110.327 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.36 -41.27 75.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.405 -0.816 . . . . 1.51 110.178 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -55.23 -45.86 76.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.284 -0.871 . . . . 2.57 111.586 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.519 ' HB3' HG21 ' A' ' 146' ' ' ILE . 14.4 mmt -70.23 -44.38 68.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 0.64 110.382 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.556 HD11 HD11 ' A' ' 83' ' ' ILE . 72.0 mt -59.18 -49.53 83.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.725 -0.67 . . . . 0.52 111.523 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -22.94 60.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.673 -0.24 . . . . 1.73 110.849 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.13 -50.94 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.905 -0.776 . . . . 1.51 108.905 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 164' ' ' MET . 42.3 t . . . . . 0 N--CA 1.444 -0.743 0 CA-C-N 115.224 -0.898 . . . . 0.89 110.794 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 110.239 -0.282 . . . . 0.64 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -107.4 136.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.385 0.612 . . . . 1.3 110.953 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.429 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 63.5 mtt -144.12 176.59 9.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.433 -0.803 . . . . 0.79 108.892 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.07 176.69 15.21 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.247 -0.977 . . . . 0.31 112.322 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 57.7 t60 -80.81 158.94 25.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.82 0.819 . . . . 0.22 111.538 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 6.5 p -71.82 151.34 8.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.5 -1.227 . . . . 0.36 109.933 175.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 20.8 t70 75.03 -25.13 0.21 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.1 0.476 . . . . 0.69 110.703 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.551 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 20.4 m170 -76.71 -17.32 59.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.487 -0.931 . . . . 0.63 108.487 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.817 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 119.78 65.3 0.28 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.401 -0.818 . . . . 0.79 113.87 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -65.28 -71.43 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.142 -0.623 . . . . 3.31 110.656 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -86.71 -32.48 20.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.517 -0.31 . . . . 1.21 110.924 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.502 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -57.76 -27.86 63.42 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.569 0.581 . . . . 1.25 112.569 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.817 HD23 ' HA3' ' A' ' 20' ' ' GLY . 1.2 mm? -75.86 -36.93 59.42 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.908 -0.404 . . . . 1.49 109.908 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 tp -73.71 -9.67 58.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.631 -0.713 . . . . 1.69 109.941 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -98.92 -44.06 6.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.884 -0.784 . . . . 1.23 108.884 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.48 87.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.279 -1.328 . . . . 0.63 109.761 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 10.9 tt . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.791 -1.095 . . . . 1.02 111.101 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.6 mt . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 108.509 -0.923 . . . . 0.71 108.509 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.408 HG21 ' SD ' ' A' ' 14' ' ' MET . 11.9 p -114.49 135.69 53.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.528 0.68 . . . . 1.17 110.896 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.9 mt -90.83 128.92 42.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.914 -1.039 . . . . 0.37 109.884 173.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 96' ' ' THR . 2.4 tm? -114.8 106.89 14.73 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.369 -0.974 . . . . 1.01 108.369 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -86.29 109.03 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.43 110.996 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.5 m -119.99 122.29 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.768 -0.651 . . . . 0.64 110.656 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.85 130.09 41.33 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.406 -0.59 . . . . 0.28 109.406 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -69.01 -15.32 63.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 120.897 0.379 . . . . 0.22 111.505 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.52 -5.52 58.16 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.037 -0.529 . . . . 0.58 111.523 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -133.23 -49.39 0.86 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.556 0.217 . . . . 0.56 111.479 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.551 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 94.75 -148.43 18.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 121.084 -0.579 . . . . 0.37 113.477 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.436 HG11 ' CE2' ' A' ' 134' ' ' TYR . 30.2 t -83.23 131.28 34.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.542 0.687 . . . . 1.03 110.355 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.789 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 83.9 mmm -131.22 176.85 2.56 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 114.645 -1.162 . . . . 0.28 109.477 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.789 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 56.5 Cg_exo -38.53 -66.43 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.566 2.844 . . . . 0.58 114.578 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.503 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 3.8 pt20 -74.82 -15.5 60.74 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.135 0.493 . . . . 0.75 111.323 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -71.01 -41.68 70.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.475 0.655 . . . . 0.31 109.482 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 93' ' ' MET . 25.7 t -63.41 -41.16 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.193 -0.912 . . . . 1.38 111.861 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.29 -34.29 68.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 2.35 110.276 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.429 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -68.65 -34.26 75.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 0.44 110.609 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.592 HG21 ' HB3' ' A' ' 134' ' ' TYR . 95.5 mt -74.14 -42.67 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.778 0.799 . . . . 0.41 109.256 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.46 ' OD1' HG12 ' A' ' 97' ' ' VAL . 1.9 m120 -65.41 -25.59 67.61 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.446 -1.252 . . . . 0.67 111.349 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -82.63 -39.21 22.45 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.256 0.55 . . . . 2.5 109.846 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.02 44.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.779 -0.646 . . . . 0.47 111.982 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.79 ' HD3' HD21 ' A' ' 136' ' ' LEU . 29.9 mmmt -75.76 -27.15 57.96 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.305 0.574 . . . . 1.66 110.438 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.82 -44.29 81.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.055 -0.975 . . . . 0.77 110.302 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.67 44.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.084 -0.507 . . . . 0.74 110.926 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.2 t30 82.64 37.19 0.05 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.657 1.218 . . . . 1.41 108.583 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 31.1 t -77.38 137.35 64.09 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 113.39 -1.732 . . . . 1.35 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 16.7 Cg_exo -67.69 138.97 46.82 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.381 2.054 . . . . 0.47 111.321 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.454 ' C ' HG23 ' A' ' 145' ' ' THR . 0.8 OUTLIER -110.59 155.75 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 122.056 0.932 . . . . 0.6 112.196 -173.137 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.854 HD13 ' HB ' ' A' ' 146' ' ' ILE . 28.4 mm -122.44 82.19 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 113.753 -1.567 . . . . 0.37 107.278 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.916 HG23 HG21 ' A' ' 145' ' ' THR . 64.0 t -69.01 146.04 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 109.044 -0.724 . . . . 0.26 109.044 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.6 103.01 4.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.545 -1.207 . . . . 0.29 110.111 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.857 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.5 mp -69.02 136.11 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.066 -1.425 . . . . 0.59 108.444 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 62.9 t30 -123.62 167.07 14.44 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.486 -1.302 . . . . 1.85 107.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.627 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 85.7 mttt 69.55 31.99 3.52 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 124.036 0.835 . . . . 0.59 111.047 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 75.6 mmm -85.11 -3.81 58.93 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.84 0.829 . . . . 0.92 108.914 173.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 4.1 p-10 -68.16 -33.1 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.269 -1.332 . . . . 0.76 109.061 168.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.626 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 25.4 mtpp -72.25 129.94 86.9 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 114.814 -1.085 . . . . 1.17 110.202 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.52 -13.99 42.2 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 122.406 2.071 . . . . 0.58 110.788 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -82.47 -1.99 52.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 1.45 110.298 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.45 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -61.36 130.19 44.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.985 -1.007 . . . . 0.27 111.333 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -124.95 76.64 66.68 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.627 -0.879 . . . . 0.95 108.627 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.539 ' HB3' ' SD ' ' A' ' 117' ' ' MET . 56.8 Cg_endo -66.71 -53.93 0.5 Allowed 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.77 2.314 . . . . 0.4 113.311 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.558 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.0 m-20 -53.93 -29.21 41.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.22 -0.9 . . . . 1.44 110.115 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -75.95 -56.92 4.21 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.798 -0.761 . . . . 3.79 109.485 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 88' ' ' ALA . 24.9 m -62.77 -29.03 46.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.424 -0.807 . . . . 0.59 112.033 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.558 ' SD ' ' HA ' ' A' ' 125' ' ' ASP . 18.2 ptm -73.05 -23.77 60.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.518 -0.473 . . . . 0.81 110.219 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -70.73 -32.24 69.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.615 -0.266 . . . . 1.31 110.694 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 3.1 mm-40 -64.23 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.844 0.83 . . . . 1.64 109.719 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.633 HD12 HD13 ' A' ' 136' ' ' LEU . 4.2 mm? -64.03 -41.52 97.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.309 -0.86 . . . . 1.36 109.658 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.757 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 1.6 mtm -72.83 -13.91 61.39 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 119.652 -0.819 . . . . 1.61 110.692 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 5.1 mm-40 -68.49 -26.73 65.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.396 -1.335 . . . . 1.67 107.396 173.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.592 ' HB3' HG21 ' A' ' 100' ' ' ILE . 78.9 m-85 -108.74 33.72 4.06 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.407 -1.269 . . . . 1.08 111.039 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 54.9 t30 61.71 43.01 10.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.631 -1.168 . . . . 1.1 112.013 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.79 HD21 ' HD3' ' A' ' 104' ' ' LYS . 36.1 mt -123.02 97.22 5.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.814 -0.63 . . . . 1.36 111.384 174.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.072 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 57.3 t -99.1 121.26 56.14 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 115.561 -0.745 . . . . 0.43 111.185 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.757 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 93.1 Cg_exo -41.86 142.72 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.373 3.382 . . . . 0.54 113.573 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.484 ' HB2' HD13 ' A' ' 146' ' ' ILE . 4.9 mm-40 -73.5 -16.12 61.29 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.514 -1.221 . . . . 3.08 109.81 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.578 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.2 pm0 -69.27 -21.87 63.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.834 . . . . 1.57 110.26 170.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.5 m0 -109.97 -18.21 13.43 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.082 0.468 . . . . 0.66 111.078 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.54 4.97 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.827 . . . . 0.53 113.506 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 1.072 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.23 -110.66 1.43 Allowed Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.39 -0.91 . . . . 0.6 111.909 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -161.22 60.07 0.29 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 122.808 1.29 . . . . 1.91 111.485 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.916 HG21 HG23 ' A' ' 112' ' ' VAL . 58.5 m -164.1 119.8 1.58 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.87 -1.059 . . . . 0.37 111.201 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.854 ' HB ' HD13 ' A' ' 111' ' ' ILE . 22.5 mm -72.77 106.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.678 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.3 m-85 -88.78 116.63 27.18 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.203 -0.908 . . . . 0.5 110.863 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 85.3 m -102.01 115.71 31.14 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.658 -0.497 . . . . 0.68 109.658 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.857 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 37.9 mtpt -94.8 85.19 4.36 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.984 -0.746 . . . . 1.44 108.984 -176.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.983 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -121.99 -176.92 3.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.712 1.244 . . . . 0.84 113.192 -164.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.431 ' N ' HD12 ' A' ' 150' ' ' LEU . 1.2 p -149.35 108.39 3.9 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.579 -1.646 . . . . 1.77 108.358 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.405 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . . . -76.44 -15.43 59.92 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.193 0.52 . . . . 0.41 109.906 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -76.31 -51.39 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.766 -0.652 . . . . 2.3 111.432 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -79.14 -9.63 59.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.03 -0.668 . . . . 0.7 111.318 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp 66.77 43.69 2.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.919 0.866 . . . . 1.36 110.465 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 2.4 tt0 -105.16 -63.07 1.27 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.217 . . . . 2.48 109.912 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.983 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -78.16 -10.7 86.02 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 114.933 -1.03 . . . . 0.29 113.432 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 22.6 mt -67.15 -40.04 86.63 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 117.702 0.751 . . . . 0.8 110.11 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -73.14 -37.84 66.47 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.384 -0.826 . . . . 2.2 109.348 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 163' ' ' GLU . 83.2 t60 -70.41 -20.75 62.9 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.561 -0.745 . . . . 0.58 111.142 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.79 -54.2 30.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.184 0.516 . . . . 1.16 109.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.9 mt -55.98 -38.56 70.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.076 -0.965 . . . . 1.51 110.196 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 49.4 mt-10 -51.97 -52.72 48.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 2.57 110.972 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.579 ' HB3' HG21 ' A' ' 146' ' ' ILE . 15.0 mmt -69.79 -34.55 73.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.959 -0.564 . . . . 0.64 110.535 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.7 mt -61.17 -51.97 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.52 111.192 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 167' ' ' LEU . 4.1 pp -66.19 -33.22 75.28 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 121.032 -0.267 . . . . 1.73 111.176 -177.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.8 tp -54.06 -51.34 64.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.895 -0.593 . . . . 1.51 109.634 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 164' ' ' MET . 61.1 t . . . . . 0 N--CA 1.447 -0.624 0 CA-C-N 115.757 -0.656 . . . . 0.89 110.793 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.557 0.218 . . . . 0.64 111.293 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -93.18 108.49 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.922 0.391 . . . . 1.3 110.256 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.466 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 45.1 mtm -130.22 172.8 11.41 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.887 -0.412 . . . . 0.79 109.887 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.81 -157.14 27.1 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.013 -0.835 . . . . 0.31 111.013 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.617 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 46.9 t60 -94.6 160.4 14.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.116 0.96 . . . . 0.22 111.839 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.87 152.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.31 -1.314 . . . . 0.36 110.489 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t70 73.44 -20.75 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.205 0.602 . . . . 0.69 110.162 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 17' ' ' VAL . 22.3 m170 -71.6 -20.75 61.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.079 -1.082 . . . . 0.63 108.079 167.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 112.83 58.41 0.42 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.34 -0.846 . . . . 0.79 113.778 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 14' ' ' MET . 2.9 tppp? -58.11 -62.78 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.628 0.714 . . . . 3.31 111.088 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 p -72.08 -40.75 68.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 1.21 111.845 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -27.66 69.05 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.937 -0.574 . . . . 1.25 112.087 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -70.28 -57.31 5.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.441 0.639 . . . . 1.49 109.574 -175.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -12.39 55.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.747 -1.115 . . . . 1.69 111.136 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.77 -37.46 9.46 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.807 0.813 . . . . 1.23 109.678 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.23 70.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.781 -1.1 . . . . 0.63 109.494 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.6 tt . . . . . 0 N--CA 1.446 -0.646 0 CA-C-N 114.713 -1.131 . . . . 1.02 110.057 179.629 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.1 mt . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.654 0.264 . . . . 0.71 110.923 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.58 138.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-O 121.771 0.796 . . . . 1.17 111.147 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 6.3 mt -98.17 132.48 43.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.961 -1.018 . . . . 0.37 110.372 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -107.77 107.26 17.95 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.463 -0.79 . . . . 1.01 110.108 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.59 94.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.152 0.501 . . . . 0.43 110.472 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.611 HG13 HD12 ' A' ' 84' ' ' LEU . 11.4 m -111.29 123.35 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.008 -0.542 . . . . 0.64 111.032 175.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -71.68 130.31 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.161 -0.472 . . . . 0.28 109.752 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.754 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -68.4 -19.37 64.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.055 0.455 . . . . 0.22 111.59 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.39 -14.45 46.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.754 -0.657 . . . . 0.58 110.649 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.448 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 6.6 t70 -118.21 -55.04 2.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.56 110.362 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.41 ' HA2' ' CG1' ' A' ' 127' ' ' VAL . . . 99.38 -128.47 9.58 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.965 -0.562 . . . . 0.37 113.319 173.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.469 HG21 ' HE2' ' A' ' 134' ' ' TYR . 8.7 p -103.86 136.94 34.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.675 0.75 . . . . 1.03 109.845 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.7 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.9 mmm -140.08 176.73 2.35 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.772 -1.104 . . . . 0.28 108.74 -171.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.9 Cg_exo -41.35 -66.96 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.15 2.567 . . . . 0.58 114.552 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.477 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 6.2 pt20 -74.11 -15.4 61.05 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.22 0.533 . . . . 0.75 111.114 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.7 -43.71 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.119 -0.697 . . . . 0.31 109.119 176.458 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.536 HG12 ' ND2' ' A' ' 101' ' ' ASN . 22.7 t -66.78 -41.83 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.237 -0.892 . . . . 1.38 111.164 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -56.45 -32.06 64.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.484 . . . . 2.35 110.424 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.53 -31.93 69.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.676 -0.693 . . . . 0.44 110.638 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.569 HG23 HD11 ' A' ' 136' ' ' LEU . 96.7 mt -77.94 -44.65 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.564 0.697 . . . . 0.41 109.371 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.536 ' ND2' HG12 ' A' ' 97' ' ' VAL . 61.2 m-20 -57.41 -38.25 74.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.523 -1.217 . . . . 0.67 110.808 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -68.79 -34.54 75.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.058 0.456 . . . . 2.5 109.872 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.96 -48.91 16.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.015 -0.538 . . . . 0.47 111.932 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.57 ' HD3' HD21 ' A' ' 136' ' ' LEU . 14.0 mmmm -66.46 -38.37 87.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.03 0.443 . . . . 1.66 110.018 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.91 -35.81 71.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 0.77 111.04 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.99 -32.71 39.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.508 -0.314 . . . . 0.74 111.301 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 83.35 42.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.36 1.076 . . . . 1.41 108.902 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 109' ' ' PRO . 1.7 p -103.76 142.86 25.47 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 114.077 -1.419 . . . . 1.35 111.208 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 108' ' ' VAL . 22.1 Cg_exo -65.17 142.27 73.06 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.361 2.041 . . . . 0.47 111.722 171.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 111' ' ' ILE . 1.3 mt -110.82 163.79 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.443 0.64 . . . . 0.6 111.782 -171.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.851 HD13 ' HB ' ' A' ' 146' ' ' ILE . 15.9 mm -142.09 84.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 N-CA-C 106.747 -1.575 . . . . 0.37 106.747 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.751 HG23 HG21 ' A' ' 145' ' ' THR . 63.1 t -76.02 152.27 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 CA-C-N 114.316 -1.311 . . . . 0.26 109.815 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.9 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -143.51 101.5 3.79 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.554 -1.203 . . . . 0.29 109.739 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.841 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.6 mp -68.65 133.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 114.106 -1.406 . . . . 0.59 108.722 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 64.6 t30 -120.37 166.84 12.99 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.125 -1.435 . . . . 1.85 107.125 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.566 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 81.5 mttt 68.42 31.66 4.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 O-C-N 124.242 0.964 . . . . 0.59 111.672 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.478 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 82.6 mmm -80.99 -6.94 59.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.466 -0.788 . . . . 0.92 109.378 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -65.5 -32.49 74.12 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.068 -0.969 . . . . 0.76 108.595 169.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.49 ' HB3' ' OE1' ' A' ' 121' ' ' GLU . 26.8 mtpp -77.56 131.37 71.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.856 -1.52 . . . . 1.17 110.724 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.78 -18.17 59.12 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.538 2.159 . . . . 0.58 111.402 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 15.3 mp0 -68.7 -22.26 64.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.257 -0.883 . . . . 1.45 110.394 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -40.93 123.62 1.98 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.556 -1.202 . . . . 0.27 112.631 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -129.2 75.94 79.61 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.959 -1.126 . . . . 0.95 107.959 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.814 ' O ' ' HG3' ' A' ' 128' ' ' MET . 33.1 Cg_endo -61.15 -60.37 0.24 Allowed 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 122.806 2.337 . . . . 0.4 113.193 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.421 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 5.1 m-20 -49.15 -27.59 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.859 0.724 . . . . 1.44 110.753 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 129' ' ' GLN . 41.8 ttp180 -77.49 -53.3 7.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.756 -0.656 . . . . 3.79 110.031 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.597 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 19.5 m -64.36 -20.62 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.659 -0.701 . . . . 0.59 112.219 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.814 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 37.3 mtp -71.45 -35.68 70.97 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.647 0.737 . . . . 0.81 109.131 171.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 132' ' ' MET . 46.2 mt-30 -66.65 -35.11 79.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.718 -1.128 . . . . 1.31 110.956 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.597 ' HG2' ' HA ' ' A' ' 127' ' ' VAL . 18.8 mm-40 -57.53 -50.07 74.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.924 0.868 . . . . 1.64 109.835 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.734 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 10.7 mp -65.01 -34.27 78.05 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.998 -1.001 . . . . 1.36 110.917 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.594 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 14.6 ptm -73.25 -11.27 60.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.974 -0.691 . . . . 1.61 110.65 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.72 -28.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.515 -0.92 . . . . 1.67 108.515 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.469 ' HE2' HG21 ' A' ' 92' ' ' VAL . 45.4 m-85 -90.12 23.24 2.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.187 -0.915 . . . . 1.08 109.408 167.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.3 t30 52.38 54.44 10.69 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 114.014 -1.448 . . . . 1.1 111.737 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.734 ' HB2' ' HB3' ' A' ' 131' ' ' LEU . 78.9 mt -117.98 98.09 6.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.844 -1.071 . . . . 1.36 109.131 169.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.015 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 40.3 t -100.19 118.95 60.45 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.031 -0.532 . . . . 0.43 111.156 -171.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.582 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.4 Cg_exo -42.82 144.04 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 124.306 3.337 . . . . 0.54 112.798 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 146' ' ' ILE . 2.3 mm-40 -72.77 -20.66 61.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.426 -1.261 . . . . 3.08 110.056 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 2.4 pm0 -68.76 -22.59 64.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.341 -0.845 . . . . 1.57 110.232 171.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.574 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 31.2 m0 -103.89 -15.76 15.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.66 110.333 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.39 23.44 9.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.53 113.736 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 1.015 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.86 -107.42 0.73 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.107 -1.044 . . . . 0.6 112.469 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -164.56 61.03 0.14 Allowed 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.664 1.221 . . . . 1.91 111.316 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.751 HG21 HG23 ' A' ' 112' ' ' VAL . 60.7 m -163.94 111.68 1.15 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.447 -1.252 . . . . 0.37 110.225 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.851 ' HB ' HD13 ' A' ' 111' ' ' ILE . 12.9 mm -68.21 105.12 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 109.026 -0.731 . . . . 0.63 109.026 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 7.7 m-85 -86.37 114.19 22.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.346 -0.843 . . . . 0.5 110.454 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 73.2 m -100.36 113.69 26.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 0.68 110.74 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.759 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.0 mttt -85.72 101.07 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.581 -0.526 . . . . 1.44 109.581 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.924 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.6 pp -133.03 -172.44 2.93 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 123.236 1.493 . . . . 0.84 113.404 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.513 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 13.5 t -159.71 117.05 2.63 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 112.811 -1.995 . . . . 1.77 106.389 172.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.03 -16.95 62.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.059 -0.719 . . . . 0.41 109.059 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -69.82 -54.12 15.06 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.732 -1.122 . . . . 2.3 110.635 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 2.3 p -80.61 -12.35 59.51 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.51 -0.476 . . . . 0.7 111.69 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.549 ' HD3' HD12 ' A' ' 158' ' ' LEU . 19.5 mmtp 67.44 41.63 2.36 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.589 -0.732 . . . . 1.36 110.617 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.629 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -97.37 -63.88 1.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.339 1.066 . . . . 2.48 110.442 -173.025 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -86.45 1.88 87.37 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.167 -1.016 . . . . 0.29 113.199 -172.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.549 HD12 ' HD3' ' A' ' 155' ' ' LYS . 27.5 mt -70.57 -42.19 71.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.0 0.9 . . . . 0.8 109.019 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -77.73 -34.81 52.43 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.44 -0.8 . . . . 2.2 109.618 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.522 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 81.6 t60 -69.4 -25.85 64.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.565 -0.454 . . . . 0.58 111.121 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.94 -53.08 60.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.36 0.6 . . . . 1.16 109.484 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 12.4 mt -54.89 -44.23 73.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.688 -1.142 . . . . 1.51 109.742 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.499 ' OE2' ' HA ' ' A' ' 160' ' ' HIS . 40.8 mt-10 -46.76 -53.81 11.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.197 0.936 . . . . 2.57 111.189 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.606 ' HB3' HG21 ' A' ' 146' ' ' ILE . 20.2 mmt -72.26 -39.72 68.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 0.64 111.051 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 83' ' ' ILE . 69.1 mt -60.13 -49.94 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 0.52 111.294 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.1 pp -70.89 -31.83 68.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.844 -0.342 . . . . 1.73 111.153 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 166' ' ' LEU . 2.6 tm? -54.2 -50.53 66.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 1.51 108.856 172.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.447 -0.601 0 CA-C-N 115.819 -0.628 . . . . 0.89 110.559 175.501 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.647 0.26 . . . . 0.64 110.827 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.31 113.95 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 1.3 109.95 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.842 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 53.3 mtt -126.5 163.94 22.25 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.072 -0.513 . . . . 0.79 109.637 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.48 -168.65 25.42 Favored Glycine 0 N--CA 1.431 -1.633 0 C-N-CA 120.828 -0.701 . . . . 0.31 111.437 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.645 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 52.1 t60 -88.51 157.89 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.893 0.854 . . . . 0.22 111.385 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.4 p -71.75 153.94 7.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.587 -1.188 . . . . 0.36 109.981 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 20.2 t70 74.85 -21.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.361 0.601 . . . . 0.69 110.514 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.547 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.2 m170 -80.3 -7.38 59.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.342 -0.984 . . . . 0.63 108.342 170.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.491 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 113.07 60.88 0.42 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.537 -0.839 . . . . 0.79 114.048 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -59.29 -76.32 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.355 0.577 . . . . 3.31 110.913 171.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 m -84.79 -32.46 23.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.864 0.364 . . . . 1.21 110.873 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.491 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.57 -31.17 63.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.382 0.512 . . . . 1.25 112.382 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 HG21 ' A' ' 85' ' ' VAL . 12.5 tp -73.67 -40.15 63.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.508 -0.553 . . . . 1.49 109.508 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HA ' HG22 ' A' ' 28' ' ' ILE . 2.9 tp -72.17 -9.52 58.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.654 -0.703 . . . . 1.69 110.562 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -94.99 -43.31 8.21 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.458 -0.941 . . . . 1.23 108.458 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.52 78.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.046 -1.434 . . . . 0.63 110.065 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 7.6 tt . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 114.975 -1.011 . . . . 1.02 110.354 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.495 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 120.49 0.186 . . . . 0.71 110.654 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.41 125.51 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 120.375 -0.53 . . . . 1.17 111.436 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.632 HG12 ' HB ' ' A' ' 111' ' ' ILE . 7.8 mt -87.49 130.19 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-N 115.62 -0.718 . . . . 0.37 109.923 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.454 ' O ' HD13 ' A' ' 84' ' ' LEU . 2.0 tm? -114.08 107.36 15.54 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.289 -1.004 . . . . 1.01 108.289 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.484 HG21 HD22 ' A' ' 24' ' ' LEU . 39.5 t -90.72 110.14 21.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.369 -0.832 . . . . 0.43 110.746 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.701 HG21 HD11 ' A' ' 131' ' ' LEU . 1.7 m -120.49 124.92 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.792 -0.64 . . . . 0.64 110.58 174.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -65.51 131.38 46.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 0.28 109.87 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -73.77 -12.54 60.73 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.182 0.515 . . . . 0.22 110.395 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 1.3 p-10 -95.94 -8.73 33.08 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.576 -0.738 . . . . 0.58 110.847 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.13 -48.9 1.45 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.407 -0.36 . . . . 0.56 110.818 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.556 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.89 -146.08 19.01 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.37 113.538 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.508 HG21 ' CE2' ' A' ' 134' ' ' TYR . 9.9 p -82.13 140.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.571 0.701 . . . . 1.03 110.229 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.688 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.6 mmm -142.21 175.12 3.15 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.836 -1.075 . . . . 0.28 108.916 -173.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 75.0 Cg_exo -42.9 -59.07 1.08 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.197 2.598 . . . . 0.58 114.971 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.525 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.8 pt20 -79.42 -17.51 54.15 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 120.419 -0.513 . . . . 0.75 110.969 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.645 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.33 -43.23 91.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 0.31 109.334 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.533 HG12 ' ND2' ' A' ' 101' ' ' ASN . 32.3 t -60.47 -45.71 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.766 -1.107 . . . . 1.38 111.913 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.66 -31.79 66.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 2.35 110.638 -175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.01 -30.29 63.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 0.44 110.736 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.0 mt -77.11 -44.73 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.882 0.849 . . . . 0.41 108.775 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.533 ' ND2' HG12 ' A' ' 97' ' ' VAL . 41.2 m-20 -63.63 -32.21 73.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.245 -1.343 . . . . 0.67 111.002 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -63.04 -45.79 90.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.441 0.639 . . . . 2.5 109.626 173.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.566 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -78.42 -51.53 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 0.47 112.752 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 29.4 mmmt -68.34 -34.08 75.45 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.931 0.396 . . . . 1.66 110.753 -173.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.74 92.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.655 -0.702 . . . . 0.77 110.837 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.71 53.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.471 -0.332 . . . . 0.74 111.158 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 t30 86.09 47.33 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.232 1.013 . . . . 1.41 109.467 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -111.37 138.4 21.36 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.362 -1.29 . . . . 1.35 110.417 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 34.6 Cg_exo -62.5 144.83 95.26 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.863 2.376 . . . . 0.47 113.436 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.566 HD11 ' CB ' ' A' ' 103' ' ' ALA . 27.1 mm -106.12 160.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.076 -0.965 . . . . 0.6 110.696 -175.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.818 HD13 ' HB ' ' A' ' 146' ' ' ILE . 29.9 mm -124.46 83.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.101 -1.444 . . . . 0.37 107.101 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.096 HG23 HG21 ' A' ' 145' ' ' THR . 62.0 t -69.03 146.98 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.636 0.731 . . . . 0.26 109.049 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -148.01 102.93 3.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.45 -1.25 . . . . 0.29 110.073 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.752 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 2.8 mp -70.57 139.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-N 113.767 -1.56 . . . . 0.59 109.068 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.1 p-10 -121.19 175.8 5.93 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.081 -1.451 . . . . 1.85 107.081 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.638 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 83.6 mttt 69.87 30.97 3.57 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.742 0.651 . . . . 0.59 111.098 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.654 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 11.3 mmt -73.18 -14.95 61.45 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.328 1.061 . . . . 0.92 108.624 167.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.586 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 2.0 p-10 -72.63 -19.64 61.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.404 -1.725 . . . . 0.76 110.602 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.469 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 36.6 mtpt -89.32 144.42 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.775 -0.648 . . . . 1.17 110.684 176.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.25 -17.22 40.01 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.789 2.326 . . . . 0.58 111.694 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 31.9 mt-10 -85.45 8.59 18.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.455 -0.793 . . . . 1.45 111.032 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.14 112.36 1.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.27 110.743 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -127.89 76.2 77.64 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.95 108.969 175.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.506 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 37.8 Cg_endo -63.71 -58.03 0.31 Allowed 'Trans proline' 0 CA--C 1.507 -0.845 0 C-N-CA 123.177 2.584 . . . . 0.4 113.022 -174.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.4 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 16.5 t70 -45.6 -29.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.285 0.991 . . . . 1.44 110.93 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.513 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 10.5 ttp180 -82.26 -56.45 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 3.79 110.173 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.75 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 16.6 m -65.64 -29.92 48.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.719 -0.673 . . . . 0.59 111.387 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . 1.025 ' HA ' HD12 ' A' ' 131' ' ' LEU . 4.4 ttt -71.12 -31.16 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.425 1.09 . . . . 0.81 110.56 176.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -73.06 -36.33 66.86 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.653 -0.419 . . . . 1.31 111.375 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.618 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.2 mt-10 -63.06 -28.88 70.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.61 1.195 . . . . 1.64 108.976 175.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.025 HD12 ' HA ' ' A' ' 128' ' ' MET . 90.9 mt -62.03 -39.23 91.58 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.4 -1.727 . . . . 1.36 109.585 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.679 ' HG2' ' HA ' ' A' ' 137' ' ' VAL . 34.5 mtp -77.95 -15.92 58.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.308 0.484 . . . . 1.61 112.308 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.495 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 9.1 mm-40 -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.083 -1.08 . . . . 1.67 108.083 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.508 ' CE2' HG21 ' A' ' 92' ' ' VAL . 85.2 m-85 -104.64 22.87 14.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.888 -1.051 . . . . 1.08 110.635 172.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.9 t30 66.78 28.85 8.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.081 -1.418 . . . . 1.1 112.623 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -116.1 116.79 28.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.627 -0.879 . . . . 1.36 108.627 170.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.929 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 91.5 t -112.21 136.84 21.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 0.43 112.51 -167.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.762 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -45.79 127.92 10.53 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 124.205 3.27 . . . . 0.54 111.681 169.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.756 ' HG2' HD13 ' A' ' 146' ' ' ILE . 1.8 pp20? -73.27 -20.9 60.73 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.661 -0.866 . . . . 3.08 108.661 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 147' ' ' PHE . 1.5 pm0 -59.01 -27.37 65.38 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.659 -0.7 . . . . 1.57 110.608 169.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.676 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 41.0 m0 -103.47 -11.79 17.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.919 0.39 . . . . 0.66 111.049 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.24 24.75 5.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.713 -0.756 . . . . 0.53 113.362 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.929 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.6 -120.22 2.21 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.6 111.952 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -156.27 58.88 0.57 Allowed 'General case' 0 C--O 1.243 0.713 0 CA-C-O 122.293 1.044 . . . . 1.91 112.192 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 1.096 HG21 HG23 ' A' ' 112' ' ' VAL . 81.1 m -165.7 129.27 2.19 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.385 -0.825 . . . . 0.37 110.739 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.818 ' HB ' HD13 ' A' ' 111' ' ' ILE . 24.0 mm -72.78 105.03 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.081 -1.081 . . . . 0.63 108.081 168.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.762 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 9.0 m-85 -89.67 112.3 23.52 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.771 -0.65 . . . . 0.5 110.804 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.94 142.44 29.67 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.479 -0.782 . . . . 0.68 110.347 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.552 ' HE2' ' HE3' ' A' ' 128' ' ' MET . 5.1 mmtp -117.64 96.83 5.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.286 -1.005 . . . . 1.44 108.286 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.752 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 4.0 pp -127.78 -175.71 3.55 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.903 1.335 . . . . 0.84 113.036 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 1.4 p -157.37 89.98 1.08 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 112.914 -1.948 . . . . 1.77 108.028 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.23 -15.26 63.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.256 0.551 . . . . 0.41 110.4 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.586 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -77.8 -42.93 32.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.565 -0.743 . . . . 2.3 112.037 175.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.437 ' OG1' ' HB2' ' A' ' 151' ' ' SER . 0.9 OUTLIER -87.34 -9.27 55.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.526 -0.869 . . . . 0.7 111.804 175.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 66.73 50.19 1.18 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.089 -0.959 . . . . 1.36 110.995 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -109.51 -65.82 1.11 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.702 1.239 . . . . 2.48 110.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.752 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -74.26 -4.05 67.42 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.054 -1.43 . . . . 0.29 113.897 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 158' ' ' LEU . 28.8 mt -71.33 -37.62 71.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.044 0.922 . . . . 0.8 109.238 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.84 -40.47 79.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.219 -0.9 . . . . 2.2 109.431 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 83.7 t60 -74.93 -10.62 59.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.079 -0.51 . . . . 0.58 111.303 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.55 -55.21 5.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.384 0.611 . . . . 1.16 109.837 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 163' ' ' GLU . 4.2 pp -62.89 -28.5 70.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.021 -0.99 . . . . 1.51 111.643 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 12.5 pt-20 -77.99 -27.3 49.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.847 -0.341 . . . . 2.57 111.23 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.567 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 14.8 mmt -74.53 -44.1 52.74 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.282 -0.636 . . . . 0.64 109.282 173.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 83' ' ' ILE . 84.2 mt -58.19 -39.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.227 -0.897 . . . . 0.52 110.203 173.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -59.7 -44.19 93.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.463 -0.79 . . . . 1.73 111.693 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.48 ' N ' HD23 ' A' ' 166' ' ' LEU . 27.2 tp -54.42 -43.02 71.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.555 0.693 . . . . 1.51 109.923 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 N--CA 1.444 -0.756 0 CA-C-N 114.991 -1.004 . . . . 0.89 110.859 175.515 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.782 ' HB ' HG22 ' A' ' 82' ' ' VAL . 90.5 m . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.518 0.199 . . . . 0.64 110.704 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.7 mt -83.42 122.61 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 1.3 110.125 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.59 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 56.2 mtt -132.75 170.37 15.36 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.148 -0.686 . . . . 0.79 109.148 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.29 179.41 16.64 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.597 -0.811 . . . . 0.31 111.762 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.596 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 50.5 t60 -85.41 158.96 20.09 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.867 0.842 . . . . 0.22 111.631 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 19' ' ' HIS . 5.7 p -73.58 155.27 6.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.495 -1.23 . . . . 0.36 109.643 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 25.9 t70 72.92 -17.56 0.4 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.211 0.529 . . . . 0.69 110.661 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.485 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 19.7 m170 -85.83 -6.57 59.07 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.001 -0.74 . . . . 0.63 109.001 171.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.807 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 131.29 39.25 0.26 Allowed Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 118.972 -1.585 . . . . 0.79 115.066 170.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -52.36 -65.97 0.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.559 1.18 . . . . 3.31 111.51 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.9 m -89.51 -29.68 18.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 1.21 110.696 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.62 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.08 -33.92 69.59 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.777 0.658 . . . . 1.25 112.777 -176.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.807 HD23 ' HA3' ' A' ' 20' ' ' GLY . 3.8 mm? -76.14 -33.33 59.4 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 122.142 -0.349 . . . . 1.49 110.447 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.73 -7.43 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.431 -0.508 . . . . 1.69 109.831 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.83 -47.96 4.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.939 0.876 . . . . 1.23 109.65 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB1' ' HB1' ' A' ' 152' ' ' ALA . . . -64.89 -42.58 94.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.213 -1.358 . . . . 0.63 110.434 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 84.9 mt . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.231 -0.895 . . . . 1.02 109.943 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.0 mt . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 109.909 -0.404 . . . . 0.71 109.909 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 12' ' ' THR . 18.7 t -115.63 118.73 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.255 0.55 . . . . 1.17 111.185 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 51.9 mt -82.41 131.38 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.32 -0.855 . . . . 0.37 109.73 172.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.43 HD13 ' C ' ' A' ' 84' ' ' LEU . 2.3 tm? -119.58 107.93 13.87 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.665 -0.865 . . . . 1.01 108.665 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.5 t -89.11 114.57 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.725 -0.67 . . . . 0.43 111.134 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 2.4 m -127.58 123.73 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.807 -0.633 . . . . 0.64 110.593 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.62 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.35 135.37 50.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.107 -0.497 . . . . 0.28 109.779 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -72.71 -15.59 61.68 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.05 0.452 . . . . 0.22 111.37 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.423 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 5.3 p-10 -90.35 -24.15 20.91 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.753 -0.658 . . . . 0.58 111.244 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.485 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 16.7 t0 -113.53 -41.63 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.56 111.245 -173.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.612 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.11 -131.54 10.7 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 114.419 0.528 . . . . 0.37 114.419 171.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.17 130.82 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.653 . . . . 1.03 110.568 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.696 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.7 mmm -131.32 177.78 2.07 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.461 -1.245 . . . . 0.28 109.377 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.696 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 61.2 Cg_exo -41.73 -63.16 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.093 2.529 . . . . 0.58 114.72 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.537 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.1 pt20 -72.97 -19.62 61.19 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.608 -0.437 . . . . 0.75 111.173 -174.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.596 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.82 -45.55 81.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.021 -0.733 . . . . 0.31 109.021 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 93' ' ' MET . 17.8 t -65.51 -43.6 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.889 -1.05 . . . . 1.38 112.065 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -57.02 -24.57 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.488 . . . . 2.35 110.71 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.59 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -76.97 -39.94 48.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.44 110.633 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.0 mt -71.53 -41.56 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.829 0.824 . . . . 0.41 109.41 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.484 ' ND2' HG12 ' A' ' 97' ' ' VAL . 23.1 m-20 -61.05 -28.79 69.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.324 -1.307 . . . . 0.67 110.89 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -83.77 -34.4 24.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.811 -0.44 . . . . 2.5 109.811 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.559 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -65.52 -42.09 92.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.198 -0.455 . . . . 0.47 111.046 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.409 ' NZ ' ' HB3' ' A' ' 135' ' ' ASN . 18.9 mmtp -73.18 -35.74 66.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.383 0.611 . . . . 1.66 109.796 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.33 -40.72 59.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.306 -1.316 . . . . 0.77 111.413 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.27 -35.19 15.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.338 -0.392 . . . . 0.74 110.96 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.4 t30 87.97 51.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.403 1.081 . . . . 1.41 109.609 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.11 141.73 23.09 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.969 -1.469 . . . . 1.35 110.58 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.01 140.65 66.84 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.549 2.166 . . . . 0.47 111.975 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.575 ' C ' HG23 ' A' ' 145' ' ' THR . 24.2 mm -104.2 158.71 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.46 0.648 . . . . 0.6 110.758 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.775 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 17.0 mm -129.32 88.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.553 -1.277 . . . . 0.37 107.553 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.942 HG23 HG21 ' A' ' 145' ' ' THR . 43.3 t -78.34 146.99 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.941 0.877 . . . . 0.26 110.338 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.896 ' HB1' HD11 ' A' ' 150' ' ' LEU . . . -139.79 111.06 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.925 -1.489 . . . . 0.29 110.144 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.802 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 2.8 mp -83.15 126.24 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.603 -1.18 . . . . 0.59 109.798 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.54 ' ND2' ' HG3' ' A' ' 116' ' ' LYS . 7.1 p-10 -114.35 168.79 9.54 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.42 -1.326 . . . . 1.85 107.42 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.62 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 89.4 mttt 70.44 31.57 2.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.927 0.767 . . . . 0.59 111.92 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.565 ' HA ' ' CB ' ' A' ' 122' ' ' ALA . 77.3 mmm -80.48 -9.7 59.76 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.505 0.669 . . . . 0.92 109.451 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.406 ' HB2' HG23 ' A' ' 154' ' ' THR . 8.3 p-10 -67.97 -32.54 73.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.968 -1.015 . . . . 0.76 109.415 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 28.6 mtmt -75.58 139.14 70.67 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.956 -1.02 . . . . 1.17 110.688 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.66 -15.8 51.96 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.885 2.39 . . . . 0.58 111.469 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -78.76 -7.81 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.11 -0.95 . . . . 1.45 110.27 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.565 ' CB ' ' HA ' ' A' ' 117' ' ' MET . . . -58.03 115.39 2.85 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.711 -0.677 . . . . 0.27 111.113 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.564 ' OD1' ' HB2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -128.71 77.58 77.32 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.432 -0.951 . . . . 0.95 108.432 173.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.576 ' HA ' HG22 ' A' ' 127' ' ' VAL . 49.5 Cg_endo -65.13 -50.8 1.86 Allowed 'Trans proline' 0 CA--C 1.5 -1.185 0 C-N-CA 123.267 2.644 . . . . 0.4 112.906 -171.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.605 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 8.1 m-20 -54.43 -26.93 33.63 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.958 -1.019 . . . . 1.44 110.042 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.564 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 37.4 ttp180 -79.09 -54.24 6.2 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.411 0.624 . . . . 3.79 109.339 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.799 HG21 ' HA ' ' A' ' 88' ' ' ALA . 21.9 m -65.22 -29.29 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.272 -0.876 . . . . 0.59 111.928 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.951 ' HA ' HD23 ' A' ' 131' ' ' LEU . 16.4 ptm -79.41 -14.87 58.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.827 0.346 . . . . 0.81 110.392 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.602 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 80.3 mt-30 -79.91 -24.85 40.83 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 121.025 -0.27 . . . . 1.31 110.487 171.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 6.5 mm-40 -67.95 -31.13 70.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.431 -0.952 . . . . 1.64 108.431 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.951 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -61.29 -46.0 92.13 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.581 -1.191 . . . . 1.36 109.335 175.21 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.561 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -74.82 -7.98 55.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 119.963 -0.695 . . . . 1.61 110.969 -178.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 28.3 mm-40 -72.26 -28.13 62.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.542 -0.91 . . . . 1.67 108.542 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -102.96 31.8 4.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.037 -0.983 . . . . 1.08 110.255 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 104' ' ' LYS . 63.3 t30 55.68 43.49 27.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.699 -1.137 . . . . 1.1 111.761 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.561 ' H ' ' HA ' ' A' ' 132' ' ' MET . 52.5 mt -112.66 104.68 12.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.968 -0.56 . . . . 1.36 109.734 172.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.093 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 24.5 t -104.28 117.08 60.21 Favored Pre-proline 0 C--N 1.314 -0.954 0 C-N-CA 120.121 -0.632 . . . . 0.43 111.322 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.718 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.2 Cg_exo -43.73 139.72 5.04 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 124.196 3.264 . . . . 0.54 112.409 171.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -71.6 -18.69 62.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.411 -1.268 . . . . 3.08 110.114 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.0 pm0 -62.25 -27.11 68.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.759 -0.655 . . . . 1.57 110.089 168.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.602 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 39.4 m0 -102.53 -27.83 12.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.387 -0.369 . . . . 0.66 110.69 -175.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.48 2.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.769 -0.729 . . . . 0.53 112.977 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 1.093 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.25 -119.26 2.54 Favored Glycine 0 CA--C 1.507 -0.46 0 C-N-CA 119.846 -1.169 . . . . 0.6 112.245 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -151.81 59.47 0.86 Allowed 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.773 0.797 . . . . 1.91 111.438 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.942 HG21 HG23 ' A' ' 112' ' ' VAL . 97.6 m -165.27 123.94 1.68 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.351 -0.841 . . . . 0.37 110.488 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.775 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 27.3 mm -75.59 104.25 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.096 -0.705 . . . . 0.63 109.096 171.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.744 ' HE2' HD23 ' A' ' 131' ' ' LEU . 12.6 m-85 -88.28 117.73 27.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.396 -0.82 . . . . 0.5 110.196 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.2 m -101.42 136.74 40.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.057 -0.349 . . . . 0.68 110.057 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.564 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.7 mttt -108.0 91.92 3.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.377 . . . . 1.44 109.981 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.052 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -120.85 -167.72 1.53 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 123.077 1.418 . . . . 0.84 113.334 -174.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.403 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.1 OUTLIER -164.81 106.48 0.83 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.315 -1.766 . . . . 1.77 106.411 174.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.543 ' HB1' ' HB1' ' A' ' 27' ' ' ALA . . . -65.83 -14.16 60.9 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.62 -0.718 . . . . 0.41 109.434 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -52.98 30.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.15 -0.932 . . . . 2.3 110.62 173.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 118' ' ' ASP . 1.1 p -84.99 -7.67 59.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.398 0.518 . . . . 0.7 112.398 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.571 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.8 mmtp 63.17 46.5 4.57 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.668 -0.696 . . . . 1.36 111.398 176.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.61 -70.79 0.78 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 123.039 1.4 . . . . 2.48 110.602 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 1.052 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -67.45 -8.51 51.65 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 113.664 -1.607 . . . . 0.29 113.269 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.571 HD12 ' HD3' ' A' ' 155' ' ' LYS . 28.6 mt -69.4 -40.48 77.34 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 117.785 0.793 . . . . 0.8 109.423 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.24 -44.2 88.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.345 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -70.87 -17.75 62.71 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.06 -0.518 . . . . 0.58 111.452 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 113' ' ' ALA . 5.9 mt -72.06 -57.49 4.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.011 0.434 . . . . 1.16 110.226 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 163' ' ' GLU . 4.3 pp -60.66 -29.35 69.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.498 -0.774 . . . . 1.51 110.804 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.411 ' N ' HD12 ' A' ' 162' ' ' LEU . 29.7 mm-40 -63.17 -51.67 65.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.993 0.425 . . . . 2.57 110.589 174.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.492 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 17.1 mmt -67.72 -46.25 72.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.64 110.533 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 98.7 mt -58.13 -44.12 86.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.682 -0.69 . . . . 0.52 110.971 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -41.37 86.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.423 -0.353 . . . . 1.73 111.19 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.42 -43.47 67.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.284 0.564 . . . . 1.51 109.567 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 111' ' ' ILE . 92.6 t . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 114.812 -1.086 . . . . 0.89 111.02 176.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.715 ' HB ' HG22 ' A' ' 82' ' ' VAL . 91.4 m . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 120.755 0.312 . . . . 0.64 110.816 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.921 HG13 HD21 ' A' ' 25' ' ' LEU . 45.9 mm -96.97 118.86 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 1.3 110.667 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.62 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 61.5 mtt -131.28 176.05 8.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.175 -0.676 . . . . 0.79 109.175 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' HA2' HD13 ' A' ' 84' ' ' LEU . . . 139.42 -159.58 25.78 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.654 -0.784 . . . . 0.31 111.653 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.599 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 11.8 t-80 -101.97 162.05 13.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.036 0.922 . . . . 0.22 112.167 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' C ' ' H ' ' A' ' 19' ' ' HIS . 7.4 p -81.86 150.61 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.255 -1.339 . . . . 0.36 110.726 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.9 t70 71.6 -23.43 0.19 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.423 0.689 . . . . 0.69 111.362 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.458 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 23.5 m170 -62.79 -38.19 89.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.997 -1.482 . . . . 0.63 106.997 163.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 140.76 55.95 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.828 . . . . 0.79 113.751 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -61.4 2.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.49 0.645 . . . . 3.31 111.483 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -87.68 -40.12 14.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.919 0.39 . . . . 1.21 111.452 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -27.44 62.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 1.25 112.179 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -62.12 -51.21 68.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 1.49 109.843 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.921 HD21 HG13 ' A' ' 13' ' ' ILE . 76.8 mt -71.38 -14.61 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.857 -0.611 . . . . 1.69 111.025 -174.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -90.47 -38.63 13.12 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.469 -0.938 . . . . 1.23 108.469 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -70.6 -35.14 72.83 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.29 -1.323 . . . . 0.63 110.186 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' A' ' 25' ' ' LEU . 13.1 tt . . . . . 0 C--N 1.317 -0.82 0 CA-C-N 114.969 -1.014 . . . . 1.02 111.102 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.0 mt . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.442 -0.577 . . . . 0.71 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.715 HG22 ' HB ' ' A' ' 12' ' ' THR . 15.2 t -107.64 124.36 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.17 0.509 . . . . 1.17 111.635 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 8.2 mt -84.41 132.27 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.524 -0.762 . . . . 0.37 110.555 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.942 HD12 HG13 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -102.3 106.39 17.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.523 -0.762 . . . . 1.01 110.412 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.2 t -84.12 94.08 3.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.933 -0.576 . . . . 0.43 109.738 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.942 HG13 HD12 ' A' ' 84' ' ' LEU . 2.4 m -119.93 123.62 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.927 -0.578 . . . . 0.64 110.523 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.524 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -72.32 131.65 42.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.929 -0.578 . . . . 0.28 110.191 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.801 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -65.5 -14.25 60.61 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.077 0.465 . . . . 0.22 111.063 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.23 8.34 44.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.523 -0.762 . . . . 0.58 111.011 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.419 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 12.9 t0 -149.08 -45.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 0.56 110.973 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.458 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 89.18 -141.49 16.29 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.335 -0.46 . . . . 0.37 113.477 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.33 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.347 0.594 . . . . 1.03 110.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.702 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 79.2 mmm -141.42 176.89 2.16 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 0.28 108.962 -173.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.702 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.3 Cg_exo -41.49 -66.62 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.165 2.577 . . . . 0.58 114.843 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.599 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 9.1 pt20 -71.71 -20.28 61.94 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.259 0.552 . . . . 0.75 110.872 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.534 ' HB ' ' H ' ' A' ' 93' ' ' MET . 0.2 OUTLIER -65.54 -44.03 88.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.513 -0.767 . . . . 0.31 109.375 178.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.555 HG12 ' ND2' ' A' ' 101' ' ' ASN . 19.8 t -67.56 -41.74 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.38 -0.827 . . . . 1.38 111.33 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -55.33 -30.68 60.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.104 0.478 . . . . 2.35 110.319 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.15 -39.09 75.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 0.44 110.798 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 72.3 mt -72.35 -43.02 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.852 0.834 . . . . 0.41 109.172 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.555 ' ND2' HG12 ' A' ' 97' ' ' VAL . 55.5 m-20 -59.91 -33.05 71.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.191 -1.368 . . . . 0.67 110.941 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -79.76 -34.49 39.79 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.735 -0.469 . . . . 2.5 109.735 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.534 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -74.42 -42.61 58.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.179 0.437 . . . . 0.47 112.179 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 12.7 mmmm -76.76 -37.92 55.07 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.058 0.456 . . . . 1.66 110.787 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.07 -30.09 70.75 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.252 -0.885 . . . . 0.77 110.709 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.96 -17.19 41.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.74 110.524 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 70.34 60.92 0.23 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.927 -1.033 . . . . 1.41 110.093 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 1.1 t -123.78 145.42 47.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 1.35 111.303 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 20.2 Cg_exo -69.8 144.89 55.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 123.352 2.701 . . . . 0.47 112.45 172.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.534 HD11 ' HB1' ' A' ' 103' ' ' ALA . 30.6 mm -111.2 158.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.422 0.63 . . . . 0.6 110.654 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.822 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 21.7 mm -129.21 84.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.599 -1.26 . . . . 0.37 107.599 171.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.934 HG13 ' HB3' ' A' ' 84' ' ' LEU . 17.7 t -74.55 152.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.636 0.732 . . . . 0.26 110.525 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 148' ' ' CYS . . . -139.35 107.24 5.67 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.613 -1.176 . . . . 0.29 110.031 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.801 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.5 mp -79.99 105.66 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.554 -1.203 . . . . 0.59 108.843 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.675 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 1.2 p-10 -106.34 173.66 6.22 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 106.807 -1.553 . . . . 1.85 106.807 -169.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.507 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 83.3 mttt 65.51 36.24 6.76 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.768 0.667 . . . . 0.59 110.491 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 84.3 mmm -82.34 -13.15 57.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.351 -0.841 . . . . 0.92 109.162 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.7 -30.92 71.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.688 -1.142 . . . . 0.76 109.062 171.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 116' ' ' LYS . 18.6 mmmt -64.91 132.04 95.36 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 114.442 -1.254 . . . . 1.17 110.024 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.84 -16.5 54.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.548 2.165 . . . . 0.58 111.065 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -90.77 10.98 23.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.101 -0.954 . . . . 1.45 110.37 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.6 118.09 4.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.448 -0.796 . . . . 0.27 110.665 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -127.64 76.02 77.33 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.736 -0.838 . . . . 0.95 108.736 174.026 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.798 ' O ' ' HG3' ' A' ' 128' ' ' MET . 37.2 Cg_endo -63.55 -63.34 0.08 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 123.135 2.557 . . . . 0.4 113.395 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.505 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 6.6 m-20 -55.47 -21.34 15.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 1.44 110.998 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.2 tpt180 -72.36 -56.54 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.695 0.759 . . . . 3.79 109.528 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.628 ' HA ' ' HG3' ' A' ' 130' ' ' GLU . 17.4 m -64.79 -29.74 48.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.808 -1.087 . . . . 0.59 111.596 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.798 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 42.5 mtp -61.44 -39.72 91.87 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.398 0.618 . . . . 0.81 109.527 174.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.595 ' O ' ' HG2' ' A' ' 132' ' ' MET . 38.1 mt-30 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.987 -1.006 . . . . 1.31 111.627 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.628 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 6.3 mt-10 -72.37 -32.56 66.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.29 0.567 . . . . 1.64 109.997 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.906 HD12 HD21 ' A' ' 136' ' ' LEU . 4.3 mm? -65.44 -37.44 86.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 1.36 110.176 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.595 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 12.5 ptm -76.49 -14.07 60.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.162 -0.615 . . . . 1.61 110.239 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 7.3 mm-40 -71.15 -28.38 64.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.966 -0.753 . . . . 1.67 108.966 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.53 20.41 10.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.007 0.908 . . . . 1.08 110.157 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 60.65 49.97 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.578 -1.646 . . . . 1.1 112.2 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.906 HD21 HD12 ' A' ' 131' ' ' LEU . 1.9 pp -131.25 120.76 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.524 -1.288 . . . . 1.36 107.524 166.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.832 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.9 t -109.29 129.19 24.19 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 0.43 112.367 -165.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 98.0 Cg_exo -43.21 146.62 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.608 3.539 . . . . 0.54 113.435 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.52 ' HB2' HD13 ' A' ' 146' ' ' ILE . 5.9 mm-40 -75.53 -22.1 57.38 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.347 -1.297 . . . . 3.08 110.412 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 2.2 pm0 -67.39 -21.4 65.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.258 -0.883 . . . . 1.57 110.036 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.483 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 38.4 m0 -105.77 -17.41 14.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.394 -0.366 . . . . 0.66 110.55 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.46 21.75 9.63 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.795 -0.716 . . . . 0.53 113.642 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.832 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -82.92 -105.28 0.48 Allowed Glycine 0 CA--C 1.51 -0.271 0 C-N-CA 120.138 -1.029 . . . . 0.6 111.943 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -166.1 62.2 0.1 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.316 1.055 . . . . 1.91 110.665 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.71 HG21 HG23 ' A' ' 112' ' ' VAL . 56.5 m -164.26 111.91 1.11 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.759 -1.109 . . . . 0.37 111.207 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.822 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.3 mm -69.49 107.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.426 -0.583 . . . . 0.63 109.426 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.697 ' HD2' HD11 ' A' ' 114' ' ' ILE . 10.7 m-85 -88.78 110.19 20.81 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.24 -0.891 . . . . 0.5 110.311 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 80.6 m -98.75 116.37 30.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.416 -0.356 . . . . 0.68 111.371 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.497 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 95.2 mttt -87.31 91.19 8.64 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.036 -0.357 . . . . 1.44 110.036 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.976 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.9 OUTLIER -122.48 173.62 7.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.331 1.062 . . . . 0.84 112.089 -173.312 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.2 OUTLIER -138.9 104.91 5.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.38 -0.97 . . . . 1.77 108.38 165.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.559 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . . . -61.68 -18.99 61.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.309 -0.86 . . . . 0.41 109.708 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -63.25 -57.78 9.33 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.993 -1.003 . . . . 2.3 110.736 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 p -78.71 -7.85 58.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.215 0.45 . . . . 0.7 112.215 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.572 ' HD3' HD12 ' A' ' 158' ' ' LEU . 15.6 mmtp 66.78 42.8 2.51 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 123.684 0.615 . . . . 1.36 111.776 174.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -115.75 -63.5 1.44 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.183 0.992 . . . . 2.48 110.006 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.976 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -68.79 -11.83 63.58 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 114.495 -1.229 . . . . 0.29 113.605 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.572 HD12 ' HD3' ' A' ' 155' ' ' LYS . 17.4 mt -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 117.856 0.828 . . . . 0.8 110.373 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 6.5 m-20 -81.49 -33.08 32.15 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.69 -0.687 . . . . 2.2 110.422 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -61.42 -32.45 72.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.05 -0.352 . . . . 0.58 110.05 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 83' ' ' ILE . 60.2 tp -59.72 -55.96 27.8 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.857 -0.61 . . . . 1.16 109.541 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.3 mt -56.67 -45.09 81.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.823 -1.08 . . . . 1.51 110.033 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 53.2 mt-10 -53.22 -43.9 67.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.639 -0.71 . . . . 2.57 111.338 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.442 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -76.19 -32.71 59.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.817 -0.353 . . . . 0.64 110.41 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 83' ' ' ILE . 80.8 mt -65.66 -51.26 64.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 0.52 111.108 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 167' ' ' LEU . 4.0 pp -65.39 -34.25 77.87 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 121.056 -0.258 . . . . 1.73 110.552 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 166' ' ' LEU . 1.3 tm? -50.7 -48.11 58.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.397 -0.594 . . . . 1.51 109.397 173.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.2 t . . . . . 0 N--CA 1.443 -0.786 0 CA-C-N 115.646 -0.706 . . . . 0.89 110.629 176.042 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.785 ' HB ' HG22 ' A' ' 82' ' ' VAL . 36.9 m . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 110.431 -0.211 . . . . 0.64 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.1 mt -99.51 127.78 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.993 -0.373 . . . . 1.3 109.993 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.63 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 63.2 mtt -134.43 165.31 25.46 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.454 -0.573 . . . . 0.79 109.454 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.04 -175.34 36.01 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.566 -0.826 . . . . 0.31 111.788 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.632 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 44.0 t60 -88.06 158.42 18.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.875 0.845 . . . . 0.22 111.648 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 7.3 p -69.8 153.41 8.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.414 -1.267 . . . . 0.36 109.356 172.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.9 t70 73.96 -22.0 0.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.236 0.541 . . . . 0.69 110.713 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.48 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 12.8 m170 -84.98 3.55 37.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.132 -1.062 . . . . 0.63 108.132 171.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.452 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 86.81 58.36 1.93 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.775 -1.102 . . . . 0.79 113.596 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.5 2.98 34.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.674 0.75 . . . . 3.31 110.183 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -136.69 -44.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.268 -0.878 . . . . 1.21 109.634 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.76 -29.26 59.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.737 -0.665 . . . . 1.25 112.022 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 85' ' ' VAL . 15.8 tp -67.64 -42.34 82.4 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.436 -0.579 . . . . 1.49 109.436 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -68.15 -11.54 59.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.189 -0.914 . . . . 1.69 110.534 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.45 -38.99 8.98 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.923 0.868 . . . . 1.23 109.593 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.77 67.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.364 -1.289 . . . . 0.63 110.6 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 9.8 tt . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 114.854 -1.066 . . . . 1.02 110.399 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.4 mt . . . . . 0 C--O 1.236 0.375 0 CA-C-O 120.695 0.283 . . . . 0.71 110.688 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.785 HG22 ' HB ' ' A' ' 12' ' ' THR . 24.7 t -120.98 125.96 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.425 0.631 . . . . 1.17 111.491 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 21.3 mt -84.46 132.27 31.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.987 -1.006 . . . . 0.37 109.636 172.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 86' ' ' VAL . 1.7 tm? -120.48 109.87 15.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.703 -0.851 . . . . 1.01 108.703 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 24' ' ' LEU . 59.8 t -92.69 111.28 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.626 -0.715 . . . . 0.43 110.731 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 2.2 m -121.0 129.36 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 116.01 -0.541 . . . . 0.64 111.031 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB1' ' HE3' ' A' ' 116' ' ' LYS . . . -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.726 -0.67 . . . . 0.28 110.074 174.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.73 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -78.49 -7.98 58.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 0.22 110.164 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.837 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 3.1 p-10 -106.27 7.15 31.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.454 -0.794 . . . . 0.58 111.096 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.48 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 22.3 t70 -144.48 -41.43 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 0.56 110.068 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.726 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 90.0 -125.93 8.09 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.37 113.912 170.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.576 HG11 ' HE2' ' A' ' 134' ' ' TYR . 6.8 p -111.82 137.19 45.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.541 0.686 . . . . 1.03 109.697 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.75 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.1 mmm -140.15 177.67 1.91 Allowed Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 114.965 -1.016 . . . . 0.28 108.564 -170.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.75 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 57.4 Cg_exo -38.98 -65.78 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.218 2.612 . . . . 0.58 114.835 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.756 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 6.3 pt20 -74.36 -17.09 60.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.961 0.41 . . . . 0.75 111.527 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.632 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -68.88 -45.49 70.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.749 0.785 . . . . 0.31 109.31 176.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.558 HG12 ' ND2' ' A' ' 101' ' ' ASN . 20.8 t -69.81 -42.92 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.896 -1.047 . . . . 1.38 111.573 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.756 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -60.94 -25.17 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.449 -0.501 . . . . 2.35 110.003 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -71.28 -40.99 70.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.841 . . . . 0.44 110.919 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -73.95 -39.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.719 0.771 . . . . 0.41 109.311 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.558 ' ND2' HG12 ' A' ' 97' ' ' VAL . 51.8 m-20 -61.3 -30.69 70.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.464 -1.243 . . . . 0.67 110.711 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -79.84 -34.61 39.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.957 -0.386 . . . . 2.5 109.957 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -66.33 -46.11 77.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.384 -0.371 . . . . 0.47 111.336 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -72.21 -34.05 68.06 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.405 0.622 . . . . 1.66 110.106 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.87 -31.97 67.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.568 -1.196 . . . . 0.77 111.582 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.79 -19.47 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.487 -0.324 . . . . 0.74 111.011 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.2 t30 77.46 72.23 0.06 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.167 0.984 . . . . 1.41 108.719 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.55 138.45 31.2 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 114.326 -1.306 . . . . 1.35 111.633 -168.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.33 143.06 56.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.443 2.762 . . . . 0.47 111.705 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' A' ' 103' ' ' ALA . 38.5 mm -109.96 154.88 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.738 0.78 . . . . 0.6 111.382 -173.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.937 HD13 ' HB ' ' A' ' 146' ' ' ILE . 12.9 mm -125.17 85.21 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 107.352 -1.351 . . . . 0.37 107.352 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.587 HG23 HG21 ' A' ' 145' ' ' THR . 57.5 t -73.43 147.23 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.545 0.688 . . . . 0.26 110.312 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -146.75 103.79 3.67 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.291 -1.322 . . . . 0.29 109.997 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.833 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -71.91 144.4 13.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.139 -1.392 . . . . 0.59 110.486 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.424 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -122.68 169.69 10.8 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.498 -1.297 . . . . 1.85 107.498 177.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.531 ' HE3' ' HB1' ' A' ' 87' ' ' ALA . 31.2 mtmt 67.74 37.49 3.22 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.163 -0.926 . . . . 0.59 112.38 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.689 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 14.3 mmt -75.95 -11.82 60.03 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.198 -0.91 . . . . 0.92 109.516 166.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.45 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 6.6 p-10 -72.86 -29.69 63.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.077 -0.965 . . . . 0.76 108.822 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.81 136.26 82.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.958 -1.019 . . . . 1.17 110.735 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.48 -15.39 48.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 123.058 2.505 . . . . 0.58 112.143 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.837 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 5.0 mm-40 -84.01 -9.0 58.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.49 -0.777 . . . . 1.45 110.704 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -42.47 109.97 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.968 0.792 . . . . 0.27 111.956 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.71 76.59 77.04 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.301 -1.0 . . . . 0.95 108.301 176.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.689 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 22.3 Cg_endo -58.81 -60.1 0.39 Allowed 'Trans proline' 0 CA--C 1.505 -0.933 0 C-N-CA 122.898 2.399 . . . . 0.4 113.286 -174.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.7 -28.88 1.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 124.066 0.854 . . . . 1.44 111.504 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 37.0 ttm-85 -78.59 -62.36 1.71 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.439 -0.578 . . . . 3.79 109.439 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 88' ' ' ALA . 4.9 m -64.69 -22.59 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.977 -1.011 . . . . 0.59 111.941 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.626 ' HG3' ' CE2' ' A' ' 147' ' ' PHE . 4.9 ttt -77.12 -31.8 56.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.179 -0.918 . . . . 0.81 110.874 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.578 ' O ' ' HG3' ' A' ' 132' ' ' MET . 88.5 mt-30 -78.1 -32.39 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 1.31 111.372 176.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.9 mm-40 -57.28 -39.6 76.04 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.558 1.17 . . . . 1.64 108.381 173.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.646 HD23 ' CE2' ' A' ' 147' ' ' PHE . 0.7 OUTLIER -61.39 -41.22 96.77 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.312 -1.767 . . . . 1.36 110.776 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.628 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.3 ppp? -82.5 -9.09 59.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.035 -0.666 . . . . 1.61 111.536 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.71 -27.91 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.976 -0.75 . . . . 1.67 108.976 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.576 ' HE2' HG11 ' A' ' 92' ' ' VAL . 34.6 m-85 -85.8 13.81 6.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.448 -0.796 . . . . 1.08 110.097 170.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.7 t30 62.84 48.29 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.222 -1.354 . . . . 1.1 111.658 172.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.84 110.49 13.74 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.408 -1.33 . . . . 1.36 107.408 165.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.04 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.9 t -104.78 129.16 25.4 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.697 -0.683 . . . . 0.43 111.543 -167.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.619 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 81.2 Cg_exo -44.61 143.6 3.91 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.421 3.414 . . . . 0.54 112.927 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HG2' ' C ' ' A' ' 145' ' ' THR . 12.3 mm-40 -67.47 -32.36 73.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.18 -1.373 . . . . 3.08 109.532 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 1.7 pm0 -61.25 -24.99 66.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.921 -1.036 . . . . 1.57 110.967 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.628 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 35.7 m0 -102.63 -8.71 20.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.001 0.429 . . . . 0.66 110.912 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.08 32.69 8.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.006 -0.616 . . . . 0.53 113.21 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 1.04 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.9 -109.12 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.252 -0.975 . . . . 0.6 112.053 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.443 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 7.3 t70 -167.43 63.45 0.08 Allowed 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.369 1.08 . . . . 1.91 110.504 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.587 HG21 HG23 ' A' ' 112' ' ' VAL . 78.4 m -164.82 115.63 1.17 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.509 -1.223 . . . . 0.37 110.478 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.937 ' HB ' HD13 ' A' ' 111' ' ' ILE . 19.0 mm -70.93 104.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.175 -0.676 . . . . 0.63 109.175 173.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.646 ' CE2' HD23 ' A' ' 131' ' ' LEU . 7.9 m-85 -86.98 113.11 22.47 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.237 -0.892 . . . . 0.5 111.305 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.56 136.57 41.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.75 -0.659 . . . . 0.68 109.827 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.561 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 8.3 mptt -111.57 101.27 9.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.24 -0.652 . . . . 1.44 109.24 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.912 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -127.25 -170.07 2.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.743 1.259 . . . . 0.84 111.827 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.554 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -164.21 106.68 0.91 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.769 -1.937 . . . . 1.77 105.769 174.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.64 -15.77 63.71 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.669 0.747 . . . . 0.41 109.117 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -62.67 -56.07 21.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.216 -1.356 . . . . 2.3 110.462 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 1.2 p -84.45 -10.36 57.57 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.37 0.508 . . . . 0.7 112.37 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 62.13 51.88 3.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.42 -0.809 . . . . 1.36 110.595 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -109.33 -65.82 1.11 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.156 0.979 . . . . 2.48 110.608 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.912 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.13 -9.09 71.29 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.318 -1.31 . . . . 0.29 114.174 -173.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.402 HD21 HD11 ' A' ' 24' ' ' LEU . 48.5 mt -72.36 -39.47 68.05 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.052 0.926 . . . . 0.8 109.362 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.541 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 13.8 m-20 -63.71 -44.7 92.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.511 172.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 80.6 t60 -71.66 -15.82 62.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.057 -0.52 . . . . 0.58 111.371 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -71.21 -53.34 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 1.16 109.651 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.68 -27.58 69.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.256 -0.884 . . . . 1.51 110.56 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 66.1 mt-10 -62.47 -48.88 77.65 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.099 0.476 . . . . 2.57 110.142 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.634 ' HB3' HG21 ' A' ' 146' ' ' ILE . 19.3 mmt -68.03 -42.85 80.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 0.64 110.549 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.5 mt -59.36 -41.95 85.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.927 -0.579 . . . . 0.52 110.593 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -39.73 89.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 1.73 111.19 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.1 tp -53.7 -43.98 69.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.413 0.625 . . . . 1.51 109.55 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 0.89 110.774 175.748 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 m . . . . . 0 C--O 1.223 -0.311 0 N-CA-C 110.678 -0.119 . . . . 0.64 110.678 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 14.9 tt -92.22 136.1 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.641 0.734 . . . . 1.3 111.467 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.483 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 58.5 mtt -148.82 174.29 12.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.591 0.756 . . . . 0.79 109.28 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.14 -167.12 32.25 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.711 -0.757 . . . . 0.31 112.761 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.584 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 43.2 t60 -93.93 164.49 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.066 0.936 . . . . 0.22 112.003 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.5 ' C ' ' H ' ' A' ' 19' ' ' HIS . 5.9 p -78.34 151.29 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.454 -1.248 . . . . 0.36 110.374 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t70 72.72 -19.85 0.29 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.4 0.619 . . . . 0.69 110.524 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 18.0 m170 -78.94 -7.93 58.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.356 -0.979 . . . . 0.63 108.356 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.419 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 100.13 44.14 2.27 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.192 -0.913 . . . . 0.79 113.413 174.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -33.26 66.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.591 0.695 . . . . 3.31 112.403 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -107.59 -34.59 6.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.914 0.388 . . . . 1.21 110.614 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -63.9 -28.87 70.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.321 -0.399 . . . . 1.25 111.772 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.419 HD23 ' HA3' ' A' ' 20' ' ' GLY . 2.7 mm? -65.62 -42.37 91.62 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.71 -0.478 . . . . 1.49 109.71 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 HD13 HD13 ' A' ' 13' ' ' ILE . 2.1 tp -71.85 -12.15 61.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.139 -0.937 . . . . 1.69 110.53 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -98.94 -41.26 7.67 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.992 0.901 . . . . 1.23 109.409 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HB1' ' HE2' ' A' ' 155' ' ' LYS . . . -66.22 -30.28 70.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.898 -1.501 . . . . 0.63 109.845 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 1.02 110.894 -176.981 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.637 HG21 HG12 ' A' ' 111' ' ' ILE . 44.3 mt . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 110.428 -0.212 . . . . 0.71 110.428 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 110' ' ' ILE . 27.2 t -90.96 117.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.733 -0.787 . . . . 1.17 111.167 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 44.3 mt -81.33 131.41 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.798 -1.092 . . . . 0.37 109.384 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.686 HD21 HG22 ' A' ' 96' ' ' THR . 2.4 tm? -121.11 107.17 12.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.82 -0.807 . . . . 1.01 108.82 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 85.5 t -89.38 109.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.593 -0.731 . . . . 0.43 110.779 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.744 HG21 HD11 ' A' ' 131' ' ' LEU . 2.1 m -121.39 126.26 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.785 -0.643 . . . . 0.64 110.95 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -72.15 127.46 32.64 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.094 -0.503 . . . . 0.28 109.645 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -68.06 -10.54 54.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.893 0.377 . . . . 0.22 111.383 -175.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.56 -8.06 55.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.837 -0.62 . . . . 0.58 110.778 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.503 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 15.9 t0 -131.69 -45.7 0.97 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.324 -0.398 . . . . 0.56 111.573 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.609 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 95.2 -144.79 17.41 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.312 -0.471 . . . . 0.37 113.062 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.6 p -92.49 143.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.337 -0.616 . . . . 1.03 109.337 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.713 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 77.2 mmm -143.61 177.73 1.71 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.401 -0.818 . . . . 0.28 109.241 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.713 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.6 Cg_exo -43.83 -63.02 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.199 2.599 . . . . 0.58 114.618 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.54 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.6 pt20 -76.69 -12.38 59.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.75 111.191 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.686 HG22 HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -72.22 -48.23 44.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.675 -0.693 . . . . 0.31 109.662 176.111 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 93' ' ' MET . 3.5 p -73.69 -27.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.548 -0.751 . . . . 1.38 112.943 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -61.72 -30.34 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.606 -0.838 . . . . 2.35 109.088 176.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.21 -35.07 66.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.495 -0.775 . . . . 0.44 110.476 174.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.3 mt -70.18 -51.16 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 109.08 -0.711 . . . . 0.41 109.08 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -51.26 -41.74 60.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.537 -1.21 . . . . 0.67 110.442 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -55.62 -50.24 70.68 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.102 -0.954 . . . . 2.5 110.208 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.535 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -74.25 -46.57 40.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.47 112.164 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.766 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 10.8 mmpt? -63.69 -35.9 82.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.986 0.422 . . . . 1.66 110.943 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.7 -43.32 72.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.093 -0.958 . . . . 0.77 111.065 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.38 -21.41 39.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.573 -0.285 . . . . 0.74 111.26 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 83.1 41.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.817 1.294 . . . . 1.41 108.842 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 109' ' ' PRO . 29.2 t -89.95 138.16 27.84 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 113.384 -1.734 . . . . 1.35 111.616 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 108' ' ' VAL . 22.3 Cg_exo -66.82 144.18 70.1 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.829 2.353 . . . . 0.47 111.56 170.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.535 HD11 ' CB ' ' A' ' 103' ' ' ALA . 49.6 mm -109.35 157.12 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 121.387 0.613 . . . . 0.6 111.157 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.768 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 22.8 mm -124.02 83.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.195 -1.409 . . . . 0.37 107.195 169.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.777 HG23 HG21 ' A' ' 145' ' ' THR . 58.2 t -70.01 145.35 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-O 121.643 0.735 . . . . 0.26 109.208 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.773 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -143.55 100.39 3.59 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.374 -1.284 . . . . 0.29 109.67 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.814 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 80.6 mt -73.99 141.92 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.301 -1.318 . . . . 0.59 110.122 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 50.9 t30 -120.9 171.52 8.57 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.325 -1.361 . . . . 1.85 107.325 -177.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.799 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 81.7 mttt 72.47 33.58 1.41 Allowed 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 123.901 0.751 . . . . 0.59 111.749 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.741 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 13.4 mmt -79.02 -14.9 58.91 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 0.92 108.879 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 3.9 p-10 -65.09 -26.8 68.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.107 -1.406 . . . . 0.76 109.515 171.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.692 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 28.5 mtpp -86.62 132.23 43.17 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.291 -0.868 . . . . 1.17 110.02 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.39 -12.2 31.96 Favored 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 122.584 2.189 . . . . 0.58 111.128 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.27 1.15 38.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.404 -1.271 . . . . 1.45 110.732 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.63 122.96 11.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.119 -0.946 . . . . 0.27 111.348 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.5 OUTLIER -130.47 76.32 77.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.595 -0.891 . . . . 0.95 108.595 175.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.741 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 25.8 Cg_endo -61.16 -65.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.745 2.964 . . . . 0.4 114.153 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.657 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 1.2 m-20 -60.24 -23.07 63.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 1.44 110.102 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.753 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.4 tpt180 -67.8 -60.35 2.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 3.79 109.944 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 88' ' ' ALA . 33.0 m -66.08 -32.98 60.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.756 -1.111 . . . . 0.59 111.757 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . 1.07 ' HA ' HD12 ' A' ' 131' ' ' LEU . 18.7 ptm -74.49 -20.51 59.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.794 0.33 . . . . 0.81 110.961 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 125' ' ' ASP . 51.9 mt-30 -74.86 -43.55 53.87 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.997 -0.44 . . . . 1.31 111.086 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.627 ' HA ' ' HG3' ' A' ' 133' ' ' GLU . 8.8 mt-10 -70.19 -24.23 63.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.895 0.855 . . . . 1.64 109.167 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' HA ' ' A' ' 128' ' ' MET . 66.8 mt -59.79 -36.71 77.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.464 -1.244 . . . . 1.36 109.27 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.878 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 3.6 mtm -77.14 -17.69 58.42 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.402 -0.519 . . . . 1.61 111.859 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.627 ' HG3' ' HA ' ' A' ' 130' ' ' GLU . 5.4 mt-10 -71.53 -17.47 62.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.437 -0.949 . . . . 1.67 108.437 174.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -94.9 12.27 28.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.802 -1.09 . . . . 1.08 109.44 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 53.1 t30 62.86 53.56 2.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.878 -1.51 . . . . 1.1 111.942 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -139.21 121.82 16.3 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.049 -1.093 . . . . 1.36 108.049 166.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.944 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 98.0 t -113.45 128.62 25.47 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.934 0.397 . . . . 0.43 111.914 -167.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.878 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 85.5 Cg_exo -45.72 145.77 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.707 3.605 . . . . 0.54 113.76 172.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.645 ' HB2' HD13 ' A' ' 146' ' ' ILE . 3.7 mm-40 -81.71 -11.39 59.07 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.321 -1.309 . . . . 3.08 110.746 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -67.65 -26.62 66.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 1.57 109.672 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.471 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.8 m0 -109.21 -2.94 17.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.66 110.735 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.04 33.72 17.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.985 -0.626 . . . . 0.53 113.721 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.944 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -86.45 -105.81 0.78 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.252 -0.975 . . . . 0.6 111.857 174.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -162.97 58.8 0.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.979 0.895 . . . . 1.91 110.907 172.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.777 HG21 HG23 ' A' ' 112' ' ' VAL . 51.5 m -166.9 116.49 0.88 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.463 -0.79 . . . . 0.37 111.0 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.768 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 18.1 mm -71.43 108.02 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.041 -0.726 . . . . 0.63 109.041 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.638 ' HE2' ' CD1' ' A' ' 131' ' ' LEU . 9.2 m-85 -89.51 120.0 30.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.5 111.039 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.486 ' SG ' HD23 ' A' ' 150' ' ' LEU . 50.6 t -99.98 153.9 18.82 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.196 0.522 . . . . 0.68 109.73 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.676 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.8 mttt -128.49 91.82 3.31 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.983 -1.008 . . . . 1.44 108.499 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.83 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -122.65 -174.1 2.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.613 1.197 . . . . 0.84 112.242 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 p -155.47 100.76 2.14 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.604 -1.635 . . . . 1.77 107.566 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.56 58.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.736 -0.786 . . . . 0.41 109.653 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -73.08 -52.49 14.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.168 -0.924 . . . . 2.3 110.48 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 p -87.82 -6.61 58.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.971 -0.691 . . . . 0.7 112.399 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.524 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 28.9 mmtp 67.45 45.87 1.5 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.583 -0.735 . . . . 1.36 111.661 171.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -105.72 -65.87 1.03 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.956 1.36 . . . . 2.48 110.617 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.83 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -72.36 -5.14 62.28 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.746 -1.57 . . . . 0.29 113.804 -173.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 26.9 mt -66.05 -41.39 90.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.376 1.088 . . . . 0.8 109.07 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -47.83 71.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.254 -0.885 . . . . 2.2 109.886 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -64.12 -27.07 68.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.58 111.68 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.8 tp -63.89 -58.89 5.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 1.16 110.451 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 11.9 mt -57.51 -39.56 76.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.032 -0.985 . . . . 1.51 110.115 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -54.18 -40.19 67.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.263 -0.88 . . . . 2.57 111.37 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.53 ' O ' HG23 ' A' ' 168' ' ' VAL . 16.4 mmt -78.5 -39.18 38.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 0.64 110.621 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 161' ' ' LEU . 89.5 mt -58.98 -46.94 91.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.52 111.383 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.86 -34.65 78.27 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.726 -0.389 . . . . 1.73 110.895 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -53.68 -47.17 70.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.012 -0.736 . . . . 1.51 109.012 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 111' ' ' ILE . 48.2 t . . . . . 0 N--CA 1.446 -0.643 0 CA-C-N 115.431 -0.804 . . . . 0.89 111.356 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 120.366 0.127 . . . . 0.64 110.841 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.656 HD12 HD21 ' A' ' 25' ' ' LEU . 50.8 mt -86.15 114.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.212 0.53 . . . . 1.3 110.601 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.705 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 21.4 mmt -112.59 -178.48 3.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.439 -0.801 . . . . 0.79 109.432 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.45 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 138.76 -174.13 22.23 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.565 -0.826 . . . . 0.31 112.206 174.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.57 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 50.5 t60 -84.42 162.45 19.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.7 0.762 . . . . 0.22 110.691 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.478 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -76.38 152.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.081 -0.963 . . . . 0.36 110.163 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 73.62 -20.36 0.3 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.031 0.532 . . . . 0.69 110.385 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.8 m170 -79.87 -8.68 59.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.696 -0.853 . . . . 0.63 108.696 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 122.6 62.09 0.21 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.386 -0.912 . . . . 0.79 114.643 169.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 70.0 mmtt -62.02 -74.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.316 0.558 . . . . 3.31 111.208 168.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 m -80.13 -34.66 37.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.768 0.318 . . . . 1.21 110.955 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.564 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.83 -30.21 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.949 0.722 . . . . 1.25 112.949 -175.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -71.72 -52.55 17.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.953 -0.388 . . . . 1.49 109.953 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.656 HD21 HD12 ' A' ' 13' ' ' ILE . 15.4 mt -70.43 -8.67 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 1.69 110.965 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -89.17 -44.18 10.49 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.244 -1.021 . . . . 1.23 108.244 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.655 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -71.49 -25.33 62.22 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.71 -1.586 . . . . 0.63 110.676 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' A' ' 25' ' ' LEU . 9.7 tt . . . . . 0 C--N 1.318 -0.8 0 CA-C-N 115.21 -0.904 . . . . 1.02 111.076 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.487 HG21 HG12 ' A' ' 111' ' ' ILE . 59.9 mt . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 120.615 0.245 . . . . 0.71 111.075 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.866 HG21 ' HE1' ' A' ' 102' ' ' HIS . 6.0 p -111.77 136.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.432 0.634 . . . . 1.17 110.766 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.587 HG12 ' HB ' ' A' ' 111' ' ' ILE . 11.9 mt -90.53 142.58 12.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.287 -0.87 . . . . 0.37 109.555 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.45 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.1 tm? -127.44 108.4 10.79 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.3 -1.0 . . . . 1.01 108.3 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 90.4 t -89.89 116.03 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.079 0.466 . . . . 0.43 111.206 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.829 HG21 HD21 ' A' ' 131' ' ' LEU . 1.7 m -123.43 125.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.643 -0.708 . . . . 0.64 111.003 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.616 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -65.95 132.04 47.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.059 -0.519 . . . . 0.28 109.88 174.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.764 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -73.24 -12.3 60.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.016 0.436 . . . . 0.22 111.158 -175.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.36 9.99 37.63 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.816 -0.629 . . . . 0.58 111.634 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -143.25 -40.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.561 0.219 . . . . 0.56 111.068 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.574 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.1 -143.27 21.95 Favored Glycine 0 C--O 1.227 -0.284 0 C-N-CA 121.367 -0.444 . . . . 0.37 114.014 171.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.49 128.74 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.763 0.792 . . . . 1.03 111.02 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.576 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -125.69 177.68 1.81 Allowed Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 114.248 -1.342 . . . . 0.28 108.955 -174.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 76.0 Cg_exo -48.93 -57.91 2.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.497 2.131 . . . . 0.58 114.085 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.1 pt20 -76.13 -12.46 60.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.246 -0.582 . . . . 0.75 110.783 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.57 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.56 -50.16 40.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.727 -0.669 . . . . 0.31 109.758 178.498 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.574 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p -74.88 -21.86 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 112.749 0.648 . . . . 1.38 112.749 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.5 mt-10 -64.58 -29.9 70.92 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.452 -0.78 . . . . 2.35 109.171 172.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.705 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -76.39 -19.4 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.555 -0.748 . . . . 0.44 110.396 173.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.627 HG12 HD11 ' A' ' 136' ' ' LEU . 96.9 mt -79.42 -46.9 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.267 0.556 . . . . 0.41 109.619 171.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -51.76 -45.34 63.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.681 -1.145 . . . . 0.67 110.156 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.866 ' HE1' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -49.12 -46.62 45.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.733 -0.667 . . . . 2.5 111.061 172.046 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.78 41.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 0.47 111.634 -169.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -73.96 -29.67 62.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.619 0.723 . . . . 1.66 110.161 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.78 -39.55 68.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.251 -1.34 . . . . 0.77 110.755 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.95 -32.61 15.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.463 -0.335 . . . . 0.74 111.591 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 62.3 t30 82.09 52.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.55 1.14 . . . . 1.41 109.123 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.434 HG23 ' HD2' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.36 143.93 28.74 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.847 -1.524 . . . . 1.35 111.155 -174.502 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 108' ' ' VAL . 24.5 Cg_exo -63.23 145.07 93.05 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.756 2.304 . . . . 0.47 112.381 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.498 ' C ' HG23 ' A' ' 145' ' ' THR . 1.0 OUTLIER -112.61 161.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.885 0.85 . . . . 0.6 111.881 -173.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.983 HD13 ' HB ' ' A' ' 146' ' ' ILE . 19.7 mm -124.39 82.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.943 -1.502 . . . . 0.37 106.943 171.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 145' ' ' THR . 62.0 t -69.77 147.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 109.056 -0.72 . . . . 0.26 109.056 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.821 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -144.78 104.36 4.01 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.638 -1.164 . . . . 0.29 110.156 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.785 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.3 mp -73.18 136.62 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.165 -1.38 . . . . 0.59 109.198 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.552 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -121.99 173.11 7.74 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 106.723 -1.584 . . . . 1.85 106.723 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.616 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 91.0 mttt 66.53 33.88 6.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 O-C-N 123.759 0.662 . . . . 0.59 111.512 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . 78.5 mmm -84.12 -14.64 49.81 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.024 -0.732 . . . . 0.92 109.024 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -66.05 -31.89 73.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.754 -1.112 . . . . 0.76 108.875 171.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.46 133.71 80.17 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.667 -1.151 . . . . 1.17 110.24 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.06 -13.94 34.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.941 2.428 . . . . 0.58 111.937 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.17 -3.41 57.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.956 -1.02 . . . . 1.45 110.712 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . -56.45 120.94 8.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.149 -0.932 . . . . 0.27 111.848 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -131.74 76.91 73.65 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.197 -1.038 . . . . 0.95 108.197 170.809 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.574 ' HB2' ' HE2' ' A' ' 149' ' ' LYS . 33.4 Cg_endo -61.67 -56.91 0.65 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.21 2.606 . . . . 0.4 113.916 -173.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.683 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 7.2 m-20 -55.53 -26.7 44.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.493 0.663 . . . . 1.44 110.319 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 123' ' ' ASN . 14.6 tpp180 -74.11 -56.57 4.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 3.79 109.395 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.75 HG21 ' HA ' ' A' ' 88' ' ' ALA . 24.1 m -66.92 -29.35 46.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.122 -0.945 . . . . 0.59 111.871 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . 1.016 ' HA ' HD23 ' A' ' 131' ' ' LEU . 19.6 ptm -76.16 -17.03 59.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.745 0.307 . . . . 0.81 110.272 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' A' ' 132' ' ' MET . 32.5 mt-30 -76.2 -30.84 58.17 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.483 -0.487 . . . . 1.31 110.424 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 130' ' ' GLU . 16.6 mt-10 -64.35 -31.13 72.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.844 -0.799 . . . . 1.64 108.844 174.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.016 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -60.57 -47.83 84.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.677 -1.147 . . . . 1.36 109.507 176.358 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.661 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 18.2 ptm -71.64 -11.84 61.04 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.403 -0.519 . . . . 1.61 111.353 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 29.4 mt-10 -74.59 -28.85 61.09 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.6 -0.889 . . . . 1.67 108.6 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.583 ' HB3' HG21 ' A' ' 100' ' ' ILE . 31.1 m-85 -98.67 31.31 2.95 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.093 -0.958 . . . . 1.08 109.815 168.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.74 40.99 22.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 113.796 -1.547 . . . . 1.1 112.77 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.627 HD11 HG12 ' A' ' 100' ' ' ILE . 70.1 mt -110.04 95.9 5.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.013 -0.54 . . . . 1.36 110.001 172.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.01 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 21.9 t -100.64 117.26 63.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.868 -0.606 . . . . 0.43 111.045 -173.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.697 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.4 Cg_exo -44.11 143.94 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 124.446 3.431 . . . . 0.54 113.049 174.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.565 ' HG2' ' C ' ' A' ' 145' ' ' THR . 7.2 mm-40 -71.6 -21.25 61.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.329 -1.305 . . . . 3.08 109.341 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.5 pm0 -66.88 -19.83 65.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.26 -0.882 . . . . 1.57 110.506 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.518 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 37.8 m0 -110.22 -9.97 14.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.871 0.367 . . . . 0.66 111.081 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.65 29.45 9.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.866 -0.683 . . . . 0.53 113.473 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 1.01 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -89.95 -108.73 1.29 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 119.954 -1.117 . . . . 0.6 112.358 176.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.14 60.91 0.12 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.649 1.214 . . . . 1.91 110.858 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.863 HG21 HG23 ' A' ' 112' ' ' VAL . 72.8 m -165.2 119.2 1.25 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.643 -1.162 . . . . 0.37 110.712 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.983 ' HB ' HD13 ' A' ' 111' ' ' ILE . 19.1 mm -72.92 104.2 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 109.264 -0.643 . . . . 0.63 109.264 174.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.697 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m-85 -87.45 117.17 26.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.339 -0.846 . . . . 0.5 110.495 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 82.8 m -103.15 132.87 49.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.99 -0.55 . . . . 0.68 110.391 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.574 ' HE2' ' HB2' ' A' ' 124' ' ' PRO . 95.4 mttt -102.4 107.78 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.226 -0.657 . . . . 1.44 109.226 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.883 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -138.01 -172.52 3.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.703 1.24 . . . . 0.84 112.401 -173.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.3 OUTLIER -160.23 105.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 113.605 -1.634 . . . . 1.77 106.996 176.377 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.2 -14.38 62.94 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.343 -0.614 . . . . 0.41 109.343 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -62.86 -57.51 10.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.841 -1.072 . . . . 2.3 110.449 171.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.07 -8.86 59.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.622 0.601 . . . . 0.7 112.622 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.655 ' HE3' ' HB1' ' A' ' 27' ' ' ALA . 37.2 mmtm 64.38 44.99 3.96 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.36 111.204 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -105.21 -67.85 0.89 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.428 1.109 . . . . 2.48 109.63 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.883 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.78 -8.37 67.86 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 113.861 -1.518 . . . . 0.29 113.816 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.1 mt -66.44 -38.97 88.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.15 0.975 . . . . 0.8 109.41 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.596 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 40.8 m-20 -70.38 -44.16 68.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.326 -0.852 . . . . 2.2 109.291 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.413 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 73.8 t60 -62.8 -22.43 66.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.949 -0.569 . . . . 0.58 111.138 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.92 -52.95 30.27 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.361 0.6 . . . . 1.16 109.497 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -66.97 -26.63 66.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.31 -0.859 . . . . 1.51 110.444 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 94.1 mt-10 -61.99 -35.39 78.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.979 0.419 . . . . 2.57 110.832 175.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.56 ' HB3' HG21 ' A' ' 146' ' ' ILE . 11.3 mmt -82.3 -37.1 26.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.237 0.541 . . . . 0.64 110.398 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 83' ' ' ILE . 79.3 mt -69.59 -44.02 79.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 0.52 111.203 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -69.81 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.746 0.308 . . . . 1.73 110.248 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -57.9 -43.42 86.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.522 -0.918 . . . . 1.51 108.522 171.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 0.89 110.615 174.992 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.232 -0.655 . . . . 0.64 109.232 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.33 134.76 26.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.712 0.768 . . . . 1.3 110.691 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.524 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 66.3 mtt -138.38 -179.75 5.98 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.052 -0.977 . . . . 0.79 108.883 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.458 ' HA2' HD13 ' A' ' 84' ' ' LEU . . . 143.93 -171.44 25.49 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.511 -0.852 . . . . 0.31 112.362 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.536 ' CE1' HG12 ' A' ' 17' ' ' VAL . 38.9 t60 -98.05 160.96 13.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.91 0.862 . . . . 0.22 111.914 -177.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.536 HG12 ' CE1' ' A' ' 16' ' ' HIS . 7.4 p -73.56 150.89 7.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.318 -1.31 . . . . 0.36 110.11 174.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.6 t70 74.01 -32.62 0.24 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.225 0.61 . . . . 0.69 110.749 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 18.9 m170 -66.32 -20.51 66.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.733 -0.84 . . . . 0.63 108.733 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 126.46 55.83 0.15 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.79 113.331 174.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' HD3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -64.99 -61.19 2.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 117.46 0.63 . . . . 3.31 110.539 176.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.5 m -87.16 -41.76 13.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.972 0.415 . . . . 1.21 110.954 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -57.64 -33.83 68.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.087 0.773 . . . . 1.25 113.087 -175.198 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -72.41 -43.66 63.58 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.064 -0.717 . . . . 1.49 109.064 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.68 -17.56 64.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 1.69 110.494 -178.531 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -94.21 -43.21 8.56 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.842 0.829 . . . . 1.23 108.958 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.24 97.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.24 -1.346 . . . . 0.63 109.587 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.2 tt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 114.452 -1.249 . . . . 1.02 111.224 -177.164 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.527 0.204 . . . . 0.71 110.604 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 110' ' ' ILE . 25.9 t -112.06 129.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 120.707 -0.397 . . . . 1.17 111.358 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.643 HG12 ' HB ' ' A' ' 111' ' ' ILE . 10.8 mt -97.92 132.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 0.37 110.975 174.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.961 ' HB3' HG13 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -109.44 112.02 23.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.512 -0.767 . . . . 1.01 111.364 -178.393 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.7 t -87.55 94.12 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.098 0.475 . . . . 0.43 110.067 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.897 HG13 HD12 ' A' ' 84' ' ' LEU . 7.3 m -117.24 128.22 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.723 -0.671 . . . . 0.64 110.698 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.54 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -79.21 134.07 36.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.464 -0.569 . . . . 0.28 109.464 175.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.702 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -71.72 -8.02 51.64 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.079 0.466 . . . . 0.22 110.812 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.471 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -85.38 -17.38 36.87 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.355 -0.839 . . . . 0.58 110.972 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.535 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 24.8 t0 -132.0 -49.36 0.94 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.453 -0.34 . . . . 0.56 111.243 -170.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.63 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.24 -137.56 13.39 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 121.007 -0.616 . . . . 0.37 113.629 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 130' ' ' GLU . 6.9 p -88.47 138.51 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.35 -0.611 . . . . 1.03 109.35 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.847 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.4 mmm -142.78 178.2 1.57 Allowed Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.232 -0.655 . . . . 0.28 109.232 -171.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.847 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 49.3 Cg_exo -36.77 -69.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.544 2.829 . . . . 0.58 114.847 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.436 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 13.5 pt20 -73.69 -20.84 60.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.031 0.443 . . . . 0.75 111.346 -175.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.92 -43.78 82.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.677 -0.692 . . . . 0.31 109.373 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.57 HG12 ' ND2' ' A' ' 101' ' ' ASN . 47.6 t -66.92 -44.78 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.07 -0.968 . . . . 1.38 110.841 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.2 mm-40 -65.86 -14.84 62.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.153 0.502 . . . . 2.35 110.227 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -81.92 -38.4 25.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.556 -0.747 . . . . 0.44 110.086 170.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 95.6 mt -73.98 -42.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.642 0.734 . . . . 0.41 109.425 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.57 ' ND2' HG12 ' A' ' 97' ' ' VAL . 26.2 m-20 -57.99 -30.31 65.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.577 -1.192 . . . . 0.67 110.503 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -80.66 -37.73 30.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.32 0.581 . . . . 2.5 109.889 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.49 70.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.882 -0.599 . . . . 0.47 111.546 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.5 mmmm -72.79 -32.06 65.3 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.145 0.497 . . . . 1.66 110.133 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -44.51 54.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.731 -1.122 . . . . 0.77 110.798 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.57 -26.92 34.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.74 110.591 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 64.51 88.47 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.434 0.694 . . . . 1.41 110.908 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.605 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -143.56 154.26 59.58 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.488 -0.778 . . . . 1.35 109.83 -176.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 108' ' ' VAL . 21.6 Cg_exo -61.21 140.51 89.27 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.482 2.121 . . . . 0.47 111.923 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.4 mt -119.68 156.52 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.152 0.977 . . . . 0.6 111.917 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.014 HD13 ' HB ' ' A' ' 146' ' ' ILE . 19.0 mm -125.36 83.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.444 -1.707 . . . . 0.37 107.49 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.961 HG13 ' HB3' ' A' ' 84' ' ' LEU . 17.9 t -76.61 148.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.775 -0.77 . . . . 0.26 108.93 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.877 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -137.74 109.42 7.05 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.819 -1.082 . . . . 0.29 110.25 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.794 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -75.98 132.78 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.128 -1.396 . . . . 0.59 109.43 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 54.4 t30 -114.06 168.68 9.6 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 107.454 -1.313 . . . . 1.85 107.454 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.616 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 73.6 mttt 72.42 31.86 1.72 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.117 0.885 . . . . 0.59 112.001 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.571 ' H ' ' HB2' ' A' ' 151' ' ' SER . 11.4 mmt -72.8 -14.96 61.63 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.699 -0.682 . . . . 0.92 109.767 166.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.616 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.1 p-10 -69.7 -22.05 63.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.851 -1.068 . . . . 0.76 108.915 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.836 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 11.0 mmpt? -88.68 133.14 36.62 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.345 -1.298 . . . . 1.17 110.609 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.11 -11.69 28.76 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.878 2.385 . . . . 0.58 111.481 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -85.38 2.23 45.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.773 -1.103 . . . . 1.45 110.314 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -55.68 107.62 0.36 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.382 -0.826 . . . . 0.27 111.062 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.75 76.52 37.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.723 -0.843 . . . . 0.95 108.723 174.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.526 ' HA ' HG22 ' A' ' 127' ' ' VAL . 45.2 Cg_endo -66.18 -55.01 0.42 Allowed 'Trans proline' 0 CA--C 1.503 -1.034 0 C-N-CA 123.079 2.52 . . . . 0.4 113.223 -171.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.403 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 11.9 m-20 -50.88 -27.64 7.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.189 -0.914 . . . . 1.44 110.386 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 32.2 tpt180 -79.63 -55.9 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 3.79 109.649 -178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.702 HG21 ' HA ' ' A' ' 88' ' ' ALA . 16.3 m -65.35 -28.94 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.476 -0.784 . . . . 0.59 112.078 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.407 ' HB2' ' HE3' ' A' ' 128' ' ' MET . 14.6 ptm -79.4 -19.33 50.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.157 -0.34 . . . . 0.81 110.486 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.65 ' O ' ' HG3' ' A' ' 132' ' ' MET . 13.0 mt-30 -74.4 -32.89 62.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.562 -0.29 . . . . 1.31 110.704 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.487 ' HB3' HG12 ' A' ' 92' ' ' VAL . 2.7 mm-40 -57.83 -46.29 84.94 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.569 0.699 . . . . 1.64 109.97 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 11.2 mp -66.38 -34.85 78.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.522 -0.763 . . . . 1.36 111.295 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.898 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -75.79 -7.89 55.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.724 -0.79 . . . . 1.61 110.738 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -82.45 -26.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.439 -0.948 . . . . 1.67 108.439 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.13 26.69 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.819 0.819 . . . . 1.08 109.854 165.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 53.78 57.0 6.46 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.983 -1.462 . . . . 1.1 111.673 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.846 ' H ' ' HA ' ' A' ' 132' ' ' MET . 62.8 mt -121.62 96.31 5.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.323 -0.853 . . . . 1.36 109.395 170.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.7 t -94.93 114.58 63.96 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.493 0.663 . . . . 0.43 112.162 -170.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.536 ' HA ' ' HD1' ' A' ' 147' ' ' PHE . 86.1 Cg_exo -45.29 152.63 0.7 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.651 3.567 . . . . 0.54 112.981 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.449 ' HB3' HD13 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -78.43 -19.36 53.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.253 -1.339 . . . . 3.08 109.663 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.424 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.8 pm0 -70.21 -17.49 63.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.246 -0.888 . . . . 1.57 110.771 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.898 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 44.0 m0 -106.61 -24.96 12.0 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.803 0.335 . . . . 0.66 111.117 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.62 15.56 5.34 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.128 -1.034 . . . . 0.53 113.998 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.608 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.05 -121.11 2.17 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.523 -1.322 . . . . 0.6 111.383 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -164.95 63.01 0.13 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 124.179 1.942 . . . . 1.91 110.496 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.518 ' CG2' HG23 ' A' ' 112' ' ' VAL . 85.9 m -141.7 104.92 4.62 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.689 -2.05 . . . . 0.37 107.361 173.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 1.014 ' HB ' HD13 ' A' ' 111' ' ' ILE . 42.2 mm -74.02 92.3 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-O 121.855 0.836 . . . . 0.63 110.054 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 114' ' ' ILE . 30.6 m-85 -75.81 107.83 8.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.038 -1.437 . . . . 0.5 110.447 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.9 m -98.96 108.22 20.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.004 -0.998 . . . . 0.68 110.211 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.794 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 76.9 mttt -83.36 99.4 10.01 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.902 -0.59 . . . . 1.44 109.867 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.877 HD21 ' HB1' ' A' ' 113' ' ' ALA . 3.4 pp -128.42 -167.09 1.72 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 0.84 112.463 -174.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.571 ' HB2' ' H ' ' A' ' 117' ' ' MET . 12.0 t -166.75 119.87 1.01 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.994 -1.912 . . . . 1.77 106.001 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.71 -5.84 51.9 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.124 -0.631 . . . . 0.41 109.372 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 19.5 mmtt -87.23 -37.37 17.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.391 -0.822 . . . . 2.3 111.498 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 11.6 p -87.69 -13.88 41.35 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.62 -0.832 . . . . 0.7 110.63 171.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 19.4 mmtp 59.64 45.39 13.17 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.95 -1.023 . . . . 1.36 109.703 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 4.4 tp10 -99.03 -68.5 0.8 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.487 -1.233 . . . . 2.48 110.557 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.877 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -80.55 2.75 77.02 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.531 -0.842 . . . . 0.29 113.454 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.436 HD12 ' CD ' ' A' ' 155' ' ' LYS . 30.5 mt -74.32 -39.62 62.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.069 0.934 . . . . 0.8 108.879 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 19.4 t70 -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.358 -0.837 . . . . 2.2 108.936 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 81.9 t60 -67.43 -17.61 64.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.525 -0.761 . . . . 0.58 111.333 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 165' ' ' ILE . 51.6 tp -68.94 -56.9 6.41 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.03 0.443 . . . . 1.16 110.028 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.43 ' HG ' ' H ' ' A' ' 162' ' ' LEU . 9.9 mt -56.17 -38.56 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.21 -0.904 . . . . 1.51 109.731 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 31.7 mm-40 -56.39 -41.93 77.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.325 -0.852 . . . . 2.57 111.445 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.587 ' HB3' HG21 ' A' ' 146' ' ' ILE . 13.7 mmt -77.52 -32.25 53.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 0.64 110.576 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 161' ' ' LEU . 75.7 mt -65.14 -47.18 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.619 . . . . 0.52 111.093 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 167' ' ' LEU . 3.9 pp -65.6 -29.29 69.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.862 0.363 . . . . 1.73 111.261 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.2 tp -56.25 -49.26 74.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.67 . . . . 1.51 109.708 170.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 N--CA 1.446 -0.638 0 CA-C-N 115.521 -0.763 . . . . 0.89 110.26 174.99 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.775 0.321 . . . . 0.64 110.31 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.458 HD12 ' HB2' ' A' ' 25' ' ' LEU . 59.5 mt -96.37 127.93 48.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.915 0.388 . . . . 1.3 110.653 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.503 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 60.1 mtt -136.34 175.55 9.5 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.037 -0.529 . . . . 0.79 109.823 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 145.48 -168.97 27.16 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.89 -0.671 . . . . 0.31 111.7 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.611 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 12.3 t-80 -89.66 158.49 17.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.86 0.838 . . . . 0.22 111.48 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.52 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.1 p -72.18 148.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.562 -1.199 . . . . 0.36 109.697 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 23.6 t70 73.81 -19.36 0.35 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.457 0.646 . . . . 0.69 110.502 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 17' ' ' VAL . 15.6 m170 -84.67 -0.68 54.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.974 -1.121 . . . . 0.63 107.974 168.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 87.76 49.48 3.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.163 -0.926 . . . . 0.79 113.86 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -63.67 -36.57 84.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.31 -0.556 . . . . 3.31 111.508 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 m -101.8 -42.41 6.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 1.21 110.454 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.487 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -54.11 -19.47 5.02 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.125 0.787 . . . . 1.25 113.125 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -74.83 -45.24 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.259 -0.645 . . . . 1.49 109.259 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.542 HD13 ' C ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -66.39 -16.12 63.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.731 -1.122 . . . . 1.69 109.199 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -97.78 -41.5 8.03 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.701 0.762 . . . . 1.23 110.194 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -29.1 69.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.817 -1.083 . . . . 0.63 110.132 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.9 tt . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 114.662 -1.154 . . . . 1.02 110.128 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.6 mt . . . . . 0 CA--C 1.522 -0.124 0 N-CA-C 109.026 -0.731 . . . . 0.71 109.026 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HB ' HD13 ' A' ' 110' ' ' ILE . 31.3 t -100.9 116.64 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 C-N-CA 119.408 -0.917 . . . . 1.17 112.183 -173.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 9.2 mt -81.3 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.899 -1.046 . . . . 0.37 109.448 171.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.552 HD12 HD21 ' A' ' 131' ' ' LEU . 2.3 tm? -117.91 105.97 12.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.084 -1.08 . . . . 1.01 108.084 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 53.8 t -90.05 112.11 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.364 -0.834 . . . . 0.43 110.864 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.0 OUTLIER -121.32 129.67 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.733 -0.667 . . . . 0.64 110.874 175.765 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -70.63 130.69 42.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.896 -0.593 . . . . 0.28 109.935 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.664 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -71.54 -13.58 61.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 0.22 110.632 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.465 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -94.46 -2.42 51.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.686 -0.688 . . . . 0.58 111.521 -178.221 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.454 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 26.4 t0 -138.03 -49.26 0.56 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.652 -0.249 . . . . 0.56 110.891 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.595 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.36 -146.89 18.46 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.343 -0.456 . . . . 0.37 113.689 171.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.5 136.12 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 1.03 109.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.73 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.2 mmm -138.14 176.5 2.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 114.87 -1.059 . . . . 0.28 108.658 -171.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.73 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 55.8 Cg_exo -38.54 -69.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.607 2.872 . . . . 0.58 114.764 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.611 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 7.6 pt20 -72.4 -16.99 61.85 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.01 0.433 . . . . 0.75 111.47 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.71 -44.01 78.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.097 -0.705 . . . . 0.31 109.097 176.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 93' ' ' MET . 20.8 t -65.86 -41.36 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.22 -0.9 . . . . 1.38 111.096 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.81 -26.73 62.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 2.35 110.777 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.7 -34.95 65.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.382 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.8 mt -74.3 -46.69 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.472 0.653 . . . . 0.41 109.28 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.501 ' ND2' HG12 ' A' ' 97' ' ' VAL . 59.7 m-20 -56.31 -40.56 74.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.608 -1.178 . . . . 0.67 110.491 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -70.65 -35.43 72.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.907 -0.588 . . . . 2.5 110.199 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -69.43 -46.92 65.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.47 111.109 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.5 mmtp -64.8 -38.68 91.79 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.19 0.519 . . . . 1.66 109.986 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -48.24 -43.31 32.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.301 -1.318 . . . . 0.77 111.239 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.73 -38.27 15.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.74 111.022 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 88.08 72.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.631 1.172 . . . . 1.41 109.113 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 109' ' ' PRO . 3.0 p -126.2 144.71 49.95 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.203 -1.362 . . . . 1.35 110.862 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.443 ' O ' HG22 ' A' ' 108' ' ' VAL . 16.9 Cg_exo -66.45 139.32 53.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.716 1.611 . . . . 0.47 111.327 170.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.488 HD11 ' HB1' ' A' ' 103' ' ' ALA . 27.0 mm -104.83 157.4 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.571 0.7 . . . . 0.6 110.68 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.06 HD13 ' HB ' ' A' ' 146' ' ' ILE . 16.3 mm -122.91 83.72 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.346 -1.353 . . . . 0.37 107.346 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.729 HG23 HG21 ' A' ' 145' ' ' THR . 63.5 t -71.14 143.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.907 0.861 . . . . 0.26 109.518 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.762 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -146.64 100.41 3.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.857 -1.52 . . . . 0.29 109.857 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.793 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 85.0 mt -72.25 140.13 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 113.749 -1.569 . . . . 0.59 109.91 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.623 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.2 p-10 -120.29 176.13 5.62 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.068 -1.456 . . . . 1.85 107.068 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.657 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 75.5 mttt 66.34 27.92 9.92 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.86 0.725 . . . . 0.59 112.165 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.488 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 85.8 mmm -80.86 -1.64 44.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.697 0.761 . . . . 0.92 109.074 171.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.657 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.4 p-10 -71.01 -31.7 68.27 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.84 -1.073 . . . . 0.76 108.664 168.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HB3' ' HE2' ' A' ' 119' ' ' LYS . 39.6 mtpt -77.41 136.75 64.25 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.128 -1.396 . . . . 1.17 110.833 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.78 -17.39 59.7 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.818 2.346 . . . . 0.58 111.683 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.05 1.62 27.04 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.695 -0.684 . . . . 1.45 110.687 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.488 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -56.03 114.9 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.594 -0.73 . . . . 0.27 110.638 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -123.69 75.46 55.49 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 107.885 -1.154 . . . . 0.95 107.885 173.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.43 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 42.4 Cg_endo -64.86 -57.17 0.31 Allowed 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 122.492 2.128 . . . . 0.4 112.46 -172.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.43 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 4.3 m-20 -50.91 -26.57 6.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 124.2 0.938 . . . . 1.44 111.037 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -77.71 -59.23 2.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.892 -0.594 . . . . 3.79 110.071 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.595 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 4.7 m -64.67 -27.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.105 -0.952 . . . . 0.59 110.398 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.666 ' HG2' ' CE ' ' A' ' 132' ' ' MET . 23.2 ttt -60.95 -51.79 67.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.726 -1.125 . . . . 0.81 109.815 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 132' ' ' MET . 35.2 mt-30 -59.15 -31.25 68.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.022 0.749 . . . . 1.31 113.022 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.517 ' HA ' ' CG ' ' A' ' 133' ' ' GLU . 4.3 pt-20 -80.91 -16.44 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.081 -0.647 . . . . 1.64 112.081 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.723 HD23 HG21 ' A' ' 112' ' ' VAL . 6.7 mp -68.17 -35.87 78.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.582 -0.847 . . . . 1.36 109.044 167.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.666 ' CE ' ' HG2' ' A' ' 128' ' ' MET . 0.5 OUTLIER -71.19 -18.75 62.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.437 -0.801 . . . . 1.61 109.618 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.517 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 7.9 mm-40 -70.45 -30.51 67.37 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.661 -0.866 . . . . 1.67 108.661 173.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -91.97 17.3 9.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.059 -0.973 . . . . 1.08 109.959 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 61.11 47.84 6.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.233 -1.349 . . . . 1.1 111.27 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.492 HD11 HD23 ' A' ' 131' ' ' LEU . 1.5 pp -131.28 121.41 24.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.096 -1.076 . . . . 1.36 108.096 167.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.759 HG13 ' HD2' ' A' ' 138' ' ' PRO . 5.0 t -122.06 142.92 37.62 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.114 0.483 . . . . 0.43 111.382 -168.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HB3' ' CD1' ' A' ' 147' ' ' PHE . 18.5 Cg_endo -69.86 -175.21 1.1 Allowed 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 123.621 2.88 . . . . 0.54 113.631 -176.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.775 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -84.61 -32.66 23.6 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.53 -1.668 . . . . 3.08 109.93 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.756 ' HG3' ' CD1' ' A' ' 141' ' ' TRP . 6.7 pt-20 -67.85 -17.66 64.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.092 -0.504 . . . . 1.57 111.205 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.756 ' CD1' ' HG3' ' A' ' 140' ' ' GLU . 21.2 m0 -109.04 -2.82 17.89 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.892 0.377 . . . . 0.66 111.183 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.81 32.13 13.68 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.058 -0.591 . . . . 0.53 113.784 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.19 -127.86 5.84 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.627 -0.796 . . . . 0.6 111.407 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -149.84 62.93 0.99 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.018 0.913 . . . . 1.91 111.894 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 112' ' ' VAL . 52.7 m -161.27 128.14 4.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.165 -0.925 . . . . 0.37 109.99 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 1.06 ' HB ' HD13 ' A' ' 111' ' ' ILE . 46.8 mm -79.78 104.89 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 108.863 -0.792 . . . . 0.63 108.863 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.765 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 5.9 m-85 -88.56 116.74 27.02 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.584 -0.734 . . . . 0.5 111.706 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.1 m -106.76 143.31 35.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.638 -0.71 . . . . 0.68 110.814 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.586 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.5 mttt -118.15 97.91 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.885 -0.783 . . . . 1.44 108.885 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.897 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -130.63 -171.47 2.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.749 1.261 . . . . 0.84 112.569 -169.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.531 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 28.9 t -157.88 115.99 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.679 -1.601 . . . . 1.77 106.873 174.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.45 -9.92 58.99 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.084 -0.71 . . . . 0.41 109.084 175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.18 -50.96 17.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.878 -1.055 . . . . 2.3 110.56 174.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 118' ' ' ASP . 2.1 p -81.39 -16.06 53.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.228 -0.589 . . . . 0.7 111.217 175.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.449 ' CD ' HD12 ' A' ' 158' ' ' LEU . 29.1 mmtp 67.21 40.66 2.75 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.307 -0.861 . . . . 1.36 110.539 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.4 OUTLIER -98.71 -64.66 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.022 -0.99 . . . . 2.48 109.663 -171.625 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.897 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -76.19 -3.01 74.89 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.111 -0.95 . . . . 0.29 113.433 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.449 HD12 ' CD ' ' A' ' 155' ' ' LYS . 18.1 mt -70.89 -36.16 72.63 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 117.974 0.887 . . . . 0.8 109.416 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 27.7 t70 -73.04 -39.95 65.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 2.2 109.257 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.423 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 61.3 t60 -68.52 -18.11 64.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.212 -0.449 . . . . 0.58 111.346 176.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.8 tp -74.81 -54.27 7.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.24 0.543 . . . . 1.16 110.08 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.52 -27.64 69.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.267 -0.879 . . . . 1.51 111.529 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 12.0 pt-20 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.431 -0.507 . . . . 2.57 110.22 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.456 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 21.7 mmt -71.72 -39.39 70.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.17 0.509 . . . . 0.64 109.649 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.25 -38.7 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.519 -0.764 . . . . 0.52 110.443 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -40.38 95.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.504 . . . . 1.73 111.146 177.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.98 -43.46 63.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.466 0.65 . . . . 1.51 109.561 173.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 68.0 t . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 114.756 -1.111 . . . . 0.89 110.769 176.267 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.52 ' HB ' ' HA ' ' A' ' 82' ' ' VAL . 89.1 m . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.251 -0.277 . . . . 0.64 110.251 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mt -112.62 122.34 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.051 -0.406 . . . . 1.3 110.402 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.771 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 59.2 mtt -139.65 173.56 11.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.048 -0.524 . . . . 0.79 109.953 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.491 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 145.32 -163.54 28.12 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.641 -0.79 . . . . 0.31 112.335 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.725 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 11.3 t-80 -97.1 161.28 13.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.822 0.82 . . . . 0.22 112.031 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.583 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.8 p -73.72 151.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.339 -1.301 . . . . 0.36 109.739 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 10.7 t70 73.39 -27.09 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.304 0.574 . . . . 0.69 110.605 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.0 m170 -77.38 -10.47 59.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.407 -0.96 . . . . 0.63 108.407 171.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.688 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 113.72 51.95 0.48 Allowed Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.605 -0.807 . . . . 0.79 114.22 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 4.2 tptm -53.31 -62.77 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.447 0.623 . . . . 3.31 111.283 174.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -96.07 -32.11 12.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.579 -0.282 . . . . 1.21 111.079 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.558 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -59.34 -20.84 57.87 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.018 0.747 . . . . 1.25 113.018 -179.006 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.688 HD23 ' HA3' ' A' ' 20' ' ' GLY . 1.5 mm? -74.52 -35.73 63.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.919 0.39 . . . . 1.49 110.001 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.02 -15.11 61.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.79 -0.641 . . . . 1.69 109.466 176.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -96.5 -32.03 12.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.706 -0.679 . . . . 1.23 109.29 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -47.32 49.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.198 -0.91 . . . . 0.63 109.051 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 tt . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 114.68 -1.145 . . . . 1.02 110.244 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.2 mt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.597 -0.52 . . . . 0.71 109.597 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' HD13 ' A' ' 110' ' ' ILE . 40.1 t -93.84 114.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.424 0.63 . . . . 1.17 111.205 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.695 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.5 mt -82.84 126.03 40.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.899 -1.046 . . . . 0.37 109.596 172.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.3 tm? -114.73 106.09 13.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.447 -0.945 . . . . 1.01 108.447 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 57.7 t -88.24 109.76 20.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.395 -0.82 . . . . 0.43 110.921 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 131' ' ' LEU . 1.7 m -121.14 135.76 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.855 -0.611 . . . . 0.64 111.338 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.696 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -74.26 134.18 42.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.935 -0.575 . . . . 0.28 109.706 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.76 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -78.61 -9.42 59.36 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.355 0.597 . . . . 0.22 109.846 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -89.25 -10.24 47.68 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.941 -1.027 . . . . 0.58 110.359 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.1 t0 -133.33 -59.51 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.07 -0.514 . . . . 0.56 111.152 -173.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.436 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 109.14 -135.11 12.65 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.37 113.637 173.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.27 131.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.786 0.803 . . . . 1.03 110.671 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.656 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 68.6 mmm -134.02 178.93 1.53 Allowed Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 114.333 -1.303 . . . . 0.28 109.402 -171.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.4 Cg_exo -45.64 -64.34 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.27 2.647 . . . . 0.58 114.735 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.725 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 7.0 pt20 -75.17 -10.93 59.92 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.636 -0.665 . . . . 0.75 111.3 -175.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.85 -49.28 54.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.738 -0.664 . . . . 0.31 109.279 175.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' HA ' HD12 ' A' ' 100' ' ' ILE . 2.5 p -72.63 -28.61 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.834 -0.621 . . . . 1.38 112.591 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 49.2 mt-10 -57.95 -29.66 65.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.544 0.611 . . . . 2.35 109.448 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.771 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -72.36 -42.85 64.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.396 -0.82 . . . . 0.44 110.743 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 97' ' ' VAL . 65.7 mt -66.05 -41.57 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.62 0.724 . . . . 0.41 109.307 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -57.9 -40.0 79.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.196 -1.366 . . . . 0.67 110.857 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -66.83 -40.45 88.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.643 -0.503 . . . . 2.5 109.643 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -70.41 -46.08 64.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.877 -0.602 . . . . 0.47 111.788 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.78 -29.06 61.98 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.052 0.453 . . . . 1.66 110.659 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.61 -43.23 62.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.689 -1.141 . . . . 0.77 110.69 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.44 -19.18 23.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.74 111.3 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 70.04 67.79 0.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.17 -0.923 . . . . 1.41 110.472 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.489 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -117.28 152.39 49.1 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 1.35 111.12 -176.244 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 108' ' ' VAL . 23.2 Cg_exo -65.34 141.58 68.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.041 2.494 . . . . 0.47 112.537 172.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.547 HD13 ' HB ' ' A' ' 82' ' ' VAL . 29.2 mm -111.27 155.47 12.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.601 0.715 . . . . 0.6 111.121 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.774 HD13 ' HB ' ' A' ' 146' ' ' ILE . 7.9 mm -125.38 87.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.429 -1.323 . . . . 0.37 107.429 170.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.679 HG23 HG21 ' A' ' 145' ' ' THR . 46.6 t -74.16 148.33 8.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.463 -0.789 . . . . 0.26 109.8 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 150' ' ' LEU . . . -143.73 106.18 4.42 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.473 -1.24 . . . . 0.29 110.427 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.83 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -79.22 135.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.508 -1.224 . . . . 0.59 109.787 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.696 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.5 p-10 -113.47 177.41 4.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.28 -1.378 . . . . 1.85 107.28 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.735 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 84.2 mttt 70.5 33.1 2.52 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.61 0.569 . . . . 0.59 111.754 176.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.665 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 29.8 mmt -73.95 -19.0 60.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.245 -1.391 . . . . 0.92 107.245 166.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.632 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -62.29 -36.44 82.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.37 -1.741 . . . . 0.76 110.503 172.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.735 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 41.1 mtpt -79.34 141.77 57.73 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.94 -0.573 . . . . 1.17 110.3 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.24 -15.95 52.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.792 2.328 . . . . 0.58 111.88 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 34.4 mt-10 -84.75 11.26 9.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.574 -0.739 . . . . 1.45 110.655 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.455 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -61.29 100.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.536 -0.756 . . . . 0.27 111.155 176.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -120.41 77.07 26.27 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.664 -0.865 . . . . 0.95 108.664 176.106 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.596 ' HD3' ' HE1' ' A' ' 117' ' ' MET . 55.7 Cg_endo -68.15 -56.01 0.22 Allowed 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 123.334 2.689 . . . . 0.4 113.512 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.541 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 2.2 m-20 -55.72 -24.5 35.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.44 110.7 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 15.4 tpp180 -74.15 -57.49 3.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.386 -0.598 . . . . 3.79 109.386 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 88' ' ' ALA . 26.5 m -64.44 -32.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.999 -1.0 . . . . 0.59 111.681 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.958 ' HA ' HD23 ' A' ' 131' ' ' LEU . 17.1 ptm -76.22 -15.79 59.96 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.889 0.376 . . . . 0.81 110.41 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.624 ' O ' ' HG2' ' A' ' 132' ' ' MET . 30.1 mt-30 -78.38 -33.95 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 1.31 110.014 171.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.04 -27.26 65.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.905 -0.776 . . . . 1.64 108.905 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.958 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.2 OUTLIER -59.44 -46.41 88.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.484 -1.235 . . . . 1.36 109.263 174.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.627 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 16.6 ptm -75.11 -13.76 60.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.409 -0.516 . . . . 1.61 111.125 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 58.9 mm-40 -70.49 -29.08 65.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.0 -1.111 . . . . 1.67 108.0 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.458 ' N ' ' HD1' ' A' ' 134' ' ' TYR . 1.6 m-85 -98.92 23.17 9.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.473 -1.239 . . . . 1.08 108.986 175.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.4 t30 60.49 49.22 6.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 113.619 -1.628 . . . . 1.1 112.259 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.627 ' H ' ' HA ' ' A' ' 132' ' ' MET . 52.4 mt -117.93 98.65 6.45 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.329 -0.85 . . . . 1.36 109.522 171.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.012 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 26.2 t -104.68 113.67 64.72 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.089 -0.644 . . . . 0.43 111.497 -172.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.6 ' CB ' ' HG2' ' A' ' 140' ' ' GLU . 82.2 Cg_exo -45.48 141.81 7.31 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.405 3.403 . . . . 0.54 112.8 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.623 ' HB2' HD13 ' A' ' 146' ' ' ILE . 6.3 mm-40 -71.56 -14.75 62.19 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.636 -1.165 . . . . 3.08 110.56 174.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.6 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.8 pm0 -68.39 -19.99 64.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.981 -0.554 . . . . 1.57 109.759 167.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.589 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 42.7 m0 -107.68 -30.3 8.65 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.994 0.426 . . . . 0.66 110.722 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.83 25.63 3.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.752 -0.737 . . . . 0.53 113.255 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 1.012 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -88.67 -107.28 1.06 Allowed Glycine 0 C--N 1.324 -0.134 0 C-N-CA 120.126 -1.035 . . . . 0.6 112.699 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -165.07 60.83 0.12 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 122.565 1.174 . . . . 1.91 110.694 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.679 HG21 HG23 ' A' ' 112' ' ' VAL . 87.4 m -164.39 122.4 1.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.687 -1.142 . . . . 0.37 110.554 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.774 ' HB ' HD13 ' A' ' 111' ' ' ILE . 16.5 mm -84.42 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.211 -0.663 . . . . 0.63 109.211 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.461 ' HE2' HD23 ' A' ' 131' ' ' LEU . 2.8 m-85 -87.62 145.5 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.884 0.849 . . . . 0.5 110.153 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.456 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 65.1 m -118.15 136.32 53.69 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.29 -1.323 . . . . 0.68 109.103 172.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.552 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 94.7 mttt -109.76 89.84 3.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.997 -0.742 . . . . 1.44 108.997 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.859 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -115.45 179.46 3.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.877 1.322 . . . . 0.84 112.054 -170.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 3.9 p -145.28 95.47 2.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.156 -1.838 . . . . 1.77 106.978 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.97 -18.38 65.36 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.463 -0.495 . . . . 0.41 109.732 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.515 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 70.6 mmtt -80.95 -43.49 19.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.701 -0.682 . . . . 2.3 111.563 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 1.9 m -76.07 -15.49 60.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.387 0.613 . . . . 0.7 110.82 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 37.7 mmtm 66.49 46.0 1.98 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.845 -1.071 . . . . 1.36 110.373 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.35 -57.46 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.039 -0.982 . . . . 2.48 110.702 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.859 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.61 1.91 84.21 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.285 -0.959 . . . . 0.29 113.543 -172.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.1 -41.52 61.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.192 -0.67 . . . . 0.8 109.192 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 15.4 m-20 -67.65 -43.93 79.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.503 -0.771 . . . . 2.2 109.318 171.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.621 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 78.1 t60 -63.31 -23.12 67.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.932 -0.576 . . . . 0.58 111.516 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 165' ' ' ILE . 55.0 tp -68.49 -55.81 10.5 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.358 0.599 . . . . 1.16 109.784 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.149 -0.932 . . . . 1.51 110.775 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 65.1 mm-40 -66.48 -45.03 81.05 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.052 0.454 . . . . 2.57 110.398 172.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.501 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 12.7 mmt -67.61 -36.88 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.181 0.515 . . . . 0.64 110.203 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 83' ' ' ILE . 77.9 mt -66.8 -32.21 57.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 0.52 110.128 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -35.07 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 1.73 110.821 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.7 tp -57.03 -42.58 80.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.766 0.793 . . . . 1.51 109.26 171.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.227 -0.897 . . . . 0.89 110.331 175.642 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.971 -0.381 . . . . 0.64 109.971 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.846 HD11 HD23 ' A' ' 25' ' ' LEU . 17.1 pt -96.64 133.51 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.638 0.733 . . . . 1.3 111.446 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.675 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 62.9 mtt -134.96 -179.62 5.73 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.856 -1.065 . . . . 0.79 109.41 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.487 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 140.63 -164.86 26.27 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.517 -0.849 . . . . 0.31 111.776 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.752 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 12.6 t-80 -92.18 158.04 16.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.64 0.733 . . . . 0.22 111.204 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.6 p -70.98 147.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.915 -1.039 . . . . 0.36 109.872 174.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.2 t70 75.0 -26.86 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.456 0.646 . . . . 0.69 110.613 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.487 ' CE1' ' HB3' ' A' ' 90' ' ' ASP . 18.4 m170 -79.44 -13.71 59.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.3 -1.0 . . . . 0.63 108.3 170.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 116.97 76.35 0.59 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.357 -0.925 . . . . 0.79 114.97 171.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 15' ' ' GLY . 20.6 mmtp -77.32 -86.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.924 -0.71 . . . . 3.31 111.097 165.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 m -75.24 -16.14 60.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.829 0.347 . . . . 1.21 111.109 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.462 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -56.21 -35.03 66.85 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 111.863 0.32 . . . . 1.25 111.863 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 20' ' ' GLY . 4.5 mm? -74.06 -40.57 62.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.665 -0.494 . . . . 1.49 109.665 176.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -62.44 -13.11 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.821 -0.627 . . . . 1.69 110.022 176.625 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -102.18 -47.5 4.51 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.706 0.765 . . . . 1.23 109.706 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.08 73.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.28 -1.327 . . . . 0.63 111.398 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 99.2 mt . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.716 -0.675 . . . . 1.02 111.083 -177.105 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.4 mt . . . . . 0 C--O 1.234 0.28 0 N-CA-C 110.363 -0.236 . . . . 0.71 110.363 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.4 136.33 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.631 -0.828 . . . . 1.17 111.337 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.737 HG12 ' HB ' ' A' ' 111' ' ' ILE . 9.5 mt -96.71 135.88 29.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.068 -0.969 . . . . 0.37 109.612 170.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.487 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 1.8 tm? -119.8 107.8 13.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.975 -1.121 . . . . 1.01 107.975 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -93.17 113.53 28.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.795 -0.639 . . . . 0.43 110.681 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.894 HG21 HD11 ' A' ' 131' ' ' LEU . 2.8 m -121.3 136.88 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.524 -0.762 . . . . 0.64 110.713 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.74 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -75.87 134.64 40.26 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.903 -0.589 . . . . 0.28 110.105 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -74.87 -10.03 59.11 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.303 0.573 . . . . 0.22 110.035 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.68 -14.48 39.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.181 -0.918 . . . . 0.58 110.624 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 19' ' ' HIS . 2.4 t0 -131.95 -63.0 0.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.56 110.298 -176.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 115.72 -129.71 8.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.256 -0.497 . . . . 0.37 112.793 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.82 140.58 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.569 0.7 . . . . 1.03 109.621 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.562 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.6 mmm -139.94 176.33 2.62 Favored Pre-proline 0 C--N 1.311 -1.073 0 CA-C-N 114.743 -1.117 . . . . 0.28 108.549 -171.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 86.6 Cg_exo -48.72 -57.21 2.5 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.662 2.241 . . . . 0.58 114.205 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.752 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 1.9 pt20 -78.88 -11.48 60.0 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.11 -0.636 . . . . 0.75 111.002 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.87 -49.6 44.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.483 -0.781 . . . . 0.31 109.4 176.427 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.549 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.0 p -76.72 -27.74 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 115.454 -0.793 . . . . 1.38 113.128 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -66.97 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.31 -0.956 . . . . 2.35 109.549 177.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -77.18 -36.46 55.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.144 -0.935 . . . . 0.44 110.032 170.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 97' ' ' VAL . 97.9 mt -68.27 -42.81 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.518 0.675 . . . . 0.41 109.434 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.94 -42.01 68.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.685 -1.143 . . . . 0.67 110.523 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -66.36 -35.0 79.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.078 -0.51 . . . . 2.5 110.093 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 -46.73 22.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.127 -0.488 . . . . 0.47 111.775 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.8 mmmt -68.77 -39.58 80.16 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.96 0.409 . . . . 1.66 110.413 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.98 69.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.53 -0.759 . . . . 0.77 110.772 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.97 63.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.74 110.495 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.8 t30 76.64 73.53 0.08 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.264 1.03 . . . . 1.41 109.301 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -137.71 147.5 57.33 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 113.545 -1.661 . . . . 1.35 110.016 -170.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -52.59 135.24 55.38 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.554 2.169 . . . . 0.47 113.156 171.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.543 ' C ' HG23 ' A' ' 145' ' ' THR . 1.2 mt -110.72 162.61 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.697 -1.138 . . . . 0.6 110.385 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.737 ' HB ' HG12 ' A' ' 83' ' ' ILE . 27.3 mm -129.58 84.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 107.394 -1.336 . . . . 0.37 107.394 172.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.909 HG23 HG21 ' A' ' 145' ' ' THR . 48.7 t -74.16 146.34 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.725 0.774 . . . . 0.26 109.237 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.88 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -141.72 105.79 4.77 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.25 -1.341 . . . . 0.29 110.512 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.752 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.0 mp -80.06 124.84 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.464 -1.244 . . . . 0.59 109.081 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.74 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.9 p-10 -107.34 177.51 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.772 -1.196 . . . . 1.85 107.772 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 80.5 mttt 71.11 37.02 1.29 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 123.981 0.8 . . . . 0.59 111.427 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.488 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 29.2 mmt -78.14 -15.07 59.19 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.803 -1.184 . . . . 0.92 107.803 168.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.2 -19.79 60.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.635 -1.62 . . . . 0.76 109.942 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.475 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 24.0 mmmt -87.68 131.02 44.84 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-N 115.305 -0.861 . . . . 1.17 110.124 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.5 -11.58 26.67 Favored 'Trans proline' 0 N--CA 1.472 0.254 0 C-N-CA 122.71 2.273 . . . . 0.58 111.709 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.91 8.57 31.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.879 -1.055 . . . . 1.45 110.567 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.476 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -54.96 106.83 0.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.967 -1.015 . . . . 0.27 111.438 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -118.95 75.72 14.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.95 108.419 172.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.488 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 57.6 Cg_endo -68.92 -54.38 0.26 Allowed 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 123.002 2.468 . . . . 0.4 113.438 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 25.3 m-20 -58.11 -28.06 64.29 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.13 -0.941 . . . . 1.44 109.629 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.88 -58.92 3.04 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 119.889 -0.725 . . . . 3.79 109.115 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.685 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 21.6 m -61.8 -31.32 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.732 -1.122 . . . . 0.59 111.988 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . 1.07 ' HA ' HD12 ' A' ' 131' ' ' LEU . 19.9 ptm -79.25 -16.42 56.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.101 -0.24 . . . . 0.81 110.805 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.693 ' O ' ' HG3' ' A' ' 132' ' ' MET . 13.8 mt-30 -80.14 -39.26 29.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.732 0.301 . . . . 1.31 110.831 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.46 -27.11 65.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.737 -0.838 . . . . 1.64 108.737 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' HA ' ' A' ' 128' ' ' MET . 77.5 mt -61.79 -45.19 94.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.506 -1.225 . . . . 1.36 110.022 174.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.828 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -76.19 -10.59 59.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.473 -0.491 . . . . 1.61 111.268 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -85.28 -15.6 42.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.366 -0.605 . . . . 1.67 109.366 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.45 17.37 14.74 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.925 -1.139 . . . . 1.08 107.925 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.6 t30 59.37 56.14 3.91 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 113.315 -1.766 . . . . 1.1 112.027 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.737 ' H ' ' HA ' ' A' ' 132' ' ' MET . 77.1 mt -121.53 96.1 4.94 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.787 -1.097 . . . . 1.36 109.03 169.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.912 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 32.9 t -105.02 113.97 64.2 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 120.032 -0.667 . . . . 0.43 111.049 -171.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.945 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 6.8 Cg_endo -56.45 157.8 17.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 123.326 2.684 . . . . 0.54 112.673 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.452 ' HB2' HD13 ' A' ' 146' ' ' ILE . 16.4 mm-40 -78.6 -13.52 59.79 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.256 -1.338 . . . . 3.08 109.974 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.945 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -68.04 -23.32 64.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 1.57 109.906 168.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.828 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 40.5 m0 -108.33 -14.9 14.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.858 0.361 . . . . 0.66 110.83 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.87 27.74 10.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.705 -0.759 . . . . 0.53 113.52 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.912 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.69 -108.36 0.72 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.238 -0.982 . . . . 0.6 111.621 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -163.28 61.1 0.18 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.575 1.179 . . . . 1.91 111.66 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.909 HG21 HG23 ' A' ' 112' ' ' VAL . 88.8 m -163.49 124.11 2.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.637 -1.165 . . . . 0.37 110.906 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.741 HG21 ' HB3' ' A' ' 164' ' ' MET . 23.3 mm -74.36 104.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 109.146 -0.687 . . . . 0.63 109.146 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.566 ' CG ' ' HB3' ' A' ' 138' ' ' PRO . 7.4 m-85 -87.67 117.82 26.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.321 -0.854 . . . . 0.5 110.401 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.3 m -101.37 144.17 30.51 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.46 -0.336 . . . . 0.68 110.501 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.5 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.8 mttt -116.77 89.47 3.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.167 -0.679 . . . . 1.44 109.167 175.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.88 HD21 ' HB1' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -117.99 176.22 5.31 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.671 1.224 . . . . 0.84 112.265 -171.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -129.72 102.46 6.35 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.916 -1.493 . . . . 1.77 107.283 164.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.73 64.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.923 -0.769 . . . . 0.41 108.923 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -64.38 -59.83 3.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.41 -1.268 . . . . 2.3 110.936 174.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.7 p -88.94 5.02 46.03 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 119.99 -0.684 . . . . 0.7 112.163 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.492 ' CD ' HD12 ' A' ' 158' ' ' LEU . 29.7 mmtp 64.37 46.85 3.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.555 -0.748 . . . . 1.36 111.834 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -104.93 -53.71 2.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.925 0.869 . . . . 2.48 110.983 -177.074 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.831 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.84 2.24 84.11 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.332 -0.937 . . . . 0.29 112.763 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.492 HD12 ' CD ' ' A' ' 155' ' ' LYS . 19.7 mt -76.32 -36.98 58.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.213 -0.662 . . . . 0.8 109.213 174.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.65 -40.84 80.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.621 -0.718 . . . . 2.2 109.371 171.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 74.2 t60 -72.81 -15.13 61.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.1 -0.5 . . . . 0.58 110.981 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER -77.2 -50.79 12.16 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.889 -0.411 . . . . 1.16 109.889 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 163' ' ' GLU . 4.5 pp -64.46 -29.76 70.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.789 -0.641 . . . . 1.51 111.281 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 11.2 pt-20 -71.8 -36.91 70.43 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.507 -0.477 . . . . 2.57 110.131 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.741 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.2 mmt -71.55 -38.27 71.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.201 0.524 . . . . 0.64 109.899 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 83' ' ' ILE . 78.9 mt -65.34 -46.76 89.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.782 -0.644 . . . . 0.52 111.007 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.501 ' CD2' ' HA ' ' A' ' 163' ' ' GLU . 1.6 pp -67.92 -29.79 68.96 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.832 -0.433 . . . . 1.73 109.832 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.76 -52.05 63.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.38 -0.827 . . . . 1.51 108.974 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.447 -0.606 0 CA-C-N 115.85 -0.613 . . . . 0.89 110.92 176.893 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 120.481 0.181 . . . . 0.64 111.11 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.549 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 43.3 mt -84.02 124.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.265 0.555 . . . . 1.3 110.535 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.474 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 66.6 mtt -127.93 174.0 9.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.393 -0.965 . . . . 0.79 108.393 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.18 -179.47 23.17 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.259 -0.972 . . . . 0.31 111.858 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.621 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 51.5 t60 -85.09 160.63 19.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.766 0.794 . . . . 0.22 111.372 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 7.5 p -74.61 152.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.604 -1.18 . . . . 0.36 109.892 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.1 t70 74.05 -21.14 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.243 0.544 . . . . 0.69 110.556 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.616 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.7 m170 -79.33 -16.31 56.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.634 -0.876 . . . . 0.63 108.634 171.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.486 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 118.19 60.38 0.28 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.363 -0.835 . . . . 0.79 114.136 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -63.78 -66.01 0.6 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.951 -0.7 . . . . 3.31 111.166 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -85.62 -33.91 21.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 1.21 111.029 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.486 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -60.94 -24.88 66.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.75 0.648 . . . . 1.25 112.75 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.539 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -71.72 -39.3 70.22 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.018 -0.273 . . . . 1.49 110.592 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD21 HD12 ' A' ' 13' ' ' ILE . 54.7 mt -71.33 -14.54 62.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.795 -0.446 . . . . 1.69 109.795 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.94 -42.2 11.33 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.081 0.944 . . . . 1.23 108.705 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.062 -1.426 . . . . 0.63 110.026 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 tt . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 115.087 -0.961 . . . . 1.02 110.984 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--O 1.233 0.226 0 N-CA-C 110.104 -0.332 . . . . 0.71 110.104 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -120.8 121.68 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 1.17 111.971 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 10.4 mt -82.97 137.79 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.878 -1.055 . . . . 0.37 109.321 170.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.633 HD12 HD21 ' A' ' 131' ' ' LEU . 2.5 tm? -123.67 105.24 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.355 -0.98 . . . . 1.01 108.355 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 89.3 t -87.73 109.77 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.637 -0.711 . . . . 0.43 110.967 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER -120.73 120.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.717 -0.674 . . . . 0.64 110.776 174.262 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -68.75 127.76 34.22 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.926 -0.768 . . . . 0.28 108.926 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.669 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -70.76 -11.59 61.04 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.924 0.392 . . . . 0.22 111.446 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -94.79 2.02 55.46 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.346 -0.542 . . . . 0.58 110.876 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.405 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.0 t0 -134.33 -52.21 0.82 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.352 -0.385 . . . . 0.56 110.977 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.616 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 97.31 -158.23 21.05 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 121.087 -0.577 . . . . 0.37 113.509 173.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.27 136.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.6 0.714 . . . . 1.03 109.646 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.738 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 73.6 mmm -136.96 177.92 1.96 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.097 -0.956 . . . . 0.28 108.808 -171.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.3 Cg_exo -40.74 -65.42 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.302 2.668 . . . . 0.58 114.814 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.469 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 7.2 pt20 -74.15 -16.88 60.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.38 0.61 . . . . 0.75 111.062 -174.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.621 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.74 -43.88 71.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 0.31 109.366 177.261 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 93' ' ' MET . 21.0 t -68.24 -39.32 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.401 -0.818 . . . . 1.38 111.276 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.46 -28.92 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 2.35 110.221 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -72.8 -42.19 64.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.819 -0.628 . . . . 0.44 111.032 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.44 -42.29 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.842 0.83 . . . . 0.41 109.596 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.513 ' ND2' HG12 ' A' ' 97' ' ' VAL . 25.0 m-20 -63.67 -28.2 69.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.273 -1.331 . . . . 0.67 110.851 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -82.17 -32.31 30.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.047 0.451 . . . . 2.5 109.879 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -67.38 -46.6 72.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.47 110.901 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.92 -33.71 72.52 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.664 0.745 . . . . 1.66 110.018 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.15 44.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.096 -1.411 . . . . 0.77 111.475 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -100.33 -39.15 8.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.649 -0.25 . . . . 0.74 111.362 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 88.5 75.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.726 1.21 . . . . 1.41 109.182 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.59 142.33 42.22 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.407 -1.27 . . . . 1.35 110.4 -173.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.57 142.48 77.88 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.628 2.219 . . . . 0.47 111.943 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 145' ' ' THR . 27.0 mm -108.48 155.38 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.64 0.733 . . . . 0.6 111.107 -172.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.075 HD13 ' HB ' ' A' ' 146' ' ' ILE . 15.7 mm -122.64 83.34 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.508 -1.293 . . . . 0.37 107.508 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.78 HG21 HD23 ' A' ' 131' ' ' LEU . 58.6 t -73.19 144.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.677 0.751 . . . . 0.26 109.307 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.818 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -141.16 101.57 4.05 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.099 -1.41 . . . . 0.29 110.013 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.969 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.4 mp -68.61 138.13 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.803 -1.544 . . . . 0.59 108.883 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 59.0 t30 -122.09 166.78 14.01 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 107.147 -1.427 . . . . 1.85 107.147 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.675 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 83.5 mttt 71.68 33.35 1.8 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 124.239 0.962 . . . . 0.59 111.515 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.597 ' CE ' ' HB3' ' A' ' 124' ' ' PRO . 9.0 mmt -74.49 -11.97 60.36 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.171 -0.922 . . . . 0.92 109.586 166.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.675 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 10.5 p-10 -70.52 -19.63 62.89 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.852 -1.067 . . . . 0.76 108.862 172.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.499 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 47.4 mtpt -95.21 131.73 29.37 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 114.769 -1.105 . . . . 1.17 110.47 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -63.68 -15.41 48.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.946 2.431 . . . . 0.58 111.748 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -82.72 7.85 13.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 1.45 110.332 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.44 115.78 2.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.276 -0.875 . . . . 0.27 110.669 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -120.47 75.45 24.96 Favored Pre-proline 0 CA--C 1.509 -0.621 0 N-CA-C 107.1 -1.444 . . . . 0.95 107.1 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.597 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 27.0 Cg_endo -61.73 -63.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 123.077 2.518 . . . . 0.4 113.298 -169.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.598 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 5.9 m-20 -64.01 -15.35 59.16 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.55 -0.75 . . . . 1.44 110.713 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 1.3 tmt_? -74.04 -55.72 5.78 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.475 -0.935 . . . . 3.79 108.475 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.614 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 5.0 m -70.72 -25.46 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.05 -0.977 . . . . 0.59 110.36 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.598 ' HB3' ' HA ' ' A' ' 125' ' ' ASP . 9.2 ttt -66.4 -42.73 87.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.995 -1.457 . . . . 0.81 110.646 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' A' ' 132' ' ' MET . 75.5 mt-30 -71.94 -24.93 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 1.31 112.282 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.557 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.3 mt-10 -65.88 -33.45 75.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.737 0.78 . . . . 1.64 109.067 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 112' ' ' VAL . 5.2 mp -65.68 -37.54 86.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.016 -0.993 . . . . 1.36 110.043 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 10.0 ptm -74.88 -11.81 60.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.951 -0.7 . . . . 1.61 110.786 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 35.6 mm-40 -69.25 -35.06 75.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.068 -1.086 . . . . 1.67 108.068 170.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -91.11 23.29 3.32 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.452 -1.249 . . . . 1.08 109.769 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 54.92 49.91 16.71 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.316 -1.311 . . . . 1.1 111.927 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.588 ' H ' ' HA ' ' A' ' 132' ' ' MET . 46.5 mt -110.15 110.54 21.44 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.502 -0.772 . . . . 1.36 109.398 170.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 138' ' ' PRO . 71.0 t -109.12 114.25 58.2 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.662 0.744 . . . . 0.43 112.064 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -44.18 153.04 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 125.057 3.838 . . . . 0.54 113.314 174.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.679 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -76.11 -19.86 58.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.947 -1.478 . . . . 3.08 109.726 178.038 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -72.19 -22.19 61.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.588 -0.733 . . . . 1.57 110.665 171.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.441 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 34.1 m0 -102.62 -12.13 17.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.071 0.462 . . . . 0.66 110.571 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.38 21.89 9.56 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.555 -0.831 . . . . 0.53 114.232 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.96 -123.04 4.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.631 -1.271 . . . . 0.6 111.28 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -157.82 64.01 0.47 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-O 124.097 1.903 . . . . 1.91 111.326 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.635 HG23 ' HB ' ' A' ' 110' ' ' ILE . 97.0 m -148.36 112.23 5.12 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.044 -1.889 . . . . 0.37 108.609 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 1.075 ' HB ' HD13 ' A' ' 111' ' ' ILE . 51.9 mm -73.56 97.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.539 0.685 . . . . 0.63 109.412 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.58 ' CE2' ' HG3' ' A' ' 128' ' ' MET . 14.8 m-85 -81.46 119.67 24.02 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.612 -1.176 . . . . 0.5 110.588 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 78.2 m -113.83 112.07 22.78 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.135 -0.484 . . . . 0.68 110.459 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.969 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 9.3 ptpt -89.51 91.43 8.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.227 0.537 . . . . 1.44 109.9 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.879 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 2.8 pp -122.37 -169.99 2.0 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.556 1.169 . . . . 0.84 112.412 -169.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.468 ' HB2' ' N ' ' A' ' 117' ' ' MET . 26.1 t -154.69 122.81 5.93 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.553 -1.658 . . . . 1.77 107.061 172.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.406 ' CB ' HD11 ' A' ' 158' ' ' LEU . . . -79.64 -8.12 59.0 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.512 0.672 . . . . 0.41 109.641 175.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -83.25 -46.49 12.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.125 -0.943 . . . . 2.3 111.165 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.8 OUTLIER -85.24 -8.01 58.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.164 -0.615 . . . . 0.7 111.285 175.147 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.543 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.7 mmtp 62.85 43.31 7.07 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.2 -0.909 . . . . 1.36 111.49 174.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -102.9 -71.84 0.71 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.649 1.214 . . . . 2.48 110.554 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.879 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -65.49 -11.03 51.81 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.932 -1.485 . . . . 0.29 113.209 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 19.4 mt -69.21 -39.05 78.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.41 0.605 . . . . 0.8 109.584 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 68.1 m-20 -63.0 -46.32 88.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.96 -0.756 . . . . 2.2 108.96 174.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -66.25 -27.89 68.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.49 -0.777 . . . . 0.58 111.151 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.7 tp -65.7 -55.73 15.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 1.16 110.279 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.2 mt -57.71 -44.16 85.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 1.51 109.909 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 35.1 mm-40 -59.66 -44.44 93.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.574 -0.739 . . . . 2.57 111.398 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.477 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -73.62 -39.74 64.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.011 0.434 . . . . 0.64 110.494 -177.432 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.55 HD11 HD11 ' A' ' 83' ' ' ILE . 51.9 mt -62.99 -44.69 99.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.807 -0.633 . . . . 0.52 110.596 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -37.64 88.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.942 -0.572 . . . . 1.73 111.076 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.4 tp -51.48 -49.06 62.56 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.376 0.608 . . . . 1.51 109.468 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.078 -0.965 . . . . 0.89 110.883 177.397 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 110.335 -0.246 . . . . 0.64 110.335 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.799 HG13 HD21 ' A' ' 25' ' ' LEU . 37.2 mm -93.85 120.07 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.899 0.38 . . . . 1.3 110.503 177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 64.0 mtt -139.12 176.23 8.88 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.629 -0.508 . . . . 0.79 109.629 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 141.06 -163.38 26.67 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.948 -0.861 . . . . 0.31 110.948 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 48.7 t60 -94.19 157.66 15.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.047 0.927 . . . . 0.22 111.444 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 19' ' ' HIS . 4.6 p -74.9 149.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.348 -1.296 . . . . 0.36 110.528 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 73.18 -21.2 0.26 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.69 110.187 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 17' ' ' VAL . 19.5 m170 -74.0 -20.15 60.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.434 -0.951 . . . . 0.63 108.434 168.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.455 ' O ' HD13 ' A' ' 24' ' ' LEU . . . 109.97 63.34 0.52 Allowed Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.388 -0.823 . . . . 0.79 114.044 172.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.92 -57.45 4.57 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.971 -0.692 . . . . 3.31 111.378 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -86.4 -28.73 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.275 0.472 . . . . 1.21 112.275 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -29.49 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.668 0.618 . . . . 1.25 112.668 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 20' ' ' GLY . 9.7 mp -69.2 -40.09 78.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.395 -0.19 . . . . 1.49 110.706 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.799 HD21 HG13 ' A' ' 13' ' ' ILE . 19.8 mt -69.61 -11.5 60.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.379 0.609 . . . . 1.69 109.919 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.07 -43.1 7.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.064 0.935 . . . . 1.23 109.001 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -50.55 15.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.01 -1.45 . . . . 0.63 111.311 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 1.02 111.699 -174.163 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.696 HG21 HG12 ' A' ' 111' ' ' ILE . 5.9 mt . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.538 0.208 . . . . 0.71 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.503 HG11 ' HE1' ' A' ' 102' ' ' HIS . 4.2 p -123.51 133.81 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.532 0.682 . . . . 1.17 109.952 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 165' ' ' ILE . 15.5 mt -90.61 134.55 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.014 -0.994 . . . . 0.37 109.775 175.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.512 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.1 tm? -116.49 104.92 11.92 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.151 -1.055 . . . . 1.01 108.151 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.6 t -85.83 112.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.744 -0.662 . . . . 0.43 111.192 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.8 m -123.37 118.29 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 115.741 -0.663 . . . . 0.64 110.751 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.99 130.85 43.3 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.224 -0.658 . . . . 0.28 109.224 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.865 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -74.18 -6.95 50.79 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.045 0.45 . . . . 0.22 111.497 -170.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.46 -10.01 45.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.879 -0.6 . . . . 0.58 110.87 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.436 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -128.83 -51.95 1.23 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.56 111.571 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.744 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 100.61 -133.86 11.47 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.523 -0.846 . . . . 0.37 113.749 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.44 134.25 37.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.541 0.686 . . . . 1.03 110.48 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.973 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 78.0 mmm -138.88 -178.77 0.9 Allowed Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 114.695 -1.139 . . . . 0.28 109.133 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.973 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 3.5 Cg_endo -46.93 -68.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.246 2.631 . . . . 0.58 114.652 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -70.29 -16.5 63.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.23 0.538 . . . . 0.75 111.005 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.45 -49.13 67.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.643 -0.708 . . . . 0.31 109.495 177.14 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.561 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.1 p -77.39 -24.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.845 -0.616 . . . . 1.38 112.438 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.44 -35.8 76.7 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.666 -0.646 . . . . 2.35 109.492 172.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -25.82 62.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 0.44 110.612 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 97' ' ' VAL . 92.2 mt -75.25 -45.12 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.192 -0.67 . . . . 0.41 109.192 174.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.23 -49.53 60.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.119 -0.946 . . . . 0.67 110.458 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.503 ' HE1' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -45.19 -57.01 4.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 2.5 110.732 171.306 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.616 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -68.96 -47.89 64.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.302 -1.317 . . . . 0.47 113.047 -170.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 13.7 mmmm -72.14 -35.65 69.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.951 0.405 . . . . 1.66 110.641 -173.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.54 75.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.396 -0.82 . . . . 0.77 110.992 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -91.91 -25.33 18.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.208 -0.451 . . . . 0.74 112.097 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 44.4 m-20 80.56 42.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.92 0.867 . . . . 1.41 109.777 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.3 t -96.91 141.99 23.87 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.106 -1.406 . . . . 1.35 111.47 -176.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 21.7 Cg_exo -66.14 142.5 67.79 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.909 2.406 . . . . 0.47 112.905 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.616 HD11 ' CB ' ' A' ' 103' ' ' ALA . 11.5 mm -108.93 158.95 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.804 0.811 . . . . 0.6 111.276 -175.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.808 HD13 ' HB ' ' A' ' 146' ' ' ILE . 23.8 mm -125.76 85.02 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.983 -1.488 . . . . 0.37 106.983 166.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.029 HG23 HG21 ' A' ' 145' ' ' THR . 57.4 t -71.48 143.34 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 121.711 0.767 . . . . 0.26 109.175 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.786 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.76 103.64 4.55 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.47 -1.241 . . . . 0.29 110.538 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.001 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.3 mp -70.45 132.81 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-N 113.588 -1.642 . . . . 0.59 108.631 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 61.1 t30 -120.87 169.63 10.26 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.384 -1.339 . . . . 1.85 107.384 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.742 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 88.2 mttt 71.96 34.06 1.55 Allowed 'General case' 0 N--CA 1.424 -1.74 0 O-C-N 124.086 0.866 . . . . 0.59 110.91 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.73 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 10.6 mmt -74.53 -10.09 59.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 115.14 -0.936 . . . . 0.92 109.2 167.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.595 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 5.1 p-10 -72.96 -21.1 60.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.548 -1.206 . . . . 0.76 110.104 172.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.574 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 27.9 mtpp -91.26 135.02 28.74 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 1.17 110.273 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.34 -15.43 49.88 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.713 2.275 . . . . 0.58 111.058 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -78.5 2.07 20.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.643 -1.162 . . . . 1.45 110.486 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.413 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -56.19 108.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.223 -0.899 . . . . 0.27 110.774 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -116.7 76.14 7.45 Favored Pre-proline 0 CA--C 1.51 -0.591 0 N-CA-C 107.03 -1.471 . . . . 0.95 107.03 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.73 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 37.7 Cg_endo -63.92 -66.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.303 0 C-N-CA 122.981 2.454 . . . . 0.4 113.234 -167.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.667 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 1.6 m-20 -64.45 -8.96 15.41 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.723 -0.671 . . . . 1.44 111.216 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -81.83 -53.94 5.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.845 -0.742 . . . . 3.79 109.434 174.686 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.865 HG21 ' HA ' ' A' ' 88' ' ' ALA . 18.5 m -68.88 -25.71 30.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.337 -0.847 . . . . 0.59 109.795 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . 1.086 ' HA ' HD12 ' A' ' 131' ' ' LEU . 8.6 ttt -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.246 -1.343 . . . . 0.81 110.242 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 132' ' ' MET . 15.3 mt-30 -72.38 -37.74 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.674 -0.694 . . . . 1.31 111.205 173.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.7 mm-40 -60.32 -30.75 69.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.253 1.025 . . . . 1.64 109.149 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.086 HD12 ' HA ' ' A' ' 128' ' ' MET . 62.7 mt -63.74 -43.47 96.37 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.781 -1.554 . . . . 1.36 109.884 177.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.619 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 7.5 ptm -75.36 -14.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.229 -0.589 . . . . 1.61 110.9 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 17.4 mm-40 -71.61 -27.4 63.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.563 -0.902 . . . . 1.67 108.563 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -99.1 22.21 10.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.56 -1.2 . . . . 1.08 108.686 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 54.93 57.46 5.61 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 113.73 -1.577 . . . . 1.1 111.807 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.619 ' H ' ' HA ' ' A' ' 132' ' ' MET . 47.9 mt -119.38 111.73 18.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.847 -1.069 . . . . 1.36 109.0 167.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.478 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.7 t -118.66 117.44 34.18 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-O 121.369 0.604 . . . . 0.43 111.26 -170.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.517 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 36.9 Cg_exo -56.09 175.47 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 124.11 3.207 . . . . 0.54 113.757 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 1.035 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -78.96 -31.81 45.14 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.011 -1.904 . . . . 3.08 109.477 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.872 ' HB2' ' HD1' ' A' ' 141' ' ' TRP . 6.7 mm-40 -58.28 -34.74 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.496 -0.775 . . . . 1.57 109.621 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.872 ' HD1' ' HB2' ' A' ' 140' ' ' GLU . 13.2 m0 -97.44 -7.69 31.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.749 -1.114 . . . . 0.66 110.926 -166.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.93 33.07 11.4 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.926 -0.654 . . . . 0.53 113.264 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.5 -125.05 5.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.174 -1.012 . . . . 0.6 111.685 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.62 62.18 0.53 Allowed 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.769 1.271 . . . . 1.91 111.448 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . 1.029 HG21 HG23 ' A' ' 112' ' ' VAL . 73.8 m -160.5 128.96 4.69 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.194 -1.367 . . . . 0.37 110.238 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 1.035 HD13 ' HG2' ' A' ' 139' ' ' GLU . 38.0 mm -76.98 106.34 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.765 -0.828 . . . . 0.63 108.765 172.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.634 ' HE2' ' CD1' ' A' ' 131' ' ' LEU . 8.3 m-85 -90.78 110.01 21.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.568 -0.742 . . . . 0.5 110.947 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 97.4 m -105.01 111.8 24.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.3 -0.409 . . . . 0.68 111.08 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 1.001 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 ptpt -88.4 91.28 8.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.339 0.59 . . . . 1.44 109.624 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.863 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -119.47 -173.31 2.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.6 1.191 . . . . 0.84 111.913 -170.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 4.8 p -153.1 101.0 2.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.692 -1.595 . . . . 1.77 107.25 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.86 62.42 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.752 -0.779 . . . . 0.41 109.358 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -75.79 -44.75 39.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.148 -0.933 . . . . 2.3 111.679 175.494 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.764 ' HB ' ' HG3' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -78.59 -17.37 56.19 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.166 -0.613 . . . . 0.7 111.657 176.08 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.2 mmtp 68.7 46.6 0.92 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.393 -0.822 . . . . 1.36 110.832 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.764 ' HG3' ' HB ' ' A' ' 154' ' ' THR . 18.1 mt-10 -108.51 -68.78 0.89 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.566 1.174 . . . . 2.48 110.547 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.863 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.17 -10.53 52.56 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.813 -1.539 . . . . 0.29 113.454 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.577 HD12 ' HD3' ' A' ' 155' ' ' LYS . 37.3 mt -69.45 -42.52 74.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 117.308 0.554 . . . . 0.8 109.827 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.37 -42.81 92.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 2.2 109.564 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' A' ' 164' ' ' MET . 84.5 t60 -67.66 -22.19 65.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.892 -0.595 . . . . 0.58 111.272 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -71.83 -52.55 16.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.133 0.492 . . . . 1.16 109.86 -176.229 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.48 -24.61 66.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.664 . . . . 1.51 111.004 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 163' ' ' GLU . 15.0 mm-40 -72.2 -40.14 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.886 0.374 . . . . 2.57 110.457 175.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.72 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.3 mmt -66.49 -41.37 89.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.64 110.085 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 83' ' ' ILE . 60.6 mt -61.29 -45.35 98.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.52 110.422 175.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -41.01 95.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.067 -0.515 . . . . 1.73 111.079 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 167' ' ' LEU . 1.6 tm? -51.21 -38.7 53.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.62 0.724 . . . . 1.51 109.234 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 0.89 110.802 177.757 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.518 ' HB ' HG22 ' A' ' 82' ' ' VAL . 22.2 m . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 110.401 -0.222 . . . . 0.64 110.401 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -97.72 138.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.215 0.531 . . . . 1.3 110.238 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.628 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 59.1 mtt -145.99 173.28 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 0.79 109.869 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.68 -174.97 22.77 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.756 -0.735 . . . . 0.31 112.362 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.655 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 13.1 t-80 -86.85 161.67 18.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.715 0.769 . . . . 0.22 111.717 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.0 p -73.08 148.88 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.764 -1.107 . . . . 0.36 109.447 173.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 33.4 t70 73.6 -25.35 0.19 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.547 0.689 . . . . 0.69 109.951 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.586 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 16.5 m170 -86.99 -4.64 59.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.386 -0.824 . . . . 0.63 109.372 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.833 ' O ' ' HG2' ' A' ' 21' ' ' LYS . . . -143.23 -53.29 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 118.466 -1.186 . . . . 0.79 113.014 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.858 ' HG3' ' HB ' ' A' ' 23' ' ' THR . 15.4 pttt 60.44 138.47 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.073 0.94 . . . . 3.31 112.048 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -62.2 -15.41 46.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.148 0.975 . . . . 1.21 108.433 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.858 ' HB ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 m -67.42 -21.36 65.57 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 1.25 111.511 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.673 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.8 tt -68.95 -32.06 71.39 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.111 -0.993 . . . . 1.49 108.447 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.571 ' O ' HG22 ' A' ' 28' ' ' ILE . 2.6 tp -68.22 -29.08 67.83 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 1.69 110.087 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.45 -38.48 26.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.267 1.032 . . . . 1.23 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HB1' ' CE ' ' A' ' 155' ' ' LYS . . . -67.37 -34.45 77.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.536 -1.665 . . . . 0.63 110.038 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 25' ' ' LEU . 4.5 tt . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 114.99 -1.005 . . . . 1.02 110.343 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 C--O 1.236 0.388 0 N-CA-C 110.419 -0.215 . . . . 0.71 110.419 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.518 HG22 ' HB ' ' A' ' 12' ' ' THR . 23.1 t -122.79 127.19 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.172 0.511 . . . . 1.17 110.998 173.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 24.3 mt -86.57 132.08 33.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.331 -0.849 . . . . 0.37 110.087 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.548 HD12 HD21 ' A' ' 131' ' ' LEU . 2.0 tm? -121.48 110.56 16.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.254 -1.017 . . . . 1.01 108.254 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 33.5 t -96.42 114.52 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.159 -0.473 . . . . 0.43 110.801 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 114' ' ' ILE . 3.4 m -119.66 142.16 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.64 111.063 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.708 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -80.73 131.02 35.4 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.793 -0.447 . . . . 0.28 109.793 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.694 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -74.97 -12.96 60.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.116 -0.633 . . . . 0.22 109.906 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.564 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -91.1 -10.36 42.26 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.17 -0.923 . . . . 0.58 111.519 -177.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.586 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 7.0 t70 -134.9 -38.22 0.8 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.755 0.312 . . . . 0.56 111.348 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.458 ' HA2' ' CG1' ' A' ' 127' ' ' VAL . . . 91.03 -133.16 11.65 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 114.157 0.423 . . . . 0.37 114.157 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.532 HG11 ' HE2' ' A' ' 134' ' ' TYR . 12.8 t -100.34 131.46 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.911 0.862 . . . . 1.03 110.551 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.523 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -131.03 173.62 5.66 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 114.017 -1.447 . . . . 0.28 108.086 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 73.1 Cg_exo -49.71 -57.07 2.55 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.325 2.017 . . . . 0.58 113.282 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.655 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -72.34 -13.97 61.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.917 0.389 . . . . 0.75 111.415 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -69.76 -52.86 21.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.609 0.719 . . . . 0.31 109.647 177.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 100' ' ' ILE . 2.0 p -83.13 -23.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 113.761 1.023 . . . . 1.38 113.761 -173.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -63.96 -25.17 68.02 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.111 -0.993 . . . . 2.35 109.428 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.628 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -74.57 -39.86 62.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.439 -0.8 . . . . 0.44 110.228 171.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.538 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 93.8 mt -62.98 -49.06 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.582 0.706 . . . . 0.41 109.754 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -55.43 -33.33 63.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.496 -1.229 . . . . 0.67 110.817 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -67.48 -43.68 80.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.696 -0.684 . . . . 2.5 110.375 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.425 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -73.97 -44.58 54.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 0.47 111.578 -177.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.67 ' HD3' HD21 ' A' ' 136' ' ' LEU . 13.5 mmmm -66.18 -32.78 74.43 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.123 0.487 . . . . 1.66 110.064 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.56 -41.75 70.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.926 -1.033 . . . . 0.77 110.83 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.39 44.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 0.74 111.305 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 84.39 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.412 1.07 . . . . 1.41 109.064 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.21 140.79 21.62 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 113.906 -1.497 . . . . 1.35 110.251 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.15 142.81 93.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.643 2.229 . . . . 0.47 111.96 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.498 ' C ' HG23 ' A' ' 145' ' ' THR . 23.0 mm -105.51 156.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.764 0.793 . . . . 0.6 110.735 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.875 HD13 ' HB ' ' A' ' 146' ' ' ILE . 14.2 mm -124.89 86.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 107.102 -1.444 . . . . 0.37 107.102 171.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.901 HG23 HG21 ' A' ' 145' ' ' THR . 59.9 t -75.16 145.83 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 121.779 0.799 . . . . 0.26 109.953 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB1' ' CD2' ' A' ' 150' ' ' LEU . . . -144.07 102.27 3.85 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.067 -1.424 . . . . 0.29 109.932 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.792 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.4 mp -72.18 140.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.148 -1.387 . . . . 0.59 109.636 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.708 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 4.4 p-10 -117.57 176.64 5.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.693 -1.225 . . . . 1.85 107.693 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.63 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 83.9 mttt 69.58 34.28 2.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.892 0.745 . . . . 0.59 111.633 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.437 ' CE ' ' HB1' ' A' ' 122' ' ' ALA . 17.5 mmt -77.78 -13.56 59.85 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.486 -0.931 . . . . 0.92 108.486 169.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.547 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -70.66 -25.94 63.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.861 -1.518 . . . . 0.76 109.519 173.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 43.5 mtpt -89.07 137.85 29.35 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.36 -0.836 . . . . 1.17 110.247 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.41 -13.94 42.39 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.839 2.36 . . . . 0.58 111.659 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 33.0 mt-10 -81.75 6.66 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.161 -0.927 . . . . 1.45 110.539 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.437 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -58.0 107.68 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.565 -0.743 . . . . 0.27 110.975 175.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -120.84 76.66 29.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.48 -0.934 . . . . 0.95 108.48 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.478 ' HA ' HG22 ' A' ' 127' ' ' VAL . 47.4 Cg_endo -66.6 -54.77 0.41 Allowed 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.74 2.293 . . . . 0.4 113.125 -172.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.433 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.1 m-20 -52.26 -26.45 11.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 1.44 110.78 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.602 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 53.7 ttt180 -79.7 -57.15 3.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.07 -0.652 . . . . 3.79 109.403 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.694 HG11 ' HA ' ' A' ' 88' ' ' ALA . 15.7 m -63.76 -24.52 36.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.406 -0.816 . . . . 0.59 112.128 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.492 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 17.2 ptm -84.74 -17.37 38.56 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.037 0.446 . . . . 0.81 109.929 174.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.8 mt-30 -76.31 -40.74 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 1.31 110.511 170.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 1.9 mm-40 -58.6 -35.49 72.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.124 0.964 . . . . 1.64 108.978 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.694 HD23 HG21 ' A' ' 112' ' ' VAL . 2.0 mp -64.52 -42.89 95.5 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.542 -1.208 . . . . 1.36 110.352 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.727 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.7 ppp? -75.58 -8.75 57.57 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.506 -0.478 . . . . 1.61 110.685 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 8.0 mm-40 -71.97 -36.68 69.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.872 -1.158 . . . . 1.67 107.872 172.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.532 ' HE2' HG11 ' A' ' 92' ' ' VAL . 23.4 m-85 -91.42 28.56 1.66 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.655 -1.157 . . . . 1.08 110.012 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.74 53.14 13.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.742 -1.572 . . . . 1.1 112.342 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.67 HD21 ' HD3' ' A' ' 104' ' ' LYS . 66.2 mt -113.94 99.03 7.36 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.338 -0.847 . . . . 1.36 108.84 168.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.947 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 35.5 t -100.76 115.42 65.36 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-O 121.565 0.698 . . . . 0.43 111.788 -168.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.692 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 87.4 Cg_exo -43.97 138.69 6.24 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 124.168 3.245 . . . . 0.54 112.072 171.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.979 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.4 OUTLIER -73.65 -14.93 61.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.199 -0.91 . . . . 3.08 109.963 178.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.1 pm0 -66.07 -26.14 67.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.488 -0.778 . . . . 1.57 110.135 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.727 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 34.5 m0 -101.63 -14.91 17.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.97 0.414 . . . . 0.66 110.465 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.07 24.55 7.56 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.804 -0.712 . . . . 0.53 113.584 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.947 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.07 -120.27 2.07 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.9 -1.143 . . . . 0.6 112.094 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -157.63 63.38 0.47 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.824 1.297 . . . . 1.91 112.268 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.901 HG21 HG23 ' A' ' 112' ' ' VAL . 56.6 m -160.19 126.13 4.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.195 -1.366 . . . . 0.37 109.992 173.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.979 HD13 ' HG2' ' A' ' 139' ' ' GLU . 30.7 mm -74.47 104.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.539 -0.911 . . . . 0.63 108.539 172.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.692 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.8 m-85 -90.75 105.08 17.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.119 -0.946 . . . . 0.5 111.381 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.85 139.75 30.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.306 -0.861 . . . . 0.68 109.786 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.555 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 mptt -114.93 102.67 10.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.18 -0.674 . . . . 1.44 109.18 176.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.792 ' HG ' ' O ' ' A' ' 114' ' ' ILE . 3.6 pp -125.61 -174.02 2.97 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.389 1.09 . . . . 0.84 111.805 -172.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 150' ' ' LEU . 1.5 p -152.16 92.31 1.7 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.1 -1.409 . . . . 1.77 108.465 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -16.06 63.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.13 0.49 . . . . 0.41 109.867 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -55.99 13.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.32 -0.855 . . . . 2.3 110.847 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -84.79 -9.03 58.57 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.95 -0.7 . . . . 0.7 112.387 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HD3' HD12 ' A' ' 158' ' ' LEU . 19.2 mmtp 71.53 42.79 0.64 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.669 0.606 . . . . 1.36 110.966 175.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 -70.72 0.76 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 122.344 1.068 . . . . 2.48 110.318 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.759 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.38 -4.82 46.41 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.269 -1.332 . . . . 0.29 113.967 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.584 HD12 ' HD3' ' A' ' 155' ' ' LYS . 22.5 mt -70.26 -36.74 74.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.155 -0.683 . . . . 0.8 109.155 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -38.89 79.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.144 -0.935 . . . . 2.2 109.035 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.2 t60 -71.48 -14.74 62.23 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.534 -0.757 . . . . 0.58 111.437 177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.89 -55.75 5.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.335 -0.617 . . . . 1.16 109.335 -177.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.92 -26.71 68.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.508 -0.769 . . . . 1.51 111.383 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 15.7 pt-20 -76.41 -30.73 57.56 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.403 -0.519 . . . . 2.57 110.79 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 29.6 mmt -73.23 -39.13 65.74 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.315 0.578 . . . . 0.64 109.507 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 83' ' ' ILE . 83.3 mt -61.83 -42.41 94.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 0.52 109.531 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -37.64 86.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.567 -0.742 . . . . 1.73 111.185 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.3 tp -53.37 -45.08 69.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.533 0.682 . . . . 1.51 109.353 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.8 t . . . . . 0 N--CA 1.445 -0.697 0 CA-C-N 114.939 -1.028 . . . . 0.89 110.646 175.667 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 112.029 -0.428 . . . . 11.58 112.029 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m -81.65 64.19 6.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.295 0.569 . . . . 10.61 111.092 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -126.77 27.84 5.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.973 0.892 . . . . 10.14 109.001 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.8 ptp -154.42 136.7 14.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.503 -1.226 . . . . 8.77 109.513 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.55 -23.17 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.93 0.395 . . . . 5.74 110.784 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -92.29 119.42 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.429 -0.582 . . . . 5.7 109.429 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -118.13 91.94 41.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 111.865 0.32 . . . . 6.85 111.865 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 1.9 Cg_endo -85.37 108.96 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.806 2.338 . . . . 2.8 110.735 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 8' ' ' PRO . 18.0 Cg_endo -60.93 128.31 25.06 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.491 2.128 . . . . 2.76 111.82 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.7 m -86.98 79.92 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.699 0.762 . . . . 2.0 110.718 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 47.9 t -72.99 84.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.295 -0.866 . . . . 1.35 109.713 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 68' ' ' PHE . 22.9 m -62.2 127.09 29.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.6 -0.727 . . . . 0.64 110.512 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -92.56 129.93 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 108.763 -0.828 . . . . 1.3 108.763 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.532 ' CE ' ' HB3' ' A' ' 68' ' ' PHE . 44.9 mtm -143.82 -171.58 3.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.783 -0.644 . . . . 0.79 109.716 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.469 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 129.96 -158.57 22.36 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.617 -0.993 . . . . 0.31 110.617 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.72 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 13.4 t-80 -91.04 157.12 17.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.851 0.834 . . . . 0.22 111.189 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 6.4 p -73.5 154.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.366 -1.288 . . . . 0.36 109.9 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.588 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 20.3 t70 74.84 -18.94 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.295 0.569 . . . . 0.69 110.559 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.535 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 15.1 m170 -83.01 -4.86 58.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.515 -0.921 . . . . 0.63 108.515 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.7 ' HA3' HD13 ' A' ' 24' ' ' LEU . . . 111.01 47.34 0.77 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.391 -0.909 . . . . 0.79 114.062 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -50.61 -66.58 0.36 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.366 0.583 . . . . 3.31 111.691 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -94.15 -30.71 14.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.202 -0.454 . . . . 1.21 111.233 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.0 -27.46 63.52 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.724 0.639 . . . . 1.25 112.724 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.7 HD13 ' HA3' ' A' ' 20' ' ' GLY . 5.5 mp -78.61 -25.31 45.15 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.95 -0.3 . . . . 1.49 110.956 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.64 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -74.9 -17.1 60.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.936 -0.764 . . . . 1.69 108.936 175.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.08 -45.71 8.53 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.052 0.929 . . . . 1.23 108.805 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 24' ' ' LEU . . . -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.719 -1.582 . . . . 0.63 110.475 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 tt -72.09 -30.96 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.91 -1.041 . . . . 1.02 110.974 -177.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 29' ' ' ARG . 45.8 mtp180 -77.98 -38.85 44.15 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.655 0.741 . . . . 3.04 109.396 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.02 26.81 1.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.137 0.97 . . . . 2.65 110.826 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.6 t -114.32 -35.7 4.89 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.563 -1.653 . . . . 1.46 109.031 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? 176.05 -158.76 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 115.777 -0.647 . . . . 3.92 110.225 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.683 HG13 ' H ' ' A' ' 34' ' ' THR . 7.7 p 49.9 -80.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.401 1.481 . . . . 3.1 114.078 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.683 ' H ' HG13 ' A' ' 33' ' ' VAL . 22.7 p -105.35 129.2 53.73 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.552 0.575 . . . . 2.78 112.552 -171.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 1.4 pt-20 -123.2 -49.86 1.93 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.633 -0.712 . . . . 6.34 110.405 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.541 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 11.0 pt20 -109.9 -7.67 14.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.714 -0.675 . . . . 6.79 110.088 -177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -66.08 131.06 45.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.462 -0.79 . . . . 6.24 110.475 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.21 72.85 9.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.57 -0.741 . . . . 4.95 110.784 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.04 159.37 29.94 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.133 -0.939 . . . . 4.68 111.097 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.36 -72.37 2.76 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.502 -0.856 . . . . 4.55 112.298 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 25' ' ' LEU . 47.1 mm -126.11 100.54 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.776 0.322 . . . . 5.57 110.311 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.6 m -156.96 -83.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.11 -0.495 . . . . 5.93 110.065 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 178.49 -58.94 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.595 -0.52 . . . . 6.63 109.595 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -68.89 109.85 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.55 . . . . 6.54 109.626 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.7 mm 68.88 154.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.167 -0.924 . . . . 5.17 110.532 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.13 150.18 17.56 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.385 -0.686 . . . . 2.51 111.385 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HA ' HD11 ' A' ' 25' ' ' LEU . . . 64.88 -172.56 0.18 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.274 0.229 . . . . 1.36 110.987 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.454 ' CZ ' HG22 ' A' ' 50' ' ' VAL . 1.9 p90 -174.2 174.74 2.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.164 0.507 . . . . 1.7 110.904 -174.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.512 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 78.0 mt-30 -95.57 111.74 23.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.287 -0.869 . . . . 1.91 109.715 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.613 HG13 HG11 ' A' ' 33' ' ' VAL . 3.8 t -82.17 140.9 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.311 0.577 . . . . 1.53 111.145 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.516 ' HA ' ' H ' ' A' ' 55' ' ' LYS . 23.2 m -93.39 84.26 4.71 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.772 -0.649 . . . . 1.51 110.744 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.648 HG23 HD13 ' A' ' 162' ' ' LEU . 14.5 p -99.76 -28.43 3.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 122.531 1.158 . . . . 2.27 107.991 171.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 56' ' ' LYS . 1.9 p30 -125.72 -59.94 1.33 Allowed 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 113.124 -1.853 . . . . 3.68 109.082 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 11.3 p-10 -171.27 43.04 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.459 -1.246 . . . . 2.99 110.139 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 54.6 mtmt 74.01 17.27 3.46 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.171 -0.922 . . . . 7.36 111.695 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.419 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . 88.2 tttt -86.56 76.36 9.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.469 0.652 . . . . 4.46 109.72 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.574 HG21 HG21 ' A' ' 165' ' ' ILE . 0.9 OUTLIER 175.61 93.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 C-N-CA 125.474 1.51 . . . . 0.92 108.95 171.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.512 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 8.0 m -90.85 95.93 10.38 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.158 -0.682 . . . . 0.96 109.158 177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.517 ' HE1' HD12 ' A' ' 57' ' ' ILE . 10.4 m-85 -59.23 150.49 25.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.698 -0.683 . . . . 1.57 111.297 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.426 ' CA ' ' HA ' ' A' ' 12' ' ' THR . 28.6 tp 72.11 -91.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.136 -0.938 . . . . 3.21 111.006 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' OD2' ' HG ' ' A' ' 60' ' ' LEU . 3.8 p30 -170.45 165.82 8.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.21 0.529 . . . . 5.61 111.058 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.2 t -129.52 136.0 28.43 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.251 -0.886 . . . . 5.45 108.63 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.34 106.41 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.035 2.49 . . . . 6.11 112.617 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.57 -22.76 7.28 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.755 -0.736 . . . . 6.36 112.118 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.5 63.23 1.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.049 0.452 . . . . 8.78 110.559 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -88.8 125.57 34.96 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.169 -0.678 . . . . 7.05 109.169 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.43 -65.0 1.08 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.24 0.543 . . . . 4.55 111.647 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.612 ' CE2' ' HB ' ' A' ' 82' ' ' VAL . 93.3 m-85 -99.53 -12.42 20.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.216 -0.447 . . . . 2.37 111.932 -175.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.7 m -74.52 -52.14 12.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.312 0.577 . . . . 4.9 110.076 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.1 m -156.01 140.11 16.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.999 -0.741 . . . . 5.84 108.999 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.443 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 61.3 mtt -105.77 97.49 7.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.899 0.381 . . . . 5.21 110.693 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -62.86 -56.99 12.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.814 -0.63 . . . . 8.21 110.602 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.38 13.25 11.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.445 -0.343 . . . . 6.36 110.797 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 74' ' ' ARG . 28.4 ttm180 70.17 -56.09 0.59 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.631 -0.713 . . . . 9.65 111.749 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.86 55.34 4.23 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.51 -0.376 . . . . 4.93 113.6 -174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.78 -1.31 43.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.627 0.727 . . . . 5.47 109.425 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.38 128.5 35.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.557 -1.202 . . . . 6.26 110.766 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.37 -48.95 5.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.132 0.491 . . . . 4.31 109.992 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.04 39.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.494 -0.928 . . . . 3.41 108.494 175.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.23 166.04 20.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.694 -1.139 . . . . 2.66 111.087 -171.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 50.2 mt -129.82 149.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.756 -0.656 . . . . 0.71 109.592 -173.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.612 ' HB ' ' CE2' ' A' ' 68' ' ' PHE . 9.5 p -116.87 136.47 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 119.957 -0.697 . . . . 1.17 110.618 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 13.0 mt -96.64 128.8 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.501 -0.772 . . . . 0.37 109.98 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 84' ' ' LEU . 2.2 tm? -114.54 109.77 18.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.956 -1.127 . . . . 1.01 107.956 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.07 118.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.333 -0.394 . . . . 0.43 111.051 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.7 m -128.24 120.62 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.698 -0.683 . . . . 0.64 110.3 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -64.73 131.81 47.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.719 -0.673 . . . . 0.28 110.262 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -67.65 -18.09 64.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.084 0.469 . . . . 0.22 110.751 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -90.13 -14.65 33.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.392 -0.822 . . . . 0.58 111.316 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.481 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.5 t0 -123.63 -47.48 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.56 110.75 -170.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.616 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.82 -151.14 27.3 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.37 113.098 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.653 HG11 ' HE2' ' A' ' 134' ' ' TYR . 21.5 t -77.96 129.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.828 0.823 . . . . 1.03 111.025 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.936 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.2 mmm -130.94 179.89 1.23 Allowed Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 114.265 -1.334 . . . . 0.28 108.615 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.936 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.11 -66.01 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.284 2.656 . . . . 0.58 114.564 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.72 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 4.5 pt20 -73.23 -15.27 61.44 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.287 0.565 . . . . 0.75 110.94 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.0 -43.83 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 0.31 109.007 176.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.57 HG12 ' ND2' ' A' ' 101' ' ' ASN . 30.1 t -66.15 -42.59 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.255 -0.884 . . . . 1.38 111.302 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.28 -29.01 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.239 -0.437 . . . . 2.35 110.098 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.538 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.609 HG23 HD11 ' A' ' 136' ' ' LEU . 96.5 mt -75.4 -44.89 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.796 0.808 . . . . 0.41 109.147 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.57 ' ND2' HG12 ' A' ' 97' ' ' VAL . 53.0 m-20 -57.1 -37.42 71.92 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.041 -1.436 . . . . 0.67 110.944 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.42 ' NE2' ' HA ' ' A' ' 68' ' ' PHE . 5.7 t60 -71.5 -37.91 71.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.274 0.559 . . . . 2.5 109.795 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -44.31 68.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.785 -0.643 . . . . 0.47 111.824 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.64 ' HD3' HD21 ' A' ' 136' ' ' LEU . 1.8 mmmp? -76.42 -28.9 56.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.051 0.453 . . . . 1.66 110.482 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.12 -44.56 61.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.174 -0.921 . . . . 0.77 110.268 173.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.14 -34.99 22.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.992 -0.549 . . . . 0.74 110.436 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.3 t30 83.87 40.82 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.843 1.257 . . . . 1.41 109.36 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.51 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 24.5 t -83.8 145.29 46.77 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 113.279 -1.782 . . . . 1.35 110.99 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 108' ' ' VAL . 21.8 Cg_exo -61.93 138.68 75.14 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.257 1.972 . . . . 0.47 111.436 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.0 OUTLIER -107.68 159.07 7.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 122.011 0.91 . . . . 0.6 112.226 -172.073 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.856 HD13 ' HB ' ' A' ' 146' ' ' ILE . 5.9 mm -126.02 87.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.538 -1.664 . . . . 0.37 106.858 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.473 HG23 HG21 ' A' ' 145' ' ' THR . 61.5 t -78.1 148.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.603 -0.726 . . . . 0.26 109.971 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 148' ' ' CYS . . . -140.12 110.19 6.51 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.569 -1.196 . . . . 0.29 110.679 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.762 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.2 mp -84.86 108.31 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.148 -1.387 . . . . 0.59 109.636 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.4 p-10 -99.45 178.02 5.0 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.626 -1.25 . . . . 1.85 107.626 -171.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.847 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 74.9 mttt 70.75 28.44 3.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.034 0.834 . . . . 0.59 110.123 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 85.5 mmm -81.54 -7.27 59.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.351 -0.981 . . . . 0.92 108.351 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.411 ' N ' ' HB3' ' A' ' 151' ' ' SER . 1.2 p-10 -68.41 -30.44 69.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.521 -1.672 . . . . 0.76 109.634 168.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -71.79 131.73 85.66 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.78 -0.645 . . . . 1.17 110.089 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.27 -15.09 47.67 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.391 2.061 . . . . 0.58 111.388 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -90.24 5.71 45.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.377 -0.829 . . . . 1.45 110.592 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.452 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -54.77 124.41 16.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.731 -0.668 . . . . 0.27 111.271 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -125.31 76.07 68.45 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.337 -0.986 . . . . 0.95 108.337 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.75 ' HA ' HG21 ' A' ' 114' ' ' ILE . 39.4 Cg_endo -64.17 -62.03 0.1 Allowed 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.025 2.483 . . . . 0.4 113.305 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 6.9 m-20 -61.63 -16.15 45.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.257 -0.883 . . . . 1.44 111.019 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -75.42 -58.39 3.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.598 0.713 . . . . 3.79 109.307 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.616 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 12.7 m -66.03 -29.48 46.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 0.59 110.194 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.537 ' HG3' ' CD2' ' A' ' 147' ' ' PHE . 15.4 ttt -59.99 -39.59 86.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 0.81 110.793 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.597 ' O ' ' HG2' ' A' ' 132' ' ' MET . 45.0 mt-30 -69.14 -29.67 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 1.31 111.933 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.609 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 9.0 mt-10 -67.05 -29.07 68.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.587 . . . . 1.64 109.533 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.561 HD12 ' CD1' ' A' ' 136' ' ' LEU . 4.0 mm? -64.73 -44.5 89.99 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.641 -0.708 . . . . 1.36 110.071 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.597 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 14.7 ptm -70.57 -10.2 58.7 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.813 -0.755 . . . . 1.61 110.83 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 35.4 mt-10 -78.73 -28.3 44.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.05 -0.722 . . . . 1.67 109.05 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.653 ' HE2' HG11 ' A' ' 92' ' ' VAL . 71.3 m-85 -92.73 22.79 4.5 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.836 0.826 . . . . 1.08 109.659 167.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.0 t30 61.33 46.23 7.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 113.855 -1.52 . . . . 1.1 111.749 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.64 HD21 ' HD3' ' A' ' 104' ' ' LYS . 72.9 mt -113.67 93.6 4.46 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.36 109.732 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.036 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 44.5 t -102.74 122.87 44.43 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.199 -0.909 . . . . 0.43 110.635 -172.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.761 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 10.6 Cg_endo -60.0 157.52 33.67 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.211 2.608 . . . . 0.54 112.902 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.466 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.8 mm-40 -79.72 -12.1 59.81 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.127 -1.397 . . . . 3.08 110.574 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.761 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -69.89 -19.63 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.899 -0.591 . . . . 1.57 109.888 167.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.521 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 45.1 m0 -110.6 -20.43 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.338 -0.392 . . . . 0.66 111.306 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.72 28.75 5.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.839 -0.696 . . . . 0.53 113.417 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 1.036 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.2 -106.8 1.95 Allowed Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.58 -0.819 . . . . 0.6 112.689 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -166.0 61.21 0.1 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 122.284 1.04 . . . . 1.91 110.419 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 98.8 m -164.06 133.93 4.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 0.37 110.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.856 ' HB ' HD13 ' A' ' 111' ' ' ILE . 28.0 mm -97.16 110.1 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 109.495 -0.557 . . . . 0.63 109.495 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.672 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 12.1 m-85 -90.05 150.51 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.5 110.295 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 91.1 m -131.25 127.0 36.92 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.663 -1.153 . . . . 0.68 109.747 171.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.1 88.13 5.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.056 -0.72 . . . . 1.44 109.056 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.077 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -115.98 170.12 8.73 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.685 1.231 . . . . 0.84 112.768 -170.534 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.411 ' HB3' ' N ' ' A' ' 118' ' ' ASP . 3.1 p -129.94 104.78 7.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.961 -1.126 . . . . 1.77 107.961 172.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.41 -9.9 59.05 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.377 -0.529 . . . . 0.41 109.762 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.817 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 3.2 mtmt -82.54 -46.39 13.44 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.128 -0.629 . . . . 2.3 112.119 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 p -86.39 -3.39 58.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 119.188 -1.005 . . . . 0.7 111.363 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 25.8 mmtp 64.89 45.59 3.18 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.287 -0.87 . . . . 1.36 110.705 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.51 -58.34 1.97 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.65 -1.159 . . . . 2.48 110.062 -175.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 1.077 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -79.76 -10.65 85.5 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.296 -0.865 . . . . 0.29 113.847 -173.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.6 -36.8 83.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.857 0.829 . . . . 0.8 109.043 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 1.6 m-20 -69.84 -42.12 74.01 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.695 -1.139 . . . . 2.2 110.182 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.83 -21.26 64.31 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.499 -0.319 . . . . 0.58 111.154 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -74.13 -51.15 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.659 -0.496 . . . . 1.16 109.659 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.648 HD13 HG23 ' A' ' 52' ' ' VAL . 4.2 pp -60.79 -27.51 68.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.795 -0.639 . . . . 1.51 110.711 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.608 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 42.0 mt-10 -64.63 -48.04 76.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.4 -0.364 . . . . 2.57 110.812 174.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -63.8 -35.63 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.32 -0.4 . . . . 0.64 110.27 176.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.574 HG21 HG21 ' A' ' 57' ' ' ILE . 73.4 mt -62.01 -48.57 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.52 110.829 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 163' ' ' GLU . 4.5 pp -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 121.007 -0.277 . . . . 1.73 110.965 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 166' ' ' LEU . 4.8 tt -54.38 -50.53 67.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.927 -0.768 . . . . 1.51 108.927 172.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.62 ' HA ' ' HG2' ' A' ' 171' ' ' MET . 65.1 t -65.38 -40.17 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.883 -0.599 . . . . 0.89 110.777 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m -60.64 -32.21 71.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.831 0.348 . . . . 1.35 111.445 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -80.16 -37.98 32.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.966 0.413 . . . . 2.73 110.871 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.969 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 21.0 ptt? -84.35 -7.93 59.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 1.88 111.004 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -35.63 -39.84 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.943 1.297 . . . . 4.27 114.127 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.89 -72.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.258 0.466 . . . . 3.91 112.258 -173.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.35 -19.58 3.09 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.714 -0.394 . . . . 5.72 111.928 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.969 ' HB2' ' HB2' ' A' ' 171' ' ' MET . 25.7 mmtp -70.17 126.45 29.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.657 0.741 . . . . 5.49 112.352 -171.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -161.01 -49.12 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.489 -1.232 . . . . 5.78 107.917 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.521 ' H ' ' HD2' ' A' ' 178' ' ' PRO . 5.7 m-20 -93.02 -55.33 0.24 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.041 -0.982 . . . . 7.88 110.43 171.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 177' ' ' ASN . 40.5 Cg_endo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.03 1.82 . . . . 9.19 111.845 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.847 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.761 -0.536 . . . . 11.58 111.761 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -70.97 121.08 17.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.991 0.424 . . . . 10.61 111.687 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -132.59 145.43 51.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.49 . . . . 10.14 110.151 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 97.5 mmm -88.26 117.85 27.46 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.469 -0.567 . . . . 8.77 109.469 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.7 t 70.48 91.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.229 0 O-C-N 123.784 0.677 . . . . 5.74 111.301 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 50.9 mt-10 -70.75 117.13 11.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.134 -0.691 . . . . 5.7 109.134 170.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 28.6 tpt180 -89.25 111.3 44.45 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.937 -0.394 . . . . 6.85 109.937 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 56.4 Cg_endo -99.79 90.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.527 2.818 . . . . 2.8 112.289 177.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.55 123.35 10.08 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.079 1.853 . . . . 2.76 111.839 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 m -77.67 70.61 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.546 0.689 . . . . 2.0 110.725 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 83.7 t -62.8 95.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.218 -0.901 . . . . 1.35 110.826 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.743 ' HB ' HG23 ' A' ' 82' ' ' VAL . 7.5 m -76.01 145.76 40.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.701 -0.681 . . . . 0.64 110.488 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.467 HD13 ' HB ' ' A' ' 83' ' ' ILE . 46.0 mm -105.06 113.61 42.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 1.3 109.978 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.587 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 67.3 mtt -127.18 172.81 10.23 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.944 -0.571 . . . . 0.79 109.877 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 148.57 -172.95 28.68 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.666 -0.778 . . . . 0.31 112.136 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.792 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 12.8 t-80 -88.88 159.66 17.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.856 0.836 . . . . 0.22 111.106 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.566 ' HA ' ' O2B' ' A' ' 179' ' ' GDP . 7.7 p -69.85 143.98 14.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.656 -1.157 . . . . 0.36 110.258 174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.591 ' HA ' " C4'" ' A' ' 179' ' ' GDP . 30.6 t70 75.93 -18.24 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.384 0.612 . . . . 0.69 110.36 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.468 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 17.0 m170 -85.05 -10.73 56.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.278 -1.008 . . . . 0.63 108.278 170.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.87 48.46 1.08 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.191 -0.913 . . . . 0.79 113.369 174.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -60.83 -53.33 58.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.108 0.454 . . . . 3.31 110.909 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.5 m -98.85 -34.72 10.37 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.374 0.607 . . . . 1.21 110.442 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.589 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.66 -21.01 24.44 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.114 0.783 . . . . 1.25 113.114 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -75.64 -34.37 60.53 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.294 -1.002 . . . . 1.49 108.294 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.618 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 7.0 tp -67.26 -23.79 65.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.322 -0.854 . . . . 1.69 109.785 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -92.54 -39.4 11.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.776 0.798 . . . . 1.23 109.681 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.29 80.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.56 -1.2 . . . . 0.63 109.738 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.3 tt -71.58 -22.27 21.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.849 -1.069 . . . . 1.02 110.394 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 73.5 mtt180 -73.0 -19.75 61.15 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 121.492 0.663 . . . . 3.04 109.862 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -107.01 23.95 13.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.671 -0.695 . . . . 2.65 111.231 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.518 ' OG ' ' HD2' ' A' ' 32' ' ' LYS . 99.2 p -104.67 -35.89 7.65 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.653 -1.158 . . . . 1.46 109.332 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HD2' ' OG ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -175.39 -168.15 0.3 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.573 -0.74 . . . . 3.92 109.96 176.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 34' ' ' THR . 10.4 p 55.84 -66.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.517 1.527 . . . . 3.1 113.549 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 33' ' ' VAL . 3.1 t -107.21 169.0 8.83 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.874 0.369 . . . . 2.78 110.549 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.12 -44.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.887 -0.597 . . . . 6.34 109.959 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -123.03 -46.98 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.61 -0.723 . . . . 6.79 110.277 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -81.6 135.01 35.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.66 -0.7 . . . . 6.24 110.772 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.88 89.88 5.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.142 0.496 . . . . 4.95 110.635 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.59 53.68 4.88 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.735 -0.666 . . . . 4.68 112.384 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.95 47.97 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.974 -0.631 . . . . 4.55 111.803 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 tp -127.63 108.2 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.858 0.837 . . . . 5.57 110.551 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 43' ' ' GLN . 1.1 m -154.36 -154.6 0.52 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.298 -1.001 . . . . 5.93 108.298 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.628 ' H ' HG22 ' A' ' 42' ' ' THR . 50.8 tp60 -76.29 66.8 2.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.781 0.801 . . . . 6.63 110.316 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.417 ' CD2' ' HB ' ' A' ' 42' ' ' THR . 32.4 p80 -170.84 162.68 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.217 -0.901 . . . . 6.54 109.894 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.1 tt -61.95 159.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 5.17 110.297 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.02 24.35 0.84 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 115.813 -0.631 . . . . 2.51 114.462 -171.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -83.05 153.16 25.05 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.442 -0.577 . . . . 1.36 109.442 174.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.24 178.88 7.83 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 119.686 -0.806 . . . . 1.7 112.373 -163.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.494 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 54.3 mt-30 -106.9 113.61 27.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.262 -0.881 . . . . 1.91 110.014 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.65 150.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.32 0.581 . . . . 1.53 111.433 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 m -97.43 81.63 3.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.56 0.695 . . . . 1.51 109.456 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -86.32 -32.63 6.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.972 -1.013 . . . . 2.27 108.383 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -140.8 -46.43 0.4 Allowed 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 113.601 -1.636 . . . . 3.68 108.762 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -178.04 77.49 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.124 -0.944 . . . . 2.99 110.536 177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 55' ' ' LYS . 22.9 mtpp 57.65 35.81 26.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.135 -0.484 . . . . 7.36 111.526 175.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -102.93 153.9 19.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.593 -0.521 . . . . 4.46 109.593 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mt 72.48 89.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.629 0.728 . . . . 0.92 110.725 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.494 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 20.2 m -90.73 101.87 14.62 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.177 -0.919 . . . . 0.96 109.694 176.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.61 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 82.0 m-85 -72.21 106.45 4.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 1.57 110.22 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.3 tp 71.27 124.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 O-C-N 124.321 1.013 . . . . 3.21 110.76 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -95.02 159.47 15.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.272 0.558 . . . . 5.61 110.548 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.531 ' HB ' ' HD3' ' A' ' 63' ' ' PRO . 87.8 m -75.8 -46.71 4.0 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.392 -0.822 . . . . 5.45 112.728 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.531 ' HD3' ' HB ' ' A' ' 62' ' ' THR . 50.4 Cg_exo -55.38 -20.0 24.27 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.267 1.978 . . . . 6.11 112.711 176.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 69' ' ' THR . . . -72.2 76.16 0.76 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 116.515 -0.311 . . . . 6.36 113.106 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -83.29 53.86 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.024 -0.732 . . . . 8.78 109.024 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.571 ' HG3' ' H ' ' A' ' 67' ' ' ALA . 11.0 tp10 -173.93 -170.98 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.196 -1.409 . . . . 7.05 107.196 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.571 ' H ' ' HG3' ' A' ' 66' ' ' GLU . . . -57.29 -57.43 12.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.325 0.512 . . . . 4.55 110.318 174.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.481 ' HB2' ' CD2' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -97.02 -172.89 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.093 -0.503 . . . . 2.37 109.736 172.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.59 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 6.4 m -55.57 149.12 14.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.544 -0.539 . . . . 4.9 109.544 170.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.52 -50.13 17.59 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 111.598 0.222 . . . . 5.84 111.598 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.7 ttm 56.48 67.09 1.04 Allowed 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.541 0.526 . . . . 5.21 110.865 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -68.54 -46.97 68.1 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.984 -0.553 . . . . 8.21 110.382 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.45 -47.45 0.76 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.889 0.376 . . . . 6.36 111.399 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -147.55 130.34 16.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.844 -0.616 . . . . 9.65 109.83 -175.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.45 -72.48 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.962 -1.113 . . . . 4.93 113.834 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.447 ' HB1' ' CG ' ' A' ' 80' ' ' ASP . . . -144.22 153.55 42.19 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.702 0.26 . . . . 5.47 111.702 -170.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -178.98 -53.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.438 0.461 . . . . 6.26 111.999 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.732 HG13 ' H ' ' A' ' 79' ' ' THR . 3.3 p -56.83 -72.07 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 113.375 0.88 . . . . 4.31 113.375 -166.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.732 ' H ' HG13 ' A' ' 78' ' ' VAL . 66.5 p -114.77 19.19 16.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.784 0.802 . . . . 3.41 109.983 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.447 ' CG ' ' HB1' ' A' ' 76' ' ' ALA . 6.8 m-20 -83.35 95.41 8.2 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.886 -1.052 . . . . 2.66 108.92 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 55.4 mt -90.43 148.54 4.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.257 -0.883 . . . . 0.71 111.899 -168.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.743 HG23 ' HB ' ' A' ' 12' ' ' THR . 9.2 p -117.06 140.36 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.457 0.646 . . . . 1.17 110.392 173.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 165' ' ' ILE . 18.8 mt -95.25 131.11 42.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.201 -0.909 . . . . 0.37 109.904 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.444 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 1.9 tm? -117.53 107.88 14.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.204 -1.036 . . . . 1.01 108.204 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.454 HG21 ' HG ' ' A' ' 24' ' ' LEU . 57.4 t -89.81 116.48 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.993 -0.549 . . . . 0.43 111.23 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 3.7 m -122.38 137.26 56.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 0.64 110.793 175.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.687 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -75.43 133.95 41.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.939 -0.573 . . . . 0.28 110.011 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -76.81 -14.88 59.87 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 120.303 -0.559 . . . . 0.22 110.129 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -10.61 53.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.561 -0.745 . . . . 0.58 110.894 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.405 ' HB3' ' CE1' ' A' ' 19' ' ' HIS . 24.3 t0 -128.03 -69.33 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.56 110.284 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.6 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 121.19 -139.8 13.54 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.14 -0.553 . . . . 0.37 113.183 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.5 p -95.67 139.72 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.432 0.634 . . . . 1.03 109.43 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.635 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 72.2 mmm -140.14 178.05 1.76 Allowed Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.419 -0.81 . . . . 0.28 108.815 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.635 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 82.9 Cg_exo -46.32 -64.69 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.885 2.39 . . . . 0.58 114.521 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.792 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 4.5 pt20 -70.56 -16.56 62.88 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.555 -0.715 . . . . 0.75 110.787 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.637 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.65 -49.7 51.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.747 -0.661 . . . . 0.31 109.603 178.152 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.612 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.7 p -74.74 -29.06 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.934 -0.575 . . . . 1.38 112.457 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -57.47 -30.18 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 2.35 109.946 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.587 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -71.14 -40.95 71.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.458 -0.792 . . . . 0.44 110.491 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 97' ' ' VAL . 76.9 mt -66.74 -44.31 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.821 0.819 . . . . 0.41 109.641 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -56.63 -42.21 78.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.67 110.842 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.481 ' CD2' ' HB2' ' A' ' 68' ' ' PHE . 5.0 t60 -71.23 -35.02 71.33 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.77 -0.455 . . . . 2.5 109.77 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.45 -52.56 38.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 0.47 111.533 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 29.7 mtpt -75.62 -22.78 56.55 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.675 -0.41 . . . . 1.66 110.908 -176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.21 72.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.551 -0.749 . . . . 0.77 110.539 171.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.57 -21.37 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.74 111.101 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.0 t30 82.32 61.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.282 0.989 . . . . 1.41 109.195 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 t -117.7 139.69 26.66 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 114.348 -1.296 . . . . 1.35 111.579 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -69.26 143.05 51.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.993 2.462 . . . . 0.47 111.362 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.505 ' C ' HG23 ' A' ' 145' ' ' THR . 1.3 mt -113.89 160.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 122.04 0.924 . . . . 0.6 112.375 -171.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.771 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 26.4 mm -129.94 86.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.816 -1.538 . . . . 0.37 106.89 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.789 HG23 HG21 ' A' ' 145' ' ' THR . 48.4 t -72.5 147.73 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.595 0.712 . . . . 0.26 109.159 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.94 105.48 4.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.646 -1.161 . . . . 0.29 110.48 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.811 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -73.99 134.08 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 114.163 -1.38 . . . . 0.59 108.97 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.687 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.7 p-10 -113.42 177.24 4.7 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.358 -1.349 . . . . 1.85 107.358 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.819 ' HD3' ' HE2' ' A' ' 119' ' ' LYS . 89.8 mttt 70.77 32.66 2.43 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 123.701 0.626 . . . . 0.59 111.907 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.544 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 10.8 mmt -79.89 -10.89 59.83 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.896 -1.15 . . . . 0.92 107.896 166.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 0.7 OUTLIER -70.47 -20.17 62.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.181 -1.827 . . . . 0.76 109.711 169.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.819 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 23.6 mtmt -100.15 134.57 20.75 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-N 115.606 -0.725 . . . . 1.17 110.407 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -64.03 -14.63 44.59 Favored 'Trans proline' 0 N--CA 1.47 0.122 0 C-N-CA 123.074 2.516 . . . . 0.58 111.907 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -81.67 6.52 14.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.417 -0.81 . . . . 1.45 110.42 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.406 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -58.08 115.4 2.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.17 -0.923 . . . . 0.27 111.231 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -122.4 76.72 44.41 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.04 -1.096 . . . . 0.95 108.04 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.544 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 43.6 Cg_endo -66.13 -60.25 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.949 2.432 . . . . 0.4 113.176 -170.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.497 ' HA ' ' HG2' ' A' ' 128' ' ' MET . 1.5 m-20 -55.87 -21.34 19.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.315 -0.857 . . . . 1.44 110.91 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -78.07 -56.83 4.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.475 0.655 . . . . 3.79 109.663 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 88' ' ' ALA . 22.6 m -66.66 -24.88 33.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.874 -1.057 . . . . 0.59 111.675 -176.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.75 ' HA ' ' HB2' ' A' ' 131' ' ' LEU . 18.8 ptm -87.86 -13.88 40.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.914 -0.315 . . . . 0.81 110.549 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.0 mt-30 -75.87 -47.9 23.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.685 0.279 . . . . 1.31 110.423 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.18 -18.3 64.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.445 0.641 . . . . 1.64 109.572 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.904 HD23 ' HE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -65.62 -43.36 89.78 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.084 -0.962 . . . . 1.36 109.012 172.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.857 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.8 ppp? -80.52 -7.5 59.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.965 -0.561 . . . . 1.61 110.55 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 45.8 mt-10 -78.59 -24.15 45.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.764 -0.828 . . . . 1.67 108.764 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.407 ' HD1' ' N ' ' A' ' 134' ' ' TYR . 1.8 m-85 -91.58 18.82 6.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.645 -1.161 . . . . 1.08 108.478 169.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 56.69 56.94 5.1 Favored 'General case' 0 CA--C 1.526 0.048 0 CA-C-N 113.716 -1.583 . . . . 1.1 111.463 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.777 ' H ' ' HA ' ' A' ' 132' ' ' MET . 70.8 mt -123.02 105.58 10.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.825 -1.08 . . . . 1.36 109.365 170.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.805 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.4 t -108.17 114.11 59.95 Favored Pre-proline 0 C--N 1.31 -1.132 0 C-N-CA 119.89 -0.724 . . . . 0.43 111.125 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.996 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 1.2 Cg_endo -54.45 160.59 6.68 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.587 2.858 . . . . 0.54 112.97 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.566 ' HB2' HD13 ' A' ' 146' ' ' ILE . 20.6 mm-40 -78.16 -17.29 57.03 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.02 -1.445 . . . . 3.08 109.697 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.996 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 2.0 pm0 -69.35 -24.48 63.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.118 -0.946 . . . . 1.57 110.256 169.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.857 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 30.7 m0 -105.99 -10.1 16.74 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.916 0.388 . . . . 0.66 110.274 -177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.16 33.83 10.34 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.896 -0.593 . . . . 0.53 113.455 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.805 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -91.31 -108.8 1.53 Allowed Glycine 0 CA--C 1.509 -0.317 0 C-N-CA 120.086 -1.054 . . . . 0.6 111.418 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -163.82 61.4 0.16 Allowed 'General case' 0 C--O 1.248 1.015 0 CA-C-O 123.497 1.618 . . . . 1.91 110.457 170.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.789 HG21 HG23 ' A' ' 112' ' ' VAL . 58.1 m -162.67 114.97 1.62 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.745 -1.571 . . . . 0.37 110.224 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.771 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 12.7 mm -68.12 106.16 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.032 -0.729 . . . . 0.63 109.032 172.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.904 ' HE2' HD23 ' A' ' 131' ' ' LEU . 7.9 m-85 -87.99 107.6 18.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.717 -0.674 . . . . 0.5 110.08 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.29 112.13 24.08 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.246 -0.434 . . . . 0.68 110.526 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.811 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 81.9 mttt -83.96 96.34 8.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.699 -0.852 . . . . 1.44 108.699 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.797 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.8 pp -122.33 -173.38 2.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.614 1.197 . . . . 0.84 111.974 -173.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 0.7 OUTLIER -154.0 93.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.498 -1.683 . . . . 1.77 107.626 -176.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.14 60.76 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.645 -0.422 . . . . 0.41 110.429 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 40.9 mttm -78.48 -48.17 15.89 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.311 -0.556 . . . . 2.3 111.541 172.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 p -84.75 -7.11 59.33 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.669 -0.812 . . . . 0.7 111.516 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.426 ' CD ' HD12 ' A' ' 158' ' ' LEU . 39.0 mmtm 66.79 42.54 2.58 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.396 -0.82 . . . . 1.36 111.548 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -102.31 -67.42 0.87 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.346 1.07 . . . . 2.48 109.911 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.797 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -70.06 -8.31 61.27 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.015 -1.448 . . . . 0.29 113.757 -174.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.426 HD12 ' CD ' ' A' ' 155' ' ' LYS . 26.6 mt -69.17 -37.96 78.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.98 0.89 . . . . 0.8 109.578 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.613 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 25.0 t70 -72.65 -39.31 67.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.657 -0.701 . . . . 2.2 109.596 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.47 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 86.6 t60 -69.28 -20.34 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.24 -0.436 . . . . 0.58 110.884 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.463 HD21 HD13 ' A' ' 83' ' ' ILE . 53.2 tp -67.18 -53.71 27.9 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.322 -0.621 . . . . 1.16 109.322 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.73 -26.97 67.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.043 -0.98 . . . . 1.51 110.72 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 49.8 mt-10 -58.74 -47.51 84.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.259 0.552 . . . . 2.57 110.202 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.651 ' HB3' HG21 ' A' ' 146' ' ' ILE . 19.5 mmt -71.9 -34.43 69.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.846 -0.616 . . . . 0.64 110.32 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 83' ' ' ILE . 84.5 mt -65.24 -46.13 91.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 0.52 110.995 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.627 ' HA ' ' OG ' ' A' ' 169' ' ' SER . 4.3 pp -67.47 -33.01 74.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.811 -0.356 . . . . 1.73 111.011 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 166' ' ' LEU . 2.3 tm? -52.99 -48.24 67.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.954 -0.758 . . . . 1.51 108.954 170.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.63 HG11 HD11 ' A' ' 81' ' ' ILE . 67.7 t -65.7 -45.6 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.581 -0.736 . . . . 0.89 111.256 177.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' A' ' 166' ' ' LEU . 64.8 p -63.39 -26.59 68.82 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.676 -0.41 . . . . 1.35 111.202 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -83.68 -25.26 30.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.517 0.675 . . . . 2.73 109.664 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.648 ' HG3' ' HB2' ' A' ' 175' ' ' LYS . 56.8 ttp -69.69 -34.94 74.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.461 -0.791 . . . . 1.88 110.043 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.67 -26.82 35.72 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.355 -0.384 . . . . 4.27 111.749 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HG2' ' HG ' ' A' ' 174' ' ' LEU . 3.4 tt0 -59.83 -77.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 3.91 111.758 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.483 ' HG ' ' HG2' ' A' ' 173' ' ' GLU . 92.4 mt -130.95 -10.07 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.571 -0.286 . . . . 5.72 111.361 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.648 ' HB2' ' HG3' ' A' ' 171' ' ' MET . 27.2 mmtm -85.48 -26.06 26.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 5.49 111.497 -170.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.411 ' HB2' ' HG2' ' A' ' 171' ' ' MET . . . -76.48 141.5 41.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.097 0.475 . . . . 5.78 112.006 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -116.63 104.19 51.68 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.5 -0.773 . . . . 7.88 109.057 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.962 2.441 . . . . 9.19 112.135 -177.128 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.715 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.406 -0.277 . . . . 11.58 112.406 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m 59.79 62.48 1.69 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.501 0.32 . . . . 10.61 110.876 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -77.42 51.76 0.9 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.526 0.679 . . . . 10.14 111.451 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.2 tpp -129.98 -56.26 1.12 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.283 -0.871 . . . . 8.77 109.147 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.91 97.69 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.692 -0.685 . . . . 5.74 110.009 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.01 133.31 51.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.146 -0.479 . . . . 5.7 110.935 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 58.38 80.73 0.27 Allowed Pre-proline 0 C--O 1.235 0.33 0 O-C-N 123.922 0.764 . . . . 6.85 111.124 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HB2' HG12 ' A' ' 10' ' ' VAL . 14.3 Cg_exo -69.0 117.86 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.615 2.21 . . . . 2.8 111.803 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.75 60.23 6.61 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.713 2.275 . . . . 2.76 111.665 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG11 ' CE1' ' A' ' 65' ' ' HIS . 6.7 p -128.19 137.12 58.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.586 . . . . 2.0 110.702 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 74.4 t -137.97 104.09 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.969 -0.56 . . . . 1.35 110.327 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.815 ' HB ' HG22 ' A' ' 82' ' ' VAL . 3.0 m -61.93 140.66 58.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.336 . . . . 0.64 110.499 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -112.89 138.14 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.177 0.513 . . . . 1.3 110.592 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.503 ' CE ' ' HB3' ' A' ' 68' ' ' PHE . 63.0 mtt -147.05 173.04 12.83 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.561 -0.745 . . . . 0.79 109.28 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 84' ' ' LEU . . . 150.1 -175.99 28.94 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.711 -0.757 . . . . 0.31 112.108 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.586 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 49.5 t60 -86.6 162.15 18.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.997 0.903 . . . . 0.22 111.563 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.52 150.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.275 -1.329 . . . . 0.36 110.172 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.721 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 21.3 t70 74.44 -14.98 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.476 0.655 . . . . 0.69 109.902 -175.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.542 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 13.6 m170 -87.57 9.0 22.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.95 -1.13 . . . . 0.63 107.95 168.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.497 ' HA2' ' O2A' ' A' ' 179' ' ' GDP . . . 76.05 54.4 5.28 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 114.801 -1.09 . . . . 0.79 113.899 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 7.82 7.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.035 0.917 . . . . 3.31 111.453 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.5 m -129.64 -50.64 1.16 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.974 -0.557 . . . . 1.21 110.011 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -57.52 -24.75 57.8 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.077 -0.51 . . . . 1.25 111.315 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.3 mp -70.43 -35.34 73.32 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 111.98 0.363 . . . . 1.49 111.98 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.959 ' HB2' ' HE2' ' A' ' 48' ' ' TYR . 2.5 pp -74.61 -17.74 60.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.61 -0.836 . . . . 1.69 109.909 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 29.5 t70 -85.55 -42.93 13.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.144 0.973 . . . . 1.23 109.217 174.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -64.52 -38.29 90.5 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.7 -1.591 . . . . 0.63 110.588 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 6.9 tt -73.33 -31.4 33.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.151 -0.931 . . . . 1.02 111.139 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 19.6 ptt180 -81.72 -31.04 32.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.8 0.81 . . . . 3.04 109.986 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -96.0 20.49 10.0 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.853 -1.067 . . . . 2.65 111.405 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 37.3 t -105.2 -18.34 14.17 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.782 -1.099 . . . . 1.46 110.9 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.647 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -167.58 -166.5 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.896 0.379 . . . . 3.92 111.385 -177.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.2 t -75.04 131.16 35.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.466 0.651 . . . . 3.1 111.858 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.84 142.52 17.67 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.281 -0.872 . . . . 2.78 110.353 169.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -105.92 -35.79 7.19 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.984 -1.007 . . . . 6.34 109.965 -176.243 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 22.2 tp60 -94.44 63.43 2.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.63 0.729 . . . . 6.79 109.567 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.427 ' CG ' ' HD2' ' A' ' 29' ' ' ARG . 29.2 tt0 -88.6 131.39 34.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.134 -0.939 . . . . 6.24 110.829 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.6 179.78 6.21 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.532 -0.544 . . . . 4.95 109.532 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' ILE . . . 174.65 -130.13 1.72 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.56 -0.829 . . . . 4.68 112.011 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 45' ' ' ILE . . . -97.5 71.97 0.69 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.831 -0.699 . . . . 4.55 112.421 -176.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.2 mt -94.94 128.0 46.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.743 0.306 . . . . 5.57 110.855 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.5 m 70.58 -63.99 0.39 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.354 -0.839 . . . . 5.93 111.454 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -167.36 -57.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.166 -0.679 . . . . 6.63 109.166 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -69.4 126.98 31.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.288 -0.869 . . . . 6.54 110.66 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 45' ' ' ILE . 2.7 pp -81.9 157.41 4.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.935 -0.575 . . . . 5.17 111.143 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.36 155.75 24.8 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.438 -0.665 . . . . 2.51 111.438 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -90.57 175.49 7.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.8 0.333 . . . . 1.36 111.232 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.959 ' HE2' ' HB2' ' A' ' 25' ' ' LEU . 18.3 p90 -138.99 169.53 17.63 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.401 -0.363 . . . . 1.7 111.257 -167.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 36' ' ' GLN . 72.7 mt-30 -119.7 115.85 24.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.57 -0.53 . . . . 1.91 109.57 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 16.6 t -87.91 150.97 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.341 . . . . 1.53 111.075 -177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.927 HG23 ' HA ' ' A' ' 54' ' ' ASP . 96.1 m -137.69 91.02 2.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.86 -0.609 . . . . 1.51 110.468 -173.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.894 HG13 ' H ' ' A' ' 53' ' ' ASN . 1.9 p -64.25 -72.43 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.259 0.552 . . . . 2.27 109.647 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.894 ' H ' HG13 ' A' ' 52' ' ' VAL . 2.9 p30 -98.19 -57.53 2.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.073 -1.084 . . . . 3.68 108.073 169.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.927 ' HA ' HG23 ' A' ' 51' ' ' THR . 15.4 t70 -175.45 79.11 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.879 -1.51 . . . . 2.99 108.507 167.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.0 tppt? -142.07 79.64 1.68 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.561 -1.274 . . . . 7.36 107.561 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 30.4 mtmm -64.04 81.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 124.389 1.056 . . . . 4.46 112.487 -169.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 55' ' ' LYS . 55.0 mt -75.64 105.9 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.254 -0.885 . . . . 0.92 109.722 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 5.1 m -83.75 94.83 8.24 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.737 -0.665 . . . . 0.96 109.658 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 85.9 m-85 -69.17 106.51 2.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.27 -0.423 . . . . 1.57 109.87 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 62.3 tp 76.47 123.43 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.391 1.057 . . . . 3.21 110.808 -173.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB2' HG21 ' A' ' 10' ' ' VAL . 22.1 t70 -89.14 105.75 17.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.305 0.574 . . . . 5.61 110.669 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.533 ' HB ' ' HD3' ' A' ' 63' ' ' PRO . 17.8 m -56.92 -49.53 93.36 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 115.372 -0.831 . . . . 5.45 111.979 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' A' ' 62' ' ' THR . 69.2 Cg_exo -43.67 -59.42 1.06 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.634 2.223 . . . . 6.11 112.678 174.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.69 58.45 0.37 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.293 -0.956 . . . . 6.36 113.696 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.629 ' CE1' HG11 ' A' ' 10' ' ' VAL . 25.6 p-80 -88.23 -10.8 48.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.044 0.45 . . . . 8.78 110.057 174.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.589 ' HB2' ' CE ' ' A' ' 71' ' ' MET . 41.1 mt-10 -83.82 -168.44 2.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.451 -0.795 . . . . 7.05 111.068 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . . . -154.38 39.42 0.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.157 -0.929 . . . . 4.55 110.066 176.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' HB3' ' CE ' ' A' ' 14' ' ' MET . 77.2 m-85 -106.72 -20.66 13.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.486 0.921 . . . . 2.37 113.486 -173.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 71' ' ' MET . 12.0 t -159.61 129.37 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.645 -0.422 . . . . 4.9 110.786 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.7 m 70.05 -62.92 0.41 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.771 -0.65 . . . . 5.84 110.9 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.653 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 9.7 ptt? -69.07 92.62 0.54 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.692 -0.685 . . . . 5.21 109.748 173.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -127.01 8.88 6.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.363 -0.38 . . . . 8.21 111.022 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.59 -15.88 29.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.204 0.526 . . . . 6.36 110.419 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -94.46 141.9 28.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.624 . . . . 9.65 110.146 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.27 116.1 4.2 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.618 -0.801 . . . . 4.93 111.221 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.789 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . . . -76.62 81.77 3.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 5.47 111.138 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -110.22 35.9 3.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.859 0.838 . . . . 6.26 109.184 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.1 143.34 37.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.135 -0.939 . . . . 4.31 109.381 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 p -81.36 69.99 8.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.273 0.471 . . . . 3.41 112.273 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -86.02 -179.58 6.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.873 -0.788 . . . . 2.66 108.873 171.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.453 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt -135.35 139.34 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.3 -0.259 . . . . 0.71 110.3 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.815 HG22 ' HB ' ' A' ' 12' ' ' THR . 39.1 t -118.02 126.95 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.368 0.604 . . . . 1.17 112.11 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.67 HG12 ' HB ' ' A' ' 111' ' ' ILE . 6.1 mt -85.04 133.97 28.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.009 -0.996 . . . . 0.37 110.562 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 96' ' ' THR . 2.0 tm? -121.28 110.35 16.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.454 -0.943 . . . . 1.01 108.454 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 93.2 t -89.04 117.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 0.43 111.397 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.9 m -126.33 123.35 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.803 -0.635 . . . . 0.64 111.218 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -62.53 131.81 50.36 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.928 -0.578 . . . . 0.28 110.014 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.732 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.22 0.533 . . . . 0.22 111.115 -176.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -90.54 -13.87 33.71 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.479 -0.782 . . . . 0.58 111.069 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.451 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.1 t70 -118.55 -50.43 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 0.56 110.537 -174.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.585 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 91.43 -162.77 28.36 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.37 113.449 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.07 136.37 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.754 0.788 . . . . 1.03 109.75 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.769 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 76.8 mmm -139.39 176.93 2.27 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.932 -1.031 . . . . 0.28 109.14 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 74.7 Cg_exo -40.13 -65.52 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.369 2.712 . . . . 0.58 114.466 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.472 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.5 pt20 -76.13 -16.64 59.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.881 -0.327 . . . . 0.75 111.243 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.633 HG21 HG12 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -68.23 -43.01 78.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.486 0.66 . . . . 0.31 109.258 176.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.542 HG12 ' ND2' ' A' ' 101' ' ' ASN . 24.9 t -66.27 -41.35 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 115.049 -0.978 . . . . 1.38 111.289 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 41.1 mm-40 -55.07 -29.6 57.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.981 0.419 . . . . 2.35 110.456 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.04 -38.14 66.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.44 110.565 175.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.596 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.9 mt -73.49 -44.43 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.84 0.829 . . . . 0.41 109.056 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.542 ' ND2' HG12 ' A' ' 97' ' ' VAL . 35.1 m-20 -59.36 -30.71 68.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.36 -1.291 . . . . 0.67 111.055 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.482 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 4.6 t60 -80.91 -34.62 33.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.168 0.509 . . . . 2.5 110.038 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.501 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -71.81 -46.21 58.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.885 -0.598 . . . . 0.47 111.482 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 13.6 mmmm -71.59 -29.23 64.46 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.242 0.544 . . . . 1.66 109.58 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.46 72.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.906 -1.043 . . . . 0.77 111.33 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.33 28.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.74 110.629 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 85.6 53.06 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 114.581 -1.19 . . . . 1.41 109.295 171.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.34 141.96 25.02 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 113.841 -1.527 . . . . 1.35 110.62 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.27 143.43 83.33 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.554 2.17 . . . . 0.47 112.025 173.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.501 HD11 ' HB1' ' A' ' 103' ' ' ALA . 31.4 mm -106.34 158.59 6.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.488 0.661 . . . . 0.6 110.976 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.828 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 41.1 mm -124.94 84.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.396 -1.335 . . . . 0.37 107.396 171.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 131' ' ' LEU . 63.0 t -70.12 147.84 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.654 0.74 . . . . 0.26 109.753 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.779 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -145.13 100.37 3.46 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.34 -1.3 . . . . 0.29 109.701 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.823 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.7 mp -70.43 139.21 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.173 -1.376 . . . . 0.59 109.082 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -120.13 171.99 8.08 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.835 -1.542 . . . . 1.85 106.835 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.523 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 90.2 mttt 66.81 30.58 7.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 O-C-N 123.704 0.627 . . . . 0.59 111.902 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.494 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 83.1 mmm -83.79 -6.39 59.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.651 0.739 . . . . 0.92 109.299 172.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 8.1 p-10 -67.11 -28.1 67.88 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.704 -1.135 . . . . 0.76 108.865 169.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.502 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 29.5 mtpp -74.97 133.19 76.05 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.205 -1.362 . . . . 1.17 110.414 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -64.97 -16.05 53.53 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.449 2.1 . . . . 0.58 110.937 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -80.84 -1.64 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.745 -1.116 . . . . 1.45 110.63 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -54.97 124.29 16.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.189 -0.914 . . . . 0.27 111.731 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -129.13 75.67 79.99 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.75 -0.833 . . . . 0.95 108.75 173.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.406 ' HB3' ' SD ' ' A' ' 117' ' ' MET . 37.0 Cg_endo -63.24 -60.33 0.18 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 123.085 2.523 . . . . 0.4 112.73 -173.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 2.5 m-20 -55.92 -18.22 8.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.555 -0.748 . . . . 1.44 111.616 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 5.4 tpm_? -78.7 -56.75 4.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.206 -0.665 . . . . 3.79 109.206 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.585 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 5.0 m -66.47 -22.98 30.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 122.303 1.049 . . . . 0.59 110.165 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.62 ' HG3' ' CD2' ' A' ' 147' ' ' PHE . 8.4 ttt -68.27 -43.94 76.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.767 -1.56 . . . . 0.81 110.522 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.561 ' HA ' ' HG3' ' A' ' 132' ' ' MET . 73.5 mt-30 -68.85 -31.74 70.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.765 -0.652 . . . . 1.31 111.752 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.741 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 12.7 mt-10 -61.52 -37.61 84.36 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.932 0.872 . . . . 1.64 109.162 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.848 HD23 HG21 ' A' ' 112' ' ' VAL . 4.9 mp -62.4 -35.75 80.18 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.502 -0.772 . . . . 1.36 109.846 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.765 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -70.14 -18.05 63.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.051 -0.659 . . . . 1.61 111.864 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 4.7 pt-20 -78.83 -17.5 55.57 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.204 -1.036 . . . . 1.67 108.204 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -97.9 23.02 8.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.777 -1.101 . . . . 1.08 109.051 167.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.43 52.86 11.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.658 -1.61 . . . . 1.1 111.763 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 132' ' ' MET . 76.7 mt -121.67 96.79 5.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.604 -0.726 . . . . 1.36 110.026 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.968 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 61.5 t -103.54 121.71 47.42 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.572 -0.74 . . . . 0.43 111.302 -174.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 86.5 Cg_exo -41.58 144.16 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.642 3.561 . . . . 0.54 113.854 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HB2' HD13 ' A' ' 146' ' ' ILE . 9.0 mm-40 -74.09 -21.92 59.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.056 -1.429 . . . . 3.08 109.354 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 138' ' ' PRO . 2.3 pm0 -70.53 -21.44 62.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.671 -1.149 . . . . 1.57 110.634 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.537 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 37.6 m0 -102.66 -34.12 9.18 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 120.846 0.355 . . . . 0.66 110.641 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 122.27 29.63 1.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.724 -0.751 . . . . 0.53 112.623 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.968 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.91 -112.46 2.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.442 -0.885 . . . . 0.6 112.48 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -162.89 60.37 0.2 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.65 1.215 . . . . 1.91 111.246 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.749 HG21 HG23 ' A' ' 112' ' ' VAL . 52.3 m -165.12 116.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.686 -1.143 . . . . 0.37 110.347 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.828 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.5 mm -70.74 105.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.062 -0.718 . . . . 0.63 109.062 173.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.1 m-85 -89.05 114.56 25.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.205 -0.907 . . . . 0.5 110.601 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 95.4 m -102.94 116.63 32.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.754 0.311 . . . . 0.68 110.769 173.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.662 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 88.1 mttt -89.72 103.7 16.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.923 -0.769 . . . . 1.44 108.923 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.899 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.3 pp -135.25 -174.14 3.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.054 1.407 . . . . 0.84 112.953 -172.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.425 ' HB2' ' H ' ' A' ' 118' ' ' ASP . 13.8 t -152.44 118.55 5.51 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.453 -1.703 . . . . 1.77 106.693 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.56 -7.77 58.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.156 -0.618 . . . . 0.41 109.369 175.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.589 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 5.1 tmtt? -74.47 -55.15 6.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.47 -0.786 . . . . 2.3 110.197 172.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.4 p -82.5 -9.14 59.54 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.148 -0.621 . . . . 0.7 111.619 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.449 ' HE3' ' HB1' ' A' ' 27' ' ' ALA . 38.6 mmtm 65.39 40.14 4.89 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.506 -0.77 . . . . 1.36 111.516 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.13 -67.3 0.85 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.708 1.242 . . . . 2.48 110.281 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.899 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -68.68 -12.62 64.64 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 113.536 -1.665 . . . . 0.29 113.844 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 158' ' ' LEU . 34.4 mt -67.42 -37.56 83.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 118.287 1.043 . . . . 0.8 109.804 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.988 -1.005 . . . . 2.2 109.401 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.5 -20.56 65.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.396 -0.82 . . . . 0.58 110.861 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.12 -57.31 7.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.23 -0.441 . . . . 1.16 110.327 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.36 -41.27 75.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.405 -0.816 . . . . 1.51 110.178 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -55.23 -45.86 76.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.284 -0.871 . . . . 2.57 111.586 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.519 ' HB3' HG21 ' A' ' 146' ' ' ILE . 14.4 mmt -70.23 -44.38 68.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 0.64 110.382 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.556 HD11 HD11 ' A' ' 83' ' ' ILE . 72.0 mt -59.18 -49.53 83.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.725 -0.67 . . . . 0.52 111.523 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 0.0 OUTLIER -73.25 -22.94 60.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.673 -0.24 . . . . 1.73 110.849 -177.274 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.13 -50.94 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.905 -0.776 . . . . 1.51 108.905 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.764 ' HA ' ' HG2' ' A' ' 171' ' ' MET . 42.3 t -64.53 -37.57 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.224 -0.898 . . . . 0.89 110.794 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 166' ' ' LEU . 22.9 m -60.8 -21.08 62.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.893 0.378 . . . . 1.35 110.568 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 170' ' ' GLU . 41.9 tt0 -104.24 3.4 32.69 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.103 -0.499 . . . . 2.73 111.291 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 22.9 mmt -40.48 -31.68 0.16 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.335 0.865 . . . . 1.88 113.335 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -55.9 -37.27 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 4.27 111.138 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -99.2 4.51 46.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.887 -0.597 . . . . 3.91 111.214 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.477 ' HB2' ' HE1' ' A' ' 171' ' ' MET . 58.0 tp -56.37 -41.83 76.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.313 0.578 . . . . 5.72 110.281 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.508 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.2 OUTLIER -95.37 34.31 1.46 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.611 -0.722 . . . . 5.49 111.44 -177.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -91.62 -25.66 19.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.468 0.651 . . . . 5.78 109.309 171.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -114.31 93.61 32.09 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.003 -0.999 . . . . 7.88 109.052 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.247 0.935 0 C-N-CA 123.266 2.644 . . . . 9.19 112.037 -177.718 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.721 " H5'" ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.765 -0.134 . . . . 11.58 112.765 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -74.56 -43.49 55.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.662 0.231 . . . . 10.61 111.517 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.7 m80 55.97 67.1 1.05 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.498 0.666 . . . . 10.14 109.472 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 42.6 ttm -133.37 -44.32 0.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.03 -0.986 . . . . 8.77 111.398 -170.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.5 m -101.81 -22.41 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.309 . . . . 5.74 111.211 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -87.52 141.12 28.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.5 -0.318 . . . . 5.7 110.448 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -106.55 107.89 60.9 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.449 . . . . 6.85 110.64 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 37.9 Cg_endo -93.36 117.97 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.334 2.689 . . . . 2.8 112.449 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.486 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 16.5 Cg_exo -68.15 91.23 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.86 2.373 . . . . 2.76 111.447 177.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.683 HG23 ' H ' ' A' ' 11' ' ' VAL . 3.8 m -79.69 -67.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 2.0 111.32 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.683 ' H ' HG23 ' A' ' 10' ' ' VAL . 87.9 t 66.28 94.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.526 0.679 . . . . 1.35 110.932 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -80.22 146.57 31.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.773 -0.649 . . . . 0.64 110.239 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -107.4 136.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.385 0.612 . . . . 1.3 110.953 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.429 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 63.5 mtt -144.12 176.59 9.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.433 -0.803 . . . . 0.79 108.892 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.07 176.69 15.21 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.247 -0.977 . . . . 0.31 112.322 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 57.7 t60 -80.81 158.94 25.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.82 0.819 . . . . 0.22 111.538 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.523 HG23 ' O1B' ' A' ' 179' ' ' GDP . 6.5 p -71.82 151.34 8.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.5 -1.227 . . . . 0.36 109.933 175.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.663 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 20.8 t70 75.03 -25.13 0.21 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.1 0.476 . . . . 0.69 110.703 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.551 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 20.4 m170 -76.71 -17.32 59.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.487 -0.931 . . . . 0.63 108.487 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.817 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 119.78 65.3 0.28 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.401 -0.818 . . . . 0.79 113.87 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.593 ' HB3' ' O2B' ' A' ' 179' ' ' GDP . 16.0 tppt? -65.28 -71.43 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.142 -0.623 . . . . 3.31 110.656 172.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -86.71 -32.48 20.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.517 -0.31 . . . . 1.21 110.924 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.502 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -57.76 -27.86 63.42 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.569 0.581 . . . . 1.25 112.569 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.817 HD23 ' HA3' ' A' ' 20' ' ' GLY . 1.2 mm? -75.86 -36.93 59.42 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.908 -0.404 . . . . 1.49 109.908 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 47' ' ' ALA . 3.3 tp -73.71 -9.67 58.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.631 -0.713 . . . . 1.69 109.941 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.455 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 20.1 t70 -98.92 -44.06 6.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.884 -0.784 . . . . 1.23 108.884 176.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.48 87.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.279 -1.328 . . . . 0.63 109.761 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 10.9 tt -67.0 -36.14 76.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.791 -1.095 . . . . 1.02 111.101 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 79.6 mtm180 -71.31 -42.79 68.2 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.694 0.759 . . . . 3.04 109.587 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -79.0 17.97 0.68 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.113 -0.949 . . . . 2.65 111.941 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -105.99 -46.66 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.531 -1.213 . . . . 1.46 109.546 175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HD3' ' CD1' ' A' ' 162' ' ' LEU . 14.5 ptmt -174.1 -163.86 0.18 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.932 -0.576 . . . . 3.92 110.077 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.77 HG13 ' H ' ' A' ' 34' ' ' THR . 5.4 p 47.36 -88.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.536 1.135 . . . . 3.1 113.235 -175.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.77 ' H ' HG13 ' A' ' 33' ' ' VAL . 23.3 p -98.43 112.39 24.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.32 0.581 . . . . 2.78 112.169 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.49 -36.89 20.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.391 -0.822 . . . . 6.34 109.48 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -172.18 -39.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.869 -1.059 . . . . 6.79 108.676 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -119.51 175.01 6.04 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 114.71 -1.132 . . . . 6.24 110.081 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.29 -176.21 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.826 0.704 . . . . 4.95 112.502 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.84 -63.77 4.42 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.956 -0.565 . . . . 4.68 112.435 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.52 68.66 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.596 -0.601 . . . . 4.55 111.596 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.0 tp -151.87 131.75 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.472 0.653 . . . . 5.57 111.391 -176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.42 ' HB ' HG12 ' A' ' 45' ' ' ILE . 1.1 m -111.27 143.77 41.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.634 -0.876 . . . . 5.93 108.634 171.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -77.42 28.01 0.15 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.044 0.387 . . . . 6.63 112.044 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -140.4 27.76 2.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.369 0.605 . . . . 6.54 109.571 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.42 HG12 ' HB ' ' A' ' 42' ' ' THR . 45.8 mm -130.43 158.38 42.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.134 -0.939 . . . . 5.17 109.702 -175.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 45' ' ' ILE . . . -101.81 132.1 10.84 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.823 -0.911 . . . . 2.51 110.823 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . 67.23 -166.99 0.21 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.763 0.331 . . . . 1.36 110.313 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -165.51 176.77 7.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.971 -0.381 . . . . 1.7 109.971 -172.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 45.3 mt-30 -97.07 115.02 26.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.843 -0.617 . . . . 1.91 109.896 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.713 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 24.9 t -76.58 160.64 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.732 -0.47 . . . . 1.53 109.732 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.894 HG23 ' HA ' ' A' ' 54' ' ' ASP . 96.1 m -155.19 83.38 1.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.259 -1.015 . . . . 1.51 108.259 -176.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.897 HG13 ' H ' ' A' ' 53' ' ' ASN . 2.2 p -56.98 -67.77 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.85 -0.613 . . . . 2.27 110.251 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.897 ' H ' HG13 ' A' ' 52' ' ' VAL . 19.3 m-20 -100.84 -60.97 1.43 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.822 -1.547 . . . . 3.68 106.822 169.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.894 ' HA ' HG23 ' A' ' 51' ' ' THR . 7.0 p-10 -161.22 39.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.327 -1.306 . . . . 2.99 109.717 171.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -107.5 110.29 22.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 7.36 109.528 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -67.76 118.79 11.48 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.93 0.769 . . . . 4.46 111.413 -174.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.713 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 17.8 mt -128.29 93.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.606 -0.725 . . . . 0.92 109.488 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 6.1 m -89.2 93.59 9.62 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.651 -0.42 . . . . 0.96 110.469 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 4.6 m-30 -49.55 -19.92 0.66 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.841 -1.072 . . . . 1.57 113.855 -177.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 41.4 tp -146.13 96.32 2.77 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.98 -0.45 . . . . 3.21 110.535 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HB3' HG12 ' A' ' 10' ' ' VAL . 21.6 t70 -143.33 -72.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 5.61 111.151 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 92.9 m -120.65 122.57 28.48 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.827 0.346 . . . . 5.45 111.51 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.791 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 72.2 Cg_endo -82.7 135.01 7.67 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.867 2.378 . . . . 6.11 111.619 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.74 -80.17 1.2 Allowed Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.634 -0.793 . . . . 6.36 111.86 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -68.52 80.79 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.506 0.558 . . . . 8.78 112.506 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 73.93 -63.29 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.95 -1.023 . . . . 7.05 112.874 170.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.87 126.89 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.052 0.541 . . . . 4.55 109.93 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' HZ ' HG21 ' A' ' 108' ' ' VAL . 40.2 m-85 -87.74 -174.47 4.77 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.223 -0.444 . . . . 2.37 109.946 166.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.2 p -58.39 -62.71 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.82 0.674 . . . . 4.9 112.82 -173.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.7 p -87.91 40.82 0.96 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.869 0.322 . . . . 5.84 111.869 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.791 ' SD ' ' HB3' ' A' ' 63' ' ' PRO . 50.9 mtt -136.35 121.22 18.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.085 0.469 . . . . 5.21 111.787 -176.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -125.81 29.08 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.766 -0.652 . . . . 8.21 109.784 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.44 -75.93 0.45 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.222 -0.445 . . . . 6.36 112.066 -170.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' O ' ' HG2' ' A' ' 63' ' ' PRO . 25.3 mtm180 -143.02 -179.75 6.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.615 0.245 . . . . 9.65 111.332 -172.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.43 111.94 0.59 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.681 -0.567 . . . . 4.93 111.681 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.18 -153.93 0.59 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.812 0.339 . . . . 5.47 110.444 -175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -131.44 48.12 2.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.431 0.634 . . . . 6.26 110.161 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 t -82.88 158.2 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.293 -0.867 . . . . 4.31 109.929 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 m -76.39 84.37 3.13 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.015 -0.365 . . . . 3.41 110.015 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.433 ' HB2' HG22 ' A' ' 108' ' ' VAL . 9.9 m-20 -63.75 143.6 57.71 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.847 -0.615 . . . . 2.66 111.263 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 47.6 mt -134.77 118.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.113 -0.949 . . . . 0.71 108.509 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.408 HG21 ' SD ' ' A' ' 14' ' ' MET . 11.9 p -114.49 135.69 53.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.528 0.68 . . . . 1.17 110.896 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.9 mt -90.83 128.92 42.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.914 -1.039 . . . . 0.37 109.884 173.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 96' ' ' THR . 2.4 tm? -114.8 106.89 14.73 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.369 -0.974 . . . . 1.01 108.369 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -86.29 109.03 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.43 110.996 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.5 m -119.99 122.29 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.768 -0.651 . . . . 0.64 110.656 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.85 130.09 41.33 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.406 -0.59 . . . . 0.28 109.406 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -69.01 -15.32 63.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 120.897 0.379 . . . . 0.22 111.505 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.52 -5.52 58.16 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.037 -0.529 . . . . 0.58 111.523 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -133.23 -49.39 0.86 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.556 0.217 . . . . 0.56 111.479 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.551 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 94.75 -148.43 18.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 121.084 -0.579 . . . . 0.37 113.477 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.436 HG11 ' CE2' ' A' ' 134' ' ' TYR . 30.2 t -83.23 131.28 34.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.542 0.687 . . . . 1.03 110.355 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.789 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 83.9 mmm -131.22 176.85 2.56 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 114.645 -1.162 . . . . 0.28 109.477 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.789 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 56.5 Cg_exo -38.53 -66.43 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.566 2.844 . . . . 0.58 114.578 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.503 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 3.8 pt20 -74.82 -15.5 60.74 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.135 0.493 . . . . 0.75 111.323 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -71.01 -41.68 70.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.475 0.655 . . . . 0.31 109.482 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 93' ' ' MET . 25.7 t -63.41 -41.16 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.193 -0.912 . . . . 1.38 111.861 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.29 -34.29 68.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 2.35 110.276 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.429 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -68.65 -34.26 75.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 0.44 110.609 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.592 HG21 ' HB3' ' A' ' 134' ' ' TYR . 95.5 mt -74.14 -42.67 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.778 0.799 . . . . 0.41 109.256 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.46 ' OD1' HG12 ' A' ' 97' ' ' VAL . 1.9 m120 -65.41 -25.59 67.61 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.446 -1.252 . . . . 0.67 111.349 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.412 ' NE2' ' HA ' ' A' ' 68' ' ' PHE . 4.3 t60 -82.63 -39.21 22.45 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.256 0.55 . . . . 2.5 109.846 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.02 44.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.779 -0.646 . . . . 0.47 111.982 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.79 ' HD3' HD21 ' A' ' 136' ' ' LEU . 29.9 mmmt -75.76 -27.15 57.96 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.305 0.574 . . . . 1.66 110.438 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.82 -44.29 81.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.055 -0.975 . . . . 0.77 110.302 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.67 44.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.084 -0.507 . . . . 0.74 110.926 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.2 t30 82.64 37.19 0.05 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.657 1.218 . . . . 1.41 108.583 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.449 HG21 ' HZ ' ' A' ' 68' ' ' PHE . 31.1 t -77.38 137.35 64.09 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 113.39 -1.732 . . . . 1.35 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 16.7 Cg_exo -67.69 138.97 46.82 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.381 2.054 . . . . 0.47 111.321 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.454 ' C ' HG23 ' A' ' 145' ' ' THR . 0.8 OUTLIER -110.59 155.75 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 122.056 0.932 . . . . 0.6 112.196 -173.137 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.854 HD13 ' HB ' ' A' ' 146' ' ' ILE . 28.4 mm -122.44 82.19 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 113.753 -1.567 . . . . 0.37 107.278 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.916 HG23 HG21 ' A' ' 145' ' ' THR . 64.0 t -69.01 146.04 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 109.044 -0.724 . . . . 0.26 109.044 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.6 103.01 4.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.545 -1.207 . . . . 0.29 110.111 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.857 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.5 mp -69.02 136.11 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.066 -1.425 . . . . 0.59 108.444 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 62.9 t30 -123.62 167.07 14.44 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.486 -1.302 . . . . 1.85 107.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.755 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 85.7 mttt 69.55 31.99 3.52 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 124.036 0.835 . . . . 0.59 111.047 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 75.6 mmm -85.11 -3.81 58.93 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.84 0.829 . . . . 0.92 108.914 173.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 4.1 p-10 -68.16 -33.1 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.269 -1.332 . . . . 0.76 109.061 168.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.626 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 25.4 mtpp -72.25 129.94 86.9 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 114.814 -1.085 . . . . 1.17 110.202 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.52 -13.99 42.2 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 122.406 2.071 . . . . 0.58 110.788 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -82.47 -1.99 52.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 1.45 110.298 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.45 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -61.36 130.19 44.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.985 -1.007 . . . . 0.27 111.333 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -124.95 76.64 66.68 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.627 -0.879 . . . . 0.95 108.627 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.539 ' HB3' ' SD ' ' A' ' 117' ' ' MET . 56.8 Cg_endo -66.71 -53.93 0.5 Allowed 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.77 2.314 . . . . 0.4 113.311 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.558 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.0 m-20 -53.93 -29.21 41.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.22 -0.9 . . . . 1.44 110.115 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -75.95 -56.92 4.21 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.798 -0.761 . . . . 3.79 109.485 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 88' ' ' ALA . 24.9 m -62.77 -29.03 46.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.424 -0.807 . . . . 0.59 112.033 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.558 ' SD ' ' HA ' ' A' ' 125' ' ' ASP . 18.2 ptm -73.05 -23.77 60.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.518 -0.473 . . . . 0.81 110.219 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -70.73 -32.24 69.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.615 -0.266 . . . . 1.31 110.694 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 3.1 mm-40 -64.23 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.844 0.83 . . . . 1.64 109.719 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.633 HD12 HD13 ' A' ' 136' ' ' LEU . 4.2 mm? -64.03 -41.52 97.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.309 -0.86 . . . . 1.36 109.658 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.757 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 1.6 mtm -72.83 -13.91 61.39 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 119.652 -0.819 . . . . 1.61 110.692 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 5.1 mm-40 -68.49 -26.73 65.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.396 -1.335 . . . . 1.67 107.396 173.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.592 ' HB3' HG21 ' A' ' 100' ' ' ILE . 78.9 m-85 -108.74 33.72 4.06 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.407 -1.269 . . . . 1.08 111.039 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 54.9 t30 61.71 43.01 10.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.631 -1.168 . . . . 1.1 112.013 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.79 HD21 ' HD3' ' A' ' 104' ' ' LYS . 36.1 mt -123.02 97.22 5.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.814 -0.63 . . . . 1.36 111.384 174.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.072 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 57.3 t -99.1 121.26 56.14 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 115.561 -0.745 . . . . 0.43 111.185 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.757 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 93.1 Cg_exo -41.86 142.72 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.373 3.382 . . . . 0.54 113.573 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.484 ' HB2' HD13 ' A' ' 146' ' ' ILE . 4.9 mm-40 -73.5 -16.12 61.29 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.514 -1.221 . . . . 3.08 109.81 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.578 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.2 pm0 -69.27 -21.87 63.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.834 . . . . 1.57 110.26 170.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.5 m0 -109.97 -18.21 13.43 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.082 0.468 . . . . 0.66 111.078 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.54 4.97 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.827 . . . . 0.53 113.506 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 1.072 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.23 -110.66 1.43 Allowed Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.39 -0.91 . . . . 0.6 111.909 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -161.22 60.07 0.29 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 122.808 1.29 . . . . 1.91 111.485 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.916 HG21 HG23 ' A' ' 112' ' ' VAL . 58.5 m -164.1 119.8 1.58 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.87 -1.059 . . . . 0.37 111.201 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.854 ' HB ' HD13 ' A' ' 111' ' ' ILE . 22.5 mm -72.77 106.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.678 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.3 m-85 -88.78 116.63 27.18 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.203 -0.908 . . . . 0.5 110.863 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 85.3 m -102.01 115.71 31.14 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.658 -0.497 . . . . 0.68 109.658 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.857 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 37.9 mtpt -94.8 85.19 4.36 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.984 -0.746 . . . . 1.44 108.984 -176.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.983 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -121.99 -176.92 3.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.712 1.244 . . . . 0.84 113.192 -164.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.431 ' N ' HD12 ' A' ' 150' ' ' LEU . 1.2 p -149.35 108.39 3.9 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.579 -1.646 . . . . 1.77 108.358 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.497 ' HB3' ' O6 ' ' A' ' 179' ' ' GDP . . . -76.44 -15.43 59.92 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.193 0.52 . . . . 0.41 109.906 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -76.31 -51.39 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.766 -0.652 . . . . 2.3 111.432 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -79.14 -9.63 59.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.03 -0.668 . . . . 0.7 111.318 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp 66.77 43.69 2.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.919 0.866 . . . . 1.36 110.465 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 2.4 tt0 -105.16 -63.07 1.27 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.217 . . . . 2.48 109.912 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.983 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -78.16 -10.7 86.02 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 114.933 -1.03 . . . . 0.29 113.432 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 22.6 mt -67.15 -40.04 86.63 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 117.702 0.751 . . . . 0.8 110.11 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -73.14 -37.84 66.47 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.384 -0.826 . . . . 2.2 109.348 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 163' ' ' GLU . 83.2 t60 -70.41 -20.75 62.9 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.561 -0.745 . . . . 0.58 111.142 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.79 -54.2 30.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.184 0.516 . . . . 1.16 109.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.425 ' CD1' ' HD3' ' A' ' 32' ' ' LYS . 9.9 mt -55.98 -38.56 70.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.076 -0.965 . . . . 1.51 110.196 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 49.4 mt-10 -51.97 -52.72 48.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 2.57 110.972 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.579 ' HB3' HG21 ' A' ' 146' ' ' ILE . 15.0 mmt -69.79 -34.55 73.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.959 -0.564 . . . . 0.64 110.535 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 57' ' ' ILE . 80.7 mt -61.17 -51.97 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.52 111.192 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 169' ' ' SER . 4.1 pp -66.19 -33.22 75.28 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 121.032 -0.267 . . . . 1.73 111.176 -177.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.8 tp -54.06 -51.34 64.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.895 -0.593 . . . . 1.51 109.634 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 164' ' ' MET . 61.1 t -65.38 -39.85 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.757 -0.656 . . . . 0.89 110.793 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.452 ' HB3' ' HA ' ' A' ' 166' ' ' LEU . 34.9 t -62.09 -21.33 64.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.829 0.307 . . . . 1.35 111.829 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -104.96 -20.18 13.62 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.118 -0.364 . . . . 2.73 111.268 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 49.3 ttp -74.07 -13.5 60.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.921 0.391 . . . . 1.88 110.531 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.5 -20.78 66.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.938 0.399 . . . . 4.27 110.417 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.46 -15.9 17.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.282 0.563 . . . . 3.91 109.725 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.9 mt -134.33 48.57 2.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.7 -0.682 . . . . 5.72 111.233 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.64 ' H ' ' HD2' ' A' ' 175' ' ' LYS . 9.2 mptt -41.55 130.36 3.12 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.002 0.521 . . . . 5.49 112.361 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -87.19 34.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 5.78 111.486 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 25.6 t-20 -92.49 120.39 67.49 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.096 -0.502 . . . . 7.88 110.444 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 8.2 Cg_exo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 123.154 2.569 . . . . 9.19 111.587 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.755 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.818 -0.513 . . . . 11.58 111.818 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -79.96 60.7 3.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.06 0.457 . . . . 10.61 111.641 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -83.48 -59.8 2.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.114 -0.494 . . . . 10.14 110.779 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.9 ptp -74.32 -7.12 51.75 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.918 -0.583 . . . . 8.77 111.889 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.4 t -66.92 -65.79 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.025 0.441 . . . . 5.74 110.671 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.1 129.1 17.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.928 -0.578 . . . . 5.7 110.476 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -118.32 96.59 49.99 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.566 -0.743 . . . . 6.85 110.007 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 43.9 Cg_endo -68.76 128.67 17.33 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.667 2.245 . . . . 2.8 112.114 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.492 ' HB3' ' O ' ' A' ' 79' ' ' THR . 19.2 Cg_endo -59.6 136.44 71.06 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.046 2.498 . . . . 2.76 111.785 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.86 144.32 11.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.551 -0.537 . . . . 2.0 109.551 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.7 t -112.86 93.24 2.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.451 -0.574 . . . . 1.35 109.451 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 61.8 m -78.48 123.11 26.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.909 -0.587 . . . . 0.64 111.293 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -93.18 108.49 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.922 0.391 . . . . 1.3 110.256 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.466 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 45.1 mtm -130.22 172.8 11.41 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.887 -0.412 . . . . 0.79 109.887 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.81 -157.14 27.1 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.013 -0.835 . . . . 0.31 111.013 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.617 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 46.9 t60 -94.6 160.4 14.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.116 0.96 . . . . 0.22 111.839 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.87 152.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.31 -1.314 . . . . 0.36 110.489 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.703 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 18.3 t70 73.44 -20.75 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.205 0.602 . . . . 0.69 110.162 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 17' ' ' VAL . 22.3 m170 -71.6 -20.75 61.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.079 -1.082 . . . . 0.63 108.079 167.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 112.83 58.41 0.42 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.34 -0.846 . . . . 0.79 113.778 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 14' ' ' MET . 2.9 tppp? -58.11 -62.78 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.628 0.714 . . . . 3.31 111.088 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 p -72.08 -40.75 68.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 1.21 111.845 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -27.66 69.05 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.937 -0.574 . . . . 1.25 112.087 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -70.28 -57.31 5.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.441 0.639 . . . . 1.49 109.574 -175.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.919 HD11 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -66.18 -12.39 55.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.747 -1.115 . . . . 1.69 111.136 -178.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.77 -37.46 9.46 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.807 0.813 . . . . 1.23 109.678 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.23 70.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.781 -1.1 . . . . 0.63 109.494 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.564 HG23 ' OH ' ' A' ' 48' ' ' TYR . 7.6 tt -72.11 -23.29 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.713 -1.131 . . . . 1.02 110.057 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 99.9 mtt180 -65.2 -48.25 74.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.816 0.817 . . . . 3.04 109.18 170.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.84 28.33 0.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.623 -1.171 . . . . 2.65 110.955 -172.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.9 t -102.38 -42.59 5.94 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.514 -1.221 . . . . 1.46 108.579 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.7 pttt 179.89 -167.33 0.09 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.421 -0.809 . . . . 3.92 109.152 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.64 HG13 ' H ' ' A' ' 34' ' ' THR . 4.3 p 50.65 -73.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.004 1.322 . . . . 3.1 112.492 -171.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.786 HG22 ' HB3' ' A' ' 38' ' ' ALA . 18.8 p -82.46 145.3 29.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.947 0.403 . . . . 2.78 110.377 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -96.39 -48.39 5.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.392 0.615 . . . . 6.34 109.887 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -136.93 -78.3 0.4 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.244 -0.889 . . . . 6.79 109.204 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -120.7 126.31 49.88 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.388 -0.824 . . . . 6.24 109.541 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.786 ' HB3' HG22 ' A' ' 34' ' ' THR . . . -171.35 172.51 5.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.387 -0.37 . . . . 4.95 110.389 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.08 -16.25 3.0 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.823 -0.703 . . . . 4.68 111.885 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.79 155.48 9.34 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.191 -0.528 . . . . 4.55 111.85 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.99 101.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.776 -0.824 . . . . 5.57 108.776 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 44' ' ' HIS . 15.1 t -143.27 -176.83 5.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.736 -0.665 . . . . 5.93 110.314 -174.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -102.67 21.37 15.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.087 -0.506 . . . . 6.63 111.927 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.523 ' H ' HG23 ' A' ' 42' ' ' THR . 30.1 p80 -135.68 115.95 13.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.015 0.436 . . . . 6.54 110.43 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.7 pt -93.59 -175.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.014 -0.539 . . . . 5.17 109.92 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' O ' HD21 ' A' ' 25' ' ' LEU . . . 72.24 -80.08 0.62 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.79 -0.719 . . . . 2.51 112.37 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.919 ' HA ' HD11 ' A' ' 25' ' ' LEU . . . -82.2 156.82 24.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.402 0.144 . . . . 1.36 111.206 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.564 ' OH ' HG23 ' A' ' 28' ' ' ILE . 1.3 p90 -165.57 -178.91 5.13 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.625 -0.43 . . . . 1.7 111.334 -166.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 89.8 mt-30 -114.47 120.67 41.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 1.91 110.39 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 57' ' ' ILE . 32.7 m -89.25 153.56 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.279 0.561 . . . . 1.53 111.536 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 54' ' ' ASP . 99.2 m -103.64 91.55 4.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.815 -0.63 . . . . 1.51 111.306 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 m -87.62 -36.85 10.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.047 -1.094 . . . . 2.27 108.047 167.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -119.61 -63.77 1.34 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.659 -1.61 . . . . 3.68 108.899 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.758 ' HA ' HG23 ' A' ' 51' ' ' THR . 23.8 t0 -169.05 81.67 0.13 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.896 -1.047 . . . . 2.99 109.867 167.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.585 ' H ' ' HA ' ' A' ' 51' ' ' THR . 47.6 mttp 60.21 31.8 20.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.274 -0.875 . . . . 7.36 112.945 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.867 ' O ' HG13 ' A' ' 57' ' ' ILE . 47.0 mttp -108.0 76.05 1.03 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.29 -0.564 . . . . 4.46 110.964 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.867 HG13 ' O ' ' A' ' 56' ' ' LYS . 66.4 mt 177.36 106.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.485 1.914 . . . . 0.92 106.838 169.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 14.0 m -102.9 96.11 6.61 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.451 -0.5 . . . . 0.96 110.584 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.626 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 79.1 m-85 -74.16 108.39 6.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.919 -0.771 . . . . 1.57 108.919 174.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.641 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 58.7 tp -122.65 143.11 49.98 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.414 0.446 . . . . 3.21 110.723 -173.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -140.3 114.51 9.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.515 0.198 . . . . 5.61 111.052 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.941 ' HA ' ' HA ' ' A' ' 67' ' ' ALA . 6.8 m 56.87 68.23 2.22 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 124.024 0.827 . . . . 5.45 112.175 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 66' ' ' GLU . 76.1 Cg_endo -77.87 63.71 8.13 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.609 2.206 . . . . 6.11 112.754 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.04 -86.93 0.54 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.55 -0.833 . . . . 6.36 112.696 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -97.03 -72.46 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 8.78 111.171 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' O ' ' HD2' ' A' ' 63' ' ' PRO . 14.3 mm-40 -89.91 128.35 36.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.889 -0.596 . . . . 7.05 110.207 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.941 ' HA ' ' HA ' ' A' ' 62' ' ' THR . . . -58.33 -43.12 88.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.718 -1.128 . . . . 4.55 111.909 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' HA ' HG21 ' A' ' 12' ' ' THR . 9.1 t80 -112.63 127.58 56.14 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.761 -0.459 . . . . 2.37 109.761 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 70' ' ' THR . 18.1 m -87.72 156.3 19.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.193 -0.458 . . . . 4.9 110.769 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 74' ' ' ARG . 76.4 m 76.93 78.28 0.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.464 0.649 . . . . 5.84 111.591 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.524 ' HG3' ' HA ' ' A' ' 106' ' ' ALA . 49.4 ttm -117.2 -63.54 1.43 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.842 -0.617 . . . . 5.21 109.563 171.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -109.1 2.03 20.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.854 -0.612 . . . . 8.21 109.735 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.55 -10.39 59.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.381 -0.827 . . . . 6.36 110.598 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HB2' HG23 ' A' ' 70' ' ' THR . 8.8 tpp180 -123.73 125.45 44.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.027 -0.533 . . . . 9.65 109.707 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.88 117.81 4.49 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.794 -0.717 . . . . 4.93 113.122 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.59 -74.76 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.453 0.701 . . . . 5.47 112.749 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -95.19 107.91 20.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.765 0.317 . . . . 6.26 110.837 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 80' ' ' ASP . 57.2 t -66.51 135.79 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 4.31 110.571 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 9' ' ' PRO . 12.5 p -104.78 -2.48 24.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.092 -0.503 . . . . 3.41 112.263 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.531 ' H ' HG12 ' A' ' 78' ' ' VAL . 7.1 m-20 -119.75 173.97 6.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.768 -0.196 . . . . 2.66 110.591 -173.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.1 mt -135.46 146.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.166 0.291 . . . . 0.71 110.923 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.58 138.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-O 121.771 0.796 . . . . 1.17 111.147 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 6.3 mt -98.17 132.48 43.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.961 -1.018 . . . . 0.37 110.372 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -107.77 107.26 17.95 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.463 -0.79 . . . . 1.01 110.108 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.59 94.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.152 0.501 . . . . 0.43 110.472 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.611 HG13 HD12 ' A' ' 84' ' ' LEU . 11.4 m -111.29 123.35 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.008 -0.542 . . . . 0.64 111.032 175.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -71.68 130.31 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.161 -0.472 . . . . 0.28 109.752 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.754 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -68.4 -19.37 64.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.055 0.455 . . . . 0.22 111.59 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.39 -14.45 46.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.754 -0.657 . . . . 0.58 110.649 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.448 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 6.6 t70 -118.21 -55.04 2.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.56 110.362 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.41 ' HA2' ' CG1' ' A' ' 127' ' ' VAL . . . 99.38 -128.47 9.58 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.965 -0.562 . . . . 0.37 113.319 173.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.469 HG21 ' HE2' ' A' ' 134' ' ' TYR . 8.7 p -103.86 136.94 34.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.675 0.75 . . . . 1.03 109.845 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.7 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.9 mmm -140.08 176.73 2.35 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.772 -1.104 . . . . 0.28 108.74 -171.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.9 Cg_exo -41.35 -66.96 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.15 2.567 . . . . 0.58 114.552 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.477 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 6.2 pt20 -74.11 -15.4 61.05 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.22 0.533 . . . . 0.75 111.114 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.7 -43.71 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.119 -0.697 . . . . 0.31 109.119 176.458 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.536 HG12 ' ND2' ' A' ' 101' ' ' ASN . 22.7 t -66.78 -41.83 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.237 -0.892 . . . . 1.38 111.164 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -56.45 -32.06 64.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.484 . . . . 2.35 110.424 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.53 -31.93 69.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.676 -0.693 . . . . 0.44 110.638 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.569 HG23 HD11 ' A' ' 136' ' ' LEU . 96.7 mt -77.94 -44.65 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.564 0.697 . . . . 0.41 109.371 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.536 ' ND2' HG12 ' A' ' 97' ' ' VAL . 61.2 m-20 -57.41 -38.25 74.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.523 -1.217 . . . . 0.67 110.808 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -68.79 -34.54 75.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.058 0.456 . . . . 2.5 109.872 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.96 -48.91 16.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.015 -0.538 . . . . 0.47 111.932 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.57 ' HD3' HD21 ' A' ' 136' ' ' LEU . 14.0 mmmm -66.46 -38.37 87.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.03 0.443 . . . . 1.66 110.018 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.91 -35.81 71.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 0.77 111.04 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.524 ' HA ' ' HG3' ' A' ' 71' ' ' MET . . . -79.99 -32.71 39.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.508 -0.314 . . . . 0.74 111.301 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 83.35 42.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.36 1.076 . . . . 1.41 108.902 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.454 ' HB ' HG11 ' A' ' 78' ' ' VAL . 1.7 p -103.76 142.86 25.47 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 114.077 -1.419 . . . . 1.35 111.208 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 108' ' ' VAL . 22.1 Cg_exo -65.17 142.27 73.06 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.361 2.041 . . . . 0.47 111.722 171.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 111' ' ' ILE . 1.3 mt -110.82 163.79 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.443 0.64 . . . . 0.6 111.782 -171.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.851 HD13 ' HB ' ' A' ' 146' ' ' ILE . 15.9 mm -142.09 84.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 N-CA-C 106.747 -1.575 . . . . 0.37 106.747 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.751 HG23 HG21 ' A' ' 145' ' ' THR . 63.1 t -76.02 152.27 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 CA-C-N 114.316 -1.311 . . . . 0.26 109.815 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.9 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -143.51 101.5 3.79 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.554 -1.203 . . . . 0.29 109.739 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.841 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.6 mp -68.65 133.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 114.106 -1.406 . . . . 0.59 108.722 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 64.6 t30 -120.37 166.84 12.99 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.125 -1.435 . . . . 1.85 107.125 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.69 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 81.5 mttt 68.42 31.66 4.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 O-C-N 124.242 0.964 . . . . 0.59 111.672 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.478 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 82.6 mmm -80.99 -6.94 59.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.466 -0.788 . . . . 0.92 109.378 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -65.5 -32.49 74.12 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.068 -0.969 . . . . 0.76 108.595 169.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.49 ' HB3' ' OE1' ' A' ' 121' ' ' GLU . 26.8 mtpp -77.56 131.37 71.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.856 -1.52 . . . . 1.17 110.724 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.78 -18.17 59.12 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.538 2.159 . . . . 0.58 111.402 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 15.3 mp0 -68.7 -22.26 64.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.257 -0.883 . . . . 1.45 110.394 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -40.93 123.62 1.98 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.556 -1.202 . . . . 0.27 112.631 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -129.2 75.94 79.61 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.959 -1.126 . . . . 0.95 107.959 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.814 ' O ' ' HG3' ' A' ' 128' ' ' MET . 33.1 Cg_endo -61.15 -60.37 0.24 Allowed 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 122.806 2.337 . . . . 0.4 113.193 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.421 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 5.1 m-20 -49.15 -27.59 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.859 0.724 . . . . 1.44 110.753 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 129' ' ' GLN . 41.8 ttp180 -77.49 -53.3 7.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.756 -0.656 . . . . 3.79 110.031 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.597 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 19.5 m -64.36 -20.62 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.659 -0.701 . . . . 0.59 112.219 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.814 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 37.3 mtp -71.45 -35.68 70.97 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.647 0.737 . . . . 0.81 109.131 171.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 132' ' ' MET . 46.2 mt-30 -66.65 -35.11 79.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.718 -1.128 . . . . 1.31 110.956 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.597 ' HG2' ' HA ' ' A' ' 127' ' ' VAL . 18.8 mm-40 -57.53 -50.07 74.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.924 0.868 . . . . 1.64 109.835 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.734 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 10.7 mp -65.01 -34.27 78.05 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.998 -1.001 . . . . 1.36 110.917 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.594 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 14.6 ptm -73.25 -11.27 60.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.974 -0.691 . . . . 1.61 110.65 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.72 -28.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.515 -0.92 . . . . 1.67 108.515 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.469 ' HE2' HG21 ' A' ' 92' ' ' VAL . 45.4 m-85 -90.12 23.24 2.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.187 -0.915 . . . . 1.08 109.408 167.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.3 t30 52.38 54.44 10.69 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 114.014 -1.448 . . . . 1.1 111.737 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.734 ' HB2' ' HB3' ' A' ' 131' ' ' LEU . 78.9 mt -117.98 98.09 6.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.844 -1.071 . . . . 1.36 109.131 169.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.015 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 40.3 t -100.19 118.95 60.45 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.031 -0.532 . . . . 0.43 111.156 -171.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.582 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.4 Cg_exo -42.82 144.04 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 124.306 3.337 . . . . 0.54 112.798 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 146' ' ' ILE . 2.3 mm-40 -72.77 -20.66 61.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.426 -1.261 . . . . 3.08 110.056 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 2.4 pm0 -68.76 -22.59 64.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.341 -0.845 . . . . 1.57 110.232 171.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.574 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 31.2 m0 -103.89 -15.76 15.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.66 110.333 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.39 23.44 9.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.53 113.736 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 1.015 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.86 -107.42 0.73 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.107 -1.044 . . . . 0.6 112.469 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -164.56 61.03 0.14 Allowed 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.664 1.221 . . . . 1.91 111.316 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.751 HG21 HG23 ' A' ' 112' ' ' VAL . 60.7 m -163.94 111.68 1.15 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.447 -1.252 . . . . 0.37 110.225 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.851 ' HB ' HD13 ' A' ' 111' ' ' ILE . 12.9 mm -68.21 105.12 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 109.026 -0.731 . . . . 0.63 109.026 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 7.7 m-85 -86.37 114.19 22.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.346 -0.843 . . . . 0.5 110.454 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 73.2 m -100.36 113.69 26.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 0.68 110.74 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.759 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.0 mttt -85.72 101.07 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.581 -0.526 . . . . 1.44 109.581 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.924 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.6 pp -133.03 -172.44 2.93 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 123.236 1.493 . . . . 0.84 113.404 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.513 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 13.5 t -159.71 117.05 2.63 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 112.811 -1.995 . . . . 1.77 106.389 172.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.03 -16.95 62.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.059 -0.719 . . . . 0.41 109.059 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.59 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 6.2 tmtt? -69.82 -54.12 15.06 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.732 -1.122 . . . . 2.3 110.635 176.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 2.3 p -80.61 -12.35 59.51 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.51 -0.476 . . . . 0.7 111.69 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.549 ' HD3' HD12 ' A' ' 158' ' ' LEU . 19.5 mmtp 67.44 41.63 2.36 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.589 -0.732 . . . . 1.36 110.617 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.629 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -97.37 -63.88 1.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.339 1.066 . . . . 2.48 110.442 -173.025 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -86.45 1.88 87.37 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.167 -1.016 . . . . 0.29 113.199 -172.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.549 HD12 ' HD3' ' A' ' 155' ' ' LYS . 27.5 mt -70.57 -42.19 71.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.0 0.9 . . . . 0.8 109.019 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -77.73 -34.81 52.43 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.44 -0.8 . . . . 2.2 109.618 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.522 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 81.6 t60 -69.4 -25.85 64.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.565 -0.454 . . . . 0.58 111.121 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.94 -53.08 60.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.36 0.6 . . . . 1.16 109.484 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 12.4 mt -54.89 -44.23 73.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.688 -1.142 . . . . 1.51 109.742 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.499 ' OE2' ' HA ' ' A' ' 160' ' ' HIS . 40.8 mt-10 -46.76 -53.81 11.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.197 0.936 . . . . 2.57 111.189 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.606 ' HB3' HG21 ' A' ' 146' ' ' ILE . 20.2 mmt -72.26 -39.72 68.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 0.64 111.051 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 83' ' ' ILE . 69.1 mt -60.13 -49.94 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 0.52 111.294 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.1 pp -70.89 -31.83 68.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.844 -0.342 . . . . 1.73 111.153 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 166' ' ' LEU . 2.6 tm? -54.2 -50.53 66.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 1.51 108.856 172.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.534 ' O ' ' HG2' ' A' ' 171' ' ' MET . 97.3 t -62.17 -45.11 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 115.819 -0.628 . . . . 0.89 110.559 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.72 ' HA ' ' HB2' ' A' ' 176' ' ' ALA . 38.4 m -58.88 -43.58 90.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.683 0.623 . . . . 1.35 112.683 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.437 ' HG2' HD12 ' A' ' 174' ' ' LEU . 47.0 mt-10 -102.75 0.48 32.94 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.597 0.591 . . . . 2.73 112.597 -171.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 27.2 ptt? -63.89 -37.42 87.32 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.955 -0.298 . . . . 1.88 111.478 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -96.12 -79.69 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.606 -0.438 . . . . 4.27 110.498 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -114.84 -90.63 0.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.888 -0.725 . . . . 3.91 111.031 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 170' ' ' GLU . 26.8 tp -144.03 6.43 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.401 0.619 . . . . 5.72 110.112 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -130.23 8.09 5.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.674 -0.693 . . . . 5.49 112.02 -166.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.72 ' HB2' ' HA ' ' A' ' 169' ' ' SER . . . 58.82 -87.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.569 0.543 . . . . 5.78 111.619 -175.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 63.5 t30 63.9 99.36 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 123.615 0.766 . . . . 7.88 111.102 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo . . . . . 0 C--O 1.247 0.943 0 C-N-CA 122.884 2.389 . . . . 9.19 112.001 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.703 " H5'" ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.108 -0.397 . . . . 11.58 112.108 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m -131.57 165.47 23.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.323 -0.251 . . . . 10.61 110.323 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 66.49 82.01 0.19 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.662 0.601 . . . . 10.14 110.723 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.9 ttp 60.09 88.39 0.08 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.673 -0.694 . . . . 8.77 110.479 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.54 134.18 62.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.774 -0.648 . . . . 5.74 110.073 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.29 106.86 4.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.043 -0.526 . . . . 5.7 110.587 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.787 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 20.3 mmm180 -106.24 -49.09 0.11 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.007 -0.542 . . . . 6.85 110.577 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.787 ' HD2' ' H ' ' A' ' 7' ' ' ARG . 24.8 Cg_endo -63.63 124.17 13.24 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.677 1.585 . . . . 2.8 111.495 173.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.52 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 36.3 Cg_endo -64.83 153.64 76.88 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.086 2.524 . . . . 2.76 112.829 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 60' ' ' LEU . 6.8 p -85.84 85.44 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.045 0.926 . . . . 2.0 109.967 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 94.1 t -54.51 109.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.774 -1.103 . . . . 1.35 111.485 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 33.4 m -85.19 136.3 33.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.783 -0.644 . . . . 0.64 110.827 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.31 113.95 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 1.3 109.95 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.842 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 53.3 mtt -126.5 163.94 22.25 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.072 -0.513 . . . . 0.79 109.637 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.48 -168.65 25.42 Favored Glycine 0 N--CA 1.431 -1.633 0 C-N-CA 120.828 -0.701 . . . . 0.31 111.437 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.645 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 52.1 t60 -88.51 157.89 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.893 0.854 . . . . 0.22 111.385 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.4 p -71.75 153.94 7.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.587 -1.188 . . . . 0.36 109.981 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.502 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 20.2 t70 74.85 -21.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.361 0.601 . . . . 0.69 110.514 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.547 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.2 m170 -80.3 -7.38 59.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.342 -0.984 . . . . 0.63 108.342 170.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 113.07 60.88 0.42 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.537 -0.839 . . . . 0.79 114.048 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -59.29 -76.32 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.355 0.577 . . . . 3.31 110.913 171.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 m -84.79 -32.46 23.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.864 0.364 . . . . 1.21 110.873 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.491 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.57 -31.17 63.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.382 0.512 . . . . 1.25 112.382 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 HG21 ' A' ' 85' ' ' VAL . 12.5 tp -73.67 -40.15 63.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.508 -0.553 . . . . 1.49 109.508 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HA ' HG22 ' A' ' 28' ' ' ILE . 2.9 tp -72.17 -9.52 58.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.654 -0.703 . . . . 1.69 110.562 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -94.99 -43.31 8.21 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.458 -0.941 . . . . 1.23 108.458 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.52 78.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.046 -1.434 . . . . 0.63 110.065 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 7.6 tt -72.73 -32.99 42.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.975 -1.011 . . . . 1.02 110.354 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -65.86 -45.42 82.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.483 0.659 . . . . 3.04 109.926 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -84.36 24.75 0.94 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.845 -1.071 . . . . 2.65 111.373 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.7 t -113.24 -34.42 5.66 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.94 -1.027 . . . . 1.46 110.786 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HZ3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -172.98 -179.58 2.06 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.865 -0.42 . . . . 3.92 109.865 -176.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 50' ' ' VAL . 7.7 p 49.93 -69.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.444 1.497 . . . . 3.1 113.278 -175.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.542 ' H ' HG13 ' A' ' 33' ' ' VAL . 16.9 p -86.67 136.5 33.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.805 0.336 . . . . 2.78 110.927 -177.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.676 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 7.6 pt-20 -114.66 -151.37 0.48 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.234 -0.439 . . . . 6.34 110.474 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -76.88 -53.7 7.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 6.79 110.814 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -86.89 120.66 28.4 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.33 -0.619 . . . . 6.24 109.33 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HA ' ' CG2' ' A' ' 41' ' ' ILE . . . 66.57 27.5 9.58 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.454 0.645 . . . . 4.95 110.785 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.676 ' HA3' ' O ' ' A' ' 35' ' ' GLU . . . -89.01 79.78 1.6 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.734 -0.666 . . . . 4.68 112.976 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.19 6.95 66.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.772 -0.728 . . . . 4.55 112.946 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 38' ' ' ALA . 5.6 tp -86.52 110.81 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.474 0.655 . . . . 5.57 110.389 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 43' ' ' GLN . 17.5 m -145.77 166.94 24.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.015 -0.735 . . . . 5.93 109.015 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.43 ' N ' HG22 ' A' ' 42' ' ' THR . 69.8 mt-30 -49.17 -49.55 42.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.076 0.465 . . . . 6.63 110.83 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -95.13 97.05 9.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.234 0.54 . . . . 6.54 109.797 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -80.47 179.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.875 -0.602 . . . . 5.17 111.71 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.19 -81.36 0.5 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.489 -0.644 . . . . 2.51 111.489 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -90.77 177.66 6.26 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.216 -0.29 . . . . 1.36 110.216 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.442 ' CZ ' HG22 ' A' ' 50' ' ' VAL . 2.3 p90 -169.07 171.48 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.425 -0.51 . . . . 1.7 110.813 -170.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -100.51 136.23 40.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.877 -0.601 . . . . 1.91 109.652 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.555 ' HA ' HG11 ' A' ' 33' ' ' VAL . 14.6 t -101.63 155.73 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.459 0.647 . . . . 1.53 111.698 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.781 HG23 ' HA ' ' A' ' 54' ' ' ASP . 60.2 m -159.26 83.9 0.78 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.063 -0.972 . . . . 1.51 108.963 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 162' ' ' LEU . 2.8 p -63.67 -54.03 37.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.695 0.759 . . . . 2.27 109.123 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.588 ' H ' HG13 ' A' ' 52' ' ' VAL . 84.6 m-20 -123.63 -57.75 1.63 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 114.214 -1.357 . . . . 3.68 107.447 174.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.781 ' HA ' HG23 ' A' ' 51' ' ' THR . 18.1 t70 -170.64 77.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.566 -1.197 . . . . 2.99 109.686 164.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.676 ' HE3' HD12 ' A' ' 166' ' ' LEU . 75.3 mmtt -128.86 90.44 3.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.034 -1.098 . . . . 7.36 108.034 172.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -71.08 81.2 0.68 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.758 0.661 . . . . 4.46 111.13 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.451 HD13 HG21 ' A' ' 165' ' ' ILE . 16.4 mt -102.0 117.6 47.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.496 -0.774 . . . . 0.92 109.857 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -93.8 95.78 9.34 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.553 -0.536 . . . . 0.96 109.553 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.573 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 33.6 m-85 -66.56 151.2 47.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.819 -0.628 . . . . 1.57 110.544 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.667 ' HB2' HG22 ' A' ' 10' ' ' VAL . 35.6 tp -111.29 153.61 25.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.792 -0.447 . . . . 3.21 109.792 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 62' ' ' THR . 6.8 p-10 -70.96 -93.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.07 0.396 . . . . 5.61 112.07 -175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.491 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 2.4 t -171.77 82.58 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.5 0.667 . . . . 5.45 110.101 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.1 -56.06 2.15 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.249 2.633 . . . . 6.11 113.492 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.0 -122.78 2.93 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.39 -0.909 . . . . 6.36 112.758 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -74.52 -40.84 61.51 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.9 0.381 . . . . 8.78 111.364 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -113.39 149.06 34.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.285 -0.416 . . . . 7.05 111.528 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 63.87 104.92 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.29 0 O-C-N 124.425 1.078 . . . . 4.55 113.299 170.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' HD2' ' CD2' ' A' ' 102' ' ' HIS . 1.7 p90 -97.78 24.01 7.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.655 0.74 . . . . 2.37 109.037 168.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t 170.65 174.3 0.06 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.463 -1.244 . . . . 4.9 108.257 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.9 m -80.66 74.71 7.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.774 -0.824 . . . . 5.84 108.774 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.1 tpp -76.06 60.79 1.47 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.542 -0.754 . . . . 5.21 111.274 -173.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.17 -11.65 14.21 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.569 -0.9 . . . . 8.21 108.569 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.91 -57.84 5.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.931 -1.031 . . . . 6.36 111.196 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 54.22 55.48 8.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.031 0.443 . . . . 9.65 110.272 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.06 -155.55 28.91 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.813 -0.708 . . . . 4.93 112.834 -174.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.67 98.1 10.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.62 0.247 . . . . 5.47 110.819 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 55.27 43.53 28.97 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.521 -0.763 . . . . 6.26 111.306 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.9 t -80.42 85.94 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.224 -1.028 . . . . 4.31 108.224 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -92.1 108.09 19.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.729 -0.668 . . . . 3.41 112.396 -170.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' HA ' ' CB ' ' A' ' 9' ' ' PRO . 21.8 m-20 -81.45 127.82 33.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.478 -0.934 . . . . 2.66 108.478 169.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.495 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt -89.9 138.57 19.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.275 -0.42 . . . . 0.71 110.654 -172.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.41 125.51 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 120.375 -0.53 . . . . 1.17 111.436 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.632 HG12 ' HB ' ' A' ' 111' ' ' ILE . 7.8 mt -87.49 130.19 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-N 115.62 -0.718 . . . . 0.37 109.923 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.454 ' O ' HD13 ' A' ' 84' ' ' LEU . 2.0 tm? -114.08 107.36 15.54 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.289 -1.004 . . . . 1.01 108.289 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.484 HG21 HD22 ' A' ' 24' ' ' LEU . 39.5 t -90.72 110.14 21.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.369 -0.832 . . . . 0.43 110.746 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.701 HG21 HD11 ' A' ' 131' ' ' LEU . 1.7 m -120.49 124.92 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.792 -0.64 . . . . 0.64 110.58 174.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -65.51 131.38 46.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 0.28 109.87 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -73.77 -12.54 60.73 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.182 0.515 . . . . 0.22 110.395 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 1.3 p-10 -95.94 -8.73 33.08 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.576 -0.738 . . . . 0.58 110.847 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.13 -48.9 1.45 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.407 -0.36 . . . . 0.56 110.818 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.556 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.89 -146.08 19.01 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.37 113.538 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.508 HG21 ' CE2' ' A' ' 134' ' ' TYR . 9.9 p -82.13 140.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.571 0.701 . . . . 1.03 110.229 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.688 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.6 mmm -142.21 175.12 3.15 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.836 -1.075 . . . . 0.28 108.916 -173.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 75.0 Cg_exo -42.9 -59.07 1.08 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.197 2.598 . . . . 0.58 114.971 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.525 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.8 pt20 -79.42 -17.51 54.15 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 120.419 -0.513 . . . . 0.75 110.969 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.645 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.33 -43.23 91.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 0.31 109.334 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.533 HG12 ' ND2' ' A' ' 101' ' ' ASN . 32.3 t -60.47 -45.71 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.766 -1.107 . . . . 1.38 111.913 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.66 -31.79 66.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 2.35 110.638 -175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.01 -30.29 63.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 0.44 110.736 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.0 mt -77.11 -44.73 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.882 0.849 . . . . 0.41 108.775 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.533 ' ND2' HG12 ' A' ' 97' ' ' VAL . 41.2 m-20 -63.63 -32.21 73.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.245 -1.343 . . . . 0.67 111.002 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.422 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 3.5 t-160 -63.04 -45.79 90.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.441 0.639 . . . . 2.5 109.626 173.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.566 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -78.42 -51.53 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 0.47 112.752 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 29.4 mmmt -68.34 -34.08 75.45 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.931 0.396 . . . . 1.66 110.753 -173.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.74 92.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.655 -0.702 . . . . 0.77 110.837 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.71 53.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.471 -0.332 . . . . 0.74 111.158 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 t30 86.09 47.33 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.232 1.013 . . . . 1.41 109.467 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -111.37 138.4 21.36 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.362 -1.29 . . . . 1.35 110.417 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 34.6 Cg_exo -62.5 144.83 95.26 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.863 2.376 . . . . 0.47 113.436 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.566 HD11 ' CB ' ' A' ' 103' ' ' ALA . 27.1 mm -106.12 160.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.076 -0.965 . . . . 0.6 110.696 -175.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.818 HD13 ' HB ' ' A' ' 146' ' ' ILE . 29.9 mm -124.46 83.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.101 -1.444 . . . . 0.37 107.101 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.096 HG23 HG21 ' A' ' 145' ' ' THR . 62.0 t -69.03 146.98 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.636 0.731 . . . . 0.26 109.049 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -148.01 102.93 3.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.45 -1.25 . . . . 0.29 110.073 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.752 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 2.8 mp -70.57 139.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-N 113.767 -1.56 . . . . 0.59 109.068 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.1 p-10 -121.19 175.8 5.93 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.081 -1.451 . . . . 1.85 107.081 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.731 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 83.6 mttt 69.87 30.97 3.57 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.742 0.651 . . . . 0.59 111.098 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.654 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 11.3 mmt -73.18 -14.95 61.45 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.328 1.061 . . . . 0.92 108.624 167.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.586 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 2.0 p-10 -72.63 -19.64 61.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.404 -1.725 . . . . 0.76 110.602 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.469 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 36.6 mtpt -89.32 144.42 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.775 -0.648 . . . . 1.17 110.684 176.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.25 -17.22 40.01 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.789 2.326 . . . . 0.58 111.694 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 31.9 mt-10 -85.45 8.59 18.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.455 -0.793 . . . . 1.45 111.032 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.14 112.36 1.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.27 110.743 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -127.89 76.2 77.64 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.95 108.969 175.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.506 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 37.8 Cg_endo -63.71 -58.03 0.31 Allowed 'Trans proline' 0 CA--C 1.507 -0.845 0 C-N-CA 123.177 2.584 . . . . 0.4 113.022 -174.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 16.5 t70 -45.6 -29.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.285 0.991 . . . . 1.44 110.93 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.513 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 10.5 ttp180 -82.26 -56.45 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 3.79 110.173 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.75 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 16.6 m -65.64 -29.92 48.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.719 -0.673 . . . . 0.59 111.387 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . 1.025 ' HA ' HD12 ' A' ' 131' ' ' LEU . 4.4 ttt -71.12 -31.16 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.425 1.09 . . . . 0.81 110.56 176.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -73.06 -36.33 66.86 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.653 -0.419 . . . . 1.31 111.375 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.618 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.2 mt-10 -63.06 -28.88 70.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.61 1.195 . . . . 1.64 108.976 175.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.025 HD12 ' HA ' ' A' ' 128' ' ' MET . 90.9 mt -62.03 -39.23 91.58 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.4 -1.727 . . . . 1.36 109.585 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.679 ' HG2' ' HA ' ' A' ' 137' ' ' VAL . 34.5 mtp -77.95 -15.92 58.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.308 0.484 . . . . 1.61 112.308 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.495 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 9.1 mm-40 -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.083 -1.08 . . . . 1.67 108.083 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.508 ' CE2' HG21 ' A' ' 92' ' ' VAL . 85.2 m-85 -104.64 22.87 14.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.888 -1.051 . . . . 1.08 110.635 172.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.9 t30 66.78 28.85 8.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.081 -1.418 . . . . 1.1 112.623 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -116.1 116.79 28.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.627 -0.879 . . . . 1.36 108.627 170.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.929 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 91.5 t -112.21 136.84 21.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 0.43 112.51 -167.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.762 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -45.79 127.92 10.53 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 124.205 3.27 . . . . 0.54 111.681 169.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.756 ' HG2' HD13 ' A' ' 146' ' ' ILE . 1.8 pp20? -73.27 -20.9 60.73 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.661 -0.866 . . . . 3.08 108.661 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 147' ' ' PHE . 1.5 pm0 -59.01 -27.37 65.38 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.659 -0.7 . . . . 1.57 110.608 169.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.676 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 41.0 m0 -103.47 -11.79 17.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.919 0.39 . . . . 0.66 111.049 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.24 24.75 5.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.713 -0.756 . . . . 0.53 113.362 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.929 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.6 -120.22 2.21 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.6 111.952 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -156.27 58.88 0.57 Allowed 'General case' 0 C--O 1.243 0.713 0 CA-C-O 122.293 1.044 . . . . 1.91 112.192 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 1.096 HG21 HG23 ' A' ' 112' ' ' VAL . 81.1 m -165.7 129.27 2.19 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.385 -0.825 . . . . 0.37 110.739 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.818 ' HB ' HD13 ' A' ' 111' ' ' ILE . 24.0 mm -72.78 105.03 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.081 -1.081 . . . . 0.63 108.081 168.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.762 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 9.0 m-85 -89.67 112.3 23.52 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.771 -0.65 . . . . 0.5 110.804 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.94 142.44 29.67 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.479 -0.782 . . . . 0.68 110.347 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.552 ' HE2' ' HE3' ' A' ' 128' ' ' MET . 5.1 mmtp -117.64 96.83 5.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.286 -1.005 . . . . 1.44 108.286 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.752 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 4.0 pp -127.78 -175.71 3.55 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.903 1.335 . . . . 0.84 113.036 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 1.4 p -157.37 89.98 1.08 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 112.914 -1.948 . . . . 1.77 108.028 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.23 -15.26 63.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.256 0.551 . . . . 0.41 110.4 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.74 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 0.1 OUTLIER -77.8 -42.93 32.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.565 -0.743 . . . . 2.3 112.037 175.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.437 ' OG1' ' HB2' ' A' ' 151' ' ' SER . 0.9 OUTLIER -87.34 -9.27 55.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.526 -0.869 . . . . 0.7 111.804 175.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 66.73 50.19 1.18 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.089 -0.959 . . . . 1.36 110.995 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -109.51 -65.82 1.11 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.702 1.239 . . . . 2.48 110.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.752 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -74.26 -4.05 67.42 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.054 -1.43 . . . . 0.29 113.897 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 158' ' ' LEU . 28.8 mt -71.33 -37.62 71.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.044 0.922 . . . . 0.8 109.238 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.84 -40.47 79.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.219 -0.9 . . . . 2.2 109.431 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 83.7 t60 -74.93 -10.62 59.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.079 -0.51 . . . . 0.58 111.303 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.55 -55.21 5.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.384 0.611 . . . . 1.16 109.837 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.626 HD13 HG11 ' A' ' 52' ' ' VAL . 4.2 pp -62.89 -28.5 70.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.021 -0.99 . . . . 1.51 111.643 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 12.5 pt-20 -77.99 -27.3 49.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.847 -0.341 . . . . 2.57 111.23 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.567 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 14.8 mmt -74.53 -44.1 52.74 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.282 -0.636 . . . . 0.64 109.282 173.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 83' ' ' ILE . 84.2 mt -58.19 -39.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.227 -0.897 . . . . 0.52 110.203 173.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.676 HD12 ' HE3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -59.7 -44.19 93.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.463 -0.79 . . . . 1.73 111.693 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.48 ' N ' HD23 ' A' ' 166' ' ' LEU . 27.2 tp -54.42 -43.02 71.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.555 0.693 . . . . 1.51 109.923 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.82 -41.1 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.991 -1.004 . . . . 0.89 110.859 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.7 m -65.13 -44.67 87.9 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.43 0.53 . . . . 1.35 112.43 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 10.5 pt-20 -103.18 3.73 36.04 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.452 0.538 . . . . 2.73 112.452 -171.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.6 ttm -44.83 -64.54 0.68 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.392 0.432 . . . . 1.88 112.14 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -97.4 -80.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 4.27 110.721 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.63 -80.22 0.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.637 0.732 . . . . 3.91 109.463 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 29.0 tp -134.09 34.52 3.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.798 -1.556 . . . . 5.72 106.798 171.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -162.82 151.6 14.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.554 -1.657 . . . . 5.49 109.039 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.72 -57.42 2.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.189 -0.46 . . . . 5.78 110.919 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 43.1 t30 69.82 101.59 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 123.569 0.543 . . . . 7.88 111.104 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.998 2.465 . . . . 9.19 112.149 -178.711 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.74 ' C2 ' ' HG3' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 111.751 -0.54 . . . . 11.58 111.751 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -64.02 -79.71 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.688 0.28 . . . . 10.61 111.208 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -100.88 -26.25 13.82 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.346 -0.613 . . . . 10.14 109.346 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -72.92 121.8 20.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 8.77 109.412 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.99 160.87 42.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.433 0.635 . . . . 5.74 112.431 -172.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' OE2' ' HD3' ' A' ' 7' ' ' ARG . 15.1 tp10 -141.37 77.04 1.57 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.065 -0.97 . . . . 5.7 108.512 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.4 ' HD3' ' OE2' ' A' ' 6' ' ' GLU . 7.9 mtp180 51.43 72.66 1.15 Allowed Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 115.666 -0.697 . . . . 6.85 110.95 -175.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' A' ' 9' ' ' PRO . 87.9 Cg_exo -47.94 -40.59 32.91 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.131 3.221 . . . . 2.8 115.672 -174.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 8' ' ' PRO . 30.2 Cg_endo -64.48 64.22 0.26 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.233 1.955 . . . . 2.76 113.365 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.2 t -95.18 83.04 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.075 -1.083 . . . . 2.0 108.075 171.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.551 HG12 ' HB ' ' A' ' 81' ' ' ILE . 2.9 m -90.32 146.64 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.081 0.467 . . . . 1.35 111.063 -169.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.782 ' HB ' HG22 ' A' ' 82' ' ' VAL . 90.5 m -94.68 125.96 39.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.861 -0.608 . . . . 0.64 110.704 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 59' ' ' PHE . 66.7 mt -83.42 122.61 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 1.3 110.125 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.59 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 56.2 mtt -132.75 170.37 15.36 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.148 -0.686 . . . . 0.79 109.148 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.29 179.41 16.64 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.597 -0.811 . . . . 0.31 111.762 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.596 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 50.5 t60 -85.41 158.96 20.09 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.867 0.842 . . . . 0.22 111.631 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 19' ' ' HIS . 5.7 p -73.58 155.27 6.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.495 -1.23 . . . . 0.36 109.643 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.678 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 25.9 t70 72.92 -17.56 0.4 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.211 0.529 . . . . 0.69 110.661 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.485 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 19.7 m170 -85.83 -6.57 59.07 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.001 -0.74 . . . . 0.63 109.001 171.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.807 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 131.29 39.25 0.26 Allowed Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 118.972 -1.585 . . . . 0.79 115.066 170.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -52.36 -65.97 0.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.559 1.18 . . . . 3.31 111.51 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.704 HG23 HG21 ' A' ' 45' ' ' ILE . 85.9 m -89.51 -29.68 18.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 1.21 110.696 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.62 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.08 -33.92 69.59 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.777 0.658 . . . . 1.25 112.777 -176.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.807 HD23 ' HA3' ' A' ' 20' ' ' GLY . 3.8 mm? -76.14 -33.33 59.4 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 122.142 -0.349 . . . . 1.49 110.447 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 1.6 tp -72.73 -7.43 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.431 -0.508 . . . . 1.69 109.831 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.83 -47.96 4.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.939 0.876 . . . . 1.23 109.65 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB1' ' HB1' ' A' ' 152' ' ' ALA . . . -64.89 -42.58 94.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.213 -1.358 . . . . 0.63 110.434 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 84.9 mt -74.07 -31.71 30.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.231 -0.895 . . . . 1.02 109.943 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.656 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 17.4 tpp180 -62.1 -36.15 80.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.409 0.623 . . . . 3.04 109.8 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -103.15 24.18 11.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.073 -0.967 . . . . 2.65 111.431 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 83.5 p -87.37 -45.98 10.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.586 -1.265 . . . . 1.46 107.586 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.508 ' HE3' ' O ' ' A' ' 51' ' ' THR . 57.5 pttt 178.84 -164.72 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.494 -1.23 . . . . 3.92 108.655 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.587 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 9.5 p 52.7 -62.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.36 1.464 . . . . 3.1 114.106 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 38' ' ' ALA . 49.5 p -107.96 176.04 5.27 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.746 0.419 . . . . 2.78 111.128 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -140.52 -38.35 0.44 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.577 0.227 . . . . 6.34 110.591 171.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -149.17 -85.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 6.79 110.742 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.68 ' HG3' HD11 ' A' ' 41' ' ' ILE . 40.5 tt0 -91.39 83.11 5.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.098 0.475 . . . . 6.24 110.857 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 34' ' ' THR . . . -155.43 132.79 10.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.641 -0.708 . . . . 4.95 109.662 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.44 -58.83 3.42 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.807 -0.711 . . . . 4.68 112.019 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.02 115.05 0.37 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.456 -0.878 . . . . 4.55 112.958 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.68 HD11 ' HG3' ' A' ' 37' ' ' GLU . 2.5 pp -145.33 149.21 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.475 -0.565 . . . . 5.57 109.475 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.3 m -155.44 -73.25 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.051 0.453 . . . . 5.93 110.373 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -162.37 -59.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.755 -0.831 . . . . 6.63 108.755 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -77.34 138.55 39.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.045 -1.094 . . . . 6.54 108.045 167.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.704 HG21 HG23 ' A' ' 22' ' ' THR . 2.5 pp -80.73 162.62 3.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.336 0.589 . . . . 5.17 111.389 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.24 -90.63 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.44 -1.064 . . . . 2.51 110.44 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB3' ' CA ' ' A' ' 60' ' ' LEU . . . -178.26 -167.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.513 0.197 . . . . 1.36 110.66 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -172.54 166.56 5.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.03 -0.532 . . . . 1.7 109.756 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.24 107.06 15.53 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.755 -0.461 . . . . 1.91 109.755 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.59 153.74 3.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.267 0.556 . . . . 1.53 110.304 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.875 HG23 ' HA ' ' A' ' 54' ' ' ASP . 16.6 m -100.5 90.92 4.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.704 0.764 . . . . 1.51 111.01 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 162' ' ' LEU . 3.8 p -77.05 -48.8 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.02 -1.104 . . . . 2.27 108.02 168.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.504 ' H ' HG13 ' A' ' 52' ' ' VAL . 1.8 p30 -112.97 -56.26 2.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.713 -1.585 . . . . 3.68 107.495 168.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.875 ' HA ' HG23 ' A' ' 51' ' ' THR . 30.6 t70 -179.67 106.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.283 -1.326 . . . . 2.99 111.045 163.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' H ' ' HA ' ' A' ' 51' ' ' THR . 45.1 mmtm 66.28 55.76 0.84 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.531 -0.758 . . . . 7.36 111.148 174.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.641 ' HG3' HG13 ' A' ' 57' ' ' ILE . 3.2 tppp? -130.3 140.46 50.66 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.704 -0.85 . . . . 4.46 108.704 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.666 HD13 HG22 ' A' ' 165' ' ' ILE . 21.8 mt 70.64 83.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 123.89 0.744 . . . . 0.92 110.275 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 60' ' ' LEU . 7.4 m -76.97 107.16 9.12 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.612 -0.884 . . . . 0.96 108.612 173.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.689 ' HB3' HD11 ' A' ' 13' ' ' ILE . 8.3 m-85 -60.76 -5.6 1.37 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.355 -0.839 . . . . 1.57 112.08 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' H ' HG22 ' A' ' 58' ' ' THR . 57.7 tp -80.06 130.61 35.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 3.21 110.149 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' HB3' HG23 ' A' ' 12' ' ' THR . 2.6 p30 -81.28 -163.57 0.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.861 -0.608 . . . . 5.61 111.143 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.69 ' HA ' ' SD ' ' A' ' 71' ' ' MET . 40.8 m 83.39 87.88 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.109 -0.951 . . . . 5.45 111.707 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -91.35 9.6 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.178 2.586 . . . . 6.11 111.799 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.54 -69.28 2.28 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.781 -0.645 . . . . 6.36 113.008 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -70.36 -65.17 0.76 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.823 0.305 . . . . 8.78 111.823 -174.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -75.28 143.1 43.17 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.76 -0.459 . . . . 7.05 109.76 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB1' ' H ' ' A' ' 71' ' ' MET . . . -119.34 68.73 0.81 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.925 0.393 . . . . 4.55 110.977 -173.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HB3' ' CE ' ' A' ' 14' ' ' MET . 80.1 m-85 -55.74 -68.22 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.34 -0.845 . . . . 2.37 112.335 -176.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.659 ' H ' ' HE3' ' A' ' 71' ' ' MET . 2.5 p -92.18 50.74 1.68 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 111.75 0.278 . . . . 4.9 111.75 -176.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 m 57.25 77.87 0.25 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.405 0.621 . . . . 5.84 110.743 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.69 ' SD ' ' HA ' ' A' ' 62' ' ' THR . 44.4 mtt -102.78 -66.42 0.93 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 5.21 110.158 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.641 ' HG3' ' H ' ' A' ' 73' ' ' ALA . 26.8 ptt180 -127.73 -78.01 0.57 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.273 -0.571 . . . . 8.21 111.236 170.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.641 ' H ' ' HG3' ' A' ' 72' ' ' ARG . . . -135.1 -75.84 0.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.09 0.405 . . . . 6.36 111.207 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.469 ' HG2' ' N ' ' A' ' 75' ' ' GLY . 29.9 ttm180 -166.84 158.92 13.15 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.437 -0.949 . . . . 9.65 108.437 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.469 ' N ' ' HG2' ' A' ' 74' ' ' ARG . . . -164.29 -118.07 0.43 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.778 -1.201 . . . . 4.93 112.661 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.64 152.99 10.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.09 -0.337 . . . . 5.47 110.09 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.422 ' HG2' ' HZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -125.36 175.63 7.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.903 -0.589 . . . . 6.26 110.359 176.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.52 -68.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 4.31 110.412 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.4 m -148.92 81.43 1.44 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.222 0.534 . . . . 3.41 109.694 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -107.35 -177.9 3.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.46 -0.791 . . . . 2.66 109.559 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.551 ' HB ' HG12 ' A' ' 11' ' ' VAL . 23.0 mt -135.86 134.38 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.909 -0.404 . . . . 0.71 109.909 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 12' ' ' THR . 18.7 t -115.63 118.73 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.255 0.55 . . . . 1.17 111.185 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 51.9 mt -82.41 131.38 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.32 -0.855 . . . . 0.37 109.73 172.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.43 HD13 ' C ' ' A' ' 84' ' ' LEU . 2.3 tm? -119.58 107.93 13.87 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.665 -0.865 . . . . 1.01 108.665 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.5 t -89.11 114.57 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.725 -0.67 . . . . 0.43 111.134 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 2.4 m -127.58 123.73 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.807 -0.633 . . . . 0.64 110.593 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.62 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.35 135.37 50.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.107 -0.497 . . . . 0.28 109.779 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -72.71 -15.59 61.68 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.05 0.452 . . . . 0.22 111.37 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.423 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 5.3 p-10 -90.35 -24.15 20.91 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.753 -0.658 . . . . 0.58 111.244 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.485 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 16.7 t0 -113.53 -41.63 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.56 111.245 -173.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.612 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.11 -131.54 10.7 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 114.419 0.528 . . . . 0.37 114.419 171.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.17 130.82 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.653 . . . . 1.03 110.568 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.696 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.7 mmm -131.32 177.78 2.07 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.461 -1.245 . . . . 0.28 109.377 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.696 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 61.2 Cg_exo -41.73 -63.16 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.093 2.529 . . . . 0.58 114.72 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.537 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.1 pt20 -72.97 -19.62 61.19 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.608 -0.437 . . . . 0.75 111.173 -174.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.596 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.82 -45.55 81.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.021 -0.733 . . . . 0.31 109.021 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 93' ' ' MET . 17.8 t -65.51 -43.6 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.889 -1.05 . . . . 1.38 112.065 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -57.02 -24.57 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.488 . . . . 2.35 110.71 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.59 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -76.97 -39.94 48.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.44 110.633 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.0 mt -71.53 -41.56 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.829 0.824 . . . . 0.41 109.41 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.484 ' ND2' HG12 ' A' ' 97' ' ' VAL . 23.1 m-20 -61.05 -28.79 69.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.324 -1.307 . . . . 0.67 110.89 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.476 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 5.0 t60 -83.77 -34.4 24.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.811 -0.44 . . . . 2.5 109.811 174.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.559 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -65.52 -42.09 92.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.198 -0.455 . . . . 0.47 111.046 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' NZ ' ' HB3' ' A' ' 135' ' ' ASN . 18.9 mmtp -73.18 -35.74 66.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.383 0.611 . . . . 1.66 109.796 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.33 -40.72 59.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.306 -1.316 . . . . 0.77 111.413 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.27 -35.19 15.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.338 -0.392 . . . . 0.74 110.96 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.4 t30 87.97 51.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.403 1.081 . . . . 1.41 109.609 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.11 141.73 23.09 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.969 -1.469 . . . . 1.35 110.58 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.01 140.65 66.84 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.549 2.166 . . . . 0.47 111.975 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.575 ' C ' HG23 ' A' ' 145' ' ' THR . 24.2 mm -104.2 158.71 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.46 0.648 . . . . 0.6 110.758 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.775 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 17.0 mm -129.32 88.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.553 -1.277 . . . . 0.37 107.553 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.942 HG23 HG21 ' A' ' 145' ' ' THR . 43.3 t -78.34 146.99 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.941 0.877 . . . . 0.26 110.338 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.896 ' HB1' HD11 ' A' ' 150' ' ' LEU . . . -139.79 111.06 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.925 -1.489 . . . . 0.29 110.144 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.802 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 2.8 mp -83.15 126.24 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.603 -1.18 . . . . 0.59 109.798 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.54 ' ND2' ' HG3' ' A' ' 116' ' ' LYS . 7.1 p-10 -114.35 168.79 9.54 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.42 -1.326 . . . . 1.85 107.42 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.734 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 89.4 mttt 70.44 31.57 2.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.927 0.767 . . . . 0.59 111.92 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.565 ' HA ' ' CB ' ' A' ' 122' ' ' ALA . 77.3 mmm -80.48 -9.7 59.76 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.505 0.669 . . . . 0.92 109.451 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.406 ' HB2' HG23 ' A' ' 154' ' ' THR . 8.3 p-10 -67.97 -32.54 73.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.968 -1.015 . . . . 0.76 109.415 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 28.6 mtmt -75.58 139.14 70.67 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.956 -1.02 . . . . 1.17 110.688 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.66 -15.8 51.96 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.885 2.39 . . . . 0.58 111.469 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -78.76 -7.81 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.11 -0.95 . . . . 1.45 110.27 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.565 ' CB ' ' HA ' ' A' ' 117' ' ' MET . . . -58.03 115.39 2.85 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.711 -0.677 . . . . 0.27 111.113 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.564 ' OD1' ' HB2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -128.71 77.58 77.32 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.432 -0.951 . . . . 0.95 108.432 173.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.576 ' HA ' HG22 ' A' ' 127' ' ' VAL . 49.5 Cg_endo -65.13 -50.8 1.86 Allowed 'Trans proline' 0 CA--C 1.5 -1.185 0 C-N-CA 123.267 2.644 . . . . 0.4 112.906 -171.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.605 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 8.1 m-20 -54.43 -26.93 33.63 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.958 -1.019 . . . . 1.44 110.042 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.564 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 37.4 ttp180 -79.09 -54.24 6.2 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.411 0.624 . . . . 3.79 109.339 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.799 HG21 ' HA ' ' A' ' 88' ' ' ALA . 21.9 m -65.22 -29.29 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.272 -0.876 . . . . 0.59 111.928 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.951 ' HA ' HD23 ' A' ' 131' ' ' LEU . 16.4 ptm -79.41 -14.87 58.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.827 0.346 . . . . 0.81 110.392 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.602 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 80.3 mt-30 -79.91 -24.85 40.83 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 121.025 -0.27 . . . . 1.31 110.487 171.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 6.5 mm-40 -67.95 -31.13 70.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.431 -0.952 . . . . 1.64 108.431 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.951 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -61.29 -46.0 92.13 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.581 -1.191 . . . . 1.36 109.335 175.21 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.561 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -74.82 -7.98 55.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 119.963 -0.695 . . . . 1.61 110.969 -178.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 28.3 mm-40 -72.26 -28.13 62.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.542 -0.91 . . . . 1.67 108.542 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -102.96 31.8 4.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.037 -0.983 . . . . 1.08 110.255 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 104' ' ' LYS . 63.3 t30 55.68 43.49 27.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.699 -1.137 . . . . 1.1 111.761 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.561 ' H ' ' HA ' ' A' ' 132' ' ' MET . 52.5 mt -112.66 104.68 12.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.968 -0.56 . . . . 1.36 109.734 172.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.093 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 24.5 t -104.28 117.08 60.21 Favored Pre-proline 0 C--N 1.314 -0.954 0 C-N-CA 120.121 -0.632 . . . . 0.43 111.322 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.718 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.2 Cg_exo -43.73 139.72 5.04 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 124.196 3.264 . . . . 0.54 112.409 171.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -71.6 -18.69 62.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.411 -1.268 . . . . 3.08 110.114 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.0 pm0 -62.25 -27.11 68.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.759 -0.655 . . . . 1.57 110.089 168.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.602 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 39.4 m0 -102.53 -27.83 12.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.387 -0.369 . . . . 0.66 110.69 -175.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.48 2.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.769 -0.729 . . . . 0.53 112.977 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 1.093 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.25 -119.26 2.54 Favored Glycine 0 CA--C 1.507 -0.46 0 C-N-CA 119.846 -1.169 . . . . 0.6 112.245 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -151.81 59.47 0.86 Allowed 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.773 0.797 . . . . 1.91 111.438 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.942 HG21 HG23 ' A' ' 112' ' ' VAL . 97.6 m -165.27 123.94 1.68 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.351 -0.841 . . . . 0.37 110.488 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.775 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 27.3 mm -75.59 104.25 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.096 -0.705 . . . . 0.63 109.096 171.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.744 ' HE2' HD23 ' A' ' 131' ' ' LEU . 12.6 m-85 -88.28 117.73 27.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.396 -0.82 . . . . 0.5 110.196 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.2 m -101.42 136.74 40.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.057 -0.349 . . . . 0.68 110.057 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.564 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.7 mttt -108.0 91.92 3.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.377 . . . . 1.44 109.981 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.052 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -120.85 -167.72 1.53 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 123.077 1.418 . . . . 0.84 113.334 -174.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.403 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.1 OUTLIER -164.81 106.48 0.83 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.315 -1.766 . . . . 1.77 106.411 174.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.543 ' HB1' ' HB1' ' A' ' 27' ' ' ALA . . . -65.83 -14.16 60.9 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.62 -0.718 . . . . 0.41 109.434 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -52.98 30.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.15 -0.932 . . . . 2.3 110.62 173.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 118' ' ' ASP . 1.1 p -84.99 -7.67 59.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.398 0.518 . . . . 0.7 112.398 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.571 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.8 mmtp 63.17 46.5 4.57 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.668 -0.696 . . . . 1.36 111.398 176.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.61 -70.79 0.78 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 123.039 1.4 . . . . 2.48 110.602 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 1.052 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -67.45 -8.51 51.65 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 113.664 -1.607 . . . . 0.29 113.269 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.571 HD12 ' HD3' ' A' ' 155' ' ' LYS . 28.6 mt -69.4 -40.48 77.34 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 117.785 0.793 . . . . 0.8 109.423 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.24 -44.2 88.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.345 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -70.87 -17.75 62.71 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.06 -0.518 . . . . 0.58 111.452 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 113' ' ' ALA . 5.9 mt -72.06 -57.49 4.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.011 0.434 . . . . 1.16 110.226 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.519 HD13 HG23 ' A' ' 52' ' ' VAL . 4.3 pp -60.66 -29.35 69.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.498 -0.774 . . . . 1.51 110.804 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.411 ' N ' HD12 ' A' ' 162' ' ' LEU . 29.7 mm-40 -63.17 -51.67 65.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.993 0.425 . . . . 2.57 110.589 174.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.492 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 17.1 mmt -67.72 -46.25 72.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.64 110.533 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.666 HG22 HD13 ' A' ' 57' ' ' ILE . 98.7 mt -58.13 -44.12 86.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.682 -0.69 . . . . 0.52 110.971 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -41.37 86.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.423 -0.353 . . . . 1.73 111.19 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.42 -43.47 67.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.284 0.564 . . . . 1.51 109.567 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 111' ' ' ILE . 92.6 t -69.21 -43.38 81.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.812 -1.086 . . . . 0.89 111.02 176.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.6 m -60.23 -39.87 88.2 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.671 0.272 . . . . 1.35 111.607 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -80.9 -14.7 57.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.121 0.486 . . . . 2.73 110.387 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.59 ' HG2' ' HA ' ' A' ' 175' ' ' LYS . 46.1 ttp -75.26 -10.36 59.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.767 -0.651 . . . . 1.88 110.536 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.524 ' O ' ' HE2' ' A' ' 175' ' ' LYS . 36.8 tt0 -46.47 -50.96 16.18 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.161 -0.472 . . . . 4.27 110.828 175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -100.13 -21.23 15.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.502 0.668 . . . . 3.91 110.242 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.59 48.28 0.85 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.475 -0.784 . . . . 5.72 110.54 -173.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.72 ' H ' ' HD2' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -48.32 118.8 2.61 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.898 0.38 . . . . 5.49 111.324 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.12 133.86 39.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.254 -0.43 . . . . 5.78 110.1 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 4.5 p-10 -110.51 124.06 34.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 121.271 0.557 . . . . 7.88 110.635 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 10.7 Cg_endo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 123.428 2.752 . . . . 9.19 111.765 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.734 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.813 -0.115 . . . . 11.58 112.813 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -81.01 118.49 22.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.273 0.471 . . . . 10.61 112.273 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 m80 58.49 67.61 0.92 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.608 -0.724 . . . . 10.14 112.655 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.7 mmt -109.55 -57.86 2.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.178 0.513 . . . . 8.77 109.927 173.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.79 -21.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.508 0.67 . . . . 5.74 109.332 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.43 93.01 9.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.474 -0.785 . . . . 5.7 110.093 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -140.18 76.62 26.54 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.582 -0.735 . . . . 6.85 110.217 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HD2' ' HD3' ' A' ' 9' ' ' PRO . 38.8 Cg_exo -57.61 -51.59 7.93 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.646 2.897 . . . . 2.8 115.486 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.598 ' HB2' ' H ' ' A' ' 57' ' ' ILE . 12.6 Cg_exo -69.15 91.53 0.45 Allowed 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 121.873 1.715 . . . . 2.76 113.529 -171.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.1 139.32 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.859 -0.61 . . . . 2.0 110.045 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 97.9 t -135.24 109.14 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.117 -0.492 . . . . 1.35 111.076 -175.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.715 ' HB ' HG22 ' A' ' 82' ' ' VAL . 91.4 m -77.87 134.69 37.89 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.755 0.312 . . . . 0.64 110.816 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.921 HG13 HD21 ' A' ' 25' ' ' LEU . 45.9 mm -96.97 118.86 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 1.3 110.667 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.62 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 61.5 mtt -131.28 176.05 8.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.175 -0.676 . . . . 0.79 109.175 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' HA2' HD13 ' A' ' 84' ' ' LEU . . . 139.42 -159.58 25.78 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.654 -0.784 . . . . 0.31 111.653 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.599 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 11.8 t-80 -101.97 162.05 13.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.036 0.922 . . . . 0.22 112.167 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.431 ' C ' ' H ' ' A' ' 19' ' ' HIS . 7.4 p -81.86 150.61 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.255 -1.339 . . . . 0.36 110.726 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.571 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 30.9 t70 71.6 -23.43 0.19 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.423 0.689 . . . . 0.69 111.362 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.458 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 23.5 m170 -62.79 -38.19 89.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.997 -1.482 . . . . 0.63 106.997 163.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 140.76 55.95 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.828 . . . . 0.79 113.751 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -61.4 2.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.49 0.645 . . . . 3.31 111.483 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -87.68 -40.12 14.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.919 0.39 . . . . 1.21 111.452 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -27.44 62.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 1.25 112.179 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -62.12 -51.21 68.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 1.49 109.843 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.921 HD21 HG13 ' A' ' 13' ' ' ILE . 76.8 mt -71.38 -14.61 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.857 -0.611 . . . . 1.69 111.025 -174.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 19.2 t70 -90.47 -38.63 13.12 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.469 -0.938 . . . . 1.23 108.469 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -70.6 -35.14 72.83 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.29 -1.323 . . . . 0.63 110.186 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' A' ' 25' ' ' LEU . 13.1 tt -76.7 -33.01 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.969 -1.014 . . . . 1.02 111.102 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 24.1 ptt85 -76.44 -35.35 58.55 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.85 0.833 . . . . 3.04 109.4 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -84.96 21.91 1.5 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.364 -1.289 . . . . 2.65 110.495 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -121.07 16.16 11.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.55 -1.205 . . . . 1.46 110.191 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 1.3 ptpp? 176.05 -153.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.342 0.592 . . . . 3.92 111.149 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' H ' ' HB2' ' A' ' 32' ' ' LYS . 21.6 t -114.31 138.7 43.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.837 -1.074 . . . . 3.1 111.222 -175.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.472 HG23 ' HA2' ' A' ' 40' ' ' GLY . 4.0 t -156.55 175.5 13.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.446 -0.946 . . . . 2.78 108.446 172.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.624 ' HG3' ' HB ' ' A' ' 41' ' ' ILE . 1.9 tm-20 58.79 -156.97 0.33 Allowed 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.323 0.39 . . . . 6.34 110.738 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -90.98 -2.31 57.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.748 -0.381 . . . . 6.79 110.964 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -140.69 139.72 34.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 6.24 111.353 -176.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.11 105.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.566 -0.743 . . . . 4.95 111.499 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.49 -28.54 2.44 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.832 -0.907 . . . . 4.68 110.832 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.472 ' HA2' HG23 ' A' ' 34' ' ' THR . . . 95.35 -157.29 21.9 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.894 -0.67 . . . . 4.55 112.782 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.624 ' HB ' ' HG3' ' A' ' 35' ' ' GLU . 12.7 tt -136.5 144.06 33.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.656 -0.498 . . . . 5.57 109.656 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.431 ' O ' HG22 ' A' ' 45' ' ' ILE . 6.2 m -100.31 -83.39 0.44 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.21 -0.293 . . . . 5.93 110.21 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 58.74 9.49 1.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.788 0.435 . . . . 6.63 111.995 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 52.85 42.84 32.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.259 -0.428 . . . . 6.54 111.094 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.462 HG12 ' N ' ' A' ' 46' ' ' GLY . 14.5 tt -91.06 160.89 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.223 0.535 . . . . 5.17 110.104 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 45' ' ' ILE . . . -96.67 98.43 2.17 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.382 -0.826 . . . . 2.51 112.141 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.77 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . 73.08 177.9 0.24 Allowed 'General case' 0 CA--C 1.534 0.34 0 O-C-N 124.195 0.585 . . . . 1.36 111.182 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.495 ' CZ ' HG22 ' A' ' 50' ' ' VAL . 2.2 p90 -171.49 170.92 5.63 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 119.846 -0.742 . . . . 1.7 112.086 -169.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HG2' ' CG2' ' A' ' 58' ' ' THR . 82.7 mt-30 -98.04 124.08 42.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.376 -0.829 . . . . 1.91 109.889 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.495 HG22 ' CZ ' ' A' ' 48' ' ' TYR . 3.5 t -94.72 150.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.158 0.504 . . . . 1.53 111.042 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.9 m -107.03 84.13 1.93 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.418 0.628 . . . . 1.51 110.792 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 53' ' ' ASN . 7.5 p -76.83 -43.07 33.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.905 -1.146 . . . . 2.27 107.905 171.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.417 ' N ' HG13 ' A' ' 52' ' ' VAL . 89.0 m-20 -133.47 -52.71 0.88 Allowed 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 113.615 -1.63 . . . . 3.68 107.656 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -173.7 92.2 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.532 -1.213 . . . . 2.99 110.57 172.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.5 mttp 62.54 36.27 13.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.632 -0.713 . . . . 7.36 112.787 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.878 ' HG2' HG13 ' A' ' 57' ' ' ILE . 12.7 ttmt -100.21 142.12 32.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.003 -0.74 . . . . 4.46 109.003 171.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.878 HG13 ' HG2' ' A' ' 56' ' ' LYS . 19.6 mt 69.12 72.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.741 0.781 . . . . 0.92 110.181 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.45 ' CG2' ' HG2' ' A' ' 49' ' ' GLN . 97.1 m -84.78 104.51 14.81 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.259 -0.882 . . . . 0.96 109.695 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.77 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 78.1 m-85 -72.09 123.25 22.44 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.216 -1.401 . . . . 1.57 107.216 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.601 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 33.0 tp -149.45 99.96 2.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.837 0.351 . . . . 3.21 111.521 -172.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.609 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 7.0 p-10 -114.18 120.62 41.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.111 -0.7 . . . . 5.61 109.111 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 40.3 m -105.82 131.56 21.64 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.83 -0.623 . . . . 5.45 110.966 -174.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 62' ' ' THR . 13.3 Cg_exo -70.7 49.57 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.201 2.6 . . . . 6.11 112.77 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.64 -56.62 0.96 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.994 -0.842 . . . . 6.36 110.994 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.401 ' HB3' ' HE1' ' A' ' 102' ' ' HIS . 59.0 m-70 -132.85 90.72 2.8 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.536 -0.542 . . . . 8.78 109.536 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 67.07 -67.27 0.17 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.126 0.891 . . . . 7.05 110.835 -174.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 61' ' ' ASP . . . -159.66 -23.95 0.07 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.084 -0.507 . . . . 4.55 110.769 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' HD2' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -71.22 134.27 46.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.23 0.538 . . . . 2.37 111.523 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.516 ' HB ' ' HG3' ' A' ' 71' ' ' MET . 3.4 m -85.39 157.59 20.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.306 -0.861 . . . . 4.9 110.294 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 p -78.9 62.8 3.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.014 0.435 . . . . 5.84 111.156 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.516 ' HG3' ' HB ' ' A' ' 69' ' ' THR . 69.0 mtm -95.91 36.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.054 -0.521 . . . . 5.21 111.707 -174.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 72' ' ' ARG . 60.2 mtt180 -84.89 -3.05 58.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 8.21 110.41 175.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.63 12.58 24.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.747 -0.66 . . . . 6.36 110.063 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -107.97 -14.95 14.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.116 -0.947 . . . . 9.65 110.905 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.41 -157.03 27.07 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.704 -0.76 . . . . 4.93 112.191 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.73 -41.32 1.18 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.767 0.318 . . . . 5.47 111.183 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -90.55 11.55 21.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.434 0.635 . . . . 6.26 110.133 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.42 79.31 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.274 -0.876 . . . . 4.31 110.396 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -72.38 134.99 45.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.649 -0.705 . . . . 3.41 111.165 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -89.52 173.38 8.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.729 -0.668 . . . . 2.66 110.818 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.0 mt -127.76 119.68 52.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.182 -0.917 . . . . 0.71 109.442 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.715 HG22 ' HB ' ' A' ' 12' ' ' THR . 15.2 t -107.64 124.36 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.17 0.509 . . . . 1.17 111.635 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 8.2 mt -84.41 132.27 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.524 -0.762 . . . . 0.37 110.555 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.942 HD12 HG13 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -102.3 106.39 17.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.523 -0.762 . . . . 1.01 110.412 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.2 t -84.12 94.08 3.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.933 -0.576 . . . . 0.43 109.738 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.942 HG13 HD12 ' A' ' 84' ' ' LEU . 2.4 m -119.93 123.62 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.927 -0.578 . . . . 0.64 110.523 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.524 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -72.32 131.65 42.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.929 -0.578 . . . . 0.28 110.191 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.801 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -65.5 -14.25 60.61 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.077 0.465 . . . . 0.22 111.063 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.23 8.34 44.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.523 -0.762 . . . . 0.58 111.011 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.419 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 12.9 t0 -149.08 -45.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 0.56 110.973 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.458 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 89.18 -141.49 16.29 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.335 -0.46 . . . . 0.37 113.477 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.33 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.347 0.594 . . . . 1.03 110.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.702 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 79.2 mmm -141.42 176.89 2.16 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 0.28 108.962 -173.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.702 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.3 Cg_exo -41.49 -66.62 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.165 2.577 . . . . 0.58 114.843 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.599 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 9.1 pt20 -71.71 -20.28 61.94 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.259 0.552 . . . . 0.75 110.872 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.534 ' HB ' ' H ' ' A' ' 93' ' ' MET . 0.2 OUTLIER -65.54 -44.03 88.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.513 -0.767 . . . . 0.31 109.375 178.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.555 HG12 ' ND2' ' A' ' 101' ' ' ASN . 19.8 t -67.56 -41.74 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.38 -0.827 . . . . 1.38 111.33 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -55.33 -30.68 60.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.104 0.478 . . . . 2.35 110.319 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.15 -39.09 75.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 0.44 110.798 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 72.3 mt -72.35 -43.02 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.852 0.834 . . . . 0.41 109.172 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.555 ' ND2' HG12 ' A' ' 97' ' ' VAL . 55.5 m-20 -59.91 -33.05 71.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.191 -1.368 . . . . 0.67 110.941 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.439 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 4.2 t60 -79.76 -34.49 39.79 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.735 -0.469 . . . . 2.5 109.735 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.534 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -74.42 -42.61 58.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.179 0.437 . . . . 0.47 112.179 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 12.7 mmmm -76.76 -37.92 55.07 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.058 0.456 . . . . 1.66 110.787 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.07 -30.09 70.75 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.252 -0.885 . . . . 0.77 110.709 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.96 -17.19 41.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.74 110.524 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 70.34 60.92 0.23 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.927 -1.033 . . . . 1.41 110.093 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 1.1 t -123.78 145.42 47.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 1.35 111.303 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 20.2 Cg_exo -69.8 144.89 55.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 123.352 2.701 . . . . 0.47 112.45 172.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.534 HD11 ' HB1' ' A' ' 103' ' ' ALA . 30.6 mm -111.2 158.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.422 0.63 . . . . 0.6 110.654 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.822 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 21.7 mm -129.21 84.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.599 -1.26 . . . . 0.37 107.599 171.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.934 HG13 ' HB3' ' A' ' 84' ' ' LEU . 17.7 t -74.55 152.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.636 0.732 . . . . 0.26 110.525 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 148' ' ' CYS . . . -139.35 107.24 5.67 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.613 -1.176 . . . . 0.29 110.031 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.801 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.5 mp -79.99 105.66 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.554 -1.203 . . . . 0.59 108.843 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.675 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 1.2 p-10 -106.34 173.66 6.22 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 106.807 -1.553 . . . . 1.85 106.807 -169.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.731 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 83.3 mttt 65.51 36.24 6.76 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.768 0.667 . . . . 0.59 110.491 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 84.3 mmm -82.34 -13.15 57.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.351 -0.841 . . . . 0.92 109.162 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.7 -30.92 71.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.688 -1.142 . . . . 0.76 109.062 171.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 116' ' ' LYS . 18.6 mmmt -64.91 132.04 95.36 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 114.442 -1.254 . . . . 1.17 110.024 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.84 -16.5 54.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.548 2.165 . . . . 0.58 111.065 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -90.77 10.98 23.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.101 -0.954 . . . . 1.45 110.37 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.6 118.09 4.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.448 -0.796 . . . . 0.27 110.665 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -127.64 76.02 77.33 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.736 -0.838 . . . . 0.95 108.736 174.026 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.798 ' O ' ' HG3' ' A' ' 128' ' ' MET . 37.2 Cg_endo -63.55 -63.34 0.08 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 123.135 2.557 . . . . 0.4 113.395 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.505 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 6.6 m-20 -55.47 -21.34 15.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 1.44 110.998 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.2 tpt180 -72.36 -56.54 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.695 0.759 . . . . 3.79 109.528 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.628 ' HA ' ' HG3' ' A' ' 130' ' ' GLU . 17.4 m -64.79 -29.74 48.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.808 -1.087 . . . . 0.59 111.596 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.798 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 42.5 mtp -61.44 -39.72 91.87 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.398 0.618 . . . . 0.81 109.527 174.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.595 ' O ' ' HG2' ' A' ' 132' ' ' MET . 38.1 mt-30 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.987 -1.006 . . . . 1.31 111.627 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.628 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 6.3 mt-10 -72.37 -32.56 66.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.29 0.567 . . . . 1.64 109.997 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.906 HD12 HD21 ' A' ' 136' ' ' LEU . 4.3 mm? -65.44 -37.44 86.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 1.36 110.176 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.595 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 12.5 ptm -76.49 -14.07 60.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.162 -0.615 . . . . 1.61 110.239 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 7.3 mm-40 -71.15 -28.38 64.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.966 -0.753 . . . . 1.67 108.966 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.53 20.41 10.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.007 0.908 . . . . 1.08 110.157 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 60.65 49.97 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.578 -1.646 . . . . 1.1 112.2 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.906 HD21 HD12 ' A' ' 131' ' ' LEU . 1.9 pp -131.25 120.76 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.524 -1.288 . . . . 1.36 107.524 166.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.832 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.9 t -109.29 129.19 24.19 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 0.43 112.367 -165.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 98.0 Cg_exo -43.21 146.62 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.608 3.539 . . . . 0.54 113.435 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.52 ' HB2' HD13 ' A' ' 146' ' ' ILE . 5.9 mm-40 -75.53 -22.1 57.38 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.347 -1.297 . . . . 3.08 110.412 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 2.2 pm0 -67.39 -21.4 65.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.258 -0.883 . . . . 1.57 110.036 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.483 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 38.4 m0 -105.77 -17.41 14.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.394 -0.366 . . . . 0.66 110.55 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.46 21.75 9.63 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.795 -0.716 . . . . 0.53 113.642 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.832 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -82.92 -105.28 0.48 Allowed Glycine 0 CA--C 1.51 -0.271 0 C-N-CA 120.138 -1.029 . . . . 0.6 111.943 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -166.1 62.2 0.1 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.316 1.055 . . . . 1.91 110.665 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.71 HG21 HG23 ' A' ' 112' ' ' VAL . 56.5 m -164.26 111.91 1.11 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.759 -1.109 . . . . 0.37 111.207 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.822 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.3 mm -69.49 107.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.426 -0.583 . . . . 0.63 109.426 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.697 ' HD2' HD11 ' A' ' 114' ' ' ILE . 10.7 m-85 -88.78 110.19 20.81 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.24 -0.891 . . . . 0.5 110.311 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 80.6 m -98.75 116.37 30.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.416 -0.356 . . . . 0.68 111.371 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.497 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 95.2 mttt -87.31 91.19 8.64 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.036 -0.357 . . . . 1.44 110.036 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.976 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.9 OUTLIER -122.48 173.62 7.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.331 1.062 . . . . 0.84 112.089 -173.312 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.2 OUTLIER -138.9 104.91 5.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.38 -0.97 . . . . 1.77 108.38 165.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.559 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . . . -61.68 -18.99 61.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.309 -0.86 . . . . 0.41 109.708 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.812 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 13.5 tmtt? -63.25 -57.78 9.33 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.993 -1.003 . . . . 2.3 110.736 173.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 p -78.71 -7.85 58.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.215 0.45 . . . . 0.7 112.215 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.572 ' HD3' HD12 ' A' ' 158' ' ' LEU . 15.6 mmtp 66.78 42.8 2.51 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 123.684 0.615 . . . . 1.36 111.776 174.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -115.75 -63.5 1.44 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.183 0.992 . . . . 2.48 110.006 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.976 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -68.79 -11.83 63.58 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 114.495 -1.229 . . . . 0.29 113.605 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.572 HD12 ' HD3' ' A' ' 155' ' ' LYS . 17.4 mt -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 117.856 0.828 . . . . 0.8 110.373 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 6.5 m-20 -81.49 -33.08 32.15 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.69 -0.687 . . . . 2.2 110.422 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -61.42 -32.45 72.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.05 -0.352 . . . . 0.58 110.05 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 83' ' ' ILE . 60.2 tp -59.72 -55.96 27.8 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.857 -0.61 . . . . 1.16 109.541 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.3 mt -56.67 -45.09 81.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.823 -1.08 . . . . 1.51 110.033 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 53.2 mt-10 -53.22 -43.9 67.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.639 -0.71 . . . . 2.57 111.338 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.442 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -76.19 -32.71 59.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.817 -0.353 . . . . 0.64 110.41 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 83' ' ' ILE . 80.8 mt -65.66 -51.26 64.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 0.52 111.108 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.568 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 4.0 pp -65.39 -34.25 77.87 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 121.056 -0.258 . . . . 1.73 110.552 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 166' ' ' LEU . 1.3 tm? -50.7 -48.11 58.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.397 -0.594 . . . . 1.51 109.397 173.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.56 -46.64 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.646 -0.706 . . . . 0.89 110.629 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 34.0 t -63.26 -23.0 67.23 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.487 0.551 . . . . 1.35 112.487 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 33.3 mm-40 -84.73 -24.09 29.01 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.789 -0.569 . . . . 2.73 111.204 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.452 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 26.0 ptt? -103.55 -7.69 20.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.381 -0.372 . . . . 1.88 111.276 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 169' ' ' SER . 11.0 pt-20 -54.32 -12.29 0.64 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.504 0.927 . . . . 4.27 113.504 -173.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.09 -58.02 9.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.224 -0.19 . . . . 3.91 110.589 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.62 -44.74 2.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.369 0.604 . . . . 5.72 109.708 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 171' ' ' MET . 19.2 mttt -78.64 64.84 3.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.453 -0.794 . . . . 5.49 111.631 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -106.71 39.43 1.84 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.458 0.647 . . . . 5.78 109.49 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 8.7 t30 -150.42 132.12 7.72 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.21 -0.905 . . . . 7.88 109.986 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 46.3 Cg_exo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 123.16 2.574 . . . . 9.19 112.62 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.812 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.957 -0.457 . . . . 11.58 111.957 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 m -79.73 57.63 2.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.214 0.53 . . . . 10.61 110.758 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -123.81 109.25 13.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.611 . . . . 10.14 110.149 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -90.57 -29.04 18.08 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.312 -0.625 . . . . 8.77 109.312 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t 70.39 -77.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.074 -0.966 . . . . 5.74 110.912 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -133.7 134.87 43.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.908 0.385 . . . . 5.7 110.035 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -147.83 114.62 4.03 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.572 -0.74 . . . . 6.85 109.76 -178.071 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 45.2 Cg_endo -70.2 124.09 10.57 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.487 2.124 . . . . 2.8 112.201 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 14.0 Cg_exo -70.37 69.82 1.95 Allowed 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.068 2.512 . . . . 2.76 112.083 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' THR . 4.8 p -90.66 114.94 28.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.61 0.719 . . . . 2.0 110.3 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 59' ' ' PHE . 76.6 t -119.26 133.06 67.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.701 -0.681 . . . . 1.35 110.453 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.785 ' HB ' HG22 ' A' ' 82' ' ' VAL . 36.9 m -93.62 126.1 38.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.866 -0.334 . . . . 0.64 110.431 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.642 ' H ' HD11 ' A' ' 60' ' ' LEU . 64.1 mt -99.51 127.78 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.993 -0.373 . . . . 1.3 109.993 177.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.63 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 63.2 mtt -134.43 165.31 25.46 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.454 -0.573 . . . . 0.79 109.454 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.04 -175.34 36.01 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.566 -0.826 . . . . 0.31 111.788 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.632 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 44.0 t60 -88.06 158.42 18.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.875 0.845 . . . . 0.22 111.648 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 7.3 p -69.8 153.41 8.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.414 -1.267 . . . . 0.36 109.356 172.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.9 t70 73.96 -22.0 0.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.236 0.541 . . . . 0.69 110.713 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.48 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 12.8 m170 -84.98 3.55 37.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.132 -1.062 . . . . 0.63 108.132 171.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.452 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 86.81 58.36 1.93 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.775 -1.102 . . . . 0.79 113.596 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.5 2.98 34.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.674 0.75 . . . . 3.31 110.183 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -136.69 -44.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.268 -0.878 . . . . 1.21 109.634 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.76 -29.26 59.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.737 -0.665 . . . . 1.25 112.022 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 85' ' ' VAL . 15.8 tp -67.64 -42.34 82.4 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.436 -0.579 . . . . 1.49 109.436 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -68.15 -11.54 59.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.189 -0.914 . . . . 1.69 110.534 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.45 -38.99 8.98 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.923 0.868 . . . . 1.23 109.593 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.77 67.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.364 -1.289 . . . . 0.63 110.6 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.44 HG23 ' OH ' ' A' ' 48' ' ' TYR . 9.8 tt -69.71 -18.57 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.854 -1.066 . . . . 1.02 110.399 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -60.62 -56.63 19.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.869 -0.605 . . . . 3.04 110.952 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -90.41 27.55 1.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.277 -0.874 . . . . 2.65 110.96 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 t -103.01 -2.19 28.01 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.606 -1.179 . . . . 1.46 111.42 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.735 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -167.75 -175.46 2.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.761 0.315 . . . . 3.92 111.171 -177.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 t -82.06 73.84 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.222 0.534 . . . . 3.1 112.074 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.79 129.23 5.99 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.543 -0.54 . . . . 2.78 109.543 173.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -54.61 1.27 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.969 0.359 . . . . 6.34 111.969 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.514 ' HA ' HD13 ' A' ' 41' ' ' ILE . 14.2 pt20 -140.52 -36.53 0.47 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.591 0.234 . . . . 6.79 111.11 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HG2' ' H ' ' A' ' 38' ' ' ALA . 29.0 tt0 -100.99 179.58 4.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.218 -0.66 . . . . 6.24 109.218 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.507 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . 71.9 -13.68 0.57 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.43 0.692 . . . . 4.95 111.519 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 1.043 ' HA3' ' HB2' ' A' ' 49' ' ' GLN . . . 145.45 -8.83 1.64 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.703 -0.76 . . . . 4.68 112.899 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -52.87 -64.94 3.7 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.468 -0.396 . . . . 4.55 112.513 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 36' ' ' GLN . 2.2 mp -107.03 107.42 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.334 -0.987 . . . . 5.57 108.334 171.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.6 t -129.76 164.09 24.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.138 -0.483 . . . . 5.93 110.899 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.467 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 13.1 mm-40 -84.98 43.72 1.02 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.555 -0.748 . . . . 6.63 110.617 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -135.89 57.46 1.78 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.314 -0.995 . . . . 6.54 108.314 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 62' ' ' THR . 16.8 tt -53.43 153.44 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.82 0.819 . . . . 5.17 112.35 -171.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.89 -43.05 1.79 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 114.395 -1.275 . . . . 2.51 110.488 -170.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 59' ' ' PHE . . . -152.48 -158.45 0.9 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.013 -0.736 . . . . 1.36 109.013 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 3.6 p90 -165.93 177.13 7.3 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.529 -0.468 . . . . 1.7 110.974 -173.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.043 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 47.8 mt-30 -95.85 121.66 37.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.45 -0.795 . . . . 1.91 110.246 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.636 HG21 ' HE2' ' A' ' 59' ' ' PHE . 61.3 t -83.19 157.66 3.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.001 -0.545 . . . . 1.53 110.661 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.916 HG23 ' HA ' ' A' ' 54' ' ' ASP . 40.6 m -152.26 83.63 1.26 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.542 -0.753 . . . . 1.51 109.354 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.789 HG13 ' H ' ' A' ' 53' ' ' ASN . 2.5 p -58.02 -62.14 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.404 0.621 . . . . 2.27 109.394 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.789 ' H ' HG13 ' A' ' 52' ' ' VAL . 98.3 m-20 -113.94 -55.15 2.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.516 -1.29 . . . . 3.68 107.516 170.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.916 ' HA ' HG23 ' A' ' 51' ' ' THR . 29.9 t70 -172.09 64.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.169 -1.378 . . . . 2.99 108.918 167.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.83 97.08 5.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.935 -1.03 . . . . 7.36 108.308 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -69.21 89.17 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.437 -0.801 . . . . 4.46 111.872 -171.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.2 mt -98.81 102.54 13.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.162 -0.681 . . . . 0.92 109.162 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.513 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 7.3 m -94.6 98.0 10.51 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.354 -0.538 . . . . 0.96 110.315 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.636 ' HE2' HG21 ' A' ' 50' ' ' VAL . 73.6 m-85 -66.15 150.23 49.07 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.633 -0.712 . . . . 1.57 110.242 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.642 HD11 ' H ' ' A' ' 13' ' ' ILE . 5.3 mp 38.52 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.226 1.01 . . . . 3.21 113.616 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -73.84 78.69 1.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.094 0.473 . . . . 5.61 110.629 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 5.1 m 60.25 80.31 0.27 Allowed Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.426 -0.807 . . . . 5.45 111.6 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 37.7 Cg_endo -65.93 88.81 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.987 2.458 . . . . 6.11 112.111 177.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.63 -85.07 0.74 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.919 -0.657 . . . . 6.36 112.393 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -79.98 -6.06 56.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.545 0.212 . . . . 8.78 111.558 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HG3' ' H ' ' A' ' 68' ' ' PHE . 9.9 tp10 -171.51 157.32 4.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.235 -0.654 . . . . 7.05 109.235 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . . . -67.79 -42.21 82.0 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.553 -0.536 . . . . 4.55 109.553 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.821 ' HZ ' HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -63.21 118.36 7.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.168 -0.924 . . . . 2.37 110.491 173.053 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.6 p -70.11 130.89 43.33 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.943 -0.392 . . . . 4.9 109.943 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 p -92.16 90.56 7.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.014 0.435 . . . . 5.84 111.258 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -66.41 95.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.753 -0.658 . . . . 5.21 110.34 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -62.03 -21.72 65.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.02 -0.991 . . . . 8.21 111.401 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.09 66.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 6.36 111.382 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 51.77 75.51 0.21 Allowed 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.52 0.512 . . . . 9.65 111.102 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.27 -108.9 0.6 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.329 -0.938 . . . . 4.93 112.113 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.42 86.51 3.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.98 0.419 . . . . 5.47 110.735 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.546 ' HA ' ' OD1' ' A' ' 80' ' ' ASP . 3.1 pt20 -75.58 55.42 0.83 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.511 0.672 . . . . 6.26 111.41 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.3 p -106.01 -19.99 6.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.59 -0.732 . . . . 4.31 109.787 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -92.59 -9.71 40.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.746 -0.661 . . . . 3.41 109.976 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.546 ' OD1' ' HA ' ' A' ' 77' ' ' GLN . 1.4 m-20 -71.88 91.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.325 -0.852 . . . . 2.66 109.501 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.4 mt -124.08 133.21 69.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.423 -0.353 . . . . 0.71 110.688 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.785 HG22 ' HB ' ' A' ' 12' ' ' THR . 24.7 t -120.98 125.96 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.425 0.631 . . . . 1.17 111.491 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 21.3 mt -84.46 132.27 31.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.987 -1.006 . . . . 0.37 109.636 172.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 86' ' ' VAL . 1.7 tm? -120.48 109.87 15.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.703 -0.851 . . . . 1.01 108.703 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 24' ' ' LEU . 59.8 t -92.69 111.28 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.626 -0.715 . . . . 0.43 110.731 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 2.2 m -121.0 129.36 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 116.01 -0.541 . . . . 0.64 111.031 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB1' ' HE3' ' A' ' 116' ' ' LYS . . . -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.726 -0.67 . . . . 0.28 110.074 174.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.73 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -78.49 -7.98 58.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 0.22 110.164 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.837 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 3.1 p-10 -106.27 7.15 31.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.454 -0.794 . . . . 0.58 111.096 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.48 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 22.3 t70 -144.48 -41.43 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 0.56 110.068 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.726 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 90.0 -125.93 8.09 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.37 113.912 170.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.576 HG11 ' HE2' ' A' ' 134' ' ' TYR . 6.8 p -111.82 137.19 45.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.541 0.686 . . . . 1.03 109.697 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.75 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.1 mmm -140.15 177.67 1.91 Allowed Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 114.965 -1.016 . . . . 0.28 108.564 -170.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.75 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 57.4 Cg_exo -38.98 -65.78 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.218 2.612 . . . . 0.58 114.835 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.756 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 6.3 pt20 -74.36 -17.09 60.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.961 0.41 . . . . 0.75 111.527 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.632 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -68.88 -45.49 70.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.749 0.785 . . . . 0.31 109.31 176.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.558 HG12 ' ND2' ' A' ' 101' ' ' ASN . 20.8 t -69.81 -42.92 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.896 -1.047 . . . . 1.38 111.573 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.756 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -60.94 -25.17 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.449 -0.501 . . . . 2.35 110.003 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -71.28 -40.99 70.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.841 . . . . 0.44 110.919 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -73.95 -39.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.719 0.771 . . . . 0.41 109.311 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.558 ' ND2' HG12 ' A' ' 97' ' ' VAL . 51.8 m-20 -61.3 -30.69 70.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.464 -1.243 . . . . 0.67 110.711 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -79.84 -34.61 39.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.957 -0.386 . . . . 2.5 109.957 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -66.33 -46.11 77.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.384 -0.371 . . . . 0.47 111.336 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -72.21 -34.05 68.06 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.405 0.622 . . . . 1.66 110.106 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.87 -31.97 67.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.568 -1.196 . . . . 0.77 111.582 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.79 -19.47 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.487 -0.324 . . . . 0.74 111.011 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.2 t30 77.46 72.23 0.06 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.167 0.984 . . . . 1.41 108.719 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.821 HG21 ' HZ ' ' A' ' 68' ' ' PHE . 3.0 t -133.55 138.45 31.2 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 114.326 -1.306 . . . . 1.35 111.633 -168.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 80' ' ' ASP . 21.4 Cg_exo -68.33 143.06 56.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.443 2.762 . . . . 0.47 111.705 170.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' A' ' 103' ' ' ALA . 38.5 mm -109.96 154.88 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.738 0.78 . . . . 0.6 111.382 -173.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.937 HD13 ' HB ' ' A' ' 146' ' ' ILE . 12.9 mm -125.17 85.21 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 107.352 -1.351 . . . . 0.37 107.352 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.587 HG23 HG21 ' A' ' 145' ' ' THR . 57.5 t -73.43 147.23 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.545 0.688 . . . . 0.26 110.312 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -146.75 103.79 3.67 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.291 -1.322 . . . . 0.29 109.997 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.833 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -71.91 144.4 13.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.139 -1.392 . . . . 0.59 110.486 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.434 ' ND2' ' C5 ' ' A' ' 179' ' ' GDP . 0.6 OUTLIER -122.68 169.69 10.8 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.498 -1.297 . . . . 1.85 107.498 177.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.531 ' HE3' ' HB1' ' A' ' 87' ' ' ALA . 31.2 mtmt 67.74 37.49 3.22 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.163 -0.926 . . . . 0.59 112.38 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.689 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 14.3 mmt -75.95 -11.82 60.03 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.198 -0.91 . . . . 0.92 109.516 166.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.45 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 6.6 p-10 -72.86 -29.69 63.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.077 -0.965 . . . . 0.76 108.822 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.81 136.26 82.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.958 -1.019 . . . . 1.17 110.735 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.48 -15.39 48.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 123.058 2.505 . . . . 0.58 112.143 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.837 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 5.0 mm-40 -84.01 -9.0 58.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.49 -0.777 . . . . 1.45 110.704 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -42.47 109.97 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.968 0.792 . . . . 0.27 111.956 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.71 76.59 77.04 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.301 -1.0 . . . . 0.95 108.301 176.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.689 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 22.3 Cg_endo -58.81 -60.1 0.39 Allowed 'Trans proline' 0 CA--C 1.505 -0.933 0 C-N-CA 122.898 2.399 . . . . 0.4 113.286 -174.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.7 -28.88 1.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 124.066 0.854 . . . . 1.44 111.504 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 37.0 ttm-85 -78.59 -62.36 1.71 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.439 -0.578 . . . . 3.79 109.439 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 88' ' ' ALA . 4.9 m -64.69 -22.59 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.977 -1.011 . . . . 0.59 111.941 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.626 ' HG3' ' CE2' ' A' ' 147' ' ' PHE . 4.9 ttt -77.12 -31.8 56.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.179 -0.918 . . . . 0.81 110.874 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.578 ' O ' ' HG3' ' A' ' 132' ' ' MET . 88.5 mt-30 -78.1 -32.39 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 1.31 111.372 176.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.9 mm-40 -57.28 -39.6 76.04 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.558 1.17 . . . . 1.64 108.381 173.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.646 HD23 ' CE2' ' A' ' 147' ' ' PHE . 0.7 OUTLIER -61.39 -41.22 96.77 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.312 -1.767 . . . . 1.36 110.776 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.628 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.3 ppp? -82.5 -9.09 59.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.035 -0.666 . . . . 1.61 111.536 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.71 -27.91 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.976 -0.75 . . . . 1.67 108.976 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.576 ' HE2' HG11 ' A' ' 92' ' ' VAL . 34.6 m-85 -85.8 13.81 6.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.448 -0.796 . . . . 1.08 110.097 170.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.7 t30 62.84 48.29 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.222 -1.354 . . . . 1.1 111.658 172.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.84 110.49 13.74 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.408 -1.33 . . . . 1.36 107.408 165.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.04 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.9 t -104.78 129.16 25.4 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.697 -0.683 . . . . 0.43 111.543 -167.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.619 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 81.2 Cg_exo -44.61 143.6 3.91 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.421 3.414 . . . . 0.54 112.927 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HG2' ' C ' ' A' ' 145' ' ' THR . 12.3 mm-40 -67.47 -32.36 73.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.18 -1.373 . . . . 3.08 109.532 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 1.7 pm0 -61.25 -24.99 66.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.921 -1.036 . . . . 1.57 110.967 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.628 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 35.7 m0 -102.63 -8.71 20.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.001 0.429 . . . . 0.66 110.912 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.08 32.69 8.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.006 -0.616 . . . . 0.53 113.21 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 1.04 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.9 -109.12 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.252 -0.975 . . . . 0.6 112.053 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.443 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 7.3 t70 -167.43 63.45 0.08 Allowed 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.369 1.08 . . . . 1.91 110.504 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.587 HG21 HG23 ' A' ' 112' ' ' VAL . 78.4 m -164.82 115.63 1.17 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.509 -1.223 . . . . 0.37 110.478 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.937 ' HB ' HD13 ' A' ' 111' ' ' ILE . 19.0 mm -70.93 104.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.175 -0.676 . . . . 0.63 109.175 173.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.646 ' CE2' HD23 ' A' ' 131' ' ' LEU . 7.9 m-85 -86.98 113.11 22.47 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.237 -0.892 . . . . 0.5 111.305 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.56 136.57 41.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.75 -0.659 . . . . 0.68 109.827 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.561 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 8.3 mptt -111.57 101.27 9.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.24 -0.652 . . . . 1.44 109.24 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.912 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -127.25 -170.07 2.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.743 1.259 . . . . 0.84 111.827 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.554 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -164.21 106.68 0.91 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.769 -1.937 . . . . 1.77 105.769 174.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.64 -15.77 63.71 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.669 0.747 . . . . 0.41 109.117 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.604 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 1.2 tmtp? -62.67 -56.07 21.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.216 -1.356 . . . . 2.3 110.462 170.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 1.2 p -84.45 -10.36 57.57 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.37 0.508 . . . . 0.7 112.37 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 62.13 51.88 3.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.42 -0.809 . . . . 1.36 110.595 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -109.33 -65.82 1.11 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.156 0.979 . . . . 2.48 110.608 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.912 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.13 -9.09 71.29 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.318 -1.31 . . . . 0.29 114.174 -173.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.402 HD21 HD11 ' A' ' 24' ' ' LEU . 48.5 mt -72.36 -39.47 68.05 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.052 0.926 . . . . 0.8 109.362 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.541 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 13.8 m-20 -63.71 -44.7 92.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.511 172.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 80.6 t60 -71.66 -15.82 62.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.057 -0.52 . . . . 0.58 111.371 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -71.21 -53.34 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 1.16 109.651 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.68 -27.58 69.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.256 -0.884 . . . . 1.51 110.56 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 66.1 mt-10 -62.47 -48.88 77.65 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.099 0.476 . . . . 2.57 110.142 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.634 ' HB3' HG21 ' A' ' 146' ' ' ILE . 19.3 mmt -68.03 -42.85 80.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 0.64 110.549 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.5 mt -59.36 -41.95 85.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.927 -0.579 . . . . 0.52 110.593 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -39.73 89.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 1.73 111.19 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.1 tp -53.7 -43.98 69.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.413 0.625 . . . . 1.51 109.55 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 90.1 t -67.18 -43.14 88.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 0.89 110.774 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.2 m -59.13 -38.85 80.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.691 0.281 . . . . 1.35 111.574 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -86.5 -8.25 57.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.142 0.496 . . . . 2.73 110.865 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.5 ttm -68.27 -11.58 59.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.291 -0.413 . . . . 1.88 111.57 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.4 ' O ' ' HD2' ' A' ' 175' ' ' LYS . 48.1 mt-10 -56.12 -36.63 68.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.033 0.444 . . . . 4.27 110.507 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -113.47 -14.06 12.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.744 -0.662 . . . . 3.91 110.281 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.9 tp -112.13 46.26 1.18 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.74 -0.663 . . . . 5.72 110.124 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.791 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -56.29 116.65 3.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.008 -0.542 . . . . 5.49 111.754 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 61.06 80.94 0.2 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 123.841 0.713 . . . . 5.78 112.075 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 8.1 t30 -77.87 124.97 86.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.964 -0.562 . . . . 7.88 110.165 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 6.5 Cg_exo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 122.858 2.372 . . . . 9.19 112.046 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.604 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 111.991 -0.444 . . . . 11.58 111.991 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.8 m -81.5 72.17 8.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.332 0.587 . . . . 10.61 111.31 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -162.19 64.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.432 -0.804 . . . . 10.14 109.105 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 69.7 mtm -80.95 64.97 5.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.688 -0.687 . . . . 8.77 111.23 -173.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.66 -26.72 5.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 5.74 109.925 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -86.13 115.51 23.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.405 -0.816 . . . . 5.7 110.218 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.68 ' HD2' HG21 ' A' ' 79' ' ' THR . 25.4 ttm180 -114.41 103.58 54.93 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.326 . . . . 6.85 110.273 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.68 137.93 40.08 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.858 2.372 . . . . 2.8 111.995 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.493 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 54.1 Cg_endo -71.27 109.03 2.49 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.59 2.194 . . . . 2.76 112.327 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.567 ' O ' HG22 ' A' ' 11' ' ' VAL . 4.3 m -92.93 -59.22 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.118 -0.492 . . . . 2.0 111.061 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.726 ' HB ' ' O ' ' A' ' 81' ' ' ILE . 1.1 m 60.13 179.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.8 0.84 . . . . 1.35 111.403 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.686 HG23 HD13 ' A' ' 60' ' ' LEU . 71.8 m -142.8 126.41 16.9 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.303 -0.248 . . . . 0.64 110.678 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 14.9 tt -92.22 136.1 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.641 0.734 . . . . 1.3 111.467 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.483 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 58.5 mtt -148.82 174.29 12.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.591 0.756 . . . . 0.79 109.28 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.14 -167.12 32.25 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.711 -0.757 . . . . 0.31 112.761 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.584 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 43.2 t60 -93.93 164.49 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.066 0.936 . . . . 0.22 112.003 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' O1B' ' A' ' 179' ' ' GDP . 5.9 p -78.34 151.29 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.454 -1.248 . . . . 0.36 110.374 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HA ' " C4'" ' A' ' 179' ' ' GDP . 28.2 t70 72.72 -19.85 0.29 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.4 0.619 . . . . 0.69 110.524 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 18.0 m170 -78.94 -7.93 58.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.356 -0.979 . . . . 0.63 108.356 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.419 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 100.13 44.14 2.27 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.192 -0.913 . . . . 0.79 113.413 174.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -33.26 66.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.591 0.695 . . . . 3.31 112.403 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -107.59 -34.59 6.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.914 0.388 . . . . 1.21 110.614 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -63.9 -28.87 70.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.321 -0.399 . . . . 1.25 111.772 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD23 ' HA3' ' A' ' 20' ' ' GLY . 2.7 mm? -65.62 -42.37 91.62 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.71 -0.478 . . . . 1.49 109.71 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.944 HD21 ' HA ' ' A' ' 47' ' ' ALA . 2.1 tp -71.85 -12.15 61.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.139 -0.937 . . . . 1.69 110.53 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -98.94 -41.26 7.67 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.992 0.901 . . . . 1.23 109.409 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HB1' ' HE2' ' A' ' 155' ' ' LYS . . . -66.22 -30.28 70.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.898 -1.501 . . . . 0.63 109.845 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 tt -77.83 -32.48 17.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 1.02 110.894 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -69.9 -18.45 63.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.588 0.709 . . . . 3.04 109.997 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -119.61 28.74 7.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.843 -1.071 . . . . 2.65 110.172 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 28.7 t -122.53 -21.65 5.66 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.769 -1.105 . . . . 1.46 111.812 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -161.66 -170.21 2.51 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.893 -0.323 . . . . 3.92 111.464 -177.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.57 ' O ' ' HB ' ' A' ' 51' ' ' THR . 45.1 t -68.81 97.5 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.635 -0.711 . . . . 3.1 112.241 -171.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.429 HG21 ' HE2' ' A' ' 48' ' ' TYR . 9.7 t -156.86 162.02 39.69 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.979 -0.555 . . . . 2.78 109.597 171.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -96.81 128.06 43.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.583 -0.735 . . . . 6.34 110.286 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -67.01 -18.62 65.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.757 -0.656 . . . . 6.79 110.363 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -145.55 111.04 5.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.895 -0.593 . . . . 6.24 110.575 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 176.03 -44.01 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.811 -1.181 . . . . 4.95 107.811 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.78 43.32 0.35 Allowed Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 114.036 -1.438 . . . . 4.68 109.802 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.904 ' HA2' ' HB2' ' A' ' 48' ' ' TYR . . . -128.55 -8.61 3.88 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.947 -0.644 . . . . 4.55 113.372 -174.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.51 125.91 74.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.862 0.363 . . . . 5.57 110.6 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.2 m -117.85 -12.5 10.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.545 . . . . 5.93 110.476 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 66.87 15.89 10.24 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.66 -0.7 . . . . 6.63 110.372 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -148.96 -162.56 1.59 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.352 -1.351 . . . . 6.54 107.352 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.0 pt -70.86 -177.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.626 -0.509 . . . . 5.17 109.626 167.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.942 ' HA2' HD23 ' A' ' 60' ' ' LEU . . . 131.79 -127.42 4.99 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.002 -1.094 . . . . 2.51 112.607 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.944 ' HA ' HD21 ' A' ' 25' ' ' LEU . . . -175.6 -165.27 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.751 0.324 . . . . 1.36 110.68 -175.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.904 ' HB2' ' HA2' ' A' ' 40' ' ' GLY . 1.2 p90 -153.89 176.12 12.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.86 -0.609 . . . . 1.7 109.643 -175.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -89.99 115.76 27.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.511 -0.313 . . . . 1.91 111.057 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.441 HG22 ' CE1' ' A' ' 48' ' ' TYR . 11.3 t -88.35 158.79 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.544 -0.298 . . . . 1.53 110.537 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.904 HG23 ' HA ' ' A' ' 54' ' ' ASP . 85.1 m -161.41 87.56 0.7 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.822 0.849 . . . . 1.51 109.17 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.867 HG13 ' H ' ' A' ' 53' ' ' ASN . 1.9 p -64.8 -69.11 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.337 0.589 . . . . 2.27 110.005 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.867 ' H ' HG13 ' A' ' 52' ' ' VAL . 86.2 m-20 -100.45 -56.02 2.46 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.674 -1.232 . . . . 3.68 107.674 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.904 ' HA ' HG23 ' A' ' 51' ' ' THR . 34.6 t70 -177.15 67.3 0.02 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.229 -1.35 . . . . 2.99 109.772 167.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' O ' HG13 ' A' ' 57' ' ' ILE . 18.2 tppt? -122.43 97.69 5.58 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.901 -1.148 . . . . 7.36 107.901 177.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -73.29 81.58 1.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.927 -0.579 . . . . 4.46 111.309 -171.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.565 HD13 HG21 ' A' ' 165' ' ' ILE . 7.2 mt -96.6 102.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.538 -0.755 . . . . 0.92 109.51 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.575 ' CG2' ' HB2' ' A' ' 61' ' ' ASP . 4.1 m -88.25 97.74 11.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.904 -0.776 . . . . 0.96 108.904 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.588 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 9.0 m-30 -56.8 13.73 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.981 1.845 . . . . 1.57 115.981 -169.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.942 HD23 ' HA2' ' A' ' 46' ' ' GLY . 32.4 tp 175.36 -68.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.377 0.535 . . . . 3.21 110.814 173.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.575 ' HB2' ' CG2' ' A' ' 58' ' ' THR . 30.8 t70 52.87 50.09 18.79 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.605 0.717 . . . . 5.61 110.711 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.1 m -149.85 108.85 3.28 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.9 -0.591 . . . . 5.45 110.848 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.15 -26.25 30.61 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.853 2.369 . . . . 6.11 111.806 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.86 136.98 2.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.006 -0.616 . . . . 6.36 112.221 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -149.26 -61.68 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.913 0.357 . . . . 8.78 110.133 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -156.75 -80.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.293 -0.412 . . . . 7.05 110.861 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.22 -89.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 4.55 111.583 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.582 ' HE1' ' HB2' ' A' ' 80' ' ' ASP . 1.1 p90 -123.48 -55.59 1.73 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.795 -0.184 . . . . 2.37 110.792 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 p -93.95 -171.67 2.63 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.784 0.326 . . . . 4.9 111.644 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.3 m -75.06 -46.22 36.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.401 -0.363 . . . . 5.84 111.185 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 61.3 mtt 57.44 74.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.899 0.381 . . . . 5.21 110.349 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -118.07 -3.4 11.11 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.869 -0.332 . . . . 8.21 111.66 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.9 -66.27 0.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.969 0.414 . . . . 6.36 110.816 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -178.11 -69.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.337 -0.986 . . . . 9.65 108.337 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.38 -97.22 1.84 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.055 -1.218 . . . . 4.93 110.055 169.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.79 63.63 2.16 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.173 0.511 . . . . 5.47 111.6 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -120.33 2.78 10.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.794 -0.639 . . . . 6.26 110.282 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.82 -1.3 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 4.31 111.717 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.68 HG21 ' HD2' ' A' ' 7' ' ' ARG . 28.5 m -93.46 -20.69 20.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.937 0.875 . . . . 3.41 109.333 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.582 ' HB2' ' HE1' ' A' ' 68' ' ' PHE . 1.8 m-20 -80.5 96.46 6.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.761 -1.108 . . . . 2.66 108.879 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.726 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 44.3 mt -88.52 130.02 38.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.451 -0.795 . . . . 0.71 110.428 -172.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 110' ' ' ILE . 27.2 t -90.96 117.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.733 -0.787 . . . . 1.17 111.167 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 44.3 mt -81.33 131.41 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.798 -1.092 . . . . 0.37 109.384 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.686 HD21 HG22 ' A' ' 96' ' ' THR . 2.4 tm? -121.11 107.17 12.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.82 -0.807 . . . . 1.01 108.82 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 85.5 t -89.38 109.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.593 -0.731 . . . . 0.43 110.779 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.744 HG21 HD11 ' A' ' 131' ' ' LEU . 2.1 m -121.39 126.26 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.785 -0.643 . . . . 0.64 110.95 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -72.15 127.46 32.64 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.094 -0.503 . . . . 0.28 109.645 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -68.06 -10.54 54.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.893 0.377 . . . . 0.22 111.383 -175.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.56 -8.06 55.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.837 -0.62 . . . . 0.58 110.778 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.503 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 15.9 t0 -131.69 -45.7 0.97 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.324 -0.398 . . . . 0.56 111.573 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.609 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 95.2 -144.79 17.41 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.312 -0.471 . . . . 0.37 113.062 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.6 p -92.49 143.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.337 -0.616 . . . . 1.03 109.337 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.713 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 77.2 mmm -143.61 177.73 1.71 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.401 -0.818 . . . . 0.28 109.241 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.713 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.6 Cg_exo -43.83 -63.02 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.199 2.599 . . . . 0.58 114.618 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.54 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.6 pt20 -76.69 -12.38 59.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.75 111.191 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.686 HG22 HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -72.22 -48.23 44.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.675 -0.693 . . . . 0.31 109.662 176.111 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 93' ' ' MET . 3.5 p -73.69 -27.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.548 -0.751 . . . . 1.38 112.943 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -61.72 -30.34 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.606 -0.838 . . . . 2.35 109.088 176.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.21 -35.07 66.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.495 -0.775 . . . . 0.44 110.476 174.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.3 mt -70.18 -51.16 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 109.08 -0.711 . . . . 0.41 109.08 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -51.26 -41.74 60.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.537 -1.21 . . . . 0.67 110.442 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.48 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 2.8 t60 -55.62 -50.24 70.68 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.102 -0.954 . . . . 2.5 110.208 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.535 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -74.25 -46.57 40.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.47 112.164 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.766 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 10.8 mmpt? -63.69 -35.9 82.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.986 0.422 . . . . 1.66 110.943 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.7 -43.32 72.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.093 -0.958 . . . . 0.77 111.065 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.38 -21.41 39.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.573 -0.285 . . . . 0.74 111.26 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 83.1 41.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.817 1.294 . . . . 1.41 108.842 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 109' ' ' PRO . 29.2 t -89.95 138.16 27.84 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 113.384 -1.734 . . . . 1.35 111.616 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 108' ' ' VAL . 22.3 Cg_exo -66.82 144.18 70.1 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.829 2.353 . . . . 0.47 111.56 170.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.535 HD11 ' CB ' ' A' ' 103' ' ' ALA . 49.6 mm -109.35 157.12 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 121.387 0.613 . . . . 0.6 111.157 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.768 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 22.8 mm -124.02 83.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.195 -1.409 . . . . 0.37 107.195 169.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.777 HG23 HG21 ' A' ' 145' ' ' THR . 58.2 t -70.01 145.35 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-O 121.643 0.735 . . . . 0.26 109.208 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.773 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -143.55 100.39 3.59 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.374 -1.284 . . . . 0.29 109.67 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.814 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 80.6 mt -73.99 141.92 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.301 -1.318 . . . . 0.59 110.122 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 50.9 t30 -120.9 171.52 8.57 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.325 -1.361 . . . . 1.85 107.325 -177.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.799 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 81.7 mttt 72.47 33.58 1.41 Allowed 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 123.901 0.751 . . . . 0.59 111.749 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.741 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 13.4 mmt -79.02 -14.9 58.91 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 0.92 108.879 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 3.9 p-10 -65.09 -26.8 68.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.107 -1.406 . . . . 0.76 109.515 171.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.692 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 28.5 mtpp -86.62 132.23 43.17 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.291 -0.868 . . . . 1.17 110.02 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.39 -12.2 31.96 Favored 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 122.584 2.189 . . . . 0.58 111.128 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.27 1.15 38.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.404 -1.271 . . . . 1.45 110.732 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.63 122.96 11.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.119 -0.946 . . . . 0.27 111.348 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.5 OUTLIER -130.47 76.32 77.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.595 -0.891 . . . . 0.95 108.595 175.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.741 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 25.8 Cg_endo -61.16 -65.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.745 2.964 . . . . 0.4 114.153 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.657 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 1.2 m-20 -60.24 -23.07 63.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 1.44 110.102 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.753 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.4 tpt180 -67.8 -60.35 2.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 3.79 109.944 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 88' ' ' ALA . 33.0 m -66.08 -32.98 60.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.756 -1.111 . . . . 0.59 111.757 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . 1.07 ' HA ' HD12 ' A' ' 131' ' ' LEU . 18.7 ptm -74.49 -20.51 59.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.794 0.33 . . . . 0.81 110.961 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 125' ' ' ASP . 51.9 mt-30 -74.86 -43.55 53.87 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.997 -0.44 . . . . 1.31 111.086 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.627 ' HA ' ' HG3' ' A' ' 133' ' ' GLU . 8.8 mt-10 -70.19 -24.23 63.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.895 0.855 . . . . 1.64 109.167 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' HA ' ' A' ' 128' ' ' MET . 66.8 mt -59.79 -36.71 77.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.464 -1.244 . . . . 1.36 109.27 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.878 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 3.6 mtm -77.14 -17.69 58.42 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.402 -0.519 . . . . 1.61 111.859 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.627 ' HG3' ' HA ' ' A' ' 130' ' ' GLU . 5.4 mt-10 -71.53 -17.47 62.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.437 -0.949 . . . . 1.67 108.437 174.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -94.9 12.27 28.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.802 -1.09 . . . . 1.08 109.44 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 53.1 t30 62.86 53.56 2.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.878 -1.51 . . . . 1.1 111.942 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -139.21 121.82 16.3 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.049 -1.093 . . . . 1.36 108.049 166.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.944 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 98.0 t -113.45 128.62 25.47 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.934 0.397 . . . . 0.43 111.914 -167.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.878 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 85.5 Cg_exo -45.72 145.77 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.707 3.605 . . . . 0.54 113.76 172.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.645 ' HB2' HD13 ' A' ' 146' ' ' ILE . 3.7 mm-40 -81.71 -11.39 59.07 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.321 -1.309 . . . . 3.08 110.746 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -67.65 -26.62 66.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 1.57 109.672 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.471 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.8 m0 -109.21 -2.94 17.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.66 110.735 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.04 33.72 17.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.985 -0.626 . . . . 0.53 113.721 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.944 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -86.45 -105.81 0.78 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.252 -0.975 . . . . 0.6 111.857 174.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -162.97 58.8 0.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.979 0.895 . . . . 1.91 110.907 172.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.777 HG21 HG23 ' A' ' 112' ' ' VAL . 51.5 m -166.9 116.49 0.88 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.463 -0.79 . . . . 0.37 111.0 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.768 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 18.1 mm -71.43 108.02 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.041 -0.726 . . . . 0.63 109.041 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.638 ' HE2' ' CD1' ' A' ' 131' ' ' LEU . 9.2 m-85 -89.51 120.0 30.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.5 111.039 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.486 ' SG ' HD23 ' A' ' 150' ' ' LEU . 50.6 t -99.98 153.9 18.82 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.196 0.522 . . . . 0.68 109.73 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.676 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.8 mttt -128.49 91.82 3.31 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.983 -1.008 . . . . 1.44 108.499 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.83 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -122.65 -174.1 2.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.613 1.197 . . . . 0.84 112.242 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 p -155.47 100.76 2.14 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.604 -1.635 . . . . 1.77 107.566 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.56 58.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.736 -0.786 . . . . 0.41 109.653 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -73.08 -52.49 14.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.168 -0.924 . . . . 2.3 110.48 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 p -87.82 -6.61 58.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.971 -0.691 . . . . 0.7 112.399 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.524 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 28.9 mmtp 67.45 45.87 1.5 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.583 -0.735 . . . . 1.36 111.661 171.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -105.72 -65.87 1.03 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.956 1.36 . . . . 2.48 110.617 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.83 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -72.36 -5.14 62.28 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.746 -1.57 . . . . 0.29 113.804 -173.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 26.9 mt -66.05 -41.39 90.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.376 1.088 . . . . 0.8 109.07 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -47.83 71.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.254 -0.885 . . . . 2.2 109.886 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -64.12 -27.07 68.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.58 111.68 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.8 tp -63.89 -58.89 5.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 1.16 110.451 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.569 HD12 ' HB ' ' A' ' 52' ' ' VAL . 11.9 mt -57.51 -39.56 76.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.032 -0.985 . . . . 1.51 110.115 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -54.18 -40.19 67.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.263 -0.88 . . . . 2.57 111.37 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.53 ' O ' HG23 ' A' ' 168' ' ' VAL . 16.4 mmt -78.5 -39.18 38.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 0.64 110.621 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.565 HG21 HD13 ' A' ' 57' ' ' ILE . 89.5 mt -58.98 -46.94 91.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.52 111.383 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 3.7 pp -66.86 -34.65 78.27 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.726 -0.389 . . . . 1.73 110.895 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -53.68 -47.17 70.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.012 -0.736 . . . . 1.51 109.012 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 111' ' ' ILE . 48.2 t -64.94 -42.48 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.431 -0.804 . . . . 0.89 111.356 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 166' ' ' LEU . 89.2 p -64.19 -26.94 68.74 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.575 -0.45 . . . . 1.35 111.265 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 67.4 mm-40 -80.23 -27.6 38.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.427 0.632 . . . . 2.73 110.011 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.419 ' HG2' ' HA ' ' A' ' 175' ' ' LYS . 48.9 ttp -80.84 -10.17 59.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.653 -0.703 . . . . 1.88 110.227 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' O ' ' HD2' ' A' ' 175' ' ' LYS . 5.0 tm-20 -47.69 -49.83 26.71 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.015 -0.539 . . . . 4.27 110.968 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -99.7 -21.32 15.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.82 0.343 . . . . 3.91 111.052 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.54 47.41 0.89 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.184 -0.462 . . . . 5.72 110.524 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.917 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 3.1 mppt? -46.98 -45.76 21.17 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.394 -0.821 . . . . 5.49 111.798 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -141.77 148.94 39.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.015 -0.539 . . . . 5.78 110.722 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -115.5 95.77 44.11 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.443 -0.577 . . . . 7.88 109.443 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 C--O 1.248 0.985 0 C-N-CA 122.97 2.447 . . . . 9.19 112.278 -177.64 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.794 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.288 -0.325 . . . . 11.58 112.288 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.417 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 50.3 m -123.17 87.02 2.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.029 0.442 . . . . 10.61 110.827 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -122.05 -29.98 4.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.235 -0.439 . . . . 10.14 109.937 173.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.8 ttm -70.2 -61.2 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.135 -0.691 . . . . 8.77 109.135 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.7 140.12 47.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.572 -0.74 . . . . 5.74 109.954 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' HG2' ' HB3' ' A' ' 2' ' ' SER . 43.3 mt-10 -115.23 147.12 40.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.263 -0.426 . . . . 5.7 110.326 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 7' ' ' ARG . 31.4 ttm180 -114.25 99.39 50.82 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.932 -0.576 . . . . 6.85 109.673 172.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.85 116.7 4.78 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.622 2.215 . . . . 2.8 110.694 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.46 121.11 9.16 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.506 2.138 . . . . 2.76 111.558 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.77 74.0 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.475 0.655 . . . . 2.0 109.818 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 99.7 t -66.26 90.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.12 -0.945 . . . . 1.35 110.104 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.681 HG23 HD13 ' A' ' 60' ' ' LEU . 19.5 m -77.86 122.86 26.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.078 -0.964 . . . . 0.64 110.841 -175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.656 HD12 HD21 ' A' ' 25' ' ' LEU . 50.8 mt -86.15 114.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.212 0.53 . . . . 1.3 110.601 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.979 ' HE1' ' HB3' ' A' ' 67' ' ' ALA . 21.4 mmt -112.59 -178.48 3.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.439 -0.801 . . . . 0.79 109.432 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.45 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 138.76 -174.13 22.23 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.565 -0.826 . . . . 0.31 112.206 174.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.57 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 50.5 t60 -84.42 162.45 19.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.7 0.762 . . . . 0.22 110.691 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.478 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -76.38 152.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.081 -0.963 . . . . 0.36 110.163 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.661 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 16.1 t70 73.62 -20.36 0.3 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.031 0.532 . . . . 0.69 110.385 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.8 m170 -79.87 -8.68 59.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.696 -0.853 . . . . 0.63 108.696 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 122.6 62.09 0.21 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.386 -0.912 . . . . 0.79 114.643 169.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.547 ' HB2' ' O3B' ' A' ' 179' ' ' GDP . 70.0 mmtt -62.02 -74.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.316 0.558 . . . . 3.31 111.208 168.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 m -80.13 -34.66 37.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.768 0.318 . . . . 1.21 110.955 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.564 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.83 -30.21 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.949 0.722 . . . . 1.25 112.949 -175.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -71.72 -52.55 17.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.953 -0.388 . . . . 1.49 109.953 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.656 HD21 HD12 ' A' ' 13' ' ' ILE . 15.4 mt -70.43 -8.67 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 1.69 110.965 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -89.17 -44.18 10.49 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.244 -1.021 . . . . 1.23 108.244 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.655 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -71.49 -25.33 62.22 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.71 -1.586 . . . . 0.63 110.676 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' A' ' 25' ' ' LEU . 9.7 tt -81.77 -27.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.21 -0.904 . . . . 1.02 111.076 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 29.7 mtp180 -75.97 -40.98 52.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.531 -0.304 . . . . 3.04 111.404 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -92.89 28.27 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.319 1.057 . . . . 2.65 110.758 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.424 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 13.8 t -105.44 -43.63 4.92 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.233 -1.348 . . . . 1.46 108.207 178.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HE3' ' CD2' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -174.06 -173.02 0.77 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.299 -0.864 . . . . 3.92 110.526 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 50' ' ' VAL . 14.2 p 53.22 -61.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.55 1.54 . . . . 3.1 113.232 -171.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 p -93.75 140.8 29.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.71 0.29 . . . . 2.78 110.367 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -117.58 -80.96 0.62 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.231 0.539 . . . . 6.34 110.71 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -123.93 0.33 8.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.932 -0.576 . . . . 6.79 110.688 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.67 178.7 4.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.084 -0.507 . . . . 6.24 110.407 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 41' ' ' ILE . . . -92.5 -8.56 44.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.064 0.765 . . . . 4.95 113.064 -166.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.6 20.42 73.87 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.99 -0.624 . . . . 4.68 112.643 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.71 -3.24 87.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.845 -0.693 . . . . 4.55 112.594 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.485 ' O ' ' HB1' ' A' ' 38' ' ' ALA . 48.2 mm -109.22 139.67 31.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.818 0.342 . . . . 5.57 110.689 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 44' ' ' HIS . 8.9 t -100.29 -160.49 0.8 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 5.93 110.062 177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -71.7 -21.9 61.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.181 0.515 . . . . 6.63 110.192 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.701 ' H ' HG23 ' A' ' 42' ' ' THR . 74.2 m-70 -74.17 113.62 11.57 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.711 -0.848 . . . . 6.54 108.711 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 47' ' ' ALA . 41.0 mm 75.65 150.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 O-C-N 124.223 0.952 . . . . 5.17 109.52 -172.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.34 -5.43 10.39 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.984 -0.627 . . . . 2.51 112.202 -175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HA ' HD13 ' A' ' 25' ' ' LEU . . . -84.84 -176.63 6.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.64 -0.28 . . . . 1.36 110.861 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -177.25 173.5 1.75 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.994 -0.373 . . . . 1.7 109.994 -175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.462 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 45.6 mt-30 -100.88 122.51 43.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.226 -0.443 . . . . 1.91 110.305 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 21.7 t -86.0 169.37 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.922 -0.581 . . . . 1.53 110.755 -177.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.819 HG23 ' HA ' ' A' ' 54' ' ' ASP . 86.1 m -159.48 83.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.353 -0.98 . . . . 1.51 108.353 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.69 HG13 ' H ' ' A' ' 53' ' ' ASN . 2.2 p -64.83 -58.43 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.668 0.747 . . . . 2.27 109.647 177.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.69 ' H ' HG13 ' A' ' 52' ' ' VAL . 2.1 p30 -110.33 -56.6 2.32 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.659 -1.155 . . . . 3.68 108.568 173.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.819 ' HA ' HG23 ' A' ' 51' ' ' THR . 5.8 p-10 -167.98 37.5 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.34 -1.3 . . . . 2.99 110.243 170.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.87 100.38 10.0 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.964 -0.562 . . . . 7.36 110.017 -177.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -72.44 86.05 1.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.34 -0.845 . . . . 4.46 111.375 -177.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.8 mt -96.08 109.66 23.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.415 -0.812 . . . . 0.92 110.177 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 3.1 m -86.34 94.04 9.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.26 -0.427 . . . . 0.96 110.296 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.54 ' O ' ' HB3' ' A' ' 60' ' ' LEU . 77.5 m-85 -72.6 88.66 1.27 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.909 -0.587 . . . . 1.57 110.68 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.681 HD13 HG23 ' A' ' 12' ' ' THR . 54.1 tp 76.46 156.99 0.18 Allowed 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.915 0.759 . . . . 3.21 110.714 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 27.0 t70 -149.44 -76.53 0.15 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.681 -0.236 . . . . 5.61 111.309 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 64' ' ' GLY . 88.5 m -105.68 102.91 40.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.654 0.264 . . . . 5.45 111.674 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 44.0 Cg_endo -97.9 36.08 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.445 2.763 . . . . 6.11 111.708 173.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 65' ' ' HIS . . . -92.14 46.41 2.64 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.045 -0.525 . . . . 6.36 112.878 -175.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.484 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 21.5 t60 166.09 -46.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.177 -1.416 . . . . 8.78 107.177 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -156.6 160.58 39.55 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 104.816 -2.291 . . . . 7.05 104.816 173.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.979 ' HB3' ' HE1' ' A' ' 14' ' ' MET . . . -73.44 -23.58 60.13 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 118.602 0.637 . . . . 4.55 109.793 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.523 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -69.55 147.18 51.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.706 -0.679 . . . . 2.37 110.491 172.145 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.8 p -61.09 146.11 48.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.064 -0.516 . . . . 4.9 111.154 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 p -77.03 75.65 3.6 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.369 0.604 . . . . 5.84 110.937 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 68.9 mtm -89.22 30.04 1.01 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.616 -0.72 . . . . 5.21 110.69 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -90.82 -53.77 4.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.055 -0.52 . . . . 8.21 110.084 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.6 -47.02 85.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 6.36 110.311 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 71' ' ' MET . 17.0 ptt180 -167.41 -179.04 4.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.785 -0.643 . . . . 9.65 109.587 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.46 -77.51 0.2 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.782 -0.723 . . . . 4.93 111.71 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.21 56.17 8.12 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.17 0.51 . . . . 5.47 111.647 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.445 ' H ' ' HG2' ' A' ' 77' ' ' GLN . 4.6 pt20 -107.43 174.18 6.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.879 -0.6 . . . . 6.26 110.402 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.734 HG23 ' H ' ' A' ' 79' ' ' THR . 3.3 m -66.49 -77.72 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 113.588 0.959 . . . . 4.31 113.588 -168.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.734 ' H ' HG23 ' A' ' 78' ' ' VAL . 4.5 t -171.17 72.62 0.05 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.626 0.727 . . . . 3.41 110.603 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.3 132.36 52.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.501 -0.772 . . . . 2.66 110.142 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.9 mt -89.85 142.55 12.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.579 -0.737 . . . . 0.71 111.075 -170.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.866 HG21 ' HE1' ' A' ' 102' ' ' HIS . 6.0 p -111.77 136.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.432 0.634 . . . . 1.17 110.766 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.587 HG12 ' HB ' ' A' ' 111' ' ' ILE . 11.9 mt -90.53 142.58 12.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.287 -0.87 . . . . 0.37 109.555 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.45 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.1 tm? -127.44 108.4 10.79 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.3 -1.0 . . . . 1.01 108.3 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 90.4 t -89.89 116.03 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.079 0.466 . . . . 0.43 111.206 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.829 HG21 HD21 ' A' ' 131' ' ' LEU . 1.7 m -123.43 125.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.643 -0.708 . . . . 0.64 111.003 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.616 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -65.95 132.04 47.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.059 -0.519 . . . . 0.28 109.88 174.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.764 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -73.24 -12.3 60.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.016 0.436 . . . . 0.22 111.158 -175.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.36 9.99 37.63 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.816 -0.629 . . . . 0.58 111.634 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -143.25 -40.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.561 0.219 . . . . 0.56 111.068 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.574 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.1 -143.27 21.95 Favored Glycine 0 C--O 1.227 -0.284 0 C-N-CA 121.367 -0.444 . . . . 0.37 114.014 171.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.49 128.74 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.763 0.792 . . . . 1.03 111.02 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.576 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -125.69 177.68 1.81 Allowed Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 114.248 -1.342 . . . . 0.28 108.955 -174.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 76.0 Cg_exo -48.93 -57.91 2.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.497 2.131 . . . . 0.58 114.085 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.1 pt20 -76.13 -12.46 60.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.246 -0.582 . . . . 0.75 110.783 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.57 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.56 -50.16 40.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.727 -0.669 . . . . 0.31 109.758 178.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.574 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p -74.88 -21.86 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 112.749 0.648 . . . . 1.38 112.749 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.5 mt-10 -64.58 -29.9 70.92 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.452 -0.78 . . . . 2.35 109.171 172.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.705 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -76.39 -19.4 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.555 -0.748 . . . . 0.44 110.396 173.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.627 HG12 HD11 ' A' ' 136' ' ' LEU . 96.9 mt -79.42 -46.9 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.267 0.556 . . . . 0.41 109.619 171.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -51.76 -45.34 63.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.681 -1.145 . . . . 0.67 110.156 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.866 ' HE1' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -49.12 -46.62 45.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.733 -0.667 . . . . 2.5 111.061 172.046 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.78 41.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 0.47 111.634 -169.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -73.96 -29.67 62.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.619 0.723 . . . . 1.66 110.161 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.78 -39.55 68.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.251 -1.34 . . . . 0.77 110.755 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.95 -32.61 15.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.463 -0.335 . . . . 0.74 111.591 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 62.3 t30 82.09 52.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.55 1.14 . . . . 1.41 109.123 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.434 HG23 ' HD2' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.36 143.93 28.74 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.847 -1.524 . . . . 1.35 111.155 -174.502 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 108' ' ' VAL . 24.5 Cg_exo -63.23 145.07 93.05 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.756 2.304 . . . . 0.47 112.381 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.498 ' C ' HG23 ' A' ' 145' ' ' THR . 1.0 OUTLIER -112.61 161.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.885 0.85 . . . . 0.6 111.881 -173.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.983 HD13 ' HB ' ' A' ' 146' ' ' ILE . 19.7 mm -124.39 82.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.943 -1.502 . . . . 0.37 106.943 171.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 145' ' ' THR . 62.0 t -69.77 147.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 109.056 -0.72 . . . . 0.26 109.056 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.821 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -144.78 104.36 4.01 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.638 -1.164 . . . . 0.29 110.156 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.785 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.3 mp -73.18 136.62 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.165 -1.38 . . . . 0.59 109.198 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.552 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -121.99 173.11 7.74 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 106.723 -1.584 . . . . 1.85 106.723 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.616 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 91.0 mttt 66.53 33.88 6.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 O-C-N 123.759 0.662 . . . . 0.59 111.512 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . 78.5 mmm -84.12 -14.64 49.81 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.024 -0.732 . . . . 0.92 109.024 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -66.05 -31.89 73.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.754 -1.112 . . . . 0.76 108.875 171.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.46 133.71 80.17 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.667 -1.151 . . . . 1.17 110.24 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.06 -13.94 34.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.941 2.428 . . . . 0.58 111.937 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.17 -3.41 57.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.956 -1.02 . . . . 1.45 110.712 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . -56.45 120.94 8.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.149 -0.932 . . . . 0.27 111.848 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -131.74 76.91 73.65 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.197 -1.038 . . . . 0.95 108.197 170.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.574 ' HB2' ' HE2' ' A' ' 149' ' ' LYS . 33.4 Cg_endo -61.67 -56.91 0.65 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.21 2.606 . . . . 0.4 113.916 -173.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.683 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 7.2 m-20 -55.53 -26.7 44.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.493 0.663 . . . . 1.44 110.319 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 123' ' ' ASN . 14.6 tpp180 -74.11 -56.57 4.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 3.79 109.395 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.75 HG21 ' HA ' ' A' ' 88' ' ' ALA . 24.1 m -66.92 -29.35 46.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.122 -0.945 . . . . 0.59 111.871 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . 1.016 ' HA ' HD23 ' A' ' 131' ' ' LEU . 19.6 ptm -76.16 -17.03 59.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.745 0.307 . . . . 0.81 110.272 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' A' ' 132' ' ' MET . 32.5 mt-30 -76.2 -30.84 58.17 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.483 -0.487 . . . . 1.31 110.424 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 130' ' ' GLU . 16.6 mt-10 -64.35 -31.13 72.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.844 -0.799 . . . . 1.64 108.844 174.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.016 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -60.57 -47.83 84.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.677 -1.147 . . . . 1.36 109.507 176.358 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.661 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 18.2 ptm -71.64 -11.84 61.04 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.403 -0.519 . . . . 1.61 111.353 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 29.4 mt-10 -74.59 -28.85 61.09 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.6 -0.889 . . . . 1.67 108.6 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.583 ' HB3' HG21 ' A' ' 100' ' ' ILE . 31.1 m-85 -98.67 31.31 2.95 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.093 -0.958 . . . . 1.08 109.815 168.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.74 40.99 22.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 113.796 -1.547 . . . . 1.1 112.77 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.627 HD11 HG12 ' A' ' 100' ' ' ILE . 70.1 mt -110.04 95.9 5.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.013 -0.54 . . . . 1.36 110.001 172.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.01 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 21.9 t -100.64 117.26 63.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.868 -0.606 . . . . 0.43 111.045 -173.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.697 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.4 Cg_exo -44.11 143.94 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 124.446 3.431 . . . . 0.54 113.049 174.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.565 ' HG2' ' C ' ' A' ' 145' ' ' THR . 7.2 mm-40 -71.6 -21.25 61.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.329 -1.305 . . . . 3.08 109.341 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.5 pm0 -66.88 -19.83 65.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.26 -0.882 . . . . 1.57 110.506 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.518 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 37.8 m0 -110.22 -9.97 14.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.871 0.367 . . . . 0.66 111.081 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.65 29.45 9.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.866 -0.683 . . . . 0.53 113.473 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 1.01 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -89.95 -108.73 1.29 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 119.954 -1.117 . . . . 0.6 112.358 176.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.14 60.91 0.12 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.649 1.214 . . . . 1.91 110.858 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.863 HG21 HG23 ' A' ' 112' ' ' VAL . 72.8 m -165.2 119.2 1.25 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.643 -1.162 . . . . 0.37 110.712 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.983 ' HB ' HD13 ' A' ' 111' ' ' ILE . 19.1 mm -72.92 104.2 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 109.264 -0.643 . . . . 0.63 109.264 174.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.697 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m-85 -87.45 117.17 26.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.339 -0.846 . . . . 0.5 110.495 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 82.8 m -103.15 132.87 49.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.99 -0.55 . . . . 0.68 110.391 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.574 ' HE2' ' HB2' ' A' ' 124' ' ' PRO . 95.4 mttt -102.4 107.78 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.226 -0.657 . . . . 1.44 109.226 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.883 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -138.01 -172.52 3.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.703 1.24 . . . . 0.84 112.401 -173.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.3 OUTLIER -160.23 105.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 113.605 -1.634 . . . . 1.77 106.996 176.377 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.2 -14.38 62.94 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.343 -0.614 . . . . 0.41 109.343 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.733 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 3.9 tmtm? -62.86 -57.51 10.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.841 -1.072 . . . . 2.3 110.449 171.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.07 -8.86 59.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.622 0.601 . . . . 0.7 112.622 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.655 ' HE3' ' HB1' ' A' ' 27' ' ' ALA . 37.2 mmtm 64.38 44.99 3.96 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.36 111.204 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -105.21 -67.85 0.89 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.428 1.109 . . . . 2.48 109.63 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.883 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.78 -8.37 67.86 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 113.861 -1.518 . . . . 0.29 113.816 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.1 mt -66.44 -38.97 88.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.15 0.975 . . . . 0.8 109.41 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.596 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 40.8 m-20 -70.38 -44.16 68.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.326 -0.852 . . . . 2.2 109.291 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.413 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 73.8 t60 -62.8 -22.43 66.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.949 -0.569 . . . . 0.58 111.138 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.92 -52.95 30.27 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.361 0.6 . . . . 1.16 109.497 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -66.97 -26.63 66.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.31 -0.859 . . . . 1.51 110.444 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 94.1 mt-10 -61.99 -35.39 78.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.979 0.419 . . . . 2.57 110.832 175.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.56 ' HB3' HG21 ' A' ' 146' ' ' ILE . 11.3 mmt -82.3 -37.1 26.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.237 0.541 . . . . 0.64 110.398 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 83' ' ' ILE . 79.3 mt -69.59 -44.02 79.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 0.52 111.203 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -69.81 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.746 0.308 . . . . 1.73 110.248 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -57.9 -43.42 86.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.522 -0.918 . . . . 1.51 108.522 171.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.96 -38.72 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 0.89 110.615 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.4 t -53.39 -46.3 69.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.472 -0.331 . . . . 1.35 111.303 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -74.95 -30.78 61.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.828 0.346 . . . . 2.73 111.07 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.562 ' HG2' ' HE2' ' A' ' 175' ' ' LYS . 13.8 tmm? -62.07 -40.72 96.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.176 -0.465 . . . . 1.88 110.329 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.32 1.53 2.89 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.489 -0.778 . . . . 4.27 112.141 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -61.71 -49.72 75.32 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.616 -0.678 . . . . 3.91 111.557 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.9 tp -120.96 -54.98 2.01 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.637 -0.425 . . . . 5.72 111.196 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.562 ' HE2' ' HG2' ' A' ' 171' ' ' MET . 0.3 OUTLIER -103.76 169.04 8.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.29 -0.414 . . . . 5.49 110.344 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.83 28.63 0.84 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.157 0.503 . . . . 5.78 110.37 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.793 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 47.1 t30 -162.89 -61.22 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 7.88 111.774 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 73.5 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.65 2.233 . . . . 9.19 112.999 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.733 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 111.814 -0.515 . . . . 11.58 111.814 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -70.7 96.75 1.26 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.015 0.436 . . . . 10.61 110.246 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.77 123.12 18.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 10.14 110.595 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 97.2 mmm -102.07 -26.72 13.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.302 -0.408 . . . . 8.77 110.777 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.29 125.97 53.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.304 0.573 . . . . 5.74 110.276 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.19 163.24 17.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.997 -0.547 . . . . 5.7 109.74 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.676 ' HG2' HG11 ' A' ' 78' ' ' VAL . 23.9 tpp180 -142.99 103.71 5.22 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.909 -0.404 . . . . 6.85 109.909 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 134.12 58.24 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.26 1.973 . . . . 2.8 111.48 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.12 94.21 0.23 Allowed 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.886 2.391 . . . . 2.76 111.995 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.8 m -72.29 143.68 13.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 2.0 110.29 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.719 ' HB ' ' HA ' ' A' ' 59' ' ' PHE . 22.8 t -113.34 162.65 11.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.844 -0.616 . . . . 1.35 109.672 -175.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 58.2 m -136.78 116.49 13.01 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.232 -0.655 . . . . 0.64 109.232 170.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.33 134.76 26.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.712 0.768 . . . . 1.3 110.691 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.524 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 66.3 mtt -138.38 -179.75 5.98 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.052 -0.977 . . . . 0.79 108.883 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.458 ' HA2' HD13 ' A' ' 84' ' ' LEU . . . 143.93 -171.44 25.49 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.511 -0.852 . . . . 0.31 112.362 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.536 ' CE1' HG12 ' A' ' 17' ' ' VAL . 38.9 t60 -98.05 160.96 13.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.91 0.862 . . . . 0.22 111.914 -177.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.536 HG12 ' CE1' ' A' ' 16' ' ' HIS . 7.4 p -73.56 150.89 7.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.318 -1.31 . . . . 0.36 110.11 174.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.605 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 17.6 t70 74.01 -32.62 0.24 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.225 0.61 . . . . 0.69 110.749 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 18.9 m170 -66.32 -20.51 66.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.733 -0.84 . . . . 0.63 108.733 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 126.46 55.83 0.15 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.79 113.331 174.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' HD3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -64.99 -61.19 2.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 117.46 0.63 . . . . 3.31 110.539 176.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.592 HG23 HG21 ' A' ' 45' ' ' ILE . 25.5 m -87.16 -41.76 13.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.972 0.415 . . . . 1.21 110.954 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -57.64 -33.83 68.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.087 0.773 . . . . 1.25 113.087 -175.198 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -72.41 -43.66 63.58 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.064 -0.717 . . . . 1.49 109.064 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.778 HD11 ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -66.68 -17.56 64.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 1.69 110.494 -178.531 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -94.21 -43.21 8.56 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.842 0.829 . . . . 1.23 108.958 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.24 97.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.24 -1.346 . . . . 0.63 109.587 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.531 HG12 ' HE3' ' A' ' 32' ' ' LYS . 10.2 tt -65.22 -25.93 38.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.452 -1.249 . . . . 1.02 111.224 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 19.0 mmm180 -65.23 -37.28 86.79 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.363 0.601 . . . . 3.04 109.892 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -103.6 22.87 13.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.061 -0.972 . . . . 2.65 111.114 -172.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.4 m -111.45 -20.68 12.13 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.414 -0.812 . . . . 1.46 112.21 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.787 ' HE2' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -168.39 -176.72 2.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.737 0.303 . . . . 3.92 110.889 -178.047 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 t -66.4 151.17 10.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.722 -0.672 . . . . 3.1 111.824 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 t -158.57 167.87 28.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.433 -0.803 . . . . 2.78 109.388 171.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -108.92 -173.21 2.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.803 0.335 . . . . 6.34 110.497 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -79.07 68.1 4.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.439 0.638 . . . . 6.79 112.445 -171.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -116.32 118.49 32.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.525 -0.761 . . . . 6.24 109.09 172.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.52 95.92 3.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.353 -0.385 . . . . 4.95 111.248 -178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.29 -4.21 55.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.893 -0.67 . . . . 4.68 112.115 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.95 85.82 0.14 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.377 -0.689 . . . . 4.55 111.377 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.65 128.41 74.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.715 0.293 . . . . 5.57 110.669 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.2 m 67.28 -77.72 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.715 -0.675 . . . . 5.93 110.609 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -155.18 10.98 0.33 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.581 -0.896 . . . . 6.63 108.581 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -90.56 101.75 14.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.338 -0.846 . . . . 6.54 110.231 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.592 HG21 HG23 ' A' ' 22' ' ' THR . 45.3 pt -96.05 -172.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.54 -0.755 . . . . 5.17 110.945 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.03 -86.32 0.14 Allowed Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.728 -0.669 . . . . 2.51 111.607 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.788 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -177.06 -170.33 0.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.62 -0.511 . . . . 1.36 109.62 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -171.68 -176.88 1.87 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.689 -0.486 . . . . 1.7 109.689 -170.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 65.4 mt-30 -87.75 112.59 22.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.393 -0.367 . . . . 1.91 110.437 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.915 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 58.6 t -77.2 167.99 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.546 -0.538 . . . . 1.53 109.546 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.854 HG23 ' HA ' ' A' ' 54' ' ' ASP . 44.2 m -154.11 82.69 1.14 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.662 -0.866 . . . . 1.51 108.662 -174.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.756 HG13 ' H ' ' A' ' 53' ' ' ASN . 2.3 p -64.62 -60.18 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.635 0.731 . . . . 2.27 109.43 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.756 ' H ' HG13 ' A' ' 52' ' ' VAL . 1.9 p30 -104.12 -63.23 1.22 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.648 -1.16 . . . . 3.68 108.294 172.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.854 ' HA ' HG23 ' A' ' 51' ' ' THR . 8.5 p-10 -168.96 43.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.48 -1.236 . . . . 2.99 109.491 169.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.749 ' HE3' ' HB3' ' A' ' 169' ' ' SER . 19.9 ttmm -111.55 124.11 51.61 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.776 -0.824 . . . . 7.36 108.776 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -72.99 80.23 1.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.796 0.685 . . . . 4.46 111.205 -174.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.915 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 9.7 mt -79.07 80.11 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.776 -0.824 . . . . 0.92 108.776 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 5.1 m -77.57 102.15 6.85 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.71 -0.677 . . . . 0.96 110.285 -177.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.719 ' HA ' ' HB ' ' A' ' 11' ' ' VAL . 7.9 m-30 -66.04 0.51 1.88 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.755 -1.111 . . . . 1.57 113.462 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 35.5 tp -175.03 126.5 0.27 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.577 0.227 . . . . 3.21 110.525 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' HG21 ' A' ' 69' ' ' THR . 2.7 t0 -77.7 115.52 17.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.087 -0.506 . . . . 5.61 110.798 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 m 67.87 104.18 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.035 -0.53 . . . . 5.45 110.88 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -40.69 98.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.846 3.031 . . . . 6.11 113.58 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.19 171.84 12.58 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.344 -1.103 . . . . 6.36 110.344 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 64.8 m-70 62.34 56.59 2.11 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.776 -0.453 . . . . 8.78 109.776 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.55 -38.39 84.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.927 -0.579 . . . . 7.05 111.859 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.7 60.62 6.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.778 0.323 . . . . 4.55 110.246 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 70.1 143.64 0.05 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.839 -1.073 . . . . 2.37 110.994 -174.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 65' ' ' HIS . 8.7 p -79.76 61.71 3.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.713 -0.676 . . . . 4.9 111.668 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.5 m 67.82 -75.11 0.07 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.378 -0.828 . . . . 5.84 111.076 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 63.2 mtt 53.2 71.32 0.5 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.967 0.413 . . . . 5.21 111.248 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -84.97 -9.63 57.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.295 -0.412 . . . . 8.21 110.837 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.02 -64.23 0.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.385 -0.37 . . . . 6.36 110.864 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 18.4 tpt180 54.17 67.09 1.06 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.72 -0.673 . . . . 9.65 110.191 -175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -54.48 36.06 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.61 -0.723 . . . . 4.93 112.19 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HB1' HG13 ' A' ' 78' ' ' VAL . . . -81.21 106.15 12.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.814 -0.439 . . . . 5.47 109.814 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -67.62 -28.0 67.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 6.26 110.125 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.676 HG11 ' HG2' ' A' ' 7' ' ' ARG . 5.2 m 33.43 -102.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.618 -1.174 . . . . 4.31 113.252 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.669 ' H ' HG23 ' A' ' 78' ' ' VAL . 28.6 m -160.26 76.31 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.749 -0.463 . . . . 3.41 109.749 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.48 ' HB2' HG21 ' A' ' 108' ' ' VAL . 56.6 m-20 -79.8 146.71 32.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.731 -0.47 . . . . 2.66 109.731 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.2 mt -134.12 133.76 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.665 -0.243 . . . . 0.71 110.604 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 110' ' ' ILE . 25.9 t -112.06 129.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 120.707 -0.397 . . . . 1.17 111.358 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.643 HG12 ' HB ' ' A' ' 111' ' ' ILE . 10.8 mt -97.92 132.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 0.37 110.975 174.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.961 ' HB3' HG13 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -109.44 112.02 23.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.512 -0.767 . . . . 1.01 111.364 -178.393 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.7 t -87.55 94.12 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.098 0.475 . . . . 0.43 110.067 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.897 HG13 HD12 ' A' ' 84' ' ' LEU . 7.3 m -117.24 128.22 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.723 -0.671 . . . . 0.64 110.698 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -79.21 134.07 36.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.464 -0.569 . . . . 0.28 109.464 175.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.702 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -71.72 -8.02 51.64 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.079 0.466 . . . . 0.22 110.812 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.471 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -85.38 -17.38 36.87 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.355 -0.839 . . . . 0.58 110.972 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.535 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 24.8 t0 -132.0 -49.36 0.94 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.453 -0.34 . . . . 0.56 111.243 -170.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.63 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.24 -137.56 13.39 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 121.007 -0.616 . . . . 0.37 113.629 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 130' ' ' GLU . 6.9 p -88.47 138.51 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.35 -0.611 . . . . 1.03 109.35 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.847 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.4 mmm -142.78 178.2 1.57 Allowed Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.232 -0.655 . . . . 0.28 109.232 -171.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.847 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 49.3 Cg_exo -36.77 -69.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.544 2.829 . . . . 0.58 114.847 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.436 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 13.5 pt20 -73.69 -20.84 60.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.031 0.443 . . . . 0.75 111.346 -175.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.92 -43.78 82.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.677 -0.692 . . . . 0.31 109.373 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.57 HG12 ' ND2' ' A' ' 101' ' ' ASN . 47.6 t -66.92 -44.78 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.07 -0.968 . . . . 1.38 110.841 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.2 mm-40 -65.86 -14.84 62.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.153 0.502 . . . . 2.35 110.227 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -81.92 -38.4 25.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.556 -0.747 . . . . 0.44 110.086 170.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 95.6 mt -73.98 -42.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.642 0.734 . . . . 0.41 109.425 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.57 ' ND2' HG12 ' A' ' 97' ' ' VAL . 26.2 m-20 -57.99 -30.31 65.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.577 -1.192 . . . . 0.67 110.503 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -80.66 -37.73 30.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.32 0.581 . . . . 2.5 109.889 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.49 70.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.882 -0.599 . . . . 0.47 111.546 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.5 mmmm -72.79 -32.06 65.3 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.145 0.497 . . . . 1.66 110.133 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -44.51 54.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.731 -1.122 . . . . 0.77 110.798 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.57 -26.92 34.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.74 110.591 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 64.51 88.47 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.434 0.694 . . . . 1.41 110.908 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.605 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -143.56 154.26 59.58 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.488 -0.778 . . . . 1.35 109.83 -176.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 108' ' ' VAL . 21.6 Cg_exo -61.21 140.51 89.27 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.482 2.121 . . . . 0.47 111.923 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.4 mt -119.68 156.52 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.152 0.977 . . . . 0.6 111.917 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.014 HD13 ' HB ' ' A' ' 146' ' ' ILE . 19.0 mm -125.36 83.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.444 -1.707 . . . . 0.37 107.49 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.961 HG13 ' HB3' ' A' ' 84' ' ' LEU . 17.9 t -76.61 148.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.775 -0.77 . . . . 0.26 108.93 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.877 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -137.74 109.42 7.05 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.819 -1.082 . . . . 0.29 110.25 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.794 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -75.98 132.78 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.128 -1.396 . . . . 0.59 109.43 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 54.4 t30 -114.06 168.68 9.6 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 107.454 -1.313 . . . . 1.85 107.454 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.736 ' HG2' ' N2 ' ' A' ' 179' ' ' GDP . 73.6 mttt 72.42 31.86 1.72 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.117 0.885 . . . . 0.59 112.001 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.571 ' H ' ' HB2' ' A' ' 151' ' ' SER . 11.4 mmt -72.8 -14.96 61.63 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.699 -0.682 . . . . 0.92 109.767 166.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.616 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.1 p-10 -69.7 -22.05 63.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.851 -1.068 . . . . 0.76 108.915 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.836 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 11.0 mmpt? -88.68 133.14 36.62 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.345 -1.298 . . . . 1.17 110.609 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.11 -11.69 28.76 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.878 2.385 . . . . 0.58 111.481 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -85.38 2.23 45.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.773 -1.103 . . . . 1.45 110.314 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -55.68 107.62 0.36 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.382 -0.826 . . . . 0.27 111.062 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.75 76.52 37.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.723 -0.843 . . . . 0.95 108.723 174.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.526 ' HA ' HG22 ' A' ' 127' ' ' VAL . 45.2 Cg_endo -66.18 -55.01 0.42 Allowed 'Trans proline' 0 CA--C 1.503 -1.034 0 C-N-CA 123.079 2.52 . . . . 0.4 113.223 -171.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.403 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 11.9 m-20 -50.88 -27.64 7.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.189 -0.914 . . . . 1.44 110.386 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 32.2 tpt180 -79.63 -55.9 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 3.79 109.649 -178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.702 HG21 ' HA ' ' A' ' 88' ' ' ALA . 16.3 m -65.35 -28.94 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.476 -0.784 . . . . 0.59 112.078 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.407 ' HB2' ' HE3' ' A' ' 128' ' ' MET . 14.6 ptm -79.4 -19.33 50.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.157 -0.34 . . . . 0.81 110.486 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.65 ' O ' ' HG3' ' A' ' 132' ' ' MET . 13.0 mt-30 -74.4 -32.89 62.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.562 -0.29 . . . . 1.31 110.704 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.487 ' HB3' HG12 ' A' ' 92' ' ' VAL . 2.7 mm-40 -57.83 -46.29 84.94 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.569 0.699 . . . . 1.64 109.97 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 11.2 mp -66.38 -34.85 78.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.522 -0.763 . . . . 1.36 111.295 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.898 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -75.79 -7.89 55.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.724 -0.79 . . . . 1.61 110.738 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -82.45 -26.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.439 -0.948 . . . . 1.67 108.439 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.13 26.69 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.819 0.819 . . . . 1.08 109.854 165.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 53.78 57.0 6.46 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.983 -1.462 . . . . 1.1 111.673 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.846 ' H ' ' HA ' ' A' ' 132' ' ' MET . 62.8 mt -121.62 96.31 5.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.323 -0.853 . . . . 1.36 109.395 170.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.7 t -94.93 114.58 63.96 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.493 0.663 . . . . 0.43 112.162 -170.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.536 ' HA ' ' HD1' ' A' ' 147' ' ' PHE . 86.1 Cg_exo -45.29 152.63 0.7 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.651 3.567 . . . . 0.54 112.981 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.449 ' HB3' HD13 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -78.43 -19.36 53.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.253 -1.339 . . . . 3.08 109.663 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.424 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.8 pm0 -70.21 -17.49 63.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.246 -0.888 . . . . 1.57 110.771 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.898 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 44.0 m0 -106.61 -24.96 12.0 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.803 0.335 . . . . 0.66 111.117 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.62 15.56 5.34 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.128 -1.034 . . . . 0.53 113.998 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.608 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.05 -121.11 2.17 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.523 -1.322 . . . . 0.6 111.383 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -164.95 63.01 0.13 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 124.179 1.942 . . . . 1.91 110.496 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.518 ' CG2' HG23 ' A' ' 112' ' ' VAL . 85.9 m -141.7 104.92 4.62 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.689 -2.05 . . . . 0.37 107.361 173.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.014 ' HB ' HD13 ' A' ' 111' ' ' ILE . 42.2 mm -74.02 92.3 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-O 121.855 0.836 . . . . 0.63 110.054 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 114' ' ' ILE . 30.6 m-85 -75.81 107.83 8.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.038 -1.437 . . . . 0.5 110.447 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.9 m -98.96 108.22 20.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.004 -0.998 . . . . 0.68 110.211 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.794 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 76.9 mttt -83.36 99.4 10.01 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.902 -0.59 . . . . 1.44 109.867 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.877 HD21 ' HB1' ' A' ' 113' ' ' ALA . 3.4 pp -128.42 -167.09 1.72 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 0.84 112.463 -174.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.571 ' HB2' ' H ' ' A' ' 117' ' ' MET . 12.0 t -166.75 119.87 1.01 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.994 -1.912 . . . . 1.77 106.001 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.71 -5.84 51.9 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.124 -0.631 . . . . 0.41 109.372 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 19.5 mmtt -87.23 -37.37 17.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.391 -0.822 . . . . 2.3 111.498 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 11.6 p -87.69 -13.88 41.35 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.62 -0.832 . . . . 0.7 110.63 171.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 19.4 mmtp 59.64 45.39 13.17 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.95 -1.023 . . . . 1.36 109.703 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 4.4 tp10 -99.03 -68.5 0.8 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.487 -1.233 . . . . 2.48 110.557 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.877 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -80.55 2.75 77.02 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.531 -0.842 . . . . 0.29 113.454 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.436 HD12 ' CD ' ' A' ' 155' ' ' LYS . 30.5 mt -74.32 -39.62 62.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.069 0.934 . . . . 0.8 108.879 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 19.4 t70 -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.358 -0.837 . . . . 2.2 108.936 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 81.9 t60 -67.43 -17.61 64.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.525 -0.761 . . . . 0.58 111.333 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 165' ' ' ILE . 51.6 tp -68.94 -56.9 6.41 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.03 0.443 . . . . 1.16 110.028 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.43 ' HG ' ' H ' ' A' ' 162' ' ' LEU . 9.9 mt -56.17 -38.56 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.21 -0.904 . . . . 1.51 109.731 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 31.7 mm-40 -56.39 -41.93 77.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.325 -0.852 . . . . 2.57 111.445 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.587 ' HB3' HG21 ' A' ' 146' ' ' ILE . 13.7 mmt -77.52 -32.25 53.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 0.64 110.576 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.712 HG21 HD13 ' A' ' 57' ' ' ILE . 75.7 mt -65.14 -47.18 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.619 . . . . 0.52 111.093 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.544 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 3.9 pp -65.6 -29.29 69.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.862 0.363 . . . . 1.73 111.261 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.2 tp -56.25 -49.26 74.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.67 . . . . 1.51 109.708 170.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.519 ' HA ' ' HG2' ' A' ' 171' ' ' MET . 57.5 t -65.92 -37.51 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.521 -0.763 . . . . 0.89 110.26 174.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.749 ' HB3' ' HE3' ' A' ' 55' ' ' LYS . 19.6 m -66.46 -7.54 20.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.922 -0.581 . . . . 1.35 111.476 175.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -96.51 -32.41 12.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.016 0.436 . . . . 2.73 110.306 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.519 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 17.3 ptp -79.36 -11.52 59.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 1.88 110.656 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 169' ' ' SER . 11.7 pt-20 -67.51 -21.28 65.49 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.732 -0.47 . . . . 4.27 109.732 176.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 174' ' ' LEU . 28.2 mt-10 -86.49 -85.72 0.16 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.932 -0.576 . . . . 3.91 110.391 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.404 ' H ' ' HB2' ' A' ' 173' ' ' GLU . 60.1 mt -139.32 -21.4 0.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.135 -0.938 . . . . 5.72 111.041 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -74.96 75.54 2.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.664 -0.698 . . . . 5.49 112.074 -170.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.09 -41.48 50.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.897 0.38 . . . . 5.78 110.119 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -133.53 111.26 12.59 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.036 0.446 . . . . 7.88 110.53 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.072 2.515 . . . . 9.19 111.401 177.805 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.736 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.861 -0.495 . . . . 11.58 111.861 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 p -80.88 102.49 10.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.964 0.412 . . . . 10.61 110.009 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -87.42 -45.7 10.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.387 -0.37 . . . . 10.14 110.889 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.6 mtp -82.45 73.65 9.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.122 0.486 . . . . 8.77 110.814 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -83.6 101.47 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.349 -0.611 . . . . 5.74 109.349 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.45 104.03 8.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 5.7 109.953 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -110.11 100.6 44.49 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.274 -0.421 . . . . 6.85 110.438 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.56 130.91 26.23 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.51 2.14 . . . . 2.8 111.221 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -48.22 114.47 1.16 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.203 2.602 . . . . 2.76 112.569 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.486 HG13 HD12 ' A' ' 60' ' ' LEU . 39.4 t -82.2 128.8 38.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.468 -0.568 . . . . 2.0 109.468 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.53 95.22 2.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.017 0.437 . . . . 1.35 110.798 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.556 HG21 ' HB2' ' A' ' 68' ' ' PHE . 88.5 m -72.2 124.95 26.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.197 -0.456 . . . . 0.64 110.31 175.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.458 HD12 ' HB2' ' A' ' 25' ' ' LEU . 59.5 mt -96.37 127.93 48.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.915 0.388 . . . . 1.3 110.653 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.535 ' CE ' ' HB3' ' A' ' 68' ' ' PHE . 60.1 mtt -136.34 175.55 9.5 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.037 -0.529 . . . . 0.79 109.823 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 145.48 -168.97 27.16 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.89 -0.671 . . . . 0.31 111.7 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.611 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 12.3 t-80 -89.66 158.49 17.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.86 0.838 . . . . 0.22 111.48 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.1 p -72.18 148.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.562 -1.199 . . . . 0.36 109.697 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 23.6 t70 73.81 -19.36 0.35 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.457 0.646 . . . . 0.69 110.502 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 17' ' ' VAL . 15.6 m170 -84.67 -0.68 54.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.974 -1.121 . . . . 0.63 107.974 168.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 87.76 49.48 3.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.163 -0.926 . . . . 0.79 113.86 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HG2' ' PB ' ' A' ' 179' ' ' GDP . 50.6 pttt -63.67 -36.57 84.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.31 -0.556 . . . . 3.31 111.508 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 m -101.8 -42.41 6.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 1.21 110.454 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.487 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -54.11 -19.47 5.02 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.125 0.787 . . . . 1.25 113.125 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -74.83 -45.24 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.259 -0.645 . . . . 1.49 109.259 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.542 HD13 ' C ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -66.39 -16.12 63.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.731 -1.122 . . . . 1.69 109.199 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 18.9 t70 -97.78 -41.5 8.03 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.701 0.762 . . . . 1.23 110.194 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -29.1 69.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.817 -1.083 . . . . 0.63 110.132 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.9 tt -71.0 -23.28 23.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.662 -1.154 . . . . 1.02 110.128 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 31' ' ' SER . 96.6 mtt180 -68.5 -56.05 9.68 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.706 -0.679 . . . . 3.04 110.045 174.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -79.49 27.57 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.835 0.826 . . . . 2.65 111.12 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 29' ' ' ARG . 23.6 t -117.99 -21.65 8.21 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.729 -1.123 . . . . 1.46 110.633 176.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER 178.95 -167.05 0.07 Allowed 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.795 -0.446 . . . . 3.92 109.795 -178.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.822 HG13 ' H ' ' A' ' 34' ' ' THR . 4.0 p 40.21 -86.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.497 1.119 . . . . 3.1 113.64 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.888 HG21 ' HA2' ' A' ' 39' ' ' GLY . 23.3 p -99.93 104.31 15.94 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.484 0.659 . . . . 2.78 110.952 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -82.39 -38.38 24.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.816 -1.084 . . . . 6.34 112.152 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -158.52 -50.46 0.06 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.935 0.398 . . . . 6.79 110.593 -174.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -86.26 133.53 33.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.899 -0.591 . . . . 6.24 110.817 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 62.87 -165.56 0.24 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.715 0.634 . . . . 4.95 112.403 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.888 ' HA2' HG21 ' A' ' 34' ' ' THR . . . 134.55 -69.07 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.764 -0.653 . . . . 4.68 111.794 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.26 79.01 0.13 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.659 -0.977 . . . . 4.55 110.659 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.6 mt -77.77 115.52 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.889 0.852 . . . . 5.57 112.0 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.0 m -150.44 147.23 27.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.647 -1.161 . . . . 5.93 107.971 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -91.54 47.21 1.35 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.392 0.615 . . . . 6.63 111.656 -169.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.439 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 5.5 p-80 -175.94 42.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.057 -0.974 . . . . 6.54 108.699 175.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 44' ' ' HIS . 50.7 mm 73.14 156.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.015 -0.993 . . . . 5.17 109.214 -168.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -155.69 103.1 0.23 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.635 -0.793 . . . . 2.51 112.695 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.805 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -66.16 169.87 6.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.692 -0.484 . . . . 1.36 109.692 172.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -161.18 164.01 30.79 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 118.614 -1.234 . . . . 1.7 113.039 -163.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HG2' HG23 ' A' ' 58' ' ' THR . 17.3 mt-30 -92.02 122.51 34.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.8 -1.091 . . . . 1.91 109.383 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.2 m -87.1 162.39 2.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.112 0.482 . . . . 1.53 110.694 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 54' ' ' ASP . 22.8 m -99.11 82.16 2.68 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.302 0.572 . . . . 1.51 109.91 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 p -78.84 -28.22 13.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.256 -1.016 . . . . 2.27 108.256 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -149.03 -52.19 0.16 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.53 -1.668 . . . . 3.68 107.848 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.513 ' HA ' HG23 ' A' ' 51' ' ' THR . 29.6 t70 -173.88 87.42 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.026 -0.988 . . . . 2.99 110.438 169.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 73.12 3.33 4.63 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.48 0.919 . . . . 7.36 113.48 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -76.84 153.32 34.93 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.614 -0.435 . . . . 4.46 110.75 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.6 mt 72.95 98.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.668 0.747 . . . . 0.92 110.722 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 49' ' ' GLN . 8.5 m -102.54 100.59 10.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.237 -0.892 . . . . 0.96 109.731 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.805 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 90.5 m-85 -74.26 119.07 17.95 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.269 -1.011 . . . . 1.57 108.269 176.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.74 ' HB3' ' HG3' ' A' ' 63' ' ' PRO . 87.8 mt -125.74 130.96 52.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.959 0.409 . . . . 3.21 111.659 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -110.3 -41.08 4.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.745 -0.661 . . . . 5.61 109.707 174.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.8 t -134.13 77.85 60.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 121.884 0.849 . . . . 5.45 110.672 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.793 ' HG2' ' HB3' ' A' ' 67' ' ' ALA . 26.1 Cg_exo -63.82 -65.6 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.166 2.578 . . . . 6.11 112.928 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.33 -71.55 0.4 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.316 -0.945 . . . . 6.36 113.556 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -75.55 -77.96 0.12 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.896 0.379 . . . . 8.78 111.757 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.54 99.42 3.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.405 0.622 . . . . 7.05 111.08 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.793 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . . . -165.59 86.06 0.37 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.862 -1.063 . . . . 4.55 110.172 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.576 ' HE2' ' HB3' ' A' ' 80' ' ' ASP . 82.6 m-85 45.02 -88.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.756 -1.111 . . . . 2.37 113.973 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 m -52.24 -42.68 63.83 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.266 0.555 . . . . 4.9 110.459 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.9 p -111.0 77.98 1.08 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.798 -0.637 . . . . 5.84 109.914 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.711 ' HG2' ' H ' ' A' ' 74' ' ' ARG . 56.6 ttm -138.58 87.59 2.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.02 0.438 . . . . 5.21 110.305 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -67.42 -31.84 72.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.634 -0.712 . . . . 8.21 110.708 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.08 86.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.881 -0.599 . . . . 6.36 111.592 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.711 ' H ' ' HG2' ' A' ' 71' ' ' MET . 27.4 ttm180 52.05 87.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.448 0.642 . . . . 9.65 111.22 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.44 23.56 1.1 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.57 -0.741 . . . . 4.93 111.739 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.48 111.36 22.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.753 0.311 . . . . 5.47 110.975 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -76.88 87.63 3.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.272 0.558 . . . . 6.26 110.099 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.71 152.44 10.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.43 -0.804 . . . . 4.31 109.104 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.2 m -72.08 81.37 0.96 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.458 -0.571 . . . . 3.41 109.458 175.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.576 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . 3.4 t0 -131.24 152.98 49.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.312 -0.858 . . . . 2.66 109.341 -173.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.6 mt -132.75 129.39 58.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.026 -0.731 . . . . 0.71 109.026 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HB ' HD13 ' A' ' 110' ' ' ILE . 31.3 t -100.9 116.64 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 C-N-CA 119.408 -0.917 . . . . 1.17 112.183 -173.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 9.2 mt -81.3 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.899 -1.046 . . . . 0.37 109.448 171.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.552 HD12 HD21 ' A' ' 131' ' ' LEU . 2.3 tm? -117.91 105.97 12.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.084 -1.08 . . . . 1.01 108.084 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 53.8 t -90.05 112.11 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.364 -0.834 . . . . 0.43 110.864 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.0 OUTLIER -121.32 129.67 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.733 -0.667 . . . . 0.64 110.874 175.765 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -70.63 130.69 42.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.896 -0.593 . . . . 0.28 109.935 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.664 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -71.54 -13.58 61.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 0.22 110.632 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.465 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -94.46 -2.42 51.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.686 -0.688 . . . . 0.58 111.521 -178.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.454 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 26.4 t0 -138.03 -49.26 0.56 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.652 -0.249 . . . . 0.56 110.891 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.595 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.36 -146.89 18.46 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.343 -0.456 . . . . 0.37 113.689 171.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.5 136.12 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 1.03 109.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.73 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.2 mmm -138.14 176.5 2.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 114.87 -1.059 . . . . 0.28 108.658 -171.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.73 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 55.8 Cg_exo -38.54 -69.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.607 2.872 . . . . 0.58 114.764 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.611 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 7.6 pt20 -72.4 -16.99 61.85 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.01 0.433 . . . . 0.75 111.47 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.71 -44.01 78.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.097 -0.705 . . . . 0.31 109.097 176.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 93' ' ' MET . 20.8 t -65.86 -41.36 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.22 -0.9 . . . . 1.38 111.096 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.81 -26.73 62.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 2.35 110.777 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.7 -34.95 65.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.382 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.8 mt -74.3 -46.69 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.472 0.653 . . . . 0.41 109.28 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.501 ' ND2' HG12 ' A' ' 97' ' ' VAL . 59.7 m-20 -56.31 -40.56 74.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.608 -1.178 . . . . 0.67 110.491 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -70.65 -35.43 72.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.907 -0.588 . . . . 2.5 110.199 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -69.43 -46.92 65.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.47 111.109 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.5 mmtp -64.8 -38.68 91.79 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.19 0.519 . . . . 1.66 109.986 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -48.24 -43.31 32.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.301 -1.318 . . . . 0.77 111.239 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.73 -38.27 15.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.74 111.022 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 88.08 72.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.631 1.172 . . . . 1.41 109.113 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 109' ' ' PRO . 3.0 p -126.2 144.71 49.95 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.203 -1.362 . . . . 1.35 110.862 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.443 ' O ' HG22 ' A' ' 108' ' ' VAL . 16.9 Cg_exo -66.45 139.32 53.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.716 1.611 . . . . 0.47 111.327 170.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.488 HD11 ' HB1' ' A' ' 103' ' ' ALA . 27.0 mm -104.83 157.4 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.571 0.7 . . . . 0.6 110.68 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.06 HD13 ' HB ' ' A' ' 146' ' ' ILE . 16.3 mm -122.91 83.72 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.346 -1.353 . . . . 0.37 107.346 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.729 HG23 HG21 ' A' ' 145' ' ' THR . 63.5 t -71.14 143.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.907 0.861 . . . . 0.26 109.518 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.762 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -146.64 100.41 3.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.857 -1.52 . . . . 0.29 109.857 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.793 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 85.0 mt -72.25 140.13 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 113.749 -1.569 . . . . 0.59 109.91 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.623 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.2 p-10 -120.29 176.13 5.62 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.068 -1.456 . . . . 1.85 107.068 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.657 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 75.5 mttt 66.34 27.92 9.92 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.86 0.725 . . . . 0.59 112.165 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.488 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 85.8 mmm -80.86 -1.64 44.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.697 0.761 . . . . 0.92 109.074 171.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.657 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.4 p-10 -71.01 -31.7 68.27 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.84 -1.073 . . . . 0.76 108.664 168.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HB3' ' HE2' ' A' ' 119' ' ' LYS . 39.6 mtpt -77.41 136.75 64.25 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.128 -1.396 . . . . 1.17 110.833 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.78 -17.39 59.7 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.818 2.346 . . . . 0.58 111.683 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.05 1.62 27.04 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.695 -0.684 . . . . 1.45 110.687 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.488 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -56.03 114.9 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.594 -0.73 . . . . 0.27 110.638 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -123.69 75.46 55.49 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 107.885 -1.154 . . . . 0.95 107.885 173.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.43 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 42.4 Cg_endo -64.86 -57.17 0.31 Allowed 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 122.492 2.128 . . . . 0.4 112.46 -172.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.43 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 4.3 m-20 -50.91 -26.57 6.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 124.2 0.938 . . . . 1.44 111.037 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -77.71 -59.23 2.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.892 -0.594 . . . . 3.79 110.071 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.595 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 4.7 m -64.67 -27.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.105 -0.952 . . . . 0.59 110.398 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.666 ' HG2' ' CE ' ' A' ' 132' ' ' MET . 23.2 ttt -60.95 -51.79 67.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.726 -1.125 . . . . 0.81 109.815 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 132' ' ' MET . 35.2 mt-30 -59.15 -31.25 68.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.022 0.749 . . . . 1.31 113.022 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.517 ' HA ' ' CG ' ' A' ' 133' ' ' GLU . 4.3 pt-20 -80.91 -16.44 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.081 -0.647 . . . . 1.64 112.081 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.723 HD23 HG21 ' A' ' 112' ' ' VAL . 6.7 mp -68.17 -35.87 78.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.582 -0.847 . . . . 1.36 109.044 167.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.666 ' CE ' ' HG2' ' A' ' 128' ' ' MET . 0.5 OUTLIER -71.19 -18.75 62.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.437 -0.801 . . . . 1.61 109.618 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.517 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 7.9 mm-40 -70.45 -30.51 67.37 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.661 -0.866 . . . . 1.67 108.661 173.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -91.97 17.3 9.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.059 -0.973 . . . . 1.08 109.959 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 61.11 47.84 6.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.233 -1.349 . . . . 1.1 111.27 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.492 HD11 HD23 ' A' ' 131' ' ' LEU . 1.5 pp -131.28 121.41 24.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.096 -1.076 . . . . 1.36 108.096 167.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.759 HG13 ' HD2' ' A' ' 138' ' ' PRO . 5.0 t -122.06 142.92 37.62 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.114 0.483 . . . . 0.43 111.382 -168.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HB3' ' CD1' ' A' ' 147' ' ' PHE . 18.5 Cg_endo -69.86 -175.21 1.1 Allowed 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 123.621 2.88 . . . . 0.54 113.631 -176.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.775 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -84.61 -32.66 23.6 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.53 -1.668 . . . . 3.08 109.93 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.756 ' HG3' ' CD1' ' A' ' 141' ' ' TRP . 6.7 pt-20 -67.85 -17.66 64.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.092 -0.504 . . . . 1.57 111.205 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.756 ' CD1' ' HG3' ' A' ' 140' ' ' GLU . 21.2 m0 -109.04 -2.82 17.89 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.892 0.377 . . . . 0.66 111.183 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.81 32.13 13.68 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.058 -0.591 . . . . 0.53 113.784 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.19 -127.86 5.84 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.627 -0.796 . . . . 0.6 111.407 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -149.84 62.93 0.99 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.018 0.913 . . . . 1.91 111.894 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 112' ' ' VAL . 52.7 m -161.27 128.14 4.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.165 -0.925 . . . . 0.37 109.99 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.06 ' HB ' HD13 ' A' ' 111' ' ' ILE . 46.8 mm -79.78 104.89 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 108.863 -0.792 . . . . 0.63 108.863 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.765 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 5.9 m-85 -88.56 116.74 27.02 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.584 -0.734 . . . . 0.5 111.706 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.1 m -106.76 143.31 35.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.638 -0.71 . . . . 0.68 110.814 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.586 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.5 mttt -118.15 97.91 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.885 -0.783 . . . . 1.44 108.885 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.897 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -130.63 -171.47 2.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.749 1.261 . . . . 0.84 112.569 -169.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.531 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 28.9 t -157.88 115.99 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.679 -1.601 . . . . 1.77 106.873 174.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.45 -9.92 58.99 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.084 -0.71 . . . . 0.41 109.084 175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.702 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 0.5 OUTLIER -74.18 -50.96 17.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.878 -1.055 . . . . 2.3 110.56 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 118' ' ' ASP . 2.1 p -81.39 -16.06 53.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.228 -0.589 . . . . 0.7 111.217 175.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.449 ' CD ' HD12 ' A' ' 158' ' ' LEU . 29.1 mmtp 67.21 40.66 2.75 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.307 -0.861 . . . . 1.36 110.539 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.4 OUTLIER -98.71 -64.66 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.022 -0.99 . . . . 2.48 109.663 -171.625 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.897 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -76.19 -3.01 74.89 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.111 -0.95 . . . . 0.29 113.433 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.449 HD12 ' CD ' ' A' ' 155' ' ' LYS . 18.1 mt -70.89 -36.16 72.63 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 117.974 0.887 . . . . 0.8 109.416 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 27.7 t70 -73.04 -39.95 65.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 2.2 109.257 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.423 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 61.3 t60 -68.52 -18.11 64.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.212 -0.449 . . . . 0.58 111.346 176.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.8 tp -74.81 -54.27 7.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.24 0.543 . . . . 1.16 110.08 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.52 -27.64 69.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.267 -0.879 . . . . 1.51 111.529 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 12.0 pt-20 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.431 -0.507 . . . . 2.57 110.22 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.456 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 21.7 mmt -71.72 -39.39 70.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.17 0.509 . . . . 0.64 109.649 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.25 -38.7 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.519 -0.764 . . . . 0.52 110.443 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -40.38 95.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.504 . . . . 1.73 111.146 177.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.98 -43.46 63.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.466 0.65 . . . . 1.51 109.561 173.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.37 -40.48 80.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.756 -1.111 . . . . 0.89 110.769 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.7 m -60.77 -35.22 75.87 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.977 0.418 . . . . 1.35 111.225 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.81 -13.93 57.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.894 -0.504 . . . . 2.73 110.499 177.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.731 ' HG2' ' HA ' ' A' ' 175' ' ' LYS . 44.5 ttp -91.45 -9.03 46.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 1.88 110.878 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -37.78 -41.87 0.54 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.065 1.135 . . . . 4.27 114.065 -176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -99.39 -41.65 7.32 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.463 -0.495 . . . . 3.91 111.497 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 171' ' ' MET . 0.9 OUTLIER -99.56 47.31 0.96 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.003 0.371 . . . . 5.72 112.003 -174.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.921 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 1.5 mppt? -49.22 141.26 8.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.004 -0.543 . . . . 5.49 111.605 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -124.3 79.02 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.338 -0.392 . . . . 5.78 110.416 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -81.3 143.97 53.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.844 -0.428 . . . . 7.88 109.844 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.945 2.43 . . . . 9.19 112.185 -179.565 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.702 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.479 -0.648 . . . . 11.58 111.479 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.0 t -106.72 2.35 25.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.873 0.368 . . . . 10.61 110.33 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -101.96 106.12 17.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.357 -0.383 . . . . 10.14 110.224 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 ttp -106.8 -20.69 13.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.787 -0.82 . . . . 8.77 108.787 170.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 m -93.01 132.89 35.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.121 -0.945 . . . . 5.74 110.148 175.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -102.52 147.31 26.92 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.468 -0.567 . . . . 5.7 109.468 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -125.37 100.56 32.13 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.996 0.426 . . . . 6.85 111.285 -173.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 23.4 Cg_exo -64.53 124.81 13.85 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.643 2.229 . . . . 2.8 110.952 175.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 36.2 Cg_exo -58.26 103.31 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.777 2.318 . . . . 2.76 113.024 -176.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -84.63 115.7 27.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.267 -1.012 . . . . 2.0 108.267 171.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 74.2 t -109.1 135.1 49.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.176 -0.465 . . . . 1.35 111.405 -171.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.52 ' HB ' ' HA ' ' A' ' 82' ' ' VAL . 89.1 m -88.66 133.79 34.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.686 -0.688 . . . . 0.64 110.251 178.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mt -112.62 122.34 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.051 -0.406 . . . . 1.3 110.402 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.771 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 59.2 mtt -139.65 173.56 11.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.048 -0.524 . . . . 0.79 109.953 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.491 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 145.32 -163.54 28.12 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.641 -0.79 . . . . 0.31 112.335 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.725 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 11.3 t-80 -97.1 161.28 13.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.822 0.82 . . . . 0.22 112.031 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.583 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.8 p -73.72 151.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.339 -1.301 . . . . 0.36 109.739 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 10.7 t70 73.39 -27.09 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.304 0.574 . . . . 0.69 110.605 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.0 m170 -77.38 -10.47 59.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.407 -0.96 . . . . 0.63 108.407 171.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.688 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 113.72 51.95 0.48 Allowed Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.605 -0.807 . . . . 0.79 114.22 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 4.2 tptm -53.31 -62.77 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.447 0.623 . . . . 3.31 111.283 174.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -96.07 -32.11 12.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.579 -0.282 . . . . 1.21 111.079 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.558 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -59.34 -20.84 57.87 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.018 0.747 . . . . 1.25 113.018 -179.006 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.688 HD23 ' HA3' ' A' ' 20' ' ' GLY . 1.5 mm? -74.52 -35.73 63.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.919 0.39 . . . . 1.49 110.001 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -74.02 -15.11 61.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.79 -0.641 . . . . 1.69 109.466 176.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -96.5 -32.03 12.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.706 -0.679 . . . . 1.23 109.29 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -47.32 49.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.198 -0.91 . . . . 0.63 109.051 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 tt -59.34 -25.99 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.68 -1.145 . . . . 1.02 110.244 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HD2' ' HA3' ' A' ' 39' ' ' GLY . 13.9 tpp85 -64.47 -50.17 68.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.666 -1.152 . . . . 3.04 110.684 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -96.66 22.5 8.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.866 0.841 . . . . 2.65 111.238 -172.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.1 m -98.77 -43.95 6.58 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.784 -1.098 . . . . 1.46 109.616 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -174.42 -169.17 0.43 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.51 -0.768 . . . . 3.92 109.238 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.596 HG13 ' H ' ' A' ' 34' ' ' THR . 3.4 p 48.28 -75.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.626 1.171 . . . . 3.1 113.754 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.596 ' H ' HG13 ' A' ' 33' ' ' VAL . 2.1 p -79.05 123.17 27.07 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.701 0.63 . . . . 2.78 112.701 -172.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.686 ' HG3' ' HG2' ' A' ' 37' ' ' GLU . 8.9 pt-20 -94.96 -146.56 0.27 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.522 -0.763 . . . . 6.34 109.365 173.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -78.86 35.24 0.24 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.38 0.61 . . . . 6.79 111.395 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.686 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 66.4 mm-40 -100.39 -179.56 4.15 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.674 -0.694 . . . . 6.24 109.572 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.71 94.28 1.01 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.901 0.381 . . . . 4.95 110.263 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' A' ' 29' ' ' ARG . . . -78.07 61.21 3.8 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.118 -0.492 . . . . 4.68 112.745 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 48' ' ' TYR . . . 167.86 126.07 0.82 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.899 -0.88 . . . . 4.55 110.899 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.6 mm -91.19 67.56 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.392 0.615 . . . . 5.57 110.424 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 44' ' ' HIS . 2.2 m -167.27 161.36 14.29 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.507 -0.924 . . . . 5.93 108.507 177.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -86.93 8.55 22.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.084 0.945 . . . . 6.63 109.168 172.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.515 ' O ' ' HB ' ' A' ' 42' ' ' THR . 85.7 m-70 -130.02 135.12 47.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.729 -1.123 . . . . 6.54 108.188 173.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 46' ' ' GLY . 9.4 tp -74.86 153.96 6.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.468 0.652 . . . . 5.17 110.654 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' HG ' ' A' ' 25' ' ' LEU . . . 171.98 -59.06 0.16 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.182 -0.917 . . . . 2.51 112.342 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.89 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -161.71 -171.99 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.735 0.303 . . . . 1.36 111.138 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.486 ' HB3' ' HA2' ' A' ' 40' ' ' GLY . 0.4 OUTLIER -170.25 177.9 4.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.7 109.951 -173.208 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -93.05 121.96 34.92 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.718 -0.845 . . . . 1.91 108.718 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.675 HG22 ' H ' ' A' ' 51' ' ' THR . 6.6 p -93.04 176.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.357 0.598 . . . . 1.53 110.714 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.675 ' H ' HG22 ' A' ' 50' ' ' VAL . 87.5 m -118.04 94.92 4.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.626 -0.715 . . . . 1.51 110.221 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 56' ' ' LYS . 11.7 p -83.59 -31.31 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 107.536 -1.283 . . . . 2.27 107.536 170.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -141.86 -52.53 0.43 Allowed 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 113.093 -1.867 . . . . 3.68 107.712 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.627 ' HA ' HG23 ' A' ' 51' ' ' THR . 8.9 p-10 179.55 101.44 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.426 -1.261 . . . . 2.99 110.173 168.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 75.6 mmtt 82.28 -9.41 1.18 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.343 -0.844 . . . . 7.36 112.592 169.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.757 ' HE2' ' HB3' ' A' ' 169' ' ' SER . 43.4 tttp -73.39 141.5 46.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.947 -0.39 . . . . 4.46 109.947 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.513 ' HB ' HG12 ' A' ' 50' ' ' VAL . 43.7 mt 82.18 103.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.679 0.791 . . . . 0.92 111.555 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.6 m -114.23 108.17 16.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.431 -0.804 . . . . 0.96 109.487 171.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 55.8 m-85 -72.41 36.58 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.425 -0.807 . . . . 1.57 112.691 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.89 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 10.1 tt -149.97 128.29 12.12 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.798 -0.564 . . . . 3.21 111.967 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -118.98 -74.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.797 -0.638 . . . . 5.61 110.143 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 m -131.08 124.23 20.37 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 5.45 110.519 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -78.94 136.41 13.16 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.764 2.31 . . . . 6.11 113.015 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.42 -136.46 4.53 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.688 -0.965 . . . . 6.36 110.688 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -88.83 -14.74 36.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.496 0.665 . . . . 8.78 109.599 171.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.95 165.46 13.55 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.337 -0.847 . . . . 7.05 110.302 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.62 -35.86 0.1 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.514 -0.921 . . . . 4.55 108.514 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.706 ' HE2' ' HA ' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -48.78 132.78 17.93 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.543 -1.208 . . . . 2.37 109.572 169.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.1 p -54.83 129.73 38.39 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.021 0.439 . . . . 4.9 111.462 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.0 m -67.9 85.46 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.512 0.672 . . . . 5.84 109.975 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.448 ' SD ' HG11 ' A' ' 78' ' ' VAL . 20.8 ptp -92.51 122.59 35.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.131 -0.94 . . . . 5.21 111.426 -175.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -118.1 -34.4 4.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.651 -0.704 . . . . 8.21 109.176 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.19 -62.7 1.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.331 -0.85 . . . . 6.36 110.463 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 59.98 -165.75 0.2 Allowed 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.451 0.469 . . . . 9.65 110.984 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.79 -137.7 7.89 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.74 -0.743 . . . . 4.93 112.243 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.0 87.45 2.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.567 0.222 . . . . 5.47 111.25 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 64.46 101.99 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.756 -0.657 . . . . 6.26 112.111 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.448 HG11 ' SD ' ' A' ' 71' ' ' MET . 13.8 m -67.11 130.43 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 4.31 110.732 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -92.38 54.89 2.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.11 -0.496 . . . . 3.41 111.45 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.741 ' HB3' HG21 ' A' ' 108' ' ' VAL . 10.2 t70 -87.03 133.71 33.56 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.418 -0.956 . . . . 2.66 108.418 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.2 mt -116.18 105.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.597 -0.52 . . . . 0.71 109.597 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' HD13 ' A' ' 110' ' ' ILE . 40.1 t -93.84 114.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.424 0.63 . . . . 1.17 111.205 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.695 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.5 mt -82.84 126.03 40.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.899 -1.046 . . . . 0.37 109.596 172.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.3 tm? -114.73 106.09 13.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.447 -0.945 . . . . 1.01 108.447 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 57.7 t -88.24 109.76 20.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.395 -0.82 . . . . 0.43 110.921 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 131' ' ' LEU . 1.7 m -121.14 135.76 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.855 -0.611 . . . . 0.64 111.338 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.696 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -74.26 134.18 42.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.935 -0.575 . . . . 0.28 109.706 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.76 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -78.61 -9.42 59.36 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.355 0.597 . . . . 0.22 109.846 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -89.25 -10.24 47.68 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.941 -1.027 . . . . 0.58 110.359 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.1 t0 -133.33 -59.51 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.07 -0.514 . . . . 0.56 111.152 -173.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.436 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 109.14 -135.11 12.65 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.37 113.637 173.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.27 131.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.786 0.803 . . . . 1.03 110.671 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.656 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 68.6 mmm -134.02 178.93 1.53 Allowed Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 114.333 -1.303 . . . . 0.28 109.402 -171.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.4 Cg_exo -45.64 -64.34 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.27 2.647 . . . . 0.58 114.735 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.725 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 7.0 pt20 -75.17 -10.93 59.92 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.636 -0.665 . . . . 0.75 111.3 -175.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.85 -49.28 54.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.738 -0.664 . . . . 0.31 109.279 175.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' HA ' HD12 ' A' ' 100' ' ' ILE . 2.5 p -72.63 -28.61 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.834 -0.621 . . . . 1.38 112.591 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 49.2 mt-10 -57.95 -29.66 65.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.544 0.611 . . . . 2.35 109.448 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.771 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -72.36 -42.85 64.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.396 -0.82 . . . . 0.44 110.743 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 97' ' ' VAL . 65.7 mt -66.05 -41.57 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.62 0.724 . . . . 0.41 109.307 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -57.9 -40.0 79.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.196 -1.366 . . . . 0.67 110.857 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -66.83 -40.45 88.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.643 -0.503 . . . . 2.5 109.643 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.706 ' HA ' ' HE2' ' A' ' 68' ' ' PHE . . . -70.41 -46.08 64.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.877 -0.602 . . . . 0.47 111.788 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.78 -29.06 61.98 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.052 0.453 . . . . 1.66 110.659 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.61 -43.23 62.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.689 -1.141 . . . . 0.77 110.69 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.44 -19.18 23.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.74 111.3 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 70.04 67.79 0.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.17 -0.923 . . . . 1.41 110.472 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.741 HG21 ' HB3' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -117.28 152.39 49.1 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 1.35 111.12 -176.244 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 108' ' ' VAL . 23.2 Cg_exo -65.34 141.58 68.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.041 2.494 . . . . 0.47 112.537 172.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.547 HD13 ' HB ' ' A' ' 82' ' ' VAL . 29.2 mm -111.27 155.47 12.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.601 0.715 . . . . 0.6 111.121 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.774 HD13 ' HB ' ' A' ' 146' ' ' ILE . 7.9 mm -125.38 87.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.429 -1.323 . . . . 0.37 107.429 170.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.679 HG23 HG21 ' A' ' 145' ' ' THR . 46.6 t -74.16 148.33 8.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.463 -0.789 . . . . 0.26 109.8 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 150' ' ' LEU . . . -143.73 106.18 4.42 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.473 -1.24 . . . . 0.29 110.427 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.83 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -79.22 135.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.508 -1.224 . . . . 0.59 109.787 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.696 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.5 p-10 -113.47 177.41 4.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.28 -1.378 . . . . 1.85 107.28 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.735 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 84.2 mttt 70.5 33.1 2.52 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.61 0.569 . . . . 0.59 111.754 176.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.665 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 29.8 mmt -73.95 -19.0 60.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.245 -1.391 . . . . 0.92 107.245 166.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.632 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -62.29 -36.44 82.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.37 -1.741 . . . . 0.76 110.503 172.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.735 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 41.1 mtpt -79.34 141.77 57.73 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.94 -0.573 . . . . 1.17 110.3 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.24 -15.95 52.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.792 2.328 . . . . 0.58 111.88 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 34.4 mt-10 -84.75 11.26 9.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.574 -0.739 . . . . 1.45 110.655 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.455 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -61.29 100.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.536 -0.756 . . . . 0.27 111.155 176.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -120.41 77.07 26.27 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.664 -0.865 . . . . 0.95 108.664 176.106 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.596 ' HD3' ' HE1' ' A' ' 117' ' ' MET . 55.7 Cg_endo -68.15 -56.01 0.22 Allowed 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 123.334 2.689 . . . . 0.4 113.512 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.541 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 2.2 m-20 -55.72 -24.5 35.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.44 110.7 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 15.4 tpp180 -74.15 -57.49 3.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.386 -0.598 . . . . 3.79 109.386 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 88' ' ' ALA . 26.5 m -64.44 -32.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.999 -1.0 . . . . 0.59 111.681 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.958 ' HA ' HD23 ' A' ' 131' ' ' LEU . 17.1 ptm -76.22 -15.79 59.96 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.889 0.376 . . . . 0.81 110.41 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.624 ' O ' ' HG2' ' A' ' 132' ' ' MET . 30.1 mt-30 -78.38 -33.95 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 1.31 110.014 171.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.04 -27.26 65.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.905 -0.776 . . . . 1.64 108.905 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.958 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.2 OUTLIER -59.44 -46.41 88.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.484 -1.235 . . . . 1.36 109.263 174.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.627 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 16.6 ptm -75.11 -13.76 60.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.409 -0.516 . . . . 1.61 111.125 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 58.9 mm-40 -70.49 -29.08 65.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.0 -1.111 . . . . 1.67 108.0 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.458 ' N ' ' HD1' ' A' ' 134' ' ' TYR . 1.6 m-85 -98.92 23.17 9.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.473 -1.239 . . . . 1.08 108.986 175.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.4 t30 60.49 49.22 6.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 113.619 -1.628 . . . . 1.1 112.259 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.627 ' H ' ' HA ' ' A' ' 132' ' ' MET . 52.4 mt -117.93 98.65 6.45 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.329 -0.85 . . . . 1.36 109.522 171.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.012 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 26.2 t -104.68 113.67 64.72 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.089 -0.644 . . . . 0.43 111.497 -172.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.6 ' CB ' ' HG2' ' A' ' 140' ' ' GLU . 82.2 Cg_exo -45.48 141.81 7.31 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.405 3.403 . . . . 0.54 112.8 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.623 ' HB2' HD13 ' A' ' 146' ' ' ILE . 6.3 mm-40 -71.56 -14.75 62.19 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.636 -1.165 . . . . 3.08 110.56 174.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.6 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.8 pm0 -68.39 -19.99 64.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.981 -0.554 . . . . 1.57 109.759 167.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.589 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 42.7 m0 -107.68 -30.3 8.65 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.994 0.426 . . . . 0.66 110.722 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.83 25.63 3.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.752 -0.737 . . . . 0.53 113.255 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 1.012 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -88.67 -107.28 1.06 Allowed Glycine 0 C--N 1.324 -0.134 0 C-N-CA 120.126 -1.035 . . . . 0.6 112.699 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -165.07 60.83 0.12 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 122.565 1.174 . . . . 1.91 110.694 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.679 HG21 HG23 ' A' ' 112' ' ' VAL . 87.4 m -164.39 122.4 1.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.687 -1.142 . . . . 0.37 110.554 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.774 ' HB ' HD13 ' A' ' 111' ' ' ILE . 16.5 mm -84.42 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.211 -0.663 . . . . 0.63 109.211 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.461 ' HE2' HD23 ' A' ' 131' ' ' LEU . 2.8 m-85 -87.62 145.5 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.884 0.849 . . . . 0.5 110.153 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.456 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 65.1 m -118.15 136.32 53.69 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.29 -1.323 . . . . 0.68 109.103 172.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.552 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 94.7 mttt -109.76 89.84 3.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.997 -0.742 . . . . 1.44 108.997 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.859 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -115.45 179.46 3.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.877 1.322 . . . . 0.84 112.054 -170.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 3.9 p -145.28 95.47 2.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.156 -1.838 . . . . 1.77 106.978 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.97 -18.38 65.36 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.463 -0.495 . . . . 0.41 109.732 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.515 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 70.6 mmtt -80.95 -43.49 19.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.701 -0.682 . . . . 2.3 111.563 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 1.9 m -76.07 -15.49 60.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.387 0.613 . . . . 0.7 110.82 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 37.7 mmtm 66.49 46.0 1.98 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.845 -1.071 . . . . 1.36 110.373 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.35 -57.46 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.039 -0.982 . . . . 2.48 110.702 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.859 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.61 1.91 84.21 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.285 -0.959 . . . . 0.29 113.543 -172.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.1 -41.52 61.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.192 -0.67 . . . . 0.8 109.192 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 15.4 m-20 -67.65 -43.93 79.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.503 -0.771 . . . . 2.2 109.318 171.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.621 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 78.1 t60 -63.31 -23.12 67.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.932 -0.576 . . . . 0.58 111.516 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 165' ' ' ILE . 55.0 tp -68.49 -55.81 10.5 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.358 0.599 . . . . 1.16 109.784 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.149 -0.932 . . . . 1.51 110.775 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 65.1 mm-40 -66.48 -45.03 81.05 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.052 0.454 . . . . 2.57 110.398 172.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.501 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 12.7 mmt -67.61 -36.88 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.181 0.515 . . . . 0.64 110.203 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 83' ' ' ILE . 77.9 mt -66.8 -32.21 57.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 0.52 110.128 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 0.1 OUTLIER -67.12 -35.07 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 1.73 110.821 176.308 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 30.7 tp -57.03 -42.58 80.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.766 0.793 . . . . 1.51 109.26 171.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.08 -40.17 80.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.227 -0.897 . . . . 0.89 110.331 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.757 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 28.8 m -67.53 -8.45 33.96 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.23 0.538 . . . . 1.35 111.185 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 167' ' ' LEU . 5.4 tp10 -83.65 -41.28 17.95 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.806 -0.813 . . . . 2.73 108.806 173.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 28.2 mtm -83.91 -9.22 58.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.986 -1.007 . . . . 1.88 112.233 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 169' ' ' SER . 11.4 pt-20 -52.6 -35.45 54.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.066 0.46 . . . . 4.27 110.299 175.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -106.33 -33.36 7.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 3.91 110.764 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 176' ' ' ALA . 3.3 mm? -105.17 46.8 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.396 . . . . 5.72 111.699 -174.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.742 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -79.39 30.48 0.23 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.234 0.54 . . . . 5.49 111.362 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 174' ' ' LEU . . . -159.84 91.31 0.96 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.686 -0.688 . . . . 5.78 109.417 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 178' ' ' PRO . 14.1 m120 -74.28 -52.05 4.26 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.156 -0.475 . . . . 7.88 111.753 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 177' ' ' ASN . 28.7 Cg_endo . . . . . 0 C--O 1.248 0.994 0 C-N-CA 122.18 1.92 . . . . 9.19 112.288 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.576 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.555 -0.218 . . . . 11.58 112.555 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -121.14 -9.9 9.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.611 -0.347 . . . . 10.61 111.766 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -67.06 -24.53 65.98 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.528 0.566 . . . . 10.14 112.528 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.7 tpp -79.41 -28.56 41.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 8.77 110.75 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.64 -51.34 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.231 -0.441 . . . . 5.74 111.323 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.35 79.16 7.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.138 -0.483 . . . . 5.7 111.204 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -136.31 87.68 22.17 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.907 -0.588 . . . . 6.85 110.018 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.91 151.99 57.2 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.507 2.138 . . . . 2.8 111.485 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.8 83.21 0.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.456 2.104 . . . . 2.76 111.778 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.82 139.33 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.665 -0.698 . . . . 2.0 110.116 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 59.4 t -118.43 93.2 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.273 0.559 . . . . 1.35 110.067 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -79.33 128.36 33.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.587 -0.733 . . . . 0.64 109.971 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.846 HD11 HD23 ' A' ' 25' ' ' LEU . 17.1 pt -96.64 133.51 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.638 0.733 . . . . 1.3 111.446 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.675 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 62.9 mtt -134.96 -179.62 5.73 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.856 -1.065 . . . . 0.79 109.41 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.487 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 140.63 -164.86 26.27 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.517 -0.849 . . . . 0.31 111.776 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.752 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 12.6 t-80 -92.18 158.04 16.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.64 0.733 . . . . 0.22 111.204 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.6 p -70.98 147.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.915 -1.039 . . . . 0.36 109.872 174.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.2 t70 75.0 -26.86 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.456 0.646 . . . . 0.69 110.613 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.487 ' CE1' ' HB3' ' A' ' 90' ' ' ASP . 18.4 m170 -79.44 -13.71 59.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.3 -1.0 . . . . 0.63 108.3 170.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 116.97 76.35 0.59 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.357 -0.925 . . . . 0.79 114.97 171.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 15' ' ' GLY . 20.6 mmtp -77.32 -86.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.924 -0.71 . . . . 3.31 111.097 165.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 m -75.24 -16.14 60.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.829 0.347 . . . . 1.21 111.109 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.462 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -56.21 -35.03 66.85 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 111.863 0.32 . . . . 1.25 111.863 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 20' ' ' GLY . 4.5 mm? -74.06 -40.57 62.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.665 -0.494 . . . . 1.49 109.665 176.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -62.44 -13.11 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.821 -0.627 . . . . 1.69 110.022 176.625 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.694 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 20.2 t70 -102.18 -47.5 4.51 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.706 0.765 . . . . 1.23 109.706 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.08 73.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.28 -1.327 . . . . 0.63 111.398 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 99.2 mt -70.34 -25.56 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.716 -0.675 . . . . 1.02 111.083 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.694 ' HE ' ' HA ' ' A' ' 26' ' ' ASP . 54.5 mtm180 -56.23 -52.54 64.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 3.04 110.501 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -81.21 13.02 3.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.131 0.967 . . . . 2.65 110.871 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 55.7 m -123.42 20.88 9.57 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.108 -1.406 . . . . 1.46 110.642 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.73 ' HG3' ' H ' ' A' ' 34' ' ' THR . 43.4 pttt -140.69 -156.24 0.66 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.9 -0.591 . . . . 3.92 109.883 175.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.809 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 10.8 p -58.41 -29.65 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 116.212 -0.449 . . . . 3.1 112.008 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.73 ' H ' ' HG3' ' A' ' 32' ' ' LYS . 10.4 t -95.73 -175.31 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.321 0.581 . . . . 2.78 111.093 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.35 -36.97 0.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.178 -0.919 . . . . 6.34 109.531 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -159.41 -51.34 0.06 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.714 -0.676 . . . . 6.79 110.336 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -74.49 123.64 25.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 6.24 110.216 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.06 39.91 25.8 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.417 0.627 . . . . 4.95 110.618 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.623 ' HA2' HG21 ' A' ' 34' ' ' THR . . . -63.97 -40.51 98.33 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.279 -0.873 . . . . 4.68 112.593 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.56 -51.53 0.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.028 -0.606 . . . . 4.55 112.009 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.2 mp -67.75 101.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.865 0.364 . . . . 5.57 110.237 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.8 m -101.38 -82.94 0.46 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.217 -0.447 . . . . 5.93 110.076 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -167.09 -62.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 6.63 110.421 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -80.6 26.47 0.39 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.15 0.5 . . . . 6.54 111.69 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.541 HG13 ' N ' ' A' ' 46' ' ' GLY . 10.8 tp -178.15 164.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.37 0.605 . . . . 5.17 110.946 -174.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.541 ' N ' HG13 ' A' ' 45' ' ' ILE . . . -139.01 53.12 0.7 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.75 -1.114 . . . . 2.51 110.42 176.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.703 ' HB2' HD13 ' A' ' 60' ' ' LEU . . . -142.46 166.6 24.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.856 0.36 . . . . 1.36 110.864 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -162.59 150.67 14.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.73 -0.668 . . . . 1.7 110.356 -178.358 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -98.35 123.98 42.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.98 -0.554 . . . . 1.91 109.669 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.715 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 41.0 t -76.51 159.51 5.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.062 0.458 . . . . 1.53 110.268 -178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.809 ' HB ' ' HB ' ' A' ' 33' ' ' VAL . 19.3 m -158.83 82.44 0.8 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.593 -0.891 . . . . 1.51 108.593 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.415 HG11 HD13 ' A' ' 162' ' ' LEU . 12.6 p -77.42 -28.85 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.05 -1.092 . . . . 2.27 108.05 173.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -145.71 -58.63 0.32 Allowed 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 113.548 -1.66 . . . . 3.68 108.217 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.412 ' HA ' HG23 ' A' ' 51' ' ' THR . 5.4 p-10 -168.51 27.86 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.636 -0.711 . . . . 2.99 110.79 173.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -98.27 97.16 8.58 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.103 -0.499 . . . . 7.36 109.835 -171.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -73.87 80.09 1.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.506 -0.77 . . . . 4.46 111.246 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.2 mt -92.95 112.87 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.233 -0.894 . . . . 0.92 109.187 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 m -89.11 89.11 7.81 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.07 0.462 . . . . 0.96 111.044 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 30.2 m-85 -71.83 145.17 48.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.649 -0.705 . . . . 1.57 110.132 174.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.703 HD13 ' HB2' ' A' ' 47' ' ' ALA . 57.1 tp -143.92 129.42 19.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 3.21 110.834 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -115.75 -171.23 1.93 Allowed 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.081 -0.711 . . . . 5.61 109.081 174.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.734 HG21 ' HB2' ' A' ' 67' ' ' ALA . 14.3 t -167.21 130.64 1.45 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.288 0.566 . . . . 5.45 111.517 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 62' ' ' THR . 58.5 Cg_endo -89.03 50.99 1.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.027 2.484 . . . . 6.11 110.894 172.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.66 66.71 2.05 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.845 -0.693 . . . . 6.36 111.735 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -141.83 -58.06 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.659 -0.318 . . . . 8.78 111.285 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.43 -71.99 0.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.056 -0.258 . . . . 7.05 110.528 -173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 62' ' ' THR . . . 65.83 95.44 0.06 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.855 0.722 . . . . 4.55 112.702 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.659 ' CE1' ' HB ' ' A' ' 82' ' ' VAL . 1.7 t80 65.72 -168.78 0.21 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.964 -0.562 . . . . 2.37 110.697 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 t -64.78 144.51 57.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.03 0.443 . . . . 4.9 109.805 171.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.8 t -81.63 2.77 27.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.108 -0.497 . . . . 5.84 111.266 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.404 ' HE3' ' CD2' ' A' ' 102' ' ' HIS . 64.4 mtt 64.07 20.78 12.34 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.154 0.502 . . . . 5.21 111.227 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -95.26 12.62 28.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.54 0.686 . . . . 8.21 109.443 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.23 -61.1 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.332 -0.849 . . . . 6.36 110.865 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 58.72 87.21 0.08 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.575 0.702 . . . . 9.65 109.936 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.43 137.72 6.11 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.925 -1.27 . . . . 4.93 109.925 -170.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.65 63.07 2.17 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.352 0.596 . . . . 5.47 109.86 -171.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -69.22 -32.38 71.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.16 -0.927 . . . . 6.26 110.945 -172.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.6 t -86.56 72.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.274 0.559 . . . . 4.31 109.83 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.456 HG23 ' OD1' ' A' ' 80' ' ' ASP . 9.5 t -99.66 -18.78 17.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.017 -0.538 . . . . 3.41 110.571 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.456 ' OD1' HG23 ' A' ' 79' ' ' THR . 8.4 p-10 -160.02 165.74 31.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.138 -0.69 . . . . 2.66 109.138 173.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.4 mt -110.73 145.88 16.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 123.255 0.347 . . . . 0.71 110.363 -170.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.659 ' HB ' ' CE1' ' A' ' 68' ' ' PHE . 12.7 p -114.4 136.33 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.631 -0.828 . . . . 1.17 111.337 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.737 HG12 ' HB ' ' A' ' 111' ' ' ILE . 9.5 mt -96.71 135.88 29.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.068 -0.969 . . . . 0.37 109.612 170.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.487 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 1.8 tm? -119.8 107.8 13.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.975 -1.121 . . . . 1.01 107.975 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -93.17 113.53 28.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.795 -0.639 . . . . 0.43 110.681 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.894 HG21 HD11 ' A' ' 131' ' ' LEU . 2.8 m -121.3 136.88 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.524 -0.762 . . . . 0.64 110.713 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.74 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -75.87 134.64 40.26 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.903 -0.589 . . . . 0.28 110.105 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -74.87 -10.03 59.11 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.303 0.573 . . . . 0.22 110.035 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.68 -14.48 39.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.181 -0.918 . . . . 0.58 110.624 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 19' ' ' HIS . 2.4 t0 -131.95 -63.0 0.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.56 110.298 -176.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 115.72 -129.71 8.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.256 -0.497 . . . . 0.37 112.793 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.82 140.58 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.569 0.7 . . . . 1.03 109.621 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.562 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.6 mmm -139.94 176.33 2.62 Favored Pre-proline 0 C--N 1.311 -1.073 0 CA-C-N 114.743 -1.117 . . . . 0.28 108.549 -171.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 86.6 Cg_exo -48.72 -57.21 2.5 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.662 2.241 . . . . 0.58 114.205 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.752 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 1.9 pt20 -78.88 -11.48 60.0 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.11 -0.636 . . . . 0.75 111.002 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.87 -49.6 44.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.483 -0.781 . . . . 0.31 109.4 176.427 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.549 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.0 p -76.72 -27.74 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 115.454 -0.793 . . . . 1.38 113.128 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -66.97 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.31 -0.956 . . . . 2.35 109.549 177.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -77.18 -36.46 55.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.144 -0.935 . . . . 0.44 110.032 170.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 97' ' ' VAL . 97.9 mt -68.27 -42.81 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.518 0.675 . . . . 0.41 109.434 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.94 -42.01 68.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.685 -1.143 . . . . 0.67 110.523 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.404 ' CD2' ' HE3' ' A' ' 71' ' ' MET . 4.8 t60 -66.36 -35.0 79.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.078 -0.51 . . . . 2.5 110.093 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 -46.73 22.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.127 -0.488 . . . . 0.47 111.775 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.8 mmmt -68.77 -39.58 80.16 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.96 0.409 . . . . 1.66 110.413 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.98 69.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.53 -0.759 . . . . 0.77 110.772 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.97 63.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.74 110.495 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.8 t30 76.64 73.53 0.08 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.264 1.03 . . . . 1.41 109.301 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.539 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -137.71 147.5 57.33 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 113.545 -1.661 . . . . 1.35 110.016 -170.225 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -52.59 135.24 55.38 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.554 2.169 . . . . 0.47 113.156 171.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.543 ' C ' HG23 ' A' ' 145' ' ' THR . 1.2 mt -110.72 162.61 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.697 -1.138 . . . . 0.6 110.385 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.737 ' HB ' HG12 ' A' ' 83' ' ' ILE . 27.3 mm -129.58 84.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 107.394 -1.336 . . . . 0.37 107.394 172.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.909 HG23 HG21 ' A' ' 145' ' ' THR . 48.7 t -74.16 146.34 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.725 0.774 . . . . 0.26 109.237 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.88 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -141.72 105.79 4.77 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.25 -1.341 . . . . 0.29 110.512 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.752 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.0 mp -80.06 124.84 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.464 -1.244 . . . . 0.59 109.081 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.74 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.9 p-10 -107.34 177.51 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.772 -1.196 . . . . 1.85 107.772 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 80.5 mttt 71.11 37.02 1.29 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 123.981 0.8 . . . . 0.59 111.427 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.488 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 29.2 mmt -78.14 -15.07 59.19 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.803 -1.184 . . . . 0.92 107.803 168.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.2 -19.79 60.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.635 -1.62 . . . . 0.76 109.942 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.475 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 24.0 mmmt -87.68 131.02 44.84 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-N 115.305 -0.861 . . . . 1.17 110.124 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.5 -11.58 26.67 Favored 'Trans proline' 0 N--CA 1.472 0.254 0 C-N-CA 122.71 2.273 . . . . 0.58 111.709 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.91 8.57 31.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.879 -1.055 . . . . 1.45 110.567 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.476 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -54.96 106.83 0.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.967 -1.015 . . . . 0.27 111.438 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -118.95 75.72 14.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.95 108.419 172.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.488 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 57.6 Cg_endo -68.92 -54.38 0.26 Allowed 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 123.002 2.468 . . . . 0.4 113.438 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 25.3 m-20 -58.11 -28.06 64.29 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.13 -0.941 . . . . 1.44 109.629 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.88 -58.92 3.04 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 119.889 -0.725 . . . . 3.79 109.115 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.685 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 21.6 m -61.8 -31.32 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.732 -1.122 . . . . 0.59 111.988 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . 1.07 ' HA ' HD12 ' A' ' 131' ' ' LEU . 19.9 ptm -79.25 -16.42 56.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.101 -0.24 . . . . 0.81 110.805 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.693 ' O ' ' HG3' ' A' ' 132' ' ' MET . 13.8 mt-30 -80.14 -39.26 29.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.732 0.301 . . . . 1.31 110.831 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.46 -27.11 65.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.737 -0.838 . . . . 1.64 108.737 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' HA ' ' A' ' 128' ' ' MET . 77.5 mt -61.79 -45.19 94.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.506 -1.225 . . . . 1.36 110.022 174.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.828 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -76.19 -10.59 59.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.473 -0.491 . . . . 1.61 111.268 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -85.28 -15.6 42.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.366 -0.605 . . . . 1.67 109.366 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.45 17.37 14.74 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.925 -1.139 . . . . 1.08 107.925 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.6 t30 59.37 56.14 3.91 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 113.315 -1.766 . . . . 1.1 112.027 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.737 ' H ' ' HA ' ' A' ' 132' ' ' MET . 77.1 mt -121.53 96.1 4.94 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.787 -1.097 . . . . 1.36 109.03 169.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.912 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 32.9 t -105.02 113.97 64.2 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 120.032 -0.667 . . . . 0.43 111.049 -171.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.945 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 6.8 Cg_endo -56.45 157.8 17.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 123.326 2.684 . . . . 0.54 112.673 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.452 ' HB2' HD13 ' A' ' 146' ' ' ILE . 16.4 mm-40 -78.6 -13.52 59.79 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.256 -1.338 . . . . 3.08 109.974 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.945 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -68.04 -23.32 64.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 1.57 109.906 168.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.828 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 40.5 m0 -108.33 -14.9 14.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.858 0.361 . . . . 0.66 110.83 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.87 27.74 10.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.705 -0.759 . . . . 0.53 113.52 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.912 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.69 -108.36 0.72 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.238 -0.982 . . . . 0.6 111.621 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -163.28 61.1 0.18 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.575 1.179 . . . . 1.91 111.66 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.909 HG21 HG23 ' A' ' 112' ' ' VAL . 88.8 m -163.49 124.11 2.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.637 -1.165 . . . . 0.37 110.906 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.741 HG21 ' HB3' ' A' ' 164' ' ' MET . 23.3 mm -74.36 104.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 109.146 -0.687 . . . . 0.63 109.146 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.566 ' CG ' ' HB3' ' A' ' 138' ' ' PRO . 7.4 m-85 -87.67 117.82 26.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.321 -0.854 . . . . 0.5 110.401 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.3 m -101.37 144.17 30.51 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.46 -0.336 . . . . 0.68 110.501 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.5 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.8 mttt -116.77 89.47 3.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.167 -0.679 . . . . 1.44 109.167 175.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.88 HD21 ' HB1' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -117.99 176.22 5.31 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.671 1.224 . . . . 0.84 112.265 -171.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -129.72 102.46 6.35 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.916 -1.493 . . . . 1.77 107.283 164.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.73 64.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.923 -0.769 . . . . 0.41 108.923 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.656 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 9.4 tmtt? -64.38 -59.83 3.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.41 -1.268 . . . . 2.3 110.936 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.7 p -88.94 5.02 46.03 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 119.99 -0.684 . . . . 0.7 112.163 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.492 ' CD ' HD12 ' A' ' 158' ' ' LEU . 29.7 mmtp 64.37 46.85 3.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.555 -0.748 . . . . 1.36 111.834 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -104.93 -53.71 2.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.925 0.869 . . . . 2.48 110.983 -177.074 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.831 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.84 2.24 84.11 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.332 -0.937 . . . . 0.29 112.763 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.492 HD12 ' CD ' ' A' ' 155' ' ' LYS . 19.7 mt -76.32 -36.98 58.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.213 -0.662 . . . . 0.8 109.213 174.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.65 -40.84 80.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.621 -0.718 . . . . 2.2 109.371 171.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 74.2 t60 -72.81 -15.13 61.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.1 -0.5 . . . . 0.58 110.981 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER -77.2 -50.79 12.16 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.889 -0.411 . . . . 1.16 109.889 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 163' ' ' GLU . 4.5 pp -64.46 -29.76 70.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.789 -0.641 . . . . 1.51 111.281 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 11.2 pt-20 -71.8 -36.91 70.43 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.507 -0.477 . . . . 2.57 110.131 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.741 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.2 mmt -71.55 -38.27 71.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.201 0.524 . . . . 0.64 109.899 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 83' ' ' ILE . 78.9 mt -65.34 -46.76 89.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.782 -0.644 . . . . 0.52 111.007 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.501 ' CD2' ' HA ' ' A' ' 163' ' ' GLU . 1.6 pp -67.92 -29.79 68.96 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.832 -0.433 . . . . 1.73 109.832 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.76 -52.05 63.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.38 -0.827 . . . . 1.51 108.974 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.95 -40.38 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.85 -0.613 . . . . 0.89 110.92 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 166' ' ' LEU . 23.6 t -64.58 -23.42 67.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.56 0.219 . . . . 1.35 111.206 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -88.37 -26.57 22.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.536 0.684 . . . . 2.73 109.789 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.6 ttp -91.8 -4.09 55.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.006 -0.997 . . . . 1.88 111.471 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -46.51 -14.0 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.488 1.292 . . . . 4.27 114.488 -173.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.407 ' HG2' ' OE2' ' A' ' 172' ' ' GLU . 6.4 mm-40 -70.0 14.84 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.521 0.677 . . . . 3.91 110.931 168.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 172' ' ' GLU . 3.0 pp -61.24 -19.55 61.8 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.55 -0.75 . . . . 5.72 110.871 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.418 ' N ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -95.79 24.74 5.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.609 -0.723 . . . . 5.49 111.324 177.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.32 101.78 2.0 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.246 -0.434 . . . . 5.78 110.182 175.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -165.05 92.86 0.92 Allowed Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.845 -0.616 . . . . 7.88 110.612 -175.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 C--O 1.246 0.883 0 C-N-CA 122.981 2.454 . . . . 9.19 111.548 173.95 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.656 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 112.095 -0.402 . . . . 11.58 112.095 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 t -82.65 122.17 27.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.813 0.34 . . . . 10.61 110.148 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -77.62 70.87 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.041 -0.527 . . . . 10.14 109.912 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 41.8 ttp -163.92 -68.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.494 -0.775 . . . . 8.77 110.319 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.4 -34.8 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 5.74 111.179 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.57 92.04 7.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.29 0.567 . . . . 5.7 109.9 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -92.46 118.81 68.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.712 -0.677 . . . . 6.85 111.217 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.28 113.31 2.34 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.249 2.633 . . . . 2.8 110.992 173.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.09 118.42 5.33 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.432 2.088 . . . . 2.76 112.63 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.1 t -88.84 89.43 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.209 -0.663 . . . . 2.0 109.209 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 46.2 t -95.31 89.31 2.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.574 0.702 . . . . 1.35 110.391 -176.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.593 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 36.2 m -75.14 119.44 19.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.784 -0.644 . . . . 0.64 111.11 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.549 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 43.3 mt -84.02 124.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.265 0.555 . . . . 1.3 110.535 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.474 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 66.6 mtt -127.93 174.0 9.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.393 -0.965 . . . . 0.79 108.393 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.18 -179.47 23.17 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.259 -0.972 . . . . 0.31 111.858 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.621 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 51.5 t60 -85.09 160.63 19.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.766 0.794 . . . . 0.22 111.372 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 7.5 p -74.61 152.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.604 -1.18 . . . . 0.36 109.892 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.643 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 21.1 t70 74.05 -21.14 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.243 0.544 . . . . 0.69 110.556 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.616 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.7 m170 -79.33 -16.31 56.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.634 -0.876 . . . . 0.63 108.634 171.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.486 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 118.19 60.38 0.28 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.363 -0.835 . . . . 0.79 114.136 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -63.78 -66.01 0.6 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.951 -0.7 . . . . 3.31 111.166 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -85.62 -33.91 21.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 1.21 111.029 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.486 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -60.94 -24.88 66.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.75 0.648 . . . . 1.25 112.75 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.539 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -71.72 -39.3 70.22 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.018 -0.273 . . . . 1.49 110.592 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 54.7 mt -71.33 -14.54 62.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.795 -0.446 . . . . 1.69 109.795 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.94 -42.2 11.33 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.081 0.944 . . . . 1.23 108.705 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.062 -1.426 . . . . 0.63 110.026 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 tt -67.29 -20.39 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.087 -0.961 . . . . 1.02 110.984 -176.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 25.6 mmm180 -57.92 -52.7 64.43 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.11 0.481 . . . . 3.04 110.087 175.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -102.19 25.58 8.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.204 -0.907 . . . . 2.65 111.617 -170.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.8 m -92.63 -5.49 51.39 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.116 -0.947 . . . . 1.46 109.435 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' NZ ' ' HB ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -176.29 -174.76 0.63 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.216 -1.401 . . . . 3.92 107.216 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.458 ' O ' ' HB ' ' A' ' 51' ' ' THR . 20.2 t -74.5 151.37 7.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.888 -0.325 . . . . 3.1 110.244 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.56 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 13.8 t -157.42 -174.11 4.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.034 -0.358 . . . . 2.78 110.034 169.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -68.63 151.64 46.44 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.442 -0.577 . . . . 6.34 109.442 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.17 20.85 0.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.42 . . . . 6.79 112.03 -176.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -137.19 120.22 16.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.656 -0.498 . . . . 6.24 109.656 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.87 141.49 56.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.119 -0.492 . . . . 4.95 111.073 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 48' ' ' TYR . . . -75.9 99.03 1.23 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.028 -0.606 . . . . 4.68 111.678 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -128.01 106.41 0.79 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.595 -0.812 . . . . 4.55 112.982 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.718 HG12 ' HA3' ' A' ' 46' ' ' GLY . 46.9 mm -76.08 128.31 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.507 -0.553 . . . . 5.57 109.507 174.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.564 HG22 ' HG2' ' A' ' 43' ' ' GLN . 77.1 m 65.85 -74.1 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.932 0.77 . . . . 5.93 111.02 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.564 ' HG2' HG22 ' A' ' 42' ' ' THR . 8.1 pt20 -167.61 -33.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.528 -0.305 . . . . 6.63 111.321 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -87.12 40.48 0.92 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 121.181 -0.208 . . . . 6.54 111.462 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.634 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 48.3 mm 65.11 157.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.436 0.636 . . . . 5.17 111.055 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.718 ' HA3' HG12 ' A' ' 41' ' ' ILE . . . -158.13 25.66 0.41 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.789 -0.719 . . . . 2.51 112.324 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . 64.23 -172.63 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.998 0.47 . . . . 1.36 111.625 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.489 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.8 p90 -179.96 165.22 1.22 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.071 0.462 . . . . 1.7 110.8 -173.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.467 ' HG3' ' OG1' ' A' ' 58' ' ' THR . 19.4 mp0 -79.68 116.14 19.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.43 -0.952 . . . . 1.91 108.43 172.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 48' ' ' TYR . 22.1 m -76.59 139.29 19.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.53 0.681 . . . . 1.53 111.488 -175.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 34' ' ' THR . 2.4 m -80.9 82.48 6.87 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.347 0.594 . . . . 1.51 110.368 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.4 p -84.04 -27.94 7.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 107.815 -1.18 . . . . 2.27 107.815 173.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -144.0 -51.43 0.31 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.432 -1.713 . . . . 3.68 108.607 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.517 ' HA ' HG23 ' A' ' 51' ' ' THR . 36.4 t70 -173.69 85.1 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.855 -1.066 . . . . 2.99 110.542 170.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.505 ' H ' ' HA ' ' A' ' 51' ' ' THR . 25.4 mtmm 57.82 78.55 0.23 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.932 -0.576 . . . . 7.36 112.473 173.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -150.29 168.51 23.84 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.932 -0.766 . . . . 4.46 108.932 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.7 mt 66.07 74.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.809 0.814 . . . . 0.92 109.585 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.467 ' OG1' ' HG3' ' A' ' 49' ' ' GLN . 2.7 m -76.46 98.81 4.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.307 -0.86 . . . . 0.96 110.109 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.767 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 81.6 m-85 -70.55 139.81 51.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.203 -0.453 . . . . 1.57 110.172 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.593 ' H ' ' HA ' ' A' ' 12' ' ' THR . 58.7 tp 49.58 83.19 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.065 0.853 . . . . 3.21 112.53 171.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -66.76 -46.27 75.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.551 -0.295 . . . . 5.61 111.637 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 41.0 m -111.01 100.84 48.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.016 0.436 . . . . 5.45 111.427 -176.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.5 96.95 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.666 2.244 . . . . 6.11 111.961 175.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.95 -137.79 2.35 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.052 -0.594 . . . . 6.36 112.13 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -81.73 -44.17 17.43 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.545 -0.539 . . . . 8.78 109.545 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -101.11 103.18 14.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.581 -0.736 . . . . 7.05 109.125 173.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' THR . . . -64.58 -34.54 78.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.62 -0.718 . . . . 4.55 110.177 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.36 124.61 23.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.668 -0.696 . . . . 2.37 109.914 172.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -56.81 123.8 16.29 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.064 -0.516 . . . . 4.9 110.687 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -62.42 124.08 19.97 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.382 -0.599 . . . . 5.84 109.382 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 74' ' ' ARG . 26.4 mmt -64.46 101.08 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.423 0.63 . . . . 5.21 110.648 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -96.34 -35.22 11.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.412 -0.813 . . . . 8.21 110.386 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.95 13.36 3.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.148 -0.478 . . . . 6.36 111.756 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 71' ' ' MET . 57.9 mtm180 -128.24 139.35 52.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 9.65 111.016 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.15 -33.09 1.55 Allowed Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.187 -0.765 . . . . 4.93 111.187 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.37 142.54 27.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.105 -0.331 . . . . 5.47 110.105 176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -85.35 129.23 34.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.018 -0.364 . . . . 6.26 110.018 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 79' ' ' THR . 2.6 t -101.63 -144.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.646 -0.872 . . . . 4.31 108.646 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.676 ' H ' HG12 ' A' ' 78' ' ' VAL . 10.6 m -86.4 63.73 8.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.791 0.805 . . . . 3.41 110.645 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.04 131.18 34.83 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.326 -0.99 . . . . 2.66 108.326 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.7 mt -126.37 142.44 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.104 -0.332 . . . . 0.71 110.104 -175.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -120.8 121.68 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 1.17 111.971 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 10.4 mt -82.97 137.79 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.878 -1.055 . . . . 0.37 109.321 170.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.633 HD12 HD21 ' A' ' 131' ' ' LEU . 2.5 tm? -123.67 105.24 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.355 -0.98 . . . . 1.01 108.355 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 89.3 t -87.73 109.77 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.637 -0.711 . . . . 0.43 110.967 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER -120.73 120.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.717 -0.674 . . . . 0.64 110.776 174.262 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -68.75 127.76 34.22 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.926 -0.768 . . . . 0.28 108.926 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.669 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -70.76 -11.59 61.04 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.924 0.392 . . . . 0.22 111.446 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -94.79 2.02 55.46 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.346 -0.542 . . . . 0.58 110.876 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.405 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.0 t0 -134.33 -52.21 0.82 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.352 -0.385 . . . . 0.56 110.977 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.616 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 97.31 -158.23 21.05 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 121.087 -0.577 . . . . 0.37 113.509 173.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.27 136.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.6 0.714 . . . . 1.03 109.646 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.738 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 73.6 mmm -136.96 177.92 1.96 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.097 -0.956 . . . . 0.28 108.808 -171.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.3 Cg_exo -40.74 -65.42 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.302 2.668 . . . . 0.58 114.814 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.469 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 7.2 pt20 -74.15 -16.88 60.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.38 0.61 . . . . 0.75 111.062 -174.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.621 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.74 -43.88 71.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 0.31 109.366 177.261 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 93' ' ' MET . 21.0 t -68.24 -39.32 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.401 -0.818 . . . . 1.38 111.276 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.46 -28.92 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 2.35 110.221 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -72.8 -42.19 64.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.819 -0.628 . . . . 0.44 111.032 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.44 -42.29 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.842 0.83 . . . . 0.41 109.596 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.513 ' ND2' HG12 ' A' ' 97' ' ' VAL . 25.0 m-20 -63.67 -28.2 69.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.273 -1.331 . . . . 0.67 110.851 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -82.17 -32.31 30.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.047 0.451 . . . . 2.5 109.879 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -67.38 -46.6 72.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.47 110.901 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.92 -33.71 72.52 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.664 0.745 . . . . 1.66 110.018 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.15 44.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.096 -1.411 . . . . 0.77 111.475 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -100.33 -39.15 8.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.649 -0.25 . . . . 0.74 111.362 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 88.5 75.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.726 1.21 . . . . 1.41 109.182 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.59 142.33 42.22 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.407 -1.27 . . . . 1.35 110.4 -173.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.57 142.48 77.88 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.628 2.219 . . . . 0.47 111.943 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 145' ' ' THR . 27.0 mm -108.48 155.38 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.64 0.733 . . . . 0.6 111.107 -172.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.075 HD13 ' HB ' ' A' ' 146' ' ' ILE . 15.7 mm -122.64 83.34 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.508 -1.293 . . . . 0.37 107.508 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.78 HG21 HD23 ' A' ' 131' ' ' LEU . 58.6 t -73.19 144.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.677 0.751 . . . . 0.26 109.307 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.818 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -141.16 101.57 4.05 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.099 -1.41 . . . . 0.29 110.013 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.969 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.4 mp -68.61 138.13 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.803 -1.544 . . . . 0.59 108.883 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 59.0 t30 -122.09 166.78 14.01 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 107.147 -1.427 . . . . 1.85 107.147 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.755 ' HG2' ' N2 ' ' A' ' 179' ' ' GDP . 83.5 mttt 71.68 33.35 1.8 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 124.239 0.962 . . . . 0.59 111.515 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.597 ' CE ' ' HB3' ' A' ' 124' ' ' PRO . 9.0 mmt -74.49 -11.97 60.36 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.171 -0.922 . . . . 0.92 109.586 166.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.675 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 10.5 p-10 -70.52 -19.63 62.89 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.852 -1.067 . . . . 0.76 108.862 172.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.499 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 47.4 mtpt -95.21 131.73 29.37 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 114.769 -1.105 . . . . 1.17 110.47 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -63.68 -15.41 48.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.946 2.431 . . . . 0.58 111.748 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -82.72 7.85 13.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 1.45 110.332 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.44 115.78 2.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.276 -0.875 . . . . 0.27 110.669 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -120.47 75.45 24.96 Favored Pre-proline 0 CA--C 1.509 -0.621 0 N-CA-C 107.1 -1.444 . . . . 0.95 107.1 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.597 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 27.0 Cg_endo -61.73 -63.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 123.077 2.518 . . . . 0.4 113.298 -169.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.598 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 5.9 m-20 -64.01 -15.35 59.16 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.55 -0.75 . . . . 1.44 110.713 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 1.3 tmt_? -74.04 -55.72 5.78 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.475 -0.935 . . . . 3.79 108.475 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.614 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 5.0 m -70.72 -25.46 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.05 -0.977 . . . . 0.59 110.36 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.598 ' HB3' ' HA ' ' A' ' 125' ' ' ASP . 9.2 ttt -66.4 -42.73 87.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.995 -1.457 . . . . 0.81 110.646 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' A' ' 132' ' ' MET . 75.5 mt-30 -71.94 -24.93 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 1.31 112.282 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.557 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.3 mt-10 -65.88 -33.45 75.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.737 0.78 . . . . 1.64 109.067 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 112' ' ' VAL . 5.2 mp -65.68 -37.54 86.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.016 -0.993 . . . . 1.36 110.043 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 10.0 ptm -74.88 -11.81 60.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.951 -0.7 . . . . 1.61 110.786 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 35.6 mm-40 -69.25 -35.06 75.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.068 -1.086 . . . . 1.67 108.068 170.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -91.11 23.29 3.32 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.452 -1.249 . . . . 1.08 109.769 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 54.92 49.91 16.71 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.316 -1.311 . . . . 1.1 111.927 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.588 ' H ' ' HA ' ' A' ' 132' ' ' MET . 46.5 mt -110.15 110.54 21.44 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.502 -0.772 . . . . 1.36 109.398 170.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 138' ' ' PRO . 71.0 t -109.12 114.25 58.2 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.662 0.744 . . . . 0.43 112.064 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -44.18 153.04 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 125.057 3.838 . . . . 0.54 113.314 174.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.679 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -76.11 -19.86 58.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.947 -1.478 . . . . 3.08 109.726 178.038 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -72.19 -22.19 61.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.588 -0.733 . . . . 1.57 110.665 171.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.441 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 34.1 m0 -102.62 -12.13 17.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.071 0.462 . . . . 0.66 110.571 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.38 21.89 9.56 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.555 -0.831 . . . . 0.53 114.232 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.96 -123.04 4.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.631 -1.271 . . . . 0.6 111.28 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -157.82 64.01 0.47 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-O 124.097 1.903 . . . . 1.91 111.326 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.635 HG23 ' HB ' ' A' ' 110' ' ' ILE . 97.0 m -148.36 112.23 5.12 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.044 -1.889 . . . . 0.37 108.609 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.075 ' HB ' HD13 ' A' ' 111' ' ' ILE . 51.9 mm -73.56 97.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.539 0.685 . . . . 0.63 109.412 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.58 ' CE2' ' HG3' ' A' ' 128' ' ' MET . 14.8 m-85 -81.46 119.67 24.02 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.612 -1.176 . . . . 0.5 110.588 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 78.2 m -113.83 112.07 22.78 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.135 -0.484 . . . . 0.68 110.459 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.969 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 9.3 ptpt -89.51 91.43 8.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.227 0.537 . . . . 1.44 109.9 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.879 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 2.8 pp -122.37 -169.99 2.0 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.556 1.169 . . . . 0.84 112.412 -169.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.468 ' HB2' ' N ' ' A' ' 117' ' ' MET . 26.1 t -154.69 122.81 5.93 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.553 -1.658 . . . . 1.77 107.061 172.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.406 ' CB ' HD11 ' A' ' 158' ' ' LEU . . . -79.64 -8.12 59.0 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.512 0.672 . . . . 0.41 109.641 175.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.469 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 1.5 mmmp? -83.25 -46.49 12.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.125 -0.943 . . . . 2.3 111.165 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.8 OUTLIER -85.24 -8.01 58.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.164 -0.615 . . . . 0.7 111.285 175.147 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.543 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.7 mmtp 62.85 43.31 7.07 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.2 -0.909 . . . . 1.36 111.49 174.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -102.9 -71.84 0.71 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.649 1.214 . . . . 2.48 110.554 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.879 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -65.49 -11.03 51.81 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.932 -1.485 . . . . 0.29 113.209 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 19.4 mt -69.21 -39.05 78.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.41 0.605 . . . . 0.8 109.584 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 68.1 m-20 -63.0 -46.32 88.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.96 -0.756 . . . . 2.2 108.96 174.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -66.25 -27.89 68.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.49 -0.777 . . . . 0.58 111.151 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.7 tp -65.7 -55.73 15.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 1.16 110.279 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.2 mt -57.71 -44.16 85.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 1.51 109.909 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 35.1 mm-40 -59.66 -44.44 93.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.574 -0.739 . . . . 2.57 111.398 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.477 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -73.62 -39.74 64.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.011 0.434 . . . . 0.64 110.494 -177.432 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.55 HD11 HD11 ' A' ' 83' ' ' ILE . 51.9 mt -62.99 -44.69 99.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.807 -0.633 . . . . 0.52 110.596 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -37.64 88.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.942 -0.572 . . . . 1.73 111.076 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.4 tp -51.48 -49.06 62.56 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.376 0.608 . . . . 1.51 109.468 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.565 ' HA ' ' SD ' ' A' ' 171' ' ' MET . 93.9 t -66.35 -38.73 82.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.078 -0.965 . . . . 0.89 110.883 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.1 m -64.52 -28.1 69.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.82 0.343 . . . . 1.35 111.189 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.79 -45.96 14.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.024 0.44 . . . . 2.73 110.68 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.565 ' SD ' ' HA ' ' A' ' 168' ' ' VAL . 20.0 ptm -65.87 -12.0 51.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.934 -0.575 . . . . 1.88 112.019 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 175' ' ' LYS . 28.0 tp10 -58.13 -25.52 61.51 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.714 0.406 . . . . 4.27 111.667 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -82.97 -1.9 53.71 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.977 -0.452 . . . . 3.91 111.316 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.657 ' HG ' ' H ' ' A' ' 175' ' ' LYS . 0.3 OUTLIER -132.75 -72.29 0.52 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 122.323 -0.235 . . . . 5.72 111.255 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.657 ' H ' ' HG ' ' A' ' 174' ' ' LEU . 42.9 mtpt 61.26 88.37 0.09 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.629 0.603 . . . . 5.49 112.629 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -144.11 25.26 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.672 0.748 . . . . 5.78 109.136 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 18.2 p-10 -161.95 151.83 13.91 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 114.687 -1.142 . . . . 7.88 109.83 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 19.8 Cg_endo . . . . . 0 C--O 1.254 1.292 0 C-N-CA 123.203 2.602 . . . . 9.19 111.755 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.755 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.802 -0.519 . . . . 11.58 111.802 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 p -99.37 2.44 45.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.992 0.425 . . . . 10.61 111.047 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -87.18 91.4 8.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 10.14 110.1 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.5 tpp -99.99 51.79 0.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.802 -0.636 . . . . 8.77 109.67 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.67 -45.37 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.037 -0.529 . . . . 5.74 109.763 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -81.73 149.78 28.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.457 -0.792 . . . . 5.7 109.754 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.747 ' HD2' HE22 ' A' ' 77' ' ' GLN . 57.0 ttp180 -97.77 119.4 62.52 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.665 -0.243 . . . . 6.85 111.079 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 1.7 Cg_endo -84.01 103.73 1.02 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.323 2.682 . . . . 2.8 111.437 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 46.2 Cg_exo -56.15 133.24 56.83 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 123.053 2.502 . . . . 2.76 113.072 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.5 t -82.75 78.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 2.0 109.889 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.62 105.24 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.548 0.69 . . . . 1.35 110.562 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.436 HG21 ' HE3' ' A' ' 14' ' ' MET . 21.0 m -78.41 128.83 34.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.237 -0.892 . . . . 0.64 110.335 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.799 HG13 HD21 ' A' ' 25' ' ' LEU . 37.2 mm -93.85 120.07 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.899 0.38 . . . . 1.3 110.503 177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.436 ' HE3' HG21 ' A' ' 12' ' ' THR . 64.0 mtt -139.12 176.23 8.88 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.629 -0.508 . . . . 0.79 109.629 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 141.06 -163.38 26.67 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.948 -0.861 . . . . 0.31 110.948 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 48.7 t60 -94.19 157.66 15.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.047 0.927 . . . . 0.22 111.444 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.513 HG23 ' O1B' ' A' ' 179' ' ' GDP . 4.6 p -74.9 149.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.348 -1.296 . . . . 0.36 110.528 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 73.18 -21.2 0.26 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.69 110.187 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 17' ' ' VAL . 19.5 m170 -74.0 -20.15 60.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.434 -0.951 . . . . 0.63 108.434 168.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.455 ' O ' HD13 ' A' ' 24' ' ' LEU . . . 109.97 63.34 0.52 Allowed Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.388 -0.823 . . . . 0.79 114.044 172.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.92 -57.45 4.57 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.971 -0.692 . . . . 3.31 111.378 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -86.4 -28.73 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.275 0.472 . . . . 1.21 112.275 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -29.49 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.668 0.618 . . . . 1.25 112.668 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 20' ' ' GLY . 9.7 mp -69.2 -40.09 78.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.395 -0.19 . . . . 1.49 110.706 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.799 HD21 HG13 ' A' ' 13' ' ' ILE . 19.8 mt -69.61 -11.5 60.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.379 0.609 . . . . 1.69 109.919 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.07 -43.1 7.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.064 0.935 . . . . 1.23 109.001 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -50.55 15.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.01 -1.45 . . . . 0.63 111.311 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.01 -31.86 52.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 1.02 111.699 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 27.8 mtm180 -54.47 -53.13 58.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.981 0.42 . . . . 3.04 110.642 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -84.23 20.01 1.72 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.942 0.877 . . . . 2.65 111.397 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.7 m -107.82 12.42 27.3 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.065 -0.97 . . . . 1.46 111.239 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -159.27 -173.32 4.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.477 -0.329 . . . . 3.92 110.284 174.201 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.55 -60.02 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.065 0.459 . . . . 3.1 111.462 -176.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.697 ' OG1' ' HB ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -68.47 121.06 15.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.797 -0.638 . . . . 2.78 109.907 175.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -142.78 -43.29 0.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.739 0.304 . . . . 6.34 111.254 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.96 -37.24 16.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.202 -0.454 . . . . 6.79 110.715 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -77.54 141.85 39.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.949 -0.569 . . . . 6.24 110.172 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 48' ' ' TYR . . . 67.61 174.91 0.26 Allowed 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.882 0.739 . . . . 4.95 110.88 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.75 26.45 60.68 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.462 -0.875 . . . . 4.68 111.418 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.83 82.97 0.3 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.426 -0.669 . . . . 4.55 111.426 -177.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.5 tp -102.77 124.63 56.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.809 0.338 . . . . 5.57 110.714 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.0 m 64.76 -83.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.406 -0.815 . . . . 5.93 110.937 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -143.82 16.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.971 0.415 . . . . 6.63 110.046 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -121.26 116.37 24.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 6.54 111.117 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 46' ' ' GLY . 5.9 tp -93.1 157.5 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.588 -0.893 . . . . 5.17 108.588 170.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' N ' HG13 ' A' ' 45' ' ' ILE . . . 175.9 -62.81 0.1 Allowed Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.319 -0.944 . . . . 2.51 113.155 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.805 ' HB2' HD13 ' A' ' 60' ' ' LEU . . . -166.69 -178.89 4.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.334 0.587 . . . . 1.36 112.183 -177.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.784 ' HE1' HD22 ' A' ' 25' ' ' LEU . 11.7 p90 -156.93 158.18 36.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.801 -1.09 . . . . 1.7 108.986 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -104.24 142.37 34.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.192 0.52 . . . . 1.91 110.907 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.617 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 22.8 t -89.17 142.35 13.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.663 -0.698 . . . . 1.53 110.139 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.697 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 57.5 m -161.44 86.4 0.67 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.393 -0.821 . . . . 1.51 109.481 -171.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 53' ' ' ASN . 4.2 p -80.93 -50.07 17.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.962 0.887 . . . . 2.27 109.042 173.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.498 ' N ' HG13 ' A' ' 52' ' ' VAL . 2.2 p30 -108.16 -64.25 1.24 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.406 -1.27 . . . . 3.68 108.92 175.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.61 ' HA ' HG23 ' A' ' 51' ' ' THR . 32.8 t70 -175.59 61.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.866 -1.061 . . . . 2.99 109.635 172.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HE2' HD13 ' A' ' 166' ' ' LEU . 96.7 mttt -97.27 165.97 11.78 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.063 -0.972 . . . . 7.36 108.894 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 59.6 mttm -131.75 80.13 1.91 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.393 0.616 . . . . 4.46 110.245 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.5 mt -117.85 112.17 37.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.352 -0.84 . . . . 0.92 109.327 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -99.55 96.33 7.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.031 -0.531 . . . . 0.96 111.069 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.585 ' CD2' HD11 ' A' ' 13' ' ' ILE . 5.9 m-85 -71.01 120.7 16.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.522 -0.763 . . . . 1.57 110.551 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.805 HD13 ' HB2' ' A' ' 47' ' ' ALA . 3.5 mm? -93.65 142.76 26.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.485 0.55 . . . . 3.21 112.485 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.654 ' HA ' HD11 ' A' ' 25' ' ' LEU . 11.9 t70 -60.88 -62.96 1.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.654 -0.703 . . . . 5.61 111.342 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 m 64.06 85.42 0.16 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.959 -0.564 . . . . 5.45 111.466 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.741 ' HD2' HG21 ' A' ' 69' ' ' THR . 1.9 Cg_endo -83.52 -14.07 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.822 2.348 . . . . 6.11 112.22 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.83 143.11 11.84 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.124 -0.56 . . . . 6.36 111.948 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -164.18 -64.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.793 0.33 . . . . 8.78 110.257 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -136.46 -59.18 0.73 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.383 -0.371 . . . . 7.05 111.399 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.468 ' H ' ' CD ' ' A' ' 66' ' ' GLU . . . -140.56 -73.26 0.35 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.677 -0.238 . . . . 4.55 111.166 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' HZ ' HG21 ' A' ' 108' ' ' VAL . 16.4 m-85 -96.95 -20.91 17.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.537 0.208 . . . . 2.37 110.772 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.741 HG21 ' HD2' ' A' ' 63' ' ' PRO . 30.7 m 75.12 -52.34 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.238 0.615 . . . . 4.9 112.211 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.6 m -89.68 10.75 22.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.244 0.545 . . . . 5.84 111.434 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.774 ' HG3' ' HA3' ' A' ' 75' ' ' GLY . 54.6 ttm -79.86 75.42 6.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.32 0.581 . . . . 5.21 110.374 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HB3' ' H ' ' A' ' 73' ' ' ALA . 1.2 tpp180 -91.08 -82.82 0.28 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.517 -0.549 . . . . 8.21 109.517 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' H ' ' HB3' ' A' ' 72' ' ' ARG . . . -110.61 -37.25 5.51 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.177 -0.675 . . . . 6.36 109.177 173.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 74' ' ' ARG . 25.0 mtm-85 -79.02 58.35 2.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.197 -0.91 . . . . 9.65 109.731 175.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.774 ' HA3' ' HG3' ' A' ' 71' ' ' MET . . . -153.04 11.65 0.58 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.534 -0.757 . . . . 4.93 111.671 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.11 -30.38 39.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.326 0.584 . . . . 5.47 110.077 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.747 HE22 ' HD2' ' A' ' 7' ' ' ARG . 11.8 pt20 -88.07 138.8 31.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.343 -0.844 . . . . 6.26 109.815 177.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.2 m -105.41 35.41 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.565 0.698 . . . . 4.31 110.44 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.3 m -98.97 -11.55 21.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.225 -0.898 . . . . 3.41 110.071 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -77.89 161.42 27.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.752 -0.658 . . . . 2.66 109.892 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.696 HG21 HG12 ' A' ' 111' ' ' ILE . 5.9 mt -119.53 156.09 22.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.177 -0.465 . . . . 0.71 110.974 -169.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.503 HG11 ' HE1' ' A' ' 102' ' ' HIS . 4.2 p -123.51 133.81 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.532 0.682 . . . . 1.17 109.952 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 165' ' ' ILE . 15.5 mt -90.61 134.55 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.014 -0.994 . . . . 0.37 109.775 175.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.512 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.1 tm? -116.49 104.92 11.92 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.151 -1.055 . . . . 1.01 108.151 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.6 t -85.83 112.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.744 -0.662 . . . . 0.43 111.192 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.8 m -123.37 118.29 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 115.741 -0.663 . . . . 0.64 110.751 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.99 130.85 43.3 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.224 -0.658 . . . . 0.28 109.224 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.865 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -74.18 -6.95 50.79 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.045 0.45 . . . . 0.22 111.497 -170.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.46 -10.01 45.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.879 -0.6 . . . . 0.58 110.87 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.436 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -128.83 -51.95 1.23 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.56 111.571 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.744 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 100.61 -133.86 11.47 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.523 -0.846 . . . . 0.37 113.749 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.44 134.25 37.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.541 0.686 . . . . 1.03 110.48 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.973 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 78.0 mmm -138.88 -178.77 0.9 Allowed Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 114.695 -1.139 . . . . 0.28 109.133 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.973 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 3.5 Cg_endo -46.93 -68.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.246 2.631 . . . . 0.58 114.652 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -70.29 -16.5 63.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.23 0.538 . . . . 0.75 111.005 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.45 -49.13 67.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.643 -0.708 . . . . 0.31 109.495 177.14 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.561 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.1 p -77.39 -24.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.845 -0.616 . . . . 1.38 112.438 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.44 -35.8 76.7 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.666 -0.646 . . . . 2.35 109.492 172.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -25.82 62.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 0.44 110.612 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 97' ' ' VAL . 92.2 mt -75.25 -45.12 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.192 -0.67 . . . . 0.41 109.192 174.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.23 -49.53 60.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.119 -0.946 . . . . 0.67 110.458 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.503 ' HE1' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -45.19 -57.01 4.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 2.5 110.732 171.306 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.616 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -68.96 -47.89 64.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.302 -1.317 . . . . 0.47 113.047 -170.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 13.7 mmmm -72.14 -35.65 69.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.951 0.405 . . . . 1.66 110.641 -173.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.54 75.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.396 -0.82 . . . . 0.77 110.992 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -91.91 -25.33 18.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.208 -0.451 . . . . 0.74 112.097 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 44.4 m-20 80.56 42.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.92 0.867 . . . . 1.41 109.777 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.3 t -96.91 141.99 23.87 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.106 -1.406 . . . . 1.35 111.47 -176.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 21.7 Cg_exo -66.14 142.5 67.79 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.909 2.406 . . . . 0.47 112.905 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.616 HD11 ' CB ' ' A' ' 103' ' ' ALA . 11.5 mm -108.93 158.95 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.804 0.811 . . . . 0.6 111.276 -175.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.808 HD13 ' HB ' ' A' ' 146' ' ' ILE . 23.8 mm -125.76 85.02 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.983 -1.488 . . . . 0.37 106.983 166.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.029 HG23 HG21 ' A' ' 145' ' ' THR . 57.4 t -71.48 143.34 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 121.711 0.767 . . . . 0.26 109.175 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.786 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.76 103.64 4.55 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.47 -1.241 . . . . 0.29 110.538 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.001 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.3 mp -70.45 132.81 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-N 113.588 -1.642 . . . . 0.59 108.631 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 61.1 t30 -120.87 169.63 10.26 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.384 -1.339 . . . . 1.85 107.384 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.831 ' HG2' ' N2 ' ' A' ' 179' ' ' GDP . 88.2 mttt 71.96 34.06 1.55 Allowed 'General case' 0 N--CA 1.424 -1.74 0 O-C-N 124.086 0.866 . . . . 0.59 110.91 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.73 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 10.6 mmt -74.53 -10.09 59.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 115.14 -0.936 . . . . 0.92 109.2 167.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.595 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 5.1 p-10 -72.96 -21.1 60.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.548 -1.206 . . . . 0.76 110.104 172.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.574 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 27.9 mtpp -91.26 135.02 28.74 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 1.17 110.273 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.34 -15.43 49.88 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.713 2.275 . . . . 0.58 111.058 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -78.5 2.07 20.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.643 -1.162 . . . . 1.45 110.486 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.413 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -56.19 108.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.223 -0.899 . . . . 0.27 110.774 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -116.7 76.14 7.45 Favored Pre-proline 0 CA--C 1.51 -0.591 0 N-CA-C 107.03 -1.471 . . . . 0.95 107.03 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.73 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 37.7 Cg_endo -63.92 -66.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.303 0 C-N-CA 122.981 2.454 . . . . 0.4 113.234 -167.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.667 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 1.6 m-20 -64.45 -8.96 15.41 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.723 -0.671 . . . . 1.44 111.216 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -81.83 -53.94 5.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.845 -0.742 . . . . 3.79 109.434 174.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.865 HG21 ' HA ' ' A' ' 88' ' ' ALA . 18.5 m -68.88 -25.71 30.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.337 -0.847 . . . . 0.59 109.795 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . 1.086 ' HA ' HD12 ' A' ' 131' ' ' LEU . 8.6 ttt -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.246 -1.343 . . . . 0.81 110.242 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 132' ' ' MET . 15.3 mt-30 -72.38 -37.74 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.674 -0.694 . . . . 1.31 111.205 173.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.7 mm-40 -60.32 -30.75 69.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.253 1.025 . . . . 1.64 109.149 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.086 HD12 ' HA ' ' A' ' 128' ' ' MET . 62.7 mt -63.74 -43.47 96.37 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.781 -1.554 . . . . 1.36 109.884 177.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.619 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 7.5 ptm -75.36 -14.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.229 -0.589 . . . . 1.61 110.9 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 17.4 mm-40 -71.61 -27.4 63.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.563 -0.902 . . . . 1.67 108.563 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -99.1 22.21 10.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.56 -1.2 . . . . 1.08 108.686 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 54.93 57.46 5.61 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 113.73 -1.577 . . . . 1.1 111.807 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.619 ' H ' ' HA ' ' A' ' 132' ' ' MET . 47.9 mt -119.38 111.73 18.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.847 -1.069 . . . . 1.36 109.0 167.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.478 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.7 t -118.66 117.44 34.18 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-O 121.369 0.604 . . . . 0.43 111.26 -170.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.517 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 36.9 Cg_exo -56.09 175.47 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 124.11 3.207 . . . . 0.54 113.757 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 1.035 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -78.96 -31.81 45.14 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.011 -1.904 . . . . 3.08 109.477 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.872 ' HB2' ' HD1' ' A' ' 141' ' ' TRP . 6.7 mm-40 -58.28 -34.74 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.496 -0.775 . . . . 1.57 109.621 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.872 ' HD1' ' HB2' ' A' ' 140' ' ' GLU . 13.2 m0 -97.44 -7.69 31.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.749 -1.114 . . . . 0.66 110.926 -166.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.93 33.07 11.4 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.926 -0.654 . . . . 0.53 113.264 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.5 -125.05 5.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.174 -1.012 . . . . 0.6 111.685 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.62 62.18 0.53 Allowed 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.769 1.271 . . . . 1.91 111.448 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . 1.029 HG21 HG23 ' A' ' 112' ' ' VAL . 73.8 m -160.5 128.96 4.69 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.194 -1.367 . . . . 0.37 110.238 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.035 HD13 ' HG2' ' A' ' 139' ' ' GLU . 38.0 mm -76.98 106.34 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.765 -0.828 . . . . 0.63 108.765 172.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.634 ' HE2' ' CD1' ' A' ' 131' ' ' LEU . 8.3 m-85 -90.78 110.01 21.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.568 -0.742 . . . . 0.5 110.947 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 97.4 m -105.01 111.8 24.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.3 -0.409 . . . . 0.68 111.08 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 1.001 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 ptpt -88.4 91.28 8.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.339 0.59 . . . . 1.44 109.624 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.863 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -119.47 -173.31 2.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.6 1.191 . . . . 0.84 111.913 -170.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 4.8 p -153.1 101.0 2.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.692 -1.595 . . . . 1.77 107.25 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.86 62.42 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.752 -0.779 . . . . 0.41 109.358 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.612 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 0.9 OUTLIER -75.79 -44.75 39.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.148 -0.933 . . . . 2.3 111.679 175.494 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.764 ' HB ' ' HG3' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -78.59 -17.37 56.19 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.166 -0.613 . . . . 0.7 111.657 176.08 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.2 mmtp 68.7 46.6 0.92 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.393 -0.822 . . . . 1.36 110.832 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.764 ' HG3' ' HB ' ' A' ' 154' ' ' THR . 18.1 mt-10 -108.51 -68.78 0.89 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.566 1.174 . . . . 2.48 110.547 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.863 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.17 -10.53 52.56 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.813 -1.539 . . . . 0.29 113.454 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.577 HD12 ' HD3' ' A' ' 155' ' ' LYS . 37.3 mt -69.45 -42.52 74.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 117.308 0.554 . . . . 0.8 109.827 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.37 -42.81 92.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 2.2 109.564 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' A' ' 164' ' ' MET . 84.5 t60 -67.66 -22.19 65.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.892 -0.595 . . . . 0.58 111.272 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -71.83 -52.55 16.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.133 0.492 . . . . 1.16 109.86 -176.229 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.48 -24.61 66.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.664 . . . . 1.51 111.004 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 163' ' ' GLU . 15.0 mm-40 -72.2 -40.14 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.886 0.374 . . . . 2.57 110.457 175.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.72 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.3 mmt -66.49 -41.37 89.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.64 110.085 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 83' ' ' ILE . 60.6 mt -61.29 -45.35 98.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.52 110.422 175.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.693 HD13 ' HE2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -60.97 -41.01 95.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.067 -0.515 . . . . 1.73 111.079 178.598 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 167' ' ' LEU . 1.6 tm? -51.21 -38.7 53.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.62 0.724 . . . . 1.51 109.234 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.59 -39.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 0.89 110.802 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.7 t -62.57 -33.75 75.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.06 0.457 . . . . 1.35 110.865 175.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 4.7 mm-40 -75.9 -25.67 56.29 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.132 -0.692 . . . . 2.73 109.132 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 45.4 ttp -74.21 -9.45 58.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.249 -0.887 . . . . 1.88 110.802 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -56.79 -24.01 47.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.788 0.328 . . . . 4.27 111.492 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -101.73 -3.88 27.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.367 0.603 . . . . 3.91 110.18 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.3 mt -115.08 1.73 13.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.051 -0.522 . . . . 5.72 111.062 -173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.535 ' HB2' ' OD1' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -64.58 130.06 42.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.007 0.432 . . . . 5.49 111.123 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -101.95 17.63 22.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.2 -0.455 . . . . 5.78 111.146 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.535 ' OD1' ' HB2' ' A' ' 175' ' ' LYS . 27.4 p-10 -82.79 135.58 45.55 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.251 -0.431 . . . . 7.88 110.654 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 11.1 Cg_exo . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.087 2.525 . . . . 9.19 111.741 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.831 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 112.053 -0.419 . . . . 11.58 112.053 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -82.39 1.61 36.44 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.833 0.349 . . . . 10.61 111.89 -174.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -82.96 110.75 18.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.009 -0.367 . . . . 10.14 110.009 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.4 mmt -76.94 106.32 8.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.253 -0.647 . . . . 8.77 109.253 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.44 146.08 34.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.964 0.412 . . . . 5.74 111.366 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.441 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 8.7 tp10 -93.84 94.63 8.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.565 -0.902 . . . . 5.7 108.565 171.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.559 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.9 ttm180 -106.63 103.48 46.78 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.944 -0.571 . . . . 6.85 109.767 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 18.0 Cg_endo -94.68 102.12 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.551 2.834 . . . . 2.8 112.479 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 20.2 Cg_exo -65.98 112.54 2.29 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.304 2.003 . . . . 2.76 110.51 175.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 61' ' ' ASP . 72.0 t -73.76 -71.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.216 -0.447 . . . . 2.0 110.389 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 93.4 t 69.69 119.47 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.798 0.808 . . . . 1.35 111.263 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.642 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 22.2 m -104.36 136.07 44.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.196 -0.456 . . . . 0.64 110.401 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -97.72 138.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.215 0.531 . . . . 1.3 110.238 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.628 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 59.1 mtt -145.99 173.28 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 0.79 109.869 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.68 -174.97 22.77 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.756 -0.735 . . . . 0.31 112.362 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.655 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 13.1 t-80 -86.85 161.67 18.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.715 0.769 . . . . 0.22 111.717 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.558 HG23 ' O2B' ' A' ' 179' ' ' GDP . 3.0 p -73.08 148.88 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.764 -1.107 . . . . 0.36 109.447 173.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' HA ' " O4'" ' A' ' 179' ' ' GDP . 33.4 t70 73.6 -25.35 0.19 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.547 0.689 . . . . 0.69 109.951 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.586 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 16.5 m170 -86.99 -4.64 59.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.386 -0.824 . . . . 0.63 109.372 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.833 ' O ' ' HG2' ' A' ' 21' ' ' LYS . . . -143.23 -53.29 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 118.466 -1.186 . . . . 0.79 113.014 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.858 ' HG3' ' HB ' ' A' ' 23' ' ' THR . 15.4 pttt 60.44 138.47 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.073 0.94 . . . . 3.31 112.048 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -62.2 -15.41 46.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.148 0.975 . . . . 1.21 108.433 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.858 ' HB ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 m -67.42 -21.36 65.57 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 1.25 111.511 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.673 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.8 tt -68.95 -32.06 71.39 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.111 -0.993 . . . . 1.49 108.447 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.655 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 2.6 tp -68.22 -29.08 67.83 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 1.69 110.087 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.45 -38.48 26.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.267 1.032 . . . . 1.23 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HB1' ' CE ' ' A' ' 155' ' ' LYS . . . -67.37 -34.45 77.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.536 -1.665 . . . . 0.63 110.038 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 25' ' ' LEU . 4.5 tt -78.2 -18.88 13.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.99 -1.005 . . . . 1.02 110.343 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 40.3 mtm180 -71.8 -63.27 1.16 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.9 0.381 . . . . 3.04 110.231 175.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -80.88 16.8 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.99 0.9 . . . . 2.65 111.656 -170.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 t -84.15 -17.62 39.42 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.608 -1.178 . . . . 1.46 109.267 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.6 174.66 5.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.517 -0.765 . . . . 3.92 109.293 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.592 ' O ' ' HB ' ' A' ' 51' ' ' THR . 94.2 t -54.61 130.01 16.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.401 0.62 . . . . 3.1 112.372 -177.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.9 t -154.62 -178.2 7.02 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.428 -0.952 . . . . 2.78 108.428 169.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -120.65 143.51 48.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.896 0.379 . . . . 6.34 111.33 -175.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.77 6.03 47.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.552 -0.907 . . . . 6.79 108.552 170.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -84.87 -179.89 7.18 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.872 -1.058 . . . . 6.24 110.193 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.11 -17.52 64.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.972 0.415 . . . . 4.95 110.708 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.39 -16.3 75.46 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.999 -0.619 . . . . 4.68 111.95 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.75 -51.51 0.53 Allowed Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.34 -0.704 . . . . 4.55 111.34 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.35 121.29 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.246 0.546 . . . . 5.57 110.034 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 m -99.88 155.36 17.71 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.072 -0.714 . . . . 5.93 109.072 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -74.13 56.21 0.61 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.137 0.494 . . . . 6.63 112.219 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -172.76 128.94 0.51 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.388 -0.967 . . . . 6.54 108.388 171.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.7 mm -88.64 155.77 3.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.737 -0.468 . . . . 5.17 109.737 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.83 -19.94 12.02 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.935 -0.65 . . . . 2.51 111.832 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -175.43 -173.0 0.61 Allowed 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.575 0.35 . . . . 1.36 110.142 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.553 ' CZ ' HG12 ' A' ' 50' ' ' VAL . 5.3 p90 -175.53 -178.62 1.14 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.831 0.348 . . . . 1.7 110.194 -171.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.531 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 36.0 mt-30 -91.9 112.98 25.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.882 -0.599 . . . . 1.91 109.899 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.553 HG12 ' CZ ' ' A' ' 48' ' ' TYR . 24.1 m -87.39 139.91 16.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.212 0.529 . . . . 1.53 111.209 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' A' ' 33' ' ' VAL . 25.9 m -84.94 82.42 8.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.319 0.581 . . . . 1.51 109.612 172.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.0 p -81.39 -19.86 11.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 122.202 1.001 . . . . 2.27 108.38 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -159.48 -52.76 0.06 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.466 -1.697 . . . . 3.68 107.574 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -167.03 80.9 0.22 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.518 -1.219 . . . . 2.99 110.646 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' H ' ' HA ' ' A' ' 51' ' ' THR . 33.8 mmtp 58.82 25.85 14.05 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.966 0.728 . . . . 7.36 112.966 172.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -102.64 154.29 19.29 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.713 -0.477 . . . . 4.46 109.713 176.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 9' ' ' PRO . 21.8 mt 73.7 82.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 124.04 0.837 . . . . 0.92 109.783 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.531 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 39.2 m -98.45 97.62 8.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.976 -0.556 . . . . 0.96 109.774 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.617 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 77.2 m-85 -61.43 133.74 56.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.778 -0.646 . . . . 1.57 109.678 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 63.0 tp 64.58 101.21 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.474 0.654 . . . . 3.21 110.82 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.598 ' HB2' HG11 ' A' ' 10' ' ' VAL . 14.6 t0 -75.41 -83.85 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.676 -0.693 . . . . 5.61 111.067 -176.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 m -136.75 117.4 10.99 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.541 -0.3 . . . . 5.45 110.731 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.05 151.02 30.24 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.434 2.09 . . . . 6.11 112.195 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.99 -102.44 0.76 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.824 -0.703 . . . . 6.36 112.349 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -60.7 -59.8 4.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.051 0.453 . . . . 8.78 110.943 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 42.0 mt-10 -127.32 98.97 5.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.058 -0.719 . . . . 7.05 109.058 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.36 55.38 0.98 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.531 0.682 . . . . 4.55 112.228 -175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -161.01 -165.16 1.3 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.047 -0.979 . . . . 2.37 109.541 173.153 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.471 HG21 ' HA ' ' A' ' 80' ' ' ASP . 8.3 t -59.54 132.57 54.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 4.9 111.748 -176.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.5 p -82.89 82.74 8.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.708 0.766 . . . . 5.84 110.697 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.7 mtm -56.21 -29.44 60.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.059 -0.973 . . . . 5.21 111.365 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.4 mtt-85 -55.43 -63.56 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 8.21 111.803 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.87 3.88 39.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 6.36 111.534 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.722 ' HA ' ' HE ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -109.36 7.71 25.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.991 0.424 . . . . 9.65 110.279 -178.639 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.29 -109.65 1.73 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.274 -0.731 . . . . 4.93 111.274 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.49 -93.64 0.1 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.344 -0.243 . . . . 5.47 110.344 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -111.05 68.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.267 0.556 . . . . 6.26 109.961 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.438 ' HB ' ' HD3' ' A' ' 7' ' ' ARG . 28.3 m -134.87 16.48 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.481 -0.781 . . . . 4.31 110.529 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -162.7 10.85 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.047 0.451 . . . . 3.41 111.401 -176.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HA ' HG21 ' A' ' 69' ' ' THR . 5.5 p-10 -80.4 88.04 5.61 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.495 0.664 . . . . 2.66 110.634 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.513 ' HB ' HG22 ' A' ' 11' ' ' VAL . 70.6 mt -145.05 132.56 16.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.535 -0.757 . . . . 0.71 110.419 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.518 HG22 ' HB ' ' A' ' 12' ' ' THR . 23.1 t -122.79 127.19 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.172 0.511 . . . . 1.17 110.998 173.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 24.3 mt -86.57 132.08 33.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.331 -0.849 . . . . 0.37 110.087 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.548 HD12 HD21 ' A' ' 131' ' ' LEU . 2.0 tm? -121.48 110.56 16.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.254 -1.017 . . . . 1.01 108.254 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 33.5 t -96.42 114.52 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.159 -0.473 . . . . 0.43 110.801 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 114' ' ' ILE . 3.4 m -119.66 142.16 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.64 111.063 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.708 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -80.73 131.02 35.4 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.793 -0.447 . . . . 0.28 109.793 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.694 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -74.97 -12.96 60.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.116 -0.633 . . . . 0.22 109.906 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.564 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -91.1 -10.36 42.26 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.17 -0.923 . . . . 0.58 111.519 -177.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.586 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 7.0 t70 -134.9 -38.22 0.8 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.755 0.312 . . . . 0.56 111.348 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.458 ' HA2' ' CG1' ' A' ' 127' ' ' VAL . . . 91.03 -133.16 11.65 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 114.157 0.423 . . . . 0.37 114.157 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.532 HG11 ' HE2' ' A' ' 134' ' ' TYR . 12.8 t -100.34 131.46 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.911 0.862 . . . . 1.03 110.551 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.523 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -131.03 173.62 5.66 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 114.017 -1.447 . . . . 0.28 108.086 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 73.1 Cg_exo -49.71 -57.07 2.55 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.325 2.017 . . . . 0.58 113.282 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.655 ' HG2' ' HD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -72.34 -13.97 61.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.917 0.389 . . . . 0.75 111.415 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -69.76 -52.86 21.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.609 0.719 . . . . 0.31 109.647 177.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 100' ' ' ILE . 2.0 p -83.13 -23.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 113.761 1.023 . . . . 1.38 113.761 -173.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -63.96 -25.17 68.02 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.111 -0.993 . . . . 2.35 109.428 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.628 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -74.57 -39.86 62.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.439 -0.8 . . . . 0.44 110.228 171.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.538 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 93.8 mt -62.98 -49.06 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.582 0.706 . . . . 0.41 109.754 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -55.43 -33.33 63.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.496 -1.229 . . . . 0.67 110.817 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -67.48 -43.68 80.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.696 -0.684 . . . . 2.5 110.375 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.425 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -73.97 -44.58 54.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 0.47 111.578 -177.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.67 ' HD3' HD21 ' A' ' 136' ' ' LEU . 13.5 mmmm -66.18 -32.78 74.43 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.123 0.487 . . . . 1.66 110.064 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.56 -41.75 70.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.926 -1.033 . . . . 0.77 110.83 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.404 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . . . -79.03 -32.39 44.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 0.74 111.305 178.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 84.39 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.412 1.07 . . . . 1.41 109.064 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.21 140.79 21.62 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 113.906 -1.497 . . . . 1.35 110.251 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.15 142.81 93.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.643 2.229 . . . . 0.47 111.96 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.498 ' C ' HG23 ' A' ' 145' ' ' THR . 23.0 mm -105.51 156.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.764 0.793 . . . . 0.6 110.735 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.875 HD13 ' HB ' ' A' ' 146' ' ' ILE . 14.2 mm -124.89 86.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 107.102 -1.444 . . . . 0.37 107.102 171.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.901 HG23 HG21 ' A' ' 145' ' ' THR . 59.9 t -75.16 145.83 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 121.779 0.799 . . . . 0.26 109.953 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB1' ' CD2' ' A' ' 150' ' ' LEU . . . -144.07 102.27 3.85 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.067 -1.424 . . . . 0.29 109.932 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.792 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.4 mp -72.18 140.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.148 -1.387 . . . . 0.59 109.636 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.708 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 4.4 p-10 -117.57 176.64 5.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.693 -1.225 . . . . 1.85 107.693 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.63 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 83.9 mttt 69.58 34.28 2.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.892 0.745 . . . . 0.59 111.633 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.437 ' CE ' ' HB1' ' A' ' 122' ' ' ALA . 17.5 mmt -77.78 -13.56 59.85 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.486 -0.931 . . . . 0.92 108.486 169.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.547 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -70.66 -25.94 63.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.861 -1.518 . . . . 0.76 109.519 173.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 43.5 mtpt -89.07 137.85 29.35 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.36 -0.836 . . . . 1.17 110.247 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.41 -13.94 42.39 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.839 2.36 . . . . 0.58 111.659 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 33.0 mt-10 -81.75 6.66 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.161 -0.927 . . . . 1.45 110.539 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.437 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -58.0 107.68 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.565 -0.743 . . . . 0.27 110.975 175.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -120.84 76.66 29.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.48 -0.934 . . . . 0.95 108.48 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.478 ' HA ' HG22 ' A' ' 127' ' ' VAL . 47.4 Cg_endo -66.6 -54.77 0.41 Allowed 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.74 2.293 . . . . 0.4 113.125 -172.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.433 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.1 m-20 -52.26 -26.45 11.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 1.44 110.78 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.602 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 53.7 ttt180 -79.7 -57.15 3.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.07 -0.652 . . . . 3.79 109.403 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.694 HG11 ' HA ' ' A' ' 88' ' ' ALA . 15.7 m -63.76 -24.52 36.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.406 -0.816 . . . . 0.59 112.128 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.492 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 17.2 ptm -84.74 -17.37 38.56 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.037 0.446 . . . . 0.81 109.929 174.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.8 mt-30 -76.31 -40.74 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 1.31 110.511 170.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 1.9 mm-40 -58.6 -35.49 72.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.124 0.964 . . . . 1.64 108.978 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.694 HD23 HG21 ' A' ' 112' ' ' VAL . 2.0 mp -64.52 -42.89 95.5 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.542 -1.208 . . . . 1.36 110.352 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.727 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.7 ppp? -75.58 -8.75 57.57 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.506 -0.478 . . . . 1.61 110.685 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 8.0 mm-40 -71.97 -36.68 69.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.872 -1.158 . . . . 1.67 107.872 172.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.532 ' HE2' HG11 ' A' ' 92' ' ' VAL . 23.4 m-85 -91.42 28.56 1.66 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.655 -1.157 . . . . 1.08 110.012 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.74 53.14 13.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.742 -1.572 . . . . 1.1 112.342 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.67 HD21 ' HD3' ' A' ' 104' ' ' LYS . 66.2 mt -113.94 99.03 7.36 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.338 -0.847 . . . . 1.36 108.84 168.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.947 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 35.5 t -100.76 115.42 65.36 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-O 121.565 0.698 . . . . 0.43 111.788 -168.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.692 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 87.4 Cg_exo -43.97 138.69 6.24 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 124.168 3.245 . . . . 0.54 112.072 171.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.979 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.4 OUTLIER -73.65 -14.93 61.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.199 -0.91 . . . . 3.08 109.963 178.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.1 pm0 -66.07 -26.14 67.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.488 -0.778 . . . . 1.57 110.135 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.727 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 34.5 m0 -101.63 -14.91 17.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.97 0.414 . . . . 0.66 110.465 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.07 24.55 7.56 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.804 -0.712 . . . . 0.53 113.584 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.947 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.07 -120.27 2.07 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.9 -1.143 . . . . 0.6 112.094 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -157.63 63.38 0.47 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.824 1.297 . . . . 1.91 112.268 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.901 HG21 HG23 ' A' ' 112' ' ' VAL . 56.6 m -160.19 126.13 4.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.195 -1.366 . . . . 0.37 109.992 173.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.979 HD13 ' HG2' ' A' ' 139' ' ' GLU . 30.7 mm -74.47 104.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.539 -0.911 . . . . 0.63 108.539 172.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.692 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.8 m-85 -90.75 105.08 17.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.119 -0.946 . . . . 0.5 111.381 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.85 139.75 30.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.306 -0.861 . . . . 0.68 109.786 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.555 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 mptt -114.93 102.67 10.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.18 -0.674 . . . . 1.44 109.18 176.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.792 ' HG ' ' O ' ' A' ' 114' ' ' ILE . 3.6 pp -125.61 -174.02 2.97 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.389 1.09 . . . . 0.84 111.805 -172.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 150' ' ' LEU . 1.5 p -152.16 92.31 1.7 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.1 -1.409 . . . . 1.77 108.465 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -16.06 63.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.13 0.49 . . . . 0.41 109.867 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.555 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 0.0 OUTLIER -66.2 -55.99 13.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.32 -0.855 . . . . 2.3 110.847 172.203 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -84.79 -9.03 58.57 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.95 -0.7 . . . . 0.7 112.387 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HD3' HD12 ' A' ' 158' ' ' LEU . 19.2 mmtp 71.53 42.79 0.64 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.669 0.606 . . . . 1.36 110.966 175.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 -70.72 0.76 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 122.344 1.068 . . . . 2.48 110.318 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.759 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.38 -4.82 46.41 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.269 -1.332 . . . . 0.29 113.967 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.584 HD12 ' HD3' ' A' ' 155' ' ' LYS . 22.5 mt -70.26 -36.74 74.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.155 -0.683 . . . . 0.8 109.155 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -38.89 79.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.144 -0.935 . . . . 2.2 109.035 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.2 t60 -71.48 -14.74 62.23 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.534 -0.757 . . . . 0.58 111.437 177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.89 -55.75 5.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.335 -0.617 . . . . 1.16 109.335 -177.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.92 -26.71 68.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.508 -0.769 . . . . 1.51 111.383 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 15.7 pt-20 -76.41 -30.73 57.56 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.403 -0.519 . . . . 2.57 110.79 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 29.6 mmt -73.23 -39.13 65.74 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.315 0.578 . . . . 0.64 109.507 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 83' ' ' ILE . 83.3 mt -61.83 -42.41 94.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 0.52 109.531 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -37.64 86.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.567 -0.742 . . . . 1.73 111.185 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.3 tp -53.37 -45.08 69.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.533 0.682 . . . . 1.51 109.353 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.39 -46.35 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.939 -1.028 . . . . 0.89 110.646 175.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.4 m -58.81 -36.88 75.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.894 0.378 . . . . 1.35 111.301 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -72.35 -42.97 64.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.472 . . . . 2.73 110.143 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.0 ttp -73.67 -11.45 60.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 1.88 111.032 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.13 -28.38 64.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 4.27 111.228 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.441 ' C ' HD12 ' A' ' 174' ' ' LEU . 50.5 mm-40 -109.2 -4.92 16.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.544 -0.298 . . . . 3.91 111.212 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.441 HD12 ' C ' ' A' ' 173' ' ' GLU . 7.7 mp -128.57 41.41 3.49 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.429 . . . . 5.72 110.935 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -96.25 136.09 37.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.463 -0.335 . . . . 5.49 110.428 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -112.07 139.83 47.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.097 -0.502 . . . . 5.78 110.341 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 59.55 77.5 0.38 Allowed Pre-proline 0 N--CA 1.466 0.36 0 O-C-N 123.618 0.574 . . . . 7.88 110.808 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo . . . . . 0 C--O 1.254 1.303 0 C-N-CA 122.757 2.305 . . . . 9.19 111.746 179.063 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GDP . . . . . 0.744 ' PB ' ' HA ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.818 0.342 . . . . 0.64 110.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -92.56 129.93 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 108.763 -0.828 . . . . 1.3 108.763 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.457 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 44.9 mtm -143.82 -171.58 3.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.783 -0.644 . . . . 0.79 109.716 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.469 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 129.96 -158.57 22.36 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.617 -0.993 . . . . 0.31 110.617 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.649 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 50.2 t60 -91.04 157.12 17.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.851 0.834 . . . . 0.22 111.189 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 6.4 p -73.5 154.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.366 -1.288 . . . . 0.36 109.9 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.505 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 20.3 t70 74.84 -18.94 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.295 0.569 . . . . 0.69 110.559 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.535 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 15.1 m170 -83.01 -4.86 58.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.515 -0.921 . . . . 0.63 108.515 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.7 ' HA3' HD13 ' A' ' 24' ' ' LEU . . . 111.01 47.34 0.77 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.391 -0.909 . . . . 0.79 114.062 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -50.61 -66.58 0.36 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.366 0.583 . . . . 3.31 111.691 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -94.15 -30.71 14.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.202 -0.454 . . . . 1.21 111.233 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.0 -27.46 63.52 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.724 0.639 . . . . 1.25 112.724 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.7 HD13 ' HA3' ' A' ' 20' ' ' GLY . 5.5 mp -78.61 -25.31 45.15 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.95 -0.3 . . . . 1.49 110.956 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.9 -17.1 60.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.936 -0.764 . . . . 1.69 108.936 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.08 -45.71 8.53 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.052 0.929 . . . . 1.23 108.805 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 24' ' ' LEU . . . -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.719 -1.582 . . . . 0.63 110.475 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 tt . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 114.91 -1.041 . . . . 1.02 110.974 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.2 mt . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.592 -0.522 . . . . 0.71 109.592 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 p -116.87 136.47 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 119.957 -0.697 . . . . 1.17 110.618 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 13.0 mt -96.64 128.8 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.501 -0.772 . . . . 0.37 109.98 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 84' ' ' LEU . 2.2 tm? -114.54 109.77 18.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.956 -1.127 . . . . 1.01 107.956 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.07 118.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.333 -0.394 . . . . 0.43 111.051 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.7 m -128.24 120.62 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.698 -0.683 . . . . 0.64 110.3 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -64.73 131.81 47.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.719 -0.673 . . . . 0.28 110.262 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -67.65 -18.09 64.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.084 0.469 . . . . 0.22 110.751 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -90.13 -14.65 33.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.392 -0.822 . . . . 0.58 111.316 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.481 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.5 t0 -123.63 -47.48 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.56 110.75 -170.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.616 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.82 -151.14 27.3 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.37 113.098 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.653 HG11 ' HE2' ' A' ' 134' ' ' TYR . 21.5 t -77.96 129.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.828 0.823 . . . . 1.03 111.025 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.936 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.2 mmm -130.94 179.89 1.23 Allowed Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 114.265 -1.334 . . . . 0.28 108.615 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.936 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.11 -66.01 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.284 2.656 . . . . 0.58 114.564 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.473 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.5 pt20 -73.23 -15.27 61.44 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.287 0.565 . . . . 0.75 110.94 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.0 -43.83 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 0.31 109.007 176.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.57 HG12 ' ND2' ' A' ' 101' ' ' ASN . 30.1 t -66.15 -42.59 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.255 -0.884 . . . . 1.38 111.302 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.28 -29.01 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.239 -0.437 . . . . 2.35 110.098 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.538 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.609 HG23 HD11 ' A' ' 136' ' ' LEU . 96.5 mt -75.4 -44.89 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.796 0.808 . . . . 0.41 109.147 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.57 ' ND2' HG12 ' A' ' 97' ' ' VAL . 53.0 m-20 -57.1 -37.42 71.92 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.041 -1.436 . . . . 0.67 110.944 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -71.5 -37.91 71.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.274 0.559 . . . . 2.5 109.795 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -44.31 68.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.785 -0.643 . . . . 0.47 111.824 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.64 ' HD3' HD21 ' A' ' 136' ' ' LEU . 1.8 mmmp? -76.42 -28.9 56.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.051 0.453 . . . . 1.66 110.482 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.12 -44.56 61.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.174 -0.921 . . . . 0.77 110.268 173.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.14 -34.99 22.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.992 -0.549 . . . . 0.74 110.436 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.3 t30 83.87 40.82 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.843 1.257 . . . . 1.41 109.36 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.481 HG13 ' HD2' ' A' ' 109' ' ' PRO . 24.5 t -83.8 145.29 46.77 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 113.279 -1.782 . . . . 1.35 110.99 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 108' ' ' VAL . 21.8 Cg_exo -61.93 138.68 75.14 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.257 1.972 . . . . 0.47 111.436 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.0 OUTLIER -107.68 159.07 7.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 122.011 0.91 . . . . 0.6 112.226 -172.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.856 HD13 ' HB ' ' A' ' 146' ' ' ILE . 5.9 mm -126.02 87.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.538 -1.664 . . . . 0.37 106.858 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.473 HG23 HG21 ' A' ' 145' ' ' THR . 61.5 t -78.1 148.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.603 -0.726 . . . . 0.26 109.971 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 148' ' ' CYS . . . -140.12 110.19 6.51 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.569 -1.196 . . . . 0.29 110.679 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.762 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.2 mp -84.86 108.31 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.148 -1.387 . . . . 0.59 109.636 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.4 p-10 -99.45 178.02 5.0 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.626 -1.25 . . . . 1.85 107.626 -171.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 74.9 mttt 70.75 28.44 3.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.034 0.834 . . . . 0.59 110.123 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 85.5 mmm -81.54 -7.27 59.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.351 -0.981 . . . . 0.92 108.351 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.411 ' N ' ' HB3' ' A' ' 151' ' ' SER . 1.2 p-10 -68.41 -30.44 69.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.521 -1.672 . . . . 0.76 109.634 168.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -71.79 131.73 85.66 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.78 -0.645 . . . . 1.17 110.089 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.27 -15.09 47.67 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.391 2.061 . . . . 0.58 111.388 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -90.24 5.71 45.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.377 -0.829 . . . . 1.45 110.592 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.452 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -54.77 124.41 16.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.731 -0.668 . . . . 0.27 111.271 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.31 76.07 68.45 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.337 -0.986 . . . . 0.95 108.337 173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.75 ' HA ' HG21 ' A' ' 114' ' ' ILE . 39.4 Cg_endo -64.17 -62.03 0.1 Allowed 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.025 2.483 . . . . 0.4 113.305 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 6.9 m-20 -61.63 -16.15 45.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.257 -0.883 . . . . 1.44 111.019 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -75.42 -58.39 3.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.598 0.713 . . . . 3.79 109.307 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.616 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 12.7 m -66.03 -29.48 46.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 0.59 110.194 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.537 ' HG3' ' CD2' ' A' ' 147' ' ' PHE . 15.4 ttt -59.99 -39.59 86.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 0.81 110.793 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.597 ' O ' ' HG2' ' A' ' 132' ' ' MET . 45.0 mt-30 -69.14 -29.67 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 1.31 111.933 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.609 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 9.0 mt-10 -67.05 -29.07 68.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.587 . . . . 1.64 109.533 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.561 HD12 ' CD1' ' A' ' 136' ' ' LEU . 4.0 mm? -64.73 -44.5 89.99 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.641 -0.708 . . . . 1.36 110.071 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.597 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 14.7 ptm -70.57 -10.2 58.7 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.813 -0.755 . . . . 1.61 110.83 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 35.4 mt-10 -78.73 -28.3 44.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.05 -0.722 . . . . 1.67 109.05 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.653 ' HE2' HG11 ' A' ' 92' ' ' VAL . 71.3 m-85 -92.73 22.79 4.5 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.836 0.826 . . . . 1.08 109.659 167.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.0 t30 61.33 46.23 7.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 113.855 -1.52 . . . . 1.1 111.749 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.64 HD21 ' HD3' ' A' ' 104' ' ' LYS . 72.9 mt -113.67 93.6 4.46 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.36 109.732 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.036 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 44.5 t -102.74 122.87 44.43 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.199 -0.909 . . . . 0.43 110.635 -172.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.761 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 10.6 Cg_endo -60.0 157.52 33.67 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.211 2.608 . . . . 0.54 112.902 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.466 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.8 mm-40 -79.72 -12.1 59.81 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.127 -1.397 . . . . 3.08 110.574 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.761 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -69.89 -19.63 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.899 -0.591 . . . . 1.57 109.888 167.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.521 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 45.1 m0 -110.6 -20.43 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.338 -0.392 . . . . 0.66 111.306 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.72 28.75 5.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.839 -0.696 . . . . 0.53 113.417 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 1.036 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.2 -106.8 1.95 Allowed Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.58 -0.819 . . . . 0.6 112.689 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -166.0 61.21 0.1 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 122.284 1.04 . . . . 1.91 110.419 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 98.8 m -164.06 133.93 4.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 0.37 110.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.856 ' HB ' HD13 ' A' ' 111' ' ' ILE . 28.0 mm -97.16 110.1 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 109.495 -0.557 . . . . 0.63 109.495 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.672 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 12.1 m-85 -90.05 150.51 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.5 110.295 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 91.1 m -131.25 127.0 36.92 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.663 -1.153 . . . . 0.68 109.747 171.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.1 88.13 5.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.056 -0.72 . . . . 1.44 109.056 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.077 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -115.98 170.12 8.73 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.685 1.231 . . . . 0.84 112.768 -170.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.411 ' HB3' ' N ' ' A' ' 118' ' ' ASP . 3.1 p -129.94 104.78 7.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.961 -1.126 . . . . 1.77 107.961 172.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.41 -9.9 59.05 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.377 -0.529 . . . . 0.41 109.762 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -82.54 -46.39 13.44 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.128 -0.629 . . . . 2.3 112.119 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 p -86.39 -3.39 58.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 119.188 -1.005 . . . . 0.7 111.363 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 25.8 mmtp 64.89 45.59 3.18 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.287 -0.87 . . . . 1.36 110.705 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.51 -58.34 1.97 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.65 -1.159 . . . . 2.48 110.062 -175.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 1.077 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -79.76 -10.65 85.5 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.296 -0.865 . . . . 0.29 113.847 -173.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.6 -36.8 83.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.857 0.829 . . . . 0.8 109.043 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 1.6 m-20 -69.84 -42.12 74.01 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.695 -1.139 . . . . 2.2 110.182 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.83 -21.26 64.31 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.499 -0.319 . . . . 0.58 111.154 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -74.13 -51.15 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.659 -0.496 . . . . 1.16 109.659 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.2 pp -60.79 -27.51 68.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.795 -0.639 . . . . 1.51 110.711 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.608 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 42.0 mt-10 -64.63 -48.04 76.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.4 -0.364 . . . . 2.57 110.812 174.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -63.8 -35.63 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.32 -0.4 . . . . 0.64 110.27 176.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 73.4 mt -62.01 -48.57 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.52 110.829 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 163' ' ' GLU . 4.5 pp -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 121.007 -0.277 . . . . 1.73 110.965 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 166' ' ' LEU . 4.8 tt -54.38 -50.53 67.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.927 -0.768 . . . . 1.51 108.927 172.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 164' ' ' MET . 65.1 t . . . . . 0 N--CA 1.444 -0.757 0 CA-C-N 115.883 -0.599 . . . . 0.89 110.777 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.743 ' HB ' HG23 ' A' ' 82' ' ' VAL . 7.5 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 110.488 -0.19 . . . . 0.64 110.488 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.467 HD13 ' HB ' ' A' ' 83' ' ' ILE . 46.0 mm -105.06 113.61 42.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 1.3 109.978 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.587 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 67.3 mtt -127.18 172.81 10.23 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.944 -0.571 . . . . 0.79 109.877 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 148.57 -172.95 28.68 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.666 -0.778 . . . . 0.31 112.136 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.637 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 49.1 t60 -88.88 159.66 17.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.856 0.836 . . . . 0.22 111.106 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.53 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.7 p -69.85 143.98 14.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.656 -1.157 . . . . 0.36 110.258 174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 30.6 t70 75.93 -18.24 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.384 0.612 . . . . 0.69 110.36 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.468 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 17.0 m170 -85.05 -10.73 56.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.278 -1.008 . . . . 0.63 108.278 170.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.87 48.46 1.08 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.191 -0.913 . . . . 0.79 113.369 174.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -60.83 -53.33 58.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.108 0.454 . . . . 3.31 110.909 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.5 m -98.85 -34.72 10.37 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.374 0.607 . . . . 1.21 110.442 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.589 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.66 -21.01 24.44 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.114 0.783 . . . . 1.25 113.114 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -75.64 -34.37 60.53 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.294 -1.002 . . . . 1.49 108.294 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 28' ' ' ILE . 7.0 tp -67.26 -23.79 65.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.322 -0.854 . . . . 1.69 109.785 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -92.54 -39.4 11.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.776 0.798 . . . . 1.23 109.681 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.29 80.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.56 -1.2 . . . . 0.63 109.738 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.3 tt . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 114.849 -1.069 . . . . 1.02 110.394 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.702 HG21 HG12 ' A' ' 111' ' ' ILE . 55.4 mt . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.916 0.389 . . . . 0.71 111.899 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.743 HG23 ' HB ' ' A' ' 12' ' ' THR . 9.2 p -117.06 140.36 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.457 0.646 . . . . 1.17 110.392 173.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 165' ' ' ILE . 18.8 mt -95.25 131.11 42.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.201 -0.909 . . . . 0.37 109.904 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.444 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 1.9 tm? -117.53 107.88 14.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.204 -1.036 . . . . 1.01 108.204 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.454 HG21 ' HG ' ' A' ' 24' ' ' LEU . 57.4 t -89.81 116.48 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.993 -0.549 . . . . 0.43 111.23 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 3.7 m -122.38 137.26 56.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 0.64 110.793 175.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.687 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -75.43 133.95 41.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.939 -0.573 . . . . 0.28 110.011 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -76.81 -14.88 59.87 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 120.303 -0.559 . . . . 0.22 110.129 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -10.61 53.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.561 -0.745 . . . . 0.58 110.894 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.405 ' HB3' ' CE1' ' A' ' 19' ' ' HIS . 24.3 t0 -128.03 -69.33 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.56 110.284 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.6 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 121.19 -139.8 13.54 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.14 -0.553 . . . . 0.37 113.183 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.5 p -95.67 139.72 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.432 0.634 . . . . 1.03 109.43 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.635 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 72.2 mmm -140.14 178.05 1.76 Allowed Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.419 -0.81 . . . . 0.28 108.815 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.635 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 82.9 Cg_exo -46.32 -64.69 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.885 2.39 . . . . 0.58 114.521 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.53 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 2.9 pt20 -70.56 -16.56 62.88 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.555 -0.715 . . . . 0.75 110.787 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.637 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.65 -49.7 51.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.747 -0.661 . . . . 0.31 109.603 178.152 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.612 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.7 p -74.74 -29.06 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.934 -0.575 . . . . 1.38 112.457 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -57.47 -30.18 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 2.35 109.946 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.587 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -71.14 -40.95 71.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.458 -0.792 . . . . 0.44 110.491 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 97' ' ' VAL . 76.9 mt -66.74 -44.31 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.821 0.819 . . . . 0.41 109.641 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -56.63 -42.21 78.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.67 110.842 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -71.23 -35.02 71.33 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.77 -0.455 . . . . 2.5 109.77 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.45 -52.56 38.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 0.47 111.533 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 29.7 mtpt -75.62 -22.78 56.55 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.675 -0.41 . . . . 1.66 110.908 -176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.21 72.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.551 -0.749 . . . . 0.77 110.539 171.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.57 -21.37 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.74 111.101 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.0 t30 82.32 61.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.282 0.989 . . . . 1.41 109.195 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 t -117.7 139.69 26.66 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 114.348 -1.296 . . . . 1.35 111.579 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -69.26 143.05 51.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.993 2.462 . . . . 0.47 111.362 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.505 ' C ' HG23 ' A' ' 145' ' ' THR . 1.3 mt -113.89 160.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 122.04 0.924 . . . . 0.6 112.375 -171.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.771 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 26.4 mm -129.94 86.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.816 -1.538 . . . . 0.37 106.89 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.789 HG23 HG21 ' A' ' 145' ' ' THR . 48.4 t -72.5 147.73 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.595 0.712 . . . . 0.26 109.159 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.94 105.48 4.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.646 -1.161 . . . . 0.29 110.48 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.811 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -73.99 134.08 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 114.163 -1.38 . . . . 0.59 108.97 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.687 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.7 p-10 -113.42 177.24 4.7 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.358 -1.349 . . . . 1.85 107.358 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.819 ' HD3' ' HE2' ' A' ' 119' ' ' LYS . 89.8 mttt 70.77 32.66 2.43 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 123.701 0.626 . . . . 0.59 111.907 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.544 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 10.8 mmt -79.89 -10.89 59.83 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.896 -1.15 . . . . 0.92 107.896 166.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 0.7 OUTLIER -70.47 -20.17 62.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.181 -1.827 . . . . 0.76 109.711 169.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.819 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 23.6 mtmt -100.15 134.57 20.75 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-N 115.606 -0.725 . . . . 1.17 110.407 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -64.03 -14.63 44.59 Favored 'Trans proline' 0 N--CA 1.47 0.122 0 C-N-CA 123.074 2.516 . . . . 0.58 111.907 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -81.67 6.52 14.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.417 -0.81 . . . . 1.45 110.42 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.406 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -58.08 115.4 2.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.17 -0.923 . . . . 0.27 111.231 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.4 76.72 44.41 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.04 -1.096 . . . . 0.95 108.04 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.544 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 43.6 Cg_endo -66.13 -60.25 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.949 2.432 . . . . 0.4 113.176 -170.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.497 ' HA ' ' HG2' ' A' ' 128' ' ' MET . 1.5 m-20 -55.87 -21.34 19.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.315 -0.857 . . . . 1.44 110.91 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -78.07 -56.83 4.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.475 0.655 . . . . 3.79 109.663 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 88' ' ' ALA . 22.6 m -66.66 -24.88 33.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.874 -1.057 . . . . 0.59 111.675 -176.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.75 ' HA ' ' HB2' ' A' ' 131' ' ' LEU . 18.8 ptm -87.86 -13.88 40.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.914 -0.315 . . . . 0.81 110.549 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.0 mt-30 -75.87 -47.9 23.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.685 0.279 . . . . 1.31 110.423 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.18 -18.3 64.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.445 0.641 . . . . 1.64 109.572 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.904 HD23 ' HE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -65.62 -43.36 89.78 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.084 -0.962 . . . . 1.36 109.012 172.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.857 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.8 ppp? -80.52 -7.5 59.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.965 -0.561 . . . . 1.61 110.55 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 45.8 mt-10 -78.59 -24.15 45.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.764 -0.828 . . . . 1.67 108.764 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.407 ' HD1' ' N ' ' A' ' 134' ' ' TYR . 1.8 m-85 -91.58 18.82 6.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.645 -1.161 . . . . 1.08 108.478 169.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 56.69 56.94 5.1 Favored 'General case' 0 CA--C 1.526 0.048 0 CA-C-N 113.716 -1.583 . . . . 1.1 111.463 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.777 ' H ' ' HA ' ' A' ' 132' ' ' MET . 70.8 mt -123.02 105.58 10.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.825 -1.08 . . . . 1.36 109.365 170.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.805 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.4 t -108.17 114.11 59.95 Favored Pre-proline 0 C--N 1.31 -1.132 0 C-N-CA 119.89 -0.724 . . . . 0.43 111.125 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.996 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 1.2 Cg_endo -54.45 160.59 6.68 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.587 2.858 . . . . 0.54 112.97 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.566 ' HB2' HD13 ' A' ' 146' ' ' ILE . 20.6 mm-40 -78.16 -17.29 57.03 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.02 -1.445 . . . . 3.08 109.697 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.996 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 2.0 pm0 -69.35 -24.48 63.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.118 -0.946 . . . . 1.57 110.256 169.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.857 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 30.7 m0 -105.99 -10.1 16.74 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.916 0.388 . . . . 0.66 110.274 -177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.16 33.83 10.34 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.896 -0.593 . . . . 0.53 113.455 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.805 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -91.31 -108.8 1.53 Allowed Glycine 0 CA--C 1.509 -0.317 0 C-N-CA 120.086 -1.054 . . . . 0.6 111.418 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -163.82 61.4 0.16 Allowed 'General case' 0 C--O 1.248 1.015 0 CA-C-O 123.497 1.618 . . . . 1.91 110.457 170.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.789 HG21 HG23 ' A' ' 112' ' ' VAL . 58.1 m -162.67 114.97 1.62 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.745 -1.571 . . . . 0.37 110.224 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.771 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 12.7 mm -68.12 106.16 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.032 -0.729 . . . . 0.63 109.032 172.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.904 ' HE2' HD23 ' A' ' 131' ' ' LEU . 7.9 m-85 -87.99 107.6 18.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.717 -0.674 . . . . 0.5 110.08 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.29 112.13 24.08 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.246 -0.434 . . . . 0.68 110.526 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.811 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 81.9 mttt -83.96 96.34 8.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.699 -0.852 . . . . 1.44 108.699 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.797 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.8 pp -122.33 -173.38 2.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.614 1.197 . . . . 0.84 111.974 -173.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 0.7 OUTLIER -154.0 93.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.498 -1.683 . . . . 1.77 107.626 -176.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.14 60.76 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.645 -0.422 . . . . 0.41 110.429 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 40.9 mttm -78.48 -48.17 15.89 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.311 -0.556 . . . . 2.3 111.541 172.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 p -84.75 -7.11 59.33 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.669 -0.812 . . . . 0.7 111.516 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.426 ' CD ' HD12 ' A' ' 158' ' ' LEU . 39.0 mmtm 66.79 42.54 2.58 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.396 -0.82 . . . . 1.36 111.548 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -102.31 -67.42 0.87 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.346 1.07 . . . . 2.48 109.911 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.797 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -70.06 -8.31 61.27 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.015 -1.448 . . . . 0.29 113.757 -174.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.426 HD12 ' CD ' ' A' ' 155' ' ' LYS . 26.6 mt -69.17 -37.96 78.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.98 0.89 . . . . 0.8 109.578 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.613 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 25.0 t70 -72.65 -39.31 67.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.657 -0.701 . . . . 2.2 109.596 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.47 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 86.6 t60 -69.28 -20.34 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.24 -0.436 . . . . 0.58 110.884 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.463 HD21 HD13 ' A' ' 83' ' ' ILE . 53.2 tp -67.18 -53.71 27.9 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.322 -0.621 . . . . 1.16 109.322 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.73 -26.97 67.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.043 -0.98 . . . . 1.51 110.72 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 49.8 mt-10 -58.74 -47.51 84.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.259 0.552 . . . . 2.57 110.202 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.651 ' HB3' HG21 ' A' ' 146' ' ' ILE . 19.5 mmt -71.9 -34.43 69.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.846 -0.616 . . . . 0.64 110.32 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 83' ' ' ILE . 84.5 mt -65.24 -46.13 91.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 0.52 110.995 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 167' ' ' LEU . 4.3 pp -67.47 -33.01 74.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.811 -0.356 . . . . 1.73 111.011 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 166' ' ' LEU . 2.3 tm? -52.99 -48.24 67.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.954 -0.758 . . . . 1.51 108.954 170.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.63 HG11 HD11 ' A' ' 81' ' ' ILE . 67.7 t . . . . . 0 N--CA 1.444 -0.731 0 CA-C-N 115.581 -0.736 . . . . 0.89 111.256 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.815 ' HB ' HG22 ' A' ' 82' ' ' VAL . 3.0 m . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.499 -0.185 . . . . 0.64 110.499 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -112.89 138.14 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.177 0.513 . . . . 1.3 110.592 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.455 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 63.0 mtt -147.05 173.04 12.83 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.561 -0.745 . . . . 0.79 109.28 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 84' ' ' LEU . . . 150.1 -175.99 28.94 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.711 -0.757 . . . . 0.31 112.108 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.586 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 49.5 t60 -86.6 162.15 18.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.997 0.903 . . . . 0.22 111.563 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.52 150.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.275 -1.329 . . . . 0.36 110.172 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.3 t70 74.44 -14.98 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.476 0.655 . . . . 0.69 109.902 -175.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.542 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 13.6 m170 -87.57 9.0 22.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.95 -1.13 . . . . 0.63 107.95 168.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 76.05 54.4 5.28 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 114.801 -1.09 . . . . 0.79 113.899 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 7.82 7.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.035 0.917 . . . . 3.31 111.453 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.5 m -129.64 -50.64 1.16 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.974 -0.557 . . . . 1.21 110.011 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -57.52 -24.75 57.8 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.077 -0.51 . . . . 1.25 111.315 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.3 mp -70.43 -35.34 73.32 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 111.98 0.363 . . . . 1.49 111.98 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 22' ' ' THR . 2.5 pp -74.61 -17.74 60.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.61 -0.836 . . . . 1.69 109.909 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' N ' HD12 ' A' ' 25' ' ' LEU . 29.5 t70 -85.55 -42.93 13.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.144 0.973 . . . . 1.23 109.217 174.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -64.52 -38.29 90.5 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.7 -1.591 . . . . 0.63 110.588 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 6.9 tt . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 115.151 -0.931 . . . . 1.02 111.139 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.453 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 110.3 -0.259 . . . . 0.71 110.3 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.815 HG22 ' HB ' ' A' ' 12' ' ' THR . 39.1 t -118.02 126.95 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.368 0.604 . . . . 1.17 112.11 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.67 HG12 ' HB ' ' A' ' 111' ' ' ILE . 6.1 mt -85.04 133.97 28.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.009 -0.996 . . . . 0.37 110.562 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 96' ' ' THR . 2.0 tm? -121.28 110.35 16.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.454 -0.943 . . . . 1.01 108.454 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 93.2 t -89.04 117.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 0.43 111.397 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.9 m -126.33 123.35 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.803 -0.635 . . . . 0.64 111.218 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -62.53 131.81 50.36 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.928 -0.578 . . . . 0.28 110.014 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.732 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.22 0.533 . . . . 0.22 111.115 -176.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -90.54 -13.87 33.71 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.479 -0.782 . . . . 0.58 111.069 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.451 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.1 t70 -118.55 -50.43 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 0.56 110.537 -174.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.585 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 91.43 -162.77 28.36 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.37 113.449 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.07 136.37 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.754 0.788 . . . . 1.03 109.75 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.769 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 76.8 mmm -139.39 176.93 2.27 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.932 -1.031 . . . . 0.28 109.14 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 74.7 Cg_exo -40.13 -65.52 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.369 2.712 . . . . 0.58 114.466 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.472 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.4 pt20 -76.13 -16.64 59.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.881 -0.327 . . . . 0.75 111.243 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.633 HG21 HG12 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -68.23 -43.01 78.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.486 0.66 . . . . 0.31 109.258 176.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.542 HG12 ' ND2' ' A' ' 101' ' ' ASN . 24.9 t -66.27 -41.35 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 115.049 -0.978 . . . . 1.38 111.289 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 41.1 mm-40 -55.07 -29.6 57.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.981 0.419 . . . . 2.35 110.456 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.04 -38.14 66.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.44 110.565 175.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.596 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.9 mt -73.49 -44.43 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.84 0.829 . . . . 0.41 109.056 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.542 ' ND2' HG12 ' A' ' 97' ' ' VAL . 35.1 m-20 -59.36 -30.71 68.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.36 -1.291 . . . . 0.67 111.055 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -80.91 -34.62 33.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.168 0.509 . . . . 2.5 110.038 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.501 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -71.81 -46.21 58.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.885 -0.598 . . . . 0.47 111.482 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 13.6 mmmm -71.59 -29.23 64.46 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.242 0.544 . . . . 1.66 109.58 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.46 72.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.906 -1.043 . . . . 0.77 111.33 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.33 28.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.74 110.629 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 85.6 53.06 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 114.581 -1.19 . . . . 1.41 109.295 171.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.34 141.96 25.02 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 113.841 -1.527 . . . . 1.35 110.62 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.27 143.43 83.33 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.554 2.17 . . . . 0.47 112.025 173.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.501 HD11 ' HB1' ' A' ' 103' ' ' ALA . 31.4 mm -106.34 158.59 6.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.488 0.661 . . . . 0.6 110.976 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.828 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 41.1 mm -124.94 84.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.396 -1.335 . . . . 0.37 107.396 171.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 131' ' ' LEU . 63.0 t -70.12 147.84 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.654 0.74 . . . . 0.26 109.753 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.779 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -145.13 100.37 3.46 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.34 -1.3 . . . . 0.29 109.701 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.823 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.7 mp -70.43 139.21 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.173 -1.376 . . . . 0.59 109.082 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -120.13 171.99 8.08 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.835 -1.542 . . . . 1.85 106.835 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.522 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 90.2 mttt 66.81 30.58 7.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 O-C-N 123.704 0.627 . . . . 0.59 111.902 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.494 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 83.1 mmm -83.79 -6.39 59.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.651 0.739 . . . . 0.92 109.299 172.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 8.1 p-10 -67.11 -28.1 67.88 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.704 -1.135 . . . . 0.76 108.865 169.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.502 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 29.5 mtpp -74.97 133.19 76.05 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.205 -1.362 . . . . 1.17 110.414 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -64.97 -16.05 53.53 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.449 2.1 . . . . 0.58 110.937 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -80.84 -1.64 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.745 -1.116 . . . . 1.45 110.63 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -54.97 124.29 16.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.189 -0.914 . . . . 0.27 111.731 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.743 HD22 ' HB2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -129.13 75.67 79.99 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.75 -0.833 . . . . 0.95 108.75 173.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.406 ' HB3' ' SD ' ' A' ' 117' ' ' MET . 37.0 Cg_endo -63.24 -60.33 0.18 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 123.085 2.523 . . . . 0.4 112.73 -173.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 2.5 m-20 -55.92 -18.22 8.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.555 -0.748 . . . . 1.44 111.616 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.743 ' HB2' HD22 ' A' ' 123' ' ' ASN . 5.4 tpm_? -78.7 -56.75 4.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.206 -0.665 . . . . 3.79 109.206 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.585 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 5.0 m -66.47 -22.98 30.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 122.303 1.049 . . . . 0.59 110.165 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.62 ' HG3' ' CD2' ' A' ' 147' ' ' PHE . 8.4 ttt -68.27 -43.94 76.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.767 -1.56 . . . . 0.81 110.522 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.561 ' HA ' ' HG3' ' A' ' 132' ' ' MET . 27.6 mt-30 -68.85 -31.74 70.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.765 -0.652 . . . . 1.31 111.752 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.741 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 12.7 mt-10 -61.52 -37.61 84.36 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.932 0.872 . . . . 1.64 109.162 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.848 HD23 HG21 ' A' ' 112' ' ' VAL . 4.9 mp -62.4 -35.75 80.18 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.502 -0.772 . . . . 1.36 109.846 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.765 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -70.14 -18.05 63.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.051 -0.659 . . . . 1.61 111.864 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 4.7 pt-20 -78.83 -17.5 55.57 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.204 -1.036 . . . . 1.67 108.204 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -97.9 23.02 8.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.777 -1.101 . . . . 1.08 109.051 167.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.43 52.86 11.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.658 -1.61 . . . . 1.1 111.763 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 132' ' ' MET . 76.7 mt -121.67 96.79 5.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.604 -0.726 . . . . 1.36 110.026 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.968 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 61.5 t -103.54 121.71 47.42 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.572 -0.74 . . . . 0.43 111.302 -174.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 86.5 Cg_exo -41.58 144.16 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.642 3.561 . . . . 0.54 113.854 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HB2' HD13 ' A' ' 146' ' ' ILE . 9.0 mm-40 -74.09 -21.92 59.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.056 -1.429 . . . . 3.08 109.354 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 138' ' ' PRO . 2.3 pm0 -70.53 -21.44 62.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.671 -1.149 . . . . 1.57 110.634 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.537 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 37.6 m0 -102.66 -34.12 9.18 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 120.846 0.355 . . . . 0.66 110.641 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 122.27 29.63 1.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.724 -0.751 . . . . 0.53 112.623 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.968 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.91 -112.46 2.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.442 -0.885 . . . . 0.6 112.48 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -162.89 60.37 0.2 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.65 1.215 . . . . 1.91 111.246 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.749 HG21 HG23 ' A' ' 112' ' ' VAL . 52.3 m -165.12 116.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.686 -1.143 . . . . 0.37 110.347 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.828 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.5 mm -70.74 105.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.062 -0.718 . . . . 0.63 109.062 173.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.1 m-85 -89.05 114.56 25.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.205 -0.907 . . . . 0.5 110.601 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 95.4 m -102.94 116.63 32.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.754 0.311 . . . . 0.68 110.769 173.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.662 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 88.1 mttt -89.72 103.7 16.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.923 -0.769 . . . . 1.44 108.923 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.899 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.3 pp -135.25 -174.14 3.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.054 1.407 . . . . 0.84 112.953 -172.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.425 ' HB2' ' H ' ' A' ' 118' ' ' ASP . 13.8 t -152.44 118.55 5.51 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.453 -1.703 . . . . 1.77 106.693 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.56 -7.77 58.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.156 -0.618 . . . . 0.41 109.369 175.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -74.47 -55.15 6.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.47 -0.786 . . . . 2.3 110.197 172.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.4 p -82.5 -9.14 59.54 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.148 -0.621 . . . . 0.7 111.619 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.449 ' HE3' ' HB1' ' A' ' 27' ' ' ALA . 38.6 mmtm 65.39 40.14 4.89 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.506 -0.77 . . . . 1.36 111.516 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.13 -67.3 0.85 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.708 1.242 . . . . 2.48 110.281 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.899 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -68.68 -12.62 64.64 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 113.536 -1.665 . . . . 0.29 113.844 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 158' ' ' LEU . 34.4 mt -67.42 -37.56 83.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 118.287 1.043 . . . . 0.8 109.804 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.988 -1.005 . . . . 2.2 109.401 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.5 -20.56 65.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.396 -0.82 . . . . 0.58 110.861 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.12 -57.31 7.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.23 -0.441 . . . . 1.16 110.327 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.36 -41.27 75.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.405 -0.816 . . . . 1.51 110.178 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -55.23 -45.86 76.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.284 -0.871 . . . . 2.57 111.586 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.519 ' HB3' HG21 ' A' ' 146' ' ' ILE . 14.4 mmt -70.23 -44.38 68.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 0.64 110.382 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.556 HD11 HD11 ' A' ' 83' ' ' ILE . 72.0 mt -59.18 -49.53 83.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.725 -0.67 . . . . 0.52 111.523 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -22.94 60.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.673 -0.24 . . . . 1.73 110.849 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.13 -50.94 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.905 -0.776 . . . . 1.51 108.905 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 164' ' ' MET . 42.3 t . . . . . 0 N--CA 1.444 -0.743 0 CA-C-N 115.224 -0.898 . . . . 0.89 110.794 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 110.239 -0.282 . . . . 0.64 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -107.4 136.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.385 0.612 . . . . 1.3 110.953 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.429 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 63.5 mtt -144.12 176.59 9.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.433 -0.803 . . . . 0.79 108.892 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.07 176.69 15.21 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.247 -0.977 . . . . 0.31 112.322 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 57.7 t60 -80.81 158.94 25.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.82 0.819 . . . . 0.22 111.538 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 6.5 p -71.82 151.34 8.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.5 -1.227 . . . . 0.36 109.933 175.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 20.8 t70 75.03 -25.13 0.21 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.1 0.476 . . . . 0.69 110.703 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.551 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 20.4 m170 -76.71 -17.32 59.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.487 -0.931 . . . . 0.63 108.487 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.817 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 119.78 65.3 0.28 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.401 -0.818 . . . . 0.79 113.87 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -65.28 -71.43 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.142 -0.623 . . . . 3.31 110.656 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -86.71 -32.48 20.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.517 -0.31 . . . . 1.21 110.924 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.502 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -57.76 -27.86 63.42 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.569 0.581 . . . . 1.25 112.569 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.817 HD23 ' HA3' ' A' ' 20' ' ' GLY . 1.2 mm? -75.86 -36.93 59.42 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.908 -0.404 . . . . 1.49 109.908 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 tp -73.71 -9.67 58.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.631 -0.713 . . . . 1.69 109.941 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -98.92 -44.06 6.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.884 -0.784 . . . . 1.23 108.884 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.48 87.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.279 -1.328 . . . . 0.63 109.761 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 10.9 tt . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.791 -1.095 . . . . 1.02 111.101 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.6 mt . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 108.509 -0.923 . . . . 0.71 108.509 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.408 HG21 ' SD ' ' A' ' 14' ' ' MET . 11.9 p -114.49 135.69 53.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.528 0.68 . . . . 1.17 110.896 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.9 mt -90.83 128.92 42.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.914 -1.039 . . . . 0.37 109.884 173.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 96' ' ' THR . 2.4 tm? -114.8 106.89 14.73 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.369 -0.974 . . . . 1.01 108.369 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -86.29 109.03 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.43 110.996 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.5 m -119.99 122.29 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.768 -0.651 . . . . 0.64 110.656 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.85 130.09 41.33 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.406 -0.59 . . . . 0.28 109.406 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -69.01 -15.32 63.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 120.897 0.379 . . . . 0.22 111.505 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.52 -5.52 58.16 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.037 -0.529 . . . . 0.58 111.523 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -133.23 -49.39 0.86 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.556 0.217 . . . . 0.56 111.479 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.551 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 94.75 -148.43 18.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 121.084 -0.579 . . . . 0.37 113.477 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.436 HG11 ' CE2' ' A' ' 134' ' ' TYR . 30.2 t -83.23 131.28 34.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.542 0.687 . . . . 1.03 110.355 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.789 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 83.9 mmm -131.22 176.85 2.56 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 114.645 -1.162 . . . . 0.28 109.477 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.789 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 56.5 Cg_exo -38.53 -66.43 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.566 2.844 . . . . 0.58 114.578 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.503 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 3.8 pt20 -74.82 -15.5 60.74 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.135 0.493 . . . . 0.75 111.323 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -71.01 -41.68 70.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.475 0.655 . . . . 0.31 109.482 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.805 HG12 HD22 ' A' ' 101' ' ' ASN . 25.7 t -63.41 -41.16 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.193 -0.912 . . . . 1.38 111.861 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.29 -34.29 68.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 2.35 110.276 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.429 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -68.65 -34.26 75.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 0.44 110.609 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.592 HG21 ' HB3' ' A' ' 134' ' ' TYR . 95.5 mt -74.14 -42.67 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.778 0.799 . . . . 0.41 109.256 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.805 HD22 HG12 ' A' ' 97' ' ' VAL . 6.4 m-80 -65.41 -25.59 67.61 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.446 -1.252 . . . . 0.67 111.349 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -82.63 -39.21 22.45 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.256 0.55 . . . . 2.5 109.846 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.02 44.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.779 -0.646 . . . . 0.47 111.982 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.79 ' HD3' HD21 ' A' ' 136' ' ' LEU . 29.9 mmmt -75.76 -27.15 57.96 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.305 0.574 . . . . 1.66 110.438 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.82 -44.29 81.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.055 -0.975 . . . . 0.77 110.302 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.67 44.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.084 -0.507 . . . . 0.74 110.926 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.2 t30 82.64 37.19 0.05 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.657 1.218 . . . . 1.41 108.583 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 31.1 t -77.38 137.35 64.09 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 113.39 -1.732 . . . . 1.35 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 16.7 Cg_exo -67.69 138.97 46.82 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.381 2.054 . . . . 0.47 111.321 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.454 ' C ' HG23 ' A' ' 145' ' ' THR . 0.8 OUTLIER -110.59 155.75 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 122.056 0.932 . . . . 0.6 112.196 -173.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.854 HD13 ' HB ' ' A' ' 146' ' ' ILE . 28.4 mm -122.44 82.19 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 113.753 -1.567 . . . . 0.37 107.278 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.916 HG23 HG21 ' A' ' 145' ' ' THR . 64.0 t -69.01 146.04 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 109.044 -0.724 . . . . 0.26 109.044 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.6 103.01 4.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.545 -1.207 . . . . 0.29 110.111 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.857 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.5 mp -69.02 136.11 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.066 -1.425 . . . . 0.59 108.444 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 62.9 t30 -123.62 167.07 14.44 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.486 -1.302 . . . . 1.85 107.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.627 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 85.7 mttt 69.55 31.99 3.52 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 124.036 0.835 . . . . 0.59 111.047 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 75.6 mmm -85.11 -3.81 58.93 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.84 0.829 . . . . 0.92 108.914 173.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 4.1 p-10 -68.16 -33.1 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.269 -1.332 . . . . 0.76 109.061 168.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.626 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 25.4 mtpp -72.25 129.94 86.9 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 114.814 -1.085 . . . . 1.17 110.202 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.52 -13.99 42.2 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 122.406 2.071 . . . . 0.58 110.788 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -82.47 -1.99 52.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 1.45 110.298 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.45 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -61.36 130.19 44.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.985 -1.007 . . . . 0.27 111.333 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.95 76.64 66.68 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.627 -0.879 . . . . 0.95 108.627 174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.539 ' HB3' ' SD ' ' A' ' 117' ' ' MET . 56.8 Cg_endo -66.71 -53.93 0.5 Allowed 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.77 2.314 . . . . 0.4 113.311 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.558 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.0 m-20 -53.93 -29.21 41.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.22 -0.9 . . . . 1.44 110.115 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -75.95 -56.92 4.21 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.798 -0.761 . . . . 3.79 109.485 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 88' ' ' ALA . 24.9 m -62.77 -29.03 46.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.424 -0.807 . . . . 0.59 112.033 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.558 ' SD ' ' HA ' ' A' ' 125' ' ' ASP . 18.2 ptm -73.05 -23.77 60.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.518 -0.473 . . . . 0.81 110.219 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -70.73 -32.24 69.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.615 -0.266 . . . . 1.31 110.694 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 3.1 mm-40 -64.23 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.844 0.83 . . . . 1.64 109.719 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.633 HD12 HD13 ' A' ' 136' ' ' LEU . 4.2 mm? -64.03 -41.52 97.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.309 -0.86 . . . . 1.36 109.658 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.757 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 1.6 mtm -72.83 -13.91 61.39 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 119.652 -0.819 . . . . 1.61 110.692 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 5.1 mm-40 -68.49 -26.73 65.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.396 -1.335 . . . . 1.67 107.396 173.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.592 ' HB3' HG21 ' A' ' 100' ' ' ILE . 78.9 m-85 -108.74 33.72 4.06 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.407 -1.269 . . . . 1.08 111.039 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 54.9 t30 61.71 43.01 10.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.631 -1.168 . . . . 1.1 112.013 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.79 HD21 ' HD3' ' A' ' 104' ' ' LYS . 36.1 mt -123.02 97.22 5.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.814 -0.63 . . . . 1.36 111.384 174.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.072 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 57.3 t -99.1 121.26 56.14 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 115.561 -0.745 . . . . 0.43 111.185 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.757 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 93.1 Cg_exo -41.86 142.72 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.373 3.382 . . . . 0.54 113.573 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.484 ' HB2' HD13 ' A' ' 146' ' ' ILE . 4.9 mm-40 -73.5 -16.12 61.29 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.514 -1.221 . . . . 3.08 109.81 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.578 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.2 pm0 -69.27 -21.87 63.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.834 . . . . 1.57 110.26 170.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.5 m0 -109.97 -18.21 13.43 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.082 0.468 . . . . 0.66 111.078 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.54 4.97 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.827 . . . . 0.53 113.506 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 1.072 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.23 -110.66 1.43 Allowed Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.39 -0.91 . . . . 0.6 111.909 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -161.22 60.07 0.29 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 122.808 1.29 . . . . 1.91 111.485 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.916 HG21 HG23 ' A' ' 112' ' ' VAL . 58.5 m -164.1 119.8 1.58 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.87 -1.059 . . . . 0.37 111.201 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.854 ' HB ' HD13 ' A' ' 111' ' ' ILE . 22.5 mm -72.77 106.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.678 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.3 m-85 -88.78 116.63 27.18 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.203 -0.908 . . . . 0.5 110.863 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 85.3 m -102.01 115.71 31.14 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.658 -0.497 . . . . 0.68 109.658 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.857 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 37.9 mtpt -94.8 85.19 4.36 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.984 -0.746 . . . . 1.44 108.984 -176.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.983 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -121.99 -176.92 3.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.712 1.244 . . . . 0.84 113.192 -164.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.431 ' N ' HD12 ' A' ' 150' ' ' LEU . 1.2 p -149.35 108.39 3.9 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.579 -1.646 . . . . 1.77 108.358 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.405 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . . . -76.44 -15.43 59.92 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.193 0.52 . . . . 0.41 109.906 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -76.31 -51.39 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.766 -0.652 . . . . 2.3 111.432 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -79.14 -9.63 59.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.03 -0.668 . . . . 0.7 111.318 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp 66.77 43.69 2.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.919 0.866 . . . . 1.36 110.465 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 2.4 tt0 -105.16 -63.07 1.27 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.217 . . . . 2.48 109.912 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.983 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -78.16 -10.7 86.02 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 114.933 -1.03 . . . . 0.29 113.432 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 22.6 mt -67.15 -40.04 86.63 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 117.702 0.751 . . . . 0.8 110.11 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -73.14 -37.84 66.47 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.384 -0.826 . . . . 2.2 109.348 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 163' ' ' GLU . 83.2 t60 -70.41 -20.75 62.9 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.561 -0.745 . . . . 0.58 111.142 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.79 -54.2 30.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.184 0.516 . . . . 1.16 109.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.9 mt -55.98 -38.56 70.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.076 -0.965 . . . . 1.51 110.196 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 49.4 mt-10 -51.97 -52.72 48.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 2.57 110.972 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.579 ' HB3' HG21 ' A' ' 146' ' ' ILE . 15.0 mmt -69.79 -34.55 73.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.959 -0.564 . . . . 0.64 110.535 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.7 mt -61.17 -51.97 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.52 111.192 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 167' ' ' LEU . 4.1 pp -66.19 -33.22 75.28 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 121.032 -0.267 . . . . 1.73 111.176 -177.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.8 tp -54.06 -51.34 64.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.895 -0.593 . . . . 1.51 109.634 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 164' ' ' MET . 61.1 t . . . . . 0 N--CA 1.447 -0.624 0 CA-C-N 115.757 -0.656 . . . . 0.89 110.793 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.557 0.218 . . . . 0.64 111.293 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -93.18 108.49 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.922 0.391 . . . . 1.3 110.256 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.466 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 45.1 mtm -130.22 172.8 11.41 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.887 -0.412 . . . . 0.79 109.887 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.81 -157.14 27.1 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.013 -0.835 . . . . 0.31 111.013 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.617 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 46.9 t60 -94.6 160.4 14.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.116 0.96 . . . . 0.22 111.839 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.87 152.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.31 -1.314 . . . . 0.36 110.489 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t70 73.44 -20.75 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.205 0.602 . . . . 0.69 110.162 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 17' ' ' VAL . 22.3 m170 -71.6 -20.75 61.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.079 -1.082 . . . . 0.63 108.079 167.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 112.83 58.41 0.42 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.34 -0.846 . . . . 0.79 113.778 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 14' ' ' MET . 2.9 tppp? -58.11 -62.78 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.628 0.714 . . . . 3.31 111.088 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 p -72.08 -40.75 68.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 1.21 111.845 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -27.66 69.05 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.937 -0.574 . . . . 1.25 112.087 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -70.28 -57.31 5.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.441 0.639 . . . . 1.49 109.574 -175.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -12.39 55.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.747 -1.115 . . . . 1.69 111.136 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.77 -37.46 9.46 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.807 0.813 . . . . 1.23 109.678 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.23 70.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.781 -1.1 . . . . 0.63 109.494 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.6 tt . . . . . 0 N--CA 1.446 -0.646 0 CA-C-N 114.713 -1.131 . . . . 1.02 110.057 179.629 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.1 mt . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.654 0.264 . . . . 0.71 110.923 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.58 138.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-O 121.771 0.796 . . . . 1.17 111.147 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 6.3 mt -98.17 132.48 43.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.961 -1.018 . . . . 0.37 110.372 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -107.77 107.26 17.95 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.463 -0.79 . . . . 1.01 110.108 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.59 94.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.152 0.501 . . . . 0.43 110.472 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.611 HG13 HD12 ' A' ' 84' ' ' LEU . 11.4 m -111.29 123.35 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.008 -0.542 . . . . 0.64 111.032 175.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -71.68 130.31 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.161 -0.472 . . . . 0.28 109.752 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.754 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -68.4 -19.37 64.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.055 0.455 . . . . 0.22 111.59 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.39 -14.45 46.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.754 -0.657 . . . . 0.58 110.649 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.448 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 6.6 t70 -118.21 -55.04 2.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.56 110.362 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.41 ' HA2' ' CG1' ' A' ' 127' ' ' VAL . . . 99.38 -128.47 9.58 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.965 -0.562 . . . . 0.37 113.319 173.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.469 HG21 ' HE2' ' A' ' 134' ' ' TYR . 8.7 p -103.86 136.94 34.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.675 0.75 . . . . 1.03 109.845 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.7 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.9 mmm -140.08 176.73 2.35 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.772 -1.104 . . . . 0.28 108.74 -171.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.9 Cg_exo -41.35 -66.96 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.15 2.567 . . . . 0.58 114.552 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.477 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.6 pt20 -74.11 -15.4 61.05 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.22 0.533 . . . . 0.75 111.114 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.7 -43.71 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.119 -0.697 . . . . 0.31 109.119 176.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.536 HG12 ' ND2' ' A' ' 101' ' ' ASN . 22.7 t -66.78 -41.83 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.237 -0.892 . . . . 1.38 111.164 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -56.45 -32.06 64.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.484 . . . . 2.35 110.424 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.53 -31.93 69.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.676 -0.693 . . . . 0.44 110.638 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.569 HG23 HD11 ' A' ' 136' ' ' LEU . 96.7 mt -77.94 -44.65 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.564 0.697 . . . . 0.41 109.371 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.536 ' ND2' HG12 ' A' ' 97' ' ' VAL . 61.2 m-20 -57.41 -38.25 74.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.523 -1.217 . . . . 0.67 110.808 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -68.79 -34.54 75.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.058 0.456 . . . . 2.5 109.872 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.96 -48.91 16.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.015 -0.538 . . . . 0.47 111.932 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.57 ' HD3' HD21 ' A' ' 136' ' ' LEU . 14.0 mmmm -66.46 -38.37 87.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.03 0.443 . . . . 1.66 110.018 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.91 -35.81 71.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 0.77 111.04 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.99 -32.71 39.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.508 -0.314 . . . . 0.74 111.301 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 83.35 42.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.36 1.076 . . . . 1.41 108.902 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 109' ' ' PRO . 1.7 p -103.76 142.86 25.47 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 114.077 -1.419 . . . . 1.35 111.208 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 108' ' ' VAL . 22.1 Cg_exo -65.17 142.27 73.06 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.361 2.041 . . . . 0.47 111.722 171.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 111' ' ' ILE . 1.3 mt -110.82 163.79 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.443 0.64 . . . . 0.6 111.782 -171.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.851 HD13 ' HB ' ' A' ' 146' ' ' ILE . 15.9 mm -142.09 84.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 N-CA-C 106.747 -1.575 . . . . 0.37 106.747 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.751 HG23 HG21 ' A' ' 145' ' ' THR . 63.1 t -76.02 152.27 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 CA-C-N 114.316 -1.311 . . . . 0.26 109.815 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.9 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -143.51 101.5 3.79 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.554 -1.203 . . . . 0.29 109.739 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.841 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.6 mp -68.65 133.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 114.106 -1.406 . . . . 0.59 108.722 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 64.6 t30 -120.37 166.84 12.99 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.125 -1.435 . . . . 1.85 107.125 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.566 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 81.5 mttt 68.42 31.66 4.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 O-C-N 124.242 0.964 . . . . 0.59 111.672 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.478 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 82.6 mmm -80.99 -6.94 59.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.466 -0.788 . . . . 0.92 109.378 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -65.5 -32.49 74.12 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.068 -0.969 . . . . 0.76 108.595 169.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.49 ' HB3' ' OE1' ' A' ' 121' ' ' GLU . 26.8 mtpp -77.56 131.37 71.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.856 -1.52 . . . . 1.17 110.724 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.78 -18.17 59.12 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.538 2.159 . . . . 0.58 111.402 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 15.3 mp0 -68.7 -22.26 64.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.257 -0.883 . . . . 1.45 110.394 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -40.93 123.62 1.98 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.556 -1.202 . . . . 0.27 112.631 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.2 75.94 79.61 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.959 -1.126 . . . . 0.95 107.959 173.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.814 ' O ' ' HG3' ' A' ' 128' ' ' MET . 33.1 Cg_endo -61.15 -60.37 0.24 Allowed 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 122.806 2.337 . . . . 0.4 113.193 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.421 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 5.1 m-20 -49.15 -27.59 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.859 0.724 . . . . 1.44 110.753 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 129' ' ' GLN . 41.8 ttp180 -77.49 -53.3 7.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.756 -0.656 . . . . 3.79 110.031 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.597 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 19.5 m -64.36 -20.62 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.659 -0.701 . . . . 0.59 112.219 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.814 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 37.3 mtp -71.45 -35.68 70.97 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.647 0.737 . . . . 0.81 109.131 171.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 132' ' ' MET . 46.2 mt-30 -66.65 -35.11 79.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.718 -1.128 . . . . 1.31 110.956 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.597 ' HG2' ' HA ' ' A' ' 127' ' ' VAL . 18.8 mm-40 -57.53 -50.07 74.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.924 0.868 . . . . 1.64 109.835 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.734 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 10.7 mp -65.01 -34.27 78.05 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.998 -1.001 . . . . 1.36 110.917 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.594 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 14.6 ptm -73.25 -11.27 60.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.974 -0.691 . . . . 1.61 110.65 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.72 -28.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.515 -0.92 . . . . 1.67 108.515 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.469 ' HE2' HG21 ' A' ' 92' ' ' VAL . 45.4 m-85 -90.12 23.24 2.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.187 -0.915 . . . . 1.08 109.408 167.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.3 t30 52.38 54.44 10.69 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 114.014 -1.448 . . . . 1.1 111.737 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.734 ' HB2' ' HB3' ' A' ' 131' ' ' LEU . 78.9 mt -117.98 98.09 6.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.844 -1.071 . . . . 1.36 109.131 169.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.015 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 40.3 t -100.19 118.95 60.45 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.031 -0.532 . . . . 0.43 111.156 -171.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.582 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.4 Cg_exo -42.82 144.04 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 124.306 3.337 . . . . 0.54 112.798 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 146' ' ' ILE . 2.3 mm-40 -72.77 -20.66 61.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.426 -1.261 . . . . 3.08 110.056 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 2.4 pm0 -68.76 -22.59 64.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.341 -0.845 . . . . 1.57 110.232 171.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.574 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 31.2 m0 -103.89 -15.76 15.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.66 110.333 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.39 23.44 9.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.53 113.736 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 1.015 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.86 -107.42 0.73 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.107 -1.044 . . . . 0.6 112.469 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -164.56 61.03 0.14 Allowed 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.664 1.221 . . . . 1.91 111.316 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.751 HG21 HG23 ' A' ' 112' ' ' VAL . 60.7 m -163.94 111.68 1.15 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.447 -1.252 . . . . 0.37 110.225 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.851 ' HB ' HD13 ' A' ' 111' ' ' ILE . 12.9 mm -68.21 105.12 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 109.026 -0.731 . . . . 0.63 109.026 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 7.7 m-85 -86.37 114.19 22.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.346 -0.843 . . . . 0.5 110.454 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 73.2 m -100.36 113.69 26.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 0.68 110.74 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.759 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.0 mttt -85.72 101.07 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.581 -0.526 . . . . 1.44 109.581 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.924 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.6 pp -133.03 -172.44 2.93 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 123.236 1.493 . . . . 0.84 113.404 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.513 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 13.5 t -159.71 117.05 2.63 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 112.811 -1.995 . . . . 1.77 106.389 172.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.03 -16.95 62.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.059 -0.719 . . . . 0.41 109.059 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -69.82 -54.12 15.06 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.732 -1.122 . . . . 2.3 110.635 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 2.3 p -80.61 -12.35 59.51 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.51 -0.476 . . . . 0.7 111.69 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.549 ' HD3' HD12 ' A' ' 158' ' ' LEU . 19.5 mmtp 67.44 41.63 2.36 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.589 -0.732 . . . . 1.36 110.617 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.629 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -97.37 -63.88 1.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.339 1.066 . . . . 2.48 110.442 -173.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -86.45 1.88 87.37 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.167 -1.016 . . . . 0.29 113.199 -172.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.549 HD12 ' HD3' ' A' ' 155' ' ' LYS . 27.5 mt -70.57 -42.19 71.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.0 0.9 . . . . 0.8 109.019 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -77.73 -34.81 52.43 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.44 -0.8 . . . . 2.2 109.618 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.522 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 81.6 t60 -69.4 -25.85 64.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.565 -0.454 . . . . 0.58 111.121 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.94 -53.08 60.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.36 0.6 . . . . 1.16 109.484 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 12.4 mt -54.89 -44.23 73.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.688 -1.142 . . . . 1.51 109.742 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.499 ' OE2' ' HA ' ' A' ' 160' ' ' HIS . 40.8 mt-10 -46.76 -53.81 11.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.197 0.936 . . . . 2.57 111.189 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.606 ' HB3' HG21 ' A' ' 146' ' ' ILE . 20.2 mmt -72.26 -39.72 68.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 0.64 111.051 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 83' ' ' ILE . 69.1 mt -60.13 -49.94 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 0.52 111.294 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.1 pp -70.89 -31.83 68.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.844 -0.342 . . . . 1.73 111.153 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 166' ' ' LEU . 2.6 tm? -54.2 -50.53 66.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 1.51 108.856 172.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.447 -0.601 0 CA-C-N 115.819 -0.628 . . . . 0.89 110.559 175.501 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.647 0.26 . . . . 0.64 110.827 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.31 113.95 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 1.3 109.95 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.842 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 53.3 mtt -126.5 163.94 22.25 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.072 -0.513 . . . . 0.79 109.637 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.48 -168.65 25.42 Favored Glycine 0 N--CA 1.431 -1.633 0 C-N-CA 120.828 -0.701 . . . . 0.31 111.437 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.645 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 52.1 t60 -88.51 157.89 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.893 0.854 . . . . 0.22 111.385 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.4 p -71.75 153.94 7.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.587 -1.188 . . . . 0.36 109.981 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 20.2 t70 74.85 -21.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.361 0.601 . . . . 0.69 110.514 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.547 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.2 m170 -80.3 -7.38 59.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.342 -0.984 . . . . 0.63 108.342 170.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.491 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 113.07 60.88 0.42 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.537 -0.839 . . . . 0.79 114.048 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -59.29 -76.32 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.355 0.577 . . . . 3.31 110.913 171.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 m -84.79 -32.46 23.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.864 0.364 . . . . 1.21 110.873 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.491 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.57 -31.17 63.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.382 0.512 . . . . 1.25 112.382 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 HG21 ' A' ' 85' ' ' VAL . 12.5 tp -73.67 -40.15 63.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.508 -0.553 . . . . 1.49 109.508 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HA ' HG22 ' A' ' 28' ' ' ILE . 2.9 tp -72.17 -9.52 58.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.654 -0.703 . . . . 1.69 110.562 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -94.99 -43.31 8.21 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.458 -0.941 . . . . 1.23 108.458 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.52 78.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.046 -1.434 . . . . 0.63 110.065 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 7.6 tt . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 114.975 -1.011 . . . . 1.02 110.354 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.495 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 120.49 0.186 . . . . 0.71 110.654 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.41 125.51 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 120.375 -0.53 . . . . 1.17 111.436 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.632 HG12 ' HB ' ' A' ' 111' ' ' ILE . 7.8 mt -87.49 130.19 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-N 115.62 -0.718 . . . . 0.37 109.923 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.454 ' O ' HD13 ' A' ' 84' ' ' LEU . 2.0 tm? -114.08 107.36 15.54 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.289 -1.004 . . . . 1.01 108.289 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.484 HG21 HD22 ' A' ' 24' ' ' LEU . 39.5 t -90.72 110.14 21.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.369 -0.832 . . . . 0.43 110.746 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.701 HG21 HD11 ' A' ' 131' ' ' LEU . 1.7 m -120.49 124.92 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.792 -0.64 . . . . 0.64 110.58 174.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -65.51 131.38 46.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 0.28 109.87 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -73.77 -12.54 60.73 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.182 0.515 . . . . 0.22 110.395 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 1.3 p-10 -95.94 -8.73 33.08 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.576 -0.738 . . . . 0.58 110.847 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.13 -48.9 1.45 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.407 -0.36 . . . . 0.56 110.818 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.556 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.89 -146.08 19.01 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.37 113.538 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.508 HG21 ' CE2' ' A' ' 134' ' ' TYR . 9.9 p -82.13 140.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.571 0.701 . . . . 1.03 110.229 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.688 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.6 mmm -142.21 175.12 3.15 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.836 -1.075 . . . . 0.28 108.916 -173.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 75.0 Cg_exo -42.9 -59.07 1.08 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.197 2.598 . . . . 0.58 114.971 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.525 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.8 pt20 -79.42 -17.51 54.15 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 120.419 -0.513 . . . . 0.75 110.969 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.645 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.33 -43.23 91.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 0.31 109.334 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.533 HG12 ' ND2' ' A' ' 101' ' ' ASN . 32.3 t -60.47 -45.71 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.766 -1.107 . . . . 1.38 111.913 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.66 -31.79 66.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 2.35 110.638 -175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.01 -30.29 63.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 0.44 110.736 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.0 mt -77.11 -44.73 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.882 0.849 . . . . 0.41 108.775 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.533 ' ND2' HG12 ' A' ' 97' ' ' VAL . 41.2 m-20 -63.63 -32.21 73.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.245 -1.343 . . . . 0.67 111.002 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -63.04 -45.79 90.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.441 0.639 . . . . 2.5 109.626 173.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.566 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -78.42 -51.53 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 0.47 112.752 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 29.4 mmmt -68.34 -34.08 75.45 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.931 0.396 . . . . 1.66 110.753 -173.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.74 92.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.655 -0.702 . . . . 0.77 110.837 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.71 53.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.471 -0.332 . . . . 0.74 111.158 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 t30 86.09 47.33 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.232 1.013 . . . . 1.41 109.467 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -111.37 138.4 21.36 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.362 -1.29 . . . . 1.35 110.417 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 34.6 Cg_exo -62.5 144.83 95.26 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.863 2.376 . . . . 0.47 113.436 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.566 HD11 ' CB ' ' A' ' 103' ' ' ALA . 27.1 mm -106.12 160.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.076 -0.965 . . . . 0.6 110.696 -175.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.818 HD13 ' HB ' ' A' ' 146' ' ' ILE . 29.9 mm -124.46 83.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.101 -1.444 . . . . 0.37 107.101 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.096 HG23 HG21 ' A' ' 145' ' ' THR . 62.0 t -69.03 146.98 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.636 0.731 . . . . 0.26 109.049 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -148.01 102.93 3.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.45 -1.25 . . . . 0.29 110.073 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.752 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 2.8 mp -70.57 139.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-N 113.767 -1.56 . . . . 0.59 109.068 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.1 p-10 -121.19 175.8 5.93 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.081 -1.451 . . . . 1.85 107.081 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.638 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 83.6 mttt 69.87 30.97 3.57 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.742 0.651 . . . . 0.59 111.098 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.654 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 11.3 mmt -73.18 -14.95 61.45 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.328 1.061 . . . . 0.92 108.624 167.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.586 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 2.0 p-10 -72.63 -19.64 61.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.404 -1.725 . . . . 0.76 110.602 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.469 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 36.6 mtpt -89.32 144.42 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.775 -0.648 . . . . 1.17 110.684 176.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.25 -17.22 40.01 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.789 2.326 . . . . 0.58 111.694 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 31.9 mt-10 -85.45 8.59 18.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.455 -0.793 . . . . 1.45 111.032 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.14 112.36 1.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.27 110.743 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.882 HD22 ' HB2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -127.89 76.2 77.64 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.95 108.969 175.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.506 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 37.8 Cg_endo -63.71 -58.03 0.31 Allowed 'Trans proline' 0 CA--C 1.507 -0.845 0 C-N-CA 123.177 2.584 . . . . 0.4 113.022 -174.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.4 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 16.5 t70 -45.6 -29.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.285 0.991 . . . . 1.44 110.93 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.882 ' HB2' HD22 ' A' ' 123' ' ' ASN . 10.5 ttp180 -82.26 -56.45 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 3.79 110.173 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.75 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 16.6 m -65.64 -29.92 48.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.719 -0.673 . . . . 0.59 111.387 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 1.025 ' HA ' HD12 ' A' ' 131' ' ' LEU . 4.4 ttt -71.12 -31.16 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.425 1.09 . . . . 0.81 110.56 176.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -73.06 -36.33 66.86 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.653 -0.419 . . . . 1.31 111.375 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.618 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.2 mt-10 -63.06 -28.88 70.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.61 1.195 . . . . 1.64 108.976 175.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.025 HD12 ' HA ' ' A' ' 128' ' ' MET . 90.9 mt -62.03 -39.23 91.58 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.4 -1.727 . . . . 1.36 109.585 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.679 ' HG2' ' HA ' ' A' ' 137' ' ' VAL . 34.5 mtp -77.95 -15.92 58.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.308 0.484 . . . . 1.61 112.308 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.495 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 9.1 mm-40 -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.083 -1.08 . . . . 1.67 108.083 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.508 ' CE2' HG21 ' A' ' 92' ' ' VAL . 85.2 m-85 -104.64 22.87 14.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.888 -1.051 . . . . 1.08 110.635 172.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.9 t30 66.78 28.85 8.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.081 -1.418 . . . . 1.1 112.623 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -116.1 116.79 28.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.627 -0.879 . . . . 1.36 108.627 170.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.929 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 91.5 t -112.21 136.84 21.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 0.43 112.51 -167.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.762 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -45.79 127.92 10.53 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 124.205 3.27 . . . . 0.54 111.681 169.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.756 ' HG2' HD13 ' A' ' 146' ' ' ILE . 1.8 pp20? -73.27 -20.9 60.73 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.661 -0.866 . . . . 3.08 108.661 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 147' ' ' PHE . 1.5 pm0 -59.01 -27.37 65.38 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.659 -0.7 . . . . 1.57 110.608 169.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.676 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 41.0 m0 -103.47 -11.79 17.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.919 0.39 . . . . 0.66 111.049 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.24 24.75 5.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.713 -0.756 . . . . 0.53 113.362 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.929 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.6 -120.22 2.21 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.6 111.952 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -156.27 58.88 0.57 Allowed 'General case' 0 C--O 1.243 0.713 0 CA-C-O 122.293 1.044 . . . . 1.91 112.192 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 1.096 HG21 HG23 ' A' ' 112' ' ' VAL . 81.1 m -165.7 129.27 2.19 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.385 -0.825 . . . . 0.37 110.739 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.818 ' HB ' HD13 ' A' ' 111' ' ' ILE . 24.0 mm -72.78 105.03 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.081 -1.081 . . . . 0.63 108.081 168.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.762 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 9.0 m-85 -89.67 112.3 23.52 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.771 -0.65 . . . . 0.5 110.804 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.94 142.44 29.67 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.479 -0.782 . . . . 0.68 110.347 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.552 ' HE2' ' HE3' ' A' ' 128' ' ' MET . 5.1 mmtp -117.64 96.83 5.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.286 -1.005 . . . . 1.44 108.286 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.752 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 4.0 pp -127.78 -175.71 3.55 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.903 1.335 . . . . 0.84 113.036 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 1.4 p -157.37 89.98 1.08 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 112.914 -1.948 . . . . 1.77 108.028 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.23 -15.26 63.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.256 0.551 . . . . 0.41 110.4 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.586 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -77.8 -42.93 32.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.565 -0.743 . . . . 2.3 112.037 175.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.437 ' OG1' ' HB2' ' A' ' 151' ' ' SER . 0.9 OUTLIER -87.34 -9.27 55.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.526 -0.869 . . . . 0.7 111.804 175.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 66.73 50.19 1.18 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.089 -0.959 . . . . 1.36 110.995 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -109.51 -65.82 1.11 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.702 1.239 . . . . 2.48 110.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.752 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -74.26 -4.05 67.42 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.054 -1.43 . . . . 0.29 113.897 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 158' ' ' LEU . 28.8 mt -71.33 -37.62 71.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.044 0.922 . . . . 0.8 109.238 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.84 -40.47 79.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.219 -0.9 . . . . 2.2 109.431 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 83.7 t60 -74.93 -10.62 59.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.079 -0.51 . . . . 0.58 111.303 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.55 -55.21 5.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.384 0.611 . . . . 1.16 109.837 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 163' ' ' GLU . 4.2 pp -62.89 -28.5 70.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.021 -0.99 . . . . 1.51 111.643 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 12.5 pt-20 -77.99 -27.3 49.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.847 -0.341 . . . . 2.57 111.23 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.567 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 14.8 mmt -74.53 -44.1 52.74 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.282 -0.636 . . . . 0.64 109.282 173.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 83' ' ' ILE . 84.2 mt -58.19 -39.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.227 -0.897 . . . . 0.52 110.203 173.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -59.7 -44.19 93.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.463 -0.79 . . . . 1.73 111.693 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.48 ' N ' HD23 ' A' ' 166' ' ' LEU . 27.2 tp -54.42 -43.02 71.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.555 0.693 . . . . 1.51 109.923 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 N--CA 1.444 -0.756 0 CA-C-N 114.991 -1.004 . . . . 0.89 110.859 175.515 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.782 ' HB ' HG22 ' A' ' 82' ' ' VAL . 90.5 m . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.518 0.199 . . . . 0.64 110.704 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.7 mt -83.42 122.61 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 1.3 110.125 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.59 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 56.2 mtt -132.75 170.37 15.36 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.148 -0.686 . . . . 0.79 109.148 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.29 179.41 16.64 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.597 -0.811 . . . . 0.31 111.762 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.596 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 50.5 t60 -85.41 158.96 20.09 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.867 0.842 . . . . 0.22 111.631 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 19' ' ' HIS . 5.7 p -73.58 155.27 6.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.495 -1.23 . . . . 0.36 109.643 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 25.9 t70 72.92 -17.56 0.4 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.211 0.529 . . . . 0.69 110.661 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.485 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 19.7 m170 -85.83 -6.57 59.07 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.001 -0.74 . . . . 0.63 109.001 171.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.807 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 131.29 39.25 0.26 Allowed Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 118.972 -1.585 . . . . 0.79 115.066 170.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -52.36 -65.97 0.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.559 1.18 . . . . 3.31 111.51 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.9 m -89.51 -29.68 18.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 1.21 110.696 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.62 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.08 -33.92 69.59 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.777 0.658 . . . . 1.25 112.777 -176.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.807 HD23 ' HA3' ' A' ' 20' ' ' GLY . 3.8 mm? -76.14 -33.33 59.4 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 122.142 -0.349 . . . . 1.49 110.447 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.73 -7.43 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.431 -0.508 . . . . 1.69 109.831 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.83 -47.96 4.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.939 0.876 . . . . 1.23 109.65 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB1' ' HB1' ' A' ' 152' ' ' ALA . . . -64.89 -42.58 94.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.213 -1.358 . . . . 0.63 110.434 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 84.9 mt . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.231 -0.895 . . . . 1.02 109.943 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.0 mt . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 109.909 -0.404 . . . . 0.71 109.909 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 12' ' ' THR . 18.7 t -115.63 118.73 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.255 0.55 . . . . 1.17 111.185 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 51.9 mt -82.41 131.38 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.32 -0.855 . . . . 0.37 109.73 172.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.43 HD13 ' C ' ' A' ' 84' ' ' LEU . 2.3 tm? -119.58 107.93 13.87 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.665 -0.865 . . . . 1.01 108.665 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.5 t -89.11 114.57 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.725 -0.67 . . . . 0.43 111.134 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 2.4 m -127.58 123.73 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.807 -0.633 . . . . 0.64 110.593 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.62 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.35 135.37 50.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.107 -0.497 . . . . 0.28 109.779 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -72.71 -15.59 61.68 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.05 0.452 . . . . 0.22 111.37 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.423 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 5.3 p-10 -90.35 -24.15 20.91 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.753 -0.658 . . . . 0.58 111.244 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.485 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 16.7 t0 -113.53 -41.63 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.56 111.245 -173.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.612 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.11 -131.54 10.7 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 114.419 0.528 . . . . 0.37 114.419 171.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.17 130.82 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.653 . . . . 1.03 110.568 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.696 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.7 mmm -131.32 177.78 2.07 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.461 -1.245 . . . . 0.28 109.377 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.696 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 61.2 Cg_exo -41.73 -63.16 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.093 2.529 . . . . 0.58 114.72 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.537 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.1 pt20 -72.97 -19.62 61.19 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.608 -0.437 . . . . 0.75 111.173 -174.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.596 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.82 -45.55 81.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.021 -0.733 . . . . 0.31 109.021 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 93' ' ' MET . 17.8 t -65.51 -43.6 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.889 -1.05 . . . . 1.38 112.065 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -57.02 -24.57 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.488 . . . . 2.35 110.71 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.59 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -76.97 -39.94 48.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.44 110.633 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.0 mt -71.53 -41.56 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.829 0.824 . . . . 0.41 109.41 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.484 ' ND2' HG12 ' A' ' 97' ' ' VAL . 23.1 m-20 -61.05 -28.79 69.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.324 -1.307 . . . . 0.67 110.89 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -83.77 -34.4 24.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.811 -0.44 . . . . 2.5 109.811 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.559 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -65.52 -42.09 92.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.198 -0.455 . . . . 0.47 111.046 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.409 ' NZ ' ' HB3' ' A' ' 135' ' ' ASN . 18.9 mmtp -73.18 -35.74 66.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.383 0.611 . . . . 1.66 109.796 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.33 -40.72 59.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.306 -1.316 . . . . 0.77 111.413 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.27 -35.19 15.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.338 -0.392 . . . . 0.74 110.96 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.4 t30 87.97 51.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.403 1.081 . . . . 1.41 109.609 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.11 141.73 23.09 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.969 -1.469 . . . . 1.35 110.58 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.01 140.65 66.84 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.549 2.166 . . . . 0.47 111.975 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.575 ' C ' HG23 ' A' ' 145' ' ' THR . 24.2 mm -104.2 158.71 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.46 0.648 . . . . 0.6 110.758 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.775 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 17.0 mm -129.32 88.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.553 -1.277 . . . . 0.37 107.553 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.942 HG23 HG21 ' A' ' 145' ' ' THR . 43.3 t -78.34 146.99 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.941 0.877 . . . . 0.26 110.338 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.896 ' HB1' HD11 ' A' ' 150' ' ' LEU . . . -139.79 111.06 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.925 -1.489 . . . . 0.29 110.144 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.802 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 2.8 mp -83.15 126.24 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.603 -1.18 . . . . 0.59 109.798 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.54 ' ND2' ' HG3' ' A' ' 116' ' ' LYS . 7.1 p-10 -114.35 168.79 9.54 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.42 -1.326 . . . . 1.85 107.42 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.62 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 89.4 mttt 70.44 31.57 2.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.927 0.767 . . . . 0.59 111.92 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.565 ' HA ' ' CB ' ' A' ' 122' ' ' ALA . 77.3 mmm -80.48 -9.7 59.76 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.505 0.669 . . . . 0.92 109.451 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.406 ' HB2' HG23 ' A' ' 154' ' ' THR . 8.3 p-10 -67.97 -32.54 73.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.968 -1.015 . . . . 0.76 109.415 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 28.6 mtmt -75.58 139.14 70.67 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.956 -1.02 . . . . 1.17 110.688 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.66 -15.8 51.96 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.885 2.39 . . . . 0.58 111.469 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -78.76 -7.81 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.11 -0.95 . . . . 1.45 110.27 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.565 ' CB ' ' HA ' ' A' ' 117' ' ' MET . . . -58.03 115.39 2.85 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.711 -0.677 . . . . 0.27 111.113 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.969 HD22 ' HB2' ' A' ' 126' ' ' ARG . 1.2 t30 -128.71 77.58 77.32 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.432 -0.951 . . . . 0.95 108.432 173.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.576 ' HA ' HG22 ' A' ' 127' ' ' VAL . 49.5 Cg_endo -65.13 -50.8 1.86 Allowed 'Trans proline' 0 CA--C 1.5 -1.185 0 C-N-CA 123.267 2.644 . . . . 0.4 112.906 -171.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.605 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 8.1 m-20 -54.43 -26.93 33.63 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.958 -1.019 . . . . 1.44 110.042 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.969 ' HB2' HD22 ' A' ' 123' ' ' ASN . 37.4 ttp180 -79.09 -54.24 6.2 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.411 0.624 . . . . 3.79 109.339 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.799 HG21 ' HA ' ' A' ' 88' ' ' ALA . 21.9 m -65.22 -29.29 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.272 -0.876 . . . . 0.59 111.928 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.951 ' HA ' HD23 ' A' ' 131' ' ' LEU . 16.4 ptm -79.41 -14.87 58.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.827 0.346 . . . . 0.81 110.392 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.602 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 80.3 mt-30 -79.91 -24.85 40.83 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 121.025 -0.27 . . . . 1.31 110.487 171.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 6.5 mm-40 -67.95 -31.13 70.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.431 -0.952 . . . . 1.64 108.431 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.951 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -61.29 -46.0 92.13 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.581 -1.191 . . . . 1.36 109.335 175.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.561 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -74.82 -7.98 55.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 119.963 -0.695 . . . . 1.61 110.969 -178.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 28.3 mm-40 -72.26 -28.13 62.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.542 -0.91 . . . . 1.67 108.542 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -102.96 31.8 4.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.037 -0.983 . . . . 1.08 110.255 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 104' ' ' LYS . 63.3 t30 55.68 43.49 27.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.699 -1.137 . . . . 1.1 111.761 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.561 ' H ' ' HA ' ' A' ' 132' ' ' MET . 52.5 mt -112.66 104.68 12.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.968 -0.56 . . . . 1.36 109.734 172.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.093 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 24.5 t -104.28 117.08 60.21 Favored Pre-proline 0 C--N 1.314 -0.954 0 C-N-CA 120.121 -0.632 . . . . 0.43 111.322 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.718 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.2 Cg_exo -43.73 139.72 5.04 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 124.196 3.264 . . . . 0.54 112.409 171.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -71.6 -18.69 62.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.411 -1.268 . . . . 3.08 110.114 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.0 pm0 -62.25 -27.11 68.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.759 -0.655 . . . . 1.57 110.089 168.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.602 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 39.4 m0 -102.53 -27.83 12.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.387 -0.369 . . . . 0.66 110.69 -175.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.48 2.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.769 -0.729 . . . . 0.53 112.977 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 1.093 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.25 -119.26 2.54 Favored Glycine 0 CA--C 1.507 -0.46 0 C-N-CA 119.846 -1.169 . . . . 0.6 112.245 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -151.81 59.47 0.86 Allowed 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.773 0.797 . . . . 1.91 111.438 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.942 HG21 HG23 ' A' ' 112' ' ' VAL . 97.6 m -165.27 123.94 1.68 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.351 -0.841 . . . . 0.37 110.488 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.775 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 27.3 mm -75.59 104.25 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.096 -0.705 . . . . 0.63 109.096 171.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.744 ' HE2' HD23 ' A' ' 131' ' ' LEU . 12.6 m-85 -88.28 117.73 27.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.396 -0.82 . . . . 0.5 110.196 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.2 m -101.42 136.74 40.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.057 -0.349 . . . . 0.68 110.057 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.564 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.7 mttt -108.0 91.92 3.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.377 . . . . 1.44 109.981 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.052 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -120.85 -167.72 1.53 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 123.077 1.418 . . . . 0.84 113.334 -174.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.403 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.1 OUTLIER -164.81 106.48 0.83 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.315 -1.766 . . . . 1.77 106.411 174.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.543 ' HB1' ' HB1' ' A' ' 27' ' ' ALA . . . -65.83 -14.16 60.9 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.62 -0.718 . . . . 0.41 109.434 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -52.98 30.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.15 -0.932 . . . . 2.3 110.62 173.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 118' ' ' ASP . 1.1 p -84.99 -7.67 59.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.398 0.518 . . . . 0.7 112.398 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.571 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.8 mmtp 63.17 46.5 4.57 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.668 -0.696 . . . . 1.36 111.398 176.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.61 -70.79 0.78 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 123.039 1.4 . . . . 2.48 110.602 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 1.052 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -67.45 -8.51 51.65 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 113.664 -1.607 . . . . 0.29 113.269 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.571 HD12 ' HD3' ' A' ' 155' ' ' LYS . 28.6 mt -69.4 -40.48 77.34 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 117.785 0.793 . . . . 0.8 109.423 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.24 -44.2 88.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.345 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -70.87 -17.75 62.71 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.06 -0.518 . . . . 0.58 111.452 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 113' ' ' ALA . 5.9 mt -72.06 -57.49 4.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.011 0.434 . . . . 1.16 110.226 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 163' ' ' GLU . 4.3 pp -60.66 -29.35 69.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.498 -0.774 . . . . 1.51 110.804 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.411 ' N ' HD12 ' A' ' 162' ' ' LEU . 29.7 mm-40 -63.17 -51.67 65.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.993 0.425 . . . . 2.57 110.589 174.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.492 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 17.1 mmt -67.72 -46.25 72.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.64 110.533 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 98.7 mt -58.13 -44.12 86.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.682 -0.69 . . . . 0.52 110.971 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -41.37 86.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.423 -0.353 . . . . 1.73 111.19 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.42 -43.47 67.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.284 0.564 . . . . 1.51 109.567 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 111' ' ' ILE . 92.6 t . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 114.812 -1.086 . . . . 0.89 111.02 176.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.715 ' HB ' HG22 ' A' ' 82' ' ' VAL . 91.4 m . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 120.755 0.312 . . . . 0.64 110.816 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.921 HG13 HD21 ' A' ' 25' ' ' LEU . 45.9 mm -96.97 118.86 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 1.3 110.667 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.62 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 61.5 mtt -131.28 176.05 8.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.175 -0.676 . . . . 0.79 109.175 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' HA2' HD13 ' A' ' 84' ' ' LEU . . . 139.42 -159.58 25.78 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.654 -0.784 . . . . 0.31 111.653 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.516 ' CE1' HG12 ' A' ' 17' ' ' VAL . 42.1 t60 -101.97 162.05 13.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.036 0.922 . . . . 0.22 112.167 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.516 HG12 ' CE1' ' A' ' 16' ' ' HIS . 7.4 p -81.86 150.61 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.255 -1.339 . . . . 0.36 110.726 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.9 t70 71.6 -23.43 0.19 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.423 0.689 . . . . 0.69 111.362 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.458 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 23.5 m170 -62.79 -38.19 89.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.997 -1.482 . . . . 0.63 106.997 163.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 140.76 55.95 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.828 . . . . 0.79 113.751 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -61.4 2.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.49 0.645 . . . . 3.31 111.483 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -87.68 -40.12 14.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.919 0.39 . . . . 1.21 111.452 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -27.44 62.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 1.25 112.179 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -62.12 -51.21 68.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 1.49 109.843 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.921 HD21 HG13 ' A' ' 13' ' ' ILE . 76.8 mt -71.38 -14.61 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.857 -0.611 . . . . 1.69 111.025 -174.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -90.47 -38.63 13.12 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.469 -0.938 . . . . 1.23 108.469 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -70.6 -35.14 72.83 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.29 -1.323 . . . . 0.63 110.186 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' A' ' 25' ' ' LEU . 13.1 tt . . . . . 0 C--N 1.317 -0.82 0 CA-C-N 114.969 -1.014 . . . . 1.02 111.102 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.0 mt . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.442 -0.577 . . . . 0.71 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.715 HG22 ' HB ' ' A' ' 12' ' ' THR . 15.2 t -107.64 124.36 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.17 0.509 . . . . 1.17 111.635 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 8.2 mt -84.41 132.27 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.524 -0.762 . . . . 0.37 110.555 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.942 HD12 HG13 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -102.3 106.39 17.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.523 -0.762 . . . . 1.01 110.412 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.2 t -84.12 94.08 3.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.933 -0.576 . . . . 0.43 109.738 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.942 HG13 HD12 ' A' ' 84' ' ' LEU . 2.4 m -119.93 123.62 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.927 -0.578 . . . . 0.64 110.523 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.524 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -72.32 131.65 42.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.929 -0.578 . . . . 0.28 110.191 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.801 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -65.5 -14.25 60.61 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.077 0.465 . . . . 0.22 111.063 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.23 8.34 44.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.523 -0.762 . . . . 0.58 111.011 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.419 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 12.9 t0 -149.08 -45.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 0.56 110.973 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.458 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 89.18 -141.49 16.29 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.335 -0.46 . . . . 0.37 113.477 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.33 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.347 0.594 . . . . 1.03 110.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.702 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 79.2 mmm -141.42 176.89 2.16 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 0.28 108.962 -173.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.702 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.3 Cg_exo -41.49 -66.62 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.165 2.577 . . . . 0.58 114.843 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.513 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 6.0 pt20 -71.71 -20.28 61.94 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.259 0.552 . . . . 0.75 110.872 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.534 ' HB ' ' H ' ' A' ' 93' ' ' MET . 0.2 OUTLIER -65.54 -44.03 88.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.513 -0.767 . . . . 0.31 109.375 178.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.555 HG12 ' ND2' ' A' ' 101' ' ' ASN . 19.8 t -67.56 -41.74 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.38 -0.827 . . . . 1.38 111.33 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -55.33 -30.68 60.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.104 0.478 . . . . 2.35 110.319 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.15 -39.09 75.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 0.44 110.798 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 72.3 mt -72.35 -43.02 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.852 0.834 . . . . 0.41 109.172 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.555 ' ND2' HG12 ' A' ' 97' ' ' VAL . 55.5 m-20 -59.91 -33.05 71.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.191 -1.368 . . . . 0.67 110.941 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -79.76 -34.49 39.79 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.735 -0.469 . . . . 2.5 109.735 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.534 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -74.42 -42.61 58.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.179 0.437 . . . . 0.47 112.179 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 12.7 mmmm -76.76 -37.92 55.07 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.058 0.456 . . . . 1.66 110.787 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.07 -30.09 70.75 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.252 -0.885 . . . . 0.77 110.709 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.96 -17.19 41.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.74 110.524 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 70.34 60.92 0.23 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.927 -1.033 . . . . 1.41 110.093 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 1.1 t -123.78 145.42 47.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 1.35 111.303 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 20.2 Cg_exo -69.8 144.89 55.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 123.352 2.701 . . . . 0.47 112.45 172.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.534 HD11 ' HB1' ' A' ' 103' ' ' ALA . 30.6 mm -111.2 158.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.422 0.63 . . . . 0.6 110.654 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.822 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 21.7 mm -129.21 84.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.599 -1.26 . . . . 0.37 107.599 171.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.934 HG13 ' HB3' ' A' ' 84' ' ' LEU . 17.7 t -74.55 152.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.636 0.732 . . . . 0.26 110.525 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 148' ' ' CYS . . . -139.35 107.24 5.67 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.613 -1.176 . . . . 0.29 110.031 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.801 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.5 mp -79.99 105.66 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.554 -1.203 . . . . 0.59 108.843 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.675 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 1.2 p-10 -106.34 173.66 6.22 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 106.807 -1.553 . . . . 1.85 106.807 -169.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.507 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 83.3 mttt 65.51 36.24 6.76 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.768 0.667 . . . . 0.59 110.491 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 84.3 mmm -82.34 -13.15 57.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.351 -0.841 . . . . 0.92 109.162 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.7 -30.92 71.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.688 -1.142 . . . . 0.76 109.062 171.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 116' ' ' LYS . 18.6 mmmt -64.91 132.04 95.36 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 114.442 -1.254 . . . . 1.17 110.024 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.84 -16.5 54.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.548 2.165 . . . . 0.58 111.065 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -90.77 10.98 23.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.101 -0.954 . . . . 1.45 110.37 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.6 118.09 4.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.448 -0.796 . . . . 0.27 110.665 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.6 OUTLIER -127.64 76.02 77.33 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.736 -0.838 . . . . 0.95 108.736 174.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.798 ' O ' ' HG3' ' A' ' 128' ' ' MET . 37.2 Cg_endo -63.55 -63.34 0.08 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 123.135 2.557 . . . . 0.4 113.395 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.505 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 6.6 m-20 -55.47 -21.34 15.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 1.44 110.998 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.2 tpt180 -72.36 -56.54 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.695 0.759 . . . . 3.79 109.528 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.628 ' HA ' ' HG3' ' A' ' 130' ' ' GLU . 17.4 m -64.79 -29.74 48.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.808 -1.087 . . . . 0.59 111.596 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.798 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 42.5 mtp -61.44 -39.72 91.87 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.398 0.618 . . . . 0.81 109.527 174.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.595 ' O ' ' HG2' ' A' ' 132' ' ' MET . 38.1 mt-30 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.987 -1.006 . . . . 1.31 111.627 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.628 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 6.3 mt-10 -72.37 -32.56 66.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.29 0.567 . . . . 1.64 109.997 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.906 HD12 HD21 ' A' ' 136' ' ' LEU . 4.3 mm? -65.44 -37.44 86.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 1.36 110.176 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.595 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 12.5 ptm -76.49 -14.07 60.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.162 -0.615 . . . . 1.61 110.239 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 7.3 mm-40 -71.15 -28.38 64.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.966 -0.753 . . . . 1.67 108.966 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.53 20.41 10.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.007 0.908 . . . . 1.08 110.157 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 60.65 49.97 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.578 -1.646 . . . . 1.1 112.2 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.906 HD21 HD12 ' A' ' 131' ' ' LEU . 1.9 pp -131.25 120.76 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.524 -1.288 . . . . 1.36 107.524 166.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.832 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.9 t -109.29 129.19 24.19 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 0.43 112.367 -165.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 98.0 Cg_exo -43.21 146.62 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.608 3.539 . . . . 0.54 113.435 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.52 ' HB2' HD13 ' A' ' 146' ' ' ILE . 5.9 mm-40 -75.53 -22.1 57.38 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.347 -1.297 . . . . 3.08 110.412 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 2.2 pm0 -67.39 -21.4 65.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.258 -0.883 . . . . 1.57 110.036 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.483 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 38.4 m0 -105.77 -17.41 14.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.394 -0.366 . . . . 0.66 110.55 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.46 21.75 9.63 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.795 -0.716 . . . . 0.53 113.642 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.832 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -82.92 -105.28 0.48 Allowed Glycine 0 CA--C 1.51 -0.271 0 C-N-CA 120.138 -1.029 . . . . 0.6 111.943 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -166.1 62.2 0.1 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.316 1.055 . . . . 1.91 110.665 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.71 HG21 HG23 ' A' ' 112' ' ' VAL . 56.5 m -164.26 111.91 1.11 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.759 -1.109 . . . . 0.37 111.207 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.822 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.3 mm -69.49 107.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.426 -0.583 . . . . 0.63 109.426 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.697 ' HD2' HD11 ' A' ' 114' ' ' ILE . 10.7 m-85 -88.78 110.19 20.81 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.24 -0.891 . . . . 0.5 110.311 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 80.6 m -98.75 116.37 30.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.416 -0.356 . . . . 0.68 111.371 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.497 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 95.2 mttt -87.31 91.19 8.64 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.036 -0.357 . . . . 1.44 110.036 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.976 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.9 OUTLIER -122.48 173.62 7.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.331 1.062 . . . . 0.84 112.089 -173.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.2 OUTLIER -138.9 104.91 5.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.38 -0.97 . . . . 1.77 108.38 165.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.559 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . . . -61.68 -18.99 61.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.309 -0.86 . . . . 0.41 109.708 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -63.25 -57.78 9.33 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.993 -1.003 . . . . 2.3 110.736 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 p -78.71 -7.85 58.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.215 0.45 . . . . 0.7 112.215 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.572 ' HD3' HD12 ' A' ' 158' ' ' LEU . 15.6 mmtp 66.78 42.8 2.51 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 123.684 0.615 . . . . 1.36 111.776 174.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -115.75 -63.5 1.44 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.183 0.992 . . . . 2.48 110.006 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.976 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -68.79 -11.83 63.58 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 114.495 -1.229 . . . . 0.29 113.605 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.572 HD12 ' HD3' ' A' ' 155' ' ' LYS . 17.4 mt -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 117.856 0.828 . . . . 0.8 110.373 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 6.5 m-20 -81.49 -33.08 32.15 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.69 -0.687 . . . . 2.2 110.422 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -61.42 -32.45 72.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.05 -0.352 . . . . 0.58 110.05 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 83' ' ' ILE . 60.2 tp -59.72 -55.96 27.8 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.857 -0.61 . . . . 1.16 109.541 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.3 mt -56.67 -45.09 81.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.823 -1.08 . . . . 1.51 110.033 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 53.2 mt-10 -53.22 -43.9 67.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.639 -0.71 . . . . 2.57 111.338 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.442 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -76.19 -32.71 59.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.817 -0.353 . . . . 0.64 110.41 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 83' ' ' ILE . 80.8 mt -65.66 -51.26 64.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 0.52 111.108 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 167' ' ' LEU . 4.0 pp -65.39 -34.25 77.87 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 121.056 -0.258 . . . . 1.73 110.552 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 166' ' ' LEU . 1.3 tm? -50.7 -48.11 58.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.397 -0.594 . . . . 1.51 109.397 173.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.2 t . . . . . 0 N--CA 1.443 -0.786 0 CA-C-N 115.646 -0.706 . . . . 0.89 110.629 176.042 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.785 ' HB ' HG22 ' A' ' 82' ' ' VAL . 36.9 m . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 110.431 -0.211 . . . . 0.64 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.1 mt -99.51 127.78 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.993 -0.373 . . . . 1.3 109.993 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.63 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 63.2 mtt -134.43 165.31 25.46 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.454 -0.573 . . . . 0.79 109.454 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.04 -175.34 36.01 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.566 -0.826 . . . . 0.31 111.788 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.632 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 44.0 t60 -88.06 158.42 18.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.875 0.845 . . . . 0.22 111.648 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 7.3 p -69.8 153.41 8.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.414 -1.267 . . . . 0.36 109.356 172.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.9 t70 73.96 -22.0 0.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.236 0.541 . . . . 0.69 110.713 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.48 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 12.8 m170 -84.98 3.55 37.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.132 -1.062 . . . . 0.63 108.132 171.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.452 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 86.81 58.36 1.93 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.775 -1.102 . . . . 0.79 113.596 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.5 2.98 34.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.674 0.75 . . . . 3.31 110.183 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -136.69 -44.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.268 -0.878 . . . . 1.21 109.634 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.76 -29.26 59.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.737 -0.665 . . . . 1.25 112.022 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 85' ' ' VAL . 15.8 tp -67.64 -42.34 82.4 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.436 -0.579 . . . . 1.49 109.436 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -68.15 -11.54 59.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.189 -0.914 . . . . 1.69 110.534 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.45 -38.99 8.98 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.923 0.868 . . . . 1.23 109.593 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.77 67.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.364 -1.289 . . . . 0.63 110.6 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 9.8 tt . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 114.854 -1.066 . . . . 1.02 110.399 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.4 mt . . . . . 0 C--O 1.236 0.375 0 CA-C-O 120.695 0.283 . . . . 0.71 110.688 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.785 HG22 ' HB ' ' A' ' 12' ' ' THR . 24.7 t -120.98 125.96 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.425 0.631 . . . . 1.17 111.491 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 21.3 mt -84.46 132.27 31.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.987 -1.006 . . . . 0.37 109.636 172.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 86' ' ' VAL . 1.7 tm? -120.48 109.87 15.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.703 -0.851 . . . . 1.01 108.703 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 24' ' ' LEU . 59.8 t -92.69 111.28 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.626 -0.715 . . . . 0.43 110.731 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 2.2 m -121.0 129.36 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 116.01 -0.541 . . . . 0.64 111.031 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB1' ' HE3' ' A' ' 116' ' ' LYS . . . -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.726 -0.67 . . . . 0.28 110.074 174.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.73 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -78.49 -7.98 58.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 0.22 110.164 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.837 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 3.1 p-10 -106.27 7.15 31.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.454 -0.794 . . . . 0.58 111.096 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.48 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 22.3 t70 -144.48 -41.43 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 0.56 110.068 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.726 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 90.0 -125.93 8.09 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.37 113.912 170.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.576 HG11 ' HE2' ' A' ' 134' ' ' TYR . 6.8 p -111.82 137.19 45.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.541 0.686 . . . . 1.03 109.697 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.75 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.1 mmm -140.15 177.67 1.91 Allowed Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 114.965 -1.016 . . . . 0.28 108.564 -170.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.75 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 57.4 Cg_exo -38.98 -65.78 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.218 2.612 . . . . 0.58 114.835 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.756 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 6.3 pt20 -74.36 -17.09 60.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.961 0.41 . . . . 0.75 111.527 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.632 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -68.88 -45.49 70.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.749 0.785 . . . . 0.31 109.31 176.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.558 HG12 ' ND2' ' A' ' 101' ' ' ASN . 20.8 t -69.81 -42.92 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.896 -1.047 . . . . 1.38 111.573 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.756 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -60.94 -25.17 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.449 -0.501 . . . . 2.35 110.003 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -71.28 -40.99 70.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.841 . . . . 0.44 110.919 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -73.95 -39.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.719 0.771 . . . . 0.41 109.311 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.558 ' ND2' HG12 ' A' ' 97' ' ' VAL . 51.8 m-20 -61.3 -30.69 70.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.464 -1.243 . . . . 0.67 110.711 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -79.84 -34.61 39.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.957 -0.386 . . . . 2.5 109.957 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -66.33 -46.11 77.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.384 -0.371 . . . . 0.47 111.336 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -72.21 -34.05 68.06 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.405 0.622 . . . . 1.66 110.106 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.87 -31.97 67.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.568 -1.196 . . . . 0.77 111.582 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.79 -19.47 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.487 -0.324 . . . . 0.74 111.011 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.2 t30 77.46 72.23 0.06 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.167 0.984 . . . . 1.41 108.719 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.55 138.45 31.2 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 114.326 -1.306 . . . . 1.35 111.633 -168.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.33 143.06 56.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.443 2.762 . . . . 0.47 111.705 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' A' ' 103' ' ' ALA . 38.5 mm -109.96 154.88 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.738 0.78 . . . . 0.6 111.382 -173.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.937 HD13 ' HB ' ' A' ' 146' ' ' ILE . 12.9 mm -125.17 85.21 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 107.352 -1.351 . . . . 0.37 107.352 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.587 HG23 HG21 ' A' ' 145' ' ' THR . 57.5 t -73.43 147.23 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.545 0.688 . . . . 0.26 110.312 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -146.75 103.79 3.67 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.291 -1.322 . . . . 0.29 109.997 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.833 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -71.91 144.4 13.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.139 -1.392 . . . . 0.59 110.486 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.424 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -122.68 169.69 10.8 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.498 -1.297 . . . . 1.85 107.498 177.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.531 ' HE3' ' HB1' ' A' ' 87' ' ' ALA . 31.2 mtmt 67.74 37.49 3.22 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.163 -0.926 . . . . 0.59 112.38 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.689 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 14.3 mmt -75.95 -11.82 60.03 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.198 -0.91 . . . . 0.92 109.516 166.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.45 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 6.6 p-10 -72.86 -29.69 63.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.077 -0.965 . . . . 0.76 108.822 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.81 136.26 82.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.958 -1.019 . . . . 1.17 110.735 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.48 -15.39 48.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 123.058 2.505 . . . . 0.58 112.143 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.837 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 5.0 mm-40 -84.01 -9.0 58.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.49 -0.777 . . . . 1.45 110.704 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -42.47 109.97 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.968 0.792 . . . . 0.27 111.956 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.71 76.59 77.04 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.301 -1.0 . . . . 0.95 108.301 176.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.689 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 22.3 Cg_endo -58.81 -60.1 0.39 Allowed 'Trans proline' 0 CA--C 1.505 -0.933 0 C-N-CA 122.898 2.399 . . . . 0.4 113.286 -174.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.7 -28.88 1.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 124.066 0.854 . . . . 1.44 111.504 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 37.0 ttm-85 -78.59 -62.36 1.71 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.439 -0.578 . . . . 3.79 109.439 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 88' ' ' ALA . 4.9 m -64.69 -22.59 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.977 -1.011 . . . . 0.59 111.941 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.626 ' HG3' ' CE2' ' A' ' 147' ' ' PHE . 4.9 ttt -77.12 -31.8 56.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.179 -0.918 . . . . 0.81 110.874 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.578 ' O ' ' HG3' ' A' ' 132' ' ' MET . 20.9 mt-30 -78.1 -32.39 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 1.31 111.372 176.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.9 mm-40 -57.28 -39.6 76.04 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.558 1.17 . . . . 1.64 108.381 173.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.646 HD23 ' CE2' ' A' ' 147' ' ' PHE . 0.7 OUTLIER -61.39 -41.22 96.77 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.312 -1.767 . . . . 1.36 110.776 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.628 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.3 ppp? -82.5 -9.09 59.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.035 -0.666 . . . . 1.61 111.536 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.71 -27.91 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.976 -0.75 . . . . 1.67 108.976 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.576 ' HE2' HG11 ' A' ' 92' ' ' VAL . 34.6 m-85 -85.8 13.81 6.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.448 -0.796 . . . . 1.08 110.097 170.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.7 t30 62.84 48.29 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.222 -1.354 . . . . 1.1 111.658 172.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.84 110.49 13.74 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.408 -1.33 . . . . 1.36 107.408 165.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.04 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.9 t -104.78 129.16 25.4 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.697 -0.683 . . . . 0.43 111.543 -167.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.619 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 81.2 Cg_exo -44.61 143.6 3.91 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.421 3.414 . . . . 0.54 112.927 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HG2' ' C ' ' A' ' 145' ' ' THR . 12.3 mm-40 -67.47 -32.36 73.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.18 -1.373 . . . . 3.08 109.532 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 1.7 pm0 -61.25 -24.99 66.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.921 -1.036 . . . . 1.57 110.967 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.628 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 35.7 m0 -102.63 -8.71 20.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.001 0.429 . . . . 0.66 110.912 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.08 32.69 8.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.006 -0.616 . . . . 0.53 113.21 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 1.04 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.9 -109.12 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.252 -0.975 . . . . 0.6 112.053 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.443 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 7.3 t70 -167.43 63.45 0.08 Allowed 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.369 1.08 . . . . 1.91 110.504 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.587 HG21 HG23 ' A' ' 112' ' ' VAL . 78.4 m -164.82 115.63 1.17 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.509 -1.223 . . . . 0.37 110.478 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.937 ' HB ' HD13 ' A' ' 111' ' ' ILE . 19.0 mm -70.93 104.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.175 -0.676 . . . . 0.63 109.175 173.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.646 ' CE2' HD23 ' A' ' 131' ' ' LEU . 7.9 m-85 -86.98 113.11 22.47 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.237 -0.892 . . . . 0.5 111.305 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.56 136.57 41.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.75 -0.659 . . . . 0.68 109.827 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.561 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 8.3 mptt -111.57 101.27 9.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.24 -0.652 . . . . 1.44 109.24 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.912 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -127.25 -170.07 2.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.743 1.259 . . . . 0.84 111.827 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.554 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -164.21 106.68 0.91 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.769 -1.937 . . . . 1.77 105.769 174.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.64 -15.77 63.71 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.669 0.747 . . . . 0.41 109.117 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -62.67 -56.07 21.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.216 -1.356 . . . . 2.3 110.462 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 1.2 p -84.45 -10.36 57.57 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.37 0.508 . . . . 0.7 112.37 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 62.13 51.88 3.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.42 -0.809 . . . . 1.36 110.595 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -109.33 -65.82 1.11 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.156 0.979 . . . . 2.48 110.608 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.912 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.13 -9.09 71.29 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.318 -1.31 . . . . 0.29 114.174 -173.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.402 HD21 HD11 ' A' ' 24' ' ' LEU . 48.5 mt -72.36 -39.47 68.05 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.052 0.926 . . . . 0.8 109.362 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.541 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 13.8 m-20 -63.71 -44.7 92.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.511 172.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 80.6 t60 -71.66 -15.82 62.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.057 -0.52 . . . . 0.58 111.371 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -71.21 -53.34 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 1.16 109.651 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.68 -27.58 69.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.256 -0.884 . . . . 1.51 110.56 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 66.1 mt-10 -62.47 -48.88 77.65 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.099 0.476 . . . . 2.57 110.142 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.634 ' HB3' HG21 ' A' ' 146' ' ' ILE . 19.3 mmt -68.03 -42.85 80.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 0.64 110.549 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.5 mt -59.36 -41.95 85.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.927 -0.579 . . . . 0.52 110.593 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -39.73 89.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 1.73 111.19 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.1 tp -53.7 -43.98 69.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.413 0.625 . . . . 1.51 109.55 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 0.89 110.774 175.748 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 m . . . . . 0 C--O 1.223 -0.311 0 N-CA-C 110.678 -0.119 . . . . 0.64 110.678 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 14.9 tt -92.22 136.1 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.641 0.734 . . . . 1.3 111.467 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.483 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 58.5 mtt -148.82 174.29 12.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.591 0.756 . . . . 0.79 109.28 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.14 -167.12 32.25 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.711 -0.757 . . . . 0.31 112.761 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.584 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 43.2 t60 -93.93 164.49 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.066 0.936 . . . . 0.22 112.003 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.512 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 5.9 p -78.34 151.29 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.454 -1.248 . . . . 0.36 110.374 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t70 72.72 -19.85 0.29 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.4 0.619 . . . . 0.69 110.524 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 18.0 m170 -78.94 -7.93 58.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.356 -0.979 . . . . 0.63 108.356 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.419 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 100.13 44.14 2.27 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.192 -0.913 . . . . 0.79 113.413 174.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -33.26 66.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.591 0.695 . . . . 3.31 112.403 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -107.59 -34.59 6.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.914 0.388 . . . . 1.21 110.614 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -63.9 -28.87 70.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.321 -0.399 . . . . 1.25 111.772 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.419 HD23 ' HA3' ' A' ' 20' ' ' GLY . 2.7 mm? -65.62 -42.37 91.62 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.71 -0.478 . . . . 1.49 109.71 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.412 HD13 HD13 ' A' ' 13' ' ' ILE . 2.1 tp -71.85 -12.15 61.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.139 -0.937 . . . . 1.69 110.53 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -98.94 -41.26 7.67 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.992 0.901 . . . . 1.23 109.409 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HB1' ' HE2' ' A' ' 155' ' ' LYS . . . -66.22 -30.28 70.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.898 -1.501 . . . . 0.63 109.845 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 1.02 110.894 -176.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.637 HG21 HG12 ' A' ' 111' ' ' ILE . 44.3 mt . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 110.428 -0.212 . . . . 0.71 110.428 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 110' ' ' ILE . 27.2 t -90.96 117.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.733 -0.787 . . . . 1.17 111.167 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 44.3 mt -81.33 131.41 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.798 -1.092 . . . . 0.37 109.384 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.686 HD21 HG22 ' A' ' 96' ' ' THR . 2.4 tm? -121.11 107.17 12.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.82 -0.807 . . . . 1.01 108.82 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 85.5 t -89.38 109.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.593 -0.731 . . . . 0.43 110.779 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.744 HG21 HD11 ' A' ' 131' ' ' LEU . 2.1 m -121.39 126.26 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.785 -0.643 . . . . 0.64 110.95 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -72.15 127.46 32.64 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.094 -0.503 . . . . 0.28 109.645 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -68.06 -10.54 54.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.893 0.377 . . . . 0.22 111.383 -175.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.56 -8.06 55.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.837 -0.62 . . . . 0.58 110.778 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.503 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 15.9 t0 -131.69 -45.7 0.97 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.324 -0.398 . . . . 0.56 111.573 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.609 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 95.2 -144.79 17.41 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.312 -0.471 . . . . 0.37 113.062 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.6 p -92.49 143.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.337 -0.616 . . . . 1.03 109.337 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.713 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 77.2 mmm -143.61 177.73 1.71 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.401 -0.818 . . . . 0.28 109.241 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.713 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.6 Cg_exo -43.83 -63.02 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.199 2.599 . . . . 0.58 114.618 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.54 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.7 pt20 -76.69 -12.38 59.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.75 111.191 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.686 HG22 HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -72.22 -48.23 44.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.675 -0.693 . . . . 0.31 109.662 176.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 93' ' ' MET . 3.5 p -73.69 -27.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.548 -0.751 . . . . 1.38 112.943 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -61.72 -30.34 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.606 -0.838 . . . . 2.35 109.088 176.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.21 -35.07 66.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.495 -0.775 . . . . 0.44 110.476 174.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.3 mt -70.18 -51.16 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 109.08 -0.711 . . . . 0.41 109.08 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -51.26 -41.74 60.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.537 -1.21 . . . . 0.67 110.442 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -55.62 -50.24 70.68 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.102 -0.954 . . . . 2.5 110.208 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.535 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -74.25 -46.57 40.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.47 112.164 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.766 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 10.8 mmpt? -63.69 -35.9 82.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.986 0.422 . . . . 1.66 110.943 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.7 -43.32 72.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.093 -0.958 . . . . 0.77 111.065 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.38 -21.41 39.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.573 -0.285 . . . . 0.74 111.26 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 83.1 41.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.817 1.294 . . . . 1.41 108.842 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 109' ' ' PRO . 29.2 t -89.95 138.16 27.84 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 113.384 -1.734 . . . . 1.35 111.616 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 108' ' ' VAL . 22.3 Cg_exo -66.82 144.18 70.1 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.829 2.353 . . . . 0.47 111.56 170.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.535 HD11 ' CB ' ' A' ' 103' ' ' ALA . 49.6 mm -109.35 157.12 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 121.387 0.613 . . . . 0.6 111.157 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.768 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 22.8 mm -124.02 83.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.195 -1.409 . . . . 0.37 107.195 169.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.777 HG23 HG21 ' A' ' 145' ' ' THR . 58.2 t -70.01 145.35 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-O 121.643 0.735 . . . . 0.26 109.208 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.773 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -143.55 100.39 3.59 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.374 -1.284 . . . . 0.29 109.67 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.814 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 80.6 mt -73.99 141.92 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.301 -1.318 . . . . 0.59 110.122 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 50.9 t30 -120.9 171.52 8.57 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.325 -1.361 . . . . 1.85 107.325 -177.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.799 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 81.7 mttt 72.47 33.58 1.41 Allowed 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 123.901 0.751 . . . . 0.59 111.749 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.741 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 13.4 mmt -79.02 -14.9 58.91 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 0.92 108.879 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 3.9 p-10 -65.09 -26.8 68.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.107 -1.406 . . . . 0.76 109.515 171.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.692 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 28.5 mtpp -86.62 132.23 43.17 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.291 -0.868 . . . . 1.17 110.02 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.39 -12.2 31.96 Favored 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 122.584 2.189 . . . . 0.58 111.128 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.27 1.15 38.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.404 -1.271 . . . . 1.45 110.732 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.63 122.96 11.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.119 -0.946 . . . . 0.27 111.348 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.6 OUTLIER -130.47 76.32 77.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.595 -0.891 . . . . 0.95 108.595 175.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.741 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 25.8 Cg_endo -61.16 -65.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.745 2.964 . . . . 0.4 114.153 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.657 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 1.2 m-20 -60.24 -23.07 63.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 1.44 110.102 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.753 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.4 tpt180 -67.8 -60.35 2.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 3.79 109.944 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 88' ' ' ALA . 33.0 m -66.08 -32.98 60.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.756 -1.111 . . . . 0.59 111.757 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 1.07 ' HA ' HD12 ' A' ' 131' ' ' LEU . 18.7 ptm -74.49 -20.51 59.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.794 0.33 . . . . 0.81 110.961 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 125' ' ' ASP . 20.3 mt-30 -74.86 -43.55 53.87 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.997 -0.44 . . . . 1.31 111.086 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.627 ' HA ' ' HG3' ' A' ' 133' ' ' GLU . 8.8 mt-10 -70.19 -24.23 63.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.895 0.855 . . . . 1.64 109.167 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' HA ' ' A' ' 128' ' ' MET . 66.8 mt -59.79 -36.71 77.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.464 -1.244 . . . . 1.36 109.27 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.878 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 3.6 mtm -77.14 -17.69 58.42 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.402 -0.519 . . . . 1.61 111.859 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.627 ' HG3' ' HA ' ' A' ' 130' ' ' GLU . 5.4 mt-10 -71.53 -17.47 62.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.437 -0.949 . . . . 1.67 108.437 174.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -94.9 12.27 28.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.802 -1.09 . . . . 1.08 109.44 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 53.1 t30 62.86 53.56 2.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.878 -1.51 . . . . 1.1 111.942 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -139.21 121.82 16.3 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.049 -1.093 . . . . 1.36 108.049 166.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.944 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 98.0 t -113.45 128.62 25.47 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.934 0.397 . . . . 0.43 111.914 -167.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.878 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 85.5 Cg_exo -45.72 145.77 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.707 3.605 . . . . 0.54 113.76 172.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.645 ' HB2' HD13 ' A' ' 146' ' ' ILE . 3.7 mm-40 -81.71 -11.39 59.07 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.321 -1.309 . . . . 3.08 110.746 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -67.65 -26.62 66.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 1.57 109.672 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.471 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.8 m0 -109.21 -2.94 17.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.66 110.735 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.04 33.72 17.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.985 -0.626 . . . . 0.53 113.721 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.944 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -86.45 -105.81 0.78 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.252 -0.975 . . . . 0.6 111.857 174.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -162.97 58.8 0.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.979 0.895 . . . . 1.91 110.907 172.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.777 HG21 HG23 ' A' ' 112' ' ' VAL . 51.5 m -166.9 116.49 0.88 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.463 -0.79 . . . . 0.37 111.0 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.768 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 18.1 mm -71.43 108.02 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.041 -0.726 . . . . 0.63 109.041 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.638 ' HE2' ' CD1' ' A' ' 131' ' ' LEU . 9.2 m-85 -89.51 120.0 30.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.5 111.039 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.486 ' SG ' HD23 ' A' ' 150' ' ' LEU . 50.6 t -99.98 153.9 18.82 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.196 0.522 . . . . 0.68 109.73 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.676 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.8 mttt -128.49 91.82 3.31 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.983 -1.008 . . . . 1.44 108.499 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.83 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -122.65 -174.1 2.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.613 1.197 . . . . 0.84 112.242 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 p -155.47 100.76 2.14 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.604 -1.635 . . . . 1.77 107.566 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.56 58.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.736 -0.786 . . . . 0.41 109.653 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -73.08 -52.49 14.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.168 -0.924 . . . . 2.3 110.48 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 p -87.82 -6.61 58.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.971 -0.691 . . . . 0.7 112.399 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.524 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 28.9 mmtp 67.45 45.87 1.5 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.583 -0.735 . . . . 1.36 111.661 171.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -105.72 -65.87 1.03 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.956 1.36 . . . . 2.48 110.617 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.83 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -72.36 -5.14 62.28 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.746 -1.57 . . . . 0.29 113.804 -173.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 26.9 mt -66.05 -41.39 90.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.376 1.088 . . . . 0.8 109.07 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -47.83 71.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.254 -0.885 . . . . 2.2 109.886 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -64.12 -27.07 68.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.58 111.68 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.8 tp -63.89 -58.89 5.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 1.16 110.451 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 11.9 mt -57.51 -39.56 76.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.032 -0.985 . . . . 1.51 110.115 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -54.18 -40.19 67.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.263 -0.88 . . . . 2.57 111.37 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.53 ' O ' HG23 ' A' ' 168' ' ' VAL . 16.4 mmt -78.5 -39.18 38.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 0.64 110.621 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 161' ' ' LEU . 89.5 mt -58.98 -46.94 91.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.52 111.383 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.86 -34.65 78.27 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.726 -0.389 . . . . 1.73 110.895 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -53.68 -47.17 70.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.012 -0.736 . . . . 1.51 109.012 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 111' ' ' ILE . 48.2 t . . . . . 0 N--CA 1.446 -0.643 0 CA-C-N 115.431 -0.804 . . . . 0.89 111.356 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 120.366 0.127 . . . . 0.64 110.841 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.656 HD12 HD21 ' A' ' 25' ' ' LEU . 50.8 mt -86.15 114.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.212 0.53 . . . . 1.3 110.601 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.705 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 21.4 mmt -112.59 -178.48 3.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.439 -0.801 . . . . 0.79 109.432 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.45 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 138.76 -174.13 22.23 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.565 -0.826 . . . . 0.31 112.206 174.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.57 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 50.5 t60 -84.42 162.45 19.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.7 0.762 . . . . 0.22 110.691 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.478 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -76.38 152.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.081 -0.963 . . . . 0.36 110.163 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 73.62 -20.36 0.3 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.031 0.532 . . . . 0.69 110.385 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.8 m170 -79.87 -8.68 59.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.696 -0.853 . . . . 0.63 108.696 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 122.6 62.09 0.21 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.386 -0.912 . . . . 0.79 114.643 169.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 70.0 mmtt -62.02 -74.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.316 0.558 . . . . 3.31 111.208 168.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 m -80.13 -34.66 37.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.768 0.318 . . . . 1.21 110.955 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.564 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.83 -30.21 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.949 0.722 . . . . 1.25 112.949 -175.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -71.72 -52.55 17.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.953 -0.388 . . . . 1.49 109.953 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.656 HD21 HD12 ' A' ' 13' ' ' ILE . 15.4 mt -70.43 -8.67 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 1.69 110.965 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -89.17 -44.18 10.49 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.244 -1.021 . . . . 1.23 108.244 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.655 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -71.49 -25.33 62.22 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.71 -1.586 . . . . 0.63 110.676 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' A' ' 25' ' ' LEU . 9.7 tt . . . . . 0 C--N 1.318 -0.8 0 CA-C-N 115.21 -0.904 . . . . 1.02 111.076 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.487 HG21 HG12 ' A' ' 111' ' ' ILE . 59.9 mt . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 120.615 0.245 . . . . 0.71 111.075 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.866 HG21 ' HE1' ' A' ' 102' ' ' HIS . 6.0 p -111.77 136.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.432 0.634 . . . . 1.17 110.766 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.587 HG12 ' HB ' ' A' ' 111' ' ' ILE . 11.9 mt -90.53 142.58 12.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.287 -0.87 . . . . 0.37 109.555 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.45 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.1 tm? -127.44 108.4 10.79 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.3 -1.0 . . . . 1.01 108.3 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 90.4 t -89.89 116.03 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.079 0.466 . . . . 0.43 111.206 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.829 HG21 HD21 ' A' ' 131' ' ' LEU . 1.7 m -123.43 125.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.643 -0.708 . . . . 0.64 111.003 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.616 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -65.95 132.04 47.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.059 -0.519 . . . . 0.28 109.88 174.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.764 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -73.24 -12.3 60.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.016 0.436 . . . . 0.22 111.158 -175.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.36 9.99 37.63 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.816 -0.629 . . . . 0.58 111.634 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -143.25 -40.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.561 0.219 . . . . 0.56 111.068 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.574 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.1 -143.27 21.95 Favored Glycine 0 C--O 1.227 -0.284 0 C-N-CA 121.367 -0.444 . . . . 0.37 114.014 171.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.49 128.74 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.763 0.792 . . . . 1.03 111.02 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.576 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -125.69 177.68 1.81 Allowed Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 114.248 -1.342 . . . . 0.28 108.955 -174.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 76.0 Cg_exo -48.93 -57.91 2.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.497 2.131 . . . . 0.58 114.085 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.1 pt20 -76.13 -12.46 60.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.246 -0.582 . . . . 0.75 110.783 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.57 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.56 -50.16 40.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.727 -0.669 . . . . 0.31 109.758 178.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.574 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p -74.88 -21.86 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 112.749 0.648 . . . . 1.38 112.749 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.5 mt-10 -64.58 -29.9 70.92 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.452 -0.78 . . . . 2.35 109.171 172.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.705 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -76.39 -19.4 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.555 -0.748 . . . . 0.44 110.396 173.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.627 HG12 HD11 ' A' ' 136' ' ' LEU . 96.9 mt -79.42 -46.9 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.267 0.556 . . . . 0.41 109.619 171.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -51.76 -45.34 63.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.681 -1.145 . . . . 0.67 110.156 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.866 ' HE1' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -49.12 -46.62 45.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.733 -0.667 . . . . 2.5 111.061 172.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.78 41.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 0.47 111.634 -169.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -73.96 -29.67 62.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.619 0.723 . . . . 1.66 110.161 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.78 -39.55 68.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.251 -1.34 . . . . 0.77 110.755 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.95 -32.61 15.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.463 -0.335 . . . . 0.74 111.591 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 62.3 t30 82.09 52.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.55 1.14 . . . . 1.41 109.123 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.434 HG23 ' HD2' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.36 143.93 28.74 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.847 -1.524 . . . . 1.35 111.155 -174.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 108' ' ' VAL . 24.5 Cg_exo -63.23 145.07 93.05 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.756 2.304 . . . . 0.47 112.381 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.498 ' C ' HG23 ' A' ' 145' ' ' THR . 1.0 OUTLIER -112.61 161.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.885 0.85 . . . . 0.6 111.881 -173.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.983 HD13 ' HB ' ' A' ' 146' ' ' ILE . 19.7 mm -124.39 82.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.943 -1.502 . . . . 0.37 106.943 171.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 145' ' ' THR . 62.0 t -69.77 147.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 109.056 -0.72 . . . . 0.26 109.056 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.821 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -144.78 104.36 4.01 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.638 -1.164 . . . . 0.29 110.156 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.785 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.3 mp -73.18 136.62 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.165 -1.38 . . . . 0.59 109.198 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.552 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -121.99 173.11 7.74 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 106.723 -1.584 . . . . 1.85 106.723 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.616 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 91.0 mttt 66.53 33.88 6.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 O-C-N 123.759 0.662 . . . . 0.59 111.512 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . 78.5 mmm -84.12 -14.64 49.81 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.024 -0.732 . . . . 0.92 109.024 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -66.05 -31.89 73.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.754 -1.112 . . . . 0.76 108.875 171.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.46 133.71 80.17 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.667 -1.151 . . . . 1.17 110.24 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.06 -13.94 34.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.941 2.428 . . . . 0.58 111.937 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.17 -3.41 57.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.956 -1.02 . . . . 1.45 110.712 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . -56.45 120.94 8.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.149 -0.932 . . . . 0.27 111.848 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -131.74 76.91 73.65 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.197 -1.038 . . . . 0.95 108.197 170.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.574 ' HB2' ' HE2' ' A' ' 149' ' ' LYS . 33.4 Cg_endo -61.67 -56.91 0.65 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.21 2.606 . . . . 0.4 113.916 -173.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.683 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 7.2 m-20 -55.53 -26.7 44.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.493 0.663 . . . . 1.44 110.319 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 123' ' ' ASN . 14.6 tpp180 -74.11 -56.57 4.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 3.79 109.395 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.75 HG21 ' HA ' ' A' ' 88' ' ' ALA . 24.1 m -66.92 -29.35 46.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.122 -0.945 . . . . 0.59 111.871 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 1.016 ' HA ' HD23 ' A' ' 131' ' ' LEU . 19.6 ptm -76.16 -17.03 59.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.745 0.307 . . . . 0.81 110.272 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' A' ' 132' ' ' MET . 10.1 mt-30 -76.2 -30.84 58.17 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.483 -0.487 . . . . 1.31 110.424 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 130' ' ' GLU . 16.6 mt-10 -64.35 -31.13 72.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.844 -0.799 . . . . 1.64 108.844 174.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.016 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -60.57 -47.83 84.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.677 -1.147 . . . . 1.36 109.507 176.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.661 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 18.2 ptm -71.64 -11.84 61.04 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.403 -0.519 . . . . 1.61 111.353 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 29.4 mt-10 -74.59 -28.85 61.09 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.6 -0.889 . . . . 1.67 108.6 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.583 ' HB3' HG21 ' A' ' 100' ' ' ILE . 31.1 m-85 -98.67 31.31 2.95 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.093 -0.958 . . . . 1.08 109.815 168.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.74 40.99 22.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 113.796 -1.547 . . . . 1.1 112.77 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.627 HD11 HG12 ' A' ' 100' ' ' ILE . 70.1 mt -110.04 95.9 5.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.013 -0.54 . . . . 1.36 110.001 172.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.01 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 21.9 t -100.64 117.26 63.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.868 -0.606 . . . . 0.43 111.045 -173.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.697 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.4 Cg_exo -44.11 143.94 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 124.446 3.431 . . . . 0.54 113.049 174.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.565 ' HG2' ' C ' ' A' ' 145' ' ' THR . 7.2 mm-40 -71.6 -21.25 61.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.329 -1.305 . . . . 3.08 109.341 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.5 pm0 -66.88 -19.83 65.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.26 -0.882 . . . . 1.57 110.506 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.518 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 37.8 m0 -110.22 -9.97 14.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.871 0.367 . . . . 0.66 111.081 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.65 29.45 9.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.866 -0.683 . . . . 0.53 113.473 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 1.01 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -89.95 -108.73 1.29 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 119.954 -1.117 . . . . 0.6 112.358 176.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.14 60.91 0.12 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.649 1.214 . . . . 1.91 110.858 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.863 HG21 HG23 ' A' ' 112' ' ' VAL . 72.8 m -165.2 119.2 1.25 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.643 -1.162 . . . . 0.37 110.712 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.983 ' HB ' HD13 ' A' ' 111' ' ' ILE . 19.1 mm -72.92 104.2 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 109.264 -0.643 . . . . 0.63 109.264 174.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.697 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m-85 -87.45 117.17 26.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.339 -0.846 . . . . 0.5 110.495 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 82.8 m -103.15 132.87 49.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.99 -0.55 . . . . 0.68 110.391 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.574 ' HE2' ' HB2' ' A' ' 124' ' ' PRO . 95.4 mttt -102.4 107.78 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.226 -0.657 . . . . 1.44 109.226 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.883 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -138.01 -172.52 3.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.703 1.24 . . . . 0.84 112.401 -173.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.3 OUTLIER -160.23 105.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 113.605 -1.634 . . . . 1.77 106.996 176.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.2 -14.38 62.94 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.343 -0.614 . . . . 0.41 109.343 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -62.86 -57.51 10.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.841 -1.072 . . . . 2.3 110.449 171.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.07 -8.86 59.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.622 0.601 . . . . 0.7 112.622 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.655 ' HE3' ' HB1' ' A' ' 27' ' ' ALA . 37.2 mmtm 64.38 44.99 3.96 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.36 111.204 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -105.21 -67.85 0.89 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.428 1.109 . . . . 2.48 109.63 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.883 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.78 -8.37 67.86 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 113.861 -1.518 . . . . 0.29 113.816 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.1 mt -66.44 -38.97 88.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.15 0.975 . . . . 0.8 109.41 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.596 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 40.8 m-20 -70.38 -44.16 68.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.326 -0.852 . . . . 2.2 109.291 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.413 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 73.8 t60 -62.8 -22.43 66.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.949 -0.569 . . . . 0.58 111.138 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.92 -52.95 30.27 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.361 0.6 . . . . 1.16 109.497 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -66.97 -26.63 66.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.31 -0.859 . . . . 1.51 110.444 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 94.1 mt-10 -61.99 -35.39 78.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.979 0.419 . . . . 2.57 110.832 175.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.56 ' HB3' HG21 ' A' ' 146' ' ' ILE . 11.3 mmt -82.3 -37.1 26.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.237 0.541 . . . . 0.64 110.398 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 83' ' ' ILE . 79.3 mt -69.59 -44.02 79.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 0.52 111.203 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -69.81 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.746 0.308 . . . . 1.73 110.248 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -57.9 -43.42 86.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.522 -0.918 . . . . 1.51 108.522 171.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 0.89 110.615 174.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.232 -0.655 . . . . 0.64 109.232 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.33 134.76 26.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.712 0.768 . . . . 1.3 110.691 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.524 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 66.3 mtt -138.38 -179.75 5.98 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.052 -0.977 . . . . 0.79 108.883 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.458 ' HA2' HD13 ' A' ' 84' ' ' LEU . . . 143.93 -171.44 25.49 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.511 -0.852 . . . . 0.31 112.362 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.536 ' CE1' HG12 ' A' ' 17' ' ' VAL . 38.9 t60 -98.05 160.96 13.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.91 0.862 . . . . 0.22 111.914 -177.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.536 HG12 ' CE1' ' A' ' 16' ' ' HIS . 7.4 p -73.56 150.89 7.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.318 -1.31 . . . . 0.36 110.11 174.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.6 t70 74.01 -32.62 0.24 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.225 0.61 . . . . 0.69 110.749 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 18.9 m170 -66.32 -20.51 66.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.733 -0.84 . . . . 0.63 108.733 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 126.46 55.83 0.15 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.79 113.331 174.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' HD3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -64.99 -61.19 2.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 117.46 0.63 . . . . 3.31 110.539 176.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.5 m -87.16 -41.76 13.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.972 0.415 . . . . 1.21 110.954 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -57.64 -33.83 68.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.087 0.773 . . . . 1.25 113.087 -175.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -72.41 -43.66 63.58 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.064 -0.717 . . . . 1.49 109.064 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.68 -17.56 64.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 1.69 110.494 -178.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -94.21 -43.21 8.56 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.842 0.829 . . . . 1.23 108.958 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.24 97.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.24 -1.346 . . . . 0.63 109.587 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.2 tt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 114.452 -1.249 . . . . 1.02 111.224 -177.164 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.527 0.204 . . . . 0.71 110.604 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 110' ' ' ILE . 25.9 t -112.06 129.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 120.707 -0.397 . . . . 1.17 111.358 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.643 HG12 ' HB ' ' A' ' 111' ' ' ILE . 10.8 mt -97.92 132.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 0.37 110.975 174.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.961 ' HB3' HG13 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -109.44 112.02 23.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.512 -0.767 . . . . 1.01 111.364 -178.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.7 t -87.55 94.12 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.098 0.475 . . . . 0.43 110.067 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.897 HG13 HD12 ' A' ' 84' ' ' LEU . 7.3 m -117.24 128.22 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.723 -0.671 . . . . 0.64 110.698 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.54 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -79.21 134.07 36.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.464 -0.569 . . . . 0.28 109.464 175.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.702 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -71.72 -8.02 51.64 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.079 0.466 . . . . 0.22 110.812 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.471 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -85.38 -17.38 36.87 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.355 -0.839 . . . . 0.58 110.972 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.535 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 24.8 t0 -132.0 -49.36 0.94 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.453 -0.34 . . . . 0.56 111.243 -170.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.63 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.24 -137.56 13.39 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 121.007 -0.616 . . . . 0.37 113.629 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 130' ' ' GLU . 6.9 p -88.47 138.51 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.35 -0.611 . . . . 1.03 109.35 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.847 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.4 mmm -142.78 178.2 1.57 Allowed Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.232 -0.655 . . . . 0.28 109.232 -171.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.847 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 49.3 Cg_exo -36.77 -69.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.544 2.829 . . . . 0.58 114.847 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.512 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 8.5 pt20 -73.69 -20.84 60.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.031 0.443 . . . . 0.75 111.346 -175.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.92 -43.78 82.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.677 -0.692 . . . . 0.31 109.373 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.57 HG12 ' ND2' ' A' ' 101' ' ' ASN . 47.6 t -66.92 -44.78 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.07 -0.968 . . . . 1.38 110.841 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.2 mm-40 -65.86 -14.84 62.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.153 0.502 . . . . 2.35 110.227 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -81.92 -38.4 25.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.556 -0.747 . . . . 0.44 110.086 170.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 95.6 mt -73.98 -42.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.642 0.734 . . . . 0.41 109.425 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.57 ' ND2' HG12 ' A' ' 97' ' ' VAL . 26.2 m-20 -57.99 -30.31 65.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.577 -1.192 . . . . 0.67 110.503 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -80.66 -37.73 30.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.32 0.581 . . . . 2.5 109.889 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.49 70.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.882 -0.599 . . . . 0.47 111.546 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.5 mmmm -72.79 -32.06 65.3 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.145 0.497 . . . . 1.66 110.133 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -44.51 54.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.731 -1.122 . . . . 0.77 110.798 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.57 -26.92 34.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.74 110.591 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 64.51 88.47 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.434 0.694 . . . . 1.41 110.908 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.605 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -143.56 154.26 59.58 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.488 -0.778 . . . . 1.35 109.83 -176.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 108' ' ' VAL . 21.6 Cg_exo -61.21 140.51 89.27 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.482 2.121 . . . . 0.47 111.923 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.4 mt -119.68 156.52 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.152 0.977 . . . . 0.6 111.917 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.014 HD13 ' HB ' ' A' ' 146' ' ' ILE . 19.0 mm -125.36 83.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.444 -1.707 . . . . 0.37 107.49 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.961 HG13 ' HB3' ' A' ' 84' ' ' LEU . 17.9 t -76.61 148.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.775 -0.77 . . . . 0.26 108.93 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.877 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -137.74 109.42 7.05 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.819 -1.082 . . . . 0.29 110.25 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.794 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -75.98 132.78 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.128 -1.396 . . . . 0.59 109.43 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 54.4 t30 -114.06 168.68 9.6 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 107.454 -1.313 . . . . 1.85 107.454 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.616 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 73.6 mttt 72.42 31.86 1.72 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.117 0.885 . . . . 0.59 112.001 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.571 ' H ' ' HB2' ' A' ' 151' ' ' SER . 11.4 mmt -72.8 -14.96 61.63 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.699 -0.682 . . . . 0.92 109.767 166.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.616 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.1 p-10 -69.7 -22.05 63.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.851 -1.068 . . . . 0.76 108.915 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.836 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 11.0 mmpt? -88.68 133.14 36.62 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.345 -1.298 . . . . 1.17 110.609 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.11 -11.69 28.76 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.878 2.385 . . . . 0.58 111.481 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -85.38 2.23 45.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.773 -1.103 . . . . 1.45 110.314 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -55.68 107.62 0.36 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.382 -0.826 . . . . 0.27 111.062 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.756 HD22 ' HB2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -121.75 76.52 37.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.723 -0.843 . . . . 0.95 108.723 174.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.526 ' HA ' HG22 ' A' ' 127' ' ' VAL . 45.2 Cg_endo -66.18 -55.01 0.42 Allowed 'Trans proline' 0 CA--C 1.503 -1.034 0 C-N-CA 123.079 2.52 . . . . 0.4 113.223 -171.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.403 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 11.9 m-20 -50.88 -27.64 7.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.189 -0.914 . . . . 1.44 110.386 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.756 ' HB2' HD22 ' A' ' 123' ' ' ASN . 32.2 tpt180 -79.63 -55.9 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 3.79 109.649 -178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.702 HG21 ' HA ' ' A' ' 88' ' ' ALA . 16.3 m -65.35 -28.94 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.476 -0.784 . . . . 0.59 112.078 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.407 ' HB2' ' HE3' ' A' ' 128' ' ' MET . 14.6 ptm -79.4 -19.33 50.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.157 -0.34 . . . . 0.81 110.486 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.65 ' O ' ' HG3' ' A' ' 132' ' ' MET . 13.0 mt-30 -74.4 -32.89 62.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.562 -0.29 . . . . 1.31 110.704 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.487 ' HB3' HG12 ' A' ' 92' ' ' VAL . 2.7 mm-40 -57.83 -46.29 84.94 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.569 0.699 . . . . 1.64 109.97 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 11.2 mp -66.38 -34.85 78.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.522 -0.763 . . . . 1.36 111.295 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.898 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -75.79 -7.89 55.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.724 -0.79 . . . . 1.61 110.738 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -82.45 -26.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.439 -0.948 . . . . 1.67 108.439 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.13 26.69 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.819 0.819 . . . . 1.08 109.854 165.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 53.78 57.0 6.46 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.983 -1.462 . . . . 1.1 111.673 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.846 ' H ' ' HA ' ' A' ' 132' ' ' MET . 62.8 mt -121.62 96.31 5.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.323 -0.853 . . . . 1.36 109.395 170.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.7 t -94.93 114.58 63.96 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.493 0.663 . . . . 0.43 112.162 -170.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.536 ' HA ' ' HD1' ' A' ' 147' ' ' PHE . 86.1 Cg_exo -45.29 152.63 0.7 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.651 3.567 . . . . 0.54 112.981 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.449 ' HB3' HD13 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -78.43 -19.36 53.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.253 -1.339 . . . . 3.08 109.663 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.424 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.8 pm0 -70.21 -17.49 63.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.246 -0.888 . . . . 1.57 110.771 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.898 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 44.0 m0 -106.61 -24.96 12.0 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.803 0.335 . . . . 0.66 111.117 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.62 15.56 5.34 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.128 -1.034 . . . . 0.53 113.998 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.608 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.05 -121.11 2.17 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.523 -1.322 . . . . 0.6 111.383 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -164.95 63.01 0.13 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 124.179 1.942 . . . . 1.91 110.496 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.518 ' CG2' HG23 ' A' ' 112' ' ' VAL . 85.9 m -141.7 104.92 4.62 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.689 -2.05 . . . . 0.37 107.361 173.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 1.014 ' HB ' HD13 ' A' ' 111' ' ' ILE . 42.2 mm -74.02 92.3 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-O 121.855 0.836 . . . . 0.63 110.054 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 114' ' ' ILE . 30.6 m-85 -75.81 107.83 8.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.038 -1.437 . . . . 0.5 110.447 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.9 m -98.96 108.22 20.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.004 -0.998 . . . . 0.68 110.211 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.794 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 76.9 mttt -83.36 99.4 10.01 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.902 -0.59 . . . . 1.44 109.867 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.877 HD21 ' HB1' ' A' ' 113' ' ' ALA . 3.4 pp -128.42 -167.09 1.72 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 0.84 112.463 -174.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.571 ' HB2' ' H ' ' A' ' 117' ' ' MET . 12.0 t -166.75 119.87 1.01 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.994 -1.912 . . . . 1.77 106.001 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.71 -5.84 51.9 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.124 -0.631 . . . . 0.41 109.372 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 19.5 mmtt -87.23 -37.37 17.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.391 -0.822 . . . . 2.3 111.498 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 11.6 p -87.69 -13.88 41.35 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.62 -0.832 . . . . 0.7 110.63 171.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 19.4 mmtp 59.64 45.39 13.17 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.95 -1.023 . . . . 1.36 109.703 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 4.4 tp10 -99.03 -68.5 0.8 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.487 -1.233 . . . . 2.48 110.557 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.877 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -80.55 2.75 77.02 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.531 -0.842 . . . . 0.29 113.454 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.436 HD12 ' CD ' ' A' ' 155' ' ' LYS . 30.5 mt -74.32 -39.62 62.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.069 0.934 . . . . 0.8 108.879 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 19.4 t70 -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.358 -0.837 . . . . 2.2 108.936 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 81.9 t60 -67.43 -17.61 64.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.525 -0.761 . . . . 0.58 111.333 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 165' ' ' ILE . 51.6 tp -68.94 -56.9 6.41 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.03 0.443 . . . . 1.16 110.028 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.43 ' HG ' ' H ' ' A' ' 162' ' ' LEU . 9.9 mt -56.17 -38.56 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.21 -0.904 . . . . 1.51 109.731 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 31.7 mm-40 -56.39 -41.93 77.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.325 -0.852 . . . . 2.57 111.445 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.587 ' HB3' HG21 ' A' ' 146' ' ' ILE . 13.7 mmt -77.52 -32.25 53.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 0.64 110.576 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 161' ' ' LEU . 75.7 mt -65.14 -47.18 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.619 . . . . 0.52 111.093 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 167' ' ' LEU . 3.9 pp -65.6 -29.29 69.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.862 0.363 . . . . 1.73 111.261 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.2 tp -56.25 -49.26 74.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.67 . . . . 1.51 109.708 170.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 N--CA 1.446 -0.638 0 CA-C-N 115.521 -0.763 . . . . 0.89 110.26 174.99 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.775 0.321 . . . . 0.64 110.31 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.458 HD12 ' HB2' ' A' ' 25' ' ' LEU . 59.5 mt -96.37 127.93 48.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.915 0.388 . . . . 1.3 110.653 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.503 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 60.1 mtt -136.34 175.55 9.5 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.037 -0.529 . . . . 0.79 109.823 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 145.48 -168.97 27.16 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.89 -0.671 . . . . 0.31 111.7 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.577 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 47.1 t60 -89.66 158.49 17.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.86 0.838 . . . . 0.22 111.48 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.52 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.1 p -72.18 148.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.562 -1.199 . . . . 0.36 109.697 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 23.6 t70 73.81 -19.36 0.35 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.457 0.646 . . . . 0.69 110.502 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 17' ' ' VAL . 15.6 m170 -84.67 -0.68 54.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.974 -1.121 . . . . 0.63 107.974 168.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 87.76 49.48 3.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.163 -0.926 . . . . 0.79 113.86 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -63.67 -36.57 84.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.31 -0.556 . . . . 3.31 111.508 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 m -101.8 -42.41 6.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 1.21 110.454 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.487 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -54.11 -19.47 5.02 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.125 0.787 . . . . 1.25 113.125 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -74.83 -45.24 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.259 -0.645 . . . . 1.49 109.259 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.542 HD13 ' C ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -66.39 -16.12 63.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.731 -1.122 . . . . 1.69 109.199 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -97.78 -41.5 8.03 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.701 0.762 . . . . 1.23 110.194 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -29.1 69.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.817 -1.083 . . . . 0.63 110.132 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.9 tt . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 114.662 -1.154 . . . . 1.02 110.128 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.6 mt . . . . . 0 CA--C 1.522 -0.124 0 N-CA-C 109.026 -0.731 . . . . 0.71 109.026 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HB ' HD13 ' A' ' 110' ' ' ILE . 31.3 t -100.9 116.64 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 C-N-CA 119.408 -0.917 . . . . 1.17 112.183 -173.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 9.2 mt -81.3 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.899 -1.046 . . . . 0.37 109.448 171.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.552 HD12 HD21 ' A' ' 131' ' ' LEU . 2.3 tm? -117.91 105.97 12.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.084 -1.08 . . . . 1.01 108.084 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 53.8 t -90.05 112.11 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.364 -0.834 . . . . 0.43 110.864 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.0 OUTLIER -121.32 129.67 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.733 -0.667 . . . . 0.64 110.874 175.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -70.63 130.69 42.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.896 -0.593 . . . . 0.28 109.935 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.664 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -71.54 -13.58 61.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 0.22 110.632 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.465 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -94.46 -2.42 51.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.686 -0.688 . . . . 0.58 111.521 -178.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.454 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 26.4 t0 -138.03 -49.26 0.56 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.652 -0.249 . . . . 0.56 110.891 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.595 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.36 -146.89 18.46 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.343 -0.456 . . . . 0.37 113.689 171.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.5 136.12 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 1.03 109.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.73 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.2 mmm -138.14 176.5 2.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 114.87 -1.059 . . . . 0.28 108.658 -171.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.73 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 55.8 Cg_exo -38.54 -69.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.607 2.872 . . . . 0.58 114.764 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.52 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 7.6 pt20 -72.4 -16.99 61.85 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.01 0.433 . . . . 0.75 111.47 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.71 -44.01 78.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.097 -0.705 . . . . 0.31 109.097 176.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 93' ' ' MET . 20.8 t -65.86 -41.36 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.22 -0.9 . . . . 1.38 111.096 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.81 -26.73 62.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 2.35 110.777 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.7 -34.95 65.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.382 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.8 mt -74.3 -46.69 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.472 0.653 . . . . 0.41 109.28 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.501 ' ND2' HG12 ' A' ' 97' ' ' VAL . 59.7 m-20 -56.31 -40.56 74.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.608 -1.178 . . . . 0.67 110.491 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -70.65 -35.43 72.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.907 -0.588 . . . . 2.5 110.199 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -69.43 -46.92 65.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.47 111.109 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.5 mmtp -64.8 -38.68 91.79 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.19 0.519 . . . . 1.66 109.986 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -48.24 -43.31 32.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.301 -1.318 . . . . 0.77 111.239 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.73 -38.27 15.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.74 111.022 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 88.08 72.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.631 1.172 . . . . 1.41 109.113 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 109' ' ' PRO . 3.0 p -126.2 144.71 49.95 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.203 -1.362 . . . . 1.35 110.862 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.443 ' O ' HG22 ' A' ' 108' ' ' VAL . 16.9 Cg_exo -66.45 139.32 53.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.716 1.611 . . . . 0.47 111.327 170.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.488 HD11 ' HB1' ' A' ' 103' ' ' ALA . 27.0 mm -104.83 157.4 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.571 0.7 . . . . 0.6 110.68 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.06 HD13 ' HB ' ' A' ' 146' ' ' ILE . 16.3 mm -122.91 83.72 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.346 -1.353 . . . . 0.37 107.346 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.729 HG23 HG21 ' A' ' 145' ' ' THR . 63.5 t -71.14 143.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.907 0.861 . . . . 0.26 109.518 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.762 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -146.64 100.41 3.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.857 -1.52 . . . . 0.29 109.857 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.793 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 85.0 mt -72.25 140.13 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 113.749 -1.569 . . . . 0.59 109.91 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.623 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.2 p-10 -120.29 176.13 5.62 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.068 -1.456 . . . . 1.85 107.068 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.657 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 75.5 mttt 66.34 27.92 9.92 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.86 0.725 . . . . 0.59 112.165 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.488 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 85.8 mmm -80.86 -1.64 44.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.697 0.761 . . . . 0.92 109.074 171.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.657 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.4 p-10 -71.01 -31.7 68.27 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.84 -1.073 . . . . 0.76 108.664 168.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HB3' ' HE2' ' A' ' 119' ' ' LYS . 39.6 mtpt -77.41 136.75 64.25 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.128 -1.396 . . . . 1.17 110.833 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.78 -17.39 59.7 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.818 2.346 . . . . 0.58 111.683 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.05 1.62 27.04 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.695 -0.684 . . . . 1.45 110.687 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.488 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -56.03 114.9 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.594 -0.73 . . . . 0.27 110.638 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.69 75.46 55.49 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 107.885 -1.154 . . . . 0.95 107.885 173.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.43 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 42.4 Cg_endo -64.86 -57.17 0.31 Allowed 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 122.492 2.128 . . . . 0.4 112.46 -172.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.43 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 4.3 m-20 -50.91 -26.57 6.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 124.2 0.938 . . . . 1.44 111.037 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -77.71 -59.23 2.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.892 -0.594 . . . . 3.79 110.071 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.595 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 4.7 m -64.67 -27.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.105 -0.952 . . . . 0.59 110.398 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.666 ' HG2' ' CE ' ' A' ' 132' ' ' MET . 23.2 ttt -60.95 -51.79 67.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.726 -1.125 . . . . 0.81 109.815 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 132' ' ' MET . 35.2 mt-30 -59.15 -31.25 68.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.022 0.749 . . . . 1.31 113.022 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.517 ' HA ' ' CG ' ' A' ' 133' ' ' GLU . 4.3 pt-20 -80.91 -16.44 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.081 -0.647 . . . . 1.64 112.081 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.723 HD23 HG21 ' A' ' 112' ' ' VAL . 6.7 mp -68.17 -35.87 78.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.582 -0.847 . . . . 1.36 109.044 167.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.666 ' CE ' ' HG2' ' A' ' 128' ' ' MET . 0.5 OUTLIER -71.19 -18.75 62.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.437 -0.801 . . . . 1.61 109.618 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.517 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 7.9 mm-40 -70.45 -30.51 67.37 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.661 -0.866 . . . . 1.67 108.661 173.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -91.97 17.3 9.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.059 -0.973 . . . . 1.08 109.959 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 61.11 47.84 6.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.233 -1.349 . . . . 1.1 111.27 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.492 HD11 HD23 ' A' ' 131' ' ' LEU . 1.5 pp -131.28 121.41 24.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.096 -1.076 . . . . 1.36 108.096 167.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.759 HG13 ' HD2' ' A' ' 138' ' ' PRO . 5.0 t -122.06 142.92 37.62 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.114 0.483 . . . . 0.43 111.382 -168.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HB3' ' CD1' ' A' ' 147' ' ' PHE . 18.5 Cg_endo -69.86 -175.21 1.1 Allowed 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 123.621 2.88 . . . . 0.54 113.631 -176.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.775 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -84.61 -32.66 23.6 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.53 -1.668 . . . . 3.08 109.93 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.756 ' HG3' ' CD1' ' A' ' 141' ' ' TRP . 6.7 pt-20 -67.85 -17.66 64.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.092 -0.504 . . . . 1.57 111.205 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.756 ' CD1' ' HG3' ' A' ' 140' ' ' GLU . 21.2 m0 -109.04 -2.82 17.89 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.892 0.377 . . . . 0.66 111.183 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.81 32.13 13.68 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.058 -0.591 . . . . 0.53 113.784 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.19 -127.86 5.84 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.627 -0.796 . . . . 0.6 111.407 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -149.84 62.93 0.99 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.018 0.913 . . . . 1.91 111.894 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 112' ' ' VAL . 52.7 m -161.27 128.14 4.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.165 -0.925 . . . . 0.37 109.99 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 1.06 ' HB ' HD13 ' A' ' 111' ' ' ILE . 46.8 mm -79.78 104.89 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 108.863 -0.792 . . . . 0.63 108.863 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.765 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 5.9 m-85 -88.56 116.74 27.02 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.584 -0.734 . . . . 0.5 111.706 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.1 m -106.76 143.31 35.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.638 -0.71 . . . . 0.68 110.814 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.586 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.5 mttt -118.15 97.91 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.885 -0.783 . . . . 1.44 108.885 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.897 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -130.63 -171.47 2.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.749 1.261 . . . . 0.84 112.569 -169.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.531 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 28.9 t -157.88 115.99 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.679 -1.601 . . . . 1.77 106.873 174.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.45 -9.92 58.99 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.084 -0.71 . . . . 0.41 109.084 175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.18 -50.96 17.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.878 -1.055 . . . . 2.3 110.56 174.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 118' ' ' ASP . 2.1 p -81.39 -16.06 53.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.228 -0.589 . . . . 0.7 111.217 175.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.449 ' CD ' HD12 ' A' ' 158' ' ' LEU . 29.1 mmtp 67.21 40.66 2.75 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.307 -0.861 . . . . 1.36 110.539 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.4 OUTLIER -98.71 -64.66 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.022 -0.99 . . . . 2.48 109.663 -171.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.897 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -76.19 -3.01 74.89 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.111 -0.95 . . . . 0.29 113.433 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.449 HD12 ' CD ' ' A' ' 155' ' ' LYS . 18.1 mt -70.89 -36.16 72.63 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 117.974 0.887 . . . . 0.8 109.416 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 27.7 t70 -73.04 -39.95 65.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 2.2 109.257 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.423 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 61.3 t60 -68.52 -18.11 64.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.212 -0.449 . . . . 0.58 111.346 176.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.8 tp -74.81 -54.27 7.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.24 0.543 . . . . 1.16 110.08 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.52 -27.64 69.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.267 -0.879 . . . . 1.51 111.529 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 12.0 pt-20 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.431 -0.507 . . . . 2.57 110.22 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.456 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 21.7 mmt -71.72 -39.39 70.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.17 0.509 . . . . 0.64 109.649 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.25 -38.7 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.519 -0.764 . . . . 0.52 110.443 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -40.38 95.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.504 . . . . 1.73 111.146 177.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.98 -43.46 63.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.466 0.65 . . . . 1.51 109.561 173.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 68.0 t . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 114.756 -1.111 . . . . 0.89 110.769 176.267 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.52 ' HB ' ' HA ' ' A' ' 82' ' ' VAL . 89.1 m . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.251 -0.277 . . . . 0.64 110.251 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mt -112.62 122.34 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.051 -0.406 . . . . 1.3 110.402 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.771 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 59.2 mtt -139.65 173.56 11.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.048 -0.524 . . . . 0.79 109.953 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.491 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 145.32 -163.54 28.12 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.641 -0.79 . . . . 0.31 112.335 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.589 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 42.7 t60 -97.1 161.28 13.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.822 0.82 . . . . 0.22 112.031 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.583 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.8 p -73.72 151.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.339 -1.301 . . . . 0.36 109.739 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 10.7 t70 73.39 -27.09 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.304 0.574 . . . . 0.69 110.605 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.0 m170 -77.38 -10.47 59.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.407 -0.96 . . . . 0.63 108.407 171.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.688 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 113.72 51.95 0.48 Allowed Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.605 -0.807 . . . . 0.79 114.22 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 4.2 tptm -53.31 -62.77 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.447 0.623 . . . . 3.31 111.283 174.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -96.07 -32.11 12.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.579 -0.282 . . . . 1.21 111.079 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.558 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -59.34 -20.84 57.87 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.018 0.747 . . . . 1.25 113.018 -179.006 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.688 HD23 ' HA3' ' A' ' 20' ' ' GLY . 1.5 mm? -74.52 -35.73 63.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.919 0.39 . . . . 1.49 110.001 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.02 -15.11 61.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.79 -0.641 . . . . 1.69 109.466 176.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -96.5 -32.03 12.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.706 -0.679 . . . . 1.23 109.29 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -47.32 49.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.198 -0.91 . . . . 0.63 109.051 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 tt . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 114.68 -1.145 . . . . 1.02 110.244 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.2 mt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 109.597 -0.52 . . . . 0.71 109.597 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' HD13 ' A' ' 110' ' ' ILE . 40.1 t -93.84 114.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.424 0.63 . . . . 1.17 111.205 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.695 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.5 mt -82.84 126.03 40.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.899 -1.046 . . . . 0.37 109.596 172.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.3 tm? -114.73 106.09 13.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.447 -0.945 . . . . 1.01 108.447 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 57.7 t -88.24 109.76 20.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.395 -0.82 . . . . 0.43 110.921 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 131' ' ' LEU . 1.7 m -121.14 135.76 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.855 -0.611 . . . . 0.64 111.338 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.696 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -74.26 134.18 42.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.935 -0.575 . . . . 0.28 109.706 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.76 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -78.61 -9.42 59.36 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.355 0.597 . . . . 0.22 109.846 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -89.25 -10.24 47.68 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.941 -1.027 . . . . 0.58 110.359 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.1 t0 -133.33 -59.51 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.07 -0.514 . . . . 0.56 111.152 -173.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.436 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 109.14 -135.11 12.65 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.37 113.637 173.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.27 131.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.786 0.803 . . . . 1.03 110.671 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.656 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 68.6 mmm -134.02 178.93 1.53 Allowed Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 114.333 -1.303 . . . . 0.28 109.402 -171.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.4 Cg_exo -45.64 -64.34 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.27 2.647 . . . . 0.58 114.735 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.583 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 7.0 pt20 -75.17 -10.93 59.92 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.636 -0.665 . . . . 0.75 111.3 -175.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.85 -49.28 54.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.738 -0.664 . . . . 0.31 109.279 175.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' HA ' HD12 ' A' ' 100' ' ' ILE . 2.5 p -72.63 -28.61 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.834 -0.621 . . . . 1.38 112.591 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 49.2 mt-10 -57.95 -29.66 65.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.544 0.611 . . . . 2.35 109.448 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.771 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -72.36 -42.85 64.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.396 -0.82 . . . . 0.44 110.743 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 97' ' ' VAL . 65.7 mt -66.05 -41.57 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.62 0.724 . . . . 0.41 109.307 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -57.9 -40.0 79.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.196 -1.366 . . . . 0.67 110.857 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -66.83 -40.45 88.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.643 -0.503 . . . . 2.5 109.643 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -70.41 -46.08 64.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.877 -0.602 . . . . 0.47 111.788 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.78 -29.06 61.98 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.052 0.453 . . . . 1.66 110.659 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.61 -43.23 62.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.689 -1.141 . . . . 0.77 110.69 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.44 -19.18 23.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.74 111.3 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 70.04 67.79 0.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.17 -0.923 . . . . 1.41 110.472 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.489 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -117.28 152.39 49.1 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 1.35 111.12 -176.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 108' ' ' VAL . 23.2 Cg_exo -65.34 141.58 68.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.041 2.494 . . . . 0.47 112.537 172.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.547 HD13 ' HB ' ' A' ' 82' ' ' VAL . 29.2 mm -111.27 155.47 12.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.601 0.715 . . . . 0.6 111.121 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.774 HD13 ' HB ' ' A' ' 146' ' ' ILE . 7.9 mm -125.38 87.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.429 -1.323 . . . . 0.37 107.429 170.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.679 HG23 HG21 ' A' ' 145' ' ' THR . 46.6 t -74.16 148.33 8.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.463 -0.789 . . . . 0.26 109.8 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 150' ' ' LEU . . . -143.73 106.18 4.42 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.473 -1.24 . . . . 0.29 110.427 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.83 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -79.22 135.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.508 -1.224 . . . . 0.59 109.787 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.696 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.5 p-10 -113.47 177.41 4.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.28 -1.378 . . . . 1.85 107.28 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.735 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 84.2 mttt 70.5 33.1 2.52 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.61 0.569 . . . . 0.59 111.754 176.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.665 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 29.8 mmt -73.95 -19.0 60.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.245 -1.391 . . . . 0.92 107.245 166.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.632 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -62.29 -36.44 82.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.37 -1.741 . . . . 0.76 110.503 172.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.735 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 41.1 mtpt -79.34 141.77 57.73 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.94 -0.573 . . . . 1.17 110.3 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.24 -15.95 52.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.792 2.328 . . . . 0.58 111.88 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 34.4 mt-10 -84.75 11.26 9.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.574 -0.739 . . . . 1.45 110.655 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.455 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -61.29 100.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.536 -0.756 . . . . 0.27 111.155 176.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.644 HD22 ' HB2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -120.41 77.07 26.27 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.664 -0.865 . . . . 0.95 108.664 176.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.596 ' HD3' ' HE1' ' A' ' 117' ' ' MET . 55.7 Cg_endo -68.15 -56.01 0.22 Allowed 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 123.334 2.689 . . . . 0.4 113.512 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.541 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 2.2 m-20 -55.72 -24.5 35.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.44 110.7 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.644 ' HB2' HD22 ' A' ' 123' ' ' ASN . 15.4 tpp180 -74.15 -57.49 3.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.386 -0.598 . . . . 3.79 109.386 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 88' ' ' ALA . 26.5 m -64.44 -32.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.999 -1.0 . . . . 0.59 111.681 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.958 ' HA ' HD23 ' A' ' 131' ' ' LEU . 17.1 ptm -76.22 -15.79 59.96 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.889 0.376 . . . . 0.81 110.41 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.624 ' O ' ' HG2' ' A' ' 132' ' ' MET . 30.1 mt-30 -78.38 -33.95 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 1.31 110.014 171.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.04 -27.26 65.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.905 -0.776 . . . . 1.64 108.905 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.958 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.2 OUTLIER -59.44 -46.41 88.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.484 -1.235 . . . . 1.36 109.263 174.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.627 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 16.6 ptm -75.11 -13.76 60.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.409 -0.516 . . . . 1.61 111.125 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 58.9 mm-40 -70.49 -29.08 65.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.0 -1.111 . . . . 1.67 108.0 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.458 ' N ' ' HD1' ' A' ' 134' ' ' TYR . 1.6 m-85 -98.92 23.17 9.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.473 -1.239 . . . . 1.08 108.986 175.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.4 t30 60.49 49.22 6.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 113.619 -1.628 . . . . 1.1 112.259 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.627 ' H ' ' HA ' ' A' ' 132' ' ' MET . 52.4 mt -117.93 98.65 6.45 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.329 -0.85 . . . . 1.36 109.522 171.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.012 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 26.2 t -104.68 113.67 64.72 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.089 -0.644 . . . . 0.43 111.497 -172.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.6 ' CB ' ' HG2' ' A' ' 140' ' ' GLU . 82.2 Cg_exo -45.48 141.81 7.31 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.405 3.403 . . . . 0.54 112.8 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.623 ' HB2' HD13 ' A' ' 146' ' ' ILE . 6.3 mm-40 -71.56 -14.75 62.19 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.636 -1.165 . . . . 3.08 110.56 174.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.6 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.8 pm0 -68.39 -19.99 64.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.981 -0.554 . . . . 1.57 109.759 167.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.589 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 42.7 m0 -107.68 -30.3 8.65 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.994 0.426 . . . . 0.66 110.722 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.83 25.63 3.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.752 -0.737 . . . . 0.53 113.255 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 1.012 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -88.67 -107.28 1.06 Allowed Glycine 0 C--N 1.324 -0.134 0 C-N-CA 120.126 -1.035 . . . . 0.6 112.699 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -165.07 60.83 0.12 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 122.565 1.174 . . . . 1.91 110.694 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.679 HG21 HG23 ' A' ' 112' ' ' VAL . 87.4 m -164.39 122.4 1.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.687 -1.142 . . . . 0.37 110.554 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.774 ' HB ' HD13 ' A' ' 111' ' ' ILE . 16.5 mm -84.42 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.211 -0.663 . . . . 0.63 109.211 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.461 ' HE2' HD23 ' A' ' 131' ' ' LEU . 2.8 m-85 -87.62 145.5 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.884 0.849 . . . . 0.5 110.153 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.456 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 65.1 m -118.15 136.32 53.69 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.29 -1.323 . . . . 0.68 109.103 172.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.552 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 94.7 mttt -109.76 89.84 3.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.997 -0.742 . . . . 1.44 108.997 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.859 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -115.45 179.46 3.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.877 1.322 . . . . 0.84 112.054 -170.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 3.9 p -145.28 95.47 2.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.156 -1.838 . . . . 1.77 106.978 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.97 -18.38 65.36 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.463 -0.495 . . . . 0.41 109.732 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.515 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 70.6 mmtt -80.95 -43.49 19.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.701 -0.682 . . . . 2.3 111.563 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 1.9 m -76.07 -15.49 60.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.387 0.613 . . . . 0.7 110.82 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 37.7 mmtm 66.49 46.0 1.98 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.845 -1.071 . . . . 1.36 110.373 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.35 -57.46 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.039 -0.982 . . . . 2.48 110.702 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.859 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.61 1.91 84.21 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.285 -0.959 . . . . 0.29 113.543 -172.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.1 -41.52 61.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.192 -0.67 . . . . 0.8 109.192 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 15.4 m-20 -67.65 -43.93 79.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.503 -0.771 . . . . 2.2 109.318 171.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.621 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 78.1 t60 -63.31 -23.12 67.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.932 -0.576 . . . . 0.58 111.516 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 165' ' ' ILE . 55.0 tp -68.49 -55.81 10.5 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.358 0.599 . . . . 1.16 109.784 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.149 -0.932 . . . . 1.51 110.775 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 65.1 mm-40 -66.48 -45.03 81.05 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.052 0.454 . . . . 2.57 110.398 172.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.501 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 12.7 mmt -67.61 -36.88 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.181 0.515 . . . . 0.64 110.203 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 83' ' ' ILE . 77.9 mt -66.8 -32.21 57.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 0.52 110.128 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -35.07 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 1.73 110.821 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.7 tp -57.03 -42.58 80.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.766 0.793 . . . . 1.51 109.26 171.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.227 -0.897 . . . . 0.89 110.331 175.642 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.971 -0.381 . . . . 0.64 109.971 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.846 HD11 HD23 ' A' ' 25' ' ' LEU . 17.1 pt -96.64 133.51 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.638 0.733 . . . . 1.3 111.446 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.675 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 62.9 mtt -134.96 -179.62 5.73 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.856 -1.065 . . . . 0.79 109.41 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.487 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 140.63 -164.86 26.27 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.517 -0.849 . . . . 0.31 111.776 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.599 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 46.9 t60 -92.18 158.04 16.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.64 0.733 . . . . 0.22 111.204 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.6 p -70.98 147.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.915 -1.039 . . . . 0.36 109.872 174.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.2 t70 75.0 -26.86 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.456 0.646 . . . . 0.69 110.613 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.487 ' CE1' ' HB3' ' A' ' 90' ' ' ASP . 18.4 m170 -79.44 -13.71 59.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.3 -1.0 . . . . 0.63 108.3 170.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 116.97 76.35 0.59 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.357 -0.925 . . . . 0.79 114.97 171.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 15' ' ' GLY . 20.6 mmtp -77.32 -86.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.924 -0.71 . . . . 3.31 111.097 165.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 m -75.24 -16.14 60.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.829 0.347 . . . . 1.21 111.109 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.462 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -56.21 -35.03 66.85 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 111.863 0.32 . . . . 1.25 111.863 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 20' ' ' GLY . 4.5 mm? -74.06 -40.57 62.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.665 -0.494 . . . . 1.49 109.665 176.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -62.44 -13.11 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.821 -0.627 . . . . 1.69 110.022 176.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -102.18 -47.5 4.51 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.706 0.765 . . . . 1.23 109.706 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.08 73.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.28 -1.327 . . . . 0.63 111.398 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 99.2 mt . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.716 -0.675 . . . . 1.02 111.083 -177.105 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.4 mt . . . . . 0 C--O 1.234 0.28 0 N-CA-C 110.363 -0.236 . . . . 0.71 110.363 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.4 136.33 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.631 -0.828 . . . . 1.17 111.337 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.737 HG12 ' HB ' ' A' ' 111' ' ' ILE . 9.5 mt -96.71 135.88 29.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.068 -0.969 . . . . 0.37 109.612 170.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.487 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 1.8 tm? -119.8 107.8 13.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.975 -1.121 . . . . 1.01 107.975 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -93.17 113.53 28.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.795 -0.639 . . . . 0.43 110.681 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.894 HG21 HD11 ' A' ' 131' ' ' LEU . 2.8 m -121.3 136.88 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.524 -0.762 . . . . 0.64 110.713 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.74 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -75.87 134.64 40.26 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.903 -0.589 . . . . 0.28 110.105 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -74.87 -10.03 59.11 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.303 0.573 . . . . 0.22 110.035 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.68 -14.48 39.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.181 -0.918 . . . . 0.58 110.624 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 19' ' ' HIS . 2.4 t0 -131.95 -63.0 0.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.56 110.298 -176.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 115.72 -129.71 8.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.256 -0.497 . . . . 0.37 112.793 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.82 140.58 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.569 0.7 . . . . 1.03 109.621 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.562 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.6 mmm -139.94 176.33 2.62 Favored Pre-proline 0 C--N 1.311 -1.073 0 CA-C-N 114.743 -1.117 . . . . 0.28 108.549 -171.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 86.6 Cg_exo -48.72 -57.21 2.5 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.662 2.241 . . . . 0.58 114.205 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.671 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 1.9 pt20 -78.88 -11.48 60.0 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.11 -0.636 . . . . 0.75 111.002 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.87 -49.6 44.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.483 -0.781 . . . . 0.31 109.4 176.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.549 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.0 p -76.72 -27.74 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 115.454 -0.793 . . . . 1.38 113.128 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -66.97 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.31 -0.956 . . . . 2.35 109.549 177.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -77.18 -36.46 55.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.144 -0.935 . . . . 0.44 110.032 170.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 97' ' ' VAL . 97.9 mt -68.27 -42.81 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.518 0.675 . . . . 0.41 109.434 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.94 -42.01 68.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.685 -1.143 . . . . 0.67 110.523 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -66.36 -35.0 79.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.078 -0.51 . . . . 2.5 110.093 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 -46.73 22.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.127 -0.488 . . . . 0.47 111.775 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.8 mmmt -68.77 -39.58 80.16 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.96 0.409 . . . . 1.66 110.413 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.98 69.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.53 -0.759 . . . . 0.77 110.772 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.97 63.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.74 110.495 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.8 t30 76.64 73.53 0.08 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.264 1.03 . . . . 1.41 109.301 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -137.71 147.5 57.33 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 113.545 -1.661 . . . . 1.35 110.016 -170.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -52.59 135.24 55.38 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.554 2.169 . . . . 0.47 113.156 171.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.543 ' C ' HG23 ' A' ' 145' ' ' THR . 1.2 mt -110.72 162.61 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.697 -1.138 . . . . 0.6 110.385 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.737 ' HB ' HG12 ' A' ' 83' ' ' ILE . 27.3 mm -129.58 84.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 107.394 -1.336 . . . . 0.37 107.394 172.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.909 HG23 HG21 ' A' ' 145' ' ' THR . 48.7 t -74.16 146.34 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.725 0.774 . . . . 0.26 109.237 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.88 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -141.72 105.79 4.77 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.25 -1.341 . . . . 0.29 110.512 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.752 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.0 mp -80.06 124.84 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.464 -1.244 . . . . 0.59 109.081 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.74 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.9 p-10 -107.34 177.51 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.772 -1.196 . . . . 1.85 107.772 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 80.5 mttt 71.11 37.02 1.29 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 123.981 0.8 . . . . 0.59 111.427 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.488 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 29.2 mmt -78.14 -15.07 59.19 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.803 -1.184 . . . . 0.92 107.803 168.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.2 -19.79 60.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.635 -1.62 . . . . 0.76 109.942 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.475 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 24.0 mmmt -87.68 131.02 44.84 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-N 115.305 -0.861 . . . . 1.17 110.124 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.5 -11.58 26.67 Favored 'Trans proline' 0 N--CA 1.472 0.254 0 C-N-CA 122.71 2.273 . . . . 0.58 111.709 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.91 8.57 31.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.879 -1.055 . . . . 1.45 110.567 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.476 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -54.96 106.83 0.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.967 -1.015 . . . . 0.27 111.438 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.95 75.72 14.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.95 108.419 172.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.488 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 57.6 Cg_endo -68.92 -54.38 0.26 Allowed 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 123.002 2.468 . . . . 0.4 113.438 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 25.3 m-20 -58.11 -28.06 64.29 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.13 -0.941 . . . . 1.44 109.629 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.88 -58.92 3.04 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 119.889 -0.725 . . . . 3.79 109.115 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.685 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 21.6 m -61.8 -31.32 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.732 -1.122 . . . . 0.59 111.988 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 1.07 ' HA ' HD12 ' A' ' 131' ' ' LEU . 19.9 ptm -79.25 -16.42 56.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.101 -0.24 . . . . 0.81 110.805 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.693 ' O ' ' HG3' ' A' ' 132' ' ' MET . 13.8 mt-30 -80.14 -39.26 29.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.732 0.301 . . . . 1.31 110.831 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.46 -27.11 65.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.737 -0.838 . . . . 1.64 108.737 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' HA ' ' A' ' 128' ' ' MET . 77.5 mt -61.79 -45.19 94.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.506 -1.225 . . . . 1.36 110.022 174.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.828 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -76.19 -10.59 59.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.473 -0.491 . . . . 1.61 111.268 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -85.28 -15.6 42.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.366 -0.605 . . . . 1.67 109.366 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.45 17.37 14.74 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.925 -1.139 . . . . 1.08 107.925 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.6 t30 59.37 56.14 3.91 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 113.315 -1.766 . . . . 1.1 112.027 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.737 ' H ' ' HA ' ' A' ' 132' ' ' MET . 77.1 mt -121.53 96.1 4.94 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.787 -1.097 . . . . 1.36 109.03 169.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.912 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 32.9 t -105.02 113.97 64.2 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 120.032 -0.667 . . . . 0.43 111.049 -171.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.945 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 6.8 Cg_endo -56.45 157.8 17.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 123.326 2.684 . . . . 0.54 112.673 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.452 ' HB2' HD13 ' A' ' 146' ' ' ILE . 16.4 mm-40 -78.6 -13.52 59.79 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.256 -1.338 . . . . 3.08 109.974 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.945 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -68.04 -23.32 64.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 1.57 109.906 168.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.828 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 40.5 m0 -108.33 -14.9 14.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.858 0.361 . . . . 0.66 110.83 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.87 27.74 10.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.705 -0.759 . . . . 0.53 113.52 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.912 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.69 -108.36 0.72 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.238 -0.982 . . . . 0.6 111.621 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -163.28 61.1 0.18 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.575 1.179 . . . . 1.91 111.66 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.909 HG21 HG23 ' A' ' 112' ' ' VAL . 88.8 m -163.49 124.11 2.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.637 -1.165 . . . . 0.37 110.906 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.741 HG21 ' HB3' ' A' ' 164' ' ' MET . 23.3 mm -74.36 104.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 109.146 -0.687 . . . . 0.63 109.146 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.566 ' CG ' ' HB3' ' A' ' 138' ' ' PRO . 7.4 m-85 -87.67 117.82 26.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.321 -0.854 . . . . 0.5 110.401 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.3 m -101.37 144.17 30.51 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.46 -0.336 . . . . 0.68 110.501 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.5 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.8 mttt -116.77 89.47 3.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.167 -0.679 . . . . 1.44 109.167 175.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.88 HD21 ' HB1' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -117.99 176.22 5.31 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.671 1.224 . . . . 0.84 112.265 -171.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -129.72 102.46 6.35 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.916 -1.493 . . . . 1.77 107.283 164.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.73 64.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.923 -0.769 . . . . 0.41 108.923 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -64.38 -59.83 3.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.41 -1.268 . . . . 2.3 110.936 174.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.7 p -88.94 5.02 46.03 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 119.99 -0.684 . . . . 0.7 112.163 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.492 ' CD ' HD12 ' A' ' 158' ' ' LEU . 29.7 mmtp 64.37 46.85 3.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.555 -0.748 . . . . 1.36 111.834 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -104.93 -53.71 2.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.925 0.869 . . . . 2.48 110.983 -177.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.831 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.84 2.24 84.11 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.332 -0.937 . . . . 0.29 112.763 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.492 HD12 ' CD ' ' A' ' 155' ' ' LYS . 19.7 mt -76.32 -36.98 58.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.213 -0.662 . . . . 0.8 109.213 174.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.65 -40.84 80.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.621 -0.718 . . . . 2.2 109.371 171.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 74.2 t60 -72.81 -15.13 61.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.1 -0.5 . . . . 0.58 110.981 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER -77.2 -50.79 12.16 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.889 -0.411 . . . . 1.16 109.889 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 163' ' ' GLU . 4.5 pp -64.46 -29.76 70.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.789 -0.641 . . . . 1.51 111.281 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 11.2 pt-20 -71.8 -36.91 70.43 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.507 -0.477 . . . . 2.57 110.131 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.741 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.2 mmt -71.55 -38.27 71.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.201 0.524 . . . . 0.64 109.899 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 83' ' ' ILE . 78.9 mt -65.34 -46.76 89.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.782 -0.644 . . . . 0.52 111.007 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.501 ' CD2' ' HA ' ' A' ' 163' ' ' GLU . 1.6 pp -67.92 -29.79 68.96 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.832 -0.433 . . . . 1.73 109.832 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.76 -52.05 63.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.38 -0.827 . . . . 1.51 108.974 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.447 -0.606 0 CA-C-N 115.85 -0.613 . . . . 0.89 110.92 176.893 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 120.481 0.181 . . . . 0.64 111.11 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.549 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 43.3 mt -84.02 124.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.265 0.555 . . . . 1.3 110.535 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.474 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 66.6 mtt -127.93 174.0 9.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.393 -0.965 . . . . 0.79 108.393 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.18 -179.47 23.17 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.259 -0.972 . . . . 0.31 111.858 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.621 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 51.5 t60 -85.09 160.63 19.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.766 0.794 . . . . 0.22 111.372 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 7.5 p -74.61 152.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.604 -1.18 . . . . 0.36 109.892 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.1 t70 74.05 -21.14 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.243 0.544 . . . . 0.69 110.556 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.616 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.7 m170 -79.33 -16.31 56.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.634 -0.876 . . . . 0.63 108.634 171.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.486 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 118.19 60.38 0.28 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.363 -0.835 . . . . 0.79 114.136 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -63.78 -66.01 0.6 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.951 -0.7 . . . . 3.31 111.166 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -85.62 -33.91 21.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 1.21 111.029 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.486 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -60.94 -24.88 66.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.75 0.648 . . . . 1.25 112.75 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.539 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -71.72 -39.3 70.22 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.018 -0.273 . . . . 1.49 110.592 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD21 HD12 ' A' ' 13' ' ' ILE . 54.7 mt -71.33 -14.54 62.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.795 -0.446 . . . . 1.69 109.795 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.94 -42.2 11.33 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.081 0.944 . . . . 1.23 108.705 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.062 -1.426 . . . . 0.63 110.026 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 tt . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 115.087 -0.961 . . . . 1.02 110.984 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--O 1.233 0.226 0 N-CA-C 110.104 -0.332 . . . . 0.71 110.104 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -120.8 121.68 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 1.17 111.971 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 10.4 mt -82.97 137.79 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.878 -1.055 . . . . 0.37 109.321 170.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.633 HD12 HD21 ' A' ' 131' ' ' LEU . 2.5 tm? -123.67 105.24 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.355 -0.98 . . . . 1.01 108.355 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 89.3 t -87.73 109.77 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.637 -0.711 . . . . 0.43 110.967 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER -120.73 120.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.717 -0.674 . . . . 0.64 110.776 174.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -68.75 127.76 34.22 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.926 -0.768 . . . . 0.28 108.926 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.669 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -70.76 -11.59 61.04 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.924 0.392 . . . . 0.22 111.446 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -94.79 2.02 55.46 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.346 -0.542 . . . . 0.58 110.876 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.405 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.0 t0 -134.33 -52.21 0.82 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.352 -0.385 . . . . 0.56 110.977 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.616 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 97.31 -158.23 21.05 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 121.087 -0.577 . . . . 0.37 113.509 173.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.27 136.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.6 0.714 . . . . 1.03 109.646 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.738 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 73.6 mmm -136.96 177.92 1.96 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.097 -0.956 . . . . 0.28 108.808 -171.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.3 Cg_exo -40.74 -65.42 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.302 2.668 . . . . 0.58 114.814 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.469 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 7.2 pt20 -74.15 -16.88 60.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.38 0.61 . . . . 0.75 111.062 -174.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.621 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.74 -43.88 71.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 0.31 109.366 177.261 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 93' ' ' MET . 21.0 t -68.24 -39.32 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.401 -0.818 . . . . 1.38 111.276 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.46 -28.92 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 2.35 110.221 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -72.8 -42.19 64.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.819 -0.628 . . . . 0.44 111.032 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.44 -42.29 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.842 0.83 . . . . 0.41 109.596 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.513 ' ND2' HG12 ' A' ' 97' ' ' VAL . 25.0 m-20 -63.67 -28.2 69.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.273 -1.331 . . . . 0.67 110.851 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -82.17 -32.31 30.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.047 0.451 . . . . 2.5 109.879 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -67.38 -46.6 72.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.47 110.901 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.92 -33.71 72.52 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.664 0.745 . . . . 1.66 110.018 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.15 44.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.096 -1.411 . . . . 0.77 111.475 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -100.33 -39.15 8.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.649 -0.25 . . . . 0.74 111.362 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 88.5 75.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.726 1.21 . . . . 1.41 109.182 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.59 142.33 42.22 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.407 -1.27 . . . . 1.35 110.4 -173.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.57 142.48 77.88 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.628 2.219 . . . . 0.47 111.943 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 145' ' ' THR . 27.0 mm -108.48 155.38 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.64 0.733 . . . . 0.6 111.107 -172.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.075 HD13 ' HB ' ' A' ' 146' ' ' ILE . 15.7 mm -122.64 83.34 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.508 -1.293 . . . . 0.37 107.508 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.78 HG21 HD23 ' A' ' 131' ' ' LEU . 58.6 t -73.19 144.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.677 0.751 . . . . 0.26 109.307 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.818 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -141.16 101.57 4.05 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.099 -1.41 . . . . 0.29 110.013 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.969 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.4 mp -68.61 138.13 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.803 -1.544 . . . . 0.59 108.883 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 59.0 t30 -122.09 166.78 14.01 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 107.147 -1.427 . . . . 1.85 107.147 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.675 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 83.5 mttt 71.68 33.35 1.8 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 124.239 0.962 . . . . 0.59 111.515 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.597 ' CE ' ' HB3' ' A' ' 124' ' ' PRO . 9.0 mmt -74.49 -11.97 60.36 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.171 -0.922 . . . . 0.92 109.586 166.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.675 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 10.5 p-10 -70.52 -19.63 62.89 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.852 -1.067 . . . . 0.76 108.862 172.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.499 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 47.4 mtpt -95.21 131.73 29.37 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 114.769 -1.105 . . . . 1.17 110.47 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -63.68 -15.41 48.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.946 2.431 . . . . 0.58 111.748 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -82.72 7.85 13.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 1.45 110.332 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.44 115.78 2.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.276 -0.875 . . . . 0.27 110.669 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.47 75.45 24.96 Favored Pre-proline 0 CA--C 1.509 -0.621 0 N-CA-C 107.1 -1.444 . . . . 0.95 107.1 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.597 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 27.0 Cg_endo -61.73 -63.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 123.077 2.518 . . . . 0.4 113.298 -169.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.598 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 5.9 m-20 -64.01 -15.35 59.16 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.55 -0.75 . . . . 1.44 110.713 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 1.3 tmt_? -74.04 -55.72 5.78 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.475 -0.935 . . . . 3.79 108.475 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.614 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 5.0 m -70.72 -25.46 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.05 -0.977 . . . . 0.59 110.36 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.598 ' HB3' ' HA ' ' A' ' 125' ' ' ASP . 9.2 ttt -66.4 -42.73 87.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.995 -1.457 . . . . 0.81 110.646 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' A' ' 132' ' ' MET . 15.0 mt-30 -71.94 -24.93 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 1.31 112.282 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.557 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.3 mt-10 -65.88 -33.45 75.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.737 0.78 . . . . 1.64 109.067 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 112' ' ' VAL . 5.2 mp -65.68 -37.54 86.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.016 -0.993 . . . . 1.36 110.043 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 10.0 ptm -74.88 -11.81 60.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.951 -0.7 . . . . 1.61 110.786 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 35.6 mm-40 -69.25 -35.06 75.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.068 -1.086 . . . . 1.67 108.068 170.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -91.11 23.29 3.32 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.452 -1.249 . . . . 1.08 109.769 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 54.92 49.91 16.71 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.316 -1.311 . . . . 1.1 111.927 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.588 ' H ' ' HA ' ' A' ' 132' ' ' MET . 46.5 mt -110.15 110.54 21.44 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.502 -0.772 . . . . 1.36 109.398 170.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 138' ' ' PRO . 71.0 t -109.12 114.25 58.2 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.662 0.744 . . . . 0.43 112.064 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -44.18 153.04 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 125.057 3.838 . . . . 0.54 113.314 174.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.679 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -76.11 -19.86 58.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.947 -1.478 . . . . 3.08 109.726 178.038 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -72.19 -22.19 61.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.588 -0.733 . . . . 1.57 110.665 171.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.441 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 34.1 m0 -102.62 -12.13 17.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.071 0.462 . . . . 0.66 110.571 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.38 21.89 9.56 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.555 -0.831 . . . . 0.53 114.232 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.96 -123.04 4.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.631 -1.271 . . . . 0.6 111.28 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -157.82 64.01 0.47 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-O 124.097 1.903 . . . . 1.91 111.326 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.635 HG23 ' HB ' ' A' ' 110' ' ' ILE . 97.0 m -148.36 112.23 5.12 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.044 -1.889 . . . . 0.37 108.609 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 1.075 ' HB ' HD13 ' A' ' 111' ' ' ILE . 51.9 mm -73.56 97.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.539 0.685 . . . . 0.63 109.412 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.58 ' CE2' ' HG3' ' A' ' 128' ' ' MET . 14.8 m-85 -81.46 119.67 24.02 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.612 -1.176 . . . . 0.5 110.588 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 78.2 m -113.83 112.07 22.78 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.135 -0.484 . . . . 0.68 110.459 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.969 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 9.3 ptpt -89.51 91.43 8.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.227 0.537 . . . . 1.44 109.9 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.879 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 2.8 pp -122.37 -169.99 2.0 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.556 1.169 . . . . 0.84 112.412 -169.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.468 ' HB2' ' N ' ' A' ' 117' ' ' MET . 26.1 t -154.69 122.81 5.93 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.553 -1.658 . . . . 1.77 107.061 172.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.406 ' CB ' HD11 ' A' ' 158' ' ' LEU . . . -79.64 -8.12 59.0 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.512 0.672 . . . . 0.41 109.641 175.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -83.25 -46.49 12.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.125 -0.943 . . . . 2.3 111.165 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.8 OUTLIER -85.24 -8.01 58.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.164 -0.615 . . . . 0.7 111.285 175.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.543 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.7 mmtp 62.85 43.31 7.07 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.2 -0.909 . . . . 1.36 111.49 174.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -102.9 -71.84 0.71 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.649 1.214 . . . . 2.48 110.554 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.879 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -65.49 -11.03 51.81 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.932 -1.485 . . . . 0.29 113.209 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 19.4 mt -69.21 -39.05 78.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.41 0.605 . . . . 0.8 109.584 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 68.1 m-20 -63.0 -46.32 88.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.96 -0.756 . . . . 2.2 108.96 174.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -66.25 -27.89 68.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.49 -0.777 . . . . 0.58 111.151 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.7 tp -65.7 -55.73 15.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 1.16 110.279 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.2 mt -57.71 -44.16 85.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 1.51 109.909 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 35.1 mm-40 -59.66 -44.44 93.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.574 -0.739 . . . . 2.57 111.398 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.477 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -73.62 -39.74 64.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.011 0.434 . . . . 0.64 110.494 -177.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.55 HD11 HD11 ' A' ' 83' ' ' ILE . 51.9 mt -62.99 -44.69 99.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.807 -0.633 . . . . 0.52 110.596 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -37.64 88.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.942 -0.572 . . . . 1.73 111.076 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.4 tp -51.48 -49.06 62.56 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.376 0.608 . . . . 1.51 109.468 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.078 -0.965 . . . . 0.89 110.883 177.397 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 110.335 -0.246 . . . . 0.64 110.335 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.799 HG13 HD21 ' A' ' 25' ' ' LEU . 37.2 mm -93.85 120.07 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.899 0.38 . . . . 1.3 110.503 177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 64.0 mtt -139.12 176.23 8.88 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.629 -0.508 . . . . 0.79 109.629 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 141.06 -163.38 26.67 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.948 -0.861 . . . . 0.31 110.948 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 48.7 t60 -94.19 157.66 15.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.047 0.927 . . . . 0.22 111.444 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 19' ' ' HIS . 4.6 p -74.9 149.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.348 -1.296 . . . . 0.36 110.528 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 73.18 -21.2 0.26 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.69 110.187 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 17' ' ' VAL . 19.5 m170 -74.0 -20.15 60.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.434 -0.951 . . . . 0.63 108.434 168.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.455 ' O ' HD13 ' A' ' 24' ' ' LEU . . . 109.97 63.34 0.52 Allowed Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.388 -0.823 . . . . 0.79 114.044 172.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.92 -57.45 4.57 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.971 -0.692 . . . . 3.31 111.378 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -86.4 -28.73 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.275 0.472 . . . . 1.21 112.275 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -29.49 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.668 0.618 . . . . 1.25 112.668 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 20' ' ' GLY . 9.7 mp -69.2 -40.09 78.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.395 -0.19 . . . . 1.49 110.706 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.799 HD21 HG13 ' A' ' 13' ' ' ILE . 19.8 mt -69.61 -11.5 60.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.379 0.609 . . . . 1.69 109.919 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.07 -43.1 7.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.064 0.935 . . . . 1.23 109.001 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -50.55 15.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.01 -1.45 . . . . 0.63 111.311 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 1.02 111.699 -174.163 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.696 HG21 HG12 ' A' ' 111' ' ' ILE . 5.9 mt . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.538 0.208 . . . . 0.71 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.503 HG11 ' HE1' ' A' ' 102' ' ' HIS . 4.2 p -123.51 133.81 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.532 0.682 . . . . 1.17 109.952 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 165' ' ' ILE . 15.5 mt -90.61 134.55 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.014 -0.994 . . . . 0.37 109.775 175.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.512 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.1 tm? -116.49 104.92 11.92 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.151 -1.055 . . . . 1.01 108.151 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.6 t -85.83 112.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.744 -0.662 . . . . 0.43 111.192 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.8 m -123.37 118.29 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 115.741 -0.663 . . . . 0.64 110.751 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.99 130.85 43.3 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.224 -0.658 . . . . 0.28 109.224 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.865 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -74.18 -6.95 50.79 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.045 0.45 . . . . 0.22 111.497 -170.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.46 -10.01 45.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.879 -0.6 . . . . 0.58 110.87 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.436 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -128.83 -51.95 1.23 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.56 111.571 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.744 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 100.61 -133.86 11.47 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.523 -0.846 . . . . 0.37 113.749 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.44 134.25 37.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.541 0.686 . . . . 1.03 110.48 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.973 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 78.0 mmm -138.88 -178.77 0.9 Allowed Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 114.695 -1.139 . . . . 0.28 109.133 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.973 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 3.5 Cg_endo -46.93 -68.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.246 2.631 . . . . 0.58 114.652 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.499 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 8.4 pt20 -70.29 -16.5 63.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.23 0.538 . . . . 0.75 111.005 -175.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.45 -49.13 67.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.643 -0.708 . . . . 0.31 109.495 177.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.561 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.1 p -77.39 -24.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.845 -0.616 . . . . 1.38 112.438 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.44 -35.8 76.7 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.666 -0.646 . . . . 2.35 109.492 172.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -25.82 62.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 0.44 110.612 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 97' ' ' VAL . 92.2 mt -75.25 -45.12 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.192 -0.67 . . . . 0.41 109.192 174.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.23 -49.53 60.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.119 -0.946 . . . . 0.67 110.458 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.503 ' HE1' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -45.19 -57.01 4.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 2.5 110.732 171.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.616 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -68.96 -47.89 64.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.302 -1.317 . . . . 0.47 113.047 -170.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 13.7 mmmm -72.14 -35.65 69.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.951 0.405 . . . . 1.66 110.641 -173.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.54 75.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.396 -0.82 . . . . 0.77 110.992 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -91.91 -25.33 18.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.208 -0.451 . . . . 0.74 112.097 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 44.4 m-20 80.56 42.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.92 0.867 . . . . 1.41 109.777 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.3 t -96.91 141.99 23.87 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.106 -1.406 . . . . 1.35 111.47 -176.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 21.7 Cg_exo -66.14 142.5 67.79 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.909 2.406 . . . . 0.47 112.905 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.616 HD11 ' CB ' ' A' ' 103' ' ' ALA . 11.5 mm -108.93 158.95 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.804 0.811 . . . . 0.6 111.276 -175.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.808 HD13 ' HB ' ' A' ' 146' ' ' ILE . 23.8 mm -125.76 85.02 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.983 -1.488 . . . . 0.37 106.983 166.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.029 HG23 HG21 ' A' ' 145' ' ' THR . 57.4 t -71.48 143.34 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 121.711 0.767 . . . . 0.26 109.175 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.786 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.76 103.64 4.55 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.47 -1.241 . . . . 0.29 110.538 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.001 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.3 mp -70.45 132.81 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-N 113.588 -1.642 . . . . 0.59 108.631 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 61.1 t30 -120.87 169.63 10.26 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.384 -1.339 . . . . 1.85 107.384 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.742 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 88.2 mttt 71.96 34.06 1.55 Allowed 'General case' 0 N--CA 1.424 -1.74 0 O-C-N 124.086 0.866 . . . . 0.59 110.91 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.73 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 10.6 mmt -74.53 -10.09 59.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 115.14 -0.936 . . . . 0.92 109.2 167.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.595 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 5.1 p-10 -72.96 -21.1 60.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.548 -1.206 . . . . 0.76 110.104 172.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.574 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 27.9 mtpp -91.26 135.02 28.74 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 1.17 110.273 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.34 -15.43 49.88 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.713 2.275 . . . . 0.58 111.058 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -78.5 2.07 20.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.643 -1.162 . . . . 1.45 110.486 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.413 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -56.19 108.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.223 -0.899 . . . . 0.27 110.774 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.7 76.14 7.45 Favored Pre-proline 0 CA--C 1.51 -0.591 0 N-CA-C 107.03 -1.471 . . . . 0.95 107.03 171.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.73 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 37.7 Cg_endo -63.92 -66.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.303 0 C-N-CA 122.981 2.454 . . . . 0.4 113.234 -167.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.667 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 1.6 m-20 -64.45 -8.96 15.41 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.723 -0.671 . . . . 1.44 111.216 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -81.83 -53.94 5.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.845 -0.742 . . . . 3.79 109.434 174.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.865 HG21 ' HA ' ' A' ' 88' ' ' ALA . 18.5 m -68.88 -25.71 30.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.337 -0.847 . . . . 0.59 109.795 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 1.086 ' HA ' HD12 ' A' ' 131' ' ' LEU . 8.6 ttt -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.246 -1.343 . . . . 0.81 110.242 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 132' ' ' MET . 15.3 mt-30 -72.38 -37.74 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.674 -0.694 . . . . 1.31 111.205 173.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.7 mm-40 -60.32 -30.75 69.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.253 1.025 . . . . 1.64 109.149 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.086 HD12 ' HA ' ' A' ' 128' ' ' MET . 62.7 mt -63.74 -43.47 96.37 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.781 -1.554 . . . . 1.36 109.884 177.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.619 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 7.5 ptm -75.36 -14.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.229 -0.589 . . . . 1.61 110.9 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 17.4 mm-40 -71.61 -27.4 63.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.563 -0.902 . . . . 1.67 108.563 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -99.1 22.21 10.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.56 -1.2 . . . . 1.08 108.686 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 54.93 57.46 5.61 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 113.73 -1.577 . . . . 1.1 111.807 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.619 ' H ' ' HA ' ' A' ' 132' ' ' MET . 47.9 mt -119.38 111.73 18.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.847 -1.069 . . . . 1.36 109.0 167.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.478 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.7 t -118.66 117.44 34.18 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-O 121.369 0.604 . . . . 0.43 111.26 -170.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.517 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 36.9 Cg_exo -56.09 175.47 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 124.11 3.207 . . . . 0.54 113.757 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 1.035 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -78.96 -31.81 45.14 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.011 -1.904 . . . . 3.08 109.477 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.872 ' HB2' ' HD1' ' A' ' 141' ' ' TRP . 6.7 mm-40 -58.28 -34.74 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.496 -0.775 . . . . 1.57 109.621 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.872 ' HD1' ' HB2' ' A' ' 140' ' ' GLU . 13.2 m0 -97.44 -7.69 31.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.749 -1.114 . . . . 0.66 110.926 -166.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.93 33.07 11.4 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.926 -0.654 . . . . 0.53 113.264 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.5 -125.05 5.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.174 -1.012 . . . . 0.6 111.685 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.62 62.18 0.53 Allowed 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.769 1.271 . . . . 1.91 111.448 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 1.029 HG21 HG23 ' A' ' 112' ' ' VAL . 73.8 m -160.5 128.96 4.69 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.194 -1.367 . . . . 0.37 110.238 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 1.035 HD13 ' HG2' ' A' ' 139' ' ' GLU . 38.0 mm -76.98 106.34 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.765 -0.828 . . . . 0.63 108.765 172.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.634 ' HE2' ' CD1' ' A' ' 131' ' ' LEU . 8.3 m-85 -90.78 110.01 21.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.568 -0.742 . . . . 0.5 110.947 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 97.4 m -105.01 111.8 24.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.3 -0.409 . . . . 0.68 111.08 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 1.001 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 ptpt -88.4 91.28 8.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.339 0.59 . . . . 1.44 109.624 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.863 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -119.47 -173.31 2.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.6 1.191 . . . . 0.84 111.913 -170.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 4.8 p -153.1 101.0 2.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.692 -1.595 . . . . 1.77 107.25 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.86 62.42 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.752 -0.779 . . . . 0.41 109.358 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -75.79 -44.75 39.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.148 -0.933 . . . . 2.3 111.679 175.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.764 ' HB ' ' HG3' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -78.59 -17.37 56.19 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.166 -0.613 . . . . 0.7 111.657 176.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.2 mmtp 68.7 46.6 0.92 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.393 -0.822 . . . . 1.36 110.832 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.764 ' HG3' ' HB ' ' A' ' 154' ' ' THR . 18.1 mt-10 -108.51 -68.78 0.89 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.566 1.174 . . . . 2.48 110.547 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.863 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.17 -10.53 52.56 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.813 -1.539 . . . . 0.29 113.454 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.577 HD12 ' HD3' ' A' ' 155' ' ' LYS . 37.3 mt -69.45 -42.52 74.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 117.308 0.554 . . . . 0.8 109.827 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.37 -42.81 92.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 2.2 109.564 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' A' ' 164' ' ' MET . 84.5 t60 -67.66 -22.19 65.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.892 -0.595 . . . . 0.58 111.272 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -71.83 -52.55 16.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.133 0.492 . . . . 1.16 109.86 -176.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.48 -24.61 66.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.664 . . . . 1.51 111.004 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 163' ' ' GLU . 15.0 mm-40 -72.2 -40.14 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.886 0.374 . . . . 2.57 110.457 175.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.72 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.3 mmt -66.49 -41.37 89.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.64 110.085 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 83' ' ' ILE . 60.6 mt -61.29 -45.35 98.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.52 110.422 175.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -41.01 95.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.067 -0.515 . . . . 1.73 111.079 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 167' ' ' LEU . 1.6 tm? -51.21 -38.7 53.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.62 0.724 . . . . 1.51 109.234 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 0.89 110.802 177.757 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.518 ' HB ' HG22 ' A' ' 82' ' ' VAL . 22.2 m . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 110.401 -0.222 . . . . 0.64 110.401 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -97.72 138.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.215 0.531 . . . . 1.3 110.238 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.628 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 59.1 mtt -145.99 173.28 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 0.79 109.869 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.68 -174.97 22.77 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.756 -0.735 . . . . 0.31 112.362 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.649 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 53.2 t60 -86.85 161.67 18.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.715 0.769 . . . . 0.22 111.717 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.0 p -73.08 148.88 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.764 -1.107 . . . . 0.36 109.447 173.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 33.4 t70 73.6 -25.35 0.19 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.547 0.689 . . . . 0.69 109.951 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.586 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 16.5 m170 -86.99 -4.64 59.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.386 -0.824 . . . . 0.63 109.372 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.833 ' O ' ' HG2' ' A' ' 21' ' ' LYS . . . -143.23 -53.29 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 118.466 -1.186 . . . . 0.79 113.014 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.858 ' HG3' ' HB ' ' A' ' 23' ' ' THR . 15.4 pttt 60.44 138.47 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.073 0.94 . . . . 3.31 112.048 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -62.2 -15.41 46.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.148 0.975 . . . . 1.21 108.433 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.858 ' HB ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 m -67.42 -21.36 65.57 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 1.25 111.511 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.673 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.8 tt -68.95 -32.06 71.39 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.111 -0.993 . . . . 1.49 108.447 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.571 ' O ' HG22 ' A' ' 28' ' ' ILE . 2.6 tp -68.22 -29.08 67.83 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 1.69 110.087 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.45 -38.48 26.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.267 1.032 . . . . 1.23 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HB1' ' CE ' ' A' ' 155' ' ' LYS . . . -67.37 -34.45 77.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.536 -1.665 . . . . 0.63 110.038 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 25' ' ' LEU . 4.5 tt . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 114.99 -1.005 . . . . 1.02 110.343 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 C--O 1.236 0.388 0 N-CA-C 110.419 -0.215 . . . . 0.71 110.419 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.518 HG22 ' HB ' ' A' ' 12' ' ' THR . 23.1 t -122.79 127.19 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.172 0.511 . . . . 1.17 110.998 173.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 24.3 mt -86.57 132.08 33.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.331 -0.849 . . . . 0.37 110.087 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.548 HD12 HD21 ' A' ' 131' ' ' LEU . 2.0 tm? -121.48 110.56 16.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.254 -1.017 . . . . 1.01 108.254 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 33.5 t -96.42 114.52 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.159 -0.473 . . . . 0.43 110.801 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 114' ' ' ILE . 3.4 m -119.66 142.16 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.64 111.063 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.708 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -80.73 131.02 35.4 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.793 -0.447 . . . . 0.28 109.793 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.694 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -74.97 -12.96 60.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.116 -0.633 . . . . 0.22 109.906 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.564 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -91.1 -10.36 42.26 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.17 -0.923 . . . . 0.58 111.519 -177.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.586 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 7.0 t70 -134.9 -38.22 0.8 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.755 0.312 . . . . 0.56 111.348 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.458 ' HA2' ' CG1' ' A' ' 127' ' ' VAL . . . 91.03 -133.16 11.65 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 114.157 0.423 . . . . 0.37 114.157 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.532 HG11 ' HE2' ' A' ' 134' ' ' TYR . 12.8 t -100.34 131.46 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.911 0.862 . . . . 1.03 110.551 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.523 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -131.03 173.62 5.66 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 114.017 -1.447 . . . . 0.28 108.086 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 73.1 Cg_exo -49.71 -57.07 2.55 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.325 2.017 . . . . 0.58 113.282 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.593 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -72.34 -13.97 61.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.917 0.389 . . . . 0.75 111.415 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -69.76 -52.86 21.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.609 0.719 . . . . 0.31 109.647 177.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 100' ' ' ILE . 2.0 p -83.13 -23.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 113.761 1.023 . . . . 1.38 113.761 -173.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -63.96 -25.17 68.02 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.111 -0.993 . . . . 2.35 109.428 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.628 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -74.57 -39.86 62.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.439 -0.8 . . . . 0.44 110.228 171.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.538 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 93.8 mt -62.98 -49.06 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.582 0.706 . . . . 0.41 109.754 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -55.43 -33.33 63.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.496 -1.229 . . . . 0.67 110.817 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -67.48 -43.68 80.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.696 -0.684 . . . . 2.5 110.375 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.425 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -73.97 -44.58 54.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 0.47 111.578 -177.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.67 ' HD3' HD21 ' A' ' 136' ' ' LEU . 13.5 mmmm -66.18 -32.78 74.43 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.123 0.487 . . . . 1.66 110.064 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.56 -41.75 70.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.926 -1.033 . . . . 0.77 110.83 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.39 44.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 0.74 111.305 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 84.39 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.412 1.07 . . . . 1.41 109.064 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.21 140.79 21.62 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 113.906 -1.497 . . . . 1.35 110.251 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.15 142.81 93.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.643 2.229 . . . . 0.47 111.96 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.498 ' C ' HG23 ' A' ' 145' ' ' THR . 23.0 mm -105.51 156.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.764 0.793 . . . . 0.6 110.735 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.875 HD13 ' HB ' ' A' ' 146' ' ' ILE . 14.2 mm -124.89 86.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 107.102 -1.444 . . . . 0.37 107.102 171.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.901 HG23 HG21 ' A' ' 145' ' ' THR . 59.9 t -75.16 145.83 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 121.779 0.799 . . . . 0.26 109.953 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB1' ' CD2' ' A' ' 150' ' ' LEU . . . -144.07 102.27 3.85 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.067 -1.424 . . . . 0.29 109.932 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.792 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.4 mp -72.18 140.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.148 -1.387 . . . . 0.59 109.636 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.708 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 4.4 p-10 -117.57 176.64 5.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.693 -1.225 . . . . 1.85 107.693 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.63 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 83.9 mttt 69.58 34.28 2.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.892 0.745 . . . . 0.59 111.633 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.437 ' CE ' ' HB1' ' A' ' 122' ' ' ALA . 17.5 mmt -77.78 -13.56 59.85 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.486 -0.931 . . . . 0.92 108.486 169.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.547 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -70.66 -25.94 63.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.861 -1.518 . . . . 0.76 109.519 173.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 43.5 mtpt -89.07 137.85 29.35 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.36 -0.836 . . . . 1.17 110.247 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.41 -13.94 42.39 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.839 2.36 . . . . 0.58 111.659 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 33.0 mt-10 -81.75 6.66 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.161 -0.927 . . . . 1.45 110.539 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.437 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -58.0 107.68 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.565 -0.743 . . . . 0.27 110.975 175.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.84 76.66 29.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.48 -0.934 . . . . 0.95 108.48 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.478 ' HA ' HG22 ' A' ' 127' ' ' VAL . 47.4 Cg_endo -66.6 -54.77 0.41 Allowed 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.74 2.293 . . . . 0.4 113.125 -172.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.433 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.1 m-20 -52.26 -26.45 11.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 1.44 110.78 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.602 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 53.7 ttt180 -79.7 -57.15 3.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.07 -0.652 . . . . 3.79 109.403 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.694 HG11 ' HA ' ' A' ' 88' ' ' ALA . 15.7 m -63.76 -24.52 36.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.406 -0.816 . . . . 0.59 112.128 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.492 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 17.2 ptm -84.74 -17.37 38.56 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.037 0.446 . . . . 0.81 109.929 174.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.8 mt-30 -76.31 -40.74 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 1.31 110.511 170.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 1.9 mm-40 -58.6 -35.49 72.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.124 0.964 . . . . 1.64 108.978 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.694 HD23 HG21 ' A' ' 112' ' ' VAL . 2.0 mp -64.52 -42.89 95.5 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.542 -1.208 . . . . 1.36 110.352 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.727 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.7 ppp? -75.58 -8.75 57.57 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.506 -0.478 . . . . 1.61 110.685 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 8.0 mm-40 -71.97 -36.68 69.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.872 -1.158 . . . . 1.67 107.872 172.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.532 ' HE2' HG11 ' A' ' 92' ' ' VAL . 23.4 m-85 -91.42 28.56 1.66 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.655 -1.157 . . . . 1.08 110.012 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.74 53.14 13.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.742 -1.572 . . . . 1.1 112.342 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.67 HD21 ' HD3' ' A' ' 104' ' ' LYS . 66.2 mt -113.94 99.03 7.36 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.338 -0.847 . . . . 1.36 108.84 168.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.947 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 35.5 t -100.76 115.42 65.36 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-O 121.565 0.698 . . . . 0.43 111.788 -168.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.692 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 87.4 Cg_exo -43.97 138.69 6.24 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 124.168 3.245 . . . . 0.54 112.072 171.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.979 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.4 OUTLIER -73.65 -14.93 61.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.199 -0.91 . . . . 3.08 109.963 178.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.1 pm0 -66.07 -26.14 67.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.488 -0.778 . . . . 1.57 110.135 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.727 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 34.5 m0 -101.63 -14.91 17.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.97 0.414 . . . . 0.66 110.465 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.07 24.55 7.56 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.804 -0.712 . . . . 0.53 113.584 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.947 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.07 -120.27 2.07 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.9 -1.143 . . . . 0.6 112.094 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -157.63 63.38 0.47 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.824 1.297 . . . . 1.91 112.268 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.901 HG21 HG23 ' A' ' 112' ' ' VAL . 56.6 m -160.19 126.13 4.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.195 -1.366 . . . . 0.37 109.992 173.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.979 HD13 ' HG2' ' A' ' 139' ' ' GLU . 30.7 mm -74.47 104.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.539 -0.911 . . . . 0.63 108.539 172.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.692 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.8 m-85 -90.75 105.08 17.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.119 -0.946 . . . . 0.5 111.381 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.85 139.75 30.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.306 -0.861 . . . . 0.68 109.786 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.555 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 mptt -114.93 102.67 10.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.18 -0.674 . . . . 1.44 109.18 176.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.792 ' HG ' ' O ' ' A' ' 114' ' ' ILE . 3.6 pp -125.61 -174.02 2.97 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.389 1.09 . . . . 0.84 111.805 -172.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 150' ' ' LEU . 1.5 p -152.16 92.31 1.7 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.1 -1.409 . . . . 1.77 108.465 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -16.06 63.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.13 0.49 . . . . 0.41 109.867 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -55.99 13.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.32 -0.855 . . . . 2.3 110.847 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -84.79 -9.03 58.57 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.95 -0.7 . . . . 0.7 112.387 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HD3' HD12 ' A' ' 158' ' ' LEU . 19.2 mmtp 71.53 42.79 0.64 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.669 0.606 . . . . 1.36 110.966 175.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 -70.72 0.76 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 122.344 1.068 . . . . 2.48 110.318 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.759 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.38 -4.82 46.41 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.269 -1.332 . . . . 0.29 113.967 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.584 HD12 ' HD3' ' A' ' 155' ' ' LYS . 22.5 mt -70.26 -36.74 74.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.155 -0.683 . . . . 0.8 109.155 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -38.89 79.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.144 -0.935 . . . . 2.2 109.035 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.2 t60 -71.48 -14.74 62.23 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.534 -0.757 . . . . 0.58 111.437 177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.89 -55.75 5.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.335 -0.617 . . . . 1.16 109.335 -177.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.92 -26.71 68.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.508 -0.769 . . . . 1.51 111.383 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 15.7 pt-20 -76.41 -30.73 57.56 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.403 -0.519 . . . . 2.57 110.79 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 29.6 mmt -73.23 -39.13 65.74 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.315 0.578 . . . . 0.64 109.507 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 83' ' ' ILE . 83.3 mt -61.83 -42.41 94.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 0.52 109.531 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -37.64 86.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.567 -0.742 . . . . 1.73 111.185 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.3 tp -53.37 -45.08 69.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.533 0.682 . . . . 1.51 109.353 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.8 t . . . . . 0 N--CA 1.445 -0.697 0 CA-C-N 114.939 -1.028 . . . . 0.89 110.646 175.667 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 112.029 -0.428 . . . . 11.58 112.029 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m -81.65 64.19 6.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.295 0.569 . . . . 10.61 111.092 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -126.77 27.84 5.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.973 0.892 . . . . 10.14 109.001 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.8 ptp -154.42 136.7 14.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.503 -1.226 . . . . 8.77 109.513 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.55 -23.17 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.93 0.395 . . . . 5.74 110.784 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -92.29 119.42 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.429 -0.582 . . . . 5.7 109.429 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -118.13 91.94 41.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 111.865 0.32 . . . . 6.85 111.865 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 1.9 Cg_endo -85.37 108.96 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.806 2.338 . . . . 2.8 110.735 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 8' ' ' PRO . 18.0 Cg_endo -60.93 128.31 25.06 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.491 2.128 . . . . 2.76 111.82 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.7 m -86.98 79.92 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.699 0.762 . . . . 2.0 110.718 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 47.9 t -72.99 84.4 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.295 -0.866 . . . . 1.35 109.713 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 68' ' ' PHE . 22.9 m -62.2 127.09 29.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.6 -0.727 . . . . 0.64 110.512 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -92.56 129.93 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 108.763 -0.828 . . . . 1.3 108.763 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.532 ' CE ' ' HB3' ' A' ' 68' ' ' PHE . 44.9 mtm -143.82 -171.58 3.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.783 -0.644 . . . . 0.79 109.716 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.469 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 129.96 -158.57 22.36 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.617 -0.993 . . . . 0.31 110.617 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.649 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 50.2 t60 -91.04 157.12 17.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.851 0.834 . . . . 0.22 111.189 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 6.4 p -73.5 154.56 7.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.366 -1.288 . . . . 0.36 109.9 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.588 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 20.3 t70 74.84 -18.94 0.41 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.295 0.569 . . . . 0.69 110.559 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.535 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 15.1 m170 -83.01 -4.86 58.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.515 -0.921 . . . . 0.63 108.515 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.7 ' HA3' HD13 ' A' ' 24' ' ' LEU . . . 111.01 47.34 0.77 Allowed Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.391 -0.909 . . . . 0.79 114.062 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -50.61 -66.58 0.36 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.366 0.583 . . . . 3.31 111.691 175.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -94.15 -30.71 14.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.202 -0.454 . . . . 1.21 111.233 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.0 -27.46 63.52 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.724 0.639 . . . . 1.25 112.724 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.7 HD13 ' HA3' ' A' ' 20' ' ' GLY . 5.5 mp -78.61 -25.31 45.15 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.95 -0.3 . . . . 1.49 110.956 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.64 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -74.9 -17.1 60.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.936 -0.764 . . . . 1.69 108.936 175.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.08 -45.71 8.53 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.052 0.929 . . . . 1.23 108.805 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 24' ' ' LEU . . . -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.719 -1.582 . . . . 0.63 110.475 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 tt -72.09 -30.96 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.91 -1.041 . . . . 1.02 110.974 -177.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 29' ' ' ARG . 45.8 mtp180 -77.98 -38.85 44.15 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.655 0.741 . . . . 3.04 109.396 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.02 26.81 1.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.137 0.97 . . . . 2.65 110.826 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.6 t -114.32 -35.7 4.89 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.563 -1.653 . . . . 1.46 109.031 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? 176.05 -158.76 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 115.777 -0.647 . . . . 3.92 110.225 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.683 HG13 ' H ' ' A' ' 34' ' ' THR . 7.7 p 49.9 -80.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.401 1.481 . . . . 3.1 114.078 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.683 ' H ' HG13 ' A' ' 33' ' ' VAL . 22.7 p -105.35 129.2 53.73 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.552 0.575 . . . . 2.78 112.552 -171.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HG3' ' H ' ' A' ' 36' ' ' GLN . 1.4 pt-20 -123.2 -49.86 1.93 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.633 -0.712 . . . . 6.34 110.405 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.541 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 11.0 pt20 -109.9 -7.67 14.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.714 -0.675 . . . . 6.79 110.088 -177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -66.08 131.06 45.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.462 -0.79 . . . . 6.24 110.475 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.21 72.85 9.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.57 -0.741 . . . . 4.95 110.784 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.04 159.37 29.94 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.133 -0.939 . . . . 4.68 111.097 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.36 -72.37 2.76 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.502 -0.856 . . . . 4.55 112.298 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 25' ' ' LEU . 47.1 mm -126.11 100.54 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.776 0.322 . . . . 5.57 110.311 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.6 m -156.96 -83.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.11 -0.495 . . . . 5.93 110.065 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 178.49 -58.94 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.595 -0.52 . . . . 6.63 109.595 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -68.89 109.85 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.55 . . . . 6.54 109.626 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.7 mm 68.88 154.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.167 -0.924 . . . . 5.17 110.532 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.13 150.18 17.56 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.385 -0.686 . . . . 2.51 111.385 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HA ' HD11 ' A' ' 25' ' ' LEU . . . 64.88 -172.56 0.18 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.274 0.229 . . . . 1.36 110.987 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.454 ' CZ ' HG22 ' A' ' 50' ' ' VAL . 1.9 p90 -174.2 174.74 2.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.164 0.507 . . . . 1.7 110.904 -174.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.512 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 78.0 mt-30 -95.57 111.74 23.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.287 -0.869 . . . . 1.91 109.715 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.613 HG13 HG11 ' A' ' 33' ' ' VAL . 3.8 t -82.17 140.9 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.311 0.577 . . . . 1.53 111.145 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.516 ' HA ' ' H ' ' A' ' 55' ' ' LYS . 23.2 m -93.39 84.26 4.71 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.772 -0.649 . . . . 1.51 110.744 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.648 HG23 HD13 ' A' ' 162' ' ' LEU . 14.5 p -99.76 -28.43 3.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 122.531 1.158 . . . . 2.27 107.991 171.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 56' ' ' LYS . 1.9 p30 -125.72 -59.94 1.33 Allowed 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 113.124 -1.853 . . . . 3.68 109.082 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 11.3 p-10 -171.27 43.04 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.459 -1.246 . . . . 2.99 110.139 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 54.6 mtmt 74.01 17.27 3.46 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.171 -0.922 . . . . 7.36 111.695 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.419 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . 88.2 tttt -86.56 76.36 9.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.469 0.652 . . . . 4.46 109.72 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.574 HG21 HG21 ' A' ' 165' ' ' ILE . 0.9 OUTLIER 175.61 93.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 C-N-CA 125.474 1.51 . . . . 0.92 108.95 171.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.512 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 8.0 m -90.85 95.93 10.38 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.158 -0.682 . . . . 0.96 109.158 177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.517 ' HE1' HD12 ' A' ' 57' ' ' ILE . 10.4 m-85 -59.23 150.49 25.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.698 -0.683 . . . . 1.57 111.297 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.426 ' CA ' ' HA ' ' A' ' 12' ' ' THR . 28.6 tp 72.11 -91.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.136 -0.938 . . . . 3.21 111.006 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' OD2' ' HG ' ' A' ' 60' ' ' LEU . 3.8 p30 -170.45 165.82 8.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.21 0.529 . . . . 5.61 111.058 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.2 t -129.52 136.0 28.43 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.251 -0.886 . . . . 5.45 108.63 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.34 106.41 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.035 2.49 . . . . 6.11 112.617 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.57 -22.76 7.28 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.755 -0.736 . . . . 6.36 112.118 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.5 63.23 1.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.049 0.452 . . . . 8.78 110.559 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -88.8 125.57 34.96 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.169 -0.678 . . . . 7.05 109.169 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.43 -65.0 1.08 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.24 0.543 . . . . 4.55 111.647 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.612 ' CE2' ' HB ' ' A' ' 82' ' ' VAL . 93.3 m-85 -99.53 -12.42 20.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.216 -0.447 . . . . 2.37 111.932 -175.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.7 m -74.52 -52.14 12.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.312 0.577 . . . . 4.9 110.076 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.1 m -156.01 140.11 16.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.999 -0.741 . . . . 5.84 108.999 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.443 ' HB3' ' HA ' ' A' ' 74' ' ' ARG . 61.3 mtt -105.77 97.49 7.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.899 0.381 . . . . 5.21 110.693 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -62.86 -56.99 12.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.814 -0.63 . . . . 8.21 110.602 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.38 13.25 11.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.445 -0.343 . . . . 6.36 110.797 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 74' ' ' ARG . 28.4 ttm180 70.17 -56.09 0.59 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.631 -0.713 . . . . 9.65 111.749 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.86 55.34 4.23 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.51 -0.376 . . . . 4.93 113.6 -174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.78 -1.31 43.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.627 0.727 . . . . 5.47 109.425 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -87.38 128.5 35.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.557 -1.202 . . . . 6.26 110.766 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.37 -48.95 5.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.132 0.491 . . . . 4.31 109.992 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.04 39.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.494 -0.928 . . . . 3.41 108.494 175.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.23 166.04 20.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.694 -1.139 . . . . 2.66 111.087 -171.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 50.2 mt -129.82 149.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.756 -0.656 . . . . 0.71 109.592 -173.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.612 ' HB ' ' CE2' ' A' ' 68' ' ' PHE . 9.5 p -116.87 136.47 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 119.957 -0.697 . . . . 1.17 110.618 174.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 13.0 mt -96.64 128.8 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.501 -0.772 . . . . 0.37 109.98 173.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 84' ' ' LEU . 2.2 tm? -114.54 109.77 18.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.956 -1.127 . . . . 1.01 107.956 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.07 118.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.333 -0.394 . . . . 0.43 111.051 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.7 m -128.24 120.62 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.698 -0.683 . . . . 0.64 110.3 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -64.73 131.81 47.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.719 -0.673 . . . . 0.28 110.262 176.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -67.65 -18.09 64.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.084 0.469 . . . . 0.22 110.751 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -90.13 -14.65 33.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.392 -0.822 . . . . 0.58 111.316 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.481 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.5 t0 -123.63 -47.48 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.56 110.75 -170.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.616 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.82 -151.14 27.3 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.37 113.098 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.653 HG11 ' HE2' ' A' ' 134' ' ' TYR . 21.5 t -77.96 129.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.828 0.823 . . . . 1.03 111.025 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.936 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.2 mmm -130.94 179.89 1.23 Allowed Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 114.265 -1.334 . . . . 0.28 108.615 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.936 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.11 -66.01 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.284 2.656 . . . . 0.58 114.564 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.473 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.5 pt20 -73.23 -15.27 61.44 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.287 0.565 . . . . 0.75 110.94 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.0 -43.83 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 0.31 109.007 176.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.57 HG12 ' ND2' ' A' ' 101' ' ' ASN . 30.1 t -66.15 -42.59 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.255 -0.884 . . . . 1.38 111.302 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.28 -29.01 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.239 -0.437 . . . . 2.35 110.098 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -72.43 -31.99 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.538 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.609 HG23 HD11 ' A' ' 136' ' ' LEU . 96.5 mt -75.4 -44.89 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.796 0.808 . . . . 0.41 109.147 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.57 ' ND2' HG12 ' A' ' 97' ' ' VAL . 53.0 m-20 -57.1 -37.42 71.92 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.041 -1.436 . . . . 0.67 110.944 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.42 ' NE2' ' HA ' ' A' ' 68' ' ' PHE . 5.7 t60 -71.5 -37.91 71.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.274 0.559 . . . . 2.5 109.795 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -44.31 68.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.785 -0.643 . . . . 0.47 111.824 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.64 ' HD3' HD21 ' A' ' 136' ' ' LEU . 1.8 mmmp? -76.42 -28.9 56.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.051 0.453 . . . . 1.66 110.482 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.12 -44.56 61.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.174 -0.921 . . . . 0.77 110.268 173.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.14 -34.99 22.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.992 -0.549 . . . . 0.74 110.436 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.3 t30 83.87 40.82 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.843 1.257 . . . . 1.41 109.36 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.51 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 24.5 t -83.8 145.29 46.77 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 113.279 -1.782 . . . . 1.35 110.99 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 108' ' ' VAL . 21.8 Cg_exo -61.93 138.68 75.14 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.257 1.972 . . . . 0.47 111.436 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.0 OUTLIER -107.68 159.07 7.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 122.011 0.91 . . . . 0.6 112.226 -172.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.856 HD13 ' HB ' ' A' ' 146' ' ' ILE . 5.9 mm -126.02 87.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.538 -1.664 . . . . 0.37 106.858 172.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.473 HG23 HG21 ' A' ' 145' ' ' THR . 61.5 t -78.1 148.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.603 -0.726 . . . . 0.26 109.971 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 148' ' ' CYS . . . -140.12 110.19 6.51 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.569 -1.196 . . . . 0.29 110.679 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.762 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.2 mp -84.86 108.31 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.148 -1.387 . . . . 0.59 109.636 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.4 p-10 -99.45 178.02 5.0 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.626 -1.25 . . . . 1.85 107.626 -171.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.847 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 74.9 mttt 70.75 28.44 3.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.034 0.834 . . . . 0.59 110.123 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 85.5 mmm -81.54 -7.27 59.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.351 -0.981 . . . . 0.92 108.351 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.411 ' N ' ' HB3' ' A' ' 151' ' ' SER . 1.2 p-10 -68.41 -30.44 69.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.521 -1.672 . . . . 0.76 109.634 168.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -71.79 131.73 85.66 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.78 -0.645 . . . . 1.17 110.089 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.27 -15.09 47.67 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.391 2.061 . . . . 0.58 111.388 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -90.24 5.71 45.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.377 -0.829 . . . . 1.45 110.592 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.452 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -54.77 124.41 16.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.731 -0.668 . . . . 0.27 111.271 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.31 76.07 68.45 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.337 -0.986 . . . . 0.95 108.337 173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.75 ' HA ' HG21 ' A' ' 114' ' ' ILE . 39.4 Cg_endo -64.17 -62.03 0.1 Allowed 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 123.025 2.483 . . . . 0.4 113.305 -170.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 6.9 m-20 -61.63 -16.15 45.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.257 -0.883 . . . . 1.44 111.019 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -75.42 -58.39 3.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.598 0.713 . . . . 3.79 109.307 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.616 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 12.7 m -66.03 -29.48 46.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.595 -1.184 . . . . 0.59 110.194 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.537 ' HG3' ' CD2' ' A' ' 147' ' ' PHE . 15.4 ttt -59.99 -39.59 86.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.073 . . . . 0.81 110.793 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.597 ' O ' ' HG2' ' A' ' 132' ' ' MET . 45.0 mt-30 -69.14 -29.67 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 1.31 111.933 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.609 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 9.0 mt-10 -67.05 -29.07 68.77 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.587 . . . . 1.64 109.533 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.561 HD12 ' CD1' ' A' ' 136' ' ' LEU . 4.0 mm? -64.73 -44.5 89.99 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.641 -0.708 . . . . 1.36 110.071 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.597 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 14.7 ptm -70.57 -10.2 58.7 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.813 -0.755 . . . . 1.61 110.83 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 35.4 mt-10 -78.73 -28.3 44.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.05 -0.722 . . . . 1.67 109.05 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.653 ' HE2' HG11 ' A' ' 92' ' ' VAL . 71.3 m-85 -92.73 22.79 4.5 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.836 0.826 . . . . 1.08 109.659 167.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.0 t30 61.33 46.23 7.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 113.855 -1.52 . . . . 1.1 111.749 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.64 HD21 ' HD3' ' A' ' 104' ' ' LYS . 72.9 mt -113.67 93.6 4.46 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.36 109.732 171.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.036 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 44.5 t -102.74 122.87 44.43 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.199 -0.909 . . . . 0.43 110.635 -172.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.761 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 10.6 Cg_endo -60.0 157.52 33.67 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.211 2.608 . . . . 0.54 112.902 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.466 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.8 mm-40 -79.72 -12.1 59.81 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.127 -1.397 . . . . 3.08 110.574 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.761 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -69.89 -19.63 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.899 -0.591 . . . . 1.57 109.888 167.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.521 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 45.1 m0 -110.6 -20.43 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.338 -0.392 . . . . 0.66 111.306 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.72 28.75 5.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.839 -0.696 . . . . 0.53 113.417 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 1.036 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.2 -106.8 1.95 Allowed Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.58 -0.819 . . . . 0.6 112.689 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -166.0 61.21 0.1 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 122.284 1.04 . . . . 1.91 110.419 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 98.8 m -164.06 133.93 4.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 0.37 110.579 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.856 ' HB ' HD13 ' A' ' 111' ' ' ILE . 28.0 mm -97.16 110.1 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 109.495 -0.557 . . . . 0.63 109.495 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.672 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 12.1 m-85 -90.05 150.51 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.5 110.295 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 91.1 m -131.25 127.0 36.92 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.663 -1.153 . . . . 0.68 109.747 171.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.1 88.13 5.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.056 -0.72 . . . . 1.44 109.056 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.077 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -115.98 170.12 8.73 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 122.685 1.231 . . . . 0.84 112.768 -170.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.411 ' HB3' ' N ' ' A' ' 118' ' ' ASP . 3.1 p -129.94 104.78 7.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.961 -1.126 . . . . 1.77 107.961 172.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.41 -9.9 59.05 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 120.377 -0.529 . . . . 0.41 109.762 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.817 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 3.2 mtmt -82.54 -46.39 13.44 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.128 -0.629 . . . . 2.3 112.119 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 p -86.39 -3.39 58.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 119.188 -1.005 . . . . 0.7 111.363 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 25.8 mmtp 64.89 45.59 3.18 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.287 -0.87 . . . . 1.36 110.705 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.51 -58.34 1.97 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.65 -1.159 . . . . 2.48 110.062 -175.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 1.077 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -79.76 -10.65 85.5 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.296 -0.865 . . . . 0.29 113.847 -173.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.6 -36.8 83.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.857 0.829 . . . . 0.8 109.043 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 1.6 m-20 -69.84 -42.12 74.01 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.695 -1.139 . . . . 2.2 110.182 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.83 -21.26 64.31 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.499 -0.319 . . . . 0.58 111.154 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -74.13 -51.15 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.659 -0.496 . . . . 1.16 109.659 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.648 HD13 HG23 ' A' ' 52' ' ' VAL . 4.2 pp -60.79 -27.51 68.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.795 -0.639 . . . . 1.51 110.711 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.608 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 42.0 mt-10 -64.63 -48.04 76.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.4 -0.364 . . . . 2.57 110.812 174.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -63.8 -35.63 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.32 -0.4 . . . . 0.64 110.27 176.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.574 HG21 HG21 ' A' ' 57' ' ' ILE . 73.4 mt -62.01 -48.57 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.52 110.829 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 163' ' ' GLU . 4.5 pp -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 121.007 -0.277 . . . . 1.73 110.965 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 166' ' ' LEU . 4.8 tt -54.38 -50.53 67.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.927 -0.768 . . . . 1.51 108.927 172.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.62 ' HA ' ' HG2' ' A' ' 171' ' ' MET . 65.1 t -65.38 -40.17 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.883 -0.599 . . . . 0.89 110.777 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m -60.64 -32.21 71.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.831 0.348 . . . . 1.35 111.445 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -80.16 -37.98 32.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.966 0.413 . . . . 2.73 110.871 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.969 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 21.0 ptt? -84.35 -7.93 59.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 1.88 111.004 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -35.63 -39.84 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.943 1.297 . . . . 4.27 114.127 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.89 -72.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.258 0.466 . . . . 3.91 112.258 -173.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.35 -19.58 3.09 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.714 -0.394 . . . . 5.72 111.928 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.969 ' HB2' ' HB2' ' A' ' 171' ' ' MET . 25.7 mmtp -70.17 126.45 29.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.657 0.741 . . . . 5.49 112.352 -171.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -161.01 -49.12 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.489 -1.232 . . . . 5.78 107.917 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.521 ' H ' ' HD2' ' A' ' 178' ' ' PRO . 5.7 m-20 -93.02 -55.33 0.24 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.041 -0.982 . . . . 7.88 110.43 171.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 177' ' ' ASN . 40.5 Cg_endo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.03 1.82 . . . . 9.19 111.845 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.847 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.761 -0.536 . . . . 11.58 111.761 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -70.97 121.08 17.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.991 0.424 . . . . 10.61 111.687 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -132.59 145.43 51.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.49 . . . . 10.14 110.151 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 97.5 mmm -88.26 117.85 27.46 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.469 -0.567 . . . . 8.77 109.469 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.7 t 70.48 91.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.229 0 O-C-N 123.784 0.677 . . . . 5.74 111.301 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 50.9 mt-10 -70.75 117.13 11.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.134 -0.691 . . . . 5.7 109.134 170.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 28.6 tpt180 -89.25 111.3 44.45 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.937 -0.394 . . . . 6.85 109.937 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 56.4 Cg_endo -99.79 90.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.527 2.818 . . . . 2.8 112.289 177.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.55 123.35 10.08 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.079 1.853 . . . . 2.76 111.839 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 m -77.67 70.61 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.546 0.689 . . . . 2.0 110.725 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 83.7 t -62.8 95.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.218 -0.901 . . . . 1.35 110.826 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.743 ' HB ' HG23 ' A' ' 82' ' ' VAL . 7.5 m -76.01 145.76 40.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.701 -0.681 . . . . 0.64 110.488 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.467 HD13 ' HB ' ' A' ' 83' ' ' ILE . 46.0 mm -105.06 113.61 42.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 1.3 109.978 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.587 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 67.3 mtt -127.18 172.81 10.23 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.944 -0.571 . . . . 0.79 109.877 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 148.57 -172.95 28.68 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.666 -0.778 . . . . 0.31 112.136 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.637 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 49.1 t60 -88.88 159.66 17.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.856 0.836 . . . . 0.22 111.106 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.566 ' HA ' ' O2B' ' A' ' 179' ' ' GDP . 7.7 p -69.85 143.98 14.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.656 -1.157 . . . . 0.36 110.258 174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.591 ' HA ' " C4'" ' A' ' 179' ' ' GDP . 30.6 t70 75.93 -18.24 0.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.384 0.612 . . . . 0.69 110.36 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.468 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 17.0 m170 -85.05 -10.73 56.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.278 -1.008 . . . . 0.63 108.278 170.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.87 48.46 1.08 Allowed Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.191 -0.913 . . . . 0.79 113.369 174.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -60.83 -53.33 58.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.108 0.454 . . . . 3.31 110.909 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.5 m -98.85 -34.72 10.37 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.374 0.607 . . . . 1.21 110.442 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.589 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.66 -21.01 24.44 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.114 0.783 . . . . 1.25 113.114 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -75.64 -34.37 60.53 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.294 -1.002 . . . . 1.49 108.294 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.618 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 7.0 tp -67.26 -23.79 65.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.322 -0.854 . . . . 1.69 109.785 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -92.54 -39.4 11.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.776 0.798 . . . . 1.23 109.681 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.29 80.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.56 -1.2 . . . . 0.63 109.738 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.3 tt -71.58 -22.27 21.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.849 -1.069 . . . . 1.02 110.394 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 73.5 mtt180 -73.0 -19.75 61.15 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 121.492 0.663 . . . . 3.04 109.862 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -107.01 23.95 13.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.671 -0.695 . . . . 2.65 111.231 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.518 ' OG ' ' HD2' ' A' ' 32' ' ' LYS . 99.2 p -104.67 -35.89 7.65 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.653 -1.158 . . . . 1.46 109.332 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HD2' ' OG ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -175.39 -168.15 0.3 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.573 -0.74 . . . . 3.92 109.96 176.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 34' ' ' THR . 10.4 p 55.84 -66.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.517 1.527 . . . . 3.1 113.549 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 33' ' ' VAL . 3.1 t -107.21 169.0 8.83 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.874 0.369 . . . . 2.78 110.549 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.12 -44.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.887 -0.597 . . . . 6.34 109.959 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -123.03 -46.98 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.61 -0.723 . . . . 6.79 110.277 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -81.6 135.01 35.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.66 -0.7 . . . . 6.24 110.772 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.88 89.88 5.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.142 0.496 . . . . 4.95 110.635 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.59 53.68 4.88 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.735 -0.666 . . . . 4.68 112.384 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.95 47.97 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.974 -0.631 . . . . 4.55 111.803 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 tp -127.63 108.2 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.858 0.837 . . . . 5.57 110.551 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 43' ' ' GLN . 1.1 m -154.36 -154.6 0.52 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.298 -1.001 . . . . 5.93 108.298 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.628 ' H ' HG22 ' A' ' 42' ' ' THR . 50.8 tp60 -76.29 66.8 2.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.781 0.801 . . . . 6.63 110.316 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.417 ' CD2' ' HB ' ' A' ' 42' ' ' THR . 32.4 p80 -170.84 162.68 7.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.217 -0.901 . . . . 6.54 109.894 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.1 tt -61.95 159.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 5.17 110.297 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.02 24.35 0.84 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 115.813 -0.631 . . . . 2.51 114.462 -171.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -83.05 153.16 25.05 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.442 -0.577 . . . . 1.36 109.442 174.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.24 178.88 7.83 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 119.686 -0.806 . . . . 1.7 112.373 -163.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.494 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 54.3 mt-30 -106.9 113.61 27.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.262 -0.881 . . . . 1.91 110.014 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.65 150.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.32 0.581 . . . . 1.53 111.433 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 m -97.43 81.63 3.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.56 0.695 . . . . 1.51 109.456 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 p -86.32 -32.63 6.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.972 -1.013 . . . . 2.27 108.383 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -140.8 -46.43 0.4 Allowed 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 113.601 -1.636 . . . . 3.68 108.762 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -178.04 77.49 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.124 -0.944 . . . . 2.99 110.536 177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 55' ' ' LYS . 22.9 mtpp 57.65 35.81 26.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.135 -0.484 . . . . 7.36 111.526 175.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -102.93 153.9 19.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.593 -0.521 . . . . 4.46 109.593 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mt 72.48 89.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.629 0.728 . . . . 0.92 110.725 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.494 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 20.2 m -90.73 101.87 14.62 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.177 -0.919 . . . . 0.96 109.694 176.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.61 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 82.0 m-85 -72.21 106.45 4.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 1.57 110.22 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.3 tp 71.27 124.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 O-C-N 124.321 1.013 . . . . 3.21 110.76 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -95.02 159.47 15.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.272 0.558 . . . . 5.61 110.548 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.531 ' HB ' ' HD3' ' A' ' 63' ' ' PRO . 87.8 m -75.8 -46.71 4.0 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.392 -0.822 . . . . 5.45 112.728 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.531 ' HD3' ' HB ' ' A' ' 62' ' ' THR . 50.4 Cg_exo -55.38 -20.0 24.27 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.267 1.978 . . . . 6.11 112.711 176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 69' ' ' THR . . . -72.2 76.16 0.76 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 116.515 -0.311 . . . . 6.36 113.106 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -83.29 53.86 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.024 -0.732 . . . . 8.78 109.024 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.571 ' HG3' ' H ' ' A' ' 67' ' ' ALA . 11.0 tp10 -173.93 -170.98 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.196 -1.409 . . . . 7.05 107.196 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.571 ' H ' ' HG3' ' A' ' 66' ' ' GLU . . . -57.29 -57.43 12.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.325 0.512 . . . . 4.55 110.318 174.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.481 ' HB2' ' CD2' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -97.02 -172.89 2.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.093 -0.503 . . . . 2.37 109.736 172.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.59 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 6.4 m -55.57 149.12 14.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.544 -0.539 . . . . 4.9 109.544 170.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.52 -50.13 17.59 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 111.598 0.222 . . . . 5.84 111.598 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.7 ttm 56.48 67.09 1.04 Allowed 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.541 0.526 . . . . 5.21 110.865 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -68.54 -46.97 68.1 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.984 -0.553 . . . . 8.21 110.382 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.45 -47.45 0.76 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.889 0.376 . . . . 6.36 111.399 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -147.55 130.34 16.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.844 -0.616 . . . . 9.65 109.83 -175.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.45 -72.48 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.962 -1.113 . . . . 4.93 113.834 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.447 ' HB1' ' CG ' ' A' ' 80' ' ' ASP . . . -144.22 153.55 42.19 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.702 0.26 . . . . 5.47 111.702 -170.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -178.98 -53.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.438 0.461 . . . . 6.26 111.999 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.732 HG13 ' H ' ' A' ' 79' ' ' THR . 3.3 p -56.83 -72.07 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 113.375 0.88 . . . . 4.31 113.375 -166.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.732 ' H ' HG13 ' A' ' 78' ' ' VAL . 66.5 p -114.77 19.19 16.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.784 0.802 . . . . 3.41 109.983 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.447 ' CG ' ' HB1' ' A' ' 76' ' ' ALA . 6.8 m-20 -83.35 95.41 8.2 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.886 -1.052 . . . . 2.66 108.92 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 55.4 mt -90.43 148.54 4.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.257 -0.883 . . . . 0.71 111.899 -168.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.743 HG23 ' HB ' ' A' ' 12' ' ' THR . 9.2 p -117.06 140.36 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.457 0.646 . . . . 1.17 110.392 173.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 165' ' ' ILE . 18.8 mt -95.25 131.11 42.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.201 -0.909 . . . . 0.37 109.904 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.444 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 1.9 tm? -117.53 107.88 14.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.204 -1.036 . . . . 1.01 108.204 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.454 HG21 ' HG ' ' A' ' 24' ' ' LEU . 57.4 t -89.81 116.48 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.993 -0.549 . . . . 0.43 111.23 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 3.7 m -122.38 137.26 56.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 0.64 110.793 175.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.687 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -75.43 133.95 41.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.939 -0.573 . . . . 0.28 110.011 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -76.81 -14.88 59.87 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 120.303 -0.559 . . . . 0.22 110.129 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -10.61 53.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.561 -0.745 . . . . 0.58 110.894 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.405 ' HB3' ' CE1' ' A' ' 19' ' ' HIS . 24.3 t0 -128.03 -69.33 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.56 110.284 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.6 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 121.19 -139.8 13.54 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.14 -0.553 . . . . 0.37 113.183 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.5 p -95.67 139.72 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.432 0.634 . . . . 1.03 109.43 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.635 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 72.2 mmm -140.14 178.05 1.76 Allowed Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.419 -0.81 . . . . 0.28 108.815 -170.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.635 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 82.9 Cg_exo -46.32 -64.69 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.885 2.39 . . . . 0.58 114.521 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.53 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 2.9 pt20 -70.56 -16.56 62.88 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 121.555 -0.715 . . . . 0.75 110.787 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.637 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.65 -49.7 51.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.747 -0.661 . . . . 0.31 109.603 178.152 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.612 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.7 p -74.74 -29.06 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.934 -0.575 . . . . 1.38 112.457 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -57.47 -30.18 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.276 0.56 . . . . 2.35 109.946 174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.587 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -71.14 -40.95 71.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.458 -0.792 . . . . 0.44 110.491 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 97' ' ' VAL . 76.9 mt -66.74 -44.31 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.821 0.819 . . . . 0.41 109.641 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -56.63 -42.21 78.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.074 -1.421 . . . . 0.67 110.842 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.481 ' CD2' ' HB2' ' A' ' 68' ' ' PHE . 5.0 t60 -71.23 -35.02 71.33 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.77 -0.455 . . . . 2.5 109.77 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.45 -52.56 38.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.97 -0.559 . . . . 0.47 111.533 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 29.7 mtpt -75.62 -22.78 56.55 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.675 -0.41 . . . . 1.66 110.908 -176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.21 72.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.551 -0.749 . . . . 0.77 110.539 171.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.57 -21.37 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.74 111.101 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.0 t30 82.32 61.43 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.282 0.989 . . . . 1.41 109.195 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 t -117.7 139.69 26.66 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 114.348 -1.296 . . . . 1.35 111.579 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -69.26 143.05 51.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.993 2.462 . . . . 0.47 111.362 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.505 ' C ' HG23 ' A' ' 145' ' ' THR . 1.3 mt -113.89 160.69 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 122.04 0.924 . . . . 0.6 112.375 -171.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.771 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 26.4 mm -129.94 86.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 113.816 -1.538 . . . . 0.37 106.89 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.789 HG23 HG21 ' A' ' 145' ' ' THR . 48.4 t -72.5 147.73 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 121.595 0.712 . . . . 0.26 109.159 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.94 105.48 4.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.646 -1.161 . . . . 0.29 110.48 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.811 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -73.99 134.08 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 114.163 -1.38 . . . . 0.59 108.97 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.687 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.7 p-10 -113.42 177.24 4.7 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.358 -1.349 . . . . 1.85 107.358 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.819 ' HD3' ' HE2' ' A' ' 119' ' ' LYS . 89.8 mttt 70.77 32.66 2.43 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 123.701 0.626 . . . . 0.59 111.907 176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.544 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 10.8 mmt -79.89 -10.89 59.83 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.896 -1.15 . . . . 0.92 107.896 166.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.578 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 0.7 OUTLIER -70.47 -20.17 62.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.181 -1.827 . . . . 0.76 109.711 169.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.819 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 23.6 mtmt -100.15 134.57 20.75 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-N 115.606 -0.725 . . . . 1.17 110.407 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -64.03 -14.63 44.59 Favored 'Trans proline' 0 N--CA 1.47 0.122 0 C-N-CA 123.074 2.516 . . . . 0.58 111.907 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -81.67 6.52 14.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.417 -0.81 . . . . 1.45 110.42 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.406 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -58.08 115.4 2.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.17 -0.923 . . . . 0.27 111.231 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.4 76.72 44.41 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.04 -1.096 . . . . 0.95 108.04 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.544 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 43.6 Cg_endo -66.13 -60.25 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 122.949 2.432 . . . . 0.4 113.176 -170.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.497 ' HA ' ' HG2' ' A' ' 128' ' ' MET . 1.5 m-20 -55.87 -21.34 19.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.315 -0.857 . . . . 1.44 110.91 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -78.07 -56.83 4.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.475 0.655 . . . . 3.79 109.663 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 88' ' ' ALA . 22.6 m -66.66 -24.88 33.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.874 -1.057 . . . . 0.59 111.675 -176.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.75 ' HA ' ' HB2' ' A' ' 131' ' ' LEU . 18.8 ptm -87.86 -13.88 40.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.914 -0.315 . . . . 0.81 110.549 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.0 mt-30 -75.87 -47.9 23.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.685 0.279 . . . . 1.31 110.423 172.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.18 -18.3 64.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.445 0.641 . . . . 1.64 109.572 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.904 HD23 ' HE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -65.62 -43.36 89.78 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.084 -0.962 . . . . 1.36 109.012 172.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.857 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.8 ppp? -80.52 -7.5 59.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.965 -0.561 . . . . 1.61 110.55 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 45.8 mt-10 -78.59 -24.15 45.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.764 -0.828 . . . . 1.67 108.764 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.407 ' HD1' ' N ' ' A' ' 134' ' ' TYR . 1.8 m-85 -91.58 18.82 6.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.645 -1.161 . . . . 1.08 108.478 169.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 56.69 56.94 5.1 Favored 'General case' 0 CA--C 1.526 0.048 0 CA-C-N 113.716 -1.583 . . . . 1.1 111.463 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.777 ' H ' ' HA ' ' A' ' 132' ' ' MET . 70.8 mt -123.02 105.58 10.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.825 -1.08 . . . . 1.36 109.365 170.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.805 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.4 t -108.17 114.11 59.95 Favored Pre-proline 0 C--N 1.31 -1.132 0 C-N-CA 119.89 -0.724 . . . . 0.43 111.125 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.996 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 1.2 Cg_endo -54.45 160.59 6.68 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 123.587 2.858 . . . . 0.54 112.97 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.566 ' HB2' HD13 ' A' ' 146' ' ' ILE . 20.6 mm-40 -78.16 -17.29 57.03 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.02 -1.445 . . . . 3.08 109.697 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.996 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 2.0 pm0 -69.35 -24.48 63.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.118 -0.946 . . . . 1.57 110.256 169.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.857 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 30.7 m0 -105.99 -10.1 16.74 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.916 0.388 . . . . 0.66 110.274 -177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.16 33.83 10.34 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.896 -0.593 . . . . 0.53 113.455 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.805 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -91.31 -108.8 1.53 Allowed Glycine 0 CA--C 1.509 -0.317 0 C-N-CA 120.086 -1.054 . . . . 0.6 111.418 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -163.82 61.4 0.16 Allowed 'General case' 0 C--O 1.248 1.015 0 CA-C-O 123.497 1.618 . . . . 1.91 110.457 170.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.789 HG21 HG23 ' A' ' 112' ' ' VAL . 58.1 m -162.67 114.97 1.62 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.745 -1.571 . . . . 0.37 110.224 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.771 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 12.7 mm -68.12 106.16 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.032 -0.729 . . . . 0.63 109.032 172.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.904 ' HE2' HD23 ' A' ' 131' ' ' LEU . 7.9 m-85 -87.99 107.6 18.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.717 -0.674 . . . . 0.5 110.08 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.29 112.13 24.08 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.246 -0.434 . . . . 0.68 110.526 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.811 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 81.9 mttt -83.96 96.34 8.81 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.699 -0.852 . . . . 1.44 108.699 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.797 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.8 pp -122.33 -173.38 2.66 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.614 1.197 . . . . 0.84 111.974 -173.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 0.7 OUTLIER -154.0 93.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.498 -1.683 . . . . 1.77 107.626 -176.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.14 60.76 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.645 -0.422 . . . . 0.41 110.429 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 40.9 mttm -78.48 -48.17 15.89 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.311 -0.556 . . . . 2.3 111.541 172.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 p -84.75 -7.11 59.33 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.669 -0.812 . . . . 0.7 111.516 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.426 ' CD ' HD12 ' A' ' 158' ' ' LEU . 39.0 mmtm 66.79 42.54 2.58 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.396 -0.82 . . . . 1.36 111.548 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -102.31 -67.42 0.87 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.346 1.07 . . . . 2.48 109.911 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.797 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -70.06 -8.31 61.27 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.015 -1.448 . . . . 0.29 113.757 -174.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.426 HD12 ' CD ' ' A' ' 155' ' ' LYS . 26.6 mt -69.17 -37.96 78.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.98 0.89 . . . . 0.8 109.578 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.613 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 25.0 t70 -72.65 -39.31 67.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.657 -0.701 . . . . 2.2 109.596 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.47 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 86.6 t60 -69.28 -20.34 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.24 -0.436 . . . . 0.58 110.884 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.463 HD21 HD13 ' A' ' 83' ' ' ILE . 53.2 tp -67.18 -53.71 27.9 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.322 -0.621 . . . . 1.16 109.322 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.73 -26.97 67.98 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.043 -0.98 . . . . 1.51 110.72 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 49.8 mt-10 -58.74 -47.51 84.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.259 0.552 . . . . 2.57 110.202 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.651 ' HB3' HG21 ' A' ' 146' ' ' ILE . 19.5 mmt -71.9 -34.43 69.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.846 -0.616 . . . . 0.64 110.32 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 83' ' ' ILE . 84.5 mt -65.24 -46.13 91.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 0.52 110.995 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.627 ' HA ' ' OG ' ' A' ' 169' ' ' SER . 4.3 pp -67.47 -33.01 74.23 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.811 -0.356 . . . . 1.73 111.011 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 166' ' ' LEU . 2.3 tm? -52.99 -48.24 67.64 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.954 -0.758 . . . . 1.51 108.954 170.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.63 HG11 HD11 ' A' ' 81' ' ' ILE . 67.7 t -65.7 -45.6 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.581 -0.736 . . . . 0.89 111.256 177.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' A' ' 166' ' ' LEU . 64.8 p -63.39 -26.59 68.82 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.676 -0.41 . . . . 1.35 111.202 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -83.68 -25.26 30.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.517 0.675 . . . . 2.73 109.664 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.648 ' HG3' ' HB2' ' A' ' 175' ' ' LYS . 56.8 ttp -69.69 -34.94 74.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.461 -0.791 . . . . 1.88 110.043 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.67 -26.82 35.72 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.355 -0.384 . . . . 4.27 111.749 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.483 ' HG2' ' HG ' ' A' ' 174' ' ' LEU . 3.4 tt0 -59.83 -77.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 3.91 111.758 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.483 ' HG ' ' HG2' ' A' ' 173' ' ' GLU . 92.4 mt -130.95 -10.07 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.571 -0.286 . . . . 5.72 111.361 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.648 ' HB2' ' HG3' ' A' ' 171' ' ' MET . 27.2 mmtm -85.48 -26.06 26.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.943 0.401 . . . . 5.49 111.497 -170.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.411 ' HB2' ' HG2' ' A' ' 171' ' ' MET . . . -76.48 141.5 41.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.097 0.475 . . . . 5.78 112.006 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -116.63 104.19 51.68 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.5 -0.773 . . . . 7.88 109.057 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.962 2.441 . . . . 9.19 112.135 -177.128 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.715 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.406 -0.277 . . . . 11.58 112.406 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m 59.79 62.48 1.69 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.501 0.32 . . . . 10.61 110.876 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -77.42 51.76 0.9 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.526 0.679 . . . . 10.14 111.451 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.2 tpp -129.98 -56.26 1.12 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.283 -0.871 . . . . 8.77 109.147 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.91 97.69 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.692 -0.685 . . . . 5.74 110.009 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -65.01 133.31 51.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.146 -0.479 . . . . 5.7 110.935 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 58.38 80.73 0.27 Allowed Pre-proline 0 C--O 1.235 0.33 0 O-C-N 123.922 0.764 . . . . 6.85 111.124 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HB2' HG12 ' A' ' 10' ' ' VAL . 14.3 Cg_exo -69.0 117.86 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.615 2.21 . . . . 2.8 111.803 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.75 60.23 6.61 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.713 2.275 . . . . 2.76 111.665 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG11 ' CE1' ' A' ' 65' ' ' HIS . 6.7 p -128.19 137.12 58.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.586 . . . . 2.0 110.702 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 74.4 t -137.97 104.09 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.969 -0.56 . . . . 1.35 110.327 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.815 ' HB ' HG22 ' A' ' 82' ' ' VAL . 3.0 m -61.93 140.66 58.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.336 . . . . 0.64 110.499 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 tt -112.89 138.14 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.177 0.513 . . . . 1.3 110.592 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.503 ' CE ' ' HB3' ' A' ' 68' ' ' PHE . 63.0 mtt -147.05 173.04 12.83 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.561 -0.745 . . . . 0.79 109.28 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 84' ' ' LEU . . . 150.1 -175.99 28.94 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.711 -0.757 . . . . 0.31 112.108 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.586 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 49.5 t60 -86.6 162.15 18.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.997 0.903 . . . . 0.22 111.563 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.52 150.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.275 -1.329 . . . . 0.36 110.172 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.721 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 21.3 t70 74.44 -14.98 0.66 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.476 0.655 . . . . 0.69 109.902 -175.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.542 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 13.6 m170 -87.57 9.0 22.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.95 -1.13 . . . . 0.63 107.95 168.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.497 ' HA2' ' O2A' ' A' ' 179' ' ' GDP . . . 76.05 54.4 5.28 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 114.801 -1.09 . . . . 0.79 113.899 172.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 7.82 7.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.035 0.917 . . . . 3.31 111.453 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.5 m -129.64 -50.64 1.16 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.974 -0.557 . . . . 1.21 110.011 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.9 m -57.52 -24.75 57.8 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.077 -0.51 . . . . 1.25 111.315 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.3 mp -70.43 -35.34 73.32 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 111.98 0.363 . . . . 1.49 111.98 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.959 ' HB2' ' HE2' ' A' ' 48' ' ' TYR . 2.5 pp -74.61 -17.74 60.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.61 -0.836 . . . . 1.69 109.909 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 29.5 t70 -85.55 -42.93 13.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.144 0.973 . . . . 1.23 109.217 174.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 31' ' ' SER . . . -64.52 -38.29 90.5 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.7 -1.591 . . . . 0.63 110.588 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 6.9 tt -73.33 -31.4 33.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.151 -0.931 . . . . 1.02 111.139 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 19.6 ptt180 -81.72 -31.04 32.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.8 0.81 . . . . 3.04 109.986 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -96.0 20.49 10.0 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.853 -1.067 . . . . 2.65 111.405 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 37.3 t -105.2 -18.34 14.17 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.782 -1.099 . . . . 1.46 110.9 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.647 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -167.58 -166.5 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.896 0.379 . . . . 3.92 111.385 -177.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.2 t -75.04 131.16 35.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.466 0.651 . . . . 3.1 111.858 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.84 142.52 17.67 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.281 -0.872 . . . . 2.78 110.353 169.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -105.92 -35.79 7.19 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.984 -1.007 . . . . 6.34 109.965 -176.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 22.2 tp60 -94.44 63.43 2.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.63 0.729 . . . . 6.79 109.567 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.427 ' CG ' ' HD2' ' A' ' 29' ' ' ARG . 29.2 tt0 -88.6 131.39 34.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.134 -0.939 . . . . 6.24 110.829 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.6 179.78 6.21 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.532 -0.544 . . . . 4.95 109.532 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' ILE . . . 174.65 -130.13 1.72 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.56 -0.829 . . . . 4.68 112.011 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 45' ' ' ILE . . . -97.5 71.97 0.69 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.831 -0.699 . . . . 4.55 112.421 -176.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.2 mt -94.94 128.0 46.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.743 0.306 . . . . 5.57 110.855 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.5 m 70.58 -63.99 0.39 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.354 -0.839 . . . . 5.93 111.454 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -167.36 -57.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.166 -0.679 . . . . 6.63 109.166 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -69.4 126.98 31.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.288 -0.869 . . . . 6.54 110.66 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 45' ' ' ILE . 2.7 pp -81.9 157.41 4.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.935 -0.575 . . . . 5.17 111.143 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.36 155.75 24.8 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.438 -0.665 . . . . 2.51 111.438 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -90.57 175.49 7.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.8 0.333 . . . . 1.36 111.232 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.959 ' HE2' ' HB2' ' A' ' 25' ' ' LEU . 18.3 p90 -138.99 169.53 17.63 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.401 -0.363 . . . . 1.7 111.257 -167.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 36' ' ' GLN . 72.7 mt-30 -119.7 115.85 24.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.57 -0.53 . . . . 1.91 109.57 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 16.6 t -87.91 150.97 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.341 . . . . 1.53 111.075 -177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.927 HG23 ' HA ' ' A' ' 54' ' ' ASP . 96.1 m -137.69 91.02 2.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.86 -0.609 . . . . 1.51 110.468 -173.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.894 HG13 ' H ' ' A' ' 53' ' ' ASN . 1.9 p -64.25 -72.43 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.259 0.552 . . . . 2.27 109.647 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.894 ' H ' HG13 ' A' ' 52' ' ' VAL . 2.9 p30 -98.19 -57.53 2.19 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.073 -1.084 . . . . 3.68 108.073 169.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.927 ' HA ' HG23 ' A' ' 51' ' ' THR . 15.4 t70 -175.45 79.11 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.879 -1.51 . . . . 2.99 108.507 167.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.0 tppt? -142.07 79.64 1.68 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.561 -1.274 . . . . 7.36 107.561 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 30.4 mtmm -64.04 81.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 124.389 1.056 . . . . 4.46 112.487 -169.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 55' ' ' LYS . 55.0 mt -75.64 105.9 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.254 -0.885 . . . . 0.92 109.722 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 48' ' ' TYR . 5.1 m -83.75 94.83 8.24 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.737 -0.665 . . . . 0.96 109.658 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 85.9 m-85 -69.17 106.51 2.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.27 -0.423 . . . . 1.57 109.87 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 62.3 tp 76.47 123.43 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.391 1.057 . . . . 3.21 110.808 -173.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB2' HG21 ' A' ' 10' ' ' VAL . 22.1 t70 -89.14 105.75 17.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.305 0.574 . . . . 5.61 110.669 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.533 ' HB ' ' HD3' ' A' ' 63' ' ' PRO . 17.8 m -56.92 -49.53 93.36 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 115.372 -0.831 . . . . 5.45 111.979 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' A' ' 62' ' ' THR . 69.2 Cg_exo -43.67 -59.42 1.06 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.634 2.223 . . . . 6.11 112.678 174.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.69 58.45 0.37 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.293 -0.956 . . . . 6.36 113.696 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.629 ' CE1' HG11 ' A' ' 10' ' ' VAL . 25.6 p-80 -88.23 -10.8 48.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.044 0.45 . . . . 8.78 110.057 174.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.589 ' HB2' ' CE ' ' A' ' 71' ' ' MET . 41.1 mt-10 -83.82 -168.44 2.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.451 -0.795 . . . . 7.05 111.068 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . . . -154.38 39.42 0.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.157 -0.929 . . . . 4.55 110.066 176.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' HB3' ' CE ' ' A' ' 14' ' ' MET . 77.2 m-85 -106.72 -20.66 13.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.486 0.921 . . . . 2.37 113.486 -173.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 71' ' ' MET . 12.0 t -159.61 129.37 5.45 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.645 -0.422 . . . . 4.9 110.786 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.7 m 70.05 -62.92 0.41 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.771 -0.65 . . . . 5.84 110.9 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.653 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 9.7 ptt? -69.07 92.62 0.54 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.692 -0.685 . . . . 5.21 109.748 173.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -127.01 8.88 6.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.363 -0.38 . . . . 8.21 111.022 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.59 -15.88 29.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.204 0.526 . . . . 6.36 110.419 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -94.46 141.9 28.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.624 . . . . 9.65 110.146 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.27 116.1 4.2 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.618 -0.801 . . . . 4.93 111.221 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.789 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . . . -76.62 81.77 3.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 5.47 111.138 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -110.22 35.9 3.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.859 0.838 . . . . 6.26 109.184 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.1 143.34 37.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.135 -0.939 . . . . 4.31 109.381 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 p -81.36 69.99 8.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.273 0.471 . . . . 3.41 112.273 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -86.02 -179.58 6.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.873 -0.788 . . . . 2.66 108.873 171.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.453 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt -135.35 139.34 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.3 -0.259 . . . . 0.71 110.3 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.815 HG22 ' HB ' ' A' ' 12' ' ' THR . 39.1 t -118.02 126.95 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.368 0.604 . . . . 1.17 112.11 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.67 HG12 ' HB ' ' A' ' 111' ' ' ILE . 6.1 mt -85.04 133.97 28.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.009 -0.996 . . . . 0.37 110.562 172.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 96' ' ' THR . 2.0 tm? -121.28 110.35 16.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.454 -0.943 . . . . 1.01 108.454 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 93.2 t -89.04 117.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.105 -0.498 . . . . 0.43 111.397 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.9 m -126.33 123.35 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.803 -0.635 . . . . 0.64 111.218 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -62.53 131.81 50.36 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.928 -0.578 . . . . 0.28 110.014 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.732 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -71.67 -19.89 62.02 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.22 0.533 . . . . 0.22 111.115 -176.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -90.54 -13.87 33.71 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.479 -0.782 . . . . 0.58 111.069 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.451 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 5.1 t70 -118.55 -50.43 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 0.56 110.537 -174.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.585 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 91.43 -162.77 28.36 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.37 113.449 172.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.07 136.37 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.754 0.788 . . . . 1.03 109.75 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.769 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 76.8 mmm -139.39 176.93 2.27 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.932 -1.031 . . . . 0.28 109.14 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 74.7 Cg_exo -40.13 -65.52 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.369 2.712 . . . . 0.58 114.466 -177.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.472 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.4 pt20 -76.13 -16.64 59.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.881 -0.327 . . . . 0.75 111.243 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.633 HG21 HG12 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -68.23 -43.01 78.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.486 0.66 . . . . 0.31 109.258 176.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.542 HG12 ' ND2' ' A' ' 101' ' ' ASN . 24.9 t -66.27 -41.35 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 115.049 -0.978 . . . . 1.38 111.289 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 41.1 mm-40 -55.07 -29.6 57.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.981 0.419 . . . . 2.35 110.456 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.04 -38.14 66.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.44 110.565 175.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.596 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.9 mt -73.49 -44.43 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.84 0.829 . . . . 0.41 109.056 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.542 ' ND2' HG12 ' A' ' 97' ' ' VAL . 35.1 m-20 -59.36 -30.71 68.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.36 -1.291 . . . . 0.67 111.055 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.482 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 4.6 t60 -80.91 -34.62 33.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.168 0.509 . . . . 2.5 110.038 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.501 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -71.81 -46.21 58.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.885 -0.598 . . . . 0.47 111.482 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 13.6 mmmm -71.59 -29.23 64.46 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.242 0.544 . . . . 1.66 109.58 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.46 72.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.906 -1.043 . . . . 0.77 111.33 173.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.33 28.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.74 110.629 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 85.6 53.06 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 114.581 -1.19 . . . . 1.41 109.295 171.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.34 141.96 25.02 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 113.841 -1.527 . . . . 1.35 110.62 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.27 143.43 83.33 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.554 2.17 . . . . 0.47 112.025 173.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.501 HD11 ' HB1' ' A' ' 103' ' ' ALA . 31.4 mm -106.34 158.59 6.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.488 0.661 . . . . 0.6 110.976 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.828 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 41.1 mm -124.94 84.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.396 -1.335 . . . . 0.37 107.396 171.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 131' ' ' LEU . 63.0 t -70.12 147.84 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.654 0.74 . . . . 0.26 109.753 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.779 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -145.13 100.37 3.46 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.34 -1.3 . . . . 0.29 109.701 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.823 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.7 mp -70.43 139.21 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.173 -1.376 . . . . 0.59 109.082 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -120.13 171.99 8.08 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.835 -1.542 . . . . 1.85 106.835 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.523 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 90.2 mttt 66.81 30.58 7.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 O-C-N 123.704 0.627 . . . . 0.59 111.902 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.494 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 83.1 mmm -83.79 -6.39 59.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.651 0.739 . . . . 0.92 109.299 172.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 8.1 p-10 -67.11 -28.1 67.88 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.704 -1.135 . . . . 0.76 108.865 169.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.502 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 29.5 mtpp -74.97 133.19 76.05 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.205 -1.362 . . . . 1.17 110.414 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -64.97 -16.05 53.53 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.449 2.1 . . . . 0.58 110.937 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -80.84 -1.64 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.745 -1.116 . . . . 1.45 110.63 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -54.97 124.29 16.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.189 -0.914 . . . . 0.27 111.731 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.743 HD22 ' HB2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -129.13 75.67 79.99 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.75 -0.833 . . . . 0.95 108.75 173.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.406 ' HB3' ' SD ' ' A' ' 117' ' ' MET . 37.0 Cg_endo -63.24 -60.33 0.18 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 123.085 2.523 . . . . 0.4 112.73 -173.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 2.5 m-20 -55.92 -18.22 8.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.555 -0.748 . . . . 1.44 111.616 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.743 ' HB2' HD22 ' A' ' 123' ' ' ASN . 5.4 tpm_? -78.7 -56.75 4.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.206 -0.665 . . . . 3.79 109.206 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.585 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 5.0 m -66.47 -22.98 30.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 122.303 1.049 . . . . 0.59 110.165 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.62 ' HG3' ' CD2' ' A' ' 147' ' ' PHE . 8.4 ttt -68.27 -43.94 76.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.767 -1.56 . . . . 0.81 110.522 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.561 ' HA ' ' HG3' ' A' ' 132' ' ' MET . 27.6 mt-30 -68.85 -31.74 70.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.765 -0.652 . . . . 1.31 111.752 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.741 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 12.7 mt-10 -61.52 -37.61 84.36 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.932 0.872 . . . . 1.64 109.162 177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.848 HD23 HG21 ' A' ' 112' ' ' VAL . 4.9 mp -62.4 -35.75 80.18 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.502 -0.772 . . . . 1.36 109.846 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.765 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -70.14 -18.05 63.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.051 -0.659 . . . . 1.61 111.864 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 4.7 pt-20 -78.83 -17.5 55.57 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.204 -1.036 . . . . 1.67 108.204 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -97.9 23.02 8.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.777 -1.101 . . . . 1.08 109.051 167.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.43 52.86 11.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.658 -1.61 . . . . 1.1 111.763 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 132' ' ' MET . 76.7 mt -121.67 96.79 5.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.604 -0.726 . . . . 1.36 110.026 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.968 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 61.5 t -103.54 121.71 47.42 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.572 -0.74 . . . . 0.43 111.302 -174.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 86.5 Cg_exo -41.58 144.16 0.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.642 3.561 . . . . 0.54 113.854 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HB2' HD13 ' A' ' 146' ' ' ILE . 9.0 mm-40 -74.09 -21.92 59.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.056 -1.429 . . . . 3.08 109.354 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 138' ' ' PRO . 2.3 pm0 -70.53 -21.44 62.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.671 -1.149 . . . . 1.57 110.634 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.537 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 37.6 m0 -102.66 -34.12 9.18 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 120.846 0.355 . . . . 0.66 110.641 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 122.27 29.63 1.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.724 -0.751 . . . . 0.53 112.623 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.968 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.91 -112.46 2.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.442 -0.885 . . . . 0.6 112.48 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -162.89 60.37 0.2 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.65 1.215 . . . . 1.91 111.246 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.749 HG21 HG23 ' A' ' 112' ' ' VAL . 52.3 m -165.12 116.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.686 -1.143 . . . . 0.37 110.347 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.828 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.5 mm -70.74 105.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.062 -0.718 . . . . 0.63 109.062 173.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.1 m-85 -89.05 114.56 25.79 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.205 -0.907 . . . . 0.5 110.601 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 95.4 m -102.94 116.63 32.92 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.754 0.311 . . . . 0.68 110.769 173.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.662 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 88.1 mttt -89.72 103.7 16.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.923 -0.769 . . . . 1.44 108.923 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.899 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.3 pp -135.25 -174.14 3.53 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.054 1.407 . . . . 0.84 112.953 -172.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.425 ' HB2' ' H ' ' A' ' 118' ' ' ASP . 13.8 t -152.44 118.55 5.51 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.453 -1.703 . . . . 1.77 106.693 173.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.56 -7.77 58.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.156 -0.618 . . . . 0.41 109.369 175.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.589 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 5.1 tmtt? -74.47 -55.15 6.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.47 -0.786 . . . . 2.3 110.197 172.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.4 p -82.5 -9.14 59.54 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.148 -0.621 . . . . 0.7 111.619 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.449 ' HE3' ' HB1' ' A' ' 27' ' ' ALA . 38.6 mmtm 65.39 40.14 4.89 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.506 -0.77 . . . . 1.36 111.516 174.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.13 -67.3 0.85 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.708 1.242 . . . . 2.48 110.281 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.899 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -68.68 -12.62 64.64 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 113.536 -1.665 . . . . 0.29 113.844 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 158' ' ' LEU . 34.4 mt -67.42 -37.56 83.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 118.287 1.043 . . . . 0.8 109.804 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.988 -1.005 . . . . 2.2 109.401 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.5 -20.56 65.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.396 -0.82 . . . . 0.58 110.861 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.12 -57.31 7.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.23 -0.441 . . . . 1.16 110.327 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.36 -41.27 75.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.405 -0.816 . . . . 1.51 110.178 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -55.23 -45.86 76.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.284 -0.871 . . . . 2.57 111.586 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.519 ' HB3' HG21 ' A' ' 146' ' ' ILE . 14.4 mmt -70.23 -44.38 68.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 0.64 110.382 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.556 HD11 HD11 ' A' ' 83' ' ' ILE . 72.0 mt -59.18 -49.53 83.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.725 -0.67 . . . . 0.52 111.523 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 0.0 OUTLIER -73.25 -22.94 60.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.673 -0.24 . . . . 1.73 110.849 -177.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.13 -50.94 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.905 -0.776 . . . . 1.51 108.905 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.764 ' HA ' ' HG2' ' A' ' 171' ' ' MET . 42.3 t -64.53 -37.57 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.224 -0.898 . . . . 0.89 110.794 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 166' ' ' LEU . 22.9 m -60.8 -21.08 62.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.893 0.378 . . . . 1.35 110.568 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 170' ' ' GLU . 41.9 tt0 -104.24 3.4 32.69 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.103 -0.499 . . . . 2.73 111.291 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 22.9 mmt -40.48 -31.68 0.16 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.335 0.865 . . . . 1.88 113.335 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -55.9 -37.27 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 4.27 111.138 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -99.2 4.51 46.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.887 -0.597 . . . . 3.91 111.214 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.477 ' HB2' ' HE1' ' A' ' 171' ' ' MET . 58.0 tp -56.37 -41.83 76.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.313 0.578 . . . . 5.72 110.281 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.508 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.2 OUTLIER -95.37 34.31 1.46 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.611 -0.722 . . . . 5.49 111.44 -177.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -91.62 -25.66 19.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.468 0.651 . . . . 5.78 109.309 171.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -114.31 93.61 32.09 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.003 -0.999 . . . . 7.88 109.052 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.247 0.935 0 C-N-CA 123.266 2.644 . . . . 9.19 112.037 -177.718 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.721 " H5'" ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.765 -0.134 . . . . 11.58 112.765 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -74.56 -43.49 55.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.662 0.231 . . . . 10.61 111.517 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.7 m80 55.97 67.1 1.05 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.498 0.666 . . . . 10.14 109.472 -171.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 42.6 ttm -133.37 -44.32 0.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.03 -0.986 . . . . 8.77 111.398 -170.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.5 m -101.81 -22.41 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.309 . . . . 5.74 111.211 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -87.52 141.12 28.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.5 -0.318 . . . . 5.7 110.448 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -106.55 107.89 60.9 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.449 . . . . 6.85 110.64 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 37.9 Cg_endo -93.36 117.97 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.334 2.689 . . . . 2.8 112.449 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.486 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 16.5 Cg_exo -68.15 91.23 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.86 2.373 . . . . 2.76 111.447 177.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.683 HG23 ' H ' ' A' ' 11' ' ' VAL . 3.8 m -79.69 -67.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 2.0 111.32 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.683 ' H ' HG23 ' A' ' 10' ' ' VAL . 87.9 t 66.28 94.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.526 0.679 . . . . 1.35 110.932 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -80.22 146.57 31.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.773 -0.649 . . . . 0.64 110.239 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -107.4 136.7 41.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.385 0.612 . . . . 1.3 110.953 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.429 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 63.5 mtt -144.12 176.59 9.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.433 -0.803 . . . . 0.79 108.892 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.07 176.69 15.21 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.247 -0.977 . . . . 0.31 112.322 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 57.7 t60 -80.81 158.94 25.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.82 0.819 . . . . 0.22 111.538 -176.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.523 HG23 ' O1B' ' A' ' 179' ' ' GDP . 6.5 p -71.82 151.34 8.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.5 -1.227 . . . . 0.36 109.933 175.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.663 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 20.8 t70 75.03 -25.13 0.21 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.1 0.476 . . . . 0.69 110.703 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.551 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 20.4 m170 -76.71 -17.32 59.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.487 -0.931 . . . . 0.63 108.487 170.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.817 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 119.78 65.3 0.28 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.401 -0.818 . . . . 0.79 113.87 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.593 ' HB3' ' O2B' ' A' ' 179' ' ' GDP . 16.0 tppt? -65.28 -71.43 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.142 -0.623 . . . . 3.31 110.656 172.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -86.71 -32.48 20.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.517 -0.31 . . . . 1.21 110.924 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.502 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -57.76 -27.86 63.42 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.569 0.581 . . . . 1.25 112.569 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.817 HD23 ' HA3' ' A' ' 20' ' ' GLY . 1.2 mm? -75.86 -36.93 59.42 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.908 -0.404 . . . . 1.49 109.908 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 47' ' ' ALA . 3.3 tp -73.71 -9.67 58.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.631 -0.713 . . . . 1.69 109.941 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.455 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 20.1 t70 -98.92 -44.06 6.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.884 -0.784 . . . . 1.23 108.884 176.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.48 87.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.279 -1.328 . . . . 0.63 109.761 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 10.9 tt -67.0 -36.14 76.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.791 -1.095 . . . . 1.02 111.101 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 79.6 mtm180 -71.31 -42.79 68.2 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.694 0.759 . . . . 3.04 109.587 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -79.0 17.97 0.68 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.113 -0.949 . . . . 2.65 111.941 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -105.99 -46.66 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.531 -1.213 . . . . 1.46 109.546 175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HD3' ' CD1' ' A' ' 162' ' ' LEU . 14.5 ptmt -174.1 -163.86 0.18 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.932 -0.576 . . . . 3.92 110.077 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.77 HG13 ' H ' ' A' ' 34' ' ' THR . 5.4 p 47.36 -88.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.536 1.135 . . . . 3.1 113.235 -175.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.77 ' H ' HG13 ' A' ' 33' ' ' VAL . 23.3 p -98.43 112.39 24.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.32 0.581 . . . . 2.78 112.169 -174.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.49 -36.89 20.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.391 -0.822 . . . . 6.34 109.48 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -172.18 -39.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.869 -1.059 . . . . 6.79 108.676 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -119.51 175.01 6.04 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 114.71 -1.132 . . . . 6.24 110.081 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.29 -176.21 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.826 0.704 . . . . 4.95 112.502 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.84 -63.77 4.42 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.956 -0.565 . . . . 4.68 112.435 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.52 68.66 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.596 -0.601 . . . . 4.55 111.596 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.0 tp -151.87 131.75 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.472 0.653 . . . . 5.57 111.391 -176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.42 ' HB ' HG12 ' A' ' 45' ' ' ILE . 1.1 m -111.27 143.77 41.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.634 -0.876 . . . . 5.93 108.634 171.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -77.42 28.01 0.15 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.044 0.387 . . . . 6.63 112.044 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -140.4 27.76 2.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.369 0.605 . . . . 6.54 109.571 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.42 HG12 ' HB ' ' A' ' 42' ' ' THR . 45.8 mm -130.43 158.38 42.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.134 -0.939 . . . . 5.17 109.702 -175.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 45' ' ' ILE . . . -101.81 132.1 10.84 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.823 -0.911 . . . . 2.51 110.823 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . 67.23 -166.99 0.21 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.763 0.331 . . . . 1.36 110.313 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -165.51 176.77 7.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.971 -0.381 . . . . 1.7 109.971 -172.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 45.3 mt-30 -97.07 115.02 26.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.843 -0.617 . . . . 1.91 109.896 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.713 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 24.9 t -76.58 160.64 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.732 -0.47 . . . . 1.53 109.732 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.894 HG23 ' HA ' ' A' ' 54' ' ' ASP . 96.1 m -155.19 83.38 1.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.259 -1.015 . . . . 1.51 108.259 -176.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.897 HG13 ' H ' ' A' ' 53' ' ' ASN . 2.2 p -56.98 -67.77 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.85 -0.613 . . . . 2.27 110.251 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.897 ' H ' HG13 ' A' ' 52' ' ' VAL . 19.3 m-20 -100.84 -60.97 1.43 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.822 -1.547 . . . . 3.68 106.822 169.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.894 ' HA ' HG23 ' A' ' 51' ' ' THR . 7.0 p-10 -161.22 39.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.327 -1.306 . . . . 2.99 109.717 171.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -107.5 110.29 22.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 7.36 109.528 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -67.76 118.79 11.48 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.93 0.769 . . . . 4.46 111.413 -174.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.713 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 17.8 mt -128.29 93.0 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.606 -0.725 . . . . 0.92 109.488 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 6.1 m -89.2 93.59 9.62 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.651 -0.42 . . . . 0.96 110.469 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 4.6 m-30 -49.55 -19.92 0.66 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.841 -1.072 . . . . 1.57 113.855 -177.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 41.4 tp -146.13 96.32 2.77 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.98 -0.45 . . . . 3.21 110.535 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HB3' HG12 ' A' ' 10' ' ' VAL . 21.6 t70 -143.33 -72.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 5.61 111.151 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 92.9 m -120.65 122.57 28.48 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.827 0.346 . . . . 5.45 111.51 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.791 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 72.2 Cg_endo -82.7 135.01 7.67 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.867 2.378 . . . . 6.11 111.619 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.74 -80.17 1.2 Allowed Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.634 -0.793 . . . . 6.36 111.86 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -68.52 80.79 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.506 0.558 . . . . 8.78 112.506 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 73.93 -63.29 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.95 -1.023 . . . . 7.05 112.874 170.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.87 126.89 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.052 0.541 . . . . 4.55 109.93 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' HZ ' HG21 ' A' ' 108' ' ' VAL . 40.2 m-85 -87.74 -174.47 4.77 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.223 -0.444 . . . . 2.37 109.946 166.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.2 p -58.39 -62.71 1.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.82 0.674 . . . . 4.9 112.82 -173.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.7 p -87.91 40.82 0.96 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.869 0.322 . . . . 5.84 111.869 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.791 ' SD ' ' HB3' ' A' ' 63' ' ' PRO . 50.9 mtt -136.35 121.22 18.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.085 0.469 . . . . 5.21 111.787 -176.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -125.81 29.08 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.766 -0.652 . . . . 8.21 109.784 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.44 -75.93 0.45 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.222 -0.445 . . . . 6.36 112.066 -170.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' O ' ' HG2' ' A' ' 63' ' ' PRO . 25.3 mtm180 -143.02 -179.75 6.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.615 0.245 . . . . 9.65 111.332 -172.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.43 111.94 0.59 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.681 -0.567 . . . . 4.93 111.681 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.18 -153.93 0.59 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.812 0.339 . . . . 5.47 110.444 -175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -131.44 48.12 2.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.431 0.634 . . . . 6.26 110.161 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 t -82.88 158.2 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.293 -0.867 . . . . 4.31 109.929 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 m -76.39 84.37 3.13 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.015 -0.365 . . . . 3.41 110.015 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.433 ' HB2' HG22 ' A' ' 108' ' ' VAL . 9.9 m-20 -63.75 143.6 57.71 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.847 -0.615 . . . . 2.66 111.263 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 47.6 mt -134.77 118.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.113 -0.949 . . . . 0.71 108.509 173.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.408 HG21 ' SD ' ' A' ' 14' ' ' MET . 11.9 p -114.49 135.69 53.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.528 0.68 . . . . 1.17 110.896 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.9 mt -90.83 128.92 42.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 114.914 -1.039 . . . . 0.37 109.884 173.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 96' ' ' THR . 2.4 tm? -114.8 106.89 14.73 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.369 -0.974 . . . . 1.01 108.369 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -86.29 109.03 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.43 110.996 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.5 m -119.99 122.29 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.768 -0.651 . . . . 0.64 110.656 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.85 130.09 41.33 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.406 -0.59 . . . . 0.28 109.406 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -69.01 -15.32 63.45 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 120.897 0.379 . . . . 0.22 111.505 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.52 -5.52 58.16 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.037 -0.529 . . . . 0.58 111.523 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -133.23 -49.39 0.86 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.556 0.217 . . . . 0.56 111.479 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.551 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 94.75 -148.43 18.98 Favored Glycine 0 C--O 1.223 -0.568 0 C-N-CA 121.084 -0.579 . . . . 0.37 113.477 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.436 HG11 ' CE2' ' A' ' 134' ' ' TYR . 30.2 t -83.23 131.28 34.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.542 0.687 . . . . 1.03 110.355 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.789 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 83.9 mmm -131.22 176.85 2.56 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 114.645 -1.162 . . . . 0.28 109.477 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.789 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 56.5 Cg_exo -38.53 -66.43 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.566 2.844 . . . . 0.58 114.578 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.503 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 3.8 pt20 -74.82 -15.5 60.74 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.135 0.493 . . . . 0.75 111.323 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -71.01 -41.68 70.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.475 0.655 . . . . 0.31 109.482 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.805 HG12 HD22 ' A' ' 101' ' ' ASN . 25.7 t -63.41 -41.16 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.193 -0.912 . . . . 1.38 111.861 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.29 -34.29 68.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 2.35 110.276 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.429 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -68.65 -34.26 75.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.929 -0.578 . . . . 0.44 110.609 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.592 HG21 ' HB3' ' A' ' 134' ' ' TYR . 95.5 mt -74.14 -42.67 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.778 0.799 . . . . 0.41 109.256 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.805 HD22 HG12 ' A' ' 97' ' ' VAL . 6.4 m-80 -65.41 -25.59 67.61 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.446 -1.252 . . . . 0.67 111.349 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.412 ' NE2' ' HA ' ' A' ' 68' ' ' PHE . 4.3 t60 -82.63 -39.21 22.45 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.256 0.55 . . . . 2.5 109.846 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.02 44.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.779 -0.646 . . . . 0.47 111.982 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.79 ' HD3' HD21 ' A' ' 136' ' ' LEU . 29.9 mmmt -75.76 -27.15 57.96 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.305 0.574 . . . . 1.66 110.438 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.82 -44.29 81.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.055 -0.975 . . . . 0.77 110.302 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.34 -22.67 44.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.084 -0.507 . . . . 0.74 110.926 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.2 t30 82.64 37.19 0.05 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.657 1.218 . . . . 1.41 108.583 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.449 HG21 ' HZ ' ' A' ' 68' ' ' PHE . 31.1 t -77.38 137.35 64.09 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 113.39 -1.732 . . . . 1.35 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 16.7 Cg_exo -67.69 138.97 46.82 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.381 2.054 . . . . 0.47 111.321 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.454 ' C ' HG23 ' A' ' 145' ' ' THR . 0.8 OUTLIER -110.59 155.75 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 122.056 0.932 . . . . 0.6 112.196 -173.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.854 HD13 ' HB ' ' A' ' 146' ' ' ILE . 28.4 mm -122.44 82.19 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 113.753 -1.567 . . . . 0.37 107.278 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.916 HG23 HG21 ' A' ' 145' ' ' THR . 64.0 t -69.01 146.04 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 109.044 -0.724 . . . . 0.26 109.044 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.6 103.01 4.44 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.545 -1.207 . . . . 0.29 110.111 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.857 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.5 mp -69.02 136.11 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 114.066 -1.425 . . . . 0.59 108.444 175.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 62.9 t30 -123.62 167.07 14.44 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.486 -1.302 . . . . 1.85 107.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.755 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 85.7 mttt 69.55 31.99 3.52 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 124.036 0.835 . . . . 0.59 111.047 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 75.6 mmm -85.11 -3.81 58.93 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.84 0.829 . . . . 0.92 108.914 173.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 4.1 p-10 -68.16 -33.1 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.269 -1.332 . . . . 0.76 109.061 168.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.626 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 25.4 mtpp -72.25 129.94 86.9 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 114.814 -1.085 . . . . 1.17 110.202 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.52 -13.99 42.2 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 122.406 2.071 . . . . 0.58 110.788 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -82.47 -1.99 52.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 1.45 110.298 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.45 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -61.36 130.19 44.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.985 -1.007 . . . . 0.27 111.333 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.95 76.64 66.68 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.627 -0.879 . . . . 0.95 108.627 174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.539 ' HB3' ' SD ' ' A' ' 117' ' ' MET . 56.8 Cg_endo -66.71 -53.93 0.5 Allowed 'Trans proline' 0 CA--C 1.506 -0.876 0 C-N-CA 122.77 2.314 . . . . 0.4 113.311 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.558 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.0 m-20 -53.93 -29.21 41.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.22 -0.9 . . . . 1.44 110.115 177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -75.95 -56.92 4.21 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.798 -0.761 . . . . 3.79 109.485 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 88' ' ' ALA . 24.9 m -62.77 -29.03 46.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.424 -0.807 . . . . 0.59 112.033 -176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.558 ' SD ' ' HA ' ' A' ' 125' ' ' ASP . 18.2 ptm -73.05 -23.77 60.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.518 -0.473 . . . . 0.81 110.219 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -70.73 -32.24 69.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.615 -0.266 . . . . 1.31 110.694 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 3.1 mm-40 -64.23 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.844 0.83 . . . . 1.64 109.719 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.633 HD12 HD13 ' A' ' 136' ' ' LEU . 4.2 mm? -64.03 -41.52 97.4 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.309 -0.86 . . . . 1.36 109.658 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.757 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 1.6 mtm -72.83 -13.91 61.39 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 119.652 -0.819 . . . . 1.61 110.692 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 5.1 mm-40 -68.49 -26.73 65.62 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.396 -1.335 . . . . 1.67 107.396 173.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.592 ' HB3' HG21 ' A' ' 100' ' ' ILE . 78.9 m-85 -108.74 33.72 4.06 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.407 -1.269 . . . . 1.08 111.039 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 54.9 t30 61.71 43.01 10.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.631 -1.168 . . . . 1.1 112.013 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.79 HD21 ' HD3' ' A' ' 104' ' ' LYS . 36.1 mt -123.02 97.22 5.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.814 -0.63 . . . . 1.36 111.384 174.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.072 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 57.3 t -99.1 121.26 56.14 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 115.561 -0.745 . . . . 0.43 111.185 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.757 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 93.1 Cg_exo -41.86 142.72 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.373 3.382 . . . . 0.54 113.573 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.484 ' HB2' HD13 ' A' ' 146' ' ' ILE . 4.9 mm-40 -73.5 -16.12 61.29 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.514 -1.221 . . . . 3.08 109.81 176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.578 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.2 pm0 -69.27 -21.87 63.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.834 . . . . 1.57 110.26 170.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.455 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.5 m0 -109.97 -18.21 13.43 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.082 0.468 . . . . 0.66 111.078 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.54 4.97 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.827 . . . . 0.53 113.506 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 1.072 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.23 -110.66 1.43 Allowed Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.39 -0.91 . . . . 0.6 111.909 173.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -161.22 60.07 0.29 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 122.808 1.29 . . . . 1.91 111.485 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.916 HG21 HG23 ' A' ' 112' ' ' VAL . 58.5 m -164.1 119.8 1.58 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.87 -1.059 . . . . 0.37 111.201 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.854 ' HB ' HD13 ' A' ' 111' ' ' ILE . 22.5 mm -72.77 106.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.678 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.3 m-85 -88.78 116.63 27.18 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.203 -0.908 . . . . 0.5 110.863 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 85.3 m -102.01 115.71 31.14 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.658 -0.497 . . . . 0.68 109.658 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.857 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 37.9 mtpt -94.8 85.19 4.36 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.984 -0.746 . . . . 1.44 108.984 -176.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.983 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -121.99 -176.92 3.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.712 1.244 . . . . 0.84 113.192 -164.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.431 ' N ' HD12 ' A' ' 150' ' ' LEU . 1.2 p -149.35 108.39 3.9 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.579 -1.646 . . . . 1.77 108.358 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.497 ' HB3' ' O6 ' ' A' ' 179' ' ' GDP . . . -76.44 -15.43 59.92 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.193 0.52 . . . . 0.41 109.906 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -76.31 -51.39 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.766 -0.652 . . . . 2.3 111.432 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -79.14 -9.63 59.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.03 -0.668 . . . . 0.7 111.318 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp 66.77 43.69 2.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.919 0.866 . . . . 1.36 110.465 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 2.4 tt0 -105.16 -63.07 1.27 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.217 . . . . 2.48 109.912 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.983 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -78.16 -10.7 86.02 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 114.933 -1.03 . . . . 0.29 113.432 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 22.6 mt -67.15 -40.04 86.63 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 117.702 0.751 . . . . 0.8 110.11 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -73.14 -37.84 66.47 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.384 -0.826 . . . . 2.2 109.348 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 163' ' ' GLU . 83.2 t60 -70.41 -20.75 62.9 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.561 -0.745 . . . . 0.58 111.142 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.79 -54.2 30.13 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.184 0.516 . . . . 1.16 109.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.425 ' CD1' ' HD3' ' A' ' 32' ' ' LYS . 9.9 mt -55.98 -38.56 70.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.076 -0.965 . . . . 1.51 110.196 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 160' ' ' HIS . 49.4 mt-10 -51.97 -52.72 48.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 2.57 110.972 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.579 ' HB3' HG21 ' A' ' 146' ' ' ILE . 15.0 mmt -69.79 -34.55 73.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.959 -0.564 . . . . 0.64 110.535 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 57' ' ' ILE . 80.7 mt -61.17 -51.97 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.52 111.192 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 169' ' ' SER . 4.1 pp -66.19 -33.22 75.28 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 121.032 -0.267 . . . . 1.73 111.176 -177.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.8 tp -54.06 -51.34 64.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.895 -0.593 . . . . 1.51 109.634 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 164' ' ' MET . 61.1 t -65.38 -39.85 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.757 -0.656 . . . . 0.89 110.793 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.452 ' HB3' ' HA ' ' A' ' 166' ' ' LEU . 34.9 t -62.09 -21.33 64.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 111.829 0.307 . . . . 1.35 111.829 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -104.96 -20.18 13.62 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.118 -0.364 . . . . 2.73 111.268 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 49.3 ttp -74.07 -13.5 60.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.921 0.391 . . . . 1.88 110.531 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.5 -20.78 66.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.938 0.399 . . . . 4.27 110.417 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.46 -15.9 17.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.282 0.563 . . . . 3.91 109.725 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.9 mt -134.33 48.57 2.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.7 -0.682 . . . . 5.72 111.233 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.64 ' H ' ' HD2' ' A' ' 175' ' ' LYS . 9.2 mptt -41.55 130.36 3.12 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.002 0.521 . . . . 5.49 112.361 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -87.19 34.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.994 -0.548 . . . . 5.78 111.486 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 25.6 t-20 -92.49 120.39 67.49 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.096 -0.502 . . . . 7.88 110.444 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 8.2 Cg_exo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 123.154 2.569 . . . . 9.19 111.587 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.755 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.818 -0.513 . . . . 11.58 111.818 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -79.96 60.7 3.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.06 0.457 . . . . 10.61 111.641 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -83.48 -59.8 2.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.114 -0.494 . . . . 10.14 110.779 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.9 ptp -74.32 -7.12 51.75 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.918 -0.583 . . . . 8.77 111.889 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.4 t -66.92 -65.79 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.025 0.441 . . . . 5.74 110.671 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.1 129.1 17.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.928 -0.578 . . . . 5.7 110.476 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -118.32 96.59 49.99 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.566 -0.743 . . . . 6.85 110.007 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 43.9 Cg_endo -68.76 128.67 17.33 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.667 2.245 . . . . 2.8 112.114 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.492 ' HB3' ' O ' ' A' ' 79' ' ' THR . 19.2 Cg_endo -59.6 136.44 71.06 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.046 2.498 . . . . 2.76 111.785 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.86 144.32 11.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.551 -0.537 . . . . 2.0 109.551 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.7 t -112.86 93.24 2.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.451 -0.574 . . . . 1.35 109.451 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 61.8 m -78.48 123.11 26.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.909 -0.587 . . . . 0.64 111.293 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -93.18 108.49 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.922 0.391 . . . . 1.3 110.256 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.466 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 45.1 mtm -130.22 172.8 11.41 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.887 -0.412 . . . . 0.79 109.887 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.81 -157.14 27.1 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.013 -0.835 . . . . 0.31 111.013 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.617 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 46.9 t60 -94.6 160.4 14.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.116 0.96 . . . . 0.22 111.839 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -78.87 152.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.31 -1.314 . . . . 0.36 110.489 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.703 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 18.3 t70 73.44 -20.75 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.205 0.602 . . . . 0.69 110.162 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 17' ' ' VAL . 22.3 m170 -71.6 -20.75 61.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.079 -1.082 . . . . 0.63 108.079 167.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 112.83 58.41 0.42 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.34 -0.846 . . . . 0.79 113.778 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 14' ' ' MET . 2.9 tppp? -58.11 -62.78 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.628 0.714 . . . . 3.31 111.088 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 p -72.08 -40.75 68.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 1.21 111.845 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -27.66 69.05 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.937 -0.574 . . . . 1.25 112.087 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -70.28 -57.31 5.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.441 0.639 . . . . 1.49 109.574 -175.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.919 HD11 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -66.18 -12.39 55.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.747 -1.115 . . . . 1.69 111.136 -178.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.77 -37.46 9.46 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.807 0.813 . . . . 1.23 109.678 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.23 70.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.781 -1.1 . . . . 0.63 109.494 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.564 HG23 ' OH ' ' A' ' 48' ' ' TYR . 7.6 tt -72.11 -23.29 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.713 -1.131 . . . . 1.02 110.057 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 99.9 mtt180 -65.2 -48.25 74.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.816 0.817 . . . . 3.04 109.18 170.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -85.84 28.33 0.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.623 -1.171 . . . . 2.65 110.955 -172.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.9 t -102.38 -42.59 5.94 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.514 -1.221 . . . . 1.46 108.579 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.7 pttt 179.89 -167.33 0.09 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.421 -0.809 . . . . 3.92 109.152 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.64 HG13 ' H ' ' A' ' 34' ' ' THR . 4.3 p 50.65 -73.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.004 1.322 . . . . 3.1 112.492 -171.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.786 HG22 ' HB3' ' A' ' 38' ' ' ALA . 18.8 p -82.46 145.3 29.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.947 0.403 . . . . 2.78 110.377 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -96.39 -48.39 5.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.392 0.615 . . . . 6.34 109.887 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -136.93 -78.3 0.4 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.244 -0.889 . . . . 6.79 109.204 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -120.7 126.31 49.88 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.388 -0.824 . . . . 6.24 109.541 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.786 ' HB3' HG22 ' A' ' 34' ' ' THR . . . -171.35 172.51 5.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.387 -0.37 . . . . 4.95 110.389 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.08 -16.25 3.0 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.823 -0.703 . . . . 4.68 111.885 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.79 155.48 9.34 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.191 -0.528 . . . . 4.55 111.85 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.99 101.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.776 -0.824 . . . . 5.57 108.776 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 44' ' ' HIS . 15.1 t -143.27 -176.83 5.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.736 -0.665 . . . . 5.93 110.314 -174.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -102.67 21.37 15.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.087 -0.506 . . . . 6.63 111.927 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.523 ' H ' HG23 ' A' ' 42' ' ' THR . 30.1 p80 -135.68 115.95 13.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.015 0.436 . . . . 6.54 110.43 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.7 pt -93.59 -175.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.014 -0.539 . . . . 5.17 109.92 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' O ' HD21 ' A' ' 25' ' ' LEU . . . 72.24 -80.08 0.62 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.79 -0.719 . . . . 2.51 112.37 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.919 ' HA ' HD11 ' A' ' 25' ' ' LEU . . . -82.2 156.82 24.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.402 0.144 . . . . 1.36 111.206 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.564 ' OH ' HG23 ' A' ' 28' ' ' ILE . 1.3 p90 -165.57 -178.91 5.13 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.625 -0.43 . . . . 1.7 111.334 -166.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 89.8 mt-30 -114.47 120.67 41.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 1.91 110.39 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 57' ' ' ILE . 32.7 m -89.25 153.56 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.279 0.561 . . . . 1.53 111.536 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 54' ' ' ASP . 99.2 m -103.64 91.55 4.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.815 -0.63 . . . . 1.51 111.306 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 m -87.62 -36.85 10.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.047 -1.094 . . . . 2.27 108.047 167.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -119.61 -63.77 1.34 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.659 -1.61 . . . . 3.68 108.899 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.758 ' HA ' HG23 ' A' ' 51' ' ' THR . 23.8 t0 -169.05 81.67 0.13 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.896 -1.047 . . . . 2.99 109.867 167.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.585 ' H ' ' HA ' ' A' ' 51' ' ' THR . 47.6 mttp 60.21 31.8 20.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.274 -0.875 . . . . 7.36 112.945 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.867 ' O ' HG13 ' A' ' 57' ' ' ILE . 47.0 mttp -108.0 76.05 1.03 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.29 -0.564 . . . . 4.46 110.964 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.867 HG13 ' O ' ' A' ' 56' ' ' LYS . 66.4 mt 177.36 106.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.485 1.914 . . . . 0.92 106.838 169.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 14.0 m -102.9 96.11 6.61 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.451 -0.5 . . . . 0.96 110.584 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.626 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 79.1 m-85 -74.16 108.39 6.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.919 -0.771 . . . . 1.57 108.919 174.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.641 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 58.7 tp -122.65 143.11 49.98 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 123.414 0.446 . . . . 3.21 110.723 -173.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -140.3 114.51 9.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.515 0.198 . . . . 5.61 111.052 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.941 ' HA ' ' HA ' ' A' ' 67' ' ' ALA . 6.8 m 56.87 68.23 2.22 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 124.024 0.827 . . . . 5.45 112.175 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 66' ' ' GLU . 76.1 Cg_endo -77.87 63.71 8.13 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.609 2.206 . . . . 6.11 112.754 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.04 -86.93 0.54 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.55 -0.833 . . . . 6.36 112.696 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -97.03 -72.46 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 8.78 111.171 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' O ' ' HD2' ' A' ' 63' ' ' PRO . 14.3 mm-40 -89.91 128.35 36.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.889 -0.596 . . . . 7.05 110.207 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.941 ' HA ' ' HA ' ' A' ' 62' ' ' THR . . . -58.33 -43.12 88.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.718 -1.128 . . . . 4.55 111.909 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' HA ' HG21 ' A' ' 12' ' ' THR . 9.1 t80 -112.63 127.58 56.14 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.761 -0.459 . . . . 2.37 109.761 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 70' ' ' THR . 18.1 m -87.72 156.3 19.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.193 -0.458 . . . . 4.9 110.769 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 74' ' ' ARG . 76.4 m 76.93 78.28 0.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.464 0.649 . . . . 5.84 111.591 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.524 ' HG3' ' HA ' ' A' ' 106' ' ' ALA . 49.4 ttm -117.2 -63.54 1.43 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.842 -0.617 . . . . 5.21 109.563 171.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -109.1 2.03 20.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.854 -0.612 . . . . 8.21 109.735 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.55 -10.39 59.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.381 -0.827 . . . . 6.36 110.598 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HB2' HG23 ' A' ' 70' ' ' THR . 8.8 tpp180 -123.73 125.45 44.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.027 -0.533 . . . . 9.65 109.707 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.88 117.81 4.49 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.794 -0.717 . . . . 4.93 113.122 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.59 -74.76 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.453 0.701 . . . . 5.47 112.749 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -95.19 107.91 20.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.765 0.317 . . . . 6.26 110.837 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 80' ' ' ASP . 57.2 t -66.51 135.79 27.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 4.31 110.571 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 9' ' ' PRO . 12.5 p -104.78 -2.48 24.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.092 -0.503 . . . . 3.41 112.263 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.531 ' H ' HG12 ' A' ' 78' ' ' VAL . 7.1 m-20 -119.75 173.97 6.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.768 -0.196 . . . . 2.66 110.591 -173.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.1 mt -135.46 146.82 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.166 0.291 . . . . 0.71 110.923 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -118.58 138.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-O 121.771 0.796 . . . . 1.17 111.147 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 6.3 mt -98.17 132.48 43.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.961 -1.018 . . . . 0.37 110.372 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -107.77 107.26 17.95 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.463 -0.79 . . . . 1.01 110.108 177.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.59 94.36 4.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.152 0.501 . . . . 0.43 110.472 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.611 HG13 HD12 ' A' ' 84' ' ' LEU . 11.4 m -111.29 123.35 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.008 -0.542 . . . . 0.64 111.032 175.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -71.68 130.31 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.161 -0.472 . . . . 0.28 109.752 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.754 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -68.4 -19.37 64.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.055 0.455 . . . . 0.22 111.59 -171.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.39 -14.45 46.25 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.754 -0.657 . . . . 0.58 110.649 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.448 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 6.6 t70 -118.21 -55.04 2.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.56 110.362 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.41 ' HA2' ' CG1' ' A' ' 127' ' ' VAL . . . 99.38 -128.47 9.58 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 115.965 -0.562 . . . . 0.37 113.319 173.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.469 HG21 ' HE2' ' A' ' 134' ' ' TYR . 8.7 p -103.86 136.94 34.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.675 0.75 . . . . 1.03 109.845 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.7 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 74.9 mmm -140.08 176.73 2.35 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.772 -1.104 . . . . 0.28 108.74 -171.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.9 Cg_exo -41.35 -66.96 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.15 2.567 . . . . 0.58 114.552 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.477 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.6 pt20 -74.11 -15.4 61.05 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.22 0.533 . . . . 0.75 111.114 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.7 -43.71 79.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.119 -0.697 . . . . 0.31 109.119 176.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.536 HG12 ' ND2' ' A' ' 101' ' ' ASN . 22.7 t -66.78 -41.83 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 115.237 -0.892 . . . . 1.38 111.164 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -56.45 -32.06 64.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.484 . . . . 2.35 110.424 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.53 -31.93 69.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.676 -0.693 . . . . 0.44 110.638 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.569 HG23 HD11 ' A' ' 136' ' ' LEU . 96.7 mt -77.94 -44.65 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.564 0.697 . . . . 0.41 109.371 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.536 ' ND2' HG12 ' A' ' 97' ' ' VAL . 61.2 m-20 -57.41 -38.25 74.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.523 -1.217 . . . . 0.67 110.808 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 5.1 t60 -68.79 -34.54 75.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.058 0.456 . . . . 2.5 109.872 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.96 -48.91 16.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.015 -0.538 . . . . 0.47 111.932 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.57 ' HD3' HD21 ' A' ' 136' ' ' LEU . 14.0 mmmm -66.46 -38.37 87.2 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.03 0.443 . . . . 1.66 110.018 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.91 -35.81 71.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.302 -0.863 . . . . 0.77 111.04 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.524 ' HA ' ' HG3' ' A' ' 71' ' ' MET . . . -79.99 -32.71 39.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.508 -0.314 . . . . 0.74 111.301 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 83.35 42.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.36 1.076 . . . . 1.41 108.902 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.454 ' HB ' HG11 ' A' ' 78' ' ' VAL . 1.7 p -103.76 142.86 25.47 Favored Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 114.077 -1.419 . . . . 1.35 111.208 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 108' ' ' VAL . 22.1 Cg_exo -65.17 142.27 73.06 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.361 2.041 . . . . 0.47 111.722 171.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 111' ' ' ILE . 1.3 mt -110.82 163.79 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.443 0.64 . . . . 0.6 111.782 -171.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.851 HD13 ' HB ' ' A' ' 146' ' ' ILE . 15.9 mm -142.09 84.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.161 0 N-CA-C 106.747 -1.575 . . . . 0.37 106.747 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.751 HG23 HG21 ' A' ' 145' ' ' THR . 63.1 t -76.02 152.27 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 CA-C-N 114.316 -1.311 . . . . 0.26 109.815 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.9 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -143.51 101.5 3.79 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.554 -1.203 . . . . 0.29 109.739 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.841 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.6 mp -68.65 133.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 114.106 -1.406 . . . . 0.59 108.722 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 64.6 t30 -120.37 166.84 12.99 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.125 -1.435 . . . . 1.85 107.125 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.69 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 81.5 mttt 68.42 31.66 4.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 O-C-N 124.242 0.964 . . . . 0.59 111.672 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.478 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 82.6 mmm -80.99 -6.94 59.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.466 -0.788 . . . . 0.92 109.378 170.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -65.5 -32.49 74.12 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.068 -0.969 . . . . 0.76 108.595 169.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.49 ' HB3' ' OE1' ' A' ' 121' ' ' GLU . 26.8 mtpp -77.56 131.37 71.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.856 -1.52 . . . . 1.17 110.724 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.78 -18.17 59.12 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.538 2.159 . . . . 0.58 111.402 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' A' ' 119' ' ' LYS . 15.3 mp0 -68.7 -22.26 64.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.257 -0.883 . . . . 1.45 110.394 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -40.93 123.62 1.98 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.556 -1.202 . . . . 0.27 112.631 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.2 75.94 79.61 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.959 -1.126 . . . . 0.95 107.959 173.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.814 ' O ' ' HG3' ' A' ' 128' ' ' MET . 33.1 Cg_endo -61.15 -60.37 0.24 Allowed 'Trans proline' 0 CA--C 1.508 -0.807 0 C-N-CA 122.806 2.337 . . . . 0.4 113.193 -174.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.421 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 5.1 m-20 -49.15 -27.59 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.859 0.724 . . . . 1.44 110.753 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 129' ' ' GLN . 41.8 ttp180 -77.49 -53.3 7.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.756 -0.656 . . . . 3.79 110.031 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.597 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 19.5 m -64.36 -20.62 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.659 -0.701 . . . . 0.59 112.219 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.814 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 37.3 mtp -71.45 -35.68 70.97 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.647 0.737 . . . . 0.81 109.131 171.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 132' ' ' MET . 46.2 mt-30 -66.65 -35.11 79.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.718 -1.128 . . . . 1.31 110.956 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.597 ' HG2' ' HA ' ' A' ' 127' ' ' VAL . 18.8 mm-40 -57.53 -50.07 74.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.924 0.868 . . . . 1.64 109.835 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.734 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 10.7 mp -65.01 -34.27 78.05 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.998 -1.001 . . . . 1.36 110.917 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.594 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 14.6 ptm -73.25 -11.27 60.45 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.974 -0.691 . . . . 1.61 110.65 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.72 -28.61 40.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.515 -0.92 . . . . 1.67 108.515 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.469 ' HE2' HG21 ' A' ' 92' ' ' VAL . 45.4 m-85 -90.12 23.24 2.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.187 -0.915 . . . . 1.08 109.408 167.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.3 t30 52.38 54.44 10.69 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 114.014 -1.448 . . . . 1.1 111.737 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.734 ' HB2' ' HB3' ' A' ' 131' ' ' LEU . 78.9 mt -117.98 98.09 6.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.844 -1.071 . . . . 1.36 109.131 169.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.015 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 40.3 t -100.19 118.95 60.45 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.031 -0.532 . . . . 0.43 111.156 -171.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.582 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.4 Cg_exo -42.82 144.04 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 124.306 3.337 . . . . 0.54 112.798 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 146' ' ' ILE . 2.3 mm-40 -72.77 -20.66 61.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.426 -1.261 . . . . 3.08 110.056 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 2.4 pm0 -68.76 -22.59 64.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.341 -0.845 . . . . 1.57 110.232 171.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.574 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 31.2 m0 -103.89 -15.76 15.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.66 110.333 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.39 23.44 9.57 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.981 -0.628 . . . . 0.53 113.736 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 1.015 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.86 -107.42 0.73 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.107 -1.044 . . . . 0.6 112.469 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -164.56 61.03 0.14 Allowed 'General case' 0 C--O 1.244 0.783 0 CA-C-O 122.664 1.221 . . . . 1.91 111.316 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.751 HG21 HG23 ' A' ' 112' ' ' VAL . 60.7 m -163.94 111.68 1.15 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.447 -1.252 . . . . 0.37 110.225 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.851 ' HB ' HD13 ' A' ' 111' ' ' ILE . 12.9 mm -68.21 105.12 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 109.026 -0.731 . . . . 0.63 109.026 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 7.7 m-85 -86.37 114.19 22.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.346 -0.843 . . . . 0.5 110.454 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 73.2 m -100.36 113.69 26.63 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.883 0.373 . . . . 0.68 110.74 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.759 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.0 mttt -85.72 101.07 12.45 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.581 -0.526 . . . . 1.44 109.581 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.924 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.6 pp -133.03 -172.44 2.93 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 123.236 1.493 . . . . 0.84 113.404 -171.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.513 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 13.5 t -159.71 117.05 2.63 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 112.811 -1.995 . . . . 1.77 106.389 172.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.03 -16.95 62.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.059 -0.719 . . . . 0.41 109.059 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.59 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 6.2 tmtt? -69.82 -54.12 15.06 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.732 -1.122 . . . . 2.3 110.635 176.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 2.3 p -80.61 -12.35 59.51 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.51 -0.476 . . . . 0.7 111.69 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.549 ' HD3' HD12 ' A' ' 158' ' ' LEU . 19.5 mmtp 67.44 41.63 2.36 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.589 -0.732 . . . . 1.36 110.617 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.629 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -97.37 -63.88 1.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.339 1.066 . . . . 2.48 110.442 -173.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -86.45 1.88 87.37 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.167 -1.016 . . . . 0.29 113.199 -172.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.549 HD12 ' HD3' ' A' ' 155' ' ' LYS . 27.5 mt -70.57 -42.19 71.41 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 118.0 0.9 . . . . 0.8 109.019 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -77.73 -34.81 52.43 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.44 -0.8 . . . . 2.2 109.618 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.522 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 81.6 t60 -69.4 -25.85 64.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.565 -0.454 . . . . 0.58 111.121 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.94 -53.08 60.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.36 0.6 . . . . 1.16 109.484 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 12.4 mt -54.89 -44.23 73.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.688 -1.142 . . . . 1.51 109.742 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.499 ' OE2' ' HA ' ' A' ' 160' ' ' HIS . 40.8 mt-10 -46.76 -53.81 11.07 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.197 0.936 . . . . 2.57 111.189 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.606 ' HB3' HG21 ' A' ' 146' ' ' ILE . 20.2 mmt -72.26 -39.72 68.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 0.64 111.051 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 83' ' ' ILE . 69.1 mt -60.13 -49.94 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 0.52 111.294 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.1 pp -70.89 -31.83 68.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.844 -0.342 . . . . 1.73 111.153 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 166' ' ' LEU . 2.6 tm? -54.2 -50.53 66.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 1.51 108.856 172.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.534 ' O ' ' HG2' ' A' ' 171' ' ' MET . 97.3 t -62.17 -45.11 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 115.819 -0.628 . . . . 0.89 110.559 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.72 ' HA ' ' HB2' ' A' ' 176' ' ' ALA . 38.4 m -58.88 -43.58 90.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.683 0.623 . . . . 1.35 112.683 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.437 ' HG2' HD12 ' A' ' 174' ' ' LEU . 47.0 mt-10 -102.75 0.48 32.94 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.597 0.591 . . . . 2.73 112.597 -171.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 27.2 ptt? -63.89 -37.42 87.32 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.955 -0.298 . . . . 1.88 111.478 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -96.12 -79.69 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.606 -0.438 . . . . 4.27 110.498 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -114.84 -90.63 0.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.888 -0.725 . . . . 3.91 111.031 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 170' ' ' GLU . 26.8 tp -144.03 6.43 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.401 0.619 . . . . 5.72 110.112 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -130.23 8.09 5.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.674 -0.693 . . . . 5.49 112.02 -166.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.72 ' HB2' ' HA ' ' A' ' 169' ' ' SER . . . 58.82 -87.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.569 0.543 . . . . 5.78 111.619 -175.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 63.5 t30 63.9 99.36 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 C-N-CA 123.615 0.766 . . . . 7.88 111.102 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo . . . . . 0 C--O 1.247 0.943 0 C-N-CA 122.884 2.389 . . . . 9.19 112.001 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.703 " H5'" ' HA ' ' A' ' 18' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.108 -0.397 . . . . 11.58 112.108 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m -131.57 165.47 23.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.323 -0.251 . . . . 10.61 110.323 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 66.49 82.01 0.19 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.662 0.601 . . . . 10.14 110.723 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.9 ttp 60.09 88.39 0.08 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.673 -0.694 . . . . 8.77 110.479 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.54 134.18 62.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.774 -0.648 . . . . 5.74 110.073 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.29 106.86 4.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.043 -0.526 . . . . 5.7 110.587 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.787 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 20.3 mmm180 -106.24 -49.09 0.11 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.007 -0.542 . . . . 6.85 110.577 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.787 ' HD2' ' H ' ' A' ' 7' ' ' ARG . 24.8 Cg_endo -63.63 124.17 13.24 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 121.677 1.585 . . . . 2.8 111.495 173.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.52 ' CB ' ' HA ' ' A' ' 80' ' ' ASP . 36.3 Cg_endo -64.83 153.64 76.88 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.086 2.524 . . . . 2.76 112.829 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 60' ' ' LEU . 6.8 p -85.84 85.44 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.045 0.926 . . . . 2.0 109.967 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 94.1 t -54.51 109.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.774 -1.103 . . . . 1.35 111.485 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 33.4 m -85.19 136.3 33.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.783 -0.644 . . . . 0.64 110.827 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.31 113.95 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 1.3 109.95 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.842 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 53.3 mtt -126.5 163.94 22.25 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.072 -0.513 . . . . 0.79 109.637 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.48 -168.65 25.42 Favored Glycine 0 N--CA 1.431 -1.633 0 C-N-CA 120.828 -0.701 . . . . 0.31 111.437 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.645 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 52.1 t60 -88.51 157.89 18.49 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.893 0.854 . . . . 0.22 111.385 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.4 p -71.75 153.94 7.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.587 -1.188 . . . . 0.36 109.981 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.502 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 20.2 t70 74.85 -21.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.361 0.601 . . . . 0.69 110.514 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.547 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.2 m170 -80.3 -7.38 59.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.342 -0.984 . . . . 0.63 108.342 170.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 113.07 60.88 0.42 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.537 -0.839 . . . . 0.79 114.048 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -59.29 -76.32 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.355 0.577 . . . . 3.31 110.913 171.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 m -84.79 -32.46 23.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.864 0.364 . . . . 1.21 110.873 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.491 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -56.57 -31.17 63.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.382 0.512 . . . . 1.25 112.382 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 HG21 ' A' ' 85' ' ' VAL . 12.5 tp -73.67 -40.15 63.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.508 -0.553 . . . . 1.49 109.508 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HA ' HG22 ' A' ' 28' ' ' ILE . 2.9 tp -72.17 -9.52 58.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.654 -0.703 . . . . 1.69 110.562 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -94.99 -43.31 8.21 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.458 -0.941 . . . . 1.23 108.458 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.52 78.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.046 -1.434 . . . . 0.63 110.065 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 7.6 tt -72.73 -32.99 42.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.975 -1.011 . . . . 1.02 110.354 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -65.86 -45.42 82.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.483 0.659 . . . . 3.04 109.926 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -84.36 24.75 0.94 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.845 -1.071 . . . . 2.65 111.373 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.7 t -113.24 -34.42 5.66 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.94 -1.027 . . . . 1.46 110.786 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HZ3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -172.98 -179.58 2.06 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.865 -0.42 . . . . 3.92 109.865 -176.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 50' ' ' VAL . 7.7 p 49.93 -69.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.444 1.497 . . . . 3.1 113.278 -175.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.542 ' H ' HG13 ' A' ' 33' ' ' VAL . 16.9 p -86.67 136.5 33.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.805 0.336 . . . . 2.78 110.927 -177.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.676 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 7.6 pt-20 -114.66 -151.37 0.48 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.234 -0.439 . . . . 6.34 110.474 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -76.88 -53.7 7.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 6.79 110.814 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -86.89 120.66 28.4 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.33 -0.619 . . . . 6.24 109.33 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HA ' ' CG2' ' A' ' 41' ' ' ILE . . . 66.57 27.5 9.58 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.454 0.645 . . . . 4.95 110.785 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.676 ' HA3' ' O ' ' A' ' 35' ' ' GLU . . . -89.01 79.78 1.6 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.734 -0.666 . . . . 4.68 112.976 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.19 6.95 66.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.772 -0.728 . . . . 4.55 112.946 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 38' ' ' ALA . 5.6 tp -86.52 110.81 20.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.474 0.655 . . . . 5.57 110.389 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 43' ' ' GLN . 17.5 m -145.77 166.94 24.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.015 -0.735 . . . . 5.93 109.015 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.43 ' N ' HG22 ' A' ' 42' ' ' THR . 69.8 mt-30 -49.17 -49.55 42.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.076 0.465 . . . . 6.63 110.83 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -95.13 97.05 9.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.234 0.54 . . . . 6.54 109.797 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -80.47 179.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.875 -0.602 . . . . 5.17 111.71 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.19 -81.36 0.5 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.489 -0.644 . . . . 2.51 111.489 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -90.77 177.66 6.26 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.216 -0.29 . . . . 1.36 110.216 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.442 ' CZ ' HG22 ' A' ' 50' ' ' VAL . 2.3 p90 -169.07 171.48 8.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.425 -0.51 . . . . 1.7 110.813 -170.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -100.51 136.23 40.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.877 -0.601 . . . . 1.91 109.652 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.555 ' HA ' HG11 ' A' ' 33' ' ' VAL . 14.6 t -101.63 155.73 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.459 0.647 . . . . 1.53 111.698 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.781 HG23 ' HA ' ' A' ' 54' ' ' ASP . 60.2 m -159.26 83.9 0.78 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.063 -0.972 . . . . 1.51 108.963 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 162' ' ' LEU . 2.8 p -63.67 -54.03 37.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.695 0.759 . . . . 2.27 109.123 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.588 ' H ' HG13 ' A' ' 52' ' ' VAL . 84.6 m-20 -123.63 -57.75 1.63 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 114.214 -1.357 . . . . 3.68 107.447 174.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.781 ' HA ' HG23 ' A' ' 51' ' ' THR . 18.1 t70 -170.64 77.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.566 -1.197 . . . . 2.99 109.686 164.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.676 ' HE3' HD12 ' A' ' 166' ' ' LEU . 75.3 mmtt -128.86 90.44 3.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.034 -1.098 . . . . 7.36 108.034 172.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -71.08 81.2 0.68 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.758 0.661 . . . . 4.46 111.13 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.451 HD13 HG21 ' A' ' 165' ' ' ILE . 16.4 mt -102.0 117.6 47.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.496 -0.774 . . . . 0.92 109.857 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -93.8 95.78 9.34 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.553 -0.536 . . . . 0.96 109.553 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.573 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 33.6 m-85 -66.56 151.2 47.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.819 -0.628 . . . . 1.57 110.544 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.667 ' HB2' HG22 ' A' ' 10' ' ' VAL . 35.6 tp -111.29 153.61 25.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.792 -0.447 . . . . 3.21 109.792 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 62' ' ' THR . 6.8 p-10 -70.96 -93.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.07 0.396 . . . . 5.61 112.07 -175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.491 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 2.4 t -171.77 82.58 0.48 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.5 0.667 . . . . 5.45 110.101 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.1 -56.06 2.15 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.249 2.633 . . . . 6.11 113.492 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.0 -122.78 2.93 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.39 -0.909 . . . . 6.36 112.758 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -74.52 -40.84 61.51 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.9 0.381 . . . . 8.78 111.364 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -113.39 149.06 34.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.285 -0.416 . . . . 7.05 111.528 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 63.87 104.92 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.29 0 O-C-N 124.425 1.078 . . . . 4.55 113.299 170.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' HD2' ' CD2' ' A' ' 102' ' ' HIS . 1.7 p90 -97.78 24.01 7.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.655 0.74 . . . . 2.37 109.037 168.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t 170.65 174.3 0.06 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.463 -1.244 . . . . 4.9 108.257 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.9 m -80.66 74.71 7.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.774 -0.824 . . . . 5.84 108.774 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.1 tpp -76.06 60.79 1.47 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.542 -0.754 . . . . 5.21 111.274 -173.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.17 -11.65 14.21 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.569 -0.9 . . . . 8.21 108.569 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.91 -57.84 5.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.931 -1.031 . . . . 6.36 111.196 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 54.22 55.48 8.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.031 0.443 . . . . 9.65 110.272 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.06 -155.55 28.91 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.813 -0.708 . . . . 4.93 112.834 -174.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.67 98.1 10.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.62 0.247 . . . . 5.47 110.819 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 55.27 43.53 28.97 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.521 -0.763 . . . . 6.26 111.306 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.9 t -80.42 85.94 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.224 -1.028 . . . . 4.31 108.224 174.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -92.1 108.09 19.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.729 -0.668 . . . . 3.41 112.396 -170.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' HA ' ' CB ' ' A' ' 9' ' ' PRO . 21.8 m-20 -81.45 127.82 33.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.478 -0.934 . . . . 2.66 108.478 169.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.495 ' CG2' HG12 ' A' ' 111' ' ' ILE . 38.3 mt -89.9 138.57 19.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.275 -0.42 . . . . 0.71 110.654 -172.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.41 125.51 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 C-N-CA 120.375 -0.53 . . . . 1.17 111.436 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.632 HG12 ' HB ' ' A' ' 111' ' ' ILE . 7.8 mt -87.49 130.19 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-N 115.62 -0.718 . . . . 0.37 109.923 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.454 ' O ' HD13 ' A' ' 84' ' ' LEU . 2.0 tm? -114.08 107.36 15.54 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.289 -1.004 . . . . 1.01 108.289 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.484 HG21 HD22 ' A' ' 24' ' ' LEU . 39.5 t -90.72 110.14 21.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.369 -0.832 . . . . 0.43 110.746 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.701 HG21 HD11 ' A' ' 131' ' ' LEU . 1.7 m -120.49 124.92 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.792 -0.64 . . . . 0.64 110.58 174.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -65.51 131.38 46.25 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 0.28 109.87 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -73.77 -12.54 60.73 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.182 0.515 . . . . 0.22 110.395 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 1.3 p-10 -95.94 -8.73 33.08 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.576 -0.738 . . . . 0.58 110.847 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.13 -48.9 1.45 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.407 -0.36 . . . . 0.56 110.818 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.556 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.89 -146.08 19.01 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 116.116 -0.493 . . . . 0.37 113.538 172.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.508 HG21 ' CE2' ' A' ' 134' ' ' TYR . 9.9 p -82.13 140.01 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.571 0.701 . . . . 1.03 110.229 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.688 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.6 mmm -142.21 175.12 3.15 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.836 -1.075 . . . . 0.28 108.916 -173.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 75.0 Cg_exo -42.9 -59.07 1.08 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.197 2.598 . . . . 0.58 114.971 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.525 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.8 pt20 -79.42 -17.51 54.15 Favored 'General case' 0 CA--C 1.526 0.042 0 C-N-CA 120.419 -0.513 . . . . 0.75 110.969 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.645 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.33 -43.23 91.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 0.31 109.334 178.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.533 HG12 ' ND2' ' A' ' 101' ' ' ASN . 32.3 t -60.47 -45.71 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 114.766 -1.107 . . . . 1.38 111.913 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -57.66 -31.79 66.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.977 -0.556 . . . . 2.35 110.638 -175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.01 -30.29 63.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 0.44 110.736 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.0 mt -77.11 -44.73 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.882 0.849 . . . . 0.41 108.775 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.533 ' ND2' HG12 ' A' ' 97' ' ' VAL . 41.2 m-20 -63.63 -32.21 73.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.245 -1.343 . . . . 0.67 111.002 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.422 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 3.5 t-160 -63.04 -45.79 90.6 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.441 0.639 . . . . 2.5 109.626 173.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.566 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -78.42 -51.53 9.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.329 -0.85 . . . . 0.47 112.752 -172.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 29.4 mmmt -68.34 -34.08 75.45 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.931 0.396 . . . . 1.66 110.753 -173.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.74 92.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.655 -0.702 . . . . 0.77 110.837 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.71 53.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.471 -0.332 . . . . 0.74 111.158 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 t30 86.09 47.33 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.232 1.013 . . . . 1.41 109.467 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -111.37 138.4 21.36 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.362 -1.29 . . . . 1.35 110.417 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 34.6 Cg_exo -62.5 144.83 95.26 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.863 2.376 . . . . 0.47 113.436 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.566 HD11 ' CB ' ' A' ' 103' ' ' ALA . 27.1 mm -106.12 160.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.076 -0.965 . . . . 0.6 110.696 -175.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.818 HD13 ' HB ' ' A' ' 146' ' ' ILE . 29.9 mm -124.46 83.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 107.101 -1.444 . . . . 0.37 107.101 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.096 HG23 HG21 ' A' ' 145' ' ' THR . 62.0 t -69.03 146.98 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.636 0.731 . . . . 0.26 109.049 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -148.01 102.93 3.43 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.45 -1.25 . . . . 0.29 110.073 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.752 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 2.8 mp -70.57 139.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-N 113.767 -1.56 . . . . 0.59 109.068 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.1 p-10 -121.19 175.8 5.93 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.081 -1.451 . . . . 1.85 107.081 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.731 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 83.6 mttt 69.87 30.97 3.57 Favored 'General case' 0 N--CA 1.434 -1.275 0 O-C-N 123.742 0.651 . . . . 0.59 111.098 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.654 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 11.3 mmt -73.18 -14.95 61.45 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 122.328 1.061 . . . . 0.92 108.624 167.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.586 ' CG ' ' HB2' ' A' ' 153' ' ' LYS . 2.0 p-10 -72.63 -19.64 61.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.404 -1.725 . . . . 0.76 110.602 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.469 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 36.6 mtpt -89.32 144.42 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.775 -0.648 . . . . 1.17 110.684 176.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.25 -17.22 40.01 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.789 2.326 . . . . 0.58 111.694 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 31.9 mt-10 -85.45 8.59 18.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.455 -0.793 . . . . 1.45 111.032 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.14 112.36 1.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.27 110.743 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.882 HD22 ' HB2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -127.89 76.2 77.64 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.95 108.969 175.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.506 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 37.8 Cg_endo -63.71 -58.03 0.31 Allowed 'Trans proline' 0 CA--C 1.507 -0.845 0 C-N-CA 123.177 2.584 . . . . 0.4 113.022 -174.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 16.5 t70 -45.6 -29.38 1.19 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.285 0.991 . . . . 1.44 110.93 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.882 ' HB2' HD22 ' A' ' 123' ' ' ASN . 10.5 ttp180 -82.26 -56.45 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 3.79 110.173 -175.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.75 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 16.6 m -65.64 -29.92 48.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.719 -0.673 . . . . 0.59 111.387 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 1.025 ' HA ' HD12 ' A' ' 131' ' ' LEU . 4.4 ttt -71.12 -31.16 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.425 1.09 . . . . 0.81 110.56 176.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -73.06 -36.33 66.86 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.653 -0.419 . . . . 1.31 111.375 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.618 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.2 mt-10 -63.06 -28.88 70.39 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.61 1.195 . . . . 1.64 108.976 175.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.025 HD12 ' HA ' ' A' ' 128' ' ' MET . 90.9 mt -62.03 -39.23 91.58 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.4 -1.727 . . . . 1.36 109.585 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.679 ' HG2' ' HA ' ' A' ' 137' ' ' VAL . 34.5 mtp -77.95 -15.92 58.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.308 0.484 . . . . 1.61 112.308 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.495 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 9.1 mm-40 -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.083 -1.08 . . . . 1.67 108.083 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.508 ' CE2' HG21 ' A' ' 92' ' ' VAL . 85.2 m-85 -104.64 22.87 14.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.888 -1.051 . . . . 1.08 110.635 172.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.9 t30 66.78 28.85 8.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.081 -1.418 . . . . 1.1 112.623 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -116.1 116.79 28.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.627 -0.879 . . . . 1.36 108.627 170.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.929 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 91.5 t -112.21 136.84 21.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 0.43 112.51 -167.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.762 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -45.79 127.92 10.53 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 124.205 3.27 . . . . 0.54 111.681 169.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.756 ' HG2' HD13 ' A' ' 146' ' ' ILE . 1.8 pp20? -73.27 -20.9 60.73 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.661 -0.866 . . . . 3.08 108.661 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 147' ' ' PHE . 1.5 pm0 -59.01 -27.37 65.38 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.659 -0.7 . . . . 1.57 110.608 169.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.676 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 41.0 m0 -103.47 -11.79 17.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.919 0.39 . . . . 0.66 111.049 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.24 24.75 5.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.713 -0.756 . . . . 0.53 113.362 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.929 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.6 -120.22 2.21 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.387 -0.911 . . . . 0.6 111.952 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -156.27 58.88 0.57 Allowed 'General case' 0 C--O 1.243 0.713 0 CA-C-O 122.293 1.044 . . . . 1.91 112.192 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 1.096 HG21 HG23 ' A' ' 112' ' ' VAL . 81.1 m -165.7 129.27 2.19 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.385 -0.825 . . . . 0.37 110.739 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.818 ' HB ' HD13 ' A' ' 111' ' ' ILE . 24.0 mm -72.78 105.03 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.081 -1.081 . . . . 0.63 108.081 168.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.762 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 9.0 m-85 -89.67 112.3 23.52 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.771 -0.65 . . . . 0.5 110.804 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 78.7 m -97.94 142.44 29.67 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.479 -0.782 . . . . 0.68 110.347 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.552 ' HE2' ' HE3' ' A' ' 128' ' ' MET . 5.1 mmtp -117.64 96.83 5.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.286 -1.005 . . . . 1.44 108.286 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.752 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 4.0 pp -127.78 -175.71 3.55 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.903 1.335 . . . . 0.84 113.036 -171.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 1.4 p -157.37 89.98 1.08 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 112.914 -1.948 . . . . 1.77 108.028 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.23 -15.26 63.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.256 0.551 . . . . 0.41 110.4 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.74 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 0.1 OUTLIER -77.8 -42.93 32.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.565 -0.743 . . . . 2.3 112.037 175.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.437 ' OG1' ' HB2' ' A' ' 151' ' ' SER . 0.9 OUTLIER -87.34 -9.27 55.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.526 -0.869 . . . . 0.7 111.804 175.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 66.73 50.19 1.18 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.089 -0.959 . . . . 1.36 110.995 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -109.51 -65.82 1.11 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.702 1.239 . . . . 2.48 110.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.752 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -74.26 -4.05 67.42 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.054 -1.43 . . . . 0.29 113.897 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 158' ' ' LEU . 28.8 mt -71.33 -37.62 71.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.044 0.922 . . . . 0.8 109.238 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.84 -40.47 79.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.219 -0.9 . . . . 2.2 109.431 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 83.7 t60 -74.93 -10.62 59.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.079 -0.51 . . . . 0.58 111.303 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.55 -55.21 5.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.384 0.611 . . . . 1.16 109.837 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.626 HD13 HG11 ' A' ' 52' ' ' VAL . 4.2 pp -62.89 -28.5 70.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.021 -0.99 . . . . 1.51 111.643 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 12.5 pt-20 -77.99 -27.3 49.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.847 -0.341 . . . . 2.57 111.23 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.567 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 14.8 mmt -74.53 -44.1 52.74 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.282 -0.636 . . . . 0.64 109.282 173.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 83' ' ' ILE . 84.2 mt -58.19 -39.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.227 -0.897 . . . . 0.52 110.203 173.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.676 HD12 ' HE3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -59.7 -44.19 93.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.463 -0.79 . . . . 1.73 111.693 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.48 ' N ' HD23 ' A' ' 166' ' ' LEU . 27.2 tp -54.42 -43.02 71.17 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.555 0.693 . . . . 1.51 109.923 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.82 -41.1 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.991 -1.004 . . . . 0.89 110.859 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.7 m -65.13 -44.67 87.9 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.43 0.53 . . . . 1.35 112.43 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 10.5 pt-20 -103.18 3.73 36.04 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.452 0.538 . . . . 2.73 112.452 -171.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.6 ttm -44.83 -64.54 0.68 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.392 0.432 . . . . 1.88 112.14 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -97.4 -80.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 4.27 110.721 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.63 -80.22 0.6 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.637 0.732 . . . . 3.91 109.463 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 29.0 tp -134.09 34.52 3.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.798 -1.556 . . . . 5.72 106.798 171.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -162.82 151.6 14.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.554 -1.657 . . . . 5.49 109.039 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.72 -57.42 2.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.189 -0.46 . . . . 5.78 110.919 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 43.1 t30 69.82 101.59 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 123.569 0.543 . . . . 7.88 111.104 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.998 2.465 . . . . 9.19 112.149 -178.711 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.74 ' C2 ' ' HG3' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 111.751 -0.54 . . . . 11.58 111.751 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -64.02 -79.71 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.688 0.28 . . . . 10.61 111.208 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -100.88 -26.25 13.82 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.346 -0.613 . . . . 10.14 109.346 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -72.92 121.8 20.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 8.77 109.412 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.99 160.87 42.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.433 0.635 . . . . 5.74 112.431 -172.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' OE2' ' HD3' ' A' ' 7' ' ' ARG . 15.1 tp10 -141.37 77.04 1.57 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.065 -0.97 . . . . 5.7 108.512 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.4 ' HD3' ' OE2' ' A' ' 6' ' ' GLU . 7.9 mtp180 51.43 72.66 1.15 Allowed Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 115.666 -0.697 . . . . 6.85 110.95 -175.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' A' ' 9' ' ' PRO . 87.9 Cg_exo -47.94 -40.59 32.91 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.131 3.221 . . . . 2.8 115.672 -174.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 8' ' ' PRO . 30.2 Cg_endo -64.48 64.22 0.26 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.233 1.955 . . . . 2.76 113.365 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.2 t -95.18 83.04 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.075 -1.083 . . . . 2.0 108.075 171.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.551 HG12 ' HB ' ' A' ' 81' ' ' ILE . 2.9 m -90.32 146.64 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.081 0.467 . . . . 1.35 111.063 -169.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.782 ' HB ' HG22 ' A' ' 82' ' ' VAL . 90.5 m -94.68 125.96 39.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.861 -0.608 . . . . 0.64 110.704 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 59' ' ' PHE . 66.7 mt -83.42 122.61 37.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.856 0.36 . . . . 1.3 110.125 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.59 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 56.2 mtt -132.75 170.37 15.36 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.148 -0.686 . . . . 0.79 109.148 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.29 179.41 16.64 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.597 -0.811 . . . . 0.31 111.762 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.596 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 50.5 t60 -85.41 158.96 20.09 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.867 0.842 . . . . 0.22 111.631 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 19' ' ' HIS . 5.7 p -73.58 155.27 6.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.495 -1.23 . . . . 0.36 109.643 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.678 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 25.9 t70 72.92 -17.56 0.4 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.211 0.529 . . . . 0.69 110.661 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.485 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 19.7 m170 -85.83 -6.57 59.07 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.001 -0.74 . . . . 0.63 109.001 171.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.807 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 131.29 39.25 0.26 Allowed Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 118.972 -1.585 . . . . 0.79 115.066 170.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -52.36 -65.97 0.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.559 1.18 . . . . 3.31 111.51 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.704 HG23 HG21 ' A' ' 45' ' ' ILE . 85.9 m -89.51 -29.68 18.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 1.21 110.696 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.62 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.08 -33.92 69.59 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.777 0.658 . . . . 1.25 112.777 -176.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.807 HD23 ' HA3' ' A' ' 20' ' ' GLY . 3.8 mm? -76.14 -33.33 59.4 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 122.142 -0.349 . . . . 1.49 110.447 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 1.6 tp -72.73 -7.43 50.53 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.431 -0.508 . . . . 1.69 109.831 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.83 -47.96 4.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.939 0.876 . . . . 1.23 109.65 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB1' ' HB1' ' A' ' 152' ' ' ALA . . . -64.89 -42.58 94.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.213 -1.358 . . . . 0.63 110.434 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 84.9 mt -74.07 -31.71 30.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.231 -0.895 . . . . 1.02 109.943 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.656 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 17.4 tpp180 -62.1 -36.15 80.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.409 0.623 . . . . 3.04 109.8 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -103.15 24.18 11.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.073 -0.967 . . . . 2.65 111.431 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 83.5 p -87.37 -45.98 10.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.586 -1.265 . . . . 1.46 107.586 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.508 ' HE3' ' O ' ' A' ' 51' ' ' THR . 57.5 pttt 178.84 -164.72 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.494 -1.23 . . . . 3.92 108.655 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.587 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 9.5 p 52.7 -62.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.36 1.464 . . . . 3.1 114.106 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 38' ' ' ALA . 49.5 p -107.96 176.04 5.27 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.746 0.419 . . . . 2.78 111.128 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -140.52 -38.35 0.44 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.577 0.227 . . . . 6.34 110.591 171.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -149.17 -85.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 6.79 110.742 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.68 ' HG3' HD11 ' A' ' 41' ' ' ILE . 40.5 tt0 -91.39 83.11 5.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.098 0.475 . . . . 6.24 110.857 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 34' ' ' THR . . . -155.43 132.79 10.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.641 -0.708 . . . . 4.95 109.662 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.44 -58.83 3.42 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.807 -0.711 . . . . 4.68 112.019 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.02 115.05 0.37 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.456 -0.878 . . . . 4.55 112.958 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.68 HD11 ' HG3' ' A' ' 37' ' ' GLU . 2.5 pp -145.33 149.21 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.475 -0.565 . . . . 5.57 109.475 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.3 m -155.44 -73.25 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.051 0.453 . . . . 5.93 110.373 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -162.37 -59.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.755 -0.831 . . . . 6.63 108.755 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -77.34 138.55 39.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.045 -1.094 . . . . 6.54 108.045 167.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.704 HG21 HG23 ' A' ' 22' ' ' THR . 2.5 pp -80.73 162.62 3.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.336 0.589 . . . . 5.17 111.389 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.24 -90.63 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.44 -1.064 . . . . 2.51 110.44 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB3' ' CA ' ' A' ' 60' ' ' LEU . . . -178.26 -167.25 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.513 0.197 . . . . 1.36 110.66 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -172.54 166.56 5.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.03 -0.532 . . . . 1.7 109.756 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.24 107.06 15.53 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.755 -0.461 . . . . 1.91 109.755 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.59 153.74 3.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.267 0.556 . . . . 1.53 110.304 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.875 HG23 ' HA ' ' A' ' 54' ' ' ASP . 16.6 m -100.5 90.92 4.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.704 0.764 . . . . 1.51 111.01 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 162' ' ' LEU . 3.8 p -77.05 -48.8 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.02 -1.104 . . . . 2.27 108.02 168.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.504 ' H ' HG13 ' A' ' 52' ' ' VAL . 1.8 p30 -112.97 -56.26 2.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.713 -1.585 . . . . 3.68 107.495 168.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.875 ' HA ' HG23 ' A' ' 51' ' ' THR . 30.6 t70 -179.67 106.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.283 -1.326 . . . . 2.99 111.045 163.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' H ' ' HA ' ' A' ' 51' ' ' THR . 45.1 mmtm 66.28 55.76 0.84 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.531 -0.758 . . . . 7.36 111.148 174.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.641 ' HG3' HG13 ' A' ' 57' ' ' ILE . 3.2 tppp? -130.3 140.46 50.66 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.704 -0.85 . . . . 4.46 108.704 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.666 HD13 HG22 ' A' ' 165' ' ' ILE . 21.8 mt 70.64 83.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 123.89 0.744 . . . . 0.92 110.275 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 60' ' ' LEU . 7.4 m -76.97 107.16 9.12 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.612 -0.884 . . . . 0.96 108.612 173.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.689 ' HB3' HD11 ' A' ' 13' ' ' ILE . 8.3 m-85 -60.76 -5.6 1.37 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.355 -0.839 . . . . 1.57 112.08 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' H ' HG22 ' A' ' 58' ' ' THR . 57.7 tp -80.06 130.61 35.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 3.21 110.149 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' HB3' HG23 ' A' ' 12' ' ' THR . 2.6 p30 -81.28 -163.57 0.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.861 -0.608 . . . . 5.61 111.143 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.69 ' HA ' ' SD ' ' A' ' 71' ' ' MET . 40.8 m 83.39 87.88 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.109 -0.951 . . . . 5.45 111.707 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -91.35 9.6 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.178 2.586 . . . . 6.11 111.799 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.54 -69.28 2.28 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.781 -0.645 . . . . 6.36 113.008 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -70.36 -65.17 0.76 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.823 0.305 . . . . 8.78 111.823 -174.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -75.28 143.1 43.17 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.76 -0.459 . . . . 7.05 109.76 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB1' ' H ' ' A' ' 71' ' ' MET . . . -119.34 68.73 0.81 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.925 0.393 . . . . 4.55 110.977 -173.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HB3' ' CE ' ' A' ' 14' ' ' MET . 80.1 m-85 -55.74 -68.22 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.34 -0.845 . . . . 2.37 112.335 -176.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.659 ' H ' ' HE3' ' A' ' 71' ' ' MET . 2.5 p -92.18 50.74 1.68 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 111.75 0.278 . . . . 4.9 111.75 -176.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 m 57.25 77.87 0.25 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.405 0.621 . . . . 5.84 110.743 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.69 ' SD ' ' HA ' ' A' ' 62' ' ' THR . 44.4 mtt -102.78 -66.42 0.93 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 5.21 110.158 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.641 ' HG3' ' H ' ' A' ' 73' ' ' ALA . 26.8 ptt180 -127.73 -78.01 0.57 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.273 -0.571 . . . . 8.21 111.236 170.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.641 ' H ' ' HG3' ' A' ' 72' ' ' ARG . . . -135.1 -75.84 0.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.09 0.405 . . . . 6.36 111.207 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.469 ' HG2' ' N ' ' A' ' 75' ' ' GLY . 29.9 ttm180 -166.84 158.92 13.15 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.437 -0.949 . . . . 9.65 108.437 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.469 ' N ' ' HG2' ' A' ' 74' ' ' ARG . . . -164.29 -118.07 0.43 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.778 -1.201 . . . . 4.93 112.661 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.64 152.99 10.44 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.09 -0.337 . . . . 5.47 110.09 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.422 ' HG2' ' HZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -125.36 175.63 7.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.903 -0.589 . . . . 6.26 110.359 176.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.52 -68.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 4.31 110.412 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.4 m -148.92 81.43 1.44 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.222 0.534 . . . . 3.41 109.694 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -107.35 -177.9 3.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.46 -0.791 . . . . 2.66 109.559 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.551 ' HB ' HG12 ' A' ' 11' ' ' VAL . 23.0 mt -135.86 134.38 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.909 -0.404 . . . . 0.71 109.909 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 12' ' ' THR . 18.7 t -115.63 118.73 59.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.255 0.55 . . . . 1.17 111.185 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 51.9 mt -82.41 131.38 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.32 -0.855 . . . . 0.37 109.73 172.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.43 HD13 ' C ' ' A' ' 84' ' ' LEU . 2.3 tm? -119.58 107.93 13.87 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.665 -0.865 . . . . 1.01 108.665 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.5 t -89.11 114.57 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.725 -0.67 . . . . 0.43 111.134 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 2.4 m -127.58 123.73 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.807 -0.633 . . . . 0.64 110.593 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.62 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.35 135.37 50.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.107 -0.497 . . . . 0.28 109.779 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.802 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -72.71 -15.59 61.68 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 121.05 0.452 . . . . 0.22 111.37 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.423 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 5.3 p-10 -90.35 -24.15 20.91 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.753 -0.658 . . . . 0.58 111.244 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.485 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 16.7 t0 -113.53 -41.63 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.56 111.245 -173.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.612 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 88.11 -131.54 10.7 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 114.419 0.528 . . . . 0.37 114.419 171.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.4 t -106.17 130.82 57.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.472 0.653 . . . . 1.03 110.568 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.696 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.7 mmm -131.32 177.78 2.07 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.461 -1.245 . . . . 0.28 109.377 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.696 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 61.2 Cg_exo -41.73 -63.16 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.093 2.529 . . . . 0.58 114.72 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.537 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 4.1 pt20 -72.97 -19.62 61.19 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.608 -0.437 . . . . 0.75 111.173 -174.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.596 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -65.82 -45.55 81.87 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.021 -0.733 . . . . 0.31 109.021 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 93' ' ' MET . 17.8 t -65.51 -43.6 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 114.889 -1.05 . . . . 1.38 112.065 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -57.02 -24.57 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.488 . . . . 2.35 110.71 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.59 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -76.97 -39.94 48.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.44 110.633 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.0 mt -71.53 -41.56 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.829 0.824 . . . . 0.41 109.41 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.484 ' ND2' HG12 ' A' ' 97' ' ' VAL . 23.1 m-20 -61.05 -28.79 69.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.324 -1.307 . . . . 0.67 110.89 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.476 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 5.0 t60 -83.77 -34.4 24.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.811 -0.44 . . . . 2.5 109.811 174.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.559 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -65.52 -42.09 92.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.198 -0.455 . . . . 0.47 111.046 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' NZ ' ' HB3' ' A' ' 135' ' ' ASN . 18.9 mmtp -73.18 -35.74 66.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.383 0.611 . . . . 1.66 109.796 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.33 -40.72 59.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.306 -1.316 . . . . 0.77 111.413 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.27 -35.19 15.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.338 -0.392 . . . . 0.74 110.96 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.4 t30 87.97 51.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.403 1.081 . . . . 1.41 109.609 173.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.11 141.73 23.09 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.969 -1.469 . . . . 1.35 110.58 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.01 140.65 66.84 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.549 2.166 . . . . 0.47 111.975 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.575 ' C ' HG23 ' A' ' 145' ' ' THR . 24.2 mm -104.2 158.71 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.46 0.648 . . . . 0.6 110.758 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.775 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 17.0 mm -129.32 88.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.553 -1.277 . . . . 0.37 107.553 171.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.942 HG23 HG21 ' A' ' 145' ' ' THR . 43.3 t -78.34 146.99 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.941 0.877 . . . . 0.26 110.338 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.896 ' HB1' HD11 ' A' ' 150' ' ' LEU . . . -139.79 111.06 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.925 -1.489 . . . . 0.29 110.144 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.802 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 2.8 mp -83.15 126.24 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.603 -1.18 . . . . 0.59 109.798 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.54 ' ND2' ' HG3' ' A' ' 116' ' ' LYS . 7.1 p-10 -114.35 168.79 9.54 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.42 -1.326 . . . . 1.85 107.42 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.734 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 89.4 mttt 70.44 31.57 2.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.927 0.767 . . . . 0.59 111.92 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.565 ' HA ' ' CB ' ' A' ' 122' ' ' ALA . 77.3 mmm -80.48 -9.7 59.76 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.505 0.669 . . . . 0.92 109.451 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.406 ' HB2' HG23 ' A' ' 154' ' ' THR . 8.3 p-10 -67.97 -32.54 73.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.968 -1.015 . . . . 0.76 109.415 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HE2' ' HD3' ' A' ' 116' ' ' LYS . 28.6 mtmt -75.58 139.14 70.67 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.956 -1.02 . . . . 1.17 110.688 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.66 -15.8 51.96 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.885 2.39 . . . . 0.58 111.469 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -78.76 -7.81 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.11 -0.95 . . . . 1.45 110.27 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.565 ' CB ' ' HA ' ' A' ' 117' ' ' MET . . . -58.03 115.39 2.85 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.711 -0.677 . . . . 0.27 111.113 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.969 HD22 ' HB2' ' A' ' 126' ' ' ARG . 1.2 t30 -128.71 77.58 77.32 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.432 -0.951 . . . . 0.95 108.432 173.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.576 ' HA ' HG22 ' A' ' 127' ' ' VAL . 49.5 Cg_endo -65.13 -50.8 1.86 Allowed 'Trans proline' 0 CA--C 1.5 -1.185 0 C-N-CA 123.267 2.644 . . . . 0.4 112.906 -171.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.605 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 8.1 m-20 -54.43 -26.93 33.63 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.958 -1.019 . . . . 1.44 110.042 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.969 ' HB2' HD22 ' A' ' 123' ' ' ASN . 37.4 ttp180 -79.09 -54.24 6.2 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.411 0.624 . . . . 3.79 109.339 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.799 HG21 ' HA ' ' A' ' 88' ' ' ALA . 21.9 m -65.22 -29.29 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.272 -0.876 . . . . 0.59 111.928 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.951 ' HA ' HD23 ' A' ' 131' ' ' LEU . 16.4 ptm -79.41 -14.87 58.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.827 0.346 . . . . 0.81 110.392 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.602 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 80.3 mt-30 -79.91 -24.85 40.83 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 121.025 -0.27 . . . . 1.31 110.487 171.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 6.5 mm-40 -67.95 -31.13 70.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.431 -0.952 . . . . 1.64 108.431 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.951 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -61.29 -46.0 92.13 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.581 -1.191 . . . . 1.36 109.335 175.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.561 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -74.82 -7.98 55.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 119.963 -0.695 . . . . 1.61 110.969 -178.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 28.3 mm-40 -72.26 -28.13 62.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.542 -0.91 . . . . 1.67 108.542 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -102.96 31.8 4.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.037 -0.983 . . . . 1.08 110.255 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 104' ' ' LYS . 63.3 t30 55.68 43.49 27.96 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.699 -1.137 . . . . 1.1 111.761 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.561 ' H ' ' HA ' ' A' ' 132' ' ' MET . 52.5 mt -112.66 104.68 12.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.968 -0.56 . . . . 1.36 109.734 172.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.093 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 24.5 t -104.28 117.08 60.21 Favored Pre-proline 0 C--N 1.314 -0.954 0 C-N-CA 120.121 -0.632 . . . . 0.43 111.322 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.718 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.2 Cg_exo -43.73 139.72 5.04 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 124.196 3.264 . . . . 0.54 112.409 171.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -71.6 -18.69 62.2 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.411 -1.268 . . . . 3.08 110.114 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.0 pm0 -62.25 -27.11 68.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.759 -0.655 . . . . 1.57 110.089 168.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.602 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 39.4 m0 -102.53 -27.83 12.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.387 -0.369 . . . . 0.66 110.69 -175.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.48 2.39 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.769 -0.729 . . . . 0.53 112.977 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 1.093 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.25 -119.26 2.54 Favored Glycine 0 CA--C 1.507 -0.46 0 C-N-CA 119.846 -1.169 . . . . 0.6 112.245 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -151.81 59.47 0.86 Allowed 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.773 0.797 . . . . 1.91 111.438 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.942 HG21 HG23 ' A' ' 112' ' ' VAL . 97.6 m -165.27 123.94 1.68 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.351 -0.841 . . . . 0.37 110.488 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.775 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 27.3 mm -75.59 104.25 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.096 -0.705 . . . . 0.63 109.096 171.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.744 ' HE2' HD23 ' A' ' 131' ' ' LEU . 12.6 m-85 -88.28 117.73 27.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.396 -0.82 . . . . 0.5 110.196 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 72.2 m -101.42 136.74 40.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.057 -0.349 . . . . 0.68 110.057 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.564 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.7 mttt -108.0 91.92 3.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.981 -0.377 . . . . 1.44 109.981 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.052 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -120.85 -167.72 1.53 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 123.077 1.418 . . . . 0.84 113.334 -174.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.403 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.1 OUTLIER -164.81 106.48 0.83 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.315 -1.766 . . . . 1.77 106.411 174.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.543 ' HB1' ' HB1' ' A' ' 27' ' ' ALA . . . -65.83 -14.16 60.9 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.62 -0.718 . . . . 0.41 109.434 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -52.98 30.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.15 -0.932 . . . . 2.3 110.62 173.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 118' ' ' ASP . 1.1 p -84.99 -7.67 59.05 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.398 0.518 . . . . 0.7 112.398 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.571 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.8 mmtp 63.17 46.5 4.57 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.668 -0.696 . . . . 1.36 111.398 176.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -107.61 -70.79 0.78 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 123.039 1.4 . . . . 2.48 110.602 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 1.052 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -67.45 -8.51 51.65 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 113.664 -1.607 . . . . 0.29 113.269 -175.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.571 HD12 ' HD3' ' A' ' 155' ' ' LYS . 28.6 mt -69.4 -40.48 77.34 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 117.785 0.793 . . . . 0.8 109.423 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -65.24 -44.2 88.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.345 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -70.87 -17.75 62.71 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.06 -0.518 . . . . 0.58 111.452 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 113' ' ' ALA . 5.9 mt -72.06 -57.49 4.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.011 0.434 . . . . 1.16 110.226 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.519 HD13 HG23 ' A' ' 52' ' ' VAL . 4.3 pp -60.66 -29.35 69.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.498 -0.774 . . . . 1.51 110.804 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.411 ' N ' HD12 ' A' ' 162' ' ' LEU . 29.7 mm-40 -63.17 -51.67 65.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.993 0.425 . . . . 2.57 110.589 174.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.492 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 17.1 mmt -67.72 -46.25 72.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.64 110.533 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.666 HG22 HD13 ' A' ' 57' ' ' ILE . 98.7 mt -58.13 -44.12 86.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.682 -0.69 . . . . 0.52 110.971 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -41.37 86.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.423 -0.353 . . . . 1.73 111.19 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.42 -43.47 67.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.284 0.564 . . . . 1.51 109.567 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 111' ' ' ILE . 92.6 t -69.21 -43.38 81.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.812 -1.086 . . . . 0.89 111.02 176.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.6 m -60.23 -39.87 88.2 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.671 0.272 . . . . 1.35 111.607 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -80.9 -14.7 57.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.121 0.486 . . . . 2.73 110.387 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.59 ' HG2' ' HA ' ' A' ' 175' ' ' LYS . 46.1 ttp -75.26 -10.36 59.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.767 -0.651 . . . . 1.88 110.536 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.524 ' O ' ' HE2' ' A' ' 175' ' ' LYS . 36.8 tt0 -46.47 -50.96 16.18 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.161 -0.472 . . . . 4.27 110.828 175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -100.13 -21.23 15.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.502 0.668 . . . . 3.91 110.242 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.59 48.28 0.85 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.475 -0.784 . . . . 5.72 110.54 -173.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.72 ' H ' ' HD2' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -48.32 118.8 2.61 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.898 0.38 . . . . 5.49 111.324 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.12 133.86 39.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.254 -0.43 . . . . 5.78 110.1 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 4.5 p-10 -110.51 124.06 34.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 121.271 0.557 . . . . 7.88 110.635 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 10.7 Cg_endo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 123.428 2.752 . . . . 9.19 111.765 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.734 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.813 -0.115 . . . . 11.58 112.813 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -81.01 118.49 22.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.273 0.471 . . . . 10.61 112.273 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 m80 58.49 67.61 0.92 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.608 -0.724 . . . . 10.14 112.655 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.7 mmt -109.55 -57.86 2.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.178 0.513 . . . . 8.77 109.927 173.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.79 -21.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.508 0.67 . . . . 5.74 109.332 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.43 93.01 9.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.474 -0.785 . . . . 5.7 110.093 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -140.18 76.62 26.54 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.582 -0.735 . . . . 6.85 110.217 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HD2' ' HD3' ' A' ' 9' ' ' PRO . 38.8 Cg_exo -57.61 -51.59 7.93 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.646 2.897 . . . . 2.8 115.486 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.598 ' HB2' ' H ' ' A' ' 57' ' ' ILE . 12.6 Cg_exo -69.15 91.53 0.45 Allowed 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 121.873 1.715 . . . . 2.76 113.529 -171.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.1 139.32 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.859 -0.61 . . . . 2.0 110.045 174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 97.9 t -135.24 109.14 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.117 -0.492 . . . . 1.35 111.076 -175.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.715 ' HB ' HG22 ' A' ' 82' ' ' VAL . 91.4 m -77.87 134.69 37.89 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.755 0.312 . . . . 0.64 110.816 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.921 HG13 HD21 ' A' ' 25' ' ' LEU . 45.9 mm -96.97 118.86 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 1.3 110.667 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.62 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 61.5 mtt -131.28 176.05 8.61 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.175 -0.676 . . . . 0.79 109.175 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' HA2' HD13 ' A' ' 84' ' ' LEU . . . 139.42 -159.58 25.78 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.654 -0.784 . . . . 0.31 111.653 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.516 ' CE1' HG12 ' A' ' 17' ' ' VAL . 42.1 t60 -101.97 162.05 13.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.036 0.922 . . . . 0.22 112.167 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.516 HG12 ' CE1' ' A' ' 16' ' ' HIS . 7.4 p -81.86 150.61 4.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.255 -1.339 . . . . 0.36 110.726 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.571 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 30.9 t70 71.6 -23.43 0.19 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.423 0.689 . . . . 0.69 111.362 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.458 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 23.5 m170 -62.79 -38.19 89.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.997 -1.482 . . . . 0.63 106.997 163.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 140.76 55.95 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.562 -0.828 . . . . 0.79 113.751 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -61.4 2.43 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.49 0.645 . . . . 3.31 111.483 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -87.68 -40.12 14.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.919 0.39 . . . . 1.21 111.452 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -27.44 62.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 1.25 112.179 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -62.12 -51.21 68.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 1.49 109.843 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.921 HD21 HG13 ' A' ' 13' ' ' ILE . 76.8 mt -71.38 -14.61 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.857 -0.611 . . . . 1.69 111.025 -174.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 19.2 t70 -90.47 -38.63 13.12 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.469 -0.938 . . . . 1.23 108.469 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -70.6 -35.14 72.83 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.29 -1.323 . . . . 0.63 110.186 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' A' ' 25' ' ' LEU . 13.1 tt -76.7 -33.01 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.969 -1.014 . . . . 1.02 111.102 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 24.1 ptt85 -76.44 -35.35 58.55 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.85 0.833 . . . . 3.04 109.4 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -84.96 21.91 1.5 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.364 -1.289 . . . . 2.65 110.495 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -121.07 16.16 11.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.55 -1.205 . . . . 1.46 110.191 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 1.3 ptpp? 176.05 -153.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.342 0.592 . . . . 3.92 111.149 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' H ' ' HB2' ' A' ' 32' ' ' LYS . 21.6 t -114.31 138.7 43.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.837 -1.074 . . . . 3.1 111.222 -175.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.472 HG23 ' HA2' ' A' ' 40' ' ' GLY . 4.0 t -156.55 175.5 13.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.446 -0.946 . . . . 2.78 108.446 172.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.624 ' HG3' ' HB ' ' A' ' 41' ' ' ILE . 1.9 tm-20 58.79 -156.97 0.33 Allowed 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.323 0.39 . . . . 6.34 110.738 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.98 -2.31 57.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.748 -0.381 . . . . 6.79 110.964 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -140.69 139.72 34.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 6.24 111.353 -176.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.11 105.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.566 -0.743 . . . . 4.95 111.499 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.49 -28.54 2.44 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.832 -0.907 . . . . 4.68 110.832 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.472 ' HA2' HG23 ' A' ' 34' ' ' THR . . . 95.35 -157.29 21.9 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.894 -0.67 . . . . 4.55 112.782 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.624 ' HB ' ' HG3' ' A' ' 35' ' ' GLU . 12.7 tt -136.5 144.06 33.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.656 -0.498 . . . . 5.57 109.656 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.431 ' O ' HG22 ' A' ' 45' ' ' ILE . 6.2 m -100.31 -83.39 0.44 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.21 -0.293 . . . . 5.93 110.21 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 58.74 9.49 1.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.788 0.435 . . . . 6.63 111.995 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 52.85 42.84 32.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.259 -0.428 . . . . 6.54 111.094 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.462 HG12 ' N ' ' A' ' 46' ' ' GLY . 14.5 tt -91.06 160.89 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.223 0.535 . . . . 5.17 110.104 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 45' ' ' ILE . . . -96.67 98.43 2.17 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.382 -0.826 . . . . 2.51 112.141 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.77 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . 73.08 177.9 0.24 Allowed 'General case' 0 CA--C 1.534 0.34 0 O-C-N 124.195 0.585 . . . . 1.36 111.182 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.495 ' CZ ' HG22 ' A' ' 50' ' ' VAL . 2.2 p90 -171.49 170.92 5.63 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 119.846 -0.742 . . . . 1.7 112.086 -169.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HG2' ' CG2' ' A' ' 58' ' ' THR . 82.7 mt-30 -98.04 124.08 42.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.376 -0.829 . . . . 1.91 109.889 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.495 HG22 ' CZ ' ' A' ' 48' ' ' TYR . 3.5 t -94.72 150.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.158 0.504 . . . . 1.53 111.042 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.9 m -107.03 84.13 1.93 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.418 0.628 . . . . 1.51 110.792 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 53' ' ' ASN . 7.5 p -76.83 -43.07 33.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.905 -1.146 . . . . 2.27 107.905 171.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.417 ' N ' HG13 ' A' ' 52' ' ' VAL . 89.0 m-20 -133.47 -52.71 0.88 Allowed 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 113.615 -1.63 . . . . 3.68 107.656 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -173.7 92.2 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.532 -1.213 . . . . 2.99 110.57 172.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.5 mttp 62.54 36.27 13.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.632 -0.713 . . . . 7.36 112.787 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.878 ' HG2' HG13 ' A' ' 57' ' ' ILE . 12.7 ttmt -100.21 142.12 32.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.003 -0.74 . . . . 4.46 109.003 171.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.878 HG13 ' HG2' ' A' ' 56' ' ' LYS . 19.6 mt 69.12 72.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.741 0.781 . . . . 0.92 110.181 -176.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.45 ' CG2' ' HG2' ' A' ' 49' ' ' GLN . 97.1 m -84.78 104.51 14.81 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.259 -0.882 . . . . 0.96 109.695 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.77 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 78.1 m-85 -72.09 123.25 22.44 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.216 -1.401 . . . . 1.57 107.216 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.601 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 33.0 tp -149.45 99.96 2.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.837 0.351 . . . . 3.21 111.521 -172.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.609 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 7.0 p-10 -114.18 120.62 41.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.111 -0.7 . . . . 5.61 109.111 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 40.3 m -105.82 131.56 21.64 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.83 -0.623 . . . . 5.45 110.966 -174.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 62' ' ' THR . 13.3 Cg_exo -70.7 49.57 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.201 2.6 . . . . 6.11 112.77 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.64 -56.62 0.96 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.994 -0.842 . . . . 6.36 110.994 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.401 ' HB3' ' HE1' ' A' ' 102' ' ' HIS . 59.0 m-70 -132.85 90.72 2.8 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.536 -0.542 . . . . 8.78 109.536 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 67.07 -67.27 0.17 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.126 0.891 . . . . 7.05 110.835 -174.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 61' ' ' ASP . . . -159.66 -23.95 0.07 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.084 -0.507 . . . . 4.55 110.769 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' HD2' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -71.22 134.27 46.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.23 0.538 . . . . 2.37 111.523 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.516 ' HB ' ' HG3' ' A' ' 71' ' ' MET . 3.4 m -85.39 157.59 20.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.306 -0.861 . . . . 4.9 110.294 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 p -78.9 62.8 3.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.014 0.435 . . . . 5.84 111.156 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.516 ' HG3' ' HB ' ' A' ' 69' ' ' THR . 69.0 mtm -95.91 36.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.054 -0.521 . . . . 5.21 111.707 -174.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 72' ' ' ARG . 60.2 mtt180 -84.89 -3.05 58.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 8.21 110.41 175.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.63 12.58 24.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.747 -0.66 . . . . 6.36 110.063 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -107.97 -14.95 14.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.116 -0.947 . . . . 9.65 110.905 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.41 -157.03 27.07 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.704 -0.76 . . . . 4.93 112.191 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.73 -41.32 1.18 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.767 0.318 . . . . 5.47 111.183 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -90.55 11.55 21.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.434 0.635 . . . . 6.26 110.133 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.42 79.31 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.274 -0.876 . . . . 4.31 110.396 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -72.38 134.99 45.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.649 -0.705 . . . . 3.41 111.165 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -89.52 173.38 8.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.729 -0.668 . . . . 2.66 110.818 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.0 mt -127.76 119.68 52.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.182 -0.917 . . . . 0.71 109.442 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.715 HG22 ' HB ' ' A' ' 12' ' ' THR . 15.2 t -107.64 124.36 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.17 0.509 . . . . 1.17 111.635 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 8.2 mt -84.41 132.27 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.524 -0.762 . . . . 0.37 110.555 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.942 HD12 HG13 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -102.3 106.39 17.17 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.523 -0.762 . . . . 1.01 110.412 178.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.2 t -84.12 94.08 3.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.933 -0.576 . . . . 0.43 109.738 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.942 HG13 HD12 ' A' ' 84' ' ' LEU . 2.4 m -119.93 123.62 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.927 -0.578 . . . . 0.64 110.523 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.524 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -72.32 131.65 42.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.929 -0.578 . . . . 0.28 110.191 174.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.801 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -65.5 -14.25 60.61 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.077 0.465 . . . . 0.22 111.063 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.23 8.34 44.74 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.523 -0.762 . . . . 0.58 111.011 -175.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.419 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 12.9 t0 -149.08 -45.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 0.56 110.973 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.458 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 89.18 -141.49 16.29 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.335 -0.46 . . . . 0.37 113.477 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.33 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.347 0.594 . . . . 1.03 110.391 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.702 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 79.2 mmm -141.42 176.89 2.16 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 0.28 108.962 -173.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.702 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.3 Cg_exo -41.49 -66.62 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.165 2.577 . . . . 0.58 114.843 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.513 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 6.0 pt20 -71.71 -20.28 61.94 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.259 0.552 . . . . 0.75 110.872 -175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.534 ' HB ' ' H ' ' A' ' 93' ' ' MET . 0.2 OUTLIER -65.54 -44.03 88.12 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.513 -0.767 . . . . 0.31 109.375 178.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.555 HG12 ' ND2' ' A' ' 101' ' ' ASN . 19.8 t -67.56 -41.74 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.38 -0.827 . . . . 1.38 111.33 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -55.33 -30.68 60.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.104 0.478 . . . . 2.35 110.319 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -70.15 -39.09 75.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.679 -0.691 . . . . 0.44 110.798 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 72.3 mt -72.35 -43.02 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.852 0.834 . . . . 0.41 109.172 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.555 ' ND2' HG12 ' A' ' 97' ' ' VAL . 55.5 m-20 -59.91 -33.05 71.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.191 -1.368 . . . . 0.67 110.941 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.439 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 4.2 t60 -79.76 -34.49 39.79 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.735 -0.469 . . . . 2.5 109.735 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.534 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -74.42 -42.61 58.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.179 0.437 . . . . 0.47 112.179 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 12.7 mmmm -76.76 -37.92 55.07 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.058 0.456 . . . . 1.66 110.787 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.07 -30.09 70.75 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.252 -0.885 . . . . 0.77 110.709 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.96 -17.19 41.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.74 110.524 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.0 t30 70.34 60.92 0.23 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.927 -1.033 . . . . 1.41 110.093 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 1.1 t -123.78 145.42 47.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 1.35 111.303 -176.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 20.2 Cg_exo -69.8 144.89 55.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 123.352 2.701 . . . . 0.47 112.45 172.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.534 HD11 ' HB1' ' A' ' 103' ' ' ALA . 30.6 mm -111.2 158.42 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.422 0.63 . . . . 0.6 110.654 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.822 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 21.7 mm -129.21 84.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.599 -1.26 . . . . 0.37 107.599 171.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.934 HG13 ' HB3' ' A' ' 84' ' ' LEU . 17.7 t -74.55 152.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.636 0.732 . . . . 0.26 110.525 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 148' ' ' CYS . . . -139.35 107.24 5.67 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.613 -1.176 . . . . 0.29 110.031 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.801 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.5 mp -79.99 105.66 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.554 -1.203 . . . . 0.59 108.843 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.675 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 1.2 p-10 -106.34 173.66 6.22 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 106.807 -1.553 . . . . 1.85 106.807 -169.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.731 ' HG2' ' C2 ' ' A' ' 179' ' ' GDP . 83.3 mttt 65.51 36.24 6.76 Favored 'General case' 0 N--CA 1.427 -1.617 0 O-C-N 123.768 0.667 . . . . 0.59 110.491 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 124' ' ' PRO . 84.3 mmm -82.34 -13.15 57.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.351 -0.841 . . . . 0.92 109.162 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.7 -30.92 71.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 114.688 -1.142 . . . . 0.76 109.062 171.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 116' ' ' LYS . 18.6 mmmt -64.91 132.04 95.36 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 114.442 -1.254 . . . . 1.17 110.024 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.84 -16.5 54.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.548 2.165 . . . . 0.58 111.065 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -90.77 10.98 23.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.101 -0.954 . . . . 1.45 110.37 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.6 118.09 4.5 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.448 -0.796 . . . . 0.27 110.665 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.6 OUTLIER -127.64 76.02 77.33 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.736 -0.838 . . . . 0.95 108.736 174.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.798 ' O ' ' HG3' ' A' ' 128' ' ' MET . 37.2 Cg_endo -63.55 -63.34 0.08 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 123.135 2.557 . . . . 0.4 113.395 -173.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.505 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 6.6 m-20 -55.47 -21.34 15.89 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.863 -0.608 . . . . 1.44 110.998 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.2 tpt180 -72.36 -56.54 5.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.695 0.759 . . . . 3.79 109.528 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.628 ' HA ' ' HG3' ' A' ' 130' ' ' GLU . 17.4 m -64.79 -29.74 48.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.808 -1.087 . . . . 0.59 111.596 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.798 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 42.5 mtp -61.44 -39.72 91.87 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.398 0.618 . . . . 0.81 109.527 174.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.595 ' O ' ' HG2' ' A' ' 132' ' ' MET . 38.1 mt-30 -68.39 -25.18 64.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.987 -1.006 . . . . 1.31 111.627 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.628 ' HG3' ' HA ' ' A' ' 127' ' ' VAL . 6.3 mt-10 -72.37 -32.56 66.54 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.29 0.567 . . . . 1.64 109.997 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.906 HD12 HD21 ' A' ' 136' ' ' LEU . 4.3 mm? -65.44 -37.44 86.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 1.36 110.176 174.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.595 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 12.5 ptm -76.49 -14.07 60.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.162 -0.615 . . . . 1.61 110.239 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 7.3 mm-40 -71.15 -28.38 64.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.966 -0.753 . . . . 1.67 108.966 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.53 20.41 10.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.007 0.908 . . . . 1.08 110.157 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 60.65 49.97 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.578 -1.646 . . . . 1.1 112.2 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.906 HD21 HD12 ' A' ' 131' ' ' LEU . 1.9 pp -131.25 120.76 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.524 -1.288 . . . . 1.36 107.524 166.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.832 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.9 t -109.29 129.19 24.19 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 0.43 112.367 -165.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 98.0 Cg_exo -43.21 146.62 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.608 3.539 . . . . 0.54 113.435 172.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.52 ' HB2' HD13 ' A' ' 146' ' ' ILE . 5.9 mm-40 -75.53 -22.1 57.38 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.347 -1.297 . . . . 3.08 110.412 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 2.2 pm0 -67.39 -21.4 65.6 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.258 -0.883 . . . . 1.57 110.036 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.483 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 38.4 m0 -105.77 -17.41 14.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.394 -0.366 . . . . 0.66 110.55 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.46 21.75 9.63 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.795 -0.716 . . . . 0.53 113.642 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.832 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -82.92 -105.28 0.48 Allowed Glycine 0 CA--C 1.51 -0.271 0 C-N-CA 120.138 -1.029 . . . . 0.6 111.943 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -166.1 62.2 0.1 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.316 1.055 . . . . 1.91 110.665 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.71 HG21 HG23 ' A' ' 112' ' ' VAL . 56.5 m -164.26 111.91 1.11 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.759 -1.109 . . . . 0.37 111.207 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.822 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 15.3 mm -69.49 107.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 109.426 -0.583 . . . . 0.63 109.426 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.697 ' HD2' HD11 ' A' ' 114' ' ' ILE . 10.7 m-85 -88.78 110.19 20.81 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.24 -0.891 . . . . 0.5 110.311 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 80.6 m -98.75 116.37 30.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.416 -0.356 . . . . 0.68 111.371 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.497 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 95.2 mttt -87.31 91.19 8.64 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.036 -0.357 . . . . 1.44 110.036 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.976 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.9 OUTLIER -122.48 173.62 7.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.331 1.062 . . . . 0.84 112.089 -173.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.2 OUTLIER -138.9 104.91 5.18 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.38 -0.97 . . . . 1.77 108.38 165.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.559 ' HA ' ' HG ' ' A' ' 158' ' ' LEU . . . -61.68 -18.99 61.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.309 -0.86 . . . . 0.41 109.708 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.812 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 13.5 tmtt? -63.25 -57.78 9.33 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.993 -1.003 . . . . 2.3 110.736 173.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.5 p -78.71 -7.85 58.14 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.215 0.45 . . . . 0.7 112.215 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.572 ' HD3' HD12 ' A' ' 158' ' ' LEU . 15.6 mmtp 66.78 42.8 2.51 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 123.684 0.615 . . . . 1.36 111.776 174.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -115.75 -63.5 1.44 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.183 0.992 . . . . 2.48 110.006 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.976 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -68.79 -11.83 63.58 Favored Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 114.495 -1.229 . . . . 0.29 113.605 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.572 HD12 ' HD3' ' A' ' 155' ' ' LYS . 17.4 mt -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 117.856 0.828 . . . . 0.8 110.373 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 6.5 m-20 -81.49 -33.08 32.15 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.69 -0.687 . . . . 2.2 110.422 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -61.42 -32.45 72.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.05 -0.352 . . . . 0.58 110.05 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 83' ' ' ILE . 60.2 tp -59.72 -55.96 27.8 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.857 -0.61 . . . . 1.16 109.541 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.3 mt -56.67 -45.09 81.9 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.823 -1.08 . . . . 1.51 110.033 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 53.2 mt-10 -53.22 -43.9 67.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.639 -0.71 . . . . 2.57 111.338 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.442 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -76.19 -32.71 59.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.817 -0.353 . . . . 0.64 110.41 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 83' ' ' ILE . 80.8 mt -65.66 -51.26 64.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 0.52 111.108 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.568 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 4.0 pp -65.39 -34.25 77.87 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 121.056 -0.258 . . . . 1.73 110.552 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 166' ' ' LEU . 1.3 tm? -50.7 -48.11 58.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.397 -0.594 . . . . 1.51 109.397 173.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.56 -46.64 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.646 -0.706 . . . . 0.89 110.629 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 34.0 t -63.26 -23.0 67.23 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.487 0.551 . . . . 1.35 112.487 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 33.3 mm-40 -84.73 -24.09 29.01 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.789 -0.569 . . . . 2.73 111.204 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.452 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 26.0 ptt? -103.55 -7.69 20.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.381 -0.372 . . . . 1.88 111.276 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 169' ' ' SER . 11.0 pt-20 -54.32 -12.29 0.64 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.504 0.927 . . . . 4.27 113.504 -173.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.09 -58.02 9.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.224 -0.19 . . . . 3.91 110.589 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.62 -44.74 2.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.369 0.604 . . . . 5.72 109.708 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 171' ' ' MET . 19.2 mttt -78.64 64.84 3.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.453 -0.794 . . . . 5.49 111.631 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -106.71 39.43 1.84 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.458 0.647 . . . . 5.78 109.49 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 8.7 t30 -150.42 132.12 7.72 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.21 -0.905 . . . . 7.88 109.986 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 46.3 Cg_exo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 123.16 2.574 . . . . 9.19 112.62 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.812 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.957 -0.457 . . . . 11.58 111.957 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 m -79.73 57.63 2.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.214 0.53 . . . . 10.61 110.758 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -123.81 109.25 13.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.857 -0.611 . . . . 10.14 110.149 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -90.57 -29.04 18.08 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.312 -0.625 . . . . 8.77 109.312 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t 70.39 -77.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.074 -0.966 . . . . 5.74 110.912 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -133.7 134.87 43.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.908 0.385 . . . . 5.7 110.035 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -147.83 114.62 4.03 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.572 -0.74 . . . . 6.85 109.76 -178.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 45.2 Cg_endo -70.2 124.09 10.57 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.487 2.124 . . . . 2.8 112.201 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 14.0 Cg_exo -70.37 69.82 1.95 Allowed 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.068 2.512 . . . . 2.76 112.083 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' THR . 4.8 p -90.66 114.94 28.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.61 0.719 . . . . 2.0 110.3 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 59' ' ' PHE . 76.6 t -119.26 133.06 67.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.701 -0.681 . . . . 1.35 110.453 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.785 ' HB ' HG22 ' A' ' 82' ' ' VAL . 36.9 m -93.62 126.1 38.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.866 -0.334 . . . . 0.64 110.431 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.642 ' H ' HD11 ' A' ' 60' ' ' LEU . 64.1 mt -99.51 127.78 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.993 -0.373 . . . . 1.3 109.993 177.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.63 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 63.2 mtt -134.43 165.31 25.46 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.454 -0.573 . . . . 0.79 109.454 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.04 -175.34 36.01 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.566 -0.826 . . . . 0.31 111.788 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.632 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 44.0 t60 -88.06 158.42 18.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.875 0.845 . . . . 0.22 111.648 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 7.3 p -69.8 153.41 8.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.414 -1.267 . . . . 0.36 109.356 172.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.9 t70 73.96 -22.0 0.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.236 0.541 . . . . 0.69 110.713 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.48 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 12.8 m170 -84.98 3.55 37.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.132 -1.062 . . . . 0.63 108.132 171.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.452 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 86.81 58.36 1.93 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.775 -1.102 . . . . 0.79 113.596 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.5 2.98 34.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.674 0.75 . . . . 3.31 110.183 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -136.69 -44.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.268 -0.878 . . . . 1.21 109.634 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -55.76 -29.26 59.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.737 -0.665 . . . . 1.25 112.022 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 85' ' ' VAL . 15.8 tp -67.64 -42.34 82.4 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.436 -0.579 . . . . 1.49 109.436 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -68.15 -11.54 59.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.189 -0.914 . . . . 1.69 110.534 -179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.45 -38.99 8.98 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.923 0.868 . . . . 1.23 109.593 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.77 67.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.364 -1.289 . . . . 0.63 110.6 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.44 HG23 ' OH ' ' A' ' 48' ' ' TYR . 9.8 tt -69.71 -18.57 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.854 -1.066 . . . . 1.02 110.399 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -60.62 -56.63 19.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.869 -0.605 . . . . 3.04 110.952 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -90.41 27.55 1.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.277 -0.874 . . . . 2.65 110.96 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 t -103.01 -2.19 28.01 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.606 -1.179 . . . . 1.46 111.42 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.735 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -167.75 -175.46 2.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.761 0.315 . . . . 3.92 111.171 -177.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 t -82.06 73.84 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.222 0.534 . . . . 3.1 112.074 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.79 129.23 5.99 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.543 -0.54 . . . . 2.78 109.543 173.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -54.61 1.27 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.969 0.359 . . . . 6.34 111.969 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.514 ' HA ' HD13 ' A' ' 41' ' ' ILE . 14.2 pt20 -140.52 -36.53 0.47 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.591 0.234 . . . . 6.79 111.11 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HG2' ' H ' ' A' ' 38' ' ' ALA . 29.0 tt0 -100.99 179.58 4.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.218 -0.66 . . . . 6.24 109.218 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.507 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . 71.9 -13.68 0.57 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.43 0.692 . . . . 4.95 111.519 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 1.043 ' HA3' ' HB2' ' A' ' 49' ' ' GLN . . . 145.45 -8.83 1.64 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.703 -0.76 . . . . 4.68 112.899 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -52.87 -64.94 3.7 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.468 -0.396 . . . . 4.55 112.513 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 36' ' ' GLN . 2.2 mp -107.03 107.42 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.334 -0.987 . . . . 5.57 108.334 171.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.6 t -129.76 164.09 24.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.138 -0.483 . . . . 5.93 110.899 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.467 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 13.1 mm-40 -84.98 43.72 1.02 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.555 -0.748 . . . . 6.63 110.617 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -135.89 57.46 1.78 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.314 -0.995 . . . . 6.54 108.314 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 62' ' ' THR . 16.8 tt -53.43 153.44 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.82 0.819 . . . . 5.17 112.35 -171.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.89 -43.05 1.79 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 114.395 -1.275 . . . . 2.51 110.488 -170.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 59' ' ' PHE . . . -152.48 -158.45 0.9 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.013 -0.736 . . . . 1.36 109.013 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 3.6 p90 -165.93 177.13 7.3 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.529 -0.468 . . . . 1.7 110.974 -173.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.043 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 47.8 mt-30 -95.85 121.66 37.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.45 -0.795 . . . . 1.91 110.246 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.636 HG21 ' HE2' ' A' ' 59' ' ' PHE . 61.3 t -83.19 157.66 3.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.001 -0.545 . . . . 1.53 110.661 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.916 HG23 ' HA ' ' A' ' 54' ' ' ASP . 40.6 m -152.26 83.63 1.26 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.542 -0.753 . . . . 1.51 109.354 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.789 HG13 ' H ' ' A' ' 53' ' ' ASN . 2.5 p -58.02 -62.14 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.404 0.621 . . . . 2.27 109.394 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.789 ' H ' HG13 ' A' ' 52' ' ' VAL . 98.3 m-20 -113.94 -55.15 2.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.516 -1.29 . . . . 3.68 107.516 170.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.916 ' HA ' HG23 ' A' ' 51' ' ' THR . 29.9 t70 -172.09 64.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.169 -1.378 . . . . 2.99 108.918 167.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.83 97.08 5.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.935 -1.03 . . . . 7.36 108.308 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -69.21 89.17 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.437 -0.801 . . . . 4.46 111.872 -171.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.2 mt -98.81 102.54 13.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.162 -0.681 . . . . 0.92 109.162 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.513 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 7.3 m -94.6 98.0 10.51 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.354 -0.538 . . . . 0.96 110.315 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.636 ' HE2' HG21 ' A' ' 50' ' ' VAL . 73.6 m-85 -66.15 150.23 49.07 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.633 -0.712 . . . . 1.57 110.242 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.642 HD11 ' H ' ' A' ' 13' ' ' ILE . 5.3 mp 38.52 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.226 1.01 . . . . 3.21 113.616 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -73.84 78.69 1.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.094 0.473 . . . . 5.61 110.629 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 5.1 m 60.25 80.31 0.27 Allowed Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.426 -0.807 . . . . 5.45 111.6 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 37.7 Cg_endo -65.93 88.81 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.987 2.458 . . . . 6.11 112.111 177.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.63 -85.07 0.74 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.919 -0.657 . . . . 6.36 112.393 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -79.98 -6.06 56.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.545 0.212 . . . . 8.78 111.558 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HG3' ' H ' ' A' ' 68' ' ' PHE . 9.9 tp10 -171.51 157.32 4.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.235 -0.654 . . . . 7.05 109.235 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . . . -67.79 -42.21 82.0 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.553 -0.536 . . . . 4.55 109.553 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.821 ' HZ ' HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -63.21 118.36 7.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.168 -0.924 . . . . 2.37 110.491 173.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.6 p -70.11 130.89 43.33 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.943 -0.392 . . . . 4.9 109.943 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 p -92.16 90.56 7.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.014 0.435 . . . . 5.84 111.258 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -66.41 95.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.753 -0.658 . . . . 5.21 110.34 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -62.03 -21.72 65.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.02 -0.991 . . . . 8.21 111.401 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.09 66.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 6.36 111.382 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 51.77 75.51 0.21 Allowed 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.52 0.512 . . . . 9.65 111.102 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.27 -108.9 0.6 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.329 -0.938 . . . . 4.93 112.113 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.42 86.51 3.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.98 0.419 . . . . 5.47 110.735 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.546 ' HA ' ' OD1' ' A' ' 80' ' ' ASP . 3.1 pt20 -75.58 55.42 0.83 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.511 0.672 . . . . 6.26 111.41 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.3 p -106.01 -19.99 6.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.59 -0.732 . . . . 4.31 109.787 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -92.59 -9.71 40.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.746 -0.661 . . . . 3.41 109.976 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.546 ' OD1' ' HA ' ' A' ' 77' ' ' GLN . 1.4 m-20 -71.88 91.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.325 -0.852 . . . . 2.66 109.501 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.4 mt -124.08 133.21 69.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.423 -0.353 . . . . 0.71 110.688 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.785 HG22 ' HB ' ' A' ' 12' ' ' THR . 24.7 t -120.98 125.96 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.425 0.631 . . . . 1.17 111.491 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 21.3 mt -84.46 132.27 31.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.987 -1.006 . . . . 0.37 109.636 172.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 86' ' ' VAL . 1.7 tm? -120.48 109.87 15.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.703 -0.851 . . . . 1.01 108.703 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 24' ' ' LEU . 59.8 t -92.69 111.28 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.626 -0.715 . . . . 0.43 110.731 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 2.2 m -121.0 129.36 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 116.01 -0.541 . . . . 0.64 111.031 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB1' ' HE3' ' A' ' 116' ' ' LYS . . . -66.28 135.94 55.14 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.726 -0.67 . . . . 0.28 110.074 174.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.73 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -78.49 -7.98 58.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.115 0.483 . . . . 0.22 110.164 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.837 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 3.1 p-10 -106.27 7.15 31.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.454 -0.794 . . . . 0.58 111.096 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.48 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 22.3 t70 -144.48 -41.43 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 0.56 110.068 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.726 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 90.0 -125.93 8.09 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.37 113.912 170.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.576 HG11 ' HE2' ' A' ' 134' ' ' TYR . 6.8 p -111.82 137.19 45.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.541 0.686 . . . . 1.03 109.697 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.75 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.1 mmm -140.15 177.67 1.91 Allowed Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 114.965 -1.016 . . . . 0.28 108.564 -170.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.75 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 57.4 Cg_exo -38.98 -65.78 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.218 2.612 . . . . 0.58 114.835 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.756 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 6.3 pt20 -74.36 -17.09 60.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.961 0.41 . . . . 0.75 111.527 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.632 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -68.88 -45.49 70.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.749 0.785 . . . . 0.31 109.31 176.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.558 HG12 ' ND2' ' A' ' 101' ' ' ASN . 20.8 t -69.81 -42.92 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.896 -1.047 . . . . 1.38 111.573 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.756 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -60.94 -25.17 66.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.449 -0.501 . . . . 2.35 110.003 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -71.28 -40.99 70.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.841 . . . . 0.44 110.919 173.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -73.95 -39.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.719 0.771 . . . . 0.41 109.311 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.558 ' ND2' HG12 ' A' ' 97' ' ' VAL . 51.8 m-20 -61.3 -30.69 70.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.464 -1.243 . . . . 0.67 110.711 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.478 ' CE1' ' HG2' ' A' ' 66' ' ' GLU . 5.4 t60 -79.84 -34.61 39.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.957 -0.386 . . . . 2.5 109.957 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -66.33 -46.11 77.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.384 -0.371 . . . . 0.47 111.336 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -72.21 -34.05 68.06 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.405 0.622 . . . . 1.66 110.106 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.87 -31.97 67.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.568 -1.196 . . . . 0.77 111.582 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.79 -19.47 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.487 -0.324 . . . . 0.74 111.011 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.2 t30 77.46 72.23 0.06 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 122.167 0.984 . . . . 1.41 108.719 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.821 HG21 ' HZ ' ' A' ' 68' ' ' PHE . 3.0 t -133.55 138.45 31.2 Favored Pre-proline 0 N--CA 1.441 -0.898 0 CA-C-N 114.326 -1.306 . . . . 1.35 111.633 -168.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 80' ' ' ASP . 21.4 Cg_exo -68.33 143.06 56.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.443 2.762 . . . . 0.47 111.705 170.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' A' ' 103' ' ' ALA . 38.5 mm -109.96 154.88 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.738 0.78 . . . . 0.6 111.382 -173.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.937 HD13 ' HB ' ' A' ' 146' ' ' ILE . 12.9 mm -125.17 85.21 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 107.352 -1.351 . . . . 0.37 107.352 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.587 HG23 HG21 ' A' ' 145' ' ' THR . 57.5 t -73.43 147.23 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.545 0.688 . . . . 0.26 110.312 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -146.75 103.79 3.67 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.291 -1.322 . . . . 0.29 109.997 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.833 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -71.91 144.4 13.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.139 -1.392 . . . . 0.59 110.486 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.434 ' ND2' ' C5 ' ' A' ' 179' ' ' GDP . 0.6 OUTLIER -122.68 169.69 10.8 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.498 -1.297 . . . . 1.85 107.498 177.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.531 ' HE3' ' HB1' ' A' ' 87' ' ' ALA . 31.2 mtmt 67.74 37.49 3.22 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.163 -0.926 . . . . 0.59 112.38 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.689 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 14.3 mmt -75.95 -11.82 60.03 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.198 -0.91 . . . . 0.92 109.516 166.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.45 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 6.6 p-10 -72.86 -29.69 63.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.077 -0.965 . . . . 0.76 108.822 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.81 136.26 82.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.958 -1.019 . . . . 1.17 110.735 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.48 -15.39 48.22 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 123.058 2.505 . . . . 0.58 112.143 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.837 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 5.0 mm-40 -84.01 -9.0 58.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.49 -0.777 . . . . 1.45 110.704 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -42.47 109.97 0.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.968 0.792 . . . . 0.27 111.956 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.71 76.59 77.04 Favored Pre-proline 0 CA--C 1.51 -0.565 0 N-CA-C 108.301 -1.0 . . . . 0.95 108.301 176.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.689 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 22.3 Cg_endo -58.81 -60.1 0.39 Allowed 'Trans proline' 0 CA--C 1.505 -0.933 0 C-N-CA 122.898 2.399 . . . . 0.4 113.286 -174.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.7 -28.88 1.11 Allowed 'General case' 0 C--N 1.322 -0.611 0 O-C-N 124.066 0.854 . . . . 1.44 111.504 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 37.0 ttm-85 -78.59 -62.36 1.71 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.439 -0.578 . . . . 3.79 109.439 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 88' ' ' ALA . 4.9 m -64.69 -22.59 31.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.977 -1.011 . . . . 0.59 111.941 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.626 ' HG3' ' CE2' ' A' ' 147' ' ' PHE . 4.9 ttt -77.12 -31.8 56.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.179 -0.918 . . . . 0.81 110.874 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.578 ' O ' ' HG3' ' A' ' 132' ' ' MET . 20.9 mt-30 -78.1 -32.39 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 1.31 111.372 176.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.9 mm-40 -57.28 -39.6 76.04 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.558 1.17 . . . . 1.64 108.381 173.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.646 HD23 ' CE2' ' A' ' 147' ' ' PHE . 0.7 OUTLIER -61.39 -41.22 96.77 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.312 -1.767 . . . . 1.36 110.776 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.628 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.3 ppp? -82.5 -9.09 59.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.035 -0.666 . . . . 1.61 111.536 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.71 -27.91 62.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.976 -0.75 . . . . 1.67 108.976 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.576 ' HE2' HG11 ' A' ' 92' ' ' VAL . 34.6 m-85 -85.8 13.81 6.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.448 -0.796 . . . . 1.08 110.097 170.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.7 t30 62.84 48.29 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.222 -1.354 . . . . 1.1 111.658 172.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.84 110.49 13.74 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.408 -1.33 . . . . 1.36 107.408 165.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.04 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.9 t -104.78 129.16 25.4 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.697 -0.683 . . . . 0.43 111.543 -167.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.619 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 81.2 Cg_exo -44.61 143.6 3.91 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.421 3.414 . . . . 0.54 112.927 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HG2' ' C ' ' A' ' 145' ' ' THR . 12.3 mm-40 -67.47 -32.36 73.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.18 -1.373 . . . . 3.08 109.532 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 140' ' ' GLU . 1.7 pm0 -61.25 -24.99 66.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.921 -1.036 . . . . 1.57 110.967 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.628 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 35.7 m0 -102.63 -8.71 20.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.001 0.429 . . . . 0.66 110.912 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.08 32.69 8.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.006 -0.616 . . . . 0.53 113.21 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 1.04 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.9 -109.12 1.85 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.252 -0.975 . . . . 0.6 112.053 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.443 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 7.3 t70 -167.43 63.45 0.08 Allowed 'General case' 0 C--O 1.252 1.185 0 CA-C-O 122.369 1.08 . . . . 1.91 110.504 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.587 HG21 HG23 ' A' ' 112' ' ' VAL . 78.4 m -164.82 115.63 1.17 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.509 -1.223 . . . . 0.37 110.478 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.937 ' HB ' HD13 ' A' ' 111' ' ' ILE . 19.0 mm -70.93 104.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.175 -0.676 . . . . 0.63 109.175 173.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.646 ' CE2' HD23 ' A' ' 131' ' ' LEU . 7.9 m-85 -86.98 113.11 22.47 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.237 -0.892 . . . . 0.5 111.305 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.56 136.57 41.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.75 -0.659 . . . . 0.68 109.827 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.561 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 8.3 mptt -111.57 101.27 9.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.24 -0.652 . . . . 1.44 109.24 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.912 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -127.25 -170.07 2.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.743 1.259 . . . . 0.84 111.827 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.554 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -164.21 106.68 0.91 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.769 -1.937 . . . . 1.77 105.769 174.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.64 -15.77 63.71 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.669 0.747 . . . . 0.41 109.117 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.604 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 1.2 tmtp? -62.67 -56.07 21.11 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.216 -1.356 . . . . 2.3 110.462 170.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 1.2 p -84.45 -10.36 57.57 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.37 0.508 . . . . 0.7 112.37 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 62.13 51.88 3.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.42 -0.809 . . . . 1.36 110.595 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -109.33 -65.82 1.11 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.156 0.979 . . . . 2.48 110.608 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.912 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.13 -9.09 71.29 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.318 -1.31 . . . . 0.29 114.174 -173.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.402 HD21 HD11 ' A' ' 24' ' ' LEU . 48.5 mt -72.36 -39.47 68.05 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.052 0.926 . . . . 0.8 109.362 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.541 ' O ' ' HG3' ' A' ' 163' ' ' GLU . 13.8 m-20 -63.71 -44.7 92.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 2.2 109.511 172.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 80.6 t60 -71.66 -15.82 62.24 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.057 -0.52 . . . . 0.58 111.371 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.7 tp -71.21 -53.34 14.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 1.16 109.651 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.68 -27.58 69.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.256 -0.884 . . . . 1.51 110.56 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 66.1 mt-10 -62.47 -48.88 77.65 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.099 0.476 . . . . 2.57 110.142 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.634 ' HB3' HG21 ' A' ' 146' ' ' ILE . 19.3 mmt -68.03 -42.85 80.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.878 -0.601 . . . . 0.64 110.549 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.5 mt -59.36 -41.95 85.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.927 -0.579 . . . . 0.52 110.593 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -39.73 89.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 1.73 111.19 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 31.1 tp -53.7 -43.98 69.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.413 0.625 . . . . 1.51 109.55 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 90.1 t -67.18 -43.14 88.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 0.89 110.774 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.2 m -59.13 -38.85 80.64 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.691 0.281 . . . . 1.35 111.574 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -86.5 -8.25 57.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.142 0.496 . . . . 2.73 110.865 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.5 ttm -68.27 -11.58 59.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.291 -0.413 . . . . 1.88 111.57 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.4 ' O ' ' HD2' ' A' ' 175' ' ' LYS . 48.1 mt-10 -56.12 -36.63 68.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.033 0.444 . . . . 4.27 110.507 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -113.47 -14.06 12.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.744 -0.662 . . . . 3.91 110.281 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.9 tp -112.13 46.26 1.18 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.74 -0.663 . . . . 5.72 110.124 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.791 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -56.29 116.65 3.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.008 -0.542 . . . . 5.49 111.754 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 61.06 80.94 0.2 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 123.841 0.713 . . . . 5.78 112.075 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 8.1 t30 -77.87 124.97 86.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.964 -0.562 . . . . 7.88 110.165 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 6.5 Cg_exo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 122.858 2.372 . . . . 9.19 112.046 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.604 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 111.991 -0.444 . . . . 11.58 111.991 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.8 m -81.5 72.17 8.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.332 0.587 . . . . 10.61 111.31 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -162.19 64.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.432 -0.804 . . . . 10.14 109.105 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 69.7 mtm -80.95 64.97 5.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.688 -0.687 . . . . 8.77 111.23 -173.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.66 -26.72 5.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 5.74 109.925 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -86.13 115.51 23.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.405 -0.816 . . . . 5.7 110.218 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.68 ' HD2' HG21 ' A' ' 79' ' ' THR . 25.4 ttm180 -114.41 103.58 54.93 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.326 . . . . 6.85 110.273 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.68 137.93 40.08 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.858 2.372 . . . . 2.8 111.995 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.493 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 54.1 Cg_endo -71.27 109.03 2.49 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.59 2.194 . . . . 2.76 112.327 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.567 ' O ' HG22 ' A' ' 11' ' ' VAL . 4.3 m -92.93 -59.22 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.118 -0.492 . . . . 2.0 111.061 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.726 ' HB ' ' O ' ' A' ' 81' ' ' ILE . 1.1 m 60.13 179.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.8 0.84 . . . . 1.35 111.403 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.686 HG23 HD13 ' A' ' 60' ' ' LEU . 71.8 m -142.8 126.41 16.9 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.303 -0.248 . . . . 0.64 110.678 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 14.9 tt -92.22 136.1 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.641 0.734 . . . . 1.3 111.467 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.483 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 58.5 mtt -148.82 174.29 12.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.591 0.756 . . . . 0.79 109.28 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.14 -167.12 32.25 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.711 -0.757 . . . . 0.31 112.761 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.584 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 43.2 t60 -93.93 164.49 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.066 0.936 . . . . 0.22 112.003 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' O1B' ' A' ' 179' ' ' GDP . 5.9 p -78.34 151.29 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.454 -1.248 . . . . 0.36 110.374 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HA ' " C4'" ' A' ' 179' ' ' GDP . 28.2 t70 72.72 -19.85 0.29 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.4 0.619 . . . . 0.69 110.524 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 18.0 m170 -78.94 -7.93 58.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.356 -0.979 . . . . 0.63 108.356 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.419 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 100.13 44.14 2.27 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.192 -0.913 . . . . 0.79 113.413 174.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -33.26 66.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.591 0.695 . . . . 3.31 112.403 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -107.59 -34.59 6.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.914 0.388 . . . . 1.21 110.614 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.5 m -63.9 -28.87 70.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.321 -0.399 . . . . 1.25 111.772 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD23 ' HA3' ' A' ' 20' ' ' GLY . 2.7 mm? -65.62 -42.37 91.62 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 109.71 -0.478 . . . . 1.49 109.71 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.944 HD21 ' HA ' ' A' ' 47' ' ' ALA . 2.1 tp -71.85 -12.15 61.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.139 -0.937 . . . . 1.69 110.53 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -98.94 -41.26 7.67 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.992 0.901 . . . . 1.23 109.409 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HB1' ' HE2' ' A' ' 155' ' ' LYS . . . -66.22 -30.28 70.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.898 -1.501 . . . . 0.63 109.845 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 tt -77.83 -32.48 17.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 1.02 110.894 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -69.9 -18.45 63.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.588 0.709 . . . . 3.04 109.997 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -119.61 28.74 7.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.843 -1.071 . . . . 2.65 110.172 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 28.7 t -122.53 -21.65 5.66 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.769 -1.105 . . . . 1.46 111.812 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -161.66 -170.21 2.51 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.893 -0.323 . . . . 3.92 111.464 -177.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.57 ' O ' ' HB ' ' A' ' 51' ' ' THR . 45.1 t -68.81 97.5 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.635 -0.711 . . . . 3.1 112.241 -171.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.429 HG21 ' HE2' ' A' ' 48' ' ' TYR . 9.7 t -156.86 162.02 39.69 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.979 -0.555 . . . . 2.78 109.597 171.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -96.81 128.06 43.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.583 -0.735 . . . . 6.34 110.286 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.01 -18.62 65.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.757 -0.656 . . . . 6.79 110.363 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -145.55 111.04 5.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.895 -0.593 . . . . 6.24 110.575 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 176.03 -44.01 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.811 -1.181 . . . . 4.95 107.811 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.78 43.32 0.35 Allowed Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 114.036 -1.438 . . . . 4.68 109.802 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.904 ' HA2' ' HB2' ' A' ' 48' ' ' TYR . . . -128.55 -8.61 3.88 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.947 -0.644 . . . . 4.55 113.372 -174.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.51 125.91 74.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.862 0.363 . . . . 5.57 110.6 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.2 m -117.85 -12.5 10.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.545 . . . . 5.93 110.476 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 66.87 15.89 10.24 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.66 -0.7 . . . . 6.63 110.372 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -148.96 -162.56 1.59 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.352 -1.351 . . . . 6.54 107.352 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.0 pt -70.86 -177.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.626 -0.509 . . . . 5.17 109.626 167.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.942 ' HA2' HD23 ' A' ' 60' ' ' LEU . . . 131.79 -127.42 4.99 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.002 -1.094 . . . . 2.51 112.607 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.944 ' HA ' HD21 ' A' ' 25' ' ' LEU . . . -175.6 -165.27 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.751 0.324 . . . . 1.36 110.68 -175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.904 ' HB2' ' HA2' ' A' ' 40' ' ' GLY . 1.2 p90 -153.89 176.12 12.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.86 -0.609 . . . . 1.7 109.643 -175.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -89.99 115.76 27.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.511 -0.313 . . . . 1.91 111.057 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.441 HG22 ' CE1' ' A' ' 48' ' ' TYR . 11.3 t -88.35 158.79 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.544 -0.298 . . . . 1.53 110.537 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.904 HG23 ' HA ' ' A' ' 54' ' ' ASP . 85.1 m -161.41 87.56 0.7 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.822 0.849 . . . . 1.51 109.17 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.867 HG13 ' H ' ' A' ' 53' ' ' ASN . 1.9 p -64.8 -69.11 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.337 0.589 . . . . 2.27 110.005 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.867 ' H ' HG13 ' A' ' 52' ' ' VAL . 86.2 m-20 -100.45 -56.02 2.46 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.674 -1.232 . . . . 3.68 107.674 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.904 ' HA ' HG23 ' A' ' 51' ' ' THR . 34.6 t70 -177.15 67.3 0.02 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.229 -1.35 . . . . 2.99 109.772 167.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' O ' HG13 ' A' ' 57' ' ' ILE . 18.2 tppt? -122.43 97.69 5.58 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.901 -1.148 . . . . 7.36 107.901 177.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -73.29 81.58 1.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.927 -0.579 . . . . 4.46 111.309 -171.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.565 HD13 HG21 ' A' ' 165' ' ' ILE . 7.2 mt -96.6 102.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.538 -0.755 . . . . 0.92 109.51 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.575 ' CG2' ' HB2' ' A' ' 61' ' ' ASP . 4.1 m -88.25 97.74 11.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.904 -0.776 . . . . 0.96 108.904 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.588 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 9.0 m-30 -56.8 13.73 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.981 1.845 . . . . 1.57 115.981 -169.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.942 HD23 ' HA2' ' A' ' 46' ' ' GLY . 32.4 tp 175.36 -68.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.377 0.535 . . . . 3.21 110.814 173.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.575 ' HB2' ' CG2' ' A' ' 58' ' ' THR . 30.8 t70 52.87 50.09 18.79 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.605 0.717 . . . . 5.61 110.711 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.1 m -149.85 108.85 3.28 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.9 -0.591 . . . . 5.45 110.848 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.15 -26.25 30.61 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.853 2.369 . . . . 6.11 111.806 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 158.86 136.98 2.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.006 -0.616 . . . . 6.36 112.221 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -149.26 -61.68 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.913 0.357 . . . . 8.78 110.133 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -156.75 -80.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.293 -0.412 . . . . 7.05 110.861 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.22 -89.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 4.55 111.583 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.582 ' HE1' ' HB2' ' A' ' 80' ' ' ASP . 1.1 p90 -123.48 -55.59 1.73 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.795 -0.184 . . . . 2.37 110.792 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 p -93.95 -171.67 2.63 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.784 0.326 . . . . 4.9 111.644 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.3 m -75.06 -46.22 36.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.401 -0.363 . . . . 5.84 111.185 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 61.3 mtt 57.44 74.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.899 0.381 . . . . 5.21 110.349 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -118.07 -3.4 11.11 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.869 -0.332 . . . . 8.21 111.66 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.9 -66.27 0.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.969 0.414 . . . . 6.36 110.816 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -178.11 -69.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.337 -0.986 . . . . 9.65 108.337 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.38 -97.22 1.84 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.055 -1.218 . . . . 4.93 110.055 169.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.79 63.63 2.16 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.173 0.511 . . . . 5.47 111.6 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -120.33 2.78 10.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.794 -0.639 . . . . 6.26 110.282 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.82 -1.3 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 4.31 111.717 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.68 HG21 ' HD2' ' A' ' 7' ' ' ARG . 28.5 m -93.46 -20.69 20.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.937 0.875 . . . . 3.41 109.333 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.582 ' HB2' ' HE1' ' A' ' 68' ' ' PHE . 1.8 m-20 -80.5 96.46 6.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.761 -1.108 . . . . 2.66 108.879 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.726 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 44.3 mt -88.52 130.02 38.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.451 -0.795 . . . . 0.71 110.428 -172.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 110' ' ' ILE . 27.2 t -90.96 117.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.733 -0.787 . . . . 1.17 111.167 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 44.3 mt -81.33 131.41 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 114.798 -1.092 . . . . 0.37 109.384 172.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.686 HD21 HG22 ' A' ' 96' ' ' THR . 2.4 tm? -121.11 107.17 12.29 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.82 -0.807 . . . . 1.01 108.82 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 85.5 t -89.38 109.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.593 -0.731 . . . . 0.43 110.779 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.744 HG21 HD11 ' A' ' 131' ' ' LEU . 2.1 m -121.39 126.26 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.785 -0.643 . . . . 0.64 110.95 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -72.15 127.46 32.64 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.094 -0.503 . . . . 0.28 109.645 174.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -68.06 -10.54 54.63 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 120.893 0.377 . . . . 0.22 111.383 -175.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.56 -8.06 55.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.837 -0.62 . . . . 0.58 110.778 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.503 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 15.9 t0 -131.69 -45.7 0.97 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.324 -0.398 . . . . 0.56 111.573 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.609 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 95.2 -144.79 17.41 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.312 -0.471 . . . . 0.37 113.062 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.6 p -92.49 143.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.337 -0.616 . . . . 1.03 109.337 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.713 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 77.2 mmm -143.61 177.73 1.71 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.401 -0.818 . . . . 0.28 109.241 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.713 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 78.6 Cg_exo -43.83 -63.02 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.199 2.599 . . . . 0.58 114.618 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.54 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.7 pt20 -76.69 -12.38 59.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.75 111.191 -174.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.686 HG22 HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -72.22 -48.23 44.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.675 -0.693 . . . . 0.31 109.662 176.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 93' ' ' MET . 3.5 p -73.69 -27.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.548 -0.751 . . . . 1.38 112.943 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.467 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -61.72 -30.34 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.606 -0.838 . . . . 2.35 109.088 176.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.21 -35.07 66.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.495 -0.775 . . . . 0.44 110.476 174.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 97.3 mt -70.18 -51.16 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 109.08 -0.711 . . . . 0.41 109.08 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -51.26 -41.74 60.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.537 -1.21 . . . . 0.67 110.442 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.48 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 2.8 t60 -55.62 -50.24 70.68 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.102 -0.954 . . . . 2.5 110.208 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.535 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -74.25 -46.57 40.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.47 112.164 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.766 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 10.8 mmpt? -63.69 -35.9 82.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 120.986 0.422 . . . . 1.66 110.943 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.7 -43.32 72.42 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.093 -0.958 . . . . 0.77 111.065 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.38 -21.41 39.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.573 -0.285 . . . . 0.74 111.26 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 83.1 41.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.817 1.294 . . . . 1.41 108.842 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 109' ' ' PRO . 29.2 t -89.95 138.16 27.84 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 113.384 -1.734 . . . . 1.35 111.616 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 108' ' ' VAL . 22.3 Cg_exo -66.82 144.18 70.1 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.829 2.353 . . . . 0.47 111.56 170.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.535 HD11 ' CB ' ' A' ' 103' ' ' ALA . 49.6 mm -109.35 157.12 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 121.387 0.613 . . . . 0.6 111.157 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.768 ' CD1' ' HB ' ' A' ' 146' ' ' ILE . 22.8 mm -124.02 83.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.195 -1.409 . . . . 0.37 107.195 169.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.777 HG23 HG21 ' A' ' 145' ' ' THR . 58.2 t -70.01 145.35 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-O 121.643 0.735 . . . . 0.26 109.208 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.773 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -143.55 100.39 3.59 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.374 -1.284 . . . . 0.29 109.67 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.814 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 80.6 mt -73.99 141.92 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.301 -1.318 . . . . 0.59 110.122 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 50.9 t30 -120.9 171.52 8.57 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.325 -1.361 . . . . 1.85 107.325 -177.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.799 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 81.7 mttt 72.47 33.58 1.41 Allowed 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 123.901 0.751 . . . . 0.59 111.749 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.741 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 13.4 mmt -79.02 -14.9 58.91 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 0.92 108.879 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 3.9 p-10 -65.09 -26.8 68.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.107 -1.406 . . . . 0.76 109.515 171.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.692 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 28.5 mtpp -86.62 132.23 43.17 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.291 -0.868 . . . . 1.17 110.02 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.39 -12.2 31.96 Favored 'Trans proline' 0 N--CA 1.472 0.226 0 C-N-CA 122.584 2.189 . . . . 0.58 111.128 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.27 1.15 38.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.404 -1.271 . . . . 1.45 110.732 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.63 122.96 11.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.119 -0.946 . . . . 0.27 111.348 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 0.6 OUTLIER -130.47 76.32 77.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.595 -0.891 . . . . 0.95 108.595 175.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.741 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 25.8 Cg_endo -61.16 -65.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.745 2.964 . . . . 0.4 114.153 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.657 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 1.2 m-20 -60.24 -23.07 63.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 1.44 110.102 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.753 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 5.4 tpt180 -67.8 -60.35 2.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 3.79 109.944 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 88' ' ' ALA . 33.0 m -66.08 -32.98 60.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.756 -1.111 . . . . 0.59 111.757 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 1.07 ' HA ' HD12 ' A' ' 131' ' ' LEU . 18.7 ptm -74.49 -20.51 59.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.794 0.33 . . . . 0.81 110.961 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 125' ' ' ASP . 20.3 mt-30 -74.86 -43.55 53.87 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.997 -0.44 . . . . 1.31 111.086 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.627 ' HA ' ' HG3' ' A' ' 133' ' ' GLU . 8.8 mt-10 -70.19 -24.23 63.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.895 0.855 . . . . 1.64 109.167 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' HA ' ' A' ' 128' ' ' MET . 66.8 mt -59.79 -36.71 77.3 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.464 -1.244 . . . . 1.36 109.27 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.878 ' SD ' ' HD2' ' A' ' 138' ' ' PRO . 3.6 mtm -77.14 -17.69 58.42 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.402 -0.519 . . . . 1.61 111.859 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.627 ' HG3' ' HA ' ' A' ' 130' ' ' GLU . 5.4 mt-10 -71.53 -17.47 62.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.437 -0.949 . . . . 1.67 108.437 174.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -94.9 12.27 28.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.802 -1.09 . . . . 1.08 109.44 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 53.1 t30 62.86 53.56 2.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.878 -1.51 . . . . 1.1 111.942 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -139.21 121.82 16.3 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.049 -1.093 . . . . 1.36 108.049 166.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.944 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 98.0 t -113.45 128.62 25.47 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.934 0.397 . . . . 0.43 111.914 -167.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.878 ' HD2' ' SD ' ' A' ' 132' ' ' MET . 85.5 Cg_exo -45.72 145.77 4.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.707 3.605 . . . . 0.54 113.76 172.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.645 ' HB2' HD13 ' A' ' 146' ' ' ILE . 3.7 mm-40 -81.71 -11.39 59.07 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.321 -1.309 . . . . 3.08 110.746 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.5 pm0 -67.65 -26.62 66.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.77 -0.65 . . . . 1.57 109.672 167.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.471 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 32.8 m0 -109.21 -2.94 17.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.66 110.735 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.04 33.72 17.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.985 -0.626 . . . . 0.53 113.721 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.944 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -86.45 -105.81 0.78 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.252 -0.975 . . . . 0.6 111.857 174.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -162.97 58.8 0.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.979 0.895 . . . . 1.91 110.907 172.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.777 HG21 HG23 ' A' ' 112' ' ' VAL . 51.5 m -166.9 116.49 0.88 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.463 -0.79 . . . . 0.37 111.0 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.768 ' HB ' ' CD1' ' A' ' 111' ' ' ILE . 18.1 mm -71.43 108.02 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.041 -0.726 . . . . 0.63 109.041 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.638 ' HE2' ' CD1' ' A' ' 131' ' ' LEU . 9.2 m-85 -89.51 120.0 30.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.5 111.039 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.486 ' SG ' HD23 ' A' ' 150' ' ' LEU . 50.6 t -99.98 153.9 18.82 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.196 0.522 . . . . 0.68 109.73 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.676 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 90.8 mttt -128.49 91.82 3.31 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.983 -1.008 . . . . 1.44 108.499 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.83 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -122.65 -174.1 2.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.613 1.197 . . . . 0.84 112.242 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 p -155.47 100.76 2.14 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.604 -1.635 . . . . 1.77 107.566 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.56 58.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.736 -0.786 . . . . 0.41 109.653 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -73.08 -52.49 14.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.168 -0.924 . . . . 2.3 110.48 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.8 p -87.82 -6.61 58.04 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.971 -0.691 . . . . 0.7 112.399 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.524 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 28.9 mmtp 67.45 45.87 1.5 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.583 -0.735 . . . . 1.36 111.661 171.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -105.72 -65.87 1.03 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.956 1.36 . . . . 2.48 110.617 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.83 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -72.36 -5.14 62.28 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.746 -1.57 . . . . 0.29 113.804 -173.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 26.9 mt -66.05 -41.39 90.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 118.376 1.088 . . . . 0.8 109.07 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -47.83 71.05 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.254 -0.885 . . . . 2.2 109.886 174.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -64.12 -27.07 68.84 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.58 111.68 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.8 tp -63.89 -58.89 5.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.141 0.496 . . . . 1.16 110.451 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.569 HD12 ' HB ' ' A' ' 52' ' ' VAL . 11.9 mt -57.51 -39.56 76.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.032 -0.985 . . . . 1.51 110.115 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -54.18 -40.19 67.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.263 -0.88 . . . . 2.57 111.37 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.53 ' O ' HG23 ' A' ' 168' ' ' VAL . 16.4 mmt -78.5 -39.18 38.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 0.64 110.621 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.565 HG21 HD13 ' A' ' 57' ' ' ILE . 89.5 mt -58.98 -46.94 91.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.52 111.383 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 3.7 pp -66.86 -34.65 78.27 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.726 -0.389 . . . . 1.73 110.895 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -53.68 -47.17 70.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.012 -0.736 . . . . 1.51 109.012 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 111' ' ' ILE . 48.2 t -64.94 -42.48 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 115.431 -0.804 . . . . 0.89 111.356 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 166' ' ' LEU . 89.2 p -64.19 -26.94 68.74 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.575 -0.45 . . . . 1.35 111.265 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 67.4 mm-40 -80.23 -27.6 38.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.427 0.632 . . . . 2.73 110.011 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.419 ' HG2' ' HA ' ' A' ' 175' ' ' LYS . 48.9 ttp -80.84 -10.17 59.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.653 -0.703 . . . . 1.88 110.227 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' O ' ' HD2' ' A' ' 175' ' ' LYS . 5.0 tm-20 -47.69 -49.83 26.71 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.015 -0.539 . . . . 4.27 110.968 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -99.7 -21.32 15.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.82 0.343 . . . . 3.91 111.052 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.54 47.41 0.89 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.184 -0.462 . . . . 5.72 110.524 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.917 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 3.1 mppt? -46.98 -45.76 21.17 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.394 -0.821 . . . . 5.49 111.798 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -141.77 148.94 39.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.015 -0.539 . . . . 5.78 110.722 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -115.5 95.77 44.11 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.443 -0.577 . . . . 7.88 109.443 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 C--O 1.248 0.985 0 C-N-CA 122.97 2.447 . . . . 9.19 112.278 -177.64 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.794 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.288 -0.325 . . . . 11.58 112.288 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.417 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 50.3 m -123.17 87.02 2.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.029 0.442 . . . . 10.61 110.827 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -122.05 -29.98 4.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.235 -0.439 . . . . 10.14 109.937 173.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.8 ttm -70.2 -61.2 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.135 -0.691 . . . . 8.77 109.135 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.7 140.12 47.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.572 -0.74 . . . . 5.74 109.954 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' HG2' ' HB3' ' A' ' 2' ' ' SER . 43.3 mt-10 -115.23 147.12 40.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.263 -0.426 . . . . 5.7 110.326 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 7' ' ' ARG . 31.4 ttm180 -114.25 99.39 50.82 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.932 -0.576 . . . . 6.85 109.673 172.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.85 116.7 4.78 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.622 2.215 . . . . 2.8 110.694 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.46 121.11 9.16 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.506 2.138 . . . . 2.76 111.558 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.77 74.0 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.475 0.655 . . . . 2.0 109.818 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 99.7 t -66.26 90.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.12 -0.945 . . . . 1.35 110.104 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.681 HG23 HD13 ' A' ' 60' ' ' LEU . 19.5 m -77.86 122.86 26.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.078 -0.964 . . . . 0.64 110.841 -175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.656 HD12 HD21 ' A' ' 25' ' ' LEU . 50.8 mt -86.15 114.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.212 0.53 . . . . 1.3 110.601 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.979 ' HE1' ' HB3' ' A' ' 67' ' ' ALA . 21.4 mmt -112.59 -178.48 3.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.439 -0.801 . . . . 0.79 109.432 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.45 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 138.76 -174.13 22.23 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.565 -0.826 . . . . 0.31 112.206 174.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.57 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 50.5 t60 -84.42 162.45 19.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.7 0.762 . . . . 0.22 110.691 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.478 ' C ' ' H ' ' A' ' 19' ' ' HIS . 3.6 p -76.38 152.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.081 -0.963 . . . . 0.36 110.163 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.661 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 16.1 t70 73.62 -20.36 0.3 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.031 0.532 . . . . 0.69 110.385 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.8 m170 -79.87 -8.68 59.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.696 -0.853 . . . . 0.63 108.696 169.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 122.6 62.09 0.21 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.386 -0.912 . . . . 0.79 114.643 169.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.547 ' HB2' ' O3B' ' A' ' 179' ' ' GDP . 70.0 mmtt -62.02 -74.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.316 0.558 . . . . 3.31 111.208 168.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 m -80.13 -34.66 37.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.768 0.318 . . . . 1.21 110.955 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.564 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -58.83 -30.21 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.949 0.722 . . . . 1.25 112.949 -175.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -71.72 -52.55 17.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.953 -0.388 . . . . 1.49 109.953 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.656 HD21 HD12 ' A' ' 13' ' ' ILE . 15.4 mt -70.43 -8.67 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 1.69 110.965 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -89.17 -44.18 10.49 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.244 -1.021 . . . . 1.23 108.244 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.655 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -71.49 -25.33 62.22 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.71 -1.586 . . . . 0.63 110.676 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' A' ' 25' ' ' LEU . 9.7 tt -81.77 -27.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.21 -0.904 . . . . 1.02 111.076 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 29.7 mtp180 -75.97 -40.98 52.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.531 -0.304 . . . . 3.04 111.404 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -92.89 28.27 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.319 1.057 . . . . 2.65 110.758 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.424 ' C ' ' HD3' ' A' ' 32' ' ' LYS . 13.8 t -105.44 -43.63 4.92 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.233 -1.348 . . . . 1.46 108.207 178.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HE3' ' CD2' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -174.06 -173.02 0.77 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.299 -0.864 . . . . 3.92 110.526 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 50' ' ' VAL . 14.2 p 53.22 -61.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.55 1.54 . . . . 3.1 113.232 -171.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 p -93.75 140.8 29.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.71 0.29 . . . . 2.78 110.367 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -117.58 -80.96 0.62 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.231 0.539 . . . . 6.34 110.71 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -123.93 0.33 8.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.932 -0.576 . . . . 6.79 110.688 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.67 178.7 4.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.084 -0.507 . . . . 6.24 110.407 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 41' ' ' ILE . . . -92.5 -8.56 44.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.064 0.765 . . . . 4.95 113.064 -166.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.6 20.42 73.87 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.99 -0.624 . . . . 4.68 112.643 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.71 -3.24 87.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.845 -0.693 . . . . 4.55 112.594 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.485 ' O ' ' HB1' ' A' ' 38' ' ' ALA . 48.2 mm -109.22 139.67 31.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.818 0.342 . . . . 5.57 110.689 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 44' ' ' HIS . 8.9 t -100.29 -160.49 0.8 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 5.93 110.062 177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.416 HE21 ' HB2' ' A' ' 43' ' ' GLN . 1.2 mp0 -71.7 -21.9 61.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.181 0.515 . . . . 6.63 110.192 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.701 ' H ' HG23 ' A' ' 42' ' ' THR . 74.2 m-70 -74.17 113.62 11.57 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.711 -0.848 . . . . 6.54 108.711 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 47' ' ' ALA . 41.0 mm 75.65 150.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 O-C-N 124.223 0.952 . . . . 5.17 109.52 -172.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.34 -5.43 10.39 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.984 -0.627 . . . . 2.51 112.202 -175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HA ' HD13 ' A' ' 25' ' ' LEU . . . -84.84 -176.63 6.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.64 -0.28 . . . . 1.36 110.861 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -177.25 173.5 1.75 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.994 -0.373 . . . . 1.7 109.994 -175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.462 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 45.6 mt-30 -100.88 122.51 43.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.226 -0.443 . . . . 1.91 110.305 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 21.7 t -86.0 169.37 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.922 -0.581 . . . . 1.53 110.755 -177.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.819 HG23 ' HA ' ' A' ' 54' ' ' ASP . 86.1 m -159.48 83.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.353 -0.98 . . . . 1.51 108.353 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.69 HG13 ' H ' ' A' ' 53' ' ' ASN . 2.2 p -64.83 -58.43 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.668 0.747 . . . . 2.27 109.647 177.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.69 ' H ' HG13 ' A' ' 52' ' ' VAL . 2.1 p30 -110.33 -56.6 2.32 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.659 -1.155 . . . . 3.68 108.568 173.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.819 ' HA ' HG23 ' A' ' 51' ' ' THR . 5.8 p-10 -167.98 37.5 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.34 -1.3 . . . . 2.99 110.243 170.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.87 100.38 10.0 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.964 -0.562 . . . . 7.36 110.017 -177.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -72.44 86.05 1.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.34 -0.845 . . . . 4.46 111.375 -177.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.8 mt -96.08 109.66 23.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.415 -0.812 . . . . 0.92 110.177 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 3.1 m -86.34 94.04 9.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.26 -0.427 . . . . 0.96 110.296 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.54 ' O ' ' HB3' ' A' ' 60' ' ' LEU . 77.5 m-85 -72.6 88.66 1.27 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.909 -0.587 . . . . 1.57 110.68 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.681 HD13 HG23 ' A' ' 12' ' ' THR . 54.1 tp 76.46 156.99 0.18 Allowed 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.915 0.759 . . . . 3.21 110.714 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 27.0 t70 -149.44 -76.53 0.15 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.681 -0.236 . . . . 5.61 111.309 177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 64' ' ' GLY . 88.5 m -105.68 102.91 40.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.654 0.264 . . . . 5.45 111.674 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 44.0 Cg_endo -97.9 36.08 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.445 2.763 . . . . 6.11 111.708 173.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 65' ' ' HIS . . . -92.14 46.41 2.64 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.045 -0.525 . . . . 6.36 112.878 -175.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.484 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 21.5 t60 166.09 -46.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.177 -1.416 . . . . 8.78 107.177 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -156.6 160.58 39.55 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 104.816 -2.291 . . . . 7.05 104.816 173.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.979 ' HB3' ' HE1' ' A' ' 14' ' ' MET . . . -73.44 -23.58 60.13 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 118.602 0.637 . . . . 4.55 109.793 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.523 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -69.55 147.18 51.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.706 -0.679 . . . . 2.37 110.491 172.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.8 p -61.09 146.11 48.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.064 -0.516 . . . . 4.9 111.154 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 p -77.03 75.65 3.6 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.369 0.604 . . . . 5.84 110.937 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 68.9 mtm -89.22 30.04 1.01 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.616 -0.72 . . . . 5.21 110.69 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -90.82 -53.77 4.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.055 -0.52 . . . . 8.21 110.084 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.6 -47.02 85.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 6.36 110.311 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 71' ' ' MET . 17.0 ptt180 -167.41 -179.04 4.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.785 -0.643 . . . . 9.65 109.587 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.46 -77.51 0.2 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.782 -0.723 . . . . 4.93 111.71 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.21 56.17 8.12 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.17 0.51 . . . . 5.47 111.647 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.445 ' H ' ' HG2' ' A' ' 77' ' ' GLN . 4.6 pt20 -107.43 174.18 6.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.879 -0.6 . . . . 6.26 110.402 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.734 HG23 ' H ' ' A' ' 79' ' ' THR . 3.3 m -66.49 -77.72 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 113.588 0.959 . . . . 4.31 113.588 -168.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.734 ' H ' HG23 ' A' ' 78' ' ' VAL . 4.5 t -171.17 72.62 0.05 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.626 0.727 . . . . 3.41 110.603 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.3 132.36 52.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.501 -0.772 . . . . 2.66 110.142 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 11' ' ' VAL . 59.9 mt -89.85 142.55 12.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.579 -0.737 . . . . 0.71 111.075 -170.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.866 HG21 ' HE1' ' A' ' 102' ' ' HIS . 6.0 p -111.77 136.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.432 0.634 . . . . 1.17 110.766 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.587 HG12 ' HB ' ' A' ' 111' ' ' ILE . 11.9 mt -90.53 142.58 12.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.287 -0.87 . . . . 0.37 109.555 173.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.45 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.1 tm? -127.44 108.4 10.79 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.3 -1.0 . . . . 1.01 108.3 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 90.4 t -89.89 116.03 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.079 0.466 . . . . 0.43 111.206 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.829 HG21 HD21 ' A' ' 131' ' ' LEU . 1.7 m -123.43 125.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.643 -0.708 . . . . 0.64 111.003 174.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.616 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -65.95 132.04 47.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.059 -0.519 . . . . 0.28 109.88 174.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.764 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -73.24 -12.3 60.81 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.016 0.436 . . . . 0.22 111.158 -175.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.36 9.99 37.63 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.816 -0.629 . . . . 0.58 111.634 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -143.25 -40.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.561 0.219 . . . . 0.56 111.068 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.574 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 83.1 -143.27 21.95 Favored Glycine 0 C--O 1.227 -0.284 0 C-N-CA 121.367 -0.444 . . . . 0.37 114.014 171.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -92.49 128.74 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.763 0.792 . . . . 1.03 111.02 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.576 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -125.69 177.68 1.81 Allowed Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 114.248 -1.342 . . . . 0.28 108.955 -174.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 76.0 Cg_exo -48.93 -57.91 2.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.497 2.131 . . . . 0.58 114.085 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 2.1 pt20 -76.13 -12.46 60.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.246 -0.582 . . . . 0.75 110.783 -174.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.57 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.56 -50.16 40.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.727 -0.669 . . . . 0.31 109.758 178.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.574 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p -74.88 -21.86 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 112.749 0.648 . . . . 1.38 112.749 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.5 mt-10 -64.58 -29.9 70.92 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.452 -0.78 . . . . 2.35 109.171 172.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.705 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -76.39 -19.4 58.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.555 -0.748 . . . . 0.44 110.396 173.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.627 HG12 HD11 ' A' ' 136' ' ' LEU . 96.9 mt -79.42 -46.9 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.267 0.556 . . . . 0.41 109.619 171.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -51.76 -45.34 63.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.681 -1.145 . . . . 0.67 110.156 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.866 ' HE1' HG21 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -49.12 -46.62 45.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.733 -0.667 . . . . 2.5 111.061 172.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.37 -38.78 41.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.026 -0.534 . . . . 0.47 111.634 -169.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -73.96 -29.67 62.12 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.619 0.723 . . . . 1.66 110.161 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.78 -39.55 68.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.251 -1.34 . . . . 0.77 110.755 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.95 -32.61 15.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.463 -0.335 . . . . 0.74 111.591 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 62.3 t30 82.09 52.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.55 1.14 . . . . 1.41 109.123 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.434 HG23 ' HD2' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.36 143.93 28.74 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.847 -1.524 . . . . 1.35 111.155 -174.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD2' HG23 ' A' ' 108' ' ' VAL . 24.5 Cg_exo -63.23 145.07 93.05 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.756 2.304 . . . . 0.47 112.381 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.498 ' C ' HG23 ' A' ' 145' ' ' THR . 1.0 OUTLIER -112.61 161.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.885 0.85 . . . . 0.6 111.881 -173.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.983 HD13 ' HB ' ' A' ' 146' ' ' ILE . 19.7 mm -124.39 82.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.943 -1.502 . . . . 0.37 106.943 171.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 145' ' ' THR . 62.0 t -69.77 147.78 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 109.056 -0.72 . . . . 0.26 109.056 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.821 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -144.78 104.36 4.01 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.638 -1.164 . . . . 0.29 110.156 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.785 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.3 mp -73.18 136.62 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.165 -1.38 . . . . 0.59 109.198 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.552 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -121.99 173.11 7.74 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 106.723 -1.584 . . . . 1.85 106.723 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.616 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 91.0 mttt 66.53 33.88 6.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 O-C-N 123.759 0.662 . . . . 0.59 111.512 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . 78.5 mmm -84.12 -14.64 49.81 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.024 -0.732 . . . . 0.92 109.024 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -66.05 -31.89 73.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.754 -1.112 . . . . 0.76 108.875 171.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.46 133.71 80.17 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.667 -1.151 . . . . 1.17 110.24 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.06 -13.94 34.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.941 2.428 . . . . 0.58 111.937 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.17 -3.41 57.34 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.956 -1.02 . . . . 1.45 110.712 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . -56.45 120.94 8.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.149 -0.932 . . . . 0.27 111.848 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -131.74 76.91 73.65 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.197 -1.038 . . . . 0.95 108.197 170.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.574 ' HB2' ' HE2' ' A' ' 149' ' ' LYS . 33.4 Cg_endo -61.67 -56.91 0.65 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.21 2.606 . . . . 0.4 113.916 -173.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.683 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 7.2 m-20 -55.53 -26.7 44.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.493 0.663 . . . . 1.44 110.319 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 123' ' ' ASN . 14.6 tpp180 -74.11 -56.57 4.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 3.79 109.395 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.75 HG21 ' HA ' ' A' ' 88' ' ' ALA . 24.1 m -66.92 -29.35 46.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.122 -0.945 . . . . 0.59 111.871 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 1.016 ' HA ' HD23 ' A' ' 131' ' ' LEU . 19.6 ptm -76.16 -17.03 59.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.745 0.307 . . . . 0.81 110.272 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' A' ' 132' ' ' MET . 10.1 mt-30 -76.2 -30.84 58.17 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.483 -0.487 . . . . 1.31 110.424 171.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 130' ' ' GLU . 16.6 mt-10 -64.35 -31.13 72.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.844 -0.799 . . . . 1.64 108.844 174.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.016 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.4 OUTLIER -60.57 -47.83 84.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.677 -1.147 . . . . 1.36 109.507 176.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.661 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 18.2 ptm -71.64 -11.84 61.04 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.403 -0.519 . . . . 1.61 111.353 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 129' ' ' GLN . 29.4 mt-10 -74.59 -28.85 61.09 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.6 -0.889 . . . . 1.67 108.6 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.583 ' HB3' HG21 ' A' ' 100' ' ' ILE . 31.1 m-85 -98.67 31.31 2.95 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.093 -0.958 . . . . 1.08 109.815 168.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.74 40.99 22.52 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 113.796 -1.547 . . . . 1.1 112.77 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.627 HD11 HG12 ' A' ' 100' ' ' ILE . 70.1 mt -110.04 95.9 5.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.013 -0.54 . . . . 1.36 110.001 172.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.01 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 21.9 t -100.64 117.26 63.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.868 -0.606 . . . . 0.43 111.045 -173.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.697 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 92.4 Cg_exo -44.11 143.94 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 124.446 3.431 . . . . 0.54 113.049 174.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.565 ' HG2' ' C ' ' A' ' 145' ' ' THR . 7.2 mm-40 -71.6 -21.25 61.88 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.329 -1.305 . . . . 3.08 109.341 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.5 pm0 -66.88 -19.83 65.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.26 -0.882 . . . . 1.57 110.506 171.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.518 ' HZ3' ' SD ' ' A' ' 132' ' ' MET . 37.8 m0 -110.22 -9.97 14.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.871 0.367 . . . . 0.66 111.081 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.65 29.45 9.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.866 -0.683 . . . . 0.53 113.473 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 1.01 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -89.95 -108.73 1.29 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 119.954 -1.117 . . . . 0.6 112.358 176.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.14 60.91 0.12 Allowed 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.649 1.214 . . . . 1.91 110.858 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.863 HG21 HG23 ' A' ' 112' ' ' VAL . 72.8 m -165.2 119.2 1.25 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.643 -1.162 . . . . 0.37 110.712 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.983 ' HB ' HD13 ' A' ' 111' ' ' ILE . 19.1 mm -72.92 104.2 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 109.264 -0.643 . . . . 0.63 109.264 174.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.697 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m-85 -87.45 117.17 26.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.339 -0.846 . . . . 0.5 110.495 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 82.8 m -103.15 132.87 49.08 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.99 -0.55 . . . . 0.68 110.391 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.574 ' HE2' ' HB2' ' A' ' 124' ' ' PRO . 95.4 mttt -102.4 107.78 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.226 -0.657 . . . . 1.44 109.226 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.883 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -138.01 -172.52 3.28 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.703 1.24 . . . . 0.84 112.401 -173.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 117' ' ' MET . 0.3 OUTLIER -160.23 105.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 113.605 -1.634 . . . . 1.77 106.996 176.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.2 -14.38 62.94 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.343 -0.614 . . . . 0.41 109.343 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.733 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 3.9 tmtm? -62.86 -57.51 10.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.841 -1.072 . . . . 2.3 110.449 171.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.07 -8.86 59.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.622 0.601 . . . . 0.7 112.622 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.655 ' HE3' ' HB1' ' A' ' 27' ' ' ALA . 37.2 mmtm 64.38 44.99 3.96 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.36 111.204 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -105.21 -67.85 0.89 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.428 1.109 . . . . 2.48 109.63 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.883 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.78 -8.37 67.86 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 113.861 -1.518 . . . . 0.29 113.816 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.1 mt -66.44 -38.97 88.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.15 0.975 . . . . 0.8 109.41 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.596 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 40.8 m-20 -70.38 -44.16 68.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.326 -0.852 . . . . 2.2 109.291 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.413 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 73.8 t60 -62.8 -22.43 66.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.949 -0.569 . . . . 0.58 111.138 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 40.3 tp -67.92 -52.95 30.27 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.361 0.6 . . . . 1.16 109.497 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -66.97 -26.63 66.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.31 -0.859 . . . . 1.51 110.444 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 159' ' ' ASP . 94.1 mt-10 -61.99 -35.39 78.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.979 0.419 . . . . 2.57 110.832 175.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.56 ' HB3' HG21 ' A' ' 146' ' ' ILE . 11.3 mmt -82.3 -37.1 26.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.237 0.541 . . . . 0.64 110.398 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 83' ' ' ILE . 79.3 mt -69.59 -44.02 79.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.712 -0.676 . . . . 0.52 111.203 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -69.81 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.746 0.308 . . . . 1.73 110.248 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -57.9 -43.42 86.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.522 -0.918 . . . . 1.51 108.522 171.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.96 -38.72 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.41 -0.814 . . . . 0.89 110.615 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.4 t -53.39 -46.3 69.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.472 -0.331 . . . . 1.35 111.303 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -74.95 -30.78 61.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.828 0.346 . . . . 2.73 111.07 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.562 ' HG2' ' HE2' ' A' ' 175' ' ' LYS . 13.8 tmm? -62.07 -40.72 96.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.176 -0.465 . . . . 1.88 110.329 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.32 1.53 2.89 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.489 -0.778 . . . . 4.27 112.141 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -61.71 -49.72 75.32 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.616 -0.678 . . . . 3.91 111.557 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.9 tp -120.96 -54.98 2.01 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.637 -0.425 . . . . 5.72 111.196 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.562 ' HE2' ' HG2' ' A' ' 171' ' ' MET . 0.3 OUTLIER -103.76 169.04 8.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.29 -0.414 . . . . 5.49 110.344 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.83 28.63 0.84 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.157 0.503 . . . . 5.78 110.37 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.793 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 47.1 t30 -162.89 -61.22 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 7.88 111.774 -177.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 73.5 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.65 2.233 . . . . 9.19 112.999 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.733 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 111.814 -0.515 . . . . 11.58 111.814 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -70.7 96.75 1.26 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.015 0.436 . . . . 10.61 110.246 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.77 123.12 18.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 10.14 110.595 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 97.2 mmm -102.07 -26.72 13.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.302 -0.408 . . . . 8.77 110.777 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.29 125.97 53.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.304 0.573 . . . . 5.74 110.276 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.19 163.24 17.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.997 -0.547 . . . . 5.7 109.74 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.676 ' HG2' HG11 ' A' ' 78' ' ' VAL . 23.9 tpp180 -142.99 103.71 5.22 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.909 -0.404 . . . . 6.85 109.909 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.84 134.12 58.24 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.26 1.973 . . . . 2.8 111.48 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.12 94.21 0.23 Allowed 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.886 2.391 . . . . 2.76 111.995 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.8 m -72.29 143.68 13.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 2.0 110.29 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.719 ' HB ' ' HA ' ' A' ' 59' ' ' PHE . 22.8 t -113.34 162.65 11.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.844 -0.616 . . . . 1.35 109.672 -175.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 58.2 m -136.78 116.49 13.01 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.232 -0.655 . . . . 0.64 109.232 170.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.33 134.76 26.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.712 0.768 . . . . 1.3 110.691 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.524 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 66.3 mtt -138.38 -179.75 5.98 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.052 -0.977 . . . . 0.79 108.883 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.458 ' HA2' HD13 ' A' ' 84' ' ' LEU . . . 143.93 -171.44 25.49 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.511 -0.852 . . . . 0.31 112.362 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.536 ' CE1' HG12 ' A' ' 17' ' ' VAL . 38.9 t60 -98.05 160.96 13.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.91 0.862 . . . . 0.22 111.914 -177.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.536 HG12 ' CE1' ' A' ' 16' ' ' HIS . 7.4 p -73.56 150.89 7.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.318 -1.31 . . . . 0.36 110.11 174.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.605 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 17.6 t70 74.01 -32.62 0.24 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.225 0.61 . . . . 0.69 110.749 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.535 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 18.9 m170 -66.32 -20.51 66.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.733 -0.84 . . . . 0.63 108.733 170.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 126.46 55.83 0.15 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.79 113.331 174.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' HD3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -64.99 -61.19 2.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 117.46 0.63 . . . . 3.31 110.539 176.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.592 HG23 HG21 ' A' ' 45' ' ' ILE . 25.5 m -87.16 -41.76 13.52 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.972 0.415 . . . . 1.21 110.954 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.45 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -57.64 -33.83 68.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.087 0.773 . . . . 1.25 113.087 -175.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -72.41 -43.66 63.58 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.064 -0.717 . . . . 1.49 109.064 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.778 HD11 ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -66.68 -17.56 64.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.388 -0.824 . . . . 1.69 110.494 -178.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -94.21 -43.21 8.56 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.842 0.829 . . . . 1.23 108.958 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.24 97.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.24 -1.346 . . . . 0.63 109.587 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.531 HG12 ' HE3' ' A' ' 32' ' ' LYS . 10.2 tt -65.22 -25.93 38.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.452 -1.249 . . . . 1.02 111.224 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 19.0 mmm180 -65.23 -37.28 86.79 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.363 0.601 . . . . 3.04 109.892 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -103.6 22.87 13.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.061 -0.972 . . . . 2.65 111.114 -172.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.4 m -111.45 -20.68 12.13 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.414 -0.812 . . . . 1.46 112.21 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.787 ' HE2' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -168.39 -176.72 2.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.737 0.303 . . . . 3.92 110.889 -178.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 t -66.4 151.17 10.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.722 -0.672 . . . . 3.1 111.824 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 t -158.57 167.87 28.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.433 -0.803 . . . . 2.78 109.388 171.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -108.92 -173.21 2.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.803 0.335 . . . . 6.34 110.497 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -79.07 68.1 4.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.439 0.638 . . . . 6.79 112.445 -171.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -116.32 118.49 32.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.525 -0.761 . . . . 6.24 109.09 172.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.52 95.92 3.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.353 -0.385 . . . . 4.95 111.248 -178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.29 -4.21 55.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.893 -0.67 . . . . 4.68 112.115 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.95 85.82 0.14 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.377 -0.689 . . . . 4.55 111.377 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.65 128.41 74.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.715 0.293 . . . . 5.57 110.669 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.2 m 67.28 -77.72 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.715 -0.675 . . . . 5.93 110.609 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -155.18 10.98 0.33 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.581 -0.896 . . . . 6.63 108.581 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -90.56 101.75 14.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.338 -0.846 . . . . 6.54 110.231 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.592 HG21 HG23 ' A' ' 22' ' ' THR . 45.3 pt -96.05 -172.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.54 -0.755 . . . . 5.17 110.945 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.03 -86.32 0.14 Allowed Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.728 -0.669 . . . . 2.51 111.607 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.788 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -177.06 -170.33 0.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.62 -0.511 . . . . 1.36 109.62 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -171.68 -176.88 1.87 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.689 -0.486 . . . . 1.7 109.689 -170.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 65.4 mt-30 -87.75 112.59 22.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.393 -0.367 . . . . 1.91 110.437 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.915 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 58.6 t -77.2 167.99 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.546 -0.538 . . . . 1.53 109.546 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.854 HG23 ' HA ' ' A' ' 54' ' ' ASP . 44.2 m -154.11 82.69 1.14 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.662 -0.866 . . . . 1.51 108.662 -174.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.756 HG13 ' H ' ' A' ' 53' ' ' ASN . 2.3 p -64.62 -60.18 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.635 0.731 . . . . 2.27 109.43 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.756 ' H ' HG13 ' A' ' 52' ' ' VAL . 1.9 p30 -104.12 -63.23 1.22 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.648 -1.16 . . . . 3.68 108.294 172.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.854 ' HA ' HG23 ' A' ' 51' ' ' THR . 8.5 p-10 -168.96 43.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.48 -1.236 . . . . 2.99 109.491 169.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.749 ' HE3' ' HB3' ' A' ' 169' ' ' SER . 19.9 ttmm -111.55 124.11 51.61 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.776 -0.824 . . . . 7.36 108.776 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -72.99 80.23 1.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.796 0.685 . . . . 4.46 111.205 -174.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.915 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 9.7 mt -79.07 80.11 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.776 -0.824 . . . . 0.92 108.776 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 5.1 m -77.57 102.15 6.85 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.71 -0.677 . . . . 0.96 110.285 -177.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.719 ' HA ' ' HB ' ' A' ' 11' ' ' VAL . 7.9 m-30 -66.04 0.51 1.88 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.755 -1.111 . . . . 1.57 113.462 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 35.5 tp -175.03 126.5 0.27 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.577 0.227 . . . . 3.21 110.525 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' O ' HG21 ' A' ' 69' ' ' THR . 2.7 t0 -77.7 115.52 17.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.087 -0.506 . . . . 5.61 110.798 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.2 m 67.87 104.18 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.035 -0.53 . . . . 5.45 110.88 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -40.69 98.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.846 3.031 . . . . 6.11 113.58 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.19 171.84 12.58 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.344 -1.103 . . . . 6.36 110.344 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 64.8 m-70 62.34 56.59 2.11 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.776 -0.453 . . . . 8.78 109.776 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.55 -38.39 84.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.927 -0.579 . . . . 7.05 111.859 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.7 60.62 6.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.778 0.323 . . . . 4.55 110.246 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' HD2' ' CD2' ' A' ' 102' ' ' HIS . 0.1 OUTLIER 70.1 143.64 0.05 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.839 -1.073 . . . . 2.37 110.994 -174.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 65' ' ' HIS . 8.7 p -79.76 61.71 3.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.713 -0.676 . . . . 4.9 111.668 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.5 m 67.82 -75.11 0.07 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.378 -0.828 . . . . 5.84 111.076 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 63.2 mtt 53.2 71.32 0.5 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.967 0.413 . . . . 5.21 111.248 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -84.97 -9.63 57.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.295 -0.412 . . . . 8.21 110.837 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.02 -64.23 0.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.385 -0.37 . . . . 6.36 110.864 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 18.4 tpt180 54.17 67.09 1.06 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.72 -0.673 . . . . 9.65 110.191 -175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -54.48 36.06 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.61 -0.723 . . . . 4.93 112.19 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HB1' HG13 ' A' ' 78' ' ' VAL . . . -81.21 106.15 12.97 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.814 -0.439 . . . . 5.47 109.814 177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -67.62 -28.0 67.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 6.26 110.125 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.676 HG11 ' HG2' ' A' ' 7' ' ' ARG . 5.2 m 33.43 -102.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.618 -1.174 . . . . 4.31 113.252 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.669 ' H ' HG23 ' A' ' 78' ' ' VAL . 28.6 m -160.26 76.31 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.749 -0.463 . . . . 3.41 109.749 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.48 ' HB2' HG21 ' A' ' 108' ' ' VAL . 56.6 m-20 -79.8 146.71 32.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.731 -0.47 . . . . 2.66 109.731 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.2 mt -134.12 133.76 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.665 -0.243 . . . . 0.71 110.604 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 110' ' ' ILE . 25.9 t -112.06 129.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 C-N-CA 120.707 -0.397 . . . . 1.17 111.358 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.643 HG12 ' HB ' ' A' ' 111' ' ' ILE . 10.8 mt -97.92 132.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.761 -0.654 . . . . 0.37 110.975 174.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.961 ' HB3' HG13 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -109.44 112.02 23.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.512 -0.767 . . . . 1.01 111.364 -178.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.7 t -87.55 94.12 4.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.098 0.475 . . . . 0.43 110.067 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.897 HG13 HD12 ' A' ' 84' ' ' LEU . 7.3 m -117.24 128.22 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.723 -0.671 . . . . 0.64 110.698 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -79.21 134.07 36.68 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.464 -0.569 . . . . 0.28 109.464 175.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.702 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -71.72 -8.02 51.64 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.079 0.466 . . . . 0.22 110.812 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.471 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -85.38 -17.38 36.87 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.355 -0.839 . . . . 0.58 110.972 -179.051 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.535 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 24.8 t0 -132.0 -49.36 0.94 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.453 -0.34 . . . . 0.56 111.243 -170.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.63 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.24 -137.56 13.39 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 121.007 -0.616 . . . . 0.37 113.629 172.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 130' ' ' GLU . 6.9 p -88.47 138.51 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.35 -0.611 . . . . 1.03 109.35 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.847 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 81.4 mmm -142.78 178.2 1.57 Allowed Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.232 -0.655 . . . . 0.28 109.232 -171.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.847 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 49.3 Cg_exo -36.77 -69.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.544 2.829 . . . . 0.58 114.847 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.512 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 8.5 pt20 -73.69 -20.84 60.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.031 0.443 . . . . 0.75 111.346 -175.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.92 -43.78 82.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.677 -0.692 . . . . 0.31 109.373 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.57 HG12 ' ND2' ' A' ' 101' ' ' ASN . 47.6 t -66.92 -44.78 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.07 -0.968 . . . . 1.38 110.841 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.2 mm-40 -65.86 -14.84 62.23 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.153 0.502 . . . . 2.35 110.227 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -81.92 -38.4 25.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.556 -0.747 . . . . 0.44 110.086 170.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 95.6 mt -73.98 -42.29 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 121.642 0.734 . . . . 0.41 109.425 -178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.57 ' ND2' HG12 ' A' ' 97' ' ' VAL . 26.2 m-20 -57.99 -30.31 65.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.577 -1.192 . . . . 0.67 110.503 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.508 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 3.9 t60 -80.66 -37.73 30.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.32 0.581 . . . . 2.5 109.889 177.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.49 70.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.882 -0.599 . . . . 0.47 111.546 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 11.5 mmmm -72.79 -32.06 65.3 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.145 0.497 . . . . 1.66 110.133 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.39 -44.51 54.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.731 -1.122 . . . . 0.77 110.798 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.57 -26.92 34.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.74 110.591 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 64.51 88.47 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.434 0.694 . . . . 1.41 110.908 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.605 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -143.56 154.26 59.58 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.488 -0.778 . . . . 1.35 109.83 -176.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 108' ' ' VAL . 21.6 Cg_exo -61.21 140.51 89.27 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.482 2.121 . . . . 0.47 111.923 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 111' ' ' ILE . 1.4 mt -119.68 156.52 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.152 0.977 . . . . 0.6 111.917 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.014 HD13 ' HB ' ' A' ' 146' ' ' ILE . 19.0 mm -125.36 83.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.444 -1.707 . . . . 0.37 107.49 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.961 HG13 ' HB3' ' A' ' 84' ' ' LEU . 17.9 t -76.61 148.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 119.775 -0.77 . . . . 0.26 108.93 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.877 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -137.74 109.42 7.05 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.819 -1.082 . . . . 0.29 110.25 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.794 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.2 mp -75.98 132.78 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 114.128 -1.396 . . . . 0.59 109.43 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 54.4 t30 -114.06 168.68 9.6 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 107.454 -1.313 . . . . 1.85 107.454 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.736 ' HG2' ' N2 ' ' A' ' 179' ' ' GDP . 73.6 mttt 72.42 31.86 1.72 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.117 0.885 . . . . 0.59 112.001 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.571 ' H ' ' HB2' ' A' ' 151' ' ' SER . 11.4 mmt -72.8 -14.96 61.63 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.699 -0.682 . . . . 0.92 109.767 166.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.616 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.1 p-10 -69.7 -22.05 63.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.851 -1.068 . . . . 0.76 108.915 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.836 ' HE2' ' HA ' ' A' ' 119' ' ' LYS . 11.0 mmpt? -88.68 133.14 36.62 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.345 -1.298 . . . . 1.17 110.609 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.11 -11.69 28.76 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.878 2.385 . . . . 0.58 111.481 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -85.38 2.23 45.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.773 -1.103 . . . . 1.45 110.314 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -55.68 107.62 0.36 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.382 -0.826 . . . . 0.27 111.062 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.756 HD22 ' HB2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -121.75 76.52 37.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.723 -0.843 . . . . 0.95 108.723 174.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.526 ' HA ' HG22 ' A' ' 127' ' ' VAL . 45.2 Cg_endo -66.18 -55.01 0.42 Allowed 'Trans proline' 0 CA--C 1.503 -1.034 0 C-N-CA 123.079 2.52 . . . . 0.4 113.223 -171.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.403 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 11.9 m-20 -50.88 -27.64 7.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.189 -0.914 . . . . 1.44 110.386 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.756 ' HB2' HD22 ' A' ' 123' ' ' ASN . 32.2 tpt180 -79.63 -55.9 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 3.79 109.649 -178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.702 HG21 ' HA ' ' A' ' 88' ' ' ALA . 16.3 m -65.35 -28.94 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.476 -0.784 . . . . 0.59 112.078 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.407 ' HB2' ' HE3' ' A' ' 128' ' ' MET . 14.6 ptm -79.4 -19.33 50.3 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.157 -0.34 . . . . 0.81 110.486 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.65 ' O ' ' HG3' ' A' ' 132' ' ' MET . 13.0 mt-30 -74.4 -32.89 62.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.562 -0.29 . . . . 1.31 110.704 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.487 ' HB3' HG12 ' A' ' 92' ' ' VAL . 2.7 mm-40 -57.83 -46.29 84.94 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.569 0.699 . . . . 1.64 109.97 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 11.2 mp -66.38 -34.85 78.88 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.522 -0.763 . . . . 1.36 111.295 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.898 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -75.79 -7.89 55.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 119.724 -0.79 . . . . 1.61 110.738 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -82.45 -26.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.439 -0.948 . . . . 1.67 108.439 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.13 26.69 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.819 0.819 . . . . 1.08 109.854 165.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 53.78 57.0 6.46 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.983 -1.462 . . . . 1.1 111.673 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.846 ' H ' ' HA ' ' A' ' 132' ' ' MET . 62.8 mt -121.62 96.31 5.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.323 -0.853 . . . . 1.36 109.395 170.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 54.7 t -94.93 114.58 63.96 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.493 0.663 . . . . 0.43 112.162 -170.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.536 ' HA ' ' HD1' ' A' ' 147' ' ' PHE . 86.1 Cg_exo -45.29 152.63 0.7 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.651 3.567 . . . . 0.54 112.981 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.449 ' HB3' HD13 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -78.43 -19.36 53.38 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.253 -1.339 . . . . 3.08 109.663 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.424 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.8 pm0 -70.21 -17.49 63.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.246 -0.888 . . . . 1.57 110.771 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.898 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 44.0 m0 -106.61 -24.96 12.0 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.803 0.335 . . . . 0.66 111.117 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.62 15.56 5.34 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.128 -1.034 . . . . 0.53 113.998 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.608 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.05 -121.11 2.17 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.523 -1.322 . . . . 0.6 111.383 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -164.95 63.01 0.13 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 124.179 1.942 . . . . 1.91 110.496 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.518 ' CG2' HG23 ' A' ' 112' ' ' VAL . 85.9 m -141.7 104.92 4.62 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.689 -2.05 . . . . 0.37 107.361 173.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.014 ' HB ' HD13 ' A' ' 111' ' ' ILE . 42.2 mm -74.02 92.3 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-O 121.855 0.836 . . . . 0.63 110.054 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 114' ' ' ILE . 30.6 m-85 -75.81 107.83 8.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.038 -1.437 . . . . 0.5 110.447 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.9 m -98.96 108.22 20.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.004 -0.998 . . . . 0.68 110.211 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.794 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 76.9 mttt -83.36 99.4 10.01 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.902 -0.59 . . . . 1.44 109.867 -176.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.877 HD21 ' HB1' ' A' ' 113' ' ' ALA . 3.4 pp -128.42 -167.09 1.72 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 123.049 1.404 . . . . 0.84 112.463 -174.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.571 ' HB2' ' H ' ' A' ' 117' ' ' MET . 12.0 t -166.75 119.87 1.01 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.994 -1.912 . . . . 1.77 106.001 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.71 -5.84 51.9 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.124 -0.631 . . . . 0.41 109.372 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 19.5 mmtt -87.23 -37.37 17.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.391 -0.822 . . . . 2.3 111.498 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 11.6 p -87.69 -13.88 41.35 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.62 -0.832 . . . . 0.7 110.63 171.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 19.4 mmtp 59.64 45.39 13.17 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.95 -1.023 . . . . 1.36 109.703 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 4.4 tp10 -99.03 -68.5 0.8 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.487 -1.233 . . . . 2.48 110.557 -169.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.877 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -80.55 2.75 77.02 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.531 -0.842 . . . . 0.29 113.454 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.436 HD12 ' CD ' ' A' ' 155' ' ' LYS . 30.5 mt -74.32 -39.62 62.74 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.069 0.934 . . . . 0.8 108.879 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 19.4 t70 -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.358 -0.837 . . . . 2.2 108.936 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 81.9 t60 -67.43 -17.61 64.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.525 -0.761 . . . . 0.58 111.333 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 165' ' ' ILE . 51.6 tp -68.94 -56.9 6.41 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.03 0.443 . . . . 1.16 110.028 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.43 ' HG ' ' H ' ' A' ' 162' ' ' LEU . 9.9 mt -56.17 -38.56 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.21 -0.904 . . . . 1.51 109.731 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 31.7 mm-40 -56.39 -41.93 77.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.325 -0.852 . . . . 2.57 111.445 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.587 ' HB3' HG21 ' A' ' 146' ' ' ILE . 13.7 mmt -77.52 -32.25 53.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 0.64 110.576 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.712 HG21 HD13 ' A' ' 57' ' ' ILE . 75.7 mt -65.14 -47.18 88.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.837 -0.619 . . . . 0.52 111.093 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.544 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 3.9 pp -65.6 -29.29 69.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.862 0.363 . . . . 1.73 111.261 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.2 tp -56.25 -49.26 74.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.67 . . . . 1.51 109.708 170.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.519 ' HA ' ' HG2' ' A' ' 171' ' ' MET . 57.5 t -65.92 -37.51 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.521 -0.763 . . . . 0.89 110.26 174.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.749 ' HB3' ' HE3' ' A' ' 55' ' ' LYS . 19.6 m -66.46 -7.54 20.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.922 -0.581 . . . . 1.35 111.476 175.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -96.51 -32.41 12.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.016 0.436 . . . . 2.73 110.306 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.519 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 17.3 ptp -79.36 -11.52 59.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 1.88 110.656 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 169' ' ' SER . 11.7 pt-20 -67.51 -21.28 65.49 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.732 -0.47 . . . . 4.27 109.732 176.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 174' ' ' LEU . 28.2 mt-10 -86.49 -85.72 0.16 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.932 -0.576 . . . . 3.91 110.391 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.404 ' H ' ' HB2' ' A' ' 173' ' ' GLU . 60.1 mt -139.32 -21.4 0.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.135 -0.938 . . . . 5.72 111.041 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -74.96 75.54 2.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.664 -0.698 . . . . 5.49 112.074 -170.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.09 -41.48 50.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.897 0.38 . . . . 5.78 110.119 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -133.53 111.26 12.59 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.036 0.446 . . . . 7.88 110.53 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 123.072 2.515 . . . . 9.19 111.401 177.805 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.736 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.861 -0.495 . . . . 11.58 111.861 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 p -80.88 102.49 10.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.964 0.412 . . . . 10.61 110.009 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -87.42 -45.7 10.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.387 -0.37 . . . . 10.14 110.889 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.6 mtp -82.45 73.65 9.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.122 0.486 . . . . 8.77 110.814 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -83.6 101.47 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.349 -0.611 . . . . 5.74 109.349 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.45 104.03 8.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 5.7 109.953 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -110.11 100.6 44.49 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.274 -0.421 . . . . 6.85 110.438 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.56 130.91 26.23 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.51 2.14 . . . . 2.8 111.221 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -48.22 114.47 1.16 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.203 2.602 . . . . 2.76 112.569 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.486 HG13 HD12 ' A' ' 60' ' ' LEU . 39.4 t -82.2 128.8 38.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.468 -0.568 . . . . 2.0 109.468 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.53 95.22 2.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.017 0.437 . . . . 1.35 110.798 -176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.556 HG21 ' HB2' ' A' ' 68' ' ' PHE . 88.5 m -72.2 124.95 26.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.197 -0.456 . . . . 0.64 110.31 175.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.458 HD12 ' HB2' ' A' ' 25' ' ' LEU . 59.5 mt -96.37 127.93 48.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.915 0.388 . . . . 1.3 110.653 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.535 ' CE ' ' HB3' ' A' ' 68' ' ' PHE . 60.1 mtt -136.34 175.55 9.5 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.037 -0.529 . . . . 0.79 109.823 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 145.48 -168.97 27.16 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.89 -0.671 . . . . 0.31 111.7 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.577 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 47.1 t60 -89.66 158.49 17.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.86 0.838 . . . . 0.22 111.48 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.1 p -72.18 148.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.562 -1.199 . . . . 0.36 109.697 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 23.6 t70 73.81 -19.36 0.35 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.457 0.646 . . . . 0.69 110.502 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 17' ' ' VAL . 15.6 m170 -84.67 -0.68 54.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.974 -1.121 . . . . 0.63 107.974 168.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 87.76 49.48 3.83 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.163 -0.926 . . . . 0.79 113.86 172.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HG2' ' PB ' ' A' ' 179' ' ' GDP . 50.6 pttt -63.67 -36.57 84.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.31 -0.556 . . . . 3.31 111.508 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 m -101.8 -42.41 6.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.401 . . . . 1.21 110.454 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.487 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -54.11 -19.47 5.02 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.125 0.787 . . . . 1.25 113.125 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -74.83 -45.24 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.259 -0.645 . . . . 1.49 109.259 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.542 HD13 ' C ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -66.39 -16.12 63.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.731 -1.122 . . . . 1.69 109.199 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 18.9 t70 -97.78 -41.5 8.03 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.701 0.762 . . . . 1.23 110.194 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -29.1 69.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.817 -1.083 . . . . 0.63 110.132 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.9 tt -71.0 -23.28 23.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.662 -1.154 . . . . 1.02 110.128 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 31' ' ' SER . 96.6 mtt180 -68.5 -56.05 9.68 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.706 -0.679 . . . . 3.04 110.045 174.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -79.49 27.57 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.835 0.826 . . . . 2.65 111.12 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 29' ' ' ARG . 23.6 t -117.99 -21.65 8.21 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.729 -1.123 . . . . 1.46 110.633 176.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER 178.95 -167.05 0.07 Allowed 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.795 -0.446 . . . . 3.92 109.795 -178.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.822 HG13 ' H ' ' A' ' 34' ' ' THR . 4.0 p 40.21 -86.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.497 1.119 . . . . 3.1 113.64 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.888 HG21 ' HA2' ' A' ' 39' ' ' GLY . 23.3 p -99.93 104.31 15.94 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.484 0.659 . . . . 2.78 110.952 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -82.39 -38.38 24.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.816 -1.084 . . . . 6.34 112.152 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -158.52 -50.46 0.06 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.935 0.398 . . . . 6.79 110.593 -174.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -86.26 133.53 33.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.899 -0.591 . . . . 6.24 110.817 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 62.87 -165.56 0.24 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.715 0.634 . . . . 4.95 112.403 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.888 ' HA2' HG21 ' A' ' 34' ' ' THR . . . 134.55 -69.07 0.53 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.764 -0.653 . . . . 4.68 111.794 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.26 79.01 0.13 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.659 -0.977 . . . . 4.55 110.659 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.6 mt -77.77 115.52 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.889 0.852 . . . . 5.57 112.0 -173.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.0 m -150.44 147.23 27.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.647 -1.161 . . . . 5.93 107.971 174.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -91.54 47.21 1.35 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.392 0.615 . . . . 6.63 111.656 -169.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.439 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 5.5 p-80 -175.94 42.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.057 -0.974 . . . . 6.54 108.699 175.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 44' ' ' HIS . 50.7 mm 73.14 156.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.015 -0.993 . . . . 5.17 109.214 -168.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -155.69 103.1 0.23 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.635 -0.793 . . . . 2.51 112.695 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.805 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -66.16 169.87 6.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.692 -0.484 . . . . 1.36 109.692 172.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -161.18 164.01 30.79 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 118.614 -1.234 . . . . 1.7 113.039 -163.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HG2' HG23 ' A' ' 58' ' ' THR . 17.3 mt-30 -92.02 122.51 34.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.8 -1.091 . . . . 1.91 109.383 176.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.2 m -87.1 162.39 2.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.112 0.482 . . . . 1.53 110.694 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 54' ' ' ASP . 22.8 m -99.11 82.16 2.68 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.302 0.572 . . . . 1.51 109.91 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 p -78.84 -28.22 13.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.256 -1.016 . . . . 2.27 108.256 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -149.03 -52.19 0.16 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.53 -1.668 . . . . 3.68 107.848 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.513 ' HA ' HG23 ' A' ' 51' ' ' THR . 29.6 t70 -173.88 87.42 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.026 -0.988 . . . . 2.99 110.438 169.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 73.12 3.33 4.63 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.48 0.919 . . . . 7.36 113.48 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -76.84 153.32 34.93 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.614 -0.435 . . . . 4.46 110.75 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.6 mt 72.95 98.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.668 0.747 . . . . 0.92 110.722 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 49' ' ' GLN . 8.5 m -102.54 100.59 10.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.237 -0.892 . . . . 0.96 109.731 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.805 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 90.5 m-85 -74.26 119.07 17.95 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.269 -1.011 . . . . 1.57 108.269 176.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.74 ' HB3' ' HG3' ' A' ' 63' ' ' PRO . 87.8 mt -125.74 130.96 52.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.959 0.409 . . . . 3.21 111.659 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -110.3 -41.08 4.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.745 -0.661 . . . . 5.61 109.707 174.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.8 t -134.13 77.85 60.32 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 121.884 0.849 . . . . 5.45 110.672 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.793 ' HG2' ' HB3' ' A' ' 67' ' ' ALA . 26.1 Cg_exo -63.82 -65.6 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.166 2.578 . . . . 6.11 112.928 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.33 -71.55 0.4 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.316 -0.945 . . . . 6.36 113.556 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -75.55 -77.96 0.12 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.896 0.379 . . . . 8.78 111.757 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.54 99.42 3.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.405 0.622 . . . . 7.05 111.08 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.793 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . . . -165.59 86.06 0.37 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.862 -1.063 . . . . 4.55 110.172 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.576 ' HE2' ' HB3' ' A' ' 80' ' ' ASP . 82.6 m-85 45.02 -88.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.756 -1.111 . . . . 2.37 113.973 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 m -52.24 -42.68 63.83 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.266 0.555 . . . . 4.9 110.459 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.9 p -111.0 77.98 1.08 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.798 -0.637 . . . . 5.84 109.914 175.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.711 ' HG2' ' H ' ' A' ' 74' ' ' ARG . 56.6 ttm -138.58 87.59 2.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.02 0.438 . . . . 5.21 110.305 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -67.42 -31.84 72.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.634 -0.712 . . . . 8.21 110.708 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.08 86.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.881 -0.599 . . . . 6.36 111.592 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.711 ' H ' ' HG2' ' A' ' 71' ' ' MET . 27.4 ttm180 52.05 87.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.448 0.642 . . . . 9.65 111.22 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.44 23.56 1.1 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.57 -0.741 . . . . 4.93 111.739 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.48 111.36 22.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.753 0.311 . . . . 5.47 110.975 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.88 87.63 3.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.272 0.558 . . . . 6.26 110.099 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.71 152.44 10.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.43 -0.804 . . . . 4.31 109.104 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.2 m -72.08 81.37 0.96 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.458 -0.571 . . . . 3.41 109.458 175.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.576 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . 3.4 t0 -131.24 152.98 49.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.312 -0.858 . . . . 2.66 109.341 -173.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.6 mt -132.75 129.39 58.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.026 -0.731 . . . . 0.71 109.026 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HB ' HD13 ' A' ' 110' ' ' ILE . 31.3 t -100.9 116.64 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 C-N-CA 119.408 -0.917 . . . . 1.17 112.183 -173.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 9.2 mt -81.3 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.899 -1.046 . . . . 0.37 109.448 171.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.552 HD12 HD21 ' A' ' 131' ' ' LEU . 2.3 tm? -117.91 105.97 12.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.084 -1.08 . . . . 1.01 108.084 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 53.8 t -90.05 112.11 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.364 -0.834 . . . . 0.43 110.864 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.0 OUTLIER -121.32 129.67 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 115.733 -0.667 . . . . 0.64 110.874 175.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -70.63 130.69 42.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.896 -0.593 . . . . 0.28 109.935 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.664 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -71.54 -13.58 61.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 0.22 110.632 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.465 ' OD1' ' HD2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -94.46 -2.42 51.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.686 -0.688 . . . . 0.58 111.521 -178.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.454 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 26.4 t0 -138.03 -49.26 0.56 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.652 -0.249 . . . . 0.56 110.891 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.595 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 97.36 -146.89 18.46 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.343 -0.456 . . . . 0.37 113.689 171.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.5 136.12 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 1.03 109.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.73 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.2 mmm -138.14 176.5 2.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 114.87 -1.059 . . . . 0.28 108.658 -171.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.73 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 55.8 Cg_exo -38.54 -69.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.607 2.872 . . . . 0.58 114.764 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.52 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 7.6 pt20 -72.4 -16.99 61.85 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.01 0.433 . . . . 0.75 111.47 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -67.71 -44.01 78.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.097 -0.705 . . . . 0.31 109.097 176.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 93' ' ' MET . 20.8 t -65.86 -41.36 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 115.22 -0.9 . . . . 1.38 111.096 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.81 -26.73 62.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.252 -0.431 . . . . 2.35 110.777 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -73.7 -34.95 65.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.382 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 96.8 mt -74.3 -46.69 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.472 0.653 . . . . 0.41 109.28 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.501 ' ND2' HG12 ' A' ' 97' ' ' VAL . 59.7 m-20 -56.31 -40.56 74.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.608 -1.178 . . . . 0.67 110.491 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -70.65 -35.43 72.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.907 -0.588 . . . . 2.5 110.199 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.488 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -69.43 -46.92 65.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.47 111.109 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.5 mmtp -64.8 -38.68 91.79 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.19 0.519 . . . . 1.66 109.986 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -48.24 -43.31 32.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.301 -1.318 . . . . 0.77 111.239 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.73 -38.27 15.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.74 111.022 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 88.08 72.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.631 1.172 . . . . 1.41 109.113 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 109' ' ' PRO . 3.0 p -126.2 144.71 49.95 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.203 -1.362 . . . . 1.35 110.862 -171.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.443 ' O ' HG22 ' A' ' 108' ' ' VAL . 16.9 Cg_exo -66.45 139.32 53.58 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.716 1.611 . . . . 0.47 111.327 170.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.488 HD11 ' HB1' ' A' ' 103' ' ' ALA . 27.0 mm -104.83 157.4 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.571 0.7 . . . . 0.6 110.68 -173.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.06 HD13 ' HB ' ' A' ' 146' ' ' ILE . 16.3 mm -122.91 83.72 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.346 -1.353 . . . . 0.37 107.346 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.729 HG23 HG21 ' A' ' 145' ' ' THR . 63.5 t -71.14 143.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 121.907 0.861 . . . . 0.26 109.518 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.762 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -146.64 100.41 3.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.857 -1.52 . . . . 0.29 109.857 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.793 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 85.0 mt -72.25 140.13 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 113.749 -1.569 . . . . 0.59 109.91 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.623 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 1.2 p-10 -120.29 176.13 5.62 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.068 -1.456 . . . . 1.85 107.068 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.657 ' HA ' ' OD1' ' A' ' 118' ' ' ASP . 75.5 mttt 66.34 27.92 9.92 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.86 0.725 . . . . 0.59 112.165 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.488 ' SD ' ' HB1' ' A' ' 122' ' ' ALA . 85.8 mmm -80.86 -1.64 44.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.697 0.761 . . . . 0.92 109.074 171.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.657 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 9.4 p-10 -71.01 -31.7 68.27 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.84 -1.073 . . . . 0.76 108.664 168.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HB3' ' HE2' ' A' ' 119' ' ' LYS . 39.6 mtpt -77.41 136.75 64.25 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.128 -1.396 . . . . 1.17 110.833 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.78 -17.39 59.7 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.818 2.346 . . . . 0.58 111.683 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.05 1.62 27.04 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.695 -0.684 . . . . 1.45 110.687 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.488 ' HB1' ' SD ' ' A' ' 117' ' ' MET . . . -56.03 114.9 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.594 -0.73 . . . . 0.27 110.638 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.69 75.46 55.49 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 107.885 -1.154 . . . . 0.95 107.885 173.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.43 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 42.4 Cg_endo -64.86 -57.17 0.31 Allowed 'Trans proline' 0 CA--C 1.502 -1.122 0 C-N-CA 122.492 2.128 . . . . 0.4 112.46 -172.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.43 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 4.3 m-20 -50.91 -26.57 6.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 124.2 0.938 . . . . 1.44 111.037 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -77.71 -59.23 2.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.892 -0.594 . . . . 3.79 110.071 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.595 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 4.7 m -64.67 -27.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.105 -0.952 . . . . 0.59 110.398 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.666 ' HG2' ' CE ' ' A' ' 132' ' ' MET . 23.2 ttt -60.95 -51.79 67.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.726 -1.125 . . . . 0.81 109.815 171.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 132' ' ' MET . 35.2 mt-30 -59.15 -31.25 68.8 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.022 0.749 . . . . 1.31 113.022 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.517 ' HA ' ' CG ' ' A' ' 133' ' ' GLU . 4.3 pt-20 -80.91 -16.44 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.081 -0.647 . . . . 1.64 112.081 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.723 HD23 HG21 ' A' ' 112' ' ' VAL . 6.7 mp -68.17 -35.87 78.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.582 -0.847 . . . . 1.36 109.044 167.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.666 ' CE ' ' HG2' ' A' ' 128' ' ' MET . 0.5 OUTLIER -71.19 -18.75 62.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.437 -0.801 . . . . 1.61 109.618 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.517 ' CG ' ' HA ' ' A' ' 130' ' ' GLU . 7.9 mm-40 -70.45 -30.51 67.37 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.661 -0.866 . . . . 1.67 108.661 173.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -91.97 17.3 9.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.059 -0.973 . . . . 1.08 109.959 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 61.11 47.84 6.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.233 -1.349 . . . . 1.1 111.27 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.492 HD11 HD23 ' A' ' 131' ' ' LEU . 1.5 pp -131.28 121.41 24.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.096 -1.076 . . . . 1.36 108.096 167.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.759 HG13 ' HD2' ' A' ' 138' ' ' PRO . 5.0 t -122.06 142.92 37.62 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 121.114 0.483 . . . . 0.43 111.382 -168.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HB3' ' CD1' ' A' ' 147' ' ' PHE . 18.5 Cg_endo -69.86 -175.21 1.1 Allowed 'Trans proline' 0 CA--C 1.498 -1.278 0 C-N-CA 123.621 2.88 . . . . 0.54 113.631 -176.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.775 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -84.61 -32.66 23.6 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.53 -1.668 . . . . 3.08 109.93 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.756 ' HG3' ' CD1' ' A' ' 141' ' ' TRP . 6.7 pt-20 -67.85 -17.66 64.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.092 -0.504 . . . . 1.57 111.205 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.756 ' CD1' ' HG3' ' A' ' 140' ' ' GLU . 21.2 m0 -109.04 -2.82 17.89 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.892 0.377 . . . . 0.66 111.183 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.81 32.13 13.68 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.058 -0.591 . . . . 0.53 113.784 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.19 -127.86 5.84 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.627 -0.796 . . . . 0.6 111.407 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -149.84 62.93 0.99 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.018 0.913 . . . . 1.91 111.894 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 112' ' ' VAL . 52.7 m -161.27 128.14 4.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.165 -0.925 . . . . 0.37 109.99 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.06 ' HB ' HD13 ' A' ' 111' ' ' ILE . 46.8 mm -79.78 104.89 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 108.863 -0.792 . . . . 0.63 108.863 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.765 ' CD1' ' HB3' ' A' ' 138' ' ' PRO . 5.9 m-85 -88.56 116.74 27.02 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.584 -0.734 . . . . 0.5 111.706 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.1 m -106.76 143.31 35.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.638 -0.71 . . . . 0.68 110.814 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.586 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.5 mttt -118.15 97.91 6.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.885 -0.783 . . . . 1.44 108.885 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.897 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.5 pp -130.63 -171.47 2.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.749 1.261 . . . . 0.84 112.569 -169.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.531 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 28.9 t -157.88 115.99 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.679 -1.601 . . . . 1.77 106.873 174.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.45 -9.92 58.99 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.084 -0.71 . . . . 0.41 109.084 175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.702 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 0.5 OUTLIER -74.18 -50.96 17.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.878 -1.055 . . . . 2.3 110.56 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 118' ' ' ASP . 2.1 p -81.39 -16.06 53.34 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.228 -0.589 . . . . 0.7 111.217 175.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.449 ' CD ' HD12 ' A' ' 158' ' ' LEU . 29.1 mmtp 67.21 40.66 2.75 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.307 -0.861 . . . . 1.36 110.539 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.4 OUTLIER -98.71 -64.66 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.022 -0.99 . . . . 2.48 109.663 -171.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.897 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -76.19 -3.01 74.89 Favored Glycine 0 N--CA 1.429 -1.781 0 CA-C-N 115.111 -0.95 . . . . 0.29 113.433 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.449 HD12 ' CD ' ' A' ' 155' ' ' LYS . 18.1 mt -70.89 -36.16 72.63 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 117.974 0.887 . . . . 0.8 109.416 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 27.7 t70 -73.04 -39.95 65.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.547 -0.751 . . . . 2.2 109.257 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.423 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 61.3 t60 -68.52 -18.11 64.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.212 -0.449 . . . . 0.58 111.346 176.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 45.8 tp -74.81 -54.27 7.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.24 0.543 . . . . 1.16 110.08 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.5 pp -62.52 -27.64 69.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.267 -0.879 . . . . 1.51 111.529 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 12.0 pt-20 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.431 -0.507 . . . . 2.57 110.22 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.456 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 21.7 mmt -71.72 -39.39 70.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.17 0.509 . . . . 0.64 109.649 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -66.25 -38.7 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.519 -0.764 . . . . 0.52 110.443 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -40.38 95.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.09 -0.504 . . . . 1.73 111.146 177.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.98 -43.46 63.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.466 0.65 . . . . 1.51 109.561 173.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.37 -40.48 80.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.756 -1.111 . . . . 0.89 110.769 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.7 m -60.77 -35.22 75.87 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.977 0.418 . . . . 1.35 111.225 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.81 -13.93 57.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.894 -0.504 . . . . 2.73 110.499 177.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.731 ' HG2' ' HA ' ' A' ' 175' ' ' LYS . 44.5 ttp -91.45 -9.03 46.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 1.88 110.878 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -37.78 -41.87 0.54 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.065 1.135 . . . . 4.27 114.065 -176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -99.39 -41.65 7.32 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.463 -0.495 . . . . 3.91 111.497 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 171' ' ' MET . 0.9 OUTLIER -99.56 47.31 0.96 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.003 0.371 . . . . 5.72 112.003 -174.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.921 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 1.5 mppt? -49.22 141.26 8.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.004 -0.543 . . . . 5.49 111.605 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -124.3 79.02 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.338 -0.392 . . . . 5.78 110.416 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -81.3 143.97 53.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.844 -0.428 . . . . 7.88 109.844 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.945 2.43 . . . . 9.19 112.185 -179.565 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.702 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.479 -0.648 . . . . 11.58 111.479 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.0 t -106.72 2.35 25.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.873 0.368 . . . . 10.61 110.33 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -101.96 106.12 17.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.357 -0.383 . . . . 10.14 110.224 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 ttp -106.8 -20.69 13.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.787 -0.82 . . . . 8.77 108.787 170.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 m -93.01 132.89 35.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.121 -0.945 . . . . 5.74 110.148 175.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -102.52 147.31 26.92 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.468 -0.567 . . . . 5.7 109.468 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -125.37 100.56 32.13 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.996 0.426 . . . . 6.85 111.285 -173.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 23.4 Cg_exo -64.53 124.81 13.85 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.643 2.229 . . . . 2.8 110.952 175.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 36.2 Cg_exo -58.26 103.31 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.777 2.318 . . . . 2.76 113.024 -176.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -84.63 115.7 27.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.267 -1.012 . . . . 2.0 108.267 171.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 74.2 t -109.1 135.1 49.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.176 -0.465 . . . . 1.35 111.405 -171.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.52 ' HB ' ' HA ' ' A' ' 82' ' ' VAL . 89.1 m -88.66 133.79 34.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.686 -0.688 . . . . 0.64 110.251 178.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.0 mt -112.62 122.34 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.051 -0.406 . . . . 1.3 110.402 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.771 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 59.2 mtt -139.65 173.56 11.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.048 -0.524 . . . . 0.79 109.953 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.491 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 145.32 -163.54 28.12 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.641 -0.79 . . . . 0.31 112.335 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.589 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 42.7 t60 -97.1 161.28 13.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.822 0.82 . . . . 0.22 112.031 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.583 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.8 p -73.72 151.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.339 -1.301 . . . . 0.36 109.739 174.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 10.7 t70 73.39 -27.09 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.304 0.574 . . . . 0.69 110.605 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 17' ' ' VAL . 17.0 m170 -77.38 -10.47 59.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.407 -0.96 . . . . 0.63 108.407 171.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.688 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . 113.72 51.95 0.48 Allowed Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.605 -0.807 . . . . 0.79 114.22 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 4.2 tptm -53.31 -62.77 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.447 0.623 . . . . 3.31 111.283 174.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -96.07 -32.11 12.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.579 -0.282 . . . . 1.21 111.079 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.558 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -59.34 -20.84 57.87 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.018 0.747 . . . . 1.25 113.018 -179.006 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.688 HD23 ' HA3' ' A' ' 20' ' ' GLY . 1.5 mm? -74.52 -35.73 63.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.919 0.39 . . . . 1.49 110.001 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -74.02 -15.11 61.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.79 -0.641 . . . . 1.69 109.466 176.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -96.5 -32.03 12.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.706 -0.679 . . . . 1.23 109.29 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.47 -47.32 49.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.198 -0.91 . . . . 0.63 109.051 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 4.7 tt -59.34 -25.99 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.68 -1.145 . . . . 1.02 110.244 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HD2' ' HA3' ' A' ' 39' ' ' GLY . 13.9 tpp85 -64.47 -50.17 68.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.666 -1.152 . . . . 3.04 110.684 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -96.66 22.5 8.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.866 0.841 . . . . 2.65 111.238 -172.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.1 m -98.77 -43.95 6.58 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.784 -1.098 . . . . 1.46 109.616 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -174.42 -169.17 0.43 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.51 -0.768 . . . . 3.92 109.238 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.596 HG13 ' H ' ' A' ' 34' ' ' THR . 3.4 p 48.28 -75.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.626 1.171 . . . . 3.1 113.754 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.596 ' H ' HG13 ' A' ' 33' ' ' VAL . 2.1 p -79.05 123.17 27.07 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.701 0.63 . . . . 2.78 112.701 -172.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.686 ' HG3' ' HG2' ' A' ' 37' ' ' GLU . 8.9 pt-20 -94.96 -146.56 0.27 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.522 -0.763 . . . . 6.34 109.365 173.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -78.86 35.24 0.24 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.38 0.61 . . . . 6.79 111.395 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.686 ' HG2' ' HG3' ' A' ' 35' ' ' GLU . 66.4 mm-40 -100.39 -179.56 4.15 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.674 -0.694 . . . . 6.24 109.572 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.71 94.28 1.01 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.901 0.381 . . . . 4.95 110.263 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' A' ' 29' ' ' ARG . . . -78.07 61.21 3.8 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.118 -0.492 . . . . 4.68 112.745 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 48' ' ' TYR . . . 167.86 126.07 0.82 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.899 -0.88 . . . . 4.55 110.899 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.6 mm -91.19 67.56 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.392 0.615 . . . . 5.57 110.424 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 44' ' ' HIS . 2.2 m -167.27 161.36 14.29 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.507 -0.924 . . . . 5.93 108.507 177.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -86.93 8.55 22.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.084 0.945 . . . . 6.63 109.168 172.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.515 ' O ' ' HB ' ' A' ' 42' ' ' THR . 85.7 m-70 -130.02 135.12 47.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.729 -1.123 . . . . 6.54 108.188 173.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 46' ' ' GLY . 9.4 tp -74.86 153.96 6.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.468 0.652 . . . . 5.17 110.654 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' O ' ' HG ' ' A' ' 25' ' ' LEU . . . 171.98 -59.06 0.16 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.182 -0.917 . . . . 2.51 112.342 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.89 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -161.71 -171.99 3.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.735 0.303 . . . . 1.36 111.138 -177.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.486 ' HB3' ' HA2' ' A' ' 40' ' ' GLY . 0.4 OUTLIER -170.25 177.9 4.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.7 109.951 -173.208 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -93.05 121.96 34.92 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.718 -0.845 . . . . 1.91 108.718 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.675 HG22 ' H ' ' A' ' 51' ' ' THR . 6.6 p -93.04 176.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.357 0.598 . . . . 1.53 110.714 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.675 ' H ' HG22 ' A' ' 50' ' ' VAL . 87.5 m -118.04 94.92 4.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.626 -0.715 . . . . 1.51 110.221 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 56' ' ' LYS . 11.7 p -83.59 -31.31 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 107.536 -1.283 . . . . 2.27 107.536 170.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -141.86 -52.53 0.43 Allowed 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 113.093 -1.867 . . . . 3.68 107.712 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.627 ' HA ' HG23 ' A' ' 51' ' ' THR . 8.9 p-10 179.55 101.44 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.426 -1.261 . . . . 2.99 110.173 168.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 75.6 mmtt 82.28 -9.41 1.18 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.343 -0.844 . . . . 7.36 112.592 169.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.757 ' HE2' ' HB3' ' A' ' 169' ' ' SER . 43.4 tttp -73.39 141.5 46.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.947 -0.39 . . . . 4.46 109.947 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.513 ' HB ' HG12 ' A' ' 50' ' ' VAL . 43.7 mt 82.18 103.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.679 0.791 . . . . 0.92 111.555 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.6 m -114.23 108.17 16.58 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.431 -0.804 . . . . 0.96 109.487 171.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 55.8 m-85 -72.41 36.58 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.425 -0.807 . . . . 1.57 112.691 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.89 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 10.1 tt -149.97 128.29 12.12 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.798 -0.564 . . . . 3.21 111.967 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -118.98 -74.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.797 -0.638 . . . . 5.61 110.143 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 m -131.08 124.23 20.37 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 5.45 110.519 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -78.94 136.41 13.16 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.764 2.31 . . . . 6.11 113.015 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.42 -136.46 4.53 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.688 -0.965 . . . . 6.36 110.688 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -88.83 -14.74 36.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.496 0.665 . . . . 8.78 109.599 171.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.95 165.46 13.55 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.337 -0.847 . . . . 7.05 110.302 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.62 -35.86 0.1 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.514 -0.921 . . . . 4.55 108.514 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.706 ' HE2' ' HA ' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -48.78 132.78 17.93 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.543 -1.208 . . . . 2.37 109.572 169.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.1 p -54.83 129.73 38.39 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.021 0.439 . . . . 4.9 111.462 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.0 m -67.9 85.46 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.512 0.672 . . . . 5.84 109.975 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.448 ' SD ' HG11 ' A' ' 78' ' ' VAL . 20.8 ptp -92.51 122.59 35.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.131 -0.94 . . . . 5.21 111.426 -175.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -118.1 -34.4 4.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.651 -0.704 . . . . 8.21 109.176 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.19 -62.7 1.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.331 -0.85 . . . . 6.36 110.463 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 59.98 -165.75 0.2 Allowed 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.451 0.469 . . . . 9.65 110.984 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.79 -137.7 7.89 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.74 -0.743 . . . . 4.93 112.243 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.0 87.45 2.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.567 0.222 . . . . 5.47 111.25 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 64.46 101.99 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.756 -0.657 . . . . 6.26 112.111 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.448 HG11 ' SD ' ' A' ' 71' ' ' MET . 13.8 m -67.11 130.43 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 4.31 110.732 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -92.38 54.89 2.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.11 -0.496 . . . . 3.41 111.45 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.741 ' HB3' HG21 ' A' ' 108' ' ' VAL . 10.2 t70 -87.03 133.71 33.56 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.418 -0.956 . . . . 2.66 108.418 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.2 mt -116.18 105.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.597 -0.52 . . . . 0.71 109.597 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' HD13 ' A' ' 110' ' ' ILE . 40.1 t -93.84 114.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.424 0.63 . . . . 1.17 111.205 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.695 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 18.5 mt -82.84 126.03 40.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.899 -1.046 . . . . 0.37 109.596 172.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.3 tm? -114.73 106.09 13.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.447 -0.945 . . . . 1.01 108.447 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 57.7 t -88.24 109.76 20.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.395 -0.82 . . . . 0.43 110.921 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 131' ' ' LEU . 1.7 m -121.14 135.76 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.855 -0.611 . . . . 0.64 111.338 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.696 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -74.26 134.18 42.64 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.935 -0.575 . . . . 0.28 109.706 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.76 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -78.61 -9.42 59.36 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.355 0.597 . . . . 0.22 109.846 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -89.25 -10.24 47.68 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.941 -1.027 . . . . 0.58 110.359 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.1 t0 -133.33 -59.51 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.07 -0.514 . . . . 0.56 111.152 -173.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.436 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 109.14 -135.11 12.65 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.37 113.637 173.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -100.27 131.23 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.786 0.803 . . . . 1.03 110.671 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.656 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 68.6 mmm -134.02 178.93 1.53 Allowed Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 114.333 -1.303 . . . . 0.28 109.402 -171.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.4 Cg_exo -45.64 -64.34 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.27 2.647 . . . . 0.58 114.735 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.583 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 7.0 pt20 -75.17 -10.93 59.92 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.636 -0.665 . . . . 0.75 111.3 -175.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.85 -49.28 54.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.738 -0.664 . . . . 0.31 109.279 175.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' HA ' HD12 ' A' ' 100' ' ' ILE . 2.5 p -72.63 -28.61 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.834 -0.621 . . . . 1.38 112.591 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 49.2 mt-10 -57.95 -29.66 65.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.544 0.611 . . . . 2.35 109.448 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.771 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -72.36 -42.85 64.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.396 -0.82 . . . . 0.44 110.743 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 97' ' ' VAL . 65.7 mt -66.05 -41.57 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-O 121.62 0.724 . . . . 0.41 109.307 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -57.9 -40.0 79.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.196 -1.366 . . . . 0.67 110.857 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -66.83 -40.45 88.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.643 -0.503 . . . . 2.5 109.643 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.706 ' HA ' ' HE2' ' A' ' 68' ' ' PHE . . . -70.41 -46.08 64.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.877 -0.602 . . . . 0.47 111.788 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.78 -29.06 61.98 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.052 0.453 . . . . 1.66 110.659 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.61 -43.23 62.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.689 -1.141 . . . . 0.77 110.69 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.44 -19.18 23.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.74 111.3 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 70.04 67.79 0.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.17 -0.923 . . . . 1.41 110.472 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.741 HG21 ' HB3' ' A' ' 80' ' ' ASP . 0.5 OUTLIER -117.28 152.39 49.1 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.644 -0.707 . . . . 1.35 111.12 -176.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 108' ' ' VAL . 23.2 Cg_exo -65.34 141.58 68.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.041 2.494 . . . . 0.47 112.537 172.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.547 HD13 ' HB ' ' A' ' 82' ' ' VAL . 29.2 mm -111.27 155.47 12.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.601 0.715 . . . . 0.6 111.121 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.774 HD13 ' HB ' ' A' ' 146' ' ' ILE . 7.9 mm -125.38 87.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.429 -1.323 . . . . 0.37 107.429 170.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.679 HG23 HG21 ' A' ' 145' ' ' THR . 46.6 t -74.16 148.33 8.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.463 -0.789 . . . . 0.26 109.8 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 150' ' ' LEU . . . -143.73 106.18 4.42 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.473 -1.24 . . . . 0.29 110.427 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.83 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.2 mp -79.22 135.06 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.508 -1.224 . . . . 0.59 109.787 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.696 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.5 p-10 -113.47 177.41 4.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.28 -1.378 . . . . 1.85 107.28 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.735 ' HD3' ' HD3' ' A' ' 119' ' ' LYS . 84.2 mttt 70.5 33.1 2.52 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.61 0.569 . . . . 0.59 111.754 176.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.665 ' HB2' ' HB3' ' A' ' 151' ' ' SER . 29.8 mmt -73.95 -19.0 60.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.245 -1.391 . . . . 0.92 107.245 166.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.632 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -62.29 -36.44 82.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.37 -1.741 . . . . 0.76 110.503 172.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.735 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 41.1 mtpt -79.34 141.77 57.73 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.94 -0.573 . . . . 1.17 110.3 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.24 -15.95 52.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.792 2.328 . . . . 0.58 111.88 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 34.4 mt-10 -84.75 11.26 9.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.574 -0.739 . . . . 1.45 110.655 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.455 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -61.29 100.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.536 -0.756 . . . . 0.27 111.155 176.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.644 HD22 ' HB2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -120.41 77.07 26.27 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.664 -0.865 . . . . 0.95 108.664 176.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.596 ' HD3' ' HE1' ' A' ' 117' ' ' MET . 55.7 Cg_endo -68.15 -56.01 0.22 Allowed 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 123.334 2.689 . . . . 0.4 113.512 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.541 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 2.2 m-20 -55.72 -24.5 35.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.427 -0.806 . . . . 1.44 110.7 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.644 ' HB2' HD22 ' A' ' 123' ' ' ASN . 15.4 tpp180 -74.15 -57.49 3.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.386 -0.598 . . . . 3.79 109.386 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 88' ' ' ALA . 26.5 m -64.44 -32.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.999 -1.0 . . . . 0.59 111.681 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.958 ' HA ' HD23 ' A' ' 131' ' ' LEU . 17.1 ptm -76.22 -15.79 59.96 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.889 0.376 . . . . 0.81 110.41 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.624 ' O ' ' HG2' ' A' ' 132' ' ' MET . 30.1 mt-30 -78.38 -33.95 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 1.31 110.014 171.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.04 -27.26 65.49 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.905 -0.776 . . . . 1.64 108.905 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.958 HD23 ' HA ' ' A' ' 128' ' ' MET . 0.2 OUTLIER -59.44 -46.41 88.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.484 -1.235 . . . . 1.36 109.263 174.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.627 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 16.6 ptm -75.11 -13.76 60.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.409 -0.516 . . . . 1.61 111.125 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 58.9 mm-40 -70.49 -29.08 65.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.0 -1.111 . . . . 1.67 108.0 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.458 ' N ' ' HD1' ' A' ' 134' ' ' TYR . 1.6 m-85 -98.92 23.17 9.23 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.473 -1.239 . . . . 1.08 108.986 175.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.4 t30 60.49 49.22 6.88 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 113.619 -1.628 . . . . 1.1 112.259 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.627 ' H ' ' HA ' ' A' ' 132' ' ' MET . 52.4 mt -117.93 98.65 6.45 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.329 -0.85 . . . . 1.36 109.522 171.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.012 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 26.2 t -104.68 113.67 64.72 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.089 -0.644 . . . . 0.43 111.497 -172.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.6 ' CB ' ' HG2' ' A' ' 140' ' ' GLU . 82.2 Cg_exo -45.48 141.81 7.31 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 124.405 3.403 . . . . 0.54 112.8 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.623 ' HB2' HD13 ' A' ' 146' ' ' ILE . 6.3 mm-40 -71.56 -14.75 62.19 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.636 -1.165 . . . . 3.08 110.56 174.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.6 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 1.8 pm0 -68.39 -19.99 64.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.981 -0.554 . . . . 1.57 109.759 167.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.589 ' HH2' ' HG3' ' A' ' 129' ' ' GLN . 42.7 m0 -107.68 -30.3 8.65 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.994 0.426 . . . . 0.66 110.722 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.83 25.63 3.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.752 -0.737 . . . . 0.53 113.255 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 1.012 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -88.67 -107.28 1.06 Allowed Glycine 0 C--N 1.324 -0.134 0 C-N-CA 120.126 -1.035 . . . . 0.6 112.699 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -165.07 60.83 0.12 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-O 122.565 1.174 . . . . 1.91 110.694 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.679 HG21 HG23 ' A' ' 112' ' ' VAL . 87.4 m -164.39 122.4 1.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.687 -1.142 . . . . 0.37 110.554 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.774 ' HB ' HD13 ' A' ' 111' ' ' ILE . 16.5 mm -84.42 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.211 -0.663 . . . . 0.63 109.211 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.461 ' HE2' HD23 ' A' ' 131' ' ' LEU . 2.8 m-85 -87.62 145.5 26.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.884 0.849 . . . . 0.5 110.153 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.456 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 65.1 m -118.15 136.32 53.69 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.29 -1.323 . . . . 0.68 109.103 172.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.552 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 94.7 mttt -109.76 89.84 3.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.997 -0.742 . . . . 1.44 108.997 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.859 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -115.45 179.46 3.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.877 1.322 . . . . 0.84 112.054 -170.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 3.9 p -145.28 95.47 2.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.156 -1.838 . . . . 1.77 106.978 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.97 -18.38 65.36 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.463 -0.495 . . . . 0.41 109.732 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.515 ' HB2' ' CG ' ' A' ' 118' ' ' ASP . 70.6 mmtt -80.95 -43.49 19.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.701 -0.682 . . . . 2.3 111.563 174.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 118' ' ' ASP . 1.9 m -76.07 -15.49 60.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.387 0.613 . . . . 0.7 110.82 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 37.7 mmtm 66.49 46.0 1.98 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.845 -1.071 . . . . 1.36 110.373 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -107.35 -57.46 2.08 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.039 -0.982 . . . . 2.48 110.702 -175.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.859 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.61 1.91 84.21 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.285 -0.959 . . . . 0.29 113.543 -172.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.1 -41.52 61.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.192 -0.67 . . . . 0.8 109.192 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 15.4 m-20 -67.65 -43.93 79.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.503 -0.771 . . . . 2.2 109.318 171.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.621 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 78.1 t60 -63.31 -23.12 67.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.932 -0.576 . . . . 0.58 111.516 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 165' ' ' ILE . 55.0 tp -68.49 -55.81 10.5 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.358 0.599 . . . . 1.16 109.784 -177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.6 pp -65.28 -24.01 67.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.149 -0.932 . . . . 1.51 110.775 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 65.1 mm-40 -66.48 -45.03 81.05 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.052 0.454 . . . . 2.57 110.398 172.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.501 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 12.7 mmt -67.61 -36.88 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.181 0.515 . . . . 0.64 110.203 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 83' ' ' ILE . 77.9 mt -66.8 -32.21 57.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 0.52 110.128 175.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 0.1 OUTLIER -67.12 -35.07 78.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 1.73 110.821 176.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 170' ' ' GLU . 30.7 tp -57.03 -42.58 80.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.766 0.793 . . . . 1.51 109.26 171.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.08 -40.17 80.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.227 -0.897 . . . . 0.89 110.331 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.757 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 28.8 m -67.53 -8.45 33.96 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.23 0.538 . . . . 1.35 111.185 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 167' ' ' LEU . 5.4 tp10 -83.65 -41.28 17.95 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.806 -0.813 . . . . 2.73 108.806 173.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 28.2 mtm -83.91 -9.22 58.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.986 -1.007 . . . . 1.88 112.233 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 169' ' ' SER . 11.4 pt-20 -52.6 -35.45 54.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.066 0.46 . . . . 4.27 110.299 175.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -106.33 -33.36 7.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 3.91 110.764 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 176' ' ' ALA . 3.3 mm? -105.17 46.8 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.396 . . . . 5.72 111.699 -174.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.742 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -79.39 30.48 0.23 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.234 0.54 . . . . 5.49 111.362 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 174' ' ' LEU . . . -159.84 91.31 0.96 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.686 -0.688 . . . . 5.78 109.417 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 178' ' ' PRO . 14.1 m120 -74.28 -52.05 4.26 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.156 -0.475 . . . . 7.88 111.753 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 177' ' ' ASN . 28.7 Cg_endo . . . . . 0 C--O 1.248 0.994 0 C-N-CA 122.18 1.92 . . . . 9.19 112.288 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.576 ' C2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.555 -0.218 . . . . 11.58 112.555 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -121.14 -9.9 9.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.611 -0.347 . . . . 10.61 111.766 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -67.06 -24.53 65.98 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.528 0.566 . . . . 10.14 112.528 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.7 tpp -79.41 -28.56 41.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.944 0.402 . . . . 8.77 110.75 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.64 -51.34 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.231 -0.441 . . . . 5.74 111.323 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -89.35 79.16 7.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.138 -0.483 . . . . 5.7 111.204 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -136.31 87.68 22.17 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.907 -0.588 . . . . 6.85 110.018 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.91 151.99 57.2 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.507 2.138 . . . . 2.8 111.485 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.8 83.21 0.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.456 2.104 . . . . 2.76 111.778 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.82 139.33 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.665 -0.698 . . . . 2.0 110.116 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 59.4 t -118.43 93.2 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.273 0.559 . . . . 1.35 110.067 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -79.33 128.36 33.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.587 -0.733 . . . . 0.64 109.971 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.846 HD11 HD23 ' A' ' 25' ' ' LEU . 17.1 pt -96.64 133.51 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.638 0.733 . . . . 1.3 111.446 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.675 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 62.9 mtt -134.96 -179.62 5.73 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.856 -1.065 . . . . 0.79 109.41 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.487 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 140.63 -164.86 26.27 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.517 -0.849 . . . . 0.31 111.776 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.599 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 46.9 t60 -92.18 158.04 16.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.64 0.733 . . . . 0.22 111.204 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 7.6 p -70.98 147.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.915 -1.039 . . . . 0.36 109.872 174.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.2 t70 75.0 -26.86 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.456 0.646 . . . . 0.69 110.613 -176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.487 ' CE1' ' HB3' ' A' ' 90' ' ' ASP . 18.4 m170 -79.44 -13.71 59.41 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.3 -1.0 . . . . 0.63 108.3 170.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 116.97 76.35 0.59 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.357 -0.925 . . . . 0.79 114.97 171.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 15' ' ' GLY . 20.6 mmtp -77.32 -86.74 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.924 -0.71 . . . . 3.31 111.097 165.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 m -75.24 -16.14 60.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.829 0.347 . . . . 1.21 111.109 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.462 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -56.21 -35.03 66.85 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 111.863 0.32 . . . . 1.25 111.863 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 20' ' ' GLY . 4.5 mm? -74.06 -40.57 62.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.665 -0.494 . . . . 1.49 109.665 176.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -62.44 -13.11 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.821 -0.627 . . . . 1.69 110.022 176.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.694 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 20.2 t70 -102.18 -47.5 4.51 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.706 0.765 . . . . 1.23 109.706 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.08 73.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.28 -1.327 . . . . 0.63 111.398 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 99.2 mt -70.34 -25.56 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.716 -0.675 . . . . 1.02 111.083 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.694 ' HE ' ' HA ' ' A' ' 26' ' ' ASP . 54.5 mtm180 -56.23 -52.54 64.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 3.04 110.501 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -81.21 13.02 3.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.131 0.967 . . . . 2.65 110.871 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 55.7 m -123.42 20.88 9.57 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.108 -1.406 . . . . 1.46 110.642 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.73 ' HG3' ' H ' ' A' ' 34' ' ' THR . 43.4 pttt -140.69 -156.24 0.66 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.9 -0.591 . . . . 3.92 109.883 175.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.809 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 10.8 p -58.41 -29.65 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 116.212 -0.449 . . . . 3.1 112.008 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.73 ' H ' ' HG3' ' A' ' 32' ' ' LYS . 10.4 t -95.73 -175.31 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.321 0.581 . . . . 2.78 111.093 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.35 -36.97 0.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.178 -0.919 . . . . 6.34 109.531 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -159.41 -51.34 0.06 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.714 -0.676 . . . . 6.79 110.336 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -74.49 123.64 25.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.207 -0.451 . . . . 6.24 110.216 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 58.06 39.91 25.8 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.417 0.627 . . . . 4.95 110.618 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.623 ' HA2' HG21 ' A' ' 34' ' ' THR . . . -63.97 -40.51 98.33 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.279 -0.873 . . . . 4.68 112.593 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.56 -51.53 0.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.028 -0.606 . . . . 4.55 112.009 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.2 mp -67.75 101.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.865 0.364 . . . . 5.57 110.237 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.8 m -101.38 -82.94 0.46 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.217 -0.447 . . . . 5.93 110.076 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -167.09 -62.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 6.63 110.421 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -80.6 26.47 0.39 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.15 0.5 . . . . 6.54 111.69 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.541 HG13 ' N ' ' A' ' 46' ' ' GLY . 10.8 tp -178.15 164.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.37 0.605 . . . . 5.17 110.946 -174.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.541 ' N ' HG13 ' A' ' 45' ' ' ILE . . . -139.01 53.12 0.7 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 114.75 -1.114 . . . . 2.51 110.42 176.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.703 ' HB2' HD13 ' A' ' 60' ' ' LEU . . . -142.46 166.6 24.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.856 0.36 . . . . 1.36 110.864 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -162.59 150.67 14.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.73 -0.668 . . . . 1.7 110.356 -178.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -98.35 123.98 42.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.98 -0.554 . . . . 1.91 109.669 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.715 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 41.0 t -76.51 159.51 5.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.062 0.458 . . . . 1.53 110.268 -178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.809 ' HB ' ' HB ' ' A' ' 33' ' ' VAL . 19.3 m -158.83 82.44 0.8 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.593 -0.891 . . . . 1.51 108.593 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.415 HG11 HD13 ' A' ' 162' ' ' LEU . 12.6 p -77.42 -28.85 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.05 -1.092 . . . . 2.27 108.05 173.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -145.71 -58.63 0.32 Allowed 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 113.548 -1.66 . . . . 3.68 108.217 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.412 ' HA ' HG23 ' A' ' 51' ' ' THR . 5.4 p-10 -168.51 27.86 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.636 -0.711 . . . . 2.99 110.79 173.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -98.27 97.16 8.58 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.103 -0.499 . . . . 7.36 109.835 -171.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -73.87 80.09 1.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.506 -0.77 . . . . 4.46 111.246 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.2 mt -92.95 112.87 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.233 -0.894 . . . . 0.92 109.187 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 m -89.11 89.11 7.81 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.07 0.462 . . . . 0.96 111.044 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 30.2 m-85 -71.83 145.17 48.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.649 -0.705 . . . . 1.57 110.132 174.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.703 HD13 ' HB2' ' A' ' 47' ' ' ALA . 57.1 tp -143.92 129.42 19.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 3.21 110.834 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB3' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -115.75 -171.23 1.93 Allowed 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.081 -0.711 . . . . 5.61 109.081 174.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.734 HG21 ' HB2' ' A' ' 67' ' ' ALA . 14.3 t -167.21 130.64 1.45 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.288 0.566 . . . . 5.45 111.517 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 62' ' ' THR . 58.5 Cg_endo -89.03 50.99 1.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.027 2.484 . . . . 6.11 110.894 172.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.66 66.71 2.05 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.845 -0.693 . . . . 6.36 111.735 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -141.83 -58.06 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.659 -0.318 . . . . 8.78 111.285 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.43 -71.99 0.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.056 -0.258 . . . . 7.05 110.528 -173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 62' ' ' THR . . . 65.83 95.44 0.06 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.855 0.722 . . . . 4.55 112.702 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.659 ' CE1' ' HB ' ' A' ' 82' ' ' VAL . 1.7 t80 65.72 -168.78 0.21 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.964 -0.562 . . . . 2.37 110.697 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 t -64.78 144.51 57.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.03 0.443 . . . . 4.9 109.805 171.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.8 t -81.63 2.77 27.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.108 -0.497 . . . . 5.84 111.266 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.404 ' HE3' ' CD2' ' A' ' 102' ' ' HIS . 64.4 mtt 64.07 20.78 12.34 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.154 0.502 . . . . 5.21 111.227 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -95.26 12.62 28.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.54 0.686 . . . . 8.21 109.443 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.23 -61.1 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.332 -0.849 . . . . 6.36 110.865 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 58.72 87.21 0.08 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.575 0.702 . . . . 9.65 109.936 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.43 137.72 6.11 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.925 -1.27 . . . . 4.93 109.925 -170.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.65 63.07 2.17 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.352 0.596 . . . . 5.47 109.86 -171.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -69.22 -32.38 71.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.16 -0.927 . . . . 6.26 110.945 -172.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.6 t -86.56 72.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.274 0.559 . . . . 4.31 109.83 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.456 HG23 ' OD1' ' A' ' 80' ' ' ASP . 9.5 t -99.66 -18.78 17.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.017 -0.538 . . . . 3.41 110.571 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.456 ' OD1' HG23 ' A' ' 79' ' ' THR . 8.4 p-10 -160.02 165.74 31.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.138 -0.69 . . . . 2.66 109.138 173.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.4 mt -110.73 145.88 16.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 123.255 0.347 . . . . 0.71 110.363 -170.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.659 ' HB ' ' CE1' ' A' ' 68' ' ' PHE . 12.7 p -114.4 136.33 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.631 -0.828 . . . . 1.17 111.337 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.737 HG12 ' HB ' ' A' ' 111' ' ' ILE . 9.5 mt -96.71 135.88 29.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.068 -0.969 . . . . 0.37 109.612 170.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.487 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 1.8 tm? -119.8 107.8 13.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.975 -1.121 . . . . 1.01 107.975 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -93.17 113.53 28.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.795 -0.639 . . . . 0.43 110.681 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.894 HG21 HD11 ' A' ' 131' ' ' LEU . 2.8 m -121.3 136.88 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.524 -0.762 . . . . 0.64 110.713 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.74 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -75.87 134.64 40.26 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.903 -0.589 . . . . 0.28 110.105 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.752 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -74.87 -10.03 59.11 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.303 0.573 . . . . 0.22 110.035 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.68 -14.48 39.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.181 -0.918 . . . . 0.58 110.624 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 19' ' ' HIS . 2.4 t0 -131.95 -63.0 0.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.56 110.298 -176.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 115.72 -129.71 8.69 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.256 -0.497 . . . . 0.37 112.793 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.82 140.58 18.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.569 0.7 . . . . 1.03 109.621 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.562 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 71.6 mmm -139.94 176.33 2.62 Favored Pre-proline 0 C--N 1.311 -1.073 0 CA-C-N 114.743 -1.117 . . . . 0.28 108.549 -171.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 86.6 Cg_exo -48.72 -57.21 2.5 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.662 2.241 . . . . 0.58 114.205 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.671 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 1.9 pt20 -78.88 -11.48 60.0 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.11 -0.636 . . . . 0.75 111.002 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -70.87 -49.6 44.3 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.483 -0.781 . . . . 0.31 109.4 176.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.549 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.0 p -76.72 -27.74 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-N 115.454 -0.793 . . . . 1.38 113.128 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -66.97 -21.75 65.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.31 -0.956 . . . . 2.35 109.549 177.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.675 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -77.18 -36.46 55.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.144 -0.935 . . . . 0.44 110.032 170.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 97' ' ' VAL . 97.9 mt -68.27 -42.81 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.518 0.675 . . . . 0.41 109.434 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.94 -42.01 68.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.685 -1.143 . . . . 0.67 110.523 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.404 ' CD2' ' HE3' ' A' ' 71' ' ' MET . 4.8 t60 -66.36 -35.0 79.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.078 -0.51 . . . . 2.5 110.093 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 -46.73 22.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.127 -0.488 . . . . 0.47 111.775 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 28.8 mmmt -68.77 -39.58 80.16 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.96 0.409 . . . . 1.66 110.413 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.26 -41.98 69.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.53 -0.759 . . . . 0.77 110.772 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.97 63.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.74 110.495 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.8 t30 76.64 73.53 0.08 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.264 1.03 . . . . 1.41 109.301 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.539 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -137.71 147.5 57.33 Favored Pre-proline 0 N--CA 1.439 -1.018 0 CA-C-N 113.545 -1.661 . . . . 1.35 110.016 -170.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -52.59 135.24 55.38 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.554 2.169 . . . . 0.47 113.156 171.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.543 ' C ' HG23 ' A' ' 145' ' ' THR . 1.2 mt -110.72 162.61 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 114.697 -1.138 . . . . 0.6 110.385 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.737 ' HB ' HG12 ' A' ' 83' ' ' ILE . 27.3 mm -129.58 84.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 107.394 -1.336 . . . . 0.37 107.394 172.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.909 HG23 HG21 ' A' ' 145' ' ' THR . 48.7 t -74.16 146.34 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.725 0.774 . . . . 0.26 109.237 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.88 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -141.72 105.79 4.77 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.25 -1.341 . . . . 0.29 110.512 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.752 ' CG2' ' HB2' ' A' ' 88' ' ' ALA . 3.0 mp -80.06 124.84 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.464 -1.244 . . . . 0.59 109.081 178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.74 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.9 p-10 -107.34 177.51 4.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 107.772 -1.196 . . . . 1.85 107.772 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 80.5 mttt 71.11 37.02 1.29 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 123.981 0.8 . . . . 0.59 111.427 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.488 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 29.2 mmt -78.14 -15.07 59.19 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.803 -1.184 . . . . 0.92 107.803 168.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.2 -19.79 60.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.635 -1.62 . . . . 0.76 109.942 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.475 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 24.0 mmmt -87.68 131.02 44.84 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-N 115.305 -0.861 . . . . 1.17 110.124 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.5 -11.58 26.67 Favored 'Trans proline' 0 N--CA 1.472 0.254 0 C-N-CA 122.71 2.273 . . . . 0.58 111.709 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -89.91 8.57 31.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.879 -1.055 . . . . 1.45 110.567 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.476 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -54.96 106.83 0.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.967 -1.015 . . . . 0.27 111.438 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.95 75.72 14.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.95 108.419 172.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.488 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 57.6 Cg_endo -68.92 -54.38 0.26 Allowed 'Trans proline' 0 CA--C 1.505 -0.942 0 C-N-CA 123.002 2.468 . . . . 0.4 113.438 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 124' ' ' PRO . 25.3 m-20 -58.11 -28.06 64.29 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.13 -0.941 . . . . 1.44 109.629 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.88 -58.92 3.04 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 119.889 -0.725 . . . . 3.79 109.115 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.685 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 21.6 m -61.8 -31.32 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.732 -1.122 . . . . 0.59 111.988 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 1.07 ' HA ' HD12 ' A' ' 131' ' ' LEU . 19.9 ptm -79.25 -16.42 56.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.101 -0.24 . . . . 0.81 110.805 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.693 ' O ' ' HG3' ' A' ' 132' ' ' MET . 13.8 mt-30 -80.14 -39.26 29.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.732 0.301 . . . . 1.31 110.831 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.46 -27.11 65.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.737 -0.838 . . . . 1.64 108.737 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' HA ' ' A' ' 128' ' ' MET . 77.5 mt -61.79 -45.19 94.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.506 -1.225 . . . . 1.36 110.022 174.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.828 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 4.0 ppp? -76.19 -10.59 59.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.473 -0.491 . . . . 1.61 111.268 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -85.28 -15.6 42.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.366 -0.605 . . . . 1.67 109.366 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -95.45 17.37 14.74 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.925 -1.139 . . . . 1.08 107.925 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.6 t30 59.37 56.14 3.91 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 113.315 -1.766 . . . . 1.1 112.027 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.737 ' H ' ' HA ' ' A' ' 132' ' ' MET . 77.1 mt -121.53 96.1 4.94 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.787 -1.097 . . . . 1.36 109.03 169.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.912 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 32.9 t -105.02 113.97 64.2 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 120.032 -0.667 . . . . 0.43 111.049 -171.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.945 ' HB2' ' HG2' ' A' ' 140' ' ' GLU . 6.8 Cg_endo -56.45 157.8 17.5 Favored 'Trans proline' 0 N--CA 1.445 -1.381 0 C-N-CA 123.326 2.684 . . . . 0.54 112.673 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.452 ' HB2' HD13 ' A' ' 146' ' ' ILE . 16.4 mm-40 -78.6 -13.52 59.79 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.256 -1.338 . . . . 3.08 109.974 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.945 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -68.04 -23.32 64.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 1.57 109.906 168.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.828 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 40.5 m0 -108.33 -14.9 14.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 120.858 0.361 . . . . 0.66 110.83 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.87 27.74 10.06 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.705 -0.759 . . . . 0.53 113.52 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.912 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -85.69 -108.36 0.72 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.238 -0.982 . . . . 0.6 111.621 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -163.28 61.1 0.18 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.575 1.179 . . . . 1.91 111.66 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.909 HG21 HG23 ' A' ' 112' ' ' VAL . 88.8 m -163.49 124.11 2.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.637 -1.165 . . . . 0.37 110.906 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.741 HG21 ' HB3' ' A' ' 164' ' ' MET . 23.3 mm -74.36 104.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 109.146 -0.687 . . . . 0.63 109.146 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.566 ' CG ' ' HB3' ' A' ' 138' ' ' PRO . 7.4 m-85 -87.67 117.82 26.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.321 -0.854 . . . . 0.5 110.401 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.3 m -101.37 144.17 30.51 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.46 -0.336 . . . . 0.68 110.501 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.5 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 91.8 mttt -116.77 89.47 3.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.167 -0.679 . . . . 1.44 109.167 175.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.88 HD21 ' HB1' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -117.99 176.22 5.31 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.671 1.224 . . . . 0.84 112.265 -171.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -129.72 102.46 6.35 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.916 -1.493 . . . . 1.77 107.283 164.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.08 -20.73 64.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.923 -0.769 . . . . 0.41 108.923 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.656 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 9.4 tmtt? -64.38 -59.83 3.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.41 -1.268 . . . . 2.3 110.936 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.7 p -88.94 5.02 46.03 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 119.99 -0.684 . . . . 0.7 112.163 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.492 ' CD ' HD12 ' A' ' 158' ' ' LEU . 29.7 mmtp 64.37 46.85 3.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.555 -0.748 . . . . 1.36 111.834 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -104.93 -53.71 2.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.925 0.869 . . . . 2.48 110.983 -177.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.831 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -88.84 2.24 84.11 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.332 -0.937 . . . . 0.29 112.763 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.492 HD12 ' CD ' ' A' ' 155' ' ' LYS . 19.7 mt -76.32 -36.98 58.02 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.213 -0.662 . . . . 0.8 109.213 174.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.65 -40.84 80.03 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.621 -0.718 . . . . 2.2 109.371 171.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 74.2 t60 -72.81 -15.13 61.64 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.1 -0.5 . . . . 0.58 110.981 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER -77.2 -50.79 12.16 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.889 -0.411 . . . . 1.16 109.889 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 163' ' ' GLU . 4.5 pp -64.46 -29.76 70.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.789 -0.641 . . . . 1.51 111.281 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 11.2 pt-20 -71.8 -36.91 70.43 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 120.507 -0.477 . . . . 2.57 110.131 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.741 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.2 mmt -71.55 -38.27 71.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.201 0.524 . . . . 0.64 109.899 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 83' ' ' ILE . 78.9 mt -65.34 -46.76 89.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.782 -0.644 . . . . 0.52 111.007 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.501 ' CD2' ' HA ' ' A' ' 163' ' ' GLU . 1.6 pp -67.92 -29.79 68.96 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.832 -0.433 . . . . 1.73 109.832 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -54.76 -52.05 63.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.38 -0.827 . . . . 1.51 108.974 170.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.95 -40.38 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.85 -0.613 . . . . 0.89 110.92 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 166' ' ' LEU . 23.6 t -64.58 -23.42 67.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.56 0.219 . . . . 1.35 111.206 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -88.37 -26.57 22.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.536 0.684 . . . . 2.73 109.789 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.6 ttp -91.8 -4.09 55.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.006 -0.997 . . . . 1.88 111.471 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -46.51 -14.0 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.488 1.292 . . . . 4.27 114.488 -173.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.407 ' HG2' ' OE2' ' A' ' 172' ' ' GLU . 6.4 mm-40 -70.0 14.84 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.521 0.677 . . . . 3.91 110.931 168.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 172' ' ' GLU . 3.0 pp -61.24 -19.55 61.8 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.55 -0.75 . . . . 5.72 110.871 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.418 ' N ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -95.79 24.74 5.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.609 -0.723 . . . . 5.49 111.324 177.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.32 101.78 2.0 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.246 -0.434 . . . . 5.78 110.182 175.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -165.05 92.86 0.92 Allowed Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.845 -0.616 . . . . 7.88 110.612 -175.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 C--O 1.246 0.883 0 C-N-CA 122.981 2.454 . . . . 9.19 111.548 173.95 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.656 ' N1 ' ' HB2' ' A' ' 153' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 112.095 -0.402 . . . . 11.58 112.095 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 t -82.65 122.17 27.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.813 0.34 . . . . 10.61 110.148 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -77.62 70.87 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.041 -0.527 . . . . 10.14 109.912 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 41.8 ttp -163.92 -68.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.494 -0.775 . . . . 8.77 110.319 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.4 -34.8 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 5.74 111.179 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.57 92.04 7.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.29 0.567 . . . . 5.7 109.9 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -92.46 118.81 68.2 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.712 -0.677 . . . . 6.85 111.217 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.28 113.31 2.34 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.249 2.633 . . . . 2.8 110.992 173.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.09 118.42 5.33 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.432 2.088 . . . . 2.76 112.63 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.1 t -88.84 89.43 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.209 -0.663 . . . . 2.0 109.209 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 46.2 t -95.31 89.31 2.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.574 0.702 . . . . 1.35 110.391 -176.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.593 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 36.2 m -75.14 119.44 19.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.784 -0.644 . . . . 0.64 111.11 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.549 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 43.3 mt -84.02 124.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.265 0.555 . . . . 1.3 110.535 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.474 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 66.6 mtt -127.93 174.0 9.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.393 -0.965 . . . . 0.79 108.393 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.18 -179.47 23.17 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.259 -0.972 . . . . 0.31 111.858 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.621 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 51.5 t60 -85.09 160.63 19.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.766 0.794 . . . . 0.22 111.372 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 7.5 p -74.61 152.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.604 -1.18 . . . . 0.36 109.892 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.643 ' HA ' " H5'" ' A' ' 179' ' ' GDP . 21.1 t70 74.05 -21.14 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.243 0.544 . . . . 0.69 110.556 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.616 ' HE1' ' O ' ' A' ' 91' ' ' GLY . 16.7 m170 -79.33 -16.31 56.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.634 -0.876 . . . . 0.63 108.634 171.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.486 ' HA2' ' OG1' ' A' ' 23' ' ' THR . . . 118.19 60.38 0.28 Allowed Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.363 -0.835 . . . . 0.79 114.136 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -63.78 -66.01 0.6 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.951 -0.7 . . . . 3.31 111.166 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -85.62 -33.91 21.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 1.21 111.029 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.486 ' OG1' ' HA2' ' A' ' 20' ' ' GLY . 0.2 OUTLIER -60.94 -24.88 66.4 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.75 0.648 . . . . 1.25 112.75 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.539 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -71.72 -39.3 70.22 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.018 -0.273 . . . . 1.49 110.592 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 54.7 mt -71.33 -14.54 62.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.795 -0.446 . . . . 1.69 109.795 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.94 -42.2 11.33 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.081 0.944 . . . . 1.23 108.705 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.062 -1.426 . . . . 0.63 110.026 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 3.8 tt -67.29 -20.39 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.087 -0.961 . . . . 1.02 110.984 -176.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 25.6 mmm180 -57.92 -52.7 64.43 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.11 0.481 . . . . 3.04 110.087 175.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -102.19 25.58 8.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.204 -0.907 . . . . 2.65 111.617 -170.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.8 m -92.63 -5.49 51.39 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.116 -0.947 . . . . 1.46 109.435 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' NZ ' ' HB ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -176.29 -174.76 0.63 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.216 -1.401 . . . . 3.92 107.216 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.458 ' O ' ' HB ' ' A' ' 51' ' ' THR . 20.2 t -74.5 151.37 7.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.888 -0.325 . . . . 3.1 110.244 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.56 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 13.8 t -157.42 -174.11 4.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.034 -0.358 . . . . 2.78 110.034 169.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -68.63 151.64 46.44 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.442 -0.577 . . . . 6.34 109.442 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.17 20.85 0.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.42 . . . . 6.79 112.03 -176.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -137.19 120.22 16.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.656 -0.498 . . . . 6.24 109.656 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.87 141.49 56.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.119 -0.492 . . . . 4.95 111.073 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 48' ' ' TYR . . . -75.9 99.03 1.23 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.028 -0.606 . . . . 4.68 111.678 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -128.01 106.41 0.79 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.595 -0.812 . . . . 4.55 112.982 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.718 HG12 ' HA3' ' A' ' 46' ' ' GLY . 46.9 mm -76.08 128.31 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.507 -0.553 . . . . 5.57 109.507 174.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.564 HG22 ' HG2' ' A' ' 43' ' ' GLN . 77.1 m 65.85 -74.1 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.932 0.77 . . . . 5.93 111.02 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.564 ' HG2' HG22 ' A' ' 42' ' ' THR . 8.1 pt20 -167.61 -33.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.528 -0.305 . . . . 6.63 111.321 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -87.12 40.48 0.92 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 121.181 -0.208 . . . . 6.54 111.462 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.634 ' HA ' ' HA2' ' A' ' 40' ' ' GLY . 48.3 mm 65.11 157.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.436 0.636 . . . . 5.17 111.055 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.718 ' HA3' HG12 ' A' ' 41' ' ' ILE . . . -158.13 25.66 0.41 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.789 -0.719 . . . . 2.51 112.324 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . 64.23 -172.63 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.998 0.47 . . . . 1.36 111.625 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.489 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 3.8 p90 -179.96 165.22 1.22 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.071 0.462 . . . . 1.7 110.8 -173.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.467 ' HG3' ' OG1' ' A' ' 58' ' ' THR . 0.8 OUTLIER -79.68 116.14 19.7 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.43 -0.952 . . . . 1.91 108.43 172.381 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 48' ' ' TYR . 22.1 m -76.59 139.29 19.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.53 0.681 . . . . 1.53 111.488 -175.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 34' ' ' THR . 2.4 m -80.9 82.48 6.87 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.347 0.594 . . . . 1.51 110.368 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.4 p -84.04 -27.94 7.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 107.815 -1.18 . . . . 2.27 107.815 173.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -144.0 -51.43 0.31 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 113.432 -1.713 . . . . 3.68 108.607 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.517 ' HA ' HG23 ' A' ' 51' ' ' THR . 36.4 t70 -173.69 85.1 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.855 -1.066 . . . . 2.99 110.542 170.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.505 ' H ' ' HA ' ' A' ' 51' ' ' THR . 25.4 mtmm 57.82 78.55 0.23 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.932 -0.576 . . . . 7.36 112.473 173.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -150.29 168.51 23.84 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.932 -0.766 . . . . 4.46 108.932 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.7 mt 66.07 74.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.809 0.814 . . . . 0.92 109.585 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.467 ' OG1' ' HG3' ' A' ' 49' ' ' GLN . 2.7 m -76.46 98.81 4.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.307 -0.86 . . . . 0.96 110.109 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.767 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 81.6 m-85 -70.55 139.81 51.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.203 -0.453 . . . . 1.57 110.172 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.593 ' H ' ' HA ' ' A' ' 12' ' ' THR . 58.7 tp 49.58 83.19 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.065 0.853 . . . . 3.21 112.53 171.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -66.76 -46.27 75.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.551 -0.295 . . . . 5.61 111.637 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 41.0 m -111.01 100.84 48.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.016 0.436 . . . . 5.45 111.427 -176.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.5 96.95 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.666 2.244 . . . . 6.11 111.961 175.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.95 -137.79 2.35 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.052 -0.594 . . . . 6.36 112.13 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -81.73 -44.17 17.43 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.545 -0.539 . . . . 8.78 109.545 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -101.11 103.18 14.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.581 -0.736 . . . . 7.05 109.125 173.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' THR . . . -64.58 -34.54 78.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.62 -0.718 . . . . 4.55 110.177 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.36 124.61 23.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.668 -0.696 . . . . 2.37 109.914 172.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -56.81 123.8 16.29 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.064 -0.516 . . . . 4.9 110.687 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -62.42 124.08 19.97 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.382 -0.599 . . . . 5.84 109.382 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 74' ' ' ARG . 26.4 mmt -64.46 101.08 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.423 0.63 . . . . 5.21 110.648 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -96.34 -35.22 11.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.412 -0.813 . . . . 8.21 110.386 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.95 13.36 3.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.148 -0.478 . . . . 6.36 111.756 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 71' ' ' MET . 57.9 mtm180 -128.24 139.35 52.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 9.65 111.016 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.15 -33.09 1.55 Allowed Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.187 -0.765 . . . . 4.93 111.187 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.37 142.54 27.58 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.105 -0.331 . . . . 5.47 110.105 176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -85.35 129.23 34.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.018 -0.364 . . . . 6.26 110.018 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 79' ' ' THR . 2.6 t -101.63 -144.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.646 -0.872 . . . . 4.31 108.646 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.676 ' H ' HG12 ' A' ' 78' ' ' VAL . 10.6 m -86.4 63.73 8.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.791 0.805 . . . . 3.41 110.645 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.04 131.18 34.83 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.326 -0.99 . . . . 2.66 108.326 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.7 mt -126.37 142.44 42.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.104 -0.332 . . . . 0.71 110.104 -175.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -120.8 121.68 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 120.137 -0.625 . . . . 1.17 111.971 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 10.4 mt -82.97 137.79 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.878 -1.055 . . . . 0.37 109.321 170.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.633 HD12 HD21 ' A' ' 131' ' ' LEU . 2.5 tm? -123.67 105.24 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.355 -0.98 . . . . 1.01 108.355 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 89.3 t -87.73 109.77 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.637 -0.711 . . . . 0.43 110.967 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER -120.73 120.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.717 -0.674 . . . . 0.64 110.776 174.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -68.75 127.76 34.22 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.926 -0.768 . . . . 0.28 108.926 174.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.669 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . . . -70.76 -11.59 61.04 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.924 0.392 . . . . 0.22 111.446 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -94.79 2.02 55.46 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.346 -0.542 . . . . 0.58 110.876 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.405 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 20.0 t0 -134.33 -52.21 0.82 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.352 -0.385 . . . . 0.56 110.977 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.616 ' O ' ' HE1' ' A' ' 19' ' ' HIS . . . 97.31 -158.23 21.05 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 121.087 -0.577 . . . . 0.37 113.509 173.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.27 136.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.6 0.714 . . . . 1.03 109.646 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.738 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 73.6 mmm -136.96 177.92 1.96 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.097 -0.956 . . . . 0.28 108.808 -171.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 63.3 Cg_exo -40.74 -65.42 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.302 2.668 . . . . 0.58 114.814 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.469 ' HG2' ' ND1' ' A' ' 16' ' ' HIS . 7.2 pt20 -74.15 -16.88 60.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.38 0.61 . . . . 0.75 111.062 -174.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.621 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -69.74 -43.88 71.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 0.31 109.366 177.261 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 93' ' ' MET . 21.0 t -68.24 -39.32 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.401 -0.818 . . . . 1.38 111.276 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.46 -28.92 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 2.35 110.221 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -72.8 -42.19 64.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.819 -0.628 . . . . 0.44 111.032 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.44 -42.29 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.842 0.83 . . . . 0.41 109.596 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.513 ' ND2' HG12 ' A' ' 97' ' ' VAL . 25.0 m-20 -63.67 -28.2 69.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.273 -1.331 . . . . 0.67 110.851 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -82.17 -32.31 30.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.047 0.451 . . . . 2.5 109.879 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 110' ' ' ILE . . . -67.38 -46.6 72.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.47 110.901 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.92 -33.71 72.52 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.664 0.745 . . . . 1.66 110.018 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.15 44.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.096 -1.411 . . . . 0.77 111.475 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -100.33 -39.15 8.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.649 -0.25 . . . . 0.74 111.362 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 88.5 75.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.726 1.21 . . . . 1.41 109.182 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.59 142.33 42.22 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.407 -1.27 . . . . 1.35 110.4 -173.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.57 142.48 77.88 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.628 2.219 . . . . 0.47 111.943 173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 145' ' ' THR . 27.0 mm -108.48 155.38 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.64 0.733 . . . . 0.6 111.107 -172.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.075 HD13 ' HB ' ' A' ' 146' ' ' ILE . 15.7 mm -122.64 83.34 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.508 -1.293 . . . . 0.37 107.508 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.78 HG21 HD23 ' A' ' 131' ' ' LEU . 58.6 t -73.19 144.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-O 121.677 0.751 . . . . 0.26 109.307 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.818 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -141.16 101.57 4.05 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.099 -1.41 . . . . 0.29 110.013 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.969 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.4 mp -68.61 138.13 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.803 -1.544 . . . . 0.59 108.883 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 59.0 t30 -122.09 166.78 14.01 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 107.147 -1.427 . . . . 1.85 107.147 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.755 ' HG2' ' N2 ' ' A' ' 179' ' ' GDP . 83.5 mttt 71.68 33.35 1.8 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 124.239 0.962 . . . . 0.59 111.515 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.597 ' CE ' ' HB3' ' A' ' 124' ' ' PRO . 9.0 mmt -74.49 -11.97 60.36 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.171 -0.922 . . . . 0.92 109.586 166.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.675 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 10.5 p-10 -70.52 -19.63 62.89 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.852 -1.067 . . . . 0.76 108.862 172.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.499 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 47.4 mtpt -95.21 131.73 29.37 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 114.769 -1.105 . . . . 1.17 110.47 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -63.68 -15.41 48.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.946 2.431 . . . . 0.58 111.748 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -82.72 7.85 13.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.46 -0.791 . . . . 1.45 110.332 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -56.44 115.78 2.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.276 -0.875 . . . . 0.27 110.669 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.47 75.45 24.96 Favored Pre-proline 0 CA--C 1.509 -0.621 0 N-CA-C 107.1 -1.444 . . . . 0.95 107.1 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.597 ' HB3' ' CE ' ' A' ' 117' ' ' MET . 27.0 Cg_endo -61.73 -63.45 0.1 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 123.077 2.518 . . . . 0.4 113.298 -169.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.598 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 5.9 m-20 -64.01 -15.35 59.16 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.55 -0.75 . . . . 1.44 110.713 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 1.3 tmt_? -74.04 -55.72 5.78 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.475 -0.935 . . . . 3.79 108.475 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.614 ' HB ' ' HA2' ' A' ' 91' ' ' GLY . 5.0 m -70.72 -25.46 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.05 -0.977 . . . . 0.59 110.36 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.598 ' HB3' ' HA ' ' A' ' 125' ' ' ASP . 9.2 ttt -66.4 -42.73 87.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.995 -1.457 . . . . 0.81 110.646 175.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' A' ' 132' ' ' MET . 15.0 mt-30 -71.94 -24.93 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 1.31 112.282 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.557 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.3 mt-10 -65.88 -33.45 75.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.737 0.78 . . . . 1.64 109.067 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 112' ' ' VAL . 5.2 mp -65.68 -37.54 86.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.016 -0.993 . . . . 1.36 110.043 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 10.0 ptm -74.88 -11.81 60.22 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.951 -0.7 . . . . 1.61 110.786 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 35.6 mm-40 -69.25 -35.06 75.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.068 -1.086 . . . . 1.67 108.068 170.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -91.11 23.29 3.32 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.452 -1.249 . . . . 1.08 109.769 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 54.92 49.91 16.71 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.316 -1.311 . . . . 1.1 111.927 177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.588 ' H ' ' HA ' ' A' ' 132' ' ' MET . 46.5 mt -110.15 110.54 21.44 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.502 -0.772 . . . . 1.36 109.398 170.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 138' ' ' PRO . 71.0 t -109.12 114.25 58.2 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.662 0.744 . . . . 0.43 112.064 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.512 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -44.18 153.04 0.34 Allowed 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 125.057 3.838 . . . . 0.54 113.314 174.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.679 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -76.11 -19.86 58.16 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.947 -1.478 . . . . 3.08 109.726 178.038 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 138' ' ' PRO . 1.6 pm0 -72.19 -22.19 61.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.588 -0.733 . . . . 1.57 110.665 171.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.441 ' CD2' ' HG2' ' A' ' 138' ' ' PRO . 34.1 m0 -102.62 -12.13 17.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.071 0.462 . . . . 0.66 110.571 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.38 21.89 9.56 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.555 -0.831 . . . . 0.53 114.232 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -95.96 -123.04 4.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.631 -1.271 . . . . 0.6 111.28 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -157.82 64.01 0.47 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-O 124.097 1.903 . . . . 1.91 111.326 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.635 HG23 ' HB ' ' A' ' 110' ' ' ILE . 97.0 m -148.36 112.23 5.12 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 113.044 -1.889 . . . . 0.37 108.609 173.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.075 ' HB ' HD13 ' A' ' 111' ' ' ILE . 51.9 mm -73.56 97.05 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.539 0.685 . . . . 0.63 109.412 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.58 ' CE2' ' HG3' ' A' ' 128' ' ' MET . 14.8 m-85 -81.46 119.67 24.02 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.612 -1.176 . . . . 0.5 110.588 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 78.2 m -113.83 112.07 22.78 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.135 -0.484 . . . . 0.68 110.459 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.969 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 9.3 ptpt -89.51 91.43 8.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.227 0.537 . . . . 1.44 109.9 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.879 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 2.8 pp -122.37 -169.99 2.0 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.556 1.169 . . . . 0.84 112.412 -169.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.468 ' HB2' ' N ' ' A' ' 117' ' ' MET . 26.1 t -154.69 122.81 5.93 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.553 -1.658 . . . . 1.77 107.061 172.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.406 ' CB ' HD11 ' A' ' 158' ' ' LEU . . . -79.64 -8.12 59.0 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.512 0.672 . . . . 0.41 109.641 175.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.469 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 1.5 mmmp? -83.25 -46.49 12.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.125 -0.943 . . . . 2.3 111.165 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.8 OUTLIER -85.24 -8.01 58.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.164 -0.615 . . . . 0.7 111.285 175.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.543 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.7 mmtp 62.85 43.31 7.07 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.2 -0.909 . . . . 1.36 111.49 174.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -102.9 -71.84 0.71 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.649 1.214 . . . . 2.48 110.554 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.879 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -65.49 -11.03 51.81 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 113.932 -1.485 . . . . 0.29 113.209 -176.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 19.4 mt -69.21 -39.05 78.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.41 0.605 . . . . 0.8 109.584 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 68.1 m-20 -63.0 -46.32 88.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.96 -0.756 . . . . 2.2 108.96 174.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -66.25 -27.89 68.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.49 -0.777 . . . . 0.58 111.151 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.7 tp -65.7 -55.73 15.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 1.16 110.279 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 158' ' ' LEU . 12.2 mt -57.71 -44.16 85.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 1.51 109.909 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 35.1 mm-40 -59.66 -44.44 93.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.574 -0.739 . . . . 2.57 111.398 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.477 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -73.62 -39.74 64.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.011 0.434 . . . . 0.64 110.494 -177.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.55 HD11 HD11 ' A' ' 83' ' ' ILE . 51.9 mt -62.99 -44.69 99.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.807 -0.633 . . . . 0.52 110.596 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -37.64 88.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.942 -0.572 . . . . 1.73 111.076 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.4 tp -51.48 -49.06 62.56 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.376 0.608 . . . . 1.51 109.468 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.565 ' HA ' ' SD ' ' A' ' 171' ' ' MET . 93.9 t -66.35 -38.73 82.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.078 -0.965 . . . . 0.89 110.883 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.1 m -64.52 -28.1 69.42 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.82 0.343 . . . . 1.35 111.189 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.79 -45.96 14.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.024 0.44 . . . . 2.73 110.68 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.565 ' SD ' ' HA ' ' A' ' 168' ' ' VAL . 20.0 ptm -65.87 -12.0 51.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.934 -0.575 . . . . 1.88 112.019 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 175' ' ' LYS . 28.0 tp10 -58.13 -25.52 61.51 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.714 0.406 . . . . 4.27 111.667 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -82.97 -1.9 53.71 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.977 -0.452 . . . . 3.91 111.316 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.657 ' HG ' ' H ' ' A' ' 175' ' ' LYS . 0.3 OUTLIER -132.75 -72.29 0.52 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 122.323 -0.235 . . . . 5.72 111.255 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.657 ' H ' ' HG ' ' A' ' 174' ' ' LEU . 42.9 mtpt 61.26 88.37 0.09 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.629 0.603 . . . . 5.49 112.629 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -144.11 25.26 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.672 0.748 . . . . 5.78 109.136 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 18.2 p-10 -161.95 151.83 13.91 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 114.687 -1.142 . . . . 7.88 109.83 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 19.8 Cg_endo . . . . . 0 C--O 1.254 1.292 0 C-N-CA 123.203 2.602 . . . . 9.19 111.755 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.755 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.802 -0.519 . . . . 11.58 111.802 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 p -99.37 2.44 45.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.992 0.425 . . . . 10.61 111.047 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -87.18 91.4 8.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.265 -0.425 . . . . 10.14 110.1 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.5 tpp -99.99 51.79 0.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.802 -0.636 . . . . 8.77 109.67 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.67 -45.37 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.037 -0.529 . . . . 5.74 109.763 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -81.73 149.78 28.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.457 -0.792 . . . . 5.7 109.754 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.747 ' HD2' HE22 ' A' ' 77' ' ' GLN . 57.0 ttp180 -97.77 119.4 62.52 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.665 -0.243 . . . . 6.85 111.079 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HB3' ' HB3' ' A' ' 56' ' ' LYS . 1.7 Cg_endo -84.01 103.73 1.02 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.323 2.682 . . . . 2.8 111.437 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 46.2 Cg_exo -56.15 133.24 56.83 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 123.053 2.502 . . . . 2.76 113.072 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.5 t -82.75 78.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 2.0 109.889 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.62 105.24 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.548 0.69 . . . . 1.35 110.562 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.436 HG21 ' HE3' ' A' ' 14' ' ' MET . 21.0 m -78.41 128.83 34.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.237 -0.892 . . . . 0.64 110.335 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.799 HG13 HD21 ' A' ' 25' ' ' LEU . 37.2 mm -93.85 120.07 42.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.899 0.38 . . . . 1.3 110.503 177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.436 ' HE3' HG21 ' A' ' 12' ' ' THR . 64.0 mtt -139.12 176.23 8.88 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 109.629 -0.508 . . . . 0.79 109.629 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 84' ' ' LEU . . . 141.06 -163.38 26.67 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.948 -0.861 . . . . 0.31 110.948 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 48.7 t60 -94.19 157.66 15.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.047 0.927 . . . . 0.22 111.444 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.513 HG23 ' O1B' ' A' ' 179' ' ' GDP . 4.6 p -74.9 149.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.348 -1.296 . . . . 0.36 110.528 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 73.18 -21.2 0.26 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.226 0.536 . . . . 0.69 110.187 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 17' ' ' VAL . 19.5 m170 -74.0 -20.15 60.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.434 -0.951 . . . . 0.63 108.434 168.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.455 ' O ' HD13 ' A' ' 24' ' ' LEU . . . 109.97 63.34 0.52 Allowed Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.388 -0.823 . . . . 0.79 114.044 172.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.92 -57.45 4.57 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.971 -0.692 . . . . 3.31 111.378 176.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -86.4 -28.73 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.275 0.472 . . . . 1.21 112.275 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -29.49 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.668 0.618 . . . . 1.25 112.668 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 20' ' ' GLY . 9.7 mp -69.2 -40.09 78.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.395 -0.19 . . . . 1.49 110.706 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.799 HD21 HG13 ' A' ' 13' ' ' ILE . 19.8 mt -69.61 -11.5 60.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.379 0.609 . . . . 1.69 109.919 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.07 -43.1 7.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.064 0.935 . . . . 1.23 109.001 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.65 -50.55 15.11 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.01 -1.45 . . . . 0.63 111.311 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.01 -31.86 52.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 1.02 111.699 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 27.8 mtm180 -54.47 -53.13 58.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.981 0.42 . . . . 3.04 110.642 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -84.23 20.01 1.72 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.942 0.877 . . . . 2.65 111.397 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.7 m -107.82 12.42 27.3 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.065 -0.97 . . . . 1.46 111.239 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -159.27 -173.32 4.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.477 -0.329 . . . . 3.92 110.284 174.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.55 -60.02 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.065 0.459 . . . . 3.1 111.462 -176.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.697 ' OG1' ' HB ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -68.47 121.06 15.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.797 -0.638 . . . . 2.78 109.907 175.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -142.78 -43.29 0.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.739 0.304 . . . . 6.34 111.254 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.96 -37.24 16.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.202 -0.454 . . . . 6.79 110.715 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -77.54 141.85 39.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.949 -0.569 . . . . 6.24 110.172 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 48' ' ' TYR . . . 67.61 174.91 0.26 Allowed 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.882 0.739 . . . . 4.95 110.88 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.75 26.45 60.68 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.462 -0.875 . . . . 4.68 111.418 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.83 82.97 0.3 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.426 -0.669 . . . . 4.55 111.426 -177.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.5 tp -102.77 124.63 56.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.809 0.338 . . . . 5.57 110.714 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.0 m 64.76 -83.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.406 -0.815 . . . . 5.93 110.937 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -143.82 16.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.971 0.415 . . . . 6.63 110.046 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -121.26 116.37 24.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 6.54 111.117 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 46' ' ' GLY . 5.9 tp -93.1 157.5 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.588 -0.893 . . . . 5.17 108.588 170.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' N ' HG13 ' A' ' 45' ' ' ILE . . . 175.9 -62.81 0.1 Allowed Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.319 -0.944 . . . . 2.51 113.155 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.805 ' HB2' HD13 ' A' ' 60' ' ' LEU . . . -166.69 -178.89 4.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.334 0.587 . . . . 1.36 112.183 -177.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.784 ' HE1' HD22 ' A' ' 25' ' ' LEU . 11.7 p90 -156.93 158.18 36.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.801 -1.09 . . . . 1.7 108.986 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -104.24 142.37 34.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.192 0.52 . . . . 1.91 110.907 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.617 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 22.8 t -89.17 142.35 13.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.663 -0.698 . . . . 1.53 110.139 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.697 ' HB ' ' OG1' ' A' ' 34' ' ' THR . 57.5 m -161.44 86.4 0.67 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.393 -0.821 . . . . 1.51 109.481 -171.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 53' ' ' ASN . 4.2 p -80.93 -50.07 17.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.962 0.887 . . . . 2.27 109.042 173.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.498 ' N ' HG13 ' A' ' 52' ' ' VAL . 2.2 p30 -108.16 -64.25 1.24 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.406 -1.27 . . . . 3.68 108.92 175.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.61 ' HA ' HG23 ' A' ' 51' ' ' THR . 32.8 t70 -175.59 61.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.866 -1.061 . . . . 2.99 109.635 172.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HE2' HD13 ' A' ' 166' ' ' LEU . 96.7 mttt -97.27 165.97 11.78 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.063 -0.972 . . . . 7.36 108.894 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 59.6 mttm -131.75 80.13 1.91 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.393 0.616 . . . . 4.46 110.245 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.5 mt -117.85 112.17 37.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.352 -0.84 . . . . 0.92 109.327 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -99.55 96.33 7.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.031 -0.531 . . . . 0.96 111.069 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.585 ' CD2' HD11 ' A' ' 13' ' ' ILE . 5.9 m-85 -71.01 120.7 16.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.522 -0.763 . . . . 1.57 110.551 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.805 HD13 ' HB2' ' A' ' 47' ' ' ALA . 3.5 mm? -93.65 142.76 26.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.485 0.55 . . . . 3.21 112.485 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.654 ' HA ' HD11 ' A' ' 25' ' ' LEU . 11.9 t70 -60.88 -62.96 1.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.654 -0.703 . . . . 5.61 111.342 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 m 64.06 85.42 0.16 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.959 -0.564 . . . . 5.45 111.466 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.741 ' HD2' HG21 ' A' ' 69' ' ' THR . 1.9 Cg_endo -83.52 -14.07 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.822 2.348 . . . . 6.11 112.22 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.83 143.11 11.84 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.124 -0.56 . . . . 6.36 111.948 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -164.18 -64.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.793 0.33 . . . . 8.78 110.257 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -136.46 -59.18 0.73 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.383 -0.371 . . . . 7.05 111.399 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.468 ' H ' ' CD ' ' A' ' 66' ' ' GLU . . . -140.56 -73.26 0.35 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.677 -0.238 . . . . 4.55 111.166 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' HZ ' HG21 ' A' ' 108' ' ' VAL . 16.4 m-85 -96.95 -20.91 17.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.537 0.208 . . . . 2.37 110.772 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.741 HG21 ' HD2' ' A' ' 63' ' ' PRO . 30.7 m 75.12 -52.34 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.238 0.615 . . . . 4.9 112.211 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.6 m -89.68 10.75 22.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.244 0.545 . . . . 5.84 111.434 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.774 ' HG3' ' HA3' ' A' ' 75' ' ' GLY . 54.6 ttm -79.86 75.42 6.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.32 0.581 . . . . 5.21 110.374 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HB3' ' H ' ' A' ' 73' ' ' ALA . 1.2 tpp180 -91.08 -82.82 0.28 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.517 -0.549 . . . . 8.21 109.517 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' H ' ' HB3' ' A' ' 72' ' ' ARG . . . -110.61 -37.25 5.51 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.177 -0.675 . . . . 6.36 109.177 173.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 74' ' ' ARG . 25.0 mtm-85 -79.02 58.35 2.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.197 -0.91 . . . . 9.65 109.731 175.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.774 ' HA3' ' HG3' ' A' ' 71' ' ' MET . . . -153.04 11.65 0.58 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.534 -0.757 . . . . 4.93 111.671 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.11 -30.38 39.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.326 0.584 . . . . 5.47 110.077 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.747 HE22 ' HD2' ' A' ' 7' ' ' ARG . 11.8 pt20 -88.07 138.8 31.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.343 -0.844 . . . . 6.26 109.815 177.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.2 m -105.41 35.41 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.565 0.698 . . . . 4.31 110.44 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.3 m -98.97 -11.55 21.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.225 -0.898 . . . . 3.41 110.071 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -77.89 161.42 27.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.752 -0.658 . . . . 2.66 109.892 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.696 HG21 HG12 ' A' ' 111' ' ' ILE . 5.9 mt -119.53 156.09 22.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.177 -0.465 . . . . 0.71 110.974 -169.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.503 HG11 ' HE1' ' A' ' 102' ' ' HIS . 4.2 p -123.51 133.81 68.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.532 0.682 . . . . 1.17 109.952 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 165' ' ' ILE . 15.5 mt -90.61 134.55 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.014 -0.994 . . . . 0.37 109.775 175.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.512 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.1 tm? -116.49 104.92 11.92 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.151 -1.055 . . . . 1.01 108.151 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.6 t -85.83 112.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.744 -0.662 . . . . 0.43 111.192 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 1.8 m -123.37 118.29 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 115.741 -0.663 . . . . 0.64 110.751 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -69.99 130.85 43.3 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.224 -0.658 . . . . 0.28 109.224 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.865 ' HA ' HG21 ' A' ' 127' ' ' VAL . . . -74.18 -6.95 50.79 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.045 0.45 . . . . 0.22 111.497 -170.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.46 -10.01 45.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.879 -0.6 . . . . 0.58 110.87 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.436 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 28.7 t0 -128.83 -51.95 1.23 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.56 111.571 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.744 ' HA2' ' HB ' ' A' ' 127' ' ' VAL . . . 100.61 -133.86 11.47 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.523 -0.846 . . . . 0.37 113.749 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 t -98.44 134.25 37.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.541 0.686 . . . . 1.03 110.48 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.973 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 78.0 mmm -138.88 -178.77 0.9 Allowed Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 114.695 -1.139 . . . . 0.28 109.133 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.973 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 3.5 Cg_endo -46.93 -68.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.246 2.631 . . . . 0.58 114.652 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.499 ' NE2' ' HB ' ' A' ' 17' ' ' VAL . 8.4 pt20 -70.29 -16.5 63.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.23 0.538 . . . . 0.75 111.005 -175.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -66.45 -49.13 67.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.643 -0.708 . . . . 0.31 109.495 177.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.561 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.1 p -77.39 -24.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 115.845 -0.616 . . . . 1.38 112.438 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.44 -35.8 76.7 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.666 -0.646 . . . . 2.35 109.492 172.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -25.82 62.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 0.44 110.612 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 97' ' ' VAL . 92.2 mt -75.25 -45.12 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.192 -0.67 . . . . 0.41 109.192 174.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.23 -49.53 60.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.119 -0.946 . . . . 0.67 110.458 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.503 ' HE1' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -45.19 -57.01 4.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.899 -1.046 . . . . 2.5 110.732 171.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.616 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -68.96 -47.89 64.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.302 -1.317 . . . . 0.47 113.047 -170.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 13.7 mmmm -72.14 -35.65 69.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.951 0.405 . . . . 1.66 110.641 -173.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.54 75.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.396 -0.82 . . . . 0.77 110.992 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -91.91 -25.33 18.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.208 -0.451 . . . . 0.74 112.097 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 44.4 m-20 80.56 42.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.92 0.867 . . . . 1.41 109.777 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.3 t -96.91 141.99 23.87 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.106 -1.406 . . . . 1.35 111.47 -176.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 21.7 Cg_exo -66.14 142.5 67.79 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 122.909 2.406 . . . . 0.47 112.905 175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.616 HD11 ' CB ' ' A' ' 103' ' ' ALA . 11.5 mm -108.93 158.95 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.804 0.811 . . . . 0.6 111.276 -175.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.808 HD13 ' HB ' ' A' ' 146' ' ' ILE . 23.8 mm -125.76 85.02 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.983 -1.488 . . . . 0.37 106.983 166.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.029 HG23 HG21 ' A' ' 145' ' ' THR . 57.4 t -71.48 143.34 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 121.711 0.767 . . . . 0.26 109.175 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.786 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -140.76 103.64 4.55 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.47 -1.241 . . . . 0.29 110.538 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.001 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 3.3 mp -70.45 132.81 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-N 113.588 -1.642 . . . . 0.59 108.631 175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 61.1 t30 -120.87 169.63 10.26 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.384 -1.339 . . . . 1.85 107.384 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.831 ' HG2' ' N2 ' ' A' ' 179' ' ' GDP . 88.2 mttt 71.96 34.06 1.55 Allowed 'General case' 0 N--CA 1.424 -1.74 0 O-C-N 124.086 0.866 . . . . 0.59 110.91 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.73 ' HE3' ' HB3' ' A' ' 124' ' ' PRO . 10.6 mmt -74.53 -10.09 59.22 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 115.14 -0.936 . . . . 0.92 109.2 167.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.595 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 5.1 p-10 -72.96 -21.1 60.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.548 -1.206 . . . . 0.76 110.104 172.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.574 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 27.9 mtpp -91.26 135.02 28.74 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 1.17 110.273 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.34 -15.43 49.88 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.713 2.275 . . . . 0.58 111.058 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -78.5 2.07 20.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.643 -1.162 . . . . 1.45 110.486 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.413 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -56.19 108.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.223 -0.899 . . . . 0.27 110.774 175.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.7 76.14 7.45 Favored Pre-proline 0 CA--C 1.51 -0.591 0 N-CA-C 107.03 -1.471 . . . . 0.95 107.03 171.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.73 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 37.7 Cg_endo -63.92 -66.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.498 -1.303 0 C-N-CA 122.981 2.454 . . . . 0.4 113.234 -167.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.667 ' HA ' ' HB3' ' A' ' 128' ' ' MET . 1.6 m-20 -64.45 -8.96 15.41 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.723 -0.671 . . . . 1.44 111.216 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -81.83 -53.94 5.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.845 -0.742 . . . . 3.79 109.434 174.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.865 HG21 ' HA ' ' A' ' 88' ' ' ALA . 18.5 m -68.88 -25.71 30.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.337 -0.847 . . . . 0.59 109.795 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 1.086 ' HA ' HD12 ' A' ' 131' ' ' LEU . 8.6 ttt -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.246 -1.343 . . . . 0.81 110.242 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 132' ' ' MET . 15.3 mt-30 -72.38 -37.74 68.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.674 -0.694 . . . . 1.31 111.205 173.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.7 mm-40 -60.32 -30.75 69.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.253 1.025 . . . . 1.64 109.149 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.086 HD12 ' HA ' ' A' ' 128' ' ' MET . 62.7 mt -63.74 -43.47 96.37 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.781 -1.554 . . . . 1.36 109.884 177.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.619 ' HA ' ' H ' ' A' ' 136' ' ' LEU . 7.5 ptm -75.36 -14.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.229 -0.589 . . . . 1.61 110.9 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 17.4 mm-40 -71.61 -27.4 63.09 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.563 -0.902 . . . . 1.67 108.563 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -99.1 22.21 10.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.56 -1.2 . . . . 1.08 108.686 174.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 54.93 57.46 5.61 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 113.73 -1.577 . . . . 1.1 111.807 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.619 ' H ' ' HA ' ' A' ' 132' ' ' MET . 47.9 mt -119.38 111.73 18.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.847 -1.069 . . . . 1.36 109.0 167.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.478 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.7 t -118.66 117.44 34.18 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-O 121.369 0.604 . . . . 0.43 111.26 -170.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.517 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 36.9 Cg_exo -56.09 175.47 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 124.11 3.207 . . . . 0.54 113.757 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 1.035 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -78.96 -31.81 45.14 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.011 -1.904 . . . . 3.08 109.477 179.044 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.872 ' HB2' ' HD1' ' A' ' 141' ' ' TRP . 6.7 mm-40 -58.28 -34.74 70.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.496 -0.775 . . . . 1.57 109.621 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.872 ' HD1' ' HB2' ' A' ' 140' ' ' GLU . 13.2 m0 -97.44 -7.69 31.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.749 -1.114 . . . . 0.66 110.926 -166.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.93 33.07 11.4 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.926 -0.654 . . . . 0.53 113.264 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.5 -125.05 5.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.174 -1.012 . . . . 0.6 111.685 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.62 62.18 0.53 Allowed 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.769 1.271 . . . . 1.91 111.448 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 1.029 HG21 HG23 ' A' ' 112' ' ' VAL . 73.8 m -160.5 128.96 4.69 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.194 -1.367 . . . . 0.37 110.238 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.035 HD13 ' HG2' ' A' ' 139' ' ' GLU . 38.0 mm -76.98 106.34 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 108.765 -0.828 . . . . 0.63 108.765 172.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.634 ' HE2' ' CD1' ' A' ' 131' ' ' LEU . 8.3 m-85 -90.78 110.01 21.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.568 -0.742 . . . . 0.5 110.947 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 97.4 m -105.01 111.8 24.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.3 -0.409 . . . . 0.68 111.08 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 1.001 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 ptpt -88.4 91.28 8.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.339 0.59 . . . . 1.44 109.624 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.863 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 3.1 pp -119.47 -173.31 2.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.6 1.191 . . . . 0.84 111.913 -170.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 117' ' ' MET . 4.8 p -153.1 101.0 2.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.692 -1.595 . . . . 1.77 107.25 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.86 62.42 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.752 -0.779 . . . . 0.41 109.358 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.612 ' HG3' ' C2 ' ' A' ' 179' ' ' GDP . 0.9 OUTLIER -75.79 -44.75 39.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.148 -0.933 . . . . 2.3 111.679 175.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.764 ' HB ' ' HG3' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -78.59 -17.37 56.19 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.166 -0.613 . . . . 0.7 111.657 176.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HD3' HD12 ' A' ' 158' ' ' LEU . 21.2 mmtp 68.7 46.6 0.92 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.393 -0.822 . . . . 1.36 110.832 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.764 ' HG3' ' HB ' ' A' ' 154' ' ' THR . 18.1 mt-10 -108.51 -68.78 0.89 Allowed 'General case' 0 C--O 1.244 0.794 0 CA-C-O 122.566 1.174 . . . . 2.48 110.547 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.863 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.17 -10.53 52.56 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.813 -1.539 . . . . 0.29 113.454 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.577 HD12 ' HD3' ' A' ' 155' ' ' LYS . 37.3 mt -69.45 -42.52 74.81 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 117.308 0.554 . . . . 0.8 109.827 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.37 -42.81 92.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 2.2 109.564 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' A' ' 164' ' ' MET . 84.5 t60 -67.66 -22.19 65.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.892 -0.595 . . . . 0.58 111.272 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -71.83 -52.55 16.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.133 0.492 . . . . 1.16 109.86 -176.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.48 -24.61 66.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.664 . . . . 1.51 111.004 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 163' ' ' GLU . 15.0 mm-40 -72.2 -40.14 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.886 0.374 . . . . 2.57 110.457 175.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.72 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.3 mmt -66.49 -41.37 89.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.64 110.085 176.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.756 HD11 HD11 ' A' ' 83' ' ' ILE . 60.6 mt -61.29 -45.35 98.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.52 110.422 175.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.693 HD13 ' HE2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -60.97 -41.01 95.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.067 -0.515 . . . . 1.73 111.079 178.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 167' ' ' LEU . 1.6 tm? -51.21 -38.7 53.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.62 0.724 . . . . 1.51 109.234 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.59 -39.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 0.89 110.802 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.7 t -62.57 -33.75 75.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.06 0.457 . . . . 1.35 110.865 175.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 166' ' ' LEU . 4.7 mm-40 -75.9 -25.67 56.29 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.132 -0.692 . . . . 2.73 109.132 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 45.4 ttp -74.21 -9.45 58.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.249 -0.887 . . . . 1.88 110.802 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -56.79 -24.01 47.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.788 0.328 . . . . 4.27 111.492 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -101.73 -3.88 27.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.367 0.603 . . . . 3.91 110.18 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.3 mt -115.08 1.73 13.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.051 -0.522 . . . . 5.72 111.062 -173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.535 ' HB2' ' OD1' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -64.58 130.06 42.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.007 0.432 . . . . 5.49 111.123 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -101.95 17.63 22.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.2 -0.455 . . . . 5.78 111.146 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.535 ' OD1' ' HB2' ' A' ' 175' ' ' LYS . 27.4 p-10 -82.79 135.58 45.55 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.251 -0.431 . . . . 7.88 110.654 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 11.1 Cg_exo . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.087 2.525 . . . . 9.19 111.741 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.831 ' N2 ' ' HG2' ' A' ' 116' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 112.053 -0.419 . . . . 11.58 112.053 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -82.39 1.61 36.44 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.833 0.349 . . . . 10.61 111.89 -174.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -82.96 110.75 18.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.009 -0.367 . . . . 10.14 110.009 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.4 mmt -76.94 106.32 8.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.253 -0.647 . . . . 8.77 109.253 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.44 146.08 34.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.964 0.412 . . . . 5.74 111.366 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.441 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 8.7 tp10 -93.84 94.63 8.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.565 -0.902 . . . . 5.7 108.565 171.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.559 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.9 ttm180 -106.63 103.48 46.78 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.944 -0.571 . . . . 6.85 109.767 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 18.0 Cg_endo -94.68 102.12 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.551 2.834 . . . . 2.8 112.479 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 20.2 Cg_exo -65.98 112.54 2.29 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.304 2.003 . . . . 2.76 110.51 175.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 61' ' ' ASP . 72.0 t -73.76 -71.29 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.216 -0.447 . . . . 2.0 110.389 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 93.4 t 69.69 119.47 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.798 0.808 . . . . 1.35 111.263 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.642 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 22.2 m -104.36 136.07 44.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.196 -0.456 . . . . 0.64 110.401 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -97.72 138.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.215 0.531 . . . . 1.3 110.238 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.628 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 59.1 mtt -145.99 173.28 12.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.708 -0.678 . . . . 0.79 109.869 -177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.68 -174.97 22.77 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.756 -0.735 . . . . 0.31 112.362 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.649 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 53.2 t60 -86.85 161.67 18.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.715 0.769 . . . . 0.22 111.717 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.558 HG23 ' O2B' ' A' ' 179' ' ' GDP . 3.0 p -73.08 148.88 8.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.764 -1.107 . . . . 0.36 109.447 173.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' HA ' " O4'" ' A' ' 179' ' ' GDP . 33.4 t70 73.6 -25.35 0.19 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.547 0.689 . . . . 0.69 109.951 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.586 ' NE2' ' HB3' ' A' ' 90' ' ' ASP . 16.5 m170 -86.99 -4.64 59.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.386 -0.824 . . . . 0.63 109.372 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.833 ' O ' ' HG2' ' A' ' 21' ' ' LYS . . . -143.23 -53.29 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 118.466 -1.186 . . . . 0.79 113.014 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.858 ' HG3' ' HB ' ' A' ' 23' ' ' THR . 15.4 pttt 60.44 138.47 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.073 0.94 . . . . 3.31 112.048 -174.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -62.2 -15.41 46.41 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.148 0.975 . . . . 1.21 108.433 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.858 ' HB ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 m -67.42 -21.36 65.57 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.904 -1.044 . . . . 1.25 111.511 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.673 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.8 tt -68.95 -32.06 71.39 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 121.111 -0.993 . . . . 1.49 108.447 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.655 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 2.6 tp -68.22 -29.08 67.83 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 1.69 110.087 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.45 -38.48 26.35 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.267 1.032 . . . . 1.23 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HB1' ' CE ' ' A' ' 155' ' ' LYS . . . -67.37 -34.45 77.32 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.536 -1.665 . . . . 0.63 110.038 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 25' ' ' LEU . 4.5 tt -78.2 -18.88 13.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.99 -1.005 . . . . 1.02 110.343 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 40.3 mtm180 -71.8 -63.27 1.16 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.9 0.381 . . . . 3.04 110.231 175.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -80.88 16.8 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.99 0.9 . . . . 2.65 111.656 -170.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 t -84.15 -17.62 39.42 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.608 -1.178 . . . . 1.46 109.267 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.6 174.66 5.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.517 -0.765 . . . . 3.92 109.293 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.592 ' O ' ' HB ' ' A' ' 51' ' ' THR . 94.2 t -54.61 130.01 16.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.401 0.62 . . . . 3.1 112.372 -177.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.9 t -154.62 -178.2 7.02 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.428 -0.952 . . . . 2.78 108.428 169.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -120.65 143.51 48.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.896 0.379 . . . . 6.34 111.33 -175.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.77 6.03 47.55 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.552 -0.907 . . . . 6.79 108.552 170.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -84.87 -179.89 7.18 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.872 -1.058 . . . . 6.24 110.193 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.11 -17.52 64.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.972 0.415 . . . . 4.95 110.708 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.39 -16.3 75.46 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.999 -0.619 . . . . 4.68 111.95 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.75 -51.51 0.53 Allowed Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.34 -0.704 . . . . 4.55 111.34 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.35 121.29 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.246 0.546 . . . . 5.57 110.034 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 m -99.88 155.36 17.71 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.072 -0.714 . . . . 5.93 109.072 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -74.13 56.21 0.61 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.137 0.494 . . . . 6.63 112.219 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -172.76 128.94 0.51 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.388 -0.967 . . . . 6.54 108.388 171.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.7 mm -88.64 155.77 3.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.737 -0.468 . . . . 5.17 109.737 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.83 -19.94 12.02 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.935 -0.65 . . . . 2.51 111.832 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -175.43 -173.0 0.61 Allowed 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.575 0.35 . . . . 1.36 110.142 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.553 ' CZ ' HG12 ' A' ' 50' ' ' VAL . 5.3 p90 -175.53 -178.62 1.14 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.831 0.348 . . . . 1.7 110.194 -171.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.531 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 36.0 mt-30 -91.9 112.98 25.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.882 -0.599 . . . . 1.91 109.899 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.553 HG12 ' CZ ' ' A' ' 48' ' ' TYR . 24.1 m -87.39 139.91 16.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.212 0.529 . . . . 1.53 111.209 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' A' ' 33' ' ' VAL . 25.9 m -84.94 82.42 8.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.319 0.581 . . . . 1.51 109.612 172.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.0 p -81.39 -19.86 11.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 122.202 1.001 . . . . 2.27 108.38 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -159.48 -52.76 0.06 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.466 -1.697 . . . . 3.68 107.574 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -167.03 80.9 0.22 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.518 -1.219 . . . . 2.99 110.646 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' H ' ' HA ' ' A' ' 51' ' ' THR . 33.8 mmtp 58.82 25.85 14.05 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.966 0.728 . . . . 7.36 112.966 172.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -102.64 154.29 19.29 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.713 -0.477 . . . . 4.46 109.713 176.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 9' ' ' PRO . 21.8 mt 73.7 82.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 124.04 0.837 . . . . 0.92 109.783 -170.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.531 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 39.2 m -98.45 97.62 8.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.976 -0.556 . . . . 0.96 109.774 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.617 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 77.2 m-85 -61.43 133.74 56.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.778 -0.646 . . . . 1.57 109.678 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 63.0 tp 64.58 101.21 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.474 0.654 . . . . 3.21 110.82 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.598 ' HB2' HG11 ' A' ' 10' ' ' VAL . 14.6 t0 -75.41 -83.85 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.676 -0.693 . . . . 5.61 111.067 -176.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 m -136.75 117.4 10.99 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.541 -0.3 . . . . 5.45 110.731 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.05 151.02 30.24 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.434 2.09 . . . . 6.11 112.195 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.99 -102.44 0.76 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.824 -0.703 . . . . 6.36 112.349 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -60.7 -59.8 4.81 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.051 0.453 . . . . 8.78 110.943 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 42.0 mt-10 -127.32 98.97 5.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.058 -0.719 . . . . 7.05 109.058 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.527 ' HB3' ' CE1' ' A' ' 102' ' ' HIS . . . -76.36 55.38 0.98 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.531 0.682 . . . . 4.55 112.228 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -161.01 -165.16 1.3 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.047 -0.979 . . . . 2.37 109.541 173.153 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.471 HG21 ' HA ' ' A' ' 80' ' ' ASP . 8.3 t -59.54 132.57 54.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 4.9 111.748 -176.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.5 p -82.89 82.74 8.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.708 0.766 . . . . 5.84 110.697 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.7 mtm -56.21 -29.44 60.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.059 -0.973 . . . . 5.21 111.365 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.4 mtt-85 -55.43 -63.56 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 8.21 111.803 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.87 3.88 39.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 6.36 111.534 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.722 ' HA ' ' HE ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -109.36 7.71 25.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.991 0.424 . . . . 9.65 110.279 -178.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.29 -109.65 1.73 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.274 -0.731 . . . . 4.93 111.274 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.49 -93.64 0.1 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.344 -0.243 . . . . 5.47 110.344 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -111.05 68.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.267 0.556 . . . . 6.26 109.961 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.438 ' HB ' ' HD3' ' A' ' 7' ' ' ARG . 28.3 m -134.87 16.48 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.481 -0.781 . . . . 4.31 110.529 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -162.7 10.85 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.047 0.451 . . . . 3.41 111.401 -176.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HA ' HG21 ' A' ' 69' ' ' THR . 5.5 p-10 -80.4 88.04 5.61 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.495 0.664 . . . . 2.66 110.634 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.513 ' HB ' HG22 ' A' ' 11' ' ' VAL . 70.6 mt -145.05 132.56 16.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.535 -0.757 . . . . 0.71 110.419 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.518 HG22 ' HB ' ' A' ' 12' ' ' THR . 23.1 t -122.79 127.19 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.172 0.511 . . . . 1.17 110.998 173.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 24.3 mt -86.57 132.08 33.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.331 -0.849 . . . . 0.37 110.087 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.548 HD12 HD21 ' A' ' 131' ' ' LEU . 2.0 tm? -121.48 110.56 16.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.254 -1.017 . . . . 1.01 108.254 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 113' ' ' ALA . 33.5 t -96.42 114.52 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 116.159 -0.473 . . . . 0.43 110.801 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.682 HG23 HG13 ' A' ' 114' ' ' ILE . 3.4 m -119.66 142.16 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.64 111.063 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.708 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . . . -80.73 131.02 35.4 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.793 -0.447 . . . . 0.28 109.793 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.694 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -74.97 -12.96 60.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 120.116 -0.633 . . . . 0.22 109.906 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.564 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -91.1 -10.36 42.26 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.17 -0.923 . . . . 0.58 111.519 -177.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.586 ' HB3' ' NE2' ' A' ' 19' ' ' HIS . 7.0 t70 -134.9 -38.22 0.8 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.755 0.312 . . . . 0.56 111.348 -173.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.458 ' HA2' ' CG1' ' A' ' 127' ' ' VAL . . . 91.03 -133.16 11.65 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 114.157 0.423 . . . . 0.37 114.157 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.532 HG11 ' HE2' ' A' ' 134' ' ' TYR . 12.8 t -100.34 131.46 47.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.911 0.862 . . . . 1.03 110.551 -178.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.523 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 69.8 mmm -131.03 173.62 5.66 Favored Pre-proline 0 C--N 1.308 -1.224 0 CA-C-N 114.017 -1.447 . . . . 0.28 108.086 -176.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 73.1 Cg_exo -49.71 -57.07 2.55 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.325 2.017 . . . . 0.58 113.282 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.593 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -72.34 -13.97 61.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.917 0.389 . . . . 0.75 111.415 -175.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -69.76 -52.86 21.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.609 0.719 . . . . 0.31 109.647 177.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 100' ' ' ILE . 2.0 p -83.13 -23.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 113.761 1.023 . . . . 1.38 113.761 -173.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 95' ' ' GLN . 12.0 pt-20 -63.96 -25.17 68.02 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.111 -0.993 . . . . 2.35 109.428 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.628 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -74.57 -39.86 62.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.439 -0.8 . . . . 0.44 110.228 171.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.538 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 93.8 mt -62.98 -49.06 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.582 0.706 . . . . 0.41 109.754 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -55.43 -33.33 63.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.496 -1.229 . . . . 0.67 110.817 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 67' ' ' ALA . 3.0 t-160 -67.48 -43.68 80.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.696 -0.684 . . . . 2.5 110.375 176.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.425 ' CB ' HD11 ' A' ' 110' ' ' ILE . . . -73.97 -44.58 54.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 0.47 111.578 -177.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.67 ' HD3' HD21 ' A' ' 136' ' ' LEU . 13.5 mmmm -66.18 -32.78 74.43 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.123 0.487 . . . . 1.66 110.064 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.56 -41.75 70.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.926 -1.033 . . . . 0.77 110.83 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.404 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . . . -79.03 -32.39 44.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 0.74 111.305 178.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.5 t30 84.39 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.412 1.07 . . . . 1.41 109.064 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.21 140.79 21.62 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 113.906 -1.497 . . . . 1.35 110.251 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.15 142.81 93.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.643 2.229 . . . . 0.47 111.96 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.498 ' C ' HG23 ' A' ' 145' ' ' THR . 23.0 mm -105.51 156.93 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.764 0.793 . . . . 0.6 110.735 -172.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.875 HD13 ' HB ' ' A' ' 146' ' ' ILE . 14.2 mm -124.89 86.06 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 107.102 -1.444 . . . . 0.37 107.102 171.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.901 HG23 HG21 ' A' ' 145' ' ' THR . 59.9 t -75.16 145.83 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 121.779 0.799 . . . . 0.26 109.953 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB1' ' CD2' ' A' ' 150' ' ' LEU . . . -144.07 102.27 3.85 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.067 -1.424 . . . . 0.29 109.932 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.792 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 3.4 mp -72.18 140.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.148 -1.387 . . . . 0.59 109.636 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.708 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 4.4 p-10 -117.57 176.64 5.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 107.693 -1.225 . . . . 1.85 107.693 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.63 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 83.9 mttt 69.58 34.28 2.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 123.892 0.745 . . . . 0.59 111.633 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.437 ' CE ' ' HB1' ' A' ' 122' ' ' ALA . 17.5 mmt -77.78 -13.56 59.85 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.486 -0.931 . . . . 0.92 108.486 169.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.547 ' OD1' ' HA ' ' A' ' 116' ' ' LYS . 7.4 p-10 -70.66 -25.94 63.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.861 -1.518 . . . . 0.76 109.519 173.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HD3' ' HD3' ' A' ' 116' ' ' LYS . 43.5 mtpt -89.07 137.85 29.35 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.36 -0.836 . . . . 1.17 110.247 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.41 -13.94 42.39 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.839 2.36 . . . . 0.58 111.659 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 89' ' ' ASP . 33.0 mt-10 -81.75 6.66 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.161 -0.927 . . . . 1.45 110.539 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.437 ' HB1' ' CE ' ' A' ' 117' ' ' MET . . . -58.0 107.68 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.565 -0.743 . . . . 0.27 110.975 175.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.84 76.66 29.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.48 -0.934 . . . . 0.95 108.48 175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.478 ' HA ' HG22 ' A' ' 127' ' ' VAL . 47.4 Cg_endo -66.6 -54.77 0.41 Allowed 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.74 2.293 . . . . 0.4 113.125 -172.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.433 ' HA ' ' SD ' ' A' ' 128' ' ' MET . 3.1 m-20 -52.26 -26.45 11.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 1.44 110.78 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.602 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 53.7 ttt180 -79.7 -57.15 3.81 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.07 -0.652 . . . . 3.79 109.403 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.694 HG11 ' HA ' ' A' ' 88' ' ' ALA . 15.7 m -63.76 -24.52 36.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.406 -0.816 . . . . 0.59 112.128 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.492 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 17.2 ptm -84.74 -17.37 38.56 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.037 0.446 . . . . 0.81 109.929 174.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 132' ' ' MET . 2.8 mt-30 -76.31 -40.74 50.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 1.31 110.511 170.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 1.9 mm-40 -58.6 -35.49 72.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.124 0.964 . . . . 1.64 108.978 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.694 HD23 HG21 ' A' ' 112' ' ' VAL . 2.0 mp -64.52 -42.89 95.5 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.542 -1.208 . . . . 1.36 110.352 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.727 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.7 ppp? -75.58 -8.75 57.57 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.506 -0.478 . . . . 1.61 110.685 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 129' ' ' GLN . 8.0 mm-40 -71.97 -36.68 69.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 107.872 -1.158 . . . . 1.67 107.872 172.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.532 ' HE2' HG11 ' A' ' 92' ' ' VAL . 23.4 m-85 -91.42 28.56 1.66 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.655 -1.157 . . . . 1.08 110.012 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.74 53.14 13.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.742 -1.572 . . . . 1.1 112.342 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.67 HD21 ' HD3' ' A' ' 104' ' ' LYS . 66.2 mt -113.94 99.03 7.36 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.338 -0.847 . . . . 1.36 108.84 168.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.947 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 35.5 t -100.76 115.42 65.36 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-O 121.565 0.698 . . . . 0.43 111.788 -168.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.692 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . 87.4 Cg_exo -43.97 138.69 6.24 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 124.168 3.245 . . . . 0.54 112.072 171.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.979 ' HG2' HD13 ' A' ' 146' ' ' ILE . 0.4 OUTLIER -73.65 -14.93 61.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.199 -0.91 . . . . 3.08 109.963 178.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 2.1 pm0 -66.07 -26.14 67.35 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.488 -0.778 . . . . 1.57 110.135 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.727 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 34.5 m0 -101.63 -14.91 17.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.97 0.414 . . . . 0.66 110.465 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.07 24.55 7.56 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.804 -0.712 . . . . 0.53 113.584 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.947 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.07 -120.27 2.07 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.9 -1.143 . . . . 0.6 112.094 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -157.63 63.38 0.47 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.824 1.297 . . . . 1.91 112.268 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.901 HG21 HG23 ' A' ' 112' ' ' VAL . 56.6 m -160.19 126.13 4.13 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.195 -1.366 . . . . 0.37 109.992 173.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.979 HD13 ' HG2' ' A' ' 139' ' ' GLU . 30.7 mm -74.47 104.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.539 -0.911 . . . . 0.63 108.539 172.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.692 ' CD1' ' HA ' ' A' ' 138' ' ' PRO . 11.8 m-85 -90.75 105.08 17.57 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.119 -0.946 . . . . 0.5 111.381 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.85 139.75 30.87 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.306 -0.861 . . . . 0.68 109.786 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.555 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 6.7 mptt -114.93 102.67 10.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.18 -0.674 . . . . 1.44 109.18 176.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.792 ' HG ' ' O ' ' A' ' 114' ' ' ILE . 3.6 pp -125.61 -174.02 2.97 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.389 1.09 . . . . 0.84 111.805 -172.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 150' ' ' LEU . 1.5 p -152.16 92.31 1.7 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.1 -1.409 . . . . 1.77 108.465 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -16.06 63.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.13 0.49 . . . . 0.41 109.867 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.555 ' HB2' ' N1 ' ' A' ' 179' ' ' GDP . 0.0 OUTLIER -66.2 -55.99 13.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.32 -0.855 . . . . 2.3 110.847 172.203 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -84.79 -9.03 58.57 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.95 -0.7 . . . . 0.7 112.387 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HD3' HD12 ' A' ' 158' ' ' LEU . 19.2 mmtp 71.53 42.79 0.64 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.669 0.606 . . . . 1.36 110.966 175.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 -70.72 0.76 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 122.344 1.068 . . . . 2.48 110.318 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.759 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.38 -4.82 46.41 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.269 -1.332 . . . . 0.29 113.967 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.584 HD12 ' HD3' ' A' ' 155' ' ' LYS . 22.5 mt -70.26 -36.74 74.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.155 -0.683 . . . . 0.8 109.155 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.98 -38.89 79.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.144 -0.935 . . . . 2.2 109.035 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.2 t60 -71.48 -14.74 62.23 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.534 -0.757 . . . . 0.58 111.437 177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.89 -55.75 5.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.335 -0.617 . . . . 1.16 109.335 -177.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.92 -26.71 68.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.508 -0.769 . . . . 1.51 111.383 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 15.7 pt-20 -76.41 -30.73 57.56 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.403 -0.519 . . . . 2.57 110.79 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 29.6 mmt -73.23 -39.13 65.74 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.315 0.578 . . . . 0.64 109.507 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 83' ' ' ILE . 83.3 mt -61.83 -42.41 94.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 0.52 109.531 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -37.64 86.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.567 -0.742 . . . . 1.73 111.185 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 35.3 tp -53.37 -45.08 69.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.533 0.682 . . . . 1.51 109.353 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.8 t -66.39 -46.35 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.939 -1.028 . . . . 0.89 110.646 175.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.4 m -58.81 -36.88 75.2 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.894 0.378 . . . . 1.35 111.301 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -72.35 -42.97 64.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.472 . . . . 2.73 110.143 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 40.0 ttp -73.67 -11.45 60.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 1.88 111.032 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.13 -28.38 64.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 4.27 111.228 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.441 ' C ' HD12 ' A' ' 174' ' ' LEU . 50.5 mm-40 -109.2 -4.92 16.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.544 -0.298 . . . . 3.91 111.212 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.441 HD12 ' C ' ' A' ' 173' ' ' GLU . 7.7 mp -128.57 41.41 3.49 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.429 . . . . 5.72 110.935 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -96.25 136.09 37.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.463 -0.335 . . . . 5.49 110.428 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -112.07 139.83 47.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.097 -0.502 . . . . 5.78 110.341 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 59.55 77.5 0.38 Allowed Pre-proline 0 N--CA 1.466 0.36 0 O-C-N 123.618 0.574 . . . . 7.88 110.808 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo . . . . . 0 C--O 1.254 1.303 0 C-N-CA 122.757 2.305 . . . . 9.19 111.746 179.063 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GDP . . . . . 0.744 ' PB ' ' HA ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_